data_5a4g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5a4g _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 122.45 1.119 . . . . 10.77 109.755 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.559 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -128.85 139.46 52.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.347 -1.297 . . . . 8.86 108.217 178.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.593 HG12 ' HG2' ' A' ' 58' ' ' GLU . 23.5 mm -49.52 117.96 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.944 0.878 . . . . 5.76 112.636 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.13 -33.97 9.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.297 -1.774 . . . . 8.55 109.923 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 1.6 p90 -179.67 -177.49 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.607 -0.724 . . . . 8.07 109.884 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -116.83 147.38 42.17 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.388 -0.824 . . . . 5.61 110.281 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -142.55 149.87 39.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.185 -0.916 . . . . 9.75 110.353 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.539 ' HB3' HG21 ' A' ' 35' ' ' VAL . 10.0 t70 -92.08 136.25 26.19 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.138 -1.06 . . . . 8.31 108.138 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -62.33 -13.22 31.29 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.116 1.877 . . . . 10.41 112.201 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.52 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -99.55 0.36 42.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.782 -0.19 . . . . 11.24 111.504 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -128.28 38.42 0.43 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 112.802 0.668 . . . . 9.83 112.802 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 27.4 Cg_endo -57.92 131.81 45.94 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.576 2.184 . . . . 11.66 112.508 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.84 -7.45 31.45 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.651 -0.785 . . . . 10.86 111.204 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.568 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -82.68 -179.78 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.534 . . . . 9.42 109.731 176.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.513 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 7.0 tpt180 -151.29 94.26 2.01 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.098 -0.334 . . . . 12.03 110.098 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 90.7 m-85 -76.49 139.68 40.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.262 -0.575 . . . . 7.9 110.708 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.71 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.799 -1.091 . . . . 10.61 111.084 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.5 pttm -168.79 164.22 7.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 11.24 111.006 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.1 Cg_endo -48.19 169.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.992 3.128 . . . . 7.51 114.403 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.64 -162.57 27.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.918 -0.658 . . . . 8.06 112.392 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 4.0 ttmm -92.92 141.74 28.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.669 -0.493 . . . . 12.05 109.669 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.5 p -58.4 136.13 85.41 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 115.218 -0.901 . . . . 9.2 110.962 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.85 -27.16 7.37 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.136 1.891 . . . . 10.25 112.028 171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 91.4 m-85 -81.91 -31.05 31.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.153 0.502 . . . . 10.49 110.851 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.516 ' HE1' ' N ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -124.67 -161.06 0.98 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.481 -0.781 . . . . 10.74 108.911 174.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 6.5 p-10 -128.17 59.05 1.51 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.019 0.914 . . . . 12.54 109.623 170.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 ptm -132.82 145.1 55.69 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.484 -1.235 . . . . 10.35 109.766 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.62 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.669 1.58 . . . . 10.11 110.414 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.33 161.27 14.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.173 0.511 . . . . 7.0 111.415 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.74 133.85 22.11 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.132 -0.692 . . . . 8.28 109.132 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 83.5 Cg_endo -85.28 150.18 10.52 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 121.265 1.31 . . . . 6.21 113.126 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 m -74.3 158.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.564 -1.198 . . . . 6.41 112.397 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.559 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 11.97 -76.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.358 2.263 . . . . 8.58 115.353 -178.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.751 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -57.84 -47.04 83.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.287 0.635 . . . . 7.04 109.596 -175.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.751 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 43.6 mt-10 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 121.629 0.728 . . . . 8.58 112.646 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 80' ' ' ARG . 8.0 mpt_? . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.686 -0.487 . . . . 12.25 109.686 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 p -135.19 177.82 7.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.165 0.507 . . . . 8.3 111.484 -174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.71 131.63 22.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.366 -0.834 . . . . 7.51 109.044 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 35.3 tt0 -79.47 141.24 36.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.952 0.406 . . . . 12.15 110.515 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.466 HG12 ' HB3' ' A' ' 95' ' ' LEU . 70.6 t -69.16 127.31 30.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 9.71 110.548 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -162.92 146.68 11.14 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.07 -0.968 . . . . 11.77 111.642 174.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.1 132.45 45.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.11 -1.405 . . . . 13.03 110.37 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.426 ' H ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.506 -0.471 0 C-N-CA 120.186 -1.007 . . . . 13.49 113.628 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 122.23 1.014 . . . . 14.94 112.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 -135.09 164.49 27.54 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.454 -1.703 . . . . 11.02 107.026 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -88.83 113.21 24.13 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.919 -0.771 . . . . 9.27 108.919 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.426 HD22 ' H ' ' A' ' 87' ' ' GLY . 3.5 mm? -87.47 129.89 34.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.082 -0.508 . . . . 10.57 111.369 -172.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.18 155.85 58.09 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.444 -0.798 . . . . 6.4 109.424 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.403 ' HG2' HG12 ' A' ' 149' ' ' VAL . 77.2 Cg_exo -55.35 139.11 81.33 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.289 1.992 . . . . 7.48 111.559 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.3 m -57.71 -28.44 63.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.64 0.608 . . . . 9.53 112.64 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.85 -2.39 58.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 10.86 111.059 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -71.68 -41.09 69.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.48 0.657 . . . . 5.39 111.015 -175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.557 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -92.51 160.26 15.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.47 -0.786 . . . . 7.08 111.614 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.67 113.27 37.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.708 -0.678 . . . . 10.63 109.192 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 7.7 mmm180 -89.53 126.14 35.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.735 -0.786 . . . . 12.12 110.446 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -149.18 132.71 16.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.862 -0.608 . . . . 14.98 110.551 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.69 -115.57 5.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.26 -0.495 . . . . 16.43 112.568 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.92 36.21 4.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.803 0.335 . . . . 15.35 111.671 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.79 -178.96 6.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.313 -0.403 . . . . 15.67 110.502 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.557 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 27.3 m -132.11 150.95 52.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.725 0.298 . . . . 9.26 111.269 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.7 mm -123.33 149.11 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.099 -0.704 . . . . 10.94 109.099 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.548 ' HB1' HG13 ' A' ' 123' ' ' VAL . . . -129.49 125.85 37.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.282 -0.266 . . . . 7.39 110.282 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 48.6 ttp -85.95 99.56 11.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.687 -1.227 . . . . 8.85 107.687 171.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 121' ' ' ASP . 12.7 p -81.78 136.82 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.254 -0.884 . . . . 10.13 111.195 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -80.65 97.42 7.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.194 -0.669 . . . . 10.7 109.194 173.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.74 139.77 40.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.662 -0.699 . . . . 15.12 109.221 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.43 -16.81 30.02 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.005 -0.543 . . . . 16.92 113.027 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -79.17 4.72 13.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.164 0.507 . . . . 18.56 111.811 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.63 9.98 58.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.708 -0.678 . . . . 16.28 112.969 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.99 175.22 16.54 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.76 -0.733 . . . . 14.36 112.241 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.602 ' HD2' ' CD1' ' A' ' 120' ' ' PHE . 97.2 m-85 -126.03 136.76 53.33 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.059 -0.349 . . . . 12.49 110.059 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.525 ' O ' HG13 ' A' ' 113' ' ' VAL . 23.0 t70 -138.03 141.53 32.69 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 13.91 111.375 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -82.51 138.5 9.7 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.718 1.612 . . . . 13.02 112.482 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.548 HG13 ' HB1' ' A' ' 111' ' ' ALA . 9.8 p -135.39 136.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.622 -0.717 . . . . 10.41 109.82 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.48 125.02 29.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.629 -0.508 . . . . 12.93 109.629 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -133.5 157.78 42.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.455 -0.793 . . . . 8.03 110.76 -172.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 ttmp? -95.19 120.3 35.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.73 -0.668 . . . . 10.66 109.388 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -143.9 104.48 4.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.969 -0.56 . . . . 8.3 111.469 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.46 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.744 -2.17 . . . . 10.1 114.265 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -151.17 163.12 39.55 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.689 -0.486 . . . . 11.03 109.689 157.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.0 m -133.59 134.24 43.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.381 -0.6 . . . . 13.17 109.381 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.35 107.18 3.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.105 0.409 . . . . 13.78 112.105 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.29 44.51 59.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.199 -0.524 . . . . 15.28 113.105 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.0 17.35 80.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.67 -0.776 . . . . 13.44 112.236 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -137.55 166.0 24.95 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.422 -0.584 . . . . 11.28 109.422 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -115.71 162.84 16.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.963 0.411 . . . . 8.43 110.246 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 66.7 mt-10 -106.27 121.16 43.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.659 . . . . 10.79 111.433 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 125' ' ' VAL . 21.1 mm -88.25 101.52 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.014 -0.994 . . . . 6.73 108.565 168.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -68.84 -45.0 72.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.553 -1.203 . . . . 9.17 109.738 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.47 ' O ' HG21 ' A' ' 125' ' ' VAL . 40.9 mt-10 -150.45 165.52 32.92 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.776 -0.647 . . . . 10.44 109.353 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 128.63 -61.49 0.65 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.981 -1.104 . . . . 8.87 113.299 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.7 mt -116.0 179.62 3.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.305 0.574 . . . . 8.5 112.347 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -129.64 152.44 49.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.875 -1.057 . . . . 14.48 110.481 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 132.35 45.98 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.058 -0.973 . . . . 12.12 110.168 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.51 -11.25 30.6 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.092 -0.803 . . . . 12.39 111.092 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.44 HE21 HG22 ' A' ' 113' ' ' VAL . 9.5 mt-30 -104.27 163.76 12.2 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 107.75 -1.204 . . . . 11.89 107.75 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 14.2 mt-30 -120.93 167.84 12.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 119.04 0.836 . . . . 11.1 111.561 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.14 156.68 41.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.217 -0.901 . . . . 5.45 108.853 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 7.6 p -76.62 128.52 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.63 0.252 . . . . 7.05 110.587 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 98' ' ' PRO . 2.4 m . . . . . 0 C--N 1.326 -0.425 0 C-N-CA 120.975 -0.29 . . . . 6.99 111.602 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.895 0.379 . . . . 12.43 111.652 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.637 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 17.7 t80 -103.88 166.57 10.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.543 -0.54 . . . . 12.83 109.543 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -60.82 2.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.824 -0.35 . . . . 13.49 111.138 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.2 tt -125.08 113.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.549 0.69 . . . . 12.27 110.301 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.68 -0.15 49.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 11.22 112.017 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.654 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 13.2 m -58.54 -43.22 89.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.88 -0.6 . . . . 12.0 111.023 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -52.03 -54.99 23.42 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.76 -0.459 . . . . 11.17 109.76 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.3 92.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.845 -1.07 . . . . 8.27 111.395 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.1 m -58.94 -35.54 73.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.865 -0.607 . . . . 9.64 111.868 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 157' ' ' SER . 80.4 mt -61.99 -22.13 65.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.242 -0.89 . . . . 10.88 111.516 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -83.43 117.79 23.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.637 -0.505 . . . . 9.36 109.637 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 105.58 -18.28 41.38 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 119.927 -1.13 . . . . 7.46 112.734 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.7 p -102.17 -76.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 7.09 110.646 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.46 -24.16 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.29 0.567 . . . . 9.62 110.211 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.899 -0.591 . . . . 9.11 110.598 178.106 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 3.1 mppt? . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 108.3 -1.0 . . . . 10.77 108.3 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.589 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.29 130.67 35.47 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.133 -0.94 . . . . 8.86 111.042 -174.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.2 mm -55.2 133.29 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 122.268 1.032 . . . . 5.76 113.107 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.74 -25.97 6.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.37 -1.741 . . . . 8.55 109.712 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.646 ' HD1' ' CD2' ' A' ' 29' ' ' TYR . 14.1 p90 179.99 179.03 0.56 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.897 -0.592 . . . . 8.07 111.098 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.732 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -118.38 154.88 31.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.919 -1.037 . . . . 5.61 109.965 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.566 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.4 ptp180 -156.4 145.36 20.32 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.153 0.502 . . . . 9.75 110.29 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 35' ' ' VAL . 2.0 t0 -67.85 133.13 92.23 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.48 -0.933 . . . . 8.31 108.48 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.564 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 84.4 Cg_endo -67.66 -12.6 36.08 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.293 1.995 . . . . 10.41 112.363 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.449 ' HE1' ' OD1' ' A' ' 32' ' ' ASP . 1.1 ptp -103.65 0.99 31.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.41 -0.359 . . . . 11.24 111.546 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 32' ' ' ASP . 3.6 m -120.43 45.01 0.74 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 121.258 0.552 . . . . 9.83 112.003 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.85 124.5 16.04 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.134 2.556 . . . . 11.66 112.711 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.82 8.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.807 -0.711 . . . . 10.86 111.656 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.573 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 20.8 tp60 -78.95 105.55 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.15 0.5 . . . . 9.42 109.968 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.54 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 41.7 ttp180 -90.93 106.95 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 12.03 110.161 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 66.7 m-85 -84.58 142.46 29.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 7.9 109.466 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.28 -26.55 68.83 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.42 -0.809 . . . . 10.61 111.005 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 16.7 ptpt -169.8 165.11 6.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.869 -0.605 . . . . 11.24 110.264 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.723 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -49.37 169.15 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.37 2.713 . . . . 7.51 113.458 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.25 -166.98 29.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.65 -0.786 . . . . 8.06 112.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 46' ' ' SER . 12.9 ttmm -95.34 153.23 17.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.192 0.52 . . . . 12.05 110.604 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 49' ' ' MET . 95.5 p -64.59 105.91 0.84 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.467 -1.242 . . . . 9.2 110.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.59 -10.12 27.67 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.3 2.666 . . . . 10.25 111.869 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.636 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 79.5 m-85 -92.0 -31.4 15.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.564 -1.198 . . . . 10.49 110.789 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.554 ' SD ' ' N ' ' A' ' 49' ' ' MET . 0.8 OUTLIER -134.64 -107.77 0.22 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.097 1.147 . . . . 10.74 114.097 172.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.551 ' H ' ' HG2' ' A' ' 49' ' ' MET . 12.6 p-10 -165.19 65.95 0.13 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.117 0.871 . . . . 12.54 113.275 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.02 148.82 56.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.784 -0.821 . . . . 10.35 108.784 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.44 132.28 30.73 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.198 1.265 . . . . 10.11 110.339 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 46' ' ' SER . 43.5 mt -61.25 163.49 6.34 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.338 0.399 . . . . 7.0 111.305 -175.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.532 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 43.0 mm -101.29 131.82 22.65 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 8.28 110.003 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.732 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 55.9 Cg_endo -86.51 139.38 5.81 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.93 1.753 . . . . 6.21 112.921 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.77 157.96 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.291 -1.322 . . . . 6.41 112.904 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 16.77 -89.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.753 2.021 . . . . 8.58 115.212 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.695 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -47.87 -40.98 23.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.73 0.412 . . . . 7.04 110.184 -177.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.475 ' CG ' ' HG2' ' A' ' 55' ' ' PRO . 26.8 tt0 . . . . . 0 C--N 1.315 -0.901 0 O-C-N 123.954 0.784 . . . . 8.58 111.677 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.045 -0.724 . . . . 12.25 109.045 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 148' ' ' VAL . 34.4 p -131.74 147.1 52.47 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.834 -0.621 . . . . 8.3 110.274 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.08 126.58 55.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.81 -0.811 . . . . 7.51 108.81 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 30.0 tt0 -83.92 133.87 34.69 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.459 -0.571 . . . . 12.15 109.459 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 145' ' ' GLN . 42.4 t -55.49 127.92 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.769 0.655 . . . . 9.71 112.769 -176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 39.1 mmtt -140.88 142.5 34.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.828 -1.078 . . . . 11.77 108.777 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.8 150.78 34.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.013 -0.675 . . . . 13.03 109.484 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.498 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.413 -0.898 . . . . 13.49 112.99 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 CA-C-O 121.475 0.655 . . . . 14.94 111.248 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -121.64 167.26 13.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.695 -1.139 . . . . 11.02 109.019 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.3 mp -90.68 111.96 23.52 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.172 -1.048 . . . . 9.27 108.172 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.69 129.87 35.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.16 0.505 . . . . 10.57 110.634 -174.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.58 156.8 52.72 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.634 -1.167 . . . . 6.4 108.804 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.28 141.25 95.41 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 C-N-CA 122.153 1.902 . . . . 7.48 110.59 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -19.24 38.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.636 0.255 . . . . 9.53 111.367 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -88.76 9.64 23.78 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 116.514 -0.312 . . . . 10.86 111.017 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 149' ' ' VAL . . . -86.63 -39.89 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.174 0.511 . . . . 5.39 111.17 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.579 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -99.92 158.47 15.79 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.758 0.651 . . . . 7.08 112.758 -170.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.91 121.56 53.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.239 -0.891 . . . . 10.63 108.86 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -94.25 122.54 36.89 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.312 -0.555 . . . . 12.12 110.895 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -149.57 131.26 14.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.105 -0.498 . . . . 14.98 111.406 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.3 5.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.161 -0.472 . . . . 16.43 113.017 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.1 25.03 10.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 15.35 111.235 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -150.76 -176.99 5.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 15.67 111.053 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.579 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 47.0 m -136.92 150.13 48.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.291 -0.413 . . . . 9.26 110.296 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -125.43 152.07 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.748 -0.464 . . . . 10.94 109.748 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.638 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -133.3 138.31 46.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.205 -0.295 . . . . 7.39 110.205 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.44 ' HE1' HG12 ' A' ' 148' ' ' VAL . 58.9 mtm -97.45 100.71 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.145 -0.687 . . . . 8.85 109.145 174.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 7.2 p -84.52 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.354 -0.839 . . . . 10.13 111.312 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -67.12 88.52 0.17 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.48 -0.782 . . . . 10.7 109.698 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -67.97 140.43 56.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.46 -0.791 . . . . 15.12 109.782 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.56 -12.0 38.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.061 -0.59 . . . . 16.92 112.808 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.18 10.47 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.493 . . . . 18.56 111.689 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.76 17.11 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.399 -0.818 . . . . 16.28 113.782 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.74 -161.25 9.38 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.505 -0.855 . . . . 14.36 112.305 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.64 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 52.8 m-85 -130.92 112.51 13.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.677 0.275 . . . . 12.49 110.325 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.44 139.05 20.34 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.426 -0.352 . . . . 13.91 110.737 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 55.7 Cg_endo -82.7 138.88 9.68 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.956 1.77 . . . . 13.02 111.989 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.638 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 13.9 p -129.5 126.69 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 10.41 110.139 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 110' ' ' ILE . 32.0 tt0 -79.18 112.84 16.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.487 -0.561 . . . . 12.93 109.487 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.468 HG13 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.64 173.5 6.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 8.03 111.375 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -104.49 126.1 51.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.161 -0.681 . . . . 10.66 109.161 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.43 ' HB1' HD11 ' A' ' 137' ' ' ILE . . . -141.95 105.64 4.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.309 -0.405 . . . . 8.3 111.244 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.04 70.78 0.3 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 117.431 -2.319 . . . . 10.1 114.329 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.88 162.55 40.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.156 -0.683 . . . . 11.03 109.156 155.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.4 m -147.04 127.87 14.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.837 -0.431 . . . . 13.17 109.837 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.99 112.25 5.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.079 -0.51 . . . . 13.78 111.753 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.62 43.82 91.18 Favored Glycine 0 C--O 1.235 0.214 0 CA-C-N 116.107 -0.497 . . . . 15.28 112.992 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.69 13.43 82.13 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.852 -0.689 . . . . 13.44 112.553 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -126.47 157.84 37.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.264 -0.643 . . . . 11.28 109.264 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.5 p -111.92 166.66 11.02 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.882 -0.327 . . . . 8.43 110.328 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 50.4 mt-10 -116.73 113.32 22.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.486 0.66 . . . . 10.79 111.11 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.0 mm -83.1 111.84 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.121 -0.945 . . . . 6.73 108.87 171.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -77.12 -49.08 16.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.974 -1.012 . . . . 9.17 109.718 -175.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.569 ' HG2' ' N ' ' A' ' 140' ' ' GLY . 31.4 tt0 -148.68 166.42 28.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.961 -0.563 . . . . 10.44 110.284 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.569 ' N ' ' HG2' ' A' ' 139' ' ' GLU . . . 113.84 -23.58 12.97 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.047 -0.597 . . . . 8.87 112.085 172.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.481 HD23 HG12 ' A' ' 123' ' ' VAL . 38.6 mt -127.49 -170.36 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.862 0.363 . . . . 8.5 111.76 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -154.56 156.16 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 14.48 109.663 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 128.01 34.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.713 -0.676 . . . . 12.12 110.196 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.68 -9.53 37.81 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.287 -0.725 . . . . 12.39 111.287 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.565 ' O ' HG21 ' A' ' 84' ' ' VAL . 29.4 mm-40 -91.33 111.18 22.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.199 -0.667 . . . . 11.89 109.199 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 57.6 mt-30 -85.0 128.59 34.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.416 -0.811 . . . . 11.1 110.97 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -119.19 135.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.709 -0.478 . . . . 5.45 109.709 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.44 HG12 ' HE1' ' A' ' 112' ' ' MET . 2.4 p -68.09 121.11 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.253 0.549 . . . . 7.05 110.581 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 5.1 m . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.211 -0.904 . . . . 6.99 110.398 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.238 0.542 . . . . 12.43 110.441 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.431 ' O ' HD11 ' A' ' 155' ' ' ILE . 47.3 m-85 -72.67 165.42 24.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.823 -0.626 . . . . 12.83 110.611 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 tp -87.8 50.87 2.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.4 0.619 . . . . 13.49 110.058 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.547 ' H ' HD11 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -83.11 39.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.461 0.648 . . . . 12.27 111.072 -177.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.0 -99.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.37 -0.832 . . . . 11.22 111.327 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.4 m -79.22 -41.48 28.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.732 0.777 . . . . 12.0 110.174 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 50.0 mm-40 -54.0 -30.17 46.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.084 -1.417 . . . . 11.17 110.701 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HB1' ' C ' ' A' ' 155' ' ' ILE . . . -68.02 -31.74 71.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.492 -1.231 . . . . 8.27 112.233 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.5 t -81.5 -19.46 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.457 0.646 . . . . 9.64 109.808 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.79 -30.4 20.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.802 -1.09 . . . . 10.88 111.898 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 21.7 mmm180 -70.6 140.94 51.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.196 0.522 . . . . 9.36 110.565 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.38 30.59 13.44 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.978 -1.01 . . . . 7.46 111.291 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.7 p 49.99 54.87 10.32 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.347 0.659 . . . . 7.09 110.882 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 67.7 t 72.87 -56.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.171 -0.922 . . . . 9.62 111.415 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.698 0.761 . . . . 9.11 110.743 -178.06 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.438 -1.067 0 CA-C-O 122.556 1.17 . . . . 10.77 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.484 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 91.1 mtt180 -119.09 148.7 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.605 -1.634 . . . . 8.86 108.883 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.718 HG12 ' OE2' ' A' ' 58' ' ' GLU . 42.9 mm -52.0 124.4 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 113.923 -1.49 . . . . 5.76 114.251 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.71 -32.89 6.5 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.322 -1.763 . . . . 8.55 109.792 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 26.3 p90 -177.64 -175.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.919 -0.582 . . . . 8.07 110.839 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.754 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.21 145.81 46.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.65 -0.705 . . . . 5.61 111.243 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.452 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -150.99 145.8 25.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.03 -0.729 . . . . 9.75 109.03 179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.751 ' HB3' ' CE ' ' A' ' 34' ' ' MET . 1.2 m-20 -78.27 147.24 72.26 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 112.307 0.484 . . . . 8.31 112.307 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HG3' HG13 ' A' ' 54' ' ' ILE . 51.9 Cg_exo -53.68 -56.78 2.35 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.593 2.195 . . . . 10.41 112.797 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.751 ' CE ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -86.87 2.64 48.45 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.398 0.888 . . . . 11.24 113.398 -170.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.661 HG21 ' CB ' ' A' ' 32' ' ' ASP . 21.6 m -120.46 51.83 2.31 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 121.657 0.741 . . . . 9.83 111.325 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.25 121.73 9.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.146 2.564 . . . . 11.66 112.622 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.62 -27.29 4.43 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.052 -0.819 . . . . 10.86 111.052 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.452 ' NE2' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -75.86 138.93 41.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.4 -0.4 . . . . 9.42 109.943 175.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.612 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 34.0 ttp180 -133.54 112.29 11.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.543 -0.299 . . . . 12.03 111.413 -174.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.611 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 73.6 m-85 -97.39 149.3 22.28 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.828 -0.804 . . . . 7.9 108.828 174.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.08 8.11 16.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.044 -0.662 . . . . 10.61 111.806 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.8 pttp -164.2 167.8 10.14 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 116.332 -0.395 . . . . 11.24 111.881 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HD3' ' CZ3' ' A' ' 30' ' ' TRP . 18.6 Cg_endo -56.0 171.04 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.807 3.004 . . . . 7.51 112.984 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.37 -166.35 28.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.539 -0.839 . . . . 8.06 112.975 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 14.1 ttmm -96.96 148.44 22.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.058 0.456 . . . . 12.05 109.869 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -66.13 141.14 97.27 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.344 -0.844 . . . . 9.2 111.576 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.12 -20.29 10.09 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.844 2.362 . . . . 10.25 111.033 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 48' ' ' TYR . 64.9 m-85 -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.509 -1.223 . . . . 10.49 109.863 -173.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.424 ' HE1' ' C ' ' A' ' 48' ' ' TYR . 2.5 ptp -168.97 168.9 9.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.236 -0.893 . . . . 10.74 109.182 173.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 p-10 -81.22 72.74 8.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.734 0.778 . . . . 12.54 112.418 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 ptm -139.43 139.48 22.75 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.196 -0.911 . . . . 10.35 108.871 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.1 135.94 45.87 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.554 2.17 . . . . 10.11 111.604 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.586 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 18.1 mt -63.17 162.15 12.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.812 -0.631 . . . . 7.0 111.04 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.472 HG13 ' HG3' ' A' ' 33' ' ' PRO . 23.8 mm -102.92 134.41 19.83 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 121.322 0.582 . . . . 8.28 109.984 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.754 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 74.1 Cg_endo -81.98 139.1 10.65 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.308 1.339 . . . . 6.21 112.544 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -55.49 157.88 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 113.872 -1.513 . . . . 6.41 113.045 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.484 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.31 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.716 2.006 . . . . 8.58 115.037 -175.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.718 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -46.94 -42.6 18.05 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.167 0.587 . . . . 7.04 111.401 -176.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 13.9 tt0 . . . . . 0 C--O 1.241 0.639 0 CA-C-O 122.453 1.121 . . . . 8.58 111.011 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 152' ' ' GLN . 90.7 mtt180 . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.82 -0.807 . . . . 12.25 108.82 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 148' ' ' VAL . 11.5 p -114.38 170.49 8.26 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.279 0.562 . . . . 8.3 111.61 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.457 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -142.89 127.0 17.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.125 -0.943 . . . . 7.51 108.561 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 41.8 tt0 -79.38 138.46 37.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 12.15 109.965 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 95' ' ' LEU . 39.2 t -57.21 132.9 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.274 -0.876 . . . . 9.71 112.654 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -137.06 143.87 42.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.772 -1.104 . . . . 11.77 109.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.07 151.27 35.55 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.114 -0.634 . . . . 13.03 109.633 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.446 -0.883 . . . . 13.49 112.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 CA--C 1.513 -0.449 0 CA-C-O 121.284 0.564 . . . . 14.94 111.767 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.599 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 29.6 mmt180 -124.48 162.6 23.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.89 -1.05 . . . . 11.02 109.081 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.568 ' HB3' HG11 ' A' ' 84' ' ' VAL . 1.8 mm? -87.31 113.33 22.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.588 -0.523 . . . . 9.27 109.588 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -89.98 129.94 36.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.117 -0.492 . . . . 10.57 110.656 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.23 159.81 57.11 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.136 -0.938 . . . . 6.4 108.955 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.434 ' HG2' HG12 ' A' ' 149' ' ' VAL . 72.8 Cg_exo -54.46 130.79 41.86 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.86 1.707 . . . . 7.48 111.233 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 t -56.75 -26.02 56.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.254 0.465 . . . . 9.53 112.254 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.26 4.56 50.29 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.07 -0.394 . . . . 10.86 111.659 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.31 -39.16 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 5.39 110.721 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -80.28 158.9 26.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 7.08 112.276 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -106.03 127.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.073 -0.967 . . . . 10.63 109.183 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -99.78 123.6 44.2 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.876 -0.73 . . . . 12.12 110.943 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -148.91 144.67 27.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.558 -0.746 . . . . 14.98 109.573 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.61 -121.63 15.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.204 -0.522 . . . . 16.43 112.322 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.39 37.25 4.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.15 0.5 . . . . 15.35 110.729 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -149.45 177.78 9.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.655 -0.702 . . . . 15.67 111.203 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 12.0 m -123.65 145.87 48.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.31 -0.405 . . . . 9.26 109.986 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.7 mm -123.31 152.18 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.041 -0.725 . . . . 10.94 109.041 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.667 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -127.65 131.34 49.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.678 0.275 . . . . 7.39 110.495 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 76.9 mtp -88.03 100.36 12.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.433 -0.58 . . . . 8.85 109.433 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -85.69 136.82 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.868 -0.605 . . . . 10.13 110.993 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB2' ' HG3' ' A' ' 146' ' ' GLN . . . -89.97 94.19 9.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.618 -0.719 . . . . 10.7 110.158 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.0 141.99 56.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.795 -0.639 . . . . 15.12 110.714 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.29 -6.59 48.34 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.149 -0.78 . . . . 16.92 111.149 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.83 -3.05 46.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.394 0.616 . . . . 18.56 110.4 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.418 ' O ' ' HB1' ' A' ' 166' ' ' ALA . . . 104.37 -21.1 38.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.244 -0.889 . . . . 16.28 113.128 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.13 177.8 26.52 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.818 -0.706 . . . . 14.36 112.598 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.22 122.44 28.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.553 -0.536 . . . . 12.49 109.553 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.505 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.2 m-20 -124.76 147.93 57.76 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.535 -0.466 . . . . 13.91 111.571 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.53 135.18 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.746 2.297 . . . . 13.02 112.55 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.667 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 12.8 p -121.4 129.97 75.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.541 -0.754 . . . . 10.41 109.916 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -74.58 116.86 15.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.988 0.423 . . . . 12.93 110.028 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.442 HG13 ' HA3' ' A' ' 140' ' ' GLY . 28.4 m -128.55 167.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.868 -0.605 . . . . 8.03 110.884 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HG2' ' CD2' ' A' ' 138' ' ' LEU . 37.6 ttmt -106.2 129.72 54.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.464 -0.569 . . . . 10.66 109.464 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.407 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -142.84 104.09 4.29 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.621 0.601 . . . . 8.3 112.621 -173.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.59 70.9 0.29 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 117.752 -2.166 . . . . 10.1 114.498 167.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 162.69 39.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.876 -0.787 . . . . 11.03 108.876 154.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -138.02 124.34 20.55 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.606 -0.438 . . . . 13.17 109.844 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.05 111.21 6.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.063 -0.517 . . . . 13.78 111.575 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.93 44.17 94.94 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.932 -0.576 . . . . 15.28 112.818 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.15 8.55 85.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 13.44 112.378 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -120.71 166.73 13.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.662 -0.496 . . . . 11.28 109.662 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -120.62 155.51 33.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.749 0.309 . . . . 8.43 110.774 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 48.1 mt-10 -97.09 110.98 23.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.495 0.664 . . . . 10.79 111.014 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.5 mm -79.71 101.15 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.167 -1.049 . . . . 6.73 108.167 169.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.599 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -65.56 -49.35 69.19 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.049 -0.978 . . . . 9.17 110.183 -174.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.95 162.49 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.358 -0.837 . . . . 10.44 110.908 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 116.33 -59.78 0.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.605 -0.807 . . . . 8.87 113.304 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 123' ' ' VAL . 25.0 mt -103.35 -174.58 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.588 0.588 . . . . 8.5 112.588 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -149.37 157.56 43.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.451 -0.795 . . . . 14.48 109.605 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 126.01 28.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.626 -0.715 . . . . 12.12 110.075 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.03 -10.46 20.64 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.493 -1.043 . . . . 12.39 110.493 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.514 ' O ' HG21 ' A' ' 84' ' ' VAL . 13.6 mm100 -100.74 120.02 39.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.444 -0.947 . . . . 11.89 108.444 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 11.1 pt20 -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.825 0.821 . . . . 11.1 110.364 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.58 145.96 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.336 -1.302 . . . . 5.45 109.603 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 81' ' ' THR . 6.8 p -69.5 124.57 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.329 0.585 . . . . 7.05 110.234 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.457 HG12 ' CB ' ' A' ' 82' ' ' ALA . 3.8 m . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.619 -0.719 . . . . 6.99 110.398 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . 28.0 tt0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.277 0.561 . . . . 12.43 111.208 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 10.7 m-85 -89.31 156.14 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.122 -0.695 . . . . 12.83 109.122 170.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.544 HD11 ' H ' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.12 84.85 1.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.512 0.672 . . . . 13.49 111.403 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 155' ' ' ILE . 9.4 tp -169.55 48.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.089 0.947 . . . . 12.27 110.15 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -66.24 -28.04 68.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.712 0.768 . . . . 11.22 111.249 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.0 m -56.2 -34.46 66.29 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 12.0 113.039 -171.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -70.64 -25.73 63.15 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.837 -0.619 . . . . 11.17 110.673 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -82.38 -19.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.376 -0.829 . . . . 8.27 110.031 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 m -81.73 -45.01 16.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.485 -0.78 . . . . 9.64 110.022 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.33 -33.78 75.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.543 -0.753 . . . . 10.88 111.055 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 13.7 ptt180 -88.48 165.91 14.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.964 -0.754 . . . . 9.36 108.964 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.12 61.82 3.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 7.46 112.449 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.35 -93.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.926 0.89 . . . . 7.09 112.469 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 46.9 t -132.33 82.56 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.131 -1.063 . . . . 9.62 108.131 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 118' ' ' GLY . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.539 -0.755 . . . . 9.11 111.561 -173.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 mptt . . . . . 0 N--CA 1.441 -0.923 0 N-CA-C 107.726 -1.213 . . . . 10.77 107.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.565 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 6.3 mtt-85 -144.09 141.46 30.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.706 -1.134 . . . . 8.86 109.659 -172.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -53.73 133.7 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 122.568 1.175 . . . . 5.76 113.242 -163.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.9 -35.33 6.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.743 -2.026 . . . . 8.55 109.642 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 3.7 p90 -179.54 -174.71 0.31 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.299 -0.864 . . . . 8.07 108.992 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.801 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m-90 -122.14 147.85 45.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 5.61 111.071 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 4.0 ptm180 -152.86 156.4 38.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.238 -0.892 . . . . 9.75 110.194 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 35' ' ' VAL . 9.8 t70 -94.1 140.49 22.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.316 -0.624 . . . . 8.31 109.316 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.79 -15.58 38.76 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.889 2.393 . . . . 10.41 112.561 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.504 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -96.44 -3.46 43.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 111.592 0.219 . . . . 11.24 111.592 175.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.2 m -127.79 37.22 0.37 Allowed Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.031 0.752 . . . . 9.83 113.031 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -61.24 91.79 0.1 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.738 2.292 . . . . 11.66 112.745 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.86 -31.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.113 -0.565 . . . . 10.86 111.838 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -68.19 -178.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.057 0.762 . . . . 9.42 113.057 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.614 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 11.3 tpp180 -147.34 91.77 2.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.238 -0.892 . . . . 12.03 108.797 172.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 49.9 m-85 -73.97 141.3 45.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.57 -0.852 . . . . 7.9 111.065 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.66 -25.57 68.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 10.61 110.841 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.504 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 20.8 pttp -171.79 164.78 4.36 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.808 -0.633 . . . . 11.24 111.008 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.801 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -49.79 169.79 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.756 2.971 . . . . 7.51 113.62 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.93 -156.45 26.68 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.414 -0.898 . . . . 8.06 112.814 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 8.4 ttmt -98.75 148.27 24.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.729 -0.471 . . . . 12.05 109.729 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' MET . 8.7 t -77.29 139.16 64.15 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-O 121.168 0.508 . . . . 9.2 111.318 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.73 -22.27 20.69 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.971 2.448 . . . . 10.25 112.871 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 48' ' ' TYR . 96.9 m-85 -85.51 -24.32 27.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.162 0.982 . . . . 10.49 109.496 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' A' ' 46' ' ' SER . 2.2 ptp -157.9 134.08 9.44 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.868 -1.515 . . . . 10.74 111.081 -165.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -77.85 63.52 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.751 0.786 . . . . 12.54 111.565 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.462 ' HE3' ' OD2' ' A' ' 32' ' ' ASP . 16.6 ptm -139.05 143.96 39.04 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.74 -1.118 . . . . 10.35 108.215 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.59 133.93 39.0 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.043 1.829 . . . . 10.11 110.743 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.3 154.41 20.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 7.0 110.82 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -93.83 133.52 27.67 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 8.28 109.872 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HB2' HD12 ' A' ' 27' ' ' ILE . 81.6 Cg_endo -85.23 147.87 10.24 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 121.928 1.752 . . . . 6.21 113.425 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG23 HG13 ' A' ' 27' ' ' ILE . 32.2 m -75.69 157.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.639 -1.164 . . . . 6.41 111.994 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.561 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.64 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.19 2.196 . . . . 8.58 115.507 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.755 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -40.25 -48.46 2.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.94 0.896 . . . . 7.04 110.42 174.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.755 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 32.4 mt-10 . . . . . 0 C--N 1.317 -0.809 0 C-N-CA 124.203 1.001 . . . . 8.58 113.054 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.658 0.742 . . . . 12.25 111.612 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.416 HG23 ' HA ' ' A' ' 148' ' ' VAL . 32.8 p -133.54 173.37 11.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.442 -1.254 . . . . 8.3 110.715 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.59 128.05 22.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.356 -0.838 . . . . 7.51 109.179 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 29.9 tt0 -84.24 135.68 34.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.109 -0.496 . . . . 12.15 110.063 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 95' ' ' LEU . 55.9 t -60.73 131.69 25.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.704 -0.68 . . . . 9.71 112.474 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 54.2 mmtt -138.53 146.16 41.58 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.714 -1.13 . . . . 11.77 109.519 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.719 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 6.6 mp -78.29 163.38 25.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.552 -0.459 . . . . 13.03 110.189 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.251 0 C-N-CA 119.774 -1.203 . . . . 13.49 113.744 -176.441 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.719 ' OE2' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.432 -1.334 0 CA-C-O 122.045 0.926 . . . . 14.94 112.835 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.618 ' CG ' ' HA ' ' A' ' 138' ' ' LEU . 1.1 mpp_? -147.45 175.4 10.84 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.873 -1.512 . . . . 11.02 111.135 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.558 ' HB3' HG11 ' A' ' 84' ' ' VAL . 2.3 mm? -100.74 112.97 25.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.166 -0.925 . . . . 9.27 109.101 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.67 130.46 34.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 10.57 110.704 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG21 ' HG ' ' A' ' 135' ' ' SER . 28.6 m -143.0 157.88 60.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.01 -0.996 . . . . 6.4 108.694 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 15.1 Cg_endo -61.84 132.81 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.252 1.301 . . . . 7.48 109.95 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 29.1 t -56.07 -21.93 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.489 0.551 . . . . 9.53 112.489 -174.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.93 4.78 48.99 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.938 -0.477 . . . . 10.86 111.504 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 98' ' ' PRO . . . -80.51 -41.06 24.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.134 0.492 . . . . 5.39 110.576 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -84.3 158.45 21.19 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.538 -0.756 . . . . 7.08 111.573 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 20.2 mm -107.3 128.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.405 -0.816 . . . . 10.63 110.083 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 19.5 mmm180 -95.79 123.72 39.49 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.899 -0.72 . . . . 12.12 110.422 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -149.25 142.84 25.44 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.804 -0.635 . . . . 14.98 110.445 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.8 -116.53 4.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.194 -0.527 . . . . 16.43 112.302 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 36.84 4.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 15.35 110.877 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -151.63 -179.17 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.064 -0.516 . . . . 15.67 111.804 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.6 m -130.9 147.71 52.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.651 -0.704 . . . . 9.26 109.508 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.5 mm -122.36 145.92 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.782 0.325 . . . . 10.94 110.204 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 141' ' ' LEU . . . -119.48 130.68 55.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.969 -0.56 . . . . 7.39 110.118 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 49.2 mmm -90.88 98.35 11.72 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.819 -0.437 . . . . 8.85 109.819 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 121' ' ' ASP . 11.2 p -83.92 139.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.173 0.511 . . . . 10.13 111.967 -170.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -87.24 100.06 12.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.561 -0.745 . . . . 10.7 109.822 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 117' ' ' GLU . 97.4 mttt -86.93 149.45 24.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.197 -0.456 . . . . 15.12 111.278 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.45 10.39 17.12 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.217 -0.753 . . . . 16.92 111.217 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 115' ' ' LYS . 36.7 mt-10 -97.77 15.96 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 18.56 110.55 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.97 19.02 73.66 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.118 -0.947 . . . . 16.28 113.416 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.9 171.66 30.62 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.966 -1.111 . . . . 14.36 112.915 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 120' ' ' PHE . 96.0 m-85 -120.27 112.67 19.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.612 -0.514 . . . . 12.49 109.612 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 113' ' ' VAL . 4.6 m-20 -103.55 147.08 33.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.363 -0.38 . . . . 13.91 110.463 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.75 122.82 2.36 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.984 1.789 . . . . 13.02 112.384 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.34 122.88 59.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.816 -1.083 . . . . 10.41 109.564 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -70.56 111.46 6.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.31 -0.626 . . . . 12.93 109.31 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.68 160.46 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.446 0.641 . . . . 8.03 111.867 -173.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -91.83 130.36 37.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.76 -1.2 . . . . 10.66 107.76 172.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.8 102.42 4.28 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.221 -0.592 . . . . 8.3 112.022 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -156.19 71.43 0.26 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 118.595 -1.764 . . . . 10.1 114.028 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.545 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -151.11 163.79 38.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 11.03 109.24 156.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.2 m -139.08 133.11 31.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.179 0.445 . . . . 13.17 110.496 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.85 103.22 4.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 13.78 111.41 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 42.39 69.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.198 -0.525 . . . . 15.28 112.946 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.41 88.94 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.019 -0.61 . . . . 13.44 112.344 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.75 152.65 35.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.255 -0.646 . . . . 11.28 109.255 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.8 p -99.77 161.62 13.5 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.011 -0.276 . . . . 8.43 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 45.3 mt-10 -111.94 117.64 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.641 0.734 . . . . 10.79 111.122 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 35.4 mm -82.94 100.97 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.923 -1.035 . . . . 6.73 108.735 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . 8.7 mt -63.34 -41.67 98.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.138 -0.937 . . . . 9.17 110.319 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.47 155.89 41.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 10.44 110.642 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.462 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 125.0 -54.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.236 -0.983 . . . . 8.87 113.742 172.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 111' ' ' ALA . 24.7 mt -98.37 -174.82 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 8.5 112.049 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.76 152.12 36.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.561 -0.745 . . . . 14.48 109.966 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.416 ' HA ' HG13 ' A' ' 84' ' ' VAL . . . -69.84 137.4 51.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.104 . . . . 12.12 111.084 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.18 -6.9 59.95 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.629 -0.796 . . . . 12.39 111.518 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -103.44 155.9 18.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.503 -0.925 . . . . 11.89 108.503 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 56.2 mt-30 -111.38 166.38 11.16 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.734 -0.786 . . . . 11.1 111.874 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.7 OUTLIER -135.91 141.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.923 -1.035 . . . . 5.45 108.617 168.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.416 ' HA ' HG23 ' A' ' 81' ' ' THR . 5.8 p -73.58 121.29 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 7.05 109.679 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 112.941 0.719 . . . . 6.99 112.941 -168.843 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 109.586 -0.524 . . . . 12.43 109.586 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 153' ' ' PHE . 21.0 t80 73.86 170.08 0.3 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.473 -1.24 . . . . 12.83 110.419 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.47 -71.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.493 -0.483 . . . . 13.49 111.422 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 155' ' ' ILE . 2.2 pp -116.76 149.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 12.27 111.086 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.33 -17.74 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 11.22 111.938 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -62.59 -52.52 63.08 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.02 -0.272 . . . . 12.0 111.213 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.54 -32.88 54.24 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.536 -0.466 . . . . 11.17 109.822 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.38 -52.44 37.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.606 0.241 . . . . 8.27 111.547 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.0 p -62.18 -29.87 70.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 9.64 112.035 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.8 -38.6 16.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.109 -0.496 . . . . 10.88 112.203 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 3.1 mpt_? -89.5 -27.1 20.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.929 0.395 . . . . 9.36 111.257 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.552 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . -89.98 -8.72 66.68 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.843 -0.694 . . . . 7.46 111.546 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.552 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 11.6 p 55.58 -78.83 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.434 1.094 . . . . 7.09 112.907 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.64 72.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 9.62 110.345 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.016 -0.538 . . . . 9.11 110.272 176.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.113 0 CA-C-O 121.4 0.619 . . . . 10.77 110.58 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.593 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 39.9 mtt180 -126.45 141.32 51.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.547 -0.751 . . . . 8.86 110.367 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.572 HG12 ' OE2' ' A' ' 58' ' ' GLU . 44.5 mm -55.66 120.08 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 5.76 112.687 -170.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.56 -38.02 5.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.287 -1.324 . . . . 8.55 110.182 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 21.4 p90 -168.82 -174.66 2.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 8.07 111.303 -175.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.582 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 m-90 -124.89 155.02 40.18 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.102 -0.954 . . . . 5.61 111.078 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -160.44 153.58 21.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 9.75 110.133 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.579 ' HB2' HG21 ' A' ' 35' ' ' VAL . 19.1 m-20 -79.17 137.07 56.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.637 -0.875 . . . . 8.31 108.637 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.8 -11.8 19.26 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.65 2.233 . . . . 10.41 111.43 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.579 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.1 null -101.78 0.97 36.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.112 -0.494 . . . . 11.24 111.321 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.612 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 6.9 m -127.81 43.65 1.11 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.244 0.545 . . . . 9.83 111.476 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 35' ' ' VAL . 16.6 Cg_exo -61.74 111.49 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.81 2.34 . . . . 11.66 112.009 -170.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.38 -26.18 4.17 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.793 -0.923 . . . . 10.86 110.793 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.44 ' HB3' HG22 ' A' ' 35' ' ' VAL . 38.1 tp60 -76.52 115.58 16.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 9.42 110.531 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 36.3 ttp180 -98.47 99.44 10.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.664 -0.698 . . . . 12.03 110.944 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.603 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 82.9 m-85 -79.77 133.02 36.3 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.343 -0.614 . . . . 7.9 109.343 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.88 -26.86 68.8 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.638 0.587 . . . . 10.61 110.766 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -160.06 147.66 12.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.437 0.636 . . . . 11.24 111.977 -172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.582 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 19.6 Cg_endo -56.33 135.68 71.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.947 3.765 . . . . 7.51 113.573 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.71 -145.93 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.076 -0.583 . . . . 8.06 111.919 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 2.0 ttmm -105.83 141.93 36.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.669 -0.863 . . . . 12.05 108.669 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.576 ' HB3' ' O ' ' A' ' 49' ' ' MET . 47.0 t -64.05 141.6 98.09 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.855 -0.612 . . . . 9.2 111.411 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.93 -21.49 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.664 2.243 . . . . 10.25 111.012 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 35.0 m-85 -84.64 -41.99 15.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.187 -1.37 . . . . 10.49 109.245 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -137.04 157.41 46.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.369 -0.832 . . . . 10.74 110.873 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.0 p-10 -84.11 53.38 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.07 0.938 . . . . 12.54 111.135 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.47 32.85 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 114.967 -1.015 . . . . 10.35 109.345 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.43 133.14 23.67 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 N-CA-C 108.86 -1.246 . . . . 10.11 108.86 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD21 ' OD1' ' A' ' 32' ' ' ASP . 31.6 mt -61.59 157.17 17.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.076 0.465 . . . . 7.0 111.331 -172.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.16 133.26 22.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 116.065 -0.516 . . . . 8.28 109.702 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.519 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 92.8 Cg_endo -78.65 138.18 14.99 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.912 1.741 . . . . 6.21 112.613 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 57' ' ' TYR . 34.5 m -61.07 159.64 2.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.301 -1.318 . . . . 6.41 112.869 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 1.629 ' HE1' ' CE2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 15.47 -87.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.564 1.946 . . . . 8.58 115.11 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' OE1' ' HA ' ' A' ' 26' ' ' ARG . 2.5 pt-20 -53.49 -34.49 58.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.244 -1.344 . . . . 7.04 111.675 -170.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 31.6 tt0 . . . . . 0 C--N 1.319 -0.718 0 O-C-N 124.44 1.088 . . . . 8.58 110.047 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 . . . . . 0 CA--C 1.51 -0.584 0 CA-C-O 121.484 0.659 . . . . 12.25 110.247 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 148' ' ' VAL . 36.2 p -131.48 147.24 52.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.447 -1.251 . . . . 8.3 110.592 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.44 54.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.819 -0.808 . . . . 7.51 108.819 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 29.9 tt0 -73.02 138.08 45.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.083 -0.508 . . . . 12.15 109.724 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 95' ' ' LEU . 54.4 t -58.96 135.21 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.522 -0.763 . . . . 9.71 111.739 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 66.5 mmtt -126.89 154.36 44.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.327 -0.851 . . . . 11.77 111.56 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.8 mp -89.2 125.7 35.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.42 -0.956 . . . . 13.03 108.42 162.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.066 0 C-N-CA 118.979 -1.581 . . . . 13.49 113.371 -173.22 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 1.6 tt0 . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.817 0.817 . . . . 14.94 111.949 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -132.17 163.8 27.73 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.892 -1.503 . . . . 11.02 107.567 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -91.6 114.53 27.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.719 -0.474 . . . . 9.27 109.719 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.14 130.61 37.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.951 -0.568 . . . . 10.57 110.974 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.54 158.24 50.72 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.405 -0.816 . . . . 6.4 109.628 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HG2' HG12 ' A' ' 149' ' ' VAL . 34.5 Cg_exo -57.72 134.38 62.53 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.204 1.936 . . . . 7.48 111.049 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 t -58.05 -28.23 64.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.916 0.339 . . . . 9.53 111.916 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.05 1.24 51.1 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.234 -0.291 . . . . 10.86 111.552 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.75 -41.08 46.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.097 0.475 . . . . 5.39 111.378 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.92 163.43 14.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.847 -0.615 . . . . 7.08 112.073 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.4 mm -113.27 103.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.809 -0.632 . . . . 10.63 109.508 173.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.2 ptt180 -102.41 132.2 48.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 117.949 -1.501 . . . . 12.12 111.113 173.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -150.31 132.58 15.47 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.736 -1.575 . . . . 14.98 109.454 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.65 -108.79 2.14 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.519 -0.848 . . . . 16.43 112.317 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.5 29.09 7.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.381 0.511 . . . . 15.35 112.381 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.415 HH11 HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -164.76 178.86 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.119 0.415 . . . . 15.67 112.119 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 7.2 m -133.15 152.29 51.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.668 -0.696 . . . . 9.26 110.137 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 34.4 mm -128.95 151.76 36.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.777 -0.453 . . . . 10.94 109.777 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -136.84 130.12 31.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.649 -0.13 . . . . 7.39 110.649 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.4 mtm -89.31 101.47 14.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 8.85 109.388 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 10.0 p -87.19 139.17 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.601 -0.727 . . . . 10.13 111.364 -174.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -74.61 85.89 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 10.7 109.642 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -71.32 145.82 49.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 15.12 110.129 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.19 -7.78 33.36 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.031 -0.531 . . . . 16.92 113.168 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.33 10.98 17.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 18.56 110.966 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 14.4 69.3 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.487 -0.779 . . . . 16.28 113.282 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.0 167.47 21.09 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.683 -0.77 . . . . 14.36 111.501 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 98.7 m-85 -113.0 108.24 17.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.905 0.383 . . . . 12.49 110.047 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 141.11 21.93 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.054 -0.521 . . . . 13.91 110.637 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -86.19 124.7 2.5 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.485 2.123 . . . . 13.02 111.943 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 111' ' ' ALA . 8.7 p -107.47 131.8 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.397 -0.82 . . . . 10.41 109.304 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -78.0 109.86 12.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.969 -0.752 . . . . 12.93 108.969 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 139' ' ' GLU . 0.2 OUTLIER -116.62 155.78 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.193 -0.912 . . . . 8.03 111.465 -171.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 ttmp? -93.54 120.05 33.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.092 -0.958 . . . . 10.66 108.87 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.56 106.89 4.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.093 -0.503 . . . . 8.3 111.004 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.52 70.53 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.893 -2.099 . . . . 10.1 114.215 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' A' ' 136' ' ' GLU . . . -150.43 162.85 39.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.16 -0.681 . . . . 11.03 109.16 155.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -141.64 123.61 15.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.178 0.513 . . . . 13.17 109.759 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.92 126.45 11.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.673 -0.694 . . . . 13.78 111.156 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.78 32.08 83.03 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 116.09 -0.505 . . . . 15.28 112.528 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.41 15.62 80.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.933 -0.651 . . . . 13.44 111.878 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -123.37 174.98 7.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.036 -0.727 . . . . 11.28 109.036 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.7 m -126.58 157.53 38.6 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.001 0.429 . . . . 8.43 110.646 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.536 ' CG ' ' HB2' ' A' ' 129' ' ' ALA . 75.4 mt-10 -101.8 118.14 36.31 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.489 0.661 . . . . 10.79 110.888 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.612 HD11 HG22 ' A' ' 125' ' ' VAL . 17.6 mm -86.09 101.23 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.097 -0.956 . . . . 6.73 108.927 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.56 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 2.6 mp -71.09 -36.77 72.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.573 -1.194 . . . . 9.17 110.264 -176.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.641 ' O ' HG21 ' A' ' 125' ' ' VAL . 12.5 tt0 -158.2 158.38 34.44 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.056 -0.72 . . . . 10.44 109.056 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 126.15 -33.69 3.43 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.903 -1.142 . . . . 8.87 111.772 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.34 -176.9 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.859 0.689 . . . . 8.5 112.859 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -148.38 155.97 41.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.731 -1.122 . . . . 14.48 108.944 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.46 133.44 47.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.293 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.54 -5.41 44.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.817 -0.913 . . . . 12.39 110.817 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.444 ' O ' HG21 ' A' ' 84' ' ' VAL . 38.5 mt-30 -101.06 122.03 42.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.364 0.602 . . . . 11.89 109.391 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 6.4 mt-30 -91.27 124.97 35.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.955 . . . . 11.1 110.718 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.39 139.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.792 -0.448 . . . . 5.45 109.792 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.417 ' HA ' HG23 ' A' ' 81' ' ' THR . 35.3 m -65.36 132.25 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 7.05 110.764 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 98' ' ' PRO . 3.2 m . . . . . 0 C--N 1.319 -0.76 0 CA-C-O 121.891 0.853 . . . . 6.99 109.247 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.398 0.518 . . . . 12.43 112.398 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.627 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 9.2 p90 -106.15 -161.38 0.79 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 12.83 109.761 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 61.7 tp 71.67 -71.25 0.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.202 0.601 . . . . 13.49 110.631 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.66 3.36 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.539 -0.755 . . . . 12.27 110.597 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.68 -21.67 65.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.841 -0.618 . . . . 11.22 110.056 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 p -59.1 -52.99 63.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.182 0.515 . . . . 12.0 110.17 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.94 -36.6 79.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.38 -0.827 . . . . 11.17 110.391 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.14 67.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.051 -0.977 . . . . 8.27 111.3 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -76.38 -19.33 58.26 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.966 -0.383 . . . . 9.64 109.966 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.01 -50.13 71.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.23 -0.655 . . . . 10.88 109.23 173.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -64.63 -34.97 79.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.257 -0.883 . . . . 9.36 110.248 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.44 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 106.82 43.65 1.4 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.439 -0.801 . . . . 7.46 111.666 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 49.2 p 54.95 -92.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.902 0.881 . . . . 7.09 112.156 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.56 74.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.501 0.667 . . . . 9.62 110.87 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 9.11 111.277 -177.739 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 107.614 -1.254 . . . . 10.77 107.614 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.575 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 22.7 ptt85 -128.13 145.44 51.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.649 -1.614 . . . . 8.86 109.093 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.637 HG12 ' CG ' ' A' ' 58' ' ' GLU . 22.5 mm -54.05 125.28 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 114.227 1.195 . . . . 5.76 114.227 -166.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.5 mt -110.26 -37.24 5.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.205 -1.816 . . . . 8.55 110.507 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 20.5 p90 -170.0 -176.03 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.397 . . . . 8.07 111.369 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.593 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -123.86 148.82 46.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.533 -0.758 . . . . 5.61 111.09 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -153.61 151.16 29.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.337 -0.392 . . . . 9.75 110.631 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.611 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 6.1 t0 -75.82 129.16 81.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.011 -1.107 . . . . 8.31 108.011 172.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HG3' HG13 ' A' ' 54' ' ' ILE . 18.7 Cg_exo -60.46 -16.99 45.38 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.098 1.865 . . . . 10.41 113.77 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.448 ' HE1' ' OD1' ' A' ' 32' ' ' ASP . 0.8 OUTLIER -104.51 4.84 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.243 -0.583 . . . . 11.24 111.921 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.611 ' CG2' ' HB3' ' A' ' 32' ' ' ASP . 4.4 m -119.42 41.88 0.44 Allowed Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 112.387 0.514 . . . . 9.83 112.387 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.09 134.63 65.62 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 11.66 112.465 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.08 43.38 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.976 -0.849 . . . . 10.86 110.976 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.554 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -92.86 116.42 29.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.217 0.532 . . . . 9.42 110.371 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 49.4 ttp180 -104.34 116.57 32.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.667 -0.697 . . . . 12.03 111.334 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 97.5 m-85 -101.84 114.23 28.13 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.862 -1.162 . . . . 7.9 107.862 171.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -64.35 -21.58 66.67 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.522 -0.871 . . . . 10.61 111.703 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.523 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 52.9 mttp -126.18 166.68 20.16 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.339 -0.544 . . . . 11.24 111.234 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 14.1 Cg_endo -56.4 171.58 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.399 2.733 . . . . 7.51 112.857 170.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.6 -170.8 29.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.651 -0.785 . . . . 8.06 112.424 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 31.2 ttmt -95.58 146.78 24.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.465 -0.568 . . . . 12.05 109.465 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.4 t -64.51 129.69 94.33 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.684 -0.689 . . . . 9.2 110.411 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.7 -26.35 33.09 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.44 2.093 . . . . 10.25 111.027 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 52.3 m-85 -73.98 -40.67 62.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.969 -1.468 . . . . 10.49 110.404 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.501 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.8 OUTLIER -154.52 160.96 41.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 10.74 110.788 174.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.2 p-10 -78.6 72.35 5.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.888 0.851 . . . . 12.54 112.804 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.2 ptm -140.41 144.74 38.12 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.531 -0.915 . . . . 10.35 108.531 168.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.4 133.3 29.84 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.095 1.863 . . . . 10.11 110.041 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.34 159.53 12.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.894 0.378 . . . . 7.0 110.382 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 33' ' ' PRO . 42.0 mm -103.24 130.84 22.83 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-O 121.25 0.548 . . . . 8.28 109.752 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.622 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 80.6 Cg_endo -75.48 144.14 28.39 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.707 1.605 . . . . 6.21 112.416 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.35 160.46 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.407 -1.27 . . . . 6.41 112.62 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.575 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.59 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.843 2.457 . . . . 8.58 116.389 -175.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.637 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -61.06 -45.21 95.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.766 0.793 . . . . 7.04 109.936 -173.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 47.5 mt-10 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 113.514 -1.675 . . . . 8.58 114.695 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.155 -0.683 . . . . 12.25 109.155 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 148' ' ' VAL . 45.9 p -140.4 144.11 36.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.082 0.468 . . . . 8.3 110.78 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 149' ' ' VAL . . . -114.94 140.64 48.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.872 -0.788 . . . . 7.51 108.872 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.48 130.54 34.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.593 -0.521 . . . . 12.15 109.593 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 145' ' ' GLN . 61.2 t -54.69 128.96 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.432 0.635 . . . . 9.71 111.554 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.02 140.3 7.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.486 -1.233 . . . . 11.77 109.981 171.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.479 HD21 ' H ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -77.58 158.01 30.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.148 -0.933 . . . . 13.03 110.484 -177.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.568 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.682 0 C-N-CA 120.883 -0.675 . . . . 13.49 112.427 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 121.493 0.663 . . . . 14.94 111.415 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 33.6 mmt180 -133.92 164.28 27.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.382 -1.281 . . . . 11.02 108.332 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.6 mp -85.16 112.21 20.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.101 -0.703 . . . . 9.27 109.101 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.0 mm? -87.81 130.23 34.94 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.84 0.352 . . . . 10.57 110.95 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.78 155.58 56.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 6.4 109.045 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.93 136.92 67.96 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.121 1.881 . . . . 7.48 111.117 170.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.432 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 15.9 t -56.46 -24.12 43.49 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.472 0.545 . . . . 9.53 112.472 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.89 9.47 27.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.217 -0.302 . . . . 10.86 111.138 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -80.44 -41.11 25.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.244 0.545 . . . . 5.39 111.339 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.8 155.61 19.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.646 0.736 . . . . 7.08 112.546 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.37 131.43 46.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.731 -1.122 . . . . 10.63 109.1 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -102.28 126.55 49.31 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.534 -0.466 . . . . 12.12 110.823 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 t -149.67 132.93 16.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.275 -0.421 . . . . 14.98 110.466 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.33 -114.22 3.61 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.262 -0.494 . . . . 16.43 113.111 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.57 36.65 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.195 0.521 . . . . 15.35 111.243 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -153.3 167.53 29.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 15.67 111.758 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.2 m -117.44 145.15 44.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.066 -0.515 . . . . 9.26 109.831 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.8 mm -125.49 153.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.306 -0.627 . . . . 10.94 109.306 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -129.42 129.88 45.24 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.353 -0.217 . . . . 7.39 110.467 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 41.2 ttp -90.61 100.86 13.63 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 8.85 108.668 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 121' ' ' ASP . 14.3 p -84.49 133.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.49 -0.777 . . . . 10.13 111.894 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -83.86 84.06 7.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 10.7 110.188 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.19 149.03 46.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 15.12 110.665 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.79 5.39 39.44 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.118 -0.793 . . . . 16.92 111.118 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -87.23 6.39 33.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.471 0.653 . . . . 18.56 110.528 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 1.27 77.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.231 -0.895 . . . . 16.28 113.469 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.78 159.17 22.87 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.735 -0.745 . . . . 14.36 112.426 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.459 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.5 m-85 -109.87 116.82 32.34 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.572 -0.529 . . . . 12.49 109.572 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.8 t70 -113.46 144.2 30.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.002 -0.279 . . . . 13.91 111.267 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -84.44 131.21 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.512 2.141 . . . . 13.02 112.505 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 10.6 p -122.97 136.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.595 . . . . 10.41 110.27 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.11 120.23 25.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.97 0.414 . . . . 12.93 109.996 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.41 HG13 ' HA3' ' A' ' 140' ' ' GLY . 22.8 m -129.11 165.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.031 -0.531 . . . . 8.03 111.567 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.73 127.17 44.57 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.873 -0.603 . . . . 10.66 109.397 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.14 106.19 4.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.198 -0.455 . . . . 8.3 111.393 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.75 71.05 0.28 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 117.655 -2.212 . . . . 10.1 114.094 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -149.51 162.16 40.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 11.03 108.817 155.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -146.96 129.76 16.17 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.645 -0.502 . . . . 13.17 109.645 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.96 110.72 4.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.034 -0.53 . . . . 13.78 111.364 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.61 40.28 90.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.056 -0.592 . . . . 15.28 112.9 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.79 0.73 90.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.72 -0.753 . . . . 13.44 112.543 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -114.49 155.69 25.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.507 -0.553 . . . . 11.28 109.507 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 57.7 m -113.4 164.85 13.07 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 110.072 -0.344 . . . . 8.43 110.072 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 50.9 mt-10 -112.53 113.57 25.79 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.57 0.7 . . . . 10.79 111.283 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 34.9 mm -83.24 104.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.946 -1.024 . . . . 6.73 108.401 170.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -70.34 -49.14 52.39 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.125 -0.943 . . . . 9.17 109.922 -174.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -144.38 162.04 37.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 10.44 111.311 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 119.31 -52.99 0.69 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.871 -0.68 . . . . 8.87 113.395 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 123' ' ' VAL . 16.0 mt -105.36 -171.63 1.95 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 8.5 111.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -144.26 155.37 43.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 14.48 110.066 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 129.51 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.15 -0.932 . . . . 12.12 110.348 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.28 -11.06 28.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.978 -0.849 . . . . 12.39 110.978 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.56 ' O ' HG21 ' A' ' 84' ' ' VAL . 88.5 mm-40 -94.19 118.22 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 11.89 109.465 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 26.1 mt-30 -85.38 132.38 34.24 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 11.1 110.797 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 149' ' ' VAL . 18.4 m -122.8 142.34 39.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.184 -0.462 . . . . 5.45 110.133 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 8.9 p -65.29 124.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.231 0.539 . . . . 7.05 111.375 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 147' ' ' VAL . 10.9 m . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.273 0.558 . . . . 6.99 111.083 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 111.323 0.12 . . . . 12.43 111.323 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 79.0 t80 72.01 -71.25 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.65 0.594 . . . . 12.83 111.062 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 155' ' ' ILE . 11.3 tp -118.02 -154.95 0.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.669 -0.863 . . . . 13.49 108.669 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.532 ' H ' ' HG ' ' A' ' 154' ' ' LEU . 61.0 mt -57.85 100.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.495 0.664 . . . . 12.27 110.191 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.67 -6.44 59.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.472 -0.786 . . . . 11.22 111.09 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.7 m -60.41 -42.89 96.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 12.0 110.807 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.41 -28.35 52.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.509 0.671 . . . . 11.17 109.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.6 -27.36 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 8.27 111.987 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 p -81.48 -38.6 26.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.947 0.403 . . . . 9.64 110.804 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.52 -26.57 61.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.791 -0.64 . . . . 10.88 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -94.63 161.68 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.667 0.746 . . . . 9.36 110.084 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.86 -70.19 0.52 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.628 -1.389 . . . . 7.46 109.628 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.7 p -144.98 -56.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.303 0.573 . . . . 7.09 109.767 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.54 -70.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.604 -0.725 . . . . 9.62 110.053 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.366 0 O-C-N 123.883 0.74 . . . . 9.11 111.856 178.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.945 0 CA-C-O 122.757 1.265 . . . . 10.77 108.015 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.579 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 2.1 mmp_? -141.15 127.66 20.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.692 -1.594 . . . . 8.86 109.203 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -55.04 140.47 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 122.361 1.077 . . . . 5.76 112.7 -172.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -118.53 -39.2 3.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.35 -1.75 . . . . 8.55 109.18 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 13.7 p90 -170.15 -178.21 2.75 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.85 . . . . 8.07 110.011 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.772 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-90 -120.83 146.97 45.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.726 . . . . 5.61 109.665 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 149.97 37.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.784 0.326 . . . . 9.75 110.18 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.659 ' HB3' HG21 ' A' ' 35' ' ' VAL . 29.3 t0 -83.75 132.12 49.91 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 108.783 -0.821 . . . . 8.31 108.783 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.434 ' CD ' HD11 ' A' ' 54' ' ' ILE . 39.3 Cg_exo -56.05 -18.77 24.03 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.674 2.249 . . . . 10.41 112.461 172.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.415 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -90.14 -1.94 58.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.754 0.279 . . . . 11.24 111.754 175.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.659 HG21 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -131.91 39.65 0.52 Allowed Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.911 0.708 . . . . 9.83 112.911 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 19.1 Cg_endo -51.21 110.85 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.976 2.451 . . . . 11.66 112.799 -171.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.2 -31.81 3.38 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.766 -0.652 . . . . 10.86 111.503 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.509 ' HB3' HG22 ' A' ' 35' ' ' VAL . 20.6 tp60 -70.52 107.38 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 9.42 111.04 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 23.5 mtm180 -86.88 97.69 10.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.259 -0.882 . . . . 12.03 110.68 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.631 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 89.4 m-85 -75.11 143.55 43.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.75 -0.659 . . . . 7.9 109.232 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.54 -29.14 70.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.551 -1.204 . . . . 10.61 111.072 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 21.1 pttm -164.17 164.03 14.69 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.476 -0.329 . . . . 11.24 111.737 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.5 Cg_endo -50.75 170.85 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.006 3.137 . . . . 7.51 113.712 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.55 -162.99 26.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.739 -0.744 . . . . 8.06 112.115 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 37.6 ttpt -94.28 149.23 21.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.126 0.489 . . . . 12.05 110.687 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.524 ' HB3' ' O ' ' A' ' 49' ' ' MET . 34.2 t -65.64 132.47 94.96 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 115.122 -0.945 . . . . 9.2 110.986 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.54 -24.72 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.204 1.936 . . . . 10.25 111.706 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.644 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 78.1 m-85 -76.5 -37.13 57.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.99 -1.005 . . . . 10.49 110.098 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.524 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.3 pmm? -156.92 163.6 38.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.865 -0.607 . . . . 10.74 110.224 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 8.7 p-10 -84.0 75.68 10.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 12.54 114.471 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -142.59 145.38 34.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.057 -0.72 . . . . 10.35 109.057 168.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.9 Cg_exo -66.6 133.91 33.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.947 1.764 . . . . 10.11 111.219 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 32' ' ' ASP . 31.6 mt -62.67 159.03 16.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.004 0.431 . . . . 7.0 111.181 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.434 HD11 ' CD ' ' A' ' 33' ' ' PRO . 1.7 mp -95.69 135.4 23.03 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.952 -0.567 . . . . 8.28 109.691 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . 64.5 Cg_endo -87.52 162.1 8.06 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.585 1.524 . . . . 6.21 113.286 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG23 HG13 ' A' ' 27' ' ' ILE . 32.6 m -89.26 156.49 3.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.647 -1.16 . . . . 6.41 111.709 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 1.634 ' HE2' ' CE1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 14.73 -80.88 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 126.971 2.108 . . . . 8.58 115.685 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.58 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.1 pt-20 -53.04 -39.98 63.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.942 -0.392 . . . . 7.04 109.942 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 57' ' ' TYR . 52.3 mt-10 . . . . . 0 C--N 1.314 -0.949 0 CA-C-N 115.192 -0.913 . . . . 8.58 110.976 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.202 -0.666 . . . . 12.25 109.202 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -130.0 154.82 47.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.269 -0.423 . . . . 8.3 109.879 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.4 134.33 54.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 7.51 109.231 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 32.8 tt0 -83.65 136.97 34.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.314 -0.624 . . . . 12.15 109.314 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 95' ' ' LEU . 71.8 t -60.51 129.01 22.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 9.71 111.881 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 26.5 mmtp -129.51 151.0 50.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.64 -1.164 . . . . 11.77 109.622 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.4 HD21 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -84.98 162.37 19.41 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.728 -0.389 . . . . 13.03 109.967 169.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.273 0 C-N-CA 120.705 -0.76 . . . . 13.49 112.837 179.793 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HG2' HD21 ' A' ' 86' ' ' LEU . 3.8 mt-10 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 120.921 0.391 . . . . 14.94 109.981 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 3.1 tpp180 -122.64 159.94 26.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 11.02 110.358 -175.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -100.72 124.12 45.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.485 -0.561 . . . . 9.27 109.485 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.65 130.36 45.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.22 -0.445 . . . . 10.57 110.405 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.31 155.19 57.84 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.352 -0.84 . . . . 6.4 109.734 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.05 127.45 25.03 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.053 1.836 . . . . 7.48 111.124 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.497 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.5 p -54.26 -31.86 54.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.074 0.464 . . . . 9.53 112.227 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.88 -17.38 64.61 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.742 -0.663 . . . . 10.86 112.405 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.8 -7.29 59.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 5.39 111.31 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.427 HD22 HD13 ' A' ' 137' ' ' ILE . 26.5 mt -86.18 118.27 25.53 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.773 0.797 . . . . 7.08 112.093 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.529 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -89.54 111.32 22.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.409 -1.269 . . . . 10.63 108.817 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.59 125.42 34.34 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.345 -0.542 . . . . 12.12 110.45 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -148.81 141.47 24.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.966 -0.561 . . . . 14.98 109.875 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.64 -117.74 6.21 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 121.266 -0.492 . . . . 16.43 112.313 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.0 37.1 4.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.166 0.508 . . . . 15.35 111.342 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -148.28 174.65 11.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.986 -0.552 . . . . 15.67 111.081 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 m -121.36 149.84 42.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.267 -0.642 . . . . 9.26 109.267 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.529 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.8 mm -128.4 148.27 32.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.645 -0.502 . . . . 10.94 109.645 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -121.41 126.42 49.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.496 -0.32 . . . . 7.39 110.205 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.409 ' HB2' HG23 ' A' ' 148' ' ' VAL . 59.4 mtp -82.27 99.68 9.46 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.416 -0.587 . . . . 8.85 109.416 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 121' ' ' ASP . 9.4 p -83.04 130.66 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.291 -0.868 . . . . 10.13 111.288 -174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -87.83 89.27 7.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.546 -0.752 . . . . 10.7 109.454 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.22 157.76 35.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.73 -0.668 . . . . 15.12 111.647 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.86 17.49 21.29 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.418 -0.81 . . . . 16.92 111.501 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -103.6 8.73 37.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.354 0.597 . . . . 18.56 110.337 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.36 9.09 70.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.184 -0.917 . . . . 16.28 113.481 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.81 170.51 23.97 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.2 -1.0 . . . . 14.36 113.038 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.618 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 87.4 m-85 -121.46 123.7 42.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.869 -0.419 . . . . 12.49 109.869 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.521 ' O ' HG13 ' A' ' 113' ' ' VAL . 26.1 m-20 -123.51 151.05 62.66 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.791 -0.364 . . . . 13.91 111.404 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.15 122.69 2.2 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.048 1.832 . . . . 13.02 112.31 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 8.1 p -108.28 132.76 55.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.32 -0.855 . . . . 10.41 109.784 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.96 119.91 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.818 -0.438 . . . . 12.93 109.818 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 123' ' ' VAL . 31.3 m -127.91 159.28 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 8.03 111.584 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.461 ' HG2' HD23 ' A' ' 138' ' ' LEU . 39.8 ttmt -104.46 128.88 52.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.319 -0.855 . . . . 10.66 109.32 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.96 106.73 5.12 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 111.82 0.304 . . . . 8.3 111.82 -174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.18 70.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 117.983 -2.056 . . . . 10.1 114.82 165.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.15 163.44 38.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.446 -1.316 . . . . 11.03 107.446 150.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -140.65 128.83 22.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.7 0.682 . . . . 13.17 110.375 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.86 117.3 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.136 0.421 . . . . 13.78 112.136 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 39.76 98.35 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 115.948 -0.569 . . . . 15.28 113.344 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.84 82.29 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.724 -0.75 . . . . 13.44 112.471 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -122.26 163.02 20.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.56 -0.904 . . . . 11.28 108.56 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.0 p -114.46 149.74 35.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.307 -0.557 . . . . 8.43 112.035 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 1.2 mp0 -93.43 119.17 32.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.46 -0.791 . . . . 10.79 111.513 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 16.2 mm -91.5 111.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.295 -0.866 . . . . 6.73 109.333 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -75.02 -51.59 13.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.63 -1.168 . . . . 9.17 109.487 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -143.05 169.03 18.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.067 -0.97 . . . . 10.44 110.893 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 117.38 -71.73 0.29 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.528 -0.844 . . . . 8.87 113.374 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 42.8 tp -108.56 172.41 6.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.778 0.289 . . . . 8.5 110.666 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.49 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 88.0 tttt -122.56 154.62 37.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.812 0.815 . . . . 14.48 111.656 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.25 135.13 54.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 113.979 -1.464 . . . . 12.12 109.834 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.48 -2.8 56.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.354 -0.927 . . . . 12.39 111.439 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.51 152.65 21.44 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.849 -0.797 . . . . 11.89 108.849 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.6 mt-30 -104.04 149.88 24.78 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.078 0.466 . . . . 11.1 111.203 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.402 ' O ' HG11 ' A' ' 149' ' ' VAL . 18.9 m -135.73 146.66 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.644 -0.707 . . . . 5.45 109.286 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 112' ' ' MET . 27.7 m -72.88 128.13 35.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.352 0.596 . . . . 7.05 110.824 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 147' ' ' VAL . 2.7 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.697 -0.683 . . . . 6.99 110.702 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.186 0.517 . . . . 12.43 112.217 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.667 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 32.8 p90 -117.64 134.63 54.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.199 0.523 . . . . 12.83 111.115 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 158' ' ' GLU . 94.5 mt -87.22 -165.3 1.26 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.558 -0.746 . . . . 13.49 110.773 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.2 pt -78.46 -161.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 12.27 111.436 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -55.63 -23.79 29.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.307 0.484 . . . . 11.22 112.307 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.8 m -54.71 -48.49 72.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.024 0.44 . . . . 12.0 110.669 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.477 ' OE1' ' HA ' ' A' ' 153' ' ' PHE . 20.1 tt0 -61.17 -29.8 70.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.369 -0.832 . . . . 11.17 110.296 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.06 -25.73 31.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.954 -0.566 . . . . 8.27 112.028 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.0 t -75.91 -30.18 58.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.196 -0.668 . . . . 9.64 109.196 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 162' ' ' ARG . 3.5 pp -88.3 -30.19 19.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.719 -0.673 . . . . 10.88 112.407 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.544 ' N ' HD11 ' A' ' 161' ' ' LEU . 25.3 ptt180 -80.73 132.78 35.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 9.36 110.637 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.86 74.02 0.21 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.729 -0.748 . . . . 7.46 111.815 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.7 p 47.15 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.556 0.742 . . . . 7.09 111.787 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.4 t 64.48 82.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.419 -0.585 . . . . 9.62 109.419 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.329 -0.851 . . . . 9.11 110.994 -177.716 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? . . . . . 0 N--CA 1.439 -0.996 0 CA-C-O 122.152 0.977 . . . . 10.77 109.958 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.524 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 45.1 mtm180 -134.65 140.34 45.95 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.927 -1.488 . . . . 8.86 109.217 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.755 HG22 ' CZ3' ' A' ' 30' ' ' TRP . 22.7 mm -54.85 129.73 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 122.455 1.121 . . . . 5.76 113.701 -167.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.925 HD11 ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -89.87 -29.49 18.54 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 112.355 -2.202 . . . . 8.55 111.376 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.611 ' HD1' ' CD2' ' A' ' 29' ' ' TYR . 46.3 p90 158.0 -172.9 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.055 1.342 . . . . 8.07 107.597 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CZ3' HG22 ' A' ' 27' ' ' ILE . 1.3 m-90 -116.95 142.69 46.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.744 0.307 . . . . 5.61 110.835 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -148.28 154.62 40.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 9.75 110.476 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.589 ' HB3' HG23 ' A' ' 35' ' ' VAL . 9.1 t70 -92.41 137.11 24.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.556 -0.905 . . . . 8.31 108.556 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.65 -13.63 35.04 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.313 2.008 . . . . 10.41 112.191 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.3 OUTLIER -99.72 2.31 44.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.59 -0.277 . . . . 11.24 111.206 175.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 32' ' ' ASP . 3.8 m -128.86 40.89 0.65 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.396 0.517 . . . . 9.83 112.396 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 14.5 Cg_endo -52.3 113.38 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.916 2.411 . . . . 11.66 112.809 -172.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.3 -35.87 2.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.46 -0.656 . . . . 10.86 111.46 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.547 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -64.2 103.09 0.58 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.641 0.734 . . . . 9.42 110.856 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 41' ' ' ASP . 2.1 tmm_? -81.96 103.49 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.015 -0.993 . . . . 12.03 109.702 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.628 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -87.91 133.59 33.89 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.297 -1.001 . . . . 7.9 108.297 173.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.774 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 17.8 t70 -63.89 -35.05 79.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.924 -1.035 . . . . 10.61 110.518 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.2 mttp -148.37 162.33 30.73 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.955 -0.566 . . . . 11.24 110.721 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.752 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.5 Cg_endo -50.21 171.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.01 3.14 . . . . 7.51 113.857 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.54 -165.91 27.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 8.06 112.491 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 7.7 ttmt -91.33 144.24 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.237 -0.653 . . . . 12.05 109.237 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 49' ' ' MET . 10.6 t -70.76 145.78 92.57 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.43 . . . . 9.2 110.863 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.52 -20.85 7.83 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.765 2.31 . . . . 10.25 111.547 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 96.4 m-85 -84.6 -39.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.426 -1.261 . . . . 10.49 109.842 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.588 ' HE1' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -136.66 151.92 49.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.663 -0.698 . . . . 10.74 110.522 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.5 p-10 -79.23 53.14 1.43 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.864 0.84 . . . . 12.54 111.418 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.4 ptm -127.02 146.59 58.27 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.418 -0.81 . . . . 10.35 109.682 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' MET . 8.2 Cg_exo -69.58 133.5 26.04 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.143 1.896 . . . . 10.11 110.286 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.69 156.68 13.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.397 0.436 . . . . 7.0 110.592 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.65 131.16 27.51 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 121.205 0.526 . . . . 8.28 110.311 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 96.7 Cg_endo -85.09 156.5 11.27 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.117 1.878 . . . . 6.21 113.158 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' A' ' 28' ' ' LEU . 27.2 m -86.73 160.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.555 -1.202 . . . . 6.41 111.136 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.524 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 5.84 -71.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.392 2.277 . . . . 8.58 116.478 -176.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.666 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.8 pt-20 -65.47 -39.22 91.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.125 0.964 . . . . 7.04 110.726 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 27' ' ' ILE . 9.9 pt-20 . . . . . 0 CA--C 1.509 -0.601 0 CA-C-N 112.473 -2.148 . . . . 8.58 114.02 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.679 ' O ' HG21 ' A' ' 149' ' ' VAL . 18.1 tpt180 . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 121.802 0.811 . . . . 12.25 112.762 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 148' ' ' VAL . 19.8 p -106.8 139.3 41.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.772 -1.104 . . . . 8.3 108.052 170.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -107.69 127.85 54.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.607 -0.516 . . . . 7.51 109.607 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 43.5 tt0 -82.25 140.48 33.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.069 0.461 . . . . 12.15 110.696 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -62.92 130.67 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.325 -0.852 . . . . 9.71 112.026 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 27.5 mmtp -137.23 153.45 50.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.465 -1.243 . . . . 11.77 109.266 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 93' ' ' GLU . 9.7 mp -83.73 152.02 24.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.758 -0.46 . . . . 13.03 109.758 168.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.477 0 N-CA-C 111.47 -0.652 . . . . 13.49 111.47 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HG2' HD21 ' A' ' 86' ' ' LEU . 1.9 mp0 . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 121.414 0.626 . . . . 14.94 110.98 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.563 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 41.1 mmt180 -131.11 156.09 45.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.972 -1.013 . . . . 11.02 110.778 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.0 mp -87.32 114.88 24.33 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.987 -1.006 . . . . 9.27 110.465 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.65 130.69 35.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.693 0.282 . . . . 10.57 110.826 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.96 152.94 56.44 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.431 -0.804 . . . . 6.4 109.856 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HG2' HG12 ' A' ' 149' ' ' VAL . 41.8 Cg_exo -56.3 122.64 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.094 1.863 . . . . 7.48 110.35 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.4 p -62.7 -22.81 66.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 9.53 112.845 -164.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.19 -4.88 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 119.754 -0.165 . . . . 10.86 111.177 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -40.93 68.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 5.39 110.452 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.2 pp -78.73 160.3 27.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.229 -0.896 . . . . 7.08 111.424 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' THR . 26.7 mm -117.11 103.72 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.282 -0.417 . . . . 10.63 110.595 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -113.76 95.18 5.2 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.543 -1.263 . . . . 12.12 111.888 174.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 t -103.79 136.62 43.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.843 -1.526 . . . . 14.98 109.212 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.14 -113.13 4.18 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.343 -0.932 . . . . 16.43 112.018 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.8 28.16 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.268 0.84 . . . . 15.35 113.268 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -170.08 171.0 7.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.374 0.509 . . . . 15.67 112.374 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 1.8 m -121.89 155.3 35.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 9.26 111.767 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 36.5 mm -129.29 150.18 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.362 -0.836 . . . . 10.94 109.467 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.623 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -134.19 127.14 31.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.297 -0.26 . . . . 7.39 110.297 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.44 ' HB2' HG13 ' A' ' 148' ' ' VAL . 4.1 mpp? -93.55 99.82 12.2 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.197 -0.668 . . . . 8.85 109.197 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.7 p -77.33 139.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.06 -0.973 . . . . 10.13 110.403 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -78.58 92.58 4.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.076 -0.511 . . . . 10.7 111.525 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 50.5 mttm -76.25 178.69 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 15.12 110.896 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.93 25.78 7.79 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.765 -0.934 . . . . 16.92 110.765 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.16 12.9 33.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.968 0.358 . . . . 18.56 111.968 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.16 16.76 36.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 16.28 113.159 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 115' ' ' LYS . . . 179.47 173.69 44.85 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.881 -0.888 . . . . 14.36 110.881 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.644 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 54.3 m-85 -87.54 -176.54 5.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.991 0.424 . . . . 12.49 110.626 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.448 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 11.5 t70 -140.89 120.04 8.36 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.742 -0.663 . . . . 13.91 109.368 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.0 110.55 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.166 2.578 . . . . 13.02 112.537 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 13.9 p -104.91 140.45 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.121 -0.945 . . . . 10.41 109.915 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.87 112.03 18.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 12.93 109.726 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.5 HG11 HG11 ' A' ' 123' ' ' VAL . 23.2 m -117.03 163.31 14.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.662 -0.699 . . . . 8.03 111.23 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -100.68 133.85 44.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.582 -0.735 . . . . 10.66 109.219 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.56 103.14 4.48 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.964 -0.295 . . . . 8.3 111.43 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.88 69.89 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.142 -1.98 . . . . 10.1 113.633 169.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.37 163.85 37.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.49 -1.3 . . . . 11.03 107.49 154.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -143.61 130.41 20.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.787 0.722 . . . . 13.17 111.036 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.12 120.87 9.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 13.78 110.616 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.23 36.11 92.98 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.316 -0.469 . . . . 15.28 112.91 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 12.45 83.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.858 -0.687 . . . . 13.44 112.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -120.87 158.97 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.006 -0.368 . . . . 11.28 110.006 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 157.91 16.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.867 0.365 . . . . 8.43 110.045 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 32.0 mt-10 -106.78 115.33 30.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.474 0.654 . . . . 10.79 109.821 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.7 mm -81.67 104.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.974 -1.012 . . . . 6.73 109.154 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.563 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 3.0 mp -69.57 -44.97 69.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.607 -1.179 . . . . 9.17 110.562 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.59 158.13 44.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.779 -0.646 . . . . 10.44 111.327 -175.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.472 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 116.85 -53.31 0.64 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.287 -0.959 . . . . 8.87 114.529 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -107.51 -170.9 1.77 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.434 0.531 . . . . 8.5 112.434 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.96 150.94 37.83 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.683 -0.689 . . . . 14.48 111.001 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.57 133.54 49.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.718 -1.128 . . . . 12.12 109.9 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.46 -2.3 53.65 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.244 -0.979 . . . . 12.39 111.575 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -104.05 143.57 32.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.254 -0.647 . . . . 11.89 109.254 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 22.9 mt-30 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.022 0.439 . . . . 11.1 111.593 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 82' ' ' ALA . 30.0 m -132.18 142.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 5.45 108.704 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.563 ' HA ' HG23 ' A' ' 81' ' ' THR . 6.9 p -76.7 104.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.755 0.788 . . . . 7.05 110.956 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 N-CA-C 108.148 -1.056 . . . . 6.99 108.148 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 120.908 0.385 . . . . 12.43 110.582 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -152.18 91.18 1.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.533 0.568 . . . . 12.83 112.533 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.9 tp -115.78 -62.12 1.64 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.017 -1.105 . . . . 13.49 108.017 164.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.93 6.0 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.399 -1.334 . . . . 12.27 107.399 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.466 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . 2.5 m-20 -83.44 35.65 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.71 -2.041 . . . . 11.22 111.537 -171.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -49.01 -49.08 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.364 0.875 . . . . 12.0 113.364 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -73.72 -26.4 60.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 11.17 110.002 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 156' ' ' ASP . . . -75.95 -20.96 57.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.173 -0.921 . . . . 8.27 111.432 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.2 m -69.22 -29.94 67.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.0 0.905 . . . . 9.64 109.244 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.23 -43.09 12.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.153 -1.385 . . . . 10.88 109.374 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 23.5 ttt180 -51.85 128.35 23.67 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.006 1.323 . . . . 9.36 112.891 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -117.85 31.16 5.81 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.43 -1.068 . . . . 7.46 110.43 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.6 p -70.71 126.27 29.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 123.924 0.426 . . . . 7.09 111.54 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 26' ' ' ARG . 48.2 t 54.21 82.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 9.62 111.332 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.81 -0.632 . . . . 9.11 110.456 179.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 pttp . . . . . 0 N--CA 1.439 -1.014 0 CA-C-O 122.159 0.981 . . . . 10.77 109.725 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.581 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 29.7 mtm180 -132.47 135.35 45.98 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.276 -1.329 . . . . 8.86 109.045 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.576 HG12 ' OE1' ' A' ' 58' ' ' GLU . 34.7 mm -48.22 126.44 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 113.426 0.899 . . . . 5.76 113.426 -171.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.63 -34.73 5.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.824 -1.534 . . . . 8.55 109.821 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' A' ' 29' ' ' TYR . 14.5 p90 -168.92 -175.17 2.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.253 -0.43 . . . . 8.07 111.007 -174.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.43 153.68 43.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.707 -0.679 . . . . 5.61 111.666 -172.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HB2' HE22 ' A' ' 38' ' ' GLN . 39.0 ptt180 -157.48 146.06 19.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.851 -0.613 . . . . 9.75 110.435 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.601 ' HB3' HG21 ' A' ' 35' ' ' VAL . 7.6 t0 -83.03 134.5 46.28 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 8.31 108.777 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.84 -22.53 62.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.233 2.622 . . . . 10.41 111.824 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.559 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -75.81 -22.22 56.56 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.895 -1.048 . . . . 11.24 110.647 178.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.743 HG12 ' CD2' ' A' ' 48' ' ' TYR . 5.3 m -128.3 50.33 5.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 121.529 0.681 . . . . 9.83 111.813 -166.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.78 119.59 6.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.187 2.591 . . . . 11.66 112.057 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.17 -30.53 4.08 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.414 -0.674 . . . . 10.86 111.414 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.569 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -70.55 136.43 49.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 9.42 109.797 174.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.86 98.97 5.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.122 -0.49 . . . . 12.03 110.749 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 16.5 m-85 -80.07 135.65 36.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.589 . . . . 7.9 111.017 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.98 -25.39 67.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.347 -0.842 . . . . 10.61 110.379 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -165.23 147.5 6.64 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-O 121.321 0.582 . . . . 11.24 110.531 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -51.61 128.92 27.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 125.139 3.893 . . . . 7.51 113.962 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.53 -161.71 11.49 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.232 -0.747 . . . . 8.06 111.232 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 25.8 ttpp -90.46 150.53 21.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.167 0.508 . . . . 12.05 109.979 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.8 t -65.82 135.13 95.34 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.211 -0.904 . . . . 9.2 110.138 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.83 -25.71 11.96 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.192 1.928 . . . . 10.25 111.626 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 98.1 m-85 -77.53 -38.08 49.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.872 -1.058 . . . . 10.49 109.995 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -153.09 164.8 37.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.089 -0.505 . . . . 10.74 110.736 172.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 5.4 p-10 -82.69 76.69 9.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.748 1.018 . . . . 12.54 113.748 -170.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.1 ptm -143.14 141.02 18.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.757 -1.11 . . . . 10.35 108.036 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 17.8 Cg_endo -62.11 133.58 44.76 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.24 1.293 . . . . 10.11 109.512 172.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.0 mt -59.49 160.11 7.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.204 -0.453 . . . . 7.0 111.419 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.6 mm -95.67 132.58 27.1 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 8.28 109.657 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 90.6 Cg_endo -79.22 141.82 16.51 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 121.468 1.445 . . . . 6.21 112.797 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.04 158.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.585 -1.189 . . . . 6.41 113.326 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 21.85 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.948 2.099 . . . . 8.58 115.475 -177.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.576 ' OE1' HG12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -51.14 -37.75 48.0 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.776 1.274 . . . . 7.04 110.16 -176.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 CA--C 1.503 -0.852 0 CA-C-N 111.835 -2.438 . . . . 8.58 110.589 171.716 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.316 0.579 . . . . 12.25 109.72 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 148' ' ' VAL . 67.2 p -133.09 144.96 50.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.292 -0.867 . . . . 8.3 109.777 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.27 127.26 55.79 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.837 -0.801 . . . . 7.51 108.837 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.89 135.47 37.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.947 -0.39 . . . . 12.15 109.947 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 95' ' ' LEU . 75.8 t -59.89 128.84 21.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.713 -0.676 . . . . 9.71 112.416 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -135.24 148.41 49.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.501 -1.227 . . . . 11.77 109.005 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.423 HD22 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -78.9 147.73 32.97 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.965 -0.694 . . . . 13.03 109.453 169.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.442 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.361 -0.923 . . . . 13.49 112.811 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HG2' HD22 ' A' ' 86' ' ' LEU . 3.3 tt0 . . . . . 0 CA--C 1.513 -0.463 0 CA-C-O 121.071 0.463 . . . . 14.94 111.422 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.726 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -115.34 173.88 6.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 11.02 110.139 -175.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 1.3 pt? -109.14 114.34 27.97 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.588 -0.893 . . . . 9.27 108.588 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -94.74 131.05 40.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.665 -1.152 . . . . 10.57 111.718 -166.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.85 157.07 75.53 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.845 -1.07 . . . . 6.4 108.638 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.408 ' HG2' HG12 ' A' ' 149' ' ' VAL . 76.0 Cg_exo -52.49 129.31 31.38 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.738 1.626 . . . . 7.48 111.398 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 p -63.62 -22.91 67.15 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.451 0.643 . . . . 9.53 111.16 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -78.14 0.44 24.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.204 -0.907 . . . . 10.86 110.811 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.76 -1.37 30.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.775 -0.648 . . . . 5.39 112.598 -174.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -115.76 156.47 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 7.08 112.247 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.7 mm -101.46 124.36 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 10.63 109.982 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 18.8 mmm180 -96.18 125.48 40.73 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.868 -0.733 . . . . 12.12 110.452 173.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -149.13 137.16 20.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 14.98 110.556 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.4 -114.61 2.69 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 116.114 -0.494 . . . . 16.43 112.797 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.76 33.39 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.993 0.425 . . . . 15.35 111.394 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -179.21 7.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.163 -0.471 . . . . 15.67 111.381 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 10.7 m -131.43 152.51 50.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.922 -0.581 . . . . 9.26 110.392 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 25.3 mm -126.47 146.13 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.295 -0.261 . . . . 10.94 110.295 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.41 54.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.454 . . . . 7.39 109.989 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 45.2 mtm -92.85 99.93 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.722 -0.844 . . . . 8.85 108.722 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 121' ' ' ASP . 8.4 p -81.47 131.85 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.242 0.544 . . . . 10.13 110.696 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.87 91.31 8.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.59 -0.732 . . . . 10.7 110.417 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HD2' ' OD2' ' A' ' 121' ' ' ASP . 55.5 mttp -70.83 151.17 45.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 15.12 109.984 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.05 7.93 19.23 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 16.92 111.486 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 115' ' ' LYS . 35.9 mt-10 -95.05 10.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.504 0.669 . . . . 18.56 110.973 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.64 75.16 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.163 -0.926 . . . . 16.28 113.613 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.24 25.84 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.482 -0.865 . . . . 14.36 112.441 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.655 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 40.5 m-85 -114.34 116.88 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.026 0.441 . . . . 12.49 109.933 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 113' ' ' VAL . 25.9 m-20 -106.17 141.89 23.71 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.882 -0.599 . . . . 13.91 110.323 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.67 127.18 4.23 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.874 1.716 . . . . 13.02 112.742 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.74 124.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 10.41 109.321 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -72.57 127.09 31.49 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.149 -0.686 . . . . 12.93 109.149 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.612 ' CG2' HD11 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -135.68 151.69 30.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.794 0.807 . . . . 8.03 111.569 -173.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.458 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 25.3 ttmm -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.231 -1.349 . . . . 10.66 109.518 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.58 110.3 17.19 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 123.108 1.433 . . . . 8.3 112.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -89.74 174.94 41.61 Favored Glycine 0 N--CA 1.411 -2.984 0 CA-C-N 111.25 -2.704 . . . . 10.1 110.718 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.17 161.32 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 126.07 1.748 . . . . 11.03 114.6 -167.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -100.88 139.24 36.86 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.312 -0.858 . . . . 13.17 108.721 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.84 111.99 4.64 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.851 0.358 . . . . 13.78 111.477 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.11 34.17 75.42 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.806 -0.712 . . . . 15.28 112.792 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.19 2.83 89.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.825 -0.703 . . . . 13.44 112.236 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -115.87 156.39 26.22 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.62 -0.511 . . . . 11.28 109.62 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 p -105.42 150.67 25.07 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.975 0.417 . . . . 8.43 111.326 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 128' ' ' GLY . 30.6 mt-10 -84.79 100.51 11.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.925 -0.579 . . . . 10.79 109.619 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.726 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 20.3 mm -83.81 112.9 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 O-C-N 121.569 -0.707 . . . . 6.73 109.502 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.8 OUTLIER -83.04 -47.45 11.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.177 -0.919 . . . . 9.17 110.288 -173.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.57 ' O ' HG21 ' A' ' 125' ' ' VAL . 9.2 tp10 -147.82 159.82 43.42 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.148 -0.686 . . . . 10.44 109.148 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 130.74 -61.28 0.67 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.046 -1.073 . . . . 8.87 112.318 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt -109.64 -170.83 1.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.262 0.553 . . . . 8.5 112.162 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -145.53 154.35 42.1 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.261 -0.882 . . . . 14.48 109.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.8 130.7 43.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.018 -0.992 . . . . 12.12 109.658 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.81 -1.51 38.86 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.721 -0.752 . . . . 12.39 111.232 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -103.57 139.21 39.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.55 -0.537 . . . . 11.89 109.55 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -91.03 138.72 31.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.891 0.377 . . . . 11.1 110.771 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.82 137.01 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.236 -0.438 . . . . 5.45 109.823 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.462 ' HA ' HG23 ' A' ' 81' ' ' THR . 57.5 t -68.07 112.77 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.973 -0.558 . . . . 7.05 111.003 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 98' ' ' PRO . 2.7 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.476 0.655 . . . . 6.99 109.995 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.405 0.622 . . . . 12.43 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 93.2 m-85 -110.54 104.39 13.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.715 . . . . 12.83 109.506 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.84 63.5 4.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.521 0.677 . . . . 13.49 110.301 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 pt -131.47 40.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.216 -0.902 . . . . 12.27 109.732 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.45 -34.66 69.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.906 -0.588 . . . . 11.22 111.081 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.605 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 15.8 m -59.03 -58.36 9.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.657 -0.497 . . . . 12.0 109.657 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -56.61 -41.95 77.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.895 -1.048 . . . . 11.17 110.456 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' HA ' ' NE ' ' A' ' 162' ' ' ARG . . . -63.64 -33.88 76.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.151 -0.932 . . . . 8.27 111.733 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.3 t -72.94 -37.44 67.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.633 0.73 . . . . 9.64 109.818 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 157' ' ' SER . 79.2 mt -71.29 -38.89 71.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.739 -1.119 . . . . 10.88 111.151 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 159' ' ' ALA . 31.7 ptt180 -80.0 -39.13 30.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.929 -0.578 . . . . 9.36 110.598 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.9 -57.17 5.02 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.196 -1.002 . . . . 7.46 111.943 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.3 p 45.16 67.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.173 0.589 . . . . 7.09 111.605 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 m 47.99 30.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.68 1.192 . . . . 9.62 112.946 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.25 0 CA-C-N 115.782 -0.644 . . . . 9.11 111.659 175.278 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 108.019 -1.104 . . . . 10.77 108.019 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HD3' ' OE1' ' A' ' 58' ' ' GLU . 13.1 mmt180 -133.57 140.52 47.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.922 -1.49 . . . . 8.86 109.74 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.849 HG12 ' OE2' ' A' ' 58' ' ' GLU . 23.6 mm -55.98 129.93 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 113.016 0.747 . . . . 5.76 113.016 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -113.23 -16.0 12.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.769 -1.105 . . . . 8.55 109.795 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.646 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 10.9 p90 167.44 179.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 8.07 110.359 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.754 ' CZ3' HG22 ' A' ' 27' ' ' ILE . 1.7 m-90 -113.24 143.23 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.072 -0.967 . . . . 5.61 111.328 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HB2' HE22 ' A' ' 38' ' ' GLN . 5.6 ptp180 -151.15 151.32 31.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 9.75 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.608 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 8.4 t70 -79.72 132.72 60.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.697 -0.853 . . . . 8.31 108.697 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -63.28 -13.71 37.53 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.095 1.863 . . . . 10.41 112.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.462 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -98.08 0.84 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.762 -0.199 . . . . 11.24 111.466 178.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 32' ' ' ASP . 10.9 m -129.62 48.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 121.351 0.596 . . . . 9.83 112.085 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.64 103.41 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.837 2.358 . . . . 11.66 113.245 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.5 -37.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 10.86 111.95 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.562 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.48 151.73 45.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.363 . . . . 9.42 110.198 177.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.636 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 2.6 tmm_? -136.35 98.83 3.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.6 -0.519 . . . . 12.03 109.6 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.648 ' HE1' ' CE2' ' A' ' 40' ' ' PHE . 42.1 m-85 -76.96 141.48 40.42 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.377 0.608 . . . . 7.9 110.972 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.7 -30.51 71.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.069 -1.423 . . . . 10.61 109.932 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 15.8 pttm -165.01 165.94 11.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.182 -0.917 . . . . 11.24 110.341 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.708 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -47.84 167.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.565 2.843 . . . . 7.51 113.654 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.08 -162.0 29.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.508 -0.853 . . . . 8.06 112.645 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.6 ttmt -103.48 140.63 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.05 -0.352 . . . . 12.05 110.05 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.558 ' HB3' ' O ' ' A' ' 49' ' ' MET . 22.6 t -65.38 142.37 98.4 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 9.2 110.649 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.412 ' CD ' ' HZ ' ' A' ' 40' ' ' PHE . 56.8 Cg_endo -79.16 -20.9 9.63 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.549 2.166 . . . . 10.25 111.33 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 53.0 m-85 -84.5 -39.64 18.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.218 -1.355 . . . . 10.49 109.726 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.558 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER -132.83 147.31 52.3 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.802 -0.635 . . . . 10.74 109.82 174.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.9 p-10 -77.82 58.23 1.84 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.084 0.945 . . . . 12.54 110.772 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG2' ' CB ' ' A' ' 49' ' ' MET . 15.6 ptm -132.7 139.98 36.34 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.831 -1.077 . . . . 10.35 109.649 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 18.1 Cg_endo -60.58 134.17 52.95 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.522 2.148 . . . . 10.11 110.249 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 32' ' ' ASP . 1.4 mm? -56.65 157.3 5.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.803 -0.359 . . . . 7.0 110.367 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.97 129.76 28.97 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-O 121.272 0.558 . . . . 8.28 109.872 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 95.4 Cg_endo -82.12 138.66 10.25 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 121.842 1.695 . . . . 6.21 112.797 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 32.0 m -56.19 157.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.198 -1.365 . . . . 6.41 112.454 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.518 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.14 -72.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.453 2.301 . . . . 8.58 116.434 -177.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.849 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.6 pt-20 -59.47 -32.71 70.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.458 0.647 . . . . 7.04 110.065 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 13.8 pt-20 . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 113.445 -1.707 . . . . 8.58 112.458 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 89.2 mtm180 . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 111.397 0.147 . . . . 12.25 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 80.7 p -156.39 170.63 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.957 0.786 . . . . 8.3 111.18 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.49 141.41 18.19 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.401 -1.333 . . . . 7.51 107.401 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -97.21 136.46 37.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.616 -0.434 . . . . 12.15 110.744 -171.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 145' ' ' GLN . 75.6 t -62.38 134.23 27.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.612 -0.722 . . . . 9.71 111.3 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -163.47 140.01 7.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.594 -1.185 . . . . 11.77 109.818 174.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.72 163.19 28.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.048 -0.978 . . . . 13.03 111.146 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.479 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 13.49 112.448 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 110.287 -0.264 . . . . 14.94 110.287 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.635 ' HG3' ' OE1' ' A' ' 136' ' ' GLU . 22.9 mmt85 -129.77 155.26 46.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.084 -0.339 . . . . 11.02 110.084 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.562 ' HB3' HG11 ' A' ' 84' ' ' VAL . 2.6 mm? -91.44 113.76 26.11 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.73 -0.841 . . . . 9.27 108.73 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.86 130.58 34.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.809 -0.356 . . . . 10.57 111.045 -175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.78 155.03 63.21 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.56 -0.904 . . . . 6.4 108.56 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.89 137.19 78.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.922 1.748 . . . . 7.48 111.046 174.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.497 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 23.6 t -62.43 -25.21 67.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.988 0.366 . . . . 9.53 111.988 -173.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.07 11.76 22.03 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.588 -0.445 . . . . 10.86 111.335 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.8 -33.14 35.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.06 0.457 . . . . 5.39 111.29 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -101.51 165.63 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 7.08 112.194 -170.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 28.7 mm -109.29 117.49 54.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.601 -0.727 . . . . 10.63 109.829 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -91.07 125.32 35.82 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.834 -0.747 . . . . 12.12 110.554 173.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -145.79 122.7 11.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.871 -0.604 . . . . 14.98 110.689 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.64 -108.01 1.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.745 -0.661 . . . . 16.43 112.848 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.77 24.62 10.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 15.35 111.732 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -155.62 179.69 8.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 15.67 111.692 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 58.1 m -134.68 150.96 50.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.862 -0.608 . . . . 9.26 110.831 -173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -119.63 146.23 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.871 -0.418 . . . . 10.94 109.871 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.237 -0.282 . . . . 7.39 110.237 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 81.7 mmm -106.56 98.1 7.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.208 -0.451 . . . . 8.85 109.999 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -88.1 142.07 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.005 0.431 . . . . 10.13 111.419 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 86.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 10.7 110.479 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 33.6 tttp -72.44 153.62 41.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.245 -0.888 . . . . 15.12 110.422 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.05 -2.04 51.1 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.945 -0.571 . . . . 16.92 112.998 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.18 17.47 10.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 18.56 111.077 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.12 11.34 85.21 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.618 -0.719 . . . . 16.28 112.785 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.9 -158.09 8.7 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.836 -0.697 . . . . 14.36 111.84 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 64.5 m-85 -128.11 124.34 36.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.376 0.608 . . . . 12.49 110.154 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.2 t70 -101.13 117.4 62.37 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.041 -0.982 . . . . 13.91 110.314 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 72.7 Cg_endo -83.1 112.09 1.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.83 3.02 . . . . 13.02 113.458 -172.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.561 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 9.5 p -105.21 142.83 17.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.423 -0.808 . . . . 10.41 110.404 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -82.23 123.41 29.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.156 0.503 . . . . 12.93 109.699 171.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -135.76 163.08 35.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.707 -0.679 . . . . 8.03 110.974 -172.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.445 ' N ' HG21 ' A' ' 125' ' ' VAL . 77.9 tttt -98.82 126.21 44.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.936 -0.575 . . . . 10.66 110.243 172.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.92 108.08 4.98 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.663 -0.699 . . . . 8.3 111.444 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.409 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -153.17 70.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.759 -2.162 . . . . 10.1 114.674 168.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.67 161.92 41.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.957 -0.757 . . . . 11.03 108.957 153.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.17 127.62 26.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.928 -0.397 . . . . 13.17 109.928 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.32 125.21 11.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.339 -0.391 . . . . 13.78 111.595 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.79 35.99 88.39 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.934 -0.576 . . . . 15.28 113.288 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.51 7.9 87.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.941 -0.647 . . . . 13.44 112.163 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.66 170.51 10.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.555 . . . . 11.28 109.503 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 13.3 p -122.36 156.51 33.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.741 0.305 . . . . 8.43 110.53 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.635 ' OE1' ' HG3' ' A' ' 94' ' ' ARG . 52.8 mt-10 -99.16 118.48 35.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.369 0.604 . . . . 10.79 110.853 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 125' ' ' VAL . 22.9 mm -85.37 103.79 12.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.096 -0.956 . . . . 6.73 108.615 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 2.4 mp -70.73 -46.63 62.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.926 -1.034 . . . . 9.17 109.805 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.508 ' O ' HG21 ' A' ' 125' ' ' VAL . 97.9 mt-10 -143.1 161.12 39.04 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.949 -0.569 . . . . 10.44 109.63 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.31 -60.36 0.59 Allowed Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.02 -1.086 . . . . 8.87 113.585 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.404 HD23 HG12 ' A' ' 123' ' ' VAL . 47.6 mt -110.44 -176.61 3.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.899 0.703 . . . . 8.5 112.899 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -143.78 157.32 44.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.792 -1.095 . . . . 14.48 109.201 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.32 129.83 41.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.296 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.21 -8.69 35.81 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.179 -0.768 . . . . 12.39 111.179 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.613 ' O ' HG21 ' A' ' 84' ' ' VAL . 29.6 mm-40 -91.12 100.32 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.507 0.67 . . . . 11.89 109.64 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.4 mt-30 -74.72 135.32 41.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.14 -0.936 . . . . 11.1 110.58 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.5 m -129.75 136.62 58.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.717 -0.475 . . . . 5.45 109.717 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 2.8 p -61.25 119.09 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.872 0.693 . . . . 7.05 112.872 -171.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.524 HG11 ' O ' ' A' ' 147' ' ' VAL . 2.7 m . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 112.233 0.457 . . . . 6.99 112.233 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.468 -0.938 . . . . 12.43 108.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 1.8 p90 -70.4 171.38 10.13 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.727 -0.389 . . . . 12.83 110.171 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.64 175.27 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.597 0.713 . . . . 13.49 112.747 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.512 ' C ' ' HB1' ' A' ' 159' ' ' ALA . 6.2 pt -114.57 77.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.607 0.718 . . . . 12.27 110.281 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -84.46 -100.44 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.359 -0.837 . . . . 11.22 111.459 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.0 p -83.36 -36.43 24.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 12.0 110.082 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 18.3 tt0 -66.07 -18.95 65.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.056 -0.975 . . . . 11.17 109.904 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HB1' ' C ' ' A' ' 155' ' ' ILE . . . -45.16 -58.33 3.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.008 -0.996 . . . . 8.27 112.156 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -66.06 -29.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.678 0.752 . . . . 9.64 110.963 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.59 -28.04 62.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.684 -1.144 . . . . 10.88 110.94 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 71.9 mtt180 -92.73 -54.15 3.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.063 -0.971 . . . . 9.36 111.024 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 56.21 56.33 24.8 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.385 -0.686 . . . . 7.46 111.385 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.7 p -62.19 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.261 0.467 . . . . 7.09 112.261 -171.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.44 47.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.623 0.725 . . . . 9.62 109.344 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.752 -0.658 . . . . 9.11 111.421 -176.401 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 pttt . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 122.472 1.13 . . . . 10.77 112.101 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.576 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 19.8 mtm180 -141.31 142.17 33.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.309 -1.769 . . . . 8.86 108.281 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.686 HG12 ' CD ' ' A' ' 58' ' ' GLU . 25.5 mm -51.95 112.8 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 113.213 0.82 . . . . 5.76 113.213 -169.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -100.9 -31.9 10.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.007 -1.452 . . . . 8.55 109.734 172.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 13.0 p90 -175.02 -174.58 0.78 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.24 0.543 . . . . 8.07 112.089 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.77 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 m-90 -123.23 148.62 45.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 114.966 -1.015 . . . . 5.61 110.701 -174.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HB2' HE22 ' A' ' 38' ' ' GLN . 29.5 ptt180 -148.22 152.53 37.36 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.472 0.482 . . . . 9.75 111.112 -176.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.577 ' HB2' HG21 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -76.66 139.37 66.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.791 -1.188 . . . . 8.31 107.791 163.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.569 ' CG ' HD13 ' A' ' 54' ' ' ILE . 44.7 Cg_exo -57.87 -15.49 22.02 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.865 2.377 . . . . 10.41 110.647 164.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -28.85 39.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 113.772 -1.558 . . . . 11.24 111.476 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 48' ' ' TYR . 18.2 m -123.57 51.42 4.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.77 0.656 . . . . 9.83 112.77 -164.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.0 114.3 2.93 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.212 2.608 . . . . 11.66 112.317 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.09 -25.52 3.5 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.26 -0.736 . . . . 10.86 111.26 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.632 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -70.94 171.59 10.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.118 -0.541 . . . . 9.42 109.926 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.595 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -150.12 91.27 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.2 -0.667 . . . . 12.03 109.2 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.632 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 70.8 m-85 -71.07 141.86 50.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.298 0.571 . . . . 7.9 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.18 -30.43 71.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.821 -1.081 . . . . 10.61 111.668 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 13.2 ptmm? -167.33 163.29 10.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 119.29 -0.386 . . . . 11.24 111.279 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -49.72 170.89 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.781 2.988 . . . . 7.51 113.859 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.69 -163.34 26.91 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.302 -0.719 . . . . 8.06 111.302 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -94.33 147.74 22.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.203 0.501 . . . . 12.05 110.242 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.2 t -66.1 139.07 96.4 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.413 -0.812 . . . . 9.2 111.226 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 -21.95 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.791 2.328 . . . . 10.25 111.957 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.641 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 33.2 m-85 -78.66 -39.02 38.08 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.865 -1.061 . . . . 10.49 109.769 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.496 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -156.94 166.55 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.454 -0.794 . . . . 10.74 109.105 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.33 80.96 4.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 12.54 112.27 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 ptm -134.99 146.04 56.96 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.737 -1.579 . . . . 10.35 106.737 173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.43 132.74 18.06 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 N-CA-C 108.234 -1.487 . . . . 10.11 108.234 165.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.28 161.73 18.86 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.165 -0.614 . . . . 7.0 110.964 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.569 HD13 ' CG ' ' A' ' 33' ' ' PRO . 22.0 mt -110.08 132.35 21.49 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 109.571 -0.529 . . . . 8.28 109.571 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.679 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 39.9 Cg_endo -76.85 133.4 13.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 120.983 1.122 . . . . 6.21 112.749 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.28 157.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.07 -1.423 . . . . 6.41 113.245 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 21.58 -89.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.285 1.834 . . . . 8.58 114.893 -177.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.686 ' CD ' HG12 ' A' ' 27' ' ' ILE . 1.2 pt-20 -45.63 -40.69 9.32 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.091 0.556 . . . . 7.04 110.13 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 41.8 tt0 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 114.904 -1.044 . . . . 8.58 110.541 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.555 ' NH1' ' HB3' ' A' ' 156' ' ' ASP . 53.7 ttt180 . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 121.67 0.748 . . . . 12.25 110.419 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -128.47 159.16 36.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.529 -1.214 . . . . 8.3 109.212 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -119.49 126.5 51.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.693 -0.854 . . . . 7.51 108.693 171.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 28.0 tt0 -75.92 131.44 39.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.146 -0.687 . . . . 12.15 109.146 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.577 HG11 ' HB3' ' A' ' 95' ' ' LEU . 41.3 t -55.64 132.02 19.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.94 0.718 . . . . 9.71 112.94 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 49.0 mmtt -136.41 140.46 43.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.607 -1.179 . . . . 11.77 109.429 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.2 157.9 36.88 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.954 -0.698 . . . . 13.03 109.496 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.704 0 C-N-CA 119.74 -1.219 . . . . 13.49 113.862 -178.303 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.148 0.499 . . . . 14.94 110.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 35.8 mmt180 -118.72 163.83 16.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.675 -0.693 . . . . 11.02 110.339 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.607 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.2 mm? -97.9 114.17 26.18 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.066 -0.716 . . . . 9.27 109.066 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.49 129.79 36.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.189 0.519 . . . . 10.57 110.99 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.82 157.22 68.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.895 -1.048 . . . . 6.4 109.17 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.415 ' HG2' HG12 ' A' ' 149' ' ' VAL . 51.2 Cg_exo -58.97 131.25 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.817 1.678 . . . . 7.48 110.356 171.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -30.12 53.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.312 -0.404 . . . . 9.53 111.32 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.9 -8.34 57.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.624 0.231 . . . . 10.86 111.624 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 149' ' ' VAL . . . -72.02 -41.32 67.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.433 0.635 . . . . 5.39 110.942 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.509 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -93.96 163.78 13.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.141 -0.936 . . . . 7.08 112.613 -169.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' THR . 22.7 mm -111.68 103.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 10.63 109.229 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 13.3 ptt180 -103.01 132.54 49.2 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 117.969 -1.493 . . . . 12.12 110.985 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -151.36 133.92 15.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.709 -1.587 . . . . 14.98 109.133 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.18 -113.63 6.06 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.352 -0.928 . . . . 16.43 111.952 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 34.99 5.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.85 0.315 . . . . 15.35 111.85 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.41 178.63 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.901 0.382 . . . . 15.67 111.801 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 5.3 m -136.68 158.55 44.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.749 -0.66 . . . . 9.26 110.431 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.1 mm -131.22 147.75 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 10.94 109.899 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -136.34 127.31 27.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.517 -0.31 . . . . 7.39 110.296 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.2 ttp -87.59 103.19 15.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.27 -0.641 . . . . 8.85 109.27 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 12.6 p -89.64 135.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 10.13 112.575 -170.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -76.01 90.28 3.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.359 -0.837 . . . . 10.7 109.672 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -85.38 152.84 22.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.425 . . . . 15.12 110.499 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.05 1.76 10.24 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.106 -0.497 . . . . 16.92 113.328 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -90.93 8.64 34.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.33 0.586 . . . . 18.56 111.062 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.19 6.45 86.34 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.29 -0.868 . . . . 16.28 112.512 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.78 156.18 19.99 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.985 -0.626 . . . . 14.36 111.567 -174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' A' ' 120' ' ' PHE . 82.5 m-85 -107.3 109.46 21.23 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.766 -0.457 . . . . 12.49 109.766 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -106.74 142.96 26.08 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 120.405 -0.518 . . . . 13.91 111.231 -172.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.66 121.28 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.281 1.987 . . . . 13.02 111.93 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 111' ' ' ALA . 5.7 p -105.43 137.29 35.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.667 -0.697 . . . . 10.41 109.663 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.93 119.95 19.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.1 -0.704 . . . . 12.93 109.1 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.06 155.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.695 -0.684 . . . . 8.03 110.918 -176.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 38.5 ttmt -101.78 128.47 48.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.904 -0.776 . . . . 10.66 108.904 171.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.92 104.55 4.7 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.452 -0.34 . . . . 8.3 110.74 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.77 70.34 0.31 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.867 -2.111 . . . . 10.1 113.866 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 161.32 42.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.305 -1.368 . . . . 11.03 107.305 151.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.0 m -141.5 128.88 21.19 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 118.38 0.537 . . . . 13.17 110.081 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.61 8.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.592 -0.731 . . . . 13.78 110.847 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.43 38.22 96.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.362 -0.447 . . . . 15.28 112.704 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.58 9.76 84.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.649 . . . . 13.44 112.434 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -120.32 164.24 16.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.165 -0.309 . . . . 11.28 110.165 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -117.31 158.34 24.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.935 0.398 . . . . 8.43 110.883 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 57.7 mt-10 -101.7 124.82 47.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.454 0.645 . . . . 10.79 110.828 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.9 mm -89.76 114.63 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 114.934 -1.03 . . . . 6.73 109.55 175.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.2 mp -87.73 -45.5 10.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.648 -1.16 . . . . 9.17 109.677 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.571 ' O ' HG21 ' A' ' 125' ' ' VAL . 9.2 tp10 -134.67 164.71 26.9 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.974 -1.121 . . . . 10.44 107.974 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 111.99 -62.49 0.3 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.275 -1.44 . . . . 8.87 113.722 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.404 ' CD2' HG12 ' A' ' 123' ' ' VAL . 54.0 mt -103.64 -173.26 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.236 0.541 . . . . 8.5 112.455 -174.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.9 ttmt -157.58 158.36 35.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 14.48 108.528 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 128.84 37.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.888 -0.596 . . . . 12.12 110.31 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.08 -10.3 40.08 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.444 -0.662 . . . . 12.39 111.444 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' HG21 ' A' ' 84' ' ' VAL . 14.9 mm100 -93.69 121.17 34.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.119 -0.697 . . . . 11.89 109.119 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 28.5 mt-30 -97.49 125.06 41.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.941 -0.572 . . . . 11.1 111.114 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.75 138.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.852 -0.613 . . . . 5.45 109.673 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.8 m -62.94 120.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.36 0.6 . . . . 7.05 111.136 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 101' ' ' ALA . 3.4 m . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 115.476 -0.784 . . . . 6.99 110.484 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.457 -0.088 0 N-CA-C 112.319 0.489 . . . . 12.43 112.319 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.644 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 78.2 m-85 -100.26 -27.74 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.478 -0.934 . . . . 12.83 108.478 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.17 137.47 36.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.833 -1.076 . . . . 13.49 108.839 177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.425 HG23 ' H ' ' A' ' 157' ' ' SER . 47.0 mt -54.07 108.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.001 0.429 . . . . 12.27 111.228 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.555 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 4.0 p30 -84.17 17.44 2.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.255 -0.43 . . . . 11.22 111.84 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.427 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 70.7 m -64.52 -17.35 63.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.72 -0.218 . . . . 12.0 111.519 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 41.4 mt-10 -58.45 -46.87 85.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.252 -0.647 . . . . 11.17 109.252 171.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.73 -27.89 68.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 8.27 110.794 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 16.0 m -62.57 -39.0 92.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.581 0.705 . . . . 9.64 110.017 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -47.77 14.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.883 -1.053 . . . . 10.88 111.638 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 53.3 mtt180 -71.49 -36.24 71.07 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.592 0.711 . . . . 9.36 110.948 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.75 105.74 3.03 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.606 -1.179 . . . . 7.46 110.782 -171.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.9 p -49.71 -54.03 21.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 7.09 111.061 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.86 -48.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.818 -0.628 . . . . 9.62 109.491 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.62 -0.718 . . . . 9.11 111.658 178.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.054 0 CA-C-O 122.507 1.146 . . . . 10.77 108.244 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 82.3 mtt180 -124.25 138.75 54.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.484 -1.235 . . . . 8.86 109.946 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.673 HG12 ' OE2' ' A' ' 58' ' ' GLU . 33.5 mm -48.72 127.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 114.369 -1.287 . . . . 5.76 114.18 -167.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.86 -38.77 3.84 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.504 -1.68 . . . . 8.55 110.029 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 2.0 p90 -176.51 -172.81 0.48 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.929 -0.578 . . . . 8.07 110.402 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m-90 -124.01 150.36 44.96 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.462 -0.79 . . . . 5.61 110.751 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.809 HH11 ' HH ' ' A' ' 29' ' ' TYR . 24.7 ptt180 -153.5 145.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.297 -0.41 . . . . 9.75 111.596 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 12.6 t0 -79.34 130.6 68.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.909 -1.145 . . . . 8.31 107.909 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HG3' HD11 ' A' ' 54' ' ' ILE . 21.6 Cg_exo -61.17 -14.43 33.75 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 122.023 1.815 . . . . 10.41 112.293 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.46 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -96.11 2.06 52.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.473 -0.331 . . . . 11.24 111.193 176.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 32' ' ' ASP . 4.9 m -129.1 39.35 0.5 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.624 0.601 . . . . 9.83 112.624 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -60.42 128.71 26.96 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.519 2.146 . . . . 11.66 112.579 -174.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.01 -6.45 19.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 10.86 111.618 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.551 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -89.95 -179.54 5.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.456 -0.372 . . . . 9.42 110.082 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.524 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 8.1 tpt180 -142.03 108.63 5.34 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.192 -0.203 . . . . 12.03 110.455 171.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -96.84 121.02 38.24 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.631 -0.828 . . . . 7.9 109.098 170.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.47 -35.3 78.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.958 -0.565 . . . . 10.61 110.125 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -147.86 149.39 33.06 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 121.78 0.8 . . . . 11.24 111.071 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 14.5 Cg_endo -52.77 142.38 51.49 Favored 'Trans proline' 0 C--N 1.348 0.515 1 C-N-CA 125.398 4.065 . . . . 7.51 114.027 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.8 -156.0 17.71 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.828 -0.624 . . . . 8.06 111.594 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 23.1 ttmt -98.1 143.56 28.51 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.093 -0.706 . . . . 12.05 109.093 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.7 t -66.83 132.66 93.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.309 -0.405 . . . . 9.2 110.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.71 -29.4 24.15 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 10.25 111.491 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 48' ' ' TYR . 96.8 m-85 -70.38 -37.75 74.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.561 -1.2 . . . . 10.49 110.581 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.546 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.4 OUTLIER -156.99 153.62 28.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.678 -0.49 . . . . 10.74 109.678 169.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 3.7 m-20 -74.42 76.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 12.54 112.447 -173.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -140.28 145.15 40.17 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.491 -0.929 . . . . 10.35 108.491 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.97 132.32 29.83 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.748 1.632 . . . . 10.11 110.208 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -61.37 160.09 11.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.342 -0.39 . . . . 7.0 110.303 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' HG3' ' A' ' 33' ' ' PRO . 6.0 mt -104.6 133.59 20.1 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.947 0.403 . . . . 8.28 110.006 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.624 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 86.9 Cg_endo -77.71 152.07 28.87 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.766 1.644 . . . . 6.21 112.447 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 m -74.44 157.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.513 -1.221 . . . . 6.41 112.051 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.459 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 0.1 OUTLIER 14.37 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.056 2.143 . . . . 8.58 115.701 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.673 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -52.81 -42.01 64.7 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.605 0.362 . . . . 7.04 110.386 -176.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 85.5 mt-10 . . . . . 0 C--N 1.316 -0.875 0 CA-C-O 121.846 0.831 . . . . 8.58 112.507 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.937 -0.764 . . . . 12.25 108.937 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.1 p -130.13 148.19 51.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.575 -0.284 . . . . 8.3 110.661 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -122.91 136.08 54.73 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 7.51 109.433 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.411 ' OE1' ' HE2' ' A' ' 85' ' ' LYS . 41.2 tt0 -76.57 141.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.226 -0.443 . . . . 12.15 110.161 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 143' ' ' ALA . 97.1 t -67.89 131.34 33.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.776 0.798 . . . . 9.71 111.936 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.411 ' HE2' ' OE1' ' A' ' 83' ' ' GLU . 27.8 mmtp -127.3 155.4 43.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.237 -1.347 . . . . 11.77 109.114 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -90.38 165.58 13.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.395 -0.595 . . . . 13.03 109.395 165.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.5 0 C-N-CA 119.819 -1.181 . . . . 13.49 113.688 179.467 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.422 ' HG2' HD21 ' A' ' 86' ' ' LEU . 2.6 mt-10 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.644 0.259 . . . . 14.94 110.4 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.611 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 36.5 mmt180 -125.8 157.57 37.17 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.924 -0.31 . . . . 11.02 110.739 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.0 mm? -94.12 126.8 39.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.904 -0.776 . . . . 9.27 108.904 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.21 129.02 50.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.221 -0.445 . . . . 10.57 109.882 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.69 157.13 65.68 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.912 -1.04 . . . . 6.4 108.842 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.79 128.33 29.16 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.523 1.482 . . . . 7.48 110.631 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.525 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 50.8 p -54.43 -25.76 26.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.645 0.609 . . . . 9.53 112.645 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.45 12.12 21.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.825 -0.35 . . . . 10.86 111.526 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.78 24.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.364 0.602 . . . . 5.39 110.338 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.509 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -99.68 158.73 15.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.799 -0.637 . . . . 7.08 111.572 -174.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 109' ' ' THR . 40.8 mm -104.02 123.67 57.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.203 -0.908 . . . . 10.63 110.356 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.4 mmm180 -95.26 121.81 37.3 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.592 -0.843 . . . . 12.12 110.629 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 t -149.5 143.49 25.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.713 -0.676 . . . . 14.98 110.605 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.67 -115.71 4.13 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 116.225 -0.443 . . . . 16.43 112.666 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.42 36.94 4.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 15.35 110.94 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -155.48 -177.98 6.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.107 0.48 . . . . 15.67 111.933 -175.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 19.1 m -131.74 147.19 52.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.529 -0.76 . . . . 9.26 109.399 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 22.6 mm -126.64 149.82 31.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 10.94 109.968 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.59 123.54 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.205 -0.294 . . . . 7.39 110.205 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 43.6 mtm -86.7 100.38 12.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.179 -0.674 . . . . 8.85 109.179 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 14.9 p -82.72 136.47 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.497 -0.774 . . . . 10.13 110.98 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -74.89 83.23 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.464 -0.939 . . . . 10.7 108.464 173.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -77.99 150.93 33.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.018 -0.992 . . . . 15.12 111.083 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.37 -5.88 18.56 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.566 -0.743 . . . . 16.92 113.15 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -73.32 -10.44 59.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 18.56 110.19 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.21 31.15 26.23 Favored Glycine 0 C--N 1.31 -0.866 0 C-N-CA 119.947 -1.121 . . . . 16.28 111.374 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.97 163.76 31.51 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 111.242 -0.743 . . . . 14.36 111.242 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.2 m-85 -97.27 112.44 24.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.806 0.336 . . . . 12.49 110.204 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 113' ' ' VAL . 4.0 t70 -101.51 139.62 20.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.893 -0.594 . . . . 13.91 109.538 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -86.16 122.24 2.13 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.045 1.83 . . . . 13.02 112.971 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.53 121.52 59.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.177 -0.92 . . . . 10.41 110.167 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.24 121.1 20.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.849 -0.797 . . . . 12.93 108.849 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.577 ' CG2' HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.17 153.26 38.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.742 0.782 . . . . 8.03 112.059 -173.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.2 ttmm -93.83 129.75 40.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.232 -1.349 . . . . 10.66 109.475 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.77 112.97 20.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.116 1.436 . . . . 8.3 112.261 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -89.44 174.36 41.52 Favored Glycine 0 N--CA 1.41 -3.062 0 CA-C-N 111.364 -2.653 . . . . 10.1 111.177 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.38 162.35 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 112.367 -1.917 . . . . 11.03 114.683 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -106.7 133.17 51.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.219 -0.9 . . . . 13.17 109.248 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.24 119.82 9.13 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.055 -0.52 . . . . 13.78 111.261 -174.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.17 29.58 75.19 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.183 -0.532 . . . . 15.28 112.544 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.46 89.7 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.633 -0.794 . . . . 13.44 112.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -116.53 153.8 31.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.077 -0.342 . . . . 11.28 110.077 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 70.5 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.091 0.472 . . . . 8.43 111.387 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 128' ' ' GLY . 24.7 mt-10 -85.51 107.85 17.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.586 -0.733 . . . . 10.79 109.65 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.577 HD11 ' CG2' ' A' ' 125' ' ' VAL . 23.2 mm -92.41 114.1 28.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 O-C-N 121.245 -0.909 . . . . 6.73 110.31 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.611 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.4 mp -86.6 -47.8 8.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.293 -1.321 . . . . 9.17 110.795 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.574 ' O ' HG21 ' A' ' 125' ' ' VAL . 37.3 mt-10 -144.29 167.25 22.9 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.052 -0.722 . . . . 10.44 109.052 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 114.51 -74.11 0.24 Allowed Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.631 -1.271 . . . . 8.87 113.413 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 61.5 tp -97.66 178.09 5.28 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.694 -0.253 . . . . 8.5 110.998 -168.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.476 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 26.3 tptp -137.62 148.84 46.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.4 0.619 . . . . 14.48 112.124 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.484 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . . . -68.15 143.45 55.39 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 114.439 -1.255 . . . . 12.12 110.802 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 1.34 85.95 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.524 -0.846 . . . . 12.39 112.124 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -103.8 152.69 21.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.552 -0.536 . . . . 11.89 109.552 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.509 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 69.4 mt-30 -97.46 140.07 32.44 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 120.929 0.395 . . . . 11.1 111.295 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -134.71 143.99 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.152 -0.477 . . . . 5.45 109.961 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.75 129.58 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.436 0.636 . . . . 7.05 111.365 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.402 HG12 ' CB ' ' A' ' 82' ' ' ALA . 2.6 m . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 122.346 1.069 . . . . 6.99 108.978 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.51 -0.552 . . . . 12.43 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.43 ' CD1' HG23 ' A' ' 155' ' ' ILE . 2.7 p90 -159.34 173.38 16.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.548 -0.296 . . . . 12.83 110.805 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.23 61.91 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 13.49 111.494 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.43 HG23 ' CD1' ' A' ' 153' ' ' PHE . 12.8 tt -149.31 2.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.777 0.798 . . . . 12.27 109.416 171.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.76 -16.41 61.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 11.22 110.651 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p -57.42 -43.14 83.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 12.0 109.556 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 38.8 tt0 -76.11 -36.52 58.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.251 -0.886 . . . . 11.17 108.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 162' ' ' ARG . . . -59.97 -27.77 67.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.27 -1.332 . . . . 8.27 111.519 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.5 t -79.0 -37.92 38.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 9.64 110.496 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.96 -26.9 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.747 0.277 . . . . 10.88 111.747 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 11.2 ptp180 -74.62 2.46 9.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.136 0.421 . . . . 9.36 112.136 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.507 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 116.47 13.18 8.3 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.462 -0.875 . . . . 7.46 112.342 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.507 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 26.1 p 52.75 -97.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.672 0.789 . . . . 7.09 112.153 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 165' ' ' VAL . 5.7 p -74.67 84.85 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.855 0.836 . . . . 9.62 109.65 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.251 -0.886 . . . . 9.11 111.534 -176.381 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 122.56 1.171 . . . . 10.77 109.809 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.486 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 77.6 mtm180 -119.54 143.32 47.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.127 -1.397 . . . . 8.86 109.87 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.558 HG12 ' OE2' ' A' ' 58' ' ' GLU . 31.1 mm -49.23 120.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 114.286 -1.324 . . . . 5.76 112.824 -169.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.5 -35.06 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.963 -1.471 . . . . 8.55 110.298 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.669 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 44.0 p90 -176.15 -173.54 0.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.858 -0.61 . . . . 8.07 109.387 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.758 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.15 154.11 41.99 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.105 -0.498 . . . . 5.61 111.599 -175.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -156.51 150.64 25.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.389 -0.823 . . . . 9.75 110.415 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 35' ' ' VAL . 9.3 t0 -82.72 134.69 46.89 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.705 -1.221 . . . . 8.31 107.705 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -62.67 -13.27 32.88 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.113 1.875 . . . . 10.41 111.967 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.484 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.1 OUTLIER -95.68 1.75 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 11.24 111.108 175.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -129.22 36.3 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 112.965 0.728 . . . . 9.83 112.965 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.8 Cg_endo -54.81 119.14 5.98 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.343 2.028 . . . . 11.66 112.517 -172.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.23 -21.0 6.97 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.889 -0.884 . . . . 10.86 110.889 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.486 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -85.0 115.42 22.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.25 -0.475 . . . . 9.42 110.635 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 47.9 ttt180 -99.73 102.8 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.343 0.592 . . . . 12.03 110.197 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 40' ' ' PHE . 82.9 m-85 -76.74 146.84 37.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 7.9 109.801 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.65 -27.7 69.4 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.128 -1.397 . . . . 10.61 110.323 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.9 pttm -169.79 165.94 5.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.386 -0.825 . . . . 11.24 110.355 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.758 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.6 Cg_endo -51.25 168.63 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.113 2.542 . . . . 7.51 113.104 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.66 -159.94 28.21 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.67 -0.776 . . . . 8.06 112.036 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.1 ttmt -98.44 147.47 24.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.24 -0.281 . . . . 12.05 110.24 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 p -70.68 128.77 90.64 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.558 -0.292 . . . . 9.2 111.462 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.65 -22.94 17.45 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.827 1.684 . . . . 10.25 110.507 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.651 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 97.8 m-85 -72.57 -24.98 61.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.759 -1.109 . . . . 10.49 110.949 -175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.24 -104.38 0.13 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.737 -0.785 . . . . 10.74 112.616 167.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -166.55 58.17 0.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.313 0.578 . . . . 12.54 111.596 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.3 ptm -133.36 149.9 73.7 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.626 -0.509 . . . . 10.35 109.626 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -66.41 131.8 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.545 1.496 . . . . 10.11 109.772 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 mt -60.59 160.04 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.699 0.625 . . . . 7.0 110.756 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.1 mm -99.4 130.73 26.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.212 -0.662 . . . . 8.28 109.212 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 58.2 Cg_endo -73.46 146.07 38.95 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 121.389 1.393 . . . . 6.21 112.145 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.493 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 31.3 m -68.81 159.69 5.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.269 -1.332 . . . . 6.41 112.251 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.486 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.87 -74.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.526 2.33 . . . . 8.58 116.216 -178.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.558 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -61.63 -38.86 89.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.669 1.223 . . . . 7.04 111.93 -168.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 50.2 mt-10 . . . . . 0 CA--C 1.501 -0.908 0 CA-C-N 111.865 -2.425 . . . . 8.58 112.291 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 109.737 -0.468 . . . . 12.25 109.737 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 148' ' ' VAL . 76.6 p -139.05 143.11 38.24 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.739 -0.664 . . . . 8.3 109.484 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 149' ' ' VAL . . . -108.43 127.75 54.18 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.435 -0.58 . . . . 7.51 109.435 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 34.4 tt0 -73.1 139.24 46.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.888 -0.596 . . . . 12.15 109.932 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -61.74 135.32 26.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.278 -0.874 . . . . 9.71 111.727 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 28.2 mmtp -131.11 156.51 45.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.602 -1.181 . . . . 11.77 109.693 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.43 143.79 27.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.497 -0.557 . . . . 13.03 109.497 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 C-N-CA 119.702 -1.237 . . . . 13.49 112.678 178.523 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 121.198 0.523 . . . . 14.94 111.762 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' HD13 ' A' ' 138' ' ' LEU . 1.5 mpp_? -119.61 156.74 29.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.829 -1.078 . . . . 11.02 109.118 170.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -90.68 113.58 25.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.629 -0.878 . . . . 9.27 108.629 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.68 129.95 34.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.646 . . . . 10.57 110.99 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.8 m -144.67 159.03 52.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.828 -1.078 . . . . 6.4 109.103 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.42 136.28 70.67 Favored 'Trans proline' 0 C--N 1.333 -0.277 0 C-N-CA 122.192 1.928 . . . . 7.48 110.589 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 m -57.92 -24.85 59.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 9.53 111.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.6 6.61 43.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.183 -0.207 . . . . 10.86 111.554 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -40.71 20.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.058 0.456 . . . . 5.39 110.707 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -90.87 161.85 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.732 -0.667 . . . . 7.08 111.98 -173.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 mm -113.15 103.79 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.892 -0.594 . . . . 10.63 109.442 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 7.2 ptt180 -101.53 134.27 44.91 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.33 -1.348 . . . . 12.12 110.997 173.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 t -150.47 128.88 12.12 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.06 -1.427 . . . . 14.98 109.589 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.76 -109.74 3.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.589 -0.815 . . . . 16.43 112.117 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.16 30.31 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.077 0.399 . . . . 15.35 112.077 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.472 HH11 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -163.75 176.91 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 15.67 112.004 -177.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.4 m -132.55 156.66 46.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 9.26 110.602 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.472 HD13 HH11 ' A' ' 108' ' ' ARG . 41.4 mm -129.26 149.48 33.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.277 -0.638 . . . . 10.94 109.277 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.551 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -128.94 141.82 51.14 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.658 0.265 . . . . 7.39 110.497 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.551 ' SD ' ' HB3' ' A' ' 122' ' ' PRO . 62.0 mmm -103.37 99.84 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.648 -0.501 . . . . 8.85 109.648 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.0 p -82.05 135.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.979 0.418 . . . . 10.13 111.003 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -80.06 93.54 5.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 10.7 110.922 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -89.06 160.5 17.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.626 -0.716 . . . . 15.12 111.343 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.43 23.94 31.42 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.737 -0.945 . . . . 16.92 110.737 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -97.54 19.41 13.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.989 0.423 . . . . 18.56 111.102 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.5 68.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.951 -0.642 . . . . 16.28 112.702 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 -175.76 47.55 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.16 -0.776 . . . . 14.36 111.16 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 81.8 m-85 -100.36 178.7 4.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.868 0.366 . . . . 12.49 110.881 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.513 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 13.4 t70 -140.52 122.85 9.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.467 0.651 . . . . 13.91 109.721 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.551 ' HB3' ' SD ' ' A' ' 112' ' ' MET . 71.1 Cg_endo -86.96 113.78 1.04 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.324 2.683 . . . . 13.02 112.422 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 111' ' ' ALA . 9.3 p -103.91 140.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.183 -0.917 . . . . 10.41 109.647 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 110' ' ' ILE . 44.9 tt0 -76.24 120.97 22.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.108 -0.701 . . . . 12.93 109.108 171.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.579 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -131.65 159.35 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 8.03 111.566 -173.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.4 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 39.9 ttmt -103.11 128.04 50.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.186 -0.916 . . . . 10.66 109.415 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.66 108.25 5.34 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.589 0.218 . . . . 8.3 111.589 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.454 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -154.52 71.04 0.28 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 118.021 -2.038 . . . . 10.1 114.006 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.584 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -150.71 163.03 39.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.554 -0.906 . . . . 11.03 108.554 157.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.7 m -131.5 137.03 48.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.139 -0.689 . . . . 13.17 109.139 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -142.73 90.63 2.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 120.888 0.375 . . . . 13.78 111.954 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.2 60.19 8.74 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.733 -0.667 . . . . 15.28 113.411 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.84 82.26 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 13.44 112.41 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.64 165.54 24.99 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.9 -0.778 . . . . 11.28 108.9 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.0 m -117.81 163.46 16.48 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.633 -0.427 . . . . 8.43 110.714 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.584 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 23.9 mt-10 -110.44 120.11 41.37 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.734 0.778 . . . . 10.79 111.258 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 22.3 mm -85.23 107.95 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.777 -1.101 . . . . 6.73 109.644 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.54 HD13 ' CG ' ' A' ' 94' ' ' ARG . 2.0 mp -68.67 -46.54 68.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.298 -0.865 . . . . 9.17 109.984 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.527 ' O ' HG21 ' A' ' 125' ' ' VAL . 38.9 mt-10 -144.45 155.79 43.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.122 -0.49 . . . . 10.44 110.101 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 129.28 -66.85 0.57 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.862 -1.161 . . . . 8.87 113.064 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 141' ' ' LEU . 3.1 mm? -97.71 -176.29 3.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.37 0.878 . . . . 8.5 113.37 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 23.0 tptm -144.34 151.91 39.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.019 -0.991 . . . . 14.48 109.89 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.17 132.41 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.345 -0.843 . . . . 12.12 110.21 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.0 47.32 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.485 -0.864 . . . . 12.39 111.315 -174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -104.17 141.15 36.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.64 -0.504 . . . . 11.89 109.64 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.5 mt-30 -97.21 147.1 24.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.695 0.283 . . . . 11.1 111.008 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.0 m -136.51 152.55 29.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.38 -0.6 . . . . 5.45 109.38 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.522 ' HA ' HG23 ' A' ' 81' ' ' THR . 32.9 m -56.53 138.86 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.72 0.637 . . . . 7.05 111.881 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 82' ' ' ALA . 43.1 t . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.235 -0.893 . . . . 6.99 110.043 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.622 -0.14 . . . . 12.43 110.622 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.89 63.2 0.46 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.062 0.545 . . . . 12.83 111.139 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.95 94.84 5.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 13.49 110.707 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.28 -9.14 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 12.27 109.709 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.72 1.25 39.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.619 -0.719 . . . . 11.22 110.232 176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -66.54 -40.41 89.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.809 -0.441 . . . . 12.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.11 -51.79 55.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.236 0.471 . . . . 11.17 110.038 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.06 66.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.834 . . . . 8.27 111.422 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 164' ' ' THR . 35.6 t -70.77 -38.39 73.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.181 0.515 . . . . 9.64 110.609 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.96 -32.44 65.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.83 0.824 . . . . 10.88 110.907 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -89.93 -67.02 0.87 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 114.327 -1.306 . . . . 9.36 111.019 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.71 77.88 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.563 -0.744 . . . . 7.46 112.658 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 160' ' ' SER . 56.1 p 47.26 -100.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.191 0.996 . . . . 7.09 113.267 174.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.33 -30.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.03 0.443 . . . . 9.62 111.235 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 121.16 0.505 . . . . 9.11 111.096 -177.704 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 pttp . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 122.385 1.088 . . . . 10.77 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.519 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 32.0 mtt180 -135.49 138.75 43.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.971 -1.468 . . . . 8.86 109.362 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.629 HG12 ' CG ' ' A' ' 58' ' ' GLU . 31.3 mm -52.92 120.64 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 121.982 0.896 . . . . 5.76 113.236 -170.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.34 -37.32 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.665 -1.607 . . . . 8.55 110.291 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 13.1 p90 -169.77 -173.47 1.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.165 0.507 . . . . 8.07 111.611 -174.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.594 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.57 145.71 50.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.252 -0.886 . . . . 5.61 110.908 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -149.26 157.52 43.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.585 . . . . 9.75 110.207 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 35' ' ' VAL . 9.1 t70 -91.32 136.08 27.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.673 -0.862 . . . . 8.31 108.673 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.45 -12.48 27.94 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.247 1.965 . . . . 10.41 112.395 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.593 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -100.47 2.57 42.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.605 0.24 . . . . 11.24 111.622 176.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.571 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 5.0 m -126.1 45.39 1.46 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.276 0.56 . . . . 9.83 111.451 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HD3' ' C ' ' A' ' 34' ' ' MET . 22.7 Cg_exo -59.56 112.19 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.585 2.19 . . . . 11.66 112.252 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -32.7 3.35 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.309 -0.716 . . . . 10.86 111.309 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.45 ' CG ' ' CE2' ' A' ' 40' ' ' PHE . 3.3 tp-100 -68.1 125.67 27.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.276 0.56 . . . . 9.42 110.856 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.599 ' HG2' ' CE2' ' A' ' 29' ' ' TYR . 5.1 tmm_? -114.55 101.56 9.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.448 -0.797 . . . . 12.03 110.086 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 56.4 m-85 -85.79 141.23 29.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.498 0.666 . . . . 7.9 109.782 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.93 -36.59 84.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.313 -1.312 . . . . 10.61 111.067 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.5 mttp -146.32 163.31 30.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 123.406 0.441 . . . . 11.24 110.998 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.562 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -51.49 171.61 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.958 3.105 . . . . 7.51 114.175 175.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.71 -171.47 25.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 8.06 112.69 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 20.9 ttmt -83.86 144.8 29.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.604 -0.517 . . . . 12.05 109.604 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -64.76 136.65 96.86 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.922 -0.581 . . . . 9.2 109.623 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.98 -24.76 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.411 2.074 . . . . 10.25 112.099 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.618 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 64.3 m-85 -82.45 -34.47 28.12 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.671 -0.695 . . . . 10.49 110.839 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.523 ' HE1' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -117.75 -165.02 1.05 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.872 -1.058 . . . . 10.74 110.308 171.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.53 60.88 1.24 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.189 0.995 . . . . 12.54 109.066 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.8 ptm -138.32 146.15 50.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 113.86 -1.518 . . . . 10.35 109.325 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 19.4 Cg_exo -66.1 132.85 31.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.107 1.871 . . . . 10.11 110.177 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -61.63 161.8 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.309 0.38 . . . . 7.0 110.43 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.61 126.77 33.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.371 -0.603 . . . . 8.28 109.371 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.594 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 53.8 Cg_endo -73.37 131.75 16.79 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 121.309 1.339 . . . . 6.21 112.351 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.27 159.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.381 -1.282 . . . . 6.41 113.315 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.519 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 10.3 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.109 2.564 . . . . 8.58 116.304 -177.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.629 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -64.58 -38.22 90.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.56 1.172 . . . . 7.04 109.737 -171.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.623 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 10.9 tt0 . . . . . 0 CA--C 1.508 -0.652 0 CA-C-N 111.863 -2.426 . . . . 8.58 111.15 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.537 ' HD3' ' H ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.78 -0.452 . . . . 12.25 109.78 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 114' ' ' ALA . 74.6 p -142.98 156.56 44.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.961 -0.563 . . . . 8.3 110.182 -175.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.479 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -120.01 129.3 54.2 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.567 -0.901 . . . . 7.51 108.567 171.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 43.3 tt0 -80.11 131.88 35.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.855 -0.611 . . . . 12.15 110.054 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 145' ' ' GLN . 77.2 t -55.6 131.36 18.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 9.71 110.955 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.36 145.06 9.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.462 -1.245 . . . . 11.77 109.455 172.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 6.3 mp -74.48 152.29 39.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.205 -0.907 . . . . 13.03 110.838 -176.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.489 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.501 -0.813 0 C-N-CA 120.011 -1.09 . . . . 13.49 112.94 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 86' ' ' LEU . 5.1 tt0 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.835 -0.431 . . . . 14.94 109.835 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -134.79 160.54 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.549 0.214 . . . . 11.02 111.36 -172.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 HG13 ' A' ' 84' ' ' VAL . 5.0 mp -91.69 116.69 29.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.137 -0.69 . . . . 9.27 109.137 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -96.41 131.86 42.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.806 0.336 . . . . 10.57 111.388 -173.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.02 150.78 54.05 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.842 -0.799 . . . . 6.4 108.842 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HG2' HG12 ' A' ' 149' ' ' VAL . 50.8 Cg_exo -59.19 133.1 50.71 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 121.839 1.693 . . . . 7.48 110.704 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.472 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 22.9 t -61.45 -31.21 71.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 9.53 110.997 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -74.67 -5.25 42.09 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.372 -0.131 . . . . 10.86 111.043 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB1' HG13 ' A' ' 149' ' ' VAL . . . -73.57 -39.76 64.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.274 0.559 . . . . 5.39 109.984 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.476 HD11 HG22 ' A' ' 109' ' ' THR . 74.5 mt -65.13 148.1 52.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.67 -1.15 . . . . 7.08 113.034 -170.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.54 127.49 52.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.755 -1.111 . . . . 10.63 108.433 170.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 16.3 mmt180 -104.72 123.46 47.67 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.909 -0.717 . . . . 12.12 110.811 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -146.58 138.99 25.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.432 -0.804 . . . . 14.98 109.691 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.98 -118.33 6.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.292 -0.48 . . . . 16.43 112.776 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.7 36.89 4.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.19 0.519 . . . . 15.35 110.949 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -148.22 173.93 12.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 15.67 111.581 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.476 HG22 HD11 ' A' ' 102' ' ' LEU . 5.8 m -121.77 146.45 47.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 9.26 109.87 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 26.3 mm -131.13 148.41 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.891 0.377 . . . . 10.94 110.047 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -116.55 159.64 21.82 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.474 -0.565 . . . . 7.39 109.474 173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 58.8 ttp -125.75 100.78 6.56 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.545 -0.909 . . . . 8.85 108.545 174.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 14.4 p -80.89 129.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.363 0.601 . . . . 10.13 111.715 -168.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HB3' HG22 ' A' ' 81' ' ' THR . . . -79.13 84.53 5.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.878 -1.056 . . . . 10.7 109.991 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -67.5 141.2 56.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.84 -0.618 . . . . 15.12 110.989 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.37 -2.21 40.43 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.627 -0.989 . . . . 16.92 110.627 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -83.57 6.54 20.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.932 -0.634 . . . . 18.56 111.123 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 6.01 70.39 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.41 -0.814 . . . . 16.28 113.241 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.9 175.41 20.85 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 14.36 112.486 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 120' ' ' PHE . 85.5 m-85 -127.05 122.28 33.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.658 -0.497 . . . . 12.49 109.658 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' VAL . 20.4 t70 -116.29 134.43 22.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.145 -0.479 . . . . 13.91 111.968 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 3.1 Cg_endo -77.56 136.33 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.987 1.791 . . . . 13.02 112.505 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.94 123.76 64.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 10.41 109.8 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.56 121.19 22.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 12.93 109.294 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.492 HG12 ' HG ' ' A' ' 141' ' ' LEU . 27.3 m -128.45 163.7 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.199 0.523 . . . . 8.03 111.608 -173.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HG2' HD23 ' A' ' 138' ' ' LEU . 40.3 ttmt -102.88 126.18 49.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.008 -0.738 . . . . 10.66 109.008 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.57 104.03 4.66 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.1 -0.5 . . . . 8.3 110.998 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.416 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -154.2 71.19 0.28 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 117.922 -2.085 . . . . 10.1 114.968 169.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -147.68 162.52 38.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.054 -1.461 . . . . 11.03 107.054 150.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -134.15 129.52 35.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.694 0.679 . . . . 13.17 110.449 175.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.16 126.01 11.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.306 -0.407 . . . . 13.78 111.378 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.11 33.96 88.65 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.113 -0.494 . . . . 15.28 112.885 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.04 11.23 81.51 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.832 -0.699 . . . . 13.44 112.05 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.35 170.99 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.317 -0.623 . . . . 11.28 109.317 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 p -119.28 143.66 47.21 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.04 0.447 . . . . 8.43 110.907 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 1.3 mp0 -85.87 122.0 29.32 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.822 -0.626 . . . . 10.79 111.584 175.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.423 HD13 HD22 ' A' ' 102' ' ' LEU . 19.5 mm -88.03 109.33 19.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.52 -0.764 . . . . 6.73 109.112 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 126' ' ' LYS . 1.3 mp -76.03 -52.17 10.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.379 -1.282 . . . . 9.17 109.264 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -144.74 170.83 15.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.688 -0.687 . . . . 10.44 110.322 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 109.85 -59.54 0.35 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.37 -0.919 . . . . 8.87 113.394 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.492 ' HG ' HG12 ' A' ' 125' ' ' VAL . 17.9 mt -96.83 -172.66 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.14 0.495 . . . . 8.5 111.828 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 63.7 tttm -149.77 154.89 39.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 14.48 109.212 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' VAL . . . -67.8 127.16 31.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.641 -0.708 . . . . 12.12 110.274 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.6 -8.35 28.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.033 -0.827 . . . . 12.39 111.033 -171.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.529 ' O ' HG21 ' A' ' 84' ' ' VAL . 32.5 mm-40 -97.27 116.63 29.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 11.89 109.343 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.1 mt-30 -91.29 135.67 33.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.754 -0.657 . . . . 11.1 111.549 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' HG11 ' A' ' 149' ' ' VAL . 2.5 p -127.97 138.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.756 -0.461 . . . . 5.45 109.756 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.5 m -62.71 134.55 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 O-C-N 123.442 0.464 . . . . 7.05 110.531 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.479 HG12 ' CB ' ' A' ' 82' ' ' ALA . 13.2 m . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 113.332 0.864 . . . . 6.99 113.332 -170.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.493 -0.558 . . . . 12.43 109.493 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.611 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 70.5 m-85 -109.41 -13.56 14.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.334 -0.394 . . . . 12.83 110.724 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.5 mt 67.25 -177.58 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 13.49 110.923 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.2 mt 62.72 52.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.997 0.904 . . . . 12.27 109.002 -175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.6 -28.18 31.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.038 -0.983 . . . . 11.22 111.441 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -59.24 -31.49 69.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.424 -1.262 . . . . 12.0 111.539 -169.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.66 -30.67 71.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.188 -1.369 . . . . 11.17 111.003 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.88 -25.68 40.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.656 -0.702 . . . . 8.27 110.525 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.5 m -80.79 -17.2 51.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 9.64 110.076 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.53 -48.82 71.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.206 -0.664 . . . . 10.88 109.206 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.02 -173.33 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.444 -0.798 . . . . 9.36 109.968 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.44 -50.39 4.4 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.779 -0.724 . . . . 7.46 112.649 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.4 p -80.98 -86.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.309 . . . . 7.09 110.993 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.7 91.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.541 -0.54 . . . . 9.62 109.541 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 9.11 110.572 -176.796 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.676 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 122.561 1.172 . . . . 10.77 109.76 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.608 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.1 mtp180 -135.71 135.19 39.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.196 -1.366 . . . . 8.86 108.986 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG12 ' CG ' ' A' ' 58' ' ' GLU . 23.3 mm -57.43 115.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 122.433 1.111 . . . . 5.76 112.173 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 mt -118.97 -35.42 3.65 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.773 -2.012 . . . . 8.55 110.679 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.64 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 19.8 p90 -168.82 179.07 4.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 8.07 109.704 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.684 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -117.29 164.3 15.02 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.185 -0.461 . . . . 5.61 111.523 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -145.31 177.22 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 9.75 110.204 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.535 ' HB3' HG21 ' A' ' 35' ' ' VAL . 12.0 t70 -124.13 138.43 30.74 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 107.845 -1.168 . . . . 8.31 107.845 170.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -60.3 -14.2 28.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.451 2.101 . . . . 10.41 112.738 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -101.43 -2.09 31.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.123 0.416 . . . . 11.24 112.123 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.0 m -125.45 38.28 0.4 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 113.58 0.956 . . . . 9.83 113.58 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 29.6 Cg_endo -58.49 133.3 53.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.305 2.003 . . . . 11.66 112.518 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.78 -6.3 29.46 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.272 -0.731 . . . . 10.86 111.272 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.691 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -87.54 179.38 6.56 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 9.42 109.194 177.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.521 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 4.5 tmm_? -157.0 93.29 1.33 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.785 -0.82 . . . . 12.03 108.785 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 91.3 m-85 -73.71 142.24 46.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.071 0.462 . . . . 7.9 109.99 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.27 -30.58 71.63 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.886 -1.052 . . . . 10.61 110.273 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.442 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -165.15 164.39 12.77 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.699 -0.682 . . . . 11.24 111.586 -177.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.684 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.1 Cg_endo -50.73 170.21 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.689 2.926 . . . . 7.51 113.313 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.01 -159.34 27.63 Favored Glycine 0 CA--C 1.508 -0.383 0 C-N-CA 120.24 -0.981 . . . . 8.06 112.735 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 3.0 ttmm -95.3 144.33 25.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.335 -0.617 . . . . 12.05 109.335 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.534 ' OG ' ' HG3' ' A' ' 49' ' ' MET . 25.0 p -64.56 145.02 98.71 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 9.2 111.873 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.24 -22.2 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.258 1.972 . . . . 10.25 112.904 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 96.0 m-85 -86.31 -15.83 39.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.41 1.1 . . . . 10.49 110.068 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.534 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.16 -164.06 1.85 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.506 -1.679 . . . . 10.74 109.012 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 5.7 p-10 -133.21 57.15 1.82 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.614 0.721 . . . . 12.54 110.781 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.407 ' HE3' ' OD2' ' A' ' 32' ' ' ASP . 8.9 ptm -133.35 142.93 46.03 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.134 -0.939 . . . . 10.35 108.954 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.09 132.13 37.8 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.617 1.545 . . . . 10.11 110.658 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.26 164.2 5.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.341 0.591 . . . . 7.0 111.854 -174.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.72 130.8 22.36 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.726 -0.842 . . . . 8.28 108.726 -177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.24 136.83 35.41 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.855 1.703 . . . . 6.21 112.405 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 27.1 m -63.18 160.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.64 -1.164 . . . . 6.41 112.419 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.676 ' CD1' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER 7.13 -66.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.476 2.31 . . . . 8.58 116.054 177.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.597 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -62.57 -48.32 79.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.236 1.017 . . . . 7.04 110.352 -171.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-N 112.532 -2.122 . . . . 8.58 113.37 174.88 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.039 -0.726 . . . . 12.25 109.039 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 148' ' ' VAL . 82.5 p -127.92 177.86 6.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.367 0.603 . . . . 8.3 110.253 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 149' ' ' VAL . . . -140.88 126.36 18.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.102 -1.073 . . . . 7.51 108.102 171.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 34.4 tt0 -79.02 139.39 38.18 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.639 -0.504 . . . . 12.15 109.639 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 145' ' ' GLN . 53.3 t -62.03 133.3 27.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.33 0.585 . . . . 9.71 112.395 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -137.47 150.57 47.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.452 -1.249 . . . . 11.77 108.393 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 8.1 mp -77.53 147.99 35.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.148 -0.686 . . . . 13.03 109.148 169.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.316 -0.945 . . . . 13.49 112.938 -178.858 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 . . . . . 0 CA--C 1.507 -0.709 0 CA-C-O 121.685 0.755 . . . . 14.94 110.668 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -112.62 170.21 8.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.435 -1.257 . . . . 11.02 110.384 -173.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.573 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -100.75 113.38 26.22 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.953 -0.758 . . . . 9.27 108.953 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.74 129.5 36.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 10.57 110.868 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 34.1 m -142.41 161.65 48.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.858 -1.064 . . . . 6.4 108.409 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.88 134.79 55.52 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.707 1.605 . . . . 7.48 110.5 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 p -67.28 -24.63 65.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.103 -0.373 . . . . 9.53 110.984 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -90.96 7.26 41.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.512 -0.313 . . . . 10.86 111.153 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.9 -40.68 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.084 0.468 . . . . 5.39 110.615 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -83.18 162.36 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.608 -0.723 . . . . 7.08 111.572 -173.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 109' ' ' THR . 18.7 mm -104.63 119.81 54.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.524 -0.762 . . . . 10.63 109.997 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -96.13 120.75 36.98 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.629 -0.828 . . . . 12.12 109.97 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -147.3 140.59 25.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.955 -0.566 . . . . 14.98 110.36 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 56.88 -112.63 3.64 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.131 -0.557 . . . . 16.43 112.556 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.96 29.38 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.823 0.305 . . . . 15.35 111.823 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.413 ' NH1' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -162.41 -176.82 5.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 15.67 111.464 -174.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 46.7 m -125.43 147.94 49.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.725 -0.671 . . . . 9.26 110.572 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.9 mm -124.82 151.79 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.351 -0.611 . . . . 10.94 109.351 176.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.43 134.17 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.49 -0.131 . . . . 7.39 110.667 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 38.5 mtm -93.98 101.46 13.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 8.85 109.432 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 9.5 p -85.32 138.45 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 10.13 111.329 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.06 95.3 3.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.07 -0.513 . . . . 10.7 110.937 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -80.02 163.3 24.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.245 0.545 . . . . 15.12 110.454 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.52 15.15 47.81 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.417 -0.811 . . . . 16.92 111.406 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.26 11.6 39.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.449 0.642 . . . . 18.56 110.619 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.28 11.9 74.52 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.158 -0.928 . . . . 16.28 113.516 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.88 168.04 25.76 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.578 -0.82 . . . . 14.36 112.203 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' A' ' 120' ' ' PHE . 80.7 m-85 -110.18 109.86 20.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.533 -0.543 . . . . 12.49 109.533 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 9.3 t70 -92.6 140.58 23.96 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.781 -0.645 . . . . 13.91 110.772 -170.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 121' ' ' ASP . 19.4 Cg_endo -84.2 127.88 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.196 1.93 . . . . 13.02 112.71 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 125' ' ' VAL . 1.8 t -115.48 129.05 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.119 -0.946 . . . . 10.41 109.351 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -73.03 120.86 19.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.37 -0.604 . . . . 12.93 109.37 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.558 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -132.48 159.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.411 0.624 . . . . 8.03 111.212 -174.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -103.94 129.32 51.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.225 -0.898 . . . . 10.66 109.647 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.55 114.83 8.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.712 -0.222 . . . . 8.3 111.303 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 117.818 -2.134 . . . . 10.1 114.251 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.24 164.62 35.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.268 -1.012 . . . . 11.03 108.268 154.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -143.61 126.75 16.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.308 0.504 . . . . 13.17 110.086 170.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.21 118.95 6.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 13.78 111.336 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.27 36.24 92.54 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.231 -0.509 . . . . 15.28 112.697 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.32 20.96 80.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.559 -0.829 . . . . 13.44 111.618 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' VAL . 38.3 mt-30 -128.49 170.49 13.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.365 -0.606 . . . . 11.28 109.365 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.5 t -125.12 156.82 37.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.604 -0.517 . . . . 8.43 109.604 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 46.6 mt-10 -101.06 112.97 25.57 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.664 0.745 . . . . 10.79 110.577 175.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.593 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 24.5 mm -79.87 106.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.741 -1.118 . . . . 6.73 109.641 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.476 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.4 mp -70.48 -49.67 46.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.885 -1.052 . . . . 9.17 109.878 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 125' ' ' VAL . 41.0 mt-10 -141.75 165.6 27.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.44 109.528 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.524 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 116.95 -67.42 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.683 -1.246 . . . . 8.87 113.593 175.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.32 -174.97 2.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 8.5 112.16 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 38.4 ttpt -149.32 154.97 39.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.558 -0.746 . . . . 14.48 109.748 -176.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.33 131.49 45.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.487 -0.779 . . . . 12.12 110.1 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.35 -7.72 47.48 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.948 -0.861 . . . . 12.39 110.948 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.581 ' O ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -100.8 119.07 38.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.812 -0.81 . . . . 11.89 108.812 177.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.7 pt20 -104.88 132.27 51.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.686 0.755 . . . . 11.1 109.676 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.512 ' O ' HG21 ' A' ' 149' ' ' VAL . 17.1 m -116.38 153.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.439 -1.255 . . . . 5.45 110.025 -172.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 81' ' ' THR . 27.3 m -57.62 134.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.44 0.638 . . . . 7.05 111.413 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 147' ' ' VAL . 43.1 t . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.092 -0.958 . . . . 6.99 111.029 -173.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.811 0.338 . . . . 12.43 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -94.55 -10.27 32.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 12.83 110.334 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 28.8 tp -70.92 -57.07 4.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.124 0.488 . . . . 13.49 109.755 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.6 tt -118.19 112.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.567 -0.742 . . . . 12.27 110.449 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -76.26 -23.33 54.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 11.22 110.718 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.472 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 9.3 m -56.14 -54.87 39.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.203 0.525 . . . . 12.0 110.92 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 34.9 mm-40 -59.4 -40.0 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.274 -0.876 . . . . 11.17 110.895 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 8.27 111.657 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.8 m -79.55 -28.95 41.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 9.64 110.431 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 157' ' ' SER . 71.8 mt -83.16 -28.29 29.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.517 -0.765 . . . . 10.88 110.561 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 20.1 mtp180 -70.53 146.13 50.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.331 -0.85 . . . . 9.36 112.404 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.44 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . -176.08 23.98 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.783 -1.098 . . . . 7.46 111.888 169.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 3.8 p 46.99 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.751 0.821 . . . . 7.09 112.964 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.6 t 59.84 66.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.558 0.694 . . . . 9.62 109.587 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.621 -0.718 . . . . 9.11 110.875 -178.016 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 122.963 1.363 . . . . 10.77 108.555 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 9.3 mmm180 -113.41 140.06 48.38 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.752 -1.567 . . . . 8.86 109.476 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.631 HG22 ' CZ3' ' A' ' 30' ' ' TRP . 11.9 mm -52.49 121.4 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 123.937 0.773 . . . . 5.76 112.661 -170.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.16 -37.43 10.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.177 -1.374 . . . . 8.55 110.284 172.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 29.8 p90 -172.24 -175.63 1.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.162 0.506 . . . . 8.07 111.125 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.714 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.29 154.25 35.24 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.14 -0.936 . . . . 5.61 110.627 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -162.91 148.98 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.567 0.542 . . . . 9.75 110.447 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.621 ' HB2' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -69.77 137.61 87.89 Favored Pre-proline 0 CA--C 1.514 -0.413 0 N-CA-C 108.386 -0.968 . . . . 8.31 108.386 169.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -62.01 -11.84 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.393 2.062 . . . . 10.41 110.77 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -98.76 1.33 45.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.613 -0.721 . . . . 11.24 111.215 177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.621 HG23 ' HB2' ' A' ' 32' ' ' ASP . 10.3 m -130.98 49.86 5.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 121.238 0.542 . . . . 9.83 112.03 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.05 121.13 7.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.781 2.321 . . . . 11.66 112.584 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.34 -25.86 11.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.82 -0.705 . . . . 10.86 112.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.488 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -69.43 105.98 2.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.415 0.626 . . . . 9.42 111.004 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.725 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 45.2 ttp180 -89.61 101.28 13.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.343 -0.844 . . . . 12.03 110.521 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 72.0 m-85 -82.94 147.24 28.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 7.9 110.252 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.83 -25.63 68.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.396 -1.275 . . . . 10.61 111.406 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 53.8 pttt -172.46 164.62 3.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 11.24 111.3 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.714 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.0 Cg_endo -50.7 170.06 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.729 2.952 . . . . 7.51 113.626 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.16 -166.03 26.83 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.692 -0.766 . . . . 8.06 112.421 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 5.3 ttmm -93.21 141.56 28.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.059 -0.719 . . . . 12.05 109.059 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.577 ' HB3' ' O ' ' A' ' 49' ' ' MET . 41.2 t -61.07 139.87 94.21 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.535 -0.757 . . . . 9.2 111.64 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.19 -20.8 18.52 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.74 2.294 . . . . 10.25 111.468 171.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 27.1 m-85 -87.67 -42.83 12.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.512 -1.222 . . . . 10.49 109.666 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -133.92 155.28 50.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.34 -0.846 . . . . 10.74 111.965 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.1 p-10 -82.35 61.42 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.282 1.039 . . . . 12.54 110.834 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.96 143.39 48.84 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.732 -1.122 . . . . 10.35 109.392 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.75 132.9 32.06 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.178 1.252 . . . . 10.11 109.218 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.44 158.69 14.21 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.029 -0.268 . . . . 7.0 110.681 -175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.95 130.51 24.96 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-O 121.217 0.532 . . . . 8.28 110.118 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 88.2 Cg_endo -79.09 139.74 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.135 1.89 . . . . 6.21 113.14 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 34.1 m -61.43 161.81 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.743 -1.571 . . . . 6.41 112.97 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.463 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.79 -84.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.049 2.14 . . . . 8.58 115.706 -178.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.591 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -48.6 -43.57 36.26 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.92 0.762 . . . . 7.04 111.421 -173.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 35.7 tt0 . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 122.271 1.034 . . . . 8.58 109.655 -171.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 108.429 -0.952 . . . . 12.25 108.429 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 146' ' ' GLN . 77.0 p -108.74 139.17 43.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.447 -0.342 . . . . 8.3 110.526 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.411 ' CB ' HG13 ' A' ' 149' ' ' VAL . . . -107.33 129.77 54.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.906 -0.776 . . . . 7.51 108.906 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.04 134.79 40.0 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.237 -0.438 . . . . 12.15 110.065 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.577 HG12 ' HB3' ' A' ' 95' ' ' LEU . 73.6 t -63.13 130.05 27.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.686 0.755 . . . . 9.71 110.958 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.04 146.56 10.87 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.33 -1.305 . . . . 11.77 109.683 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.13 161.33 31.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 13.03 111.091 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.524 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.786 0 C-N-CA 120.432 -0.889 . . . . 13.49 112.82 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 110.212 -0.292 . . . . 14.94 110.212 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.555 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -126.43 160.0 31.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.446 -0.343 . . . . 11.02 110.1 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -89.3 114.54 25.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.844 -0.799 . . . . 9.27 108.844 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -87.71 133.19 33.89 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.054 0.454 . . . . 10.57 111.365 -173.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.498 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 6.4 p -145.85 146.7 29.79 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.333 -0.849 . . . . 6.4 109.419 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.6 130.77 41.76 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.338 2.025 . . . . 7.48 110.518 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.9 p -55.22 -24.35 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.134 0.79 . . . . 9.53 113.134 -172.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -90.4 6.84 41.54 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.854 -0.529 . . . . 10.86 111.929 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . . . -82.16 -39.14 23.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.257 0.551 . . . . 5.39 110.629 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -91.93 156.04 17.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.6 -0.727 . . . . 7.08 111.767 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.1 mm -120.07 103.51 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 115.409 -0.814 . . . . 10.63 110.376 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER -109.3 98.23 7.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.581 -1.248 . . . . 12.12 112.166 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -107.44 142.98 36.43 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.896 -1.502 . . . . 14.98 109.386 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.36 -107.07 1.93 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.59 -0.814 . . . . 16.43 112.23 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.66 17.48 11.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.028 0.751 . . . . 15.35 113.028 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 17.5 ptt180 -160.0 166.61 29.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.129 0.788 . . . . 15.67 113.129 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.1 m -113.79 154.42 27.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.229 -0.896 . . . . 9.26 110.729 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 32.8 mm -133.97 149.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.981 -0.554 . . . . 10.94 109.834 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.567 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -135.19 130.17 34.91 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.476 0.31 . . . . 7.39 110.289 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 37.6 ttp -84.24 100.2 11.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.737 -0.838 . . . . 8.85 108.737 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 121' ' ' ASP . 13.6 p -87.77 134.48 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.602 -0.726 . . . . 10.13 111.736 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -83.98 94.45 8.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.668 -0.696 . . . . 10.7 109.638 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HZ1' ' HB2' ' A' ' 121' ' ' ASP . 54.2 mttp -75.41 148.82 38.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 15.12 110.748 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.18 -0.71 30.27 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.592 -0.731 . . . . 16.92 111.991 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.35 9.47 20.41 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.466 0.65 . . . . 18.56 110.59 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.77 10.69 78.63 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.282 -0.872 . . . . 16.28 113.295 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.65 160.77 23.89 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.436 -0.888 . . . . 14.36 112.475 -174.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 91.9 m-85 -112.3 126.57 55.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 12.49 109.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 113' ' ' VAL . 5.9 m-20 -129.24 150.69 76.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.968 -0.293 . . . . 13.91 111.495 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 123.65 2.01 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.47 2.113 . . . . 13.02 112.147 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 111' ' ' ALA . 6.1 p -108.98 134.67 50.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.349 -0.841 . . . . 10.41 110.015 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 110' ' ' ILE . 34.1 tt0 -74.26 120.47 19.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.514 . . . . 12.93 109.611 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.538 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -128.62 156.45 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.721 -0.672 . . . . 8.03 111.657 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.8 ttmm -101.61 126.67 48.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.918 -1.037 . . . . 10.66 109.459 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.46 107.79 5.01 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.379 -0.373 . . . . 8.3 111.625 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.01 0.29 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 117.684 -2.198 . . . . 10.1 114.539 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -149.57 163.04 38.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.494 -0.928 . . . . 11.03 108.494 154.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.93 128.28 26.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 118.12 0.418 . . . . 13.17 110.163 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.66 126.76 9.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.327 -0.397 . . . . 13.78 111.48 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.85 24.59 74.29 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.194 -0.457 . . . . 15.28 112.498 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 14.45 81.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.61 -0.805 . . . . 13.44 111.388 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -119.21 171.09 8.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.528 -0.545 . . . . 11.28 109.528 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.515 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 6.2 p -119.13 154.17 33.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 116.405 -0.361 . . . . 8.43 110.222 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 51.8 mt-10 -100.83 124.53 46.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.438 0.637 . . . . 10.79 111.4 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 20.2 mm -88.86 112.16 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.183 -0.917 . . . . 6.73 109.908 174.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.8 mp -79.18 -44.99 20.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.603 -1.181 . . . . 9.17 109.649 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.482 ' O ' HG21 ' A' ' 125' ' ' VAL . 39.6 mt-10 -146.04 166.71 25.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.824 -0.626 . . . . 10.44 109.318 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 120.42 -70.47 0.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.798 -1.191 . . . . 8.87 113.528 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 mt -97.52 -179.19 4.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.382 0.611 . . . . 8.5 112.306 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -137.55 151.79 48.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.954 -1.021 . . . . 14.48 109.732 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.11 135.79 51.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.842 -1.072 . . . . 12.12 110.632 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.94 50.02 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.328 -0.709 . . . . 12.39 111.328 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -103.68 156.97 17.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.568 -0.53 . . . . 11.89 109.568 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 38.2 mt-30 -111.03 146.32 36.92 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.11 0.481 . . . . 11.1 110.703 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 p -132.84 137.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.448 -0.796 . . . . 5.45 109.011 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.61 124.13 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.35 0.595 . . . . 7.05 110.69 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.411 HG13 ' CB ' ' A' ' 82' ' ' ALA . 1.9 m . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.676 -0.693 . . . . 6.99 109.71 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.422 ' O ' HD13 ' A' ' 154' ' ' LEU . 10.7 pt20 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.468 -0.567 . . . . 12.43 109.468 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.4 85.44 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.62 0.248 . . . . 12.83 110.381 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.523 HD13 ' H ' ' A' ' 154' ' ' LEU . 6.3 mp -40.3 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.796 1.31 . . . . 13.49 112.43 -171.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.0 mt -149.35 114.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.936 -0.764 . . . . 12.27 108.936 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.93 -77.39 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.708 0.766 . . . . 11.22 112.454 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.3 p -64.48 -42.31 95.96 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.826 -1.079 . . . . 12.0 112.633 -162.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -68.63 -28.32 66.8 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.837 -0.62 . . . . 11.17 109.979 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.26 -18.86 54.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.435 -0.802 . . . . 8.27 110.562 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.3 t -81.29 -41.65 21.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.857 -0.61 . . . . 9.64 109.572 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.45 -35.67 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.706 -0.679 . . . . 10.88 110.937 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 162' ' ' ARG . 34.9 mtt180 -98.44 -161.47 0.88 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.363 -0.606 . . . . 9.36 109.363 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 177.89 -56.55 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.912 -0.661 . . . . 7.46 111.889 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.6 p -102.48 -26.38 13.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.672 . . . . 7.09 110.042 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.6 t -87.75 76.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.561 -0.745 . . . . 9.62 110.14 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.097 -0.501 . . . . 9.11 110.911 -179.5 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 107.924 -1.139 . . . . 10.77 107.924 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.408 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 18.2 mmm180 -126.14 137.07 53.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.762 -1.563 . . . . 8.86 110.564 -174.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.677 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.6 mm -46.36 131.91 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.343 -1.299 . . . . 5.76 113.66 -168.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -120.29 -29.9 4.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.843 -1.526 . . . . 8.55 108.227 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 16.4 p90 -175.24 -176.63 0.95 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.315 -0.857 . . . . 8.07 111.602 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.672 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.99 153.67 45.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.119 -0.946 . . . . 5.61 110.593 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -157.36 152.22 25.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 9.75 110.4 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HB3' HG21 ' A' ' 35' ' ' VAL . 9.7 t70 -86.85 137.39 33.55 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.278 -0.638 . . . . 8.31 109.278 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HG3' HG13 ' A' ' 54' ' ' ILE . 16.5 Cg_exo -63.4 -14.93 45.25 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.495 2.13 . . . . 10.41 112.358 177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.502 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -97.32 0.57 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.718 0.294 . . . . 11.24 111.147 176.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -126.84 40.08 0.54 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.276 0.473 . . . . 9.83 112.276 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 13.8 Cg_endo -52.06 126.16 19.39 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.66 2.24 . . . . 11.66 112.812 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.36 -20.31 28.1 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 10.86 111.491 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.576 ' HB3' HG22 ' A' ' 35' ' ' VAL . 20.2 tp60 -81.42 102.92 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.239 0.542 . . . . 9.42 110.339 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 21.1 ttp180 -89.95 111.85 23.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.571 -0.74 . . . . 12.03 110.515 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.716 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 91.8 m-85 -92.67 127.72 38.27 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 108.036 -1.098 . . . . 7.9 108.036 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.79 -18.12 64.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.332 -0.547 . . . . 10.61 112.173 -171.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.525 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.3 mttt -141.4 170.09 10.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.738 -0.385 . . . . 11.24 111.01 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -52.82 170.43 0.29 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.522 2.815 . . . . 7.51 113.586 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.9 -167.15 29.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.39 -0.91 . . . . 8.06 113.421 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 9.4 ttmt -97.03 148.06 23.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.203 -0.666 . . . . 12.05 109.203 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.409 ' HA ' HD23 ' A' ' 53' ' ' LEU . 75.6 p -62.9 136.51 96.56 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 115.457 -0.792 . . . . 9.2 110.57 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.25 -25.4 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.894 1.729 . . . . 10.25 111.59 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.609 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 88.0 m-85 -81.82 -31.19 31.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.625 -0.716 . . . . 10.49 110.631 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.51 ' HE1' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.12 -159.74 0.88 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.501 -0.925 . . . . 10.74 108.501 173.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -130.67 54.92 1.86 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.687 0.756 . . . . 12.54 109.751 172.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 ptm -127.71 145.04 53.39 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 114.526 -1.216 . . . . 10.35 109.394 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.57 133.28 47.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.679 1.586 . . . . 10.11 109.971 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 46' ' ' SER . 24.2 mt -62.67 165.05 6.86 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.408 0.442 . . . . 7.0 110.735 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 32.8 mm -99.7 129.21 29.29 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.497 -0.557 . . . . 8.28 109.497 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.672 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 56.0 Cg_endo -83.28 138.2 8.65 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.851 1.701 . . . . 6.21 113.274 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.46 159.51 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.725 -1.58 . . . . 6.41 113.431 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 14.98 -86.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.966 2.106 . . . . 8.58 115.512 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.677 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -49.65 -38.76 33.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.977 0.418 . . . . 7.04 110.26 -177.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 114.885 -1.052 . . . . 8.58 111.263 173.298 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.192 0.52 . . . . 12.25 110.242 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 148' ' ' VAL . 45.4 p -131.37 146.78 52.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.13 -0.941 . . . . 8.3 109.792 -176.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.0 128.08 56.07 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.867 -0.79 . . . . 7.51 108.867 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.76 131.71 35.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.07 -0.345 . . . . 12.15 110.07 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 145' ' ' GLN . 73.4 t -56.7 127.2 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-O 122.293 1.044 . . . . 9.71 112.066 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.83 136.27 8.99 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.888 -1.96 . . . . 11.77 109.035 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.506 ' CD1' ' H ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.61 168.83 19.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.894 -1.048 . . . . 13.03 112.44 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.586 0 CA-C-N 114.635 -1.166 . . . . 13.49 111.135 -169.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.994 -0.743 . . . . 14.94 108.994 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 1.9 ttp180 -132.44 149.2 52.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.71 . . . . 11.02 111.062 -172.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.7 mm? -77.51 120.83 23.03 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.391 0.432 . . . . 9.27 110.458 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.06 131.87 43.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.311 -0.404 . . . . 10.57 111.318 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.7 156.12 59.66 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 6.4 109.467 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HG2' HG12 ' A' ' 149' ' ' VAL . 52.7 Cg_exo -57.46 134.06 61.0 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.117 1.878 . . . . 7.48 110.663 171.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.535 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 21.7 t -61.56 -26.05 67.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.958 0.355 . . . . 9.53 111.958 -173.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.0 4.8 49.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.941 -0.474 . . . . 10.86 111.568 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.417 ' CB ' HG13 ' A' ' 149' ' ' VAL . . . -75.73 -32.88 60.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.413 0.625 . . . . 5.39 110.54 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.483 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 2.9 pp -101.99 168.21 9.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.278 -0.874 . . . . 7.08 111.918 -172.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 109' ' ' THR . 27.6 mm -121.26 101.84 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.062 -0.517 . . . . 10.63 110.129 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.611 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 2.7 ppt_? -109.35 108.04 18.45 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.195 -1.402 . . . . 12.12 111.131 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -123.73 136.11 54.25 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.76 -1.564 . . . . 14.98 109.143 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.64 -102.99 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.401 -0.904 . . . . 16.43 112.333 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.22 4.53 10.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.914 0.709 . . . . 15.35 112.914 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 176.14 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.773 0.657 . . . . 15.67 112.773 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.5 m -123.99 156.74 35.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.015 -0.993 . . . . 9.26 111.712 -169.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 26.4 mm -128.46 149.82 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.081 -0.711 . . . . 10.94 109.081 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.544 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -132.61 140.37 48.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.603 0.24 . . . . 7.39 110.924 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 67.9 mtp -92.52 100.75 13.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.434 -0.58 . . . . 8.85 109.434 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 121' ' ' ASP . 14.7 p -88.86 132.95 32.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 10.13 111.789 -174.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -79.19 83.85 5.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.376 -0.829 . . . . 10.7 109.774 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 46.5 mttm -75.18 146.93 40.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.771 -0.65 . . . . 15.12 110.972 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.0 5.2 42.28 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 16.92 111.138 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -85.61 9.77 15.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.626 0.727 . . . . 18.56 110.679 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.48 19.02 50.83 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.149 -0.932 . . . . 16.28 113.816 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.31 173.12 36.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.348 -0.93 . . . . 14.36 112.581 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.656 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 71.2 m-85 -109.84 109.24 19.83 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.194 -0.669 . . . . 12.49 109.194 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.0 t70 -101.57 145.72 30.95 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 13.91 110.502 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 20.1 Cg_endo -89.32 132.82 2.24 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.151 1.9 . . . . 13.02 112.406 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 111' ' ' ALA . 2.8 p -118.84 137.05 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.625 -0.716 . . . . 10.41 109.542 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 111.85 13.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 12.93 110.101 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.59 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -119.1 160.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.929 -1.032 . . . . 8.03 110.826 -175.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 23.5 ttmm -104.46 125.86 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.846 -0.615 . . . . 10.66 109.555 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.65 109.67 5.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.678 -0.237 . . . . 8.3 111.61 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.437 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -153.63 70.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.166 -1.968 . . . . 10.1 113.905 169.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -149.34 162.24 40.47 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.831 -0.803 . . . . 11.03 108.831 155.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 23.6 m -138.89 129.4 25.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.11 0.481 . . . . 13.17 109.871 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.73 102.31 5.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.645 -0.707 . . . . 13.78 110.675 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.63 24.39 76.25 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.041 -0.527 . . . . 15.28 112.492 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 97.51 -10.72 64.99 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.766 -0.73 . . . . 13.44 112.195 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 130' ' ' THR . 2.4 mp0 -97.49 162.98 13.05 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.84 -0.8 . . . . 11.28 108.84 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.4 p -114.63 155.36 26.69 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.431 -0.507 . . . . 8.43 111.172 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 25.7 mt-10 -100.02 128.5 46.09 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.5 0.667 . . . . 10.79 110.967 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 24.3 mm -92.02 101.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.133 -0.94 . . . . 6.73 109.772 175.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.477 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.6 mp -67.18 -45.63 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.836 -1.075 . . . . 9.17 109.845 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.541 ' O ' HG21 ' A' ' 125' ' ' VAL . 38.0 mt-10 -146.34 163.29 36.04 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.356 -0.609 . . . . 10.44 109.356 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.83 -46.95 1.05 Allowed Glycine 0 C--N 1.316 -0.572 0 C-N-CA 119.497 -1.335 . . . . 8.87 114.242 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.7 mt -123.22 -178.49 4.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.416 0.895 . . . . 8.5 113.416 -170.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.9 ttpt -142.39 155.23 45.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.569 -1.196 . . . . 14.48 108.846 -176.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.61 129.6 40.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.985 -0.552 . . . . 12.12 110.063 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.17 48.46 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.251 -0.74 . . . . 12.39 111.251 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.668 ' O ' HG21 ' A' ' 84' ' ' VAL . 15.8 mm100 -97.89 100.8 12.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.446 0.641 . . . . 11.89 109.334 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.437 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 38.1 mt-30 -74.11 127.4 32.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.356 -0.838 . . . . 11.1 110.307 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.69 135.83 56.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.601 0.238 . . . . 5.45 110.67 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.484 ' HA ' HG23 ' A' ' 81' ' ' THR . 42.6 t -66.43 115.05 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.864 -0.607 . . . . 7.05 110.473 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.417 HG13 ' CB ' ' A' ' 101' ' ' ALA . 4.1 m . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 6.99 110.759 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.922 0.391 . . . . 12.43 110.966 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.26 82.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 12.83 110.818 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 -168.72 2.15 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.514 -0.55 . . . . 13.49 109.514 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 157' ' ' SER . 28.8 pt -59.57 163.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 12.27 111.91 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.9 24.54 0.62 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.008 0.908 . . . . 11.22 111.206 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 155' ' ' ILE . 6.4 p -56.92 -27.11 60.48 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 114.456 -1.247 . . . . 12.0 111.218 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 1.5 mm-40 -57.9 -35.79 71.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 112.922 -1.945 . . . . 11.17 111.057 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.53 64.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.595 -0.73 . . . . 8.27 110.895 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.2 m -76.23 -25.64 55.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.507 0.67 . . . . 9.64 109.571 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.76 -16.53 44.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.111 -0.949 . . . . 10.88 110.756 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 13.4 mmm180 -89.45 131.21 35.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.316 0.579 . . . . 9.36 111.469 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.448 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . -148.06 62.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.292 -1.523 . . . . 7.46 109.292 173.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . 0.448 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 17.8 p 50.0 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.592 -0.521 . . . . 7.09 109.592 -161.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 166' ' ' ALA . 2.7 p -100.18 -65.89 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 9.62 109.997 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.569 ' H ' HG12 ' A' ' 165' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.385 0 C-N-CA 124.993 1.317 . . . . 9.11 108.547 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.23 -1.026 . . . . 10.77 108.23 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.498 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.3 mtm180 -136.73 138.61 41.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.168 -1.378 . . . . 8.86 109.484 -173.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -49.59 124.13 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.962 0.887 . . . . 5.76 112.21 -173.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.16 -37.6 4.99 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.648 -1.614 . . . . 8.55 110.942 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.613 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 4.0 p90 -176.29 -178.64 0.99 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 8.07 109.464 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.699 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.0 156.61 30.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.867 -0.606 . . . . 5.61 111.009 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.899 HH11 ' HH ' ' A' ' 29' ' ' TYR . 30.3 ptt180 -160.03 149.7 18.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.853 -1.067 . . . . 9.75 110.311 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.488 ' CB ' HG21 ' A' ' 35' ' ' VAL . 1.8 t0 -88.19 138.69 30.53 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.046 -0.724 . . . . 8.31 109.046 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HG3' HG13 ' A' ' 54' ' ' ILE . 32.8 Cg_exo -57.55 -20.61 42.28 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 123.498 2.799 . . . . 10.41 113.088 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -89.44 -24.4 21.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.354 0.597 . . . . 11.24 109.993 -177.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 ' CB ' ' A' ' 32' ' ' ASP . 3.3 m -117.95 37.16 0.24 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.107 -0.951 . . . . 9.83 113.526 -161.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 57.7 Cg_endo -60.78 108.29 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.881 2.387 . . . . 11.66 112.166 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.31 -18.29 0.91 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.496 -0.859 . . . . 10.86 112.474 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -77.26 -177.74 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.215 0.531 . . . . 9.42 111.646 174.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.633 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 5.2 tpp180 -148.26 91.73 1.95 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 12.03 109.729 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 77.5 m-85 -75.63 137.02 40.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.851 -0.74 . . . . 7.9 110.442 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.84 -29.94 71.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.745 -1.116 . . . . 10.61 110.032 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -165.04 164.28 13.03 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.338 -0.846 . . . . 11.24 110.608 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.699 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.3 Cg_endo -48.63 169.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.872 3.048 . . . . 7.51 114.351 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.14 -174.44 26.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.679 -0.772 . . . . 8.06 112.606 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.9 ttpm? -86.19 146.0 26.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.186 0.517 . . . . 12.05 110.986 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.513 ' HB3' ' O ' ' A' ' 49' ' ' MET . 32.9 t -58.43 136.33 85.53 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.764 -1.107 . . . . 9.2 110.924 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.55 -20.43 15.81 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 122.192 1.928 . . . . 10.25 110.912 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 46.6 m-85 -86.15 -42.63 13.7 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.672 -1.603 . . . . 10.49 109.597 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.5 mtm -129.5 152.65 48.81 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 115.779 -0.646 . . . . 10.74 111.339 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.74 60.7 5.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.747 1.261 . . . . 12.54 111.294 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.453 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -139.51 145.55 44.28 Favored Pre-proline 0 C--N 1.304 -1.371 0 CA-C-N 113.891 -1.504 . . . . 10.35 109.208 177.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 39.8 Cg_endo -67.57 133.86 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.934 1.756 . . . . 10.11 111.936 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.4 163.23 11.1 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.576 -0.528 . . . . 7.0 109.576 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.475 HG13 ' HG3' ' A' ' 33' ' ' PRO . 24.1 mm -98.02 132.81 23.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 120.989 0.423 . . . . 8.28 110.565 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.87 147.51 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.91 1.74 . . . . 6.21 112.208 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 35.2 m -73.02 158.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 114.657 -1.156 . . . . 6.41 112.679 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.498 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.89 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.235 2.214 . . . . 8.58 115.865 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.472 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.6 pt-20 -48.47 -44.16 35.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.477 0.711 . . . . 7.04 111.231 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' GLU . 33.5 tt0 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.759 -1.109 . . . . 8.58 111.414 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.891 -0.781 . . . . 12.25 108.891 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 148' ' ' VAL . 68.0 p -131.12 159.19 38.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 8.3 110.097 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 149' ' ' VAL . . . -121.59 128.64 52.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.668 -0.864 . . . . 7.51 108.668 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 33.9 tt0 -84.56 130.46 34.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.465 -0.569 . . . . 12.15 109.465 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 143' ' ' ALA . 20.5 m -64.35 141.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 122.888 1.328 . . . . 9.71 111.401 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.407 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -164.13 174.28 11.46 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.335 -2.212 . . . . 11.77 109.514 173.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 10.0 mp -70.48 167.91 17.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.572 0.701 . . . . 13.03 112.125 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.531 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.54 0 CA-C-N 115.33 -0.85 . . . . 13.49 112.604 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' HG2' HD21 ' A' ' 86' ' ' LEU . 7.8 mt-10 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.065 0.46 . . . . 14.94 110.575 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.632 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 1.5 mmp_? -121.11 168.13 11.89 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.87 -0.605 . . . . 11.02 111.248 -171.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.6 mm? -97.85 114.21 26.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.464 -0.789 . . . . 9.27 109.294 176.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.2 mm? -91.39 130.91 37.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.349 -0.841 . . . . 10.57 111.258 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.609 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 3.3 p -139.32 146.81 50.31 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.525 -1.216 . . . . 6.4 108.927 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 132.01 49.18 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.145 1.897 . . . . 7.48 109.595 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t -57.74 -25.55 60.57 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 9.53 112.312 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.38 4.48 52.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.945 0.35 . . . . 10.86 111.945 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . . . -79.84 -33.6 40.07 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.225 -0.59 . . . . 5.39 110.51 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.495 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -91.91 155.1 18.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.584 0.707 . . . . 7.08 111.967 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -99.18 125.43 52.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.08 -0.964 . . . . 10.63 109.029 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.8 mmm180 -98.1 125.69 43.21 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.677 -0.809 . . . . 12.12 110.911 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.9 t -149.15 127.26 12.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.722 -0.672 . . . . 14.98 110.818 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.41 -121.91 16.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.03 -0.532 . . . . 16.43 112.794 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.09 36.79 2.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 15.35 111.418 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -156.98 177.43 11.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.002 -0.544 . . . . 15.67 111.526 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 25.8 m -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.644 -0.707 . . . . 9.26 109.26 174.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.5 mm -126.92 150.7 33.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 10.94 109.125 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.564 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -136.35 130.02 32.22 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.242 -0.286 . . . . 7.39 110.839 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.407 ' HE1' HG12 ' A' ' 148' ' ' VAL . 38.7 mtm -84.71 100.25 11.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.846 -0.798 . . . . 8.85 108.846 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 11.3 p -81.95 134.46 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.825 -1.079 . . . . 10.13 111.208 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -83.59 91.56 7.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.539 -0.755 . . . . 10.7 110.235 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.48 147.94 35.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 15.12 111.035 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.16 -2.35 47.16 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.658 -0.701 . . . . 16.92 112.021 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.17 6.84 12.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.456 0.646 . . . . 18.56 111.058 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.67 67.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.243 -0.889 . . . . 16.28 113.197 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.6 -174.74 13.51 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.336 -0.935 . . . . 14.36 112.981 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.641 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 97.5 m-85 -132.08 128.26 37.83 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.068 0.547 . . . . 12.49 109.783 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.2 m-20 -125.37 147.72 58.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.594 -0.275 . . . . 13.91 111.024 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -85.37 124.87 2.86 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.391 2.061 . . . . 13.02 112.484 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 111' ' ' ALA . 4.4 p -106.19 135.73 43.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.87 -1.059 . . . . 10.41 109.078 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.23 122.75 28.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.057 -0.72 . . . . 12.93 109.057 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.746 HG21 ' O ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -137.02 157.16 35.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.402 0.62 . . . . 8.03 112.215 -173.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 76.1 tttt -93.73 128.68 40.06 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.092 -0.958 . . . . 10.66 110.208 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.19 104.39 4.44 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.782 -0.644 . . . . 8.3 111.075 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.32 71.28 0.28 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 117.924 -2.084 . . . . 10.1 113.882 169.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.566 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -149.83 164.14 36.14 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.892 -0.781 . . . . 11.03 108.892 157.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -133.48 128.32 35.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.709 -0.478 . . . . 13.17 109.709 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.87 122.49 7.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.514 -0.312 . . . . 13.78 111.58 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.31 92.31 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.933 -0.576 . . . . 15.28 113.101 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.99 78.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 13.44 111.687 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -130.6 171.67 12.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.936 -0.765 . . . . 11.28 108.936 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -115.21 156.58 25.08 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.649 -0.501 . . . . 8.43 109.649 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.566 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 50.7 mt-10 -102.36 124.07 47.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.562 0.696 . . . . 10.79 111.375 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.595 HD13 HG22 ' A' ' 125' ' ' VAL . 26.0 mm -86.04 111.83 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.963 -1.017 . . . . 6.73 109.16 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.632 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 3.8 mp -81.15 -45.69 16.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.974 -1.012 . . . . 9.17 111.006 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.746 ' O ' HG21 ' A' ' 125' ' ' VAL . 42.6 mt-10 -146.59 173.02 12.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.139 -0.689 . . . . 10.44 109.139 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 93.2 -63.01 2.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.144 -1.027 . . . . 8.87 113.715 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.534 HD12 HG12 ' A' ' 123' ' ' VAL . 35.9 tp -105.41 145.09 31.28 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.234 -1.024 . . . . 8.5 108.234 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.686 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 85.8 tttt -136.34 143.8 44.29 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 112.734 0.642 . . . . 14.48 112.734 -161.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -49.62 123.91 8.62 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.845 -1.525 . . . . 12.12 111.375 -173.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.1 1.12 38.72 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 114.853 -1.067 . . . . 12.39 111.286 -171.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.686 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 14.8 mm100 -103.7 125.52 50.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.766 -0.773 . . . . 11.89 110.097 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 mp0 -85.39 142.83 29.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.728 -0.669 . . . . 11.1 110.577 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 149' ' ' VAL . 16.1 m -135.27 147.27 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.472 0.177 . . . . 5.45 110.597 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.506 ' HA ' HG23 ' A' ' 81' ' ' THR . 22.6 m -57.84 133.72 22.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 O-C-N 123.855 0.722 . . . . 7.05 111.878 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.473 HG22 ' CB ' ' A' ' 82' ' ' ALA . 45.9 t . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.2 -0.909 . . . . 6.99 110.546 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.83 0.348 . . . . 12.43 111.02 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.65 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 96.4 m-85 -99.91 -166.72 1.37 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 12.83 110.001 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.2 171.35 20.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.287 0.565 . . . . 13.49 110.23 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.9 mt 63.84 61.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 114.393 -1.276 . . . . 12.27 111.183 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.26 -9.37 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 11.22 111.279 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.8 p -61.52 -41.13 96.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.308 0.575 . . . . 12.0 110.593 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.51 -30.8 63.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 11.17 109.799 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.65 -17.9 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.98 -1.009 . . . . 8.27 110.482 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.3 m -81.44 -31.66 32.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.511 -0.768 . . . . 9.64 110.465 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.3 -31.03 48.7 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.297 -0.865 . . . . 10.88 110.833 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -81.47 166.97 19.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.725 -0.671 . . . . 9.36 109.546 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.95 71.95 2.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.089 -0.576 . . . . 7.46 111.84 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.9 p 53.4 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.273 1.029 . . . . 7.09 112.022 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.43 -45.92 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 110.209 -0.293 . . . . 9.62 110.209 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 O-C-N 123.589 0.556 . . . . 9.11 111.601 -177.892 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 107.942 -1.132 . . . . 10.77 107.942 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.525 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 3.1 mtp180 -134.8 140.81 46.16 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.161 -1.381 . . . . 8.86 109.239 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG12 ' HG2' ' A' ' 58' ' ' GLU . 46.2 mm -51.96 118.24 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.068 -0.969 . . . . 5.76 113.286 -169.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.19 -32.97 7.0 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.8 -1.546 . . . . 8.55 110.009 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' A' ' 29' ' ' TYR . 37.6 p90 -179.51 -176.09 0.37 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.734 -0.667 . . . . 8.07 109.625 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.602 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -118.77 154.98 31.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.714 . . . . 5.61 110.908 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.444 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 39.2 ptt180 -164.06 148.01 9.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.834 0.708 . . . . 9.75 109.721 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 1.005 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 9.4 m-20 -70.73 142.05 88.04 Favored Pre-proline 0 CA--C 1.51 -0.585 0 N-CA-C 108.986 -0.746 . . . . 8.31 108.986 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.536 ' HD3' ' CG1' ' A' ' 54' ' ' ILE . 74.6 Cg_endo -68.87 -11.82 32.86 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 123.142 2.562 . . . . 10.41 112.353 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 1.005 ' SD ' ' HB3' ' A' ' 32' ' ' ASP . 1.2 pmm? -102.75 1.34 34.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.289 . . . . 11.24 111.265 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 32' ' ' ASP . 3.8 m -124.63 39.41 0.45 Allowed Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 112.627 0.603 . . . . 9.83 112.627 177.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.2 Cg_endo -54.41 126.37 22.02 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.305 2.003 . . . . 11.66 112.334 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.86 -12.51 17.65 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.174 -0.771 . . . . 10.86 111.174 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 15.7 tp60 -90.61 108.22 19.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.323 0.583 . . . . 9.42 110.394 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.578 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.7 tmm_? -91.48 97.35 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 12.03 109.414 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 78.5 m-85 -77.25 146.59 36.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 7.9 110.715 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.1 -26.68 68.94 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.255 -1.339 . . . . 10.61 111.264 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 12.7 ptmm? -173.12 168.37 2.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.005 -0.543 . . . . 11.24 110.156 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.2 Cg_endo -52.35 169.29 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.502 2.134 . . . . 7.51 112.52 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.72 -160.01 27.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 8.06 111.644 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.541 ' HB3' ' HZ2' ' A' ' 45' ' ' LYS . 7.1 ttpm? -99.98 151.23 21.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.444 0.64 . . . . 12.05 110.627 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 49' ' ' MET . 36.3 t -67.89 145.32 97.84 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.718 -1.128 . . . . 9.2 111.86 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.08 -19.9 4.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.783 2.322 . . . . 10.25 111.504 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 59.3 m-85 -81.45 -38.01 27.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.79 -1.096 . . . . 10.49 109.321 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.7 pmm? -153.46 171.41 18.72 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.395 -0.82 . . . . 10.74 110.338 172.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.16 76.65 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.512 0.93 . . . . 12.54 113.512 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 9.6 ptm -143.9 147.12 37.08 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.857 -1.164 . . . . 10.35 107.857 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 36.6 Cg_endo -67.23 135.99 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.336 1.357 . . . . 10.11 110.12 171.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.89 166.98 6.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.265 0.555 . . . . 7.0 112.096 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.536 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 39.1 mm -101.95 130.51 24.25 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.696 -0.684 . . . . 8.28 109.65 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 17.6 Cg_endo -83.02 134.13 6.91 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.359 1.373 . . . . 6.21 112.21 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 35.3 m -56.03 157.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.254 -1.339 . . . . 6.41 113.099 -176.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.48 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.935 2.094 . . . . 8.58 115.122 -177.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.544 ' HG2' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -45.68 -41.94 11.03 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.022 0.529 . . . . 7.04 110.747 -178.067 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 32.7 tt0 . . . . . 0 C--N 1.317 -0.828 0 O-C-N 123.669 0.606 . . . . 8.58 111.8 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.969 0.414 . . . . 12.25 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 148' ' ' VAL . 25.9 p -125.37 137.5 54.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.552 -0.749 . . . . 8.3 109.949 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -110.47 128.0 55.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.247 -0.649 . . . . 7.51 109.247 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 34.3 tt0 -74.27 132.78 42.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.072 -0.714 . . . . 12.15 109.072 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 95' ' ' LEU . 49.6 t -55.04 132.63 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.013 -0.539 . . . . 9.71 112.301 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 25.3 mmtp -138.37 148.35 44.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.966 -1.016 . . . . 11.77 109.284 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.83 149.98 36.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.854 -0.795 . . . . 13.03 108.854 167.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.45 ' N ' HD22 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.507 -0.407 0 C-N-CA 120.166 -1.016 . . . . 13.49 112.527 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 . . . . . 0 CA--C 1.51 -0.566 0 CA-C-O 121.775 0.798 . . . . 14.94 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 136' ' ' GLU . 2.1 mpp_? -132.29 169.61 16.23 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.316 -1.311 . . . . 11.02 109.5 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.583 ' HB3' HG11 ' A' ' 84' ' ' VAL . 2.4 mm? -94.19 112.69 24.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.555 -0.906 . . . . 9.27 108.555 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -88.44 131.78 34.73 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.532 -0.758 . . . . 10.57 110.667 -175.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.84 147.0 25.66 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.059 -0.973 . . . . 6.4 109.089 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.05 130.01 37.27 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.407 2.071 . . . . 7.48 110.742 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 40.3 t -56.28 -28.07 57.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.017 0.747 . . . . 9.53 113.017 -170.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.4 9.22 13.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.544 -0.462 . . . . 10.86 111.504 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -82.81 -33.7 27.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.156 0.503 . . . . 5.39 111.469 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.6 pp -100.63 165.08 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.324 0.583 . . . . 7.08 112.334 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 109' ' ' THR . 25.3 mm -104.29 118.62 51.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.45 -0.796 . . . . 10.63 110.294 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -103.91 94.83 5.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.811 0.339 . . . . 12.12 110.392 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.5 t -145.59 131.16 18.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.5 0.666 . . . . 14.98 111.602 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.88 -123.38 6.16 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.106 -0.952 . . . . 16.43 111.999 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.92 28.18 8.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.102 0.477 . . . . 15.35 111.16 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.42 178.36 9.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 15.67 111.165 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.1 m -128.58 149.99 50.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.937 -0.574 . . . . 9.26 110.35 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 110' ' ' ILE . 3.7 mp -126.23 153.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 110.214 -0.291 . . . . 10.94 110.214 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.621 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -130.78 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.459 -0.2 . . . . 7.39 110.459 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 64.1 mtm -99.4 102.88 14.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.539 -0.541 . . . . 8.85 109.539 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 121' ' ' ASP . 8.3 p -85.77 137.24 21.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.111 0.482 . . . . 10.13 111.451 -172.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 91.98 3.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.651 -0.704 . . . . 10.7 111.513 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -80.06 162.92 24.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.975 -0.557 . . . . 15.12 110.376 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.24 17.87 26.12 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.848 -0.614 . . . . 16.92 112.083 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.52 11.41 39.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 18.56 110.805 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.28 -6.59 67.34 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.56 -0.746 . . . . 16.28 112.467 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.3 167.25 12.92 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.851 -0.499 . . . . 14.36 111.851 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.646 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 56.5 m-85 -117.54 111.27 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.467 0.651 . . . . 12.49 109.976 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 113' ' ' VAL . 30.4 t70 -91.49 134.11 30.04 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.093 -0.958 . . . . 13.91 111.328 -171.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 61.2 Cg_endo -80.58 137.1 11.32 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.201 1.934 . . . . 13.02 113.268 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 12.2 p -123.64 127.13 73.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.987 -1.006 . . . . 10.41 109.821 177.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -82.62 114.63 21.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.652 -0.499 . . . . 12.93 109.652 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.431 HG13 ' HA3' ' A' ' 140' ' ' GLY . 35.6 m -130.06 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.671 -0.695 . . . . 8.03 111.208 -173.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 3.5 ttmp? -109.52 127.33 54.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.146 -0.479 . . . . 10.66 110.471 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 137' ' ' ILE . . . -143.18 112.4 6.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 8.3 111.457 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.5 72.12 0.27 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 118.178 -1.963 . . . . 10.1 113.659 166.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -148.03 158.43 44.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.806 -0.812 . . . . 11.03 108.806 156.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 22.6 m -147.13 122.22 10.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.344 0.592 . . . . 13.17 109.891 169.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.02 107.45 8.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.14 -0.937 . . . . 13.78 110.7 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.97 38.16 92.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.188 -0.53 . . . . 15.28 112.4 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.01 87.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 13.44 112.584 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 130' ' ' THR . 30.2 mm-40 -106.04 154.53 20.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.286 -0.635 . . . . 11.28 109.286 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -115.25 165.97 12.36 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.455 -0.498 . . . . 8.43 111.229 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 49.0 mt-10 -114.35 121.11 42.63 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.442 0.639 . . . . 10.79 111.521 175.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.4 mm -85.69 102.72 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.267 -0.879 . . . . 6.73 108.663 169.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -64.35 -51.95 60.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.835 -1.075 . . . . 9.17 109.766 -176.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -141.36 160.99 38.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.377 -0.829 . . . . 10.44 110.567 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 122.26 -64.01 0.52 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.539 -0.839 . . . . 8.87 112.975 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.417 ' HG ' HG12 ' A' ' 125' ' ' VAL . 30.6 mt -102.83 -177.31 3.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.931 0.715 . . . . 8.5 112.931 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -143.98 159.65 42.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.865 -1.061 . . . . 14.48 110.102 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.09 129.22 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.245 -0.889 . . . . 12.12 110.463 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.46 -7.0 26.46 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.729 -0.948 . . . . 12.39 110.729 -171.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.528 ' O ' HG21 ' A' ' 84' ' ' VAL . 14.4 mm100 -97.83 117.41 32.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.514 . . . . 11.89 110.303 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -86.96 127.18 35.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.551 -0.749 . . . . 11.1 111.406 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.62 140.98 46.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.898 -0.592 . . . . 5.45 110.179 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 60.9 t -66.26 125.19 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 7.05 110.548 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 82' ' ' ALA . 3.9 m . . . . . 0 C--N 1.325 -0.458 0 N-CA-C 112.221 0.452 . . . . 6.99 112.221 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 121.577 0.704 . . . . 12.43 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.1 18.39 5.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.722 -0.672 . . . . 12.83 110.833 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.92 -67.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.732 0.813 . . . . 13.49 109.936 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.7 mt -98.08 75.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.229 -0.656 . . . . 12.27 109.229 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -72.87 -17.12 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.972 -0.558 . . . . 11.22 111.134 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 m -66.67 -48.57 68.92 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.945 -0.702 . . . . 12.0 109.972 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.21 -22.03 59.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.653 -0.419 . . . . 11.17 110.589 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 162' ' ' ARG . . . -54.73 -42.18 71.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 8.27 110.067 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' SER . . . . . 0.496 ' OG ' HD13 ' A' ' 103' ' ' ILE . 29.4 t -64.16 -30.01 71.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.238 -0.892 . . . . 9.64 111.506 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.3 mt -85.45 -33.46 21.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 10.88 111.345 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 5.8 ptm180 -77.5 161.96 27.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.907 -0.588 . . . . 9.36 110.696 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.53 57.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.344 -0.702 . . . . 7.46 111.344 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.6 p 48.33 57.15 6.5 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.082 0.553 . . . . 7.09 111.677 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t 64.62 94.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.743 -0.662 . . . . 9.62 109.837 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.637 . . . . 9.11 111.816 -174.64 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.922 0 CA-C-O 122.352 1.073 . . . . 10.77 108.201 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.64 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 5.7 ppt_? -129.71 141.19 50.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.564 -1.653 . . . . 8.86 109.085 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.4 mm -68.02 128.55 31.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 113.566 0.951 . . . . 5.76 113.566 -169.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 26' ' ' ARG . 4.4 mp -117.94 -47.64 2.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.991 -1.459 . . . . 8.55 110.39 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 14.4 p90 -155.65 -179.59 8.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 8.07 111.023 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.73 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.23 149.62 41.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.172 -0.922 . . . . 5.61 110.499 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HB2' HE22 ' A' ' 38' ' ' GLN . 38.9 ptt180 -148.27 146.3 28.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 9.75 110.08 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.531 ' HB3' HG21 ' A' ' 35' ' ' VAL . 2.3 t0 -78.57 131.45 68.08 Favored Pre-proline 0 C--N 1.314 -0.944 0 N-CA-C 109.798 -0.445 . . . . 8.31 109.798 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.43 ' HG3' HG13 ' A' ' 54' ' ' ILE . 63.5 Cg_exo -45.11 -48.86 10.65 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.79 2.327 . . . . 10.41 111.944 -176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.627 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.3 pmm? -91.57 9.99 29.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.212 -1.358 . . . . 11.24 112.985 -167.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.615 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 6.6 m -126.32 44.92 1.32 Allowed Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 121.429 0.633 . . . . 9.83 111.562 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.627 ' HD3' ' C ' ' A' ' 34' ' ' MET . 26.0 Cg_exo -61.66 119.9 7.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.194 2.596 . . . . 11.66 113.177 -169.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.5 4.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.467 -0.653 . . . . 10.86 111.467 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.558 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.09 142.56 30.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 9.42 109.925 176.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -129.38 93.97 3.68 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.935 0.398 . . . . 12.03 110.606 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 23.8 m-85 -73.01 143.38 47.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.507 -0.769 . . . . 7.9 110.974 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.14 -27.82 68.99 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.348 -1.297 . . . . 10.61 110.455 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.469 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.0 ptpt -166.23 162.84 12.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.931 -0.577 . . . . 11.24 111.218 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.611 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.3 Cg_endo -51.3 169.56 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.64 2.893 . . . . 7.51 113.78 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -171.1 30.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.503 -0.856 . . . . 8.06 113.028 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 6.1 ttmm -88.63 143.26 27.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.447 -0.575 . . . . 12.05 109.447 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 49' ' ' MET . 37.8 t -62.28 136.2 95.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 9.2 110.425 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 -21.06 19.51 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 122.186 1.924 . . . . 10.25 110.904 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 1.62 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 34.9 m-85 -84.94 -41.23 16.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.878 -1.51 . . . . 10.49 109.485 -175.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.1 mtm -133.72 153.51 51.64 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.36 -0.836 . . . . 10.74 111.27 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.7 p-10 -80.63 59.28 3.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.084 0.945 . . . . 12.54 111.168 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.445 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -136.33 143.25 42.76 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.899 -1.046 . . . . 10.35 109.356 176.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 24.9 Cg_endo -63.93 133.41 38.6 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.0 1.8 . . . . 10.11 111.158 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.8 mt -61.97 163.76 7.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 7.0 110.62 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 33' ' ' PRO . 44.2 mm -105.27 129.39 24.84 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 8.28 109.956 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.73 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 60.3 Cg_endo -73.83 140.14 28.56 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.818 1.678 . . . . 6.21 112.189 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.43 156.51 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.395 -1.275 . . . . 6.41 112.791 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.64 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.73 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.945 2.098 . . . . 8.58 115.553 -176.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.567 ' HG2' HG12 ' A' ' 27' ' ' ILE . 3.2 pt-20 -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.378 1.561 . . . . 7.04 110.54 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 111.022 -2.808 . . . . 8.58 111.705 168.772 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' HD2' ' N ' ' A' ' 80' ' ' ARG . 6.4 mpt_? . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 121.227 0.537 . . . . 12.25 109.746 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.6 p -132.39 154.15 50.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 8.3 111.046 -172.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.4 127.28 49.51 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.468 -0.938 . . . . 7.51 108.468 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 42.1 tt0 -76.59 133.26 39.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.624 -0.51 . . . . 12.15 109.624 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 145' ' ' GLN . 48.0 t -53.32 130.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 9.71 112.755 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 50.0 mmtt -134.89 142.8 46.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.856 -1.065 . . . . 11.77 109.925 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -75.53 158.32 32.7 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.504 -0.554 . . . . 13.03 109.504 171.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.571 0 C-N-CA 120.426 -0.893 . . . . 13.49 112.653 179.726 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HG2' HD21 ' A' ' 86' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.512 -0.499 0 CA-C-O 121.575 0.702 . . . . 14.94 111.494 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.5 ' CD ' ' HA ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -123.01 158.57 30.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.775 -1.102 . . . . 11.02 109.959 -176.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -98.37 122.08 41.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.152 0.501 . . . . 9.27 109.894 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.25 134.33 38.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.073 -0.512 . . . . 10.57 110.606 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.07 147.99 23.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 6.4 109.052 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.22 130.65 41.29 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.271 1.98 . . . . 7.48 110.212 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.489 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 19.0 t -57.41 -27.08 62.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.465 0.543 . . . . 9.53 112.465 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.36 3.97 33.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 10.86 111.547 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -77.93 -41.24 36.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.196 0.522 . . . . 5.39 110.91 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -86.17 158.88 19.66 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.728 -0.669 . . . . 7.08 111.898 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -101.61 126.35 55.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.327 -0.851 . . . . 10.63 108.826 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 11.6 mmm180 -101.13 128.41 47.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.519 -0.872 . . . . 12.12 111.027 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -149.32 129.17 13.35 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.285 -0.87 . . . . 14.98 110.516 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.76 -109.3 1.05 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 116.008 -0.542 . . . . 16.43 112.957 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.62 17.24 13.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 15.35 111.35 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.14 177.34 7.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.181 0.515 . . . . 15.67 111.745 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.7 m -129.2 144.71 51.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 9.26 109.377 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.8 mm -126.56 153.04 34.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 10.94 109.375 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -134.68 132.47 38.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.394 -0.191 . . . . 7.39 111.088 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.461 ' HE3' HG22 ' A' ' 148' ' ' VAL . 49.7 ttp -94.55 105.57 17.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.176 -0.675 . . . . 8.85 109.176 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 121' ' ' ASP . 7.1 p -88.26 134.01 29.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.89 -1.05 . . . . 10.13 112.423 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -83.3 92.47 7.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.187 -0.915 . . . . 10.7 110.108 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -86.5 149.96 24.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.057 -0.52 . . . . 15.12 111.332 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.05 0.15 74.12 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.156 -0.778 . . . . 16.92 111.156 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.27 -1.57 30.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.344 0.593 . . . . 18.56 110.887 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.89 -8.55 63.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.153 -0.93 . . . . 16.28 113.021 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.03 159.4 22.26 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.289 -0.958 . . . . 14.36 112.303 -174.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 88.8 m-85 -109.53 121.23 44.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.377 -0.601 . . . . 12.49 109.377 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.581 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.6 m-20 -122.29 151.58 59.36 Favored Pre-proline 0 CA--C 1.514 -0.421 0 C-N-CA 120.555 -0.458 . . . . 13.91 111.471 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 84.1 Cg_endo -88.77 136.27 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.417 2.078 . . . . 13.02 112.433 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.63 138.31 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.331 -0.85 . . . . 10.41 109.179 176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.6 130.9 36.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.854 -0.424 . . . . 12.93 109.854 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.588 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -140.98 158.36 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.818 -0.628 . . . . 8.03 111.157 -175.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.5 ttmm -100.2 128.61 46.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.632 -0.713 . . . . 10.66 109.89 174.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -140.84 105.62 4.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.478 -0.328 . . . . 8.3 111.638 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.443 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -153.0 72.38 0.27 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 118.441 -1.838 . . . . 10.1 113.938 169.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -148.92 162.69 39.35 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.402 -0.962 . . . . 11.03 108.402 154.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.4 m -139.72 132.59 29.24 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.672 -0.411 . . . . 13.17 110.001 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.22 99.89 3.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.066 -0.516 . . . . 13.78 111.443 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.8 40.03 89.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.09 -0.576 . . . . 15.28 112.43 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.22 1.83 90.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.031 -0.604 . . . . 13.44 112.195 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.13 164.0 12.67 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.037 -1.097 . . . . 11.28 108.037 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 21.0 p -117.05 162.1 18.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.152 -0.619 . . . . 8.43 111.108 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 36.6 mt-10 -112.99 123.94 51.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.616 0.722 . . . . 10.79 111.277 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 24.4 mm -88.11 107.43 17.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.878 -1.056 . . . . 6.73 109.323 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.5 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.9 mp -72.68 -49.9 28.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 9.17 109.85 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.494 ' O ' HG21 ' A' ' 125' ' ' VAL . 46.6 mt-10 -142.11 166.76 23.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.008 -0.738 . . . . 10.44 109.008 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 114.29 -51.97 0.68 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.395 -1.383 . . . . 8.87 113.885 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.64 -174.92 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 8.5 112.744 -172.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.25 157.09 42.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 14.48 109.523 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.64 126.71 30.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 12.12 109.95 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.85 -7.09 29.48 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.996 -0.842 . . . . 12.39 110.996 -170.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.541 ' O ' HG21 ' A' ' 84' ' ' VAL . 29.0 mm-40 -95.5 112.92 24.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.209 -0.664 . . . . 11.89 109.209 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.415 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 28.5 mt-30 -85.95 123.65 31.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.028 -0.533 . . . . 11.1 110.502 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.55 139.8 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.864 -0.607 . . . . 5.45 110.323 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 18.6 m -66.24 120.61 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.805 -0.634 . . . . 7.05 111.478 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.411 HG13 ' HB1' ' A' ' 101' ' ' ALA . 2.8 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 6.99 109.889 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.19 -0.3 . . . . 12.43 110.19 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 56.4 t80 -88.24 -31.36 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.967 -0.753 . . . . 12.83 108.967 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 154' ' ' LEU . 1.1 mm? -97.42 -161.29 0.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.858 -1.064 . . . . 13.49 108.768 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 157' ' ' SER . 10.4 mm -95.86 -128.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.701 -0.851 . . . . 12.27 108.701 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . 0.409 ' H ' HG23 ' A' ' 155' ' ' ILE . 6.6 m-20 -82.99 30.01 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.289 0.566 . . . . 11.22 110.005 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 155' ' ' ILE . 5.2 m -72.5 -18.97 61.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.676 -0.693 . . . . 12.0 111.813 -172.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -44.1 77.79 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.397 -0.921 . . . . 11.17 109.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.47 66.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.307 -0.86 . . . . 8.27 110.832 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.3 m -70.01 -61.98 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.829 0.823 . . . . 9.64 109.65 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.2 -31.66 70.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 113.74 -1.573 . . . . 10.88 112.256 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -82.52 -39.23 22.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 124.753 1.283 . . . . 9.36 110.032 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 52.26 60.35 7.82 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.105 -0.952 . . . . 7.46 113.015 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 32.8 p 50.63 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.986 0.914 . . . . 7.09 112.435 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.1 p -72.41 95.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.831 . . . . 9.62 112.08 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 9.11 110.269 177.416 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.998 0.428 . . . . 34.49 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.29 168.82 14.44 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.942 -0.647 . . . . 33.2 111.83 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 p -105.57 111.44 24.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 34.24 110.156 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.66 42.59 0.78 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.346 -0.388 . . . . 32.38 111.708 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -131.53 38.85 3.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.47 0.652 . . . . 33.02 109.939 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.91 -31.06 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.586 -0.734 . . . . 31.57 111.441 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -84.74 156.31 21.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.064 -0.347 . . . . 29.46 110.064 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.76 -147.67 7.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 28.42 111.672 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.51 157.14 56.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.824 2.349 . . . . 27.92 111.868 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -100.54 -167.64 1.47 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.066 -0.346 . . . . 26.82 110.066 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.27 159.91 14.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.413 . . . . 25.18 110.66 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.85 42.22 21.18 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.361 -0.696 . . . . 23.19 111.361 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.434 ' HA ' ' H ' ' A' ' 152' ' ' GLN . 7.3 p-80 -103.29 87.76 2.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.337 0.589 . . . . 21.58 111.92 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -72.83 120.18 79.45 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 108.949 -0.76 . . . . 19.89 108.949 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.32 52.93 3.32 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.73 2.953 . . . . 18.59 114.434 -165.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.35 -28.92 7.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.11 0.411 . . . . 17.12 112.11 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.722 ' O ' ' HA ' ' A' ' 152' ' ' GLN . . . -148.63 115.87 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.872 0.367 . . . . 14.96 111.476 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.97 -3.07 59.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 13.21 111.459 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.23 86.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.948 0.899 . . . . 12.37 113.042 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -93.51 96.09 9.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.783 -1.099 . . . . 13.82 108.83 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 66.53 36.17 5.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.805 -1.543 . . . . 12.48 110.564 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -109.65 -1.0 18.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.413 1.102 . . . . 14.31 108.452 167.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.3 t -153.86 -174.93 5.14 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.608 -1.633 . . . . 11.34 109.015 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 -96.9 1.43 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.572 -0.823 . . . . 10.62 112.528 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -137.5 66.21 1.46 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.45 1.119 . . . . 10.77 109.755 -174.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.559 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -128.85 139.46 52.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.347 -1.297 . . . . 8.86 108.217 178.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.593 HG12 ' HG2' ' A' ' 58' ' ' GLU . 23.5 mm -49.52 117.96 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.944 0.878 . . . . 5.76 112.636 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.13 -33.97 9.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.297 -1.774 . . . . 8.55 109.923 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 1.6 p90 -179.67 -177.49 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.607 -0.724 . . . . 8.07 109.884 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -116.83 147.38 42.17 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.388 -0.824 . . . . 5.61 110.281 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ptt180 -142.55 149.87 39.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.185 -0.916 . . . . 9.75 110.353 -176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.539 ' HB3' HG21 ' A' ' 35' ' ' VAL . 10.0 t70 -92.08 136.25 26.19 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.138 -1.06 . . . . 8.31 108.138 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -62.33 -13.22 31.29 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.116 1.877 . . . . 10.41 112.201 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.52 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -99.55 0.36 42.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.782 -0.19 . . . . 11.24 111.504 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -128.28 38.42 0.43 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 112.802 0.668 . . . . 9.83 112.802 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 27.4 Cg_endo -57.92 131.81 45.94 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.576 2.184 . . . . 11.66 112.508 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.84 -7.45 31.45 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.651 -0.785 . . . . 10.86 111.204 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.568 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -82.68 -179.78 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.534 . . . . 9.42 109.731 176.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.513 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 7.0 tpt180 -151.29 94.26 2.01 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.098 -0.334 . . . . 12.03 110.098 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 90.7 m-85 -76.49 139.68 40.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.262 -0.575 . . . . 7.9 110.708 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.71 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.799 -1.091 . . . . 10.61 111.084 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.51 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.5 pttm -168.79 164.22 7.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 11.24 111.006 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.1 Cg_endo -48.19 169.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.992 3.128 . . . . 7.51 114.403 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.64 -162.57 27.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.918 -0.658 . . . . 8.06 112.392 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 4.0 ttmm -92.92 141.74 28.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.669 -0.493 . . . . 12.05 109.669 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.5 p -58.4 136.13 85.41 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 115.218 -0.901 . . . . 9.2 110.962 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.85 -27.16 7.37 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.136 1.891 . . . . 10.25 112.028 171.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 91.4 m-85 -81.91 -31.05 31.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.153 0.502 . . . . 10.49 110.851 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.516 ' HE1' ' N ' ' A' ' 49' ' ' MET . 0.0 OUTLIER -124.67 -161.06 0.98 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.481 -0.781 . . . . 10.74 108.911 174.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 6.5 p-10 -128.17 59.05 1.51 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.019 0.914 . . . . 12.54 109.623 170.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 ptm -132.82 145.1 55.69 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.484 -1.235 . . . . 10.35 109.766 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.62 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.669 1.58 . . . . 10.11 110.414 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.33 161.27 14.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.173 0.511 . . . . 7.0 111.415 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.7 mp -98.74 133.85 22.11 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.132 -0.692 . . . . 8.28 109.132 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 83.5 Cg_endo -85.28 150.18 10.52 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 121.265 1.31 . . . . 6.21 113.126 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 m -74.3 158.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.564 -1.198 . . . . 6.41 112.397 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.559 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 11.97 -76.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.358 2.263 . . . . 8.58 115.353 -178.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.751 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -57.84 -47.04 83.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.287 0.635 . . . . 7.04 109.596 -175.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.751 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 43.6 mt-10 68.99 79.3 0.21 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.629 0.728 . . . . 8.58 112.646 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 81.26 68.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.795 -1.548 . . . . 7.64 113.099 157.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.624 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 62.5 t30 -164.11 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.645 -1.161 . . . . 7.58 108.493 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.438 ' HB1' ' HB ' ' A' ' 27' ' ' ILE . . . 42.58 -86.1 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.247 1.019 . . . . 5.41 113.364 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' OD2' ' HA2' ' A' ' 71' ' ' GLY . 16.8 m-20 -84.69 21.24 1.57 Allowed 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 121.748 0.785 . . . . 7.01 111.685 -174.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' O ' ' HB1' ' A' ' 65' ' ' ALA . . . 60.57 22.74 59.67 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 114.314 -1.312 . . . . 7.2 113.076 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 64' ' ' GLY . . . 70.59 57.96 0.24 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.14 0.553 . . . . 7.82 110.418 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 78.88 1.41 2.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.191 -0.913 . . . . 9.19 112.99 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 64' ' ' GLY . 57.6 t -67.36 -51.19 55.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.038 0.923 . . . . 7.42 109.148 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.558 ' HB2' ' CA ' ' A' ' 63' ' ' ASP . 23.1 mmt180 -70.78 -155.49 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 10.88 110.923 171.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.505 HG23 ' N ' ' A' ' 70' ' ' ASP . 9.9 mt -50.35 162.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 112.318 -2.219 . . . . 9.13 110.988 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.505 ' N ' HG23 ' A' ' 69' ' ' ILE . 36.4 t70 -70.41 32.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.57 -0.741 . . . . 13.02 112.179 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.597 ' HA2' ' OD2' ' A' ' 63' ' ' ASP . . . 73.83 14.74 79.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.361 -0.447 . . . . 12.13 112.33 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.541 ' HD2' ' O ' ' A' ' 116' ' ' GLY . 0.8 OUTLIER -112.24 141.04 46.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.58 -1.267 . . . . 12.89 107.58 175.173 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.68 92.15 2.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.64 0.734 . . . . 12.25 109.644 -170.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.0 t -76.86 40.13 0.24 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.946 -1.479 . . . . 10.97 110.691 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.542 ' C ' ' H ' ' A' ' 77' ' ' LEU . 10.1 tp60 -123.03 99.22 6.27 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.268 -0.878 . . . . 14.62 108.729 -172.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.476 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 62.7 t30 -71.41 22.37 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.236 -0.893 . . . . 11.22 112.246 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 75' ' ' GLN . 23.3 tp 65.95 -70.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.087 0.955 . . . . 13.96 111.569 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.0 24.11 7.18 Favored Glycine 0 CA--C 1.503 -0.691 0 CA-C-N 116.185 -0.461 . . . . 11.94 112.791 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 4.0 t -148.18 113.06 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.766 -0.457 . . . . 10.24 109.766 -174.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' H ' ' HA ' ' A' ' 150' ' ' SER . 8.0 mpt_? -105.33 167.3 9.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.686 -0.487 . . . . 12.25 109.686 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 p -135.19 177.82 7.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.165 0.507 . . . . 8.3 111.484 -174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -142.71 131.63 22.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.366 -0.834 . . . . 7.51 109.044 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 35.3 tt0 -79.47 141.24 36.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.952 0.406 . . . . 12.15 110.515 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.466 HG12 ' HB3' ' A' ' 95' ' ' LEU . 70.6 t -69.16 127.31 30.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 9.71 110.548 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -162.92 146.68 11.14 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.07 -0.968 . . . . 11.77 111.642 174.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.5 mp -70.1 132.45 45.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.11 -1.405 . . . . 13.03 110.37 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' H ' HD22 ' A' ' 96' ' ' LEU . . . -126.52 22.86 5.79 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.186 -1.007 . . . . 13.49 113.628 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.66 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 6.5 ptp180 -141.63 156.41 45.66 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.936 0.398 . . . . 16.96 111.183 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.0 mt -152.35 113.58 4.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.978 -1.01 . . . . 18.49 108.372 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.27 -47.97 1.04 Allowed Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 108.56 -1.816 . . . . 18.67 108.56 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.1 m -69.87 177.94 2.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.028 -1.086 . . . . 17.16 108.766 166.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.457 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 2.9 m -86.27 108.76 18.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.903 -0.59 . . . . 14.8 110.38 -170.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.66 ' HA ' ' HG3' ' A' ' 88' ' ' ARG . 18.0 mt-10 -58.47 119.54 7.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 124.461 1.1 . . . . 14.94 112.539 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.475 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 23.1 mmt85 -135.09 164.49 27.54 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.454 -1.703 . . . . 11.02 107.026 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -88.83 113.21 24.13 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.919 -0.771 . . . . 9.27 108.919 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.426 HD22 ' H ' ' A' ' 87' ' ' GLY . 3.5 mm? -87.47 129.89 34.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.082 -0.508 . . . . 10.57 111.369 -172.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.18 155.85 58.09 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.444 -0.798 . . . . 6.4 109.424 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.403 ' HG2' HG12 ' A' ' 149' ' ' VAL . 77.2 Cg_exo -55.35 139.11 81.33 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.289 1.992 . . . . 7.48 111.559 171.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.3 m -57.71 -28.44 63.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.64 0.608 . . . . 9.53 112.64 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.85 -2.39 58.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 10.86 111.059 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -71.68 -41.09 69.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.48 0.657 . . . . 5.39 111.015 -175.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.557 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -92.51 160.26 15.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.47 -0.786 . . . . 7.08 111.614 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.67 113.27 37.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.708 -0.678 . . . . 10.63 109.192 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 7.7 mmm180 -89.53 126.14 35.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.735 -0.786 . . . . 12.12 110.446 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -149.18 132.71 16.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.862 -0.608 . . . . 14.98 110.551 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.69 -115.57 5.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.26 -0.495 . . . . 16.43 112.568 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.92 36.21 4.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.803 0.335 . . . . 15.35 111.671 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.79 -178.96 6.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.313 -0.403 . . . . 15.67 110.502 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.557 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 27.3 m -132.11 150.95 52.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.725 0.298 . . . . 9.26 111.269 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.479 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.7 mm -123.33 149.11 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.099 -0.704 . . . . 10.94 109.099 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.548 ' HB1' HG13 ' A' ' 123' ' ' VAL . . . -129.49 125.85 37.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.282 -0.266 . . . . 7.39 110.282 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 48.6 ttp -85.95 99.56 11.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.687 -1.227 . . . . 8.85 107.687 171.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 121' ' ' ASP . 12.7 p -81.78 136.82 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.254 -0.884 . . . . 10.13 111.195 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -80.65 97.42 7.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.194 -0.669 . . . . 10.7 109.194 173.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.74 139.77 40.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.662 -0.699 . . . . 15.12 109.221 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.541 ' O ' ' HD2' ' A' ' 72' ' ' ARG . . . -58.43 -16.81 30.02 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.005 -0.543 . . . . 16.92 113.027 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -79.17 4.72 13.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.164 0.507 . . . . 18.56 111.811 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.63 9.98 58.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.708 -0.678 . . . . 16.28 112.969 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.99 175.22 16.54 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.76 -0.733 . . . . 14.36 112.241 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.602 ' HD2' ' CD1' ' A' ' 120' ' ' PHE . 97.2 m-85 -126.03 136.76 53.33 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.059 -0.349 . . . . 12.49 110.059 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.525 ' O ' HG13 ' A' ' 113' ' ' VAL . 23.0 t70 -138.03 141.53 32.69 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 13.91 111.375 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -82.51 138.5 9.7 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.718 1.612 . . . . 13.02 112.482 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.548 HG13 ' HB1' ' A' ' 111' ' ' ALA . 9.8 p -135.39 136.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.622 -0.717 . . . . 10.41 109.82 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.48 125.02 29.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.629 -0.508 . . . . 12.93 109.629 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -133.5 157.78 42.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.455 -0.793 . . . . 8.03 110.76 -172.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.521 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 ttmp? -95.19 120.3 35.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.73 -0.668 . . . . 10.66 109.388 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.434 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -143.9 104.48 4.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.969 -0.56 . . . . 8.3 111.469 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.46 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.744 -2.17 . . . . 10.1 114.265 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.51 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -151.17 163.12 39.55 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.689 -0.486 . . . . 11.03 109.689 157.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.0 m -133.59 134.24 43.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.381 -0.6 . . . . 13.17 109.381 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.35 107.18 3.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.105 0.409 . . . . 13.78 112.105 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.29 44.51 59.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.199 -0.524 . . . . 15.28 113.105 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.0 17.35 80.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.67 -0.776 . . . . 13.44 112.236 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -137.55 166.0 24.95 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.422 -0.584 . . . . 11.28 109.422 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -115.71 162.84 16.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.963 0.411 . . . . 8.43 110.246 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 66.7 mt-10 -106.27 121.16 43.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.659 . . . . 10.79 111.433 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 125' ' ' VAL . 21.1 mm -88.25 101.52 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.014 -0.994 . . . . 6.73 108.565 168.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.9 mp -68.84 -45.0 72.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.553 -1.203 . . . . 9.17 109.738 -176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.47 ' O ' HG21 ' A' ' 125' ' ' VAL . 40.9 mt-10 -150.45 165.52 32.92 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.776 -0.647 . . . . 10.44 109.353 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.498 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 128.63 -61.49 0.65 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.981 -1.104 . . . . 8.87 113.299 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.7 mt -116.0 179.62 3.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.305 0.574 . . . . 8.5 112.347 -173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -129.64 152.44 49.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.875 -1.057 . . . . 14.48 110.481 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 132.35 45.98 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.058 -0.973 . . . . 12.12 110.168 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.51 -11.25 30.6 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.092 -0.803 . . . . 12.39 111.092 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.44 HE21 HG22 ' A' ' 113' ' ' VAL . 9.5 mt-30 -104.27 163.76 12.2 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 107.75 -1.204 . . . . 11.89 107.75 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.511 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 14.2 mt-30 -120.93 167.84 12.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 119.04 0.836 . . . . 11.1 111.561 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.14 156.68 41.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.217 -0.901 . . . . 5.45 108.853 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 7.6 p -76.62 128.52 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.63 0.252 . . . . 7.05 110.587 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.403 HG12 ' HG2' ' A' ' 98' ' ' PRO . 2.4 m -130.13 -19.79 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.975 -0.29 . . . . 6.99 111.602 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.451 ' HA ' ' H ' ' A' ' 80' ' ' ARG . 37.6 m 43.94 60.21 2.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.378 0.609 . . . . 9.37 112.478 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -146.8 163.26 28.58 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.284 -1.126 . . . . 8.6 110.284 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.722 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -121.23 149.04 43.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.703 0.752 . . . . 12.43 111.652 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.637 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 17.7 t80 -103.88 166.57 10.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.543 -0.54 . . . . 12.83 109.543 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -60.82 2.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.824 -0.35 . . . . 13.49 111.138 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.2 tt -125.08 113.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.549 0.69 . . . . 12.27 110.301 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.68 -0.15 49.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 11.22 112.017 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.654 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 13.2 m -58.54 -43.22 89.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.88 -0.6 . . . . 12.0 111.023 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -52.03 -54.99 23.42 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.76 -0.459 . . . . 11.17 109.76 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.3 92.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.845 -1.07 . . . . 8.27 111.395 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.1 m -58.94 -35.54 73.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.865 -0.607 . . . . 9.64 111.868 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 157' ' ' SER . 80.4 mt -61.99 -22.13 65.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.242 -0.89 . . . . 10.88 111.516 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -83.43 117.79 23.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.637 -0.505 . . . . 9.36 109.637 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 105.58 -18.28 41.38 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 119.927 -1.13 . . . . 7.46 112.734 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.7 p -102.17 -76.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 7.09 110.646 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.46 -24.16 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.29 0.567 . . . . 9.62 110.211 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -107.11 141.66 38.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.899 -0.591 . . . . 9.11 110.598 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.769 ' HD2' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -131.26 -121.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.877 -0.786 . . . . 15.17 108.877 175.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 mtm 66.99 153.14 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.763 0.792 . . . . 12.15 112.044 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 171' ' ' THR . 0.3 OUTLIER -80.35 139.0 36.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.742 -0.663 . . . . 15.5 110.851 -177.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 74.55 -26.12 0.19 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.846 0.858 . . . . 15.01 112.301 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 167' ' ' ARG . 80.2 p 52.85 28.26 6.28 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.031 0.932 . . . . 14.52 113.203 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.9 t -90.1 -179.61 5.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.779 0.323 . . . . 14.89 110.723 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -152.57 155.89 38.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 118.777 -0.63 . . . . 15.85 109.897 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 53.68 49.69 56.83 Favored Glycine 0 C--O 1.242 0.653 0 C-N-CA 119.778 -1.201 . . . . 17.54 110.732 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.6 tp -160.02 70.14 0.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.672 -0.764 . . . . 17.85 109.612 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.07 -52.8 6.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.896 -0.593 . . . . 19.67 110.286 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.0 m -126.86 139.28 52.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.892 -0.595 . . . . 19.71 110.188 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 39.9 tp -134.91 92.48 2.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.07 0.462 . . . . 21.47 110.517 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -118.23 -51.09 2.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.827 -0.624 . . . . 23.66 110.038 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.198 -0.906 . . . . 23.71 110.493 -178.999 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.297 -0.26 . . . . 34.49 110.297 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.96 79.02 1.33 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.11 -0.567 . . . . 33.2 112.351 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 m -72.34 -33.19 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.951 0.405 . . . . 34.24 110.61 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.22 127.98 33.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 32.38 110.516 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -79.74 63.39 4.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.441 0.639 . . . . 33.02 110.749 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.4 171.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.577 -0.738 . . . . 31.57 109.459 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -146.5 168.39 21.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.014 0.435 . . . . 29.46 111.447 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.47 -152.77 16.77 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.457 -0.792 . . . . 28.42 111.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -101.32 23.91 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.701 2.934 . . . . 27.92 111.754 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.8 m80 59.46 73.55 0.48 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.714 -0.847 . . . . 26.82 108.714 -170.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' OD2' ' HB2' ' A' ' 13' ' ' HIS . 18.4 t70 -53.4 128.07 27.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.531 -1.213 . . . . 25.18 112.447 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.42 45.02 1.28 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.458 -0.792 . . . . 23.19 111.649 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.403 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -62.27 139.72 58.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.359 0.599 . . . . 21.58 111.418 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.614 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 16.6 t70 -64.55 -36.53 18.43 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.721 -1.127 . . . . 19.89 113.085 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 21.1 Cg_endo -63.2 57.37 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.408 2.072 . . . . 18.59 112.739 170.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.98 -11.31 17.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 17.12 111.298 -176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.73 68.82 1.34 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.435 0.636 . . . . 14.96 110.148 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.21 60.33 3.92 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 13.21 112.674 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.01 -75.7 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.789 0.328 . . . . 12.37 110.655 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 22' ' ' LYS . 34.9 tt0 -91.66 77.06 5.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.727 -0.472 . . . . 13.82 109.727 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp 70.81 -10.32 0.74 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.474 -0.784 . . . . 12.48 110.822 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' H ' ' C ' ' A' ' 20' ' ' GLU . 32.5 ttpt 65.95 18.14 10.99 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.17 0.986 . . . . 14.31 109.666 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 m -164.86 118.11 1.27 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.872 -1.513 . . . . 11.34 108.728 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.48 -114.29 0.6 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.512 -1.328 . . . . 10.62 113.833 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 3.1 mppt? -121.2 71.9 0.97 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.3 -1.0 . . . . 10.77 108.3 -172.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.589 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.29 130.67 35.47 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.133 -0.94 . . . . 8.86 111.042 -174.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.2 mm -55.2 133.29 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 122.268 1.032 . . . . 5.76 113.107 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.74 -25.97 6.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.37 -1.741 . . . . 8.55 109.712 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.646 ' HD1' ' CD2' ' A' ' 29' ' ' TYR . 14.1 p90 179.99 179.03 0.56 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.897 -0.592 . . . . 8.07 111.098 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.732 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -118.38 154.88 31.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.919 -1.037 . . . . 5.61 109.965 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.566 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.4 ptp180 -156.4 145.36 20.32 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.153 0.502 . . . . 9.75 110.29 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.631 ' HB3' HG23 ' A' ' 35' ' ' VAL . 2.0 t0 -67.85 133.13 92.23 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.48 -0.933 . . . . 8.31 108.48 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.564 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 84.4 Cg_endo -67.66 -12.6 36.08 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.293 1.995 . . . . 10.41 112.363 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.445 ' HE1' ' OD1' ' A' ' 32' ' ' ASP . 1.1 ptp -103.65 0.99 31.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.41 -0.359 . . . . 11.24 111.546 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG23 ' HB3' ' A' ' 32' ' ' ASP . 3.6 m -120.43 45.01 0.74 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 121.258 0.552 . . . . 9.83 112.003 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.85 124.5 16.04 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.134 2.556 . . . . 11.66 112.711 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.82 8.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.807 -0.711 . . . . 10.86 111.656 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.573 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 20.8 tp60 -78.95 105.55 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.15 0.5 . . . . 9.42 109.968 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.54 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 41.7 ttp180 -90.93 106.95 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 12.03 110.161 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 66.7 m-85 -84.58 142.46 29.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 7.9 109.466 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.28 -26.55 68.83 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.42 -0.809 . . . . 10.61 111.005 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 16.7 ptpt -169.8 165.11 6.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.869 -0.605 . . . . 11.24 110.264 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.723 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -49.37 169.15 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.37 2.713 . . . . 7.51 113.458 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.25 -166.98 29.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.65 -0.786 . . . . 8.06 112.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 46' ' ' SER . 12.9 ttmm -95.34 153.23 17.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.192 0.52 . . . . 12.05 110.604 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 49' ' ' MET . 95.5 p -64.59 105.91 0.84 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.467 -1.242 . . . . 9.2 110.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.59 -10.12 27.67 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.3 2.666 . . . . 10.25 111.869 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.636 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 79.5 m-85 -92.0 -31.4 15.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.564 -1.198 . . . . 10.49 110.789 -178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.554 ' SD ' ' N ' ' A' ' 49' ' ' MET . 0.8 OUTLIER -134.64 -107.77 0.22 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.097 1.147 . . . . 10.74 114.097 172.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.551 ' H ' ' HG2' ' A' ' 49' ' ' MET . 12.6 p-10 -165.19 65.95 0.13 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.117 0.871 . . . . 12.54 113.275 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.02 148.82 56.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.784 -0.821 . . . . 10.35 108.784 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.44 132.28 30.73 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.198 1.265 . . . . 10.11 110.339 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 46' ' ' SER . 43.5 mt -61.25 163.49 6.34 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.338 0.399 . . . . 7.0 111.305 -175.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.532 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 43.0 mm -101.29 131.82 22.65 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 8.28 110.003 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.732 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 55.9 Cg_endo -86.51 139.38 5.81 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.93 1.753 . . . . 6.21 112.921 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.77 157.96 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.291 -1.322 . . . . 6.41 112.904 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 16.77 -89.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.753 2.021 . . . . 8.58 115.212 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.695 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -47.87 -40.98 23.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.73 0.412 . . . . 7.04 110.184 -177.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' CG ' ' HG2' ' A' ' 55' ' ' PRO . 26.8 tt0 68.48 85.54 0.14 Allowed 'General case' 0 C--N 1.315 -0.901 0 O-C-N 123.954 0.784 . . . . 8.58 111.677 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 74.36 60.32 0.08 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.591 -1.64 . . . . 7.64 112.699 162.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.556 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 60.8 t30 -135.45 -52.16 0.76 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 7.58 110.67 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -48.45 -74.83 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.652 0.739 . . . . 5.41 109.56 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 10.0 p-10 -111.19 31.47 6.05 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 122.646 1.212 . . . . 7.01 109.042 171.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.95 -11.83 56.07 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 113.675 -1.602 . . . . 7.2 110.286 170.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.84 -37.01 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.124 -0.538 . . . . 7.82 111.556 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.445 ' O ' HD11 ' A' ' 161' ' ' LEU . . . -90.1 -80.5 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.859 0.689 . . . . 9.19 112.859 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 62' ' ' ALA . 3.3 t -65.63 -28.44 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.322 0.582 . . . . 7.42 111.122 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 21.9 ptt180 -56.83 166.01 1.08 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.624 -1.171 . . . . 10.88 111.579 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 70' ' ' ASP . 16.6 mt -91.22 152.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 9.13 109.096 174.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' N ' HG23 ' A' ' 69' ' ' ILE . 19.6 t70 -76.23 40.36 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.212 0.529 . . . . 13.02 111.181 -176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.25 20.47 63.05 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 111.508 -0.637 . . . . 12.13 111.508 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.97 129.74 37.87 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.352 -0.981 . . . . 12.89 108.352 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.01 127.48 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.482 -1.303 . . . . 12.25 107.482 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 t -71.12 57.81 0.23 Allowed 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.502 1.126 . . . . 10.97 112.918 -168.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -107.65 81.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.184 -1.043 . . . . 14.62 108.184 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -71.26 112.34 7.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.655 0.741 . . . . 11.22 110.279 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -69.63 -64.86 0.8 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.56 -1.2 . . . . 13.96 108.419 173.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.85 74.32 1.71 Allowed Glycine 0 CA--C 1.495 -1.178 0 N-CA-C 110.699 -0.96 . . . . 11.94 110.699 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.458 HG22 ' CZ ' ' A' ' 120' ' ' PHE . 9.7 p -88.05 151.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.957 -1.122 . . . . 10.24 111.731 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -111.09 125.14 53.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.045 -0.724 . . . . 12.25 109.045 173.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 148' ' ' VAL . 34.4 p -131.74 147.1 52.47 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.834 -0.621 . . . . 8.3 110.274 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.08 126.58 55.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.81 -0.811 . . . . 7.51 108.81 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 30.0 tt0 -83.92 133.87 34.69 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.459 -0.571 . . . . 12.15 109.459 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 145' ' ' GLN . 42.4 t -55.49 127.92 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.769 0.655 . . . . 9.71 112.769 -176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 39.1 mmtt -140.88 142.5 34.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.828 -1.078 . . . . 11.77 108.777 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.3 mp -77.8 150.78 34.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.013 -0.675 . . . . 13.03 109.484 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.498 ' N ' HD22 ' A' ' 96' ' ' LEU . . . -168.74 47.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.413 -0.898 . . . . 13.49 112.99 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -69.01 132.19 46.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.034 0.445 . . . . 16.96 111.219 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.6 84.79 2.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.441 -0.948 . . . . 18.49 108.441 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.74 -3.68 74.7 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 109.625 -1.39 . . . . 18.67 109.625 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.7 t -110.82 178.56 4.32 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.936 -1.132 . . . . 17.16 108.506 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.57 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 14.2 m -84.44 161.17 20.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.636 -0.876 . . . . 14.8 108.636 174.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -60.98 103.33 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.475 0.655 . . . . 14.94 111.248 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 92' ' ' THR . 34.9 mmt180 -121.64 167.26 13.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.695 -1.139 . . . . 11.02 109.019 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.3 mp -90.68 111.96 23.52 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.172 -1.048 . . . . 9.27 108.172 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.69 129.87 35.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.16 0.505 . . . . 10.57 110.634 -174.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.58 156.8 52.72 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.634 -1.167 . . . . 6.4 108.804 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.28 141.25 95.41 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 C-N-CA 122.153 1.902 . . . . 7.48 110.59 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -19.24 38.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.636 0.255 . . . . 9.53 111.367 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -88.76 9.64 23.78 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 116.514 -0.312 . . . . 10.86 111.017 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 149' ' ' VAL . . . -86.63 -39.89 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.174 0.511 . . . . 5.39 111.17 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.579 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -99.92 158.47 15.79 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.758 0.651 . . . . 7.08 112.758 -170.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.91 121.56 53.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.239 -0.891 . . . . 10.63 108.86 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -94.25 122.54 36.89 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.312 -0.555 . . . . 12.12 110.895 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -149.57 131.26 14.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.105 -0.498 . . . . 14.98 111.406 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.3 5.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.161 -0.472 . . . . 16.43 113.017 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.1 25.03 10.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 15.35 111.235 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -150.76 -176.99 5.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 15.67 111.053 -175.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.579 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 47.0 m -136.92 150.13 48.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.291 -0.413 . . . . 9.26 110.296 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.515 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -125.43 152.07 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.748 -0.464 . . . . 10.94 109.748 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.638 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -133.3 138.31 46.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.205 -0.295 . . . . 7.39 110.205 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.44 ' HE1' HG12 ' A' ' 148' ' ' VAL . 58.9 mtm -97.45 100.71 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.145 -0.687 . . . . 8.85 109.145 174.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 7.2 p -84.52 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.354 -0.839 . . . . 10.13 111.312 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.429 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -67.12 88.52 0.17 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.48 -0.782 . . . . 10.7 109.698 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -67.97 140.43 56.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.46 -0.791 . . . . 15.12 109.782 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.56 -12.0 38.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.061 -0.59 . . . . 16.92 112.808 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.18 10.47 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.493 . . . . 18.56 111.689 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.76 17.11 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.399 -0.818 . . . . 16.28 113.782 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.74 -161.25 9.38 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.505 -0.855 . . . . 14.36 112.305 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.64 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 52.8 m-85 -130.92 112.51 13.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.677 0.275 . . . . 12.49 110.325 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -100.44 139.05 20.34 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.426 -0.352 . . . . 13.91 110.737 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 55.7 Cg_endo -82.7 138.88 9.68 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.956 1.77 . . . . 13.02 111.989 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.638 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 13.9 p -129.5 126.69 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 10.41 110.139 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 110' ' ' ILE . 32.0 tt0 -79.18 112.84 16.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.487 -0.561 . . . . 12.93 109.487 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.468 HG13 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.64 173.5 6.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 8.03 111.375 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -104.49 126.1 51.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.161 -0.681 . . . . 10.66 109.161 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.43 ' HB1' HD11 ' A' ' 137' ' ' ILE . . . -141.95 105.64 4.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.309 -0.405 . . . . 8.3 111.244 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.04 70.78 0.3 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 117.431 -2.319 . . . . 10.1 114.329 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.88 162.55 40.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.156 -0.683 . . . . 11.03 109.156 155.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.4 m -147.04 127.87 14.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.837 -0.431 . . . . 13.17 109.837 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.99 112.25 5.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.079 -0.51 . . . . 13.78 111.753 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.62 43.82 91.18 Favored Glycine 0 C--O 1.235 0.214 0 CA-C-N 116.107 -0.497 . . . . 15.28 112.992 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.69 13.43 82.13 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.852 -0.689 . . . . 13.44 112.553 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -126.47 157.84 37.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.264 -0.643 . . . . 11.28 109.264 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.5 p -111.92 166.66 11.02 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.882 -0.327 . . . . 8.43 110.328 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 50.4 mt-10 -116.73 113.32 22.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.486 0.66 . . . . 10.79 111.11 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.0 mm -83.1 111.84 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.121 -0.945 . . . . 6.73 108.87 171.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.434 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -77.12 -49.08 16.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.974 -1.012 . . . . 9.17 109.718 -175.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.569 ' HG2' ' N ' ' A' ' 140' ' ' GLY . 31.4 tt0 -148.68 166.42 28.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.961 -0.563 . . . . 10.44 110.284 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.569 ' N ' ' HG2' ' A' ' 139' ' ' GLU . . . 113.84 -23.58 12.97 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.047 -0.597 . . . . 8.87 112.085 172.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.481 HD23 HG12 ' A' ' 123' ' ' VAL . 38.6 mt -127.49 -170.36 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.862 0.363 . . . . 8.5 111.76 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -154.56 156.16 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 14.48 109.663 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 128.01 34.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.713 -0.676 . . . . 12.12 110.196 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.68 -9.53 37.81 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.287 -0.725 . . . . 12.39 111.287 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.565 ' O ' HG21 ' A' ' 84' ' ' VAL . 29.4 mm-40 -91.33 111.18 22.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.199 -0.667 . . . . 11.89 109.199 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 57.6 mt-30 -85.0 128.59 34.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.416 -0.811 . . . . 11.1 110.97 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -119.19 135.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.709 -0.478 . . . . 5.45 109.709 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.44 HG12 ' HE1' ' A' ' 112' ' ' MET . 2.4 p -68.09 121.11 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.253 0.549 . . . . 7.05 110.581 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 5.1 m -106.31 -21.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.211 -0.904 . . . . 6.99 110.398 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t 65.07 -72.57 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.253 -0.885 . . . . 9.37 112.208 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.23 104.34 1.2 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.069 -0.812 . . . . 8.6 111.069 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 68.17 79.94 0.21 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.238 0.542 . . . . 12.43 110.441 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.431 ' O ' HD11 ' A' ' 155' ' ' ILE . 47.3 m-85 -72.67 165.42 24.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.823 -0.626 . . . . 12.83 110.611 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 tp -87.8 50.87 2.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.4 0.619 . . . . 13.49 110.058 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.547 ' H ' HD11 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -83.11 39.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.461 0.648 . . . . 12.27 111.072 -177.205 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.0 -99.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.37 -0.832 . . . . 11.22 111.327 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.4 m -79.22 -41.48 28.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.732 0.777 . . . . 12.0 110.174 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 50.0 mm-40 -54.0 -30.17 46.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.084 -1.417 . . . . 11.17 110.701 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HB1' ' C ' ' A' ' 155' ' ' ILE . . . -68.02 -31.74 71.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.492 -1.231 . . . . 8.27 112.233 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.5 t -81.5 -19.46 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.457 0.646 . . . . 9.64 109.808 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.445 HD11 ' O ' ' A' ' 66' ' ' ALA . 94.0 mt -87.79 -30.4 20.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.802 -1.09 . . . . 10.88 111.898 -173.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 21.7 mmm180 -70.6 140.94 51.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.196 0.522 . . . . 9.36 110.565 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.38 30.59 13.44 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.978 -1.01 . . . . 7.46 111.291 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.7 p 49.99 54.87 10.32 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.347 0.659 . . . . 7.09 110.882 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 67.7 t 72.87 -56.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.171 -0.922 . . . . 9.62 111.415 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 55.2 54.04 9.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.698 0.761 . . . . 9.11 110.743 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.73 ' O ' ' HG3' ' A' ' 168' ' ' MET . 1.6 tmt_? -77.28 88.64 3.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 15.17 109.217 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.73 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 23.3 mtm -158.65 39.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.969 -0.56 . . . . 12.15 111.167 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -74.02 -74.92 0.17 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.935 -0.706 . . . . 15.5 110.324 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.16 -55.8 28.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.43 . . . . 15.01 110.399 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -118.96 129.33 55.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 14.52 110.532 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.1 t -88.42 175.85 7.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.409 -0.589 . . . . 14.89 109.409 178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.3 m -80.02 63.55 4.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.336 0.589 . . . . 15.85 110.66 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.67 21.18 5.99 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.266 -0.879 . . . . 17.54 111.559 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.7 mp -93.39 -148.37 0.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.334 -0.617 . . . . 17.85 109.334 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 59.06 -141.0 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 110.006 -0.368 . . . . 19.67 110.006 176.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.1 t 41.3 84.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.365 1.041 . . . . 19.71 112.814 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.12 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.503 -0.771 . . . . 21.47 110.571 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.8 -54.19 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 23.66 110.56 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.581 ' HA ' HE21 ' A' ' 180' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.262 -0.875 . . . . 23.71 110.197 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.166 -0.309 . . . . 34.49 110.166 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.14 59.87 7.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.45 -0.881 . . . . 33.2 112.855 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t 57.93 63.75 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.503 0.668 . . . . 34.24 111.684 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.53 98.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.641 -1.163 . . . . 32.38 111.843 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 m -61.98 -42.35 99.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 33.02 110.739 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.15 120.38 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 31.57 110.57 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -146.57 -57.21 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 29.46 110.197 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.75 -136.72 2.18 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.173 -0.771 . . . . 28.42 111.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.08 149.09 86.05 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.386 2.057 . . . . 27.92 111.879 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -154.56 121.76 5.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.633 -0.506 . . . . 26.82 109.633 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.81 168.79 18.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.688 0.28 . . . . 25.18 110.326 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 14' ' ' ASP . . . 132.47 -14.6 5.04 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.649 -0.786 . . . . 23.19 112.387 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 73.1 -39.04 0.43 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.244 0.618 . . . . 21.58 111.566 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 12' ' ' GLY . 32.1 m-20 -67.06 135.84 94.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.265 . . . . 19.89 110.286 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 178.53 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.437 2.091 . . . . 18.59 112.414 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.25 89.8 3.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.145 -0.687 . . . . 17.12 109.145 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.75 82.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.2 -0.909 . . . . 14.96 110.595 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.59 78.96 1.81 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.549 -0.75 . . . . 13.21 112.237 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.63 94.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.844 -0.178 . . . . 12.37 110.604 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 44.63 79.18 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.206 0.941 . . . . 13.82 112.324 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.5 tp 65.58 16.69 10.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.846 -1.07 . . . . 12.48 111.268 174.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 72.79 -4.92 2.0 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.242 -0.89 . . . . 14.31 110.744 -178.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 p -117.54 38.8 3.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.402 0.62 . . . . 11.34 110.669 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.56 4.01 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.22 -0.9 . . . . 10.62 113.023 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.55 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -165.72 54.8 0.11 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.556 1.17 . . . . 10.77 109.432 -177.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.686 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 91.1 mtt180 -119.09 148.7 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.605 -1.634 . . . . 8.86 108.883 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.718 HG12 ' OE2' ' A' ' 58' ' ' GLU . 42.9 mm -52.0 124.4 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 113.923 -1.49 . . . . 5.76 114.251 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.71 -32.89 6.5 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.322 -1.763 . . . . 8.55 109.792 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 26.3 p90 -177.64 -175.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.919 -0.582 . . . . 8.07 110.839 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.754 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.21 145.81 46.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.65 -0.705 . . . . 5.61 111.243 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.452 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -150.99 145.8 25.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.03 -0.729 . . . . 9.75 109.03 179.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.751 ' HB3' ' CE ' ' A' ' 34' ' ' MET . 1.2 m-20 -78.27 147.24 72.26 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 112.307 0.484 . . . . 8.31 112.307 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.472 ' HG3' HG13 ' A' ' 54' ' ' ILE . 51.9 Cg_exo -53.68 -56.78 2.35 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.593 2.195 . . . . 10.41 112.797 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.751 ' CE ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -86.87 2.64 48.45 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.398 0.888 . . . . 11.24 113.398 -170.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.661 HG21 ' CB ' ' A' ' 32' ' ' ASP . 21.6 m -120.46 51.83 2.31 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 121.657 0.741 . . . . 9.83 111.325 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.25 121.73 9.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.146 2.564 . . . . 11.66 112.622 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.62 -27.29 4.43 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.052 -0.819 . . . . 10.86 111.052 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.452 ' NE2' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -75.86 138.93 41.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.4 -0.4 . . . . 9.42 109.943 175.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.612 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 34.0 ttp180 -133.54 112.29 11.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.543 -0.299 . . . . 12.03 111.413 -174.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.611 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 73.6 m-85 -97.39 149.3 22.28 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.828 -0.804 . . . . 7.9 108.828 174.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.08 8.11 16.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.044 -0.662 . . . . 10.61 111.806 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.446 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.8 pttp -164.2 167.8 10.14 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 116.332 -0.395 . . . . 11.24 111.881 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HD3' ' CZ3' ' A' ' 30' ' ' TRP . 18.6 Cg_endo -56.0 171.04 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.807 3.004 . . . . 7.51 112.984 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.37 -166.35 28.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.539 -0.839 . . . . 8.06 112.975 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 14.1 ttmm -96.96 148.44 22.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.058 0.456 . . . . 12.05 109.869 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -66.13 141.14 97.27 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.344 -0.844 . . . . 9.2 111.576 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.12 -20.29 10.09 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.844 2.362 . . . . 10.25 111.033 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 48' ' ' TYR . 64.9 m-85 -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.509 -1.223 . . . . 10.49 109.863 -173.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.424 ' HE1' ' C ' ' A' ' 48' ' ' TYR . 2.5 ptp -168.97 168.9 9.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.236 -0.893 . . . . 10.74 109.182 173.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 p-10 -81.22 72.74 8.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.734 0.778 . . . . 12.54 112.418 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 ptm -139.43 139.48 22.75 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.196 -0.911 . . . . 10.35 108.871 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.1 135.94 45.87 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.554 2.17 . . . . 10.11 111.604 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.586 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 18.1 mt -63.17 162.15 12.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.812 -0.631 . . . . 7.0 111.04 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.472 HG13 ' HG3' ' A' ' 33' ' ' PRO . 23.8 mm -102.92 134.41 19.83 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 121.322 0.582 . . . . 8.28 109.984 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.754 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 74.1 Cg_endo -81.98 139.1 10.65 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.308 1.339 . . . . 6.21 112.544 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -55.49 157.88 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 113.872 -1.513 . . . . 6.41 113.045 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.484 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.31 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.716 2.006 . . . . 8.58 115.037 -175.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.718 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -46.94 -42.6 18.05 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.167 0.587 . . . . 7.04 111.401 -176.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.54 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 13.9 tt0 66.92 88.22 0.11 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.453 1.121 . . . . 8.58 111.011 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 63.92 65.12 0.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.564 -2.107 . . . . 7.64 112.245 165.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.567 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 12.8 t-20 -148.13 -29.18 0.31 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.624 -0.716 . . . . 7.58 112.512 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HB1' ' HA ' ' A' ' 66' ' ' ALA . . . -33.4 -56.72 0.42 Allowed 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.862 1.265 . . . . 5.41 111.831 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' HB3' ' H ' ' A' ' 68' ' ' ARG . 31.5 t70 -125.79 64.77 1.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.563 -0.744 . . . . 7.01 110.4 171.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.88 -55.28 5.02 Favored Glycine 0 CA--C 1.497 -1.06 0 CA-C-N 114.826 -1.079 . . . . 7.2 110.82 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.82 19.08 3.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.604 -1.298 . . . . 7.82 108.966 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 63' ' ' ASP . . . 61.4 33.21 18.85 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.679 -1.146 . . . . 9.19 110.881 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.09 -30.28 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.015 -0.993 . . . . 7.42 109.479 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.497 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 70.4 mtm180 -125.8 -169.64 2.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.616 -1.175 . . . . 10.88 111.749 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.611 ' C ' ' H ' ' A' ' 71' ' ' GLY . 6.2 mt -55.75 167.83 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.3 -2.227 . . . . 9.13 113.616 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.686 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 9.5 t70 -57.97 22.05 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.602 1.961 . . . . 13.02 112.811 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 82.88 11.21 81.88 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.546 -0.621 . . . . 12.13 111.546 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -87.91 117.7 26.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.263 0.554 . . . . 12.89 109.778 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.0 t -121.64 140.91 44.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.143 -0.935 . . . . 12.25 111.079 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -128.72 59.21 1.55 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.617 0.723 . . . . 10.97 109.156 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 64.99 71.16 0.46 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.821 -1.081 . . . . 14.62 110.099 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -129.1 87.63 2.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.601 -0.727 . . . . 11.22 110.522 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' HB3' ' O ' ' A' ' 150' ' ' SER . 39.5 tp -57.68 -55.82 29.96 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.554 -0.459 . . . . 13.96 110.25 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.48 5.87 1.2 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.764 -0.732 . . . . 11.94 111.887 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 79' ' ' VAL . 24.4 t 58.25 45.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 122.139 0.971 . . . . 10.24 110.654 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 152' ' ' GLN . 90.7 mtt180 -87.47 150.85 23.49 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.395 -0.922 . . . . 12.25 108.82 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.437 HG23 ' HA ' ' A' ' 148' ' ' VAL . 11.5 p -114.38 170.49 8.26 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.279 0.562 . . . . 8.3 111.61 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.457 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -142.89 127.0 17.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.125 -0.943 . . . . 7.51 108.561 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 41.8 tt0 -79.38 138.46 37.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 12.15 109.965 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.568 HG11 ' HB3' ' A' ' 95' ' ' LEU . 39.2 t -57.21 132.9 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.274 -0.876 . . . . 9.71 112.654 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -137.06 143.87 42.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.772 -1.104 . . . . 11.77 109.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.07 151.27 35.55 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.114 -0.634 . . . . 13.03 109.633 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' HD22 ' A' ' 96' ' ' LEU . . . -174.83 48.92 0.13 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.446 -0.883 . . . . 13.49 112.758 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.53 ' HD2' ' O ' ' A' ' 91' ' ' SER . 17.9 ptt180 -64.01 147.31 52.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 16.96 111.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 tp -147.32 85.9 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.663 -0.495 . . . . 18.49 109.663 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.73 -4.76 85.68 Favored Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 108.963 -1.655 . . . . 18.67 108.963 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.53 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 12.5 p -111.42 170.56 8.04 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.006 -1.597 . . . . 17.16 109.013 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.724 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 28.4 m -82.03 164.11 21.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.733 -1.121 . . . . 14.8 108.851 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -56.46 106.96 0.33 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.284 0.564 . . . . 14.94 111.767 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 92' ' ' THR . 29.6 mmt180 -124.48 162.6 23.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.89 -1.05 . . . . 11.02 109.081 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.568 ' HB3' HG11 ' A' ' 84' ' ' VAL . 1.8 mm? -87.31 113.33 22.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.588 -0.523 . . . . 9.27 109.588 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -89.98 129.94 36.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.117 -0.492 . . . . 10.57 110.656 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.23 159.81 57.11 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.136 -0.938 . . . . 6.4 108.955 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.434 ' HG2' HG12 ' A' ' 149' ' ' VAL . 72.8 Cg_exo -54.46 130.79 41.86 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.86 1.707 . . . . 7.48 111.233 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 t -56.75 -26.02 56.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.254 0.465 . . . . 9.53 112.254 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.26 4.56 50.29 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.07 -0.394 . . . . 10.86 111.659 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.31 -39.16 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 5.39 110.721 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -80.28 158.9 26.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 7.08 112.276 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -106.03 127.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.073 -0.967 . . . . 10.63 109.183 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -99.78 123.6 44.2 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.876 -0.73 . . . . 12.12 110.943 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -148.91 144.67 27.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.558 -0.746 . . . . 14.98 109.573 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.61 -121.63 15.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.204 -0.522 . . . . 16.43 112.322 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.39 37.25 4.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.15 0.5 . . . . 15.35 110.729 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -149.45 177.78 9.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.655 -0.702 . . . . 15.67 111.203 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 12.0 m -123.65 145.87 48.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.31 -0.405 . . . . 9.26 109.986 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.7 mm -123.31 152.18 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.041 -0.725 . . . . 10.94 109.041 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.667 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -127.65 131.34 49.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.678 0.275 . . . . 7.39 110.495 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 76.9 mtp -88.03 100.36 12.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.433 -0.58 . . . . 8.85 109.433 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -85.69 136.82 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.868 -0.605 . . . . 10.13 110.993 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB2' ' HG3' ' A' ' 146' ' ' GLN . . . -89.97 94.19 9.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.618 -0.719 . . . . 10.7 110.158 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.0 141.99 56.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.795 -0.639 . . . . 15.12 110.714 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.29 -6.59 48.34 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.149 -0.78 . . . . 16.92 111.149 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.83 -3.05 46.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.394 0.616 . . . . 18.56 110.4 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.418 ' O ' ' HB1' ' A' ' 166' ' ' ALA . . . 104.37 -21.1 38.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.244 -0.889 . . . . 16.28 113.128 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.13 177.8 26.52 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.818 -0.706 . . . . 14.36 112.598 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.22 122.44 28.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.553 -0.536 . . . . 12.49 109.553 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.505 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.2 m-20 -124.76 147.93 57.76 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.535 -0.466 . . . . 13.91 111.571 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.53 135.18 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.746 2.297 . . . . 13.02 112.55 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.667 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 12.8 p -121.4 129.97 75.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.541 -0.754 . . . . 10.41 109.916 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -74.58 116.86 15.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.988 0.423 . . . . 12.93 110.028 176.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.442 HG13 ' HA3' ' A' ' 140' ' ' GLY . 28.4 m -128.55 167.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.868 -0.605 . . . . 8.03 110.884 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.423 ' HG2' ' CD2' ' A' ' 138' ' ' LEU . 37.6 ttmt -106.2 129.72 54.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.464 -0.569 . . . . 10.66 109.464 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.407 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -142.84 104.09 4.29 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.621 0.601 . . . . 8.3 112.621 -173.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.59 70.9 0.29 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 117.752 -2.166 . . . . 10.1 114.498 167.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 162.69 39.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.876 -0.787 . . . . 11.03 108.876 154.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -138.02 124.34 20.55 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.606 -0.438 . . . . 13.17 109.844 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.05 111.21 6.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.063 -0.517 . . . . 13.78 111.575 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.93 44.17 94.94 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.932 -0.576 . . . . 15.28 112.818 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.15 8.55 85.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 13.44 112.378 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -120.71 166.73 13.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.662 -0.496 . . . . 11.28 109.662 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -120.62 155.51 33.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.749 0.309 . . . . 8.43 110.774 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 48.1 mt-10 -97.09 110.98 23.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.495 0.664 . . . . 10.79 111.014 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.5 mm -79.71 101.15 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.167 -1.049 . . . . 6.73 108.167 169.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.599 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -65.56 -49.35 69.19 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.049 -0.978 . . . . 9.17 110.183 -174.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.95 162.49 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.358 -0.837 . . . . 10.44 110.908 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 116.33 -59.78 0.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.605 -0.807 . . . . 8.87 113.304 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.491 HD23 HG12 ' A' ' 123' ' ' VAL . 25.0 mt -103.35 -174.58 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.588 0.588 . . . . 8.5 112.588 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -149.37 157.56 43.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.451 -0.795 . . . . 14.48 109.605 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 126.01 28.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.626 -0.715 . . . . 12.12 110.075 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.03 -10.46 20.64 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.493 -1.043 . . . . 12.39 110.493 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.514 ' O ' HG21 ' A' ' 84' ' ' VAL . 13.6 mm100 -100.74 120.02 39.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.444 -0.947 . . . . 11.89 108.444 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 11.1 pt20 -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.825 0.821 . . . . 11.1 110.364 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.58 145.96 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.336 -1.302 . . . . 5.45 109.603 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 81' ' ' THR . 6.8 p -69.5 124.57 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.329 0.585 . . . . 7.05 110.234 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.457 HG12 ' CB ' ' A' ' 82' ' ' ALA . 3.8 m -105.58 0.05 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.619 -0.719 . . . . 6.99 110.398 -174.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 77' ' ' LEU . 8.5 t 71.91 -57.14 0.63 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.385 -1.279 . . . . 9.37 111.706 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.92 167.45 11.09 Favored Glycine 0 C--N 1.332 0.344 0 O-C-N 123.592 0.558 . . . . 8.6 113.398 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . 28.0 tt0 -91.32 90.4 7.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.277 0.561 . . . . 12.43 111.208 -176.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 10.7 m-85 -89.31 156.14 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.122 -0.695 . . . . 12.83 109.122 170.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.544 HD11 ' H ' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.12 84.85 1.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.512 0.672 . . . . 13.49 111.403 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 155' ' ' ILE . 9.4 tp -169.55 48.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.089 0.947 . . . . 12.27 110.15 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -66.24 -28.04 68.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.712 0.768 . . . . 11.22 111.249 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.0 m -56.2 -34.46 66.29 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 12.0 113.039 -171.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -70.64 -25.73 63.15 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.837 -0.619 . . . . 11.17 110.673 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.401 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -82.38 -19.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.376 -0.829 . . . . 8.27 110.031 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 m -81.73 -45.01 16.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.485 -0.78 . . . . 9.64 110.022 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.33 -33.78 75.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.543 -0.753 . . . . 10.88 111.055 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 13.7 ptt180 -88.48 165.91 14.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.964 -0.754 . . . . 9.36 108.964 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.12 61.82 3.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 7.46 112.449 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 44.35 -93.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.926 0.89 . . . . 7.09 112.469 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 46.9 t -132.33 82.56 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.131 -1.063 . . . . 9.62 108.131 175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 118' ' ' GLY . . . -67.24 104.19 1.41 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.539 -0.755 . . . . 9.11 111.561 -173.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.831 ' O ' ' HG3' ' A' ' 168' ' ' MET . 0.5 OUTLIER -71.09 88.08 0.78 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.193 -0.912 . . . . 15.17 109.402 173.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.831 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 10.6 mtm -173.37 168.27 4.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.846 -1.07 . . . . 12.15 110.31 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -124.55 -169.2 1.93 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.215 -1.031 . . . . 15.5 108.215 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.89 -148.27 0.14 Allowed 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.215 0.531 . . . . 15.01 109.791 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 68.8 p 51.64 30.43 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.69 -1.141 . . . . 14.52 112.986 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.1 m -79.69 -70.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.471 -0.332 . . . . 14.89 111.204 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.7 t 62.47 179.98 0.14 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.231 0.539 . . . . 15.85 111.178 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.38 -27.32 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.051 -0.595 . . . . 17.54 111.985 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.13 -171.63 1.87 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.493 -0.558 . . . . 17.85 109.493 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.68 -85.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 19.67 109.947 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 p -158.01 51.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 122.315 1.055 . . . . 19.71 110.178 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.94 76.11 8.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.437 -0.802 . . . . 21.47 110.452 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 1.626 ' HD2' ' CD1' ' A' ' 179' ' ' PHE . 96.6 m-85 -128.97 59.01 1.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 23.66 110.334 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.359 -0.829 . . . . 23.71 111.356 -179.396 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.903 -0.406 . . . . 34.49 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.14 88.07 0.11 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.426 -0.892 . . . . 33.2 112.666 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 t -137.12 -147.29 0.24 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.744 -0.465 . . . . 34.24 109.744 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.25 78.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.268 0.556 . . . . 32.38 110.74 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -73.78 -52.38 13.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.886 -0.597 . . . . 33.02 110.416 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -109.26 -39.22 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.05 -0.523 . . . . 31.57 110.49 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 68.91 -67.36 0.21 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.254 0.622 . . . . 29.46 111.283 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 159.74 9.28 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.528 -1.029 . . . . 28.42 110.528 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.34 -164.38 0.2 Allowed 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.61 2.207 . . . . 27.92 112.63 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -58.39 155.11 12.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.894 0.378 . . . . 26.82 111.338 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 83.23 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 25.18 110.583 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.84 -88.66 1.81 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.837 -0.696 . . . . 23.19 111.544 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -106.48 122.16 45.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.863 0.363 . . . . 21.58 110.393 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -124.34 144.53 46.04 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.651 -0.704 . . . . 19.89 109.311 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 109.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.403 2.069 . . . . 18.59 111.556 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HB2' ' H ' ' A' ' 21' ' ' LEU . . . -81.32 39.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 17.12 111.773 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 116.26 10.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 14.96 110.28 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.16 -62.73 0.28 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.183 -0.767 . . . . 13.21 111.183 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.57 -71.07 0.22 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 12.37 109.878 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -169.44 77.47 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.727 -0.842 . . . . 13.82 108.727 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.457 ' H ' ' HB2' ' A' ' 16' ' ' ALA . 3.7 tt 79.02 -58.57 0.41 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.42 -0.956 . . . . 12.48 108.42 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -158.23 -79.66 0.07 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.202 -0.908 . . . . 14.31 109.551 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 26' ' ' ARG . 14.5 t -109.73 -175.86 2.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.809 -0.441 . . . . 11.34 109.809 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 120.15 -56.5 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.977 -0.849 . . . . 10.62 110.977 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.439 ' HD2' ' C ' ' A' ' 24' ' ' GLY . 13.6 mptt -121.88 67.34 0.91 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.726 -1.213 . . . . 10.77 107.726 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.589 ' CD ' ' HA ' ' A' ' 63' ' ' ASP . 6.3 mtt-85 -144.09 141.46 30.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.706 -1.134 . . . . 8.86 109.659 -172.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -53.73 133.7 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 122.568 1.175 . . . . 5.76 113.242 -163.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.9 -35.33 6.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.743 -2.026 . . . . 8.55 109.642 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 3.7 p90 -179.54 -174.71 0.31 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.299 -0.864 . . . . 8.07 108.992 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.801 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m-90 -122.14 147.85 45.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 5.61 111.071 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.463 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 4.0 ptm180 -152.86 156.4 38.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.238 -0.892 . . . . 9.75 110.194 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 35' ' ' VAL . 9.8 t70 -94.1 140.49 22.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.316 -0.624 . . . . 8.31 109.316 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.79 -15.58 38.76 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.889 2.393 . . . . 10.41 112.561 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.504 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -96.44 -3.46 43.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 111.592 0.219 . . . . 11.24 111.592 175.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.559 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.2 m -127.79 37.22 0.37 Allowed Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.031 0.752 . . . . 9.83 113.031 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -61.24 91.79 0.1 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.738 2.292 . . . . 11.66 112.745 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.86 -31.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.113 -0.565 . . . . 10.86 111.838 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.463 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -68.19 -178.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.057 0.762 . . . . 9.42 113.057 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.614 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 11.3 tpp180 -147.34 91.77 2.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.238 -0.892 . . . . 12.03 108.797 172.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 49.9 m-85 -73.97 141.3 45.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.57 -0.852 . . . . 7.9 111.065 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.66 -25.57 68.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 10.61 110.841 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 20.8 pttp -171.79 164.78 4.36 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.808 -0.633 . . . . 11.24 111.008 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.801 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -49.79 169.79 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.756 2.971 . . . . 7.51 113.62 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.93 -156.45 26.68 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.414 -0.898 . . . . 8.06 112.814 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 8.4 ttmt -98.75 148.27 24.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.729 -0.471 . . . . 12.05 109.729 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' MET . 8.7 t -77.29 139.16 64.15 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-O 121.168 0.508 . . . . 9.2 111.318 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.73 -22.27 20.69 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.971 2.448 . . . . 10.25 112.871 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 48' ' ' TYR . 96.9 m-85 -85.51 -24.32 27.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.162 0.982 . . . . 10.49 109.496 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.48 ' O ' ' HB3' ' A' ' 46' ' ' SER . 2.2 ptp -157.9 134.08 9.44 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.868 -1.515 . . . . 10.74 111.081 -165.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -77.85 63.52 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.751 0.786 . . . . 12.54 111.565 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.462 ' HE3' ' OD2' ' A' ' 32' ' ' ASP . 16.6 ptm -139.05 143.96 39.04 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.74 -1.118 . . . . 10.35 108.215 173.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.59 133.93 39.0 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.043 1.829 . . . . 10.11 110.743 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.3 154.41 20.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 7.0 110.82 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -93.83 133.52 27.67 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 8.28 109.872 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.533 ' HB2' HD12 ' A' ' 27' ' ' ILE . 81.6 Cg_endo -85.23 147.87 10.24 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 121.928 1.752 . . . . 6.21 113.425 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG23 HG13 ' A' ' 27' ' ' ILE . 32.2 m -75.69 157.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.639 -1.164 . . . . 6.41 111.994 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.561 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.64 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.19 2.196 . . . . 8.58 115.507 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.755 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -40.25 -48.46 2.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.94 0.896 . . . . 7.04 110.42 174.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.755 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 32.4 mt-10 69.71 83.04 0.16 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 124.203 1.001 . . . . 8.58 113.054 176.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 87.68 64.35 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 113.836 -1.529 . . . . 7.64 111.592 160.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.628 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 16.6 t-20 -165.71 -110.04 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.547 -1.661 . . . . 7.58 107.472 171.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.41 ' CB ' ' HA ' ' A' ' 70' ' ' ASP . . . -175.7 -105.04 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.649 0.262 . . . . 5.41 110.657 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HA ' ' CD ' ' A' ' 26' ' ' ARG . 7.2 t70 -163.79 67.1 0.17 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.877 0.846 . . . . 7.01 111.042 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.24 -14.03 52.01 Favored Glycine 0 CA--C 1.503 -0.676 0 CA-C-N 114.772 -1.104 . . . . 7.2 111.942 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.9 20.53 12.14 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.043 0.496 . . . . 7.82 111.56 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.36 -69.18 0.38 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.704 0.261 . . . . 9.19 111.704 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG12 ' H ' ' A' ' 68' ' ' ARG . 7.1 p -71.22 -59.37 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.178 0.513 . . . . 7.42 111.049 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.613 ' HG2' ' OG1' ' A' ' 164' ' ' THR . 12.8 mtp180 -85.56 -177.74 6.5 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.582 1.182 . . . . 10.88 111.334 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.467 HG22 ' HG2' ' A' ' 72' ' ' ARG . 8.1 mt -99.27 150.83 4.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 112.702 -2.044 . . . . 9.13 112.014 -165.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.423 ' N ' HG23 ' A' ' 69' ' ' ILE . 33.1 t70 -75.54 47.7 0.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.778 -1.101 . . . . 13.02 111.087 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.65 30.91 66.29 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.564 -0.744 . . . . 12.13 112.833 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.467 ' HG2' HG22 ' A' ' 69' ' ' ILE . 2.1 ptt180 -100.91 126.28 47.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.529 -1.286 . . . . 12.89 107.529 170.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.29 100.24 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.287 -0.869 . . . . 12.25 110.005 -171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -78.91 51.46 1.13 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.96 -1.473 . . . . 10.97 110.552 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.15 77.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.105 -0.952 . . . . 14.62 111.17 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.67 129.39 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 11.22 109.584 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.7 mm? -65.22 -32.26 73.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.78 -0.646 . . . . 13.96 110.126 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.485 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 91.06 16.62 53.72 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.371 -1.092 . . . . 11.94 110.371 -177.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 152' ' ' GLN . 44.8 t 72.14 129.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.387 0.613 . . . . 10.24 110.436 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -88.28 114.21 24.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.658 0.742 . . . . 12.25 111.612 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 HG13 ' A' ' 79' ' ' VAL . 32.8 p -133.54 173.37 11.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.442 -1.254 . . . . 8.3 110.715 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.59 128.05 22.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.356 -0.838 . . . . 7.51 109.179 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 29.9 tt0 -84.24 135.68 34.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.109 -0.496 . . . . 12.15 110.063 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 95' ' ' LEU . 55.9 t -60.73 131.69 25.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.704 -0.68 . . . . 9.71 112.474 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 54.2 mmtt -138.53 146.16 41.58 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.714 -1.13 . . . . 11.77 109.519 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.719 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 6.6 mp -78.29 163.38 25.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.552 -0.459 . . . . 13.03 110.189 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.25 -45.55 0.04 OUTLIER Glycine 0 C--O 1.236 0.251 0 C-N-CA 119.774 -1.203 . . . . 13.49 113.744 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 92' ' ' THR . 15.4 ttm-85 -62.46 162.13 10.71 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.459 1.104 . . . . 16.96 112.245 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -158.73 109.9 2.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.74 -0.466 . . . . 18.49 109.74 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 -50.17 0.8 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.491 -1.444 . . . . 18.67 109.491 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.0 t -84.78 178.08 7.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.06 -1.07 . . . . 17.16 108.684 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.648 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -76.72 117.44 18.35 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.086 -0.961 . . . . 14.8 110.949 -170.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.719 ' OE2' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -70.65 160.35 32.74 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.981 -1.463 . . . . 14.94 112.835 -165.509 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.618 ' CG ' ' HA ' ' A' ' 138' ' ' LEU . 1.1 mpp_? -147.45 175.4 10.84 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.873 -1.512 . . . . 11.02 111.135 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.558 ' HB3' HG11 ' A' ' 84' ' ' VAL . 2.3 mm? -100.74 112.97 25.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.166 -0.925 . . . . 9.27 109.101 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.67 130.46 34.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 10.57 110.704 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.407 HG21 ' HG ' ' A' ' 135' ' ' SER . 28.6 m -143.0 157.88 60.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.01 -0.996 . . . . 6.4 108.694 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 15.1 Cg_endo -61.84 132.81 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.252 1.301 . . . . 7.48 109.95 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 29.1 t -56.07 -21.93 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.489 0.551 . . . . 9.53 112.489 -174.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.93 4.78 48.99 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.938 -0.477 . . . . 10.86 111.504 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB3' ' HG2' ' A' ' 98' ' ' PRO . . . -80.51 -41.06 24.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.134 0.492 . . . . 5.39 110.576 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -84.3 158.45 21.19 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.538 -0.756 . . . . 7.08 111.573 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 20.2 mm -107.3 128.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.405 -0.816 . . . . 10.63 110.083 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.463 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 19.5 mmm180 -95.79 123.72 39.49 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.899 -0.72 . . . . 12.12 110.422 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -149.25 142.84 25.44 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.804 -0.635 . . . . 14.98 110.445 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.8 -116.53 4.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.194 -0.527 . . . . 16.43 112.302 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 36.84 4.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 15.35 110.877 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -151.63 -179.17 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.064 -0.516 . . . . 15.67 111.804 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.6 m -130.9 147.71 52.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.651 -0.704 . . . . 9.26 109.508 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.5 mm -122.36 145.92 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.782 0.325 . . . . 10.94 110.204 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 141' ' ' LEU . . . -119.48 130.68 55.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.969 -0.56 . . . . 7.39 110.118 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.598 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 49.2 mmm -90.88 98.35 11.72 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.819 -0.437 . . . . 8.85 109.819 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.54 HG13 ' O ' ' A' ' 121' ' ' ASP . 11.2 p -83.92 139.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.173 0.511 . . . . 10.13 111.967 -170.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -87.24 100.06 12.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.561 -0.745 . . . . 10.7 109.822 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 117' ' ' GLU . 97.4 mttt -86.93 149.45 24.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.197 -0.456 . . . . 15.12 111.278 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.45 10.39 17.12 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.217 -0.753 . . . . 16.92 111.217 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 115' ' ' LYS . 36.7 mt-10 -97.77 15.96 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 18.56 110.55 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.97 19.02 73.66 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.118 -0.947 . . . . 16.28 113.416 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.9 171.66 30.62 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.966 -1.111 . . . . 14.36 112.915 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 120' ' ' PHE . 96.0 m-85 -120.27 112.67 19.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.612 -0.514 . . . . 12.49 109.612 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.54 ' O ' HG13 ' A' ' 113' ' ' VAL . 4.6 m-20 -103.55 147.08 33.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.363 -0.38 . . . . 13.91 110.463 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.75 122.82 2.36 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.984 1.789 . . . . 13.02 112.384 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.34 122.88 59.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.816 -1.083 . . . . 10.41 109.564 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -70.56 111.46 6.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.31 -0.626 . . . . 12.93 109.31 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.462 HG13 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.68 160.46 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.446 0.641 . . . . 8.03 111.867 -173.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -91.83 130.36 37.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.76 -1.2 . . . . 10.66 107.76 172.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.8 102.42 4.28 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.221 -0.592 . . . . 8.3 112.022 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -156.19 71.43 0.26 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 118.595 -1.764 . . . . 10.1 114.028 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.545 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -151.11 163.79 38.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 11.03 109.24 156.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.2 m -139.08 133.11 31.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.179 0.445 . . . . 13.17 110.496 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.85 103.22 4.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 13.78 111.41 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 42.39 69.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.198 -0.525 . . . . 15.28 112.946 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.41 88.94 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.019 -0.61 . . . . 13.44 112.344 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.75 152.65 35.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.255 -0.646 . . . . 11.28 109.255 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.8 p -99.77 161.62 13.5 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.011 -0.276 . . . . 8.43 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 45.3 mt-10 -111.94 117.64 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.641 0.734 . . . . 10.79 111.122 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 35.4 mm -82.94 100.97 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.923 -1.035 . . . . 6.73 108.735 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.618 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . 8.7 mt -63.34 -41.67 98.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.138 -0.937 . . . . 9.17 110.319 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -148.47 155.89 41.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 10.44 110.642 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.462 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 125.0 -54.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.236 -0.983 . . . . 8.87 113.742 172.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.402 HD12 ' HB3' ' A' ' 111' ' ' ALA . 24.7 mt -98.37 -174.82 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 8.5 112.049 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.76 152.12 36.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.561 -0.745 . . . . 14.48 109.966 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.416 ' HA ' HG13 ' A' ' 84' ' ' VAL . . . -69.84 137.4 51.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.104 . . . . 12.12 111.084 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.18 -6.9 59.95 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.629 -0.796 . . . . 12.39 111.518 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -103.44 155.9 18.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.503 -0.925 . . . . 11.89 108.503 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 56.2 mt-30 -111.38 166.38 11.16 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.734 -0.786 . . . . 11.1 111.874 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.7 OUTLIER -135.91 141.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.923 -1.035 . . . . 5.45 108.617 168.229 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.416 ' HA ' HG23 ' A' ' 81' ' ' THR . 5.8 p -73.58 121.29 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 7.05 109.679 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.5 -29.51 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.941 0.719 . . . . 6.99 112.941 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.4 m -120.46 -26.01 5.47 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.767 -0.773 . . . . 9.37 112.382 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 174.16 143.21 4.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.704 -1.236 . . . . 8.6 113.228 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.486 ' HA ' HG11 ' A' ' 79' ' ' VAL . 16.9 pt20 -106.29 41.56 1.4 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.586 -0.524 . . . . 12.43 109.586 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.669 ' HE1' ' CE2' ' A' ' 153' ' ' PHE . 21.0 t80 73.86 170.08 0.3 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.473 -1.24 . . . . 12.83 110.419 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.47 -71.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.493 -0.483 . . . . 13.49 111.422 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 155' ' ' ILE . 2.2 pp -116.76 149.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 12.27 111.086 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.33 -17.74 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 11.22 111.938 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -62.59 -52.52 63.08 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.02 -0.272 . . . . 12.0 111.213 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.54 -32.88 54.24 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.536 -0.466 . . . . 11.17 109.822 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.38 -52.44 37.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.606 0.241 . . . . 8.27 111.547 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.0 p -62.18 -29.87 70.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 9.64 112.035 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.8 -38.6 16.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.109 -0.496 . . . . 10.88 112.203 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 3.1 mpt_? -89.5 -27.1 20.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.929 0.395 . . . . 9.36 111.257 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.552 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . -89.98 -8.72 66.68 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.843 -0.694 . . . . 7.46 111.546 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.613 ' OG1' ' HG2' ' A' ' 68' ' ' ARG . 11.6 p 55.58 -78.83 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.434 1.094 . . . . 7.09 112.907 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.64 72.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 9.62 110.345 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.06 115.14 13.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.016 -0.538 . . . . 9.11 110.272 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.513 ' CD ' ' H ' ' A' ' 168' ' ' MET . 0.0 OUTLIER -89.8 -134.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.554 -0.748 . . . . 15.17 109.712 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.513 ' H ' ' CD ' ' A' ' 167' ' ' ARG . 20.4 mtm 63.93 178.95 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.534 0.734 . . . . 12.15 112.546 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -129.9 -33.04 1.82 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.65 . . . . 15.5 111.899 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.18 98.9 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.252 0.549 . . . . 15.01 111.541 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.4 p -81.25 106.45 13.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.608 -0.723 . . . . 14.52 110.013 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.5 m -87.58 -102.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.443 -0.344 . . . . 14.89 111.491 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 80.4 p 43.67 -145.38 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.189 0.596 . . . . 15.85 111.176 -174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 25.9 71.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.64 -0.79 . . . . 17.54 112.462 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.2 mt -90.22 22.55 3.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.252 0.549 . . . . 17.85 110.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -152.2 118.46 5.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.372 -0.831 . . . . 19.67 109.341 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.49 108.29 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.963 0.411 . . . . 19.71 110.544 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 56.2 mt -109.51 178.35 4.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 21.47 110.367 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 1.59 ' HD1' ' CD2' ' A' ' 179' ' ' PHE . 94.6 m-85 -128.05 129.31 46.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.891 0.377 . . . . 23.66 110.766 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.4 -0.809 . . . . 23.71 110.204 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.16 -0.311 . . . . 34.49 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.05 63.76 3.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.147 -0.549 . . . . 33.2 112.109 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -159.15 9.81 0.13 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.971 0.415 . . . . 34.24 110.156 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.17 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 32.38 110.748 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 m -70.0 116.94 10.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 33.02 111.198 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.6 120.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.415 -0.587 . . . . 31.57 109.415 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.95 147.11 24.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 29.46 110.938 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.34 131.83 2.47 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.844 -0.616 . . . . 28.42 111.906 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -86.72 177.36 4.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.357 2.704 . . . . 27.92 111.936 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.89 79.82 7.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 26.82 109.692 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.19 145.62 49.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.574 -0.739 . . . . 25.18 111.615 -174.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.26 34.52 1.4 Allowed Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.654 -0.703 . . . . 23.19 112.111 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -140.59 121.28 14.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 21.58 109.878 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.1 136.71 26.57 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.222 -0.444 . . . . 19.89 110.913 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.7 147.36 63.06 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.255 1.97 . . . . 18.59 111.586 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.98 -45.73 7.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.045 0.45 . . . . 17.12 111.199 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.23 76.09 9.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.03 -0.532 . . . . 14.96 111.23 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.17 -88.79 2.06 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.282 -0.727 . . . . 13.21 111.282 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.22 -75.19 0.37 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.746 -0.464 . . . . 12.37 109.746 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -163.93 68.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.476 0.655 . . . . 13.82 110.628 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt 67.23 -75.54 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.209 -1.36 . . . . 12.48 110.905 172.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.63 -43.51 98.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 112.895 -1.957 . . . . 14.31 110.703 -164.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.96 40.27 3.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.622 -1.172 . . . . 11.34 109.865 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.94 -35.66 8.92 Favored Glycine 0 CA--C 1.49 -1.476 0 CA-C-N 114.618 -1.173 . . . . 10.62 111.224 174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -171.53 53.33 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.653 -0.773 . . . . 10.77 110.58 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.593 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 39.9 mtt180 -126.45 141.32 51.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.547 -0.751 . . . . 8.86 110.367 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.572 HG12 ' OE2' ' A' ' 58' ' ' GLU . 44.5 mm -55.66 120.08 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 5.76 112.687 -170.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.56 -38.02 5.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.287 -1.324 . . . . 8.55 110.182 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.649 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 21.4 p90 -168.82 -174.66 2.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 8.07 111.303 -175.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.582 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.6 m-90 -124.89 155.02 40.18 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.102 -0.954 . . . . 5.61 111.078 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -160.44 153.58 21.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 9.75 110.133 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.579 ' HB2' HG21 ' A' ' 35' ' ' VAL . 19.1 m-20 -79.17 137.07 56.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.637 -0.875 . . . . 8.31 108.637 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.8 -11.8 19.26 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.65 2.233 . . . . 10.41 111.43 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.579 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.1 null -101.78 0.97 36.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.112 -0.494 . . . . 11.24 111.321 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.612 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 6.9 m -127.81 43.65 1.11 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.244 0.545 . . . . 9.83 111.476 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.612 ' HD3' ' N ' ' A' ' 35' ' ' VAL . 16.6 Cg_exo -61.74 111.49 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.81 2.34 . . . . 11.66 112.009 -170.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.38 -26.18 4.17 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.793 -0.923 . . . . 10.86 110.793 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.44 ' HB3' HG22 ' A' ' 35' ' ' VAL . 38.1 tp60 -76.52 115.58 16.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 9.42 110.531 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 36.3 ttp180 -98.47 99.44 10.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.664 -0.698 . . . . 12.03 110.944 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.603 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 82.9 m-85 -79.77 133.02 36.3 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.343 -0.614 . . . . 7.9 109.343 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.88 -26.86 68.8 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.638 0.587 . . . . 10.61 110.766 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -160.06 147.66 12.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.437 0.636 . . . . 11.24 111.977 -172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.582 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 19.6 Cg_endo -56.33 135.68 71.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.947 3.765 . . . . 7.51 113.573 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.71 -145.93 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.076 -0.583 . . . . 8.06 111.919 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 2.0 ttmm -105.83 141.93 36.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.669 -0.863 . . . . 12.05 108.669 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.576 ' HB3' ' O ' ' A' ' 49' ' ' MET . 47.0 t -64.05 141.6 98.09 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.855 -0.612 . . . . 9.2 111.411 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.93 -21.49 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.664 2.243 . . . . 10.25 111.012 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 35.0 m-85 -84.64 -41.99 15.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.187 -1.37 . . . . 10.49 109.245 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.576 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -137.04 157.41 46.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.369 -0.832 . . . . 10.74 110.873 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.0 p-10 -84.11 53.38 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.07 0.938 . . . . 12.54 111.135 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.47 32.85 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 114.967 -1.015 . . . . 10.35 109.345 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.43 133.14 23.67 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 N-CA-C 108.86 -1.246 . . . . 10.11 108.86 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD21 ' OD1' ' A' ' 32' ' ' ASP . 31.6 mt -61.59 157.17 17.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.076 0.465 . . . . 7.0 111.331 -172.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.16 133.26 22.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 116.065 -0.516 . . . . 8.28 109.702 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.519 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 92.8 Cg_endo -78.65 138.18 14.99 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.912 1.741 . . . . 6.21 112.613 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 57' ' ' TYR . 34.5 m -61.07 159.64 2.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.301 -1.318 . . . . 6.41 112.869 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 1.629 ' HE1' ' CE2' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 15.47 -87.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.564 1.946 . . . . 8.58 115.11 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' OE1' ' HA ' ' A' ' 26' ' ' ARG . 2.5 pt-20 -53.49 -34.49 58.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.244 -1.344 . . . . 7.04 111.675 -170.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 31.6 tt0 55.06 74.39 0.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 O-C-N 124.44 1.088 . . . . 8.58 110.047 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 54.23 86.0 0.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.327 -1.306 . . . . 7.64 112.742 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.413 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 28.8 t30 -121.14 -44.09 2.41 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.82 -1.178 . . . . 7.58 107.82 169.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.69 -63.2 0.31 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 113.741 -1.572 . . . . 5.41 112.411 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CG ' ' HB3' ' A' ' 68' ' ' ARG . 3.1 p-10 -166.43 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 119.047 -1.061 . . . . 7.01 113.082 -171.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 -0.6 74.55 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.314 -1.312 . . . . 7.2 112.074 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 67.66 49.73 0.95 Allowed 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.351 0.677 . . . . 7.82 110.269 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.36 -48.07 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.0 -0.545 . . . . 9.19 111.796 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 t -81.82 -85.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.477 -0.329 . . . . 7.42 111.027 -173.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.545 ' HB3' ' CG ' ' A' ' 63' ' ' ASP . 16.1 ptp180 48.51 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.703 1.601 . . . . 10.88 115.254 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.446 HG23 ' N ' ' A' ' 70' ' ' ASP . 8.2 mt -112.55 154.98 13.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 112.345 -2.207 . . . . 9.13 109.071 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' N ' HG23 ' A' ' 69' ' ' ILE . 22.8 t70 -79.35 49.2 0.96 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.246 0.546 . . . . 13.02 111.148 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.4 33.55 76.67 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.564 -0.744 . . . . 12.13 112.148 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' HG2' HG23 ' A' ' 69' ' ' ILE . 12.3 ptm180 -135.16 -175.42 3.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.986 -1.116 . . . . 12.89 107.986 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.77 120.69 61.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.669 0.747 . . . . 12.25 110.389 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 t -104.29 101.62 11.33 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.51 -1.223 . . . . 10.97 108.254 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.21 73.72 0.67 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.919 -1.037 . . . . 14.62 111.257 -172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -136.61 138.71 41.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.481 -0.933 . . . . 11.22 108.481 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.42 -20.63 66.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.341 -0.845 . . . . 13.96 111.228 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.97 -49.21 0.79 Allowed Glycine 0 CA--C 1.496 -1.129 0 N-CA-C 109.586 -1.406 . . . . 11.94 109.586 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.568 HG11 ' O ' ' A' ' 79' ' ' VAL . 9.0 p 38.37 73.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 122.9 1.333 . . . . 10.24 113.063 165.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -80.48 133.35 35.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.73 -1.123 . . . . 12.25 110.247 -174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 148' ' ' VAL . 36.2 p -131.48 147.24 52.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.447 -1.251 . . . . 8.3 110.592 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.44 54.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.819 -0.808 . . . . 7.51 108.819 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 29.9 tt0 -73.02 138.08 45.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.083 -0.508 . . . . 12.15 109.724 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 95' ' ' LEU . 54.4 t -58.96 135.21 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.522 -0.763 . . . . 9.71 111.739 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 66.5 mmtt -126.89 154.36 44.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.327 -0.851 . . . . 11.77 111.56 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.8 mp -89.2 125.7 35.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.42 -0.956 . . . . 13.03 108.42 162.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.8 8.57 11.72 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 118.979 -1.581 . . . . 13.49 113.371 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.687 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 7.3 ptp180 -141.27 158.17 44.25 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.07 0.462 . . . . 16.96 110.548 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.3 tp -158.47 113.67 2.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.955 -1.02 . . . . 18.49 108.41 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.86 -50.46 0.84 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 108.59 -1.804 . . . . 18.67 108.59 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 15.2 m -73.38 165.87 24.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.174 -1.047 . . . . 17.16 108.174 165.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -72.15 106.48 4.39 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.728 -0.669 . . . . 14.8 111.085 -171.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.687 ' HA ' ' HG3' ' A' ' 88' ' ' ARG . 1.6 tt0 -53.31 124.09 13.71 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 124.585 1.178 . . . . 14.94 111.949 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.56 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -132.17 163.8 27.73 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.892 -1.503 . . . . 11.02 107.567 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.569 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -91.6 114.53 27.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.719 -0.474 . . . . 9.27 109.719 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.14 130.61 37.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.951 -0.568 . . . . 10.57 110.974 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.54 158.24 50.72 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.405 -0.816 . . . . 6.4 109.628 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HG2' HG12 ' A' ' 149' ' ' VAL . 34.5 Cg_exo -57.72 134.38 62.53 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.204 1.936 . . . . 7.48 111.049 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 t -58.05 -28.23 64.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.916 0.339 . . . . 9.53 111.916 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.05 1.24 51.1 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.234 -0.291 . . . . 10.86 111.552 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.75 -41.08 46.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.097 0.475 . . . . 5.39 111.378 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.447 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.92 163.43 14.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.847 -0.615 . . . . 7.08 112.073 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.4 mm -113.27 103.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.809 -0.632 . . . . 10.63 109.508 173.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.2 ptt180 -102.41 132.2 48.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 117.949 -1.501 . . . . 12.12 111.113 173.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -150.31 132.58 15.47 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.736 -1.575 . . . . 14.98 109.454 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.65 -108.79 2.14 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.519 -0.848 . . . . 16.43 112.317 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.5 29.09 7.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.381 0.511 . . . . 15.35 112.381 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.415 HH11 HD13 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -164.76 178.86 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.119 0.415 . . . . 15.67 112.119 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 7.2 m -133.15 152.29 51.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.668 -0.696 . . . . 9.26 110.137 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 34.4 mm -128.95 151.76 36.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.777 -0.453 . . . . 10.94 109.777 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.559 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -136.84 130.12 31.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.649 -0.13 . . . . 7.39 110.649 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.4 mtm -89.31 101.47 14.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 8.85 109.388 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 10.0 p -87.19 139.17 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.601 -0.727 . . . . 10.13 111.364 -174.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -74.61 85.89 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 10.7 109.642 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -71.32 145.82 49.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 15.12 110.129 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.19 -7.78 33.36 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.031 -0.531 . . . . 16.92 113.168 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.33 10.98 17.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 18.56 110.966 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 14.4 69.3 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.487 -0.779 . . . . 16.28 113.282 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.0 167.47 21.09 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.683 -0.77 . . . . 14.36 111.501 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 98.7 m-85 -113.0 108.24 17.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.905 0.383 . . . . 12.49 110.047 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -101.54 141.11 21.93 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.054 -0.521 . . . . 13.91 110.637 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -86.19 124.7 2.5 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.485 2.123 . . . . 13.02 111.943 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 111' ' ' ALA . 8.7 p -107.47 131.8 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.397 -0.82 . . . . 10.41 109.304 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -78.0 109.86 12.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.969 -0.752 . . . . 12.93 108.969 171.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 139' ' ' GLU . 0.2 OUTLIER -116.62 155.78 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.193 -0.912 . . . . 8.03 111.465 -171.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.466 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 4.3 ttmp? -93.54 120.05 33.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.092 -0.958 . . . . 10.66 108.87 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.56 106.89 4.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.093 -0.503 . . . . 8.3 111.004 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.52 70.53 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.893 -2.099 . . . . 10.1 114.215 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.536 ' HB2' ' CG ' ' A' ' 136' ' ' GLU . . . -150.43 162.85 39.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.16 -0.681 . . . . 11.03 109.16 155.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -141.64 123.61 15.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.178 0.513 . . . . 13.17 109.759 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.92 126.45 11.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.673 -0.694 . . . . 13.78 111.156 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.78 32.08 83.03 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 116.09 -0.505 . . . . 15.28 112.528 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.41 15.62 80.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.933 -0.651 . . . . 13.44 111.878 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -123.37 174.98 7.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.036 -0.727 . . . . 11.28 109.036 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.7 m -126.58 157.53 38.6 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.001 0.429 . . . . 8.43 110.646 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.536 ' CG ' ' HB2' ' A' ' 129' ' ' ALA . 75.4 mt-10 -101.8 118.14 36.31 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.489 0.661 . . . . 10.79 110.888 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.612 HD11 HG22 ' A' ' 125' ' ' VAL . 17.6 mm -86.09 101.23 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.097 -0.956 . . . . 6.73 108.927 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.56 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 2.6 mp -71.09 -36.77 72.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.573 -1.194 . . . . 9.17 110.264 -176.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.641 ' O ' HG21 ' A' ' 125' ' ' VAL . 12.5 tt0 -158.2 158.38 34.44 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.056 -0.72 . . . . 10.44 109.056 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 126.15 -33.69 3.43 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.903 -1.142 . . . . 8.87 111.772 174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.34 -176.9 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.859 0.689 . . . . 8.5 112.859 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -148.38 155.97 41.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.731 -1.122 . . . . 14.48 108.944 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.46 133.44 47.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.293 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.54 -5.41 44.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.817 -0.913 . . . . 12.39 110.817 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.444 ' O ' HG21 ' A' ' 84' ' ' VAL . 38.5 mt-30 -101.06 122.03 42.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.364 0.602 . . . . 11.89 109.391 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 6.4 mt-30 -91.27 124.97 35.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.955 . . . . 11.1 110.718 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.39 139.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.792 -0.448 . . . . 5.45 109.792 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.417 ' HA ' HG23 ' A' ' 81' ' ' THR . 35.3 m -65.36 132.25 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 7.05 110.764 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.508 HG12 ' HG2' ' A' ' 98' ' ' PRO . 3.2 m -119.29 19.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.891 0.853 . . . . 6.99 109.247 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.5 m 73.79 154.54 0.15 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.713 -1.585 . . . . 9.37 112.038 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.25 71.51 2.24 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.671 -0.972 . . . . 8.6 110.671 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -60.34 140.98 56.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.398 0.518 . . . . 12.43 112.398 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.627 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 9.2 p90 -106.15 -161.38 0.79 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 12.83 109.761 174.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 61.7 tp 71.67 -71.25 0.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.202 0.601 . . . . 13.49 110.631 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.66 3.36 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.539 -0.755 . . . . 12.27 110.597 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.68 -21.67 65.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.841 -0.618 . . . . 11.22 110.056 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 p -59.1 -52.99 63.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.182 0.515 . . . . 12.0 110.17 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.94 -36.6 79.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.38 -0.827 . . . . 11.17 110.391 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.14 67.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.051 -0.977 . . . . 8.27 111.3 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -76.38 -19.33 58.26 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.966 -0.383 . . . . 9.64 109.966 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.01 -50.13 71.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.23 -0.655 . . . . 10.88 109.23 173.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -64.63 -34.97 79.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.257 -0.883 . . . . 9.36 110.248 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.44 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 106.82 43.65 1.4 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.439 -0.801 . . . . 7.46 111.666 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 49.2 p 54.95 -92.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.902 0.881 . . . . 7.09 112.156 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.56 74.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.501 0.667 . . . . 9.62 110.87 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.33 146.94 53.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 9.11 111.277 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.739 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -109.24 111.12 22.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.296 -0.411 . . . . 15.17 110.386 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.423 ' HE3' ' HB2' ' A' ' 168' ' ' MET . 2.1 mpp? -149.9 -69.27 0.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.354 -0.839 . . . . 12.15 110.168 173.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -138.34 -68.21 0.46 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.193 -0.912 . . . . 15.5 110.156 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 171' ' ' THR . 0.0 OUTLIER -134.03 -54.24 0.86 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 15.01 110.067 -177.527 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.437 ' N ' ' HG2' ' A' ' 170' ' ' GLU . 11.1 p -153.46 -46.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.111 0.564 . . . . 14.52 110.295 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.2 t 175.79 161.51 0.3 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.318 -0.855 . . . . 14.89 110.38 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.2 m -98.6 -2.66 38.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 15.85 109.714 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 46.66 1.14 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.557 -1.017 . . . . 17.54 110.557 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.605 HD11 ' N ' ' A' ' 176' ' ' GLU . 2.2 tm? -56.98 150.91 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.471 . . . . 17.85 110.111 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.605 ' N ' HD11 ' A' ' 175' ' ' LEU . 33.6 mt-10 -68.52 77.0 0.28 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.342 0.592 . . . . 19.67 110.942 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.95 132.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.412 -0.813 . . . . 19.71 109.198 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 178' ' ' LEU . 1.4 pt? -136.95 145.44 44.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.098 0.475 . . . . 21.47 111.036 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -74.08 146.72 43.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.532 -0.758 . . . . 23.66 110.39 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.318 -0.849 . . . . 23.71 109.772 177.4 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.892 0.377 . . . . 34.49 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.83 108.49 0.21 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.247 -0.741 . . . . 33.2 111.247 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m 63.78 -161.1 0.29 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.972 0.415 . . . . 34.24 110.918 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.54 12.48 8.9 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.778 0.831 . . . . 32.38 111.825 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -110.04 -5.92 15.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 33.02 111.001 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.03 -28.64 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 31.57 111.022 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -142.73 141.61 31.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.327 -0.397 . . . . 29.46 110.384 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.95 -172.96 36.01 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.638 -0.791 . . . . 28.42 111.872 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.84 27.36 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.016 2.477 . . . . 27.92 112.421 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -137.92 46.09 2.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.505 -0.316 . . . . 26.82 110.98 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.06 44.58 1.14 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.631 0.729 . . . . 25.18 110.507 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.85 23.01 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.103 -0.953 . . . . 23.19 110.811 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -150.74 152.63 34.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.205 0.503 . . . . 21.58 110.463 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -96.53 160.82 28.66 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.283 -0.636 . . . . 19.89 109.283 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.81 -50.9 10.25 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.129 1.886 . . . . 18.59 111.952 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.4 ' HB2' ' NH1' ' A' ' 39' ' ' ARG . . . 68.22 115.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.086 -0.961 . . . . 17.12 111.82 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.37 108.28 17.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.685 -0.689 . . . . 14.96 110.209 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.75 -96.89 0.31 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.982 -0.628 . . . . 13.21 111.665 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.66 -87.28 0.05 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.904 -0.174 . . . . 12.37 110.604 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 68.63 122.28 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.557 0.694 . . . . 13.82 110.926 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.428 ' C ' HD11 ' A' ' 21' ' ' LEU . 3.3 tm? 78.07 -45.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.517 -1.219 . . . . 12.48 110.349 176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -18.55 61.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.389 0.614 . . . . 14.31 109.511 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -105.15 145.85 30.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.428 -0.805 . . . . 11.34 110.508 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.1 43.89 1.65 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.758 -0.735 . . . . 10.62 111.738 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.1 mptm? 72.68 62.62 0.11 Allowed 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.614 -1.254 . . . . 10.77 107.614 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.575 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 22.7 ptt85 -128.13 145.44 51.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.649 -1.614 . . . . 8.86 109.093 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.637 HG12 ' CG ' ' A' ' 58' ' ' GLU . 22.5 mm -54.05 125.28 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 114.227 1.195 . . . . 5.76 114.227 -166.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.5 mt -110.26 -37.24 5.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.205 -1.816 . . . . 8.55 110.507 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.638 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 20.5 p90 -170.0 -176.03 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.397 . . . . 8.07 111.369 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.593 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -123.86 148.82 46.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.533 -0.758 . . . . 5.61 111.09 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -153.61 151.16 29.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.337 -0.392 . . . . 9.75 110.631 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.611 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 6.1 t0 -75.82 129.16 81.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.011 -1.107 . . . . 8.31 108.011 172.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HG3' HG13 ' A' ' 54' ' ' ILE . 18.7 Cg_exo -60.46 -16.99 45.38 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.098 1.865 . . . . 10.41 113.77 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.448 ' HE1' ' OD1' ' A' ' 32' ' ' ASP . 0.8 OUTLIER -104.51 4.84 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.243 -0.583 . . . . 11.24 111.921 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.611 ' CG2' ' HB3' ' A' ' 32' ' ' ASP . 4.4 m -119.42 41.88 0.44 Allowed Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 112.387 0.514 . . . . 9.83 112.387 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.09 134.63 65.62 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 11.66 112.465 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.08 43.38 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.976 -0.849 . . . . 10.86 110.976 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.554 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -92.86 116.42 29.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.217 0.532 . . . . 9.42 110.371 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 49.4 ttp180 -104.34 116.57 32.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.667 -0.697 . . . . 12.03 111.334 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 97.5 m-85 -101.84 114.23 28.13 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.862 -1.162 . . . . 7.9 107.862 171.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -64.35 -21.58 66.67 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.522 -0.871 . . . . 10.61 111.703 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.523 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 52.9 mttp -126.18 166.68 20.16 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.339 -0.544 . . . . 11.24 111.234 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 14.1 Cg_endo -56.4 171.58 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.399 2.733 . . . . 7.51 112.857 170.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.6 -170.8 29.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.651 -0.785 . . . . 8.06 112.424 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 31.2 ttmt -95.58 146.78 24.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.465 -0.568 . . . . 12.05 109.465 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.4 t -64.51 129.69 94.33 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.684 -0.689 . . . . 9.2 110.411 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.7 -26.35 33.09 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.44 2.093 . . . . 10.25 111.027 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 52.3 m-85 -73.98 -40.67 62.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.969 -1.468 . . . . 10.49 110.404 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.501 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.8 OUTLIER -154.52 160.96 41.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 10.74 110.788 174.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.406 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.2 p-10 -78.6 72.35 5.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.888 0.851 . . . . 12.54 112.804 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.2 ptm -140.41 144.74 38.12 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.531 -0.915 . . . . 10.35 108.531 168.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.4 133.3 29.84 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.095 1.863 . . . . 10.11 110.041 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.34 159.53 12.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.894 0.378 . . . . 7.0 110.382 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.406 HG13 ' HG3' ' A' ' 33' ' ' PRO . 42.0 mm -103.24 130.84 22.83 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-O 121.25 0.548 . . . . 8.28 109.752 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.622 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 80.6 Cg_endo -75.48 144.14 28.39 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.707 1.605 . . . . 6.21 112.416 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.35 160.46 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.407 -1.27 . . . . 6.41 112.62 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.575 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.59 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.843 2.457 . . . . 8.58 116.389 -175.001 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.637 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -61.06 -45.21 95.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.766 0.793 . . . . 7.04 109.936 -173.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.631 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 47.5 mt-10 71.72 43.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.514 -1.675 . . . . 8.58 114.695 167.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 173.73 56.38 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.316 1.01 . . . . 7.64 111.966 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.543 ' H ' HG13 ' A' ' 27' ' ' ILE . 10.4 t30 62.71 -52.13 0.17 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.624 -2.08 . . . . 7.58 114.647 170.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -170.51 -18.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.873 -0.603 . . . . 5.41 112.38 -176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.606 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 56.9 m-20 55.83 37.0 28.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.797 0.808 . . . . 7.01 109.632 -164.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.34 31.14 42.09 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 114.73 -1.123 . . . . 7.2 112.577 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 88.94 48.66 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.809 1.244 . . . . 7.82 111.466 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 72.45 -26.84 0.18 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.264 1.209 . . . . 9.19 114.264 170.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.97 -20.56 26.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.587 1.184 . . . . 7.42 109.92 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.66 ' HB3' ' OG1' ' A' ' 164' ' ' THR . 5.9 ttt180 66.86 113.95 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 111.988 -2.369 . . . . 10.88 112.836 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 72' ' ' ARG . 2.6 mt -126.16 156.2 36.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 113.608 -1.633 . . . . 9.13 110.465 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.28 54.32 2.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.1 0.952 . . . . 13.02 110.236 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.48 -20.16 9.52 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 114.441 -1.254 . . . . 12.13 114.687 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.502 ' O ' HG22 ' A' ' 69' ' ' ILE . 17.0 ptm180 -72.65 127.01 31.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.803 -0.814 . . . . 12.89 108.803 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.23 135.52 62.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.275 0.559 . . . . 12.25 111.828 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.536 ' C ' ' H ' ' A' ' 76' ' ' ASN . 8.0 t -147.82 117.44 7.06 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.904 -1.044 . . . . 10.97 109.457 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.81 35.93 0.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.578 1.18 . . . . 14.62 109.598 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.536 ' H ' ' C ' ' A' ' 74' ' ' THR . 38.6 m-80 -156.57 98.55 1.82 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.384 -1.735 . . . . 11.22 107.922 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.0 mt -83.2 -3.92 57.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.494 0.664 . . . . 13.96 110.746 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.31 -1.28 26.47 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.202 -0.908 . . . . 11.94 112.184 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 124.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.851 0.358 . . . . 10.24 110.349 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -113.53 138.65 49.84 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.155 -0.683 . . . . 12.25 109.155 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 148' ' ' VAL . 45.9 p -140.4 144.11 36.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.082 0.468 . . . . 8.3 110.78 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 149' ' ' VAL . . . -114.94 140.64 48.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.872 -0.788 . . . . 7.51 108.872 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.48 130.54 34.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.593 -0.521 . . . . 12.15 109.593 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 145' ' ' GLN . 61.2 t -54.69 128.96 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.432 0.635 . . . . 9.71 111.554 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.02 140.3 7.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.486 -1.233 . . . . 11.77 109.981 171.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.479 HD21 ' H ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -77.58 158.01 30.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.148 -0.933 . . . . 13.03 110.484 -177.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.568 ' N ' HD22 ' A' ' 96' ' ' LEU . . . -169.53 47.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.883 -0.675 . . . . 13.49 112.427 -171.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -68.58 134.47 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.821 0.343 . . . . 16.96 110.924 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.9 mt -135.68 85.52 2.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.709 -0.848 . . . . 18.49 108.709 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.88 2.09 75.68 Favored Glycine 0 CA--C 1.504 -0.641 0 N-CA-C 108.418 -1.873 . . . . 18.67 108.418 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -110.44 178.3 4.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 112.829 -1.686 . . . . 17.16 108.572 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -94.44 156.37 16.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.552 -0.907 . . . . 14.8 108.552 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.88 105.76 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.493 0.663 . . . . 14.94 111.415 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.435 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 33.6 mmt180 -133.92 164.28 27.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.382 -1.281 . . . . 11.02 108.332 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.6 mp -85.16 112.21 20.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.101 -0.703 . . . . 9.27 109.101 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.0 mm? -87.81 130.23 34.94 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.84 0.352 . . . . 10.57 110.95 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.78 155.58 56.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 6.4 109.045 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.93 136.92 67.96 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.121 1.881 . . . . 7.48 111.117 170.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.432 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 15.9 t -56.46 -24.12 43.49 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.472 0.545 . . . . 9.53 112.472 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.89 9.47 27.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.217 -0.302 . . . . 10.86 111.138 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -80.44 -41.11 25.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.244 0.545 . . . . 5.39 111.339 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.8 155.61 19.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.646 0.736 . . . . 7.08 112.546 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.37 131.43 46.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.731 -1.122 . . . . 10.63 109.1 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -102.28 126.55 49.31 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.534 -0.466 . . . . 12.12 110.823 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 t -149.67 132.93 16.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.275 -0.421 . . . . 14.98 110.466 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.33 -114.22 3.61 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.262 -0.494 . . . . 16.43 113.111 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.57 36.65 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.195 0.521 . . . . 15.35 111.243 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -153.3 167.53 29.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 15.67 111.758 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.2 m -117.44 145.15 44.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.066 -0.515 . . . . 9.26 109.831 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.542 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.8 mm -125.49 153.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.306 -0.627 . . . . 10.94 109.306 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -129.42 129.88 45.24 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.353 -0.217 . . . . 7.39 110.467 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 41.2 ttp -90.61 100.86 13.63 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 8.85 108.668 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 121' ' ' ASP . 14.3 p -84.49 133.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.49 -0.777 . . . . 10.13 111.894 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -83.86 84.06 7.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 10.7 110.188 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.19 149.03 46.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 15.12 110.665 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.79 5.39 39.44 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.118 -0.793 . . . . 16.92 111.118 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -87.23 6.39 33.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.471 0.653 . . . . 18.56 110.528 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 1.27 77.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.231 -0.895 . . . . 16.28 113.469 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.78 159.17 22.87 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.735 -0.745 . . . . 14.36 112.426 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.459 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.5 m-85 -109.87 116.82 32.34 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.572 -0.529 . . . . 12.49 109.572 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.452 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.8 t70 -113.46 144.2 30.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.002 -0.279 . . . . 13.91 111.267 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -84.44 131.21 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.512 2.141 . . . . 13.02 112.505 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 10.6 p -122.97 136.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.595 . . . . 10.41 110.27 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -83.11 120.23 25.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.97 0.414 . . . . 12.93 109.996 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.41 HG13 ' HA3' ' A' ' 140' ' ' GLY . 22.8 m -129.11 165.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.031 -0.531 . . . . 8.03 111.567 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.73 127.17 44.57 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.873 -0.603 . . . . 10.66 109.397 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.14 106.19 4.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.198 -0.455 . . . . 8.3 111.393 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.75 71.05 0.28 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 117.655 -2.212 . . . . 10.1 114.094 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -149.51 162.16 40.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 11.03 108.817 155.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -146.96 129.76 16.17 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.645 -0.502 . . . . 13.17 109.645 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.96 110.72 4.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.034 -0.53 . . . . 13.78 111.364 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.61 40.28 90.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.056 -0.592 . . . . 15.28 112.9 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.79 0.73 90.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.72 -0.753 . . . . 13.44 112.543 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -114.49 155.69 25.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.507 -0.553 . . . . 11.28 109.507 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.432 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 57.7 m -113.4 164.85 13.07 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 110.072 -0.344 . . . . 8.43 110.072 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 50.9 mt-10 -112.53 113.57 25.79 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.57 0.7 . . . . 10.79 111.283 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 34.9 mm -83.24 104.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.946 -1.024 . . . . 6.73 108.401 170.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -70.34 -49.14 52.39 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.125 -0.943 . . . . 9.17 109.922 -174.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -144.38 162.04 37.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 10.44 111.311 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 119.31 -52.99 0.69 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.871 -0.68 . . . . 8.87 113.395 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 123' ' ' VAL . 16.0 mt -105.36 -171.63 1.95 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 8.5 111.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -144.26 155.37 43.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 14.48 110.066 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 129.51 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.15 -0.932 . . . . 12.12 110.348 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.28 -11.06 28.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.978 -0.849 . . . . 12.39 110.978 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.56 ' O ' HG21 ' A' ' 84' ' ' VAL . 88.5 mm-40 -94.19 118.22 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 11.89 109.465 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 26.1 mt-30 -85.38 132.38 34.24 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 11.1 110.797 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 149' ' ' VAL . 18.4 m -122.8 142.34 39.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.184 -0.462 . . . . 5.45 110.133 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 8.9 p -65.29 124.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.231 0.539 . . . . 7.05 111.375 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 147' ' ' VAL . 10.9 m -129.34 29.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.273 0.558 . . . . 6.99 111.083 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.2 m -53.01 112.7 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.105 -0.952 . . . . 9.37 110.999 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 157.93 127.12 0.93 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.935 -0.866 . . . . 8.6 110.935 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -150.79 76.61 1.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.708 0.254 . . . . 12.43 111.323 -175.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 79.0 t80 72.01 -71.25 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.65 0.594 . . . . 12.83 111.062 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.532 ' HG ' ' H ' ' A' ' 155' ' ' ILE . 11.3 tp -118.02 -154.95 0.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.669 -0.863 . . . . 13.49 108.669 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.532 ' H ' ' HG ' ' A' ' 154' ' ' LEU . 61.0 mt -57.85 100.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.495 0.664 . . . . 12.27 110.191 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -82.67 -6.44 59.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.472 -0.786 . . . . 11.22 111.09 -172.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.7 m -60.41 -42.89 96.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 12.0 110.807 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.41 -28.35 52.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.509 0.671 . . . . 11.17 109.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.6 -27.36 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 8.27 111.987 -174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 p -81.48 -38.6 26.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.947 0.403 . . . . 9.64 110.804 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.52 -26.57 61.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.791 -0.64 . . . . 10.88 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -94.63 161.68 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.667 0.746 . . . . 9.36 110.084 178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.86 -70.19 0.52 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.628 -1.389 . . . . 7.46 109.628 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 68' ' ' ARG . 21.7 p -144.98 -56.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.303 0.573 . . . . 7.09 109.767 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.54 -70.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.604 -0.725 . . . . 9.62 110.053 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 70.69 132.58 0.03 OUTLIER 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.883 0.74 . . . . 9.11 111.856 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -88.62 110.38 20.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.176 -1.046 . . . . 15.17 108.176 175.128 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 13.1 ptp -103.59 123.92 47.85 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 113.985 -1.461 . . . . 12.15 112.224 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -152.07 -44.93 0.11 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.427 -1.26 . . . . 15.5 108.045 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.33 -58.94 2.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.842 -1.072 . . . . 15.01 109.11 173.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.2 p -108.92 117.78 35.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.662 -0.699 . . . . 14.52 110.725 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.5 m -91.45 151.21 20.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 14.89 109.934 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.2 m -94.47 76.09 3.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.506 0.669 . . . . 15.85 110.203 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -68.3 -38.02 86.97 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.011 -0.995 . . . . 17.54 111.137 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.6 mt -98.87 73.64 1.99 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.049 -0.352 . . . . 17.85 110.049 170.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.79 -26.69 19.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.238 -0.585 . . . . 19.67 110.211 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.9 t -74.88 89.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.169 0.509 . . . . 19.71 110.687 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -141.65 93.86 2.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 21.47 109.696 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 1.646 ' HD2' ' CD1' ' A' ' 179' ' ' PHE . 84.2 m-85 -127.39 -79.48 0.59 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.212 -0.449 . . . . 23.66 110.446 -178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.404 HE21 ' HB2' ' A' ' 180' ' ' GLN . 1.3 mp0 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.79 -0.624 . . . . 23.71 109.639 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.575 0.226 . . . . 34.49 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.46 -47.89 0.17 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.595 -0.812 . . . . 33.2 111.978 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 6' ' ' VAL . 18.7 t -81.6 102.64 10.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.347 0.594 . . . . 34.24 109.546 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.06 4.77 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.677 -0.692 . . . . 32.38 111.985 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -77.39 -30.44 53.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 33.02 110.19 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 3' ' ' SER . 35.8 m -93.88 38.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.383 0.611 . . . . 31.57 110.875 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -73.66 -21.15 60.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.61 . . . . 29.46 111.409 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.62 139.18 3.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.753 -0.737 . . . . 28.42 112.124 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.77 -30.91 69.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.845 2.364 . . . . 27.92 112.561 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -153.34 136.21 15.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.471 -0.332 . . . . 26.82 110.426 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.7 175.5 7.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.852 -0.613 . . . . 25.18 110.67 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 -99.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.085 -0.507 . . . . 23.19 112.056 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -154.33 -59.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.589 0.709 . . . . 21.58 110.304 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 52.65 65.31 6.19 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 113.991 -1.459 . . . . 19.89 112.285 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -35.66 98.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.268 2.645 . . . . 18.59 112.721 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 52.39 46.81 25.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.144 0.497 . . . . 17.12 111.606 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.08 162.82 36.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.714 -0.675 . . . . 14.96 109.776 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.37 37.0 63.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.546 -0.835 . . . . 13.21 112.023 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.52 10.9 15.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 12.37 111.088 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 29.2 tt0 52.28 66.19 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.341 -1.3 . . . . 13.82 111.779 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 175.85 -81.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.608 -1.178 . . . . 12.48 108.931 172.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -82.72 97.2 8.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.418 1.104 . . . . 14.31 108.969 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p 55.91 52.12 11.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.446 -2.161 . . . . 11.34 112.288 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.3 -62.69 2.53 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.471 -0.786 . . . . 10.62 111.374 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -148.48 67.96 1.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.757 1.265 . . . . 10.77 108.015 176.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.579 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 2.1 mmp_? -141.15 127.66 20.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.692 -1.594 . . . . 8.86 109.203 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -55.04 140.47 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 122.361 1.077 . . . . 5.76 112.7 -172.873 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -118.53 -39.2 3.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.35 -1.75 . . . . 8.55 109.18 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.666 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 13.7 p90 -170.15 -178.21 2.75 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.85 . . . . 8.07 110.011 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.772 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-90 -120.83 146.97 45.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.726 . . . . 5.61 109.665 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 149.97 37.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.784 0.326 . . . . 9.75 110.18 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.659 ' HB3' HG21 ' A' ' 35' ' ' VAL . 29.3 t0 -83.75 132.12 49.91 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 108.783 -0.821 . . . . 8.31 108.783 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.434 ' CD ' HD11 ' A' ' 54' ' ' ILE . 39.3 Cg_exo -56.05 -18.77 24.03 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.674 2.249 . . . . 10.41 112.461 172.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.415 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -90.14 -1.94 58.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.754 0.279 . . . . 11.24 111.754 175.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.659 HG21 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -131.91 39.65 0.52 Allowed Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.911 0.708 . . . . 9.83 112.911 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 19.1 Cg_endo -51.21 110.85 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.976 2.451 . . . . 11.66 112.799 -171.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.2 -31.81 3.38 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.766 -0.652 . . . . 10.86 111.503 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.509 ' HB3' HG22 ' A' ' 35' ' ' VAL . 20.6 tp60 -70.52 107.38 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 9.42 111.04 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 23.5 mtm180 -86.88 97.69 10.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.259 -0.882 . . . . 12.03 110.68 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.631 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 89.4 m-85 -75.11 143.55 43.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.75 -0.659 . . . . 7.9 109.232 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.54 -29.14 70.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.551 -1.204 . . . . 10.61 111.072 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 21.1 pttm -164.17 164.03 14.69 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.476 -0.329 . . . . 11.24 111.737 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.5 Cg_endo -50.75 170.85 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.006 3.137 . . . . 7.51 113.712 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.55 -162.99 26.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.739 -0.744 . . . . 8.06 112.115 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 37.6 ttpt -94.28 149.23 21.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.126 0.489 . . . . 12.05 110.687 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.524 ' HB3' ' O ' ' A' ' 49' ' ' MET . 34.2 t -65.64 132.47 94.96 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 115.122 -0.945 . . . . 9.2 110.986 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.54 -24.72 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.204 1.936 . . . . 10.25 111.706 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.644 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 78.1 m-85 -76.5 -37.13 57.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.99 -1.005 . . . . 10.49 110.098 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.524 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.3 pmm? -156.92 163.6 38.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.865 -0.607 . . . . 10.74 110.224 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.403 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 8.7 p-10 -84.0 75.68 10.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 12.54 114.471 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -142.59 145.38 34.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.057 -0.72 . . . . 10.35 109.057 168.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.9 Cg_exo -66.6 133.91 33.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.947 1.764 . . . . 10.11 111.219 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 32' ' ' ASP . 31.6 mt -62.67 159.03 16.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.004 0.431 . . . . 7.0 111.181 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.434 HD11 ' CD ' ' A' ' 33' ' ' PRO . 1.7 mp -95.69 135.4 23.03 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.952 -0.567 . . . . 8.28 109.691 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . 64.5 Cg_endo -87.52 162.1 8.06 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.585 1.524 . . . . 6.21 113.286 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG23 HG13 ' A' ' 27' ' ' ILE . 32.6 m -89.26 156.49 3.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.647 -1.16 . . . . 6.41 111.709 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 1.634 ' HE2' ' CE1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 14.73 -80.88 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 126.971 2.108 . . . . 8.58 115.685 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.58 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.1 pt-20 -53.04 -39.98 63.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.942 -0.392 . . . . 7.04 109.942 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 57' ' ' TYR . 52.3 mt-10 62.73 95.25 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.192 -0.913 . . . . 8.58 110.976 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HG2' ' HA3' ' A' ' 64' ' ' GLY . 26.6 tt0 63.33 52.74 2.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.554 -1.657 . . . . 7.64 111.986 159.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.536 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 10.4 t30 -122.6 -35.37 3.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.664 -1.607 . . . . 7.58 110.006 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -30.79 33.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 113.792 -1.549 . . . . 5.41 111.368 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 8.6 p-10 -162.03 22.18 0.11 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.312 -0.858 . . . . 7.01 110.757 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -89.72 -31.03 11.77 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.083 -0.962 . . . . 7.2 111.375 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.19 -41.48 6.37 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.592 -0.804 . . . . 7.82 110.37 -172.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.26 -24.21 22.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.703 -0.68 . . . . 9.19 110.047 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.609 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 3.7 t 65.78 -39.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.149 -1.387 . . . . 7.42 111.908 -169.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -57.74 136.36 56.89 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.735 -0.469 . . . . 10.88 109.735 165.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.502 HG23 ' N ' ' A' ' 70' ' ' ASP . 15.4 mt -67.49 159.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.1 0.476 . . . . 9.13 110.349 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' N ' HG23 ' A' ' 69' ' ' ILE . 33.8 t70 -74.07 35.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.457 -0.792 . . . . 13.02 111.017 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 69.31 11.05 63.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.344 -0.455 . . . . 12.13 112.945 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' HG13 ' A' ' 73' ' ' VAL . 13.9 ptm180 -100.43 177.88 4.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 119.218 -0.42 . . . . 12.89 110.3 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.457 HG13 ' HG3' ' A' ' 72' ' ' ARG . 5.0 p 33.31 115.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 115.432 1.642 . . . . 12.25 115.432 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -71.34 59.89 0.29 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.265 -1.334 . . . . 10.97 111.792 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -91.24 67.74 5.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.807 0.813 . . . . 14.62 109.161 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -112.14 119.65 39.13 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.88 -1.054 . . . . 11.22 109.23 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.474 ' H ' HD23 ' A' ' 77' ' ' LEU . 2.9 mm? -47.0 -37.6 9.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.595 -1.184 . . . . 13.96 111.85 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 126.26 42.01 0.31 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.111 -1.596 . . . . 11.94 109.111 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 92.7 t 78.19 121.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 113.964 -1.118 . . . . 10.24 110.659 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.38 124.2 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.202 -0.666 . . . . 12.25 109.202 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.2 p -130.0 154.82 47.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.269 -0.423 . . . . 8.3 109.879 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.4 134.33 54.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 7.51 109.231 174.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 32.8 tt0 -83.65 136.97 34.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.314 -0.624 . . . . 12.15 109.314 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 95' ' ' LEU . 71.8 t -60.51 129.01 22.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 9.71 111.881 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 26.5 mmtp -129.51 151.0 50.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.64 -1.164 . . . . 11.77 109.622 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.4 HD21 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -84.98 162.37 19.41 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.728 -0.389 . . . . 13.03 109.967 169.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.05 46.86 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.273 0 C-N-CA 120.705 -0.76 . . . . 13.49 112.837 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.574 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -84.23 -178.62 6.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.872 0.368 . . . . 16.96 111.696 -177.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.26 124.08 28.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.731 -0.668 . . . . 18.49 109.419 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.5 -159.47 14.5 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 115.222 -0.899 . . . . 18.67 111.59 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -86.31 76.71 9.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.949 0.881 . . . . 17.16 109.087 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.574 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 2.5 m -153.87 168.28 26.88 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.559 -1.201 . . . . 14.8 108.841 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.4 ' HG2' HD21 ' A' ' 86' ' ' LEU . 3.8 mt-10 -142.05 113.71 7.87 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.921 0.391 . . . . 14.94 109.981 163.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 3.1 tpp180 -122.64 159.94 26.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 11.02 110.358 -175.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.483 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -100.72 124.12 45.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.485 -0.561 . . . . 9.27 109.485 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.65 130.36 45.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.22 -0.445 . . . . 10.57 110.405 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.31 155.19 57.84 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.352 -0.84 . . . . 6.4 109.734 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.05 127.45 25.03 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.053 1.836 . . . . 7.48 111.124 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.497 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.5 p -54.26 -31.86 54.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.074 0.464 . . . . 9.53 112.227 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.88 -17.38 64.61 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.742 -0.663 . . . . 10.86 112.405 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.8 -7.29 59.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 5.39 111.31 -175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.427 HD22 HD13 ' A' ' 137' ' ' ILE . 26.5 mt -86.18 118.27 25.53 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.773 0.797 . . . . 7.08 112.093 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.529 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -89.54 111.32 22.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.409 -1.269 . . . . 10.63 108.817 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.59 125.42 34.34 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.345 -0.542 . . . . 12.12 110.45 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -148.81 141.47 24.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.966 -0.561 . . . . 14.98 109.875 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.64 -117.74 6.21 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 121.266 -0.492 . . . . 16.43 112.313 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.0 37.1 4.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.166 0.508 . . . . 15.35 111.342 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -148.28 174.65 11.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.986 -0.552 . . . . 15.67 111.081 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 m -121.36 149.84 42.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.267 -0.642 . . . . 9.26 109.267 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.529 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.8 mm -128.4 148.27 32.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.645 -0.502 . . . . 10.94 109.645 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -121.41 126.42 49.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.496 -0.32 . . . . 7.39 110.205 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.409 ' HB2' HG23 ' A' ' 148' ' ' VAL . 59.4 mtp -82.27 99.68 9.46 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.416 -0.587 . . . . 8.85 109.416 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 121' ' ' ASP . 9.4 p -83.04 130.66 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.291 -0.868 . . . . 10.13 111.288 -174.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.455 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -87.83 89.27 7.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.546 -0.752 . . . . 10.7 109.454 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.22 157.76 35.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.73 -0.668 . . . . 15.12 111.647 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.86 17.49 21.29 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.418 -0.81 . . . . 16.92 111.501 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -103.6 8.73 37.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.354 0.597 . . . . 18.56 110.337 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.36 9.09 70.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.184 -0.917 . . . . 16.28 113.481 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.81 170.51 23.97 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.2 -1.0 . . . . 14.36 113.038 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.618 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 87.4 m-85 -121.46 123.7 42.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.869 -0.419 . . . . 12.49 109.869 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.521 ' O ' HG13 ' A' ' 113' ' ' VAL . 26.1 m-20 -123.51 151.05 62.66 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.791 -0.364 . . . . 13.91 111.404 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.15 122.69 2.2 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.048 1.832 . . . . 13.02 112.31 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.615 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 8.1 p -108.28 132.76 55.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.32 -0.855 . . . . 10.41 109.784 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -72.96 119.91 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.818 -0.438 . . . . 12.93 109.818 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 123' ' ' VAL . 31.3 m -127.91 159.28 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 8.03 111.584 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.461 ' HG2' HD23 ' A' ' 138' ' ' LEU . 39.8 ttmt -104.46 128.88 52.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.319 -0.855 . . . . 10.66 109.32 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.96 106.73 5.12 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 111.82 0.304 . . . . 8.3 111.82 -174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.18 70.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 117.983 -2.056 . . . . 10.1 114.82 165.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.561 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.15 163.44 38.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.446 -1.316 . . . . 11.03 107.446 150.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -140.65 128.83 22.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.7 0.682 . . . . 13.17 110.375 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.86 117.3 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.136 0.421 . . . . 13.78 112.136 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 39.76 98.35 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 115.948 -0.569 . . . . 15.28 113.344 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.84 82.29 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.724 -0.75 . . . . 13.44 112.471 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -122.26 163.02 20.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.56 -0.904 . . . . 11.28 108.56 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.0 p -114.46 149.74 35.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.307 -0.557 . . . . 8.43 112.035 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 1.2 mp0 -93.43 119.17 32.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.46 -0.791 . . . . 10.79 111.513 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 16.2 mm -91.5 111.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.295 -0.866 . . . . 6.73 109.333 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -75.02 -51.59 13.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.63 -1.168 . . . . 9.17 109.487 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -143.05 169.03 18.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.067 -0.97 . . . . 10.44 110.893 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 117.38 -71.73 0.29 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.528 -0.844 . . . . 8.87 113.374 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 42.8 tp -108.56 172.41 6.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.778 0.289 . . . . 8.5 110.666 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.49 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 88.0 tttt -122.56 154.62 37.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.812 0.815 . . . . 14.48 111.656 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.25 135.13 54.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 113.979 -1.464 . . . . 12.12 109.834 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.48 -2.8 56.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.354 -0.927 . . . . 12.39 111.439 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.51 152.65 21.44 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.849 -0.797 . . . . 11.89 108.849 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.6 mt-30 -104.04 149.88 24.78 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.078 0.466 . . . . 11.1 111.203 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.402 ' O ' HG11 ' A' ' 149' ' ' VAL . 18.9 m -135.73 146.66 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.644 -0.707 . . . . 5.45 109.286 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.409 HG23 ' HB2' ' A' ' 112' ' ' MET . 27.7 m -72.88 128.13 35.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.352 0.596 . . . . 7.05 110.824 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 147' ' ' VAL . 2.7 m -132.5 13.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.697 -0.683 . . . . 6.99 110.702 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.4 m -36.12 106.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.267 0.979 . . . . 9.37 112.593 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.08 -73.94 0.32 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.321 -0.854 . . . . 8.6 111.291 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 38.57 56.75 1.83 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.179 0.992 . . . . 12.43 112.217 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.667 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 32.8 p90 -117.64 134.63 54.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.199 0.523 . . . . 12.83 111.115 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 158' ' ' GLU . 94.5 mt -87.22 -165.3 1.26 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.558 -0.746 . . . . 13.49 110.773 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 36.2 pt -78.46 -161.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 12.27 111.436 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -55.63 -23.79 29.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.307 0.484 . . . . 11.22 112.307 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.8 m -54.71 -48.49 72.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.024 0.44 . . . . 12.0 110.669 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.477 ' OE1' ' HA ' ' A' ' 153' ' ' PHE . 20.1 tt0 -61.17 -29.8 70.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.369 -0.832 . . . . 11.17 110.296 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.06 -25.73 31.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.954 -0.566 . . . . 8.27 112.028 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.0 t -75.91 -30.18 58.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.196 -0.668 . . . . 9.64 109.196 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 162' ' ' ARG . 3.5 pp -88.3 -30.19 19.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.719 -0.673 . . . . 10.88 112.407 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.544 ' N ' HD11 ' A' ' 161' ' ' LEU . 25.3 ptt180 -80.73 132.78 35.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 9.36 110.637 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.86 74.02 0.21 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.729 -0.748 . . . . 7.46 111.815 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.7 p 47.15 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.556 0.742 . . . . 7.09 111.787 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.4 t 64.48 82.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.419 -0.585 . . . . 9.62 109.419 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.76 135.66 57.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.329 -0.851 . . . . 9.11 110.994 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 167' ' ' ARG . 3.2 ppt_? -71.26 -8.99 57.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.808 -0.633 . . . . 15.17 110.887 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.0 mtm -99.09 132.05 44.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.576 -0.738 . . . . 12.15 109.518 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -86.4 -136.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 15.5 110.346 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -80.93 47.94 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 15.01 111.47 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.5 p -91.43 40.9 1.05 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.429 0.633 . . . . 14.52 110.078 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.8 t -114.49 -179.38 3.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.236 -0.893 . . . . 14.89 109.939 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t 68.41 80.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.736 0.648 . . . . 15.85 111.099 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.12 -15.26 65.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.44 -0.886 . . . . 17.54 111.066 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.5 tp 68.03 79.85 0.21 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.373 0.669 . . . . 17.85 110.615 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -95.51 -162.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 19.67 110.062 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.78 -24.46 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.207 0.527 . . . . 19.71 109.966 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 72.2 mt 66.37 -84.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.01 -0.995 . . . . 21.47 111.26 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 1.663 ' HD1' ' CD2' ' A' ' 179' ' ' PHE . 43.9 t80 -171.75 75.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.457 . . . . 23.66 110.225 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 116.197 -0.456 . . . . 23.71 110.115 176.849 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.729 0.299 . . . . 34.49 110.781 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.441 ' C ' ' HG ' ' A' ' 3' ' ' SER . . . 71.27 -91.33 0.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.702 -0.761 . . . . 33.2 111.531 -177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.441 ' HG ' ' C ' ' A' ' 2' ' ' GLY . 52.7 p 47.32 -95.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.996 0.918 . . . . 34.24 112.01 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -165.51 150.2 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.357 -0.383 . . . . 32.38 110.109 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 p -108.29 -34.29 6.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.965 -0.561 . . . . 33.02 110.696 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 28.71 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.116 -0.493 . . . . 31.57 111.61 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -124.56 -70.17 0.77 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.12 0.486 . . . . 29.46 110.983 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.24 -175.77 22.1 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.292 -0.723 . . . . 28.42 111.292 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.52 -72.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.885 2.39 . . . . 27.92 111.635 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -171.25 137.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.102 -0.703 . . . . 26.82 109.102 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.23 -164.85 1.24 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.88 0.371 . . . . 25.18 110.692 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.71 174.31 42.73 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.372 -0.691 . . . . 23.19 111.372 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -125.07 10.67 8.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.459 0.647 . . . . 21.58 109.854 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.2 78.63 74.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 19.89 110.711 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -177.62 3.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.446 2.097 . . . . 18.59 111.92 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.85 48.17 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 17.12 110.148 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.24 123.36 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 14.96 110.716 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.72 32.1 4.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 13.21 112.918 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.459 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . -128.14 1.4 5.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.585 0.707 . . . . 12.37 110.131 177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.5 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 26.5 tt0 -77.24 73.07 3.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.04 . . . . 13.82 108.956 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 19.6 mt 77.89 -22.47 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.568 -1.197 . . . . 12.48 111.391 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 20' ' ' GLU . 75.0 mmtt -78.81 60.64 2.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.185 0.517 . . . . 14.31 110.355 174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.5 m 67.94 82.96 0.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 11.34 109.848 -174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 19' ' ' ALA . . . -170.76 -50.72 0.04 OUTLIER Glycine 0 CA--C 1.497 -1.072 0 CA-C-N 115.572 -0.74 . . . . 10.62 111.71 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -138.33 68.51 1.39 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 122.152 0.977 . . . . 10.77 109.958 -172.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.524 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 45.1 mtm180 -134.65 140.34 45.95 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.927 -1.488 . . . . 8.86 109.217 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.755 HG22 ' CZ3' ' A' ' 30' ' ' TRP . 22.7 mm -54.85 129.73 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 122.455 1.121 . . . . 5.76 113.701 -167.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.925 HD11 ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -89.87 -29.49 18.54 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 112.355 -2.202 . . . . 8.55 111.376 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.611 ' HD1' ' CD2' ' A' ' 29' ' ' TYR . 46.3 p90 158.0 -172.9 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.055 1.342 . . . . 8.07 107.597 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CZ3' HG22 ' A' ' 27' ' ' ILE . 1.3 m-90 -116.95 142.69 46.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.744 0.307 . . . . 5.61 110.835 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -148.28 154.62 40.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 9.75 110.476 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.589 ' HB3' HG23 ' A' ' 35' ' ' VAL . 9.1 t70 -92.41 137.11 24.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.556 -0.905 . . . . 8.31 108.556 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.65 -13.63 35.04 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.313 2.008 . . . . 10.41 112.191 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.457 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.3 OUTLIER -99.72 2.31 44.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.59 -0.277 . . . . 11.24 111.206 175.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 32' ' ' ASP . 3.8 m -128.86 40.89 0.65 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.396 0.517 . . . . 9.83 112.396 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 14.5 Cg_endo -52.3 113.38 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.916 2.411 . . . . 11.66 112.809 -172.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.3 -35.87 2.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.46 -0.656 . . . . 10.86 111.46 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.547 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -64.2 103.09 0.58 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.641 0.734 . . . . 9.42 110.856 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.774 ' NH1' ' HA ' ' A' ' 41' ' ' ASP . 2.1 tmm_? -81.96 103.49 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.015 -0.993 . . . . 12.03 109.702 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.628 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -87.91 133.59 33.89 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.297 -1.001 . . . . 7.9 108.297 173.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.774 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 17.8 t70 -63.89 -35.05 79.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.924 -1.035 . . . . 10.61 110.518 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.2 mttp -148.37 162.33 30.73 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.955 -0.566 . . . . 11.24 110.721 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.752 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.5 Cg_endo -50.21 171.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.01 3.14 . . . . 7.51 113.857 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.54 -165.91 27.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 8.06 112.491 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 7.7 ttmt -91.33 144.24 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.237 -0.653 . . . . 12.05 109.237 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 49' ' ' MET . 10.6 t -70.76 145.78 92.57 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.43 . . . . 9.2 110.863 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.52 -20.85 7.83 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.765 2.31 . . . . 10.25 111.547 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 96.4 m-85 -84.6 -39.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.426 -1.261 . . . . 10.49 109.842 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.588 ' HE1' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -136.66 151.92 49.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.663 -0.698 . . . . 10.74 110.522 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.5 p-10 -79.23 53.14 1.43 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.864 0.84 . . . . 12.54 111.418 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 16.4 ptm -127.02 146.59 58.27 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.418 -0.81 . . . . 10.35 109.682 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 51' ' ' MET . 8.2 Cg_exo -69.58 133.5 26.04 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.143 1.896 . . . . 10.11 110.286 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.69 156.68 13.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.397 0.436 . . . . 7.0 110.592 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.65 131.16 27.51 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 121.205 0.526 . . . . 8.28 110.311 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 96.7 Cg_endo -85.09 156.5 11.27 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.117 1.878 . . . . 6.21 113.158 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.531 HG22 ' HG ' ' A' ' 28' ' ' LEU . 27.2 m -86.73 160.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.555 -1.202 . . . . 6.41 111.136 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.524 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 5.84 -71.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.392 2.277 . . . . 8.58 116.478 -176.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.666 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.8 pt-20 -65.47 -39.22 91.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.125 0.964 . . . . 7.04 110.726 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 60' ' ' GLU . 9.9 pt-20 39.25 42.96 0.84 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 112.473 -2.148 . . . . 8.58 114.02 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 5.0 mt-10 177.8 59.5 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.427 -1.261 . . . . 7.64 112.251 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.453 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 36.0 t-20 -170.91 -86.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.591 -0.732 . . . . 7.58 111.826 167.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' A' ' 27' ' ' ILE . . . 47.48 83.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.152 0.977 . . . . 5.41 112.268 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.577 ' HA ' ' HB ' ' A' ' 67' ' ' VAL . 1.1 m-20 49.64 44.19 24.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.588 -2.096 . . . . 7.01 111.393 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -54.93 -56.15 24.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.399 -0.819 . . . . 7.2 113.056 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -171.55 -0.62 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.027 0.441 . . . . 7.82 110.904 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.73 -49.37 1.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.32 -0.622 . . . . 9.19 109.32 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 1.8 t -65.43 -27.16 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.362 -0.835 . . . . 7.42 108.766 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 24.9 ttt180 -46.4 112.22 0.47 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.291 -1.322 . . . . 10.88 112.502 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.43 HG22 ' HG2' ' A' ' 72' ' ' ARG . 10.1 mt -98.63 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.235 -1.348 . . . . 9.13 110.18 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.05 57.34 4.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.976 0.893 . . . . 13.02 110.492 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' O ' HG21 ' A' ' 73' ' ' VAL . . . 49.11 46.7 33.65 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 113.668 -1.606 . . . . 12.13 113.038 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HG2' HG22 ' A' ' 69' ' ' ILE . 26.7 ptt180 -59.35 123.7 17.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.665 -0.494 . . . . 12.89 109.665 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 71' ' ' GLY . 51.6 t -117.92 130.19 73.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.904 -0.589 . . . . 12.25 110.464 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 t -95.38 48.5 1.16 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.201 -0.908 . . . . 10.97 110.679 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 53.5 79.87 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.694 -1.139 . . . . 14.62 112.153 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -140.95 122.77 15.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.546 -0.297 . . . . 11.22 110.951 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.42 -47.32 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.762 -0.829 . . . . 13.96 108.762 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 150' ' ' SER . . . 179.66 -43.13 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.313 -1.515 . . . . 11.94 109.313 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.479 ' CG1' ' HA ' ' A' ' 150' ' ' SER . 39.9 t 66.47 163.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.644 -0.778 . . . . 10.24 111.337 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.679 ' O ' HG21 ' A' ' 149' ' ' VAL . 18.1 tpt180 -102.72 172.04 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.802 0.811 . . . . 12.25 112.762 -171.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 148' ' ' VAL . 19.8 p -106.8 139.3 41.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.772 -1.104 . . . . 8.3 108.052 170.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 147' ' ' VAL . . . -107.69 127.85 54.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.607 -0.516 . . . . 7.51 109.607 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 43.5 tt0 -82.25 140.48 33.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.069 0.461 . . . . 12.15 110.696 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.488 HG12 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -62.92 130.67 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.325 -0.852 . . . . 9.71 112.026 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 27.5 mmtp -137.23 153.45 50.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.465 -1.243 . . . . 11.77 109.266 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 93' ' ' GLU . 9.7 mp -83.73 152.02 24.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.758 -0.46 . . . . 13.03 109.758 168.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.79 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 111.47 -0.652 . . . . 13.49 111.47 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.839 ' HG3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -64.04 -178.09 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.201 0.815 . . . . 16.96 113.201 -174.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.9 tp -139.58 112.45 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 18.49 109.549 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.88 -148.4 18.91 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 111.286 -0.726 . . . . 18.67 111.286 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -101.14 75.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.92 0.867 . . . . 17.16 109.322 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.839 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 1.7 m -155.42 168.31 27.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.457 -1.247 . . . . 14.8 107.865 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.458 ' HG2' HD21 ' A' ' 86' ' ' LEU . 1.9 mp0 -139.24 121.86 16.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.414 0.626 . . . . 14.94 110.98 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.563 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 41.1 mmt180 -131.11 156.09 45.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.972 -1.013 . . . . 11.02 110.778 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.0 mp -87.32 114.88 24.33 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.987 -1.006 . . . . 9.27 110.465 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.65 130.69 35.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.693 0.282 . . . . 10.57 110.826 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.96 152.94 56.44 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.431 -0.804 . . . . 6.4 109.856 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.507 ' HG2' HG12 ' A' ' 149' ' ' VAL . 41.8 Cg_exo -56.3 122.64 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.094 1.863 . . . . 7.48 110.35 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.4 p -62.7 -22.81 66.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 9.53 112.845 -164.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.19 -4.88 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 119.754 -0.165 . . . . 10.86 111.177 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -40.93 68.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 5.39 110.452 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.2 pp -78.73 160.3 27.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.229 -0.896 . . . . 7.08 111.424 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 109' ' ' THR . 26.7 mm -117.11 103.72 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.282 -0.417 . . . . 10.63 110.595 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -113.76 95.18 5.2 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.543 -1.263 . . . . 12.12 111.888 174.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 t -103.79 136.62 43.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.843 -1.526 . . . . 14.98 109.212 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.14 -113.13 4.18 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.343 -0.932 . . . . 16.43 112.018 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.8 28.16 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.268 0.84 . . . . 15.35 113.268 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -170.08 171.0 7.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.374 0.509 . . . . 15.67 112.374 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 1.8 m -121.89 155.3 35.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 9.26 111.767 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 36.5 mm -129.29 150.18 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.362 -0.836 . . . . 10.94 109.467 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.623 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -134.19 127.14 31.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.297 -0.26 . . . . 7.39 110.297 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.44 ' HB2' HG13 ' A' ' 148' ' ' VAL . 4.1 mpp? -93.55 99.82 12.2 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.197 -0.668 . . . . 8.85 109.197 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.7 p -77.33 139.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.06 -0.973 . . . . 10.13 110.403 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -78.58 92.58 4.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.076 -0.511 . . . . 10.7 111.525 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 50.5 mttm -76.25 178.69 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 15.12 110.896 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.93 25.78 7.79 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.765 -0.934 . . . . 16.92 110.765 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.16 12.9 33.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.968 0.358 . . . . 18.56 111.968 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.16 16.76 36.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 16.28 113.159 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 115' ' ' LYS . . . 179.47 173.69 44.85 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.881 -0.888 . . . . 14.36 110.881 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.644 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 54.3 m-85 -87.54 -176.54 5.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.991 0.424 . . . . 12.49 110.626 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.448 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 11.5 t70 -140.89 120.04 8.36 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.742 -0.663 . . . . 13.91 109.368 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.0 110.55 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.166 2.578 . . . . 13.02 112.537 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 13.9 p -104.91 140.45 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.121 -0.945 . . . . 10.41 109.915 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.87 112.03 18.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 12.93 109.726 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.5 HG11 HG11 ' A' ' 123' ' ' VAL . 23.2 m -117.03 163.31 14.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.662 -0.699 . . . . 8.03 111.23 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -100.68 133.85 44.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.582 -0.735 . . . . 10.66 109.219 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.56 103.14 4.48 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.964 -0.295 . . . . 8.3 111.43 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.88 69.89 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.142 -1.98 . . . . 10.1 113.633 169.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.37 163.85 37.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.49 -1.3 . . . . 11.03 107.49 154.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -143.61 130.41 20.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.787 0.722 . . . . 13.17 111.036 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.12 120.87 9.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 13.78 110.616 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.23 36.11 92.98 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.316 -0.469 . . . . 15.28 112.91 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 12.45 83.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.858 -0.687 . . . . 13.44 112.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -120.87 158.97 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.006 -0.368 . . . . 11.28 110.006 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 157.91 16.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.867 0.365 . . . . 8.43 110.045 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 32.0 mt-10 -106.78 115.33 30.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.474 0.654 . . . . 10.79 109.821 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.7 mm -81.67 104.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.974 -1.012 . . . . 6.73 109.154 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.563 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 3.0 mp -69.57 -44.97 69.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.607 -1.179 . . . . 9.17 110.562 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.59 158.13 44.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.779 -0.646 . . . . 10.44 111.327 -175.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.472 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 116.85 -53.31 0.64 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.287 -0.959 . . . . 8.87 114.529 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -107.51 -170.9 1.77 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.434 0.531 . . . . 8.5 112.434 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.96 150.94 37.83 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.683 -0.689 . . . . 14.48 111.001 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.57 133.54 49.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.718 -1.128 . . . . 12.12 109.9 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.46 -2.3 53.65 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.244 -0.979 . . . . 12.39 111.575 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -104.05 143.57 32.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.254 -0.647 . . . . 11.89 109.254 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 22.9 mt-30 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.022 0.439 . . . . 11.1 111.593 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 82' ' ' ALA . 30.0 m -132.18 142.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 5.45 108.704 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.563 ' HA ' HG23 ' A' ' 81' ' ' THR . 6.9 p -76.7 104.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.755 0.788 . . . . 7.05 110.956 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -92.92 -15.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.148 -1.056 . . . . 6.99 108.148 177.056 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 78' ' ' GLY . 1.2 m -57.46 163.26 2.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.333 -1.303 . . . . 9.37 111.427 162.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -81.51 63.64 4.32 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.938 -0.865 . . . . 8.6 110.938 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 66.83 89.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.043 0.537 . . . . 12.43 110.582 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -152.18 91.18 1.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.533 0.568 . . . . 12.83 112.533 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.9 tp -115.78 -62.12 1.64 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.017 -1.105 . . . . 13.49 108.017 164.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.93 6.0 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.399 -1.334 . . . . 12.27 107.399 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.466 ' HB3' ' HB1' ' A' ' 159' ' ' ALA . 2.5 m-20 -83.44 35.65 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.71 -2.041 . . . . 11.22 111.537 -171.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -49.01 -49.08 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.364 0.875 . . . . 12.0 113.364 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -73.72 -26.4 60.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 11.17 110.002 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.466 ' HB1' ' HB3' ' A' ' 156' ' ' ASP . . . -75.95 -20.96 57.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.173 -0.921 . . . . 8.27 111.432 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.2 m -69.22 -29.94 67.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.0 0.905 . . . . 9.64 109.244 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.466 ' HA ' HG11 ' A' ' 73' ' ' VAL . 11.4 mt -87.23 -43.09 12.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.153 -1.385 . . . . 10.88 109.374 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 23.5 ttt180 -51.85 128.35 23.67 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.006 1.323 . . . . 9.36 112.891 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -117.85 31.16 5.81 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.43 -1.068 . . . . 7.46 110.43 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.6 p -70.71 126.27 29.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 123.924 0.426 . . . . 7.09 111.54 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 26' ' ' ARG . 48.2 t 54.21 82.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 9.62 111.332 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.96 123.62 26.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.81 -0.632 . . . . 9.11 110.456 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.428 ' O ' ' HD3' ' A' ' 167' ' ' ARG . 3.2 tmt_? -62.82 -40.04 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.22 -0.9 . . . . 15.17 108.893 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.63 159.84 41.09 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.173 -1.376 . . . . 12.15 110.726 -176.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -81.22 83.21 6.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.878 -0.416 . . . . 15.5 109.878 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 45.84 85.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.922 0.764 . . . . 15.01 112.259 170.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.5 p -79.42 -10.35 59.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.329 0.492 . . . . 14.52 112.329 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.6 t -89.07 147.16 24.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.423 0.63 . . . . 14.89 111.189 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.7 p -167.19 13.29 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.811 -1.086 . . . . 15.85 111.721 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.77 -36.18 53.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 17.54 111.885 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.2 tp -100.53 129.92 46.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.413 -0.588 . . . . 17.85 109.413 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.81 -174.74 5.09 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.161 -0.215 . . . . 19.67 111.0 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.79 -57.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.489 -0.559 . . . . 19.71 109.489 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.6 tp 63.21 83.4 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.436 -0.802 . . . . 21.47 110.433 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -74.98 151.54 38.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.426 -0.806 . . . . 23.66 110.563 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.547 -0.739 . . . . 23.71 109.642 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.879 0.371 . . . . 34.49 110.478 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.65 49.12 3.82 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.205 -0.521 . . . . 33.2 113.031 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t -151.11 21.86 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.07 -0.715 . . . . 34.24 109.07 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.94 89.43 2.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.745 -0.662 . . . . 32.38 111.517 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.7 p 51.02 35.28 12.4 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.234 0.827 . . . . 33.02 113.234 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t 61.99 92.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.13 0.491 . . . . 31.57 110.998 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -88.28 -9.94 51.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.075 0.464 . . . . 29.46 110.241 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.95 -164.46 26.44 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.125 -0.79 . . . . 28.42 111.125 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.15 2.27 5.74 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.892 2.395 . . . . 27.92 112.892 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 74.72 130.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.293 -0.867 . . . . 26.82 111.512 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.72 173.52 15.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.123 -0.944 . . . . 25.18 108.605 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.43 59.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.808 -1.187 . . . . 23.19 113.301 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -103.84 57.07 0.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.082 -0.71 . . . . 21.58 109.082 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.499 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 26.5 t70 -73.01 -48.49 7.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 119.077 -0.487 . . . . 19.89 112.185 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 17.8 Cg_endo -60.23 101.55 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.316 1.344 . . . . 18.59 111.897 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.48 91.54 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.577 . . . . 17.12 110.899 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.478 ' H ' ' HB2' ' A' ' 21' ' ' LEU . . . -82.91 56.93 3.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 14.96 109.836 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -86.9 0.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.756 -0.937 . . . . 13.21 110.756 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.28 -18.15 4.12 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.11 -0.545 . . . . 12.37 110.464 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -84.78 61.0 6.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.984 0.897 . . . . 13.82 110.196 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.478 ' HB2' ' H ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -158.33 -66.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.457 -1.247 . . . . 12.48 108.51 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -83.18 56.3 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.904 0.859 . . . . 14.31 109.712 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 t 40.53 51.65 2.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.143 -1.844 . . . . 11.34 113.018 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.91 42.66 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 110.618 -0.993 . . . . 10.62 110.618 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -166.0 57.75 0.1 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.159 0.981 . . . . 10.77 109.725 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.581 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 29.7 mtm180 -132.47 135.35 45.98 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.276 -1.329 . . . . 8.86 109.045 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.576 HG12 ' OE1' ' A' ' 58' ' ' GLU . 34.7 mm -48.22 126.44 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 113.426 0.899 . . . . 5.76 113.426 -171.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.63 -34.73 5.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.824 -1.534 . . . . 8.55 109.821 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.657 ' HD1' ' CD2' ' A' ' 29' ' ' TYR . 14.5 p90 -168.92 -175.17 2.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.253 -0.43 . . . . 8.07 111.007 -174.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.529 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.43 153.68 43.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.707 -0.679 . . . . 5.61 111.666 -172.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.569 ' HB2' HE22 ' A' ' 38' ' ' GLN . 39.0 ptt180 -157.48 146.06 19.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.851 -0.613 . . . . 9.75 110.435 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.601 ' HB3' HG21 ' A' ' 35' ' ' VAL . 7.6 t0 -83.03 134.5 46.28 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 8.31 108.777 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.84 -22.53 62.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.233 2.622 . . . . 10.41 111.824 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.559 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -75.81 -22.22 56.56 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.895 -1.048 . . . . 11.24 110.647 178.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.743 HG12 ' CD2' ' A' ' 48' ' ' TYR . 5.3 m -128.3 50.33 5.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 121.529 0.681 . . . . 9.83 111.813 -166.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.78 119.59 6.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.187 2.591 . . . . 11.66 112.057 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.17 -30.53 4.08 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.414 -0.674 . . . . 10.86 111.414 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.569 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -70.55 136.43 49.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 9.42 109.797 174.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.86 98.97 5.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.122 -0.49 . . . . 12.03 110.749 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 16.5 m-85 -80.07 135.65 36.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.589 . . . . 7.9 111.017 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.98 -25.39 67.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.347 -0.842 . . . . 10.61 110.379 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -165.23 147.5 6.64 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-O 121.321 0.582 . . . . 11.24 110.531 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -51.61 128.92 27.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 125.139 3.893 . . . . 7.51 113.962 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.53 -161.71 11.49 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.232 -0.747 . . . . 8.06 111.232 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 25.8 ttpp -90.46 150.53 21.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.167 0.508 . . . . 12.05 109.979 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.8 t -65.82 135.13 95.34 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.211 -0.904 . . . . 9.2 110.138 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.83 -25.71 11.96 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.192 1.928 . . . . 10.25 111.626 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 98.1 m-85 -77.53 -38.08 49.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.872 -1.058 . . . . 10.49 109.995 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -153.09 164.8 37.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.089 -0.505 . . . . 10.74 110.736 172.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.414 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 5.4 p-10 -82.69 76.69 9.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.748 1.018 . . . . 12.54 113.748 -170.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.1 ptm -143.14 141.02 18.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.757 -1.11 . . . . 10.35 108.036 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 17.8 Cg_endo -62.11 133.58 44.76 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.24 1.293 . . . . 10.11 109.512 172.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.0 mt -59.49 160.11 7.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.204 -0.453 . . . . 7.0 111.419 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.6 mm -95.67 132.58 27.1 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 8.28 109.657 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 90.6 Cg_endo -79.22 141.82 16.51 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 121.468 1.445 . . . . 6.21 112.797 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.04 158.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.585 -1.189 . . . . 6.41 113.326 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 21.85 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.948 2.099 . . . . 8.58 115.475 -177.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.576 ' OE1' HG12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -51.14 -37.75 48.0 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.776 1.274 . . . . 7.04 110.16 -176.525 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 59.35 40.29 21.27 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 111.835 -2.438 . . . . 8.58 110.589 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' OE2' ' HA2' ' A' ' 64' ' ' GLY . 13.5 tt0 -161.85 49.41 0.2 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.175 -1.375 . . . . 7.64 112.091 -172.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 71.12 -53.29 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.104 -2.316 . . . . 7.58 114.575 162.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -166.11 -41.79 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.075 -0.512 . . . . 5.41 111.902 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.597 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 4.9 t70 173.45 74.1 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.986 0.804 . . . . 7.01 109.611 -169.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.473 ' HA2' ' OE2' ' A' ' 60' ' ' GLU . . . 90.46 -17.73 52.85 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 115.438 -0.801 . . . . 7.2 112.132 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 72.66 -6.87 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.985 0.735 . . . . 7.82 112.985 172.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 164' ' ' THR . . . -112.62 -39.41 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.744 -0.382 . . . . 9.19 111.539 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 68' ' ' ARG . 15.0 p -102.66 -47.84 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.218 0.532 . . . . 7.42 110.4 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.597 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 3.7 ptp180 49.04 -177.01 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.839 -1.528 . . . . 10.88 113.644 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.514 HG21 ' H ' ' A' ' 71' ' ' GLY . 5.4 mt -73.16 155.61 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.624 -0.716 . . . . 9.13 110.728 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' N ' HG21 ' A' ' 69' ' ' ILE . 14.8 t70 -74.72 -43.87 52.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 13.02 109.065 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' H ' HG21 ' A' ' 69' ' ' ILE . . . -59.53 -38.51 93.71 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 113.96 -1.473 . . . . 12.13 113.231 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -84.57 109.59 18.07 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.593 0.711 . . . . 12.89 109.827 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.407 HG13 ' H ' ' A' ' 75' ' ' GLN . 67.3 t -103.09 140.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.842 -1.072 . . . . 12.25 111.019 -172.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -143.64 30.9 1.33 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.17 0.986 . . . . 10.97 109.68 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.407 ' H ' HG13 ' A' ' 73' ' ' VAL . 3.5 tp-100 -112.69 86.91 2.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.328 -1.306 . . . . 14.62 109.168 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 151' ' ' GLY . 1.6 p-10 -70.99 95.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.2 1.0 . . . . 11.22 111.551 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.8 -12.24 22.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.632 -1.167 . . . . 13.96 109.436 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 164.64 40.16 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.311 -1.116 . . . . 11.94 110.311 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.486 HG12 ' CZ ' ' A' ' 120' ' ' PHE . 93.7 t 63.79 108.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.63 -0.785 . . . . 10.24 111.221 -173.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 29.6 tpt180 -84.33 130.64 34.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 12.25 109.72 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 148' ' ' VAL . 67.2 p -133.09 144.96 50.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.292 -0.867 . . . . 8.3 109.777 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.27 127.26 55.79 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.837 -0.801 . . . . 7.51 108.837 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.89 135.47 37.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.947 -0.39 . . . . 12.15 109.947 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.588 ' CG1' ' HB2' ' A' ' 95' ' ' LEU . 75.8 t -59.89 128.84 21.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.713 -0.676 . . . . 9.71 112.416 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -135.24 148.41 49.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.501 -1.227 . . . . 11.77 109.005 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.423 HD22 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -78.9 147.73 32.97 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.965 -0.694 . . . . 13.03 109.453 169.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.442 ' N ' HD22 ' A' ' 96' ' ' LEU . . . -170.27 51.54 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.361 -0.923 . . . . 13.49 112.811 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 23.0 ptt180 -67.24 144.11 56.12 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.698 -0.295 . . . . 16.96 110.611 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 86.92 1.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.041 -0.726 . . . . 18.49 109.041 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.37 -5.71 84.61 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 108.728 -1.749 . . . . 18.67 108.728 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 16.3 m -111.62 156.79 21.25 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.001 -1.6 . . . . 17.16 107.835 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 m -71.84 157.95 36.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.105 -0.702 . . . . 14.8 109.105 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 88' ' ' ARG . 3.3 tt0 -58.96 97.45 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 124.163 0.914 . . . . 14.94 111.422 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.726 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -115.34 173.88 6.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 11.02 110.139 -175.88 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.588 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 1.3 pt? -109.14 114.34 27.97 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.588 -0.893 . . . . 9.27 108.588 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -94.74 131.05 40.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.665 -1.152 . . . . 10.57 111.718 -166.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.7 m -136.85 157.07 75.53 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.845 -1.07 . . . . 6.4 108.638 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.408 ' HG2' HG12 ' A' ' 149' ' ' VAL . 76.0 Cg_exo -52.49 129.31 31.38 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.738 1.626 . . . . 7.48 111.398 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 p -63.62 -22.91 67.15 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.451 0.643 . . . . 9.53 111.16 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -78.14 0.44 24.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.204 -0.907 . . . . 10.86 110.811 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.76 -1.37 30.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.775 -0.648 . . . . 5.39 112.598 -174.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.457 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -115.76 156.47 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 7.08 112.247 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.7 mm -101.46 124.36 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 10.63 109.982 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 18.8 mmm180 -96.18 125.48 40.73 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.868 -0.733 . . . . 12.12 110.452 173.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -149.13 137.16 20.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 14.98 110.556 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.4 -114.61 2.69 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 116.114 -0.494 . . . . 16.43 112.797 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.76 33.39 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.993 0.425 . . . . 15.35 111.394 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -179.21 7.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.163 -0.471 . . . . 15.67 111.381 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.457 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 10.7 m -131.43 152.51 50.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.922 -0.581 . . . . 9.26 110.392 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 25.3 mm -126.47 146.13 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.295 -0.261 . . . . 10.94 110.295 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.65 137.41 54.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.454 . . . . 7.39 109.989 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 45.2 mtm -92.85 99.93 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.722 -0.844 . . . . 8.85 108.722 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 121' ' ' ASP . 8.4 p -81.47 131.85 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.242 0.544 . . . . 10.13 110.696 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.87 91.31 8.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.59 -0.732 . . . . 10.7 110.417 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HD2' ' OD2' ' A' ' 121' ' ' ASP . 55.5 mttp -70.83 151.17 45.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 15.12 109.984 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.05 7.93 19.23 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 16.92 111.486 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.411 ' H ' ' C ' ' A' ' 115' ' ' LYS . 35.9 mt-10 -95.05 10.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.504 0.669 . . . . 18.56 110.973 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.64 75.16 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.163 -0.926 . . . . 16.28 113.613 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.24 25.84 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.482 -0.865 . . . . 14.36 112.441 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.655 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 40.5 m-85 -114.34 116.88 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.026 0.441 . . . . 12.49 109.933 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.539 ' O ' HG13 ' A' ' 113' ' ' VAL . 25.9 m-20 -106.17 141.89 23.71 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.882 -0.599 . . . . 13.91 110.323 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.67 127.18 4.23 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.874 1.716 . . . . 13.02 112.742 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.74 124.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 10.41 109.321 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -72.57 127.09 31.49 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.149 -0.686 . . . . 12.93 109.149 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.612 ' CG2' HD11 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -135.68 151.69 30.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.794 0.807 . . . . 8.03 111.569 -173.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.458 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 25.3 ttmm -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.231 -1.349 . . . . 10.66 109.518 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.58 110.3 17.19 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 123.108 1.433 . . . . 8.3 112.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -89.74 174.94 41.61 Favored Glycine 0 N--CA 1.411 -2.984 0 CA-C-N 111.25 -2.704 . . . . 10.1 110.718 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.17 161.32 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 126.07 1.748 . . . . 11.03 114.6 -167.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -100.88 139.24 36.86 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.312 -0.858 . . . . 13.17 108.721 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.84 111.99 4.64 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.851 0.358 . . . . 13.78 111.477 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.11 34.17 75.42 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.806 -0.712 . . . . 15.28 112.792 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.19 2.83 89.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.825 -0.703 . . . . 13.44 112.236 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -115.87 156.39 26.22 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.62 -0.511 . . . . 11.28 109.62 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 p -105.42 150.67 25.07 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.975 0.417 . . . . 8.43 111.326 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 128' ' ' GLY . 30.6 mt-10 -84.79 100.51 11.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.925 -0.579 . . . . 10.79 109.619 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.726 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 20.3 mm -83.81 112.9 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 O-C-N 121.569 -0.707 . . . . 6.73 109.502 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.8 OUTLIER -83.04 -47.45 11.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.177 -0.919 . . . . 9.17 110.288 -173.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.57 ' O ' HG21 ' A' ' 125' ' ' VAL . 9.2 tp10 -147.82 159.82 43.42 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.148 -0.686 . . . . 10.44 109.148 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 130.74 -61.28 0.67 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.046 -1.073 . . . . 8.87 112.318 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 26.5 mt -109.64 -170.83 1.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.262 0.553 . . . . 8.5 112.162 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -145.53 154.35 42.1 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.261 -0.882 . . . . 14.48 109.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.8 130.7 43.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.018 -0.992 . . . . 12.12 109.658 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.81 -1.51 38.86 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.721 -0.752 . . . . 12.39 111.232 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -103.57 139.21 39.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.55 -0.537 . . . . 11.89 109.55 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -91.03 138.72 31.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.891 0.377 . . . . 11.1 110.771 177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.82 137.01 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.236 -0.438 . . . . 5.45 109.823 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.462 ' HA ' HG23 ' A' ' 81' ' ' THR . 57.5 t -68.07 112.77 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.973 -0.558 . . . . 7.05 111.003 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 98' ' ' PRO . 2.7 m -103.75 -2.99 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.476 0.655 . . . . 6.99 109.995 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.509 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 45.0 t -161.66 111.93 1.63 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.117 -0.947 . . . . 9.37 109.391 171.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 76' ' ' ASN . . . -79.45 -136.63 1.37 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.406 -0.902 . . . . 8.6 112.057 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -107.6 120.72 42.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.405 0.622 . . . . 12.43 109.965 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 93.2 m-85 -110.54 104.39 13.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.715 . . . . 12.83 109.506 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.84 63.5 4.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.521 0.677 . . . . 13.49 110.301 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 pt -131.47 40.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.216 -0.902 . . . . 12.27 109.732 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.45 -34.66 69.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.906 -0.588 . . . . 11.22 111.081 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.605 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 15.8 m -59.03 -58.36 9.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.657 -0.497 . . . . 12.0 109.657 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -56.61 -41.95 77.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.895 -1.048 . . . . 11.17 110.456 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' HA ' ' NE ' ' A' ' 162' ' ' ARG . . . -63.64 -33.88 76.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.151 -0.932 . . . . 8.27 111.733 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.3 t -72.94 -37.44 67.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.633 0.73 . . . . 9.64 109.818 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 157' ' ' SER . 79.2 mt -71.29 -38.89 71.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.739 -1.119 . . . . 10.88 111.151 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 159' ' ' ALA . 31.7 ptt180 -80.0 -39.13 30.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.929 -0.578 . . . . 9.36 110.598 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.9 -57.17 5.02 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.196 -1.002 . . . . 7.46 111.943 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 66' ' ' ALA . 1.3 p 45.16 67.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.173 0.589 . . . . 7.09 111.605 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 m 47.99 30.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.68 1.192 . . . . 9.62 112.946 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 58.15 -151.85 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.782 -0.644 . . . . 9.11 111.659 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 167' ' ' ARG . 3.5 tmm_? -67.4 -35.38 79.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.464 0.65 . . . . 15.17 109.418 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.32 165.88 28.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.955 -1.02 . . . . 12.15 110.74 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -118.78 -18.49 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.741 0.782 . . . . 15.5 110.696 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -43.08 -63.39 0.81 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 113.837 -1.529 . . . . 15.01 111.58 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.3 p -87.79 4.66 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.665 . . . . 14.52 111.552 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.7 m -91.24 -35.31 14.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.18 -0.674 . . . . 14.89 109.18 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 39.0 m -82.81 -95.46 0.05 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.115 -0.948 . . . . 15.85 109.261 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.53 -69.99 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.779 -0.724 . . . . 17.54 112.666 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.2 25.13 14.5 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.12 0.486 . . . . 17.85 111.139 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -153.39 55.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.487 0.66 . . . . 19.67 110.044 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.45 -3.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 19.71 110.09 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.63 -159.54 0.86 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.487 -0.779 . . . . 21.47 109.762 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -86.23 -35.83 19.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 23.66 109.757 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.437 -0.792 . . . . 23.71 110.137 -179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 tpp . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.75 0.309 . . . . 34.49 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.13 78.55 0.86 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.763 -0.732 . . . . 33.2 112.556 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.7 m -149.16 30.72 0.77 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 34.24 110.442 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.08 112.69 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 32.38 110.064 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m 65.96 97.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.47 0.481 . . . . 33.02 111.076 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.557 ' O ' ' HB3' ' A' ' 7' ' ' ASN . 16.7 m -60.14 164.22 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.297 -0.41 . . . . 31.57 111.408 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.557 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 5.5 t30 78.06 142.96 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.061 0.851 . . . . 29.46 109.782 -170.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 155' ' ' ILE . . . -68.47 120.77 11.89 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.507 -0.854 . . . . 28.42 112.767 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -86.0 28.02 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.48 2.787 . . . . 27.92 112.558 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.52 ' HB3' ' O ' ' A' ' 156' ' ' ASP . 9.1 t60 -142.83 83.54 1.81 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.629 -0.878 . . . . 26.82 108.629 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 10' ' ' HIS . 10.1 m-20 67.92 -86.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.804 -0.634 . . . . 25.18 109.916 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.1 -112.59 4.98 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.647 -0.787 . . . . 23.19 112.484 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 64.35 78.98 0.27 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.317 0.579 . . . . 21.58 110.286 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.98 147.28 85.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.665 -0.698 . . . . 19.89 110.427 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.31 132.1 13.42 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.014 1.809 . . . . 18.59 112.339 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.17 -61.44 1.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.71 -0.478 . . . . 17.12 109.71 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.46 79.58 1.67 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 14.96 110.009 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.89 66.73 3.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.93 -0.652 . . . . 13.21 112.356 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.66 27.11 10.09 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.35 0.595 . . . . 12.37 111.555 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 57.67 69.22 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.522 -1.217 . . . . 13.82 109.902 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.521 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.8 tp 59.5 12.8 2.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.408 -1.724 . . . . 12.48 111.979 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 6.7 ttpm? 71.06 -35.42 0.33 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.756 0.822 . . . . 14.31 111.14 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.501 ' H ' ' C ' ' A' ' 21' ' ' LEU . 73.4 m 48.18 73.4 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.036 0.922 . . . . 11.34 110.441 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.69 122.41 0.77 Allowed Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.707 -1.133 . . . . 10.62 110.606 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.99 59.61 0.19 Allowed 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.019 -1.104 . . . . 10.77 108.019 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HD3' ' OE1' ' A' ' 58' ' ' GLU . 13.1 mmt180 -133.57 140.52 47.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.922 -1.49 . . . . 8.86 109.74 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.849 HG12 ' OE2' ' A' ' 58' ' ' GLU . 23.6 mm -55.98 129.93 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 113.016 0.747 . . . . 5.76 113.016 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -113.23 -16.0 12.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.769 -1.105 . . . . 8.55 109.795 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.646 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 10.9 p90 167.44 179.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 8.07 110.359 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.754 ' CZ3' HG22 ' A' ' 27' ' ' ILE . 1.7 m-90 -113.24 143.23 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.072 -0.967 . . . . 5.61 111.328 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HB2' HE22 ' A' ' 38' ' ' GLN . 5.6 ptp180 -151.15 151.32 31.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 9.75 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.608 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 8.4 t70 -79.72 132.72 60.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.697 -0.853 . . . . 8.31 108.697 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -63.28 -13.71 37.53 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.095 1.863 . . . . 10.41 112.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.462 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -98.08 0.84 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.762 -0.199 . . . . 11.24 111.466 178.355 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.608 ' CG2' ' HB3' ' A' ' 32' ' ' ASP . 10.9 m -129.62 48.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 121.351 0.596 . . . . 9.83 112.085 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.64 103.41 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.837 2.358 . . . . 11.66 113.245 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.5 -37.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 10.86 111.95 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.562 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.48 151.73 45.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.363 . . . . 9.42 110.198 177.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.636 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 2.6 tmm_? -136.35 98.83 3.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.6 -0.519 . . . . 12.03 109.6 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.648 ' HE1' ' CE2' ' A' ' 40' ' ' PHE . 42.1 m-85 -76.96 141.48 40.42 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.377 0.608 . . . . 7.9 110.972 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.7 -30.51 71.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.069 -1.423 . . . . 10.61 109.932 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 15.8 pttm -165.01 165.94 11.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.182 -0.917 . . . . 11.24 110.341 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.708 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -47.84 167.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.565 2.843 . . . . 7.51 113.654 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.08 -162.0 29.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.508 -0.853 . . . . 8.06 112.645 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.6 ttmt -103.48 140.63 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.05 -0.352 . . . . 12.05 110.05 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.558 ' HB3' ' O ' ' A' ' 49' ' ' MET . 22.6 t -65.38 142.37 98.4 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 9.2 110.649 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.412 ' CD ' ' HZ ' ' A' ' 40' ' ' PHE . 56.8 Cg_endo -79.16 -20.9 9.63 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.549 2.166 . . . . 10.25 111.33 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 53.0 m-85 -84.5 -39.64 18.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.218 -1.355 . . . . 10.49 109.726 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.558 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER -132.83 147.31 52.3 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.802 -0.635 . . . . 10.74 109.82 174.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.9 p-10 -77.82 58.23 1.84 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.084 0.945 . . . . 12.54 110.772 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.406 ' HG2' ' CB ' ' A' ' 49' ' ' MET . 15.6 ptm -132.7 139.98 36.34 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.831 -1.077 . . . . 10.35 109.649 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 18.1 Cg_endo -60.58 134.17 52.95 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.522 2.148 . . . . 10.11 110.249 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 32' ' ' ASP . 1.4 mm? -56.65 157.3 5.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.803 -0.359 . . . . 7.0 110.367 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.97 129.76 28.97 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-O 121.272 0.558 . . . . 8.28 109.872 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.587 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 95.4 Cg_endo -82.12 138.66 10.25 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 121.842 1.695 . . . . 6.21 112.797 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 32.0 m -56.19 157.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.198 -1.365 . . . . 6.41 112.454 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.518 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.14 -72.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.453 2.301 . . . . 8.58 116.434 -177.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.849 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.6 pt-20 -59.47 -32.71 70.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.458 0.647 . . . . 7.04 110.065 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 13.8 pt-20 51.3 89.72 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.445 -1.707 . . . . 8.58 112.458 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 78.33 67.15 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 113.2 -1.818 . . . . 7.64 111.121 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.693 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 20.2 t-20 -152.27 -34.44 0.13 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.527 -0.76 . . . . 7.58 111.067 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 68' ' ' ARG . . . -55.25 -75.52 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.075 0.941 . . . . 5.41 108.91 173.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -129.76 53.8 1.89 Allowed 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 113.739 -1.573 . . . . 7.01 108.452 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.79 41.44 1.03 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 112.731 -2.031 . . . . 7.2 113.742 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 56.11 28.12 12.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 7.82 110.648 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.68 -53.64 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.237 -0.892 . . . . 9.19 109.759 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.42 ' HA ' HG23 ' A' ' 164' ' ' THR . 10.7 t -76.45 -84.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.107 -0.497 . . . . 7.42 109.883 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 14.0 mtm105 -91.99 149.22 21.65 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.224 -0.658 . . . . 10.88 109.224 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.492 HD13 ' NE ' ' A' ' 72' ' ' ARG . 1.7 mt -148.52 140.67 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.142 -0.481 . . . . 9.13 109.859 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -117.48 -20.99 8.83 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.046 0.927 . . . . 13.02 109.436 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.27 -6.26 46.43 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 114.263 -1.335 . . . . 12.13 112.09 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' NE ' HD13 ' A' ' 69' ' ' ILE . 31.0 ptt180 -138.41 162.18 35.1 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.35 -1.352 . . . . 12.89 107.35 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -105.85 126.39 61.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.978 -0.689 . . . . 12.25 110.506 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 p -83.89 84.19 7.66 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.235 -0.893 . . . . 10.97 110.597 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.37 67.65 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.357 -0.838 . . . . 14.62 111.078 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.75 120.35 27.74 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.49 -0.93 . . . . 11.22 108.49 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.46 13.68 29.02 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.172 -1.376 . . . . 13.96 110.573 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.13 -66.47 1.26 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.223 -0.898 . . . . 11.94 111.466 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.79 103.98 12.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.156 -0.522 . . . . 10.24 110.189 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.685 ' HB3' ' N ' ' A' ' 150' ' ' SER . 89.2 mtm180 -116.15 132.03 56.77 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.201 -0.454 . . . . 12.25 111.397 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 80.7 p -156.39 170.63 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.957 0.786 . . . . 8.3 111.18 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.49 141.41 18.19 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.401 -1.333 . . . . 7.51 107.401 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -97.21 136.46 37.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.616 -0.434 . . . . 12.15 110.744 -171.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.613 HG21 ' O ' ' A' ' 145' ' ' GLN . 75.6 t -62.38 134.23 27.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.612 -0.722 . . . . 9.71 111.3 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -163.47 140.01 7.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.594 -1.185 . . . . 11.77 109.818 174.247 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.72 163.19 28.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.048 -0.978 . . . . 13.03 111.146 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.479 ' N ' HD22 ' A' ' 96' ' ' LEU . . . 170.89 45.74 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 13.49 112.448 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.589 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -83.89 175.37 9.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.918 0.39 . . . . 16.96 111.5 -176.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.31 115.41 21.62 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.477 0.656 . . . . 18.49 110.075 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.31 -147.18 17.85 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 115.184 -0.917 . . . . 18.67 111.814 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.3 p -95.4 77.47 3.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.95 0.881 . . . . 17.16 109.119 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.589 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -152.47 167.61 28.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.673 -1.149 . . . . 14.8 108.268 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -142.83 118.95 10.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 118.06 0.391 . . . . 14.94 110.287 162.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.635 ' HG3' ' OE1' ' A' ' 136' ' ' GLU . 22.9 mmt85 -129.77 155.26 46.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.084 -0.339 . . . . 11.02 110.084 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.562 ' HB3' HG11 ' A' ' 84' ' ' VAL . 2.6 mm? -91.44 113.76 26.11 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.73 -0.841 . . . . 9.27 108.73 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.86 130.58 34.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.809 -0.356 . . . . 10.57 111.045 -175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.78 155.03 63.21 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.56 -0.904 . . . . 6.4 108.56 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.89 137.19 78.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.922 1.748 . . . . 7.48 111.046 174.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.497 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 23.6 t -62.43 -25.21 67.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.988 0.366 . . . . 9.53 111.988 -173.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.07 11.76 22.03 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.588 -0.445 . . . . 10.86 111.335 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.8 -33.14 35.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.06 0.457 . . . . 5.39 111.29 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -101.51 165.63 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 7.08 112.194 -170.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 28.7 mm -109.29 117.49 54.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.601 -0.727 . . . . 10.63 109.829 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -91.07 125.32 35.82 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.834 -0.747 . . . . 12.12 110.554 173.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -145.79 122.7 11.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.871 -0.604 . . . . 14.98 110.689 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.64 -108.01 1.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.745 -0.661 . . . . 16.43 112.848 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.77 24.62 10.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 15.35 111.732 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 108' ' ' ARG . 0.1 OUTLIER -155.62 179.69 8.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 15.67 111.692 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 58.1 m -134.68 150.96 50.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.862 -0.608 . . . . 9.26 110.831 -173.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -119.63 146.23 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.871 -0.418 . . . . 10.94 109.871 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.561 ' HB1' ' CG1' ' A' ' 123' ' ' VAL . . . -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.237 -0.282 . . . . 7.39 110.237 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.585 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 81.7 mmm -106.56 98.1 7.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.208 -0.451 . . . . 8.85 109.999 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -88.1 142.07 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.005 0.431 . . . . 10.13 111.419 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 86.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 10.7 110.479 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 33.6 tttp -72.44 153.62 41.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.245 -0.888 . . . . 15.12 110.422 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.05 -2.04 51.1 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.945 -0.571 . . . . 16.92 112.998 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.18 17.47 10.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 18.56 111.077 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.12 11.34 85.21 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.618 -0.719 . . . . 16.28 112.785 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.9 -158.09 8.7 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.836 -0.697 . . . . 14.36 111.84 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 64.5 m-85 -128.11 124.34 36.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.376 0.608 . . . . 12.49 110.154 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.535 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.2 t70 -101.13 117.4 62.37 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.041 -0.982 . . . . 13.91 110.314 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 72.7 Cg_endo -83.1 112.09 1.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.83 3.02 . . . . 13.02 113.458 -172.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.561 ' CG1' ' HB1' ' A' ' 111' ' ' ALA . 9.5 p -105.21 142.83 17.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.423 -0.808 . . . . 10.41 110.404 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -82.23 123.41 29.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.156 0.503 . . . . 12.93 109.699 171.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -135.76 163.08 35.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.707 -0.679 . . . . 8.03 110.974 -172.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.445 ' N ' HG21 ' A' ' 125' ' ' VAL . 77.9 tttt -98.82 126.21 44.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.936 -0.575 . . . . 10.66 110.243 172.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.92 108.08 4.98 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.663 -0.699 . . . . 8.3 111.444 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.409 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -153.17 70.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.759 -2.162 . . . . 10.1 114.674 168.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.67 161.92 41.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.957 -0.757 . . . . 11.03 108.957 153.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.17 127.62 26.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.928 -0.397 . . . . 13.17 109.928 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.32 125.21 11.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.339 -0.391 . . . . 13.78 111.595 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.79 35.99 88.39 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.934 -0.576 . . . . 15.28 113.288 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.51 7.9 87.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.941 -0.647 . . . . 13.44 112.163 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.66 170.51 10.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.555 . . . . 11.28 109.503 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 13.3 p -122.36 156.51 33.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.741 0.305 . . . . 8.43 110.53 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.635 ' OE1' ' HG3' ' A' ' 94' ' ' ARG . 52.8 mt-10 -99.16 118.48 35.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.369 0.604 . . . . 10.79 110.853 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 125' ' ' VAL . 22.9 mm -85.37 103.79 12.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.096 -0.956 . . . . 6.73 108.615 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 2.4 mp -70.73 -46.63 62.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.926 -1.034 . . . . 9.17 109.805 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.508 ' O ' HG21 ' A' ' 125' ' ' VAL . 97.9 mt-10 -143.1 161.12 39.04 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.949 -0.569 . . . . 10.44 109.63 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.463 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.31 -60.36 0.59 Allowed Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.02 -1.086 . . . . 8.87 113.585 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.404 HD23 HG12 ' A' ' 123' ' ' VAL . 47.6 mt -110.44 -176.61 3.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.899 0.703 . . . . 8.5 112.899 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -143.78 157.32 44.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.792 -1.095 . . . . 14.48 109.201 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.32 129.83 41.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.296 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.21 -8.69 35.81 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.179 -0.768 . . . . 12.39 111.179 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.613 ' O ' HG21 ' A' ' 84' ' ' VAL . 29.6 mm-40 -91.12 100.32 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.507 0.67 . . . . 11.89 109.64 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.521 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.4 mt-30 -74.72 135.32 41.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.14 -0.936 . . . . 11.1 110.58 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.5 m -129.75 136.62 58.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.717 -0.475 . . . . 5.45 109.717 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 2.8 p -61.25 119.09 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.872 0.693 . . . . 7.05 112.872 -171.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.602 HG21 ' N ' ' A' ' 150' ' ' SER . 2.7 m -137.25 -55.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.233 0.457 . . . . 6.99 112.233 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.685 ' N ' ' HB3' ' A' ' 80' ' ' ARG . 51.1 m -165.12 -35.16 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.018 -0.734 . . . . 9.37 109.018 -174.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.443 ' CA ' ' H ' ' A' ' 81' ' ' THR . . . 65.29 -121.06 19.9 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 114.947 -1.024 . . . . 8.6 113.583 170.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.98 135.31 10.23 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.468 -0.938 . . . . 12.43 108.468 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 1.8 p90 -70.4 171.38 10.13 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.727 -0.389 . . . . 12.83 110.171 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.64 175.27 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.597 0.713 . . . . 13.49 112.747 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.512 ' C ' ' HB1' ' A' ' 159' ' ' ALA . 6.2 pt -114.57 77.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.607 0.718 . . . . 12.27 110.281 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 26.3 m-20 -84.46 -100.44 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.359 -0.837 . . . . 11.22 111.459 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.0 p -83.36 -36.43 24.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 12.0 110.082 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.548 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 18.3 tt0 -66.07 -18.95 65.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.056 -0.975 . . . . 11.17 109.904 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.512 ' HB1' ' C ' ' A' ' 155' ' ' ILE . . . -45.16 -58.33 3.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.008 -0.996 . . . . 8.27 112.156 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -66.06 -29.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.678 0.752 . . . . 9.64 110.963 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 46.8 mt -72.59 -28.04 62.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.684 -1.144 . . . . 10.88 110.94 -176.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.548 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 71.9 mtt180 -92.73 -54.15 3.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.063 -0.971 . . . . 9.36 111.024 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 56.21 56.33 24.8 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.385 -0.686 . . . . 7.46 111.385 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.42 HG23 ' HA ' ' A' ' 67' ' ' VAL . 41.7 p -62.19 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.261 0.467 . . . . 7.09 112.261 -171.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.44 47.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.623 0.725 . . . . 9.62 109.344 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -106.29 25.04 11.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.752 -0.658 . . . . 9.11 111.421 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -74.13 102.72 4.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.949 0.88 . . . . 15.17 110.005 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.1 76.08 9.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.088 -1.414 . . . . 12.15 110.548 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -148.62 96.14 2.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.523 -0.762 . . . . 15.5 109.579 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 59.98 40.25 19.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.126 -1.397 . . . . 15.01 111.717 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.0 p -54.42 -45.86 73.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.159 0.505 . . . . 14.52 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.7 t -174.79 -162.5 0.12 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.56 -0.745 . . . . 14.89 109.597 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -52.35 114.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 15.85 110.881 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.87 53.45 4.26 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 17.54 112.425 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.422 HD23 ' C ' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -62.54 156.5 22.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.768 0.318 . . . . 17.85 110.807 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.45 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 19.67 110.685 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.4 p -169.45 23.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.767 0.794 . . . . 19.71 110.537 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.81 166.79 14.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 21.47 109.856 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.44 178.76 5.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.393 -0.595 . . . . 23.66 109.393 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.446 -0.788 . . . . 23.71 110.663 -176.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HE1' ' OD1' ' A' ' 7' ' ' ASN . 23.2 ptm . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.639 0.257 . . . . 34.49 111.119 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.39 -91.52 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.78 -0.724 . . . . 33.2 112.03 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 t -168.55 -168.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 34.24 109.651 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.404 ' C ' ' HG1' ' A' ' 5' ' ' THR . . . 63.02 11.02 4.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.044 0.938 . . . . 32.38 112.818 171.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 4' ' ' ALA . 17.9 p 48.16 40.09 13.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.666 0.786 . . . . 33.02 112.027 -177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.46 135.37 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.437 . . . . 31.57 110.85 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.436 ' OD1' ' HE1' ' A' ' 1' ' ' MET . 91.7 m-20 -92.97 -28.03 16.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.502 0.668 . . . . 29.46 109.906 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.93 -174.27 44.03 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.362 -0.835 . . . . 28.42 111.895 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -91.42 37.98 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.223 2.615 . . . . 27.92 111.925 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -90.37 -33.6 16.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 26.82 110.371 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -159.45 146.37 16.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.902 -0.59 . . . . 25.18 109.889 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.25 -164.46 31.88 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.906 -0.664 . . . . 23.19 111.699 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -78.69 -88.58 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.768 0.284 . . . . 21.58 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 52.17 83.69 0.22 Allowed Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.679 0.612 . . . . 19.89 111.799 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.4 -168.82 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.628 2.218 . . . . 18.59 112.266 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.65 45.37 2.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.266 0.555 . . . . 17.12 110.024 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 130.08 42.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 14.96 111.102 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.86 -127.75 5.83 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.409 -0.814 . . . . 13.21 111.926 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.02 -50.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.915 -0.168 . . . . 12.37 111.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.519 ' HA ' ' O ' ' A' ' 23' ' ' THR . 32.8 tt0 62.59 58.32 1.66 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.722 1.249 . . . . 13.82 108.541 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' C ' HD11 ' A' ' 21' ' ' LEU . 3.4 tm? -163.17 -61.06 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.901 -1.954 . . . . 12.48 106.736 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.499 ' HA ' ' NH2' ' A' ' 26' ' ' ARG . 33.5 ttmt -51.32 -48.25 62.42 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 114.729 -1.123 . . . . 14.31 108.864 169.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.9 p -140.78 166.99 23.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.882 -1.508 . . . . 11.34 108.381 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.09 -57.03 0.47 Allowed Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 120.074 -1.06 . . . . 10.62 111.33 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.51 ' HE2' ' O ' ' A' ' 20' ' ' GLU . 17.3 pttt -146.91 61.58 1.19 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.472 1.13 . . . . 10.77 112.101 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.576 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 19.8 mtm180 -141.31 142.17 33.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.309 -1.769 . . . . 8.86 108.281 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.686 HG12 ' CD ' ' A' ' 58' ' ' GLU . 25.5 mm -51.95 112.8 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 113.213 0.82 . . . . 5.76 113.213 -169.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -100.9 -31.9 10.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.007 -1.452 . . . . 8.55 109.734 172.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 13.0 p90 -175.02 -174.58 0.78 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.24 0.543 . . . . 8.07 112.089 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.77 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 m-90 -123.23 148.62 45.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 114.966 -1.015 . . . . 5.61 110.701 -174.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.538 ' HB2' HE22 ' A' ' 38' ' ' GLN . 29.5 ptt180 -148.22 152.53 37.36 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.472 0.482 . . . . 9.75 111.112 -176.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.577 ' HB2' HG21 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -76.66 139.37 66.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.791 -1.188 . . . . 8.31 107.791 163.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.569 ' CG ' HD13 ' A' ' 54' ' ' ILE . 44.7 Cg_exo -57.87 -15.49 22.02 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.865 2.377 . . . . 10.41 110.647 164.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -28.85 39.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 113.772 -1.558 . . . . 11.24 111.476 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.586 HG12 ' CD2' ' A' ' 48' ' ' TYR . 18.2 m -123.57 51.42 4.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.77 0.656 . . . . 9.83 112.77 -164.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.0 114.3 2.93 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.212 2.608 . . . . 11.66 112.317 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.09 -25.52 3.5 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.26 -0.736 . . . . 10.86 111.26 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.632 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -70.94 171.59 10.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.118 -0.541 . . . . 9.42 109.926 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.595 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -150.12 91.27 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.2 -0.667 . . . . 12.03 109.2 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.632 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 70.8 m-85 -71.07 141.86 50.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.298 0.571 . . . . 7.9 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.18 -30.43 71.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.821 -1.081 . . . . 10.61 111.668 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.473 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 13.2 ptmm? -167.33 163.29 10.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 119.29 -0.386 . . . . 11.24 111.279 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -49.72 170.89 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.781 2.988 . . . . 7.51 113.859 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.69 -163.34 26.91 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.302 -0.719 . . . . 8.06 111.302 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -94.33 147.74 22.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.203 0.501 . . . . 12.05 110.242 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.2 t -66.1 139.07 96.4 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.413 -0.812 . . . . 9.2 111.226 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 -21.95 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.791 2.328 . . . . 10.25 111.957 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.641 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 33.2 m-85 -78.66 -39.02 38.08 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.865 -1.061 . . . . 10.49 109.769 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.496 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -156.94 166.55 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.454 -0.794 . . . . 10.74 109.105 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -78.33 80.96 4.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 12.54 112.27 -172.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.4 ptm -134.99 146.04 56.96 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.737 -1.579 . . . . 10.35 106.737 173.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.43 132.74 18.06 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 N-CA-C 108.234 -1.487 . . . . 10.11 108.234 165.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.28 161.73 18.86 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.165 -0.614 . . . . 7.0 110.964 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.569 HD13 ' CG ' ' A' ' 33' ' ' PRO . 22.0 mt -110.08 132.35 21.49 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 109.571 -0.529 . . . . 8.28 109.571 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.679 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 39.9 Cg_endo -76.85 133.4 13.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 120.983 1.122 . . . . 6.21 112.749 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.28 157.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.07 -1.423 . . . . 6.41 113.245 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 21.58 -89.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.285 1.834 . . . . 8.58 114.893 -177.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.686 ' CD ' HG12 ' A' ' 27' ' ' ILE . 1.2 pt-20 -45.63 -40.69 9.32 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.091 0.556 . . . . 7.04 110.13 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 41.8 tt0 59.85 81.03 0.18 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.904 -1.044 . . . . 8.58 110.541 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 47.23 77.1 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.505 -1.225 . . . . 7.64 111.359 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.438 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 27.6 t-20 -110.54 -39.84 4.79 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.171 -1.048 . . . . 7.58 108.171 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.04 56.76 7.51 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.709 -1.132 . . . . 5.41 111.935 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.471 ' OD2' HG12 ' A' ' 69' ' ' ILE . 11.8 m-20 61.73 40.8 12.68 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.407 -1.724 . . . . 7.01 111.55 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.01 -15.12 43.26 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.249 -1.14 . . . . 7.2 110.249 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.01 46.77 2.44 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.228 -1.027 . . . . 7.82 108.228 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HB2' ' HA ' ' A' ' 63' ' ' ASP . . . -173.94 -33.57 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.734 -1.575 . . . . 9.19 107.67 -171.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 t 74.55 -38.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 112.707 -2.042 . . . . 7.42 113.647 173.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -147.02 140.15 25.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.571 0.701 . . . . 10.88 111.117 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.507 HG22 ' HG2' ' A' ' 72' ' ' ARG . 3.8 mt -67.66 156.65 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.643 -1.162 . . . . 9.13 111.855 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.403 ' N ' HG23 ' A' ' 69' ' ' ILE . 23.3 t70 -90.48 57.27 3.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.175 0.988 . . . . 13.02 109.964 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.86 -8.11 38.49 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.422 -1.263 . . . . 12.13 114.89 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.507 ' HG2' HG22 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -81.3 132.96 35.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.901 -1.148 . . . . 12.89 107.901 176.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.77 93.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.651 0.739 . . . . 12.25 109.531 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -75.16 59.73 1.0 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.844 -1.525 . . . . 10.97 110.491 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 43.26 70.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.167 -0.924 . . . . 14.62 111.344 -172.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -153.53 130.96 11.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.924 -1.035 . . . . 11.22 108.908 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.11 -22.52 59.44 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.692 0.758 . . . . 13.96 109.764 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 -22.93 3.39 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.098 -0.956 . . . . 11.94 112.167 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.8 t 59.27 46.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 122.316 1.055 . . . . 10.24 108.579 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.555 ' NH1' ' HB3' ' A' ' 156' ' ' ASP . 53.7 ttt180 -81.62 119.0 23.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.592 -1.185 . . . . 12.25 110.419 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 p -128.47 159.16 36.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.529 -1.214 . . . . 8.3 109.212 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -119.49 126.5 51.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.693 -0.854 . . . . 7.51 108.693 171.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 28.0 tt0 -75.92 131.44 39.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.146 -0.687 . . . . 12.15 109.146 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.577 HG11 ' HB3' ' A' ' 95' ' ' LEU . 41.3 t -55.64 132.02 19.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.94 0.718 . . . . 9.71 112.94 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 49.0 mmtt -136.41 140.46 43.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.607 -1.179 . . . . 11.77 109.429 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.2 157.9 36.88 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.954 -0.698 . . . . 13.03 109.496 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.09 49.25 0.05 OUTLIER Glycine 0 CA--C 1.503 -0.704 0 C-N-CA 119.74 -1.219 . . . . 13.49 113.862 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.648 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -89.29 -177.56 5.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.799 0.666 . . . . 16.96 112.799 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 tt -139.94 112.89 8.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.944 -1.026 . . . . 18.49 108.275 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.16 -167.58 16.44 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.121 -0.792 . . . . 18.67 111.121 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 p -89.92 75.78 7.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.242 1.02 . . . . 17.16 109.967 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.648 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 1.6 m -154.8 167.67 29.46 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.862 -1.533 . . . . 14.8 106.862 175.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.589 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 3.8 mt-10 -141.68 109.49 5.74 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.657 0.662 . . . . 14.94 110.518 165.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.537 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 35.8 mmt180 -118.72 163.83 16.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.675 -0.693 . . . . 11.02 110.339 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.607 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.2 mm? -97.9 114.17 26.18 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.066 -0.716 . . . . 9.27 109.066 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.49 129.79 36.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.189 0.519 . . . . 10.57 110.99 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.82 157.22 68.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.895 -1.048 . . . . 6.4 109.17 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.415 ' HG2' HG12 ' A' ' 149' ' ' VAL . 51.2 Cg_exo -58.97 131.25 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.817 1.678 . . . . 7.48 110.356 171.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -30.12 53.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.312 -0.404 . . . . 9.53 111.32 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.9 -8.34 57.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.624 0.231 . . . . 10.86 111.624 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB1' HG13 ' A' ' 149' ' ' VAL . . . -72.02 -41.32 67.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.433 0.635 . . . . 5.39 110.942 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.509 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -93.96 163.78 13.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.141 -0.936 . . . . 7.08 112.613 -169.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 109' ' ' THR . 22.7 mm -111.68 103.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 10.63 109.229 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 13.3 ptt180 -103.01 132.54 49.2 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 117.969 -1.493 . . . . 12.12 110.985 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -151.36 133.92 15.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.709 -1.587 . . . . 14.98 109.133 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.18 -113.63 6.06 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.352 -0.928 . . . . 16.43 111.952 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 34.99 5.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.85 0.315 . . . . 15.35 111.85 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.41 178.63 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.901 0.382 . . . . 15.67 111.801 -178.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 5.3 m -136.68 158.55 44.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.749 -0.66 . . . . 9.26 110.431 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 25.1 mm -131.22 147.75 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 10.94 109.899 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -136.34 127.31 27.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.517 -0.31 . . . . 7.39 110.296 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 33.2 ttp -87.59 103.19 15.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.27 -0.641 . . . . 8.85 109.27 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 12.6 p -89.64 135.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 10.13 112.575 -170.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.563 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -76.01 90.28 3.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.359 -0.837 . . . . 10.7 109.672 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -85.38 152.84 22.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.425 . . . . 15.12 110.499 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.05 1.76 10.24 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.106 -0.497 . . . . 16.92 113.328 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -90.93 8.64 34.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.33 0.586 . . . . 18.56 111.062 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.19 6.45 86.34 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.29 -0.868 . . . . 16.28 112.512 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.78 156.18 19.99 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.985 -0.626 . . . . 14.36 111.567 -174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' A' ' 120' ' ' PHE . 82.5 m-85 -107.3 109.46 21.23 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.766 -0.457 . . . . 12.49 109.766 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -106.74 142.96 26.08 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 120.405 -0.518 . . . . 13.91 111.231 -172.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.66 121.28 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.281 1.987 . . . . 13.02 111.93 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.532 HG13 ' HB2' ' A' ' 111' ' ' ALA . 5.7 p -105.43 137.29 35.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.667 -0.697 . . . . 10.41 109.663 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.93 119.95 19.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.1 -0.704 . . . . 12.93 109.1 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.06 155.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.695 -0.684 . . . . 8.03 110.918 -176.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 38.5 ttmt -101.78 128.47 48.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.904 -0.776 . . . . 10.66 108.904 171.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.92 104.55 4.7 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.452 -0.34 . . . . 8.3 110.74 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.77 70.34 0.31 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.867 -2.111 . . . . 10.1 113.866 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.518 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 161.32 42.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.305 -1.368 . . . . 11.03 107.305 151.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.0 m -141.5 128.88 21.19 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 118.38 0.537 . . . . 13.17 110.081 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.61 8.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.592 -0.731 . . . . 13.78 110.847 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.43 38.22 96.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.362 -0.447 . . . . 15.28 112.704 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.58 9.76 84.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.649 . . . . 13.44 112.434 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -120.32 164.24 16.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.165 -0.309 . . . . 11.28 110.165 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -117.31 158.34 24.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.935 0.398 . . . . 8.43 110.883 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 57.7 mt-10 -101.7 124.82 47.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.454 0.645 . . . . 10.79 110.828 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.9 mm -89.76 114.63 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 114.934 -1.03 . . . . 6.73 109.55 175.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.537 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.2 mp -87.73 -45.5 10.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.648 -1.16 . . . . 9.17 109.677 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.571 ' O ' HG21 ' A' ' 125' ' ' VAL . 9.2 tp10 -134.67 164.71 26.9 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.974 -1.121 . . . . 10.44 107.974 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.474 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 111.99 -62.49 0.3 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.275 -1.44 . . . . 8.87 113.722 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.404 ' CD2' HG12 ' A' ' 123' ' ' VAL . 54.0 mt -103.64 -173.26 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.236 0.541 . . . . 8.5 112.455 -174.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.9 ttmt -157.58 158.36 35.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 14.48 108.528 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 128.84 37.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.888 -0.596 . . . . 12.12 110.31 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.08 -10.3 40.08 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.444 -0.662 . . . . 12.39 111.444 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' HG21 ' A' ' 84' ' ' VAL . 14.9 mm100 -93.69 121.17 34.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.119 -0.697 . . . . 11.89 109.119 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.563 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 28.5 mt-30 -97.49 125.06 41.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.941 -0.572 . . . . 11.1 111.114 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.75 138.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.852 -0.613 . . . . 5.45 109.673 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 5.8 m -62.94 120.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.36 0.6 . . . . 7.05 111.136 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.448 HG13 ' HB1' ' A' ' 101' ' ' ALA . 3.4 m -110.17 -20.16 6.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.476 -0.784 . . . . 6.99 110.484 -176.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m 38.1 45.88 0.79 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 124.305 1.003 . . . . 9.37 112.861 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.16 46.99 2.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.277 -1.129 . . . . 8.6 110.277 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -75.78 23.01 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.319 0.489 . . . . 12.43 112.319 -171.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.644 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 78.2 m-85 -100.26 -27.74 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.478 -0.934 . . . . 12.83 108.478 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.17 137.47 36.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.833 -1.076 . . . . 13.49 108.839 177.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.425 HG23 ' H ' ' A' ' 157' ' ' SER . 47.0 mt -54.07 108.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.001 0.429 . . . . 12.27 111.228 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.555 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 4.0 p30 -84.17 17.44 2.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.255 -0.43 . . . . 11.22 111.84 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.427 ' HA ' ' OG ' ' A' ' 160' ' ' SER . 70.7 m -64.52 -17.35 63.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.72 -0.218 . . . . 12.0 111.519 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.602 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 41.4 mt-10 -58.45 -46.87 85.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.252 -0.647 . . . . 11.17 109.252 171.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.73 -27.89 68.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 8.27 110.794 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 16.0 m -62.57 -39.0 92.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.581 0.705 . . . . 9.64 110.017 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -47.77 14.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.883 -1.053 . . . . 10.88 111.638 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.602 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 53.3 mtt180 -71.49 -36.24 71.07 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.592 0.711 . . . . 9.36 110.948 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.75 105.74 3.03 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.606 -1.179 . . . . 7.46 110.782 -171.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.9 p -49.71 -54.03 21.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 7.09 111.061 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.86 -48.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.818 -0.628 . . . . 9.62 109.491 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 53.32 67.8 0.94 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.62 -0.718 . . . . 9.11 111.658 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.631 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -70.42 -19.48 62.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.28 -0.873 . . . . 15.17 109.831 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.83 -10.06 59.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.972 -1.013 . . . . 12.15 110.763 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -111.17 142.98 42.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.755 -0.657 . . . . 15.5 109.776 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -150.01 114.96 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.809 -0.441 . . . . 15.01 109.809 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.6 p -98.89 40.01 1.23 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.032 -0.531 . . . . 14.52 112.092 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 17.8 m -67.04 -46.62 73.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.172 0.511 . . . . 14.89 110.055 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 p -89.64 59.44 4.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.632 . . . . 15.85 110.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.19 66.8 0.23 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.817 -0.706 . . . . 17.54 111.687 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.02 121.6 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.032 -0.358 . . . . 17.85 110.032 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -81.03 -41.81 22.08 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.542 -0.463 . . . . 19.67 110.594 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.42 -72.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.545 -0.752 . . . . 19.71 110.665 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 82.7 mt -146.79 37.14 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.648 0.261 . . . . 21.47 111.55 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 1.654 ' HD1' ' CD2' ' A' ' 179' ' ' PHE . 22.5 m-85 -85.64 104.64 15.56 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.685 -0.406 . . . . 23.66 110.489 175.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.475 -0.774 . . . . 23.71 109.755 177.587 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 121.206 0.527 . . . . 34.49 110.239 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.27 51.84 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.973 -0.632 . . . . 33.2 112.262 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 p -121.07 118.98 31.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 34.24 110.5 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.09 -54.97 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.633 . . . . 32.38 110.34 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.2 m -99.9 135.52 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.421 -0.585 . . . . 33.02 109.421 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -49.94 -64.03 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 123.247 0.342 . . . . 31.57 111.538 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 55.07 75.14 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.813 0.695 . . . . 29.46 111.364 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.68 149.34 49.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.497 -0.859 . . . . 28.42 111.883 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.41 111.82 1.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.359 2.039 . . . . 27.92 111.699 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 66.91 177.72 0.23 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.551 -0.749 . . . . 26.82 111.793 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.7 -55.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.353 -0.839 . . . . 25.18 109.157 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.81 -118.8 0.56 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.822 -1.081 . . . . 23.19 110.877 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 39.6 m80 52.17 56.0 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 21.58 110.661 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -108.58 98.91 30.79 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.836 -0.62 . . . . 19.89 110.185 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 13' ' ' HIS . 3.6 Cg_exo -74.51 107.43 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.418 2.078 . . . . 18.59 112.513 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.76 0.32 10.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.048 0.451 . . . . 17.12 110.161 173.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.59 50.57 3.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 114.976 -1.011 . . . . 14.96 110.188 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.02 38.68 3.08 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.645 -0.707 . . . . 13.21 112.484 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.72 -23.95 13.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.727 0.299 . . . . 12.37 110.859 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 71.04 113.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.015 -0.993 . . . . 13.82 110.242 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' C ' HD21 ' A' ' 21' ' ' LEU . 6.6 tt -26.45 -49.27 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.872 1.669 . . . . 12.48 114.018 -176.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -41.67 -39.58 1.71 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.067 -1.424 . . . . 14.31 111.721 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.1 p -140.47 47.21 1.78 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.368 -0.975 . . . . 11.34 108.368 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -56.01 -36.44 67.34 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 114.616 -1.174 . . . . 10.62 112.285 -175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.604 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -170.23 61.36 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.507 1.146 . . . . 10.77 108.244 178.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.457 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 82.3 mtt180 -124.25 138.75 54.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.484 -1.235 . . . . 8.86 109.946 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.673 HG12 ' OE2' ' A' ' 58' ' ' GLU . 33.5 mm -48.72 127.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 114.369 -1.287 . . . . 5.76 114.18 -167.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.86 -38.77 3.84 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.504 -1.68 . . . . 8.55 110.029 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 2.0 p90 -176.51 -172.81 0.48 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.929 -0.578 . . . . 8.07 110.402 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m-90 -124.01 150.36 44.96 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.462 -0.79 . . . . 5.61 110.751 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.809 HH11 ' HH ' ' A' ' 29' ' ' TYR . 24.7 ptt180 -153.5 145.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.297 -0.41 . . . . 9.75 111.596 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . 12.6 t0 -79.34 130.6 68.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.909 -1.145 . . . . 8.31 107.909 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HG3' HD11 ' A' ' 54' ' ' ILE . 21.6 Cg_exo -61.17 -14.43 33.75 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 122.023 1.815 . . . . 10.41 112.293 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.46 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -96.11 2.06 52.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.473 -0.331 . . . . 11.24 111.193 176.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 32' ' ' ASP . 4.9 m -129.1 39.35 0.5 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.624 0.601 . . . . 9.83 112.624 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -60.42 128.71 26.96 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.519 2.146 . . . . 11.66 112.579 -174.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.01 -6.45 19.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 10.86 111.618 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.551 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -89.95 -179.54 5.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.456 -0.372 . . . . 9.42 110.082 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.524 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 8.1 tpt180 -142.03 108.63 5.34 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.192 -0.203 . . . . 12.03 110.455 171.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.761 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -96.84 121.02 38.24 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.631 -0.828 . . . . 7.9 109.098 170.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.47 -35.3 78.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.958 -0.565 . . . . 10.61 110.125 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.512 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -147.86 149.39 33.06 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 121.78 0.8 . . . . 11.24 111.071 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 14.5 Cg_endo -52.77 142.38 51.49 Favored 'Trans proline' 0 C--N 1.348 0.515 1 C-N-CA 125.398 4.065 . . . . 7.51 114.027 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.8 -156.0 17.71 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.828 -0.624 . . . . 8.06 111.594 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 23.1 ttmt -98.1 143.56 28.51 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.093 -0.706 . . . . 12.05 109.093 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.7 t -66.83 132.66 93.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.309 -0.405 . . . . 9.2 110.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.71 -29.4 24.15 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 10.25 111.491 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.667 ' HE1' ' CE2' ' A' ' 48' ' ' TYR . 96.8 m-85 -70.38 -37.75 74.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.561 -1.2 . . . . 10.49 110.581 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.546 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.4 OUTLIER -156.99 153.62 28.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.678 -0.49 . . . . 10.74 109.678 169.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 3.7 m-20 -74.42 76.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 12.54 112.447 -173.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -140.28 145.15 40.17 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.491 -0.929 . . . . 10.35 108.491 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.97 132.32 29.83 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.748 1.632 . . . . 10.11 110.208 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -61.37 160.09 11.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.342 -0.39 . . . . 7.0 110.303 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.444 HD11 ' HG3' ' A' ' 33' ' ' PRO . 6.0 mt -104.6 133.59 20.1 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.947 0.403 . . . . 8.28 110.006 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.624 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 86.9 Cg_endo -77.71 152.07 28.87 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.766 1.644 . . . . 6.21 112.447 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 m -74.44 157.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.513 -1.221 . . . . 6.41 112.051 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.459 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 0.1 OUTLIER 14.37 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.056 2.143 . . . . 8.58 115.701 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.673 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -52.81 -42.01 64.7 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.605 0.362 . . . . 7.04 110.386 -176.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 85.5 mt-10 67.88 86.34 0.13 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.846 0.831 . . . . 8.58 112.507 177.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 72.31 60.64 0.13 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.645 -1.616 . . . . 7.64 112.242 162.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.563 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 46.1 t30 -141.04 -51.21 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.693 -1.14 . . . . 7.58 110.855 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.712 ' O ' ' HA ' ' A' ' 68' ' ' ARG . . . -38.78 -59.56 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.579 0.549 . . . . 5.41 110.351 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HA ' ' H ' ' A' ' 68' ' ' ARG . 28.8 t70 -175.7 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.251 -1.34 . . . . 7.01 107.737 170.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.9 -20.41 57.41 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 114.006 -1.452 . . . . 7.2 113.333 -174.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.63 36.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.931 -0.766 . . . . 7.82 108.931 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.96 31.05 20.98 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.653 -1.158 . . . . 9.19 110.439 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 61' ' ' ASN . 21.0 t -66.9 -68.22 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 7.42 109.771 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' A' ' 62' ' ' ALA . 2.4 ttp180 65.32 136.43 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.286 -1.324 . . . . 10.88 112.54 -177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 70' ' ' ASP . 20.5 mt -74.5 153.2 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.356 -0.838 . . . . 9.13 110.003 177.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' N ' HG23 ' A' ' 69' ' ' ILE . 9.6 p-10 -87.79 25.94 1.42 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.482 -0.781 . . . . 13.02 111.091 -177.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.07 13.41 83.69 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.21 -0.904 . . . . 12.13 110.899 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' H ' HG23 ' A' ' 69' ' ' ILE . 40.2 mtm180 49.77 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.295 1.038 . . . . 12.89 112.543 -170.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.4 t -129.52 -59.83 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.603 -1.181 . . . . 12.25 110.349 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 t -50.53 113.31 0.86 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.676 -1.602 . . . . 10.97 111.14 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -80.71 54.75 2.19 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.529 -1.214 . . . . 14.62 110.805 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.19 146.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.144 -1.389 . . . . 11.22 111.366 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.19 -15.72 35.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.632 -0.713 . . . . 13.96 111.496 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.04 -33.43 1.14 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.72 -0.752 . . . . 11.94 112.424 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.437 HG12 ' CZ ' ' A' ' 120' ' ' PHE . 63.8 t 64.85 88.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.097 0.951 . . . . 10.24 111.346 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -90.82 132.01 36.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.528 -1.215 . . . . 12.25 108.937 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.1 p -130.13 148.19 51.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.575 -0.284 . . . . 8.3 110.661 -174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -122.91 136.08 54.73 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 7.51 109.433 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.411 ' OE1' ' HE2' ' A' ' 85' ' ' LYS . 41.2 tt0 -76.57 141.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.226 -0.443 . . . . 12.15 110.161 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 143' ' ' ALA . 97.1 t -67.89 131.34 33.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.776 0.798 . . . . 9.71 111.936 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' HE2' ' OE1' ' A' ' 83' ' ' GLU . 27.8 mmtp -127.3 155.4 43.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.237 -1.347 . . . . 11.77 109.114 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -90.38 165.58 13.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.395 -0.595 . . . . 13.03 109.395 165.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.03 53.65 0.03 OUTLIER Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.819 -1.181 . . . . 13.49 113.688 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.728 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -92.23 -177.29 4.61 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.852 -0.339 . . . . 16.96 111.66 176.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 tp -140.19 110.88 6.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.28 0.562 . . . . 18.49 110.189 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.82 -162.3 16.68 Favored Glycine 0 C--N 1.319 -0.383 0 CA-C-N 115.689 -0.687 . . . . 18.67 111.484 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.2 p -81.9 76.45 8.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.954 0.883 . . . . 17.16 109.525 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.728 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -154.01 166.52 32.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.557 -1.202 . . . . 14.8 107.832 178.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.563 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 2.6 mt-10 -144.37 111.78 6.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 118.368 0.531 . . . . 14.94 110.4 162.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.611 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 36.5 mmt180 -125.8 157.57 37.17 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.924 -0.31 . . . . 11.02 110.739 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.0 mm? -94.12 126.8 39.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.904 -0.776 . . . . 9.27 108.904 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.21 129.02 50.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.221 -0.445 . . . . 10.57 109.882 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.69 157.13 65.68 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.912 -1.04 . . . . 6.4 108.842 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.79 128.33 29.16 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.523 1.482 . . . . 7.48 110.631 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.525 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 50.8 p -54.43 -25.76 26.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.645 0.609 . . . . 9.53 112.645 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.45 12.12 21.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.825 -0.35 . . . . 10.86 111.526 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.43 -28.78 24.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.364 0.602 . . . . 5.39 110.338 175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.509 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -99.68 158.73 15.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.799 -0.637 . . . . 7.08 111.572 -174.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 109' ' ' THR . 40.8 mm -104.02 123.67 57.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.203 -0.908 . . . . 10.63 110.356 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.4 mmm180 -95.26 121.81 37.3 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.592 -0.843 . . . . 12.12 110.629 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 t -149.5 143.49 25.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.713 -0.676 . . . . 14.98 110.605 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.67 -115.71 4.13 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 116.225 -0.443 . . . . 16.43 112.666 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.42 36.94 4.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 15.35 110.94 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -155.48 -177.98 6.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.107 0.48 . . . . 15.67 111.933 -175.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.509 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 19.1 m -131.74 147.19 52.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.529 -0.76 . . . . 9.26 109.399 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 22.6 mm -126.64 149.82 31.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 10.94 109.968 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.59 123.54 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.205 -0.294 . . . . 7.39 110.205 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 43.6 mtm -86.7 100.38 12.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.179 -0.674 . . . . 8.85 109.179 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 14.9 p -82.72 136.47 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.497 -0.774 . . . . 10.13 110.98 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -74.89 83.23 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.464 -0.939 . . . . 10.7 108.464 173.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -77.99 150.93 33.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.018 -0.992 . . . . 15.12 111.083 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.37 -5.88 18.56 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.566 -0.743 . . . . 16.92 113.15 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -73.32 -10.44 59.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 18.56 110.19 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.21 31.15 26.23 Favored Glycine 0 C--N 1.31 -0.866 0 C-N-CA 119.947 -1.121 . . . . 16.28 111.374 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.97 163.76 31.51 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 111.242 -0.743 . . . . 14.36 111.242 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.2 m-85 -97.27 112.44 24.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.806 0.336 . . . . 12.49 110.204 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 113' ' ' VAL . 4.0 t70 -101.51 139.62 20.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.893 -0.594 . . . . 13.91 109.538 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -86.16 122.24 2.13 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.045 1.83 . . . . 13.02 112.971 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.53 121.52 59.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.177 -0.92 . . . . 10.41 110.167 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.24 121.1 20.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.849 -0.797 . . . . 12.93 108.849 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.577 ' CG2' HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.17 153.26 38.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.742 0.782 . . . . 8.03 112.059 -173.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.443 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.2 ttmm -93.83 129.75 40.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.232 -1.349 . . . . 10.66 109.475 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.77 112.97 20.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.116 1.436 . . . . 8.3 112.261 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 136' ' ' GLU . . . -89.44 174.36 41.52 Favored Glycine 0 N--CA 1.41 -3.062 0 CA-C-N 111.364 -2.653 . . . . 10.1 111.177 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.38 162.35 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 112.367 -1.917 . . . . 11.03 114.683 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -106.7 133.17 51.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.219 -0.9 . . . . 13.17 109.248 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.24 119.82 9.13 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.055 -0.52 . . . . 13.78 111.261 -174.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.17 29.58 75.19 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.183 -0.532 . . . . 15.28 112.544 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.46 89.7 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.633 -0.794 . . . . 13.44 112.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -116.53 153.8 31.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.077 -0.342 . . . . 11.28 110.077 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.525 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 70.5 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.091 0.472 . . . . 8.43 111.387 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 128' ' ' GLY . 24.7 mt-10 -85.51 107.85 17.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.586 -0.733 . . . . 10.79 109.65 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.577 HD11 ' CG2' ' A' ' 125' ' ' VAL . 23.2 mm -92.41 114.1 28.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 O-C-N 121.245 -0.909 . . . . 6.73 110.31 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.611 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.4 mp -86.6 -47.8 8.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.293 -1.321 . . . . 9.17 110.795 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.574 ' O ' HG21 ' A' ' 125' ' ' VAL . 37.3 mt-10 -144.29 167.25 22.9 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.052 -0.722 . . . . 10.44 109.052 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 114.51 -74.11 0.24 Allowed Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.631 -1.271 . . . . 8.87 113.413 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.476 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 61.5 tp -97.66 178.09 5.28 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.694 -0.253 . . . . 8.5 110.998 -168.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.476 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 26.3 tptp -137.62 148.84 46.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.4 0.619 . . . . 14.48 112.124 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . . . -68.15 143.45 55.39 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 114.439 -1.255 . . . . 12.12 110.802 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 1.34 85.95 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.524 -0.846 . . . . 12.39 112.124 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -103.8 152.69 21.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.552 -0.536 . . . . 11.89 109.552 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.509 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 69.4 mt-30 -97.46 140.07 32.44 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 120.929 0.395 . . . . 11.1 111.295 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -134.71 143.99 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.152 -0.477 . . . . 5.45 109.961 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 27.1 m -67.75 129.58 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.436 0.636 . . . . 7.05 111.365 -175.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.402 HG12 ' CB ' ' A' ' 82' ' ' ALA . 2.6 m -121.89 26.37 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.346 1.069 . . . . 6.99 108.978 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -71.34 16.61 0.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.848 -1.524 . . . . 9.37 112.861 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 149' ' ' VAL . . . -77.13 -28.32 58.55 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.128 -0.789 . . . . 8.6 111.128 174.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -156.32 139.66 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.51 -0.552 . . . . 12.43 109.51 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.43 ' CD1' HG23 ' A' ' 155' ' ' ILE . 2.7 p90 -159.34 173.38 16.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.548 -0.296 . . . . 12.83 110.805 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.23 61.91 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 13.49 111.494 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.43 HG23 ' CD1' ' A' ' 153' ' ' PHE . 12.8 tt -149.31 2.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.777 0.798 . . . . 12.27 109.416 171.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -72.76 -16.41 61.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 11.22 110.651 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p -57.42 -43.14 83.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 12.0 109.556 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 38.8 tt0 -76.11 -36.52 58.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.251 -0.886 . . . . 11.17 108.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 162' ' ' ARG . . . -59.97 -27.77 67.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.27 -1.332 . . . . 8.27 111.519 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.5 t -79.0 -37.92 38.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 9.64 110.496 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.96 -26.9 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.747 0.277 . . . . 10.88 111.747 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 11.2 ptp180 -74.62 2.46 9.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.136 0.421 . . . . 9.36 112.136 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.507 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 116.47 13.18 8.3 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.462 -0.875 . . . . 7.46 112.342 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.507 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 26.1 p 52.75 -97.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.672 0.789 . . . . 7.09 112.153 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.408 HG11 ' O ' ' A' ' 165' ' ' VAL . 5.7 p -74.67 84.85 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.855 0.836 . . . . 9.62 109.65 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.6 22.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.251 -0.886 . . . . 9.11 111.534 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.668 ' O ' ' HG3' ' A' ' 168' ' ' MET . 5.9 tmm_? -75.09 90.35 2.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 15.17 110.433 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.668 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 14.5 mtm -161.87 26.31 0.12 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.973 -1.012 . . . . 12.15 109.953 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -138.65 47.17 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.422 -0.808 . . . . 15.5 110.217 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.89 1.48 56.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.116 -0.947 . . . . 15.01 110.207 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.7 p -131.34 151.08 51.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 14.52 110.469 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 13.6 t -169.88 171.65 7.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 14.89 109.504 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.3 t -151.61 166.49 31.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.665 -0.495 . . . . 15.85 109.665 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.28 49.02 7.72 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 17.54 111.379 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.87 44.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 17.85 111.588 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.31 113.62 25.55 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.111 -0.7 . . . . 19.67 109.111 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.6 m 45.68 -163.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 124.132 0.895 . . . . 19.71 111.674 -175.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 57.63 50.27 11.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.083 0.401 . . . . 21.47 112.083 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 56.04 100.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.763 1.023 . . . . 23.66 113.763 168.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.935 -0.555 . . . . 23.71 109.697 176.149 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.689 0.281 . . . . 34.49 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.16 17.86 79.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.98 -0.628 . . . . 33.2 112.222 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -84.11 -46.99 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.059 -0.071 . . . . 34.24 110.91 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.05 58.31 4.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.327 0.584 . . . . 32.38 110.572 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 m -56.19 -40.88 74.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.326 -0.852 . . . . 33.02 111.311 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 m -98.74 12.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 31.57 110.776 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.49 -53.67 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 29.46 111.278 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.54 -146.53 7.86 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.952 -0.642 . . . . 28.42 111.932 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.13 132.0 16.1 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.563 2.175 . . . . 27.92 112.488 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -116.64 44.78 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.369 -0.604 . . . . 26.82 109.369 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 61.3 -165.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.051 -0.977 . . . . 25.18 111.55 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 -149.37 22.8 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.4 -0.68 . . . . 23.19 111.4 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -111.55 121.57 45.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.94 -0.393 . . . . 21.58 109.94 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -116.59 88.45 24.53 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.711 0.291 . . . . 19.89 110.572 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.57 171.83 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.605 2.203 . . . . 18.59 112.276 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.5 3.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.095 0.474 . . . . 17.12 110.467 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.86 -177.8 3.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 14.96 109.873 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.75 -120.66 1.29 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.218 -0.991 . . . . 13.21 111.729 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.94 5.03 23.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.067 0.461 . . . . 12.37 110.334 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 64.53 74.32 0.4 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.665 -1.152 . . . . 13.82 109.74 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.8 mt 63.37 86.13 0.12 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.622 0.725 . . . . 12.48 110.31 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -49.62 -32.61 13.27 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.165 -1.38 . . . . 14.31 112.313 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 t -163.99 54.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.043 0.925 . . . . 11.34 110.101 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -56.73 14.56 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 110.559 -1.016 . . . . 10.62 110.559 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -160.79 53.48 0.3 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.56 1.171 . . . . 10.77 109.809 173.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 77.6 mtm180 -119.54 143.32 47.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.127 -1.397 . . . . 8.86 109.87 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.558 HG12 ' OE2' ' A' ' 58' ' ' GLU . 31.1 mm -49.23 120.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 114.286 -1.324 . . . . 5.76 112.824 -169.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.5 -35.06 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.963 -1.471 . . . . 8.55 110.298 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.669 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 44.0 p90 -176.15 -173.54 0.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.858 -0.61 . . . . 8.07 109.387 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.758 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.15 154.11 41.99 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.105 -0.498 . . . . 5.61 111.599 -175.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -156.51 150.64 25.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.389 -0.823 . . . . 9.75 110.415 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.545 ' HB3' HG23 ' A' ' 35' ' ' VAL . 9.3 t0 -82.72 134.69 46.89 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.705 -1.221 . . . . 8.31 107.705 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -62.67 -13.27 32.88 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.113 1.875 . . . . 10.41 111.967 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.484 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.1 OUTLIER -95.68 1.75 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 11.24 111.108 175.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG23 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -129.22 36.3 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 112.965 0.728 . . . . 9.83 112.965 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.8 Cg_endo -54.81 119.14 5.98 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.343 2.028 . . . . 11.66 112.517 -172.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.23 -21.0 6.97 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.889 -0.884 . . . . 10.86 110.889 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.486 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -85.0 115.42 22.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.25 -0.475 . . . . 9.42 110.635 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 47.9 ttt180 -99.73 102.8 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.343 0.592 . . . . 12.03 110.197 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 40' ' ' PHE . 82.9 m-85 -76.74 146.84 37.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 7.9 109.801 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.65 -27.7 69.4 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.128 -1.397 . . . . 10.61 110.323 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.9 pttm -169.79 165.94 5.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.386 -0.825 . . . . 11.24 110.355 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.758 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.6 Cg_endo -51.25 168.63 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.113 2.542 . . . . 7.51 113.104 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.66 -159.94 28.21 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.67 -0.776 . . . . 8.06 112.036 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.1 ttmt -98.44 147.47 24.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.24 -0.281 . . . . 12.05 110.24 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 p -70.68 128.77 90.64 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.558 -0.292 . . . . 9.2 111.462 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.65 -22.94 17.45 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.827 1.684 . . . . 10.25 110.507 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.651 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 97.8 m-85 -72.57 -24.98 61.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.759 -1.109 . . . . 10.49 110.949 -175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.24 -104.38 0.13 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.737 -0.785 . . . . 10.74 112.616 167.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -166.55 58.17 0.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.313 0.578 . . . . 12.54 111.596 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.3 ptm -133.36 149.9 73.7 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.626 -0.509 . . . . 10.35 109.626 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -66.41 131.8 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.545 1.496 . . . . 10.11 109.772 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 mt -60.59 160.04 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.699 0.625 . . . . 7.0 110.756 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.1 mm -99.4 130.73 26.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.212 -0.662 . . . . 8.28 109.212 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 58.2 Cg_endo -73.46 146.07 38.95 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 121.389 1.393 . . . . 6.21 112.145 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.493 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 31.3 m -68.81 159.69 5.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.269 -1.332 . . . . 6.41 112.251 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.486 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.87 -74.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.526 2.33 . . . . 8.58 116.216 -178.007 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.558 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.6 OUTLIER -61.63 -38.86 89.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.669 1.223 . . . . 7.04 111.93 -168.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 50.2 mt-10 49.96 36.42 11.66 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 111.865 -2.425 . . . . 8.58 112.291 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.436 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 49.0 mt-10 -163.22 54.63 0.18 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 124.803 1.314 . . . . 7.64 111.834 -171.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.466 ' HB2' ' CD ' ' A' ' 58' ' ' GLU . 64.8 t30 -148.68 -34.93 0.2 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.568 -1.196 . . . . 7.58 110.309 173.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -29.77 -59.22 0.17 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 125.413 1.485 . . . . 5.41 111.969 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.474 ' HB3' ' H ' ' A' ' 68' ' ' ARG . 37.8 t70 -130.14 65.36 1.51 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.596 -1.184 . . . . 7.01 108.953 173.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.99 -54.16 4.94 Favored Glycine 0 CA--C 1.503 -0.677 0 CA-C-N 114.23 -1.35 . . . . 7.2 111.498 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.45 28.05 0.65 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.076 -1.062 . . . . 7.82 109.005 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.88 24.76 11.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.311 -1.313 . . . . 9.19 110.815 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.429 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 47.5 t -53.43 -53.32 25.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.746 -0.835 . . . . 7.42 108.746 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 54.9 mtm180 73.16 141.29 0.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.713 1.375 . . . . 10.88 114.713 165.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.527 ' CG2' ' HG2' ' A' ' 72' ' ' ARG . 17.2 mt -75.74 155.09 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 113.338 -1.755 . . . . 9.13 110.226 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.428 ' N ' HG23 ' A' ' 69' ' ' ILE . 24.4 t70 -85.53 64.12 8.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.597 1.189 . . . . 13.02 109.324 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.04 25.31 59.5 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 112.925 -1.943 . . . . 12.13 114.554 170.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HG2' ' CG2' ' A' ' 69' ' ' ILE . 7.7 ptm180 -121.66 179.33 4.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.546 -1.279 . . . . 12.89 107.546 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 t -124.32 123.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.337 -0.616 . . . . 12.25 109.337 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -110.54 30.69 6.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.188 0.995 . . . . 10.97 109.897 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 60.04 107.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.649 -1.614 . . . . 14.62 111.45 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 7.1 p-10 -88.24 91.72 8.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.825 0.822 . . . . 11.22 111.189 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.79 -17.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.58 -1.191 . . . . 13.96 110.562 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.78 -60.2 4.74 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.123 -1.037 . . . . 11.94 111.107 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.1 98.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 113.969 -1.115 . . . . 10.24 109.481 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 65.6 ttt180 -126.22 132.37 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 12.25 109.737 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.522 HG23 ' HA ' ' A' ' 148' ' ' VAL . 76.6 p -139.05 143.11 38.24 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.739 -0.664 . . . . 8.3 109.484 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 149' ' ' VAL . . . -108.43 127.75 54.18 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.435 -0.58 . . . . 7.51 109.435 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 34.4 tt0 -73.1 139.24 46.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.888 -0.596 . . . . 12.15 109.932 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.58 HG11 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -61.74 135.32 26.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.278 -0.874 . . . . 9.71 111.727 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 28.2 mmtp -131.11 156.51 45.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.602 -1.181 . . . . 11.77 109.693 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.43 143.79 27.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.497 -0.557 . . . . 13.03 109.497 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.39 -33.12 2.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.702 -1.237 . . . . 13.49 112.678 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HG2' ' HA ' ' A' ' 93' ' ' GLU . 9.3 ptt180 -47.37 143.52 3.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.258 1.207 . . . . 16.96 114.258 -169.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tt -155.57 86.17 1.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.286 -1.376 . . . . 18.49 107.286 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 -6.38 82.2 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 109.07 -1.612 . . . . 18.67 109.07 -172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 5.5 p -111.26 173.93 6.1 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.4 -1.4 . . . . 17.16 108.504 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m -86.66 148.01 25.65 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.746 0.784 . . . . 14.8 110.645 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.554 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 10.9 tt0 -67.39 114.79 6.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.14 -1.845 . . . . 14.94 111.762 -170.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' CG ' HD13 ' A' ' 138' ' ' LEU . 1.5 mpp_? -119.61 156.74 29.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.829 -1.078 . . . . 11.02 109.118 170.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.599 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -90.68 113.58 25.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.629 -0.878 . . . . 9.27 108.629 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.68 129.95 34.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.646 . . . . 10.57 110.99 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.8 m -144.67 159.03 52.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.828 -1.078 . . . . 6.4 109.103 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.42 136.28 70.67 Favored 'Trans proline' 0 C--N 1.333 -0.277 0 C-N-CA 122.192 1.928 . . . . 7.48 110.589 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 m -57.92 -24.85 59.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 9.53 111.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.6 6.61 43.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.183 -0.207 . . . . 10.86 111.554 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -40.71 20.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.058 0.456 . . . . 5.39 110.707 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.469 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -90.87 161.85 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.732 -0.667 . . . . 7.08 111.98 -173.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.404 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 mm -113.15 103.79 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.892 -0.594 . . . . 10.63 109.442 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 7.2 ptt180 -101.53 134.27 44.91 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.33 -1.348 . . . . 12.12 110.997 173.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 t -150.47 128.88 12.12 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.06 -1.427 . . . . 14.98 109.589 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.76 -109.74 3.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.589 -0.815 . . . . 16.43 112.117 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.16 30.31 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.077 0.399 . . . . 15.35 112.077 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.472 HH11 HD13 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -163.75 176.91 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 15.67 112.004 -177.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.4 m -132.55 156.66 46.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 9.26 110.602 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.472 HD13 HH11 ' A' ' 108' ' ' ARG . 41.4 mm -129.26 149.48 33.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.277 -0.638 . . . . 10.94 109.277 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.551 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -128.94 141.82 51.14 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.658 0.265 . . . . 7.39 110.497 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.551 ' SD ' ' HB3' ' A' ' 122' ' ' PRO . 62.0 mmm -103.37 99.84 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.648 -0.501 . . . . 8.85 109.648 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.0 p -82.05 135.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.979 0.418 . . . . 10.13 111.003 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -80.06 93.54 5.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 10.7 110.922 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -89.06 160.5 17.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.626 -0.716 . . . . 15.12 111.343 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.43 23.94 31.42 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.737 -0.945 . . . . 16.92 110.737 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -97.54 19.41 13.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.989 0.423 . . . . 18.56 111.102 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.5 68.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.951 -0.642 . . . . 16.28 112.702 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 -175.76 47.55 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.16 -0.776 . . . . 14.36 111.16 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 81.8 m-85 -100.36 178.7 4.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.868 0.366 . . . . 12.49 110.881 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.513 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 13.4 t70 -140.52 122.85 9.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.467 0.651 . . . . 13.91 109.721 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.551 ' HB3' ' SD ' ' A' ' 112' ' ' MET . 71.1 Cg_endo -86.96 113.78 1.04 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.324 2.683 . . . . 13.02 112.422 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 111' ' ' ALA . 9.3 p -103.91 140.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.183 -0.917 . . . . 10.41 109.647 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.417 ' HA ' HD12 ' A' ' 110' ' ' ILE . 44.9 tt0 -76.24 120.97 22.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.108 -0.701 . . . . 12.93 109.108 171.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.579 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -131.65 159.35 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 8.03 111.566 -173.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.4 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 39.9 ttmt -103.11 128.04 50.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.186 -0.916 . . . . 10.66 109.415 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.66 108.25 5.34 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.589 0.218 . . . . 8.3 111.589 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.454 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -154.52 71.04 0.28 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 118.021 -2.038 . . . . 10.1 114.006 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.584 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -150.71 163.03 39.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.554 -0.906 . . . . 11.03 108.554 157.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.7 m -131.5 137.03 48.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.139 -0.689 . . . . 13.17 109.139 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -142.73 90.63 2.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 120.888 0.375 . . . . 13.78 111.954 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.2 60.19 8.74 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.733 -0.667 . . . . 15.28 113.411 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.84 82.26 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 13.44 112.41 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.64 165.54 24.99 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.9 -0.778 . . . . 11.28 108.9 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.0 m -117.81 163.46 16.48 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.633 -0.427 . . . . 8.43 110.714 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.584 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 23.9 mt-10 -110.44 120.11 41.37 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.734 0.778 . . . . 10.79 111.258 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 22.3 mm -85.23 107.95 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.777 -1.101 . . . . 6.73 109.644 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.54 HD13 ' CG ' ' A' ' 94' ' ' ARG . 2.0 mp -68.67 -46.54 68.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.298 -0.865 . . . . 9.17 109.984 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.527 ' O ' HG21 ' A' ' 125' ' ' VAL . 38.9 mt-10 -144.45 155.79 43.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.122 -0.49 . . . . 10.44 110.101 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 129.28 -66.85 0.57 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.862 -1.161 . . . . 8.87 113.064 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 141' ' ' LEU . 3.1 mm? -97.71 -176.29 3.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.37 0.878 . . . . 8.5 113.37 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.426 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 23.0 tptm -144.34 151.91 39.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.019 -0.991 . . . . 14.48 109.89 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.17 132.41 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.345 -0.843 . . . . 12.12 110.21 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.0 47.32 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.485 -0.864 . . . . 12.39 111.315 -174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -104.17 141.15 36.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.64 -0.504 . . . . 11.89 109.64 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.5 mt-30 -97.21 147.1 24.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.695 0.283 . . . . 11.1 111.008 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.0 m -136.51 152.55 29.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.38 -0.6 . . . . 5.45 109.38 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.522 ' HA ' HG23 ' A' ' 81' ' ' THR . 32.9 m -56.53 138.86 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.72 0.637 . . . . 7.05 111.881 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 82' ' ' ALA . 43.1 t -136.28 -39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.235 -0.893 . . . . 6.99 110.043 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 12.0 t -137.45 96.83 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.081 -0.711 . . . . 9.37 109.081 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -171.57 61.9 0.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.71 -0.956 . . . . 8.6 110.71 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -123.66 -136.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.629 -0.286 . . . . 12.43 110.622 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.89 63.2 0.46 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.062 0.545 . . . . 12.83 111.139 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.95 94.84 5.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 13.49 110.707 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.28 -9.14 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 12.27 109.709 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.72 1.25 39.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.619 -0.719 . . . . 11.22 110.232 176.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -66.54 -40.41 89.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.809 -0.441 . . . . 12.0 109.809 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.11 -51.79 55.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.236 0.471 . . . . 11.17 110.038 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.06 66.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.834 . . . . 8.27 111.422 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 164' ' ' THR . 35.6 t -70.77 -38.39 73.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.181 0.515 . . . . 9.64 110.609 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.96 -32.44 65.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.83 0.824 . . . . 10.88 110.907 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -89.93 -67.02 0.87 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 114.327 -1.306 . . . . 9.36 111.019 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.71 77.88 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.563 -0.744 . . . . 7.46 112.658 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 160' ' ' SER . 56.1 p 47.26 -100.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.191 0.996 . . . . 7.09 113.267 174.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.33 -30.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.03 0.443 . . . . 9.62 111.235 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.56 58.62 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.16 0.505 . . . . 9.11 111.096 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.475 ' HD2' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -71.98 -106.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.745 -0.661 . . . . 15.17 110.931 173.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.3 mtm 62.98 103.44 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.925 0.49 . . . . 12.15 112.271 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -47.25 -51.68 18.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.512 -0.767 . . . . 15.5 110.539 175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.411 ' C ' ' HG1' ' A' ' 171' ' ' THR . 33.3 tt0 -108.65 27.75 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.812 0.815 . . . . 15.01 110.254 -174.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.411 ' HG1' ' C ' ' A' ' 170' ' ' GLU . 75.4 p 51.08 33.3 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.38 -1.282 . . . . 14.52 113.593 173.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.4 t -153.25 170.29 20.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.251 0.548 . . . . 14.89 111.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 65.3 p -134.78 32.72 3.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 15.85 108.785 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.29 8.94 68.78 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.447 -0.797 . . . . 17.54 111.894 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.1 97.96 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 17.85 108.965 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -120.89 -60.89 1.62 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.669 -0.696 . . . . 19.67 110.319 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.451 HG21 ' H ' ' A' ' 178' ' ' LEU . 3.0 m 36.17 -108.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.984 0.735 . . . . 19.71 112.984 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.451 ' H ' HG21 ' A' ' 177' ' ' VAL . 80.3 mt -116.29 29.1 8.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.709 -0.619 . . . . 21.47 111.256 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -93.61 158.84 15.49 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.523 -0.547 . . . . 23.66 109.523 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.408 ' OXT' ' HG3' ' A' ' 180' ' ' GLN . 3.5 pt20 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.268 -0.872 . . . . 23.71 110.548 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.394 0.14 . . . . 34.49 110.821 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.63 -127.13 33.65 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.918 -0.658 . . . . 33.2 111.842 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 t -89.88 120.58 31.23 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.742 -0.466 . . . . 34.24 109.742 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.68 44.41 1.03 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.026 0.441 . . . . 32.38 110.392 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 m -84.43 -19.4 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.917 -0.583 . . . . 33.02 110.274 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.3 m -86.22 -20.02 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 31.57 110.771 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -103.44 83.88 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.325 -0.62 . . . . 29.46 109.325 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.57 -151.98 33.22 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.066 -0.814 . . . . 28.42 111.066 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.06 153.54 5.75 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.412 2.075 . . . . 27.92 111.982 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -55.27 -64.3 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.506 -0.553 . . . . 26.82 109.506 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -98.46 120.89 39.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 25.18 109.049 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.3 -73.55 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.523 -0.846 . . . . 23.19 111.533 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -83.98 54.77 3.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.535 . . . . 21.58 109.554 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -118.21 146.87 40.35 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.7 -0.682 . . . . 19.89 110.804 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.7 114.37 2.72 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 123.061 2.508 . . . . 18.59 111.67 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.43 4.83 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 17.12 111.911 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.2 72.08 0.35 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.974 0.796 . . . . 14.96 111.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.56 70.6 2.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 13.21 111.43 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.82 1.77 54.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.457 0.54 . . . . 12.37 112.457 -173.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 22' ' ' LYS . 32.6 tt0 62.77 75.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 13.82 111.074 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.7 tp 70.61 -17.51 0.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.451 0.7 . . . . 12.48 112.482 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 20' ' ' GLU . 35.1 ttmt -80.47 61.1 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.451 0.643 . . . . 14.31 110.441 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t 42.12 49.96 4.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.905 -1.498 . . . . 11.34 112.764 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.27 -55.84 1.89 Allowed Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.514 -0.85 . . . . 10.62 111.01 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -153.72 66.8 0.74 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.385 1.088 . . . . 10.77 110.043 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.519 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 32.0 mtt180 -135.49 138.75 43.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.971 -1.468 . . . . 8.86 109.362 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.629 HG12 ' CG ' ' A' ' 58' ' ' GLU . 31.3 mm -52.92 120.64 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 121.982 0.896 . . . . 5.76 113.236 -170.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.34 -37.32 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.665 -1.607 . . . . 8.55 110.291 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 13.1 p90 -169.77 -173.47 1.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.165 0.507 . . . . 8.07 111.611 -174.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.594 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.57 145.71 50.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.252 -0.886 . . . . 5.61 110.908 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -149.26 157.52 43.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.585 . . . . 9.75 110.207 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' HB3' HG21 ' A' ' 35' ' ' VAL . 9.1 t70 -91.32 136.08 27.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.673 -0.862 . . . . 8.31 108.673 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.45 -12.48 27.94 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.247 1.965 . . . . 10.41 112.395 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.593 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -100.47 2.57 42.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.605 0.24 . . . . 11.24 111.622 176.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.571 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 5.0 m -126.1 45.39 1.46 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.276 0.56 . . . . 9.83 111.451 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' HD3' ' C ' ' A' ' 34' ' ' MET . 22.7 Cg_exo -59.56 112.19 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.585 2.19 . . . . 11.66 112.252 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -32.7 3.35 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.309 -0.716 . . . . 10.86 111.309 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.45 ' CG ' ' CE2' ' A' ' 40' ' ' PHE . 3.3 tp-100 -68.1 125.67 27.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.276 0.56 . . . . 9.42 110.856 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.599 ' HG2' ' CE2' ' A' ' 29' ' ' TYR . 5.1 tmm_? -114.55 101.56 9.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.448 -0.797 . . . . 12.03 110.086 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.7 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 56.4 m-85 -85.79 141.23 29.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.498 0.666 . . . . 7.9 109.782 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.93 -36.59 84.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.313 -1.312 . . . . 10.61 111.067 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.5 mttp -146.32 163.31 30.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 123.406 0.441 . . . . 11.24 110.998 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.562 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -51.49 171.61 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.958 3.105 . . . . 7.51 114.175 175.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.71 -171.47 25.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 8.06 112.69 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 20.9 ttmt -83.86 144.8 29.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.604 -0.517 . . . . 12.05 109.604 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -64.76 136.65 96.86 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.922 -0.581 . . . . 9.2 109.623 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.98 -24.76 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.411 2.074 . . . . 10.25 112.099 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.618 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 64.3 m-85 -82.45 -34.47 28.12 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.671 -0.695 . . . . 10.49 110.839 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.523 ' HE1' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -117.75 -165.02 1.05 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.872 -1.058 . . . . 10.74 110.308 171.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.53 60.88 1.24 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.189 0.995 . . . . 12.54 109.066 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.404 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.8 ptm -138.32 146.15 50.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 113.86 -1.518 . . . . 10.35 109.325 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 19.4 Cg_exo -66.1 132.85 31.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.107 1.871 . . . . 10.11 110.177 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -61.63 161.8 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.309 0.38 . . . . 7.0 110.43 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.61 126.77 33.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.371 -0.603 . . . . 8.28 109.371 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.594 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 53.8 Cg_endo -73.37 131.75 16.79 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 121.309 1.339 . . . . 6.21 112.351 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.27 159.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.381 -1.282 . . . . 6.41 113.315 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.519 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 10.3 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.109 2.564 . . . . 8.58 116.304 -177.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.629 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -64.58 -38.22 90.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.56 1.172 . . . . 7.04 109.737 -171.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.623 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 10.9 tt0 54.63 40.55 31.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 111.863 -2.426 . . . . 8.58 111.15 170.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.54 45.96 0.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.909 -1.496 . . . . 7.64 109.644 -172.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.404 ' HA ' HG13 ' A' ' 27' ' ' ILE . 18.4 t-20 44.12 126.11 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.818 1.784 . . . . 7.58 115.818 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.488 ' H ' ' HB ' ' A' ' 27' ' ' ILE . . . -26.78 -63.16 0.08 Allowed 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 109.518 -3.492 . . . . 5.41 112.306 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 15.0 t70 -169.24 90.43 0.22 Allowed 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 118.257 -1.377 . . . . 7.01 113.229 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 66' ' ' ALA . . . 74.19 26.14 69.2 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.431 -0.804 . . . . 7.2 111.97 169.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 72.69 -32.61 0.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.545 0.738 . . . . 7.82 112.908 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 64' ' ' GLY . . . -158.19 -4.02 0.09 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.197 0.443 . . . . 9.19 112.197 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 164' ' ' THR . 21.5 t -74.67 -74.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 111.675 0.25 . . . . 7.42 111.675 -174.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 33.8 mtm180 65.57 142.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.009 0.909 . . . . 10.88 113.172 -173.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.524 HG23 ' N ' ' A' ' 70' ' ' ASP . 17.6 mt -87.18 161.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.809 -1.087 . . . . 9.13 110.218 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' N ' HG23 ' A' ' 69' ' ' ILE . 37.6 t70 -79.34 47.67 0.83 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.913 -0.585 . . . . 13.02 110.736 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.2 30.73 64.57 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.568 -0.742 . . . . 12.13 112.517 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -131.61 172.83 11.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.547 -0.908 . . . . 12.89 108.547 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.4 t -116.1 136.05 54.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.873 -0.417 . . . . 12.25 109.873 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.9 44.69 0.76 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.576 0.703 . . . . 10.97 111.432 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -90.12 70.04 7.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.249 -0.887 . . . . 14.62 109.205 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -133.6 119.01 18.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.806 -1.088 . . . . 11.22 108.27 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 77' ' ' LEU . 1.7 mm? -70.88 -2.68 15.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.579 -1.191 . . . . 13.96 112.822 -165.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.6 24.51 0.25 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.864 -0.684 . . . . 11.94 112.505 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.0 t 63.71 94.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.707 0.765 . . . . 10.24 111.22 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.601 ' HG3' ' O ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -96.28 131.52 42.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.053 -0.976 . . . . 12.25 109.78 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 114' ' ' ALA . 74.6 p -142.98 156.56 44.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.961 -0.563 . . . . 8.3 110.182 -175.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.479 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -120.01 129.3 54.2 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.567 -0.901 . . . . 7.51 108.567 171.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 43.3 tt0 -80.11 131.88 35.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.855 -0.611 . . . . 12.15 110.054 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 145' ' ' GLN . 77.2 t -55.6 131.36 18.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 9.71 110.955 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.36 145.06 9.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.462 -1.245 . . . . 11.77 109.455 172.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 6.3 mp -74.48 152.29 39.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.205 -0.907 . . . . 13.03 110.838 -176.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.489 ' N ' HD22 ' A' ' 96' ' ' LEU . . . 178.4 45.63 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.011 -1.09 . . . . 13.49 112.94 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.721 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -75.7 -177.95 3.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.21 0.528 . . . . 16.96 112.029 -178.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.17 112.34 9.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.533 -0.758 . . . . 18.49 109.147 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.1 -169.37 19.76 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 115.406 -0.816 . . . . 18.67 111.234 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 m -84.89 75.09 10.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.491 1.138 . . . . 17.16 109.47 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.721 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 2.1 m -155.36 168.75 26.05 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.641 -1.618 . . . . 14.8 106.758 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.508 ' HA ' ' CG ' ' A' ' 88' ' ' ARG . 5.1 tt0 -143.43 116.59 8.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.803 0.729 . . . . 14.94 109.835 163.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -134.79 160.54 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.549 0.214 . . . . 11.02 111.36 -172.015 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.477 HD21 HG13 ' A' ' 84' ' ' VAL . 5.0 mp -91.69 116.69 29.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.137 -0.69 . . . . 9.27 109.137 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -96.41 131.86 42.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.806 0.336 . . . . 10.57 111.388 -173.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.02 150.78 54.05 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.842 -0.799 . . . . 6.4 108.842 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HG2' HG12 ' A' ' 149' ' ' VAL . 50.8 Cg_exo -59.19 133.1 50.71 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 121.839 1.693 . . . . 7.48 110.704 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.472 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 22.9 t -61.45 -31.21 71.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 9.53 110.997 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -74.67 -5.25 42.09 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.372 -0.131 . . . . 10.86 111.043 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.437 ' HB1' HG13 ' A' ' 149' ' ' VAL . . . -73.57 -39.76 64.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.274 0.559 . . . . 5.39 109.984 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.476 HD11 HG22 ' A' ' 109' ' ' THR . 74.5 mt -65.13 148.1 52.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.67 -1.15 . . . . 7.08 113.034 -170.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.54 127.49 52.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.755 -1.111 . . . . 10.63 108.433 170.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 16.3 mmt180 -104.72 123.46 47.67 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.909 -0.717 . . . . 12.12 110.811 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -146.58 138.99 25.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.432 -0.804 . . . . 14.98 109.691 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.98 -118.33 6.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.292 -0.48 . . . . 16.43 112.776 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.7 36.89 4.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.19 0.519 . . . . 15.35 110.949 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -148.22 173.93 12.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 15.67 111.581 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.476 HG22 HD11 ' A' ' 102' ' ' LEU . 5.8 m -121.77 146.45 47.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 9.26 109.87 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.554 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 26.3 mm -131.13 148.41 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.891 0.377 . . . . 10.94 110.047 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.588 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -116.55 159.64 21.82 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.474 -0.565 . . . . 7.39 109.474 173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.413 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 58.8 ttp -125.75 100.78 6.56 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.545 -0.909 . . . . 8.85 108.545 174.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 14.4 p -80.89 129.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.363 0.601 . . . . 10.13 111.715 -168.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.441 ' HB3' HG22 ' A' ' 81' ' ' THR . . . -79.13 84.53 5.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.878 -1.056 . . . . 10.7 109.991 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -67.5 141.2 56.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.84 -0.618 . . . . 15.12 110.989 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.37 -2.21 40.43 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.627 -0.989 . . . . 16.92 110.627 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -83.57 6.54 20.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.932 -0.634 . . . . 18.56 111.123 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 6.01 70.39 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.41 -0.814 . . . . 16.28 113.241 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.9 175.41 20.85 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 14.36 112.486 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 120' ' ' PHE . 85.5 m-85 -127.05 122.28 33.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.658 -0.497 . . . . 12.49 109.658 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' VAL . 20.4 t70 -116.29 134.43 22.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.145 -0.479 . . . . 13.91 111.968 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.588 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 3.1 Cg_endo -77.56 136.33 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.987 1.791 . . . . 13.02 112.505 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.94 123.76 64.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 10.41 109.8 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -75.56 121.19 22.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 12.93 109.294 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.492 HG12 ' HG ' ' A' ' 141' ' ' LEU . 27.3 m -128.45 163.7 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.199 0.523 . . . . 8.03 111.608 -173.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.462 ' HG2' HD23 ' A' ' 138' ' ' LEU . 40.3 ttmt -102.88 126.18 49.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.008 -0.738 . . . . 10.66 109.008 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.57 104.03 4.66 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.1 -0.5 . . . . 8.3 110.998 -176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.416 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -154.2 71.19 0.28 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 117.922 -2.085 . . . . 10.1 114.968 169.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -147.68 162.52 38.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.054 -1.461 . . . . 11.03 107.054 150.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -134.15 129.52 35.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.694 0.679 . . . . 13.17 110.449 175.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.16 126.01 11.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.306 -0.407 . . . . 13.78 111.378 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.11 33.96 88.65 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.113 -0.494 . . . . 15.28 112.885 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.04 11.23 81.51 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.832 -0.699 . . . . 13.44 112.05 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.35 170.99 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.317 -0.623 . . . . 11.28 109.317 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 p -119.28 143.66 47.21 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.04 0.447 . . . . 8.43 110.907 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 1.3 mp0 -85.87 122.0 29.32 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.822 -0.626 . . . . 10.79 111.584 175.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.423 HD13 HD22 ' A' ' 102' ' ' LEU . 19.5 mm -88.03 109.33 19.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.52 -0.764 . . . . 6.73 109.112 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.462 HD23 ' HG2' ' A' ' 126' ' ' LYS . 1.3 mp -76.03 -52.17 10.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.379 -1.282 . . . . 9.17 109.264 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -144.74 170.83 15.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.688 -0.687 . . . . 10.44 110.322 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 109.85 -59.54 0.35 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.37 -0.919 . . . . 8.87 113.394 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.492 ' HG ' HG12 ' A' ' 125' ' ' VAL . 17.9 mt -96.83 -172.66 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.14 0.495 . . . . 8.5 111.828 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 63.7 tttm -149.77 154.89 39.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 14.48 109.212 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 84' ' ' VAL . . . -67.8 127.16 31.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.641 -0.708 . . . . 12.12 110.274 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.6 -8.35 28.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.033 -0.827 . . . . 12.39 111.033 -171.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.529 ' O ' HG21 ' A' ' 84' ' ' VAL . 32.5 mm-40 -97.27 116.63 29.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 11.89 109.343 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.553 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.1 mt-30 -91.29 135.67 33.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.754 -0.657 . . . . 11.1 111.549 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.43 ' O ' HG11 ' A' ' 149' ' ' VAL . 2.5 p -127.97 138.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.756 -0.461 . . . . 5.45 109.756 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.5 m -62.71 134.55 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 O-C-N 123.442 0.464 . . . . 7.05 110.531 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 150' ' ' SER . 13.2 m -119.94 -58.09 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.332 0.864 . . . . 6.99 113.332 -170.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.601 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 22.9 t 158.21 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.357 -0.979 . . . . 9.37 108.357 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 151.86 134.49 2.13 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.505 -0.855 . . . . 8.6 112.552 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -109.49 102.8 11.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.493 -0.558 . . . . 12.43 109.493 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.611 ' HE2' ' CE1' ' A' ' 153' ' ' PHE . 70.5 m-85 -109.41 -13.56 14.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.334 -0.394 . . . . 12.83 110.724 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.5 mt 67.25 -177.58 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 13.49 110.923 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.2 mt 62.72 52.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.997 0.904 . . . . 12.27 109.002 -175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.6 -28.18 31.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.038 -0.983 . . . . 11.22 111.441 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -59.24 -31.49 69.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.424 -1.262 . . . . 12.0 111.539 -169.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.66 -30.67 71.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.188 -1.369 . . . . 11.17 111.003 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.88 -25.68 40.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.656 -0.702 . . . . 8.27 110.525 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.5 m -80.79 -17.2 51.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 9.64 110.076 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 90.8 mt -65.53 -48.82 71.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.206 -0.664 . . . . 10.88 109.206 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -76.02 -173.33 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.444 -0.798 . . . . 9.36 109.968 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.44 -50.39 4.4 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.779 -0.724 . . . . 7.46 112.649 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.433 ' HA ' HG12 ' A' ' 67' ' ' VAL . 20.4 p -80.98 -86.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.309 . . . . 7.09 110.993 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.7 91.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.541 -0.54 . . . . 9.62 109.541 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.95 155.77 3.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 9.11 110.572 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.407 ' NE ' ' H ' ' A' ' 168' ' ' MET . 0.0 OUTLIER -120.35 -109.14 0.35 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.486 -0.486 . . . . 15.17 111.674 170.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.407 ' H ' ' NE ' ' A' ' 167' ' ' ARG . 26.0 mtm 58.2 16.62 4.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.508 0.723 . . . . 12.15 112.441 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 62.12 81.44 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.833 0.825 . . . . 15.5 109.38 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -62.29 -39.99 94.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.952 -1.476 . . . . 15.01 111.935 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.3 p -131.4 93.11 3.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 14.52 111.019 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 13.5 t -150.57 170.7 18.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.144 0.497 . . . . 14.89 110.849 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.7 t -149.48 -8.31 0.33 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.398 -0.819 . . . . 15.85 110.248 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -91.23 32.77 5.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.85 -0.691 . . . . 17.54 112.139 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.507 HD21 ' H ' ' A' ' 175' ' ' LEU . 2.6 pt? -86.15 148.59 25.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.405 0.621 . . . . 17.85 110.275 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 50.99 43.83 28.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 113.829 -1.532 . . . . 19.67 112.837 171.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.19 103.79 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.486 -0.324 . . . . 19.71 110.494 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.8 tp -153.44 -41.97 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.437 -0.347 . . . . 21.47 110.8 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -163.29 144.61 9.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.665 -0.494 . . . . 23.66 109.665 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.51 -0.757 . . . . 23.71 110.349 178.065 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.698 0.285 . . . . 34.49 110.706 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.68 48.81 0.73 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.934 -0.867 . . . . 33.2 110.934 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -62.85 -20.65 65.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.663 0.268 . . . . 34.24 111.658 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.82 -6.95 41.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.727 0.299 . . . . 32.38 111.393 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -117.24 21.49 13.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 33.02 111.924 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.86 124.68 71.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.351 0.596 . . . . 31.57 110.815 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -74.72 -24.77 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.451 -0.795 . . . . 29.46 110.443 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.29 44.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.197 -0.761 . . . . 28.42 111.197 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.34 157.05 52.35 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.397 2.065 . . . . 27.92 112.64 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -76.2 92.9 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.011 0.434 . . . . 26.82 110.308 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -116.35 -56.44 2.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 25.18 109.845 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.93 -70.21 2.32 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.896 -0.668 . . . . 23.19 113.943 170.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -102.05 -179.5 4.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.999 0.428 . . . . 21.58 112.069 -170.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.76 156.73 72.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 19.89 110.14 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.36 -79.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.307 2.005 . . . . 18.59 113.027 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.53 16.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.307 0.643 . . . . 17.12 112.094 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.21 63.26 0.66 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.965 0.412 . . . . 14.96 111.237 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.15 -130.27 6.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.724 -0.75 . . . . 13.21 112.198 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.86 17.61 9.02 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.5 0.72 . . . . 12.37 112.226 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 28.7 tt0 60.4 69.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.737 -1.12 . . . . 13.82 110.348 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 34.8 mt 73.77 -42.24 0.51 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.932 -1.031 . . . . 12.48 111.758 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.0 tttp 70.43 -63.67 0.39 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.72 0.638 . . . . 14.31 111.485 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -130.47 -179.27 5.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.493 -0.321 . . . . 11.34 110.385 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 -56.91 0.5 Allowed Glycine 0 CA--C 1.498 -1.029 0 N-CA-C 110.972 -0.851 . . . . 10.62 110.972 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.676 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -167.22 63.3 0.08 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.561 1.172 . . . . 10.77 109.76 178.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.608 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.1 mtp180 -135.71 135.19 39.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.196 -1.366 . . . . 8.86 108.986 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG12 ' CG ' ' A' ' 58' ' ' GLU . 23.3 mm -57.43 115.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 122.433 1.111 . . . . 5.76 112.173 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 mt -118.97 -35.42 3.65 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.773 -2.012 . . . . 8.55 110.679 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.64 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 19.8 p90 -168.82 179.07 4.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 8.07 109.704 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.684 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -117.29 164.3 15.02 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.185 -0.461 . . . . 5.61 111.523 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -145.31 177.22 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 9.75 110.204 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.535 ' HB3' HG21 ' A' ' 35' ' ' VAL . 12.0 t70 -124.13 138.43 30.74 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 107.845 -1.168 . . . . 8.31 107.845 170.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -60.3 -14.2 28.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.451 2.101 . . . . 10.41 112.738 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -101.43 -2.09 31.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.123 0.416 . . . . 11.24 112.123 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.0 m -125.45 38.28 0.4 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 113.58 0.956 . . . . 9.83 113.58 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 29.6 Cg_endo -58.49 133.3 53.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.305 2.003 . . . . 11.66 112.518 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.78 -6.3 29.46 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.272 -0.731 . . . . 10.86 111.272 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.691 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -87.54 179.38 6.56 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 9.42 109.194 177.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.521 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 4.5 tmm_? -157.0 93.29 1.33 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.785 -0.82 . . . . 12.03 108.785 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 1.641 ' HD2' ' CD1' ' A' ' 40' ' ' PHE . 91.3 m-85 -73.71 142.24 46.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.071 0.462 . . . . 7.9 109.99 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.27 -30.58 71.63 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.886 -1.052 . . . . 10.61 110.273 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.442 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -165.15 164.39 12.77 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.699 -0.682 . . . . 11.24 111.586 -177.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.684 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.1 Cg_endo -50.73 170.21 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.689 2.926 . . . . 7.51 113.313 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.01 -159.34 27.63 Favored Glycine 0 CA--C 1.508 -0.383 0 C-N-CA 120.24 -0.981 . . . . 8.06 112.735 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 3.0 ttmm -95.3 144.33 25.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.335 -0.617 . . . . 12.05 109.335 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.534 ' OG ' ' HG3' ' A' ' 49' ' ' MET . 25.0 p -64.56 145.02 98.71 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 9.2 111.873 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.24 -22.2 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.258 1.972 . . . . 10.25 112.904 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 96.0 m-85 -86.31 -15.83 39.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.41 1.1 . . . . 10.49 110.068 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.534 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.16 -164.06 1.85 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.506 -1.679 . . . . 10.74 109.012 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 5.7 p-10 -133.21 57.15 1.82 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.614 0.721 . . . . 12.54 110.781 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.407 ' HE3' ' OD2' ' A' ' 32' ' ' ASP . 8.9 ptm -133.35 142.93 46.03 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.134 -0.939 . . . . 10.35 108.954 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.09 132.13 37.8 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.617 1.545 . . . . 10.11 110.658 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.26 164.2 5.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.341 0.591 . . . . 7.0 111.854 -174.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.72 130.8 22.36 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.726 -0.842 . . . . 8.28 108.726 -177.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.24 136.83 35.41 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.855 1.703 . . . . 6.21 112.405 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 27.1 m -63.18 160.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.64 -1.164 . . . . 6.41 112.419 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.676 ' CD1' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER 7.13 -66.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.476 2.31 . . . . 8.58 116.054 177.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.597 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -62.57 -48.32 79.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.236 1.017 . . . . 7.04 110.352 -171.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 38.99 43.47 0.78 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 112.532 -2.122 . . . . 8.58 113.37 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -178.23 59.54 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.235 -1.348 . . . . 7.64 110.586 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -147.57 -39.0 0.19 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.51 -1.223 . . . . 7.58 109.7 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.54 -14.51 62.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.08 -0.964 . . . . 5.41 110.126 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.608 ' O ' HG13 ' A' ' 67' ' ' VAL . 2.0 t70 -84.83 9.89 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.309 -0.859 . . . . 7.01 109.681 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.88 -51.16 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.009 -0.996 . . . . 7.2 111.105 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.76 30.57 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.881 -0.659 . . . . 7.82 110.101 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.28 32.02 20.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.756 0.789 . . . . 9.19 109.726 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG13 ' O ' ' A' ' 63' ' ' ASP . 8.4 p -72.78 -51.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.718 -1.128 . . . . 7.42 110.766 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.459 ' N ' HG11 ' A' ' 67' ' ' VAL . 29.0 mtm180 -66.62 -70.82 0.22 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.52 -1.218 . . . . 10.88 110.242 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 70' ' ' ASP . 12.0 mt -102.15 157.55 4.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 113.545 -1.661 . . . . 9.13 110.966 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' N ' HG21 ' A' ' 69' ' ' ILE . 38.3 t70 -76.49 36.68 0.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.436 -0.802 . . . . 13.02 111.469 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 55.33 21.03 24.97 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.155 -0.929 . . . . 12.13 112.596 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 74' ' ' THR . 13.1 ptm180 -93.13 174.0 7.44 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.872 0.368 . . . . 12.89 110.457 -173.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.6 p -17.73 -57.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 125.794 1.934 . . . . 12.25 115.384 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 72' ' ' ARG . 10.1 t 34.26 62.89 0.45 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.332 1.053 . . . . 10.97 112.885 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -81.19 67.07 6.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.407 -0.815 . . . . 14.62 109.392 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.502 ' OD1' ' HG3' ' A' ' 152' ' ' GLN . 13.0 m120 -136.4 165.43 25.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.17 -0.923 . . . . 11.22 109.104 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.59 10.07 33.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 13.96 110.153 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.67 14.47 9.49 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 114.843 -1.071 . . . . 11.94 110.445 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t 60.39 74.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.881 0.848 . . . . 10.24 110.083 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -81.78 151.83 27.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.977 -1.011 . . . . 12.25 109.039 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 148' ' ' VAL . 82.5 p -127.92 177.86 6.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.367 0.603 . . . . 8.3 110.253 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 149' ' ' VAL . . . -140.88 126.36 18.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.102 -1.073 . . . . 7.51 108.102 171.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 34.4 tt0 -79.02 139.39 38.18 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.639 -0.504 . . . . 12.15 109.639 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 145' ' ' GLN . 53.3 t -62.03 133.3 27.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.33 0.585 . . . . 9.71 112.395 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -137.47 150.57 47.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.452 -1.249 . . . . 11.77 108.393 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 8.1 mp -77.53 147.99 35.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.148 -0.686 . . . . 13.03 109.148 169.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.73 40.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.316 -0.945 . . . . 13.49 112.938 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' THR . 2.4 ptt180 -63.44 126.3 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.161 0.505 . . . . 16.96 111.423 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -120.36 84.06 2.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.267 -0.642 . . . . 18.49 109.267 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.33 -1.62 84.47 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 109.68 -1.368 . . . . 18.67 109.68 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.4 p -110.69 -178.65 3.54 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.138 -1.031 . . . . 17.16 110.397 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 88' ' ' ARG . 5.6 m -76.61 159.95 29.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.508 -0.553 . . . . 14.8 109.508 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 11.1 mt-10 -59.16 97.79 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.685 0.755 . . . . 14.94 110.668 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.593 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -112.62 170.21 8.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.435 -1.257 . . . . 11.02 110.384 -173.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.573 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -100.75 113.38 26.22 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.953 -0.758 . . . . 9.27 108.953 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.74 129.5 36.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 10.57 110.868 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 34.1 m -142.41 161.65 48.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.858 -1.064 . . . . 6.4 108.409 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.88 134.79 55.52 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.707 1.605 . . . . 7.48 110.5 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 p -67.28 -24.63 65.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.103 -0.373 . . . . 9.53 110.984 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -90.96 7.26 41.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.512 -0.313 . . . . 10.86 111.153 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -84.9 -40.68 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.084 0.468 . . . . 5.39 110.615 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -83.18 162.36 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.608 -0.723 . . . . 7.08 111.572 -173.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 109' ' ' THR . 18.7 mm -104.63 119.81 54.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.524 -0.762 . . . . 10.63 109.997 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -96.13 120.75 36.98 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.629 -0.828 . . . . 12.12 109.97 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -147.3 140.59 25.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.955 -0.566 . . . . 14.98 110.36 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 56.88 -112.63 3.64 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.131 -0.557 . . . . 16.43 112.556 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.96 29.38 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.823 0.305 . . . . 15.35 111.823 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.413 ' NH1' HD12 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -162.41 -176.82 5.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 15.67 111.464 -174.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 46.7 m -125.43 147.94 49.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.725 -0.671 . . . . 9.26 110.572 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.9 mm -124.82 151.79 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.351 -0.611 . . . . 10.94 109.351 176.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -136.43 134.17 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.49 -0.131 . . . . 7.39 110.667 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 38.5 mtm -93.98 101.46 13.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 8.85 109.432 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 9.5 p -85.32 138.45 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 10.13 111.329 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.06 95.3 3.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.07 -0.513 . . . . 10.7 110.937 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -80.02 163.3 24.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.245 0.545 . . . . 15.12 110.454 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.52 15.15 47.81 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.417 -0.811 . . . . 16.92 111.406 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.26 11.6 39.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.449 0.642 . . . . 18.56 110.619 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.28 11.9 74.52 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.158 -0.928 . . . . 16.28 113.516 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.88 168.04 25.76 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.578 -0.82 . . . . 14.36 112.203 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.639 ' HD1' ' CD2' ' A' ' 120' ' ' PHE . 80.7 m-85 -110.18 109.86 20.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.533 -0.543 . . . . 12.49 109.533 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 9.3 t70 -92.6 140.58 23.96 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.781 -0.645 . . . . 13.91 110.772 -170.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 121' ' ' ASP . 19.4 Cg_endo -84.2 127.88 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.196 1.93 . . . . 13.02 112.71 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 125' ' ' VAL . 1.8 t -115.48 129.05 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.119 -0.946 . . . . 10.41 109.351 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -73.03 120.86 19.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.37 -0.604 . . . . 12.93 109.37 171.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.558 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -132.48 159.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.411 0.624 . . . . 8.03 111.212 -174.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -103.94 129.32 51.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.225 -0.898 . . . . 10.66 109.647 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.55 114.83 8.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.712 -0.222 . . . . 8.3 111.303 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 117.818 -2.134 . . . . 10.1 114.251 168.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -150.24 164.62 35.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.268 -1.012 . . . . 11.03 108.268 154.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -143.61 126.75 16.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.308 0.504 . . . . 13.17 110.086 170.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.21 118.95 6.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 13.78 111.336 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.27 36.24 92.54 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.231 -0.509 . . . . 15.28 112.697 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.32 20.96 80.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.559 -0.829 . . . . 13.44 111.618 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' VAL . 38.3 mt-30 -128.49 170.49 13.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.365 -0.606 . . . . 11.28 109.365 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.5 t -125.12 156.82 37.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.604 -0.517 . . . . 8.43 109.604 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 46.6 mt-10 -101.06 112.97 25.57 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.664 0.745 . . . . 10.79 110.577 175.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.593 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 24.5 mm -79.87 106.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.741 -1.118 . . . . 6.73 109.641 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.476 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.4 mp -70.48 -49.67 46.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.885 -1.052 . . . . 9.17 109.878 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 125' ' ' VAL . 41.0 mt-10 -141.75 165.6 27.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.44 109.528 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.524 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 116.95 -67.42 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.683 -1.246 . . . . 8.87 113.593 175.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.32 -174.97 2.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 8.5 112.16 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.427 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 38.4 ttpt -149.32 154.97 39.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.558 -0.746 . . . . 14.48 109.748 -176.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.33 131.49 45.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.487 -0.779 . . . . 12.12 110.1 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.35 -7.72 47.48 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.948 -0.861 . . . . 12.39 110.948 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.581 ' O ' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -100.8 119.07 38.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.812 -0.81 . . . . 11.89 108.812 177.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.7 pt20 -104.88 132.27 51.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.686 0.755 . . . . 11.1 109.676 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.512 ' O ' HG21 ' A' ' 149' ' ' VAL . 17.1 m -116.38 153.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.439 -1.255 . . . . 5.45 110.025 -172.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.45 ' HA ' HG23 ' A' ' 81' ' ' THR . 27.3 m -57.62 134.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.44 0.638 . . . . 7.05 111.413 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 147' ' ' VAL . 43.1 t -129.7 -37.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.092 -0.958 . . . . 6.99 111.029 -173.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -135.9 53.27 1.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.043 -0.526 . . . . 9.37 109.891 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.48 -169.15 12.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.633 -0.712 . . . . 8.6 112.043 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.502 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 95.4 mt-30 -78.9 95.5 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.811 0.338 . . . . 12.43 110.63 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -94.55 -10.27 32.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 12.83 110.334 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 28.8 tp -70.92 -57.07 4.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.124 0.488 . . . . 13.49 109.755 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.6 tt -118.19 112.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.567 -0.742 . . . . 12.27 110.449 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -76.26 -23.33 54.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 11.22 110.718 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.472 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 9.3 m -56.14 -54.87 39.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.203 0.525 . . . . 12.0 110.92 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 34.9 mm-40 -59.4 -40.0 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.274 -0.876 . . . . 11.17 110.895 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 8.27 111.657 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.8 m -79.55 -28.95 41.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 9.64 110.431 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 157' ' ' SER . 71.8 mt -83.16 -28.29 29.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.517 -0.765 . . . . 10.88 110.561 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 20.1 mtp180 -70.53 146.13 50.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.331 -0.85 . . . . 9.36 112.404 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.44 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . -176.08 23.98 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.783 -1.098 . . . . 7.46 111.888 169.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 3.8 p 46.99 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.751 0.821 . . . . 7.09 112.964 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.6 t 59.84 66.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.558 0.694 . . . . 9.62 109.587 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.6 92.33 3.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.621 -0.718 . . . . 9.11 110.875 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.705 ' O ' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -84.7 8.59 16.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.868 0.842 . . . . 15.17 109.916 177.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.508 ' SD ' HG21 ' A' ' 171' ' ' THR . 0.0 OUTLIER -156.62 -178.37 7.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.695 -1.138 . . . . 12.15 108.955 177.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 7.25 6.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.318 0.58 . . . . 15.5 109.977 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' A' ' 168' ' ' MET . 10.0 pt-20 -95.53 36.15 1.29 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.618 -0.719 . . . . 15.01 112.506 -166.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.508 HG21 ' SD ' ' A' ' 168' ' ' MET . 16.4 p -103.95 -22.53 13.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.86 0.362 . . . . 14.52 111.894 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 t -88.3 -50.3 6.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.38 -0.373 . . . . 14.89 111.517 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.1 p -120.62 -5.09 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.693 -0.231 . . . . 15.85 111.139 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.28 -35.76 72.52 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.952 -0.642 . . . . 17.54 112.417 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.451 HD21 ' H ' ' A' ' 175' ' ' LEU . 2.1 pt? -130.41 41.69 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 17.85 109.541 176.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.5 ' HG2' ' H ' ' A' ' 177' ' ' VAL . 9.4 tt0 65.27 177.0 0.2 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.697 -1.138 . . . . 19.67 109.901 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.5 ' H ' ' HG2' ' A' ' 176' ' ' GLU . 9.9 p -124.9 -7.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.363 0.602 . . . . 19.71 111.172 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -115.05 -44.67 3.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 21.47 110.674 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.87 134.69 56.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 23.66 110.905 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.747 -0.644 . . . . 23.71 109.799 179.089 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.953 -0.388 . . . . 34.49 109.953 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 3' ' ' SER . . . -105.48 -153.26 21.31 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.835 -0.698 . . . . 33.2 112.121 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 38.4 t 74.46 -53.93 0.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.3 0.64 . . . . 34.24 111.015 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.51 141.42 51.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.814 -0.439 . . . . 32.38 109.814 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -77.63 66.76 3.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 33.02 110.795 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -104.91 151.12 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.739 -0.664 . . . . 31.57 110.453 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -98.34 144.86 27.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.955 -0.566 . . . . 29.46 110.502 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.34 -155.19 25.59 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.593 -0.813 . . . . 28.42 112.15 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.03 -74.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.987 2.458 . . . . 27.92 111.517 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -153.71 53.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.608 0.718 . . . . 26.82 109.865 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -98.7 88.63 4.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.988 -1.005 . . . . 25.18 109.963 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 143.15 27.95 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 23.19 112.203 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.467 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 30.2 m80 -119.83 48.98 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.144 0.497 . . . . 21.58 110.03 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -100.79 101.4 15.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 19.89 109.712 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' HIS . 4.8 Cg_exo -76.81 86.0 1.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.97 2.447 . . . . 18.59 112.02 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.61 58.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 17.12 110.64 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.27 96.39 1.11 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.077 -0.511 . . . . 14.96 110.348 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . 129.35 -99.07 0.46 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.055 -0.818 . . . . 13.21 111.055 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.67 -63.32 0.14 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.042 0.937 . . . . 12.37 112.692 178.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 63.02 63.84 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.076 0.941 . . . . 13.82 111.489 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.24 -100.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.25 -1.341 . . . . 12.48 109.968 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.36 -40.7 10.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.389 0.614 . . . . 14.31 109.705 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.9 m -149.9 149.88 31.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 11.34 109.475 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.63 -44.26 0.38 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 10.62 111.777 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -150.14 52.61 0.91 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.963 1.363 . . . . 10.77 108.555 177.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 9.3 mmm180 -113.41 140.06 48.38 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.752 -1.567 . . . . 8.86 109.476 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.644 ' HB ' ' CB ' ' A' ' 62' ' ' ALA . 11.9 mm -52.49 121.4 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 123.937 0.773 . . . . 5.76 112.661 -170.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.16 -37.43 10.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.177 -1.374 . . . . 8.55 110.284 172.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 29.8 p90 -172.24 -175.63 1.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.162 0.506 . . . . 8.07 111.125 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.714 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.29 154.25 35.24 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.14 -0.936 . . . . 5.61 110.627 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -162.91 148.98 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.567 0.542 . . . . 9.75 110.447 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.621 ' HB2' HG23 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -69.77 137.61 87.89 Favored Pre-proline 0 CA--C 1.514 -0.413 0 N-CA-C 108.386 -0.968 . . . . 8.31 108.386 169.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -62.01 -11.84 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.393 2.062 . . . . 10.41 110.77 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -98.76 1.33 45.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.613 -0.721 . . . . 11.24 111.215 177.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.621 HG23 ' HB2' ' A' ' 32' ' ' ASP . 10.3 m -130.98 49.86 5.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 121.238 0.542 . . . . 9.83 112.03 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.05 121.13 7.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.781 2.321 . . . . 11.66 112.584 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.34 -25.86 11.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.82 -0.705 . . . . 10.86 112.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.488 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -69.43 105.98 2.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.415 0.626 . . . . 9.42 111.004 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.725 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 45.2 ttp180 -89.61 101.28 13.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.343 -0.844 . . . . 12.03 110.521 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.488 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 72.0 m-85 -82.94 147.24 28.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 7.9 110.252 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.83 -25.63 68.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.396 -1.275 . . . . 10.61 111.406 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.48 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 53.8 pttt -172.46 164.62 3.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 11.24 111.3 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.714 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.0 Cg_endo -50.7 170.06 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.729 2.952 . . . . 7.51 113.626 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.16 -166.03 26.83 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.692 -0.766 . . . . 8.06 112.421 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 5.3 ttmm -93.21 141.56 28.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.059 -0.719 . . . . 12.05 109.059 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.577 ' HB3' ' O ' ' A' ' 49' ' ' MET . 41.2 t -61.07 139.87 94.21 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.535 -0.757 . . . . 9.2 111.64 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.19 -20.8 18.52 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.74 2.294 . . . . 10.25 111.468 171.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 27.1 m-85 -87.67 -42.83 12.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.512 -1.222 . . . . 10.49 109.666 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -133.92 155.28 50.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.34 -0.846 . . . . 10.74 111.965 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.1 p-10 -82.35 61.42 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.282 1.039 . . . . 12.54 110.834 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.96 143.39 48.84 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.732 -1.122 . . . . 10.35 109.392 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.75 132.9 32.06 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.178 1.252 . . . . 10.11 109.218 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.44 158.69 14.21 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.029 -0.268 . . . . 7.0 110.681 -175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.95 130.51 24.96 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-O 121.217 0.532 . . . . 8.28 110.118 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.457 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 88.2 Cg_endo -79.09 139.74 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.135 1.89 . . . . 6.21 113.14 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 34.1 m -61.43 161.81 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.743 -1.571 . . . . 6.41 112.97 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.463 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.79 -84.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.049 2.14 . . . . 8.58 115.706 -178.086 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.591 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.1 OUTLIER -48.6 -43.57 36.26 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.92 0.762 . . . . 7.04 111.421 -173.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.457 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 35.7 tt0 47.39 64.06 1.74 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.271 1.034 . . . . 8.58 109.655 -171.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 45.4 mt-10 -142.79 35.07 1.41 Allowed 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 114.173 -1.376 . . . . 7.64 109.526 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 63' ' ' ASP . 66.4 t30 60.74 13.14 4.14 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 111.83 -2.441 . . . . 7.58 113.694 162.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.644 ' CB ' ' HB ' ' A' ' 27' ' ' ILE . . . 69.96 -7.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.061 -1.881 . . . . 5.41 112.017 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.541 ' OD1' ' HB ' ' A' ' 67' ' ' VAL . 11.1 t70 -162.7 -162.46 0.79 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.799 -1.091 . . . . 7.01 109.598 -174.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.5 ' H ' ' CG ' ' A' ' 63' ' ' ASP . . . -133.8 21.39 3.98 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.012 -0.835 . . . . 7.2 111.012 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 62.97 39.4 10.31 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.159 0.564 . . . . 7.82 111.318 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.11 -45.34 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.6 -0.727 . . . . 9.19 110.33 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.541 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 4.5 t -72.52 -65.28 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.972 -0.751 . . . . 7.42 108.972 176.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 7.7 mtt180 64.07 131.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.017 -1.447 . . . . 10.88 113.812 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.545 HG22 ' HG2' ' A' ' 72' ' ' ARG . 10.1 mt -67.8 153.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.425 -1.262 . . . . 9.13 111.005 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 69' ' ' ILE . 31.9 t70 -82.76 48.22 1.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 13.02 110.855 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.44 32.33 80.69 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.63 -0.713 . . . . 12.13 112.252 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HG2' HG22 ' A' ' 69' ' ' ILE . 1.4 ptt180 -104.44 129.11 52.43 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.042 -0.725 . . . . 12.89 109.042 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.36 34.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.248 1.499 . . . . 12.25 108.318 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.437 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 2.9 t -133.59 76.88 1.69 Allowed 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 112.26 -2.246 . . . . 10.97 109.764 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -79.77 73.75 6.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.139 -0.937 . . . . 14.62 110.644 -177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -137.43 107.14 6.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.038 -0.983 . . . . 11.22 109.48 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.5 -6.49 48.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.034 -1.439 . . . . 13.96 110.974 -174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.31 -12.79 20.88 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.087 -0.96 . . . . 11.94 112.063 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.5 t -138.49 91.56 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.923 0.868 . . . . 10.24 110.651 -172.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.93 118.06 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.947 -1.024 . . . . 12.25 108.429 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 146' ' ' GLN . 77.0 p -108.74 139.17 43.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.447 -0.342 . . . . 8.3 110.526 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.411 ' CB ' HG13 ' A' ' 149' ' ' VAL . . . -107.33 129.77 54.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.906 -0.776 . . . . 7.51 108.906 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -76.04 134.79 40.0 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.237 -0.438 . . . . 12.15 110.065 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.577 HG12 ' HB3' ' A' ' 95' ' ' LEU . 73.6 t -63.13 130.05 27.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.686 0.755 . . . . 9.71 110.958 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.04 146.56 10.87 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.33 -1.305 . . . . 11.77 109.683 176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.13 161.33 31.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 13.03 111.091 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.524 ' N ' HD22 ' A' ' 96' ' ' LEU . . . 171.06 55.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.432 -0.889 . . . . 13.49 112.82 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.552 ' HG2' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -90.62 -178.81 5.39 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 111.837 0.31 . . . . 16.96 111.837 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.4 mt -135.25 108.21 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 18.49 109.365 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.56 -164.22 22.47 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.7 -0.682 . . . . 18.67 111.397 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.443 ' C ' ' HG1' ' A' ' 92' ' ' THR . 13.6 p -90.33 75.36 6.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.017 0.913 . . . . 17.16 110.047 176.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.476 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 1.6 m -155.58 167.34 30.7 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.247 -1.39 . . . . 14.8 107.247 173.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.552 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 4.6 mt-10 -141.44 114.44 8.58 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 118.228 0.467 . . . . 14.94 110.212 167.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.555 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -126.43 160.0 31.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.446 -0.343 . . . . 11.02 110.1 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.595 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -89.3 114.54 25.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.844 -0.799 . . . . 9.27 108.844 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -87.71 133.19 33.89 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.054 0.454 . . . . 10.57 111.365 -173.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.498 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 6.4 p -145.85 146.7 29.79 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.333 -0.849 . . . . 6.4 109.419 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.6 130.77 41.76 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.338 2.025 . . . . 7.48 110.518 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.9 p -55.22 -24.35 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.134 0.79 . . . . 9.53 113.134 -172.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -90.4 6.84 41.54 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.854 -0.529 . . . . 10.86 111.929 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . . . -82.16 -39.14 23.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.257 0.551 . . . . 5.39 110.629 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -91.93 156.04 17.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.6 -0.727 . . . . 7.08 111.767 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.1 mm -120.07 103.51 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 115.409 -0.814 . . . . 10.63 110.376 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER -109.3 98.23 7.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.581 -1.248 . . . . 12.12 112.166 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -107.44 142.98 36.43 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.896 -1.502 . . . . 14.98 109.386 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.36 -107.07 1.93 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.59 -0.814 . . . . 16.43 112.23 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.66 17.48 11.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.028 0.751 . . . . 15.35 113.028 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 17.5 ptt180 -160.0 166.61 29.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.129 0.788 . . . . 15.67 113.129 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.1 m -113.79 154.42 27.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.229 -0.896 . . . . 9.26 110.729 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 32.8 mm -133.97 149.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.981 -0.554 . . . . 10.94 109.834 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.567 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -135.19 130.17 34.91 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.476 0.31 . . . . 7.39 110.289 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 37.6 ttp -84.24 100.2 11.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.737 -0.838 . . . . 8.85 108.737 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 121' ' ' ASP . 13.6 p -87.77 134.48 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.602 -0.726 . . . . 10.13 111.736 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . -83.98 94.45 8.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.668 -0.696 . . . . 10.7 109.638 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HZ1' ' HB2' ' A' ' 121' ' ' ASP . 54.2 mttp -75.41 148.82 38.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 15.12 110.748 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.18 -0.71 30.27 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.592 -0.731 . . . . 16.92 111.991 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.35 9.47 20.41 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.466 0.65 . . . . 18.56 110.59 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.77 10.69 78.63 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.282 -0.872 . . . . 16.28 113.295 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.65 160.77 23.89 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.436 -0.888 . . . . 14.36 112.475 -174.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.635 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 91.9 m-85 -112.3 126.57 55.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 12.49 109.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.454 ' O ' HG13 ' A' ' 113' ' ' VAL . 5.9 m-20 -129.24 150.69 76.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.968 -0.293 . . . . 13.91 111.495 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 123.65 2.01 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.47 2.113 . . . . 13.02 112.147 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.567 HG13 ' HB2' ' A' ' 111' ' ' ALA . 6.1 p -108.98 134.67 50.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.349 -0.841 . . . . 10.41 110.015 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.456 ' HA ' HD11 ' A' ' 110' ' ' ILE . 34.1 tt0 -74.26 120.47 19.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.514 . . . . 12.93 109.611 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.538 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -128.62 156.45 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.721 -0.672 . . . . 8.03 111.657 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.437 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.8 ttmm -101.61 126.67 48.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.918 -1.037 . . . . 10.66 109.459 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.46 107.79 5.01 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.379 -0.373 . . . . 8.3 111.625 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.01 0.29 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 117.684 -2.198 . . . . 10.1 114.539 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -149.57 163.04 38.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.494 -0.928 . . . . 11.03 108.494 154.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.93 128.28 26.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 118.12 0.418 . . . . 13.17 110.163 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.66 126.76 9.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.327 -0.397 . . . . 13.78 111.48 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.85 24.59 74.29 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.194 -0.457 . . . . 15.28 112.498 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 14.45 81.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.61 -0.805 . . . . 13.44 111.388 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -119.21 171.09 8.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.528 -0.545 . . . . 11.28 109.528 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.515 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 6.2 p -119.13 154.17 33.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 116.405 -0.361 . . . . 8.43 110.222 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 51.8 mt-10 -100.83 124.53 46.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.438 0.637 . . . . 10.79 111.4 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 20.2 mm -88.86 112.16 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.183 -0.917 . . . . 6.73 109.908 174.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.555 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.8 mp -79.18 -44.99 20.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.603 -1.181 . . . . 9.17 109.649 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.482 ' O ' HG21 ' A' ' 125' ' ' VAL . 39.6 mt-10 -146.04 166.71 25.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.824 -0.626 . . . . 10.44 109.318 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 120.42 -70.47 0.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.798 -1.191 . . . . 8.87 113.528 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 mt -97.52 -179.19 4.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.382 0.611 . . . . 8.5 112.306 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -137.55 151.79 48.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.954 -1.021 . . . . 14.48 109.732 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.11 135.79 51.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.842 -1.072 . . . . 12.12 110.632 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.94 50.02 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.328 -0.709 . . . . 12.39 111.328 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -103.68 156.97 17.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.568 -0.53 . . . . 11.89 109.568 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 38.2 mt-30 -111.03 146.32 36.92 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.11 0.481 . . . . 11.1 110.703 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.7 p -132.84 137.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.448 -0.796 . . . . 5.45 109.011 172.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.61 124.13 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.35 0.595 . . . . 7.05 110.69 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.411 HG13 ' CB ' ' A' ' 82' ' ' ALA . 1.9 m -112.29 5.41 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.676 -0.693 . . . . 6.99 109.71 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.3 t 71.91 -53.54 0.69 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.465 -1.243 . . . . 9.37 110.849 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.04 -152.32 17.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.071 -0.585 . . . . 8.6 111.654 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.422 ' O ' HD13 ' A' ' 154' ' ' LEU . 10.7 pt20 -130.26 166.14 20.97 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.468 -0.567 . . . . 12.43 109.468 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.4 85.44 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.62 0.248 . . . . 12.83 110.381 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.523 HD13 ' H ' ' A' ' 154' ' ' LEU . 6.3 mp -40.3 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.796 1.31 . . . . 13.49 112.43 -171.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.0 mt -149.35 114.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.936 -0.764 . . . . 12.27 108.936 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.93 -77.39 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.708 0.766 . . . . 11.22 112.454 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.3 p -64.48 -42.31 95.96 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.826 -1.079 . . . . 12.0 112.633 -162.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -68.63 -28.32 66.8 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.837 -0.62 . . . . 11.17 109.979 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.26 -18.86 54.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.435 -0.802 . . . . 8.27 110.562 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.3 t -81.29 -41.65 21.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.857 -0.61 . . . . 9.64 109.572 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.45 -35.67 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.706 -0.679 . . . . 10.88 110.937 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 162' ' ' ARG . 34.9 mtt180 -98.44 -161.47 0.88 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.363 -0.606 . . . . 9.36 109.363 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 177.89 -56.55 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.912 -0.661 . . . . 7.46 111.889 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.6 p -102.48 -26.38 13.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.672 . . . . 7.09 110.042 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.6 t -87.75 76.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.561 -0.745 . . . . 9.62 110.14 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 67' ' ' VAL . . . -151.16 97.95 2.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.097 -0.501 . . . . 9.11 110.911 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.728 ' HD3' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -127.85 -80.7 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.21 -1.033 . . . . 15.17 108.21 178.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.404 ' H ' ' HB2' ' A' ' 167' ' ' ARG . 15.5 mtm 49.47 80.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.555 -1.657 . . . . 12.15 112.232 173.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.04 117.18 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.43 0.634 . . . . 15.5 110.142 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -104.58 94.81 5.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.127 0.489 . . . . 15.01 109.87 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.2 p -74.05 84.26 1.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.45 -0.796 . . . . 14.52 111.093 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 17.3 m -95.35 -73.99 0.57 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.918 -0.583 . . . . 14.89 110.243 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.8 m -157.77 133.88 9.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.181 0.515 . . . . 15.85 109.946 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.65 79.14 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.196 -0.911 . . . . 17.54 113.321 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 10.2 mp 62.81 -158.84 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.827 0.451 . . . . 17.85 110.299 -174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.23 119.49 11.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.465 -0.569 . . . . 19.67 109.465 175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.33 144.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.296 0.57 . . . . 19.71 111.036 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.66 -76.34 0.4 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.458 -0.941 . . . . 21.47 108.458 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.1 t80 179.61 133.31 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.05 -1.093 . . . . 23.66 108.05 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 120.763 -0.375 . . . . 23.71 111.11 -175.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.932 0.396 . . . . 34.49 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.02 42.39 4.69 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.686 -0.688 . . . . 33.2 112.029 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.6 m 71.29 168.93 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.003 0.521 . . . . 34.24 111.49 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.494 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . . . 66.66 174.96 0.24 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.544 -0.753 . . . . 32.38 111.524 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 p -78.77 -81.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.188 0.44 . . . . 33.02 112.188 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.78 105.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.085 0.469 . . . . 31.57 111.181 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 4' ' ' ALA . 19.2 m120 -129.32 -54.78 1.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 29.46 109.655 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.98 -158.11 15.83 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.595 -0.73 . . . . 28.42 111.439 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.09 165.04 21.91 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.415 2.077 . . . . 27.92 112.18 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -78.39 98.22 5.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.366 -0.379 . . . . 26.82 110.219 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.99 97.06 3.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.189 0.518 . . . . 25.18 110.285 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.58 -25.23 0.95 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.055 -0.818 . . . . 23.19 111.055 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -175.55 125.31 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 21.58 109.625 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -157.79 157.93 29.99 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.838 -0.801 . . . . 19.89 108.838 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.12 65.84 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.051 1.834 . . . . 18.59 112.149 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.85 -83.69 0.22 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.25 . . . . 17.12 110.893 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.93 92.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 14.96 110.019 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . 76.15 48.34 9.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.577 -0.821 . . . . 13.21 111.923 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -32.18 73.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 12.37 111.046 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.76 52.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.513 1.149 . . . . 13.82 108.97 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 35.5 mt -160.36 -67.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 112.979 -1.919 . . . . 12.48 107.706 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 40.8 ttmt 59.24 35.29 23.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.259 1.028 . . . . 14.31 110.156 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -155.13 107.67 2.73 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.95 -1.023 . . . . 11.34 110.808 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -100.7 164.74 18.79 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.375 -0.83 . . . . 10.62 111.241 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.0 OUTLIER 70.78 59.47 0.2 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.924 -1.139 . . . . 10.77 107.924 -178.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.408 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 18.2 mmm180 -126.14 137.07 53.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.762 -1.563 . . . . 8.86 110.564 -174.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.677 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.6 mm -46.36 131.91 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.343 -1.299 . . . . 5.76 113.66 -168.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -120.29 -29.9 4.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.843 -1.526 . . . . 8.55 108.227 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.634 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 16.4 p90 -175.24 -176.63 0.95 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.315 -0.857 . . . . 8.07 111.602 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.672 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.99 153.67 45.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.119 -0.946 . . . . 5.61 110.593 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -157.36 152.22 25.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 9.75 110.4 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.603 ' HB3' HG21 ' A' ' 35' ' ' VAL . 9.7 t70 -86.85 137.39 33.55 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.278 -0.638 . . . . 8.31 109.278 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HG3' HG13 ' A' ' 54' ' ' ILE . 16.5 Cg_exo -63.4 -14.93 45.25 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.495 2.13 . . . . 10.41 112.358 177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.502 ' HE1' ' N ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -97.32 0.57 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.718 0.294 . . . . 11.24 111.147 176.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.603 HG21 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -126.84 40.08 0.54 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.276 0.473 . . . . 9.83 112.276 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 13.8 Cg_endo -52.06 126.16 19.39 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.66 2.24 . . . . 11.66 112.812 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.36 -20.31 28.1 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 10.86 111.491 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.576 ' HB3' HG22 ' A' ' 35' ' ' VAL . 20.2 tp60 -81.42 102.92 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.239 0.542 . . . . 9.42 110.339 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 21.1 ttp180 -89.95 111.85 23.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.571 -0.74 . . . . 12.03 110.515 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.716 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 91.8 m-85 -92.67 127.72 38.27 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 108.036 -1.098 . . . . 7.9 108.036 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.79 -18.12 64.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.332 -0.547 . . . . 10.61 112.173 -171.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.525 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.3 mttt -141.4 170.09 10.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.738 -0.385 . . . . 11.24 111.01 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -52.82 170.43 0.29 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.522 2.815 . . . . 7.51 113.586 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.9 -167.15 29.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.39 -0.91 . . . . 8.06 113.421 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 9.4 ttmt -97.03 148.06 23.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.203 -0.666 . . . . 12.05 109.203 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.409 ' HA ' HD23 ' A' ' 53' ' ' LEU . 75.6 p -62.9 136.51 96.56 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 115.457 -0.792 . . . . 9.2 110.57 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.25 -25.4 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.894 1.729 . . . . 10.25 111.59 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.609 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 88.0 m-85 -81.82 -31.19 31.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.625 -0.716 . . . . 10.49 110.631 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.51 ' HE1' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.12 -159.74 0.88 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.501 -0.925 . . . . 10.74 108.501 173.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -130.67 54.92 1.86 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.687 0.756 . . . . 12.54 109.751 172.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 ptm -127.71 145.04 53.39 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 114.526 -1.216 . . . . 10.35 109.394 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.57 133.28 47.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.679 1.586 . . . . 10.11 109.971 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 46' ' ' SER . 24.2 mt -62.67 165.05 6.86 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.408 0.442 . . . . 7.0 110.735 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.41 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 32.8 mm -99.7 129.21 29.29 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.497 -0.557 . . . . 8.28 109.497 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.672 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 56.0 Cg_endo -83.28 138.2 8.65 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.851 1.701 . . . . 6.21 113.274 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.46 159.51 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.725 -1.58 . . . . 6.41 113.431 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 57' ' ' TYR . 0.1 OUTLIER 14.98 -86.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.966 2.106 . . . . 8.58 115.512 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.677 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -49.65 -38.76 33.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.977 0.418 . . . . 7.04 110.26 -177.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 63.69 84.85 0.14 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.885 -1.052 . . . . 8.58 111.263 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 62.27 60.05 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.102 0.953 . . . . 7.64 110.684 168.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.579 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 1.9 t-20 -138.39 -5.45 1.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.67 -1.605 . . . . 7.58 110.154 173.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.31 -35.08 62.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.828 0.823 . . . . 5.41 110.416 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.601 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 8.0 p-10 -76.02 -4.2 39.98 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.16 -1.382 . . . . 7.01 112.558 -167.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 52.6 36.34 47.79 Favored Glycine 0 C--N 1.313 -0.696 0 O-C-N 124.168 0.917 . . . . 7.2 113.144 178.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 75.03 56.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.294 0.644 . . . . 7.82 111.442 177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 79.78 12.78 1.08 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.536 -0.756 . . . . 9.19 112.201 165.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 164' ' ' THR . 11.9 t -58.89 -54.0 39.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.639 -1.245 . . . . 7.42 107.639 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.601 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 10.5 ptp180 -105.94 -168.4 1.44 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.053 -1.885 . . . . 10.88 109.709 172.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.588 HD13 ' H ' ' A' ' 69' ' ' ILE . 2.5 mp -57.73 144.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 115.44 -0.8 . . . . 9.13 111.203 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' HB3' ' NE ' ' A' ' 72' ' ' ARG . 37.5 t70 -86.72 51.9 2.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 13.02 110.168 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.11 29.7 15.53 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.746 -0.661 . . . . 12.13 113.659 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.493 ' HG2' HG23 ' A' ' 69' ' ' ILE . 15.3 ptp180 -106.05 -155.92 0.56 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 122.607 0.363 . . . . 12.89 110.324 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.4 m -32.24 -33.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.586 1.554 . . . . 12.25 114.679 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.2 t 42.49 85.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.743 1.217 . . . . 10.97 113.84 177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.04 76.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.534 -0.757 . . . . 14.62 110.02 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -151.06 133.74 15.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.022 -0.733 . . . . 11.22 109.022 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.8 -20.1 63.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.199 0.524 . . . . 13.96 111.077 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.92 -44.67 1.2 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.266 -0.734 . . . . 11.94 111.266 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.439 HG12 ' CZ ' ' A' ' 120' ' ' PHE . 64.2 t 67.06 95.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.586 0.708 . . . . 10.24 110.756 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -81.48 127.86 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.501 -0.772 . . . . 12.25 110.242 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 148' ' ' VAL . 45.4 p -131.37 146.78 52.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.13 -0.941 . . . . 8.3 109.792 -176.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.0 128.08 56.07 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.867 -0.79 . . . . 7.51 108.867 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.76 131.71 35.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.07 -0.345 . . . . 12.15 110.07 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.668 HG21 ' O ' ' A' ' 145' ' ' GLN . 73.4 t -56.7 127.2 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-O 122.293 1.044 . . . . 9.71 112.066 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.83 136.27 8.99 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.888 -1.96 . . . . 11.77 109.035 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.506 ' CD1' ' H ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.61 168.83 19.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.894 -1.048 . . . . 13.03 112.44 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.45 52.86 0.01 OUTLIER Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.635 -1.166 . . . . 13.49 111.135 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.648 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -74.55 -177.36 3.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.404 -0.898 . . . . 16.96 113.001 -170.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.56 111.86 13.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.071 -0.968 . . . . 18.49 108.62 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.21 -157.7 17.74 Favored Glycine 0 C--N 1.317 -0.474 0 CA-C-N 115.331 -0.849 . . . . 18.67 111.417 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.3 m -91.67 77.21 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.713 -0.847 . . . . 17.16 108.713 174.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.648 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 1.5 m -154.4 169.29 24.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 14.8 109.777 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -138.07 113.9 9.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.994 -0.743 . . . . 14.94 108.994 157.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 1.9 ttp180 -132.44 149.2 52.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.71 . . . . 11.02 111.062 -172.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.613 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.7 mm? -77.51 120.83 23.03 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.391 0.432 . . . . 9.27 110.458 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.06 131.87 43.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.311 -0.404 . . . . 10.57 111.318 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.7 156.12 59.66 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 6.4 109.467 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HG2' HG12 ' A' ' 149' ' ' VAL . 52.7 Cg_exo -57.46 134.06 61.0 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.117 1.878 . . . . 7.48 110.663 171.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.535 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 21.7 t -61.56 -26.05 67.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.958 0.355 . . . . 9.53 111.958 -173.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.0 4.8 49.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.941 -0.474 . . . . 10.86 111.568 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.417 ' CB ' HG13 ' A' ' 149' ' ' VAL . . . -75.73 -32.88 60.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.413 0.625 . . . . 5.39 110.54 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.483 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 2.9 pp -101.99 168.21 9.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.278 -0.874 . . . . 7.08 111.918 -172.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 109' ' ' THR . 27.6 mm -121.26 101.84 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.062 -0.517 . . . . 10.63 110.129 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.611 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 2.7 ppt_? -109.35 108.04 18.45 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.195 -1.402 . . . . 12.12 111.131 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -123.73 136.11 54.25 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.76 -1.564 . . . . 14.98 109.143 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.64 -102.99 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.401 -0.904 . . . . 16.43 112.333 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.22 4.53 10.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.914 0.709 . . . . 15.35 112.914 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 176.14 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.773 0.657 . . . . 15.67 112.773 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.546 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.5 m -123.99 156.74 35.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.015 -0.993 . . . . 9.26 111.712 -169.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 26.4 mm -128.46 149.82 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.081 -0.711 . . . . 10.94 109.081 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.544 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -132.61 140.37 48.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.603 0.24 . . . . 7.39 110.924 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 67.9 mtp -92.52 100.75 13.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.434 -0.58 . . . . 8.85 109.434 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 121' ' ' ASP . 14.7 p -88.86 132.95 32.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 10.13 111.789 -174.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -79.19 83.85 5.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.376 -0.829 . . . . 10.7 109.774 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 46.5 mttm -75.18 146.93 40.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.771 -0.65 . . . . 15.12 110.972 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 172' ' ' THR . . . -76.0 5.2 42.28 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 16.92 111.138 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -85.61 9.77 15.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.626 0.727 . . . . 18.56 110.679 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.48 19.02 50.83 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.149 -0.932 . . . . 16.28 113.816 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.31 173.12 36.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.348 -0.93 . . . . 14.36 112.581 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.656 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 71.2 m-85 -109.84 109.24 19.83 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.194 -0.669 . . . . 12.49 109.194 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.574 ' O ' HG13 ' A' ' 113' ' ' VAL . 7.0 t70 -101.57 145.72 30.95 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 13.91 110.502 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.488 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 20.1 Cg_endo -89.32 132.82 2.24 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.151 1.9 . . . . 13.02 112.406 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.544 HG13 ' HB2' ' A' ' 111' ' ' ALA . 2.8 p -118.84 137.05 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.625 -0.716 . . . . 10.41 109.542 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 111.85 13.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 12.93 110.101 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.59 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -119.1 160.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.929 -1.032 . . . . 8.03 110.826 -175.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 23.5 ttmm -104.46 125.86 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.846 -0.615 . . . . 10.66 109.555 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.65 109.67 5.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.678 -0.237 . . . . 8.3 111.61 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.437 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -153.63 70.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.166 -1.968 . . . . 10.1 113.905 169.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -149.34 162.24 40.47 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.831 -0.803 . . . . 11.03 108.831 155.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 23.6 m -138.89 129.4 25.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.11 0.481 . . . . 13.17 109.871 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.73 102.31 5.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.645 -0.707 . . . . 13.78 110.675 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.63 24.39 76.25 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.041 -0.527 . . . . 15.28 112.492 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 97.51 -10.72 64.99 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.766 -0.73 . . . . 13.44 112.195 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.482 ' O ' ' HA ' ' A' ' 130' ' ' THR . 2.4 mp0 -97.49 162.98 13.05 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.84 -0.8 . . . . 11.28 108.84 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.4 p -114.63 155.36 26.69 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.431 -0.507 . . . . 8.43 111.172 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 25.7 mt-10 -100.02 128.5 46.09 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.5 0.667 . . . . 10.79 110.967 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 24.3 mm -92.02 101.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.133 -0.94 . . . . 6.73 109.772 175.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.477 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.6 mp -67.18 -45.63 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.836 -1.075 . . . . 9.17 109.845 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.541 ' O ' HG21 ' A' ' 125' ' ' VAL . 38.0 mt-10 -146.34 163.29 36.04 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.356 -0.609 . . . . 10.44 109.356 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.83 -46.95 1.05 Allowed Glycine 0 C--N 1.316 -0.572 0 C-N-CA 119.497 -1.335 . . . . 8.87 114.242 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.7 mt -123.22 -178.49 4.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.416 0.895 . . . . 8.5 113.416 -170.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.432 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.9 ttpt -142.39 155.23 45.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.569 -1.196 . . . . 14.48 108.846 -176.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.61 129.6 40.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.985 -0.552 . . . . 12.12 110.063 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.17 48.46 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.251 -0.74 . . . . 12.39 111.251 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.668 ' O ' HG21 ' A' ' 84' ' ' VAL . 15.8 mm100 -97.89 100.8 12.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.446 0.641 . . . . 11.89 109.334 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.437 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 38.1 mt-30 -74.11 127.4 32.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.356 -0.838 . . . . 11.1 110.307 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.69 135.83 56.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.601 0.238 . . . . 5.45 110.67 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.484 ' HA ' HG23 ' A' ' 81' ' ' THR . 42.6 t -66.43 115.05 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.864 -0.607 . . . . 7.05 110.473 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.417 HG13 ' CB ' ' A' ' 101' ' ' ALA . 4.1 m -105.07 -17.75 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 6.99 110.759 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.6 m 57.92 22.68 8.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.356 -0.838 . . . . 9.37 112.038 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.82 146.45 48.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.119 -0.562 . . . . 8.6 112.713 -175.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.4 -88.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.391 . . . . 12.43 110.966 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.26 82.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 12.83 110.818 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 -168.72 2.15 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.514 -0.55 . . . . 13.49 109.514 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 157' ' ' SER . 28.8 pt -59.57 163.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 12.27 111.91 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.9 24.54 0.62 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.008 0.908 . . . . 11.22 111.206 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 155' ' ' ILE . 6.4 p -56.92 -27.11 60.48 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 114.456 -1.247 . . . . 12.0 111.218 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.702 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 1.5 mm-40 -57.9 -35.79 71.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 112.922 -1.945 . . . . 11.17 111.057 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.53 64.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.595 -0.73 . . . . 8.27 110.895 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.2 m -76.23 -25.64 55.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.507 0.67 . . . . 9.64 109.571 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.76 -16.53 44.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.111 -0.949 . . . . 10.88 110.756 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.702 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 13.4 mmm180 -89.45 131.21 35.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.316 0.579 . . . . 9.36 111.469 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.448 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . -148.06 62.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.292 -1.523 . . . . 7.46 109.292 173.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.56 ' O ' HG12 ' A' ' 67' ' ' VAL . 17.8 p 50.0 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.592 -0.521 . . . . 7.09 109.592 -161.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.569 HG12 ' H ' ' A' ' 166' ' ' ALA . 2.7 p -100.18 -65.89 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 9.62 109.997 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.569 ' H ' HG12 ' A' ' 165' ' ' VAL . . . 156.13 -178.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.993 1.317 . . . . 9.11 108.547 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -155.25 58.82 0.65 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.157 0.979 . . . . 15.17 111.935 175.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.438 ' HE1' ' HB2' ' A' ' 166' ' ' ALA . 28.9 mtm -111.15 77.4 1.04 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.578 -1.192 . . . . 12.15 109.522 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 168' ' ' MET . 35.6 tt0 68.1 83.17 0.16 Allowed 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.607 -0.516 . . . . 15.5 109.607 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.59 -84.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.265 -0.88 . . . . 15.01 110.45 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.8 p 37.14 59.51 1.11 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.677 0.61 . . . . 14.52 112.346 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.546 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 8.8 t -102.76 161.58 13.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.894 0.378 . . . . 14.89 110.148 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.9 p -131.8 -2.88 3.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.543 -0.753 . . . . 15.85 111.08 -176.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.18 41.72 3.02 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.86 -0.686 . . . . 17.54 113.457 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp 71.52 -63.55 0.42 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.756 0.788 . . . . 17.85 111.805 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.01 -163.54 1.56 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.471 -1.24 . . . . 19.67 109.848 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.1 m -58.69 142.3 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.907 0.384 . . . . 19.71 110.417 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.06 120.55 30.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.979 0.418 . . . . 21.47 110.369 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -72.51 -57.15 4.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 23.66 110.546 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.942 -0.572 . . . . 23.71 110.703 -178.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.719 0.295 . . . . 34.49 110.849 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.67 -139.22 24.23 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.828 -0.701 . . . . 33.2 112.096 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t 57.16 47.96 16.19 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.381 0.61 . . . . 34.24 110.141 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.62 158.78 18.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 32.38 111.056 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -132.18 100.4 5.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.638 0.732 . . . . 33.02 110.659 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.19 -35.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.624 -0.716 . . . . 31.57 112.086 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -127.7 155.09 44.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.916 0.389 . . . . 29.46 111.029 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 9' ' ' PRO . . . 177.18 148.71 7.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 28.42 112.046 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 8' ' ' GLY . 5.7 Cg_exo -78.33 111.6 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.759 2.306 . . . . 27.92 111.772 176.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -69.4 -78.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.771 0.32 . . . . 26.82 111.014 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 168.01 147.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.116 -1.068 . . . . 25.18 108.116 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.42 -160.15 33.64 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.117 -1.04 . . . . 23.19 112.266 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.6 m80 51.48 53.72 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.747 0.419 . . . . 21.58 111.015 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p-10 -115.62 118.67 38.86 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.064 -0.516 . . . . 19.89 110.142 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 14' ' ' ASP . 30.3 Cg_exo -63.81 -170.38 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.229 2.619 . . . . 18.59 113.026 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 58.26 51.53 8.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.371 0.605 . . . . 17.12 110.341 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.23 82.38 3.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.438 -0.801 . . . . 14.96 110.437 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.34 78.87 0.24 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.778 -0.725 . . . . 13.21 112.095 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.38 -2.26 27.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.393 0.616 . . . . 12.37 110.842 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 59.33 61.16 2.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.681 -1.145 . . . . 13.82 110.732 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.9 mt 51.56 26.45 3.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 113.068 -1.878 . . . . 12.48 113.414 170.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -80.62 -1.51 42.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.339 0.59 . . . . 14.31 109.99 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 p -121.4 63.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.496 -0.774 . . . . 11.34 109.762 172.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -72.15 74.25 0.84 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.129 -0.941 . . . . 10.62 112.506 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.8 mptm? 71.02 64.23 0.17 Allowed 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.23 -1.026 . . . . 10.77 108.23 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.498 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.3 mtm180 -136.73 138.61 41.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.168 -1.378 . . . . 8.86 109.484 -173.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -49.59 124.13 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.962 0.887 . . . . 5.76 112.21 -173.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 mt -112.16 -37.6 4.99 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.648 -1.614 . . . . 8.55 110.942 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.613 ' HD2' ' CD1' ' A' ' 29' ' ' TYR . 4.0 p90 -176.29 -178.64 0.99 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 8.07 109.464 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.699 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.0 156.61 30.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.867 -0.606 . . . . 5.61 111.009 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.899 HH11 ' HH ' ' A' ' 29' ' ' TYR . 30.3 ptt180 -160.03 149.7 18.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.853 -1.067 . . . . 9.75 110.311 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.488 ' CB ' HG21 ' A' ' 35' ' ' VAL . 1.8 t0 -88.19 138.69 30.53 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.046 -0.724 . . . . 8.31 109.046 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.475 ' HG3' HG13 ' A' ' 54' ' ' ILE . 32.8 Cg_exo -57.55 -20.61 42.28 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 123.498 2.799 . . . . 10.41 113.088 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -89.44 -24.4 21.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.354 0.597 . . . . 11.24 109.993 -177.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.488 HG21 ' CB ' ' A' ' 32' ' ' ASP . 3.3 m -117.95 37.16 0.24 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.107 -0.951 . . . . 9.83 113.526 -161.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 57.7 Cg_endo -60.78 108.29 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.881 2.387 . . . . 11.66 112.166 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.31 -18.29 0.91 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.496 -0.859 . . . . 10.86 112.474 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -77.26 -177.74 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.215 0.531 . . . . 9.42 111.646 174.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.633 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 5.2 tpp180 -148.26 91.73 1.95 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 12.03 109.729 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 77.5 m-85 -75.63 137.02 40.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.851 -0.74 . . . . 7.9 110.442 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.84 -29.94 71.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.745 -1.116 . . . . 10.61 110.032 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -165.04 164.28 13.03 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.338 -0.846 . . . . 11.24 110.608 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.699 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.3 Cg_endo -48.63 169.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.872 3.048 . . . . 7.51 114.351 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.14 -174.44 26.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.679 -0.772 . . . . 8.06 112.606 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.9 ttpm? -86.19 146.0 26.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.186 0.517 . . . . 12.05 110.986 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.513 ' HB3' ' O ' ' A' ' 49' ' ' MET . 32.9 t -58.43 136.33 85.53 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.764 -1.107 . . . . 9.2 110.924 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.55 -20.43 15.81 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 122.192 1.928 . . . . 10.25 110.912 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.636 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 46.6 m-85 -86.15 -42.63 13.7 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.672 -1.603 . . . . 10.49 109.597 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.513 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.5 mtm -129.5 152.65 48.81 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 115.779 -0.646 . . . . 10.74 111.339 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.74 60.7 5.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.747 1.261 . . . . 12.54 111.294 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.453 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -139.51 145.55 44.28 Favored Pre-proline 0 C--N 1.304 -1.371 0 CA-C-N 113.891 -1.504 . . . . 10.35 109.208 177.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 39.8 Cg_endo -67.57 133.86 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.934 1.756 . . . . 10.11 111.936 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.4 163.23 11.1 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.576 -0.528 . . . . 7.0 109.576 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.475 HG13 ' HG3' ' A' ' 33' ' ' PRO . 24.1 mm -98.02 132.81 23.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 120.989 0.423 . . . . 8.28 110.565 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.87 147.51 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.91 1.74 . . . . 6.21 112.208 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 35.2 m -73.02 158.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 114.657 -1.156 . . . . 6.41 112.679 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.498 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.89 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.235 2.214 . . . . 8.58 115.865 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.64 ' CD ' ' HB3' ' A' ' 61' ' ' ASN . 2.6 pt-20 -48.47 -44.16 35.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.477 0.711 . . . . 7.04 111.231 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' GLU . 33.5 tt0 58.25 95.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.759 -1.109 . . . . 8.58 111.414 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.567 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 31.2 tt0 75.84 63.46 0.05 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.033 -1.439 . . . . 7.64 112.801 167.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.64 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 7.5 t30 -146.07 -50.2 0.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.995 -1.002 . . . . 7.58 110.406 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.51 -53.2 12.71 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.124 -0.489 . . . . 5.41 109.968 172.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.633 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 34.6 t70 -171.9 60.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 7.01 110.59 174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' ' 60' ' ' GLU . . . -73.01 -38.5 55.63 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 119.497 -1.335 . . . . 7.2 111.389 171.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.06 50.33 1.82 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.709 -0.746 . . . . 7.82 110.388 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.589 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . . . 62.04 33.52 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.554 -0.748 . . . . 9.19 111.504 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -10.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.081 -0.711 . . . . 7.42 109.081 172.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.633 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 4.1 tmm_? -35.54 141.12 0.09 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.293 -1.321 . . . . 10.88 112.989 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 72' ' ' ARG . 22.7 mt -67.12 144.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.514 -0.766 . . . . 9.13 110.126 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -86.95 46.39 1.37 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.872 0.844 . . . . 13.02 110.524 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.418 ' O ' HG21 ' A' ' 73' ' ' VAL . . . 52.38 35.22 43.23 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.466 -1.243 . . . . 12.13 112.947 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.51 ' HG2' HG22 ' A' ' 69' ' ' ILE . 26.2 ptt180 -58.52 122.79 14.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.518 0.675 . . . . 12.89 110.534 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 71' ' ' GLY . 73.9 t -131.21 137.45 55.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.57 -0.741 . . . . 12.25 110.015 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.603 ' O ' ' HG2' ' A' ' 152' ' ' GLN . 9.2 t -141.89 102.38 4.14 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.895 0.855 . . . . 10.97 110.165 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -124.43 64.63 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 14.62 109.023 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.28 113.32 26.84 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.023 -0.989 . . . . 11.22 110.312 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.58 -44.83 70.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.297 -0.411 . . . . 13.96 110.657 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -79.28 -40.49 15.92 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.51 -0.636 . . . . 11.94 111.51 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 47.6 t 72.72 113.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.416 0.627 . . . . 10.24 111.206 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.485 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 23.6 ttm180 -82.15 131.53 35.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.891 -0.781 . . . . 12.25 108.891 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.506 HG23 ' HA ' ' A' ' 148' ' ' VAL . 68.0 p -131.12 159.19 38.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 8.3 110.097 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.473 ' CB ' HG22 ' A' ' 149' ' ' VAL . . . -121.59 128.64 52.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.668 -0.864 . . . . 7.51 108.668 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 33.9 tt0 -84.56 130.46 34.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.465 -0.569 . . . . 12.15 109.465 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' A' ' 143' ' ' ALA . 20.5 m -64.35 141.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 122.888 1.328 . . . . 9.71 111.401 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.407 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -164.13 174.28 11.46 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.335 -2.212 . . . . 11.77 109.514 173.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 10.0 mp -70.48 167.91 17.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.572 0.701 . . . . 13.03 112.125 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.531 ' N ' HD22 ' A' ' 96' ' ' LEU . . . 157.3 46.08 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.33 -0.85 . . . . 13.49 112.604 176.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.811 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -89.54 -178.22 5.51 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.688 -0.405 . . . . 16.96 111.933 -176.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.32 106.98 8.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.878 -0.601 . . . . 18.49 109.471 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.21 -162.72 23.13 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.899 -0.591 . . . . 18.67 111.784 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.1 m -91.34 75.37 6.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.282 1.039 . . . . 17.16 109.76 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.811 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 2.0 m -154.94 168.74 25.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.589 -1.634 . . . . 14.8 106.589 176.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.522 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 7.8 mt-10 -143.3 109.8 5.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.859 0.754 . . . . 14.94 110.575 165.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.632 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 1.5 mmp_? -121.11 168.13 11.89 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.87 -0.605 . . . . 11.02 111.248 -171.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.6 mm? -97.85 114.21 26.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.464 -0.789 . . . . 9.27 109.294 176.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.2 mm? -91.39 130.91 37.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.349 -0.841 . . . . 10.57 111.258 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.609 ' CG2' ' HB2' ' A' ' 101' ' ' ALA . 3.3 p -139.32 146.81 50.31 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.525 -1.216 . . . . 6.4 108.927 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 132.01 49.18 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.145 1.897 . . . . 7.48 109.595 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t -57.74 -25.55 60.57 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 9.53 112.312 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.38 4.48 52.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.945 0.35 . . . . 10.86 111.945 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.609 ' HB2' ' CG2' ' A' ' 97' ' ' VAL . . . -79.84 -33.6 40.07 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.225 -0.59 . . . . 5.39 110.51 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.495 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -91.91 155.1 18.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.584 0.707 . . . . 7.08 111.967 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -99.18 125.43 52.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.08 -0.964 . . . . 10.63 109.029 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.8 mmm180 -98.1 125.69 43.21 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.677 -0.809 . . . . 12.12 110.911 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.9 t -149.15 127.26 12.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.722 -0.672 . . . . 14.98 110.818 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.41 -121.91 16.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.03 -0.532 . . . . 16.43 112.794 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.09 36.79 2.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 15.35 111.418 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -156.98 177.43 11.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.002 -0.544 . . . . 15.67 111.526 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.495 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 25.8 m -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.644 -0.707 . . . . 9.26 109.26 174.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.5 mm -126.92 150.7 33.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 10.94 109.125 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.564 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -136.35 130.02 32.22 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.242 -0.286 . . . . 7.39 110.839 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.407 ' HE1' HG12 ' A' ' 148' ' ' VAL . 38.7 mtm -84.71 100.25 11.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.846 -0.798 . . . . 8.85 108.846 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 11.3 p -81.95 134.46 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.825 -1.079 . . . . 10.13 111.208 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -83.59 91.56 7.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.539 -0.755 . . . . 10.7 110.235 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.48 147.94 35.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 15.12 111.035 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.16 -2.35 47.16 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.658 -0.701 . . . . 16.92 112.021 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.17 6.84 12.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.456 0.646 . . . . 18.56 111.058 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.67 67.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.243 -0.889 . . . . 16.28 113.197 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.6 -174.74 13.51 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.336 -0.935 . . . . 14.36 112.981 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.641 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 97.5 m-85 -132.08 128.26 37.83 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.068 0.547 . . . . 12.49 109.783 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.478 ' O ' HG13 ' A' ' 113' ' ' VAL . 8.2 m-20 -125.37 147.72 58.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.594 -0.275 . . . . 13.91 111.024 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -85.37 124.87 2.86 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.391 2.061 . . . . 13.02 112.484 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.564 HG13 ' HB2' ' A' ' 111' ' ' ALA . 4.4 p -106.19 135.73 43.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.87 -1.059 . . . . 10.41 109.078 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -82.23 122.75 28.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.057 -0.72 . . . . 12.93 109.057 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.746 HG21 ' O ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -137.02 157.16 35.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.402 0.62 . . . . 8.03 112.215 -173.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.518 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 76.1 tttt -93.73 128.68 40.06 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.092 -0.958 . . . . 10.66 110.208 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.19 104.39 4.44 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.782 -0.644 . . . . 8.3 111.075 -177.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.32 71.28 0.28 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 117.924 -2.084 . . . . 10.1 113.882 169.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.566 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -149.83 164.14 36.14 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.892 -0.781 . . . . 11.03 108.892 157.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -133.48 128.32 35.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.709 -0.478 . . . . 13.17 109.709 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.87 122.49 7.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.514 -0.312 . . . . 13.78 111.58 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.31 92.31 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.933 -0.576 . . . . 15.28 113.101 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.99 78.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 13.44 111.687 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -130.6 171.67 12.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.936 -0.765 . . . . 11.28 108.936 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -115.21 156.58 25.08 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.649 -0.501 . . . . 8.43 109.649 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.566 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 50.7 mt-10 -102.36 124.07 47.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.562 0.696 . . . . 10.79 111.375 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.595 HD13 HG22 ' A' ' 125' ' ' VAL . 26.0 mm -86.04 111.83 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.963 -1.017 . . . . 6.73 109.16 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.632 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 3.8 mp -81.15 -45.69 16.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.974 -1.012 . . . . 9.17 111.006 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.746 ' O ' HG21 ' A' ' 125' ' ' VAL . 42.6 mt-10 -146.59 173.02 12.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.139 -0.689 . . . . 10.44 109.139 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 93.2 -63.01 2.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.144 -1.027 . . . . 8.87 113.715 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.534 HD12 HG12 ' A' ' 123' ' ' VAL . 35.9 tp -105.41 145.09 31.28 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.234 -1.024 . . . . 8.5 108.234 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.686 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 85.8 tttt -136.34 143.8 44.29 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 112.734 0.642 . . . . 14.48 112.734 -161.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 84' ' ' VAL . . . -49.62 123.91 8.62 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.845 -1.525 . . . . 12.12 111.375 -173.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.1 1.12 38.72 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 114.853 -1.067 . . . . 12.39 111.286 -171.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.686 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 14.8 mm100 -103.7 125.52 50.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.766 -0.773 . . . . 11.89 110.097 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.522 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 mp0 -85.39 142.83 29.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.728 -0.669 . . . . 11.1 110.577 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 149' ' ' VAL . 16.1 m -135.27 147.27 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.472 0.177 . . . . 5.45 110.597 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.506 ' HA ' HG23 ' A' ' 81' ' ' THR . 22.6 m -57.84 133.72 22.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 O-C-N 123.855 0.722 . . . . 7.05 111.878 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.473 HG22 ' CB ' ' A' ' 82' ' ' ALA . 45.9 t -131.41 -35.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.2 -0.909 . . . . 6.99 110.546 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.485 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 17.2 t -147.12 71.54 1.22 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.654 -0.869 . . . . 9.37 108.654 173.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -142.09 175.76 22.51 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.68 -0.691 . . . . 8.6 111.993 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.603 ' HG2' ' O ' ' A' ' 74' ' ' THR . 22.6 mt-30 -75.27 142.15 43.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.83 0.348 . . . . 12.43 111.02 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.65 ' HD2' ' CD1' ' A' ' 153' ' ' PHE . 96.4 m-85 -99.91 -166.72 1.37 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 12.83 110.001 177.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.2 171.35 20.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.287 0.565 . . . . 13.49 110.23 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 26.9 mt 63.84 61.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 114.393 -1.276 . . . . 12.27 111.183 176.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.26 -9.37 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 11.22 111.279 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.8 p -61.52 -41.13 96.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.308 0.575 . . . . 12.0 110.593 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -73.51 -30.8 63.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 11.17 109.799 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.65 -17.9 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.98 -1.009 . . . . 8.27 110.482 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.3 m -81.44 -31.66 32.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.511 -0.768 . . . . 9.64 110.465 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.3 -31.03 48.7 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.297 -0.865 . . . . 10.88 110.833 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -81.47 166.97 19.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.725 -0.671 . . . . 9.36 109.546 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.95 71.95 2.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.089 -0.576 . . . . 7.46 111.84 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.9 p 53.4 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.273 1.029 . . . . 7.09 112.022 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.43 -45.92 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 110.209 -0.293 . . . . 9.62 110.209 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 51.53 90.43 0.02 OUTLIER 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.589 0.556 . . . . 9.11 111.601 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -84.63 168.74 15.04 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 122.271 1.034 . . . . 15.17 109.794 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 11.8 mmt -107.45 -35.1 6.86 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.257 -1.792 . . . . 12.15 110.111 -169.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 63.72 -80.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.348 1.03 . . . . 15.5 111.974 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -144.35 -75.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.47 0.652 . . . . 15.01 109.878 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 23.8 p -87.22 113.26 22.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.081 -0.963 . . . . 14.52 111.329 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.1 m -63.57 -55.62 22.37 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.719 -0.673 . . . . 14.89 110.157 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.5 m 58.74 -166.5 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.524 -0.762 . . . . 15.85 111.845 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 83.18 5.57 88.9 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.216 -0.754 . . . . 17.54 111.216 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.5 mt -122.77 18.34 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.433 -0.383 . . . . 17.85 110.948 -170.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 71.55 -44.07 0.58 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.972 0.795 . . . . 19.67 111.86 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.37 148.62 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.373 0.606 . . . . 19.71 111.336 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.64 -92.88 0.31 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.677 -0.692 . . . . 21.47 109.297 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -142.54 79.04 1.64 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.494 -0.928 . . . . 23.66 108.494 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 115.279 -0.873 . . . . 23.71 110.863 -171.561 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.876 0.369 . . . . 34.49 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.59 -143.33 36.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.813 -0.708 . . . . 33.2 111.501 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.2 p -167.74 175.32 7.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.62 0.248 . . . . 34.24 110.552 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.55 105.89 14.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.489 -0.323 . . . . 32.38 110.223 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 m -75.19 84.03 2.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.187 0.518 . . . . 33.02 110.184 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.99 119.08 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.561 0.696 . . . . 31.57 111.218 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.38 -30.8 20.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.551 -0.749 . . . . 29.46 109.556 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.29 -172.75 45.73 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.605 -0.998 . . . . 28.42 110.605 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.66 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.398 2.066 . . . . 27.92 111.16 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -174.27 143.42 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.496 -0.557 . . . . 26.82 109.496 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -72.0 150.99 43.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.323 -0.399 . . . . 25.18 110.319 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.05 -134.74 4.69 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.691 -0.766 . . . . 23.19 112.121 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -117.9 128.99 55.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.147 0.498 . . . . 21.58 110.197 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.535 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.6 m-20 -70.13 -47.17 21.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.379 -0.828 . . . . 19.89 111.581 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 20.8 Cg_endo -62.04 133.71 45.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.608 1.538 . . . . 18.59 111.73 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.53 -43.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 17.12 110.515 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.69 72.53 1.49 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.067 -0.515 . . . . 14.96 110.809 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.33 94.87 0.15 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.933 -0.651 . . . . 13.21 111.802 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.55 -72.11 0.67 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.802 -0.234 . . . . 12.37 111.528 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.06 118.0 0.02 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.753 0.787 . . . . 13.82 111.514 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.503 HD11 ' O ' ' A' ' 21' ' ' LEU . 2.8 tm? 73.81 -31.09 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.276 -1.329 . . . . 12.48 111.891 172.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -78.09 65.83 3.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.579 0.704 . . . . 14.31 111.263 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 m 46.47 48.16 13.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.654 -1.157 . . . . 11.34 111.821 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.17 -78.38 1.41 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.222 -0.99 . . . . 10.62 111.643 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -130.5 59.55 1.65 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.942 -1.132 . . . . 10.77 107.942 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.525 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 3.1 mtp180 -134.8 140.81 46.16 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.161 -1.381 . . . . 8.86 109.239 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG12 ' HG2' ' A' ' 58' ' ' GLU . 46.2 mm -51.96 118.24 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.068 -0.969 . . . . 5.76 113.286 -169.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.19 -32.97 7.0 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.8 -1.546 . . . . 8.55 110.009 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.63 ' HE1' ' CE2' ' A' ' 29' ' ' TYR . 37.6 p90 -179.51 -176.09 0.37 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.734 -0.667 . . . . 8.07 109.625 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.602 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -118.77 154.98 31.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.714 . . . . 5.61 110.908 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.444 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 39.2 ptt180 -164.06 148.01 9.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.834 0.708 . . . . 9.75 109.721 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 1.005 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 9.4 m-20 -70.73 142.05 88.04 Favored Pre-proline 0 CA--C 1.51 -0.585 0 N-CA-C 108.986 -0.746 . . . . 8.31 108.986 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.536 ' HD3' ' CG1' ' A' ' 54' ' ' ILE . 74.6 Cg_endo -68.87 -11.82 32.86 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 123.142 2.562 . . . . 10.41 112.353 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 1.005 ' SD ' ' HB3' ' A' ' 32' ' ' ASP . 1.2 pmm? -102.75 1.34 34.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.289 . . . . 11.24 111.265 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.613 HG21 ' HB2' ' A' ' 32' ' ' ASP . 3.8 m -124.63 39.41 0.45 Allowed Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 112.627 0.603 . . . . 9.83 112.627 177.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.2 Cg_endo -54.41 126.37 22.02 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.305 2.003 . . . . 11.66 112.334 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.86 -12.51 17.65 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.174 -0.771 . . . . 10.86 111.174 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.518 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 15.7 tp60 -90.61 108.22 19.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.323 0.583 . . . . 9.42 110.394 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.578 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.7 tmm_? -91.48 97.35 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 12.03 109.414 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.518 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 78.5 m-85 -77.25 146.59 36.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 7.9 110.715 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.1 -26.68 68.94 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.255 -1.339 . . . . 10.61 111.264 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 12.7 ptmm? -173.12 168.37 2.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.005 -0.543 . . . . 11.24 110.156 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.2 Cg_endo -52.35 169.29 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.502 2.134 . . . . 7.51 112.52 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.72 -160.01 27.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 8.06 111.644 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.541 ' HB3' ' HZ2' ' A' ' 45' ' ' LYS . 7.1 ttpm? -99.98 151.23 21.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.444 0.64 . . . . 12.05 110.627 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 49' ' ' MET . 36.3 t -67.89 145.32 97.84 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.718 -1.128 . . . . 9.2 111.86 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.08 -19.9 4.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.783 2.322 . . . . 10.25 111.504 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 48' ' ' TYR . 59.3 m-85 -81.45 -38.01 27.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.79 -1.096 . . . . 10.49 109.321 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.541 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.7 pmm? -153.46 171.41 18.72 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.395 -0.82 . . . . 10.74 110.338 172.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.16 76.65 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.512 0.93 . . . . 12.54 113.512 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 9.6 ptm -143.9 147.12 37.08 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.857 -1.164 . . . . 10.35 107.857 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.485 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 36.6 Cg_endo -67.23 135.99 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.336 1.357 . . . . 10.11 110.12 171.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.89 166.98 6.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.265 0.555 . . . . 7.0 112.096 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.536 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 39.1 mm -101.95 130.51 24.25 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.696 -0.684 . . . . 8.28 109.65 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 17.6 Cg_endo -83.02 134.13 6.91 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.359 1.373 . . . . 6.21 112.21 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.402 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 35.3 m -56.03 157.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.254 -1.339 . . . . 6.41 113.099 -176.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.48 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.935 2.094 . . . . 8.58 115.122 -177.409 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.666 ' OE1' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -45.68 -41.94 11.03 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.022 0.529 . . . . 7.04 110.747 -178.067 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 32.7 tt0 69.6 86.05 0.13 Allowed 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.669 0.606 . . . . 8.58 111.8 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 63.99 69.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 7.64 111.751 164.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.666 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 13.3 t-20 -158.83 -28.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.417 -0.81 . . . . 7.58 112.393 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.513 ' HB3' ' OE2' ' A' ' 58' ' ' GLU . . . -39.45 -51.09 2.14 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.683 0.793 . . . . 5.41 110.918 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.58 -11.0 0.4 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.504 -1.226 . . . . 7.01 110.304 173.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.5 -55.79 0.67 Allowed Glycine 0 C--N 1.3 -1.462 0 N-CA-C 109.136 -1.586 . . . . 7.2 109.136 -157.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.49 -65.97 0.24 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.143 -1.028 . . . . 7.82 109.646 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 176.69 29.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.62 -1.173 . . . . 9.19 109.248 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.653 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 9.7 t -67.53 -74.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.327 -0.852 . . . . 7.42 109.088 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.653 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 20.2 ptt180 162.66 148.83 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.058 1.343 . . . . 10.88 108.334 170.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 41.6 mm -67.81 -55.45 16.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 118.586 -1.246 . . . . 9.13 110.448 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.575 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 15.9 t70 75.33 -45.62 0.56 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 125.583 1.802 . . . . 13.02 110.082 -170.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.565 ' N ' HG23 ' A' ' 69' ' ' ILE . . . -43.54 -40.18 4.84 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.157 -1.838 . . . . 12.13 114.059 174.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 74' ' ' THR . 2.0 ptm180 -139.26 -166.28 2.01 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.924 -0.398 . . . . 12.89 109.924 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.509 HG23 ' H ' ' A' ' 76' ' ' ASN . 7.7 p -34.77 -33.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.087 1.355 . . . . 12.25 113.87 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.478 ' HB ' ' HB ' ' A' ' 69' ' ' ILE . 9.8 t 42.62 54.22 4.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.938 0.895 . . . . 10.97 112.475 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 53.25 64.58 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.929 -1.032 . . . . 14.62 111.712 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' H ' HG23 ' A' ' 73' ' ' VAL . 5.9 m-20 -125.25 95.41 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.947 -1.024 . . . . 11.22 109.511 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.05 -17.09 64.29 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.474 -1.239 . . . . 13.96 111.658 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -37.27 1.14 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.218 -0.753 . . . . 11.94 111.218 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.0 t 65.85 94.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.735 0.779 . . . . 10.24 111.065 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.484 ' HB3' ' OG ' ' A' ' 150' ' ' SER . 36.5 ttt180 -93.7 139.28 31.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.12 -0.946 . . . . 12.25 110.344 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 148' ' ' VAL . 25.9 p -125.37 137.5 54.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.552 -0.749 . . . . 8.3 109.949 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.463 ' CB ' HG12 ' A' ' 149' ' ' VAL . . . -110.47 128.0 55.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.247 -0.649 . . . . 7.51 109.247 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 34.3 tt0 -74.27 132.78 42.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.072 -0.714 . . . . 12.15 109.072 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 95' ' ' LEU . 49.6 t -55.04 132.63 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.013 -0.539 . . . . 9.71 112.301 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 25.3 mmtp -138.37 148.35 44.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.966 -1.016 . . . . 11.77 109.284 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.83 149.98 36.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.854 -0.795 . . . . 13.03 108.854 167.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.45 ' N ' HD22 ' A' ' 96' ' ' LEU . . . -167.33 41.42 0.24 Allowed Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 120.166 -1.016 . . . . 13.49 112.527 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -77.85 145.84 36.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 16.96 111.387 -175.637 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.2 tp -155.96 87.41 1.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.833 -0.621 . . . . 18.49 109.426 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.66 -10.13 75.37 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.672 -1.371 . . . . 18.67 109.672 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 41.0 p -110.99 156.85 20.65 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.793 -1.188 . . . . 17.16 107.793 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.432 ' HB ' ' NH1' ' A' ' 94' ' ' ARG . 13.3 m -71.82 158.2 36.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.487 -0.56 . . . . 14.8 109.487 175.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.503 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 12.3 mt-10 -55.09 113.0 1.19 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.775 0.798 . . . . 14.94 111.635 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' HG2' ' HB3' ' A' ' 136' ' ' GLU . 2.1 mpp_? -132.29 169.61 16.23 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.316 -1.311 . . . . 11.02 109.5 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.583 ' HB3' HG11 ' A' ' 84' ' ' VAL . 2.4 mm? -94.19 112.69 24.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.555 -0.906 . . . . 9.27 108.555 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -88.44 131.78 34.73 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.532 -0.758 . . . . 10.57 110.667 -175.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.6 p -147.84 147.0 25.66 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.059 -0.973 . . . . 6.4 109.089 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -54.05 130.01 37.27 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.407 2.071 . . . . 7.48 110.742 173.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 40.3 t -56.28 -28.07 57.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.017 0.747 . . . . 9.53 113.017 -170.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.4 9.22 13.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.544 -0.462 . . . . 10.86 111.504 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.503 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -82.81 -33.7 27.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.156 0.503 . . . . 5.39 111.469 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.6 pp -100.63 165.08 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.324 0.583 . . . . 7.08 112.334 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 109' ' ' THR . 25.3 mm -104.29 118.62 51.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.45 -0.796 . . . . 10.63 110.294 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -103.91 94.83 5.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.811 0.339 . . . . 12.12 110.392 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.5 t -145.59 131.16 18.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.5 0.666 . . . . 14.98 111.602 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.88 -123.38 6.16 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.106 -0.952 . . . . 16.43 111.999 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.92 28.18 8.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.102 0.477 . . . . 15.35 111.16 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.42 178.36 9.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 15.67 111.165 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.1 m -128.58 149.99 50.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.937 -0.574 . . . . 9.26 110.35 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.507 HD13 ' N ' ' A' ' 110' ' ' ILE . 3.7 mp -126.23 153.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 110.214 -0.291 . . . . 10.94 110.214 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.621 ' HB2' ' CG1' ' A' ' 123' ' ' VAL . . . -130.78 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.459 -0.2 . . . . 7.39 110.459 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 64.1 mtm -99.4 102.88 14.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.539 -0.541 . . . . 8.85 109.539 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.458 HG13 ' O ' ' A' ' 121' ' ' ASP . 8.3 p -85.77 137.24 21.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.111 0.482 . . . . 10.13 111.451 -172.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 91.98 3.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.651 -0.704 . . . . 10.7 111.513 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -80.06 162.92 24.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.975 -0.557 . . . . 15.12 110.376 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.24 17.87 26.12 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.848 -0.614 . . . . 16.92 112.083 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.52 11.41 39.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 18.56 110.805 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.28 -6.59 67.34 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.56 -0.746 . . . . 16.28 112.467 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.3 167.25 12.92 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.851 -0.499 . . . . 14.36 111.851 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.646 ' HE1' ' CE2' ' A' ' 120' ' ' PHE . 56.5 m-85 -117.54 111.27 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.467 0.651 . . . . 12.49 109.976 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.458 ' O ' HG13 ' A' ' 113' ' ' VAL . 30.4 t70 -91.49 134.11 30.04 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.093 -0.958 . . . . 13.91 111.328 -171.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 61.2 Cg_endo -80.58 137.1 11.32 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.201 1.934 . . . . 13.02 113.268 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.621 ' CG1' ' HB2' ' A' ' 111' ' ' ALA . 12.2 p -123.64 127.13 73.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.987 -1.006 . . . . 10.41 109.821 177.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -82.62 114.63 21.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.652 -0.499 . . . . 12.93 109.652 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.431 HG13 ' HA3' ' A' ' 140' ' ' GLY . 35.6 m -130.06 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.671 -0.695 . . . . 8.03 111.208 -173.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' HZ3' ' HB2' ' A' ' 126' ' ' LYS . 3.5 ttmp? -109.52 127.33 54.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.146 -0.479 . . . . 10.66 110.471 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.418 ' HB1' HD11 ' A' ' 137' ' ' ILE . . . -143.18 112.4 6.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 8.3 111.457 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.5 72.12 0.27 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 118.178 -1.963 . . . . 10.1 113.659 166.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 136' ' ' GLU . . . -148.03 158.43 44.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.806 -0.812 . . . . 11.03 108.806 156.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 22.6 m -147.13 122.22 10.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.344 0.592 . . . . 13.17 109.891 169.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.02 107.45 8.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.14 -0.937 . . . . 13.78 110.7 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.97 38.16 92.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.188 -0.53 . . . . 15.28 112.4 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.01 87.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 13.44 112.584 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 130' ' ' THR . 30.2 mm-40 -106.04 154.53 20.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.286 -0.635 . . . . 11.28 109.286 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -115.25 165.97 12.36 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.455 -0.498 . . . . 8.43 111.229 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 129' ' ' ALA . 49.0 mt-10 -114.35 121.11 42.63 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.442 0.639 . . . . 10.79 111.521 175.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.58 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.4 mm -85.69 102.72 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.267 -0.879 . . . . 6.73 108.663 169.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 126' ' ' LYS . 0.0 OUTLIER -64.35 -51.95 60.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.835 -1.075 . . . . 9.17 109.766 -176.234 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -141.36 160.99 38.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.377 -0.829 . . . . 10.44 110.567 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 125' ' ' VAL . . . 122.26 -64.01 0.52 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.539 -0.839 . . . . 8.87 112.975 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.417 ' HG ' HG12 ' A' ' 125' ' ' VAL . 30.6 mt -102.83 -177.31 3.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.931 0.715 . . . . 8.5 112.931 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -143.98 159.65 42.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.865 -1.061 . . . . 14.48 110.102 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.09 129.22 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.245 -0.889 . . . . 12.12 110.463 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.46 -7.0 26.46 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.729 -0.948 . . . . 12.39 110.729 -171.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.528 ' O ' HG21 ' A' ' 84' ' ' VAL . 14.4 mm100 -97.83 117.41 32.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.514 . . . . 11.89 110.303 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -86.96 127.18 35.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.551 -0.749 . . . . 11.1 111.406 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.62 140.98 46.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.898 -0.592 . . . . 5.45 110.179 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 60.9 t -66.26 125.19 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 7.05 110.548 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.463 HG12 ' CB ' ' A' ' 82' ' ' ALA . 3.9 m -116.1 -19.3 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.221 0.452 . . . . 6.99 112.221 -174.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 80' ' ' ARG . 11.6 p -162.26 100.61 1.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.511 0.672 . . . . 9.37 111.584 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.14 -12.88 47.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.797 -0.921 . . . . 8.6 110.797 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 59.74 52.54 5.44 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.577 0.704 . . . . 12.43 111.088 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.1 18.39 5.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.722 -0.672 . . . . 12.83 110.833 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.92 -67.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.732 0.813 . . . . 13.49 109.936 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.7 mt -98.08 75.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.229 -0.656 . . . . 12.27 109.229 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -72.87 -17.12 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.972 -0.558 . . . . 11.22 111.134 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 m -66.67 -48.57 68.92 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.945 -0.702 . . . . 12.0 109.972 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.21 -22.03 59.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.653 -0.419 . . . . 11.17 110.589 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 162' ' ' ARG . . . -54.73 -42.18 71.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 8.27 110.067 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.496 ' OG ' HD13 ' A' ' 103' ' ' ILE . 29.4 t -64.16 -30.01 71.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.238 -0.892 . . . . 9.64 111.506 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.3 mt -85.45 -33.46 21.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 10.88 111.345 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 5.8 ptm180 -77.5 161.96 27.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.907 -0.588 . . . . 9.36 110.696 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.53 57.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.344 -0.702 . . . . 7.46 111.344 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.6 p 48.33 57.15 6.5 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.082 0.553 . . . . 7.09 111.677 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t 64.62 94.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.743 -0.662 . . . . 9.62 109.837 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.85 -173.94 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.637 . . . . 9.11 111.816 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.743 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 0.4 OUTLIER 63.68 107.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.495 -0.775 . . . . 15.17 109.603 -169.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.622 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 8.2 mtm -149.58 -123.02 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.381 -0.372 . . . . 12.15 111.055 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . 0.54 ' OE1' ' HB3' ' A' ' 168' ' ' MET . 0.8 OUTLIER -71.64 -61.6 1.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.566 -0.288 . . . . 15.5 110.233 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 56.28 47.05 19.99 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.602 -0.726 . . . . 15.01 110.278 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.4 p -96.37 125.22 40.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.642 -0.708 . . . . 14.52 111.023 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.8 t -153.06 151.7 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.072 -0.513 . . . . 14.89 110.349 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.8 m -134.8 28.51 3.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.893 -0.594 . . . . 15.85 110.353 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.78 -53.26 30.4 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.103 -0.57 . . . . 17.54 112.637 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.1 tt 67.13 100.74 0.05 OUTLIER 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.103 0.531 . . . . 17.85 109.959 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.07 -165.21 0.22 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.297 -0.865 . . . . 19.67 110.278 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.82 78.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.722 0.773 . . . . 19.71 109.538 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.69 145.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.78 -1.1 . . . . 21.47 110.605 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 179' ' ' PHE . 45.4 t80 -74.55 118.14 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.993 -0.442 . . . . 23.66 109.873 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.522 -0.752 . . . . 23.71 110.67 -178.072 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' HG3' ' N ' ' A' ' 2' ' ' GLY . 13.9 tpt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 119.092 -0.48 . . . . 34.49 109.81 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.424 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -52.56 146.38 16.63 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.607 -0.806 . . . . 33.2 112.855 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t 61.99 15.71 7.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.844 0.458 . . . . 34.24 111.859 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.38 21.26 2.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.753 0.311 . . . . 32.38 111.51 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.4 m -72.32 119.89 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 33.02 110.261 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.49 141.91 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.919 -0.582 . . . . 31.57 110.965 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -96.07 -48.33 5.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 29.46 110.264 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' HD2' ' A' ' 10' ' ' HIS . . . -136.76 156.79 23.37 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.886 -0.673 . . . . 28.42 111.58 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.53 -56.39 1.54 Allowed 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.066 2.511 . . . . 27.92 113.163 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.455 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 60.3 m-70 67.1 137.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.218 0.532 . . . . 26.82 110.881 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.57 -23.41 60.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.323 -0.399 . . . . 25.18 111.103 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.25 130.87 1.7 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.733 -0.746 . . . . 23.19 112.34 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -141.95 73.91 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.468 -0.567 . . . . 21.58 109.468 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -137.52 98.79 9.8 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.858 -0.61 . . . . 19.89 110.269 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.41 72.49 4.88 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.44 2.093 . . . . 18.59 111.866 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.4 -42.11 17.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.121 0.486 . . . . 17.12 110.305 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.7 -173.82 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 14.96 111.556 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.68 120.9 1.06 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.864 -0.894 . . . . 13.21 110.864 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 23' ' ' THR . . . -71.62 78.19 0.82 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.296 1.046 . . . . 12.37 111.563 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 34.3 tt0 -161.66 71.69 0.38 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.161 -1.836 . . . . 13.82 109.704 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 4.2 mm? 76.46 -43.17 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.472 -0.785 . . . . 12.48 110.984 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.71 -24.58 67.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.974 -1.012 . . . . 14.31 109.145 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 19' ' ' ALA . 76.8 m -165.17 150.72 9.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.081 -0.963 . . . . 11.34 108.737 -176.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.25 -104.08 0.6 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.333 -0.937 . . . . 10.62 112.077 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.535 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -114.78 61.3 0.68 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.352 1.073 . . . . 10.77 108.201 176.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.64 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 5.7 ppt_? -129.71 141.19 50.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.564 -1.653 . . . . 8.86 109.085 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.4 mm -68.02 128.55 31.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 113.566 0.951 . . . . 5.76 113.566 -169.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 26' ' ' ARG . 4.4 mp -117.94 -47.64 2.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.991 -1.459 . . . . 8.55 110.39 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' A' ' 29' ' ' TYR . 14.4 p90 -155.65 -179.59 8.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 8.07 111.023 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.73 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.23 149.62 41.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.172 -0.922 . . . . 5.61 110.499 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HB2' HE22 ' A' ' 38' ' ' GLN . 38.9 ptt180 -148.27 146.3 28.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 9.75 110.08 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.531 ' HB3' HG21 ' A' ' 35' ' ' VAL . 2.3 t0 -78.57 131.45 68.08 Favored Pre-proline 0 C--N 1.314 -0.944 0 N-CA-C 109.798 -0.445 . . . . 8.31 109.798 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.43 ' HG3' HG13 ' A' ' 54' ' ' ILE . 63.5 Cg_exo -45.11 -48.86 10.65 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.79 2.327 . . . . 10.41 111.944 -176.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.627 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.3 pmm? -91.57 9.99 29.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.212 -1.358 . . . . 11.24 112.985 -167.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.615 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 6.6 m -126.32 44.92 1.32 Allowed Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 121.429 0.633 . . . . 9.83 111.562 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.627 ' HD3' ' C ' ' A' ' 34' ' ' MET . 26.0 Cg_exo -61.66 119.9 7.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.194 2.596 . . . . 11.66 113.177 -169.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.5 4.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.467 -0.653 . . . . 10.86 111.467 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.558 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.09 142.56 30.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 9.42 109.925 176.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -129.38 93.97 3.68 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.935 0.398 . . . . 12.03 110.606 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.574 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 23.8 m-85 -73.01 143.38 47.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.507 -0.769 . . . . 7.9 110.974 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.14 -27.82 68.99 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.348 -1.297 . . . . 10.61 110.455 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.469 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.0 ptpt -166.23 162.84 12.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.931 -0.577 . . . . 11.24 111.218 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.611 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.3 Cg_endo -51.3 169.56 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.64 2.893 . . . . 7.51 113.78 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -171.1 30.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.503 -0.856 . . . . 8.06 113.028 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 6.1 ttmm -88.63 143.26 27.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.447 -0.575 . . . . 12.05 109.447 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 49' ' ' MET . 37.8 t -62.28 136.2 95.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 9.2 110.425 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 -21.06 19.51 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 122.186 1.924 . . . . 10.25 110.904 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 1.62 ' HD1' ' CD2' ' A' ' 48' ' ' TYR . 34.9 m-85 -84.94 -41.23 16.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.878 -1.51 . . . . 10.49 109.485 -175.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.492 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.1 mtm -133.72 153.51 51.64 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.36 -0.836 . . . . 10.74 111.27 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.7 p-10 -80.63 59.28 3.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.084 0.945 . . . . 12.54 111.168 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.445 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -136.33 143.25 42.76 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.899 -1.046 . . . . 10.35 109.356 176.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 24.9 Cg_endo -63.93 133.41 38.6 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.0 1.8 . . . . 10.11 111.158 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.8 mt -61.97 163.76 7.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 7.0 110.62 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 33' ' ' PRO . 44.2 mm -105.27 129.39 24.84 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 8.28 109.956 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.73 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 60.3 Cg_endo -73.83 140.14 28.56 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.818 1.678 . . . . 6.21 112.189 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.43 156.51 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.395 -1.275 . . . . 6.41 112.791 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.64 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.73 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.945 2.098 . . . . 8.58 115.553 -176.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.567 ' HG2' HG12 ' A' ' 27' ' ' ILE . 3.2 pt-20 -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.378 1.561 . . . . 7.04 110.54 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 68.26 63.71 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 111.022 -2.808 . . . . 8.58 111.705 168.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 54.78 79.04 0.15 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.932 -1.486 . . . . 7.64 110.354 -171.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -117.27 -43.52 2.83 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.36 -0.607 . . . . 7.58 109.36 174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . 63.36 -62.24 0.14 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.51 -1.677 . . . . 5.41 110.801 -171.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 5.6 t70 179.79 115.9 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 124.087 0.867 . . . . 7.01 109.632 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.68 7.12 79.38 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-N 115.429 -0.805 . . . . 7.2 112.702 163.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 67.49 9.78 7.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 124.653 0.854 . . . . 7.82 112.212 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.8 -35.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.31 0.576 . . . . 9.19 109.956 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 164' ' ' THR . 40.5 t -54.75 -50.3 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.683 -1.144 . . . . 7.42 110.961 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 12.1 ptm180 59.01 177.56 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.182 1.793 . . . . 10.88 112.309 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.515 HG21 ' H ' ' A' ' 71' ' ' GLY . 10.7 mt -40.27 146.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.301 -1.318 . . . . 9.13 112.984 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.76 -39.85 42.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.521 -1.218 . . . . 13.02 109.098 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' H ' HG21 ' A' ' 69' ' ' ILE . . . -50.96 -40.07 42.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.698 -2.046 . . . . 12.13 112.637 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 ptp180 -142.07 107.01 4.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.999 0.905 . . . . 12.89 110.358 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 74' ' ' THR . 19.1 t -108.35 157.5 8.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.772 -1.104 . . . . 12.25 111.7 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.487 ' N ' HG13 ' A' ' 73' ' ' VAL . 7.8 t 37.38 74.23 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.576 1.151 . . . . 10.97 113.103 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -93.16 39.25 1.04 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.88 1.324 . . . . 14.62 108.052 173.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 78' ' ' GLY . 19.4 t-20 -156.89 107.04 2.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.976 -1.92 . . . . 11.22 109.02 -174.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.56 18.25 0.17 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.288 -1.324 . . . . 13.96 110.962 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 76' ' ' ASN . . . 90.29 -51.27 3.38 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.973 -1.251 . . . . 11.94 109.973 -173.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.56 HG12 ' CE1' ' A' ' 120' ' ' PHE . 49.1 t 53.16 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.418 0.628 . . . . 10.24 112.268 167.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 150' ' ' SER . 6.4 mpt_? -84.59 121.4 27.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.82 -0.627 . . . . 12.25 109.746 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.401 HG21 HG13 ' A' ' 79' ' ' VAL . 40.6 p -132.39 154.15 50.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 8.3 111.046 -172.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.4 127.28 49.51 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.468 -0.938 . . . . 7.51 108.468 171.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 42.1 tt0 -76.59 133.26 39.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.624 -0.51 . . . . 12.15 109.624 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.541 HG21 ' O ' ' A' ' 145' ' ' GLN . 48.0 t -53.32 130.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 9.71 112.755 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 50.0 mmtt -134.89 142.8 46.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.856 -1.065 . . . . 11.77 109.925 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.459 HD21 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -75.53 158.32 32.7 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.504 -0.554 . . . . 13.03 109.504 171.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.71 41.38 0.05 OUTLIER Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.426 -0.893 . . . . 13.49 112.653 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.647 ' HG3' ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -77.42 -178.03 4.99 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.329 0.492 . . . . 16.96 112.329 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.84 109.06 8.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 18.49 109.803 171.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.94 -169.52 20.34 Favored Glycine 0 C--N 1.321 -0.297 0 CA-C-N 115.33 -0.85 . . . . 18.67 111.013 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.8 p -90.16 74.24 7.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.365 1.079 . . . . 17.16 109.358 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.647 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m -156.5 169.11 25.39 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.07 -1.826 . . . . 14.8 106.07 177.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.459 ' HG2' HD21 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -138.65 119.04 13.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 119.035 0.834 . . . . 14.94 111.494 170.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.5 ' CD ' ' HA ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -123.01 158.57 30.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.775 -1.102 . . . . 11.02 109.959 -176.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.589 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -98.37 122.08 41.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.152 0.501 . . . . 9.27 109.894 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.25 134.33 38.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.073 -0.512 . . . . 10.57 110.606 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.07 147.99 23.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 6.4 109.052 -175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.22 130.65 41.29 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.271 1.98 . . . . 7.48 110.212 173.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.489 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 19.0 t -57.41 -27.08 62.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.465 0.543 . . . . 9.53 112.465 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.36 3.97 33.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 10.86 111.547 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -77.93 -41.24 36.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.196 0.522 . . . . 5.39 110.91 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.512 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -86.17 158.88 19.66 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.728 -0.669 . . . . 7.08 111.898 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -101.61 126.35 55.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.327 -0.851 . . . . 10.63 108.826 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 11.6 mmm180 -101.13 128.41 47.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.519 -0.872 . . . . 12.12 111.027 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -149.32 129.17 13.35 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.285 -0.87 . . . . 14.98 110.516 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.76 -109.3 1.05 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 116.008 -0.542 . . . . 16.43 112.957 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.62 17.24 13.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 15.35 111.35 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.14 177.34 7.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.181 0.515 . . . . 15.67 111.745 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.512 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.7 m -129.2 144.71 51.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 9.26 109.377 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.8 mm -126.56 153.04 34.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 10.94 109.375 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -134.68 132.47 38.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.394 -0.191 . . . . 7.39 111.088 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.461 ' HE3' HG22 ' A' ' 148' ' ' VAL . 49.7 ttp -94.55 105.57 17.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.176 -0.675 . . . . 8.85 109.176 176.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 121' ' ' ASP . 7.1 p -88.26 134.01 29.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.89 -1.05 . . . . 10.13 112.423 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -83.3 92.47 7.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.187 -0.915 . . . . 10.7 110.108 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -86.5 149.96 24.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.057 -0.52 . . . . 15.12 111.332 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.05 0.15 74.12 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.156 -0.778 . . . . 16.92 111.156 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.27 -1.57 30.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.344 0.593 . . . . 18.56 110.887 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.89 -8.55 63.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.153 -0.93 . . . . 16.28 113.021 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.03 159.4 22.26 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.289 -0.958 . . . . 14.36 112.303 -174.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 120' ' ' PHE . 88.8 m-85 -109.53 121.23 44.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.377 -0.601 . . . . 12.49 109.377 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.581 ' O ' HG13 ' A' ' 113' ' ' VAL . 3.6 m-20 -122.29 151.58 59.36 Favored Pre-proline 0 CA--C 1.514 -0.421 0 C-N-CA 120.555 -0.458 . . . . 13.91 111.471 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 84.1 Cg_endo -88.77 136.27 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.417 2.078 . . . . 13.02 112.433 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.63 138.31 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.331 -0.85 . . . . 10.41 109.179 176.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.6 130.9 36.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.854 -0.424 . . . . 12.93 109.854 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.588 HG22 HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -140.98 158.36 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.818 -0.628 . . . . 8.03 111.157 -175.232 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.5 ttmm -100.2 128.61 46.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.632 -0.713 . . . . 10.66 109.89 174.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' CB ' HD23 ' A' ' 102' ' ' LEU . . . -140.84 105.62 4.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.478 -0.328 . . . . 8.3 111.638 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.443 ' H ' HD11 ' A' ' 138' ' ' LEU . . . -153.0 72.38 0.27 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 118.441 -1.838 . . . . 10.1 113.938 169.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 136' ' ' GLU . . . -148.92 162.69 39.35 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.402 -0.962 . . . . 11.03 108.402 154.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.4 m -139.72 132.59 29.24 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.672 -0.411 . . . . 13.17 110.001 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.22 99.89 3.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.066 -0.516 . . . . 13.78 111.443 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.8 40.03 89.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.09 -0.576 . . . . 15.28 112.43 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.22 1.83 90.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.031 -0.604 . . . . 13.44 112.195 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.13 164.0 12.67 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.037 -1.097 . . . . 11.28 108.037 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 21.0 p -117.05 162.1 18.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.152 -0.619 . . . . 8.43 111.108 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 129' ' ' ALA . 36.6 mt-10 -112.99 123.94 51.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.616 0.722 . . . . 10.79 111.277 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 24.4 mm -88.11 107.43 17.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.878 -1.056 . . . . 6.73 109.323 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.5 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.9 mp -72.68 -49.9 28.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 9.17 109.85 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.494 ' O ' HG21 ' A' ' 125' ' ' VAL . 46.6 mt-10 -142.11 166.76 23.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.008 -0.738 . . . . 10.44 109.008 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 114.29 -51.97 0.68 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.395 -1.383 . . . . 8.87 113.885 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.64 -174.92 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 8.5 112.744 -172.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.25 157.09 42.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 14.48 109.523 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.64 126.71 30.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 12.12 109.95 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.85 -7.09 29.48 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.996 -0.842 . . . . 12.39 110.996 -170.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.541 ' O ' HG21 ' A' ' 84' ' ' VAL . 29.0 mm-40 -95.5 112.92 24.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.209 -0.664 . . . . 11.89 109.209 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.415 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 28.5 mt-30 -85.95 123.65 31.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.028 -0.533 . . . . 11.1 110.502 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.55 139.8 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.864 -0.607 . . . . 5.45 110.323 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 18.6 m -66.24 120.61 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.805 -0.634 . . . . 7.05 111.478 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.411 HG13 ' HB1' ' A' ' 101' ' ' ALA . 2.8 m -108.5 -1.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 6.99 109.889 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 36.2 t -174.13 115.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.547 -1.206 . . . . 9.37 108.833 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.51 66.12 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.665 -0.779 . . . . 8.6 111.405 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -161.44 137.7 8.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.487 0.315 . . . . 12.43 110.19 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 153' ' ' PHE . 56.4 t80 -88.24 -31.36 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.967 -0.753 . . . . 12.83 108.967 173.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 154' ' ' LEU . 1.1 mm? -97.42 -161.29 0.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.858 -1.064 . . . . 13.49 108.768 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 157' ' ' SER . 10.4 mm -95.86 -128.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.701 -0.851 . . . . 12.27 108.701 174.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.409 ' H ' HG23 ' A' ' 155' ' ' ILE . 6.6 m-20 -82.99 30.01 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.289 0.566 . . . . 11.22 110.005 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.41 ' H ' ' C ' ' A' ' 155' ' ' ILE . 5.2 m -72.5 -18.97 61.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.676 -0.693 . . . . 12.0 111.813 -172.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -44.1 77.79 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.397 -0.921 . . . . 11.17 109.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.47 66.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.307 -0.86 . . . . 8.27 110.832 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.3 m -70.01 -61.98 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.829 0.823 . . . . 9.64 109.65 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.2 -31.66 70.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 113.74 -1.573 . . . . 10.88 112.256 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -82.52 -39.23 22.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 124.753 1.283 . . . . 9.36 110.032 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 52.26 60.35 7.82 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.105 -0.952 . . . . 7.46 113.015 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 67' ' ' VAL . 32.8 p 50.63 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.986 0.914 . . . . 7.09 112.435 -172.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.1 p -72.41 95.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.831 . . . . 9.62 112.08 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -153.16 102.46 2.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 9.11 110.269 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.755 ' O ' ' HG3' ' A' ' 168' ' ' MET . 4.0 tmt_? -94.61 93.72 7.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.879 -0.415 . . . . 15.17 109.879 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.755 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 9.8 mtm -169.78 142.51 2.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.212 -0.904 . . . . 12.15 109.874 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -93.46 -160.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.283 0.563 . . . . 15.5 109.865 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 61.18 31.4 19.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.6 -1.182 . . . . 15.01 112.491 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 23.3 p -76.38 63.37 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.327 0.584 . . . . 14.52 110.882 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.8 m -74.35 -60.57 2.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.786 -0.643 . . . . 14.89 110.878 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t 53.29 53.22 12.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 15.85 110.336 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -103.46 21.55 38.83 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.833 -0.698 . . . . 17.54 112.046 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.409 HD21 ' H ' ' A' ' 175' ' ' LEU . 2.7 pt? -68.43 152.05 45.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.61 0.243 . . . . 17.85 110.626 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -168.94 98.31 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.996 -0.547 . . . . 19.67 109.892 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -105.18 -11.52 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 19.71 110.4 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 91.3 mt 71.39 -168.31 0.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.476 -0.784 . . . . 21.47 110.887 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 1.637 ' HD1' ' CD2' ' A' ' 179' ' ' PHE . 59.0 t80 -78.33 -37.18 45.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.764 0.283 . . . . 23.66 111.764 -174.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.346 -0.835 . . . . 23.71 110.657 -177.188 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 122.45 1.119 . . . . 10.380000000000001 109.755 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.555 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -128.85 139.46 52.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.347 -1.297 . . . . 8.3699999999999992 108.217 178.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 58' ' ' GLU . 23.5 mm -49.52 117.96 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.944 0.878 . . . . 5.7599999999999998 112.636 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.13 -33.97 9.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.297 -1.774 . . . . 8.2200000000000006 109.923 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 1.6 p90 -179.67 -177.49 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.607 -0.724 . . . . 7.9900000000000002 109.884 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.727 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -116.83 147.38 42.17 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.388 -0.824 . . . . 5.6100000000000003 110.281 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HB2' HE22 ' A' ' 38' ' ' GLN . 28.3 ptt180 -142.55 149.87 39.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.185 -0.916 . . . . 9.0600000000000005 110.353 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.79 ' HB3' HG22 ' A' ' 35' ' ' VAL . 10.0 t70 -92.08 136.25 26.19 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.138 -1.06 . . . . 8.3100000000000005 108.138 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' A' ' 54' ' ' ILE . 16.8 Cg_exo -62.33 -13.22 31.29 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.116 1.877 . . . . 10.41 112.201 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.55 0.36 42.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.782 -0.19 . . . . 10.85 111.504 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -128.28 38.42 0.43 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 112.802 0.668 . . . . 9.3200000000000003 112.802 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 27.4 Cg_endo -57.92 131.81 45.94 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.576 2.184 . . . . 11.1 112.508 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.84 -7.45 31.45 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.651 -0.785 . . . . 10.31 111.204 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.577 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -82.68 -179.78 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.534 . . . . 9.2100000000000009 109.731 176.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 7.0 tpt180 -151.29 94.26 2.01 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.098 -0.334 . . . . 11.51 110.098 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 90.7 m-85 -76.49 139.68 40.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.262 -0.575 . . . . 7.5 110.708 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.71 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.799 -1.091 . . . . 10.609999999999999 111.084 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.5 pttm -168.79 164.22 7.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 10.91 111.006 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.727 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.1 Cg_endo -48.19 169.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.992 3.128 . . . . 7.5099999999999998 114.403 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.64 -162.57 27.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.918 -0.658 . . . . 7.5899999999999999 112.392 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 4.0 ttmm -92.92 141.74 28.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.669 -0.493 . . . . 11.68 109.669 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.5 p -58.4 136.13 85.41 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 115.218 -0.901 . . . . 9.1999999999999993 110.962 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.85 -27.16 7.37 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.136 1.891 . . . . 10.25 112.028 171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 91.4 m-85 -81.91 -31.05 31.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.153 0.502 . . . . 10.49 110.851 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.624 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.67 -161.06 0.98 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.481 -0.781 . . . . 10.380000000000001 108.911 174.173 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 6.5 p-10 -128.17 59.05 1.51 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.019 0.914 . . . . 12.539999999999999 109.623 170.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 ptm -132.82 145.1 55.69 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.484 -1.235 . . . . 9.8699999999999992 109.766 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.62 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.669 1.58 . . . . 9.5099999999999998 110.414 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.33 161.27 14.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.173 0.511 . . . . 6.71 111.415 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 ' HD3' ' A' ' 33' ' ' PRO . 1.7 mp -98.74 133.85 22.11 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.132 -0.692 . . . . 7.8899999999999997 109.132 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 83.5 Cg_endo -85.28 150.18 10.52 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 121.265 1.31 . . . . 5.7699999999999996 113.126 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 m -74.3 158.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.564 -1.198 . . . . 5.96 112.397 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 11.97 -76.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.358 2.263 . . . . 7.8399999999999999 115.353 -178.083 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -57.84 -47.04 83.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.287 0.635 . . . . 6.6200000000000001 109.596 -175.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 43.6 mt-10 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 121.629 0.728 . . . . 8.5800000000000001 112.646 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 80' ' ' ARG . 8.0 mpt_? . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.686 -0.487 . . . . 11.640000000000001 109.686 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 114' ' ' ALA . 42.8 p -135.19 177.82 7.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.165 0.507 . . . . 8.0 111.484 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -142.71 131.63 22.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.366 -0.834 . . . . 6.6500000000000004 109.044 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 35.3 tt0 -79.47 141.24 36.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.952 0.406 . . . . 12.15 110.515 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 95' ' ' LEU . 70.6 t -69.16 127.31 30.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 9.7100000000000009 110.548 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -162.92 146.68 11.14 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.07 -0.968 . . . . 11.029999999999999 111.642 174.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 93' ' ' GLU . 7.5 mp -70.1 132.45 45.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.11 -1.405 . . . . 12.76 110.37 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.494 ' H ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.506 -0.471 0 C-N-CA 120.186 -1.007 . . . . 13.25 113.628 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.474 ' HB3' HD23 ' A' ' 86' ' ' LEU . 18.0 mt-10 . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 122.23 1.014 . . . . 14.94 112.539 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 23.1 mmt85 -135.09 164.49 27.54 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.454 -1.703 . . . . 10.57 107.026 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -88.83 113.21 24.13 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.919 -0.771 . . . . 8.8800000000000008 108.919 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.5 mm? -87.47 129.89 34.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.082 -0.508 . . . . 9.7799999999999994 111.369 -172.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.18 155.85 58.09 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.444 -0.798 . . . . 6.4000000000000004 109.424 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.35 139.11 81.33 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.289 1.992 . . . . 6.5499999999999998 111.559 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.3 m -57.71 -28.44 63.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.64 0.608 . . . . 9.2899999999999991 112.64 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.85 -2.39 58.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 10.859999999999999 111.059 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -71.68 -41.09 69.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.48 0.657 . . . . 5.3399999999999999 111.015 -175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -92.51 160.26 15.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.47 -0.786 . . . . 6.9699999999999998 111.614 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.67 113.27 37.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.708 -0.678 . . . . 10.199999999999999 109.192 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 7.7 mmm180 -89.53 126.14 35.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.735 -0.786 . . . . 12.119999999999999 110.446 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -149.18 132.71 16.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.862 -0.608 . . . . 14.609999999999999 110.551 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.69 -115.57 5.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.26 -0.495 . . . . 15.52 112.568 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.92 36.21 4.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.803 0.335 . . . . 14.99 111.671 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.79 -178.96 6.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.313 -0.403 . . . . 15.199999999999999 110.502 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 27.3 m -132.11 150.95 52.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.725 0.298 . . . . 9.2599999999999998 111.269 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.7 mm -123.33 149.11 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.099 -0.704 . . . . 10.550000000000001 109.099 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -129.49 125.85 37.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.282 -0.266 . . . . 7.3899999999999997 110.282 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.521 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 48.6 ttp -85.95 99.56 11.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.687 -1.227 . . . . 8.8499999999999996 107.687 171.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 121' ' ' ASP . 12.7 p -81.78 136.82 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.254 -0.884 . . . . 9.6899999999999995 111.195 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.65 97.42 7.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.194 -0.669 . . . . 10.699999999999999 109.194 173.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.74 139.77 40.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.662 -0.699 . . . . 14.880000000000001 109.221 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.43 -16.81 30.02 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.005 -0.543 . . . . 16.920000000000002 113.027 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -79.17 4.72 13.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.164 0.507 . . . . 18.559999999999999 111.811 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.63 9.98 58.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.708 -0.678 . . . . 15.619999999999999 112.969 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.99 175.22 16.54 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.76 -0.733 . . . . 14.19 112.241 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.2 m-85 -126.03 136.76 53.33 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.059 -0.349 . . . . 12.029999999999999 110.059 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 113' ' ' VAL . 23.0 t70 -138.03 141.53 32.69 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 13.91 111.375 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -82.51 138.5 9.7 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.718 1.612 . . . . 12.35 112.482 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.8 p -135.39 136.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.622 -0.717 . . . . 9.4299999999999997 109.82 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.8 tt0 -81.48 125.02 29.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.629 -0.508 . . . . 12.93 109.629 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -133.5 157.78 42.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.455 -0.793 . . . . 8.0299999999999994 110.76 -172.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 4.3 ttmp? -95.19 120.3 35.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.73 -0.668 . . . . 10.390000000000001 109.388 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.46 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -143.9 104.48 4.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.969 -0.56 . . . . 8.3000000000000007 111.469 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.46 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.744 -2.17 . . . . 10.1 114.265 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.17 163.12 39.55 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.689 -0.486 . . . . 10.609999999999999 109.689 157.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.0 m -133.59 134.24 43.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.381 -0.6 . . . . 13.17 109.381 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.35 107.18 3.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.105 0.409 . . . . 12.98 112.105 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.29 44.51 59.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.199 -0.524 . . . . 14.34 113.105 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.0 17.35 80.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.67 -0.776 . . . . 13.119999999999999 112.236 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -137.55 166.0 24.95 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.422 -0.584 . . . . 10.619999999999999 109.422 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -115.71 162.84 16.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.963 0.411 . . . . 7.8200000000000003 110.246 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 66.7 mt-10 -106.27 121.16 43.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.659 . . . . 10.789999999999999 111.433 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 125' ' ' VAL . 21.1 mm -88.25 101.52 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.014 -0.994 . . . . 6.7300000000000004 108.565 168.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.9 mp -68.84 -45.0 72.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.553 -1.203 . . . . 8.7899999999999991 109.738 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 125' ' ' VAL . 40.9 mt-10 -150.45 165.52 32.92 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.776 -0.647 . . . . 10.44 109.353 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.555 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 128.63 -61.49 0.65 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.981 -1.104 . . . . 8.8699999999999992 113.299 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 123' ' ' VAL . 36.7 mt -116.0 179.62 3.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.305 0.574 . . . . 8.5 112.347 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -129.64 152.44 49.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.875 -1.057 . . . . 14.15 110.481 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 132.35 45.98 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.058 -0.973 . . . . 12.119999999999999 110.168 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.51 -11.25 30.6 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.092 -0.803 . . . . 11.539999999999999 111.092 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.5 HE21 HG21 ' A' ' 113' ' ' VAL . 9.5 mt-30 -104.27 163.76 12.2 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 107.75 -1.204 . . . . 11.24 107.75 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 14.2 mt-30 -120.93 167.84 12.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 119.04 0.836 . . . . 10.49 111.561 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.14 156.68 41.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.217 -0.901 . . . . 5.4500000000000002 108.853 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 7.6 p -76.62 128.52 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.63 0.252 . . . . 6.5599999999999996 110.587 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.4 m . . . . . 0 C--N 1.326 -0.425 0 C-N-CA 120.975 -0.29 . . . . 6.9900000000000002 111.602 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.895 0.379 . . . . 11.84 111.652 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -103.88 166.57 10.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.543 -0.54 . . . . 12.24 109.543 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -60.82 2.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.824 -0.35 . . . . 13.16 111.138 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.2 tt -125.08 113.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.549 0.69 . . . . 11.949999999999999 110.301 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.68 -0.15 49.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 11.220000000000001 112.017 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.667 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 13.2 m -58.54 -43.22 89.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.88 -0.6 . . . . 11.9 111.023 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -52.03 -54.99 23.42 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.76 -0.459 . . . . 11.17 109.76 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.3 92.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.845 -1.07 . . . . 7.8200000000000003 111.395 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.1 m -58.94 -35.54 73.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.865 -0.607 . . . . 9.6400000000000006 111.868 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 157' ' ' SER . 80.4 mt -61.99 -22.13 65.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.242 -0.89 . . . . 10.57 111.516 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -83.43 117.79 23.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.637 -0.505 . . . . 8.9000000000000004 109.637 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 105.58 -18.28 41.38 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 119.927 -1.13 . . . . 7.1500000000000004 112.734 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.7 p -102.17 -76.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 7.0899999999999999 110.646 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.46 -24.16 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.29 0.567 . . . . 9.1999999999999993 110.211 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.899 -0.591 . . . . 9.1099999999999994 110.598 178.106 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 3.1 mppt? . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 108.3 -1.0 . . . . 10.380000000000001 108.3 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.584 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.29 130.67 35.47 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.133 -0.94 . . . . 8.3699999999999992 111.042 -174.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.717 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.2 mm -55.2 133.29 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 122.268 1.032 . . . . 5.7599999999999998 113.107 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.74 -25.97 6.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.37 -1.741 . . . . 8.2200000000000006 109.712 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.558 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 14.1 p90 179.99 179.03 0.56 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.897 -0.592 . . . . 7.9900000000000002 111.098 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -118.38 154.88 31.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.919 -1.037 . . . . 5.6100000000000003 109.965 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.4 ptp180 -156.4 145.36 20.32 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.153 0.502 . . . . 9.0600000000000005 110.29 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.0 t0 -67.85 133.13 92.23 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.48 -0.933 . . . . 8.3100000000000005 108.48 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.556 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 84.4 Cg_endo -67.66 -12.6 36.08 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.293 1.995 . . . . 10.41 112.363 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.473 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 1.1 ptp -103.65 0.99 31.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.41 -0.359 . . . . 10.85 111.546 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.6 m -120.43 45.01 0.74 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 121.258 0.552 . . . . 9.3200000000000003 112.003 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.85 124.5 16.04 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.134 2.556 . . . . 11.1 112.711 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.82 8.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.807 -0.711 . . . . 10.31 111.656 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.588 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 6.8 tp-100 -78.95 105.55 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.15 0.5 . . . . 9.2100000000000009 109.968 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.558 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 41.7 ttp180 -90.93 106.95 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 11.51 110.161 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 66.7 m-85 -84.58 142.46 29.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 7.5 109.466 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.28 -26.55 68.83 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.42 -0.809 . . . . 10.609999999999999 111.005 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 16.7 ptpt -169.8 165.11 6.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.869 -0.605 . . . . 10.91 110.264 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -49.37 169.15 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.37 2.713 . . . . 7.5099999999999998 113.458 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.25 -166.98 29.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.65 -0.786 . . . . 7.5899999999999999 112.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 46' ' ' SER . 12.9 ttmm -95.34 153.23 17.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.192 0.52 . . . . 11.68 110.604 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.494 ' HA ' HD21 ' A' ' 53' ' ' LEU . 95.5 p -64.59 105.91 0.84 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.467 -1.242 . . . . 9.1999999999999993 110.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' SER . 41.6 Cg_endo -67.59 -10.12 27.67 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.3 2.666 . . . . 10.25 111.869 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -92.0 -31.4 15.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.564 -1.198 . . . . 10.49 110.789 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.616 ' HG2' ' H ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -134.64 -107.77 0.22 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.097 1.147 . . . . 10.380000000000001 114.097 172.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 49' ' ' MET . 12.6 p-10 -165.19 65.95 0.13 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.117 0.871 . . . . 12.539999999999999 113.275 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.02 148.82 56.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.784 -0.821 . . . . 9.8699999999999992 108.784 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.44 132.28 30.73 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.198 1.265 . . . . 9.5099999999999998 110.339 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 46' ' ' SER . 43.5 mt -61.25 163.49 6.34 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.338 0.399 . . . . 6.71 111.305 -175.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 43.0 mm -101.29 131.82 22.65 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 7.8899999999999997 110.003 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.724 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 55.9 Cg_endo -86.51 139.38 5.81 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.93 1.753 . . . . 5.7699999999999996 112.921 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.77 157.96 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.291 -1.322 . . . . 5.96 112.904 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.584 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.77 -89.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.753 2.021 . . . . 7.8399999999999999 115.212 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.717 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -47.87 -40.98 23.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.73 0.412 . . . . 6.6200000000000001 110.184 -177.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.484 ' CG ' ' HG2' ' A' ' 55' ' ' PRO . 26.8 tt0 . . . . . 0 C--N 1.315 -0.901 0 O-C-N 123.954 0.784 . . . . 8.5800000000000001 111.677 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.045 -0.724 . . . . 11.640000000000001 109.045 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 148' ' ' VAL . 34.4 p -131.74 147.1 52.47 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.834 -0.621 . . . . 8.0 110.274 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.08 126.58 55.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.81 -0.811 . . . . 6.6500000000000004 108.81 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 30.0 tt0 -83.92 133.87 34.69 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.459 -0.571 . . . . 12.15 109.459 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.613 HG11 HD23 ' A' ' 95' ' ' LEU . 42.4 t -55.49 127.92 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.769 0.655 . . . . 9.7100000000000009 112.769 -176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 39.1 mmtt -140.88 142.5 34.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.828 -1.078 . . . . 11.029999999999999 108.777 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 9.3 mp -77.8 150.78 34.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.013 -0.675 . . . . 12.76 109.484 171.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.413 -0.898 . . . . 13.25 112.99 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 CA-C-O 121.475 0.655 . . . . 14.94 111.248 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -121.64 167.26 13.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.695 -1.139 . . . . 10.57 109.019 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 84' ' ' VAL . 5.3 mp -90.68 111.96 23.52 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.172 -1.048 . . . . 8.8800000000000008 108.172 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.69 129.87 35.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.16 0.505 . . . . 9.7799999999999994 110.634 -174.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.58 156.8 52.72 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.634 -1.167 . . . . 6.4000000000000004 108.804 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.28 141.25 95.41 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 C-N-CA 122.153 1.902 . . . . 6.5499999999999998 110.59 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -19.24 38.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.636 0.255 . . . . 9.2899999999999991 111.367 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -88.76 9.64 23.78 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 116.514 -0.312 . . . . 10.859999999999999 111.017 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -86.63 -39.89 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.174 0.511 . . . . 5.3399999999999999 111.17 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -99.92 158.47 15.79 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.758 0.651 . . . . 6.9699999999999998 112.758 -170.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.91 121.56 53.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.239 -0.891 . . . . 10.199999999999999 108.86 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -94.25 122.54 36.89 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.312 -0.555 . . . . 12.119999999999999 110.895 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -149.57 131.26 14.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.105 -0.498 . . . . 14.609999999999999 111.406 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.3 5.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.161 -0.472 . . . . 15.52 113.017 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.1 25.03 10.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 14.99 111.235 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.76 -176.99 5.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 15.199999999999999 111.053 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.586 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 47.0 m -136.92 150.13 48.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.291 -0.413 . . . . 9.2599999999999998 110.296 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -125.43 152.07 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.748 -0.464 . . . . 10.550000000000001 109.748 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -133.3 138.31 46.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.205 -0.295 . . . . 7.3899999999999997 110.205 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 58.9 mtm -97.45 100.71 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.145 -0.687 . . . . 8.8499999999999996 109.145 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 7.2 p -84.52 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.354 -0.839 . . . . 9.6899999999999995 111.312 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -67.12 88.52 0.17 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.48 -0.782 . . . . 10.699999999999999 109.698 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -67.97 140.43 56.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.46 -0.791 . . . . 14.880000000000001 109.782 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.56 -12.0 38.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.061 -0.59 . . . . 16.920000000000002 112.808 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.18 10.47 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.493 . . . . 18.559999999999999 111.689 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.76 17.11 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.399 -0.818 . . . . 15.619999999999999 113.782 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.74 -161.25 9.38 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.505 -0.855 . . . . 14.19 112.305 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 52.8 m-85 -130.92 112.51 13.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.677 0.275 . . . . 12.029999999999999 110.325 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -100.44 139.05 20.34 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.426 -0.352 . . . . 13.91 110.737 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 55.7 Cg_endo -82.7 138.88 9.68 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.956 1.77 . . . . 12.35 111.989 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.654 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 13.9 p -129.5 126.69 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 9.4299999999999997 110.139 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 110' ' ' ILE . 32.0 tt0 -79.18 112.84 16.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.487 -0.561 . . . . 12.93 109.487 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 123' ' ' VAL . 27.5 m -120.64 173.5 6.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 8.0299999999999994 111.375 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -104.49 126.1 51.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.161 -0.681 . . . . 10.390000000000001 109.161 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -141.95 105.64 4.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.309 -0.405 . . . . 8.3000000000000007 111.244 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.04 70.78 0.3 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 117.431 -2.319 . . . . 10.1 114.329 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.88 162.55 40.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.156 -0.683 . . . . 10.609999999999999 109.156 155.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.4 m -147.04 127.87 14.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.837 -0.431 . . . . 13.17 109.837 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.99 112.25 5.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.079 -0.51 . . . . 12.98 111.753 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.62 43.82 91.18 Favored Glycine 0 C--O 1.235 0.214 0 CA-C-N 116.107 -0.497 . . . . 14.34 112.992 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.69 13.43 82.13 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.852 -0.689 . . . . 13.119999999999999 112.553 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -126.47 157.84 37.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.264 -0.643 . . . . 10.619999999999999 109.264 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.5 p -111.92 166.66 11.02 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.882 -0.327 . . . . 7.8200000000000003 110.328 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.921 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.4 mt-10 -116.73 113.32 22.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.486 0.66 . . . . 10.789999999999999 111.11 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.0 mm -83.1 111.84 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.121 -0.945 . . . . 6.7300000000000004 108.87 171.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -77.12 -49.08 16.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.974 -1.012 . . . . 8.7899999999999991 109.718 -175.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 140' ' ' GLY . 31.4 tt0 -148.68 166.42 28.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.961 -0.563 . . . . 10.44 110.284 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 139' ' ' GLU . . . 113.84 -23.58 12.97 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.047 -0.597 . . . . 8.8699999999999992 112.085 172.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 123' ' ' VAL . 38.6 mt -127.49 -170.36 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.862 0.363 . . . . 8.5 111.76 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -154.56 156.16 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 14.15 109.663 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.08 128.01 34.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.713 -0.676 . . . . 12.119999999999999 110.196 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.68 -9.53 37.81 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.287 -0.725 . . . . 11.539999999999999 111.287 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.4 mm-40 -91.33 111.18 22.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.199 -0.667 . . . . 11.24 109.199 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 57.6 mt-30 -85.0 128.59 34.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.416 -0.811 . . . . 10.49 110.97 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -119.19 135.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.709 -0.478 . . . . 5.4500000000000002 109.709 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 81' ' ' THR . 2.4 p -68.09 121.11 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.253 0.549 . . . . 6.5599999999999996 110.581 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 101' ' ' ALA . 5.1 m . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.211 -0.904 . . . . 6.9900000000000002 110.398 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.238 0.542 . . . . 11.84 110.441 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.438 ' O ' HD13 ' A' ' 155' ' ' ILE . 47.3 m-85 -72.67 165.42 24.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.823 -0.626 . . . . 12.24 110.611 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 tp -87.8 50.87 2.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.4 0.619 . . . . 13.16 110.058 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -83.11 39.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.461 0.648 . . . . 11.949999999999999 111.072 -177.205 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.0 -99.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.37 -0.832 . . . . 11.220000000000001 111.327 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.4 m -79.22 -41.48 28.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.732 0.777 . . . . 11.9 110.174 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 50.0 mm-40 -54.0 -30.17 46.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.084 -1.417 . . . . 11.17 110.701 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.461 ' HB2' ' CA ' ' A' ' 155' ' ' ILE . . . -68.02 -31.74 71.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.492 -1.231 . . . . 7.8200000000000003 112.233 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.5 t -81.5 -19.46 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.457 0.646 . . . . 9.6400000000000006 109.808 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.79 -30.4 20.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.802 -1.09 . . . . 10.57 111.898 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 21.7 mmm180 -70.6 140.94 51.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.196 0.522 . . . . 8.9000000000000004 110.565 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.38 30.59 13.44 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.978 -1.01 . . . . 7.1500000000000004 111.291 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.7 p 49.99 54.87 10.32 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.347 0.659 . . . . 7.0899999999999999 110.882 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 67.7 t 72.87 -56.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.171 -0.922 . . . . 9.1999999999999993 111.415 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.698 0.761 . . . . 9.1099999999999994 110.743 -178.06 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.438 -1.067 0 CA-C-O 122.556 1.17 . . . . 10.380000000000001 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.483 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 91.1 mtt180 -119.09 148.7 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.605 -1.634 . . . . 8.3699999999999992 108.883 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 ' OE2' ' A' ' 58' ' ' GLU . 42.9 mm -52.0 124.4 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 113.923 -1.49 . . . . 5.7599999999999998 114.251 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.71 -32.89 6.5 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.322 -1.763 . . . . 8.2200000000000006 109.792 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.722 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 26.3 p90 -177.64 -175.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.919 -0.582 . . . . 7.9900000000000002 110.839 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.749 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.21 145.81 46.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.65 -0.705 . . . . 5.6100000000000003 111.243 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -150.99 145.8 25.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.03 -0.729 . . . . 9.0600000000000005 109.03 179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.753 ' HB3' ' CE ' ' A' ' 34' ' ' MET . 1.2 m-20 -78.27 147.24 72.26 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 112.307 0.484 . . . . 8.3100000000000005 112.307 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HG3' HG13 ' A' ' 54' ' ' ILE . 51.9 Cg_exo -53.68 -56.78 2.35 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.593 2.195 . . . . 10.41 112.797 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.753 ' CE ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -86.87 2.64 48.45 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.398 0.888 . . . . 10.85 113.398 -170.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 32' ' ' ASP . 21.6 m -120.46 51.83 2.31 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 121.657 0.741 . . . . 9.3200000000000003 111.325 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.25 121.73 9.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.146 2.564 . . . . 11.1 112.622 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.62 -27.29 4.43 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.052 -0.819 . . . . 10.31 111.052 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' OE1' ' HE1' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -75.86 138.93 41.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.4 -0.4 . . . . 9.2100000000000009 109.943 175.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.615 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 34.0 ttp180 -133.54 112.29 11.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.543 -0.299 . . . . 11.51 111.413 -174.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 73.6 m-85 -97.39 149.3 22.28 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.828 -0.804 . . . . 7.5 108.828 174.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.08 8.11 16.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.044 -0.662 . . . . 10.609999999999999 111.806 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.8 pttp -164.2 167.8 10.14 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 116.332 -0.395 . . . . 10.91 111.881 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.619 ' HD3' ' CZ3' ' A' ' 30' ' ' TRP . 18.6 Cg_endo -56.0 171.04 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.807 3.004 . . . . 7.5099999999999998 112.984 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.37 -166.35 28.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.539 -0.839 . . . . 7.5899999999999999 112.975 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 14.1 ttmm -96.96 148.44 22.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.058 0.456 . . . . 11.68 109.869 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -66.13 141.14 97.27 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.344 -0.844 . . . . 9.1999999999999993 111.576 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.12 -20.29 10.09 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.844 2.362 . . . . 10.25 111.033 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.509 -1.223 . . . . 10.49 109.863 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.5 ptp -168.97 168.9 9.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.236 -0.893 . . . . 10.380000000000001 109.182 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 p-10 -81.22 72.74 8.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.734 0.778 . . . . 12.539999999999999 112.418 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 ptm -139.43 139.48 22.75 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.196 -0.911 . . . . 9.8699999999999992 108.871 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.1 135.94 45.87 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.554 2.17 . . . . 9.5099999999999998 111.604 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.591 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 18.1 mt -63.17 162.15 12.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.812 -0.631 . . . . 6.71 111.04 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.522 HG13 ' HG3' ' A' ' 33' ' ' PRO . 23.8 mm -102.92 134.41 19.83 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 121.322 0.582 . . . . 7.8899999999999997 109.984 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.749 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 74.1 Cg_endo -81.98 139.1 10.65 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.308 1.339 . . . . 5.7699999999999996 112.544 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -55.49 157.88 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 113.872 -1.513 . . . . 5.96 113.045 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.31 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.716 2.006 . . . . 7.8399999999999999 115.037 -175.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.735 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -46.94 -42.6 18.05 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.167 0.587 . . . . 6.6200000000000001 111.401 -176.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.585 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 13.9 tt0 . . . . . 0 C--O 1.241 0.639 0 CA-C-O 122.453 1.121 . . . . 8.5800000000000001 111.011 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 152' ' ' GLN . 90.7 mtt180 . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.82 -0.807 . . . . 11.640000000000001 108.82 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 148' ' ' VAL . 11.5 p -114.38 170.49 8.26 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.279 0.562 . . . . 8.0 111.61 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -142.89 127.0 17.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.125 -0.943 . . . . 6.6500000000000004 108.561 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 41.8 tt0 -79.38 138.46 37.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 12.15 109.965 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 95' ' ' LEU . 39.2 t -57.21 132.9 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.274 -0.876 . . . . 9.7100000000000009 112.654 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -137.06 143.87 42.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.772 -1.104 . . . . 11.029999999999999 109.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.07 151.27 35.55 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.114 -0.634 . . . . 12.76 109.633 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.446 -0.883 . . . . 13.25 112.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 CA--C 1.513 -0.449 0 CA-C-O 121.284 0.564 . . . . 14.94 111.767 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.63 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 29.6 mmt180 -124.48 162.6 23.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.89 -1.05 . . . . 10.57 109.081 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 84' ' ' VAL . 1.8 mm? -87.31 113.33 22.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.588 -0.523 . . . . 8.8800000000000008 109.588 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -89.98 129.94 36.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.117 -0.492 . . . . 9.7799999999999994 110.656 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.23 159.81 57.11 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.136 -0.938 . . . . 6.4000000000000004 108.955 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HG2' HG11 ' A' ' 149' ' ' VAL . 72.8 Cg_exo -54.46 130.79 41.86 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.86 1.707 . . . . 6.5499999999999998 111.233 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 t -56.75 -26.02 56.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.254 0.465 . . . . 9.2899999999999991 112.254 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.26 4.56 50.29 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.07 -0.394 . . . . 10.859999999999999 111.659 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.31 -39.16 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 5.3399999999999999 110.721 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -80.28 158.9 26.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 6.9699999999999998 112.276 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -106.03 127.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.073 -0.967 . . . . 10.199999999999999 109.183 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -99.78 123.6 44.2 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.876 -0.73 . . . . 12.119999999999999 110.943 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -148.91 144.67 27.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.558 -0.746 . . . . 14.609999999999999 109.573 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.61 -121.63 15.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.204 -0.522 . . . . 15.52 112.322 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.39 37.25 4.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.15 0.5 . . . . 14.99 110.729 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -149.45 177.78 9.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.655 -0.702 . . . . 15.199999999999999 111.203 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 12.0 m -123.65 145.87 48.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.31 -0.405 . . . . 9.2599999999999998 109.986 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.7 mm -123.31 152.18 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.041 -0.725 . . . . 10.550000000000001 109.041 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -127.65 131.34 49.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.678 0.275 . . . . 7.3899999999999997 110.495 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 76.9 mtp -88.03 100.36 12.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.433 -0.58 . . . . 8.8499999999999996 109.433 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -85.69 136.82 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.868 -0.605 . . . . 9.6899999999999995 110.993 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 146' ' ' GLN . . . -89.97 94.19 9.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.618 -0.719 . . . . 10.699999999999999 110.158 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.0 141.99 56.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.795 -0.639 . . . . 14.880000000000001 110.714 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.29 -6.59 48.34 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.149 -0.78 . . . . 16.920000000000002 111.149 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.83 -3.05 46.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.394 0.616 . . . . 18.559999999999999 110.4 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 166' ' ' ALA . . . 104.37 -21.1 38.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.244 -0.889 . . . . 15.619999999999999 113.128 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.13 177.8 26.52 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.818 -0.706 . . . . 14.19 112.598 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.22 122.44 28.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.553 -0.536 . . . . 12.029999999999999 109.553 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.2 m-20 -124.76 147.93 57.76 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.535 -0.466 . . . . 13.91 111.571 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.53 135.18 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.746 2.297 . . . . 12.35 112.55 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.675 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.8 p -121.4 129.97 75.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.541 -0.754 . . . . 9.4299999999999997 109.916 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 110' ' ' ILE . 38.5 tt0 -74.58 116.86 15.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.988 0.423 . . . . 12.93 110.028 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 123' ' ' VAL . 28.4 m -128.55 167.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.868 -0.605 . . . . 8.0299999999999994 110.884 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 138' ' ' LEU . 37.6 ttmt -106.2 129.72 54.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.464 -0.569 . . . . 10.390000000000001 109.464 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.84 104.09 4.29 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.621 0.601 . . . . 8.3000000000000007 112.621 -173.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.59 70.9 0.29 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 117.752 -2.166 . . . . 10.1 114.498 167.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 162.69 39.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.876 -0.787 . . . . 10.609999999999999 108.876 154.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -138.02 124.34 20.55 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.606 -0.438 . . . . 13.17 109.844 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.05 111.21 6.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.063 -0.517 . . . . 12.98 111.575 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.93 44.17 94.94 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.932 -0.576 . . . . 14.34 112.818 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.15 8.55 85.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 13.119999999999999 112.378 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -120.71 166.73 13.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.662 -0.496 . . . . 10.619999999999999 109.662 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -120.62 155.51 33.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.749 0.309 . . . . 7.8200000000000003 110.774 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 48.1 mt-10 -97.09 110.98 23.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.495 0.664 . . . . 10.789999999999999 111.014 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.5 mm -79.71 101.15 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.167 -1.049 . . . . 6.7300000000000004 108.167 169.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.63 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -65.56 -49.35 69.19 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.049 -0.978 . . . . 8.7899999999999991 110.183 -174.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.95 162.49 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.358 -0.837 . . . . 10.44 110.908 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.33 -59.78 0.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.605 -0.807 . . . . 8.8699999999999992 113.304 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 123' ' ' VAL . 25.0 mt -103.35 -174.58 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.588 0.588 . . . . 8.5 112.588 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -149.37 157.56 43.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.451 -0.795 . . . . 14.15 109.605 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 126.01 28.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.626 -0.715 . . . . 12.119999999999999 110.075 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.03 -10.46 20.64 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.493 -1.043 . . . . 11.539999999999999 110.493 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.6 mm100 -100.74 120.02 39.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.444 -0.947 . . . . 11.24 108.444 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 11.1 pt20 -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.825 0.821 . . . . 10.49 110.364 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.58 145.96 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.336 -1.302 . . . . 5.4500000000000002 109.603 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.8 p -69.5 124.57 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.329 0.585 . . . . 6.5599999999999996 110.234 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.8 m . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.619 -0.719 . . . . 6.9900000000000002 110.398 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . 28.0 tt0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.277 0.561 . . . . 11.84 111.208 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -89.31 156.14 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.122 -0.695 . . . . 12.24 109.122 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.62 ' H ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.12 84.85 1.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.512 0.672 . . . . 13.16 111.403 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 155' ' ' ILE . 9.4 tp -169.55 48.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.089 0.947 . . . . 11.949999999999999 110.15 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -66.24 -28.04 68.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.712 0.768 . . . . 11.220000000000001 111.249 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.0 m -56.2 -34.46 66.29 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 11.9 113.039 -171.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -70.64 -25.73 63.15 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.837 -0.619 . . . . 11.17 110.673 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -82.38 -19.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.376 -0.829 . . . . 7.8200000000000003 110.031 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 m -81.73 -45.01 16.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.485 -0.78 . . . . 9.6400000000000006 110.022 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.33 -33.78 75.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.543 -0.753 . . . . 10.57 111.055 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 13.7 ptt180 -88.48 165.91 14.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.964 -0.754 . . . . 8.9000000000000004 108.964 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.12 61.82 3.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 7.1500000000000004 112.449 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 44.35 -93.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.926 0.89 . . . . 7.0899999999999999 112.469 -178.363 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.404 ' H ' ' HB ' ' A' ' 164' ' ' THR . 46.9 t -132.33 82.56 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.131 -1.063 . . . . 9.1999999999999993 108.131 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' GLY . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.539 -0.755 . . . . 9.1099999999999994 111.561 -173.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 mptt . . . . . 0 N--CA 1.441 -0.923 0 N-CA-C 107.726 -1.213 . . . . 10.380000000000001 107.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 6.3 mtt-85 -144.09 141.46 30.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.706 -1.134 . . . . 8.3699999999999992 109.659 -172.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -53.73 133.7 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 122.568 1.175 . . . . 5.7599999999999998 113.242 -163.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.9 -35.33 6.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.743 -2.026 . . . . 8.2200000000000006 109.642 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 3.7 p90 -179.54 -174.71 0.31 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.299 -0.864 . . . . 7.9900000000000002 108.992 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.782 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m-90 -122.14 147.85 45.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 5.6100000000000003 111.071 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 4.0 ptm180 -152.86 156.4 38.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.238 -0.892 . . . . 9.0600000000000005 110.194 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.714 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.8 t70 -94.1 140.49 22.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.316 -0.624 . . . . 8.3100000000000005 109.316 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.79 -15.58 38.76 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.889 2.393 . . . . 10.41 112.561 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.44 -3.46 43.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 111.592 0.219 . . . . 10.85 111.592 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.2 m -127.79 37.22 0.37 Allowed Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.031 0.752 . . . . 9.3200000000000003 113.031 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -61.24 91.79 0.1 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.738 2.292 . . . . 11.1 112.745 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.86 -31.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.113 -0.565 . . . . 10.31 111.838 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -68.19 -178.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.057 0.762 . . . . 9.2100000000000009 113.057 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.626 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 11.3 tpp180 -147.34 91.77 2.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.238 -0.892 . . . . 11.51 108.797 172.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 49.9 m-85 -73.97 141.3 45.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.57 -0.852 . . . . 7.5 111.065 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.66 -25.57 68.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 10.609999999999999 110.841 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 20.8 pttp -171.79 164.78 4.36 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.808 -0.633 . . . . 10.91 111.008 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -49.79 169.79 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.756 2.971 . . . . 7.5099999999999998 113.62 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.93 -156.45 26.68 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.414 -0.898 . . . . 7.5899999999999999 112.814 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 8.4 ttmt -98.75 148.27 24.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.729 -0.471 . . . . 11.68 109.729 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' MET . 8.7 t -77.29 139.16 64.15 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-O 121.168 0.508 . . . . 9.1999999999999993 111.318 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.73 -22.27 20.69 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.971 2.448 . . . . 10.25 112.871 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.9 m-85 -85.51 -24.32 27.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.162 0.982 . . . . 10.49 109.496 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 46' ' ' SER . 2.2 ptp -157.9 134.08 9.44 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.868 -1.515 . . . . 10.380000000000001 111.081 -165.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -77.85 63.52 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.751 0.786 . . . . 12.539999999999999 111.565 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.6 ptm -139.05 143.96 39.04 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.74 -1.118 . . . . 9.8699999999999992 108.215 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.59 133.93 39.0 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.043 1.829 . . . . 9.5099999999999998 110.743 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.3 154.41 20.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 6.71 110.82 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -93.83 133.52 27.67 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 7.8899999999999997 109.872 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 27' ' ' ILE . 81.6 Cg_endo -85.23 147.87 10.24 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 121.928 1.752 . . . . 5.7699999999999996 113.425 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG13 ' A' ' 27' ' ' ILE . 32.2 m -75.69 157.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.639 -1.164 . . . . 5.96 111.994 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.64 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.19 2.196 . . . . 7.8399999999999999 115.507 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.737 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -40.25 -48.46 2.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.94 0.896 . . . . 6.6200000000000001 110.42 174.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.737 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 32.4 mt-10 . . . . . 0 C--N 1.317 -0.809 0 C-N-CA 124.203 1.001 . . . . 8.5800000000000001 113.054 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.658 0.742 . . . . 11.640000000000001 111.612 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 148' ' ' VAL . 32.8 p -133.54 173.37 11.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.442 -1.254 . . . . 8.0 110.715 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.59 128.05 22.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.356 -0.838 . . . . 6.6500000000000004 109.179 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 29.9 tt0 -84.24 135.68 34.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.109 -0.496 . . . . 12.15 110.063 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 95' ' ' LEU . 55.9 t -60.73 131.69 25.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.704 -0.68 . . . . 9.7100000000000009 112.474 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 54.2 mmtt -138.53 146.16 41.58 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.714 -1.13 . . . . 11.029999999999999 109.519 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.729 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 6.6 mp -78.29 163.38 25.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.552 -0.459 . . . . 12.76 110.189 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.251 0 C-N-CA 119.774 -1.203 . . . . 13.25 113.744 -176.441 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.729 ' OE2' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.432 -1.334 0 CA-C-O 122.045 0.926 . . . . 14.94 112.835 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.62 ' CG ' ' HA ' ' A' ' 138' ' ' LEU . 1.1 mpp_? -147.45 175.4 10.84 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.873 -1.512 . . . . 10.57 111.135 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 84' ' ' VAL . 2.3 mm? -100.74 112.97 25.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.166 -0.925 . . . . 8.8800000000000008 109.101 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.67 130.46 34.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 9.7799999999999994 110.704 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -143.0 157.88 60.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.01 -0.996 . . . . 6.4000000000000004 108.694 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 101' ' ' ALA . 15.1 Cg_endo -61.84 132.81 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.252 1.301 . . . . 6.5499999999999998 109.95 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.467 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 29.1 t -56.07 -21.93 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.489 0.551 . . . . 9.2899999999999991 112.489 -174.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.93 4.78 48.99 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.938 -0.477 . . . . 10.859999999999999 111.504 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . . . -80.51 -41.06 24.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.134 0.492 . . . . 5.3399999999999999 110.576 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -84.3 158.45 21.19 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.538 -0.756 . . . . 6.9699999999999998 111.573 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 20.2 mm -107.3 128.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.405 -0.816 . . . . 10.199999999999999 110.083 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 19.5 mmm180 -95.79 123.72 39.49 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.899 -0.72 . . . . 12.119999999999999 110.422 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -149.25 142.84 25.44 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.804 -0.635 . . . . 14.609999999999999 110.445 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.8 -116.53 4.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.194 -0.527 . . . . 15.52 112.302 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 36.84 4.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 14.99 110.877 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -151.63 -179.17 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.064 -0.516 . . . . 15.199999999999999 111.804 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.6 m -130.9 147.71 52.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.651 -0.704 . . . . 9.2599999999999998 109.508 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.5 mm -122.36 145.92 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.782 0.325 . . . . 10.550000000000001 110.204 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 141' ' ' LEU . . . -119.48 130.68 55.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.969 -0.56 . . . . 7.3899999999999997 110.118 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 49.2 mmm -90.88 98.35 11.72 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.819 -0.437 . . . . 8.8499999999999996 109.819 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 121' ' ' ASP . 11.2 p -83.92 139.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.173 0.511 . . . . 9.6899999999999995 111.967 -170.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.24 100.06 12.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.561 -0.745 . . . . 10.699999999999999 109.822 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.93 149.45 24.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.197 -0.456 . . . . 14.880000000000001 111.278 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.45 10.39 17.12 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.217 -0.753 . . . . 16.920000000000002 111.217 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.77 15.96 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 18.559999999999999 110.55 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.97 19.02 73.66 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.118 -0.947 . . . . 15.619999999999999 113.416 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.9 171.66 30.62 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.966 -1.111 . . . . 14.19 112.915 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 96.0 m-85 -120.27 112.67 19.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.612 -0.514 . . . . 12.029999999999999 109.612 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.6 m-20 -103.55 147.08 33.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.363 -0.38 . . . . 13.91 110.463 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.75 122.82 2.36 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.984 1.789 . . . . 12.35 112.384 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.34 122.88 59.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.816 -1.083 . . . . 9.4299999999999997 109.564 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -70.56 111.46 6.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.31 -0.626 . . . . 12.93 109.31 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.483 HG12 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.68 160.46 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.446 0.641 . . . . 8.0299999999999994 111.867 -173.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -91.83 130.36 37.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.76 -1.2 . . . . 10.390000000000001 107.76 172.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.8 102.42 4.28 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.221 -0.592 . . . . 8.3000000000000007 112.022 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -156.19 71.43 0.26 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 118.595 -1.764 . . . . 10.1 114.028 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.11 163.79 38.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 10.609999999999999 109.24 156.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.2 m -139.08 133.11 31.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.179 0.445 . . . . 13.17 110.496 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.85 103.22 4.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 12.98 111.41 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 42.39 69.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.198 -0.525 . . . . 14.34 112.946 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.41 88.94 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.019 -0.61 . . . . 13.119999999999999 112.344 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.75 152.65 35.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.255 -0.646 . . . . 10.619999999999999 109.255 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.8 p -99.77 161.62 13.5 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.011 -0.276 . . . . 7.8200000000000003 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 45.3 mt-10 -111.94 117.64 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.641 0.734 . . . . 10.789999999999999 111.122 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 35.4 mm -82.94 100.97 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.923 -1.035 . . . . 6.7300000000000004 108.735 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . 8.7 mt -63.34 -41.67 98.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.138 -0.937 . . . . 8.7899999999999991 110.319 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 37.0 mt-10 -148.47 155.89 41.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 10.44 110.642 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 125.0 -54.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.236 -0.983 . . . . 8.8699999999999992 113.742 172.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 111' ' ' ALA . 24.7 mt -98.37 -174.82 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 8.5 112.049 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.76 152.12 36.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.561 -0.745 . . . . 14.15 109.966 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.84 137.4 51.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.104 . . . . 12.119999999999999 111.084 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.18 -6.9 59.95 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.629 -0.796 . . . . 11.539999999999999 111.518 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -103.44 155.9 18.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.503 -0.925 . . . . 11.24 108.503 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.2 mt-30 -111.38 166.38 11.16 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.734 -0.786 . . . . 10.49 111.874 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.7 OUTLIER -135.91 141.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.923 -1.035 . . . . 5.4500000000000002 108.617 168.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 p -73.58 121.29 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 6.5599999999999996 109.679 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 112.941 0.719 . . . . 6.9900000000000002 112.941 -168.843 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 109.586 -0.524 . . . . 11.84 109.586 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.0 t80 73.86 170.08 0.3 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.473 -1.24 . . . . 12.24 110.419 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.47 -71.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.493 -0.483 . . . . 13.16 111.422 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.2 pp -116.76 149.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 11.949999999999999 111.086 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.464 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 2.9 p-10 -72.33 -17.74 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 11.220000000000001 111.938 -172.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -62.59 -52.52 63.08 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.02 -0.272 . . . . 11.9 111.213 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.54 -32.88 54.24 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.536 -0.466 . . . . 11.17 109.822 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -50.38 -52.44 37.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.606 0.241 . . . . 7.8200000000000003 111.547 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.0 p -62.18 -29.87 70.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 9.6400000000000006 112.035 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.8 -38.6 16.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.109 -0.496 . . . . 10.57 112.203 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 3.1 mpt_? -89.5 -27.1 20.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.929 0.395 . . . . 8.9000000000000004 111.257 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.98 -8.72 66.68 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.843 -0.694 . . . . 7.1500000000000004 111.546 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p 55.58 -78.83 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.434 1.094 . . . . 7.0899999999999999 112.907 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.64 72.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 9.1999999999999993 110.345 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.016 -0.538 . . . . 9.1099999999999994 110.272 176.996 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.113 0 CA-C-O 121.4 0.619 . . . . 10.380000000000001 110.58 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.613 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 39.9 mtt180 -126.45 141.32 51.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.547 -0.751 . . . . 8.3699999999999992 110.367 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' OE2' ' A' ' 58' ' ' GLU . 44.5 mm -55.66 120.08 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 5.7599999999999998 112.687 -170.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.56 -38.02 5.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.287 -1.324 . . . . 8.2200000000000006 110.182 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.76 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 21.4 p90 -168.82 -174.66 2.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 7.9900000000000002 111.303 -175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 1.6 m-90 -124.89 155.02 40.18 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.102 -0.954 . . . . 5.6100000000000003 111.078 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -160.44 153.58 21.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 9.0600000000000005 110.133 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 19.1 m-20 -79.17 137.07 56.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.637 -0.875 . . . . 8.3100000000000005 108.637 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.8 -11.8 19.26 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.65 2.233 . . . . 10.41 111.43 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.596 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.1 null -101.78 0.97 36.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.112 -0.494 . . . . 10.85 111.321 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' ASP . 6.9 m -127.81 43.65 1.11 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.244 0.545 . . . . 9.3200000000000003 111.476 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 35' ' ' VAL . 16.6 Cg_exo -61.74 111.49 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.81 2.34 . . . . 11.1 112.009 -170.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.38 -26.18 4.17 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.793 -0.923 . . . . 10.31 110.793 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.461 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 38.1 tp60 -76.52 115.58 16.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 9.2100000000000009 110.531 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 36.3 ttp180 -98.47 99.44 10.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.664 -0.698 . . . . 11.51 110.944 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.76 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 82.9 m-85 -79.77 133.02 36.3 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.343 -0.614 . . . . 7.5 109.343 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.88 -26.86 68.8 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.638 0.587 . . . . 10.609999999999999 110.766 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -160.06 147.66 12.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.437 0.636 . . . . 10.91 111.977 -172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 19.6 Cg_endo -56.33 135.68 71.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.947 3.765 . . . . 7.5099999999999998 113.573 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.71 -145.93 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.076 -0.583 . . . . 7.5899999999999999 111.919 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 2.0 ttmm -105.83 141.93 36.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.669 -0.863 . . . . 11.68 108.669 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB3' ' O ' ' A' ' 49' ' ' MET . 47.0 t -64.05 141.6 98.09 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.855 -0.612 . . . . 9.1999999999999993 111.411 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.93 -21.49 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.664 2.243 . . . . 10.25 111.012 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.571 ' CD2' HG11 ' A' ' 35' ' ' VAL . 35.0 m-85 -84.64 -41.99 15.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.187 -1.37 . . . . 10.49 109.245 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -137.04 157.41 46.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.369 -0.832 . . . . 10.380000000000001 110.873 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.0 p-10 -84.11 53.38 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.07 0.938 . . . . 12.539999999999999 111.135 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.47 32.85 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 114.967 -1.015 . . . . 9.8699999999999992 109.345 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.43 133.14 23.67 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 N-CA-C 108.86 -1.246 . . . . 9.5099999999999998 108.86 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.498 HD23 ' OD1' ' A' ' 32' ' ' ASP . 31.6 mt -61.59 157.17 17.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.076 0.465 . . . . 6.71 111.331 -172.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.16 133.26 22.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 116.065 -0.516 . . . . 7.8899999999999997 109.702 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.564 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 92.8 Cg_endo -78.65 138.18 14.99 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.912 1.741 . . . . 5.7699999999999996 112.613 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HB ' ' CE1' ' A' ' 57' ' ' TYR . 34.5 m -61.07 159.64 2.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.301 -1.318 . . . . 5.96 112.869 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 15.47 -87.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.564 1.946 . . . . 7.8399999999999999 115.11 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 26' ' ' ARG . 2.5 pt-20 -53.49 -34.49 58.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.244 -1.344 . . . . 6.6200000000000001 111.675 -170.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 31.6 tt0 . . . . . 0 C--N 1.319 -0.718 0 O-C-N 124.44 1.088 . . . . 8.5800000000000001 110.047 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 . . . . . 0 CA--C 1.51 -0.584 0 CA-C-O 121.484 0.659 . . . . 11.640000000000001 110.247 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.51 HG22 ' HA ' ' A' ' 148' ' ' VAL . 36.2 p -131.48 147.24 52.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.447 -1.251 . . . . 8.0 110.592 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.44 54.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.819 -0.808 . . . . 6.6500000000000004 108.819 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 29.9 tt0 -73.02 138.08 45.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.083 -0.508 . . . . 12.15 109.724 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' LEU . 54.4 t -58.96 135.21 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.522 -0.763 . . . . 9.7100000000000009 111.739 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 66.5 mmtt -126.89 154.36 44.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.327 -0.851 . . . . 11.029999999999999 111.56 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.8 mp -89.2 125.7 35.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.42 -0.956 . . . . 12.76 108.42 162.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.066 0 C-N-CA 118.979 -1.581 . . . . 13.25 113.371 -173.22 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 1.6 tt0 . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.817 0.817 . . . . 14.94 111.949 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -132.17 163.8 27.73 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.892 -1.503 . . . . 10.57 107.567 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -91.6 114.53 27.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.719 -0.474 . . . . 8.8800000000000008 109.719 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.14 130.61 37.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.951 -0.568 . . . . 9.7799999999999994 110.974 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.54 158.24 50.72 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.405 -0.816 . . . . 6.4000000000000004 109.628 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.572 ' HG2' HG11 ' A' ' 149' ' ' VAL . 34.5 Cg_exo -57.72 134.38 62.53 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.204 1.936 . . . . 6.5499999999999998 111.049 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 t -58.05 -28.23 64.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.916 0.339 . . . . 9.2899999999999991 111.916 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.05 1.24 51.1 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.234 -0.291 . . . . 10.859999999999999 111.552 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -76.75 -41.08 46.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.097 0.475 . . . . 5.3399999999999999 111.378 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.92 163.43 14.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.847 -0.615 . . . . 6.9699999999999998 112.073 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.4 mm -113.27 103.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.809 -0.632 . . . . 10.199999999999999 109.508 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.2 ptt180 -102.41 132.2 48.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 117.949 -1.501 . . . . 12.119999999999999 111.113 173.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -150.31 132.58 15.47 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.736 -1.575 . . . . 14.609999999999999 109.454 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.65 -108.79 2.14 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.519 -0.848 . . . . 15.52 112.317 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.5 29.09 7.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.381 0.511 . . . . 14.99 112.381 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -164.76 178.86 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.119 0.415 . . . . 15.199999999999999 112.119 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 7.2 m -133.15 152.29 51.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.668 -0.696 . . . . 9.2599999999999998 110.137 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 124' ' ' GLU . 34.4 mm -128.95 151.76 36.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.777 -0.453 . . . . 10.550000000000001 109.777 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.84 130.12 31.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.649 -0.13 . . . . 7.3899999999999997 110.649 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.4 mtm -89.31 101.47 14.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 8.8499999999999996 109.388 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 10.0 p -87.19 139.17 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.601 -0.727 . . . . 9.6899999999999995 111.364 -174.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.61 85.89 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 10.699999999999999 109.642 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -71.32 145.82 49.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 14.880000000000001 110.129 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.19 -7.78 33.36 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.031 -0.531 . . . . 16.920000000000002 113.168 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.33 10.98 17.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 18.559999999999999 110.966 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 14.4 69.3 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.487 -0.779 . . . . 15.619999999999999 113.282 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.0 167.47 21.09 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.683 -0.77 . . . . 14.19 111.501 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.7 m-85 -113.0 108.24 17.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.905 0.383 . . . . 12.029999999999999 110.047 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 16.8 t70 -101.54 141.11 21.93 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.054 -0.521 . . . . 13.91 110.637 -173.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 9.4 Cg_endo -86.19 124.7 2.5 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.485 2.123 . . . . 12.35 111.943 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 111' ' ' ALA . 8.7 p -107.47 131.8 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.397 -0.82 . . . . 9.4299999999999997 109.304 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 110' ' ' ILE . 31.2 tt0 -78.0 109.86 12.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.969 -0.752 . . . . 12.93 108.969 171.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.832 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -116.62 155.78 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.193 -0.912 . . . . 8.0299999999999994 111.465 -171.205 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -93.54 120.05 33.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.092 -0.958 . . . . 10.390000000000001 108.87 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.56 106.89 4.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.093 -0.503 . . . . 8.3000000000000007 111.004 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.52 70.53 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.893 -2.099 . . . . 10.1 114.215 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.43 162.85 39.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.16 -0.681 . . . . 10.609999999999999 109.16 155.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -141.64 123.61 15.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.178 0.513 . . . . 13.17 109.759 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.92 126.45 11.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.673 -0.694 . . . . 12.98 111.156 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.78 32.08 83.03 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 116.09 -0.505 . . . . 14.34 112.528 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.41 15.62 80.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.933 -0.651 . . . . 13.119999999999999 111.878 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -123.37 174.98 7.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.036 -0.727 . . . . 10.619999999999999 109.036 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.7 m -126.58 157.53 38.6 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.001 0.429 . . . . 7.8200000000000003 110.646 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 75.4 mt-10 -101.8 118.14 36.31 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.489 0.661 . . . . 10.789999999999999 110.888 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 125' ' ' VAL . 17.6 mm -86.09 101.23 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.097 -0.956 . . . . 6.7300000000000004 108.927 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 2.6 mp -71.09 -36.77 72.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.573 -1.194 . . . . 8.7899999999999991 110.264 -176.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 125' ' ' VAL . 12.5 tt0 -158.2 158.38 34.44 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.056 -0.72 . . . . 10.44 109.056 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 126.15 -33.69 3.43 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.903 -1.142 . . . . 8.8699999999999992 111.772 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.34 -176.9 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.859 0.689 . . . . 8.5 112.859 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -148.38 155.97 41.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.731 -1.122 . . . . 14.15 108.944 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.46 133.44 47.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.735 -0.666 . . . . 12.119999999999999 110.293 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.54 -5.41 44.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.817 -0.913 . . . . 11.539999999999999 110.817 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 84' ' ' VAL . 38.5 mt-30 -101.06 122.03 42.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.364 0.602 . . . . 11.24 109.391 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 55.8 mt-30 -91.27 124.97 35.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.955 . . . . 10.49 110.718 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.39 139.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.792 -0.448 . . . . 5.4500000000000002 109.792 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 81' ' ' THR . 35.3 m -65.36 132.25 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 6.5599999999999996 110.764 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.572 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.2 m . . . . . 0 C--N 1.319 -0.76 0 CA-C-O 121.891 0.853 . . . . 6.9900000000000002 109.247 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.398 0.518 . . . . 11.84 112.398 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -106.15 -161.38 0.79 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 12.24 109.761 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 61.7 tp 71.67 -71.25 0.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.202 0.601 . . . . 13.16 110.631 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.66 3.36 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.539 -0.755 . . . . 11.949999999999999 110.597 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.68 -21.67 65.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.841 -0.618 . . . . 11.220000000000001 110.056 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 p -59.1 -52.99 63.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.182 0.515 . . . . 11.9 110.17 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.94 -36.6 79.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.38 -0.827 . . . . 11.17 110.391 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.14 67.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.051 -0.977 . . . . 7.8200000000000003 111.3 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -76.38 -19.33 58.26 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.966 -0.383 . . . . 9.6400000000000006 109.966 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.01 -50.13 71.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.23 -0.655 . . . . 10.57 109.23 173.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -64.63 -34.97 79.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.257 -0.883 . . . . 8.9000000000000004 110.248 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.437 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 106.82 43.65 1.4 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.439 -0.801 . . . . 7.1500000000000004 111.666 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 49.2 p 54.95 -92.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.902 0.881 . . . . 7.0899999999999999 112.156 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.56 74.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.501 0.667 . . . . 9.1999999999999993 110.87 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 9.1099999999999994 111.277 -177.739 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 107.614 -1.254 . . . . 10.380000000000001 107.614 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.574 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 22.7 ptt85 -128.13 145.44 51.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.649 -1.614 . . . . 8.3699999999999992 109.093 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.658 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.5 mm -54.05 125.28 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 114.227 1.195 . . . . 5.7599999999999998 114.227 -166.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.5 mt -110.26 -37.24 5.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.205 -1.816 . . . . 8.2200000000000006 110.507 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 20.5 p90 -170.0 -176.03 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.397 . . . . 7.9900000000000002 111.369 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -123.86 148.82 46.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.533 -0.758 . . . . 5.6100000000000003 111.09 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -153.61 151.16 29.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.337 -0.392 . . . . 9.0600000000000005 110.631 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.746 ' HB3' HG22 ' A' ' 35' ' ' VAL . 6.1 t0 -75.82 129.16 81.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.011 -1.107 . . . . 8.3100000000000005 108.011 172.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 54' ' ' ILE . 18.7 Cg_exo -60.46 -16.99 45.38 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.098 1.865 . . . . 10.41 113.77 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -104.51 4.84 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.243 -0.583 . . . . 10.85 111.921 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.4 m -119.42 41.88 0.44 Allowed Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 112.387 0.514 . . . . 9.3200000000000003 112.387 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.09 134.63 65.62 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 11.1 112.465 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.08 43.38 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.976 -0.849 . . . . 10.31 110.976 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.578 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -92.86 116.42 29.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.217 0.532 . . . . 9.2100000000000009 110.371 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 49.4 ttp180 -104.34 116.57 32.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.667 -0.697 . . . . 11.51 111.334 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 97.5 m-85 -101.84 114.23 28.13 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.862 -1.162 . . . . 7.5 107.862 171.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -64.35 -21.58 66.67 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.522 -0.871 . . . . 10.609999999999999 111.703 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 52.9 mttp -126.18 166.68 20.16 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.339 -0.544 . . . . 10.91 111.234 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 14.1 Cg_endo -56.4 171.58 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.399 2.733 . . . . 7.5099999999999998 112.857 170.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.6 -170.8 29.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.651 -0.785 . . . . 7.5899999999999999 112.424 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 31.2 ttmt -95.58 146.78 24.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.465 -0.568 . . . . 11.68 109.465 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.4 t -64.51 129.69 94.33 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.684 -0.689 . . . . 9.1999999999999993 110.411 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.7 -26.35 33.09 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.44 2.093 . . . . 10.25 111.027 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 52.3 m-85 -73.98 -40.67 62.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.969 -1.468 . . . . 10.49 110.404 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.8 OUTLIER -154.52 160.96 41.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 10.380000000000001 110.788 174.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.2 p-10 -78.6 72.35 5.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.888 0.851 . . . . 12.539999999999999 112.804 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.2 ptm -140.41 144.74 38.12 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.531 -0.915 . . . . 9.8699999999999992 108.531 168.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.4 133.3 29.84 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.095 1.863 . . . . 9.5099999999999998 110.041 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.34 159.53 12.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.894 0.378 . . . . 6.71 110.382 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 33' ' ' PRO . 42.0 mm -103.24 130.84 22.83 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-O 121.25 0.548 . . . . 7.8899999999999997 109.752 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.636 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 80.6 Cg_endo -75.48 144.14 28.39 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.707 1.605 . . . . 5.7699999999999996 112.416 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.35 160.46 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.407 -1.27 . . . . 5.96 112.62 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.574 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.59 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.843 2.457 . . . . 7.8399999999999999 116.389 -175.001 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -61.06 -45.21 95.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.766 0.793 . . . . 6.6200000000000001 109.936 -173.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 47.5 mt-10 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 113.514 -1.675 . . . . 8.5800000000000001 114.695 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.155 -0.683 . . . . 11.640000000000001 109.155 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.9 p -140.4 144.11 36.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.082 0.468 . . . . 8.0 110.78 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.479 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -114.94 140.64 48.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.872 -0.788 . . . . 6.6500000000000004 108.872 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 34.4 tt0 -87.48 130.54 34.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.593 -0.521 . . . . 12.15 109.593 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 145' ' ' GLN . 61.2 t -54.69 128.96 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.432 0.635 . . . . 9.7100000000000009 111.554 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -163.02 140.3 7.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.486 -1.233 . . . . 11.029999999999999 109.981 171.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.88 HD23 ' H ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -77.58 158.01 30.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.148 -0.933 . . . . 12.76 110.484 -177.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.549 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.682 0 C-N-CA 120.883 -0.675 . . . . 13.25 112.427 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 121.493 0.663 . . . . 14.94 111.415 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 33.6 mmt180 -133.92 164.28 27.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.382 -1.281 . . . . 10.57 108.332 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.6 mp -85.16 112.21 20.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.101 -0.703 . . . . 8.8800000000000008 109.101 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.0 mm? -87.81 130.23 34.94 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.84 0.352 . . . . 9.7799999999999994 110.95 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.78 155.58 56.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 6.4000000000000004 109.045 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.93 136.92 67.96 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.121 1.881 . . . . 6.5499999999999998 111.117 170.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 15.9 t -56.46 -24.12 43.49 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.472 0.545 . . . . 9.2899999999999991 112.472 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.89 9.47 27.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.217 -0.302 . . . . 10.859999999999999 111.138 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -80.44 -41.11 25.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.244 0.545 . . . . 5.3399999999999999 111.339 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.8 155.61 19.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.646 0.736 . . . . 6.9699999999999998 112.546 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.37 131.43 46.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.731 -1.122 . . . . 10.199999999999999 109.1 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -102.28 126.55 49.31 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.534 -0.466 . . . . 12.119999999999999 110.823 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 t -149.67 132.93 16.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.275 -0.421 . . . . 14.609999999999999 110.466 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.33 -114.22 3.61 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.262 -0.494 . . . . 15.52 113.111 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.57 36.65 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.195 0.521 . . . . 14.99 111.243 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -153.3 167.53 29.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 15.199999999999999 111.758 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.2 m -117.44 145.15 44.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.066 -0.515 . . . . 9.2599999999999998 109.831 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.8 mm -125.49 153.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.306 -0.627 . . . . 10.550000000000001 109.306 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -129.42 129.88 45.24 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.353 -0.217 . . . . 7.3899999999999997 110.467 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 41.2 ttp -90.61 100.86 13.63 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 8.8499999999999996 108.668 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.3 p -84.49 133.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.49 -0.777 . . . . 9.6899999999999995 111.894 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.86 84.06 7.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 10.699999999999999 110.188 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.19 149.03 46.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 14.880000000000001 110.665 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.79 5.39 39.44 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.118 -0.793 . . . . 16.920000000000002 111.118 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -87.23 6.39 33.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.471 0.653 . . . . 18.559999999999999 110.528 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 1.27 77.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.231 -0.895 . . . . 15.619999999999999 113.469 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.78 159.17 22.87 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.735 -0.745 . . . . 14.19 112.426 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.486 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.5 m-85 -109.87 116.82 32.34 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.572 -0.529 . . . . 12.029999999999999 109.572 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.8 t70 -113.46 144.2 30.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.002 -0.279 . . . . 13.91 111.267 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -84.44 131.21 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.512 2.141 . . . . 12.35 112.505 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.619 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 10.6 p -122.97 136.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.595 . . . . 9.4299999999999997 110.27 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 110' ' ' ILE . 35.0 tt0 -83.11 120.23 25.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.97 0.414 . . . . 12.93 109.996 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 123' ' ' VAL . 22.8 m -129.11 165.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.031 -0.531 . . . . 8.0299999999999994 111.567 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.73 127.17 44.57 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.873 -0.603 . . . . 10.390000000000001 109.397 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.14 106.19 4.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.198 -0.455 . . . . 8.3000000000000007 111.393 -175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.75 71.05 0.28 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 117.655 -2.212 . . . . 10.1 114.094 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.51 162.16 40.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 10.609999999999999 108.817 155.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -146.96 129.76 16.17 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.645 -0.502 . . . . 13.17 109.645 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.96 110.72 4.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.034 -0.53 . . . . 12.98 111.364 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.61 40.28 90.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.056 -0.592 . . . . 14.34 112.9 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.79 0.73 90.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.72 -0.753 . . . . 13.119999999999999 112.543 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -114.49 155.69 25.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.507 -0.553 . . . . 10.619999999999999 109.507 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 57.7 m -113.4 164.85 13.07 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 110.072 -0.344 . . . . 7.8200000000000003 110.072 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.9 mt-10 -112.53 113.57 25.79 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.57 0.7 . . . . 10.789999999999999 111.283 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 34.9 mm -83.24 104.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.946 -1.024 . . . . 6.7300000000000004 108.401 170.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -70.34 -49.14 52.39 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.125 -0.943 . . . . 8.7899999999999991 109.922 -174.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -144.38 162.04 37.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 10.44 111.311 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 119.31 -52.99 0.69 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.871 -0.68 . . . . 8.8699999999999992 113.395 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 123' ' ' VAL . 16.0 mt -105.36 -171.63 1.95 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 8.5 111.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -144.26 155.37 43.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 14.15 110.066 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 129.51 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.15 -0.932 . . . . 12.119999999999999 110.348 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.28 -11.06 28.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.978 -0.849 . . . . 11.539999999999999 110.978 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 84' ' ' VAL . 88.5 mm-40 -94.19 118.22 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 11.24 109.465 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 64.6 mt-30 -85.38 132.38 34.24 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 10.49 110.797 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.4 m -122.8 142.34 39.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.184 -0.462 . . . . 5.4500000000000002 110.133 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 8.9 p -65.29 124.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.231 0.539 . . . . 6.5599999999999996 111.375 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 101' ' ' ALA . 10.9 m . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.273 0.558 . . . . 6.9900000000000002 111.083 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 153' ' ' PHE . 12.3 mm100 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 111.323 0.12 . . . . 11.84 111.323 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 152' ' ' GLN . 79.0 t80 72.01 -71.25 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.65 0.594 . . . . 12.24 111.062 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 155' ' ' ILE . 11.3 tp -118.02 -154.95 0.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.669 -0.863 . . . . 13.16 108.669 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.54 ' H ' ' HG ' ' A' ' 154' ' ' LEU . 61.0 mt -57.85 100.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.495 0.664 . . . . 11.949999999999999 110.191 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 5.6 p-10 -82.67 -6.44 59.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.472 -0.786 . . . . 11.220000000000001 111.09 -172.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.7 m -60.41 -42.89 96.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 11.9 110.807 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.41 -28.35 52.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.509 0.671 . . . . 11.17 109.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -74.6 -27.36 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 7.8200000000000003 111.987 -174.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 p -81.48 -38.6 26.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.947 0.403 . . . . 9.6400000000000006 110.804 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.52 -26.57 61.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.791 -0.64 . . . . 10.57 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 162' ' ' ARG . 1.8 ptm180 -94.63 161.68 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.667 0.746 . . . . 8.9000000000000004 110.084 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.86 -70.19 0.52 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.628 -1.389 . . . . 7.1500000000000004 109.628 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.7 p -144.98 -56.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.303 0.573 . . . . 7.0899999999999999 109.767 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.54 -70.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.604 -0.725 . . . . 9.1999999999999993 110.053 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.366 0 O-C-N 123.883 0.74 . . . . 9.1099999999999994 111.856 178.899 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.945 0 CA-C-O 122.757 1.265 . . . . 10.380000000000001 108.015 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.579 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 2.1 mmp_? -141.15 127.66 20.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.692 -1.594 . . . . 8.3699999999999992 109.203 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -55.04 140.47 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 122.361 1.077 . . . . 5.7599999999999998 112.7 -172.873 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -118.53 -39.2 3.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.35 -1.75 . . . . 8.2200000000000006 109.18 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 13.7 p90 -170.15 -178.21 2.75 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.85 . . . . 7.9900000000000002 110.011 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.76 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-90 -120.83 146.97 45.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.726 . . . . 5.6100000000000003 109.665 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 149.97 37.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.784 0.326 . . . . 9.0600000000000005 110.18 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.798 ' HB3' HG22 ' A' ' 35' ' ' VAL . 29.3 t0 -83.75 132.12 49.91 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 108.783 -0.821 . . . . 8.3100000000000005 108.783 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.432 ' CD ' HD13 ' A' ' 54' ' ' ILE . 39.3 Cg_exo -56.05 -18.77 24.03 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.674 2.249 . . . . 10.41 112.461 172.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.507 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -90.14 -1.94 58.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.754 0.279 . . . . 10.85 111.754 175.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -131.91 39.65 0.52 Allowed Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.911 0.708 . . . . 9.3200000000000003 112.911 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 19.1 Cg_endo -51.21 110.85 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.976 2.451 . . . . 11.1 112.799 -171.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.2 -31.81 3.38 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.766 -0.652 . . . . 10.31 111.503 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.494 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 5.6 tp-100 -70.52 107.38 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 9.2100000000000009 111.04 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.604 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 23.5 mtm180 -86.88 97.69 10.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.259 -0.882 . . . . 11.51 110.68 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.4 m-85 -75.11 143.55 43.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.75 -0.659 . . . . 7.5 109.232 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.54 -29.14 70.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.551 -1.204 . . . . 10.609999999999999 111.072 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 21.1 pttm -164.17 164.03 14.69 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.476 -0.329 . . . . 10.91 111.737 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.5 Cg_endo -50.75 170.85 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.006 3.137 . . . . 7.5099999999999998 113.712 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.55 -162.99 26.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.739 -0.744 . . . . 7.5899999999999999 112.115 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 37.6 ttpt -94.28 149.23 21.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.126 0.489 . . . . 11.68 110.687 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 49' ' ' MET . 34.2 t -65.64 132.47 94.96 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 115.122 -0.945 . . . . 9.1999999999999993 110.986 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.54 -24.72 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.204 1.936 . . . . 10.25 111.706 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' A' ' 35' ' ' VAL . 78.1 m-85 -76.5 -37.13 57.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.99 -1.005 . . . . 10.49 110.098 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.3 pmm? -156.92 163.6 38.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.865 -0.607 . . . . 10.380000000000001 110.224 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.0 75.68 10.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 12.539999999999999 114.471 -167.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -142.59 145.38 34.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.057 -0.72 . . . . 9.8699999999999992 109.057 168.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.9 Cg_exo -66.6 133.91 33.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.947 1.764 . . . . 9.5099999999999998 111.219 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 32' ' ' ASP . 31.6 mt -62.67 159.03 16.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.004 0.431 . . . . 6.71 111.181 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 ' CD ' ' A' ' 33' ' ' PRO . 1.7 mp -95.69 135.4 23.03 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.952 -0.567 . . . . 7.8899999999999997 109.691 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.577 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . 64.5 Cg_endo -87.52 162.1 8.06 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.585 1.524 . . . . 5.7699999999999996 113.286 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG22 HG13 ' A' ' 27' ' ' ILE . 32.6 m -89.26 156.49 3.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.647 -1.16 . . . . 5.96 111.709 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.579 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.73 -80.88 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 126.971 2.108 . . . . 7.8399999999999999 115.685 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.1 pt-20 -53.04 -39.98 63.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.942 -0.392 . . . . 6.6200000000000001 109.942 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 57' ' ' TYR . 52.3 mt-10 . . . . . 0 C--N 1.314 -0.949 0 CA-C-N 115.192 -0.913 . . . . 8.5800000000000001 110.976 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.202 -0.666 . . . . 11.640000000000001 109.202 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 148' ' ' VAL . 60.2 p -130.0 154.82 47.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.269 -0.423 . . . . 8.0 109.879 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 134.33 54.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 6.6500000000000004 109.231 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 32.8 tt0 -83.65 136.97 34.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.314 -0.624 . . . . 12.15 109.314 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 95' ' ' LEU . 71.8 t -60.51 129.01 22.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 9.7100000000000009 111.881 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 26.5 mmtp -129.51 151.0 50.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.64 -1.164 . . . . 11.029999999999999 109.622 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -84.98 162.37 19.41 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.728 -0.389 . . . . 12.76 109.967 169.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.273 0 C-N-CA 120.705 -0.76 . . . . 13.25 112.837 179.793 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HG2' HD23 ' A' ' 86' ' ' LEU . 3.8 mt-10 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 120.921 0.391 . . . . 14.94 109.981 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.506 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 3.1 tpp180 -122.64 159.94 26.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 10.57 110.358 -175.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -100.72 124.12 45.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.485 -0.561 . . . . 8.8800000000000008 109.485 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.65 130.36 45.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.22 -0.445 . . . . 9.7799999999999994 110.405 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.31 155.19 57.84 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.352 -0.84 . . . . 6.4000000000000004 109.734 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.05 127.45 25.03 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.053 1.836 . . . . 6.5499999999999998 111.124 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.489 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.5 p -54.26 -31.86 54.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.074 0.464 . . . . 9.2899999999999991 112.227 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.88 -17.38 64.61 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.742 -0.663 . . . . 10.859999999999999 112.405 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -83.8 -7.29 59.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 5.3399999999999999 111.31 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.539 HD21 HD11 ' A' ' 137' ' ' ILE . 26.5 mt -86.18 118.27 25.53 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.773 0.797 . . . . 6.9699999999999998 112.093 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -89.54 111.32 22.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.409 -1.269 . . . . 10.199999999999999 108.817 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.59 125.42 34.34 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.345 -0.542 . . . . 12.119999999999999 110.45 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -148.81 141.47 24.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.966 -0.561 . . . . 14.609999999999999 109.875 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.64 -117.74 6.21 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 121.266 -0.492 . . . . 15.52 112.313 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.0 37.1 4.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.166 0.508 . . . . 14.99 111.342 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -148.28 174.65 11.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.986 -0.552 . . . . 15.199999999999999 111.081 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 m -121.36 149.84 42.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.267 -0.642 . . . . 9.2599999999999998 109.267 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.8 mm -128.4 148.27 32.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.645 -0.502 . . . . 10.550000000000001 109.645 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.625 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -121.41 126.42 49.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.496 -0.32 . . . . 7.3899999999999997 110.205 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.442 ' HB2' HG22 ' A' ' 148' ' ' VAL . 59.4 mtp -82.27 99.68 9.46 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.416 -0.587 . . . . 8.8499999999999996 109.416 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.4 p -83.04 130.66 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.291 -0.868 . . . . 9.6899999999999995 111.288 -174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.83 89.27 7.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.546 -0.752 . . . . 10.699999999999999 109.454 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.22 157.76 35.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.73 -0.668 . . . . 14.880000000000001 111.647 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.86 17.49 21.29 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.418 -0.81 . . . . 16.920000000000002 111.501 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -103.6 8.73 37.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.354 0.597 . . . . 18.559999999999999 110.337 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.36 9.09 70.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.184 -0.917 . . . . 15.619999999999999 113.481 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.81 170.51 23.97 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.2 -1.0 . . . . 14.19 113.038 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.4 m-85 -121.46 123.7 42.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.869 -0.419 . . . . 12.029999999999999 109.869 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.544 ' O ' HG12 ' A' ' 113' ' ' VAL . 26.1 m-20 -123.51 151.05 62.66 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.791 -0.364 . . . . 13.91 111.404 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.15 122.69 2.2 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.048 1.832 . . . . 12.35 112.31 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 8.1 p -108.28 132.76 55.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.32 -0.855 . . . . 9.4299999999999997 109.784 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.6 tt0 -72.96 119.91 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.818 -0.438 . . . . 12.93 109.818 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.533 HG13 HG13 ' A' ' 123' ' ' VAL . 31.3 m -127.91 159.28 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 8.0299999999999994 111.584 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' HD22 ' A' ' 138' ' ' LEU . 39.8 ttmt -104.46 128.88 52.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.319 -0.855 . . . . 10.390000000000001 109.32 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.96 106.73 5.12 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 111.82 0.304 . . . . 8.3000000000000007 111.82 -174.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.18 70.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 117.983 -2.056 . . . . 10.1 114.82 165.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.15 163.44 38.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.446 -1.316 . . . . 10.609999999999999 107.446 150.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -140.65 128.83 22.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.7 0.682 . . . . 13.17 110.375 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.86 117.3 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.136 0.421 . . . . 12.98 112.136 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 39.76 98.35 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 115.948 -0.569 . . . . 14.34 113.344 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.84 82.29 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.724 -0.75 . . . . 13.119999999999999 112.471 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -122.26 163.02 20.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.56 -0.904 . . . . 10.619999999999999 108.56 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.0 p -114.46 149.74 35.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.307 -0.557 . . . . 7.8200000000000003 112.035 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.2 mp0 -93.43 119.17 32.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.46 -0.791 . . . . 10.789999999999999 111.513 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.539 HD11 HD21 ' A' ' 102' ' ' LEU . 16.2 mm -91.5 111.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.295 -0.866 . . . . 6.7300000000000004 109.333 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -75.02 -51.59 13.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.63 -1.168 . . . . 8.7899999999999991 109.487 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -143.05 169.03 18.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.067 -0.97 . . . . 10.44 110.893 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 117.38 -71.73 0.29 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.528 -0.844 . . . . 8.8699999999999992 113.374 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 42.8 tp -108.56 172.41 6.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.778 0.289 . . . . 8.5 110.666 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.482 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 88.0 tttt -122.56 154.62 37.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.812 0.815 . . . . 14.15 111.656 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -66.25 135.13 54.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 113.979 -1.464 . . . . 12.119999999999999 109.834 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.48 -2.8 56.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.354 -0.927 . . . . 11.539999999999999 111.439 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -103.51 152.65 21.44 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.849 -0.797 . . . . 11.24 108.849 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 99.2 mt-30 -104.04 149.88 24.78 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.078 0.466 . . . . 10.49 111.203 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.9 m -135.73 146.66 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.644 -0.707 . . . . 5.4500000000000002 109.286 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 112' ' ' MET . 27.7 m -72.88 128.13 35.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.352 0.596 . . . . 6.5599999999999996 110.824 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.7 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.697 -0.683 . . . . 6.9900000000000002 110.702 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.186 0.517 . . . . 11.84 112.217 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.495 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 32.8 p90 -117.64 134.63 54.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.199 0.523 . . . . 12.24 111.115 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 158' ' ' GLU . 94.5 mt -87.22 -165.3 1.26 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.558 -0.746 . . . . 13.16 110.773 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 157' ' ' SER . 36.2 pt -78.46 -161.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 11.949999999999999 111.436 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -55.63 -23.79 29.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.307 0.484 . . . . 11.220000000000001 112.307 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.44 ' H ' HG13 ' A' ' 155' ' ' ILE . 15.8 m -54.71 -48.49 72.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.024 0.44 . . . . 11.9 110.669 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 153' ' ' PHE . 20.1 tt0 -61.17 -29.8 70.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.369 -0.832 . . . . 11.17 110.296 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.06 -25.73 31.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.954 -0.566 . . . . 7.8200000000000003 112.028 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.0 t -75.91 -30.18 58.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.196 -0.668 . . . . 9.6400000000000006 109.196 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 162' ' ' ARG . 3.5 pp -88.3 -30.19 19.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.719 -0.673 . . . . 10.57 112.407 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 161' ' ' LEU . 25.3 ptt180 -80.73 132.78 35.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 8.9000000000000004 110.637 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.86 74.02 0.21 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.729 -0.748 . . . . 7.1500000000000004 111.815 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.7 p 47.15 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.556 0.742 . . . . 7.0899999999999999 111.787 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.4 t 64.48 82.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.419 -0.585 . . . . 9.1999999999999993 109.419 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.329 -0.851 . . . . 9.1099999999999994 110.994 -177.716 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 5.0 ptmm? . . . . . 0 N--CA 1.439 -0.996 0 CA-C-O 122.152 0.977 . . . . 10.380000000000001 109.958 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.522 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 45.1 mtm180 -134.65 140.34 45.95 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.927 -1.488 . . . . 8.3699999999999992 109.217 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.767 HG21 ' CZ3' ' A' ' 30' ' ' TRP . 22.7 mm -54.85 129.73 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 122.455 1.121 . . . . 5.7599999999999998 113.701 -167.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.86 HD13 ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -89.87 -29.49 18.54 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 112.355 -2.202 . . . . 8.2200000000000006 111.376 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CD1' HD13 ' A' ' 28' ' ' LEU . 46.3 p90 158.0 -172.9 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.055 1.342 . . . . 7.9900000000000002 107.597 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.767 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.3 m-90 -116.95 142.69 46.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.744 0.307 . . . . 5.6100000000000003 110.835 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -148.28 154.62 40.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 9.0600000000000005 110.476 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.667 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -92.41 137.11 24.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.556 -0.905 . . . . 8.3100000000000005 108.556 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.65 -13.63 35.04 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.313 2.008 . . . . 10.41 112.191 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -99.72 2.31 44.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.59 -0.277 . . . . 10.85 111.206 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.8 m -128.86 40.89 0.65 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.396 0.517 . . . . 9.3200000000000003 112.396 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 14.5 Cg_endo -52.3 113.38 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.916 2.411 . . . . 11.1 112.809 -172.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.3 -35.87 2.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.46 -0.656 . . . . 10.31 111.46 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -64.2 103.09 0.58 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.641 0.734 . . . . 9.2100000000000009 110.856 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.784 ' NH1' ' HA ' ' A' ' 41' ' ' ASP . 2.1 tmm_? -81.96 103.49 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.015 -0.993 . . . . 11.51 109.702 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -87.91 133.59 33.89 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.297 -1.001 . . . . 7.5 108.297 173.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 17.8 t70 -63.89 -35.05 79.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.924 -1.035 . . . . 10.609999999999999 110.518 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.2 mttp -148.37 162.33 30.73 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.955 -0.566 . . . . 10.91 110.721 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.5 Cg_endo -50.21 171.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.01 3.14 . . . . 7.5099999999999998 113.857 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.54 -165.91 27.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 7.5899999999999999 112.491 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 7.7 ttmt -91.33 144.24 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.237 -0.653 . . . . 11.68 109.237 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 49' ' ' MET . 10.6 t -70.76 145.78 92.57 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.43 . . . . 9.1999999999999993 110.863 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.52 -20.85 7.83 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.765 2.31 . . . . 10.25 111.547 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.774 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 96.4 m-85 -84.6 -39.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.426 -1.261 . . . . 10.49 109.842 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.774 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -136.66 151.92 49.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.663 -0.698 . . . . 10.380000000000001 110.522 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.5 p-10 -79.23 53.14 1.43 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.864 0.84 . . . . 12.539999999999999 111.418 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG2' ' HB2' ' A' ' 49' ' ' MET . 16.4 ptm -127.02 146.59 58.27 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.418 -0.81 . . . . 9.8699999999999992 109.682 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' MET . 8.2 Cg_exo -69.58 133.5 26.04 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.143 1.896 . . . . 9.5099999999999998 110.286 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.69 156.68 13.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.397 0.436 . . . . 6.71 110.592 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.65 131.16 27.51 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 121.205 0.526 . . . . 7.8899999999999997 110.311 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 59' ' ' GLU . 96.7 Cg_endo -85.09 156.5 11.27 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.117 1.878 . . . . 5.7699999999999996 113.158 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 28' ' ' LEU . 27.2 m -86.73 160.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.555 -1.202 . . . . 5.96 111.136 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.522 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 5.84 -71.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.392 2.277 . . . . 7.8399999999999999 116.478 -176.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.682 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.8 pt-20 -65.47 -39.22 91.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.125 0.964 . . . . 6.6200000000000001 110.726 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.592 ' HA ' HD11 ' A' ' 27' ' ' ILE . 9.9 pt-20 . . . . . 0 CA--C 1.509 -0.601 0 CA-C-N 112.473 -2.148 . . . . 8.5800000000000001 114.02 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 149' ' ' VAL . 18.1 tpt180 . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 121.802 0.811 . . . . 11.640000000000001 112.762 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 148' ' ' VAL . 19.8 p -106.8 139.3 41.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.772 -1.104 . . . . 8.0 108.052 170.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 147' ' ' VAL . . . -107.69 127.85 54.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.607 -0.516 . . . . 6.6500000000000004 109.607 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 43.5 tt0 -82.25 140.48 33.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.069 0.461 . . . . 12.15 110.696 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.715 HG11 HD23 ' A' ' 95' ' ' LEU . 79.7 t -62.92 130.67 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.325 -0.852 . . . . 9.7100000000000009 112.026 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 27.5 mmtp -137.23 153.45 50.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.465 -1.243 . . . . 11.029999999999999 109.266 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 93' ' ' GLU . 9.7 mp -83.73 152.02 24.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.758 -0.46 . . . . 12.76 109.758 168.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.477 0 N-CA-C 111.47 -0.652 . . . . 13.25 111.47 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HG2' HD23 ' A' ' 86' ' ' LEU . 1.9 mp0 . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 121.414 0.626 . . . . 14.94 110.98 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 41.1 mmt180 -131.11 156.09 45.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.972 -1.013 . . . . 10.57 110.778 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.715 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -87.32 114.88 24.33 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.987 -1.006 . . . . 8.8800000000000008 110.465 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.65 130.69 35.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.693 0.282 . . . . 9.7799999999999994 110.826 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.96 152.94 56.44 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.431 -0.804 . . . . 6.4000000000000004 109.856 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 149' ' ' VAL . 41.8 Cg_exo -56.3 122.64 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.094 1.863 . . . . 6.5499999999999998 110.35 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.4 p -62.7 -22.81 66.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 9.2899999999999991 112.845 -164.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.19 -4.88 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 119.754 -0.165 . . . . 10.859999999999999 111.177 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -40.93 68.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 5.3399999999999999 110.452 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 104' ' ' ARG . 3.2 pp -78.73 160.3 27.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.229 -0.896 . . . . 6.9699999999999998 111.424 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 mm -117.11 103.72 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.282 -0.417 . . . . 10.199999999999999 110.595 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -113.76 95.18 5.2 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.543 -1.263 . . . . 12.119999999999999 111.888 174.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 t -103.79 136.62 43.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.843 -1.526 . . . . 14.609999999999999 109.212 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.14 -113.13 4.18 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.343 -0.932 . . . . 15.52 112.018 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.8 28.16 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.268 0.84 . . . . 14.99 113.268 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -170.08 171.0 7.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.374 0.509 . . . . 15.199999999999999 112.374 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 1.8 m -121.89 155.3 35.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 9.2599999999999998 111.767 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 36.5 mm -129.29 150.18 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.362 -0.836 . . . . 10.550000000000001 109.467 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -134.19 127.14 31.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.297 -0.26 . . . . 7.3899999999999997 110.297 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 148' ' ' VAL . 4.1 mpp? -93.55 99.82 12.2 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.197 -0.668 . . . . 8.8499999999999996 109.197 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.7 p -77.33 139.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.06 -0.973 . . . . 9.6899999999999995 110.403 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -78.58 92.58 4.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.076 -0.511 . . . . 10.699999999999999 111.525 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 50.5 mttm -76.25 178.69 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 14.880000000000001 110.896 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.93 25.78 7.79 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.765 -0.934 . . . . 16.920000000000002 110.765 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.16 12.9 33.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.968 0.358 . . . . 18.559999999999999 111.968 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.16 16.76 36.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 15.619999999999999 113.159 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 115' ' ' LYS . . . 179.47 173.69 44.85 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.881 -0.888 . . . . 14.19 110.881 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 148' ' ' VAL . 54.3 m-85 -87.54 -176.54 5.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.991 0.424 . . . . 12.029999999999999 110.626 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 11.5 t70 -140.89 120.04 8.36 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.742 -0.663 . . . . 13.91 109.368 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.0 110.55 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.166 2.578 . . . . 12.35 112.537 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 125' ' ' VAL . 13.9 p -104.91 140.45 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.121 -0.945 . . . . 9.4299999999999997 109.915 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.87 112.03 18.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 12.93 109.726 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 123' ' ' VAL . 23.2 m -117.03 163.31 14.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.662 -0.699 . . . . 8.0299999999999994 111.23 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -100.68 133.85 44.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.582 -0.735 . . . . 10.390000000000001 109.219 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.56 103.14 4.48 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.964 -0.295 . . . . 8.3000000000000007 111.43 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -152.88 69.89 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.142 -1.98 . . . . 10.1 113.633 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.37 163.85 37.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.49 -1.3 . . . . 10.609999999999999 107.49 154.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -143.61 130.41 20.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.787 0.722 . . . . 13.17 111.036 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.12 120.87 9.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 12.98 110.616 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.23 36.11 92.98 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.316 -0.469 . . . . 14.34 112.91 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 12.45 83.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.858 -0.687 . . . . 13.119999999999999 112.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -120.87 158.97 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.006 -0.368 . . . . 10.619999999999999 110.006 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 157.91 16.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.867 0.365 . . . . 7.8200000000000003 110.045 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.992 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 32.0 mt-10 -106.78 115.33 30.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.474 0.654 . . . . 10.789999999999999 109.821 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.7 mm -81.67 104.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.974 -1.012 . . . . 6.7300000000000004 109.154 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 3.0 mp -69.57 -44.97 69.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.607 -1.179 . . . . 8.7899999999999991 110.562 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.59 158.13 44.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.779 -0.646 . . . . 10.44 111.327 -175.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.85 -53.31 0.64 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.287 -0.959 . . . . 8.8699999999999992 114.529 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.436 HD21 HG11 ' A' ' 123' ' ' VAL . 18.0 mt -107.51 -170.9 1.77 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.434 0.531 . . . . 8.5 112.434 -174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.96 150.94 37.83 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.683 -0.689 . . . . 14.15 111.001 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.57 133.54 49.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.718 -1.128 . . . . 12.119999999999999 109.9 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.46 -2.3 53.65 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.244 -0.979 . . . . 11.539999999999999 111.575 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -104.05 143.57 32.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.254 -0.647 . . . . 11.24 109.254 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 82.9 mt-30 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.022 0.439 . . . . 10.49 111.593 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' ALA . 30.0 m -132.18 142.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 5.4500000000000002 108.704 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.9 p -76.7 104.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.755 0.788 . . . . 6.5599999999999996 110.956 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 N-CA-C 108.148 -1.056 . . . . 6.9900000000000002 108.148 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 120.908 0.385 . . . . 11.84 110.582 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -152.18 91.18 1.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.533 0.568 . . . . 12.24 112.533 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.9 tp -115.78 -62.12 1.64 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.017 -1.105 . . . . 13.16 108.017 164.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.93 6.0 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.399 -1.334 . . . . 11.949999999999999 107.399 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.5 m-20 -83.44 35.65 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.71 -2.041 . . . . 11.220000000000001 111.537 -171.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -49.01 -49.08 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.364 0.875 . . . . 11.9 113.364 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -73.72 -26.4 60.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 11.17 110.002 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 156' ' ' ASP . . . -75.95 -20.96 57.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.173 -0.921 . . . . 7.8200000000000003 111.432 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.2 m -69.22 -29.94 67.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.0 0.905 . . . . 9.6400000000000006 109.244 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.23 -43.09 12.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.153 -1.385 . . . . 10.57 109.374 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 23.5 ttt180 -51.85 128.35 23.67 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.006 1.323 . . . . 8.9000000000000004 112.891 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -117.85 31.16 5.81 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.43 -1.068 . . . . 7.1500000000000004 110.43 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.6 p -70.71 126.27 29.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 123.924 0.426 . . . . 7.0899999999999999 111.54 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 26' ' ' ARG . 48.2 t 54.21 82.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 9.1999999999999993 111.332 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.81 -0.632 . . . . 9.1099999999999994 110.456 179.0 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 pttp . . . . . 0 N--CA 1.439 -1.014 0 CA-C-O 122.159 0.981 . . . . 10.380000000000001 109.725 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.564 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 29.7 mtm180 -132.47 135.35 45.98 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.276 -1.329 . . . . 8.3699999999999992 109.045 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG12 ' OE1' ' A' ' 58' ' ' GLU . 34.7 mm -48.22 126.44 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 113.426 0.899 . . . . 5.7599999999999998 113.426 -171.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.63 -34.73 5.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.824 -1.534 . . . . 8.2200000000000006 109.821 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.691 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.5 p90 -168.92 -175.17 2.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.253 -0.43 . . . . 7.9900000000000002 111.007 -174.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.43 153.68 43.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.707 -0.679 . . . . 5.6100000000000003 111.666 -172.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB2' HE22 ' A' ' 38' ' ' GLN . 39.0 ptt180 -157.48 146.06 19.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.851 -0.613 . . . . 9.0600000000000005 110.435 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.903 ' HB3' HG22 ' A' ' 35' ' ' VAL . 7.6 t0 -83.03 134.5 46.28 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 8.3100000000000005 108.777 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.84 -22.53 62.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.233 2.622 . . . . 10.41 111.824 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.561 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -75.81 -22.22 56.56 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.895 -1.048 . . . . 10.85 110.647 178.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.3 m -128.3 50.33 5.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 121.529 0.681 . . . . 9.3200000000000003 111.813 -166.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.78 119.59 6.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.187 2.591 . . . . 11.1 112.057 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.17 -30.53 4.08 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.414 -0.674 . . . . 10.31 111.414 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.642 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -70.55 136.43 49.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 9.2100000000000009 109.797 174.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.86 98.97 5.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.122 -0.49 . . . . 11.51 110.749 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.691 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 m-85 -80.07 135.65 36.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.589 . . . . 7.5 111.017 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.98 -25.39 67.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.347 -0.842 . . . . 10.609999999999999 110.379 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -165.23 147.5 6.64 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-O 121.321 0.582 . . . . 10.91 110.531 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -51.61 128.92 27.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 125.139 3.893 . . . . 7.5099999999999998 113.962 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.53 -161.71 11.49 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.232 -0.747 . . . . 7.5899999999999999 111.232 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 25.8 ttpp -90.46 150.53 21.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.167 0.508 . . . . 11.68 109.979 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.8 t -65.82 135.13 95.34 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.211 -0.904 . . . . 9.1999999999999993 110.138 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.83 -25.71 11.96 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.192 1.928 . . . . 10.25 111.626 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CD2' HG11 ' A' ' 35' ' ' VAL . 98.1 m-85 -77.53 -38.08 49.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.872 -1.058 . . . . 10.49 109.995 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -153.09 164.8 37.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.089 -0.505 . . . . 10.380000000000001 110.736 172.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 5.4 p-10 -82.69 76.69 9.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.748 1.018 . . . . 12.539999999999999 113.748 -170.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.1 ptm -143.14 141.02 18.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.757 -1.11 . . . . 9.8699999999999992 108.036 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 17.8 Cg_endo -62.11 133.58 44.76 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.24 1.293 . . . . 9.5099999999999998 109.512 172.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.0 mt -59.49 160.11 7.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.204 -0.453 . . . . 6.71 111.419 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.6 mm -95.67 132.58 27.1 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 7.8899999999999997 109.657 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 90.6 Cg_endo -79.22 141.82 16.51 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 121.468 1.445 . . . . 5.7699999999999996 112.797 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.04 158.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.585 -1.189 . . . . 5.96 113.326 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 21.85 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.948 2.099 . . . . 7.8399999999999999 115.475 -177.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.592 ' OE1' HG12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -51.14 -37.75 48.0 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.776 1.274 . . . . 6.6200000000000001 110.16 -176.525 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 CA--C 1.503 -0.852 0 CA-C-N 111.835 -2.438 . . . . 8.5800000000000001 110.589 171.716 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.316 0.579 . . . . 11.640000000000001 109.72 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 148' ' ' VAL . 67.2 p -133.09 144.96 50.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.292 -0.867 . . . . 8.0 109.777 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.27 127.26 55.79 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.837 -0.801 . . . . 6.6500000000000004 108.837 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.89 135.47 37.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.947 -0.39 . . . . 12.15 109.947 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 95' ' ' LEU . 75.8 t -59.89 128.84 21.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.713 -0.676 . . . . 9.7100000000000009 112.416 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -135.24 148.41 49.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.501 -1.227 . . . . 11.029999999999999 109.005 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -78.9 147.73 32.97 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.965 -0.694 . . . . 12.76 109.453 169.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.361 -0.923 . . . . 13.25 112.811 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' HD23 ' A' ' 86' ' ' LEU . 3.3 tt0 . . . . . 0 CA--C 1.513 -0.463 0 CA-C-O 121.071 0.463 . . . . 14.94 111.422 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -115.34 173.88 6.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 10.57 110.139 -175.88 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 84' ' ' VAL . 1.3 pt? -109.14 114.34 27.97 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.588 -0.893 . . . . 8.8800000000000008 108.588 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -94.74 131.05 40.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.665 -1.152 . . . . 9.7799999999999994 111.718 -166.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 137' ' ' ILE . 32.7 m -136.85 157.07 75.53 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.845 -1.07 . . . . 6.4000000000000004 108.638 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.446 ' HG2' HG11 ' A' ' 149' ' ' VAL . 76.0 Cg_exo -52.49 129.31 31.38 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.738 1.626 . . . . 6.5499999999999998 111.398 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 p -63.62 -22.91 67.15 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.451 0.643 . . . . 9.2899999999999991 111.16 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -78.14 0.44 24.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.204 -0.907 . . . . 10.859999999999999 110.811 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -102.76 -1.37 30.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.775 -0.648 . . . . 5.3399999999999999 112.598 -174.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -115.76 156.47 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 6.9699999999999998 112.247 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.7 mm -101.46 124.36 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 10.199999999999999 109.982 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 18.8 mmm180 -96.18 125.48 40.73 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.868 -0.733 . . . . 12.119999999999999 110.452 173.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -149.13 137.16 20.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 14.609999999999999 110.556 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.4 -114.61 2.69 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 116.114 -0.494 . . . . 15.52 112.797 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.76 33.39 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.993 0.425 . . . . 14.99 111.394 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -179.21 7.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.163 -0.471 . . . . 15.199999999999999 111.381 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 10.7 m -131.43 152.51 50.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.922 -0.581 . . . . 9.2599999999999998 110.392 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 25.3 mm -126.47 146.13 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.295 -0.261 . . . . 10.550000000000001 110.295 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -122.65 137.41 54.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.454 . . . . 7.3899999999999997 109.989 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 45.2 mtm -92.85 99.93 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.722 -0.844 . . . . 8.8499999999999996 108.722 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 121' ' ' ASP . 8.4 p -81.47 131.85 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.242 0.544 . . . . 9.6899999999999995 110.696 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' A' ' 146' ' ' GLN . . . -86.87 91.31 8.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.59 -0.732 . . . . 10.699999999999999 110.417 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HD2' ' OD2' ' A' ' 121' ' ' ASP . 55.5 mttp -70.83 151.17 45.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 14.880000000000001 109.984 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.05 7.93 19.23 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 16.920000000000002 111.486 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -95.05 10.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.504 0.669 . . . . 18.559999999999999 110.973 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.64 75.16 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.163 -0.926 . . . . 15.619999999999999 113.613 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.24 25.84 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.482 -0.865 . . . . 14.19 112.441 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 40.5 m-85 -114.34 116.88 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.026 0.441 . . . . 12.029999999999999 109.933 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 113' ' ' VAL . 25.9 m-20 -106.17 141.89 23.71 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.882 -0.599 . . . . 13.91 110.323 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 60.2 Cg_endo -83.67 127.18 4.23 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.874 1.716 . . . . 12.35 112.742 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.74 124.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 9.4299999999999997 109.321 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -72.57 127.09 31.49 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.149 -0.686 . . . . 12.93 109.149 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -135.68 151.69 30.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.794 0.807 . . . . 8.0299999999999994 111.569 -173.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 25.3 ttmm -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.231 -1.349 . . . . 10.390000000000001 109.518 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.58 110.3 17.19 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 123.108 1.433 . . . . 8.3000000000000007 112.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 138' ' ' LEU . . . -89.74 174.94 41.61 Favored Glycine 0 N--CA 1.411 -2.984 0 CA-C-N 111.25 -2.704 . . . . 10.1 110.718 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.17 161.32 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 126.07 1.748 . . . . 10.609999999999999 114.6 -167.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -100.88 139.24 36.86 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.312 -0.858 . . . . 13.17 108.721 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.84 111.99 4.64 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.851 0.358 . . . . 12.98 111.477 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.11 34.17 75.42 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.806 -0.712 . . . . 14.34 112.792 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.19 2.83 89.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.825 -0.703 . . . . 13.119999999999999 112.236 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -115.87 156.39 26.22 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.62 -0.511 . . . . 10.619999999999999 109.62 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 p -105.42 150.67 25.07 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.975 0.417 . . . . 7.8200000000000003 111.326 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.79 100.51 11.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.925 -0.579 . . . . 10.789999999999999 109.619 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.74 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 20.3 mm -83.81 112.9 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 O-C-N 121.569 -0.707 . . . . 6.7300000000000004 109.502 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -83.04 -47.45 11.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.177 -0.919 . . . . 8.7899999999999991 110.288 -173.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -147.82 159.82 43.42 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.148 -0.686 . . . . 10.44 109.148 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 130.74 -61.28 0.67 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.046 -1.073 . . . . 8.8699999999999992 112.318 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' A' ' 111' ' ' ALA . 26.5 mt -109.64 -170.83 1.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.262 0.553 . . . . 8.5 112.162 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -145.53 154.35 42.1 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.261 -0.882 . . . . 14.15 109.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.8 130.7 43.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.018 -0.992 . . . . 12.119999999999999 109.658 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.81 -1.51 38.86 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.721 -0.752 . . . . 11.539999999999999 111.232 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -103.57 139.21 39.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.55 -0.537 . . . . 11.24 109.55 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 48.2 mt-30 -91.03 138.72 31.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.891 0.377 . . . . 10.49 110.771 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.82 137.01 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.236 -0.438 . . . . 5.4500000000000002 109.823 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 81' ' ' THR . 57.5 t -68.07 112.77 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.973 -0.558 . . . . 6.5599999999999996 111.003 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' A' ' 98' ' ' PRO . 2.7 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.476 0.655 . . . . 6.9900000000000002 109.995 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.405 0.622 . . . . 11.84 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -110.54 104.39 13.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.715 . . . . 12.24 109.506 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.84 63.5 4.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.521 0.677 . . . . 13.16 110.301 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 pt -131.47 40.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.216 -0.902 . . . . 11.949999999999999 109.732 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.45 -34.66 69.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.906 -0.588 . . . . 11.220000000000001 111.081 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.616 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 15.8 m -59.03 -58.36 9.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.657 -0.497 . . . . 11.9 109.657 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -56.61 -41.95 77.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.895 -1.048 . . . . 11.17 110.456 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -63.64 -33.88 76.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.151 -0.932 . . . . 7.8200000000000003 111.733 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.3 t -72.94 -37.44 67.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.633 0.73 . . . . 9.6400000000000006 109.818 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 157' ' ' SER . 79.2 mt -71.29 -38.89 71.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.739 -1.119 . . . . 10.57 111.151 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 31.7 ptt180 -80.0 -39.13 30.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.929 -0.578 . . . . 8.9000000000000004 110.598 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.9 -57.17 5.02 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.196 -1.002 . . . . 7.1500000000000004 111.943 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.3 p 45.16 67.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.173 0.589 . . . . 7.0899999999999999 111.605 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 m 47.99 30.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.68 1.192 . . . . 9.1999999999999993 112.946 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.25 0 CA-C-N 115.782 -0.644 . . . . 9.1099999999999994 111.659 175.278 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 108.019 -1.104 . . . . 10.380000000000001 108.019 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HD3' ' OE1' ' A' ' 58' ' ' GLU . 13.1 mmt180 -133.57 140.52 47.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.922 -1.49 . . . . 8.3699999999999992 109.74 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.873 HG12 ' OE2' ' A' ' 58' ' ' GLU . 23.6 mm -55.98 129.93 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 113.016 0.747 . . . . 5.7599999999999998 113.016 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -113.23 -16.0 12.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.769 -1.105 . . . . 8.2200000000000006 109.795 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 10.9 p90 167.44 179.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 7.9900000000000002 110.359 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.765 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.7 m-90 -113.24 143.23 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.072 -0.967 . . . . 5.6100000000000003 111.328 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.649 ' HB2' HE22 ' A' ' 38' ' ' GLN . 5.6 ptp180 -151.15 151.32 31.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 9.0600000000000005 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.934 ' HB3' HG22 ' A' ' 35' ' ' VAL . 8.4 t70 -79.72 132.72 60.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.697 -0.853 . . . . 8.3100000000000005 108.697 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -63.28 -13.71 37.53 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.095 1.863 . . . . 10.41 112.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.416 ' HE3' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -98.08 0.84 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.762 -0.199 . . . . 10.85 111.466 178.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 32' ' ' ASP . 10.9 m -129.62 48.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 121.351 0.596 . . . . 9.3200000000000003 112.085 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.64 103.41 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.837 2.358 . . . . 11.1 113.245 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.5 -37.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 10.31 111.95 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.48 151.73 45.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.363 . . . . 9.2100000000000009 110.198 177.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.658 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 2.6 tmm_? -136.35 98.83 3.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.6 -0.519 . . . . 11.51 109.6 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 42.1 m-85 -76.96 141.48 40.42 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.377 0.608 . . . . 7.5 110.972 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.7 -30.51 71.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.069 -1.423 . . . . 10.609999999999999 109.932 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 15.8 pttm -165.01 165.94 11.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.182 -0.917 . . . . 10.91 110.341 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.692 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -47.84 167.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.565 2.843 . . . . 7.5099999999999998 113.654 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.08 -162.0 29.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.508 -0.853 . . . . 7.5899999999999999 112.645 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.534 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.6 ttmt -103.48 140.63 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.05 -0.352 . . . . 11.68 110.05 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 49' ' ' MET . 22.6 t -65.38 142.37 98.4 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 9.1999999999999993 110.649 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' CD ' ' HZ ' ' A' ' 40' ' ' PHE . 56.8 Cg_endo -79.16 -20.9 9.63 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.549 2.166 . . . . 10.25 111.33 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.473 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 53.0 m-85 -84.5 -39.64 18.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.218 -1.355 . . . . 10.49 109.726 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.552 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER -132.83 147.31 52.3 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.802 -0.635 . . . . 10.380000000000001 109.82 174.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.9 p-10 -77.82 58.23 1.84 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.084 0.945 . . . . 12.539999999999999 110.772 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 49' ' ' MET . 15.6 ptm -132.7 139.98 36.34 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.831 -1.077 . . . . 9.8699999999999992 109.649 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 18.1 Cg_endo -60.58 134.17 52.95 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.522 2.148 . . . . 9.5099999999999998 110.249 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 32' ' ' ASP . 1.4 mm? -56.65 157.3 5.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.803 -0.359 . . . . 6.71 110.367 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.97 129.76 28.97 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-O 121.272 0.558 . . . . 7.8899999999999997 109.872 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 95.4 Cg_endo -82.12 138.66 10.25 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 121.842 1.695 . . . . 5.7699999999999996 112.797 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 32.0 m -56.19 157.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.198 -1.365 . . . . 5.96 112.454 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.14 -72.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.453 2.301 . . . . 7.8399999999999999 116.434 -177.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.873 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.6 pt-20 -59.47 -32.71 70.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.458 0.647 . . . . 6.6200000000000001 110.065 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 13.8 pt-20 . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 113.445 -1.707 . . . . 8.5800000000000001 112.458 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 89.2 mtm180 . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 111.397 0.147 . . . . 11.640000000000001 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 80.7 p -156.39 170.63 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.957 0.786 . . . . 8.0 111.18 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.49 141.41 18.19 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.401 -1.333 . . . . 6.6500000000000004 107.401 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 44.2 tt0 -97.21 136.46 37.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.616 -0.434 . . . . 12.15 110.744 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 145' ' ' GLN . 75.6 t -62.38 134.23 27.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.612 -0.722 . . . . 9.7100000000000009 111.3 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -163.47 140.01 7.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.594 -1.185 . . . . 11.029999999999999 109.818 174.247 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.72 163.19 28.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.048 -0.978 . . . . 12.76 111.146 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 13.25 112.448 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 110.287 -0.264 . . . . 14.94 110.287 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG3' ' OE1' ' A' ' 136' ' ' GLU . 22.9 mmt85 -129.77 155.26 46.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.084 -0.339 . . . . 10.57 110.084 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.6 mm? -91.44 113.76 26.11 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.73 -0.841 . . . . 8.8800000000000008 108.73 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.86 130.58 34.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.809 -0.356 . . . . 9.7799999999999994 111.045 -175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.78 155.03 63.21 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.56 -0.904 . . . . 6.4000000000000004 108.56 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.89 137.19 78.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.922 1.748 . . . . 6.5499999999999998 111.046 174.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 23.6 t -62.43 -25.21 67.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.988 0.366 . . . . 9.2899999999999991 111.988 -173.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.07 11.76 22.03 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.588 -0.445 . . . . 10.859999999999999 111.335 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.8 -33.14 35.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.06 0.457 . . . . 5.3399999999999999 111.29 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -101.51 165.63 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 6.9699999999999998 112.194 -170.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 28.7 mm -109.29 117.49 54.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.601 -0.727 . . . . 10.199999999999999 109.829 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -91.07 125.32 35.82 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.834 -0.747 . . . . 12.119999999999999 110.554 173.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -145.79 122.7 11.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.871 -0.604 . . . . 14.609999999999999 110.689 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.64 -108.01 1.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.745 -0.661 . . . . 15.52 112.848 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.77 24.62 10.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 14.99 111.732 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.62 179.69 8.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 15.199999999999999 111.692 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.563 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 58.1 m -134.68 150.96 50.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.862 -0.608 . . . . 9.2599999999999998 110.831 -173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -119.63 146.23 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.871 -0.418 . . . . 10.550000000000001 109.871 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.577 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.237 -0.282 . . . . 7.3899999999999997 110.237 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 81.7 mmm -106.56 98.1 7.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.208 -0.451 . . . . 8.8499999999999996 109.999 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -88.1 142.07 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.005 0.431 . . . . 9.6899999999999995 111.419 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 86.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 10.699999999999999 110.479 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 33.6 tttp -72.44 153.62 41.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.245 -0.888 . . . . 14.880000000000001 110.422 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.05 -2.04 51.1 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.945 -0.571 . . . . 16.920000000000002 112.998 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.18 17.47 10.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 18.559999999999999 111.077 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.12 11.34 85.21 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.618 -0.719 . . . . 15.619999999999999 112.785 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.9 -158.09 8.7 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.836 -0.697 . . . . 14.19 111.84 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 64.5 m-85 -128.11 124.34 36.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.376 0.608 . . . . 12.029999999999999 110.154 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 113' ' ' VAL . 10.2 t70 -101.13 117.4 62.37 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.041 -0.982 . . . . 13.91 110.314 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 72.7 Cg_endo -83.1 112.09 1.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.83 3.02 . . . . 12.35 113.458 -172.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 125' ' ' VAL . 9.5 p -105.21 142.83 17.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.423 -0.808 . . . . 9.4299999999999997 110.404 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -82.23 123.41 29.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.156 0.503 . . . . 12.93 109.699 171.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -135.76 163.08 35.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.707 -0.679 . . . . 8.0299999999999994 110.974 -172.041 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' N ' HG23 ' A' ' 125' ' ' VAL . 77.9 tttt -98.82 126.21 44.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.936 -0.575 . . . . 10.390000000000001 110.243 172.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.92 108.08 4.98 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.663 -0.699 . . . . 8.3000000000000007 111.444 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.17 70.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.759 -2.162 . . . . 10.1 114.674 168.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.67 161.92 41.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.957 -0.757 . . . . 10.609999999999999 108.957 153.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.17 127.62 26.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.928 -0.397 . . . . 13.17 109.928 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.32 125.21 11.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.339 -0.391 . . . . 12.98 111.595 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.79 35.99 88.39 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.934 -0.576 . . . . 14.34 113.288 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.51 7.9 87.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.941 -0.647 . . . . 13.119999999999999 112.163 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.66 170.51 10.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.555 . . . . 10.619999999999999 109.503 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 13.3 p -122.36 156.51 33.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.741 0.305 . . . . 7.8200000000000003 110.53 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 52.8 mt-10 -99.16 118.48 35.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.369 0.604 . . . . 10.789999999999999 110.853 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 125' ' ' VAL . 22.9 mm -85.37 103.79 12.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.096 -0.956 . . . . 6.7300000000000004 108.615 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.4 mp -70.73 -46.63 62.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.926 -1.034 . . . . 8.7899999999999991 109.805 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 125' ' ' VAL . 97.9 mt-10 -143.1 161.12 39.04 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.949 -0.569 . . . . 10.44 109.63 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.31 -60.36 0.59 Allowed Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.02 -1.086 . . . . 8.8699999999999992 113.585 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.546 HD21 HG11 ' A' ' 123' ' ' VAL . 47.6 mt -110.44 -176.61 3.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.899 0.703 . . . . 8.5 112.899 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -143.78 157.32 44.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.792 -1.095 . . . . 14.15 109.201 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.32 129.83 41.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.735 -0.666 . . . . 12.119999999999999 110.296 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.21 -8.69 35.81 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.179 -0.768 . . . . 11.539999999999999 111.179 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.6 mm-40 -91.12 100.32 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.507 0.67 . . . . 11.24 109.64 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.4 mt-30 -74.72 135.32 41.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.14 -0.936 . . . . 10.49 110.58 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.5 m -129.75 136.62 58.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.717 -0.475 . . . . 5.4500000000000002 109.717 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 2.8 p -61.25 119.09 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.872 0.693 . . . . 6.5599999999999996 112.872 -171.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 147' ' ' VAL . 2.7 m . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 112.233 0.457 . . . . 6.9900000000000002 112.233 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.468 -0.938 . . . . 11.84 108.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.4 171.38 10.13 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.727 -0.389 . . . . 12.24 110.171 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.64 175.27 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.597 0.713 . . . . 13.16 112.747 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.549 ' C ' ' HB2' ' A' ' 159' ' ' ALA . 6.2 pt -114.57 77.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.607 0.718 . . . . 11.949999999999999 110.281 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -84.46 -100.44 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.359 -0.837 . . . . 11.220000000000001 111.459 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.0 p -83.36 -36.43 24.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 11.9 110.082 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 18.3 tt0 -66.07 -18.95 65.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.056 -0.975 . . . . 11.17 109.904 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 155' ' ' ILE . . . -45.16 -58.33 3.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.008 -0.996 . . . . 7.8200000000000003 112.156 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -66.06 -29.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.678 0.752 . . . . 9.6400000000000006 110.963 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 158' ' ' GLU . 46.8 mt -72.59 -28.04 62.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.684 -1.144 . . . . 10.57 110.94 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 71.9 mtt180 -92.73 -54.15 3.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.063 -0.971 . . . . 8.9000000000000004 111.024 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 56.21 56.33 24.8 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.385 -0.686 . . . . 7.1500000000000004 111.385 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.7 p -62.19 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.261 0.467 . . . . 7.0899999999999999 112.261 -171.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.44 47.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.623 0.725 . . . . 9.1999999999999993 109.344 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.752 -0.658 . . . . 9.1099999999999994 111.421 -176.401 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 pttt . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 122.472 1.13 . . . . 10.380000000000001 112.101 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.598 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 19.8 mtm180 -141.31 142.17 33.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.309 -1.769 . . . . 8.3699999999999992 108.281 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.703 HG12 ' CD ' ' A' ' 58' ' ' GLU . 25.5 mm -51.95 112.8 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 113.213 0.82 . . . . 5.7599999999999998 113.213 -169.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -100.9 -31.9 10.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.007 -1.452 . . . . 8.2200000000000006 109.734 172.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.0 p90 -175.02 -174.58 0.78 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.24 0.543 . . . . 7.9900000000000002 112.089 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 m-90 -123.23 148.62 45.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 114.966 -1.015 . . . . 5.6100000000000003 110.701 -174.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.602 ' HB2' HE22 ' A' ' 38' ' ' GLN . 29.5 ptt180 -148.22 152.53 37.36 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.472 0.482 . . . . 9.0600000000000005 111.112 -176.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.804 ' HB2' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -76.66 139.37 66.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.791 -1.188 . . . . 8.3100000000000005 107.791 163.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.584 ' CG ' HD12 ' A' ' 54' ' ' ILE . 44.7 Cg_exo -57.87 -15.49 22.02 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.865 2.377 . . . . 10.41 110.647 164.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -28.85 39.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 113.772 -1.558 . . . . 10.85 111.476 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 18.2 m -123.57 51.42 4.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.77 0.656 . . . . 9.3200000000000003 112.77 -164.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.0 114.3 2.93 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.212 2.608 . . . . 11.1 112.317 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.09 -25.52 3.5 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.26 -0.736 . . . . 10.31 111.26 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.644 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -70.94 171.59 10.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.118 -0.541 . . . . 9.2100000000000009 109.926 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -150.12 91.27 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.2 -0.667 . . . . 11.51 109.2 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 70.8 m-85 -71.07 141.86 50.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.298 0.571 . . . . 7.5 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.18 -30.43 71.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.821 -1.081 . . . . 10.609999999999999 111.668 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 13.2 ptmm? -167.33 163.29 10.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 119.29 -0.386 . . . . 10.91 111.279 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -49.72 170.89 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.781 2.988 . . . . 7.5099999999999998 113.859 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.69 -163.34 26.91 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.302 -0.719 . . . . 7.5899999999999999 111.302 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 51' ' ' MET . 38.9 ttpt -94.33 147.74 22.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.203 0.501 . . . . 11.68 110.242 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.2 t -66.1 139.07 96.4 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.413 -0.812 . . . . 9.1999999999999993 111.226 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 -21.95 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.791 2.328 . . . . 10.25 111.957 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' A' ' 35' ' ' VAL . 33.2 m-85 -78.66 -39.02 38.08 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.865 -1.061 . . . . 10.49 109.769 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -156.94 166.55 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.454 -0.794 . . . . 10.380000000000001 109.105 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 8.3 p-10 -78.33 80.96 4.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 12.539999999999999 112.27 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 4.4 ptm -134.99 146.04 56.96 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.737 -1.579 . . . . 9.8699999999999992 106.737 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.43 132.74 18.06 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 N-CA-C 108.234 -1.487 . . . . 9.5099999999999998 108.234 165.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.28 161.73 18.86 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.165 -0.614 . . . . 6.71 110.964 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 33' ' ' PRO . 22.0 mt -110.08 132.35 21.49 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 109.571 -0.529 . . . . 7.8899999999999997 109.571 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.667 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 39.9 Cg_endo -76.85 133.4 13.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 120.983 1.122 . . . . 5.7699999999999996 112.749 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.28 157.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.07 -1.423 . . . . 5.96 113.245 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 21.58 -89.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.285 1.834 . . . . 7.8399999999999999 114.893 -177.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.703 ' CD ' HG12 ' A' ' 27' ' ' ILE . 1.2 pt-20 -45.63 -40.69 9.32 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.091 0.556 . . . . 6.6200000000000001 110.13 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 41.8 tt0 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 114.904 -1.044 . . . . 8.5800000000000001 110.541 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.565 ' NH1' ' HB3' ' A' ' 156' ' ' ASP . 53.7 ttt180 . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 121.67 0.748 . . . . 11.640000000000001 110.419 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 148' ' ' VAL . 75.9 p -128.47 159.16 36.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.529 -1.214 . . . . 8.0 109.212 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.434 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -119.49 126.5 51.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.693 -0.854 . . . . 6.6500000000000004 108.693 171.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 28.0 tt0 -75.92 131.44 39.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.146 -0.687 . . . . 12.15 109.146 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 95' ' ' LEU . 41.3 t -55.64 132.02 19.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.94 0.718 . . . . 9.7100000000000009 112.94 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 49.0 mmtt -136.41 140.46 43.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.607 -1.179 . . . . 11.029999999999999 109.429 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.2 157.9 36.88 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.954 -0.698 . . . . 12.76 109.496 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.704 0 C-N-CA 119.74 -1.219 . . . . 13.25 113.862 -178.303 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.148 0.499 . . . . 14.94 110.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 35.8 mmt180 -118.72 163.83 16.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.675 -0.693 . . . . 10.57 110.339 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.2 mm? -97.9 114.17 26.18 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.066 -0.716 . . . . 8.8800000000000008 109.066 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.49 129.79 36.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.189 0.519 . . . . 9.7799999999999994 110.99 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.82 157.22 68.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.895 -1.048 . . . . 6.4000000000000004 109.17 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.97 131.25 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.817 1.678 . . . . 6.5499999999999998 110.356 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -30.12 53.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.312 -0.404 . . . . 9.2899999999999991 111.32 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.9 -8.34 57.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.624 0.231 . . . . 10.859999999999999 111.624 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -72.02 -41.32 67.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.433 0.635 . . . . 5.3399999999999999 110.942 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -93.96 163.78 13.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.141 -0.936 . . . . 6.9699999999999998 112.613 -169.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' THR . 22.7 mm -111.68 103.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 10.199999999999999 109.229 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 13.3 ptt180 -103.01 132.54 49.2 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 117.969 -1.493 . . . . 12.119999999999999 110.985 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -151.36 133.92 15.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.709 -1.587 . . . . 14.609999999999999 109.133 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.18 -113.63 6.06 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.352 -0.928 . . . . 15.52 111.952 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 34.99 5.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.85 0.315 . . . . 14.99 111.85 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.408 HH11 HD11 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -164.41 178.63 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.901 0.382 . . . . 15.199999999999999 111.801 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.3 m -136.68 158.55 44.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.749 -0.66 . . . . 9.2599999999999998 110.431 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.408 HD11 HH11 ' A' ' 108' ' ' ARG . 25.1 mm -131.22 147.75 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 10.550000000000001 109.899 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.574 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.34 127.31 27.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.517 -0.31 . . . . 7.3899999999999997 110.296 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.411 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 33.2 ttp -87.59 103.19 15.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.27 -0.641 . . . . 8.8499999999999996 109.27 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 12.6 p -89.64 135.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 9.6899999999999995 112.575 -170.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -76.01 90.28 3.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.359 -0.837 . . . . 10.699999999999999 109.672 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -85.38 152.84 22.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.425 . . . . 14.880000000000001 110.499 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.05 1.76 10.24 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.106 -0.497 . . . . 16.920000000000002 113.328 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -90.93 8.64 34.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.33 0.586 . . . . 18.559999999999999 111.062 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.19 6.45 86.34 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.29 -0.868 . . . . 15.619999999999999 112.512 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.78 156.18 19.99 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.985 -0.626 . . . . 14.19 111.567 -174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 82.5 m-85 -107.3 109.46 21.23 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.766 -0.457 . . . . 12.029999999999999 109.766 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -106.74 142.96 26.08 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 120.405 -0.518 . . . . 13.91 111.231 -172.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.66 121.28 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.281 1.987 . . . . 12.35 111.93 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 111' ' ' ALA . 5.7 p -105.43 137.29 35.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.667 -0.697 . . . . 9.4299999999999997 109.663 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.93 119.95 19.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.1 -0.704 . . . . 12.93 109.1 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.06 155.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.695 -0.684 . . . . 8.0299999999999994 110.918 -176.085 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 139' ' ' GLU . 38.5 ttmt -101.78 128.47 48.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.904 -0.776 . . . . 10.390000000000001 108.904 171.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.92 104.55 4.7 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.452 -0.34 . . . . 8.3000000000000007 110.74 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.77 70.34 0.31 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.867 -2.111 . . . . 10.1 113.866 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 161.32 42.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.305 -1.368 . . . . 10.609999999999999 107.305 151.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.0 m -141.5 128.88 21.19 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 118.38 0.537 . . . . 13.17 110.081 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.61 8.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.592 -0.731 . . . . 12.98 110.847 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.43 38.22 96.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.362 -0.447 . . . . 14.34 112.704 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.58 9.76 84.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.649 . . . . 13.119999999999999 112.434 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -120.32 164.24 16.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.165 -0.309 . . . . 10.619999999999999 110.165 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -117.31 158.34 24.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.935 0.398 . . . . 7.8200000000000003 110.883 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 57.7 mt-10 -101.7 124.82 47.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.454 0.645 . . . . 10.789999999999999 110.828 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 125' ' ' VAL . 23.9 mm -89.76 114.63 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 114.934 -1.03 . . . . 6.7300000000000004 109.55 175.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.2 mp -87.73 -45.5 10.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.648 -1.16 . . . . 8.7899999999999991 109.677 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -134.67 164.71 26.9 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.974 -1.121 . . . . 10.44 107.974 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.533 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 111.99 -62.49 0.3 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.275 -1.44 . . . . 8.8699999999999992 113.722 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.64 -173.26 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.236 0.541 . . . . 8.5 112.455 -174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.9 ttmt -157.58 158.36 35.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 14.15 108.528 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 128.84 37.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.888 -0.596 . . . . 12.119999999999999 110.31 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.08 -10.3 40.08 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.444 -0.662 . . . . 11.539999999999999 111.444 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 84' ' ' VAL . 25.5 mm-40 -93.69 121.17 34.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.119 -0.697 . . . . 11.24 109.119 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.695 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 28.5 mt-30 -97.49 125.06 41.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.941 -0.572 . . . . 10.49 111.114 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.75 138.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.852 -0.613 . . . . 5.4500000000000002 109.673 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 m -62.94 120.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.36 0.6 . . . . 6.5599999999999996 111.136 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 101' ' ' ALA . 3.4 m . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 115.476 -0.784 . . . . 6.9900000000000002 110.484 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.457 -0.088 0 N-CA-C 112.319 0.489 . . . . 11.84 112.319 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -100.26 -27.74 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.478 -0.934 . . . . 12.24 108.478 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.17 137.47 36.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.833 -1.076 . . . . 13.16 108.839 177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 157' ' ' SER . 47.0 mt -54.07 108.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.001 0.429 . . . . 11.949999999999999 111.228 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.565 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 4.0 p30 -84.17 17.44 2.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.255 -0.43 . . . . 11.220000000000001 111.84 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 155' ' ' ILE . 70.7 m -64.52 -17.35 63.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.72 -0.218 . . . . 11.9 111.519 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 41.4 mt-10 -58.45 -46.87 85.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.252 -0.647 . . . . 11.17 109.252 171.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.73 -27.89 68.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 7.8200000000000003 110.794 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 16.0 m -62.57 -39.0 92.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.581 0.705 . . . . 9.6400000000000006 110.017 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -47.77 14.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.883 -1.053 . . . . 10.57 111.638 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 53.3 mtt180 -71.49 -36.24 71.07 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.592 0.711 . . . . 8.9000000000000004 110.948 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.75 105.74 3.03 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.606 -1.179 . . . . 7.1500000000000004 110.782 -171.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.9 p -49.71 -54.03 21.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 7.0899999999999999 111.061 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.86 -48.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.818 -0.628 . . . . 9.1999999999999993 109.491 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.62 -0.718 . . . . 9.1099999999999994 111.658 178.657 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.054 0 CA-C-O 122.507 1.146 . . . . 10.380000000000001 108.244 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 82.3 mtt180 -124.25 138.75 54.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.484 -1.235 . . . . 8.3699999999999992 109.946 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.691 HG12 ' OE2' ' A' ' 58' ' ' GLU . 33.5 mm -48.72 127.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 114.369 -1.287 . . . . 5.7599999999999998 114.18 -167.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.86 -38.77 3.84 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.504 -1.68 . . . . 8.2200000000000006 110.029 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.759 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.0 p90 -176.51 -172.81 0.48 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.929 -0.578 . . . . 7.9900000000000002 110.402 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.738 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m-90 -124.01 150.36 44.96 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.462 -0.79 . . . . 5.6100000000000003 110.751 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.436 ' HB2' HE22 ' A' ' 38' ' ' GLN . 24.7 ptt180 -153.5 145.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.297 -0.41 . . . . 9.0600000000000005 111.596 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.6 t0 -79.34 130.6 68.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.909 -1.145 . . . . 8.3100000000000005 107.909 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.514 ' HG3' HD12 ' A' ' 54' ' ' ILE . 21.6 Cg_exo -61.17 -14.43 33.75 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 122.023 1.815 . . . . 10.41 112.293 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.11 2.06 52.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.473 -0.331 . . . . 10.85 111.193 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.9 m -129.1 39.35 0.5 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.624 0.601 . . . . 9.3200000000000003 112.624 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -60.42 128.71 26.96 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.519 2.146 . . . . 11.1 112.579 -174.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.01 -6.45 19.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 10.31 111.618 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -89.95 -179.54 5.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.456 -0.372 . . . . 9.2100000000000009 110.082 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.501 ' HD2' ' CE2' ' A' ' 29' ' ' TYR . 8.1 tpt180 -142.03 108.63 5.34 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.192 -0.203 . . . . 11.51 110.455 171.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.759 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -96.84 121.02 38.24 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.631 -0.828 . . . . 7.5 109.098 170.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.47 -35.3 78.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.958 -0.565 . . . . 10.609999999999999 110.125 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -147.86 149.39 33.06 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 121.78 0.8 . . . . 10.91 111.071 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.738 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 14.5 Cg_endo -52.77 142.38 51.49 Favored 'Trans proline' 0 C--N 1.348 0.515 1 C-N-CA 125.398 4.065 . . . . 7.5099999999999998 114.027 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.8 -156.0 17.71 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.828 -0.624 . . . . 7.5899999999999999 111.594 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 23.1 ttmt -98.1 143.56 28.51 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.093 -0.706 . . . . 11.68 109.093 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.7 t -66.83 132.66 93.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.309 -0.405 . . . . 9.1999999999999993 110.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.71 -29.4 24.15 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 10.25 111.491 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.556 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.8 m-85 -70.38 -37.75 74.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.561 -1.2 . . . . 10.49 110.581 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.546 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.4 OUTLIER -156.99 153.62 28.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.678 -0.49 . . . . 10.380000000000001 109.678 169.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 3.7 m-20 -74.42 76.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 12.539999999999999 112.447 -173.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -140.28 145.15 40.17 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.491 -0.929 . . . . 9.8699999999999992 108.491 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.4 Cg_exo -65.97 132.32 29.83 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.748 1.632 . . . . 9.5099999999999998 110.208 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -61.37 160.09 11.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.342 -0.39 . . . . 6.71 110.303 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 33' ' ' PRO . 6.0 mt -104.6 133.59 20.1 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.947 0.403 . . . . 7.8899999999999997 110.006 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.617 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 86.9 Cg_endo -77.71 152.07 28.87 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.766 1.644 . . . . 5.7699999999999996 112.447 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 m -74.44 157.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.513 -1.221 . . . . 5.96 112.051 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.37 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.056 2.143 . . . . 7.8399999999999999 115.701 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.691 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -52.81 -42.01 64.7 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.605 0.362 . . . . 6.6200000000000001 110.386 -176.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 85.5 mt-10 . . . . . 0 C--N 1.316 -0.875 0 CA-C-O 121.846 0.831 . . . . 8.5800000000000001 112.507 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.937 -0.764 . . . . 11.640000000000001 108.937 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 148' ' ' VAL . 33.1 p -130.13 148.19 51.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.575 -0.284 . . . . 8.0 110.661 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.91 136.08 54.73 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 6.6500000000000004 109.433 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.428 ' OE1' ' HE2' ' A' ' 85' ' ' LYS . 41.2 tt0 -76.57 141.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.226 -0.443 . . . . 12.15 110.161 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 143' ' ' ALA . 97.1 t -67.89 131.34 33.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.776 0.798 . . . . 9.7100000000000009 111.936 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' OE1' ' A' ' 83' ' ' GLU . 27.8 mmtp -127.3 155.4 43.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.237 -1.347 . . . . 11.029999999999999 109.114 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -90.38 165.58 13.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.395 -0.595 . . . . 12.76 109.395 165.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.5 0 C-N-CA 119.819 -1.181 . . . . 13.25 113.688 179.467 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HG2' HD23 ' A' ' 86' ' ' LEU . 2.6 mt-10 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.644 0.259 . . . . 14.94 110.4 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.638 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 36.5 mmt180 -125.8 157.57 37.17 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.924 -0.31 . . . . 10.57 110.739 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.0 mm? -94.12 126.8 39.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.904 -0.776 . . . . 8.8800000000000008 108.904 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.21 129.02 50.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.221 -0.445 . . . . 9.7799999999999994 109.882 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.69 157.13 65.68 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.912 -1.04 . . . . 6.4000000000000004 108.842 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.79 128.33 29.16 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.523 1.482 . . . . 6.5499999999999998 110.631 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.506 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 50.8 p -54.43 -25.76 26.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.645 0.609 . . . . 9.2899999999999991 112.645 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.45 12.12 21.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.825 -0.35 . . . . 10.859999999999999 111.526 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -85.43 -28.78 24.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.364 0.602 . . . . 5.3399999999999999 110.338 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -99.68 158.73 15.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.799 -0.637 . . . . 6.9699999999999998 111.572 -174.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 40.8 mm -104.02 123.67 57.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.203 -0.908 . . . . 10.199999999999999 110.356 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.44 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.4 mmm180 -95.26 121.81 37.3 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.592 -0.843 . . . . 12.119999999999999 110.629 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 t -149.5 143.49 25.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.713 -0.676 . . . . 14.609999999999999 110.605 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.67 -115.71 4.13 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 116.225 -0.443 . . . . 15.52 112.666 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.42 36.94 4.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 14.99 110.94 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -155.48 -177.98 6.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.107 0.48 . . . . 15.199999999999999 111.933 -175.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 19.1 m -131.74 147.19 52.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.529 -0.76 . . . . 9.2599999999999998 109.399 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 22.6 mm -126.64 149.82 31.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 10.550000000000001 109.968 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.59 123.54 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.205 -0.294 . . . . 7.3899999999999997 110.205 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 43.6 mtm -86.7 100.38 12.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.179 -0.674 . . . . 8.8499999999999996 109.179 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 14.9 p -82.72 136.47 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.497 -0.774 . . . . 9.6899999999999995 110.98 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.89 83.23 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.464 -0.939 . . . . 10.699999999999999 108.464 173.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -77.99 150.93 33.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.018 -0.992 . . . . 14.880000000000001 111.083 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.37 -5.88 18.56 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.566 -0.743 . . . . 16.920000000000002 113.15 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -73.32 -10.44 59.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 18.559999999999999 110.19 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.21 31.15 26.23 Favored Glycine 0 C--N 1.31 -0.866 0 C-N-CA 119.947 -1.121 . . . . 15.619999999999999 111.374 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.97 163.76 31.51 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 111.242 -0.743 . . . . 14.19 111.242 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.2 m-85 -97.27 112.44 24.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.806 0.336 . . . . 12.029999999999999 110.204 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.0 t70 -101.51 139.62 20.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.893 -0.594 . . . . 13.91 109.538 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -86.16 122.24 2.13 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.045 1.83 . . . . 12.35 112.971 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.53 121.52 59.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.177 -0.92 . . . . 9.4299999999999997 110.167 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.24 121.1 20.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.849 -0.797 . . . . 12.93 108.849 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.17 153.26 38.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.742 0.782 . . . . 8.0299999999999994 112.059 -173.426 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.2 ttmm -93.83 129.75 40.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.232 -1.349 . . . . 10.390000000000001 109.475 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.77 112.97 20.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.116 1.436 . . . . 8.3000000000000007 112.261 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 136' ' ' GLU . . . -89.44 174.36 41.52 Favored Glycine 0 N--CA 1.41 -3.062 0 CA-C-N 111.364 -2.653 . . . . 10.1 111.177 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.38 162.35 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 112.367 -1.917 . . . . 10.609999999999999 114.683 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -106.7 133.17 51.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.219 -0.9 . . . . 13.17 109.248 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.24 119.82 9.13 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.055 -0.52 . . . . 12.98 111.261 -174.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.17 29.58 75.19 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.183 -0.532 . . . . 14.34 112.544 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.46 89.7 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.633 -0.794 . . . . 13.119999999999999 112.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -116.53 153.8 31.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.077 -0.342 . . . . 10.619999999999999 110.077 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 70.5 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.091 0.472 . . . . 7.8200000000000003 111.387 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB2' ' C ' ' A' ' 128' ' ' GLY . 24.7 mt-10 -85.51 107.85 17.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.586 -0.733 . . . . 10.789999999999999 109.65 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 125' ' ' VAL . 23.2 mm -92.41 114.1 28.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 O-C-N 121.245 -0.909 . . . . 6.7300000000000004 110.31 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.638 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.4 mp -86.6 -47.8 8.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.293 -1.321 . . . . 8.7899999999999991 110.795 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mt-10 -144.29 167.25 22.9 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.052 -0.722 . . . . 10.44 109.052 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 114.51 -74.11 0.24 Allowed Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.631 -1.271 . . . . 8.8699999999999992 113.413 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 61.5 tp -97.66 178.09 5.28 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.694 -0.253 . . . . 8.5 110.998 -168.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.486 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 26.3 tptp -137.62 148.84 46.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.4 0.619 . . . . 14.15 112.124 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.496 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . . . -68.15 143.45 55.39 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 114.439 -1.255 . . . . 12.119999999999999 110.802 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 1.34 85.95 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.524 -0.846 . . . . 11.539999999999999 112.124 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -103.8 152.69 21.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.552 -0.536 . . . . 11.24 109.552 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 69.4 mt-30 -97.46 140.07 32.44 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 120.929 0.395 . . . . 10.49 111.295 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -134.71 143.99 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.152 -0.477 . . . . 5.4500000000000002 109.961 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.1 m -67.75 129.58 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.436 0.636 . . . . 6.5599999999999996 111.365 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.6 m . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 122.346 1.069 . . . . 6.9900000000000002 108.978 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.51 -0.552 . . . . 11.84 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.445 ' CD1' HG22 ' A' ' 155' ' ' ILE . 2.7 p90 -159.34 173.38 16.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.548 -0.296 . . . . 12.24 110.805 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.23 61.91 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 13.16 111.494 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 153' ' ' PHE . 12.8 tt -149.31 2.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.777 0.798 . . . . 11.949999999999999 109.416 171.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 10.3 p-10 -72.76 -16.41 61.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 11.220000000000001 110.651 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p -57.42 -43.14 83.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 11.9 109.556 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 38.8 tt0 -76.11 -36.52 58.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.251 -0.886 . . . . 11.17 108.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -59.97 -27.77 67.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.27 -1.332 . . . . 7.8200000000000003 111.519 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 164' ' ' THR . 32.5 t -79.0 -37.92 38.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 9.6400000000000006 110.496 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.96 -26.9 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.747 0.277 . . . . 10.57 111.747 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 11.2 ptp180 -74.62 2.46 9.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.136 0.421 . . . . 8.9000000000000004 112.136 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.47 13.18 8.3 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.462 -0.875 . . . . 7.1500000000000004 112.342 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 26.1 p 52.75 -97.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.672 0.789 . . . . 7.0899999999999999 112.153 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' VAL . 5.7 p -74.67 84.85 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.855 0.836 . . . . 9.1999999999999993 109.65 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.251 -0.886 . . . . 9.1099999999999994 111.534 -176.381 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 122.56 1.171 . . . . 10.380000000000001 109.809 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.487 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 77.6 mtm180 -119.54 143.32 47.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.127 -1.397 . . . . 8.3699999999999992 109.87 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.571 HG12 ' OE2' ' A' ' 58' ' ' GLU . 31.1 mm -49.23 120.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 114.286 -1.324 . . . . 5.7599999999999998 112.824 -169.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.5 -35.06 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.963 -1.471 . . . . 8.2200000000000006 110.298 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.429 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 44.0 p90 -176.15 -173.54 0.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.858 -0.61 . . . . 7.9900000000000002 109.387 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.731 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.15 154.11 41.99 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.105 -0.498 . . . . 5.6100000000000003 111.599 -175.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -156.51 150.64 25.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.389 -0.823 . . . . 9.0600000000000005 110.415 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.3 t0 -82.72 134.69 46.89 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.705 -1.221 . . . . 8.3100000000000005 107.705 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -62.67 -13.27 32.88 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.113 1.875 . . . . 10.41 111.967 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.68 1.75 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 10.85 111.108 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -129.22 36.3 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 112.965 0.728 . . . . 9.3200000000000003 112.965 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.8 Cg_endo -54.81 119.14 5.98 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.343 2.028 . . . . 11.1 112.517 -172.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.23 -21.0 6.97 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.889 -0.884 . . . . 10.31 110.889 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -85.0 115.42 22.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.25 -0.475 . . . . 9.2100000000000009 110.635 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 47.9 ttt180 -99.73 102.8 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.343 0.592 . . . . 11.51 110.197 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 82.9 m-85 -76.74 146.84 37.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 7.5 109.801 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.65 -27.7 69.4 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.128 -1.397 . . . . 10.609999999999999 110.323 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.9 pttm -169.79 165.94 5.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.386 -0.825 . . . . 10.91 110.355 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.731 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.6 Cg_endo -51.25 168.63 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.113 2.542 . . . . 7.5099999999999998 113.104 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.66 -159.94 28.21 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.67 -0.776 . . . . 7.5899999999999999 112.036 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.1 ttmt -98.44 147.47 24.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.24 -0.281 . . . . 11.68 110.24 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 p -70.68 128.77 90.64 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.558 -0.292 . . . . 9.1999999999999993 111.462 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.65 -22.94 17.45 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.827 1.684 . . . . 10.25 110.507 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.558 ' CD2' HG11 ' A' ' 35' ' ' VAL . 97.8 m-85 -72.57 -24.98 61.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.759 -1.109 . . . . 10.49 110.949 -175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.24 -104.38 0.13 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.737 -0.785 . . . . 10.380000000000001 112.616 167.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -166.55 58.17 0.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.313 0.578 . . . . 12.539999999999999 111.596 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.3 ptm -133.36 149.9 73.7 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.626 -0.509 . . . . 9.8699999999999992 109.626 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -66.41 131.8 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.545 1.496 . . . . 9.5099999999999998 109.772 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 mt -60.59 160.04 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.699 0.625 . . . . 6.71 110.756 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.1 mm -99.4 130.73 26.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.212 -0.662 . . . . 7.8899999999999997 109.212 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 58.2 Cg_endo -73.46 146.07 38.95 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 121.389 1.393 . . . . 5.7699999999999996 112.145 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 31.3 m -68.81 159.69 5.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.269 -1.332 . . . . 5.96 112.251 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.487 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.87 -74.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.526 2.33 . . . . 7.8399999999999999 116.216 -178.007 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -61.63 -38.86 89.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.669 1.223 . . . . 6.6200000000000001 111.93 -168.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 50.2 mt-10 . . . . . 0 CA--C 1.501 -0.908 0 CA-C-N 111.865 -2.425 . . . . 8.5800000000000001 112.291 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 109.737 -0.468 . . . . 11.640000000000001 109.737 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 148' ' ' VAL . 76.6 p -139.05 143.11 38.24 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.739 -0.664 . . . . 8.0 109.484 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -108.43 127.75 54.18 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.435 -0.58 . . . . 6.6500000000000004 109.435 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 34.4 tt0 -73.1 139.24 46.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.888 -0.596 . . . . 12.15 109.932 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -61.74 135.32 26.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.278 -0.874 . . . . 9.7100000000000009 111.727 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 28.2 mmtp -131.11 156.51 45.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.602 -1.181 . . . . 11.029999999999999 109.693 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.43 143.79 27.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.497 -0.557 . . . . 12.76 109.497 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 C-N-CA 119.702 -1.237 . . . . 13.25 112.678 178.523 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 121.198 0.523 . . . . 14.94 111.762 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 138' ' ' LEU . 1.5 mpp_? -119.61 156.74 29.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.829 -1.078 . . . . 10.57 109.118 170.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -90.68 113.58 25.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.629 -0.878 . . . . 8.8800000000000008 108.629 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.68 129.95 34.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.646 . . . . 9.7799999999999994 110.99 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.8 m -144.67 159.03 52.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.828 -1.078 . . . . 6.4000000000000004 109.103 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.42 136.28 70.67 Favored 'Trans proline' 0 C--N 1.333 -0.277 0 C-N-CA 122.192 1.928 . . . . 6.5499999999999998 110.589 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 m -57.92 -24.85 59.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 9.2899999999999991 111.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.6 6.61 43.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.183 -0.207 . . . . 10.859999999999999 111.554 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -40.71 20.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.058 0.456 . . . . 5.3399999999999999 110.707 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -90.87 161.85 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.732 -0.667 . . . . 6.9699999999999998 111.98 -173.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 mm -113.15 103.79 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.892 -0.594 . . . . 10.199999999999999 109.442 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 7.2 ptt180 -101.53 134.27 44.91 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.33 -1.348 . . . . 12.119999999999999 110.997 173.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 t -150.47 128.88 12.12 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.06 -1.427 . . . . 14.609999999999999 109.589 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.76 -109.74 3.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.589 -0.815 . . . . 15.52 112.117 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.16 30.31 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.077 0.399 . . . . 14.99 112.077 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.547 HH11 HD11 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -163.75 176.91 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 15.199999999999999 112.004 -177.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.4 m -132.55 156.66 46.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 9.2599999999999998 110.602 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.547 HD11 HH11 ' A' ' 108' ' ' ARG . 41.4 mm -129.26 149.48 33.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.277 -0.638 . . . . 10.550000000000001 109.277 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.592 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -128.94 141.82 51.14 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.658 0.265 . . . . 7.3899999999999997 110.497 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 122' ' ' PRO . 62.0 mmm -103.37 99.84 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.648 -0.501 . . . . 8.8499999999999996 109.648 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.0 p -82.05 135.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.979 0.418 . . . . 9.6899999999999995 111.003 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.06 93.54 5.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 10.699999999999999 110.922 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -89.06 160.5 17.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.626 -0.716 . . . . 14.880000000000001 111.343 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.43 23.94 31.42 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.737 -0.945 . . . . 16.920000000000002 110.737 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -97.54 19.41 13.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.989 0.423 . . . . 18.559999999999999 111.102 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.5 68.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.951 -0.642 . . . . 15.619999999999999 112.702 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 -175.76 47.55 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.16 -0.776 . . . . 14.19 111.16 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 81.8 m-85 -100.36 178.7 4.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.868 0.366 . . . . 12.029999999999999 110.881 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.525 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 13.4 t70 -140.52 122.85 9.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.467 0.651 . . . . 13.91 109.721 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HB3' ' SD ' ' A' ' 112' ' ' MET . 71.1 Cg_endo -86.96 113.78 1.04 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.324 2.683 . . . . 12.35 112.422 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.3 p -103.91 140.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.183 -0.917 . . . . 9.4299999999999997 109.647 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 110' ' ' ILE . 44.9 tt0 -76.24 120.97 22.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.108 -0.701 . . . . 12.93 109.108 171.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -131.65 159.35 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 8.0299999999999994 111.566 -173.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.4 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 39.9 ttmt -103.11 128.04 50.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.186 -0.916 . . . . 10.390000000000001 109.415 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.66 108.25 5.34 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.589 0.218 . . . . 8.3000000000000007 111.589 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.52 71.04 0.28 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 118.021 -2.038 . . . . 10.1 114.006 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.011 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.71 163.03 39.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.554 -0.906 . . . . 10.609999999999999 108.554 157.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.7 m -131.5 137.03 48.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.139 -0.689 . . . . 13.17 109.139 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -142.73 90.63 2.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 120.888 0.375 . . . . 12.98 111.954 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.2 60.19 8.74 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.733 -0.667 . . . . 14.34 113.411 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.84 82.26 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 13.119999999999999 112.41 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.64 165.54 24.99 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.9 -0.778 . . . . 10.619999999999999 108.9 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.0 m -117.81 163.46 16.48 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.633 -0.427 . . . . 7.8200000000000003 110.714 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 1.011 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 23.9 mt-10 -110.44 120.11 41.37 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.734 0.778 . . . . 10.789999999999999 111.258 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.796 HD12 HG21 ' A' ' 125' ' ' VAL . 22.3 mm -85.23 107.95 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.777 -1.101 . . . . 6.7300000000000004 109.644 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.0 mp -68.67 -46.54 68.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.298 -0.865 . . . . 8.7899999999999991 109.984 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.9 mt-10 -144.45 155.79 43.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.122 -0.49 . . . . 10.44 110.101 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 129.28 -66.85 0.57 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.862 -1.161 . . . . 8.8699999999999992 113.064 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 111' ' ' ALA . 3.1 mm? -97.71 -176.29 3.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.37 0.878 . . . . 8.5 113.37 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 23.0 tptm -144.34 151.91 39.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.019 -0.991 . . . . 14.15 109.89 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.17 132.41 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.345 -0.843 . . . . 12.119999999999999 110.21 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.0 47.32 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.485 -0.864 . . . . 11.539999999999999 111.315 -174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -104.17 141.15 36.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.64 -0.504 . . . . 11.24 109.64 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 86.8 mt-30 -97.21 147.1 24.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.695 0.283 . . . . 10.49 111.008 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.0 m -136.51 152.55 29.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.38 -0.6 . . . . 5.4500000000000002 109.38 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 81' ' ' THR . 32.9 m -56.53 138.86 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.72 0.637 . . . . 6.5599999999999996 111.881 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 82' ' ' ALA . 43.1 t . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.235 -0.893 . . . . 6.9900000000000002 110.043 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.622 -0.14 . . . . 11.84 110.622 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.89 63.2 0.46 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.062 0.545 . . . . 12.24 111.139 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.95 94.84 5.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 13.16 110.707 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.28 -9.14 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 11.949999999999999 109.709 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.72 1.25 39.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.619 -0.719 . . . . 11.220000000000001 110.232 176.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -66.54 -40.41 89.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.809 -0.441 . . . . 11.9 109.809 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.11 -51.79 55.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.236 0.471 . . . . 11.17 110.038 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.06 66.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.834 . . . . 7.8200000000000003 111.422 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 164' ' ' THR . 35.6 t -70.77 -38.39 73.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.181 0.515 . . . . 9.6400000000000006 110.609 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.96 -32.44 65.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.83 0.824 . . . . 10.57 110.907 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -89.93 -67.02 0.87 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 114.327 -1.306 . . . . 8.9000000000000004 111.019 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.71 77.88 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.563 -0.744 . . . . 7.1500000000000004 112.658 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' SER . 56.1 p 47.26 -100.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.191 0.996 . . . . 7.0899999999999999 113.267 174.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.33 -30.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.03 0.443 . . . . 9.1999999999999993 111.235 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 121.16 0.505 . . . . 9.1099999999999994 111.096 -177.704 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 pttp . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 122.385 1.088 . . . . 10.380000000000001 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 32.0 mtt180 -135.49 138.75 43.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.971 -1.468 . . . . 8.3699999999999992 109.362 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.616 HG12 ' CG ' ' A' ' 58' ' ' GLU . 31.3 mm -52.92 120.64 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 121.982 0.896 . . . . 5.7599999999999998 113.236 -170.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.34 -37.32 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.665 -1.607 . . . . 8.2200000000000006 110.291 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.708 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.1 p90 -169.77 -173.47 1.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.165 0.507 . . . . 7.9900000000000002 111.611 -174.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.58 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.57 145.71 50.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.252 -0.886 . . . . 5.6100000000000003 110.908 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -149.26 157.52 43.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.585 . . . . 9.0600000000000005 110.207 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -91.32 136.08 27.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.673 -0.862 . . . . 8.3100000000000005 108.673 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.45 -12.48 27.94 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.247 1.965 . . . . 10.41 112.395 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.608 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -100.47 2.57 42.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.605 0.24 . . . . 10.85 111.622 176.404 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.0 m -126.1 45.39 1.46 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.276 0.56 . . . . 9.3200000000000003 111.451 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HD3' ' C ' ' A' ' 34' ' ' MET . 22.7 Cg_exo -59.56 112.19 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.585 2.19 . . . . 11.1 112.252 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -32.7 3.35 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.309 -0.716 . . . . 10.31 111.309 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.45 ' CG ' ' CE2' ' A' ' 40' ' ' PHE . 28.4 tp60 -68.1 125.67 27.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.276 0.56 . . . . 9.2100000000000009 110.856 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.602 ' HG2' ' CE2' ' A' ' 29' ' ' TYR . 5.1 tmm_? -114.55 101.56 9.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.448 -0.797 . . . . 11.51 110.086 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 56.4 m-85 -85.79 141.23 29.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.498 0.666 . . . . 7.5 109.782 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.93 -36.59 84.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.313 -1.312 . . . . 10.609999999999999 111.067 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.5 mttp -146.32 163.31 30.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 123.406 0.441 . . . . 10.91 110.998 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -51.49 171.61 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.958 3.105 . . . . 7.5099999999999998 114.175 175.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.71 -171.47 25.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 7.5899999999999999 112.69 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 20.9 ttmt -83.86 144.8 29.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.604 -0.517 . . . . 11.68 109.604 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -64.76 136.65 96.86 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.922 -0.581 . . . . 9.1999999999999993 109.623 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.98 -24.76 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.411 2.074 . . . . 10.25 112.099 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 64.3 m-85 -82.45 -34.47 28.12 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.671 -0.695 . . . . 10.49 110.839 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.6 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -117.75 -165.02 1.05 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.872 -1.058 . . . . 10.380000000000001 110.308 171.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.53 60.88 1.24 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.189 0.995 . . . . 12.539999999999999 109.066 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.8 ptm -138.32 146.15 50.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 113.86 -1.518 . . . . 9.8699999999999992 109.325 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 19.4 Cg_exo -66.1 132.85 31.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.107 1.871 . . . . 9.5099999999999998 110.177 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -61.63 161.8 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.309 0.38 . . . . 6.71 110.43 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.61 126.77 33.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.371 -0.603 . . . . 7.8899999999999997 109.371 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 53.8 Cg_endo -73.37 131.75 16.79 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 121.309 1.339 . . . . 5.7699999999999996 112.351 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.27 159.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.381 -1.282 . . . . 5.96 113.315 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 10.3 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.109 2.564 . . . . 7.8399999999999999 116.304 -177.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -64.58 -38.22 90.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.56 1.172 . . . . 6.6200000000000001 109.737 -171.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 10.9 tt0 . . . . . 0 CA--C 1.508 -0.652 0 CA-C-N 111.863 -2.426 . . . . 8.5800000000000001 111.15 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.78 -0.452 . . . . 11.640000000000001 109.78 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 114' ' ' ALA . 74.6 p -142.98 156.56 44.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.961 -0.563 . . . . 8.0 110.182 -175.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -120.01 129.3 54.2 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.567 -0.901 . . . . 6.6500000000000004 108.567 171.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 43.3 tt0 -80.11 131.88 35.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.855 -0.611 . . . . 12.15 110.054 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 95' ' ' LEU . 77.2 t -55.6 131.36 18.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 9.7100000000000009 110.955 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.36 145.06 9.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.462 -1.245 . . . . 11.029999999999999 109.455 172.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.476 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.3 mp -74.48 152.29 39.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.205 -0.907 . . . . 12.76 110.838 -176.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.501 -0.813 0 C-N-CA 120.011 -1.09 . . . . 13.25 112.94 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HG2' HD23 ' A' ' 86' ' ' LEU . 5.1 tt0 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.835 -0.431 . . . . 14.94 109.835 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -134.79 160.54 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.549 0.214 . . . . 10.57 111.36 -172.015 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.619 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -91.69 116.69 29.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.137 -0.69 . . . . 8.8800000000000008 109.137 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -96.41 131.86 42.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.806 0.336 . . . . 9.7799999999999994 111.388 -173.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.02 150.78 54.05 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.842 -0.799 . . . . 6.4000000000000004 108.842 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HG2' HG11 ' A' ' 149' ' ' VAL . 50.8 Cg_exo -59.19 133.1 50.71 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 121.839 1.693 . . . . 6.5499999999999998 110.704 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 22.9 t -61.45 -31.21 71.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 9.2899999999999991 110.997 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -74.67 -5.25 42.09 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.372 -0.131 . . . . 10.859999999999999 111.043 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -73.57 -39.76 64.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.274 0.559 . . . . 5.3399999999999999 109.984 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 109' ' ' THR . 74.5 mt -65.13 148.1 52.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.67 -1.15 . . . . 6.9699999999999998 113.034 -170.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.54 127.49 52.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.755 -1.111 . . . . 10.199999999999999 108.433 170.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 16.3 mmt180 -104.72 123.46 47.67 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.909 -0.717 . . . . 12.119999999999999 110.811 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -146.58 138.99 25.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.432 -0.804 . . . . 14.609999999999999 109.691 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.98 -118.33 6.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.292 -0.48 . . . . 15.52 112.776 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.7 36.89 4.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.19 0.519 . . . . 14.99 110.949 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -148.22 173.93 12.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 15.199999999999999 111.581 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.506 HG21 HD13 ' A' ' 102' ' ' LEU . 5.8 m -121.77 146.45 47.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 9.2599999999999998 109.87 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 26.3 mm -131.13 148.41 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.891 0.377 . . . . 10.550000000000001 110.047 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -116.55 159.64 21.82 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.474 -0.565 . . . . 7.3899999999999997 109.474 173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.449 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 58.8 ttp -125.75 100.78 6.56 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.545 -0.909 . . . . 8.8499999999999996 108.545 174.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 14.4 p -80.89 129.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.363 0.601 . . . . 9.6899999999999995 111.715 -168.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 81' ' ' THR . . . -79.13 84.53 5.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.878 -1.056 . . . . 10.699999999999999 109.991 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -67.5 141.2 56.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.84 -0.618 . . . . 14.880000000000001 110.989 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.37 -2.21 40.43 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.627 -0.989 . . . . 16.920000000000002 110.627 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -83.57 6.54 20.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.932 -0.634 . . . . 18.559999999999999 111.123 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 6.01 70.39 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.41 -0.814 . . . . 15.619999999999999 113.241 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.9 175.41 20.85 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 14.19 112.486 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 85.5 m-85 -127.05 122.28 33.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.658 -0.497 . . . . 12.029999999999999 109.658 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 113' ' ' VAL . 20.4 t70 -116.29 134.43 22.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.145 -0.479 . . . . 13.91 111.968 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 3.1 Cg_endo -77.56 136.33 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.987 1.791 . . . . 12.35 112.505 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.94 123.76 64.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 9.4299999999999997 109.8 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.0 tt0 -75.56 121.19 22.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 12.93 109.294 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 141' ' ' LEU . 27.3 m -128.45 163.7 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.199 0.523 . . . . 8.0299999999999994 111.608 -173.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 138' ' ' LEU . 40.3 ttmt -102.88 126.18 49.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.008 -0.738 . . . . 10.390000000000001 109.008 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.453 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.57 104.03 4.66 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.1 -0.5 . . . . 8.3000000000000007 110.998 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.496 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.2 71.19 0.28 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 117.922 -2.085 . . . . 10.1 114.968 169.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -147.68 162.52 38.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.054 -1.461 . . . . 10.609999999999999 107.054 150.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -134.15 129.52 35.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.694 0.679 . . . . 13.17 110.449 175.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.16 126.01 11.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.306 -0.407 . . . . 12.98 111.378 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.11 33.96 88.65 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.113 -0.494 . . . . 14.34 112.885 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.04 11.23 81.51 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.832 -0.699 . . . . 13.119999999999999 112.05 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.35 170.99 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.317 -0.623 . . . . 10.619999999999999 109.317 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 p -119.28 143.66 47.21 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.04 0.447 . . . . 7.8200000000000003 110.907 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.3 mp0 -85.87 122.0 29.32 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.822 -0.626 . . . . 10.789999999999999 111.584 175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.492 HD11 HD21 ' A' ' 102' ' ' LEU . 19.5 mm -88.03 109.33 19.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.52 -0.764 . . . . 6.7300000000000004 109.112 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 128' ' ' GLY . 1.3 mp -76.03 -52.17 10.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.379 -1.282 . . . . 8.7899999999999991 109.264 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -144.74 170.83 15.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.688 -0.687 . . . . 10.44 110.322 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 109.85 -59.54 0.35 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.37 -0.919 . . . . 8.8699999999999992 113.394 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 125' ' ' VAL . 17.9 mt -96.83 -172.66 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.14 0.495 . . . . 8.5 111.828 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 63.7 tttm -149.77 154.89 39.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 14.15 109.212 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . . . -67.8 127.16 31.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.641 -0.708 . . . . 12.119999999999999 110.274 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.6 -8.35 28.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.033 -0.827 . . . . 11.539999999999999 111.033 -171.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mm-40 -97.27 116.63 29.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 11.24 109.343 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 94.2 mt-30 -91.29 135.67 33.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.754 -0.657 . . . . 10.49 111.549 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 149' ' ' VAL . 2.5 p -127.97 138.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.756 -0.461 . . . . 5.4500000000000002 109.756 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.5 m -62.71 134.55 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 O-C-N 123.442 0.464 . . . . 6.5599999999999996 110.531 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 101' ' ' ALA . 13.2 m . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 113.332 0.864 . . . . 6.9900000000000002 113.332 -170.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.493 -0.558 . . . . 11.84 109.493 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -109.41 -13.56 14.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.334 -0.394 . . . . 12.24 110.724 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.5 mt 67.25 -177.58 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 13.16 110.923 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.2 mt 62.72 52.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.997 0.904 . . . . 11.949999999999999 109.002 -175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.6 -28.18 31.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.038 -0.983 . . . . 11.220000000000001 111.441 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -59.24 -31.49 69.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.424 -1.262 . . . . 11.9 111.539 -169.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.66 -30.67 71.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.188 -1.369 . . . . 11.17 111.003 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.88 -25.68 40.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.656 -0.702 . . . . 7.8200000000000003 110.525 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.5 m -80.79 -17.2 51.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 9.6400000000000006 110.076 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' HH11 ' A' ' 162' ' ' ARG . 90.8 mt -65.53 -48.82 71.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.206 -0.664 . . . . 10.57 109.206 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.431 HH11 ' HB2' ' A' ' 161' ' ' LEU . 9.6 mpt_? -76.02 -173.33 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.444 -0.798 . . . . 8.9000000000000004 109.968 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.44 -50.39 4.4 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.779 -0.724 . . . . 7.1500000000000004 112.649 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.4 p -80.98 -86.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.309 . . . . 7.0899999999999999 110.993 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.7 91.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.541 -0.54 . . . . 9.1999999999999993 109.541 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 9.1099999999999994 110.572 -176.796 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 122.561 1.172 . . . . 10.380000000000001 109.76 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.607 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.1 mtp180 -135.71 135.19 39.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.196 -1.366 . . . . 8.3699999999999992 108.986 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.602 HG12 ' CG ' ' A' ' 58' ' ' GLU . 23.3 mm -57.43 115.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 122.433 1.111 . . . . 5.7599999999999998 112.173 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 mt -118.97 -35.42 3.65 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.773 -2.012 . . . . 8.2200000000000006 110.679 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.692 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 19.8 p90 -168.82 179.07 4.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 7.9900000000000002 109.704 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.669 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -117.29 164.3 15.02 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.185 -0.461 . . . . 5.6100000000000003 111.523 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -145.31 177.22 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 9.0600000000000005 110.204 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.0 t70 -124.13 138.43 30.74 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 107.845 -1.168 . . . . 8.3100000000000005 107.845 170.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -60.3 -14.2 28.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.451 2.101 . . . . 10.41 112.738 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -101.43 -2.09 31.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.123 0.416 . . . . 10.85 112.123 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.806 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.0 m -125.45 38.28 0.4 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 113.58 0.956 . . . . 9.3200000000000003 113.58 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 29.6 Cg_endo -58.49 133.3 53.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.305 2.003 . . . . 11.1 112.518 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.78 -6.3 29.46 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.272 -0.731 . . . . 10.31 111.272 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.703 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -87.54 179.38 6.56 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 9.2100000000000009 109.194 177.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.505 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 4.5 tmm_? -157.0 93.29 1.33 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.785 -0.82 . . . . 11.51 108.785 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.703 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 91.3 m-85 -73.71 142.24 46.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.071 0.462 . . . . 7.5 109.99 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.27 -30.58 71.63 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.886 -1.052 . . . . 10.609999999999999 110.273 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -165.15 164.39 12.77 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.699 -0.682 . . . . 10.91 111.586 -177.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.669 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.1 Cg_endo -50.73 170.21 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.689 2.926 . . . . 7.5099999999999998 113.313 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.01 -159.34 27.63 Favored Glycine 0 CA--C 1.508 -0.383 0 C-N-CA 120.24 -0.981 . . . . 7.5899999999999999 112.735 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 3.0 ttmm -95.3 144.33 25.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.335 -0.617 . . . . 11.68 109.335 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.548 ' OG ' ' HG3' ' A' ' 49' ' ' MET . 25.0 p -64.56 145.02 98.71 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 9.1999999999999993 111.873 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.24 -22.2 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.258 1.972 . . . . 10.25 112.904 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.31 -15.83 39.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.41 1.1 . . . . 10.49 110.068 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.548 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.16 -164.06 1.85 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.506 -1.679 . . . . 10.380000000000001 109.012 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 5.7 p-10 -133.21 57.15 1.82 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.614 0.721 . . . . 12.539999999999999 110.781 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -133.35 142.93 46.03 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.134 -0.939 . . . . 9.8699999999999992 108.954 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.09 132.13 37.8 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.617 1.545 . . . . 9.5099999999999998 110.658 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.26 164.2 5.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.341 0.591 . . . . 6.71 111.854 -174.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.72 130.8 22.36 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.726 -0.842 . . . . 7.8899999999999997 108.726 -177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.24 136.83 35.41 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.855 1.703 . . . . 5.7699999999999996 112.405 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 27.1 m -63.18 160.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.64 -1.164 . . . . 5.96 112.419 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.692 ' CD1' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER 7.13 -66.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.476 2.31 . . . . 7.8399999999999999 116.054 177.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.602 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -62.57 -48.32 79.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.236 1.017 . . . . 6.6200000000000001 110.352 -171.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' HD11 ' A' ' 27' ' ' ILE . 12.2 pt-20 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-N 112.532 -2.122 . . . . 8.5800000000000001 113.37 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.039 -0.726 . . . . 11.640000000000001 109.039 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 148' ' ' VAL . 82.5 p -127.92 177.86 6.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.367 0.603 . . . . 8.0 110.253 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.414 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -140.88 126.36 18.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.102 -1.073 . . . . 6.6500000000000004 108.102 171.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 34.4 tt0 -79.02 139.39 38.18 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.639 -0.504 . . . . 12.15 109.639 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 95' ' ' LEU . 53.3 t -62.03 133.3 27.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.33 0.585 . . . . 9.7100000000000009 112.395 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -137.47 150.57 47.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.452 -1.249 . . . . 11.029999999999999 108.393 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 8.1 mp -77.53 147.99 35.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.148 -0.686 . . . . 12.76 109.148 169.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.316 -0.945 . . . . 13.25 112.938 -178.858 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 . . . . . 0 CA--C 1.507 -0.709 0 CA-C-O 121.685 0.755 . . . . 14.94 110.668 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -112.62 170.21 8.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.435 -1.257 . . . . 10.57 110.384 -173.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -100.75 113.38 26.22 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.953 -0.758 . . . . 8.8800000000000008 108.953 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.74 129.5 36.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 9.7799999999999994 110.868 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 34.1 m -142.41 161.65 48.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.858 -1.064 . . . . 6.4000000000000004 108.409 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.88 134.79 55.52 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.707 1.605 . . . . 6.5499999999999998 110.5 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 p -67.28 -24.63 65.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.103 -0.373 . . . . 9.2899999999999991 110.984 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -90.96 7.26 41.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.512 -0.313 . . . . 10.859999999999999 111.153 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 149' ' ' VAL . . . -84.9 -40.68 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.084 0.468 . . . . 5.3399999999999999 110.615 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -83.18 162.36 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.608 -0.723 . . . . 6.9699999999999998 111.572 -173.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 18.7 mm -104.63 119.81 54.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.524 -0.762 . . . . 10.199999999999999 109.997 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -96.13 120.75 36.98 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.629 -0.828 . . . . 12.119999999999999 109.97 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -147.3 140.59 25.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.955 -0.566 . . . . 14.609999999999999 110.36 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 56.88 -112.63 3.64 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.131 -0.557 . . . . 15.52 112.556 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.96 29.38 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.823 0.305 . . . . 14.99 111.823 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.416 ' NH1' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -162.41 -176.82 5.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 15.199999999999999 111.464 -174.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 46.7 m -125.43 147.94 49.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.725 -0.671 . . . . 9.2599999999999998 110.572 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.9 mm -124.82 151.79 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.351 -0.611 . . . . 10.550000000000001 109.351 176.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -136.43 134.17 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.49 -0.131 . . . . 7.3899999999999997 110.667 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.437 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 38.5 mtm -93.98 101.46 13.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 8.8499999999999996 109.432 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 9.5 p -85.32 138.45 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 9.6899999999999995 111.329 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.06 95.3 3.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.07 -0.513 . . . . 10.699999999999999 110.937 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -80.02 163.3 24.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.245 0.545 . . . . 14.880000000000001 110.454 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.52 15.15 47.81 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.417 -0.811 . . . . 16.920000000000002 111.406 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.26 11.6 39.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.449 0.642 . . . . 18.559999999999999 110.619 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.28 11.9 74.52 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.158 -0.928 . . . . 15.619999999999999 113.516 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.88 168.04 25.76 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.578 -0.82 . . . . 14.19 112.203 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 80.7 m-85 -110.18 109.86 20.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.533 -0.543 . . . . 12.029999999999999 109.533 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 9.3 t70 -92.6 140.58 23.96 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.781 -0.645 . . . . 13.91 110.772 -170.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 121' ' ' ASP . 19.4 Cg_endo -84.2 127.88 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.196 1.93 . . . . 12.35 112.71 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.8 t -115.48 129.05 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.119 -0.946 . . . . 9.4299999999999997 109.351 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 110' ' ' ILE . 43.0 tt0 -73.03 120.86 19.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.37 -0.604 . . . . 12.93 109.37 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.753 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -132.48 159.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.411 0.624 . . . . 8.0299999999999994 111.212 -174.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.0 ttmm -103.94 129.32 51.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.225 -0.898 . . . . 10.390000000000001 109.647 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.55 114.83 8.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.712 -0.222 . . . . 8.3000000000000007 111.303 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.428 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.21 70.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 117.818 -2.134 . . . . 10.1 114.251 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.862 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.24 164.62 35.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.268 -1.012 . . . . 10.609999999999999 108.268 154.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -143.61 126.75 16.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.308 0.504 . . . . 13.17 110.086 170.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.21 118.95 6.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 12.98 111.336 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.27 36.24 92.54 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.231 -0.509 . . . . 14.34 112.697 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.32 20.96 80.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.559 -0.829 . . . . 13.119999999999999 111.618 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' VAL . 38.3 mt-30 -128.49 170.49 13.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.365 -0.606 . . . . 10.619999999999999 109.365 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.5 t -125.12 156.82 37.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.604 -0.517 . . . . 7.8200000000000003 109.604 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 46.6 mt-10 -101.06 112.97 25.57 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.664 0.745 . . . . 10.789999999999999 110.577 175.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 125' ' ' VAL . 24.5 mm -79.87 106.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.741 -1.118 . . . . 6.7300000000000004 109.641 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.49 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.4 mp -70.48 -49.67 46.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.885 -1.052 . . . . 8.7899999999999991 109.878 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 125' ' ' VAL . 41.0 mt-10 -141.75 165.6 27.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.44 109.528 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 116.95 -67.42 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.683 -1.246 . . . . 8.8699999999999992 113.593 175.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.32 -174.97 2.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 8.5 112.16 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 38.4 ttpt -149.32 154.97 39.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.558 -0.746 . . . . 14.15 109.748 -176.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.33 131.49 45.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.487 -0.779 . . . . 12.119999999999999 110.1 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.35 -7.72 47.48 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.948 -0.861 . . . . 11.539999999999999 110.948 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.1 mm-40 -100.8 119.07 38.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.812 -0.81 . . . . 11.24 108.812 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.2 pt20 -104.88 132.27 51.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.686 0.755 . . . . 10.49 109.676 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 149' ' ' VAL . 17.1 m -116.38 153.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.439 -1.255 . . . . 5.4500000000000002 110.025 -172.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.3 m -57.62 134.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.44 0.638 . . . . 6.5599999999999996 111.413 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 147' ' ' VAL . 43.1 t . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.092 -0.958 . . . . 6.9900000000000002 111.029 -173.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.811 0.338 . . . . 11.84 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -94.55 -10.27 32.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 12.24 110.334 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 28.8 tp -70.92 -57.07 4.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.124 0.488 . . . . 13.16 109.755 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.6 tt -118.19 112.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.567 -0.742 . . . . 11.949999999999999 110.449 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -76.26 -23.33 54.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 11.220000000000001 110.718 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 9.3 m -56.14 -54.87 39.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.203 0.525 . . . . 11.9 110.92 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 34.9 mm-40 -59.4 -40.0 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.274 -0.876 . . . . 11.17 110.895 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 7.8200000000000003 111.657 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.8 m -79.55 -28.95 41.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 9.6400000000000006 110.431 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 157' ' ' SER . 71.8 mt -83.16 -28.29 29.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.517 -0.765 . . . . 10.57 110.561 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 20.1 mtp180 -70.53 146.13 50.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.331 -0.85 . . . . 8.9000000000000004 112.404 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.08 23.98 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.783 -1.098 . . . . 7.1500000000000004 111.888 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.8 p 46.99 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.751 0.821 . . . . 7.0899999999999999 112.964 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.6 t 59.84 66.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.558 0.694 . . . . 9.1999999999999993 109.587 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.621 -0.718 . . . . 9.1099999999999994 110.875 -178.016 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 122.963 1.363 . . . . 10.380000000000001 108.555 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 9.3 mmm180 -113.41 140.06 48.38 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.752 -1.567 . . . . 8.3699999999999992 109.476 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.637 HG21 ' CZ3' ' A' ' 30' ' ' TRP . 11.9 mm -52.49 121.4 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 123.937 0.773 . . . . 5.7599999999999998 112.661 -170.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.16 -37.43 10.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.177 -1.374 . . . . 8.2200000000000006 110.284 172.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 29.8 p90 -172.24 -175.63 1.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.162 0.506 . . . . 7.9900000000000002 111.125 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.689 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.29 154.25 35.24 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.14 -0.936 . . . . 5.6100000000000003 110.627 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -162.91 148.98 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.567 0.542 . . . . 9.0600000000000005 110.447 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -69.77 137.61 87.89 Favored Pre-proline 0 CA--C 1.514 -0.413 0 N-CA-C 108.386 -0.968 . . . . 8.3100000000000005 108.386 169.203 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -62.01 -11.84 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.393 2.062 . . . . 10.41 110.77 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -98.76 1.33 45.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.613 -0.721 . . . . 10.85 111.215 177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.607 HG22 ' HB2' ' A' ' 32' ' ' ASP . 10.3 m -130.98 49.86 5.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 121.238 0.542 . . . . 9.3200000000000003 112.03 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.05 121.13 7.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.781 2.321 . . . . 11.1 112.584 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.34 -25.86 11.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.82 -0.705 . . . . 10.31 112.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' A' ' 35' ' ' VAL . 7.0 tp-100 -69.43 105.98 2.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.415 0.626 . . . . 9.2100000000000009 111.004 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.734 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 45.2 ttp180 -89.61 101.28 13.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.343 -0.844 . . . . 11.51 110.521 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 72.0 m-85 -82.94 147.24 28.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 7.5 110.252 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.83 -25.63 68.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.396 -1.275 . . . . 10.609999999999999 111.406 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 53.8 pttt -172.46 164.62 3.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 10.91 111.3 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.0 Cg_endo -50.7 170.06 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.729 2.952 . . . . 7.5099999999999998 113.626 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.16 -166.03 26.83 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.692 -0.766 . . . . 7.5899999999999999 112.421 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 5.3 ttmm -93.21 141.56 28.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.059 -0.719 . . . . 11.68 109.059 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 49' ' ' MET . 41.2 t -61.07 139.87 94.21 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.535 -0.757 . . . . 9.1999999999999993 111.64 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.19 -20.8 18.52 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.74 2.294 . . . . 10.25 111.468 171.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CD2' HG11 ' A' ' 35' ' ' VAL . 27.1 m-85 -87.67 -42.83 12.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.512 -1.222 . . . . 10.49 109.666 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -133.92 155.28 50.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.34 -0.846 . . . . 10.380000000000001 111.965 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.1 p-10 -82.35 61.42 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.282 1.039 . . . . 12.539999999999999 110.834 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -131.96 143.39 48.84 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.732 -1.122 . . . . 9.8699999999999992 109.392 173.362 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.75 132.9 32.06 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.178 1.252 . . . . 9.5099999999999998 109.218 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.44 158.69 14.21 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.029 -0.268 . . . . 6.71 110.681 -175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.95 130.51 24.96 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-O 121.217 0.532 . . . . 7.8899999999999997 110.118 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 88.2 Cg_endo -79.09 139.74 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.135 1.89 . . . . 5.7699999999999996 113.14 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 34.1 m -61.43 161.81 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.743 -1.571 . . . . 5.96 112.97 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.79 -84.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.049 2.14 . . . . 7.8399999999999999 115.706 -178.086 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -48.6 -43.57 36.26 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.92 0.762 . . . . 6.6200000000000001 111.421 -173.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 35.7 tt0 . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 122.271 1.034 . . . . 8.5800000000000001 109.655 -171.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 108.429 -0.952 . . . . 11.640000000000001 108.429 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 146' ' ' GLN . 77.0 p -108.74 139.17 43.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.447 -0.342 . . . . 8.0 110.526 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -107.33 129.77 54.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.906 -0.776 . . . . 6.6500000000000004 108.906 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 39.9 tt0 -76.04 134.79 40.0 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.237 -0.438 . . . . 12.15 110.065 -176.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 95' ' ' LEU . 73.6 t -63.13 130.05 27.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.686 0.755 . . . . 9.7100000000000009 110.958 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.04 146.56 10.87 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.33 -1.305 . . . . 11.029999999999999 109.683 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.13 161.33 31.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 12.76 111.091 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.47 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.786 0 C-N-CA 120.432 -0.889 . . . . 13.25 112.82 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 110.212 -0.292 . . . . 14.94 110.212 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -126.43 160.0 31.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.446 -0.343 . . . . 10.57 110.1 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -89.3 114.54 25.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.844 -0.799 . . . . 8.8800000000000008 108.844 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -87.71 133.19 33.89 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.054 0.454 . . . . 9.7799999999999994 111.365 -173.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 6.4 p -145.85 146.7 29.79 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.333 -0.849 . . . . 6.4000000000000004 109.419 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 97' ' ' VAL . 50.8 Cg_exo -56.6 130.77 41.76 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.338 2.025 . . . . 6.5499999999999998 110.518 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.9 p -55.22 -24.35 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.134 0.79 . . . . 9.2899999999999991 113.134 -172.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -90.4 6.84 41.54 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.854 -0.529 . . . . 10.859999999999999 111.929 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -82.16 -39.14 23.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.257 0.551 . . . . 5.3399999999999999 110.629 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -91.93 156.04 17.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.6 -0.727 . . . . 6.9699999999999998 111.767 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.1 mm -120.07 103.51 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 115.409 -0.814 . . . . 10.199999999999999 110.376 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER -109.3 98.23 7.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.581 -1.248 . . . . 12.119999999999999 112.166 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -107.44 142.98 36.43 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.896 -1.502 . . . . 14.609999999999999 109.386 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.36 -107.07 1.93 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.59 -0.814 . . . . 15.52 112.23 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.66 17.48 11.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.028 0.751 . . . . 14.99 113.028 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 17.5 ptt180 -160.0 166.61 29.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.129 0.788 . . . . 15.199999999999999 113.129 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.1 m -113.79 154.42 27.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.229 -0.896 . . . . 9.2599999999999998 110.729 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 124' ' ' GLU . 32.8 mm -133.97 149.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.981 -0.554 . . . . 10.550000000000001 109.834 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -135.19 130.17 34.91 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.476 0.31 . . . . 7.3899999999999997 110.289 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 37.6 ttp -84.24 100.2 11.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.737 -0.838 . . . . 8.8499999999999996 108.737 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 121' ' ' ASP . 13.6 p -87.77 134.48 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.602 -0.726 . . . . 9.6899999999999995 111.736 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.98 94.45 8.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.668 -0.696 . . . . 10.699999999999999 109.638 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -75.41 148.82 38.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 14.880000000000001 110.748 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.18 -0.71 30.27 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.592 -0.731 . . . . 16.920000000000002 111.991 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.35 9.47 20.41 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.466 0.65 . . . . 18.559999999999999 110.59 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.77 10.69 78.63 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.282 -0.872 . . . . 15.619999999999999 113.295 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.65 160.77 23.89 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.436 -0.888 . . . . 14.19 112.475 -174.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 91.9 m-85 -112.3 126.57 55.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 12.029999999999999 109.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -129.24 150.69 76.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.968 -0.293 . . . . 13.91 111.495 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 123.65 2.01 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.47 2.113 . . . . 12.35 112.147 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.614 HG12 ' HB3' ' A' ' 111' ' ' ALA . 6.1 p -108.98 134.67 50.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.349 -0.841 . . . . 9.4299999999999997 110.015 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.519 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.1 tt0 -74.26 120.47 19.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.514 . . . . 12.93 109.611 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.792 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -128.62 156.45 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.721 -0.672 . . . . 8.0299999999999994 111.657 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.8 ttmm -101.61 126.67 48.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.918 -1.037 . . . . 10.390000000000001 109.459 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -142.46 107.79 5.01 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.379 -0.373 . . . . 8.3000000000000007 111.625 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.01 0.29 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 117.684 -2.198 . . . . 10.1 114.539 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.57 163.04 38.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.494 -0.928 . . . . 10.609999999999999 108.494 154.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.93 128.28 26.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 118.12 0.418 . . . . 13.17 110.163 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.66 126.76 9.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.327 -0.397 . . . . 12.98 111.48 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.85 24.59 74.29 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.194 -0.457 . . . . 14.34 112.498 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 14.45 81.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.61 -0.805 . . . . 13.119999999999999 111.388 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -119.21 171.09 8.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.528 -0.545 . . . . 10.619999999999999 109.528 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 6.2 p -119.13 154.17 33.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 116.405 -0.361 . . . . 7.8200000000000003 110.222 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 51.8 mt-10 -100.83 124.53 46.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.438 0.637 . . . . 10.789999999999999 111.4 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 125' ' ' VAL . 20.2 mm -88.86 112.16 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.183 -0.917 . . . . 6.7300000000000004 109.908 174.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.8 mp -79.18 -44.99 20.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.603 -1.181 . . . . 8.7899999999999991 109.649 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' VAL . 39.6 mt-10 -146.04 166.71 25.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.824 -0.626 . . . . 10.44 109.318 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 120.42 -70.47 0.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.798 -1.191 . . . . 8.8699999999999992 113.528 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 mt -97.52 -179.19 4.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.382 0.611 . . . . 8.5 112.306 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -137.55 151.79 48.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.954 -1.021 . . . . 14.15 109.732 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.11 135.79 51.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.842 -1.072 . . . . 12.119999999999999 110.632 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.94 50.02 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.328 -0.709 . . . . 11.539999999999999 111.328 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -103.68 156.97 17.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.568 -0.53 . . . . 11.24 109.568 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.79 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.2 mt-30 -111.03 146.32 36.92 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.11 0.481 . . . . 10.49 110.703 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 101' ' ' ALA . 1.7 p -132.84 137.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.448 -0.796 . . . . 5.4500000000000002 109.011 172.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.61 124.13 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.35 0.595 . . . . 6.5599999999999996 110.69 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 101' ' ' ALA . 1.9 m . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.676 -0.693 . . . . 6.9900000000000002 109.71 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.468 -0.567 . . . . 11.84 109.468 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.4 85.44 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.62 0.248 . . . . 12.24 110.381 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.686 ' H ' HD12 ' A' ' 154' ' ' LEU . 6.3 mp -40.3 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.796 1.31 . . . . 13.16 112.43 -171.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.0 mt -149.35 114.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.936 -0.764 . . . . 11.949999999999999 108.936 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.93 -77.39 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.708 0.766 . . . . 11.220000000000001 112.454 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.3 p -64.48 -42.31 95.96 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.826 -1.079 . . . . 11.9 112.633 -162.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -68.63 -28.32 66.8 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.837 -0.62 . . . . 11.17 109.979 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.26 -18.86 54.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.435 -0.802 . . . . 7.8200000000000003 110.562 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.3 t -81.29 -41.65 21.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.857 -0.61 . . . . 9.6400000000000006 109.572 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.45 -35.67 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.706 -0.679 . . . . 10.57 110.937 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 162' ' ' ARG . 34.9 mtt180 -98.44 -161.47 0.88 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.363 -0.606 . . . . 8.9000000000000004 109.363 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 177.89 -56.55 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.912 -0.661 . . . . 7.1500000000000004 111.889 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.6 p -102.48 -26.38 13.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.672 . . . . 7.0899999999999999 110.042 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.6 t -87.75 76.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.561 -0.745 . . . . 9.1999999999999993 110.14 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.097 -0.501 . . . . 9.1099999999999994 110.911 -179.5 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 107.924 -1.139 . . . . 10.380000000000001 107.924 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.405 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 18.2 mmm180 -126.14 137.07 53.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.762 -1.563 . . . . 8.3699999999999992 110.564 -174.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.6 mm -46.36 131.91 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.343 -1.299 . . . . 5.7599999999999998 113.66 -168.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -120.29 -29.9 4.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.843 -1.526 . . . . 8.2200000000000006 108.227 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.743 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 16.4 p90 -175.24 -176.63 0.95 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.315 -0.857 . . . . 7.9900000000000002 111.602 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.662 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.99 153.67 45.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.119 -0.946 . . . . 5.6100000000000003 110.593 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -157.36 152.22 25.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 9.0600000000000005 110.4 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.73 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.7 t70 -86.85 137.39 33.55 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.278 -0.638 . . . . 8.3100000000000005 109.278 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HG3' HG13 ' A' ' 54' ' ' ILE . 16.5 Cg_exo -63.4 -14.93 45.25 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.495 2.13 . . . . 10.41 112.358 177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.32 0.57 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.718 0.294 . . . . 10.85 111.147 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -126.84 40.08 0.54 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.276 0.473 . . . . 9.3200000000000003 112.276 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 13.8 Cg_endo -52.06 126.16 19.39 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.66 2.24 . . . . 11.1 112.812 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.36 -20.31 28.1 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 10.31 111.491 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.555 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 20.2 tp60 -81.42 102.92 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.239 0.542 . . . . 9.2100000000000009 110.339 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.536 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 21.1 ttp180 -89.95 111.85 23.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.571 -0.74 . . . . 11.51 110.515 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.743 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 91.8 m-85 -92.67 127.72 38.27 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 108.036 -1.098 . . . . 7.5 108.036 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.79 -18.12 64.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.332 -0.547 . . . . 10.609999999999999 112.173 -171.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.3 mttt -141.4 170.09 10.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.738 -0.385 . . . . 10.91 111.01 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -52.82 170.43 0.29 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.522 2.815 . . . . 7.5099999999999998 113.586 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.9 -167.15 29.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.39 -0.91 . . . . 7.5899999999999999 113.421 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 9.4 ttmt -97.03 148.06 23.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.203 -0.666 . . . . 11.68 109.203 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.477 ' HA ' HD21 ' A' ' 53' ' ' LEU . 75.6 p -62.9 136.51 96.56 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 115.457 -0.792 . . . . 9.1999999999999993 110.57 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.25 -25.4 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.894 1.729 . . . . 10.25 111.59 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.55 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 88.0 m-85 -81.82 -31.19 31.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.625 -0.716 . . . . 10.49 110.631 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.12 -159.74 0.88 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.501 -0.925 . . . . 10.380000000000001 108.501 173.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -130.67 54.92 1.86 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.687 0.756 . . . . 12.539999999999999 109.751 172.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 ptm -127.71 145.04 53.39 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 114.526 -1.216 . . . . 9.8699999999999992 109.394 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.57 133.28 47.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.679 1.586 . . . . 9.5099999999999998 109.971 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 46' ' ' SER . 24.2 mt -62.67 165.05 6.86 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.408 0.442 . . . . 6.71 110.735 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' A' ' 33' ' ' PRO . 32.8 mm -99.7 129.21 29.29 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.497 -0.557 . . . . 7.8899999999999997 109.497 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 56.0 Cg_endo -83.28 138.2 8.65 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.851 1.701 . . . . 5.7699999999999996 113.274 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.46 159.51 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.725 -1.58 . . . . 5.96 113.431 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.98 -86.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.966 2.106 . . . . 7.8399999999999999 115.512 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.695 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -49.65 -38.76 33.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.977 0.418 . . . . 6.6200000000000001 110.26 -177.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 114.885 -1.052 . . . . 8.5800000000000001 111.263 173.298 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 158' ' ' GLU . 61.2 ttm-85 . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.192 0.52 . . . . 11.640000000000001 110.242 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.4 p -131.37 146.78 52.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.13 -0.941 . . . . 8.0 109.792 -176.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.0 128.08 56.07 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.867 -0.79 . . . . 6.6500000000000004 108.867 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.76 131.71 35.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.07 -0.345 . . . . 12.15 110.07 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' GLN . 73.4 t -56.7 127.2 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-O 122.293 1.044 . . . . 9.7100000000000009 112.066 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.83 136.27 8.99 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.888 -1.96 . . . . 11.029999999999999 109.035 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.603 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.61 168.83 19.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.894 -1.048 . . . . 12.76 112.44 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.586 0 CA-C-N 114.635 -1.166 . . . . 13.25 111.135 -169.959 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.994 -0.743 . . . . 14.94 108.994 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 1.9 ttp180 -132.44 149.2 52.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.71 . . . . 10.57 111.062 -172.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.7 mm? -77.51 120.83 23.03 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.391 0.432 . . . . 8.8800000000000008 110.458 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.06 131.87 43.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.311 -0.404 . . . . 9.7799999999999994 111.318 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.7 156.12 59.66 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 6.4000000000000004 109.467 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.46 134.06 61.0 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.117 1.878 . . . . 6.5499999999999998 110.663 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 21.7 t -61.56 -26.05 67.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.958 0.355 . . . . 9.2899999999999991 111.958 -173.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.0 4.8 49.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.941 -0.474 . . . . 10.859999999999999 111.568 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -75.73 -32.88 60.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.413 0.625 . . . . 5.3399999999999999 110.54 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 2.9 pp -101.99 168.21 9.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.278 -0.874 . . . . 6.9699999999999998 111.918 -172.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' THR . 27.6 mm -121.26 101.84 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.062 -0.517 . . . . 10.199999999999999 110.129 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 104' ' ' ARG . 2.7 ppt_? -109.35 108.04 18.45 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.195 -1.402 . . . . 12.119999999999999 111.131 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -123.73 136.11 54.25 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.76 -1.564 . . . . 14.609999999999999 109.143 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.64 -102.99 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.401 -0.904 . . . . 15.52 112.333 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.22 4.53 10.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.914 0.709 . . . . 14.99 112.914 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 176.14 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.773 0.657 . . . . 15.199999999999999 112.773 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.5 m -123.99 156.74 35.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.015 -0.993 . . . . 9.2599999999999998 111.712 -169.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 26.4 mm -128.46 149.82 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.081 -0.711 . . . . 10.550000000000001 109.081 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -132.61 140.37 48.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.603 0.24 . . . . 7.3899999999999997 110.924 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 67.9 mtp -92.52 100.75 13.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.434 -0.58 . . . . 8.8499999999999996 109.434 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.7 p -88.86 132.95 32.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 9.6899999999999995 111.789 -174.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -79.19 83.85 5.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.376 -0.829 . . . . 10.699999999999999 109.774 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 46.5 mttm -75.18 146.93 40.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.771 -0.65 . . . . 14.880000000000001 110.972 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.0 5.2 42.28 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 16.920000000000002 111.138 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -85.61 9.77 15.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.626 0.727 . . . . 18.559999999999999 110.679 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.48 19.02 50.83 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.149 -0.932 . . . . 15.619999999999999 113.816 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.31 173.12 36.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.348 -0.93 . . . . 14.19 112.581 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 71.2 m-85 -109.84 109.24 19.83 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.194 -0.669 . . . . 12.029999999999999 109.194 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.596 ' O ' HG12 ' A' ' 113' ' ' VAL . 7.0 t70 -101.57 145.72 30.95 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 13.91 110.502 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 20.1 Cg_endo -89.32 132.82 2.24 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.151 1.9 . . . . 12.35 112.406 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.647 HG12 ' HB3' ' A' ' 111' ' ' ALA . 2.8 p -118.84 137.05 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.625 -0.716 . . . . 9.4299999999999997 109.542 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 111.85 13.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 12.93 110.101 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -119.1 160.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.929 -1.032 . . . . 8.0299999999999994 110.826 -175.399 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 23.5 ttmm -104.46 125.86 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.846 -0.615 . . . . 10.390000000000001 109.555 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.65 109.67 5.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.678 -0.237 . . . . 8.3000000000000007 111.61 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.579 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.63 70.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.166 -1.968 . . . . 10.1 113.905 169.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.34 162.24 40.47 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.831 -0.803 . . . . 10.609999999999999 108.831 155.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 23.6 m -138.89 129.4 25.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.11 0.481 . . . . 13.17 109.871 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.73 102.31 5.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.645 -0.707 . . . . 12.98 110.675 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.63 24.39 76.25 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.041 -0.527 . . . . 14.34 112.492 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 97.51 -10.72 64.99 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.766 -0.73 . . . . 13.119999999999999 112.195 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 130' ' ' THR . 2.4 mp0 -97.49 162.98 13.05 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.84 -0.8 . . . . 10.619999999999999 108.84 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.4 p -114.63 155.36 26.69 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.431 -0.507 . . . . 7.8200000000000003 111.172 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.905 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 25.7 mt-10 -100.02 128.5 46.09 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.5 0.667 . . . . 10.789999999999999 110.967 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 125' ' ' VAL . 24.3 mm -92.02 101.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.133 -0.94 . . . . 6.7300000000000004 109.772 175.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.579 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.6 mp -67.18 -45.63 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.836 -1.075 . . . . 8.7899999999999991 109.845 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.0 mt-10 -146.34 163.29 36.04 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.356 -0.609 . . . . 10.44 109.356 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.83 -46.95 1.05 Allowed Glycine 0 C--N 1.316 -0.572 0 C-N-CA 119.497 -1.335 . . . . 8.8699999999999992 114.242 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.7 mt -123.22 -178.49 4.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.416 0.895 . . . . 8.5 113.416 -170.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.9 ttpt -142.39 155.23 45.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.569 -1.196 . . . . 14.15 108.846 -176.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.61 129.6 40.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.985 -0.552 . . . . 12.119999999999999 110.063 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.17 48.46 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.251 -0.74 . . . . 11.539999999999999 111.251 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.8 mm100 -97.89 100.8 12.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.446 0.641 . . . . 11.24 109.334 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.1 mt-30 -74.11 127.4 32.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.356 -0.838 . . . . 10.49 110.307 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 149' ' ' VAL . 19.5 m -117.69 135.83 56.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.601 0.238 . . . . 5.4500000000000002 110.67 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.593 ' HA ' HG22 ' A' ' 81' ' ' THR . 42.6 t -66.43 115.05 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.864 -0.607 . . . . 6.5599999999999996 110.473 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 4.1 m . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 6.9900000000000002 110.759 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.922 0.391 . . . . 11.84 110.966 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.26 82.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 12.24 110.818 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 -168.72 2.15 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.514 -0.55 . . . . 13.16 109.514 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 157' ' ' SER . 28.8 pt -59.57 163.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 11.949999999999999 111.91 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.9 24.54 0.62 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.008 0.908 . . . . 11.220000000000001 111.206 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 155' ' ' ILE . 6.4 p -56.92 -27.11 60.48 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 114.456 -1.247 . . . . 11.9 111.218 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 1.5 mm-40 -57.9 -35.79 71.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 112.922 -1.945 . . . . 11.17 111.057 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.53 64.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.595 -0.73 . . . . 7.8200000000000003 110.895 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.2 m -76.23 -25.64 55.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.507 0.67 . . . . 9.6400000000000006 109.571 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.76 -16.53 44.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.111 -0.949 . . . . 10.57 110.756 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.7 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 13.4 mmm180 -89.45 131.21 35.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.316 0.579 . . . . 8.9000000000000004 111.469 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -148.06 62.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.292 -1.523 . . . . 7.1500000000000004 109.292 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p 50.0 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.592 -0.521 . . . . 7.0899999999999999 109.592 -161.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 166' ' ' ALA . 2.7 p -100.18 -65.89 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 9.1999999999999993 109.997 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.651 ' H ' HG13 ' A' ' 165' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.385 0 C-N-CA 124.993 1.317 . . . . 9.1099999999999994 108.547 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.8 mptm? . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.23 -1.026 . . . . 10.380000000000001 108.23 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.3 mtm180 -136.73 138.61 41.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.168 -1.378 . . . . 8.3699999999999992 109.484 -173.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' CH2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -49.59 124.13 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.962 0.887 . . . . 5.7599999999999998 112.21 -173.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 28' ' ' LEU . 20.9 mt -112.16 -37.6 4.99 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.648 -1.614 . . . . 8.2200000000000006 110.942 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 4.0 p90 -176.29 -178.64 0.99 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 7.9900000000000002 109.464 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.683 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.0 156.61 30.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.867 -0.606 . . . . 5.6100000000000003 111.009 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 30.3 ptt180 -160.03 149.7 18.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.853 -1.067 . . . . 9.0600000000000005 110.311 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HB3' HG22 ' A' ' 35' ' ' VAL . 1.8 t0 -88.19 138.69 30.53 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.046 -0.724 . . . . 8.3100000000000005 109.046 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HG3' HG13 ' A' ' 54' ' ' ILE . 32.8 Cg_exo -57.55 -20.61 42.28 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 123.498 2.799 . . . . 10.41 113.088 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -89.44 -24.4 21.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.354 0.597 . . . . 10.85 109.993 -177.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.3 m -117.95 37.16 0.24 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.107 -0.951 . . . . 9.3200000000000003 113.526 -161.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 57.7 Cg_endo -60.78 108.29 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.881 2.387 . . . . 11.1 112.166 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.31 -18.29 0.91 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.496 -0.859 . . . . 10.31 112.474 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -77.26 -177.74 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.215 0.531 . . . . 9.2100000000000009 111.646 174.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.644 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 5.2 tpp180 -148.26 91.73 1.95 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 11.51 109.729 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 77.5 m-85 -75.63 137.02 40.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.851 -0.74 . . . . 7.5 110.442 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.84 -29.94 71.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.745 -1.116 . . . . 10.609999999999999 110.032 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -165.04 164.28 13.03 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.338 -0.846 . . . . 10.91 110.608 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.3 Cg_endo -48.63 169.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.872 3.048 . . . . 7.5099999999999998 114.351 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.14 -174.44 26.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.679 -0.772 . . . . 7.5899999999999999 112.606 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.9 ttpm? -86.19 146.0 26.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.186 0.517 . . . . 11.68 110.986 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 49' ' ' MET . 32.9 t -58.43 136.33 85.53 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.764 -1.107 . . . . 9.1999999999999993 110.924 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.55 -20.43 15.81 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 122.192 1.928 . . . . 10.25 110.912 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -86.15 -42.63 13.7 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.672 -1.603 . . . . 10.49 109.597 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.514 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.5 mtm -129.5 152.65 48.81 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 115.779 -0.646 . . . . 10.380000000000001 111.339 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.74 60.7 5.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.747 1.261 . . . . 12.539999999999999 111.294 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -139.51 145.55 44.28 Favored Pre-proline 0 C--N 1.304 -1.371 0 CA-C-N 113.891 -1.504 . . . . 9.8699999999999992 109.208 177.116 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 39.8 Cg_endo -67.57 133.86 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.934 1.756 . . . . 9.5099999999999998 111.936 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.4 163.23 11.1 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.576 -0.528 . . . . 6.71 109.576 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' A' ' 33' ' ' PRO . 24.1 mm -98.02 132.81 23.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 120.989 0.423 . . . . 7.8899999999999997 110.565 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.87 147.51 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.91 1.74 . . . . 5.7699999999999996 112.208 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 35.2 m -73.02 158.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 114.657 -1.156 . . . . 5.96 112.679 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.496 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.89 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.235 2.214 . . . . 7.8399999999999999 115.865 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.6 pt-20 -48.47 -44.16 35.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.477 0.711 . . . . 6.6200000000000001 111.231 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' N ' ' HG2' ' A' ' 58' ' ' GLU . 33.5 tt0 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.759 -1.109 . . . . 8.5800000000000001 111.414 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.891 -0.781 . . . . 11.640000000000001 108.891 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 148' ' ' VAL . 68.0 p -131.12 159.19 38.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 8.0 110.097 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -121.59 128.64 52.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.668 -0.864 . . . . 6.6500000000000004 108.668 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 33.9 tt0 -84.56 130.46 34.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.465 -0.569 . . . . 12.15 109.465 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 143' ' ' ALA . 20.5 m -64.35 141.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 122.888 1.328 . . . . 9.7100000000000009 111.401 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -164.13 174.28 11.46 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.335 -2.212 . . . . 11.029999999999999 109.514 173.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 10.0 mp -70.48 167.91 17.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.572 0.701 . . . . 12.76 112.125 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.426 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.54 0 CA-C-N 115.33 -0.85 . . . . 13.25 112.604 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG2' HD23 ' A' ' 86' ' ' LEU . 7.8 mt-10 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.065 0.46 . . . . 14.94 110.575 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.633 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 1.5 mmp_? -121.11 168.13 11.89 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.87 -0.605 . . . . 10.57 111.248 -171.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.6 mm? -97.85 114.21 26.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.464 -0.789 . . . . 8.8800000000000008 109.294 176.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.2 mm? -91.39 130.91 37.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.349 -0.841 . . . . 9.7799999999999994 111.258 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.604 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 3.3 p -139.32 146.81 50.31 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.525 -1.216 . . . . 6.4000000000000004 108.927 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.7 Cg_exo -56.51 132.01 49.18 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.145 1.897 . . . . 6.5499999999999998 109.595 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t -57.74 -25.55 60.57 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 9.2899999999999991 112.312 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.38 4.48 52.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.945 0.35 . . . . 10.859999999999999 111.945 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.604 ' HB3' ' CG2' ' A' ' 97' ' ' VAL . . . -79.84 -33.6 40.07 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.225 -0.59 . . . . 5.3399999999999999 110.51 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -91.91 155.1 18.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.584 0.707 . . . . 6.9699999999999998 111.967 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -99.18 125.43 52.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.08 -0.964 . . . . 10.199999999999999 109.029 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.8 mmm180 -98.1 125.69 43.21 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.677 -0.809 . . . . 12.119999999999999 110.911 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.9 t -149.15 127.26 12.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.722 -0.672 . . . . 14.609999999999999 110.818 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.41 -121.91 16.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.03 -0.532 . . . . 15.52 112.794 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.09 36.79 2.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 14.99 111.418 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -156.98 177.43 11.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.002 -0.544 . . . . 15.199999999999999 111.526 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 25.8 m -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.644 -0.707 . . . . 9.2599999999999998 109.26 174.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.5 mm -126.92 150.7 33.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 10.550000000000001 109.125 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.602 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.35 130.02 32.22 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.242 -0.286 . . . . 7.3899999999999997 110.839 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.454 ' HE3' HG11 ' A' ' 148' ' ' VAL . 38.7 mtm -84.71 100.25 11.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.846 -0.798 . . . . 8.8499999999999996 108.846 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 11.3 p -81.95 134.46 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.825 -1.079 . . . . 9.6899999999999995 111.208 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.59 91.56 7.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.539 -0.755 . . . . 10.699999999999999 110.235 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.48 147.94 35.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 14.880000000000001 111.035 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.16 -2.35 47.16 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.658 -0.701 . . . . 16.920000000000002 112.021 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.17 6.84 12.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.456 0.646 . . . . 18.559999999999999 111.058 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.67 67.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.243 -0.889 . . . . 15.619999999999999 113.197 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.6 -174.74 13.51 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.336 -0.935 . . . . 14.19 112.981 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.08 128.26 37.83 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.068 0.547 . . . . 12.029999999999999 109.783 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 113' ' ' VAL . 8.2 m-20 -125.37 147.72 58.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.594 -0.275 . . . . 13.91 111.024 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -85.37 124.87 2.86 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.391 2.061 . . . . 12.35 112.484 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.623 HG11 HD13 ' A' ' 141' ' ' LEU . 4.4 p -106.19 135.73 43.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.87 -1.059 . . . . 9.4299999999999997 109.078 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.1 tt0 -82.23 122.75 28.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.057 -0.72 . . . . 12.93 109.057 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -137.02 157.16 35.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.402 0.62 . . . . 8.0299999999999994 112.215 -173.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 76.1 tttt -93.73 128.68 40.06 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.092 -0.958 . . . . 10.390000000000001 110.208 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.404 ' HB3' ' OG1' ' A' ' 109' ' ' THR . . . -142.19 104.39 4.44 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.782 -0.644 . . . . 8.3000000000000007 111.075 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.32 71.28 0.28 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 117.924 -2.084 . . . . 10.1 113.882 169.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.83 164.14 36.14 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.892 -0.781 . . . . 10.609999999999999 108.892 157.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -133.48 128.32 35.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.709 -0.478 . . . . 13.17 109.709 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.87 122.49 7.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.514 -0.312 . . . . 12.98 111.58 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.31 92.31 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.933 -0.576 . . . . 14.34 113.101 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.99 78.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 13.119999999999999 111.687 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -130.6 171.67 12.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.936 -0.765 . . . . 10.619999999999999 108.936 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -115.21 156.58 25.08 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.649 -0.501 . . . . 7.8200000000000003 109.649 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.7 mt-10 -102.36 124.07 47.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.562 0.696 . . . . 10.789999999999999 111.375 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 125' ' ' VAL . 26.0 mm -86.04 111.83 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.963 -1.017 . . . . 6.7300000000000004 109.16 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 3.8 mp -81.15 -45.69 16.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.974 -1.012 . . . . 8.7899999999999991 111.006 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 125' ' ' VAL . 42.6 mt-10 -146.59 173.02 12.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.139 -0.689 . . . . 10.44 109.139 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 93.2 -63.01 2.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.144 -1.027 . . . . 8.8699999999999992 113.715 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD13 HG11 ' A' ' 123' ' ' VAL . 35.9 tp -105.41 145.09 31.28 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.234 -1.024 . . . . 8.5 108.234 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 85.8 tttt -136.34 143.8 44.29 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 112.734 0.642 . . . . 14.15 112.734 -161.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 1.037 ' HA ' HG23 ' A' ' 84' ' ' VAL . . . -49.62 123.91 8.62 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.845 -1.525 . . . . 12.119999999999999 111.375 -173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.1 1.12 38.72 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 114.853 -1.067 . . . . 11.539999999999999 111.286 -171.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 74.6 mm-40 -103.7 125.52 50.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.766 -0.773 . . . . 11.24 110.097 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 mp0 -85.39 142.83 29.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.728 -0.669 . . . . 10.49 110.577 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 16.1 m -135.27 147.27 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.472 0.177 . . . . 5.4500000000000002 110.597 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 81' ' ' THR . 22.6 m -57.84 133.72 22.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 O-C-N 123.855 0.722 . . . . 6.5599999999999996 111.878 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 82' ' ' ALA . 45.9 t . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.2 -0.909 . . . . 6.9900000000000002 110.546 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.83 0.348 . . . . 11.84 111.02 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.91 -166.72 1.37 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 12.24 110.001 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.2 171.35 20.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.287 0.565 . . . . 13.16 110.23 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 158' ' ' GLU . 26.9 mt 63.84 61.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 114.393 -1.276 . . . . 11.949999999999999 111.183 176.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.26 -9.37 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 11.220000000000001 111.279 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.8 p -61.52 -41.13 96.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.308 0.575 . . . . 11.9 110.593 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' A' ' 155' ' ' ILE . 51.5 mm-40 -73.51 -30.8 63.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 11.17 109.799 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.65 -17.9 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.98 -1.009 . . . . 7.8200000000000003 110.482 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.3 m -81.44 -31.66 32.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.511 -0.768 . . . . 9.6400000000000006 110.465 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.3 -31.03 48.7 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.297 -0.865 . . . . 10.57 110.833 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -81.47 166.97 19.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.725 -0.671 . . . . 8.9000000000000004 109.546 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.95 71.95 2.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.089 -0.576 . . . . 7.1500000000000004 111.84 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.9 p 53.4 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.273 1.029 . . . . 7.0899999999999999 112.022 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.43 -45.92 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 110.209 -0.293 . . . . 9.1999999999999993 110.209 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 O-C-N 123.589 0.556 . . . . 9.1099999999999994 111.601 -177.892 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 107.942 -1.132 . . . . 10.380000000000001 107.942 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.525 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 3.1 mtp180 -134.8 140.81 46.16 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.161 -1.381 . . . . 8.3699999999999992 109.239 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' A' ' 58' ' ' GLU . 46.2 mm -51.96 118.24 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.068 -0.969 . . . . 5.7599999999999998 113.286 -169.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.19 -32.97 7.0 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.8 -1.546 . . . . 8.2200000000000006 110.009 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 37.6 p90 -179.51 -176.09 0.37 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.734 -0.667 . . . . 7.9900000000000002 109.625 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -118.77 154.98 31.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.714 . . . . 5.6100000000000003 110.908 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 39.2 ptt180 -164.06 148.01 9.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.834 0.708 . . . . 9.0600000000000005 109.721 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 1.027 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 9.4 m-20 -70.73 142.05 88.04 Favored Pre-proline 0 CA--C 1.51 -0.585 0 N-CA-C 108.986 -0.746 . . . . 8.3100000000000005 108.986 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' CG1' ' A' ' 54' ' ' ILE . 74.6 Cg_endo -68.87 -11.82 32.86 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 123.142 2.562 . . . . 10.41 112.353 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . 1.027 ' SD ' ' HB3' ' A' ' 32' ' ' ASP . 1.2 pmm? -102.75 1.34 34.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.289 . . . . 10.85 111.265 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 3.8 m -124.63 39.41 0.45 Allowed Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 112.627 0.603 . . . . 9.3200000000000003 112.627 177.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.2 Cg_endo -54.41 126.37 22.02 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.305 2.003 . . . . 11.1 112.334 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.86 -12.51 17.65 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.174 -0.771 . . . . 10.31 111.174 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 6.4 tp-100 -90.61 108.22 19.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.323 0.583 . . . . 9.2100000000000009 110.394 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.589 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.7 tmm_? -91.48 97.35 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 11.51 109.414 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 78.5 m-85 -77.25 146.59 36.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 7.5 110.715 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.1 -26.68 68.94 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.255 -1.339 . . . . 10.609999999999999 111.264 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 12.7 ptmm? -173.12 168.37 2.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.005 -0.543 . . . . 10.91 110.156 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.2 Cg_endo -52.35 169.29 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.502 2.134 . . . . 7.5099999999999998 112.52 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.72 -160.01 27.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 7.5899999999999999 111.644 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 7.1 ttpm? -99.98 151.23 21.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.444 0.64 . . . . 11.68 110.627 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 49' ' ' MET . 36.3 t -67.89 145.32 97.84 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.718 -1.128 . . . . 9.1999999999999993 111.86 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.08 -19.9 4.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.783 2.322 . . . . 10.25 111.504 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CD2' HG11 ' A' ' 35' ' ' VAL . 59.3 m-85 -81.45 -38.01 27.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.79 -1.096 . . . . 10.49 109.321 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.7 pmm? -153.46 171.41 18.72 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.395 -0.82 . . . . 10.380000000000001 110.338 172.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.16 76.65 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.512 0.93 . . . . 12.539999999999999 113.512 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.414 ' C ' ' HG3' ' A' ' 45' ' ' LYS . 9.6 ptm -143.9 147.12 37.08 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.857 -1.164 . . . . 9.8699999999999992 107.857 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 36.6 Cg_endo -67.23 135.99 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.336 1.357 . . . . 9.5099999999999998 110.12 171.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.89 166.98 6.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.265 0.555 . . . . 6.71 112.096 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.546 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 39.1 mm -101.95 130.51 24.25 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.696 -0.684 . . . . 7.8899999999999997 109.65 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 17.6 Cg_endo -83.02 134.13 6.91 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.359 1.373 . . . . 5.7699999999999996 112.21 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 35.3 m -56.03 157.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.254 -1.339 . . . . 5.96 113.099 -176.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.48 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.935 2.094 . . . . 7.8399999999999999 115.122 -177.409 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.545 ' HG2' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -45.68 -41.94 11.03 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.022 0.529 . . . . 6.6200000000000001 110.747 -178.067 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 32.7 tt0 . . . . . 0 C--N 1.317 -0.828 0 O-C-N 123.669 0.606 . . . . 8.5800000000000001 111.8 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.969 0.414 . . . . 11.640000000000001 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 148' ' ' VAL . 25.9 p -125.37 137.5 54.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.552 -0.749 . . . . 8.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.497 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -110.47 128.0 55.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.247 -0.649 . . . . 6.6500000000000004 109.247 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 34.3 tt0 -74.27 132.78 42.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.072 -0.714 . . . . 12.15 109.072 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.614 HG13 ' HB3' ' A' ' 95' ' ' LEU . 49.6 t -55.04 132.63 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.013 -0.539 . . . . 9.7100000000000009 112.301 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 25.3 mmtp -138.37 148.35 44.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.966 -1.016 . . . . 11.029999999999999 109.284 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.83 149.98 36.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.854 -0.795 . . . . 12.76 108.854 167.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.427 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.507 -0.407 0 C-N-CA 120.166 -1.016 . . . . 13.25 112.527 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 . . . . . 0 CA--C 1.51 -0.566 0 CA-C-O 121.775 0.798 . . . . 14.94 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.519 ' HG2' HD12 ' A' ' 138' ' ' LEU . 2.1 mpp_? -132.29 169.61 16.23 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.316 -1.311 . . . . 10.57 109.5 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -94.19 112.69 24.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.555 -0.906 . . . . 8.8800000000000008 108.555 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -88.44 131.78 34.73 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.532 -0.758 . . . . 9.7799999999999994 110.667 -175.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 98' ' ' PRO . 5.6 p -147.84 147.0 25.66 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.059 -0.973 . . . . 6.4000000000000004 109.089 -176.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 97' ' ' VAL . 74.9 Cg_exo -54.05 130.01 37.27 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.407 2.071 . . . . 6.5499999999999998 110.742 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 40.3 t -56.28 -28.07 57.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.017 0.747 . . . . 9.2899999999999991 113.017 -170.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.4 9.22 13.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.544 -0.462 . . . . 10.859999999999999 111.504 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -82.81 -33.7 27.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.156 0.503 . . . . 5.3399999999999999 111.469 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.532 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.6 pp -100.63 165.08 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.324 0.583 . . . . 6.9699999999999998 112.334 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 25.3 mm -104.29 118.62 51.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.45 -0.796 . . . . 10.199999999999999 110.294 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 11.0 mmm180 -103.91 94.83 5.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.811 0.339 . . . . 12.119999999999999 110.392 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.5 t -145.59 131.16 18.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.5 0.666 . . . . 14.609999999999999 111.602 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.88 -123.38 6.16 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.106 -0.952 . . . . 15.52 111.999 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.92 28.18 8.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.102 0.477 . . . . 14.99 111.16 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.42 178.36 9.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 15.199999999999999 111.165 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.1 m -128.58 149.99 50.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.937 -0.574 . . . . 9.2599999999999998 110.35 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.7 mp -126.23 153.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 110.214 -0.291 . . . . 10.550000000000001 110.214 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -130.78 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.459 -0.2 . . . . 7.3899999999999997 110.459 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.441 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 64.1 mtm -99.4 102.88 14.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.539 -0.541 . . . . 8.8499999999999996 109.539 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 8.3 p -85.77 137.24 21.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.111 0.482 . . . . 9.6899999999999995 111.451 -172.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 91.98 3.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.651 -0.704 . . . . 10.699999999999999 111.513 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -80.06 162.92 24.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.975 -0.557 . . . . 14.880000000000001 110.376 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.24 17.87 26.12 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.848 -0.614 . . . . 16.920000000000002 112.083 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.52 11.41 39.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 18.559999999999999 110.805 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.28 -6.59 67.34 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.56 -0.746 . . . . 15.619999999999999 112.467 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.3 167.25 12.92 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.851 -0.499 . . . . 14.19 111.851 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 56.5 m-85 -117.54 111.27 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.467 0.651 . . . . 12.029999999999999 109.976 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 30.4 t70 -91.49 134.11 30.04 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.093 -0.958 . . . . 13.91 111.328 -171.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 61.2 Cg_endo -80.58 137.1 11.32 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.201 1.934 . . . . 12.35 113.268 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.643 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.2 p -123.64 127.13 73.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.987 -1.006 . . . . 9.4299999999999997 109.821 177.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -82.62 114.63 21.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.652 -0.499 . . . . 12.93 109.652 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.455 HG12 ' HA3' ' A' ' 140' ' ' GLY . 35.6 m -130.06 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.671 -0.695 . . . . 8.0299999999999994 111.208 -173.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 3.5 ttmp? -109.52 127.33 54.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.146 -0.479 . . . . 10.390000000000001 110.471 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -143.18 112.4 6.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 8.3000000000000007 111.457 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.5 72.12 0.27 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 118.178 -1.963 . . . . 10.1 113.659 166.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.03 158.43 44.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.806 -0.812 . . . . 10.609999999999999 108.806 156.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 22.6 m -147.13 122.22 10.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.344 0.592 . . . . 13.17 109.891 169.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.02 107.45 8.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.14 -0.937 . . . . 12.98 110.7 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.97 38.16 92.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.188 -0.53 . . . . 14.34 112.4 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.01 87.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 13.119999999999999 112.584 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 130' ' ' THR . 30.2 mm-40 -106.04 154.53 20.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.286 -0.635 . . . . 10.619999999999999 109.286 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -115.25 165.97 12.36 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.455 -0.498 . . . . 7.8200000000000003 111.229 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 49.0 mt-10 -114.35 121.11 42.63 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.442 0.639 . . . . 10.789999999999999 111.521 175.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.4 mm -85.69 102.72 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.267 -0.879 . . . . 6.7300000000000004 108.663 169.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.519 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.35 -51.95 60.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.835 -1.075 . . . . 8.7899999999999991 109.766 -176.234 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -141.36 160.99 38.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.377 -0.829 . . . . 10.44 110.567 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.455 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 122.26 -64.01 0.52 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.539 -0.839 . . . . 8.8699999999999992 112.975 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 125' ' ' VAL . 30.6 mt -102.83 -177.31 3.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.931 0.715 . . . . 8.5 112.931 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -143.98 159.65 42.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.865 -1.061 . . . . 14.15 110.102 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.09 129.22 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.245 -0.889 . . . . 12.119999999999999 110.463 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.46 -7.0 26.46 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.729 -0.948 . . . . 11.539999999999999 110.729 -171.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.529 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.4 mm100 -97.83 117.41 32.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.514 . . . . 11.24 110.303 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -86.96 127.18 35.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.551 -0.749 . . . . 10.49 111.406 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.62 140.98 46.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.898 -0.592 . . . . 5.4500000000000002 110.179 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.561 ' HA ' HG22 ' A' ' 81' ' ' THR . 60.9 t -66.26 125.19 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 6.5599999999999996 110.548 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 82' ' ' ALA . 3.9 m . . . . . 0 C--N 1.325 -0.458 0 N-CA-C 112.221 0.452 . . . . 6.9900000000000002 112.221 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 121.577 0.704 . . . . 11.84 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.1 18.39 5.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.722 -0.672 . . . . 12.24 110.833 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.92 -67.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.732 0.813 . . . . 13.16 109.936 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.7 mt -98.08 75.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.229 -0.656 . . . . 11.949999999999999 109.229 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -72.87 -17.12 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.972 -0.558 . . . . 11.220000000000001 111.134 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 m -66.67 -48.57 68.92 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.945 -0.702 . . . . 11.9 109.972 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.21 -22.03 59.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.653 -0.419 . . . . 11.17 110.589 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 162' ' ' ARG . . . -54.73 -42.18 71.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 7.8200000000000003 110.067 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' SER . . . . . 0.5 ' OG ' HD12 ' A' ' 103' ' ' ILE . 29.4 t -64.16 -30.01 71.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.238 -0.892 . . . . 9.6400000000000006 111.506 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.3 mt -85.45 -33.46 21.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 10.57 111.345 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 5.8 ptm180 -77.5 161.96 27.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.907 -0.588 . . . . 8.9000000000000004 110.696 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.53 57.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.344 -0.702 . . . . 7.1500000000000004 111.344 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.6 p 48.33 57.15 6.5 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.082 0.553 . . . . 7.0899999999999999 111.677 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t 64.62 94.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.743 -0.662 . . . . 9.1999999999999993 109.837 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.637 . . . . 9.1099999999999994 111.816 -174.64 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.922 0 CA-C-O 122.352 1.073 . . . . 10.380000000000001 108.201 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.629 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 5.7 ppt_? -129.71 141.19 50.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.564 -1.653 . . . . 8.3699999999999992 109.085 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.4 mm -68.02 128.55 31.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 113.566 0.951 . . . . 5.7599999999999998 113.566 -169.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 26' ' ' ARG . 4.4 mp -117.94 -47.64 2.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.991 -1.459 . . . . 8.2200000000000006 110.39 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.4 p90 -155.65 -179.59 8.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 7.9900000000000002 111.023 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.721 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.23 149.62 41.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.172 -0.922 . . . . 5.6100000000000003 110.499 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HB2' HE22 ' A' ' 38' ' ' GLN . 38.9 ptt180 -148.27 146.3 28.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 9.0600000000000005 110.08 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.3 t0 -78.57 131.45 68.08 Favored Pre-proline 0 C--N 1.314 -0.944 0 N-CA-C 109.798 -0.445 . . . . 8.3100000000000005 109.798 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HG3' HG13 ' A' ' 54' ' ' ILE . 63.5 Cg_exo -45.11 -48.86 10.65 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.79 2.327 . . . . 10.41 111.944 -176.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.643 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.3 pmm? -91.57 9.99 29.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.212 -1.358 . . . . 10.85 112.985 -167.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 32' ' ' ASP . 6.6 m -126.32 44.92 1.32 Allowed Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 121.429 0.633 . . . . 9.3200000000000003 111.562 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.643 ' HD3' ' C ' ' A' ' 34' ' ' MET . 26.0 Cg_exo -61.66 119.9 7.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.194 2.596 . . . . 11.1 113.177 -169.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.5 4.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.467 -0.653 . . . . 10.31 111.467 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.09 142.56 30.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 9.2100000000000009 109.925 176.762 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -129.38 93.97 3.68 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.935 0.398 . . . . 11.51 110.606 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 23.8 m-85 -73.01 143.38 47.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.507 -0.769 . . . . 7.5 110.974 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.14 -27.82 68.99 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.348 -1.297 . . . . 10.609999999999999 110.455 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.0 ptpt -166.23 162.84 12.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.931 -0.577 . . . . 10.91 111.218 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.3 Cg_endo -51.3 169.56 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.64 2.893 . . . . 7.5099999999999998 113.78 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -171.1 30.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.503 -0.856 . . . . 7.5899999999999999 113.028 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 6.1 ttmm -88.63 143.26 27.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.447 -0.575 . . . . 11.68 109.447 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' MET . 37.8 t -62.28 136.2 95.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 9.1999999999999993 110.425 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 -21.06 19.51 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 122.186 1.924 . . . . 10.25 110.904 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -84.94 -41.23 16.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.878 -1.51 . . . . 10.49 109.485 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 3.1 mtm -133.72 153.51 51.64 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.36 -0.836 . . . . 10.380000000000001 111.27 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.7 p-10 -80.63 59.28 3.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.084 0.945 . . . . 12.539999999999999 111.168 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -136.33 143.25 42.76 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.899 -1.046 . . . . 9.8699999999999992 109.356 176.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 24.9 Cg_endo -63.93 133.41 38.6 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.0 1.8 . . . . 9.5099999999999998 111.158 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.8 mt -61.97 163.76 7.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 6.71 110.62 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' HG3' ' A' ' 33' ' ' PRO . 44.2 mm -105.27 129.39 24.84 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 7.8899999999999997 109.956 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.721 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 60.3 Cg_endo -73.83 140.14 28.56 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.818 1.678 . . . . 5.7699999999999996 112.189 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.43 156.51 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.395 -1.275 . . . . 5.96 112.791 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.629 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.73 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.945 2.098 . . . . 7.8399999999999999 115.553 -176.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.578 ' HG2' HG12 ' A' ' 27' ' ' ILE . 3.2 pt-20 -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.378 1.561 . . . . 6.6200000000000001 110.54 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 111.022 -2.808 . . . . 8.5800000000000001 111.705 168.772 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' N ' ' HD2' ' A' ' 80' ' ' ARG . 6.4 mpt_? . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 121.227 0.537 . . . . 11.640000000000001 109.746 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 148' ' ' VAL . 40.6 p -132.39 154.15 50.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 8.0 111.046 -172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 127.28 49.51 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.468 -0.938 . . . . 6.6500000000000004 108.468 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 42.1 tt0 -76.59 133.26 39.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.624 -0.51 . . . . 12.15 109.624 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 145' ' ' GLN . 48.0 t -53.32 130.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 9.7100000000000009 112.755 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 50.0 mmtt -134.89 142.8 46.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.856 -1.065 . . . . 11.029999999999999 109.925 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -75.53 158.32 32.7 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.504 -0.554 . . . . 12.76 109.504 171.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.571 0 C-N-CA 120.426 -0.893 . . . . 13.25 112.653 179.726 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.512 -0.499 0 CA-C-O 121.575 0.702 . . . . 14.94 111.494 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.514 ' CD ' ' HA ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -123.01 158.57 30.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.775 -1.102 . . . . 10.57 109.959 -176.335 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -98.37 122.08 41.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.152 0.501 . . . . 8.8800000000000008 109.894 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.25 134.33 38.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.073 -0.512 . . . . 9.7799999999999994 110.606 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 98' ' ' PRO . 3.8 p -150.07 147.99 23.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 6.4000000000000004 109.052 -175.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.4 Cg_exo -56.22 130.65 41.29 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.271 1.98 . . . . 6.5499999999999998 110.212 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.494 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 19.0 t -57.41 -27.08 62.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.465 0.543 . . . . 9.2899999999999991 112.465 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.36 3.97 33.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 10.859999999999999 111.547 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.61 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -77.93 -41.24 36.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.196 0.522 . . . . 5.3399999999999999 110.91 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -86.17 158.88 19.66 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.728 -0.669 . . . . 6.9699999999999998 111.898 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -101.61 126.35 55.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.327 -0.851 . . . . 10.199999999999999 108.826 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 11.6 mmm180 -101.13 128.41 47.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.519 -0.872 . . . . 12.119999999999999 111.027 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -149.32 129.17 13.35 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.285 -0.87 . . . . 14.609999999999999 110.516 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.76 -109.3 1.05 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 116.008 -0.542 . . . . 15.52 112.957 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.62 17.24 13.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 14.99 111.35 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.14 177.34 7.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.181 0.515 . . . . 15.199999999999999 111.745 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.7 m -129.2 144.71 51.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 9.2599999999999998 109.377 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.8 mm -126.56 153.04 34.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 10.550000000000001 109.375 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -134.68 132.47 38.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.394 -0.191 . . . . 7.3899999999999997 111.088 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 49.7 ttp -94.55 105.57 17.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.176 -0.675 . . . . 8.8499999999999996 109.176 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 121' ' ' ASP . 7.1 p -88.26 134.01 29.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.89 -1.05 . . . . 9.6899999999999995 112.423 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -83.3 92.47 7.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.187 -0.915 . . . . 10.699999999999999 110.108 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -86.5 149.96 24.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.057 -0.52 . . . . 14.880000000000001 111.332 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.05 0.15 74.12 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.156 -0.778 . . . . 16.920000000000002 111.156 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.27 -1.57 30.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.344 0.593 . . . . 18.559999999999999 110.887 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.89 -8.55 63.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.153 -0.93 . . . . 15.619999999999999 113.021 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.03 159.4 22.26 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.289 -0.958 . . . . 14.19 112.303 -174.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 88.8 m-85 -109.53 121.23 44.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.377 -0.601 . . . . 12.029999999999999 109.377 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.6 m-20 -122.29 151.58 59.36 Favored Pre-proline 0 CA--C 1.514 -0.421 0 C-N-CA 120.555 -0.458 . . . . 13.91 111.471 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 84.1 Cg_endo -88.77 136.27 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.417 2.078 . . . . 12.35 112.433 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.63 138.31 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.331 -0.85 . . . . 9.4299999999999997 109.179 176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.6 130.9 36.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.854 -0.424 . . . . 12.93 109.854 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -140.98 158.36 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.818 -0.628 . . . . 8.0299999999999994 111.157 -175.232 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.5 ttmm -100.2 128.61 46.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.632 -0.713 . . . . 10.390000000000001 109.89 174.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.438 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -140.84 105.62 4.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.478 -0.328 . . . . 8.3000000000000007 111.638 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.0 72.38 0.27 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 118.441 -1.838 . . . . 10.1 113.938 169.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.92 162.69 39.35 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.402 -0.962 . . . . 10.609999999999999 108.402 154.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.4 m -139.72 132.59 29.24 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.672 -0.411 . . . . 13.17 110.001 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.22 99.89 3.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.066 -0.516 . . . . 12.98 111.443 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.8 40.03 89.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.09 -0.576 . . . . 14.34 112.43 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.22 1.83 90.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.031 -0.604 . . . . 13.119999999999999 112.195 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.13 164.0 12.67 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.037 -1.097 . . . . 10.619999999999999 108.037 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 21.0 p -117.05 162.1 18.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.152 -0.619 . . . . 7.8200000000000003 111.108 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 36.6 mt-10 -112.99 123.94 51.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.616 0.722 . . . . 10.789999999999999 111.277 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 125' ' ' VAL . 24.4 mm -88.11 107.43 17.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.878 -1.056 . . . . 6.7300000000000004 109.323 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.9 mp -72.68 -49.9 28.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 8.7899999999999991 109.85 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 125' ' ' VAL . 46.6 mt-10 -142.11 166.76 23.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.008 -0.738 . . . . 10.44 109.008 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.538 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 114.29 -51.97 0.68 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.395 -1.383 . . . . 8.8699999999999992 113.885 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.64 -174.92 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 8.5 112.744 -172.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.7 ttmt -151.25 157.09 42.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 14.15 109.523 -175.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.64 126.71 30.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 12.119999999999999 109.95 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.85 -7.09 29.48 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.996 -0.842 . . . . 11.539999999999999 110.996 -170.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.0 mm-40 -95.5 112.92 24.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.209 -0.664 . . . . 11.24 109.209 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 71.5 mt-30 -85.95 123.65 31.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.028 -0.533 . . . . 10.49 110.502 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.55 139.8 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.864 -0.607 . . . . 5.4500000000000002 110.323 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 18.6 m -66.24 120.61 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.805 -0.634 . . . . 6.5599999999999996 111.478 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.8 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 6.9900000000000002 109.889 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.19 -0.3 . . . . 11.84 110.19 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -88.24 -31.36 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.967 -0.753 . . . . 12.24 108.967 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 154' ' ' LEU . 1.1 mm? -97.42 -161.29 0.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.858 -1.064 . . . . 13.16 108.768 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 10.4 mm -95.86 -128.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.701 -0.851 . . . . 11.949999999999999 108.701 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.99 30.01 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.289 0.566 . . . . 11.220000000000001 110.005 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -72.5 -18.97 61.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.676 -0.693 . . . . 11.9 111.813 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -44.1 77.79 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.397 -0.921 . . . . 11.17 109.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.47 66.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.307 -0.86 . . . . 7.8200000000000003 110.832 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.3 m -70.01 -61.98 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.829 0.823 . . . . 9.6400000000000006 109.65 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.2 -31.66 70.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 113.74 -1.573 . . . . 10.57 112.256 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -82.52 -39.23 22.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 124.753 1.283 . . . . 8.9000000000000004 110.032 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 52.26 60.35 7.82 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.105 -0.952 . . . . 7.1500000000000004 113.015 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 32.8 p 50.63 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.986 0.914 . . . . 7.0899999999999999 112.435 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.1 p -72.41 95.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.831 . . . . 9.1999999999999993 112.08 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 9.1099999999999994 110.269 177.416 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.998 0.428 . . . . 34.32 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.29 168.82 14.44 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.942 -0.647 . . . . 33.090000000000003 111.83 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 p -105.57 111.44 24.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 34.119999999999997 110.156 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.66 42.59 0.78 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.346 -0.388 . . . . 32.32 111.708 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -131.53 38.85 3.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.47 0.652 . . . . 32.740000000000002 109.939 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.91 -31.06 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.586 -0.734 . . . . 31.289999999999999 111.441 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -84.74 156.31 21.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.064 -0.347 . . . . 29.460000000000001 110.064 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.76 -147.67 7.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 28.280000000000001 111.672 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.51 157.14 56.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.824 2.349 . . . . 27.510000000000002 111.868 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -100.54 -167.64 1.47 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.066 -0.346 . . . . 26.48 110.066 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.27 159.91 14.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.413 . . . . 24.899999999999999 110.66 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.85 42.22 21.18 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.361 -0.696 . . . . 23.190000000000001 111.361 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.49 ' HA ' ' H ' ' A' ' 152' ' ' GLN . 7.3 p-80 -103.29 87.76 2.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.337 0.589 . . . . 21.309999999999999 111.92 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -72.83 120.18 79.45 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 108.949 -0.76 . . . . 19.890000000000001 108.949 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.32 52.93 3.32 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.73 2.953 . . . . 18.120000000000001 114.434 -165.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 82' ' ' ALA . . . -112.35 -28.92 7.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.11 0.411 . . . . 16.579999999999998 112.11 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.725 ' O ' ' HA ' ' A' ' 152' ' ' GLN . . . -148.63 115.87 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.872 0.367 . . . . 14.800000000000001 111.476 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.418 ' HA2' ' H ' ' A' ' 153' ' ' PHE . . . -96.97 -3.07 59.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 13.17 111.459 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.23 86.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.948 0.899 . . . . 12.17 113.042 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -93.51 96.09 9.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.783 -1.099 . . . . 13.82 108.83 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 66.53 36.17 5.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.805 -1.543 . . . . 12.130000000000001 110.564 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -109.65 -1.0 18.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.413 1.102 . . . . 14.1 108.452 167.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.3 t -153.86 -174.93 5.14 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.608 -1.633 . . . . 11.050000000000001 109.015 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 -96.9 1.43 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.572 -0.823 . . . . 10.050000000000001 112.528 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -137.5 66.21 1.46 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.45 1.119 . . . . 10.380000000000001 109.755 -174.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.555 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -128.85 139.46 52.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.347 -1.297 . . . . 8.3699999999999992 108.217 178.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 58' ' ' GLU . 23.5 mm -49.52 117.96 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.944 0.878 . . . . 5.7599999999999998 112.636 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.13 -33.97 9.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.297 -1.774 . . . . 8.2200000000000006 109.923 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 1.6 p90 -179.67 -177.49 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.607 -0.724 . . . . 7.9900000000000002 109.884 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.727 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -116.83 147.38 42.17 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.388 -0.824 . . . . 5.6100000000000003 110.281 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HB2' HE22 ' A' ' 38' ' ' GLN . 28.3 ptt180 -142.55 149.87 39.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.185 -0.916 . . . . 9.0600000000000005 110.353 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.79 ' HB3' HG22 ' A' ' 35' ' ' VAL . 10.0 t70 -92.08 136.25 26.19 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.138 -1.06 . . . . 8.3100000000000005 108.138 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' A' ' 54' ' ' ILE . 16.8 Cg_exo -62.33 -13.22 31.29 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.116 1.877 . . . . 10.41 112.201 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.55 0.36 42.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.782 -0.19 . . . . 10.85 111.504 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -128.28 38.42 0.43 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 112.802 0.668 . . . . 9.3200000000000003 112.802 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 27.4 Cg_endo -57.92 131.81 45.94 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.576 2.184 . . . . 11.1 112.508 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.84 -7.45 31.45 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.651 -0.785 . . . . 10.31 111.204 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.577 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -82.68 -179.78 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.534 . . . . 9.2100000000000009 109.731 176.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 7.0 tpt180 -151.29 94.26 2.01 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.098 -0.334 . . . . 11.51 110.098 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 90.7 m-85 -76.49 139.68 40.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.262 -0.575 . . . . 7.5 110.708 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.71 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.799 -1.091 . . . . 10.609999999999999 111.084 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.5 pttm -168.79 164.22 7.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 10.91 111.006 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.727 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.1 Cg_endo -48.19 169.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.992 3.128 . . . . 7.5099999999999998 114.403 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.64 -162.57 27.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.918 -0.658 . . . . 7.5899999999999999 112.392 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 4.0 ttmm -92.92 141.74 28.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.669 -0.493 . . . . 11.68 109.669 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.5 p -58.4 136.13 85.41 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 115.218 -0.901 . . . . 9.1999999999999993 110.962 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.85 -27.16 7.37 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.136 1.891 . . . . 10.25 112.028 171.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 91.4 m-85 -81.91 -31.05 31.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.153 0.502 . . . . 10.49 110.851 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.624 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.67 -161.06 0.98 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.481 -0.781 . . . . 10.380000000000001 108.911 174.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 6.5 p-10 -128.17 59.05 1.51 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.019 0.914 . . . . 12.539999999999999 109.623 170.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 ptm -132.82 145.1 55.69 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.484 -1.235 . . . . 9.8699999999999992 109.766 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.62 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.669 1.58 . . . . 9.5099999999999998 110.414 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.33 161.27 14.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.173 0.511 . . . . 6.71 111.415 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 ' HD3' ' A' ' 33' ' ' PRO . 1.7 mp -98.74 133.85 22.11 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.132 -0.692 . . . . 7.8899999999999997 109.132 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 83.5 Cg_endo -85.28 150.18 10.52 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 121.265 1.31 . . . . 5.7699999999999996 113.126 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 m -74.3 158.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.564 -1.198 . . . . 5.96 112.397 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 11.97 -76.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.358 2.263 . . . . 7.8399999999999999 115.353 -178.083 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -57.84 -47.04 83.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.287 0.635 . . . . 6.6200000000000001 109.596 -175.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 43.6 mt-10 68.99 79.3 0.21 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.629 0.728 . . . . 8.5800000000000001 112.646 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 81.26 68.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.795 -1.548 . . . . 7.6399999999999997 113.099 157.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.635 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 62.5 t30 -164.11 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.645 -1.161 . . . . 7.0199999999999996 108.493 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HB2' ' H ' ' A' ' 27' ' ' ILE . . . 42.58 -86.1 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.247 1.019 . . . . 5.4100000000000001 113.364 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.595 ' OD2' ' HA2' ' A' ' 71' ' ' GLY . 16.8 m-20 -84.69 21.24 1.57 Allowed 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 121.748 0.785 . . . . 7.0099999999999998 111.685 -174.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 60.57 22.74 59.67 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 114.314 -1.312 . . . . 7.2000000000000002 113.076 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 64' ' ' GLY . . . 70.59 57.96 0.24 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.14 0.553 . . . . 7.8200000000000003 110.418 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 78.88 1.41 2.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.191 -0.913 . . . . 8.6500000000000004 112.99 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 64' ' ' GLY . 57.6 t -67.36 -51.19 55.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.038 0.923 . . . . 7.3099999999999996 109.148 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HB2' ' CA ' ' A' ' 63' ' ' ASP . 23.1 mmt180 -70.78 -155.49 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 10.210000000000001 110.923 171.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 70' ' ' ASP . 9.9 mt -50.35 162.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 112.318 -2.219 . . . . 8.8599999999999994 110.988 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' N ' HG22 ' A' ' 69' ' ' ILE . 36.4 t70 -70.41 32.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.57 -0.741 . . . . 13.02 112.179 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.595 ' HA2' ' OD2' ' A' ' 63' ' ' ASP . . . 73.83 14.74 79.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.361 -0.447 . . . . 12.130000000000001 112.33 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 116' ' ' GLY . 0.8 OUTLIER -112.24 141.04 46.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.58 -1.267 . . . . 12.380000000000001 107.58 175.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.68 92.15 2.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.64 0.734 . . . . 11.609999999999999 109.644 -170.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.0 t -76.86 40.13 0.24 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.946 -1.479 . . . . 10.710000000000001 110.691 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.507 ' C ' ' H ' ' A' ' 77' ' ' LEU . 10.1 tp60 -123.03 99.22 6.27 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.268 -0.878 . . . . 14.09 108.729 -172.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 62.7 t30 -71.41 22.37 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.236 -0.893 . . . . 11.220000000000001 112.246 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 75' ' ' GLN . 23.3 tp 65.95 -70.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.087 0.955 . . . . 13.710000000000001 111.569 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.0 24.11 7.18 Favored Glycine 0 CA--C 1.503 -0.691 0 CA-C-N 116.185 -0.461 . . . . 11.44 112.791 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 4.0 t -148.18 113.06 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.766 -0.457 . . . . 9.9900000000000002 109.766 -174.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' H ' ' HA ' ' A' ' 150' ' ' SER . 8.0 mpt_? -105.33 167.3 9.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.686 -0.487 . . . . 11.640000000000001 109.686 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 114' ' ' ALA . 42.8 p -135.19 177.82 7.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.165 0.507 . . . . 8.0 111.484 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.415 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . . . -142.71 131.63 22.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.366 -0.834 . . . . 6.6500000000000004 109.044 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 35.3 tt0 -79.47 141.24 36.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.952 0.406 . . . . 12.15 110.515 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 95' ' ' LEU . 70.6 t -69.16 127.31 30.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 9.7100000000000009 110.548 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -162.92 146.68 11.14 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.07 -0.968 . . . . 11.029999999999999 111.642 174.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 93' ' ' GLU . 7.5 mp -70.1 132.45 45.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.11 -1.405 . . . . 12.76 110.37 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.494 ' H ' HD23 ' A' ' 96' ' ' LEU . . . -126.52 22.86 5.79 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.186 -1.007 . . . . 13.25 113.628 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.698 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 6.5 ptp180 -141.63 156.41 45.66 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.936 0.398 . . . . 16.350000000000001 111.183 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.0 mt -152.35 113.58 4.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.978 -1.01 . . . . 18.219999999999999 108.372 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.27 -47.97 1.04 Allowed Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 108.56 -1.816 . . . . 17.91 108.56 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 15.1 m -69.87 177.94 2.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.028 -1.086 . . . . 17.109999999999999 108.766 166.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 2.9 m -86.27 108.76 18.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.903 -0.59 . . . . 14.73 110.38 -170.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.698 ' HA ' ' HG3' ' A' ' 88' ' ' ARG . 18.0 mt-10 -58.47 119.54 7.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 124.461 1.1 . . . . 14.94 112.539 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 23.1 mmt85 -135.09 164.49 27.54 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.454 -1.703 . . . . 10.57 107.026 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -88.83 113.21 24.13 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.919 -0.771 . . . . 8.8800000000000008 108.919 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.5 mm? -87.47 129.89 34.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.082 -0.508 . . . . 9.7799999999999994 111.369 -172.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.18 155.85 58.09 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.444 -0.798 . . . . 6.4000000000000004 109.424 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.35 139.11 81.33 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.289 1.992 . . . . 6.5499999999999998 111.559 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.3 m -57.71 -28.44 63.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.64 0.608 . . . . 9.2899999999999991 112.64 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.85 -2.39 58.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 10.859999999999999 111.059 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -71.68 -41.09 69.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.48 0.657 . . . . 5.3399999999999999 111.015 -175.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -92.51 160.26 15.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.47 -0.786 . . . . 6.9699999999999998 111.614 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.67 113.27 37.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.708 -0.678 . . . . 10.199999999999999 109.192 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 7.7 mmm180 -89.53 126.14 35.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.735 -0.786 . . . . 12.119999999999999 110.446 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -149.18 132.71 16.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.862 -0.608 . . . . 14.609999999999999 110.551 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.69 -115.57 5.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.26 -0.495 . . . . 15.52 112.568 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.92 36.21 4.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.803 0.335 . . . . 14.99 111.671 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.79 -178.96 6.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.313 -0.403 . . . . 15.199999999999999 110.502 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 27.3 m -132.11 150.95 52.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.725 0.298 . . . . 9.2599999999999998 111.269 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.7 mm -123.33 149.11 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.099 -0.704 . . . . 10.550000000000001 109.099 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -129.49 125.85 37.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.282 -0.266 . . . . 7.3899999999999997 110.282 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.521 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 48.6 ttp -85.95 99.56 11.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.687 -1.227 . . . . 8.8499999999999996 107.687 171.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 121' ' ' ASP . 12.7 p -81.78 136.82 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.254 -0.884 . . . . 9.6899999999999995 111.195 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.65 97.42 7.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.194 -0.669 . . . . 10.699999999999999 109.194 173.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.74 139.77 40.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.662 -0.699 . . . . 14.880000000000001 109.221 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.561 ' O ' ' HD2' ' A' ' 72' ' ' ARG . . . -58.43 -16.81 30.02 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.005 -0.543 . . . . 16.920000000000002 113.027 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -79.17 4.72 13.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.164 0.507 . . . . 18.559999999999999 111.811 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.63 9.98 58.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.708 -0.678 . . . . 15.619999999999999 112.969 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.99 175.22 16.54 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.76 -0.733 . . . . 14.19 112.241 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.2 m-85 -126.03 136.76 53.33 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.059 -0.349 . . . . 12.029999999999999 110.059 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 113' ' ' VAL . 23.0 t70 -138.03 141.53 32.69 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 13.91 111.375 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -82.51 138.5 9.7 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.718 1.612 . . . . 12.35 112.482 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.8 p -135.39 136.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.622 -0.717 . . . . 9.4299999999999997 109.82 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.8 tt0 -81.48 125.02 29.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.629 -0.508 . . . . 12.93 109.629 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -133.5 157.78 42.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.455 -0.793 . . . . 8.0299999999999994 110.76 -172.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 4.3 ttmp? -95.19 120.3 35.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.73 -0.668 . . . . 10.390000000000001 109.388 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.46 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -143.9 104.48 4.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.969 -0.56 . . . . 8.3000000000000007 111.469 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.46 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.744 -2.17 . . . . 10.1 114.265 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.17 163.12 39.55 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.689 -0.486 . . . . 10.609999999999999 109.689 157.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.0 m -133.59 134.24 43.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.381 -0.6 . . . . 13.17 109.381 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.35 107.18 3.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.105 0.409 . . . . 12.98 112.105 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.29 44.51 59.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.199 -0.524 . . . . 14.34 113.105 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.0 17.35 80.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.67 -0.776 . . . . 13.119999999999999 112.236 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -137.55 166.0 24.95 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.422 -0.584 . . . . 10.619999999999999 109.422 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -115.71 162.84 16.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.963 0.411 . . . . 7.8200000000000003 110.246 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 66.7 mt-10 -106.27 121.16 43.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.659 . . . . 10.789999999999999 111.433 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 125' ' ' VAL . 21.1 mm -88.25 101.52 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.014 -0.994 . . . . 6.7300000000000004 108.565 168.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.9 mp -68.84 -45.0 72.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.553 -1.203 . . . . 8.7899999999999991 109.738 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 125' ' ' VAL . 40.9 mt-10 -150.45 165.52 32.92 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.776 -0.647 . . . . 10.44 109.353 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.555 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 128.63 -61.49 0.65 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.981 -1.104 . . . . 8.8699999999999992 113.299 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 123' ' ' VAL . 36.7 mt -116.0 179.62 3.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.305 0.574 . . . . 8.5 112.347 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -129.64 152.44 49.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.875 -1.057 . . . . 14.15 110.481 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 132.35 45.98 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.058 -0.973 . . . . 12.119999999999999 110.168 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.51 -11.25 30.6 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.092 -0.803 . . . . 11.539999999999999 111.092 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.5 HE21 HG21 ' A' ' 113' ' ' VAL . 9.5 mt-30 -104.27 163.76 12.2 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 107.75 -1.204 . . . . 11.24 107.75 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 14.2 mt-30 -120.93 167.84 12.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 119.04 0.836 . . . . 10.49 111.561 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.14 156.68 41.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.217 -0.901 . . . . 5.4500000000000002 108.853 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 7.6 p -76.62 128.52 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.63 0.252 . . . . 6.5599999999999996 110.587 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.4 m -130.13 -19.79 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.975 -0.29 . . . . 6.9900000000000002 111.602 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.526 ' HA ' ' H ' ' A' ' 80' ' ' ARG . 37.6 m 43.94 60.21 2.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.378 0.609 . . . . 9.0600000000000005 112.478 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -146.8 163.26 28.58 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.284 -1.126 . . . . 8.5 110.284 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.725 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -121.23 149.04 43.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.703 0.752 . . . . 11.84 111.652 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.418 ' H ' ' HA2' ' A' ' 18' ' ' GLY . 17.7 t80 -103.88 166.57 10.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.543 -0.54 . . . . 12.24 109.543 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -60.82 2.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.824 -0.35 . . . . 13.16 111.138 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.2 tt -125.08 113.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.549 0.69 . . . . 11.949999999999999 110.301 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.68 -0.15 49.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 11.220000000000001 112.017 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.667 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 13.2 m -58.54 -43.22 89.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.88 -0.6 . . . . 11.9 111.023 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -52.03 -54.99 23.42 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.76 -0.459 . . . . 11.17 109.76 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.3 92.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.845 -1.07 . . . . 7.8200000000000003 111.395 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.1 m -58.94 -35.54 73.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.865 -0.607 . . . . 9.6400000000000006 111.868 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 157' ' ' SER . 80.4 mt -61.99 -22.13 65.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.242 -0.89 . . . . 10.57 111.516 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -83.43 117.79 23.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.637 -0.505 . . . . 8.9000000000000004 109.637 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 105.58 -18.28 41.38 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 119.927 -1.13 . . . . 7.1500000000000004 112.734 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.7 p -102.17 -76.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 7.0899999999999999 110.646 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.46 -24.16 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.29 0.567 . . . . 9.1999999999999993 110.211 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -107.11 141.66 38.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.899 -0.591 . . . . 9.1099999999999994 110.598 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.745 ' HD2' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -131.26 -121.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.877 -0.786 . . . . 14.58 108.877 175.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 mtm 66.99 153.14 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.763 0.792 . . . . 11.94 112.044 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 171' ' ' THR . 0.3 OUTLIER -80.35 139.0 36.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.742 -0.663 . . . . 14.99 110.851 -177.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 74.55 -26.12 0.19 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.846 0.858 . . . . 15.01 112.301 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 167' ' ' ARG . 80.2 p 52.85 28.26 6.28 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.031 0.932 . . . . 14.25 113.203 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.9 t -90.1 -179.61 5.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.779 0.323 . . . . 14.890000000000001 110.723 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -152.57 155.89 38.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 118.777 -0.63 . . . . 15.85 109.897 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 53.68 49.69 56.83 Favored Glycine 0 C--O 1.242 0.653 0 C-N-CA 119.778 -1.201 . . . . 17.539999999999999 110.732 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.6 tp -160.02 70.14 0.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.672 -0.764 . . . . 17.850000000000001 109.612 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.07 -52.8 6.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.896 -0.593 . . . . 19.670000000000002 110.286 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.0 m -126.86 139.28 52.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.892 -0.595 . . . . 19.52 110.188 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 39.9 tp -134.91 92.48 2.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.07 0.462 . . . . 21.149999999999999 110.517 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -118.23 -51.09 2.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.827 -0.624 . . . . 23.25 110.038 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.198 -0.906 . . . . 23.52 110.493 -178.999 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.297 -0.26 . . . . 34.32 110.297 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.96 79.02 1.33 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.11 -0.567 . . . . 33.090000000000003 112.351 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 m -72.34 -33.19 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.951 0.405 . . . . 34.119999999999997 110.61 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.22 127.98 33.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 32.32 110.516 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -79.74 63.39 4.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.441 0.639 . . . . 32.740000000000002 110.749 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.4 171.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.577 -0.738 . . . . 31.289999999999999 109.459 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -146.5 168.39 21.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.014 0.435 . . . . 29.460000000000001 111.447 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.47 -152.77 16.77 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.457 -0.792 . . . . 28.280000000000001 111.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -101.32 23.91 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.701 2.934 . . . . 27.510000000000002 111.754 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.8 m80 59.46 73.55 0.48 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.714 -0.847 . . . . 26.48 108.714 -170.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 13' ' ' HIS . 18.4 t70 -53.4 128.07 27.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.531 -1.213 . . . . 24.899999999999999 112.447 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.42 45.02 1.28 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.458 -0.792 . . . . 23.190000000000001 111.649 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.402 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -62.27 139.72 58.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.359 0.599 . . . . 21.309999999999999 111.418 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.62 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 16.6 t70 -64.55 -36.53 18.43 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.721 -1.127 . . . . 19.890000000000001 113.085 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 21.1 Cg_endo -63.2 57.37 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.408 2.072 . . . . 18.120000000000001 112.739 170.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 166' ' ' ALA . . . -103.98 -11.31 17.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 16.579999999999998 111.298 -176.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.73 68.82 1.34 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.435 0.636 . . . . 14.800000000000001 110.148 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.21 60.33 3.92 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 13.17 112.674 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.01 -75.7 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.789 0.328 . . . . 12.17 110.655 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.66 77.06 5.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.727 -0.472 . . . . 13.82 109.727 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp 70.81 -10.32 0.74 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.474 -0.784 . . . . 12.130000000000001 110.822 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 15' ' ' PRO . 32.5 ttpt 65.95 18.14 10.99 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.17 0.986 . . . . 14.1 109.666 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 m -164.86 118.11 1.27 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.872 -1.513 . . . . 11.050000000000001 108.728 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.48 -114.29 0.6 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.512 -1.328 . . . . 10.050000000000001 113.833 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 3.1 mppt? -121.2 71.9 0.97 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.3 -1.0 . . . . 10.380000000000001 108.3 -172.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.584 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.29 130.67 35.47 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.133 -0.94 . . . . 8.3699999999999992 111.042 -174.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.763 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 41.2 mm -55.2 133.29 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 122.268 1.032 . . . . 5.7599999999999998 113.107 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.74 -25.97 6.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.37 -1.741 . . . . 8.2200000000000006 109.712 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.558 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 14.1 p90 179.99 179.03 0.56 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.897 -0.592 . . . . 7.9900000000000002 111.098 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -118.38 154.88 31.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.919 -1.037 . . . . 5.6100000000000003 109.965 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.4 ptp180 -156.4 145.36 20.32 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.153 0.502 . . . . 9.0600000000000005 110.29 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.0 t0 -67.85 133.13 92.23 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.48 -0.933 . . . . 8.3100000000000005 108.48 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.556 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 84.4 Cg_endo -67.66 -12.6 36.08 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.293 1.995 . . . . 10.41 112.363 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.473 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 1.1 ptp -103.65 0.99 31.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.41 -0.359 . . . . 10.85 111.546 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.6 m -120.43 45.01 0.74 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 121.258 0.552 . . . . 9.3200000000000003 112.003 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.85 124.5 16.04 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.134 2.556 . . . . 11.1 112.711 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.82 8.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.807 -0.711 . . . . 10.31 111.656 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.588 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 6.8 tp-100 -78.95 105.55 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.15 0.5 . . . . 9.2100000000000009 109.968 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.558 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 41.7 ttp180 -90.93 106.95 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 11.51 110.161 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 66.7 m-85 -84.58 142.46 29.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 7.5 109.466 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.28 -26.55 68.83 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.42 -0.809 . . . . 10.609999999999999 111.005 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 16.7 ptpt -169.8 165.11 6.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.869 -0.605 . . . . 10.91 110.264 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -49.37 169.15 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.37 2.713 . . . . 7.5099999999999998 113.458 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.25 -166.98 29.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.65 -0.786 . . . . 7.5899999999999999 112.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 46' ' ' SER . 12.9 ttmm -95.34 153.23 17.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.192 0.52 . . . . 11.68 110.604 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.494 ' HA ' HD21 ' A' ' 53' ' ' LEU . 95.5 p -64.59 105.91 0.84 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.467 -1.242 . . . . 9.1999999999999993 110.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' SER . 41.6 Cg_endo -67.59 -10.12 27.67 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.3 2.666 . . . . 10.25 111.869 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -92.0 -31.4 15.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.564 -1.198 . . . . 10.49 110.789 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.616 ' HG2' ' H ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -134.64 -107.77 0.22 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.097 1.147 . . . . 10.380000000000001 114.097 172.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 49' ' ' MET . 12.6 p-10 -165.19 65.95 0.13 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.117 0.871 . . . . 12.539999999999999 113.275 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.02 148.82 56.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.784 -0.821 . . . . 9.8699999999999992 108.784 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.44 132.28 30.73 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.198 1.265 . . . . 9.5099999999999998 110.339 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 46' ' ' SER . 43.5 mt -61.25 163.49 6.34 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.338 0.399 . . . . 6.71 111.305 -175.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 43.0 mm -101.29 131.82 22.65 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 7.8899999999999997 110.003 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.724 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 55.9 Cg_endo -86.51 139.38 5.81 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.93 1.753 . . . . 5.7699999999999996 112.921 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.77 157.96 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.291 -1.322 . . . . 5.96 112.904 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.584 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.77 -89.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.753 2.021 . . . . 7.8399999999999999 115.212 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.717 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -47.87 -40.98 23.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.73 0.412 . . . . 6.6200000000000001 110.184 -177.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.484 ' CG ' ' HG2' ' A' ' 55' ' ' PRO . 26.8 tt0 68.48 85.54 0.14 Allowed 'General case' 0 C--N 1.315 -0.901 0 O-C-N 123.954 0.784 . . . . 8.5800000000000001 111.677 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' H ' HD11 ' A' ' 27' ' ' ILE . 28.8 tt0 74.36 60.32 0.08 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.591 -1.64 . . . . 7.6399999999999997 112.699 162.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.569 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 60.8 t30 -135.45 -52.16 0.76 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 7.0199999999999996 110.67 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.763 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -48.45 -74.83 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.652 0.739 . . . . 5.4100000000000001 109.56 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 10.0 p-10 -111.19 31.47 6.05 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 122.646 1.212 . . . . 7.0099999999999998 109.042 171.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.95 -11.83 56.07 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 113.675 -1.602 . . . . 7.2000000000000002 110.286 170.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.84 -37.01 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.124 -0.538 . . . . 7.8200000000000003 111.556 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' O ' HD13 ' A' ' 161' ' ' LEU . . . -90.1 -80.5 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.859 0.689 . . . . 8.6500000000000004 112.859 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 62' ' ' ALA . 3.3 t -65.63 -28.44 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.322 0.582 . . . . 7.3099999999999996 111.122 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 21.9 ptt180 -56.83 166.01 1.08 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.624 -1.171 . . . . 10.210000000000001 111.579 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.6 mt -91.22 152.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 8.8599999999999994 109.096 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 40.36 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.212 0.529 . . . . 13.02 111.181 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.25 20.47 63.05 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 111.508 -0.637 . . . . 12.130000000000001 111.508 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.97 129.74 37.87 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.352 -0.981 . . . . 12.380000000000001 108.352 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.01 127.48 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.482 -1.303 . . . . 11.609999999999999 107.482 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 t -71.12 57.81 0.23 Allowed 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.502 1.126 . . . . 10.710000000000001 112.918 -168.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -107.65 81.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.184 -1.043 . . . . 14.09 108.184 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -71.26 112.34 7.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.655 0.741 . . . . 11.220000000000001 110.279 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 77' ' ' LEU . 2.6 tm? -69.63 -64.86 0.8 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.56 -1.2 . . . . 13.710000000000001 108.419 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.85 74.32 1.71 Allowed Glycine 0 CA--C 1.495 -1.178 0 N-CA-C 110.699 -0.96 . . . . 11.44 110.699 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 120' ' ' PHE . 9.7 p -88.05 151.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.957 -1.122 . . . . 9.9900000000000002 111.731 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -111.09 125.14 53.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.045 -0.724 . . . . 11.640000000000001 109.045 173.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 148' ' ' VAL . 34.4 p -131.74 147.1 52.47 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.834 -0.621 . . . . 8.0 110.274 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.08 126.58 55.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.81 -0.811 . . . . 6.6500000000000004 108.81 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 30.0 tt0 -83.92 133.87 34.69 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.459 -0.571 . . . . 12.15 109.459 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.613 HG11 HD23 ' A' ' 95' ' ' LEU . 42.4 t -55.49 127.92 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.769 0.655 . . . . 9.7100000000000009 112.769 -176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 39.1 mmtt -140.88 142.5 34.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.828 -1.078 . . . . 11.029999999999999 108.777 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 9.3 mp -77.8 150.78 34.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.013 -0.675 . . . . 12.76 109.484 171.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -168.74 47.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.413 -0.898 . . . . 13.25 112.99 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -69.01 132.19 46.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.034 0.445 . . . . 16.350000000000001 111.219 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.6 84.79 2.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.441 -0.948 . . . . 18.219999999999999 108.441 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.74 -3.68 74.7 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 109.625 -1.39 . . . . 17.91 109.625 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.7 t -110.82 178.56 4.32 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.936 -1.132 . . . . 17.109999999999999 108.506 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.574 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 14.2 m -84.44 161.17 20.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.636 -0.876 . . . . 14.73 108.636 174.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -60.98 103.33 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.475 0.655 . . . . 14.94 111.248 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' THR . 34.9 mmt180 -121.64 167.26 13.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.695 -1.139 . . . . 10.57 109.019 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 84' ' ' VAL . 5.3 mp -90.68 111.96 23.52 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.172 -1.048 . . . . 8.8800000000000008 108.172 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.69 129.87 35.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.16 0.505 . . . . 9.7799999999999994 110.634 -174.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.58 156.8 52.72 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.634 -1.167 . . . . 6.4000000000000004 108.804 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.28 141.25 95.41 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 C-N-CA 122.153 1.902 . . . . 6.5499999999999998 110.59 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -19.24 38.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.636 0.255 . . . . 9.2899999999999991 111.367 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -88.76 9.64 23.78 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 116.514 -0.312 . . . . 10.859999999999999 111.017 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -86.63 -39.89 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.174 0.511 . . . . 5.3399999999999999 111.17 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -99.92 158.47 15.79 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.758 0.651 . . . . 6.9699999999999998 112.758 -170.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.91 121.56 53.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.239 -0.891 . . . . 10.199999999999999 108.86 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -94.25 122.54 36.89 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.312 -0.555 . . . . 12.119999999999999 110.895 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -149.57 131.26 14.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.105 -0.498 . . . . 14.609999999999999 111.406 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.3 5.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.161 -0.472 . . . . 15.52 113.017 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.1 25.03 10.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 14.99 111.235 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.76 -176.99 5.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 15.199999999999999 111.053 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.586 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 47.0 m -136.92 150.13 48.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.291 -0.413 . . . . 9.2599999999999998 110.296 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -125.43 152.07 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.748 -0.464 . . . . 10.550000000000001 109.748 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -133.3 138.31 46.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.205 -0.295 . . . . 7.3899999999999997 110.205 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 58.9 mtm -97.45 100.71 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.145 -0.687 . . . . 8.8499999999999996 109.145 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 7.2 p -84.52 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.354 -0.839 . . . . 9.6899999999999995 111.312 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -67.12 88.52 0.17 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.48 -0.782 . . . . 10.699999999999999 109.698 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -67.97 140.43 56.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.46 -0.791 . . . . 14.880000000000001 109.782 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.56 -12.0 38.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.061 -0.59 . . . . 16.920000000000002 112.808 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.18 10.47 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.493 . . . . 18.559999999999999 111.689 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.76 17.11 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.399 -0.818 . . . . 15.619999999999999 113.782 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.74 -161.25 9.38 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.505 -0.855 . . . . 14.19 112.305 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 52.8 m-85 -130.92 112.51 13.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.677 0.275 . . . . 12.029999999999999 110.325 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -100.44 139.05 20.34 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.426 -0.352 . . . . 13.91 110.737 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 55.7 Cg_endo -82.7 138.88 9.68 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.956 1.77 . . . . 12.35 111.989 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.654 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 13.9 p -129.5 126.69 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 9.4299999999999997 110.139 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 110' ' ' ILE . 32.0 tt0 -79.18 112.84 16.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.487 -0.561 . . . . 12.93 109.487 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 123' ' ' VAL . 27.5 m -120.64 173.5 6.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 8.0299999999999994 111.375 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -104.49 126.1 51.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.161 -0.681 . . . . 10.390000000000001 109.161 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -141.95 105.64 4.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.309 -0.405 . . . . 8.3000000000000007 111.244 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.04 70.78 0.3 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 117.431 -2.319 . . . . 10.1 114.329 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.88 162.55 40.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.156 -0.683 . . . . 10.609999999999999 109.156 155.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.4 m -147.04 127.87 14.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.837 -0.431 . . . . 13.17 109.837 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.99 112.25 5.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.079 -0.51 . . . . 12.98 111.753 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.62 43.82 91.18 Favored Glycine 0 C--O 1.235 0.214 0 CA-C-N 116.107 -0.497 . . . . 14.34 112.992 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.69 13.43 82.13 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.852 -0.689 . . . . 13.119999999999999 112.553 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -126.47 157.84 37.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.264 -0.643 . . . . 10.619999999999999 109.264 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.5 p -111.92 166.66 11.02 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.882 -0.327 . . . . 7.8200000000000003 110.328 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.921 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.4 mt-10 -116.73 113.32 22.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.486 0.66 . . . . 10.789999999999999 111.11 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.0 mm -83.1 111.84 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.121 -0.945 . . . . 6.7300000000000004 108.87 171.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -77.12 -49.08 16.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.974 -1.012 . . . . 8.7899999999999991 109.718 -175.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 140' ' ' GLY . 31.4 tt0 -148.68 166.42 28.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.961 -0.563 . . . . 10.44 110.284 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 139' ' ' GLU . . . 113.84 -23.58 12.97 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.047 -0.597 . . . . 8.8699999999999992 112.085 172.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 123' ' ' VAL . 38.6 mt -127.49 -170.36 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.862 0.363 . . . . 8.5 111.76 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -154.56 156.16 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 14.15 109.663 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.08 128.01 34.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.713 -0.676 . . . . 12.119999999999999 110.196 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.68 -9.53 37.81 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.287 -0.725 . . . . 11.539999999999999 111.287 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.4 mm-40 -91.33 111.18 22.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.199 -0.667 . . . . 11.24 109.199 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 57.6 mt-30 -85.0 128.59 34.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.416 -0.811 . . . . 10.49 110.97 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -119.19 135.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.709 -0.478 . . . . 5.4500000000000002 109.709 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 81' ' ' THR . 2.4 p -68.09 121.11 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.253 0.549 . . . . 6.5599999999999996 110.581 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 101' ' ' ALA . 5.1 m -106.31 -21.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.211 -0.904 . . . . 6.9900000000000002 110.398 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t 65.07 -72.57 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.253 -0.885 . . . . 9.0600000000000005 112.208 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.23 104.34 1.2 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.069 -0.812 . . . . 8.5 111.069 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 68.17 79.94 0.21 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.238 0.542 . . . . 11.84 110.441 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.438 ' O ' HD13 ' A' ' 155' ' ' ILE . 47.3 m-85 -72.67 165.42 24.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.823 -0.626 . . . . 12.24 110.611 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 tp -87.8 50.87 2.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.4 0.619 . . . . 13.16 110.058 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 155' ' ' ILE . 0.2 OUTLIER -83.11 39.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.461 0.648 . . . . 11.949999999999999 111.072 -177.205 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.0 -99.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.37 -0.832 . . . . 11.220000000000001 111.327 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.4 m -79.22 -41.48 28.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.732 0.777 . . . . 11.9 110.174 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 50.0 mm-40 -54.0 -30.17 46.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.084 -1.417 . . . . 11.17 110.701 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.461 ' HB2' ' CA ' ' A' ' 155' ' ' ILE . . . -68.02 -31.74 71.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.492 -1.231 . . . . 7.8200000000000003 112.233 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.5 t -81.5 -19.46 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.457 0.646 . . . . 9.6400000000000006 109.808 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 66' ' ' ALA . 94.0 mt -87.79 -30.4 20.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.802 -1.09 . . . . 10.57 111.898 -173.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 21.7 mmm180 -70.6 140.94 51.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.196 0.522 . . . . 8.9000000000000004 110.565 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.38 30.59 13.44 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.978 -1.01 . . . . 7.1500000000000004 111.291 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.7 p 49.99 54.87 10.32 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.347 0.659 . . . . 7.0899999999999999 110.882 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 67.7 t 72.87 -56.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.171 -0.922 . . . . 9.1999999999999993 111.415 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . . . 55.2 54.04 9.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.698 0.761 . . . . 9.1099999999999994 110.743 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.727 ' O ' ' HG3' ' A' ' 168' ' ' MET . 1.6 tmt_? -77.28 88.64 3.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 14.58 109.217 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.727 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 23.3 mtm -158.65 39.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.969 -0.56 . . . . 11.94 111.167 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -74.02 -74.92 0.17 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.935 -0.706 . . . . 14.99 110.324 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.16 -55.8 28.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.43 . . . . 15.01 110.399 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -118.96 129.33 55.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 14.25 110.532 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 168' ' ' MET . 15.1 t -88.42 175.85 7.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.409 -0.589 . . . . 14.890000000000001 109.409 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.3 m -80.02 63.55 4.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.336 0.589 . . . . 15.85 110.66 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.67 21.18 5.99 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.266 -0.879 . . . . 17.539999999999999 111.559 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.446 ' HB3' ' H ' ' A' ' 176' ' ' GLU . 6.7 mp -93.39 -148.37 0.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.334 -0.617 . . . . 17.850000000000001 109.334 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.446 ' H ' ' HB3' ' A' ' 175' ' ' LEU . 39.4 mt-10 59.06 -141.0 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 110.006 -0.368 . . . . 19.670000000000002 110.006 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.1 t 41.3 84.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.365 1.041 . . . . 19.52 112.814 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.12 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.503 -0.771 . . . . 21.149999999999999 110.571 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.8 -54.19 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 23.25 110.56 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.262 -0.875 . . . . 23.52 110.197 178.883 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.166 -0.309 . . . . 34.32 110.166 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.14 59.87 7.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.45 -0.881 . . . . 33.090000000000003 112.855 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t 57.93 63.75 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.503 0.668 . . . . 34.119999999999997 111.684 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.53 98.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.641 -1.163 . . . . 32.32 111.843 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 m -61.98 -42.35 99.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 32.740000000000002 110.739 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.15 120.38 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 31.289999999999999 110.57 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -146.57 -57.21 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 29.460000000000001 110.197 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.75 -136.72 2.18 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.173 -0.771 . . . . 28.280000000000001 111.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.08 149.09 86.05 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.386 2.057 . . . . 27.510000000000002 111.879 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -154.56 121.76 5.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.633 -0.506 . . . . 26.48 109.633 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.81 168.79 18.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.688 0.28 . . . . 24.899999999999999 110.326 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.47 -14.6 5.04 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.649 -0.786 . . . . 23.190000000000001 112.387 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 73.1 -39.04 0.43 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.244 0.618 . . . . 21.309999999999999 111.566 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -67.06 135.84 94.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.265 . . . . 19.890000000000001 110.286 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 178.53 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.437 2.091 . . . . 18.120000000000001 112.414 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.25 89.8 3.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.145 -0.687 . . . . 16.579999999999998 109.145 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.75 82.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.2 -0.909 . . . . 14.800000000000001 110.595 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.59 78.96 1.81 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.549 -0.75 . . . . 13.17 112.237 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.63 94.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.844 -0.178 . . . . 12.17 110.604 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 44.63 79.18 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.206 0.941 . . . . 13.82 112.324 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 21' ' ' LEU . 45.5 tp 65.58 16.69 10.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.846 -1.07 . . . . 12.130000000000001 111.268 174.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 72.79 -4.92 2.0 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.242 -0.89 . . . . 14.1 110.744 -178.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 p -117.54 38.8 3.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.402 0.62 . . . . 11.050000000000001 110.669 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.56 4.01 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.22 -0.9 . . . . 10.050000000000001 113.023 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -165.72 54.8 0.11 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.556 1.17 . . . . 10.380000000000001 109.432 -177.16 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.706 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 91.1 mtt180 -119.09 148.7 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.605 -1.634 . . . . 8.3699999999999992 108.883 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 ' OE2' ' A' ' 58' ' ' GLU . 42.9 mm -52.0 124.4 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 113.923 -1.49 . . . . 5.7599999999999998 114.251 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.71 -32.89 6.5 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.322 -1.763 . . . . 8.2200000000000006 109.792 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.722 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 26.3 p90 -177.64 -175.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.919 -0.582 . . . . 7.9900000000000002 110.839 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.749 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.21 145.81 46.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.65 -0.705 . . . . 5.6100000000000003 111.243 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -150.99 145.8 25.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.03 -0.729 . . . . 9.0600000000000005 109.03 179.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.753 ' HB3' ' CE ' ' A' ' 34' ' ' MET . 1.2 m-20 -78.27 147.24 72.26 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 112.307 0.484 . . . . 8.3100000000000005 112.307 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HG3' HG13 ' A' ' 54' ' ' ILE . 51.9 Cg_exo -53.68 -56.78 2.35 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.593 2.195 . . . . 10.41 112.797 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.753 ' CE ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -86.87 2.64 48.45 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.398 0.888 . . . . 10.85 113.398 -170.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 32' ' ' ASP . 21.6 m -120.46 51.83 2.31 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 121.657 0.741 . . . . 9.3200000000000003 111.325 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.25 121.73 9.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.146 2.564 . . . . 11.1 112.622 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.62 -27.29 4.43 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.052 -0.819 . . . . 10.31 111.052 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' OE1' ' HE1' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -75.86 138.93 41.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.4 -0.4 . . . . 9.2100000000000009 109.943 175.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.615 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 34.0 ttp180 -133.54 112.29 11.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.543 -0.299 . . . . 11.51 111.413 -174.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 73.6 m-85 -97.39 149.3 22.28 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.828 -0.804 . . . . 7.5 108.828 174.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.08 8.11 16.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.044 -0.662 . . . . 10.609999999999999 111.806 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.8 pttp -164.2 167.8 10.14 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 116.332 -0.395 . . . . 10.91 111.881 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.619 ' HD3' ' CZ3' ' A' ' 30' ' ' TRP . 18.6 Cg_endo -56.0 171.04 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.807 3.004 . . . . 7.5099999999999998 112.984 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.37 -166.35 28.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.539 -0.839 . . . . 7.5899999999999999 112.975 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 14.1 ttmm -96.96 148.44 22.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.058 0.456 . . . . 11.68 109.869 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -66.13 141.14 97.27 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.344 -0.844 . . . . 9.1999999999999993 111.576 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.12 -20.29 10.09 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.844 2.362 . . . . 10.25 111.033 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.509 -1.223 . . . . 10.49 109.863 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.5 ptp -168.97 168.9 9.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.236 -0.893 . . . . 10.380000000000001 109.182 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 p-10 -81.22 72.74 8.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.734 0.778 . . . . 12.539999999999999 112.418 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 ptm -139.43 139.48 22.75 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.196 -0.911 . . . . 9.8699999999999992 108.871 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.1 135.94 45.87 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.554 2.17 . . . . 9.5099999999999998 111.604 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 18.1 mt -63.17 162.15 12.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.812 -0.631 . . . . 6.71 111.04 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.522 HG13 ' HG3' ' A' ' 33' ' ' PRO . 23.8 mm -102.92 134.41 19.83 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 121.322 0.582 . . . . 7.8899999999999997 109.984 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.749 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 74.1 Cg_endo -81.98 139.1 10.65 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.308 1.339 . . . . 5.7699999999999996 112.544 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -55.49 157.88 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 113.872 -1.513 . . . . 5.96 113.045 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.31 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.716 2.006 . . . . 7.8399999999999999 115.037 -175.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.735 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -46.94 -42.6 18.05 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.167 0.587 . . . . 6.6200000000000001 111.401 -176.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.585 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 13.9 tt0 66.92 88.22 0.11 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.453 1.121 . . . . 8.5800000000000001 111.011 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' H ' HD11 ' A' ' 27' ' ' ILE . 15.5 tt0 63.92 65.12 0.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.564 -2.107 . . . . 7.6399999999999997 112.245 165.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 12.8 t-20 -148.13 -29.18 0.31 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.624 -0.716 . . . . 7.0199999999999996 112.512 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 66' ' ' ALA . . . -33.4 -56.72 0.42 Allowed 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.862 1.265 . . . . 5.4100000000000001 111.831 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.587 ' HB3' ' H ' ' A' ' 68' ' ' ARG . 31.5 t70 -125.79 64.77 1.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.563 -0.744 . . . . 7.0099999999999998 110.4 171.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.88 -55.28 5.02 Favored Glycine 0 CA--C 1.497 -1.06 0 CA-C-N 114.826 -1.079 . . . . 7.2000000000000002 110.82 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.82 19.08 3.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.604 -1.298 . . . . 7.8200000000000003 108.966 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 63' ' ' ASP . . . 61.4 33.21 18.85 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.679 -1.146 . . . . 8.6500000000000004 110.881 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.09 -30.28 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.015 -0.993 . . . . 7.3099999999999996 109.479 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.587 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 70.4 mtm180 -125.8 -169.64 2.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.616 -1.175 . . . . 10.210000000000001 111.749 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 71' ' ' GLY . 6.2 mt -55.75 167.83 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.3 -2.227 . . . . 8.8599999999999994 113.616 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.706 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 9.5 t70 -57.97 22.05 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.602 1.961 . . . . 13.02 112.811 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 82.88 11.21 81.88 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.546 -0.621 . . . . 12.130000000000001 111.546 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -87.91 117.7 26.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.263 0.554 . . . . 12.380000000000001 109.778 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.0 t -121.64 140.91 44.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.143 -0.935 . . . . 11.609999999999999 111.079 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -128.72 59.21 1.55 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.617 0.723 . . . . 10.710000000000001 109.156 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 64.99 71.16 0.46 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.821 -1.081 . . . . 14.09 110.099 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -129.1 87.63 2.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.601 -0.727 . . . . 11.220000000000001 110.522 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 150' ' ' SER . 39.5 tp -57.68 -55.82 29.96 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.554 -0.459 . . . . 13.710000000000001 110.25 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.48 5.87 1.2 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.764 -0.732 . . . . 11.44 111.887 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 79' ' ' VAL . 24.4 t 58.25 45.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 122.139 0.971 . . . . 9.9900000000000002 110.654 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 152' ' ' GLN . 90.7 mtt180 -87.47 150.85 23.49 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.395 -0.922 . . . . 11.640000000000001 108.82 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 148' ' ' VAL . 11.5 p -114.38 170.49 8.26 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.279 0.562 . . . . 8.0 111.61 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -142.89 127.0 17.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.125 -0.943 . . . . 6.6500000000000004 108.561 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 41.8 tt0 -79.38 138.46 37.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 12.15 109.965 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 95' ' ' LEU . 39.2 t -57.21 132.9 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.274 -0.876 . . . . 9.7100000000000009 112.654 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -137.06 143.87 42.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.772 -1.104 . . . . 11.029999999999999 109.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.07 151.27 35.55 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.114 -0.634 . . . . 12.76 109.633 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -174.83 48.92 0.13 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.446 -0.883 . . . . 13.25 112.758 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 91' ' ' SER . 17.9 ptt180 -64.01 147.31 52.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 16.350000000000001 111.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 tp -147.32 85.9 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.663 -0.495 . . . . 18.219999999999999 109.663 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.73 -4.76 85.68 Favored Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 108.963 -1.655 . . . . 17.91 108.963 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.533 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 12.5 p -111.42 170.56 8.04 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.006 -1.597 . . . . 17.109999999999999 109.013 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.731 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 28.4 m -82.03 164.11 21.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.733 -1.121 . . . . 14.73 108.851 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' N ' HG22 ' A' ' 92' ' ' THR . 11.0 mt-10 -56.46 106.96 0.33 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.284 0.564 . . . . 14.94 111.767 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.731 ' HG2' ' O ' ' A' ' 92' ' ' THR . 29.6 mmt180 -124.48 162.6 23.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.89 -1.05 . . . . 10.57 109.081 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 84' ' ' VAL . 1.8 mm? -87.31 113.33 22.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.588 -0.523 . . . . 8.8800000000000008 109.588 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -89.98 129.94 36.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.117 -0.492 . . . . 9.7799999999999994 110.656 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.23 159.81 57.11 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.136 -0.938 . . . . 6.4000000000000004 108.955 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HG2' HG11 ' A' ' 149' ' ' VAL . 72.8 Cg_exo -54.46 130.79 41.86 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.86 1.707 . . . . 6.5499999999999998 111.233 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 t -56.75 -26.02 56.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.254 0.465 . . . . 9.2899999999999991 112.254 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.26 4.56 50.29 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.07 -0.394 . . . . 10.859999999999999 111.659 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.31 -39.16 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 5.3399999999999999 110.721 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -80.28 158.9 26.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 6.9699999999999998 112.276 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -106.03 127.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.073 -0.967 . . . . 10.199999999999999 109.183 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -99.78 123.6 44.2 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.876 -0.73 . . . . 12.119999999999999 110.943 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -148.91 144.67 27.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.558 -0.746 . . . . 14.609999999999999 109.573 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.61 -121.63 15.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.204 -0.522 . . . . 15.52 112.322 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.39 37.25 4.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.15 0.5 . . . . 14.99 110.729 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -149.45 177.78 9.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.655 -0.702 . . . . 15.199999999999999 111.203 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 12.0 m -123.65 145.87 48.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.31 -0.405 . . . . 9.2599999999999998 109.986 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.7 mm -123.31 152.18 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.041 -0.725 . . . . 10.550000000000001 109.041 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -127.65 131.34 49.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.678 0.275 . . . . 7.3899999999999997 110.495 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 76.9 mtp -88.03 100.36 12.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.433 -0.58 . . . . 8.8499999999999996 109.433 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -85.69 136.82 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.868 -0.605 . . . . 9.6899999999999995 110.993 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 146' ' ' GLN . . . -89.97 94.19 9.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.618 -0.719 . . . . 10.699999999999999 110.158 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.0 141.99 56.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.795 -0.639 . . . . 14.880000000000001 110.714 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.29 -6.59 48.34 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.149 -0.78 . . . . 16.920000000000002 111.149 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.83 -3.05 46.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.394 0.616 . . . . 18.559999999999999 110.4 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 166' ' ' ALA . . . 104.37 -21.1 38.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.244 -0.889 . . . . 15.619999999999999 113.128 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.13 177.8 26.52 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.818 -0.706 . . . . 14.19 112.598 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.22 122.44 28.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.553 -0.536 . . . . 12.029999999999999 109.553 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.2 m-20 -124.76 147.93 57.76 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.535 -0.466 . . . . 13.91 111.571 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.53 135.18 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.746 2.297 . . . . 12.35 112.55 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.675 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.8 p -121.4 129.97 75.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.541 -0.754 . . . . 9.4299999999999997 109.916 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 110' ' ' ILE . 38.5 tt0 -74.58 116.86 15.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.988 0.423 . . . . 12.93 110.028 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 123' ' ' VAL . 28.4 m -128.55 167.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.868 -0.605 . . . . 8.0299999999999994 110.884 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 138' ' ' LEU . 37.6 ttmt -106.2 129.72 54.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.464 -0.569 . . . . 10.390000000000001 109.464 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.84 104.09 4.29 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.621 0.601 . . . . 8.3000000000000007 112.621 -173.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.59 70.9 0.29 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 117.752 -2.166 . . . . 10.1 114.498 167.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 162.69 39.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.876 -0.787 . . . . 10.609999999999999 108.876 154.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -138.02 124.34 20.55 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.606 -0.438 . . . . 13.17 109.844 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.05 111.21 6.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.063 -0.517 . . . . 12.98 111.575 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.93 44.17 94.94 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.932 -0.576 . . . . 14.34 112.818 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.15 8.55 85.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 13.119999999999999 112.378 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -120.71 166.73 13.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.662 -0.496 . . . . 10.619999999999999 109.662 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -120.62 155.51 33.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.749 0.309 . . . . 7.8200000000000003 110.774 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 48.1 mt-10 -97.09 110.98 23.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.495 0.664 . . . . 10.789999999999999 111.014 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.5 mm -79.71 101.15 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.167 -1.049 . . . . 6.7300000000000004 108.167 169.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.63 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -65.56 -49.35 69.19 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.049 -0.978 . . . . 8.7899999999999991 110.183 -174.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.95 162.49 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.358 -0.837 . . . . 10.44 110.908 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.33 -59.78 0.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.605 -0.807 . . . . 8.8699999999999992 113.304 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 123' ' ' VAL . 25.0 mt -103.35 -174.58 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.588 0.588 . . . . 8.5 112.588 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -149.37 157.56 43.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.451 -0.795 . . . . 14.15 109.605 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 126.01 28.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.626 -0.715 . . . . 12.119999999999999 110.075 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.03 -10.46 20.64 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.493 -1.043 . . . . 11.539999999999999 110.493 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.6 mm100 -100.74 120.02 39.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.444 -0.947 . . . . 11.24 108.444 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 11.1 pt20 -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.825 0.821 . . . . 10.49 110.364 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.58 145.96 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.336 -1.302 . . . . 5.4500000000000002 109.603 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.8 p -69.5 124.57 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.329 0.585 . . . . 6.5599999999999996 110.234 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.8 m -105.58 0.05 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.619 -0.719 . . . . 6.9900000000000002 110.398 -174.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 77' ' ' LEU . 8.5 t 71.91 -57.14 0.63 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.385 -1.279 . . . . 9.0600000000000005 111.706 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.92 167.45 11.09 Favored Glycine 0 C--N 1.332 0.344 0 O-C-N 123.592 0.558 . . . . 8.5 113.398 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . 28.0 tt0 -91.32 90.4 7.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.277 0.561 . . . . 11.84 111.208 -176.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -89.31 156.14 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.122 -0.695 . . . . 12.24 109.122 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.62 ' H ' HD13 ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.12 84.85 1.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.512 0.672 . . . . 13.16 111.403 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 155' ' ' ILE . 9.4 tp -169.55 48.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.089 0.947 . . . . 11.949999999999999 110.15 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -66.24 -28.04 68.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.712 0.768 . . . . 11.220000000000001 111.249 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.0 m -56.2 -34.46 66.29 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 11.9 113.039 -171.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -70.64 -25.73 63.15 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.837 -0.619 . . . . 11.17 110.673 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -82.38 -19.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.376 -0.829 . . . . 7.8200000000000003 110.031 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 m -81.73 -45.01 16.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.485 -0.78 . . . . 9.6400000000000006 110.022 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.33 -33.78 75.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.543 -0.753 . . . . 10.57 111.055 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 13.7 ptt180 -88.48 165.91 14.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.964 -0.754 . . . . 8.9000000000000004 108.964 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.12 61.82 3.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 7.1500000000000004 112.449 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 44.35 -93.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.926 0.89 . . . . 7.0899999999999999 112.469 -178.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.404 ' H ' ' HB ' ' A' ' 164' ' ' THR . 46.9 t -132.33 82.56 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.131 -1.063 . . . . 9.1999999999999993 108.131 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' GLY . . . -67.24 104.19 1.41 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.539 -0.755 . . . . 9.1099999999999994 111.561 -173.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.815 ' O ' ' HG3' ' A' ' 168' ' ' MET . 0.5 OUTLIER -71.09 88.08 0.78 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.193 -0.912 . . . . 14.58 109.402 173.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.815 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 10.6 mtm -173.37 168.27 4.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.846 -1.07 . . . . 11.94 110.31 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -124.55 -169.2 1.93 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.215 -1.031 . . . . 14.99 108.215 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.89 -148.27 0.14 Allowed 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.215 0.531 . . . . 15.01 109.791 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 68.8 p 51.64 30.43 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.69 -1.141 . . . . 14.25 112.986 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.1 m -79.69 -70.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.471 -0.332 . . . . 14.890000000000001 111.204 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.7 t 62.47 179.98 0.14 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.231 0.539 . . . . 15.85 111.178 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.38 -27.32 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.051 -0.595 . . . . 17.539999999999999 111.985 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.13 -171.63 1.87 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.493 -0.558 . . . . 17.850000000000001 109.493 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.68 -85.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 19.670000000000002 109.947 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 p -158.01 51.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 122.315 1.055 . . . . 19.52 110.178 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.94 76.11 8.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.437 -0.802 . . . . 21.149999999999999 110.452 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.97 59.01 1.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 23.25 110.334 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.359 -0.829 . . . . 23.52 111.356 -179.396 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.903 -0.406 . . . . 34.32 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.14 88.07 0.11 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.426 -0.892 . . . . 33.090000000000003 112.666 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 t -137.12 -147.29 0.24 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.744 -0.465 . . . . 34.119999999999997 109.744 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.25 78.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.268 0.556 . . . . 32.32 110.74 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -73.78 -52.38 13.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.886 -0.597 . . . . 32.740000000000002 110.416 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -109.26 -39.22 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.05 -0.523 . . . . 31.289999999999999 110.49 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 68.91 -67.36 0.21 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.254 0.622 . . . . 29.460000000000001 111.283 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 159.74 9.28 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.528 -1.029 . . . . 28.280000000000001 110.528 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.34 -164.38 0.2 Allowed 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.61 2.207 . . . . 27.510000000000002 112.63 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -58.39 155.11 12.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.894 0.378 . . . . 26.48 111.338 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 83.23 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 24.899999999999999 110.583 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.84 -88.66 1.81 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.837 -0.696 . . . . 23.190000000000001 111.544 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -106.48 122.16 45.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.863 0.363 . . . . 21.309999999999999 110.393 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -124.34 144.53 46.04 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.651 -0.704 . . . . 19.890000000000001 109.311 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 109.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.403 2.069 . . . . 18.120000000000001 111.556 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -81.32 39.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 16.579999999999998 111.773 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 116.26 10.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 14.800000000000001 110.28 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.16 -62.73 0.28 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.183 -0.767 . . . . 13.17 111.183 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.57 -71.07 0.22 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 12.17 109.878 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -169.44 77.47 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.727 -0.842 . . . . 13.82 108.727 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.567 ' H ' ' HB1' ' A' ' 16' ' ' ALA . 3.7 tt 79.02 -58.57 0.41 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.42 -0.956 . . . . 12.130000000000001 108.42 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -158.23 -79.66 0.07 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.202 -0.908 . . . . 14.1 109.551 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.436 ' HA ' ' HG3' ' A' ' 26' ' ' ARG . 14.5 t -109.73 -175.86 2.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.809 -0.441 . . . . 11.050000000000001 109.809 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 120.15 -56.5 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.977 -0.849 . . . . 10.050000000000001 110.977 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 24' ' ' GLY . 13.6 mptt -121.88 67.34 0.91 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.726 -1.213 . . . . 10.380000000000001 107.726 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.616 ' CD ' ' HA ' ' A' ' 63' ' ' ASP . 6.3 mtt-85 -144.09 141.46 30.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.706 -1.134 . . . . 8.3699999999999992 109.659 -172.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -53.73 133.7 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 122.568 1.175 . . . . 5.7599999999999998 113.242 -163.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.9 -35.33 6.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.743 -2.026 . . . . 8.2200000000000006 109.642 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 3.7 p90 -179.54 -174.71 0.31 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.299 -0.864 . . . . 7.9900000000000002 108.992 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.782 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m-90 -122.14 147.85 45.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 5.6100000000000003 111.071 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 4.0 ptm180 -152.86 156.4 38.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.238 -0.892 . . . . 9.0600000000000005 110.194 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.714 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.8 t70 -94.1 140.49 22.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.316 -0.624 . . . . 8.3100000000000005 109.316 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.79 -15.58 38.76 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.889 2.393 . . . . 10.41 112.561 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.44 -3.46 43.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 111.592 0.219 . . . . 10.85 111.592 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.2 m -127.79 37.22 0.37 Allowed Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.031 0.752 . . . . 9.3200000000000003 113.031 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -61.24 91.79 0.1 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.738 2.292 . . . . 11.1 112.745 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.86 -31.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.113 -0.565 . . . . 10.31 111.838 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -68.19 -178.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.057 0.762 . . . . 9.2100000000000009 113.057 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.626 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 11.3 tpp180 -147.34 91.77 2.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.238 -0.892 . . . . 11.51 108.797 172.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 49.9 m-85 -73.97 141.3 45.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.57 -0.852 . . . . 7.5 111.065 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.66 -25.57 68.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 10.609999999999999 110.841 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 20.8 pttp -171.79 164.78 4.36 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.808 -0.633 . . . . 10.91 111.008 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -49.79 169.79 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.756 2.971 . . . . 7.5099999999999998 113.62 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.93 -156.45 26.68 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.414 -0.898 . . . . 7.5899999999999999 112.814 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 8.4 ttmt -98.75 148.27 24.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.729 -0.471 . . . . 11.68 109.729 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' MET . 8.7 t -77.29 139.16 64.15 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-O 121.168 0.508 . . . . 9.1999999999999993 111.318 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.73 -22.27 20.69 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.971 2.448 . . . . 10.25 112.871 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.9 m-85 -85.51 -24.32 27.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.162 0.982 . . . . 10.49 109.496 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 46' ' ' SER . 2.2 ptp -157.9 134.08 9.44 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.868 -1.515 . . . . 10.380000000000001 111.081 -165.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -77.85 63.52 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.751 0.786 . . . . 12.539999999999999 111.565 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.6 ptm -139.05 143.96 39.04 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.74 -1.118 . . . . 9.8699999999999992 108.215 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.59 133.93 39.0 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.043 1.829 . . . . 9.5099999999999998 110.743 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.3 154.41 20.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 6.71 110.82 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -93.83 133.52 27.67 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 7.8899999999999997 109.872 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 27' ' ' ILE . 81.6 Cg_endo -85.23 147.87 10.24 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 121.928 1.752 . . . . 5.7699999999999996 113.425 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG13 ' A' ' 27' ' ' ILE . 32.2 m -75.69 157.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.639 -1.164 . . . . 5.96 111.994 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.64 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.19 2.196 . . . . 7.8399999999999999 115.507 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.737 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -40.25 -48.46 2.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.94 0.896 . . . . 6.6200000000000001 110.42 174.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.737 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 32.4 mt-10 69.71 83.04 0.16 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 124.203 1.001 . . . . 8.5800000000000001 113.054 176.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 87.68 64.35 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 113.836 -1.529 . . . . 7.6399999999999997 111.592 160.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 16.6 t-20 -165.71 -110.04 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.547 -1.661 . . . . 7.0199999999999996 107.472 171.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 70' ' ' ASP . . . -175.7 -105.04 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.649 0.262 . . . . 5.4100000000000001 110.657 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.616 ' HA ' ' CD ' ' A' ' 26' ' ' ARG . 7.2 t70 -163.79 67.1 0.17 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.877 0.846 . . . . 7.0099999999999998 111.042 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.24 -14.03 52.01 Favored Glycine 0 CA--C 1.503 -0.676 0 CA-C-N 114.772 -1.104 . . . . 7.2000000000000002 111.942 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.9 20.53 12.14 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.043 0.496 . . . . 7.8200000000000003 111.56 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.36 -69.18 0.38 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.704 0.261 . . . . 8.6500000000000004 111.704 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG13 ' H ' ' A' ' 68' ' ' ARG . 7.1 p -71.22 -59.37 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.178 0.513 . . . . 7.3099999999999996 111.049 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.619 ' HG2' ' OG1' ' A' ' 164' ' ' THR . 12.8 mtp180 -85.56 -177.74 6.5 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.582 1.182 . . . . 10.210000000000001 111.334 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.473 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.1 mt -99.27 150.83 4.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 112.702 -2.044 . . . . 8.8599999999999994 112.014 -165.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 33.1 t70 -75.54 47.7 0.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.778 -1.101 . . . . 13.02 111.087 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.65 30.91 66.29 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.564 -0.744 . . . . 12.130000000000001 112.833 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.473 ' HG2' HG21 ' A' ' 69' ' ' ILE . 2.1 ptt180 -100.91 126.28 47.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.529 -1.286 . . . . 12.380000000000001 107.529 170.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.29 100.24 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.287 -0.869 . . . . 11.609999999999999 110.005 -171.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -78.91 51.46 1.13 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.96 -1.473 . . . . 10.710000000000001 110.552 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.15 77.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.105 -0.952 . . . . 14.09 111.17 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.67 129.39 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 11.220000000000001 109.584 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.7 mm? -65.22 -32.26 73.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.78 -0.646 . . . . 13.710000000000001 110.126 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 91.06 16.62 53.72 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.371 -1.092 . . . . 11.44 110.371 -177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 152' ' ' GLN . 44.8 t 72.14 129.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.387 0.613 . . . . 9.9900000000000002 110.436 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -88.28 114.21 24.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.658 0.742 . . . . 11.640000000000001 111.612 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 148' ' ' VAL . 32.8 p -133.54 173.37 11.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.442 -1.254 . . . . 8.0 110.715 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.59 128.05 22.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.356 -0.838 . . . . 6.6500000000000004 109.179 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 29.9 tt0 -84.24 135.68 34.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.109 -0.496 . . . . 12.15 110.063 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 95' ' ' LEU . 55.9 t -60.73 131.69 25.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.704 -0.68 . . . . 9.7100000000000009 112.474 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 54.2 mmtt -138.53 146.16 41.58 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.714 -1.13 . . . . 11.029999999999999 109.519 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.729 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 6.6 mp -78.29 163.38 25.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.552 -0.459 . . . . 12.76 110.189 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.25 -45.55 0.04 OUTLIER Glycine 0 C--O 1.236 0.251 0 C-N-CA 119.774 -1.203 . . . . 13.25 113.744 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 92' ' ' THR . 15.4 ttm-85 -62.46 162.13 10.71 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.459 1.104 . . . . 16.350000000000001 112.245 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -158.73 109.9 2.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.74 -0.466 . . . . 18.219999999999999 109.74 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 -50.17 0.8 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.491 -1.444 . . . . 17.91 109.491 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.0 t -84.78 178.08 7.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.06 -1.07 . . . . 17.109999999999999 108.684 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.687 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -76.72 117.44 18.35 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.086 -0.961 . . . . 14.73 110.949 -170.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.729 ' OE2' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -70.65 160.35 32.74 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.981 -1.463 . . . . 14.94 112.835 -165.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.62 ' CG ' ' HA ' ' A' ' 138' ' ' LEU . 1.1 mpp_? -147.45 175.4 10.84 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.873 -1.512 . . . . 10.57 111.135 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 84' ' ' VAL . 2.3 mm? -100.74 112.97 25.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.166 -0.925 . . . . 8.8800000000000008 109.101 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.67 130.46 34.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 9.7799999999999994 110.704 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -143.0 157.88 60.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.01 -0.996 . . . . 6.4000000000000004 108.694 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 101' ' ' ALA . 15.1 Cg_endo -61.84 132.81 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.252 1.301 . . . . 6.5499999999999998 109.95 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.467 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 29.1 t -56.07 -21.93 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.489 0.551 . . . . 9.2899999999999991 112.489 -174.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.93 4.78 48.99 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.938 -0.477 . . . . 10.859999999999999 111.504 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . . . -80.51 -41.06 24.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.134 0.492 . . . . 5.3399999999999999 110.576 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -84.3 158.45 21.19 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.538 -0.756 . . . . 6.9699999999999998 111.573 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 20.2 mm -107.3 128.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.405 -0.816 . . . . 10.199999999999999 110.083 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 19.5 mmm180 -95.79 123.72 39.49 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.899 -0.72 . . . . 12.119999999999999 110.422 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -149.25 142.84 25.44 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.804 -0.635 . . . . 14.609999999999999 110.445 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.8 -116.53 4.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.194 -0.527 . . . . 15.52 112.302 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 36.84 4.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 14.99 110.877 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -151.63 -179.17 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.064 -0.516 . . . . 15.199999999999999 111.804 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.6 m -130.9 147.71 52.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.651 -0.704 . . . . 9.2599999999999998 109.508 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.5 mm -122.36 145.92 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.782 0.325 . . . . 10.550000000000001 110.204 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 141' ' ' LEU . . . -119.48 130.68 55.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.969 -0.56 . . . . 7.3899999999999997 110.118 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 49.2 mmm -90.88 98.35 11.72 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.819 -0.437 . . . . 8.8499999999999996 109.819 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 121' ' ' ASP . 11.2 p -83.92 139.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.173 0.511 . . . . 9.6899999999999995 111.967 -170.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.24 100.06 12.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.561 -0.745 . . . . 10.699999999999999 109.822 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.93 149.45 24.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.197 -0.456 . . . . 14.880000000000001 111.278 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.45 10.39 17.12 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.217 -0.753 . . . . 16.920000000000002 111.217 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.77 15.96 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 18.559999999999999 110.55 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.97 19.02 73.66 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.118 -0.947 . . . . 15.619999999999999 113.416 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.9 171.66 30.62 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.966 -1.111 . . . . 14.19 112.915 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 96.0 m-85 -120.27 112.67 19.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.612 -0.514 . . . . 12.029999999999999 109.612 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.6 m-20 -103.55 147.08 33.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.363 -0.38 . . . . 13.91 110.463 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.75 122.82 2.36 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.984 1.789 . . . . 12.35 112.384 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.34 122.88 59.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.816 -1.083 . . . . 9.4299999999999997 109.564 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -70.56 111.46 6.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.31 -0.626 . . . . 12.93 109.31 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.483 HG12 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.68 160.46 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.446 0.641 . . . . 8.0299999999999994 111.867 -173.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -91.83 130.36 37.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.76 -1.2 . . . . 10.390000000000001 107.76 172.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.8 102.42 4.28 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.221 -0.592 . . . . 8.3000000000000007 112.022 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -156.19 71.43 0.26 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 118.595 -1.764 . . . . 10.1 114.028 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.11 163.79 38.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 10.609999999999999 109.24 156.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.2 m -139.08 133.11 31.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.179 0.445 . . . . 13.17 110.496 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.85 103.22 4.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 12.98 111.41 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 42.39 69.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.198 -0.525 . . . . 14.34 112.946 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.41 88.94 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.019 -0.61 . . . . 13.119999999999999 112.344 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.75 152.65 35.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.255 -0.646 . . . . 10.619999999999999 109.255 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.8 p -99.77 161.62 13.5 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.011 -0.276 . . . . 7.8200000000000003 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 45.3 mt-10 -111.94 117.64 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.641 0.734 . . . . 10.789999999999999 111.122 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 35.4 mm -82.94 100.97 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.923 -1.035 . . . . 6.7300000000000004 108.735 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . 8.7 mt -63.34 -41.67 98.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.138 -0.937 . . . . 8.7899999999999991 110.319 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 37.0 mt-10 -148.47 155.89 41.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 10.44 110.642 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 125.0 -54.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.236 -0.983 . . . . 8.8699999999999992 113.742 172.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 111' ' ' ALA . 24.7 mt -98.37 -174.82 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 8.5 112.049 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.76 152.12 36.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.561 -0.745 . . . . 14.15 109.966 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.84 137.4 51.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.104 . . . . 12.119999999999999 111.084 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.18 -6.9 59.95 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.629 -0.796 . . . . 11.539999999999999 111.518 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -103.44 155.9 18.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.503 -0.925 . . . . 11.24 108.503 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.2 mt-30 -111.38 166.38 11.16 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.734 -0.786 . . . . 10.49 111.874 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.7 OUTLIER -135.91 141.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.923 -1.035 . . . . 5.4500000000000002 108.617 168.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 p -73.58 121.29 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 6.5599999999999996 109.679 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.5 -29.51 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.941 0.719 . . . . 6.9900000000000002 112.941 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.4 m -120.46 -26.01 5.47 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.767 -0.773 . . . . 9.0600000000000005 112.382 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 173' ' ' SER . . . 174.16 143.21 4.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.704 -1.236 . . . . 8.5 113.228 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.572 ' HA ' HG13 ' A' ' 79' ' ' VAL . 16.9 pt20 -106.29 41.56 1.4 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.586 -0.524 . . . . 11.84 109.586 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.0 t80 73.86 170.08 0.3 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.473 -1.24 . . . . 12.24 110.419 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.47 -71.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.493 -0.483 . . . . 13.16 111.422 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.456 ' O ' HD12 ' A' ' 155' ' ' ILE . 2.2 pp -116.76 149.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 11.949999999999999 111.086 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.464 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 2.9 p-10 -72.33 -17.74 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 11.220000000000001 111.938 -172.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -62.59 -52.52 63.08 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.02 -0.272 . . . . 11.9 111.213 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.54 -32.88 54.24 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.536 -0.466 . . . . 11.17 109.822 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -50.38 -52.44 37.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.606 0.241 . . . . 7.8200000000000003 111.547 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.0 p -62.18 -29.87 70.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 9.6400000000000006 112.035 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.8 -38.6 16.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.109 -0.496 . . . . 10.57 112.203 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 3.1 mpt_? -89.5 -27.1 20.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.929 0.395 . . . . 8.9000000000000004 111.257 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.98 -8.72 66.68 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.843 -0.694 . . . . 7.1500000000000004 111.546 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.619 ' OG1' ' HG2' ' A' ' 68' ' ' ARG . 11.6 p 55.58 -78.83 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.434 1.094 . . . . 7.0899999999999999 112.907 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.64 72.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 9.1999999999999993 110.345 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.06 115.14 13.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.016 -0.538 . . . . 9.1099999999999994 110.272 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.537 ' CD ' ' H ' ' A' ' 168' ' ' MET . 0.0 OUTLIER -89.8 -134.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.554 -0.748 . . . . 14.58 109.712 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.537 ' H ' ' CD ' ' A' ' 167' ' ' ARG . 20.4 mtm 63.93 178.95 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.534 0.734 . . . . 11.94 112.546 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -129.9 -33.04 1.82 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.65 . . . . 14.99 111.899 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.18 98.9 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.252 0.549 . . . . 15.01 111.541 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.4 p -81.25 106.45 13.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.608 -0.723 . . . . 14.25 110.013 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.5 m -87.58 -102.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.443 -0.344 . . . . 14.890000000000001 111.491 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.405 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 80.4 p 43.67 -145.38 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.189 0.596 . . . . 15.85 111.176 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 25.9 71.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.64 -0.79 . . . . 17.539999999999999 112.462 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.2 mt -90.22 22.55 3.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.252 0.549 . . . . 17.850000000000001 110.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -152.2 118.46 5.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.372 -0.831 . . . . 19.670000000000002 109.341 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.49 108.29 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.963 0.411 . . . . 19.52 110.544 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 56.2 mt -109.51 178.35 4.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 21.149999999999999 110.367 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.05 129.31 46.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.891 0.377 . . . . 23.25 110.766 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.4 -0.809 . . . . 23.52 110.204 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.16 -0.311 . . . . 34.32 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.05 63.76 3.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.147 -0.549 . . . . 33.090000000000003 112.109 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -159.15 9.81 0.13 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.971 0.415 . . . . 34.119999999999997 110.156 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.17 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 32.32 110.748 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 m -70.0 116.94 10.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 32.740000000000002 111.198 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.6 120.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.415 -0.587 . . . . 31.289999999999999 109.415 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.95 147.11 24.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 29.460000000000001 110.938 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.34 131.83 2.47 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.844 -0.616 . . . . 28.280000000000001 111.906 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -86.72 177.36 4.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.357 2.704 . . . . 27.510000000000002 111.936 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.89 79.82 7.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 26.48 109.692 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.19 145.62 49.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.574 -0.739 . . . . 24.899999999999999 111.615 -174.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.26 34.52 1.4 Allowed Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.654 -0.703 . . . . 23.190000000000001 112.111 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -140.59 121.28 14.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 21.309999999999999 109.878 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.1 136.71 26.57 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.222 -0.444 . . . . 19.890000000000001 110.913 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.7 147.36 63.06 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.255 1.97 . . . . 18.120000000000001 111.586 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.98 -45.73 7.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.045 0.45 . . . . 16.579999999999998 111.199 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.23 76.09 9.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.03 -0.532 . . . . 14.800000000000001 111.23 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.17 -88.79 2.06 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.282 -0.727 . . . . 13.17 111.282 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HB3' ' HA2' ' A' ' 24' ' ' GLY . . . -139.22 -75.19 0.37 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.746 -0.464 . . . . 12.17 109.746 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -163.93 68.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.476 0.655 . . . . 13.82 110.628 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt 67.23 -75.54 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.209 -1.36 . . . . 12.130000000000001 110.905 172.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.63 -43.51 98.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 112.895 -1.957 . . . . 14.1 110.703 -164.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.96 40.27 3.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.622 -1.172 . . . . 11.050000000000001 109.865 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 19' ' ' ALA . . . -87.94 -35.66 8.92 Favored Glycine 0 CA--C 1.49 -1.476 0 CA-C-N 114.618 -1.173 . . . . 10.050000000000001 111.224 174.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -171.53 53.33 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.653 -0.773 . . . . 10.380000000000001 110.58 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.613 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 39.9 mtt180 -126.45 141.32 51.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.547 -0.751 . . . . 8.3699999999999992 110.367 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' OE2' ' A' ' 58' ' ' GLU . 44.5 mm -55.66 120.08 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 5.7599999999999998 112.687 -170.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.56 -38.02 5.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.287 -1.324 . . . . 8.2200000000000006 110.182 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.76 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 21.4 p90 -168.82 -174.66 2.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 7.9900000000000002 111.303 -175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 1.6 m-90 -124.89 155.02 40.18 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.102 -0.954 . . . . 5.6100000000000003 111.078 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -160.44 153.58 21.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 9.0600000000000005 110.133 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 19.1 m-20 -79.17 137.07 56.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.637 -0.875 . . . . 8.3100000000000005 108.637 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.8 -11.8 19.26 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.65 2.233 . . . . 10.41 111.43 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.596 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.1 null -101.78 0.97 36.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.112 -0.494 . . . . 10.85 111.321 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' ASP . 6.9 m -127.81 43.65 1.11 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.244 0.545 . . . . 9.3200000000000003 111.476 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 35' ' ' VAL . 16.6 Cg_exo -61.74 111.49 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.81 2.34 . . . . 11.1 112.009 -170.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.38 -26.18 4.17 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.793 -0.923 . . . . 10.31 110.793 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.461 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 38.1 tp60 -76.52 115.58 16.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 9.2100000000000009 110.531 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 36.3 ttp180 -98.47 99.44 10.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.664 -0.698 . . . . 11.51 110.944 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.76 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 82.9 m-85 -79.77 133.02 36.3 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.343 -0.614 . . . . 7.5 109.343 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.88 -26.86 68.8 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.638 0.587 . . . . 10.609999999999999 110.766 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -160.06 147.66 12.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.437 0.636 . . . . 10.91 111.977 -172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 19.6 Cg_endo -56.33 135.68 71.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.947 3.765 . . . . 7.5099999999999998 113.573 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.71 -145.93 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.076 -0.583 . . . . 7.5899999999999999 111.919 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 2.0 ttmm -105.83 141.93 36.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.669 -0.863 . . . . 11.68 108.669 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB3' ' O ' ' A' ' 49' ' ' MET . 47.0 t -64.05 141.6 98.09 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.855 -0.612 . . . . 9.1999999999999993 111.411 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.93 -21.49 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.664 2.243 . . . . 10.25 111.012 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.571 ' CD2' HG11 ' A' ' 35' ' ' VAL . 35.0 m-85 -84.64 -41.99 15.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.187 -1.37 . . . . 10.49 109.245 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -137.04 157.41 46.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.369 -0.832 . . . . 10.380000000000001 110.873 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.0 p-10 -84.11 53.38 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.07 0.938 . . . . 12.539999999999999 111.135 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.47 32.85 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 114.967 -1.015 . . . . 9.8699999999999992 109.345 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.43 133.14 23.67 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 N-CA-C 108.86 -1.246 . . . . 9.5099999999999998 108.86 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.498 HD23 ' OD1' ' A' ' 32' ' ' ASP . 31.6 mt -61.59 157.17 17.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.076 0.465 . . . . 6.71 111.331 -172.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.16 133.26 22.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 116.065 -0.516 . . . . 7.8899999999999997 109.702 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.564 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 92.8 Cg_endo -78.65 138.18 14.99 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.912 1.741 . . . . 5.7699999999999996 112.613 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HB ' ' CE1' ' A' ' 57' ' ' TYR . 34.5 m -61.07 159.64 2.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.301 -1.318 . . . . 5.96 112.869 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 15.47 -87.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.564 1.946 . . . . 7.8399999999999999 115.11 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 26' ' ' ARG . 2.5 pt-20 -53.49 -34.49 58.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.244 -1.344 . . . . 6.6200000000000001 111.675 -170.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 31.6 tt0 55.06 74.39 0.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 O-C-N 124.44 1.088 . . . . 8.5800000000000001 110.047 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 54.23 86.0 0.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.327 -1.306 . . . . 7.6399999999999997 112.742 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 28.8 t30 -121.14 -44.09 2.41 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.82 -1.178 . . . . 7.0199999999999996 107.82 169.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.69 -63.2 0.31 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 113.741 -1.572 . . . . 5.4100000000000001 112.411 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.552 ' CG ' ' HB3' ' A' ' 68' ' ' ARG . 3.1 p-10 -166.43 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 119.047 -1.061 . . . . 7.0099999999999998 113.082 -171.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 -0.6 74.55 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.314 -1.312 . . . . 7.2000000000000002 112.074 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 67.66 49.73 0.95 Allowed 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.351 0.677 . . . . 7.8200000000000003 110.269 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.36 -48.07 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.0 -0.545 . . . . 8.6500000000000004 111.796 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 15.9 t -81.82 -85.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.477 -0.329 . . . . 7.3099999999999996 111.027 -173.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HB3' ' CG ' ' A' ' 63' ' ' ASP . 16.1 ptp180 48.51 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.703 1.601 . . . . 10.210000000000001 115.254 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' HG2' ' A' ' 72' ' ' ARG . 8.2 mt -112.55 154.98 13.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 112.345 -2.207 . . . . 8.8599999999999994 109.071 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.405 ' N ' HG22 ' A' ' 69' ' ' ILE . 22.8 t70 -79.35 49.2 0.96 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.246 0.546 . . . . 13.02 111.148 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.4 33.55 76.67 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.564 -0.744 . . . . 12.130000000000001 112.148 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 69' ' ' ILE . 12.3 ptm180 -135.16 -175.42 3.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.986 -1.116 . . . . 12.380000000000001 107.986 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.77 120.69 61.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.669 0.747 . . . . 11.609999999999999 110.389 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 t -104.29 101.62 11.33 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.51 -1.223 . . . . 10.710000000000001 108.254 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.21 73.72 0.67 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.919 -1.037 . . . . 14.09 111.257 -172.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -136.61 138.71 41.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.481 -0.933 . . . . 11.220000000000001 108.481 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.42 -20.63 66.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.341 -0.845 . . . . 13.710000000000001 111.228 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.97 -49.21 0.79 Allowed Glycine 0 CA--C 1.496 -1.129 0 N-CA-C 109.586 -1.406 . . . . 11.44 109.586 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 79' ' ' VAL . 9.0 p 38.37 73.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 122.9 1.333 . . . . 9.9900000000000002 113.063 165.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 150' ' ' SER . 14.2 mtp180 -80.48 133.35 35.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.73 -1.123 . . . . 11.640000000000001 110.247 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.51 HG22 ' HA ' ' A' ' 148' ' ' VAL . 36.2 p -131.48 147.24 52.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.447 -1.251 . . . . 8.0 110.592 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.44 54.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.819 -0.808 . . . . 6.6500000000000004 108.819 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 29.9 tt0 -73.02 138.08 45.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.083 -0.508 . . . . 12.15 109.724 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' LEU . 54.4 t -58.96 135.21 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.522 -0.763 . . . . 9.7100000000000009 111.739 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 66.5 mmtt -126.89 154.36 44.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.327 -0.851 . . . . 11.029999999999999 111.56 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.8 mp -89.2 125.7 35.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.42 -0.956 . . . . 12.76 108.42 162.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.8 8.57 11.72 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 118.979 -1.581 . . . . 13.25 113.371 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.762 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 7.3 ptp180 -141.27 158.17 44.25 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.07 0.462 . . . . 16.350000000000001 110.548 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.3 tp -158.47 113.67 2.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.955 -1.02 . . . . 18.219999999999999 108.41 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.86 -50.46 0.84 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 108.59 -1.804 . . . . 17.91 108.59 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 15.2 m -73.38 165.87 24.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.174 -1.047 . . . . 17.109999999999999 108.174 165.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -72.15 106.48 4.39 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.728 -0.669 . . . . 14.73 111.085 -171.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.762 ' HA ' ' HG3' ' A' ' 88' ' ' ARG . 1.6 tt0 -53.31 124.09 13.71 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 124.585 1.178 . . . . 14.94 111.949 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -132.17 163.8 27.73 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.892 -1.503 . . . . 10.57 107.567 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -91.6 114.53 27.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.719 -0.474 . . . . 8.8800000000000008 109.719 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.14 130.61 37.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.951 -0.568 . . . . 9.7799999999999994 110.974 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.54 158.24 50.72 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.405 -0.816 . . . . 6.4000000000000004 109.628 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.572 ' HG2' HG11 ' A' ' 149' ' ' VAL . 34.5 Cg_exo -57.72 134.38 62.53 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.204 1.936 . . . . 6.5499999999999998 111.049 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 t -58.05 -28.23 64.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.916 0.339 . . . . 9.2899999999999991 111.916 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.05 1.24 51.1 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.234 -0.291 . . . . 10.859999999999999 111.552 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -76.75 -41.08 46.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.097 0.475 . . . . 5.3399999999999999 111.378 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.92 163.43 14.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.847 -0.615 . . . . 6.9699999999999998 112.073 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.4 mm -113.27 103.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.809 -0.632 . . . . 10.199999999999999 109.508 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.2 ptt180 -102.41 132.2 48.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 117.949 -1.501 . . . . 12.119999999999999 111.113 173.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -150.31 132.58 15.47 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.736 -1.575 . . . . 14.609999999999999 109.454 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.65 -108.79 2.14 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.519 -0.848 . . . . 15.52 112.317 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.5 29.09 7.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.381 0.511 . . . . 14.99 112.381 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -164.76 178.86 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.119 0.415 . . . . 15.199999999999999 112.119 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 7.2 m -133.15 152.29 51.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.668 -0.696 . . . . 9.2599999999999998 110.137 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 124' ' ' GLU . 34.4 mm -128.95 151.76 36.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.777 -0.453 . . . . 10.550000000000001 109.777 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.84 130.12 31.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.649 -0.13 . . . . 7.3899999999999997 110.649 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.4 mtm -89.31 101.47 14.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 8.8499999999999996 109.388 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 10.0 p -87.19 139.17 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.601 -0.727 . . . . 9.6899999999999995 111.364 -174.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.61 85.89 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 10.699999999999999 109.642 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -71.32 145.82 49.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 14.880000000000001 110.129 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.19 -7.78 33.36 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.031 -0.531 . . . . 16.920000000000002 113.168 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.33 10.98 17.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 18.559999999999999 110.966 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 14.4 69.3 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.487 -0.779 . . . . 15.619999999999999 113.282 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.0 167.47 21.09 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.683 -0.77 . . . . 14.19 111.501 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.7 m-85 -113.0 108.24 17.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.905 0.383 . . . . 12.029999999999999 110.047 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 16.8 t70 -101.54 141.11 21.93 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.054 -0.521 . . . . 13.91 110.637 -173.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 9.4 Cg_endo -86.19 124.7 2.5 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.485 2.123 . . . . 12.35 111.943 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 111' ' ' ALA . 8.7 p -107.47 131.8 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.397 -0.82 . . . . 9.4299999999999997 109.304 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 110' ' ' ILE . 31.2 tt0 -78.0 109.86 12.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.969 -0.752 . . . . 12.93 108.969 171.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.832 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -116.62 155.78 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.193 -0.912 . . . . 8.0299999999999994 111.465 -171.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -93.54 120.05 33.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.092 -0.958 . . . . 10.390000000000001 108.87 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.56 106.89 4.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.093 -0.503 . . . . 8.3000000000000007 111.004 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.52 70.53 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.893 -2.099 . . . . 10.1 114.215 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.43 162.85 39.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.16 -0.681 . . . . 10.609999999999999 109.16 155.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -141.64 123.61 15.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.178 0.513 . . . . 13.17 109.759 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.92 126.45 11.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.673 -0.694 . . . . 12.98 111.156 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.78 32.08 83.03 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 116.09 -0.505 . . . . 14.34 112.528 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.41 15.62 80.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.933 -0.651 . . . . 13.119999999999999 111.878 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -123.37 174.98 7.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.036 -0.727 . . . . 10.619999999999999 109.036 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.7 m -126.58 157.53 38.6 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.001 0.429 . . . . 7.8200000000000003 110.646 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 75.4 mt-10 -101.8 118.14 36.31 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.489 0.661 . . . . 10.789999999999999 110.888 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 125' ' ' VAL . 17.6 mm -86.09 101.23 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.097 -0.956 . . . . 6.7300000000000004 108.927 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 2.6 mp -71.09 -36.77 72.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.573 -1.194 . . . . 8.7899999999999991 110.264 -176.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 125' ' ' VAL . 12.5 tt0 -158.2 158.38 34.44 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.056 -0.72 . . . . 10.44 109.056 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 126.15 -33.69 3.43 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.903 -1.142 . . . . 8.8699999999999992 111.772 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.34 -176.9 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.859 0.689 . . . . 8.5 112.859 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -148.38 155.97 41.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.731 -1.122 . . . . 14.15 108.944 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.46 133.44 47.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.735 -0.666 . . . . 12.119999999999999 110.293 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.54 -5.41 44.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.817 -0.913 . . . . 11.539999999999999 110.817 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 84' ' ' VAL . 38.5 mt-30 -101.06 122.03 42.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.364 0.602 . . . . 11.24 109.391 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 55.8 mt-30 -91.27 124.97 35.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.955 . . . . 10.49 110.718 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.39 139.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.792 -0.448 . . . . 5.4500000000000002 109.792 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 81' ' ' THR . 35.3 m -65.36 132.25 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 6.5599999999999996 110.764 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.572 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.2 m -119.29 19.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.891 0.853 . . . . 6.9900000000000002 109.247 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 27.5 m 73.79 154.54 0.15 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.713 -1.585 . . . . 9.0600000000000005 112.038 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.25 71.51 2.24 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.671 -0.972 . . . . 8.5 110.671 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -60.34 140.98 56.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.398 0.518 . . . . 11.84 112.398 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -106.15 -161.38 0.79 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 12.24 109.761 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 61.7 tp 71.67 -71.25 0.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.202 0.601 . . . . 13.16 110.631 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.66 3.36 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.539 -0.755 . . . . 11.949999999999999 110.597 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.68 -21.67 65.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.841 -0.618 . . . . 11.220000000000001 110.056 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 p -59.1 -52.99 63.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.182 0.515 . . . . 11.9 110.17 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.94 -36.6 79.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.38 -0.827 . . . . 11.17 110.391 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.14 67.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.051 -0.977 . . . . 7.8200000000000003 111.3 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -76.38 -19.33 58.26 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.966 -0.383 . . . . 9.6400000000000006 109.966 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.01 -50.13 71.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.23 -0.655 . . . . 10.57 109.23 173.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -64.63 -34.97 79.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.257 -0.883 . . . . 8.9000000000000004 110.248 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.437 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 106.82 43.65 1.4 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.439 -0.801 . . . . 7.1500000000000004 111.666 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 49.2 p 54.95 -92.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.902 0.881 . . . . 7.0899999999999999 112.156 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.56 74.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.501 0.667 . . . . 9.1999999999999993 110.87 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.33 146.94 53.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 9.1099999999999994 111.277 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.728 ' HD3' ' C ' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -109.24 111.12 22.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.296 -0.411 . . . . 14.58 110.386 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -149.9 -69.27 0.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.354 -0.839 . . . . 11.94 110.168 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -138.34 -68.21 0.46 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.193 -0.912 . . . . 14.99 110.156 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 171' ' ' THR . 0.0 OUTLIER -134.03 -54.24 0.86 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 15.01 110.067 -177.527 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.424 ' N ' ' HG2' ' A' ' 170' ' ' GLU . 11.1 p -153.46 -46.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.111 0.564 . . . . 14.25 110.295 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.2 t 175.79 161.51 0.3 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.318 -0.855 . . . . 14.890000000000001 110.38 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.2 m -98.6 -2.66 38.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 15.85 109.714 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 46.66 1.14 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.557 -1.017 . . . . 17.539999999999999 110.557 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.613 HD13 ' N ' ' A' ' 176' ' ' GLU . 2.2 tm? -56.98 150.91 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.471 . . . . 17.850000000000001 110.111 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.613 ' N ' HD13 ' A' ' 175' ' ' LEU . 33.6 mt-10 -68.52 77.0 0.28 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.342 0.592 . . . . 19.670000000000002 110.942 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.95 132.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.412 -0.813 . . . . 19.52 109.198 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 178' ' ' LEU . 1.4 pt? -136.95 145.44 44.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.098 0.475 . . . . 21.149999999999999 111.036 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -74.08 146.72 43.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.532 -0.758 . . . . 23.25 110.39 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.318 -0.849 . . . . 23.52 109.772 177.4 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.892 0.377 . . . . 34.32 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.83 108.49 0.21 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.247 -0.741 . . . . 33.090000000000003 111.247 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m 63.78 -161.1 0.29 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.972 0.415 . . . . 34.119999999999997 110.918 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.54 12.48 8.9 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.778 0.831 . . . . 32.32 111.825 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -110.04 -5.92 15.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 32.740000000000002 111.001 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.03 -28.64 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 31.289999999999999 111.022 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -142.73 141.61 31.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.327 -0.397 . . . . 29.460000000000001 110.384 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.95 -172.96 36.01 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.638 -0.791 . . . . 28.280000000000001 111.872 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.84 27.36 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.016 2.477 . . . . 27.510000000000002 112.421 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -137.92 46.09 2.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.505 -0.316 . . . . 26.48 110.98 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.06 44.58 1.14 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.631 0.729 . . . . 24.899999999999999 110.507 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.85 23.01 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.103 -0.953 . . . . 23.190000000000001 110.811 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -150.74 152.63 34.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.205 0.503 . . . . 21.309999999999999 110.463 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -96.53 160.82 28.66 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.283 -0.636 . . . . 19.890000000000001 109.283 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.81 -50.9 10.25 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.129 1.886 . . . . 18.120000000000001 111.952 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . . . 68.22 115.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.086 -0.961 . . . . 16.579999999999998 111.82 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.37 108.28 17.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.685 -0.689 . . . . 14.800000000000001 110.209 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.75 -96.89 0.31 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.982 -0.628 . . . . 13.17 111.665 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.66 -87.28 0.05 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.904 -0.174 . . . . 12.17 110.604 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 68.63 122.28 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.557 0.694 . . . . 13.82 110.926 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? 78.07 -45.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.517 -1.219 . . . . 12.130000000000001 110.349 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -18.55 61.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.389 0.614 . . . . 14.1 109.511 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -105.15 145.85 30.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.428 -0.805 . . . . 11.050000000000001 110.508 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.1 43.89 1.65 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.758 -0.735 . . . . 10.050000000000001 111.738 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.1 mptm? 72.68 62.62 0.11 Allowed 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.614 -1.254 . . . . 10.380000000000001 107.614 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.574 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 22.7 ptt85 -128.13 145.44 51.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.649 -1.614 . . . . 8.3699999999999992 109.093 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.667 HG13 ' H ' ' A' ' 61' ' ' ASN . 22.5 mm -54.05 125.28 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 114.227 1.195 . . . . 5.7599999999999998 114.227 -166.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.5 mt -110.26 -37.24 5.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.205 -1.816 . . . . 8.2200000000000006 110.507 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 20.5 p90 -170.0 -176.03 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.397 . . . . 7.9900000000000002 111.369 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -123.86 148.82 46.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.533 -0.758 . . . . 5.6100000000000003 111.09 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -153.61 151.16 29.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.337 -0.392 . . . . 9.0600000000000005 110.631 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.746 ' HB3' HG22 ' A' ' 35' ' ' VAL . 6.1 t0 -75.82 129.16 81.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.011 -1.107 . . . . 8.3100000000000005 108.011 172.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 54' ' ' ILE . 18.7 Cg_exo -60.46 -16.99 45.38 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.098 1.865 . . . . 10.41 113.77 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -104.51 4.84 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.243 -0.583 . . . . 10.85 111.921 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.4 m -119.42 41.88 0.44 Allowed Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 112.387 0.514 . . . . 9.3200000000000003 112.387 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.09 134.63 65.62 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 11.1 112.465 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.08 43.38 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.976 -0.849 . . . . 10.31 110.976 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.578 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -92.86 116.42 29.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.217 0.532 . . . . 9.2100000000000009 110.371 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 49.4 ttp180 -104.34 116.57 32.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.667 -0.697 . . . . 11.51 111.334 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 97.5 m-85 -101.84 114.23 28.13 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.862 -1.162 . . . . 7.5 107.862 171.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -64.35 -21.58 66.67 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.522 -0.871 . . . . 10.609999999999999 111.703 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 52.9 mttp -126.18 166.68 20.16 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.339 -0.544 . . . . 10.91 111.234 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 14.1 Cg_endo -56.4 171.58 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.399 2.733 . . . . 7.5099999999999998 112.857 170.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.6 -170.8 29.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.651 -0.785 . . . . 7.5899999999999999 112.424 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 31.2 ttmt -95.58 146.78 24.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.465 -0.568 . . . . 11.68 109.465 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.4 t -64.51 129.69 94.33 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.684 -0.689 . . . . 9.1999999999999993 110.411 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.7 -26.35 33.09 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.44 2.093 . . . . 10.25 111.027 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 52.3 m-85 -73.98 -40.67 62.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.969 -1.468 . . . . 10.49 110.404 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.8 OUTLIER -154.52 160.96 41.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 10.380000000000001 110.788 174.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.2 p-10 -78.6 72.35 5.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.888 0.851 . . . . 12.539999999999999 112.804 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.2 ptm -140.41 144.74 38.12 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.531 -0.915 . . . . 9.8699999999999992 108.531 168.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.4 133.3 29.84 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.095 1.863 . . . . 9.5099999999999998 110.041 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.34 159.53 12.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.894 0.378 . . . . 6.71 110.382 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 33' ' ' PRO . 42.0 mm -103.24 130.84 22.83 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-O 121.25 0.548 . . . . 7.8899999999999997 109.752 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.636 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 80.6 Cg_endo -75.48 144.14 28.39 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.707 1.605 . . . . 5.7699999999999996 112.416 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.35 160.46 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.407 -1.27 . . . . 5.96 112.62 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.574 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.59 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.843 2.457 . . . . 7.8399999999999999 116.389 -175.001 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -61.06 -45.21 95.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.766 0.793 . . . . 6.6200000000000001 109.936 -173.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 47.5 mt-10 71.72 43.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.514 -1.675 . . . . 8.5800000000000001 114.695 167.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 173.73 56.38 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.316 1.01 . . . . 7.6399999999999997 111.966 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.667 ' H ' HG13 ' A' ' 27' ' ' ILE . 10.4 t30 62.71 -52.13 0.17 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.624 -2.08 . . . . 7.0199999999999996 114.647 170.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 63' ' ' ASP . . . -170.51 -18.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.873 -0.603 . . . . 5.4100000000000001 112.38 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 56.9 m-20 55.83 37.0 28.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.797 0.808 . . . . 7.0099999999999998 109.632 -164.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 53.34 31.14 42.09 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 114.73 -1.123 . . . . 7.2000000000000002 112.577 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' GLY . . . 88.94 48.66 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.809 1.244 . . . . 7.8200000000000003 111.466 -175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 72.45 -26.84 0.18 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.264 1.209 . . . . 8.6500000000000004 114.264 170.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.97 -20.56 26.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.587 1.184 . . . . 7.3099999999999996 109.92 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.683 ' HB3' ' OG1' ' A' ' 164' ' ' THR . 5.9 ttt180 66.86 113.95 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 111.988 -2.369 . . . . 10.210000000000001 112.836 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 72' ' ' ARG . 2.6 mt -126.16 156.2 36.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 113.608 -1.633 . . . . 8.8599999999999994 110.465 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.28 54.32 2.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.1 0.952 . . . . 13.02 110.236 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.48 -20.16 9.52 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 114.441 -1.254 . . . . 12.130000000000001 114.687 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' O ' HG21 ' A' ' 69' ' ' ILE . 17.0 ptm180 -72.65 127.01 31.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.803 -0.814 . . . . 12.380000000000001 108.803 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.23 135.52 62.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.275 0.559 . . . . 11.609999999999999 111.828 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 76' ' ' ASN . 8.0 t -147.82 117.44 7.06 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.904 -1.044 . . . . 10.710000000000001 109.457 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.81 35.93 0.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.578 1.18 . . . . 14.09 109.598 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 74' ' ' THR . 38.6 m-80 -156.57 98.55 1.82 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.384 -1.735 . . . . 11.220000000000001 107.922 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.0 mt -83.2 -3.92 57.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.494 0.664 . . . . 13.710000000000001 110.746 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.31 -1.28 26.47 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.202 -0.908 . . . . 11.44 112.184 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 124.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.851 0.358 . . . . 9.9900000000000002 110.349 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -113.53 138.65 49.84 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.155 -0.683 . . . . 11.640000000000001 109.155 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.9 p -140.4 144.11 36.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.082 0.468 . . . . 8.0 110.78 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.479 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -114.94 140.64 48.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.872 -0.788 . . . . 6.6500000000000004 108.872 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 34.4 tt0 -87.48 130.54 34.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.593 -0.521 . . . . 12.15 109.593 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 145' ' ' GLN . 61.2 t -54.69 128.96 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.432 0.635 . . . . 9.7100000000000009 111.554 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -163.02 140.3 7.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.486 -1.233 . . . . 11.029999999999999 109.981 171.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.88 HD23 ' H ' ' A' ' 86' ' ' LEU . 0.5 OUTLIER -77.58 158.01 30.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.148 -0.933 . . . . 12.76 110.484 -177.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.549 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -169.53 47.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.883 -0.675 . . . . 13.25 112.427 -171.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -68.58 134.47 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.821 0.343 . . . . 16.350000000000001 110.924 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.9 mt -135.68 85.52 2.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.709 -0.848 . . . . 18.219999999999999 108.709 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.88 2.09 75.68 Favored Glycine 0 CA--C 1.504 -0.641 0 N-CA-C 108.418 -1.873 . . . . 17.91 108.418 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -110.44 178.3 4.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 112.829 -1.686 . . . . 17.109999999999999 108.572 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -94.44 156.37 16.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.552 -0.907 . . . . 14.73 108.552 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.88 105.76 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.493 0.663 . . . . 14.94 111.415 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 33.6 mmt180 -133.92 164.28 27.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.382 -1.281 . . . . 10.57 108.332 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.6 mp -85.16 112.21 20.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.101 -0.703 . . . . 8.8800000000000008 109.101 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.0 mm? -87.81 130.23 34.94 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.84 0.352 . . . . 9.7799999999999994 110.95 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.78 155.58 56.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 6.4000000000000004 109.045 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.93 136.92 67.96 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.121 1.881 . . . . 6.5499999999999998 111.117 170.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 15.9 t -56.46 -24.12 43.49 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.472 0.545 . . . . 9.2899999999999991 112.472 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.89 9.47 27.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.217 -0.302 . . . . 10.859999999999999 111.138 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -80.44 -41.11 25.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.244 0.545 . . . . 5.3399999999999999 111.339 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.8 155.61 19.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.646 0.736 . . . . 6.9699999999999998 112.546 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.37 131.43 46.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.731 -1.122 . . . . 10.199999999999999 109.1 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -102.28 126.55 49.31 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.534 -0.466 . . . . 12.119999999999999 110.823 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 t -149.67 132.93 16.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.275 -0.421 . . . . 14.609999999999999 110.466 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.33 -114.22 3.61 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.262 -0.494 . . . . 15.52 113.111 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.57 36.65 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.195 0.521 . . . . 14.99 111.243 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -153.3 167.53 29.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 15.199999999999999 111.758 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.2 m -117.44 145.15 44.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.066 -0.515 . . . . 9.2599999999999998 109.831 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.8 mm -125.49 153.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.306 -0.627 . . . . 10.550000000000001 109.306 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -129.42 129.88 45.24 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.353 -0.217 . . . . 7.3899999999999997 110.467 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 41.2 ttp -90.61 100.86 13.63 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 8.8499999999999996 108.668 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.3 p -84.49 133.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.49 -0.777 . . . . 9.6899999999999995 111.894 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.86 84.06 7.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 10.699999999999999 110.188 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.19 149.03 46.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 14.880000000000001 110.665 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.79 5.39 39.44 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.118 -0.793 . . . . 16.920000000000002 111.118 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -87.23 6.39 33.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.471 0.653 . . . . 18.559999999999999 110.528 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 1.27 77.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.231 -0.895 . . . . 15.619999999999999 113.469 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.78 159.17 22.87 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.735 -0.745 . . . . 14.19 112.426 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.486 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.5 m-85 -109.87 116.82 32.34 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.572 -0.529 . . . . 12.029999999999999 109.572 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.8 t70 -113.46 144.2 30.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.002 -0.279 . . . . 13.91 111.267 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -84.44 131.21 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.512 2.141 . . . . 12.35 112.505 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.619 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 10.6 p -122.97 136.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.595 . . . . 9.4299999999999997 110.27 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 110' ' ' ILE . 35.0 tt0 -83.11 120.23 25.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.97 0.414 . . . . 12.93 109.996 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 123' ' ' VAL . 22.8 m -129.11 165.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.031 -0.531 . . . . 8.0299999999999994 111.567 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.73 127.17 44.57 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.873 -0.603 . . . . 10.390000000000001 109.397 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.14 106.19 4.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.198 -0.455 . . . . 8.3000000000000007 111.393 -175.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.75 71.05 0.28 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 117.655 -2.212 . . . . 10.1 114.094 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.51 162.16 40.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 10.609999999999999 108.817 155.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -146.96 129.76 16.17 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.645 -0.502 . . . . 13.17 109.645 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.96 110.72 4.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.034 -0.53 . . . . 12.98 111.364 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.61 40.28 90.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.056 -0.592 . . . . 14.34 112.9 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.79 0.73 90.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.72 -0.753 . . . . 13.119999999999999 112.543 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -114.49 155.69 25.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.507 -0.553 . . . . 10.619999999999999 109.507 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 57.7 m -113.4 164.85 13.07 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 110.072 -0.344 . . . . 7.8200000000000003 110.072 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.9 mt-10 -112.53 113.57 25.79 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.57 0.7 . . . . 10.789999999999999 111.283 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 34.9 mm -83.24 104.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.946 -1.024 . . . . 6.7300000000000004 108.401 170.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -70.34 -49.14 52.39 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.125 -0.943 . . . . 8.7899999999999991 109.922 -174.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -144.38 162.04 37.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 10.44 111.311 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 119.31 -52.99 0.69 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.871 -0.68 . . . . 8.8699999999999992 113.395 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 123' ' ' VAL . 16.0 mt -105.36 -171.63 1.95 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 8.5 111.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -144.26 155.37 43.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 14.15 110.066 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 129.51 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.15 -0.932 . . . . 12.119999999999999 110.348 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.28 -11.06 28.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.978 -0.849 . . . . 11.539999999999999 110.978 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 84' ' ' VAL . 88.5 mm-40 -94.19 118.22 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 11.24 109.465 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 64.6 mt-30 -85.38 132.38 34.24 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 10.49 110.797 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.4 m -122.8 142.34 39.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.184 -0.462 . . . . 5.4500000000000002 110.133 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 8.9 p -65.29 124.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.231 0.539 . . . . 6.5599999999999996 111.375 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 101' ' ' ALA . 10.9 m -129.34 29.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.273 0.558 . . . . 6.9900000000000002 111.083 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.2 m -53.01 112.7 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.105 -0.952 . . . . 9.0600000000000005 110.999 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 157.93 127.12 0.93 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.935 -0.866 . . . . 8.5 110.935 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 153' ' ' PHE . 15.8 mm-40 -150.79 76.61 1.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.708 0.254 . . . . 11.84 111.323 -175.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 152' ' ' GLN . 79.0 t80 72.01 -71.25 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.65 0.594 . . . . 12.24 111.062 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 155' ' ' ILE . 11.3 tp -118.02 -154.95 0.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.669 -0.863 . . . . 13.16 108.669 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.54 ' H ' ' HG ' ' A' ' 154' ' ' LEU . 61.0 mt -57.85 100.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.495 0.664 . . . . 11.949999999999999 110.191 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 5.6 p-10 -82.67 -6.44 59.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.472 -0.786 . . . . 11.220000000000001 111.09 -172.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.7 m -60.41 -42.89 96.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 11.9 110.807 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.41 -28.35 52.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.509 0.671 . . . . 11.17 109.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -74.6 -27.36 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 7.8200000000000003 111.987 -174.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 p -81.48 -38.6 26.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.947 0.403 . . . . 9.6400000000000006 110.804 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.52 -26.57 61.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.791 -0.64 . . . . 10.57 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 162' ' ' ARG . 1.8 ptm180 -94.63 161.68 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.667 0.746 . . . . 8.9000000000000004 110.084 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.86 -70.19 0.52 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.628 -1.389 . . . . 7.1500000000000004 109.628 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.683 ' OG1' ' HB3' ' A' ' 68' ' ' ARG . 21.7 p -144.98 -56.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.303 0.573 . . . . 7.0899999999999999 109.767 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.54 -70.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.604 -0.725 . . . . 9.1999999999999993 110.053 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 70.69 132.58 0.03 OUTLIER 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.883 0.74 . . . . 9.1099999999999994 111.856 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -88.62 110.38 20.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.176 -1.046 . . . . 14.58 108.176 175.128 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 13.1 ptp -103.59 123.92 47.85 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 113.985 -1.461 . . . . 11.94 112.224 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -152.07 -44.93 0.11 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.427 -1.26 . . . . 14.99 108.045 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.33 -58.94 2.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.842 -1.072 . . . . 15.01 109.11 173.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.2 p -108.92 117.78 35.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.662 -0.699 . . . . 14.25 110.725 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.5 m -91.45 151.21 20.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 14.890000000000001 109.934 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.2 m -94.47 76.09 3.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.506 0.669 . . . . 15.85 110.203 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -68.3 -38.02 86.97 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.011 -0.995 . . . . 17.539999999999999 111.137 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.404 ' CD1' ' HB ' ' A' ' 155' ' ' ILE . 80.6 mt -98.87 73.64 1.99 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.049 -0.352 . . . . 17.850000000000001 110.049 170.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.79 -26.69 19.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.238 -0.585 . . . . 19.670000000000002 110.211 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.9 t -74.88 89.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.169 0.509 . . . . 19.52 110.687 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -141.65 93.86 2.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 21.149999999999999 109.696 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.39 -79.48 0.59 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.212 -0.449 . . . . 23.25 110.446 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.79 -0.624 . . . . 23.52 109.639 179.796 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.575 0.226 . . . . 34.32 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.46 -47.89 0.17 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.595 -0.812 . . . . 33.090000000000003 111.978 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.493 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.7 t -81.6 102.64 10.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.347 0.594 . . . . 34.119999999999997 109.546 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.06 4.77 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.677 -0.692 . . . . 32.32 111.985 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -77.39 -30.44 53.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 32.740000000000002 110.19 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 3' ' ' SER . 35.8 m -93.88 38.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.383 0.611 . . . . 31.289999999999999 110.875 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -73.66 -21.15 60.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.61 . . . . 29.460000000000001 111.409 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.62 139.18 3.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.753 -0.737 . . . . 28.280000000000001 112.124 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.77 -30.91 69.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.845 2.364 . . . . 27.510000000000002 112.561 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -153.34 136.21 15.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.471 -0.332 . . . . 26.48 110.426 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.7 175.5 7.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.852 -0.613 . . . . 24.899999999999999 110.67 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 -99.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.085 -0.507 . . . . 23.190000000000001 112.056 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -154.33 -59.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.589 0.709 . . . . 21.309999999999999 110.304 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 52.65 65.31 6.19 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 113.991 -1.459 . . . . 19.890000000000001 112.285 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -35.66 98.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.268 2.645 . . . . 18.120000000000001 112.721 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 52.39 46.81 25.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.144 0.497 . . . . 16.579999999999998 111.606 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.08 162.82 36.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.714 -0.675 . . . . 14.800000000000001 109.776 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.37 37.0 63.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.546 -0.835 . . . . 13.17 112.023 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.52 10.9 15.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 12.17 111.088 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 29.2 tt0 52.28 66.19 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.341 -1.3 . . . . 13.82 111.779 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 175.85 -81.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.608 -1.178 . . . . 12.130000000000001 108.931 172.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -82.72 97.2 8.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.418 1.104 . . . . 14.1 108.969 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p 55.91 52.12 11.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.446 -2.161 . . . . 11.050000000000001 112.288 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.3 -62.69 2.53 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.471 -0.786 . . . . 10.050000000000001 111.374 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -148.48 67.96 1.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.757 1.265 . . . . 10.380000000000001 108.015 176.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.579 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 2.1 mmp_? -141.15 127.66 20.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.692 -1.594 . . . . 8.3699999999999992 109.203 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -55.04 140.47 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 122.361 1.077 . . . . 5.7599999999999998 112.7 -172.873 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -118.53 -39.2 3.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.35 -1.75 . . . . 8.2200000000000006 109.18 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 13.7 p90 -170.15 -178.21 2.75 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.85 . . . . 7.9900000000000002 110.011 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.76 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-90 -120.83 146.97 45.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.726 . . . . 5.6100000000000003 109.665 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 149.97 37.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.784 0.326 . . . . 9.0600000000000005 110.18 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.798 ' HB3' HG22 ' A' ' 35' ' ' VAL . 29.3 t0 -83.75 132.12 49.91 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 108.783 -0.821 . . . . 8.3100000000000005 108.783 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.432 ' CD ' HD13 ' A' ' 54' ' ' ILE . 39.3 Cg_exo -56.05 -18.77 24.03 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.674 2.249 . . . . 10.41 112.461 172.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.493 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -90.14 -1.94 58.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.754 0.279 . . . . 10.85 111.754 175.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -131.91 39.65 0.52 Allowed Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.911 0.708 . . . . 9.3200000000000003 112.911 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 19.1 Cg_endo -51.21 110.85 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.976 2.451 . . . . 11.1 112.799 -171.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.2 -31.81 3.38 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.766 -0.652 . . . . 10.31 111.503 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.494 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 5.6 tp-100 -70.52 107.38 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 9.2100000000000009 111.04 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.604 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 23.5 mtm180 -86.88 97.69 10.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.259 -0.882 . . . . 11.51 110.68 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.4 m-85 -75.11 143.55 43.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.75 -0.659 . . . . 7.5 109.232 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.54 -29.14 70.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.551 -1.204 . . . . 10.609999999999999 111.072 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 21.1 pttm -164.17 164.03 14.69 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.476 -0.329 . . . . 10.91 111.737 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.5 Cg_endo -50.75 170.85 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.006 3.137 . . . . 7.5099999999999998 113.712 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.55 -162.99 26.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.739 -0.744 . . . . 7.5899999999999999 112.115 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 37.6 ttpt -94.28 149.23 21.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.126 0.489 . . . . 11.68 110.687 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 49' ' ' MET . 34.2 t -65.64 132.47 94.96 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 115.122 -0.945 . . . . 9.1999999999999993 110.986 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.54 -24.72 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.204 1.936 . . . . 10.25 111.706 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' A' ' 35' ' ' VAL . 78.1 m-85 -76.5 -37.13 57.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.99 -1.005 . . . . 10.49 110.098 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.3 pmm? -156.92 163.6 38.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.865 -0.607 . . . . 10.380000000000001 110.224 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.0 75.68 10.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 12.539999999999999 114.471 -167.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -142.59 145.38 34.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.057 -0.72 . . . . 9.8699999999999992 109.057 168.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.9 Cg_exo -66.6 133.91 33.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.947 1.764 . . . . 9.5099999999999998 111.219 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 32' ' ' ASP . 31.6 mt -62.67 159.03 16.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.004 0.431 . . . . 6.71 111.181 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 ' CD ' ' A' ' 33' ' ' PRO . 1.7 mp -95.69 135.4 23.03 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.952 -0.567 . . . . 7.8899999999999997 109.691 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.577 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . 64.5 Cg_endo -87.52 162.1 8.06 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.585 1.524 . . . . 5.7699999999999996 113.286 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG22 HG13 ' A' ' 27' ' ' ILE . 32.6 m -89.26 156.49 3.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.647 -1.16 . . . . 5.96 111.709 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.579 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.73 -80.88 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 126.971 2.108 . . . . 7.8399999999999999 115.685 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.1 pt-20 -53.04 -39.98 63.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.942 -0.392 . . . . 6.6200000000000001 109.942 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 57' ' ' TYR . 52.3 mt-10 62.73 95.25 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.192 -0.913 . . . . 8.5800000000000001 110.976 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.478 ' HG2' ' HA3' ' A' ' 64' ' ' GLY . 26.6 tt0 63.33 52.74 2.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.554 -1.657 . . . . 7.6399999999999997 111.986 159.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.556 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 20.2 t-20 -122.6 -35.37 3.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.664 -1.607 . . . . 7.0199999999999996 110.006 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -30.79 33.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 113.792 -1.549 . . . . 5.4100000000000001 111.368 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 8.6 p-10 -162.03 22.18 0.11 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.312 -0.858 . . . . 7.0099999999999998 110.757 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.478 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -89.72 -31.03 11.77 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.083 -0.962 . . . . 7.2000000000000002 111.375 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.19 -41.48 6.37 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.592 -0.804 . . . . 7.8200000000000003 110.37 -172.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.26 -24.21 22.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.703 -0.68 . . . . 8.6500000000000004 110.047 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 3.7 t 65.78 -39.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.149 -1.387 . . . . 7.3099999999999996 111.908 -169.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -57.74 136.36 56.89 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.735 -0.469 . . . . 10.210000000000001 109.735 165.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 70' ' ' ASP . 15.4 mt -67.49 159.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.1 0.476 . . . . 8.8599999999999994 110.349 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' N ' HG22 ' A' ' 69' ' ' ILE . 33.8 t70 -74.07 35.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.457 -0.792 . . . . 13.02 111.017 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 69.31 11.05 63.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.344 -0.455 . . . . 12.130000000000001 112.945 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HG3' HG12 ' A' ' 73' ' ' VAL . 13.9 ptm180 -100.43 177.88 4.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 119.218 -0.42 . . . . 12.380000000000001 110.3 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 72' ' ' ARG . 5.0 p 33.31 115.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 115.432 1.642 . . . . 11.609999999999999 115.432 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -71.34 59.89 0.29 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.265 -1.334 . . . . 10.710000000000001 111.792 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -91.24 67.74 5.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.807 0.813 . . . . 14.09 109.161 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -112.14 119.65 39.13 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.88 -1.054 . . . . 11.220000000000001 109.23 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.625 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.9 mm? -47.0 -37.6 9.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.595 -1.184 . . . . 13.710000000000001 111.85 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 126.26 42.01 0.31 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.111 -1.596 . . . . 11.44 109.111 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 92.7 t 78.19 121.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 113.964 -1.118 . . . . 9.9900000000000002 110.659 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.38 124.2 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.202 -0.666 . . . . 11.640000000000001 109.202 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 148' ' ' VAL . 60.2 p -130.0 154.82 47.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.269 -0.423 . . . . 8.0 109.879 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 134.33 54.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 6.6500000000000004 109.231 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 32.8 tt0 -83.65 136.97 34.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.314 -0.624 . . . . 12.15 109.314 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 95' ' ' LEU . 71.8 t -60.51 129.01 22.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 9.7100000000000009 111.881 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 26.5 mmtp -129.51 151.0 50.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.64 -1.164 . . . . 11.029999999999999 109.622 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -84.98 162.37 19.41 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.728 -0.389 . . . . 12.76 109.967 169.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.05 46.86 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.273 0 C-N-CA 120.705 -0.76 . . . . 13.25 112.837 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.599 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -84.23 -178.62 6.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.872 0.368 . . . . 16.350000000000001 111.696 -177.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.26 124.08 28.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.731 -0.668 . . . . 18.219999999999999 109.419 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.5 -159.47 14.5 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 115.222 -0.899 . . . . 17.91 111.59 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -86.31 76.71 9.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.949 0.881 . . . . 17.109999999999999 109.087 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.599 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 2.5 m -153.87 168.28 26.88 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.559 -1.201 . . . . 14.73 108.841 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HG2' HD23 ' A' ' 86' ' ' LEU . 3.8 mt-10 -142.05 113.71 7.87 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.921 0.391 . . . . 14.94 109.981 163.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.506 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 3.1 tpp180 -122.64 159.94 26.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 10.57 110.358 -175.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -100.72 124.12 45.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.485 -0.561 . . . . 8.8800000000000008 109.485 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.65 130.36 45.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.22 -0.445 . . . . 9.7799999999999994 110.405 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.31 155.19 57.84 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.352 -0.84 . . . . 6.4000000000000004 109.734 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.05 127.45 25.03 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.053 1.836 . . . . 6.5499999999999998 111.124 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.489 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.5 p -54.26 -31.86 54.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.074 0.464 . . . . 9.2899999999999991 112.227 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.88 -17.38 64.61 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.742 -0.663 . . . . 10.859999999999999 112.405 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -83.8 -7.29 59.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 5.3399999999999999 111.31 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.539 HD21 HD11 ' A' ' 137' ' ' ILE . 26.5 mt -86.18 118.27 25.53 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.773 0.797 . . . . 6.9699999999999998 112.093 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -89.54 111.32 22.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.409 -1.269 . . . . 10.199999999999999 108.817 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.59 125.42 34.34 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.345 -0.542 . . . . 12.119999999999999 110.45 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -148.81 141.47 24.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.966 -0.561 . . . . 14.609999999999999 109.875 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.64 -117.74 6.21 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 121.266 -0.492 . . . . 15.52 112.313 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.0 37.1 4.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.166 0.508 . . . . 14.99 111.342 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -148.28 174.65 11.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.986 -0.552 . . . . 15.199999999999999 111.081 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 m -121.36 149.84 42.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.267 -0.642 . . . . 9.2599999999999998 109.267 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.8 mm -128.4 148.27 32.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.645 -0.502 . . . . 10.550000000000001 109.645 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.625 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -121.41 126.42 49.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.496 -0.32 . . . . 7.3899999999999997 110.205 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.442 ' HB2' HG22 ' A' ' 148' ' ' VAL . 59.4 mtp -82.27 99.68 9.46 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.416 -0.587 . . . . 8.8499999999999996 109.416 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.4 p -83.04 130.66 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.291 -0.868 . . . . 9.6899999999999995 111.288 -174.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.83 89.27 7.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.546 -0.752 . . . . 10.699999999999999 109.454 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.22 157.76 35.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.73 -0.668 . . . . 14.880000000000001 111.647 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.86 17.49 21.29 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.418 -0.81 . . . . 16.920000000000002 111.501 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -103.6 8.73 37.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.354 0.597 . . . . 18.559999999999999 110.337 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.36 9.09 70.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.184 -0.917 . . . . 15.619999999999999 113.481 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.81 170.51 23.97 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.2 -1.0 . . . . 14.19 113.038 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.4 m-85 -121.46 123.7 42.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.869 -0.419 . . . . 12.029999999999999 109.869 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.544 ' O ' HG12 ' A' ' 113' ' ' VAL . 26.1 m-20 -123.51 151.05 62.66 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.791 -0.364 . . . . 13.91 111.404 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.15 122.69 2.2 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.048 1.832 . . . . 12.35 112.31 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 8.1 p -108.28 132.76 55.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.32 -0.855 . . . . 9.4299999999999997 109.784 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.6 tt0 -72.96 119.91 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.818 -0.438 . . . . 12.93 109.818 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.533 HG13 HG13 ' A' ' 123' ' ' VAL . 31.3 m -127.91 159.28 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 8.0299999999999994 111.584 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' HD22 ' A' ' 138' ' ' LEU . 39.8 ttmt -104.46 128.88 52.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.319 -0.855 . . . . 10.390000000000001 109.32 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.96 106.73 5.12 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 111.82 0.304 . . . . 8.3000000000000007 111.82 -174.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.18 70.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 117.983 -2.056 . . . . 10.1 114.82 165.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.15 163.44 38.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.446 -1.316 . . . . 10.609999999999999 107.446 150.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -140.65 128.83 22.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.7 0.682 . . . . 13.17 110.375 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.86 117.3 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.136 0.421 . . . . 12.98 112.136 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 39.76 98.35 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 115.948 -0.569 . . . . 14.34 113.344 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.84 82.29 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.724 -0.75 . . . . 13.119999999999999 112.471 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -122.26 163.02 20.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.56 -0.904 . . . . 10.619999999999999 108.56 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.0 p -114.46 149.74 35.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.307 -0.557 . . . . 7.8200000000000003 112.035 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.2 mp0 -93.43 119.17 32.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.46 -0.791 . . . . 10.789999999999999 111.513 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.539 HD11 HD21 ' A' ' 102' ' ' LEU . 16.2 mm -91.5 111.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.295 -0.866 . . . . 6.7300000000000004 109.333 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -75.02 -51.59 13.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.63 -1.168 . . . . 8.7899999999999991 109.487 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -143.05 169.03 18.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.067 -0.97 . . . . 10.44 110.893 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 117.38 -71.73 0.29 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.528 -0.844 . . . . 8.8699999999999992 113.374 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 42.8 tp -108.56 172.41 6.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.778 0.289 . . . . 8.5 110.666 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.482 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 88.0 tttt -122.56 154.62 37.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.812 0.815 . . . . 14.15 111.656 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -66.25 135.13 54.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 113.979 -1.464 . . . . 12.119999999999999 109.834 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.48 -2.8 56.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.354 -0.927 . . . . 11.539999999999999 111.439 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -103.51 152.65 21.44 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.849 -0.797 . . . . 11.24 108.849 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 99.2 mt-30 -104.04 149.88 24.78 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.078 0.466 . . . . 10.49 111.203 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.9 m -135.73 146.66 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.644 -0.707 . . . . 5.4500000000000002 109.286 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 112' ' ' MET . 27.7 m -72.88 128.13 35.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.352 0.596 . . . . 6.5599999999999996 110.824 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.7 m -132.5 13.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.697 -0.683 . . . . 6.9900000000000002 110.702 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.4 m -36.12 106.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.267 0.979 . . . . 9.0600000000000005 112.593 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.08 -73.94 0.32 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.321 -0.854 . . . . 8.5 111.291 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 38.57 56.75 1.83 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.179 0.992 . . . . 11.84 112.217 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.495 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 32.8 p90 -117.64 134.63 54.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.199 0.523 . . . . 12.24 111.115 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 158' ' ' GLU . 94.5 mt -87.22 -165.3 1.26 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.558 -0.746 . . . . 13.16 110.773 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 157' ' ' SER . 36.2 pt -78.46 -161.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 11.949999999999999 111.436 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -55.63 -23.79 29.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.307 0.484 . . . . 11.220000000000001 112.307 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.44 ' H ' HG13 ' A' ' 155' ' ' ILE . 15.8 m -54.71 -48.49 72.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.024 0.44 . . . . 11.9 110.669 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 153' ' ' PHE . 20.1 tt0 -61.17 -29.8 70.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.369 -0.832 . . . . 11.17 110.296 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.06 -25.73 31.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.954 -0.566 . . . . 7.8200000000000003 112.028 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.0 t -75.91 -30.18 58.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.196 -0.668 . . . . 9.6400000000000006 109.196 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 162' ' ' ARG . 3.5 pp -88.3 -30.19 19.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.719 -0.673 . . . . 10.57 112.407 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 161' ' ' LEU . 25.3 ptt180 -80.73 132.78 35.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 8.9000000000000004 110.637 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.86 74.02 0.21 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.729 -0.748 . . . . 7.1500000000000004 111.815 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.7 p 47.15 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.556 0.742 . . . . 7.0899999999999999 111.787 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.4 t 64.48 82.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.419 -0.585 . . . . 9.1999999999999993 109.419 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.76 135.66 57.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.329 -0.851 . . . . 9.1099999999999994 110.994 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.597 ' HD2' ' O ' ' A' ' 167' ' ' ARG . 3.2 ppt_? -71.26 -8.99 57.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.808 -0.633 . . . . 14.58 110.887 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.0 mtm -99.09 132.05 44.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.576 -0.738 . . . . 11.94 109.518 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -86.4 -136.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 14.99 110.346 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -80.93 47.94 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 15.01 111.47 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.5 p -91.43 40.9 1.05 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.429 0.633 . . . . 14.25 110.078 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.8 t -114.49 -179.38 3.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.236 -0.893 . . . . 14.890000000000001 109.939 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t 68.41 80.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.736 0.648 . . . . 15.85 111.099 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.12 -15.26 65.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.44 -0.886 . . . . 17.539999999999999 111.066 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.5 tp 68.03 79.85 0.21 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.373 0.669 . . . . 17.850000000000001 110.615 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -95.51 -162.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 19.670000000000002 110.062 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.78 -24.46 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.207 0.527 . . . . 19.52 109.966 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 72.2 mt 66.37 -84.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.01 -0.995 . . . . 21.149999999999999 111.26 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -171.75 75.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.457 . . . . 23.25 110.225 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 116.197 -0.456 . . . . 23.52 110.115 176.849 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.729 0.299 . . . . 34.32 110.781 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.27 -91.33 0.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.702 -0.761 . . . . 33.090000000000003 111.531 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p 47.32 -95.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.996 0.918 . . . . 34.119999999999997 112.01 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 7' ' ' ASN . . . -165.51 150.2 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.357 -0.383 . . . . 32.32 110.109 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 p -108.29 -34.29 6.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.965 -0.561 . . . . 32.740000000000002 110.696 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 28.71 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.116 -0.493 . . . . 31.289999999999999 111.61 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.443 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 3.3 m-20 -124.56 -70.17 0.77 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.12 0.486 . . . . 29.460000000000001 110.983 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.24 -175.77 22.1 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.292 -0.723 . . . . 28.280000000000001 111.292 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.52 -72.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.885 2.39 . . . . 27.510000000000002 111.635 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -171.25 137.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.102 -0.703 . . . . 26.48 109.102 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.23 -164.85 1.24 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.88 0.371 . . . . 24.899999999999999 110.692 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.71 174.31 42.73 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.372 -0.691 . . . . 23.190000000000001 111.372 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -125.07 10.67 8.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.459 0.647 . . . . 21.309999999999999 109.854 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.2 78.63 74.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 19.890000000000001 110.711 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -177.62 3.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.446 2.097 . . . . 18.120000000000001 111.92 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.85 48.17 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 16.579999999999998 110.148 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.24 123.36 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 14.800000000000001 110.716 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.72 32.1 4.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 13.17 112.918 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . -128.14 1.4 5.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.585 0.707 . . . . 12.17 110.131 177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 26.5 tt0 -77.24 73.07 3.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.04 . . . . 13.82 108.956 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 19.6 mt 77.89 -22.47 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.568 -1.197 . . . . 12.130000000000001 111.391 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.81 60.64 2.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.185 0.517 . . . . 14.1 110.355 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.5 m 67.94 82.96 0.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 11.050000000000001 109.848 -174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 19' ' ' ALA . . . -170.76 -50.72 0.04 OUTLIER Glycine 0 CA--C 1.497 -1.072 0 CA-C-N 115.572 -0.74 . . . . 10.050000000000001 111.71 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 5.0 ptmm? -138.33 68.51 1.39 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 122.152 0.977 . . . . 10.380000000000001 109.958 -172.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.522 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 45.1 mtm180 -134.65 140.34 45.95 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.927 -1.488 . . . . 8.3699999999999992 109.217 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.767 HG21 ' CZ3' ' A' ' 30' ' ' TRP . 22.7 mm -54.85 129.73 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 122.455 1.121 . . . . 5.7599999999999998 113.701 -167.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.86 HD13 ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -89.87 -29.49 18.54 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 112.355 -2.202 . . . . 8.2200000000000006 111.376 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CD1' HD13 ' A' ' 28' ' ' LEU . 46.3 p90 158.0 -172.9 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.055 1.342 . . . . 7.9900000000000002 107.597 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.767 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.3 m-90 -116.95 142.69 46.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.744 0.307 . . . . 5.6100000000000003 110.835 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -148.28 154.62 40.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 9.0600000000000005 110.476 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.667 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -92.41 137.11 24.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.556 -0.905 . . . . 8.3100000000000005 108.556 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.65 -13.63 35.04 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.313 2.008 . . . . 10.41 112.191 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -99.72 2.31 44.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.59 -0.277 . . . . 10.85 111.206 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.8 m -128.86 40.89 0.65 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.396 0.517 . . . . 9.3200000000000003 112.396 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 14.5 Cg_endo -52.3 113.38 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.916 2.411 . . . . 11.1 112.809 -172.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.3 -35.87 2.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.46 -0.656 . . . . 10.31 111.46 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -64.2 103.09 0.58 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.641 0.734 . . . . 9.2100000000000009 110.856 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.784 ' NH1' ' HA ' ' A' ' 41' ' ' ASP . 2.1 tmm_? -81.96 103.49 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.015 -0.993 . . . . 11.51 109.702 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -87.91 133.59 33.89 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.297 -1.001 . . . . 7.5 108.297 173.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 17.8 t70 -63.89 -35.05 79.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.924 -1.035 . . . . 10.609999999999999 110.518 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.2 mttp -148.37 162.33 30.73 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.955 -0.566 . . . . 10.91 110.721 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.5 Cg_endo -50.21 171.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.01 3.14 . . . . 7.5099999999999998 113.857 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.54 -165.91 27.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 7.5899999999999999 112.491 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 7.7 ttmt -91.33 144.24 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.237 -0.653 . . . . 11.68 109.237 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 49' ' ' MET . 10.6 t -70.76 145.78 92.57 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.43 . . . . 9.1999999999999993 110.863 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.52 -20.85 7.83 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.765 2.31 . . . . 10.25 111.547 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.774 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 96.4 m-85 -84.6 -39.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.426 -1.261 . . . . 10.49 109.842 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.774 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -136.66 151.92 49.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.663 -0.698 . . . . 10.380000000000001 110.522 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.5 p-10 -79.23 53.14 1.43 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.864 0.84 . . . . 12.539999999999999 111.418 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG2' ' HB2' ' A' ' 49' ' ' MET . 16.4 ptm -127.02 146.59 58.27 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.418 -0.81 . . . . 9.8699999999999992 109.682 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' MET . 8.2 Cg_exo -69.58 133.5 26.04 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.143 1.896 . . . . 9.5099999999999998 110.286 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.69 156.68 13.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.397 0.436 . . . . 6.71 110.592 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.65 131.16 27.51 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 121.205 0.526 . . . . 7.8899999999999997 110.311 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 59' ' ' GLU . 96.7 Cg_endo -85.09 156.5 11.27 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.117 1.878 . . . . 5.7699999999999996 113.158 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 28' ' ' LEU . 27.2 m -86.73 160.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.555 -1.202 . . . . 5.96 111.136 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.522 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 5.84 -71.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.392 2.277 . . . . 7.8399999999999999 116.478 -176.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.682 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.8 pt-20 -65.47 -39.22 91.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.125 0.964 . . . . 6.6200000000000001 110.726 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.592 ' HA ' HD11 ' A' ' 27' ' ' ILE . 9.9 pt-20 39.25 42.96 0.84 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 112.473 -2.148 . . . . 8.5800000000000001 114.02 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 5.0 mt-10 177.8 59.5 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.427 -1.261 . . . . 7.6399999999999997 112.251 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.468 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 36.0 t-20 -170.91 -86.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.591 -0.732 . . . . 7.0199999999999996 111.826 167.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.646 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . . . 47.48 83.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.152 0.977 . . . . 5.4100000000000001 112.268 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.591 ' HA ' ' HB ' ' A' ' 67' ' ' VAL . 1.1 m-20 49.64 44.19 24.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.588 -2.096 . . . . 7.0099999999999998 111.393 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -54.93 -56.15 24.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.399 -0.819 . . . . 7.2000000000000002 113.056 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 66' ' ' ALA . . . -171.55 -0.62 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.027 0.441 . . . . 7.8200000000000003 110.904 -176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 65' ' ' ALA . . . -128.73 -49.37 1.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.32 -0.622 . . . . 8.6500000000000004 109.32 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 1.8 t -65.43 -27.16 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.362 -0.835 . . . . 7.3099999999999996 108.766 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 24.9 ttt180 -46.4 112.22 0.47 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.291 -1.322 . . . . 10.210000000000001 112.502 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' A' ' 72' ' ' ARG . 10.1 mt -98.63 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.235 -1.348 . . . . 8.8599999999999994 110.18 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.05 57.34 4.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.976 0.893 . . . . 13.02 110.492 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 73' ' ' VAL . . . 49.11 46.7 33.65 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 113.668 -1.606 . . . . 12.130000000000001 113.038 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HG2' HG21 ' A' ' 69' ' ' ILE . 26.7 ptt180 -59.35 123.7 17.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.665 -0.494 . . . . 12.380000000000001 109.665 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 161' ' ' LEU . 51.6 t -117.92 130.19 73.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.904 -0.589 . . . . 11.609999999999999 110.464 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 t -95.38 48.5 1.16 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.201 -0.908 . . . . 10.710000000000001 110.679 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 53.5 79.87 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.694 -1.139 . . . . 14.09 112.153 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -140.95 122.77 15.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.546 -0.297 . . . . 11.220000000000001 110.951 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.42 -47.32 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.762 -0.829 . . . . 13.710000000000001 108.762 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 150' ' ' SER . . . 179.66 -43.13 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.313 -1.515 . . . . 11.44 109.313 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 150' ' ' SER . 39.9 t 66.47 163.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.644 -0.778 . . . . 9.9900000000000002 111.337 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 149' ' ' VAL . 18.1 tpt180 -102.72 172.04 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.802 0.811 . . . . 11.640000000000001 112.762 -171.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 148' ' ' VAL . 19.8 p -106.8 139.3 41.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.772 -1.104 . . . . 8.0 108.052 170.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 147' ' ' VAL . . . -107.69 127.85 54.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.607 -0.516 . . . . 6.6500000000000004 109.607 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 43.5 tt0 -82.25 140.48 33.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.069 0.461 . . . . 12.15 110.696 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.715 HG11 HD23 ' A' ' 95' ' ' LEU . 79.7 t -62.92 130.67 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.325 -0.852 . . . . 9.7100000000000009 112.026 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 27.5 mmtp -137.23 153.45 50.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.465 -1.243 . . . . 11.029999999999999 109.266 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 93' ' ' GLU . 9.7 mp -83.73 152.02 24.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.758 -0.46 . . . . 12.76 109.758 168.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.79 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 111.47 -0.652 . . . . 13.25 111.47 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.831 ' HG3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -64.04 -178.09 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.201 0.815 . . . . 16.350000000000001 113.201 -174.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.9 tp -139.58 112.45 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 18.219999999999999 109.549 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.88 -148.4 18.91 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 111.286 -0.726 . . . . 17.91 111.286 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -101.14 75.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.92 0.867 . . . . 17.109999999999999 109.322 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.831 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 1.7 m -155.42 168.31 27.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.457 -1.247 . . . . 14.73 107.865 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HG2' HD23 ' A' ' 86' ' ' LEU . 1.9 mp0 -139.24 121.86 16.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.414 0.626 . . . . 14.94 110.98 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 41.1 mmt180 -131.11 156.09 45.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.972 -1.013 . . . . 10.57 110.778 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.715 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -87.32 114.88 24.33 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.987 -1.006 . . . . 8.8800000000000008 110.465 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.65 130.69 35.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.693 0.282 . . . . 9.7799999999999994 110.826 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.96 152.94 56.44 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.431 -0.804 . . . . 6.4000000000000004 109.856 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 149' ' ' VAL . 41.8 Cg_exo -56.3 122.64 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.094 1.863 . . . . 6.5499999999999998 110.35 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.4 p -62.7 -22.81 66.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 9.2899999999999991 112.845 -164.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.19 -4.88 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 119.754 -0.165 . . . . 10.859999999999999 111.177 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -40.93 68.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 5.3399999999999999 110.452 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 104' ' ' ARG . 3.2 pp -78.73 160.3 27.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.229 -0.896 . . . . 6.9699999999999998 111.424 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 mm -117.11 103.72 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.282 -0.417 . . . . 10.199999999999999 110.595 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -113.76 95.18 5.2 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.543 -1.263 . . . . 12.119999999999999 111.888 174.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 t -103.79 136.62 43.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.843 -1.526 . . . . 14.609999999999999 109.212 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.14 -113.13 4.18 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.343 -0.932 . . . . 15.52 112.018 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.8 28.16 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.268 0.84 . . . . 14.99 113.268 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -170.08 171.0 7.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.374 0.509 . . . . 15.199999999999999 112.374 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 1.8 m -121.89 155.3 35.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 9.2599999999999998 111.767 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 36.5 mm -129.29 150.18 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.362 -0.836 . . . . 10.550000000000001 109.467 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -134.19 127.14 31.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.297 -0.26 . . . . 7.3899999999999997 110.297 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 148' ' ' VAL . 4.1 mpp? -93.55 99.82 12.2 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.197 -0.668 . . . . 8.8499999999999996 109.197 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.7 p -77.33 139.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.06 -0.973 . . . . 9.6899999999999995 110.403 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -78.58 92.58 4.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.076 -0.511 . . . . 10.699999999999999 111.525 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 50.5 mttm -76.25 178.69 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 14.880000000000001 110.896 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.93 25.78 7.79 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.765 -0.934 . . . . 16.920000000000002 110.765 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.16 12.9 33.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.968 0.358 . . . . 18.559999999999999 111.968 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.16 16.76 36.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 15.619999999999999 113.159 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 115' ' ' LYS . . . 179.47 173.69 44.85 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.881 -0.888 . . . . 14.19 110.881 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 148' ' ' VAL . 54.3 m-85 -87.54 -176.54 5.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.991 0.424 . . . . 12.029999999999999 110.626 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 11.5 t70 -140.89 120.04 8.36 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.742 -0.663 . . . . 13.91 109.368 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.0 110.55 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.166 2.578 . . . . 12.35 112.537 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 125' ' ' VAL . 13.9 p -104.91 140.45 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.121 -0.945 . . . . 9.4299999999999997 109.915 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.87 112.03 18.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 12.93 109.726 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 123' ' ' VAL . 23.2 m -117.03 163.31 14.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.662 -0.699 . . . . 8.0299999999999994 111.23 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -100.68 133.85 44.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.582 -0.735 . . . . 10.390000000000001 109.219 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.56 103.14 4.48 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.964 -0.295 . . . . 8.3000000000000007 111.43 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -152.88 69.89 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.142 -1.98 . . . . 10.1 113.633 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.37 163.85 37.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.49 -1.3 . . . . 10.609999999999999 107.49 154.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -143.61 130.41 20.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.787 0.722 . . . . 13.17 111.036 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.12 120.87 9.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 12.98 110.616 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.23 36.11 92.98 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.316 -0.469 . . . . 14.34 112.91 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 12.45 83.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.858 -0.687 . . . . 13.119999999999999 112.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -120.87 158.97 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.006 -0.368 . . . . 10.619999999999999 110.006 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 157.91 16.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.867 0.365 . . . . 7.8200000000000003 110.045 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.992 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 32.0 mt-10 -106.78 115.33 30.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.474 0.654 . . . . 10.789999999999999 109.821 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.7 mm -81.67 104.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.974 -1.012 . . . . 6.7300000000000004 109.154 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 3.0 mp -69.57 -44.97 69.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.607 -1.179 . . . . 8.7899999999999991 110.562 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.59 158.13 44.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.779 -0.646 . . . . 10.44 111.327 -175.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.85 -53.31 0.64 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.287 -0.959 . . . . 8.8699999999999992 114.529 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.436 HD21 HG11 ' A' ' 123' ' ' VAL . 18.0 mt -107.51 -170.9 1.77 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.434 0.531 . . . . 8.5 112.434 -174.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.96 150.94 37.83 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.683 -0.689 . . . . 14.15 111.001 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.57 133.54 49.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.718 -1.128 . . . . 12.119999999999999 109.9 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.46 -2.3 53.65 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.244 -0.979 . . . . 11.539999999999999 111.575 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -104.05 143.57 32.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.254 -0.647 . . . . 11.24 109.254 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 82.9 mt-30 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.022 0.439 . . . . 10.49 111.593 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' ALA . 30.0 m -132.18 142.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 5.4500000000000002 108.704 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.9 p -76.7 104.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.755 0.788 . . . . 6.5599999999999996 110.956 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -92.92 -15.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.148 -1.056 . . . . 6.9900000000000002 108.148 177.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.491 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 1.2 m -57.46 163.26 2.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.333 -1.303 . . . . 9.0600000000000005 111.427 162.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 160' ' ' SER . . . -81.51 63.64 4.32 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.938 -0.865 . . . . 8.5 110.938 170.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 66.83 89.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.043 0.537 . . . . 11.84 110.582 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -152.18 91.18 1.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.533 0.568 . . . . 12.24 112.533 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.9 tp -115.78 -62.12 1.64 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.017 -1.105 . . . . 13.16 108.017 164.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.93 6.0 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.399 -1.334 . . . . 11.949999999999999 107.399 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.5 m-20 -83.44 35.65 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.71 -2.041 . . . . 11.220000000000001 111.537 -171.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -49.01 -49.08 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.364 0.875 . . . . 11.9 113.364 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -73.72 -26.4 60.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 11.17 110.002 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 156' ' ' ASP . . . -75.95 -20.96 57.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.173 -0.921 . . . . 7.8200000000000003 111.432 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 151' ' ' GLY . 9.2 m -69.22 -29.94 67.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.0 0.905 . . . . 9.6400000000000006 109.244 172.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.534 ' HA ' HG13 ' A' ' 73' ' ' VAL . 11.4 mt -87.23 -43.09 12.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.153 -1.385 . . . . 10.57 109.374 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 23.5 ttt180 -51.85 128.35 23.67 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.006 1.323 . . . . 8.9000000000000004 112.891 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -117.85 31.16 5.81 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.43 -1.068 . . . . 7.1500000000000004 110.43 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.6 p -70.71 126.27 29.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 123.924 0.426 . . . . 7.0899999999999999 111.54 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 26' ' ' ARG . 48.2 t 54.21 82.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 9.1999999999999993 111.332 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.96 123.62 26.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.81 -0.632 . . . . 9.1099999999999994 110.456 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 167' ' ' ARG . 3.2 tmt_? -62.82 -40.04 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.22 -0.9 . . . . 14.58 108.893 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.63 159.84 41.09 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.173 -1.376 . . . . 11.94 110.726 -176.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -81.22 83.21 6.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.878 -0.416 . . . . 14.99 109.878 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 45.84 85.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.922 0.764 . . . . 15.01 112.259 170.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.5 p -79.42 -10.35 59.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.329 0.492 . . . . 14.25 112.329 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.6 t -89.07 147.16 24.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.423 0.63 . . . . 14.890000000000001 111.189 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.7 p -167.19 13.29 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.811 -1.086 . . . . 15.85 111.721 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.77 -36.18 53.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 17.539999999999999 111.885 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.2 tp -100.53 129.92 46.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.413 -0.588 . . . . 17.850000000000001 109.413 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.81 -174.74 5.09 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.161 -0.215 . . . . 19.670000000000002 111.0 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.79 -57.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.489 -0.559 . . . . 19.52 109.489 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.6 tp 63.21 83.4 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.436 -0.802 . . . . 21.149999999999999 110.433 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -74.98 151.54 38.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.426 -0.806 . . . . 23.25 110.563 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.547 -0.739 . . . . 23.52 109.642 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.879 0.371 . . . . 34.32 110.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.65 49.12 3.82 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.205 -0.521 . . . . 33.090000000000003 113.031 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t -151.11 21.86 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.07 -0.715 . . . . 34.119999999999997 109.07 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.94 89.43 2.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.745 -0.662 . . . . 32.32 111.517 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.7 p 51.02 35.28 12.4 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.234 0.827 . . . . 32.740000000000002 113.234 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t 61.99 92.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.13 0.491 . . . . 31.289999999999999 110.998 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -88.28 -9.94 51.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.075 0.464 . . . . 29.460000000000001 110.241 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.95 -164.46 26.44 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.125 -0.79 . . . . 28.280000000000001 111.125 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.15 2.27 5.74 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.892 2.395 . . . . 27.510000000000002 112.892 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 74.72 130.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.293 -0.867 . . . . 26.48 111.512 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.72 173.52 15.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.123 -0.944 . . . . 24.899999999999999 108.605 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.43 59.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.808 -1.187 . . . . 23.190000000000001 113.301 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -103.84 57.07 0.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.082 -0.71 . . . . 21.309999999999999 109.082 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.503 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 26.5 t70 -73.01 -48.49 7.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 119.077 -0.487 . . . . 19.890000000000001 112.185 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 17.8 Cg_endo -60.23 101.55 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.316 1.344 . . . . 18.120000000000001 111.897 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.48 91.54 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.577 . . . . 16.579999999999998 110.899 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' H ' ' HB2' ' A' ' 21' ' ' LEU . . . -82.91 56.93 3.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 14.800000000000001 109.836 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -86.9 0.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.756 -0.937 . . . . 13.17 110.756 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.28 -18.15 4.12 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.11 -0.545 . . . . 12.17 110.464 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -84.78 61.0 6.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.984 0.897 . . . . 13.82 110.196 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.522 ' HB2' ' H ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -158.33 -66.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.457 -1.247 . . . . 12.130000000000001 108.51 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -83.18 56.3 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.904 0.859 . . . . 14.1 109.712 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 t 40.53 51.65 2.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.143 -1.844 . . . . 11.050000000000001 113.018 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.91 42.66 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 110.618 -0.993 . . . . 10.050000000000001 110.618 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -166.0 57.75 0.1 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.159 0.981 . . . . 10.380000000000001 109.725 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.564 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 29.7 mtm180 -132.47 135.35 45.98 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.276 -1.329 . . . . 8.3699999999999992 109.045 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG12 ' OE1' ' A' ' 58' ' ' GLU . 34.7 mm -48.22 126.44 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 113.426 0.899 . . . . 5.7599999999999998 113.426 -171.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.63 -34.73 5.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.824 -1.534 . . . . 8.2200000000000006 109.821 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.691 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.5 p90 -168.92 -175.17 2.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.253 -0.43 . . . . 7.9900000000000002 111.007 -174.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.43 153.68 43.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.707 -0.679 . . . . 5.6100000000000003 111.666 -172.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB2' HE22 ' A' ' 38' ' ' GLN . 39.0 ptt180 -157.48 146.06 19.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.851 -0.613 . . . . 9.0600000000000005 110.435 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.903 ' HB3' HG22 ' A' ' 35' ' ' VAL . 7.6 t0 -83.03 134.5 46.28 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 8.3100000000000005 108.777 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.84 -22.53 62.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.233 2.622 . . . . 10.41 111.824 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.561 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -75.81 -22.22 56.56 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.895 -1.048 . . . . 10.85 110.647 178.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.3 m -128.3 50.33 5.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 121.529 0.681 . . . . 9.3200000000000003 111.813 -166.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.78 119.59 6.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.187 2.591 . . . . 11.1 112.057 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.17 -30.53 4.08 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.414 -0.674 . . . . 10.31 111.414 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.642 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -70.55 136.43 49.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 9.2100000000000009 109.797 174.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.86 98.97 5.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.122 -0.49 . . . . 11.51 110.749 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.691 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 m-85 -80.07 135.65 36.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.589 . . . . 7.5 111.017 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.98 -25.39 67.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.347 -0.842 . . . . 10.609999999999999 110.379 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -165.23 147.5 6.64 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-O 121.321 0.582 . . . . 10.91 110.531 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -51.61 128.92 27.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 125.139 3.893 . . . . 7.5099999999999998 113.962 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.53 -161.71 11.49 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.232 -0.747 . . . . 7.5899999999999999 111.232 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 25.8 ttpp -90.46 150.53 21.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.167 0.508 . . . . 11.68 109.979 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.8 t -65.82 135.13 95.34 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.211 -0.904 . . . . 9.1999999999999993 110.138 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.83 -25.71 11.96 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.192 1.928 . . . . 10.25 111.626 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CD2' HG11 ' A' ' 35' ' ' VAL . 98.1 m-85 -77.53 -38.08 49.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.872 -1.058 . . . . 10.49 109.995 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -153.09 164.8 37.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.089 -0.505 . . . . 10.380000000000001 110.736 172.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 5.4 p-10 -82.69 76.69 9.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.748 1.018 . . . . 12.539999999999999 113.748 -170.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.1 ptm -143.14 141.02 18.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.757 -1.11 . . . . 9.8699999999999992 108.036 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 17.8 Cg_endo -62.11 133.58 44.76 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.24 1.293 . . . . 9.5099999999999998 109.512 172.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.0 mt -59.49 160.11 7.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.204 -0.453 . . . . 6.71 111.419 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.6 mm -95.67 132.58 27.1 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 7.8899999999999997 109.657 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 90.6 Cg_endo -79.22 141.82 16.51 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 121.468 1.445 . . . . 5.7699999999999996 112.797 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.04 158.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.585 -1.189 . . . . 5.96 113.326 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 21.85 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.948 2.099 . . . . 7.8399999999999999 115.475 -177.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.592 ' OE1' HG12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -51.14 -37.75 48.0 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.776 1.274 . . . . 6.6200000000000001 110.16 -176.525 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 59.35 40.29 21.27 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 111.835 -2.438 . . . . 8.5800000000000001 110.589 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' OE2' ' HA2' ' A' ' 64' ' ' GLY . 13.5 tt0 -161.85 49.41 0.2 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.175 -1.375 . . . . 7.6399999999999997 112.091 -172.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 71.12 -53.29 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.104 -2.316 . . . . 7.0199999999999996 114.575 162.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -166.11 -41.79 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.075 -0.512 . . . . 5.4100000000000001 111.902 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.619 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 4.9 t70 173.45 74.1 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.986 0.804 . . . . 7.0099999999999998 109.611 -169.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.468 ' HA2' ' OE2' ' A' ' 60' ' ' GLU . . . 90.46 -17.73 52.85 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 115.438 -0.801 . . . . 7.2000000000000002 112.132 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 72.66 -6.87 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.985 0.735 . . . . 7.8200000000000003 112.985 172.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 164' ' ' THR . . . -112.62 -39.41 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.744 -0.382 . . . . 8.6500000000000004 111.539 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 68' ' ' ARG . 15.0 p -102.66 -47.84 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.218 0.532 . . . . 7.3099999999999996 110.4 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 3.7 ptp180 49.04 -177.01 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.839 -1.528 . . . . 10.210000000000001 113.644 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' ' 71' ' ' GLY . 5.4 mt -73.16 155.61 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.624 -0.716 . . . . 8.8599999999999994 110.728 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.72 -43.87 52.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 13.02 109.065 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.616 ' H ' HG22 ' A' ' 69' ' ' ILE . . . -59.53 -38.51 93.71 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 113.96 -1.473 . . . . 12.130000000000001 113.231 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -84.57 109.59 18.07 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.593 0.711 . . . . 12.380000000000001 109.827 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 75' ' ' GLN . 67.3 t -103.09 140.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.842 -1.072 . . . . 11.609999999999999 111.019 -172.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -143.64 30.9 1.33 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.17 0.986 . . . . 10.710000000000001 109.68 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.411 ' H ' HG12 ' A' ' 73' ' ' VAL . 3.5 tp-100 -112.69 86.91 2.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.328 -1.306 . . . . 14.09 109.168 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 151' ' ' GLY . 1.6 p-10 -70.99 95.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.2 1.0 . . . . 11.220000000000001 111.551 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.8 -12.24 22.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.632 -1.167 . . . . 13.710000000000001 109.436 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 164.64 40.16 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.311 -1.116 . . . . 11.44 110.311 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.492 HG11 ' CZ ' ' A' ' 120' ' ' PHE . 93.7 t 63.79 108.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.63 -0.785 . . . . 9.9900000000000002 111.221 -173.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 29.6 tpt180 -84.33 130.64 34.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 11.640000000000001 109.72 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 148' ' ' VAL . 67.2 p -133.09 144.96 50.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.292 -0.867 . . . . 8.0 109.777 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.27 127.26 55.79 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.837 -0.801 . . . . 6.6500000000000004 108.837 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.89 135.47 37.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.947 -0.39 . . . . 12.15 109.947 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 95' ' ' LEU . 75.8 t -59.89 128.84 21.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.713 -0.676 . . . . 9.7100000000000009 112.416 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -135.24 148.41 49.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.501 -1.227 . . . . 11.029999999999999 109.005 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -78.9 147.73 32.97 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.965 -0.694 . . . . 12.76 109.453 169.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -170.27 51.54 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.361 -0.923 . . . . 13.25 112.811 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.505 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 23.0 ptt180 -67.24 144.11 56.12 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.698 -0.295 . . . . 16.350000000000001 110.611 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 86.92 1.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.041 -0.726 . . . . 18.219999999999999 109.041 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.37 -5.71 84.61 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 108.728 -1.749 . . . . 17.91 108.728 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 16.3 m -111.62 156.79 21.25 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.001 -1.6 . . . . 17.109999999999999 107.835 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 m -71.84 157.95 36.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.105 -0.702 . . . . 14.73 109.105 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 88' ' ' ARG . 3.3 tt0 -58.96 97.45 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 124.163 0.914 . . . . 14.94 111.422 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -115.34 173.88 6.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 10.57 110.139 -175.88 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 84' ' ' VAL . 1.3 pt? -109.14 114.34 27.97 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.588 -0.893 . . . . 8.8800000000000008 108.588 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -94.74 131.05 40.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.665 -1.152 . . . . 9.7799999999999994 111.718 -166.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 137' ' ' ILE . 32.7 m -136.85 157.07 75.53 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.845 -1.07 . . . . 6.4000000000000004 108.638 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.446 ' HG2' HG11 ' A' ' 149' ' ' VAL . 76.0 Cg_exo -52.49 129.31 31.38 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.738 1.626 . . . . 6.5499999999999998 111.398 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 p -63.62 -22.91 67.15 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.451 0.643 . . . . 9.2899999999999991 111.16 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -78.14 0.44 24.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.204 -0.907 . . . . 10.859999999999999 110.811 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -102.76 -1.37 30.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.775 -0.648 . . . . 5.3399999999999999 112.598 -174.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -115.76 156.47 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 6.9699999999999998 112.247 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.7 mm -101.46 124.36 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 10.199999999999999 109.982 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 18.8 mmm180 -96.18 125.48 40.73 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.868 -0.733 . . . . 12.119999999999999 110.452 173.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -149.13 137.16 20.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 14.609999999999999 110.556 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.4 -114.61 2.69 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 116.114 -0.494 . . . . 15.52 112.797 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.76 33.39 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.993 0.425 . . . . 14.99 111.394 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -179.21 7.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.163 -0.471 . . . . 15.199999999999999 111.381 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 10.7 m -131.43 152.51 50.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.922 -0.581 . . . . 9.2599999999999998 110.392 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 25.3 mm -126.47 146.13 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.295 -0.261 . . . . 10.550000000000001 110.295 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -122.65 137.41 54.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.454 . . . . 7.3899999999999997 109.989 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 45.2 mtm -92.85 99.93 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.722 -0.844 . . . . 8.8499999999999996 108.722 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 121' ' ' ASP . 8.4 p -81.47 131.85 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.242 0.544 . . . . 9.6899999999999995 110.696 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' A' ' 146' ' ' GLN . . . -86.87 91.31 8.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.59 -0.732 . . . . 10.699999999999999 110.417 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HD2' ' OD2' ' A' ' 121' ' ' ASP . 55.5 mttp -70.83 151.17 45.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 14.880000000000001 109.984 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.05 7.93 19.23 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 16.920000000000002 111.486 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -95.05 10.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.504 0.669 . . . . 18.559999999999999 110.973 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.64 75.16 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.163 -0.926 . . . . 15.619999999999999 113.613 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.24 25.84 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.482 -0.865 . . . . 14.19 112.441 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.492 ' CZ ' HG11 ' A' ' 79' ' ' VAL . 40.5 m-85 -114.34 116.88 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.026 0.441 . . . . 12.029999999999999 109.933 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 113' ' ' VAL . 25.9 m-20 -106.17 141.89 23.71 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.882 -0.599 . . . . 13.91 110.323 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 60.2 Cg_endo -83.67 127.18 4.23 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.874 1.716 . . . . 12.35 112.742 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.74 124.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 9.4299999999999997 109.321 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -72.57 127.09 31.49 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.149 -0.686 . . . . 12.93 109.149 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -135.68 151.69 30.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.794 0.807 . . . . 8.0299999999999994 111.569 -173.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 25.3 ttmm -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.231 -1.349 . . . . 10.390000000000001 109.518 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.58 110.3 17.19 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 123.108 1.433 . . . . 8.3000000000000007 112.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 138' ' ' LEU . . . -89.74 174.94 41.61 Favored Glycine 0 N--CA 1.411 -2.984 0 CA-C-N 111.25 -2.704 . . . . 10.1 110.718 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.17 161.32 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 126.07 1.748 . . . . 10.609999999999999 114.6 -167.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -100.88 139.24 36.86 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.312 -0.858 . . . . 13.17 108.721 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.84 111.99 4.64 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.851 0.358 . . . . 12.98 111.477 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.11 34.17 75.42 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.806 -0.712 . . . . 14.34 112.792 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.19 2.83 89.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.825 -0.703 . . . . 13.119999999999999 112.236 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -115.87 156.39 26.22 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.62 -0.511 . . . . 10.619999999999999 109.62 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 p -105.42 150.67 25.07 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.975 0.417 . . . . 7.8200000000000003 111.326 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.79 100.51 11.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.925 -0.579 . . . . 10.789999999999999 109.619 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.74 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 20.3 mm -83.81 112.9 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 O-C-N 121.569 -0.707 . . . . 6.7300000000000004 109.502 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -83.04 -47.45 11.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.177 -0.919 . . . . 8.7899999999999991 110.288 -173.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -147.82 159.82 43.42 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.148 -0.686 . . . . 10.44 109.148 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 130.74 -61.28 0.67 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.046 -1.073 . . . . 8.8699999999999992 112.318 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' A' ' 111' ' ' ALA . 26.5 mt -109.64 -170.83 1.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.262 0.553 . . . . 8.5 112.162 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -145.53 154.35 42.1 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.261 -0.882 . . . . 14.15 109.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.8 130.7 43.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.018 -0.992 . . . . 12.119999999999999 109.658 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.81 -1.51 38.86 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.721 -0.752 . . . . 11.539999999999999 111.232 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -103.57 139.21 39.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.55 -0.537 . . . . 11.24 109.55 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 114' ' ' ALA . 48.2 mt-30 -91.03 138.72 31.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.891 0.377 . . . . 10.49 110.771 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.82 137.01 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.236 -0.438 . . . . 5.4500000000000002 109.823 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 81' ' ' THR . 57.5 t -68.07 112.77 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.973 -0.558 . . . . 6.5599999999999996 111.003 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' A' ' 98' ' ' PRO . 2.7 m -103.75 -2.99 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.476 0.655 . . . . 6.9900000000000002 109.995 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 45.0 t -161.66 111.93 1.63 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.117 -0.947 . . . . 9.0600000000000005 109.391 171.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' ASN . . . -79.45 -136.63 1.37 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.406 -0.902 . . . . 8.5 112.057 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -107.6 120.72 42.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.405 0.622 . . . . 11.84 109.965 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -110.54 104.39 13.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.715 . . . . 12.24 109.506 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.84 63.5 4.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.521 0.677 . . . . 13.16 110.301 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 pt -131.47 40.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.216 -0.902 . . . . 11.949999999999999 109.732 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.45 -34.66 69.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.906 -0.588 . . . . 11.220000000000001 111.081 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.616 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 15.8 m -59.03 -58.36 9.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.657 -0.497 . . . . 11.9 109.657 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -56.61 -41.95 77.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.895 -1.048 . . . . 11.17 110.456 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -63.64 -33.88 76.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.151 -0.932 . . . . 7.8200000000000003 111.733 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.3 t -72.94 -37.44 67.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.633 0.73 . . . . 9.6400000000000006 109.818 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 157' ' ' SER . 79.2 mt -71.29 -38.89 71.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.739 -1.119 . . . . 10.57 111.151 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 31.7 ptt180 -80.0 -39.13 30.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.929 -0.578 . . . . 8.9000000000000004 110.598 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.9 -57.17 5.02 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.196 -1.002 . . . . 7.1500000000000004 111.943 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 68' ' ' ARG . 1.3 p 45.16 67.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.173 0.589 . . . . 7.0899999999999999 111.605 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 m 47.99 30.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.68 1.192 . . . . 9.1999999999999993 112.946 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 58.15 -151.85 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.782 -0.644 . . . . 9.1099999999999994 111.659 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 167' ' ' ARG . 3.5 tmm_? -67.4 -35.38 79.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.464 0.65 . . . . 14.58 109.418 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.32 165.88 28.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.955 -1.02 . . . . 11.94 110.74 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.403 HE21 ' HG ' ' A' ' 173' ' ' SER . 61.6 tp60 -118.78 -18.49 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.741 0.782 . . . . 14.99 110.696 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.44 ' H ' ' CD ' ' A' ' 170' ' ' GLU . 1.4 mp0 -43.08 -63.39 0.81 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 113.837 -1.529 . . . . 15.01 111.58 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.3 p -87.79 4.66 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.665 . . . . 14.25 111.552 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.7 m -91.24 -35.31 14.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.18 -0.674 . . . . 14.890000000000001 109.18 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.403 ' HG ' HE21 ' A' ' 169' ' ' GLN . 39.0 m -82.81 -95.46 0.05 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.115 -0.948 . . . . 15.85 109.261 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.53 -69.99 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.779 -0.724 . . . . 17.539999999999999 112.666 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.2 25.13 14.5 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.12 0.486 . . . . 17.850000000000001 111.139 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -153.39 55.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.487 0.66 . . . . 19.670000000000002 110.044 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.45 -3.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 19.52 110.09 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.63 -159.54 0.86 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.487 -0.779 . . . . 21.149999999999999 109.762 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -86.23 -35.83 19.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 23.25 109.757 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.437 -0.792 . . . . 23.52 110.137 -179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 tpp . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.75 0.309 . . . . 34.32 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.13 78.55 0.86 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.763 -0.732 . . . . 33.090000000000003 112.556 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.7 m -149.16 30.72 0.77 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 34.119999999999997 110.442 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.08 112.69 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 32.32 110.064 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m 65.96 97.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.47 0.481 . . . . 32.740000000000002 111.076 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 7' ' ' ASN . 16.7 m -60.14 164.22 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.297 -0.41 . . . . 31.289999999999999 111.408 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.57 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 5.5 t30 78.06 142.96 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.061 0.851 . . . . 29.460000000000001 109.782 -170.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 155' ' ' ILE . . . -68.47 120.77 11.89 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.507 -0.854 . . . . 28.280000000000001 112.767 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -86.0 28.02 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.48 2.787 . . . . 27.510000000000002 112.558 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.531 ' HB3' ' O ' ' A' ' 156' ' ' ASP . 9.1 t60 -142.83 83.54 1.81 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.629 -0.878 . . . . 26.48 108.629 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' HIS . 10.1 m-20 67.92 -86.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.804 -0.634 . . . . 24.899999999999999 109.916 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.1 -112.59 4.98 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.647 -0.787 . . . . 23.190000000000001 112.484 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 64.35 78.98 0.27 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.317 0.579 . . . . 21.309999999999999 110.286 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.98 147.28 85.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.665 -0.698 . . . . 19.890000000000001 110.427 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.31 132.1 13.42 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.014 1.809 . . . . 18.120000000000001 112.339 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.17 -61.44 1.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.71 -0.478 . . . . 16.579999999999998 109.71 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.46 79.58 1.67 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 14.800000000000001 110.009 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.89 66.73 3.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.93 -0.652 . . . . 13.17 112.356 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.66 27.11 10.09 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.35 0.595 . . . . 12.17 111.555 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 57.67 69.22 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.522 -1.217 . . . . 13.82 109.902 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 21' ' ' LEU . 18.8 tp 59.5 12.8 2.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.408 -1.724 . . . . 12.130000000000001 111.979 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 6.7 ttpm? 71.06 -35.42 0.33 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.756 0.822 . . . . 14.1 111.14 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.472 ' H ' ' C ' ' A' ' 21' ' ' LEU . 73.4 m 48.18 73.4 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.036 0.922 . . . . 11.050000000000001 110.441 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.69 122.41 0.77 Allowed Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.707 -1.133 . . . . 10.050000000000001 110.606 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.99 59.61 0.19 Allowed 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.019 -1.104 . . . . 10.380000000000001 108.019 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HD3' ' OE1' ' A' ' 58' ' ' GLU . 13.1 mmt180 -133.57 140.52 47.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.922 -1.49 . . . . 8.3699999999999992 109.74 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.873 HG12 ' OE2' ' A' ' 58' ' ' GLU . 23.6 mm -55.98 129.93 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 113.016 0.747 . . . . 5.7599999999999998 113.016 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -113.23 -16.0 12.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.769 -1.105 . . . . 8.2200000000000006 109.795 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 10.9 p90 167.44 179.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 7.9900000000000002 110.359 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.765 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.7 m-90 -113.24 143.23 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.072 -0.967 . . . . 5.6100000000000003 111.328 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.649 ' HB2' HE22 ' A' ' 38' ' ' GLN . 5.6 ptp180 -151.15 151.32 31.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 9.0600000000000005 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.934 ' HB3' HG22 ' A' ' 35' ' ' VAL . 8.4 t70 -79.72 132.72 60.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.697 -0.853 . . . . 8.3100000000000005 108.697 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -63.28 -13.71 37.53 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.095 1.863 . . . . 10.41 112.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.416 ' HE3' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -98.08 0.84 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.762 -0.199 . . . . 10.85 111.466 178.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 32' ' ' ASP . 10.9 m -129.62 48.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 121.351 0.596 . . . . 9.3200000000000003 112.085 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.64 103.41 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.837 2.358 . . . . 11.1 113.245 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.5 -37.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 10.31 111.95 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.48 151.73 45.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.363 . . . . 9.2100000000000009 110.198 177.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.658 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 2.6 tmm_? -136.35 98.83 3.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.6 -0.519 . . . . 11.51 109.6 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 42.1 m-85 -76.96 141.48 40.42 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.377 0.608 . . . . 7.5 110.972 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.7 -30.51 71.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.069 -1.423 . . . . 10.609999999999999 109.932 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 15.8 pttm -165.01 165.94 11.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.182 -0.917 . . . . 10.91 110.341 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.692 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -47.84 167.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.565 2.843 . . . . 7.5099999999999998 113.654 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.08 -162.0 29.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.508 -0.853 . . . . 7.5899999999999999 112.645 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.6 ttmt -103.48 140.63 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.05 -0.352 . . . . 11.68 110.05 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 49' ' ' MET . 22.6 t -65.38 142.37 98.4 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 9.1999999999999993 110.649 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' CD ' ' HZ ' ' A' ' 40' ' ' PHE . 56.8 Cg_endo -79.16 -20.9 9.63 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.549 2.166 . . . . 10.25 111.33 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.473 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 53.0 m-85 -84.5 -39.64 18.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.218 -1.355 . . . . 10.49 109.726 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.552 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER -132.83 147.31 52.3 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.802 -0.635 . . . . 10.380000000000001 109.82 174.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.9 p-10 -77.82 58.23 1.84 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.084 0.945 . . . . 12.539999999999999 110.772 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 49' ' ' MET . 15.6 ptm -132.7 139.98 36.34 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.831 -1.077 . . . . 9.8699999999999992 109.649 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 18.1 Cg_endo -60.58 134.17 52.95 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.522 2.148 . . . . 9.5099999999999998 110.249 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 32' ' ' ASP . 1.4 mm? -56.65 157.3 5.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.803 -0.359 . . . . 6.71 110.367 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.97 129.76 28.97 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-O 121.272 0.558 . . . . 7.8899999999999997 109.872 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 95.4 Cg_endo -82.12 138.66 10.25 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 121.842 1.695 . . . . 5.7699999999999996 112.797 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 32.0 m -56.19 157.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.198 -1.365 . . . . 5.96 112.454 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.14 -72.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.453 2.301 . . . . 7.8399999999999999 116.434 -177.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.873 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.6 pt-20 -59.47 -32.71 70.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.458 0.647 . . . . 6.6200000000000001 110.065 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 13.8 pt-20 51.3 89.72 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.445 -1.707 . . . . 8.5800000000000001 112.458 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 78.33 67.15 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 113.2 -1.818 . . . . 7.6399999999999997 111.121 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.707 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 20.2 t-20 -152.27 -34.44 0.13 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.527 -0.76 . . . . 7.0199999999999996 111.067 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' ARG . . . -55.25 -75.52 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.075 0.941 . . . . 5.4100000000000001 108.91 173.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -129.76 53.8 1.89 Allowed 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 113.739 -1.573 . . . . 7.0099999999999998 108.452 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.79 41.44 1.03 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 112.731 -2.031 . . . . 7.2000000000000002 113.742 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 56.11 28.12 12.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 7.8200000000000003 110.648 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.68 -53.64 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.237 -0.892 . . . . 8.6500000000000004 109.759 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HA ' HG22 ' A' ' 164' ' ' THR . 10.7 t -76.45 -84.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.107 -0.497 . . . . 7.3099999999999996 109.883 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 14.0 mtm105 -91.99 149.22 21.65 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.224 -0.658 . . . . 10.210000000000001 109.224 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.499 HD12 ' NE ' ' A' ' 72' ' ' ARG . 1.7 mt -148.52 140.67 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.142 -0.481 . . . . 8.8599999999999994 109.859 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -117.48 -20.99 8.83 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.046 0.927 . . . . 13.02 109.436 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.27 -6.26 46.43 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 114.263 -1.335 . . . . 12.130000000000001 112.09 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' NE ' HD12 ' A' ' 69' ' ' ILE . 31.0 ptt180 -138.41 162.18 35.1 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.35 -1.352 . . . . 12.380000000000001 107.35 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -105.85 126.39 61.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.978 -0.689 . . . . 11.609999999999999 110.506 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 p -83.89 84.19 7.66 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.235 -0.893 . . . . 10.710000000000001 110.597 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.37 67.65 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.357 -0.838 . . . . 14.09 111.078 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.75 120.35 27.74 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.49 -0.93 . . . . 11.220000000000001 108.49 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.46 13.68 29.02 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.172 -1.376 . . . . 13.710000000000001 110.573 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.13 -66.47 1.26 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.223 -0.898 . . . . 11.44 111.466 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.79 103.98 12.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.156 -0.522 . . . . 9.9900000000000002 110.189 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.672 ' HB3' ' N ' ' A' ' 150' ' ' SER . 89.2 mtm180 -116.15 132.03 56.77 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.201 -0.454 . . . . 11.640000000000001 111.397 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 80.7 p -156.39 170.63 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.957 0.786 . . . . 8.0 111.18 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.49 141.41 18.19 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.401 -1.333 . . . . 6.6500000000000004 107.401 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 44.2 tt0 -97.21 136.46 37.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.616 -0.434 . . . . 12.15 110.744 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 145' ' ' GLN . 75.6 t -62.38 134.23 27.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.612 -0.722 . . . . 9.7100000000000009 111.3 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -163.47 140.01 7.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.594 -1.185 . . . . 11.029999999999999 109.818 174.247 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.72 163.19 28.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.048 -0.978 . . . . 12.76 111.146 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 170.89 45.74 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 13.25 112.448 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.61 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -83.89 175.37 9.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.918 0.39 . . . . 16.350000000000001 111.5 -176.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.31 115.41 21.62 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.477 0.656 . . . . 18.219999999999999 110.075 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.31 -147.18 17.85 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 115.184 -0.917 . . . . 17.91 111.814 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.3 p -95.4 77.47 3.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.95 0.881 . . . . 17.109999999999999 109.119 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.61 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -152.47 167.61 28.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.673 -1.149 . . . . 14.73 108.268 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -142.83 118.95 10.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 118.06 0.391 . . . . 14.94 110.287 162.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG3' ' OE1' ' A' ' 136' ' ' GLU . 22.9 mmt85 -129.77 155.26 46.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.084 -0.339 . . . . 10.57 110.084 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.6 mm? -91.44 113.76 26.11 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.73 -0.841 . . . . 8.8800000000000008 108.73 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.86 130.58 34.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.809 -0.356 . . . . 9.7799999999999994 111.045 -175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.78 155.03 63.21 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.56 -0.904 . . . . 6.4000000000000004 108.56 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.89 137.19 78.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.922 1.748 . . . . 6.5499999999999998 111.046 174.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 23.6 t -62.43 -25.21 67.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.988 0.366 . . . . 9.2899999999999991 111.988 -173.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.07 11.76 22.03 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.588 -0.445 . . . . 10.859999999999999 111.335 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.8 -33.14 35.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.06 0.457 . . . . 5.3399999999999999 111.29 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -101.51 165.63 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 6.9699999999999998 112.194 -170.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 28.7 mm -109.29 117.49 54.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.601 -0.727 . . . . 10.199999999999999 109.829 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -91.07 125.32 35.82 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.834 -0.747 . . . . 12.119999999999999 110.554 173.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -145.79 122.7 11.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.871 -0.604 . . . . 14.609999999999999 110.689 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.64 -108.01 1.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.745 -0.661 . . . . 15.52 112.848 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.77 24.62 10.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 14.99 111.732 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.62 179.69 8.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 15.199999999999999 111.692 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.563 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 58.1 m -134.68 150.96 50.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.862 -0.608 . . . . 9.2599999999999998 110.831 -173.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -119.63 146.23 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.871 -0.418 . . . . 10.550000000000001 109.871 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.577 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.237 -0.282 . . . . 7.3899999999999997 110.237 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 81.7 mmm -106.56 98.1 7.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.208 -0.451 . . . . 8.8499999999999996 109.999 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -88.1 142.07 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.005 0.431 . . . . 9.6899999999999995 111.419 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 86.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 10.699999999999999 110.479 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 33.6 tttp -72.44 153.62 41.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.245 -0.888 . . . . 14.880000000000001 110.422 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.05 -2.04 51.1 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.945 -0.571 . . . . 16.920000000000002 112.998 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.18 17.47 10.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 18.559999999999999 111.077 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.12 11.34 85.21 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.618 -0.719 . . . . 15.619999999999999 112.785 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.9 -158.09 8.7 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.836 -0.697 . . . . 14.19 111.84 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 64.5 m-85 -128.11 124.34 36.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.376 0.608 . . . . 12.029999999999999 110.154 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 113' ' ' VAL . 10.2 t70 -101.13 117.4 62.37 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.041 -0.982 . . . . 13.91 110.314 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 72.7 Cg_endo -83.1 112.09 1.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.83 3.02 . . . . 12.35 113.458 -172.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 125' ' ' VAL . 9.5 p -105.21 142.83 17.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.423 -0.808 . . . . 9.4299999999999997 110.404 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -82.23 123.41 29.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.156 0.503 . . . . 12.93 109.699 171.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -135.76 163.08 35.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.707 -0.679 . . . . 8.0299999999999994 110.974 -172.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' N ' HG23 ' A' ' 125' ' ' VAL . 77.9 tttt -98.82 126.21 44.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.936 -0.575 . . . . 10.390000000000001 110.243 172.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.92 108.08 4.98 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.663 -0.699 . . . . 8.3000000000000007 111.444 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.17 70.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.759 -2.162 . . . . 10.1 114.674 168.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.67 161.92 41.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.957 -0.757 . . . . 10.609999999999999 108.957 153.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.17 127.62 26.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.928 -0.397 . . . . 13.17 109.928 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.32 125.21 11.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.339 -0.391 . . . . 12.98 111.595 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.79 35.99 88.39 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.934 -0.576 . . . . 14.34 113.288 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.51 7.9 87.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.941 -0.647 . . . . 13.119999999999999 112.163 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.66 170.51 10.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.555 . . . . 10.619999999999999 109.503 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 13.3 p -122.36 156.51 33.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.741 0.305 . . . . 7.8200000000000003 110.53 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 52.8 mt-10 -99.16 118.48 35.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.369 0.604 . . . . 10.789999999999999 110.853 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 125' ' ' VAL . 22.9 mm -85.37 103.79 12.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.096 -0.956 . . . . 6.7300000000000004 108.615 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.4 mp -70.73 -46.63 62.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.926 -1.034 . . . . 8.7899999999999991 109.805 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 125' ' ' VAL . 97.9 mt-10 -143.1 161.12 39.04 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.949 -0.569 . . . . 10.44 109.63 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.31 -60.36 0.59 Allowed Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.02 -1.086 . . . . 8.8699999999999992 113.585 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.546 HD21 HG11 ' A' ' 123' ' ' VAL . 47.6 mt -110.44 -176.61 3.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.899 0.703 . . . . 8.5 112.899 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -143.78 157.32 44.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.792 -1.095 . . . . 14.15 109.201 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.32 129.83 41.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.735 -0.666 . . . . 12.119999999999999 110.296 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.21 -8.69 35.81 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.179 -0.768 . . . . 11.539999999999999 111.179 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.6 mm-40 -91.12 100.32 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.507 0.67 . . . . 11.24 109.64 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.4 mt-30 -74.72 135.32 41.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.14 -0.936 . . . . 10.49 110.58 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.5 m -129.75 136.62 58.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.717 -0.475 . . . . 5.4500000000000002 109.717 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 2.8 p -61.25 119.09 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.872 0.693 . . . . 6.5599999999999996 112.872 -171.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.561 HG23 ' N ' ' A' ' 150' ' ' SER . 2.7 m -137.25 -55.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.233 0.457 . . . . 6.9900000000000002 112.233 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.672 ' N ' ' HB3' ' A' ' 80' ' ' ARG . 51.1 m -165.12 -35.16 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.018 -0.734 . . . . 9.0600000000000005 109.018 -174.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.489 ' CA ' ' H ' ' A' ' 81' ' ' THR . . . 65.29 -121.06 19.9 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 114.947 -1.024 . . . . 8.5 113.583 170.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.98 135.31 10.23 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.468 -0.938 . . . . 11.84 108.468 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.4 171.38 10.13 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.727 -0.389 . . . . 12.24 110.171 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.64 175.27 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.597 0.713 . . . . 13.16 112.747 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.549 ' C ' ' HB2' ' A' ' 159' ' ' ALA . 6.2 pt -114.57 77.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.607 0.718 . . . . 11.949999999999999 110.281 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 26.3 m-20 -84.46 -100.44 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.359 -0.837 . . . . 11.220000000000001 111.459 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.0 p -83.36 -36.43 24.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 11.9 110.082 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 18.3 tt0 -66.07 -18.95 65.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.056 -0.975 . . . . 11.17 109.904 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 155' ' ' ILE . . . -45.16 -58.33 3.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.008 -0.996 . . . . 7.8200000000000003 112.156 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -66.06 -29.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.678 0.752 . . . . 9.6400000000000006 110.963 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 158' ' ' GLU . 46.8 mt -72.59 -28.04 62.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.684 -1.144 . . . . 10.57 110.94 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 71.9 mtt180 -92.73 -54.15 3.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.063 -0.971 . . . . 8.9000000000000004 111.024 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 56.21 56.33 24.8 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.385 -0.686 . . . . 7.1500000000000004 111.385 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 67' ' ' VAL . 41.7 p -62.19 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.261 0.467 . . . . 7.0899999999999999 112.261 -171.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.44 47.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.623 0.725 . . . . 9.1999999999999993 109.344 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -106.29 25.04 11.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.752 -0.658 . . . . 9.1099999999999994 111.421 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -74.13 102.72 4.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.949 0.88 . . . . 14.58 110.005 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.1 76.08 9.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.088 -1.414 . . . . 11.94 110.548 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -148.62 96.14 2.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.523 -0.762 . . . . 14.99 109.579 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 59.98 40.25 19.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.126 -1.397 . . . . 15.01 111.717 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.0 p -54.42 -45.86 73.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.159 0.505 . . . . 14.25 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.7 t -174.79 -162.5 0.12 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.56 -0.745 . . . . 14.890000000000001 109.597 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -52.35 114.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 15.85 110.881 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.87 53.45 4.26 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 17.539999999999999 112.425 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.422 ' H ' ' CD1' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -62.54 156.5 22.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.768 0.318 . . . . 17.850000000000001 110.807 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.45 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 19.670000000000002 110.685 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.4 p -169.45 23.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.767 0.794 . . . . 19.52 110.537 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.81 166.79 14.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 21.149999999999999 109.856 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.44 178.76 5.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.393 -0.595 . . . . 23.25 109.393 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.446 -0.788 . . . . 23.52 110.663 -176.718 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptm . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.639 0.257 . . . . 34.32 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.39 -91.52 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.78 -0.724 . . . . 33.090000000000003 112.03 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 t -168.55 -168.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 34.119999999999997 109.651 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.02 11.02 4.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.044 0.938 . . . . 32.32 112.818 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 p 48.16 40.09 13.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.666 0.786 . . . . 32.740000000000002 112.027 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.46 135.37 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.437 . . . . 31.289999999999999 110.85 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -92.97 -28.03 16.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.502 0.668 . . . . 29.460000000000001 109.906 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.93 -174.27 44.03 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.362 -0.835 . . . . 28.280000000000001 111.895 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -91.42 37.98 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.223 2.615 . . . . 27.510000000000002 111.925 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -90.37 -33.6 16.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 26.48 110.371 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -159.45 146.37 16.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.902 -0.59 . . . . 24.899999999999999 109.889 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.25 -164.46 31.88 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.906 -0.664 . . . . 23.190000000000001 111.699 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -78.69 -88.58 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.768 0.284 . . . . 21.309999999999999 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 52.17 83.69 0.22 Allowed Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.679 0.612 . . . . 19.890000000000001 111.799 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.4 -168.82 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.628 2.218 . . . . 18.120000000000001 112.266 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.65 45.37 2.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.266 0.555 . . . . 16.579999999999998 110.024 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 130.08 42.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 14.800000000000001 111.102 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.86 -127.75 5.83 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.409 -0.814 . . . . 13.17 111.926 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.02 -50.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.915 -0.168 . . . . 12.17 111.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 32.8 tt0 62.59 58.32 1.66 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.722 1.249 . . . . 13.82 108.541 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.443 ' C ' HD13 ' A' ' 21' ' ' LEU . 3.4 tm? -163.17 -61.06 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.901 -1.954 . . . . 12.130000000000001 106.736 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HA ' ' NH2' ' A' ' 26' ' ' ARG . 33.5 ttmt -51.32 -48.25 62.42 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 114.729 -1.123 . . . . 14.1 108.864 169.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.9 p -140.78 166.99 23.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.882 -1.508 . . . . 11.050000000000001 108.381 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.09 -57.03 0.47 Allowed Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 120.074 -1.06 . . . . 10.050000000000001 111.33 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HE2' ' O ' ' A' ' 20' ' ' GLU . 17.3 pttt -146.91 61.58 1.19 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.472 1.13 . . . . 10.380000000000001 112.101 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.598 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 19.8 mtm180 -141.31 142.17 33.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.309 -1.769 . . . . 8.3699999999999992 108.281 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.703 HG12 ' CD ' ' A' ' 58' ' ' GLU . 25.5 mm -51.95 112.8 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 113.213 0.82 . . . . 5.7599999999999998 113.213 -169.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -100.9 -31.9 10.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.007 -1.452 . . . . 8.2200000000000006 109.734 172.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.0 p90 -175.02 -174.58 0.78 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.24 0.543 . . . . 7.9900000000000002 112.089 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 m-90 -123.23 148.62 45.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 114.966 -1.015 . . . . 5.6100000000000003 110.701 -174.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.602 ' HB2' HE22 ' A' ' 38' ' ' GLN . 29.5 ptt180 -148.22 152.53 37.36 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.472 0.482 . . . . 9.0600000000000005 111.112 -176.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.804 ' HB2' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -76.66 139.37 66.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.791 -1.188 . . . . 8.3100000000000005 107.791 163.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.584 ' CG ' HD12 ' A' ' 54' ' ' ILE . 44.7 Cg_exo -57.87 -15.49 22.02 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.865 2.377 . . . . 10.41 110.647 164.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -28.85 39.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 113.772 -1.558 . . . . 10.85 111.476 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 18.2 m -123.57 51.42 4.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.77 0.656 . . . . 9.3200000000000003 112.77 -164.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.0 114.3 2.93 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.212 2.608 . . . . 11.1 112.317 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.09 -25.52 3.5 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.26 -0.736 . . . . 10.31 111.26 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.644 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -70.94 171.59 10.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.118 -0.541 . . . . 9.2100000000000009 109.926 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -150.12 91.27 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.2 -0.667 . . . . 11.51 109.2 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 70.8 m-85 -71.07 141.86 50.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.298 0.571 . . . . 7.5 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.18 -30.43 71.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.821 -1.081 . . . . 10.609999999999999 111.668 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 13.2 ptmm? -167.33 163.29 10.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 119.29 -0.386 . . . . 10.91 111.279 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -49.72 170.89 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.781 2.988 . . . . 7.5099999999999998 113.859 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.69 -163.34 26.91 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.302 -0.719 . . . . 7.5899999999999999 111.302 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 51' ' ' MET . 38.9 ttpt -94.33 147.74 22.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.203 0.501 . . . . 11.68 110.242 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.2 t -66.1 139.07 96.4 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.413 -0.812 . . . . 9.1999999999999993 111.226 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 -21.95 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.791 2.328 . . . . 10.25 111.957 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' A' ' 35' ' ' VAL . 33.2 m-85 -78.66 -39.02 38.08 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.865 -1.061 . . . . 10.49 109.769 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -156.94 166.55 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.454 -0.794 . . . . 10.380000000000001 109.105 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 8.3 p-10 -78.33 80.96 4.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 12.539999999999999 112.27 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 4.4 ptm -134.99 146.04 56.96 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.737 -1.579 . . . . 9.8699999999999992 106.737 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.43 132.74 18.06 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 N-CA-C 108.234 -1.487 . . . . 9.5099999999999998 108.234 165.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.28 161.73 18.86 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.165 -0.614 . . . . 6.71 110.964 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 33' ' ' PRO . 22.0 mt -110.08 132.35 21.49 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 109.571 -0.529 . . . . 7.8899999999999997 109.571 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.667 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 39.9 Cg_endo -76.85 133.4 13.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 120.983 1.122 . . . . 5.7699999999999996 112.749 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.28 157.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.07 -1.423 . . . . 5.96 113.245 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 21.58 -89.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.285 1.834 . . . . 7.8399999999999999 114.893 -177.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.703 ' CD ' HG12 ' A' ' 27' ' ' ILE . 1.2 pt-20 -45.63 -40.69 9.32 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.091 0.556 . . . . 6.6200000000000001 110.13 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 41.8 tt0 59.85 81.03 0.18 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.904 -1.044 . . . . 8.5800000000000001 110.541 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 47.23 77.1 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.505 -1.225 . . . . 7.6399999999999997 111.359 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.455 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 27.6 t-20 -110.54 -39.84 4.79 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.171 -1.048 . . . . 7.0199999999999996 108.171 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.04 56.76 7.51 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.709 -1.132 . . . . 5.4100000000000001 111.935 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 66' ' ' ALA . 11.8 m-20 61.73 40.8 12.68 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.407 -1.724 . . . . 7.0099999999999998 111.55 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.01 -15.12 43.26 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.249 -1.14 . . . . 7.2000000000000002 110.249 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.01 46.77 2.44 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.228 -1.027 . . . . 7.8200000000000003 108.228 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 63' ' ' ASP . . . -173.94 -33.57 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.734 -1.575 . . . . 8.6500000000000004 107.67 -171.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 164' ' ' THR . 4.0 t 74.55 -38.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 112.707 -2.042 . . . . 7.3099999999999996 113.647 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -147.02 140.15 25.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.571 0.701 . . . . 10.210000000000001 111.117 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.532 HG21 ' HG2' ' A' ' 72' ' ' ARG . 3.8 mt -67.66 156.65 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.643 -1.162 . . . . 8.8599999999999994 111.855 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' HB2' HH22 ' A' ' 26' ' ' ARG . 23.3 t70 -90.48 57.27 3.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.175 0.988 . . . . 13.02 109.964 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.86 -8.11 38.49 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.422 -1.263 . . . . 12.130000000000001 114.89 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -81.3 132.96 35.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.901 -1.148 . . . . 12.380000000000001 107.901 176.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.77 93.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.651 0.739 . . . . 11.609999999999999 109.531 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -75.16 59.73 1.0 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.844 -1.525 . . . . 10.710000000000001 110.491 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 43.26 70.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.167 -0.924 . . . . 14.09 111.344 -172.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -153.53 130.96 11.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.924 -1.035 . . . . 11.220000000000001 108.908 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.11 -22.52 59.44 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.692 0.758 . . . . 13.710000000000001 109.764 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 -22.93 3.39 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.098 -0.956 . . . . 11.44 112.167 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.8 t 59.27 46.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 122.316 1.055 . . . . 9.9900000000000002 108.579 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.565 ' NH1' ' HB3' ' A' ' 156' ' ' ASP . 53.7 ttt180 -81.62 119.0 23.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.592 -1.185 . . . . 11.640000000000001 110.419 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 148' ' ' VAL . 75.9 p -128.47 159.16 36.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.529 -1.214 . . . . 8.0 109.212 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -119.49 126.5 51.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.693 -0.854 . . . . 6.6500000000000004 108.693 171.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 28.0 tt0 -75.92 131.44 39.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.146 -0.687 . . . . 12.15 109.146 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 95' ' ' LEU . 41.3 t -55.64 132.02 19.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.94 0.718 . . . . 9.7100000000000009 112.94 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 49.0 mmtt -136.41 140.46 43.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.607 -1.179 . . . . 11.029999999999999 109.429 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.2 157.9 36.88 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.954 -0.698 . . . . 12.76 109.496 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.09 49.25 0.05 OUTLIER Glycine 0 CA--C 1.503 -0.704 0 C-N-CA 119.74 -1.219 . . . . 13.25 113.862 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.647 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -89.29 -177.56 5.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.799 0.666 . . . . 16.350000000000001 112.799 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 tt -139.94 112.89 8.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.944 -1.026 . . . . 18.219999999999999 108.275 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.16 -167.58 16.44 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.121 -0.792 . . . . 17.91 111.121 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 p -89.92 75.78 7.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.242 1.02 . . . . 17.109999999999999 109.967 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.647 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 1.6 m -154.8 167.67 29.46 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.862 -1.533 . . . . 14.73 106.862 175.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 3.8 mt-10 -141.68 109.49 5.74 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.657 0.662 . . . . 14.94 110.518 165.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 35.8 mmt180 -118.72 163.83 16.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.675 -0.693 . . . . 10.57 110.339 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.2 mm? -97.9 114.17 26.18 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.066 -0.716 . . . . 8.8800000000000008 109.066 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.49 129.79 36.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.189 0.519 . . . . 9.7799999999999994 110.99 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.82 157.22 68.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.895 -1.048 . . . . 6.4000000000000004 109.17 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.97 131.25 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.817 1.678 . . . . 6.5499999999999998 110.356 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -30.12 53.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.312 -0.404 . . . . 9.2899999999999991 111.32 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.9 -8.34 57.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.624 0.231 . . . . 10.859999999999999 111.624 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -72.02 -41.32 67.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.433 0.635 . . . . 5.3399999999999999 110.942 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -93.96 163.78 13.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.141 -0.936 . . . . 6.9699999999999998 112.613 -169.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' THR . 22.7 mm -111.68 103.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 10.199999999999999 109.229 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 13.3 ptt180 -103.01 132.54 49.2 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 117.969 -1.493 . . . . 12.119999999999999 110.985 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -151.36 133.92 15.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.709 -1.587 . . . . 14.609999999999999 109.133 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.18 -113.63 6.06 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.352 -0.928 . . . . 15.52 111.952 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 34.99 5.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.85 0.315 . . . . 14.99 111.85 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.408 HH11 HD11 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -164.41 178.63 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.901 0.382 . . . . 15.199999999999999 111.801 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.3 m -136.68 158.55 44.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.749 -0.66 . . . . 9.2599999999999998 110.431 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.408 HD11 HH11 ' A' ' 108' ' ' ARG . 25.1 mm -131.22 147.75 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 10.550000000000001 109.899 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.574 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.34 127.31 27.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.517 -0.31 . . . . 7.3899999999999997 110.296 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.411 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 33.2 ttp -87.59 103.19 15.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.27 -0.641 . . . . 8.8499999999999996 109.27 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 12.6 p -89.64 135.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 9.6899999999999995 112.575 -170.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -76.01 90.28 3.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.359 -0.837 . . . . 10.699999999999999 109.672 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -85.38 152.84 22.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.425 . . . . 14.880000000000001 110.499 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.05 1.76 10.24 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.106 -0.497 . . . . 16.920000000000002 113.328 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -90.93 8.64 34.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.33 0.586 . . . . 18.559999999999999 111.062 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.19 6.45 86.34 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.29 -0.868 . . . . 15.619999999999999 112.512 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.78 156.18 19.99 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.985 -0.626 . . . . 14.19 111.567 -174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 82.5 m-85 -107.3 109.46 21.23 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.766 -0.457 . . . . 12.029999999999999 109.766 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -106.74 142.96 26.08 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 120.405 -0.518 . . . . 13.91 111.231 -172.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.66 121.28 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.281 1.987 . . . . 12.35 111.93 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 111' ' ' ALA . 5.7 p -105.43 137.29 35.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.667 -0.697 . . . . 9.4299999999999997 109.663 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.93 119.95 19.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.1 -0.704 . . . . 12.93 109.1 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.06 155.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.695 -0.684 . . . . 8.0299999999999994 110.918 -176.085 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 139' ' ' GLU . 38.5 ttmt -101.78 128.47 48.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.904 -0.776 . . . . 10.390000000000001 108.904 171.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.92 104.55 4.7 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.452 -0.34 . . . . 8.3000000000000007 110.74 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.77 70.34 0.31 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.867 -2.111 . . . . 10.1 113.866 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 161.32 42.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.305 -1.368 . . . . 10.609999999999999 107.305 151.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.0 m -141.5 128.88 21.19 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 118.38 0.537 . . . . 13.17 110.081 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.61 8.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.592 -0.731 . . . . 12.98 110.847 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.43 38.22 96.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.362 -0.447 . . . . 14.34 112.704 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.58 9.76 84.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.649 . . . . 13.119999999999999 112.434 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -120.32 164.24 16.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.165 -0.309 . . . . 10.619999999999999 110.165 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -117.31 158.34 24.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.935 0.398 . . . . 7.8200000000000003 110.883 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 57.7 mt-10 -101.7 124.82 47.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.454 0.645 . . . . 10.789999999999999 110.828 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 125' ' ' VAL . 23.9 mm -89.76 114.63 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 114.934 -1.03 . . . . 6.7300000000000004 109.55 175.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.2 mp -87.73 -45.5 10.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.648 -1.16 . . . . 8.7899999999999991 109.677 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -134.67 164.71 26.9 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.974 -1.121 . . . . 10.44 107.974 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.533 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 111.99 -62.49 0.3 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.275 -1.44 . . . . 8.8699999999999992 113.722 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.64 -173.26 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.236 0.541 . . . . 8.5 112.455 -174.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.9 ttmt -157.58 158.36 35.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 14.15 108.528 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 128.84 37.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.888 -0.596 . . . . 12.119999999999999 110.31 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.08 -10.3 40.08 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.444 -0.662 . . . . 11.539999999999999 111.444 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 84' ' ' VAL . 25.5 mm-40 -93.69 121.17 34.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.119 -0.697 . . . . 11.24 109.119 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.695 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 28.5 mt-30 -97.49 125.06 41.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.941 -0.572 . . . . 10.49 111.114 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.75 138.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.852 -0.613 . . . . 5.4500000000000002 109.673 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 m -62.94 120.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.36 0.6 . . . . 6.5599999999999996 111.136 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 101' ' ' ALA . 3.4 m -110.17 -20.16 6.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.476 -0.784 . . . . 6.9900000000000002 110.484 -176.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m 38.1 45.88 0.79 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 124.305 1.003 . . . . 9.0600000000000005 112.861 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.16 46.99 2.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.277 -1.129 . . . . 8.5 110.277 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.427 ' HG2' ' H ' ' A' ' 152' ' ' GLN . 13.9 pt20 -75.78 23.01 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.319 0.489 . . . . 11.84 112.319 -171.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -100.26 -27.74 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.478 -0.934 . . . . 12.24 108.478 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.17 137.47 36.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.833 -1.076 . . . . 13.16 108.839 177.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 157' ' ' SER . 47.0 mt -54.07 108.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.001 0.429 . . . . 11.949999999999999 111.228 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.565 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 4.0 p30 -84.17 17.44 2.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.255 -0.43 . . . . 11.220000000000001 111.84 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 155' ' ' ILE . 70.7 m -64.52 -17.35 63.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.72 -0.218 . . . . 11.9 111.519 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 41.4 mt-10 -58.45 -46.87 85.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.252 -0.647 . . . . 11.17 109.252 171.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.73 -27.89 68.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 7.8200000000000003 110.794 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 16.0 m -62.57 -39.0 92.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.581 0.705 . . . . 9.6400000000000006 110.017 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -47.77 14.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.883 -1.053 . . . . 10.57 111.638 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 53.3 mtt180 -71.49 -36.24 71.07 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.592 0.711 . . . . 8.9000000000000004 110.948 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.75 105.74 3.03 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.606 -1.179 . . . . 7.1500000000000004 110.782 -171.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.406 ' H ' HG13 ' A' ' 67' ' ' VAL . 13.9 p -49.71 -54.03 21.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 7.0899999999999999 111.061 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.86 -48.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.818 -0.628 . . . . 9.1999999999999993 109.491 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 53.32 67.8 0.94 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.62 -0.718 . . . . 9.1099999999999994 111.658 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.603 ' HD3' ' C ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -70.42 -19.48 62.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.28 -0.873 . . . . 14.58 109.831 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.83 -10.06 59.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.972 -1.013 . . . . 11.94 110.763 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -111.17 142.98 42.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.755 -0.657 . . . . 14.99 109.776 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -150.01 114.96 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.809 -0.441 . . . . 15.01 109.809 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.6 p -98.89 40.01 1.23 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.032 -0.531 . . . . 14.25 112.092 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 17.8 m -67.04 -46.62 73.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.172 0.511 . . . . 14.890000000000001 110.055 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 p -89.64 59.44 4.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.632 . . . . 15.85 110.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.19 66.8 0.23 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.817 -0.706 . . . . 17.539999999999999 111.687 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.02 121.6 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.032 -0.358 . . . . 17.850000000000001 110.032 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -81.03 -41.81 22.08 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.542 -0.463 . . . . 19.670000000000002 110.594 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.42 -72.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.545 -0.752 . . . . 19.52 110.665 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 82.7 mt -146.79 37.14 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.648 0.261 . . . . 21.149999999999999 111.55 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.64 104.64 15.56 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.685 -0.406 . . . . 23.25 110.489 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.475 -0.774 . . . . 23.52 109.755 177.587 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 121.206 0.527 . . . . 34.32 110.239 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.27 51.84 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.973 -0.632 . . . . 33.090000000000003 112.262 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 p -121.07 118.98 31.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 34.119999999999997 110.5 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.09 -54.97 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.633 . . . . 32.32 110.34 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.2 m -99.9 135.52 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.421 -0.585 . . . . 32.740000000000002 109.421 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -49.94 -64.03 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 123.247 0.342 . . . . 31.289999999999999 111.538 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 55.07 75.14 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.813 0.695 . . . . 29.460000000000001 111.364 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.68 149.34 49.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.497 -0.859 . . . . 28.280000000000001 111.883 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.41 111.82 1.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.359 2.039 . . . . 27.510000000000002 111.699 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 66.91 177.72 0.23 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.551 -0.749 . . . . 26.48 111.793 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.7 -55.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.353 -0.839 . . . . 24.899999999999999 109.157 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.81 -118.8 0.56 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.822 -1.081 . . . . 23.190000000000001 110.877 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.41 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 39.6 m80 52.17 56.0 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 21.309999999999999 110.661 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -108.58 98.91 30.79 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.836 -0.62 . . . . 19.890000000000001 110.185 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 13' ' ' HIS . 3.6 Cg_exo -74.51 107.43 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.418 2.078 . . . . 18.120000000000001 112.513 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.76 0.32 10.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.048 0.451 . . . . 16.579999999999998 110.161 173.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.59 50.57 3.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 114.976 -1.011 . . . . 14.800000000000001 110.188 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.02 38.68 3.08 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.645 -0.707 . . . . 13.17 112.484 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB3' ' HA2' ' A' ' 24' ' ' GLY . . . -103.72 -23.95 13.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.727 0.299 . . . . 12.17 110.859 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 71.04 113.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.015 -0.993 . . . . 13.82 110.242 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 tt -26.45 -49.27 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.872 1.669 . . . . 12.130000000000001 114.018 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -41.67 -39.58 1.71 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.067 -1.424 . . . . 14.1 111.721 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.1 p -140.47 47.21 1.78 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.368 -0.975 . . . . 11.050000000000001 108.368 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 19' ' ' ALA . . . -56.01 -36.44 67.34 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 114.616 -1.174 . . . . 10.050000000000001 112.285 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -170.23 61.36 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.507 1.146 . . . . 10.380000000000001 108.244 178.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 82.3 mtt180 -124.25 138.75 54.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.484 -1.235 . . . . 8.3699999999999992 109.946 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.691 HG12 ' OE2' ' A' ' 58' ' ' GLU . 33.5 mm -48.72 127.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 114.369 -1.287 . . . . 5.7599999999999998 114.18 -167.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.86 -38.77 3.84 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.504 -1.68 . . . . 8.2200000000000006 110.029 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.759 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.0 p90 -176.51 -172.81 0.48 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.929 -0.578 . . . . 7.9900000000000002 110.402 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.738 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m-90 -124.01 150.36 44.96 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.462 -0.79 . . . . 5.6100000000000003 110.751 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' HB2' HE22 ' A' ' 38' ' ' GLN . 24.7 ptt180 -153.5 145.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.297 -0.41 . . . . 9.0600000000000005 111.596 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.6 t0 -79.34 130.6 68.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.909 -1.145 . . . . 8.3100000000000005 107.909 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.514 ' HG3' HD12 ' A' ' 54' ' ' ILE . 21.6 Cg_exo -61.17 -14.43 33.75 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 122.023 1.815 . . . . 10.41 112.293 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.11 2.06 52.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.473 -0.331 . . . . 10.85 111.193 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.9 m -129.1 39.35 0.5 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.624 0.601 . . . . 9.3200000000000003 112.624 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -60.42 128.71 26.96 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.519 2.146 . . . . 11.1 112.579 -174.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.01 -6.45 19.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 10.31 111.618 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -89.95 -179.54 5.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.456 -0.372 . . . . 9.2100000000000009 110.082 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.501 ' HD2' ' CE2' ' A' ' 29' ' ' TYR . 8.1 tpt180 -142.03 108.63 5.34 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.192 -0.203 . . . . 11.51 110.455 171.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.759 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -96.84 121.02 38.24 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.631 -0.828 . . . . 7.5 109.098 170.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.47 -35.3 78.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.958 -0.565 . . . . 10.609999999999999 110.125 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -147.86 149.39 33.06 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 121.78 0.8 . . . . 10.91 111.071 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.738 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 14.5 Cg_endo -52.77 142.38 51.49 Favored 'Trans proline' 0 C--N 1.348 0.515 1 C-N-CA 125.398 4.065 . . . . 7.5099999999999998 114.027 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.8 -156.0 17.71 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.828 -0.624 . . . . 7.5899999999999999 111.594 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 23.1 ttmt -98.1 143.56 28.51 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.093 -0.706 . . . . 11.68 109.093 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.7 t -66.83 132.66 93.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.309 -0.405 . . . . 9.1999999999999993 110.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.71 -29.4 24.15 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 10.25 111.491 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.556 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.8 m-85 -70.38 -37.75 74.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.561 -1.2 . . . . 10.49 110.581 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.546 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.4 OUTLIER -156.99 153.62 28.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.678 -0.49 . . . . 10.380000000000001 109.678 169.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 3.7 m-20 -74.42 76.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 12.539999999999999 112.447 -173.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -140.28 145.15 40.17 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.491 -0.929 . . . . 9.8699999999999992 108.491 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.4 Cg_exo -65.97 132.32 29.83 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.748 1.632 . . . . 9.5099999999999998 110.208 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -61.37 160.09 11.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.342 -0.39 . . . . 6.71 110.303 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 33' ' ' PRO . 6.0 mt -104.6 133.59 20.1 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.947 0.403 . . . . 7.8899999999999997 110.006 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.617 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 86.9 Cg_endo -77.71 152.07 28.87 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.766 1.644 . . . . 5.7699999999999996 112.447 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 m -74.44 157.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.513 -1.221 . . . . 5.96 112.051 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.37 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.056 2.143 . . . . 7.8399999999999999 115.701 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.691 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -52.81 -42.01 64.7 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.605 0.362 . . . . 6.6200000000000001 110.386 -176.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 85.5 mt-10 67.88 86.34 0.13 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.846 0.831 . . . . 8.5800000000000001 112.507 177.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' H ' HD11 ' A' ' 27' ' ' ILE . 16.4 tt0 72.31 60.64 0.13 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.645 -1.616 . . . . 7.6399999999999997 112.242 162.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.569 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 46.1 t30 -141.04 -51.21 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.693 -1.14 . . . . 7.0199999999999996 110.855 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.733 ' O ' ' HA ' ' A' ' 68' ' ' ARG . . . -38.78 -59.56 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.579 0.549 . . . . 5.4100000000000001 110.351 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HA ' ' H ' ' A' ' 68' ' ' ARG . 28.8 t70 -175.7 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.251 -1.34 . . . . 7.0099999999999998 107.737 170.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.9 -20.41 57.41 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 114.006 -1.452 . . . . 7.2000000000000002 113.333 -174.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.63 36.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.931 -0.766 . . . . 7.8200000000000003 108.931 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.96 31.05 20.98 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.653 -1.158 . . . . 8.6500000000000004 110.439 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 61' ' ' ASN . 21.0 t -66.9 -68.22 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 7.3099999999999996 109.771 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 62' ' ' ALA . 2.4 ttp180 65.32 136.43 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.286 -1.324 . . . . 10.210000000000001 112.54 -177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 72' ' ' ARG . 20.5 mt -74.5 153.2 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.356 -0.838 . . . . 8.8599999999999994 110.003 177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -87.79 25.94 1.42 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.482 -0.781 . . . . 13.02 111.091 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.07 13.41 83.69 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.21 -0.904 . . . . 12.130000000000001 110.899 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 69' ' ' ILE . 40.2 mtm180 49.77 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.295 1.038 . . . . 12.380000000000001 112.543 -170.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.4 t -129.52 -59.83 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.603 -1.181 . . . . 11.609999999999999 110.349 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 74' ' ' THR . 1.3 t -50.53 113.31 0.86 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.676 -1.602 . . . . 10.710000000000001 111.14 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -80.71 54.75 2.19 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.529 -1.214 . . . . 14.09 110.805 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.19 146.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.144 -1.389 . . . . 11.220000000000001 111.366 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.19 -15.72 35.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.632 -0.713 . . . . 13.710000000000001 111.496 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.04 -33.43 1.14 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.72 -0.752 . . . . 11.44 112.424 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG11 ' CZ ' ' A' ' 120' ' ' PHE . 63.8 t 64.85 88.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.097 0.951 . . . . 9.9900000000000002 111.346 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -90.82 132.01 36.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.528 -1.215 . . . . 11.640000000000001 108.937 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 148' ' ' VAL . 33.1 p -130.13 148.19 51.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.575 -0.284 . . . . 8.0 110.661 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.91 136.08 54.73 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 6.6500000000000004 109.433 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' OE1' ' HE2' ' A' ' 85' ' ' LYS . 41.2 tt0 -76.57 141.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.226 -0.443 . . . . 12.15 110.161 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 143' ' ' ALA . 97.1 t -67.89 131.34 33.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.776 0.798 . . . . 9.7100000000000009 111.936 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' OE1' ' A' ' 83' ' ' GLU . 27.8 mmtp -127.3 155.4 43.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.237 -1.347 . . . . 11.029999999999999 109.114 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -90.38 165.58 13.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.395 -0.595 . . . . 12.76 109.395 165.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.03 53.65 0.03 OUTLIER Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.819 -1.181 . . . . 13.25 113.688 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.736 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -92.23 -177.29 4.61 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.852 -0.339 . . . . 16.350000000000001 111.66 176.294 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 tp -140.19 110.88 6.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.28 0.562 . . . . 18.219999999999999 110.189 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.82 -162.3 16.68 Favored Glycine 0 C--N 1.319 -0.383 0 CA-C-N 115.689 -0.687 . . . . 17.91 111.484 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.2 p -81.9 76.45 8.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.954 0.883 . . . . 17.109999999999999 109.525 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.736 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -154.01 166.52 32.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.557 -1.202 . . . . 14.73 107.832 178.345 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.571 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 2.6 mt-10 -144.37 111.78 6.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 118.368 0.531 . . . . 14.94 110.4 162.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.638 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 36.5 mmt180 -125.8 157.57 37.17 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.924 -0.31 . . . . 10.57 110.739 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.0 mm? -94.12 126.8 39.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.904 -0.776 . . . . 8.8800000000000008 108.904 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.21 129.02 50.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.221 -0.445 . . . . 9.7799999999999994 109.882 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.69 157.13 65.68 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.912 -1.04 . . . . 6.4000000000000004 108.842 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.79 128.33 29.16 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.523 1.482 . . . . 6.5499999999999998 110.631 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.506 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 50.8 p -54.43 -25.76 26.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.645 0.609 . . . . 9.2899999999999991 112.645 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.45 12.12 21.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.825 -0.35 . . . . 10.859999999999999 111.526 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -85.43 -28.78 24.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.364 0.602 . . . . 5.3399999999999999 110.338 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -99.68 158.73 15.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.799 -0.637 . . . . 6.9699999999999998 111.572 -174.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 40.8 mm -104.02 123.67 57.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.203 -0.908 . . . . 10.199999999999999 110.356 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.44 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.4 mmm180 -95.26 121.81 37.3 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.592 -0.843 . . . . 12.119999999999999 110.629 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 t -149.5 143.49 25.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.713 -0.676 . . . . 14.609999999999999 110.605 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.67 -115.71 4.13 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 116.225 -0.443 . . . . 15.52 112.666 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.42 36.94 4.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 14.99 110.94 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -155.48 -177.98 6.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.107 0.48 . . . . 15.199999999999999 111.933 -175.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 19.1 m -131.74 147.19 52.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.529 -0.76 . . . . 9.2599999999999998 109.399 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 22.6 mm -126.64 149.82 31.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 10.550000000000001 109.968 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.59 123.54 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.205 -0.294 . . . . 7.3899999999999997 110.205 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 43.6 mtm -86.7 100.38 12.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.179 -0.674 . . . . 8.8499999999999996 109.179 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 14.9 p -82.72 136.47 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.497 -0.774 . . . . 9.6899999999999995 110.98 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.89 83.23 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.464 -0.939 . . . . 10.699999999999999 108.464 173.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -77.99 150.93 33.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.018 -0.992 . . . . 14.880000000000001 111.083 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.37 -5.88 18.56 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.566 -0.743 . . . . 16.920000000000002 113.15 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -73.32 -10.44 59.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 18.559999999999999 110.19 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.21 31.15 26.23 Favored Glycine 0 C--N 1.31 -0.866 0 C-N-CA 119.947 -1.121 . . . . 15.619999999999999 111.374 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.97 163.76 31.51 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 111.242 -0.743 . . . . 14.19 111.242 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.2 m-85 -97.27 112.44 24.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.806 0.336 . . . . 12.029999999999999 110.204 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.0 t70 -101.51 139.62 20.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.893 -0.594 . . . . 13.91 109.538 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -86.16 122.24 2.13 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.045 1.83 . . . . 12.35 112.971 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.53 121.52 59.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.177 -0.92 . . . . 9.4299999999999997 110.167 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.24 121.1 20.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.849 -0.797 . . . . 12.93 108.849 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.17 153.26 38.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.742 0.782 . . . . 8.0299999999999994 112.059 -173.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.2 ttmm -93.83 129.75 40.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.232 -1.349 . . . . 10.390000000000001 109.475 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.77 112.97 20.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.116 1.436 . . . . 8.3000000000000007 112.261 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 136' ' ' GLU . . . -89.44 174.36 41.52 Favored Glycine 0 N--CA 1.41 -3.062 0 CA-C-N 111.364 -2.653 . . . . 10.1 111.177 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.38 162.35 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 112.367 -1.917 . . . . 10.609999999999999 114.683 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -106.7 133.17 51.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.219 -0.9 . . . . 13.17 109.248 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.24 119.82 9.13 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.055 -0.52 . . . . 12.98 111.261 -174.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.17 29.58 75.19 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.183 -0.532 . . . . 14.34 112.544 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.46 89.7 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.633 -0.794 . . . . 13.119999999999999 112.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -116.53 153.8 31.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.077 -0.342 . . . . 10.619999999999999 110.077 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 70.5 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.091 0.472 . . . . 7.8200000000000003 111.387 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB2' ' C ' ' A' ' 128' ' ' GLY . 24.7 mt-10 -85.51 107.85 17.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.586 -0.733 . . . . 10.789999999999999 109.65 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 125' ' ' VAL . 23.2 mm -92.41 114.1 28.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 O-C-N 121.245 -0.909 . . . . 6.7300000000000004 110.31 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.638 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.4 mp -86.6 -47.8 8.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.293 -1.321 . . . . 8.7899999999999991 110.795 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mt-10 -144.29 167.25 22.9 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.052 -0.722 . . . . 10.44 109.052 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 114.51 -74.11 0.24 Allowed Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.631 -1.271 . . . . 8.8699999999999992 113.413 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 61.5 tp -97.66 178.09 5.28 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.694 -0.253 . . . . 8.5 110.998 -168.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.486 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 26.3 tptp -137.62 148.84 46.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.4 0.619 . . . . 14.15 112.124 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . . . -68.15 143.45 55.39 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 114.439 -1.255 . . . . 12.119999999999999 110.802 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 1.34 85.95 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.524 -0.846 . . . . 11.539999999999999 112.124 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -103.8 152.69 21.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.552 -0.536 . . . . 11.24 109.552 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 69.4 mt-30 -97.46 140.07 32.44 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 120.929 0.395 . . . . 10.49 111.295 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -134.71 143.99 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.152 -0.477 . . . . 5.4500000000000002 109.961 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.1 m -67.75 129.58 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.436 0.636 . . . . 6.5599999999999996 111.365 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.6 m -121.89 26.37 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.346 1.069 . . . . 6.9900000000000002 108.978 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -71.34 16.61 0.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.848 -1.524 . . . . 9.0600000000000005 112.861 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.13 -28.32 58.55 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.128 -0.789 . . . . 8.5 111.128 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -156.32 139.66 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.51 -0.552 . . . . 11.84 109.51 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.445 ' CD1' HG22 ' A' ' 155' ' ' ILE . 2.7 p90 -159.34 173.38 16.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.548 -0.296 . . . . 12.24 110.805 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.23 61.91 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 13.16 111.494 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 153' ' ' PHE . 12.8 tt -149.31 2.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.777 0.798 . . . . 11.949999999999999 109.416 171.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 10.3 p-10 -72.76 -16.41 61.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 11.220000000000001 110.651 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p -57.42 -43.14 83.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 11.9 109.556 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 38.8 tt0 -76.11 -36.52 58.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.251 -0.886 . . . . 11.17 108.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -59.97 -27.77 67.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.27 -1.332 . . . . 7.8200000000000003 111.519 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 164' ' ' THR . 32.5 t -79.0 -37.92 38.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 9.6400000000000006 110.496 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.96 -26.9 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.747 0.277 . . . . 10.57 111.747 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 11.2 ptp180 -74.62 2.46 9.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.136 0.421 . . . . 8.9000000000000004 112.136 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.47 13.18 8.3 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.462 -0.875 . . . . 7.1500000000000004 112.342 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 26.1 p 52.75 -97.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.672 0.789 . . . . 7.0899999999999999 112.153 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' VAL . 5.7 p -74.67 84.85 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.855 0.836 . . . . 9.1999999999999993 109.65 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.6 22.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.251 -0.886 . . . . 9.1099999999999994 111.534 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.662 ' O ' ' HG3' ' A' ' 168' ' ' MET . 5.9 tmm_? -75.09 90.35 2.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 14.58 110.433 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.662 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 14.5 mtm -161.87 26.31 0.12 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.973 -1.012 . . . . 11.94 109.953 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -138.65 47.17 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.422 -0.808 . . . . 14.99 110.217 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.89 1.48 56.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.116 -0.947 . . . . 15.01 110.207 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.7 p -131.34 151.08 51.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 14.25 110.469 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 13.6 t -169.88 171.65 7.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 14.890000000000001 109.504 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.3 t -151.61 166.49 31.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.665 -0.495 . . . . 15.85 109.665 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.28 49.02 7.72 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 17.539999999999999 111.379 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.87 44.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 17.850000000000001 111.588 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.31 113.62 25.55 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.111 -0.7 . . . . 19.670000000000002 109.111 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.478 HG23 HD23 ' A' ' 178' ' ' LEU . 18.6 m 45.68 -163.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 124.132 0.895 . . . . 19.52 111.674 -175.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 177' ' ' VAL . 2.9 mm? 57.63 50.27 11.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.083 0.401 . . . . 21.149999999999999 112.083 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 56.04 100.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.763 1.023 . . . . 23.25 113.763 168.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.935 -0.555 . . . . 23.52 109.697 176.149 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.689 0.281 . . . . 34.32 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.16 17.86 79.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.98 -0.628 . . . . 33.090000000000003 112.222 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -84.11 -46.99 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.059 -0.071 . . . . 34.119999999999997 110.91 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.05 58.31 4.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.327 0.584 . . . . 32.32 110.572 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 m -56.19 -40.88 74.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.326 -0.852 . . . . 32.740000000000002 111.311 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 m -98.74 12.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 31.289999999999999 110.776 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.49 -53.67 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 29.460000000000001 111.278 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.54 -146.53 7.86 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.952 -0.642 . . . . 28.280000000000001 111.932 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.13 132.0 16.1 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.563 2.175 . . . . 27.510000000000002 112.488 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -116.64 44.78 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.369 -0.604 . . . . 26.48 109.369 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 61.3 -165.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.051 -0.977 . . . . 24.899999999999999 111.55 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 -149.37 22.8 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.4 -0.68 . . . . 23.190000000000001 111.4 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -111.55 121.57 45.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.94 -0.393 . . . . 21.309999999999999 109.94 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -116.59 88.45 24.53 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.711 0.291 . . . . 19.890000000000001 110.572 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.57 171.83 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.605 2.203 . . . . 18.120000000000001 112.276 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.5 3.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.095 0.474 . . . . 16.579999999999998 110.467 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.86 -177.8 3.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 14.800000000000001 109.873 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.75 -120.66 1.29 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.218 -0.991 . . . . 13.17 111.729 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.94 5.03 23.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.067 0.461 . . . . 12.17 110.334 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 64.53 74.32 0.4 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.665 -1.152 . . . . 13.82 109.74 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.8 mt 63.37 86.13 0.12 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.622 0.725 . . . . 12.130000000000001 110.31 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -49.62 -32.61 13.27 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.165 -1.38 . . . . 14.1 112.313 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 t -163.99 54.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.043 0.925 . . . . 11.050000000000001 110.101 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -56.73 14.56 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 110.559 -1.016 . . . . 10.050000000000001 110.559 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -160.79 53.48 0.3 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.56 1.171 . . . . 10.380000000000001 109.809 173.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.487 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 77.6 mtm180 -119.54 143.32 47.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.127 -1.397 . . . . 8.3699999999999992 109.87 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.571 HG12 ' OE2' ' A' ' 58' ' ' GLU . 31.1 mm -49.23 120.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 114.286 -1.324 . . . . 5.7599999999999998 112.824 -169.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.5 -35.06 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.963 -1.471 . . . . 8.2200000000000006 110.298 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.429 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 44.0 p90 -176.15 -173.54 0.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.858 -0.61 . . . . 7.9900000000000002 109.387 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.731 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.15 154.11 41.99 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.105 -0.498 . . . . 5.6100000000000003 111.599 -175.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -156.51 150.64 25.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.389 -0.823 . . . . 9.0600000000000005 110.415 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.3 t0 -82.72 134.69 46.89 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.705 -1.221 . . . . 8.3100000000000005 107.705 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -62.67 -13.27 32.88 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.113 1.875 . . . . 10.41 111.967 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.68 1.75 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 10.85 111.108 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -129.22 36.3 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 112.965 0.728 . . . . 9.3200000000000003 112.965 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.8 Cg_endo -54.81 119.14 5.98 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.343 2.028 . . . . 11.1 112.517 -172.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.23 -21.0 6.97 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.889 -0.884 . . . . 10.31 110.889 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -85.0 115.42 22.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.25 -0.475 . . . . 9.2100000000000009 110.635 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 47.9 ttt180 -99.73 102.8 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.343 0.592 . . . . 11.51 110.197 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 82.9 m-85 -76.74 146.84 37.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 7.5 109.801 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.65 -27.7 69.4 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.128 -1.397 . . . . 10.609999999999999 110.323 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.9 pttm -169.79 165.94 5.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.386 -0.825 . . . . 10.91 110.355 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.731 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.6 Cg_endo -51.25 168.63 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.113 2.542 . . . . 7.5099999999999998 113.104 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.66 -159.94 28.21 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.67 -0.776 . . . . 7.5899999999999999 112.036 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.1 ttmt -98.44 147.47 24.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.24 -0.281 . . . . 11.68 110.24 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 p -70.68 128.77 90.64 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.558 -0.292 . . . . 9.1999999999999993 111.462 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.65 -22.94 17.45 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.827 1.684 . . . . 10.25 110.507 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.558 ' CD2' HG11 ' A' ' 35' ' ' VAL . 97.8 m-85 -72.57 -24.98 61.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.759 -1.109 . . . . 10.49 110.949 -175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.24 -104.38 0.13 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.737 -0.785 . . . . 10.380000000000001 112.616 167.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -166.55 58.17 0.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.313 0.578 . . . . 12.539999999999999 111.596 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.3 ptm -133.36 149.9 73.7 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.626 -0.509 . . . . 9.8699999999999992 109.626 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -66.41 131.8 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.545 1.496 . . . . 9.5099999999999998 109.772 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 mt -60.59 160.04 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.699 0.625 . . . . 6.71 110.756 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.1 mm -99.4 130.73 26.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.212 -0.662 . . . . 7.8899999999999997 109.212 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 58.2 Cg_endo -73.46 146.07 38.95 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 121.389 1.393 . . . . 5.7699999999999996 112.145 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 31.3 m -68.81 159.69 5.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.269 -1.332 . . . . 5.96 112.251 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.487 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.87 -74.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.526 2.33 . . . . 7.8399999999999999 116.216 -178.007 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -61.63 -38.86 89.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.669 1.223 . . . . 6.6200000000000001 111.93 -168.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 50.2 mt-10 49.96 36.42 11.66 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 111.865 -2.425 . . . . 8.5800000000000001 112.291 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 49.0 mt-10 -163.22 54.63 0.18 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 124.803 1.314 . . . . 7.6399999999999997 111.834 -171.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 58' ' ' GLU . 64.8 t30 -148.68 -34.93 0.2 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.568 -1.196 . . . . 7.0199999999999996 110.309 173.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -29.77 -59.22 0.17 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 125.413 1.485 . . . . 5.4100000000000001 111.969 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' HB3' ' H ' ' A' ' 68' ' ' ARG . 37.8 t70 -130.14 65.36 1.51 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.596 -1.184 . . . . 7.0099999999999998 108.953 173.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.99 -54.16 4.94 Favored Glycine 0 CA--C 1.503 -0.677 0 CA-C-N 114.23 -1.35 . . . . 7.2000000000000002 111.498 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.45 28.05 0.65 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.076 -1.062 . . . . 7.8200000000000003 109.005 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.88 24.76 11.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.311 -1.313 . . . . 8.6500000000000004 110.815 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.439 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 47.5 t -53.43 -53.32 25.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.746 -0.835 . . . . 7.3099999999999996 108.746 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.553 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 54.9 mtm180 73.16 141.29 0.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.713 1.375 . . . . 10.210000000000001 114.713 165.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.547 ' CG2' ' HG2' ' A' ' 72' ' ' ARG . 17.2 mt -75.74 155.09 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 113.338 -1.755 . . . . 8.8599999999999994 110.226 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 69' ' ' ILE . 24.4 t70 -85.53 64.12 8.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.597 1.189 . . . . 13.02 109.324 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.04 25.31 59.5 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 112.925 -1.943 . . . . 12.130000000000001 114.554 170.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HG2' ' CG2' ' A' ' 69' ' ' ILE . 7.7 ptm180 -121.66 179.33 4.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.546 -1.279 . . . . 12.380000000000001 107.546 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 t -124.32 123.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.337 -0.616 . . . . 11.609999999999999 109.337 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -110.54 30.69 6.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.188 0.995 . . . . 10.710000000000001 109.897 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 60.04 107.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.649 -1.614 . . . . 14.09 111.45 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 7.1 p-10 -88.24 91.72 8.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.825 0.822 . . . . 11.220000000000001 111.189 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.79 -17.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.58 -1.191 . . . . 13.710000000000001 110.562 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.78 -60.2 4.74 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.123 -1.037 . . . . 11.44 111.107 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.1 98.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 113.969 -1.115 . . . . 9.9900000000000002 109.481 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 65.6 ttt180 -126.22 132.37 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 11.640000000000001 109.737 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 148' ' ' VAL . 76.6 p -139.05 143.11 38.24 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.739 -0.664 . . . . 8.0 109.484 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -108.43 127.75 54.18 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.435 -0.58 . . . . 6.6500000000000004 109.435 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 34.4 tt0 -73.1 139.24 46.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.888 -0.596 . . . . 12.15 109.932 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -61.74 135.32 26.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.278 -0.874 . . . . 9.7100000000000009 111.727 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 28.2 mmtp -131.11 156.51 45.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.602 -1.181 . . . . 11.029999999999999 109.693 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.43 143.79 27.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.497 -0.557 . . . . 12.76 109.497 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.39 -33.12 2.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.702 -1.237 . . . . 13.25 112.678 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 93' ' ' GLU . 9.3 ptt180 -47.37 143.52 3.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.258 1.207 . . . . 16.350000000000001 114.258 -169.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tt -155.57 86.17 1.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.286 -1.376 . . . . 18.219999999999999 107.286 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 -6.38 82.2 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 109.07 -1.612 . . . . 17.91 109.07 -172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 5.5 p -111.26 173.93 6.1 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.4 -1.4 . . . . 17.109999999999999 108.504 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m -86.66 148.01 25.65 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.746 0.784 . . . . 14.73 110.645 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.524 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 10.9 tt0 -67.39 114.79 6.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.14 -1.845 . . . . 14.94 111.762 -170.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 138' ' ' LEU . 1.5 mpp_? -119.61 156.74 29.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.829 -1.078 . . . . 10.57 109.118 170.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -90.68 113.58 25.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.629 -0.878 . . . . 8.8800000000000008 108.629 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.68 129.95 34.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.646 . . . . 9.7799999999999994 110.99 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.8 m -144.67 159.03 52.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.828 -1.078 . . . . 6.4000000000000004 109.103 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.42 136.28 70.67 Favored 'Trans proline' 0 C--N 1.333 -0.277 0 C-N-CA 122.192 1.928 . . . . 6.5499999999999998 110.589 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 m -57.92 -24.85 59.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 9.2899999999999991 111.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.6 6.61 43.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.183 -0.207 . . . . 10.859999999999999 111.554 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -40.71 20.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.058 0.456 . . . . 5.3399999999999999 110.707 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -90.87 161.85 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.732 -0.667 . . . . 6.9699999999999998 111.98 -173.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 mm -113.15 103.79 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.892 -0.594 . . . . 10.199999999999999 109.442 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 7.2 ptt180 -101.53 134.27 44.91 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.33 -1.348 . . . . 12.119999999999999 110.997 173.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 t -150.47 128.88 12.12 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.06 -1.427 . . . . 14.609999999999999 109.589 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.76 -109.74 3.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.589 -0.815 . . . . 15.52 112.117 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.16 30.31 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.077 0.399 . . . . 14.99 112.077 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.547 HH11 HD11 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -163.75 176.91 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 15.199999999999999 112.004 -177.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.4 m -132.55 156.66 46.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 9.2599999999999998 110.602 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.547 HD11 HH11 ' A' ' 108' ' ' ARG . 41.4 mm -129.26 149.48 33.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.277 -0.638 . . . . 10.550000000000001 109.277 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.592 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -128.94 141.82 51.14 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.658 0.265 . . . . 7.3899999999999997 110.497 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 122' ' ' PRO . 62.0 mmm -103.37 99.84 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.648 -0.501 . . . . 8.8499999999999996 109.648 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.0 p -82.05 135.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.979 0.418 . . . . 9.6899999999999995 111.003 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.06 93.54 5.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 10.699999999999999 110.922 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -89.06 160.5 17.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.626 -0.716 . . . . 14.880000000000001 111.343 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.43 23.94 31.42 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.737 -0.945 . . . . 16.920000000000002 110.737 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -97.54 19.41 13.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.989 0.423 . . . . 18.559999999999999 111.102 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.5 68.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.951 -0.642 . . . . 15.619999999999999 112.702 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 -175.76 47.55 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.16 -0.776 . . . . 14.19 111.16 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 81.8 m-85 -100.36 178.7 4.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.868 0.366 . . . . 12.029999999999999 110.881 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.525 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 13.4 t70 -140.52 122.85 9.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.467 0.651 . . . . 13.91 109.721 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HB3' ' SD ' ' A' ' 112' ' ' MET . 71.1 Cg_endo -86.96 113.78 1.04 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.324 2.683 . . . . 12.35 112.422 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.3 p -103.91 140.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.183 -0.917 . . . . 9.4299999999999997 109.647 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 110' ' ' ILE . 44.9 tt0 -76.24 120.97 22.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.108 -0.701 . . . . 12.93 109.108 171.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -131.65 159.35 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 8.0299999999999994 111.566 -173.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.4 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 39.9 ttmt -103.11 128.04 50.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.186 -0.916 . . . . 10.390000000000001 109.415 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.66 108.25 5.34 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.589 0.218 . . . . 8.3000000000000007 111.589 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.52 71.04 0.28 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 118.021 -2.038 . . . . 10.1 114.006 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.011 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.71 163.03 39.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.554 -0.906 . . . . 10.609999999999999 108.554 157.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.7 m -131.5 137.03 48.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.139 -0.689 . . . . 13.17 109.139 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -142.73 90.63 2.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 120.888 0.375 . . . . 12.98 111.954 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.2 60.19 8.74 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.733 -0.667 . . . . 14.34 113.411 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.84 82.26 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 13.119999999999999 112.41 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -134.64 165.54 24.99 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.9 -0.778 . . . . 10.619999999999999 108.9 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.0 m -117.81 163.46 16.48 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.633 -0.427 . . . . 7.8200000000000003 110.714 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 1.011 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 23.9 mt-10 -110.44 120.11 41.37 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.734 0.778 . . . . 10.789999999999999 111.258 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.796 HD12 HG21 ' A' ' 125' ' ' VAL . 22.3 mm -85.23 107.95 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.777 -1.101 . . . . 6.7300000000000004 109.644 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.0 mp -68.67 -46.54 68.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.298 -0.865 . . . . 8.7899999999999991 109.984 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.9 mt-10 -144.45 155.79 43.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.122 -0.49 . . . . 10.44 110.101 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 129.28 -66.85 0.57 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.862 -1.161 . . . . 8.8699999999999992 113.064 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 111' ' ' ALA . 3.1 mm? -97.71 -176.29 3.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.37 0.878 . . . . 8.5 113.37 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 23.0 tptm -144.34 151.91 39.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.019 -0.991 . . . . 14.15 109.89 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.17 132.41 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.345 -0.843 . . . . 12.119999999999999 110.21 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.0 47.32 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.485 -0.864 . . . . 11.539999999999999 111.315 -174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -104.17 141.15 36.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.64 -0.504 . . . . 11.24 109.64 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 86.8 mt-30 -97.21 147.1 24.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.695 0.283 . . . . 10.49 111.008 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.0 m -136.51 152.55 29.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.38 -0.6 . . . . 5.4500000000000002 109.38 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 81' ' ' THR . 32.9 m -56.53 138.86 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.72 0.637 . . . . 6.5599999999999996 111.881 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 82' ' ' ALA . 43.1 t -136.28 -39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.235 -0.893 . . . . 6.9900000000000002 110.043 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 12.0 t -137.45 96.83 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.081 -0.711 . . . . 9.0600000000000005 109.081 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -171.57 61.9 0.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.71 -0.956 . . . . 8.5 110.71 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -123.66 -136.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.629 -0.286 . . . . 11.84 110.622 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.89 63.2 0.46 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.062 0.545 . . . . 12.24 111.139 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.95 94.84 5.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 13.16 110.707 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.28 -9.14 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 11.949999999999999 109.709 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 169' ' ' GLN . 1.4 t70 -82.72 1.25 39.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.619 -0.719 . . . . 11.220000000000001 110.232 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -66.54 -40.41 89.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.809 -0.441 . . . . 11.9 109.809 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.11 -51.79 55.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.236 0.471 . . . . 11.17 110.038 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.06 66.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.834 . . . . 7.8200000000000003 111.422 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 164' ' ' THR . 35.6 t -70.77 -38.39 73.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.181 0.515 . . . . 9.6400000000000006 110.609 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.96 -32.44 65.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.83 0.824 . . . . 10.57 110.907 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -89.93 -67.02 0.87 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 114.327 -1.306 . . . . 8.9000000000000004 111.019 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.71 77.88 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.563 -0.744 . . . . 7.1500000000000004 112.658 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' SER . 56.1 p 47.26 -100.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.191 0.996 . . . . 7.0899999999999999 113.267 174.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.33 -30.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.03 0.443 . . . . 9.1999999999999993 111.235 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.56 58.62 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.16 0.505 . . . . 9.1099999999999994 111.096 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 164' ' ' THR . 0.0 OUTLIER -71.98 -106.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.745 -0.661 . . . . 14.58 110.931 173.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.3 mtm 62.98 103.44 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.925 0.49 . . . . 11.94 112.271 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.405 ' HB2' ' OD1' ' A' ' 156' ' ' ASP . 24.6 tm0? -47.25 -51.68 18.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.512 -0.767 . . . . 14.99 110.539 175.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -108.65 27.75 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.812 0.815 . . . . 15.01 110.254 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 75.4 p 51.08 33.3 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.38 -1.282 . . . . 14.25 113.593 173.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.4 t -153.25 170.29 20.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.251 0.548 . . . . 14.890000000000001 111.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 65.3 p -134.78 32.72 3.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 15.85 108.785 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.29 8.94 68.78 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.447 -0.797 . . . . 17.539999999999999 111.894 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.1 97.96 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 17.850000000000001 108.965 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -120.89 -60.89 1.62 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.669 -0.696 . . . . 19.670000000000002 110.319 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 178' ' ' LEU . 3.0 m 36.17 -108.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.984 0.735 . . . . 19.52 112.984 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.448 ' H ' HG23 ' A' ' 177' ' ' VAL . 80.3 mt -116.29 29.1 8.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.709 -0.619 . . . . 21.149999999999999 111.256 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -93.61 158.84 15.49 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.523 -0.547 . . . . 23.25 109.523 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.409 ' HG3' ' OXT' ' A' ' 180' ' ' GLN . 8.6 pt20 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.268 -0.872 . . . . 23.52 110.548 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.394 0.14 . . . . 34.32 110.821 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.63 -127.13 33.65 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.918 -0.658 . . . . 33.090000000000003 111.842 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 t -89.88 120.58 31.23 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.742 -0.466 . . . . 34.119999999999997 109.742 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.68 44.41 1.03 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.026 0.441 . . . . 32.32 110.392 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 m -84.43 -19.4 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.917 -0.583 . . . . 32.740000000000002 110.274 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.3 m -86.22 -20.02 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 31.289999999999999 110.771 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -103.44 83.88 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.325 -0.62 . . . . 29.460000000000001 109.325 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.57 -151.98 33.22 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.066 -0.814 . . . . 28.280000000000001 111.066 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.06 153.54 5.75 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.412 2.075 . . . . 27.510000000000002 111.982 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -55.27 -64.3 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.506 -0.553 . . . . 26.48 109.506 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -98.46 120.89 39.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 24.899999999999999 109.049 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.3 -73.55 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.523 -0.846 . . . . 23.190000000000001 111.533 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -83.98 54.77 3.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.535 . . . . 21.309999999999999 109.554 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -118.21 146.87 40.35 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.7 -0.682 . . . . 19.890000000000001 110.804 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.7 114.37 2.72 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 123.061 2.508 . . . . 18.120000000000001 111.67 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.43 4.83 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 16.579999999999998 111.911 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.2 72.08 0.35 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.974 0.796 . . . . 14.800000000000001 111.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.56 70.6 2.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 13.17 111.43 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.82 1.77 54.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.457 0.54 . . . . 12.17 112.457 -173.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' LYS . 32.6 tt0 62.77 75.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 13.82 111.074 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.7 tp 70.61 -17.51 0.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.451 0.7 . . . . 12.130000000000001 112.482 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' GLU . 35.1 ttmt -80.47 61.1 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.451 0.643 . . . . 14.1 110.441 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t 42.12 49.96 4.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.905 -1.498 . . . . 11.050000000000001 112.764 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.27 -55.84 1.89 Allowed Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.514 -0.85 . . . . 10.050000000000001 111.01 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -153.72 66.8 0.74 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.385 1.088 . . . . 10.380000000000001 110.043 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 32.0 mtt180 -135.49 138.75 43.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.971 -1.468 . . . . 8.3699999999999992 109.362 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.616 HG12 ' CG ' ' A' ' 58' ' ' GLU . 31.3 mm -52.92 120.64 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 121.982 0.896 . . . . 5.7599999999999998 113.236 -170.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.34 -37.32 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.665 -1.607 . . . . 8.2200000000000006 110.291 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.708 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.1 p90 -169.77 -173.47 1.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.165 0.507 . . . . 7.9900000000000002 111.611 -174.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.58 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.57 145.71 50.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.252 -0.886 . . . . 5.6100000000000003 110.908 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -149.26 157.52 43.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.585 . . . . 9.0600000000000005 110.207 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -91.32 136.08 27.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.673 -0.862 . . . . 8.3100000000000005 108.673 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.45 -12.48 27.94 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.247 1.965 . . . . 10.41 112.395 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.608 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -100.47 2.57 42.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.605 0.24 . . . . 10.85 111.622 176.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.0 m -126.1 45.39 1.46 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.276 0.56 . . . . 9.3200000000000003 111.451 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HD3' ' C ' ' A' ' 34' ' ' MET . 22.7 Cg_exo -59.56 112.19 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.585 2.19 . . . . 11.1 112.252 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -32.7 3.35 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.309 -0.716 . . . . 10.31 111.309 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.45 ' CG ' ' CE2' ' A' ' 40' ' ' PHE . 28.4 tp60 -68.1 125.67 27.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.276 0.56 . . . . 9.2100000000000009 110.856 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.602 ' HG2' ' CE2' ' A' ' 29' ' ' TYR . 5.1 tmm_? -114.55 101.56 9.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.448 -0.797 . . . . 11.51 110.086 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 56.4 m-85 -85.79 141.23 29.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.498 0.666 . . . . 7.5 109.782 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.93 -36.59 84.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.313 -1.312 . . . . 10.609999999999999 111.067 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.5 mttp -146.32 163.31 30.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 123.406 0.441 . . . . 10.91 110.998 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -51.49 171.61 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.958 3.105 . . . . 7.5099999999999998 114.175 175.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.71 -171.47 25.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 7.5899999999999999 112.69 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 20.9 ttmt -83.86 144.8 29.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.604 -0.517 . . . . 11.68 109.604 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -64.76 136.65 96.86 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.922 -0.581 . . . . 9.1999999999999993 109.623 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.98 -24.76 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.411 2.074 . . . . 10.25 112.099 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 64.3 m-85 -82.45 -34.47 28.12 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.671 -0.695 . . . . 10.49 110.839 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.6 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -117.75 -165.02 1.05 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.872 -1.058 . . . . 10.380000000000001 110.308 171.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.53 60.88 1.24 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.189 0.995 . . . . 12.539999999999999 109.066 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.8 ptm -138.32 146.15 50.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 113.86 -1.518 . . . . 9.8699999999999992 109.325 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 19.4 Cg_exo -66.1 132.85 31.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.107 1.871 . . . . 9.5099999999999998 110.177 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -61.63 161.8 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.309 0.38 . . . . 6.71 110.43 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.61 126.77 33.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.371 -0.603 . . . . 7.8899999999999997 109.371 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 53.8 Cg_endo -73.37 131.75 16.79 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 121.309 1.339 . . . . 5.7699999999999996 112.351 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.27 159.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.381 -1.282 . . . . 5.96 113.315 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 10.3 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.109 2.564 . . . . 7.8399999999999999 116.304 -177.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -64.58 -38.22 90.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.56 1.172 . . . . 6.6200000000000001 109.737 -171.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 10.9 tt0 54.63 40.55 31.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 111.863 -2.426 . . . . 8.5800000000000001 111.15 170.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.54 45.96 0.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.909 -1.496 . . . . 7.6399999999999997 109.644 -172.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' A' ' 27' ' ' ILE . 18.4 t-20 44.12 126.11 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.818 1.784 . . . . 7.0199999999999996 115.818 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.605 ' H ' ' HB ' ' A' ' 27' ' ' ILE . . . -26.78 -63.16 0.08 Allowed 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 109.518 -3.492 . . . . 5.4100000000000001 112.306 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 15.0 t70 -169.24 90.43 0.22 Allowed 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 118.257 -1.377 . . . . 7.0099999999999998 113.229 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.14 69.2 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.431 -0.804 . . . . 7.2000000000000002 111.97 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 72.69 -32.61 0.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.545 0.738 . . . . 7.8200000000000003 112.908 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.19 -4.02 0.09 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.197 0.443 . . . . 8.6500000000000004 112.197 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 164' ' ' THR . 21.5 t -74.67 -74.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 111.675 0.25 . . . . 7.3099999999999996 111.675 -174.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 33.8 mtm180 65.57 142.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.009 0.909 . . . . 10.210000000000001 113.172 -173.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 70' ' ' ASP . 17.6 mt -87.18 161.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.809 -1.087 . . . . 8.8599999999999994 110.218 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' N ' HG22 ' A' ' 69' ' ' ILE . 37.6 t70 -79.34 47.67 0.83 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.913 -0.585 . . . . 13.02 110.736 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.2 30.73 64.57 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.568 -0.742 . . . . 12.130000000000001 112.517 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -131.61 172.83 11.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.547 -0.908 . . . . 12.380000000000001 108.547 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.4 t -116.1 136.05 54.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.873 -0.417 . . . . 11.609999999999999 109.873 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.9 44.69 0.76 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.576 0.703 . . . . 10.710000000000001 111.432 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -90.12 70.04 7.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.249 -0.887 . . . . 14.09 109.205 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -133.6 119.01 18.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.806 -1.088 . . . . 11.220000000000001 108.27 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' H ' HD22 ' A' ' 77' ' ' LEU . 1.7 mm? -70.88 -2.68 15.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.579 -1.191 . . . . 13.710000000000001 112.822 -165.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.6 24.51 0.25 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.864 -0.684 . . . . 11.44 112.505 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.0 t 63.71 94.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.707 0.765 . . . . 9.9900000000000002 111.22 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.611 ' HD3' ' H ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -96.28 131.52 42.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.053 -0.976 . . . . 11.640000000000001 109.78 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 114' ' ' ALA . 74.6 p -142.98 156.56 44.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.961 -0.563 . . . . 8.0 110.182 -175.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -120.01 129.3 54.2 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.567 -0.901 . . . . 6.6500000000000004 108.567 171.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 43.3 tt0 -80.11 131.88 35.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.855 -0.611 . . . . 12.15 110.054 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 95' ' ' LEU . 77.2 t -55.6 131.36 18.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 9.7100000000000009 110.955 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.36 145.06 9.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.462 -1.245 . . . . 11.029999999999999 109.455 172.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.476 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.3 mp -74.48 152.29 39.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.205 -0.907 . . . . 12.76 110.838 -176.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 178.4 45.63 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.011 -1.09 . . . . 13.25 112.94 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.717 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -75.7 -177.95 3.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.21 0.528 . . . . 16.350000000000001 112.029 -178.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.17 112.34 9.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.533 -0.758 . . . . 18.219999999999999 109.147 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.1 -169.37 19.76 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 115.406 -0.816 . . . . 17.91 111.234 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 m -84.89 75.09 10.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.491 1.138 . . . . 17.109999999999999 109.47 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.717 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 2.1 m -155.36 168.75 26.05 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.641 -1.618 . . . . 14.73 106.758 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 5.1 tt0 -143.43 116.59 8.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.803 0.729 . . . . 14.94 109.835 163.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -134.79 160.54 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.549 0.214 . . . . 10.57 111.36 -172.015 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.619 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -91.69 116.69 29.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.137 -0.69 . . . . 8.8800000000000008 109.137 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -96.41 131.86 42.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.806 0.336 . . . . 9.7799999999999994 111.388 -173.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.02 150.78 54.05 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.842 -0.799 . . . . 6.4000000000000004 108.842 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HG2' HG11 ' A' ' 149' ' ' VAL . 50.8 Cg_exo -59.19 133.1 50.71 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 121.839 1.693 . . . . 6.5499999999999998 110.704 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 22.9 t -61.45 -31.21 71.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 9.2899999999999991 110.997 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -74.67 -5.25 42.09 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.372 -0.131 . . . . 10.859999999999999 111.043 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -73.57 -39.76 64.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.274 0.559 . . . . 5.3399999999999999 109.984 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 109' ' ' THR . 74.5 mt -65.13 148.1 52.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.67 -1.15 . . . . 6.9699999999999998 113.034 -170.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.54 127.49 52.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.755 -1.111 . . . . 10.199999999999999 108.433 170.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 16.3 mmt180 -104.72 123.46 47.67 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.909 -0.717 . . . . 12.119999999999999 110.811 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -146.58 138.99 25.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.432 -0.804 . . . . 14.609999999999999 109.691 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.98 -118.33 6.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.292 -0.48 . . . . 15.52 112.776 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.7 36.89 4.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.19 0.519 . . . . 14.99 110.949 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -148.22 173.93 12.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 15.199999999999999 111.581 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.506 HG21 HD13 ' A' ' 102' ' ' LEU . 5.8 m -121.77 146.45 47.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 9.2599999999999998 109.87 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 26.3 mm -131.13 148.41 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.891 0.377 . . . . 10.550000000000001 110.047 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -116.55 159.64 21.82 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.474 -0.565 . . . . 7.3899999999999997 109.474 173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.449 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 58.8 ttp -125.75 100.78 6.56 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.545 -0.909 . . . . 8.8499999999999996 108.545 174.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 14.4 p -80.89 129.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.363 0.601 . . . . 9.6899999999999995 111.715 -168.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 81' ' ' THR . . . -79.13 84.53 5.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.878 -1.056 . . . . 10.699999999999999 109.991 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -67.5 141.2 56.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.84 -0.618 . . . . 14.880000000000001 110.989 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.37 -2.21 40.43 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.627 -0.989 . . . . 16.920000000000002 110.627 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -83.57 6.54 20.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.932 -0.634 . . . . 18.559999999999999 111.123 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 6.01 70.39 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.41 -0.814 . . . . 15.619999999999999 113.241 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.9 175.41 20.85 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 14.19 112.486 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 85.5 m-85 -127.05 122.28 33.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.658 -0.497 . . . . 12.029999999999999 109.658 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 113' ' ' VAL . 20.4 t70 -116.29 134.43 22.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.145 -0.479 . . . . 13.91 111.968 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 3.1 Cg_endo -77.56 136.33 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.987 1.791 . . . . 12.35 112.505 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.94 123.76 64.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 9.4299999999999997 109.8 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.0 tt0 -75.56 121.19 22.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 12.93 109.294 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 141' ' ' LEU . 27.3 m -128.45 163.7 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.199 0.523 . . . . 8.0299999999999994 111.608 -173.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 138' ' ' LEU . 40.3 ttmt -102.88 126.18 49.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.008 -0.738 . . . . 10.390000000000001 109.008 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.453 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.57 104.03 4.66 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.1 -0.5 . . . . 8.3000000000000007 110.998 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.496 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.2 71.19 0.28 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 117.922 -2.085 . . . . 10.1 114.968 169.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -147.68 162.52 38.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.054 -1.461 . . . . 10.609999999999999 107.054 150.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -134.15 129.52 35.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.694 0.679 . . . . 13.17 110.449 175.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.16 126.01 11.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.306 -0.407 . . . . 12.98 111.378 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.11 33.96 88.65 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.113 -0.494 . . . . 14.34 112.885 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.04 11.23 81.51 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.832 -0.699 . . . . 13.119999999999999 112.05 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.35 170.99 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.317 -0.623 . . . . 10.619999999999999 109.317 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 p -119.28 143.66 47.21 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.04 0.447 . . . . 7.8200000000000003 110.907 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.3 mp0 -85.87 122.0 29.32 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.822 -0.626 . . . . 10.789999999999999 111.584 175.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.492 HD11 HD21 ' A' ' 102' ' ' LEU . 19.5 mm -88.03 109.33 19.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.52 -0.764 . . . . 6.7300000000000004 109.112 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 128' ' ' GLY . 1.3 mp -76.03 -52.17 10.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.379 -1.282 . . . . 8.7899999999999991 109.264 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -144.74 170.83 15.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.688 -0.687 . . . . 10.44 110.322 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 109.85 -59.54 0.35 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.37 -0.919 . . . . 8.8699999999999992 113.394 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 125' ' ' VAL . 17.9 mt -96.83 -172.66 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.14 0.495 . . . . 8.5 111.828 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 63.7 tttm -149.77 154.89 39.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 14.15 109.212 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . . . -67.8 127.16 31.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.641 -0.708 . . . . 12.119999999999999 110.274 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.6 -8.35 28.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.033 -0.827 . . . . 11.539999999999999 111.033 -171.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mm-40 -97.27 116.63 29.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 11.24 109.343 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 94.2 mt-30 -91.29 135.67 33.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.754 -0.657 . . . . 10.49 111.549 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 149' ' ' VAL . 2.5 p -127.97 138.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.756 -0.461 . . . . 5.4500000000000002 109.756 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.5 m -62.71 134.55 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 O-C-N 123.442 0.464 . . . . 6.5599999999999996 110.531 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 101' ' ' ALA . 13.2 m -119.94 -58.09 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.332 0.864 . . . . 6.9900000000000002 113.332 -170.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.609 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 22.9 t 158.21 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.357 -0.979 . . . . 9.0600000000000005 108.357 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 151.86 134.49 2.13 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.505 -0.855 . . . . 8.5 112.552 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -109.49 102.8 11.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.493 -0.558 . . . . 11.84 109.493 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.453 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 70.5 m-85 -109.41 -13.56 14.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.334 -0.394 . . . . 12.24 110.724 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.5 mt 67.25 -177.58 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 13.16 110.923 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.2 mt 62.72 52.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.997 0.904 . . . . 11.949999999999999 109.002 -175.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.6 -28.18 31.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.038 -0.983 . . . . 11.220000000000001 111.441 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -59.24 -31.49 69.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.424 -1.262 . . . . 11.9 111.539 -169.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.66 -30.67 71.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.188 -1.369 . . . . 11.17 111.003 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.88 -25.68 40.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.656 -0.702 . . . . 7.8200000000000003 110.525 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.5 m -80.79 -17.2 51.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 9.6400000000000006 110.076 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' HH11 ' A' ' 162' ' ' ARG . 90.8 mt -65.53 -48.82 71.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.206 -0.664 . . . . 10.57 109.206 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.431 HH11 ' HB2' ' A' ' 161' ' ' LEU . 9.6 mpt_? -76.02 -173.33 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.444 -0.798 . . . . 8.9000000000000004 109.968 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.44 -50.39 4.4 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.779 -0.724 . . . . 7.1500000000000004 112.649 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.467 ' HA ' HG11 ' A' ' 67' ' ' VAL . 20.4 p -80.98 -86.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.309 . . . . 7.0899999999999999 110.993 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.7 91.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.541 -0.54 . . . . 9.1999999999999993 109.541 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.95 155.77 3.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 9.1099999999999994 110.572 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.448 ' NE ' ' H ' ' A' ' 168' ' ' MET . 0.0 OUTLIER -120.35 -109.14 0.35 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.486 -0.486 . . . . 14.58 111.674 170.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.448 ' H ' ' NE ' ' A' ' 167' ' ' ARG . 26.0 mtm 58.2 16.62 4.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.508 0.723 . . . . 11.94 112.441 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 62.12 81.44 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.833 0.825 . . . . 14.99 109.38 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -62.29 -39.99 94.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.952 -1.476 . . . . 15.01 111.935 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.3 p -131.4 93.11 3.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 14.25 111.019 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 13.5 t -150.57 170.7 18.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.144 0.497 . . . . 14.890000000000001 110.849 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.7 t -149.48 -8.31 0.33 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.398 -0.819 . . . . 15.85 110.248 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -91.23 32.77 5.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.85 -0.691 . . . . 17.539999999999999 112.139 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 175' ' ' LEU . 2.6 pt? -86.15 148.59 25.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.405 0.621 . . . . 17.850000000000001 110.275 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 50.99 43.83 28.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 113.829 -1.532 . . . . 19.670000000000002 112.837 171.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.19 103.79 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.486 -0.324 . . . . 19.52 110.494 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.8 tp -153.44 -41.97 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.437 -0.347 . . . . 21.149999999999999 110.8 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -163.29 144.61 9.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.665 -0.494 . . . . 23.25 109.665 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.51 -0.757 . . . . 23.52 110.349 178.065 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.698 0.285 . . . . 34.32 110.706 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.68 48.81 0.73 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.934 -0.867 . . . . 33.090000000000003 110.934 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -62.85 -20.65 65.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.663 0.268 . . . . 34.119999999999997 111.658 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.82 -6.95 41.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.727 0.299 . . . . 32.32 111.393 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -117.24 21.49 13.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 32.740000000000002 111.924 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.86 124.68 71.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.351 0.596 . . . . 31.289999999999999 110.815 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -74.72 -24.77 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.451 -0.795 . . . . 29.460000000000001 110.443 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.29 44.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.197 -0.761 . . . . 28.280000000000001 111.197 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.34 157.05 52.35 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.397 2.065 . . . . 27.510000000000002 112.64 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -76.2 92.9 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.011 0.434 . . . . 26.48 110.308 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -116.35 -56.44 2.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 24.899999999999999 109.845 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.93 -70.21 2.32 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.896 -0.668 . . . . 23.190000000000001 113.943 170.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -102.05 -179.5 4.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.999 0.428 . . . . 21.309999999999999 112.069 -170.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.76 156.73 72.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 19.890000000000001 110.14 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.36 -79.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.307 2.005 . . . . 18.120000000000001 113.027 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.53 16.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.307 0.643 . . . . 16.579999999999998 112.094 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.21 63.26 0.66 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.965 0.412 . . . . 14.800000000000001 111.237 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.15 -130.27 6.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.724 -0.75 . . . . 13.17 112.198 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.86 17.61 9.02 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.5 0.72 . . . . 12.17 112.226 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 28.7 tt0 60.4 69.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.737 -1.12 . . . . 13.82 110.348 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 34.8 mt 73.77 -42.24 0.51 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.932 -1.031 . . . . 12.130000000000001 111.758 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.0 tttp 70.43 -63.67 0.39 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.72 0.638 . . . . 14.1 111.485 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -130.47 -179.27 5.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.493 -0.321 . . . . 11.050000000000001 110.385 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 -56.91 0.5 Allowed Glycine 0 CA--C 1.498 -1.029 0 N-CA-C 110.972 -0.851 . . . . 10.050000000000001 110.972 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -167.22 63.3 0.08 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.561 1.172 . . . . 10.380000000000001 109.76 178.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.607 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.1 mtp180 -135.71 135.19 39.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.196 -1.366 . . . . 8.3699999999999992 108.986 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.602 HG12 ' CG ' ' A' ' 58' ' ' GLU . 23.3 mm -57.43 115.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 122.433 1.111 . . . . 5.7599999999999998 112.173 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 mt -118.97 -35.42 3.65 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.773 -2.012 . . . . 8.2200000000000006 110.679 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.692 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 19.8 p90 -168.82 179.07 4.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 7.9900000000000002 109.704 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.669 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -117.29 164.3 15.02 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.185 -0.461 . . . . 5.6100000000000003 111.523 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -145.31 177.22 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 9.0600000000000005 110.204 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.0 t70 -124.13 138.43 30.74 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 107.845 -1.168 . . . . 8.3100000000000005 107.845 170.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -60.3 -14.2 28.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.451 2.101 . . . . 10.41 112.738 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -101.43 -2.09 31.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.123 0.416 . . . . 10.85 112.123 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.806 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.0 m -125.45 38.28 0.4 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 113.58 0.956 . . . . 9.3200000000000003 113.58 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 29.6 Cg_endo -58.49 133.3 53.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.305 2.003 . . . . 11.1 112.518 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.78 -6.3 29.46 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.272 -0.731 . . . . 10.31 111.272 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.703 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -87.54 179.38 6.56 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 9.2100000000000009 109.194 177.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.505 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 4.5 tmm_? -157.0 93.29 1.33 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.785 -0.82 . . . . 11.51 108.785 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.703 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 91.3 m-85 -73.71 142.24 46.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.071 0.462 . . . . 7.5 109.99 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.27 -30.58 71.63 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.886 -1.052 . . . . 10.609999999999999 110.273 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -165.15 164.39 12.77 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.699 -0.682 . . . . 10.91 111.586 -177.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.669 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.1 Cg_endo -50.73 170.21 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.689 2.926 . . . . 7.5099999999999998 113.313 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.01 -159.34 27.63 Favored Glycine 0 CA--C 1.508 -0.383 0 C-N-CA 120.24 -0.981 . . . . 7.5899999999999999 112.735 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 3.0 ttmm -95.3 144.33 25.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.335 -0.617 . . . . 11.68 109.335 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.548 ' OG ' ' HG3' ' A' ' 49' ' ' MET . 25.0 p -64.56 145.02 98.71 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 9.1999999999999993 111.873 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.24 -22.2 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.258 1.972 . . . . 10.25 112.904 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.31 -15.83 39.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.41 1.1 . . . . 10.49 110.068 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.548 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.16 -164.06 1.85 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.506 -1.679 . . . . 10.380000000000001 109.012 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 5.7 p-10 -133.21 57.15 1.82 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.614 0.721 . . . . 12.539999999999999 110.781 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -133.35 142.93 46.03 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.134 -0.939 . . . . 9.8699999999999992 108.954 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.09 132.13 37.8 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.617 1.545 . . . . 9.5099999999999998 110.658 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.26 164.2 5.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.341 0.591 . . . . 6.71 111.854 -174.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.72 130.8 22.36 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.726 -0.842 . . . . 7.8899999999999997 108.726 -177.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.24 136.83 35.41 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.855 1.703 . . . . 5.7699999999999996 112.405 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 27.1 m -63.18 160.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.64 -1.164 . . . . 5.96 112.419 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.692 ' CD1' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER 7.13 -66.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.476 2.31 . . . . 7.8399999999999999 116.054 177.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.602 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -62.57 -48.32 79.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.236 1.017 . . . . 6.6200000000000001 110.352 -171.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' HD11 ' A' ' 27' ' ' ILE . 12.2 pt-20 38.99 43.47 0.78 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 112.532 -2.122 . . . . 8.5800000000000001 113.37 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 40.0 tt0 -178.23 59.54 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.235 -1.348 . . . . 7.6399999999999997 110.586 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -147.57 -39.0 0.19 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.51 -1.223 . . . . 7.0199999999999996 109.7 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.54 -14.51 62.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.08 -0.964 . . . . 5.4100000000000001 110.126 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.612 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.0 t70 -84.83 9.89 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.309 -0.859 . . . . 7.0099999999999998 109.681 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.88 -51.16 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.009 -0.996 . . . . 7.2000000000000002 111.105 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.76 30.57 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.881 -0.659 . . . . 7.8200000000000003 110.101 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.28 32.02 20.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.756 0.789 . . . . 8.6500000000000004 109.726 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 63' ' ' ASP . 8.4 p -72.78 -51.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.718 -1.128 . . . . 7.3099999999999996 110.766 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' N ' HG13 ' A' ' 67' ' ' VAL . 29.0 mtm180 -66.62 -70.82 0.22 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.52 -1.218 . . . . 10.210000000000001 110.242 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.0 mt -102.15 157.55 4.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 113.545 -1.661 . . . . 8.8599999999999994 110.966 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 69' ' ' ILE . 38.3 t70 -76.49 36.68 0.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.436 -0.802 . . . . 13.02 111.469 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 55.33 21.03 24.97 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.155 -0.929 . . . . 12.130000000000001 112.596 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' O ' HG22 ' A' ' 74' ' ' THR . 13.1 ptm180 -93.13 174.0 7.44 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.872 0.368 . . . . 12.380000000000001 110.457 -173.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 74' ' ' THR . 2.6 p -17.73 -57.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 125.794 1.934 . . . . 11.609999999999999 115.384 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.57 ' H ' HG13 ' A' ' 73' ' ' VAL . 10.1 t 34.26 62.89 0.45 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.332 1.053 . . . . 10.710000000000001 112.885 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -81.19 67.07 6.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.407 -0.815 . . . . 14.09 109.392 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.516 ' OD1' ' HG3' ' A' ' 152' ' ' GLN . 13.0 m120 -136.4 165.43 25.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.17 -0.923 . . . . 11.220000000000001 109.104 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.59 10.07 33.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 13.710000000000001 110.153 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.67 14.47 9.49 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 114.843 -1.071 . . . . 11.44 110.445 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t 60.39 74.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.881 0.848 . . . . 9.9900000000000002 110.083 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -81.78 151.83 27.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.977 -1.011 . . . . 11.640000000000001 109.039 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 148' ' ' VAL . 82.5 p -127.92 177.86 6.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.367 0.603 . . . . 8.0 110.253 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.414 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -140.88 126.36 18.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.102 -1.073 . . . . 6.6500000000000004 108.102 171.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 34.4 tt0 -79.02 139.39 38.18 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.639 -0.504 . . . . 12.15 109.639 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 95' ' ' LEU . 53.3 t -62.03 133.3 27.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.33 0.585 . . . . 9.7100000000000009 112.395 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -137.47 150.57 47.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.452 -1.249 . . . . 11.029999999999999 108.393 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 8.1 mp -77.53 147.99 35.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.148 -0.686 . . . . 12.76 109.148 169.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.73 40.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.316 -0.945 . . . . 13.25 112.938 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 92' ' ' THR . 2.4 ptt180 -63.44 126.3 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.161 0.505 . . . . 16.350000000000001 111.423 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -120.36 84.06 2.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.267 -0.642 . . . . 18.219999999999999 109.267 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.33 -1.62 84.47 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 109.68 -1.368 . . . . 17.91 109.68 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.4 p -110.69 -178.65 3.54 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.138 -1.031 . . . . 17.109999999999999 110.397 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 88' ' ' ARG . 5.6 m -76.61 159.95 29.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.508 -0.553 . . . . 14.73 109.508 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 11.1 mt-10 -59.16 97.79 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.685 0.755 . . . . 14.94 110.668 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -112.62 170.21 8.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.435 -1.257 . . . . 10.57 110.384 -173.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -100.75 113.38 26.22 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.953 -0.758 . . . . 8.8800000000000008 108.953 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.74 129.5 36.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 9.7799999999999994 110.868 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 34.1 m -142.41 161.65 48.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.858 -1.064 . . . . 6.4000000000000004 108.409 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.88 134.79 55.52 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.707 1.605 . . . . 6.5499999999999998 110.5 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 p -67.28 -24.63 65.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.103 -0.373 . . . . 9.2899999999999991 110.984 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -90.96 7.26 41.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.512 -0.313 . . . . 10.859999999999999 111.153 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 149' ' ' VAL . . . -84.9 -40.68 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.084 0.468 . . . . 5.3399999999999999 110.615 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -83.18 162.36 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.608 -0.723 . . . . 6.9699999999999998 111.572 -173.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 18.7 mm -104.63 119.81 54.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.524 -0.762 . . . . 10.199999999999999 109.997 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -96.13 120.75 36.98 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.629 -0.828 . . . . 12.119999999999999 109.97 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -147.3 140.59 25.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.955 -0.566 . . . . 14.609999999999999 110.36 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 56.88 -112.63 3.64 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.131 -0.557 . . . . 15.52 112.556 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.96 29.38 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.823 0.305 . . . . 14.99 111.823 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' NH1' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -162.41 -176.82 5.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 15.199999999999999 111.464 -174.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 46.7 m -125.43 147.94 49.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.725 -0.671 . . . . 9.2599999999999998 110.572 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.9 mm -124.82 151.79 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.351 -0.611 . . . . 10.550000000000001 109.351 176.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -136.43 134.17 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.49 -0.131 . . . . 7.3899999999999997 110.667 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.437 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 38.5 mtm -93.98 101.46 13.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 8.8499999999999996 109.432 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 9.5 p -85.32 138.45 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 9.6899999999999995 111.329 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.06 95.3 3.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.07 -0.513 . . . . 10.699999999999999 110.937 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -80.02 163.3 24.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.245 0.545 . . . . 14.880000000000001 110.454 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.52 15.15 47.81 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.417 -0.811 . . . . 16.920000000000002 111.406 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.26 11.6 39.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.449 0.642 . . . . 18.559999999999999 110.619 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.28 11.9 74.52 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.158 -0.928 . . . . 15.619999999999999 113.516 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.88 168.04 25.76 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.578 -0.82 . . . . 14.19 112.203 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 80.7 m-85 -110.18 109.86 20.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.533 -0.543 . . . . 12.029999999999999 109.533 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 9.3 t70 -92.6 140.58 23.96 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.781 -0.645 . . . . 13.91 110.772 -170.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 121' ' ' ASP . 19.4 Cg_endo -84.2 127.88 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.196 1.93 . . . . 12.35 112.71 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.8 t -115.48 129.05 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.119 -0.946 . . . . 9.4299999999999997 109.351 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 110' ' ' ILE . 43.0 tt0 -73.03 120.86 19.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.37 -0.604 . . . . 12.93 109.37 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.753 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -132.48 159.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.411 0.624 . . . . 8.0299999999999994 111.212 -174.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.0 ttmm -103.94 129.32 51.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.225 -0.898 . . . . 10.390000000000001 109.647 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.55 114.83 8.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.712 -0.222 . . . . 8.3000000000000007 111.303 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.428 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.21 70.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 117.818 -2.134 . . . . 10.1 114.251 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.862 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.24 164.62 35.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.268 -1.012 . . . . 10.609999999999999 108.268 154.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -143.61 126.75 16.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.308 0.504 . . . . 13.17 110.086 170.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.21 118.95 6.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 12.98 111.336 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.27 36.24 92.54 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.231 -0.509 . . . . 14.34 112.697 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.32 20.96 80.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.559 -0.829 . . . . 13.119999999999999 111.618 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' VAL . 38.3 mt-30 -128.49 170.49 13.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.365 -0.606 . . . . 10.619999999999999 109.365 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.5 t -125.12 156.82 37.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.604 -0.517 . . . . 7.8200000000000003 109.604 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 46.6 mt-10 -101.06 112.97 25.57 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.664 0.745 . . . . 10.789999999999999 110.577 175.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 125' ' ' VAL . 24.5 mm -79.87 106.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.741 -1.118 . . . . 6.7300000000000004 109.641 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.49 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.4 mp -70.48 -49.67 46.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.885 -1.052 . . . . 8.7899999999999991 109.878 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 125' ' ' VAL . 41.0 mt-10 -141.75 165.6 27.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.44 109.528 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 116.95 -67.42 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.683 -1.246 . . . . 8.8699999999999992 113.593 175.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.32 -174.97 2.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 8.5 112.16 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 38.4 ttpt -149.32 154.97 39.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.558 -0.746 . . . . 14.15 109.748 -176.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.33 131.49 45.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.487 -0.779 . . . . 12.119999999999999 110.1 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.35 -7.72 47.48 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.948 -0.861 . . . . 11.539999999999999 110.948 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.579 ' O ' HG23 ' A' ' 84' ' ' VAL . 19.1 mm-40 -100.8 119.07 38.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.812 -0.81 . . . . 11.24 108.812 177.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 14.2 pt20 -104.88 132.27 51.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.686 0.755 . . . . 10.49 109.676 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 149' ' ' VAL . 17.1 m -116.38 153.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.439 -1.255 . . . . 5.4500000000000002 110.025 -172.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.3 m -57.62 134.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.44 0.638 . . . . 6.5599999999999996 111.413 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 147' ' ' VAL . 43.1 t -129.7 -37.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.092 -0.958 . . . . 6.9900000000000002 111.029 -173.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -135.9 53.27 1.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.043 -0.526 . . . . 9.0600000000000005 109.891 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.48 -169.15 12.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.633 -0.712 . . . . 8.5 112.043 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.516 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 95.4 mt-30 -78.9 95.5 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.811 0.338 . . . . 11.84 110.63 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -94.55 -10.27 32.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 12.24 110.334 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 28.8 tp -70.92 -57.07 4.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.124 0.488 . . . . 13.16 109.755 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.6 tt -118.19 112.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.567 -0.742 . . . . 11.949999999999999 110.449 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -76.26 -23.33 54.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 11.220000000000001 110.718 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 9.3 m -56.14 -54.87 39.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.203 0.525 . . . . 11.9 110.92 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 34.9 mm-40 -59.4 -40.0 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.274 -0.876 . . . . 11.17 110.895 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 7.8200000000000003 111.657 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.8 m -79.55 -28.95 41.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 9.6400000000000006 110.431 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 157' ' ' SER . 71.8 mt -83.16 -28.29 29.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.517 -0.765 . . . . 10.57 110.561 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 20.1 mtp180 -70.53 146.13 50.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.331 -0.85 . . . . 8.9000000000000004 112.404 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.08 23.98 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.783 -1.098 . . . . 7.1500000000000004 111.888 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.8 p 46.99 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.751 0.821 . . . . 7.0899999999999999 112.964 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.6 t 59.84 66.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.558 0.694 . . . . 9.1999999999999993 109.587 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.6 92.33 3.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.621 -0.718 . . . . 9.1099999999999994 110.875 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.673 ' HD3' ' O ' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -84.7 8.59 16.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.868 0.842 . . . . 14.58 109.916 177.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.518 ' SD ' HG23 ' A' ' 171' ' ' THR . 0.0 OUTLIER -156.62 -178.37 7.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.695 -1.138 . . . . 11.94 108.955 177.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -127.57 7.25 6.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.318 0.58 . . . . 14.99 109.977 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 168' ' ' MET . 10.0 pt-20 -95.53 36.15 1.29 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.618 -0.719 . . . . 15.01 112.506 -166.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.518 HG23 ' SD ' ' A' ' 168' ' ' MET . 16.4 p -103.95 -22.53 13.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.86 0.362 . . . . 14.25 111.894 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 t -88.3 -50.3 6.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.38 -0.373 . . . . 14.890000000000001 111.517 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.1 p -120.62 -5.09 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.693 -0.231 . . . . 15.85 111.139 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.28 -35.76 72.52 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.952 -0.642 . . . . 17.539999999999999 112.417 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 175' ' ' LEU . 2.1 pt? -130.41 41.69 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 17.850000000000001 109.541 176.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 177' ' ' VAL . 9.4 tt0 65.27 177.0 0.2 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.697 -1.138 . . . . 19.670000000000002 109.901 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.516 ' H ' ' HG2' ' A' ' 176' ' ' GLU . 9.9 p -124.9 -7.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.363 0.602 . . . . 19.52 111.172 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -115.05 -44.67 3.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 21.149999999999999 110.674 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.87 134.69 56.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 23.25 110.905 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.747 -0.644 . . . . 23.52 109.799 179.089 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.953 -0.388 . . . . 34.32 109.953 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 3' ' ' SER . . . -105.48 -153.26 21.31 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.835 -0.698 . . . . 33.090000000000003 112.121 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 38.4 t 74.46 -53.93 0.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.3 0.64 . . . . 34.119999999999997 111.015 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.51 141.42 51.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.814 -0.439 . . . . 32.32 109.814 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -77.63 66.76 3.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 32.740000000000002 110.795 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -104.91 151.12 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.739 -0.664 . . . . 31.289999999999999 110.453 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -98.34 144.86 27.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.955 -0.566 . . . . 29.460000000000001 110.502 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.34 -155.19 25.59 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.593 -0.813 . . . . 28.280000000000001 112.15 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.03 -74.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.987 2.458 . . . . 27.510000000000002 111.517 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -153.71 53.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.608 0.718 . . . . 26.48 109.865 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -98.7 88.63 4.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.988 -1.005 . . . . 24.899999999999999 109.963 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 143.15 27.95 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 23.190000000000001 112.203 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 30.2 m80 -119.83 48.98 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.144 0.497 . . . . 21.309999999999999 110.03 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -100.79 101.4 15.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 19.890000000000001 109.712 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 13' ' ' HIS . 4.8 Cg_exo -76.81 86.0 1.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.97 2.447 . . . . 18.120000000000001 112.02 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.61 58.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 16.579999999999998 110.64 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.27 96.39 1.11 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.077 -0.511 . . . . 14.800000000000001 110.348 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . 129.35 -99.07 0.46 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.055 -0.818 . . . . 13.17 111.055 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.436 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . . . 63.67 -63.32 0.14 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.042 0.937 . . . . 12.17 112.692 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 63.02 63.84 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.076 0.941 . . . . 13.82 111.489 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.24 -100.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.25 -1.341 . . . . 12.130000000000001 109.968 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.36 -40.7 10.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.389 0.614 . . . . 14.1 109.705 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.9 m -149.9 149.88 31.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 11.050000000000001 109.475 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 19' ' ' ALA . . . 161.63 -44.26 0.38 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 10.050000000000001 111.777 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -150.14 52.61 0.91 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.963 1.363 . . . . 10.380000000000001 108.555 177.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 9.3 mmm180 -113.41 140.06 48.38 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.752 -1.567 . . . . 8.3699999999999992 109.476 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.975 ' HB ' ' HB2' ' A' ' 62' ' ' ALA . 11.9 mm -52.49 121.4 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 123.937 0.773 . . . . 5.7599999999999998 112.661 -170.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 75' ' ' GLN . 2.8 mm? -96.16 -37.43 10.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.177 -1.374 . . . . 8.2200000000000006 110.284 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 29.8 p90 -172.24 -175.63 1.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.162 0.506 . . . . 7.9900000000000002 111.125 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.689 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.29 154.25 35.24 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.14 -0.936 . . . . 5.6100000000000003 110.627 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -162.91 148.98 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.567 0.542 . . . . 9.0600000000000005 110.447 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -69.77 137.61 87.89 Favored Pre-proline 0 CA--C 1.514 -0.413 0 N-CA-C 108.386 -0.968 . . . . 8.3100000000000005 108.386 169.203 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -62.01 -11.84 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.393 2.062 . . . . 10.41 110.77 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -98.76 1.33 45.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.613 -0.721 . . . . 10.85 111.215 177.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.607 HG22 ' HB2' ' A' ' 32' ' ' ASP . 10.3 m -130.98 49.86 5.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 121.238 0.542 . . . . 9.3200000000000003 112.03 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.05 121.13 7.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.781 2.321 . . . . 11.1 112.584 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.34 -25.86 11.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.82 -0.705 . . . . 10.31 112.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' A' ' 35' ' ' VAL . 7.0 tp-100 -69.43 105.98 2.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.415 0.626 . . . . 9.2100000000000009 111.004 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.734 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 45.2 ttp180 -89.61 101.28 13.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.343 -0.844 . . . . 11.51 110.521 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 72.0 m-85 -82.94 147.24 28.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 7.5 110.252 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.83 -25.63 68.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.396 -1.275 . . . . 10.609999999999999 111.406 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 53.8 pttt -172.46 164.62 3.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 10.91 111.3 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.0 Cg_endo -50.7 170.06 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.729 2.952 . . . . 7.5099999999999998 113.626 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.16 -166.03 26.83 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.692 -0.766 . . . . 7.5899999999999999 112.421 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 5.3 ttmm -93.21 141.56 28.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.059 -0.719 . . . . 11.68 109.059 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 49' ' ' MET . 41.2 t -61.07 139.87 94.21 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.535 -0.757 . . . . 9.1999999999999993 111.64 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.19 -20.8 18.52 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.74 2.294 . . . . 10.25 111.468 171.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CD2' HG11 ' A' ' 35' ' ' VAL . 27.1 m-85 -87.67 -42.83 12.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.512 -1.222 . . . . 10.49 109.666 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -133.92 155.28 50.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.34 -0.846 . . . . 10.380000000000001 111.965 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.1 p-10 -82.35 61.42 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.282 1.039 . . . . 12.539999999999999 110.834 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -131.96 143.39 48.84 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.732 -1.122 . . . . 9.8699999999999992 109.392 173.362 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.75 132.9 32.06 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.178 1.252 . . . . 9.5099999999999998 109.218 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.44 158.69 14.21 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.029 -0.268 . . . . 6.71 110.681 -175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.95 130.51 24.96 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-O 121.217 0.532 . . . . 7.8899999999999997 110.118 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 88.2 Cg_endo -79.09 139.74 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.135 1.89 . . . . 5.7699999999999996 113.14 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 34.1 m -61.43 161.81 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.743 -1.571 . . . . 5.96 112.97 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.79 -84.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.049 2.14 . . . . 7.8399999999999999 115.706 -178.086 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -48.6 -43.57 36.26 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.92 0.762 . . . . 6.6200000000000001 111.421 -173.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 35.7 tt0 47.39 64.06 1.74 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.271 1.034 . . . . 8.5800000000000001 109.655 -171.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 45.4 mt-10 -142.79 35.07 1.41 Allowed 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 114.173 -1.376 . . . . 7.6399999999999997 109.526 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' ASP . 66.4 t30 60.74 13.14 4.14 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 111.83 -2.441 . . . . 7.0199999999999996 113.694 162.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.975 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . . . 69.96 -7.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.061 -1.881 . . . . 5.4100000000000001 112.017 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 68' ' ' ARG . 11.1 t70 -162.7 -162.46 0.79 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.799 -1.091 . . . . 7.0099999999999998 109.598 -174.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 63' ' ' ASP . . . -133.8 21.39 3.98 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.012 -0.835 . . . . 7.2000000000000002 111.012 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 62.97 39.4 10.31 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.159 0.564 . . . . 7.8200000000000003 111.318 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.11 -45.34 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.6 -0.727 . . . . 8.6500000000000004 110.33 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.55 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 4.5 t -72.52 -65.28 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.972 -0.751 . . . . 7.3099999999999996 108.972 176.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.558 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 7.7 mtt180 64.07 131.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.017 -1.447 . . . . 10.210000000000001 113.812 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.556 HG21 ' HG2' ' A' ' 72' ' ' ARG . 10.1 mt -67.8 153.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.425 -1.262 . . . . 8.8599999999999994 111.005 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.76 48.22 1.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 13.02 110.855 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.44 32.33 80.69 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.63 -0.713 . . . . 12.130000000000001 112.252 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.556 ' HG2' HG21 ' A' ' 69' ' ' ILE . 1.4 ptt180 -104.44 129.11 52.43 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.042 -0.725 . . . . 12.380000000000001 109.042 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.36 34.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.248 1.499 . . . . 11.609999999999999 108.318 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.53 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 2.9 t -133.59 76.88 1.69 Allowed 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 112.26 -2.246 . . . . 10.710000000000001 109.764 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.417 ' H ' HD13 ' A' ' 28' ' ' LEU . 5.4 tp-100 -79.77 73.75 6.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.139 -0.937 . . . . 14.09 110.644 -177.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -137.43 107.14 6.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.038 -0.983 . . . . 11.220000000000001 109.48 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.5 -6.49 48.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.034 -1.439 . . . . 13.710000000000001 110.974 -174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.31 -12.79 20.88 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.087 -0.96 . . . . 11.44 112.063 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.5 t -138.49 91.56 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.923 0.868 . . . . 9.9900000000000002 110.651 -172.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.93 118.06 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.947 -1.024 . . . . 11.640000000000001 108.429 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 146' ' ' GLN . 77.0 p -108.74 139.17 43.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.447 -0.342 . . . . 8.0 110.526 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -107.33 129.77 54.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.906 -0.776 . . . . 6.6500000000000004 108.906 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 39.9 tt0 -76.04 134.79 40.0 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.237 -0.438 . . . . 12.15 110.065 -176.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 95' ' ' LEU . 73.6 t -63.13 130.05 27.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.686 0.755 . . . . 9.7100000000000009 110.958 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.04 146.56 10.87 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.33 -1.305 . . . . 11.029999999999999 109.683 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.13 161.33 31.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 12.76 111.091 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.47 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 171.06 55.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.432 -0.889 . . . . 13.25 112.82 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -90.62 -178.81 5.39 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 111.837 0.31 . . . . 16.350000000000001 111.837 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.4 mt -135.25 108.21 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 18.219999999999999 109.365 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.56 -164.22 22.47 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.7 -0.682 . . . . 17.91 111.397 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 p -90.33 75.36 6.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.017 0.913 . . . . 17.109999999999999 110.047 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.473 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 1.6 m -155.58 167.34 30.7 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.247 -1.39 . . . . 14.73 107.247 173.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 4.6 mt-10 -141.44 114.44 8.58 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 118.228 0.467 . . . . 14.94 110.212 167.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -126.43 160.0 31.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.446 -0.343 . . . . 10.57 110.1 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -89.3 114.54 25.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.844 -0.799 . . . . 8.8800000000000008 108.844 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -87.71 133.19 33.89 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.054 0.454 . . . . 9.7799999999999994 111.365 -173.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 6.4 p -145.85 146.7 29.79 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.333 -0.849 . . . . 6.4000000000000004 109.419 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 97' ' ' VAL . 50.8 Cg_exo -56.6 130.77 41.76 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.338 2.025 . . . . 6.5499999999999998 110.518 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.9 p -55.22 -24.35 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.134 0.79 . . . . 9.2899999999999991 113.134 -172.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -90.4 6.84 41.54 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.854 -0.529 . . . . 10.859999999999999 111.929 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -82.16 -39.14 23.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.257 0.551 . . . . 5.3399999999999999 110.629 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -91.93 156.04 17.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.6 -0.727 . . . . 6.9699999999999998 111.767 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.1 mm -120.07 103.51 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 115.409 -0.814 . . . . 10.199999999999999 110.376 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER -109.3 98.23 7.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.581 -1.248 . . . . 12.119999999999999 112.166 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -107.44 142.98 36.43 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.896 -1.502 . . . . 14.609999999999999 109.386 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.36 -107.07 1.93 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.59 -0.814 . . . . 15.52 112.23 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.66 17.48 11.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.028 0.751 . . . . 14.99 113.028 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 17.5 ptt180 -160.0 166.61 29.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.129 0.788 . . . . 15.199999999999999 113.129 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.1 m -113.79 154.42 27.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.229 -0.896 . . . . 9.2599999999999998 110.729 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 124' ' ' GLU . 32.8 mm -133.97 149.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.981 -0.554 . . . . 10.550000000000001 109.834 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -135.19 130.17 34.91 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.476 0.31 . . . . 7.3899999999999997 110.289 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 37.6 ttp -84.24 100.2 11.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.737 -0.838 . . . . 8.8499999999999996 108.737 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 121' ' ' ASP . 13.6 p -87.77 134.48 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.602 -0.726 . . . . 9.6899999999999995 111.736 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.98 94.45 8.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.668 -0.696 . . . . 10.699999999999999 109.638 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -75.41 148.82 38.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 14.880000000000001 110.748 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.18 -0.71 30.27 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.592 -0.731 . . . . 16.920000000000002 111.991 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.35 9.47 20.41 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.466 0.65 . . . . 18.559999999999999 110.59 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.77 10.69 78.63 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.282 -0.872 . . . . 15.619999999999999 113.295 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.65 160.77 23.89 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.436 -0.888 . . . . 14.19 112.475 -174.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 91.9 m-85 -112.3 126.57 55.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 12.029999999999999 109.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -129.24 150.69 76.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.968 -0.293 . . . . 13.91 111.495 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 123.65 2.01 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.47 2.113 . . . . 12.35 112.147 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.614 HG12 ' HB3' ' A' ' 111' ' ' ALA . 6.1 p -108.98 134.67 50.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.349 -0.841 . . . . 9.4299999999999997 110.015 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.519 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.1 tt0 -74.26 120.47 19.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.514 . . . . 12.93 109.611 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.792 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -128.62 156.45 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.721 -0.672 . . . . 8.0299999999999994 111.657 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.8 ttmm -101.61 126.67 48.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.918 -1.037 . . . . 10.390000000000001 109.459 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -142.46 107.79 5.01 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.379 -0.373 . . . . 8.3000000000000007 111.625 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.01 0.29 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 117.684 -2.198 . . . . 10.1 114.539 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.57 163.04 38.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.494 -0.928 . . . . 10.609999999999999 108.494 154.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.93 128.28 26.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 118.12 0.418 . . . . 13.17 110.163 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.66 126.76 9.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.327 -0.397 . . . . 12.98 111.48 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.85 24.59 74.29 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.194 -0.457 . . . . 14.34 112.498 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 14.45 81.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.61 -0.805 . . . . 13.119999999999999 111.388 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -119.21 171.09 8.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.528 -0.545 . . . . 10.619999999999999 109.528 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 6.2 p -119.13 154.17 33.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 116.405 -0.361 . . . . 7.8200000000000003 110.222 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 51.8 mt-10 -100.83 124.53 46.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.438 0.637 . . . . 10.789999999999999 111.4 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 125' ' ' VAL . 20.2 mm -88.86 112.16 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.183 -0.917 . . . . 6.7300000000000004 109.908 174.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.8 mp -79.18 -44.99 20.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.603 -1.181 . . . . 8.7899999999999991 109.649 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' VAL . 39.6 mt-10 -146.04 166.71 25.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.824 -0.626 . . . . 10.44 109.318 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 120.42 -70.47 0.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.798 -1.191 . . . . 8.8699999999999992 113.528 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 mt -97.52 -179.19 4.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.382 0.611 . . . . 8.5 112.306 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -137.55 151.79 48.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.954 -1.021 . . . . 14.15 109.732 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.11 135.79 51.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.842 -1.072 . . . . 12.119999999999999 110.632 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.94 50.02 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.328 -0.709 . . . . 11.539999999999999 111.328 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -103.68 156.97 17.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.568 -0.53 . . . . 11.24 109.568 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.79 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.2 mt-30 -111.03 146.32 36.92 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.11 0.481 . . . . 10.49 110.703 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 101' ' ' ALA . 1.7 p -132.84 137.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.448 -0.796 . . . . 5.4500000000000002 109.011 172.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.61 124.13 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.35 0.595 . . . . 6.5599999999999996 110.69 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 101' ' ' ALA . 1.9 m -112.29 5.41 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.676 -0.693 . . . . 6.9900000000000002 109.71 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.3 t 71.91 -53.54 0.69 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.465 -1.243 . . . . 9.0600000000000005 110.849 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.04 -152.32 17.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.071 -0.585 . . . . 8.5 111.654 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -130.26 166.14 20.97 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.468 -0.567 . . . . 11.84 109.468 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.4 85.44 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.62 0.248 . . . . 12.24 110.381 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.686 ' H ' HD12 ' A' ' 154' ' ' LEU . 6.3 mp -40.3 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.796 1.31 . . . . 13.16 112.43 -171.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.0 mt -149.35 114.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.936 -0.764 . . . . 11.949999999999999 108.936 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.93 -77.39 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.708 0.766 . . . . 11.220000000000001 112.454 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.3 p -64.48 -42.31 95.96 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.826 -1.079 . . . . 11.9 112.633 -162.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -68.63 -28.32 66.8 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.837 -0.62 . . . . 11.17 109.979 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.26 -18.86 54.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.435 -0.802 . . . . 7.8200000000000003 110.562 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.3 t -81.29 -41.65 21.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.857 -0.61 . . . . 9.6400000000000006 109.572 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.45 -35.67 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.706 -0.679 . . . . 10.57 110.937 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 162' ' ' ARG . 34.9 mtt180 -98.44 -161.47 0.88 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.363 -0.606 . . . . 8.9000000000000004 109.363 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 177.89 -56.55 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.912 -0.661 . . . . 7.1500000000000004 111.889 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.6 p -102.48 -26.38 13.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.672 . . . . 7.0899999999999999 110.042 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.6 t -87.75 76.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.561 -0.745 . . . . 9.1999999999999993 110.14 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 67' ' ' VAL . . . -151.16 97.95 2.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.097 -0.501 . . . . 9.1099999999999994 110.911 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.696 ' HD3' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -127.85 -80.7 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.21 -1.033 . . . . 14.58 108.21 178.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.441 ' H ' ' HB2' ' A' ' 167' ' ' ARG . 15.5 mtm 49.47 80.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.555 -1.657 . . . . 11.94 112.232 173.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -69.04 117.18 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.43 0.634 . . . . 14.99 110.142 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -104.58 94.81 5.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.127 0.489 . . . . 15.01 109.87 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.2 p -74.05 84.26 1.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.45 -0.796 . . . . 14.25 111.093 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 17.3 m -95.35 -73.99 0.57 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.918 -0.583 . . . . 14.890000000000001 110.243 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.8 m -157.77 133.88 9.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.181 0.515 . . . . 15.85 109.946 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.65 79.14 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.196 -0.911 . . . . 17.539999999999999 113.321 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 176' ' ' GLU . 10.2 mp 62.81 -158.84 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.827 0.451 . . . . 17.850000000000001 110.299 -174.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.419 ' H ' ' HB3' ' A' ' 175' ' ' LEU . 1.8 mp0 -65.23 119.49 11.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.465 -0.569 . . . . 19.670000000000002 109.465 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.33 144.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.296 0.57 . . . . 19.52 111.036 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.66 -76.34 0.4 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.458 -0.941 . . . . 21.149999999999999 108.458 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.1 t80 179.61 133.31 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.05 -1.093 . . . . 23.25 108.05 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 120.763 -0.375 . . . . 23.52 111.11 -175.893 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.932 0.396 . . . . 34.32 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.02 42.39 4.69 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.686 -0.688 . . . . 33.090000000000003 112.029 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.6 m 71.29 168.93 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.003 0.521 . . . . 34.119999999999997 111.49 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . . . 66.66 174.96 0.24 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.544 -0.753 . . . . 32.32 111.524 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 p -78.77 -81.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.188 0.44 . . . . 32.740000000000002 112.188 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.78 105.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.085 0.469 . . . . 31.289999999999999 111.181 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 19.2 m120 -129.32 -54.78 1.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 29.460000000000001 109.655 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.98 -158.11 15.83 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.595 -0.73 . . . . 28.280000000000001 111.439 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.09 165.04 21.91 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.415 2.077 . . . . 27.510000000000002 112.18 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -78.39 98.22 5.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.366 -0.379 . . . . 26.48 110.219 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.99 97.06 3.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.189 0.518 . . . . 24.899999999999999 110.285 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.58 -25.23 0.95 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.055 -0.818 . . . . 23.190000000000001 111.055 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -175.55 125.31 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 21.309999999999999 109.625 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -157.79 157.93 29.99 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.838 -0.801 . . . . 19.890000000000001 108.838 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.12 65.84 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.051 1.834 . . . . 18.120000000000001 112.149 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.85 -83.69 0.22 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.25 . . . . 16.579999999999998 110.893 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.93 92.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 14.800000000000001 110.019 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . 76.15 48.34 9.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.577 -0.821 . . . . 13.17 111.923 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -32.18 73.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 12.17 111.046 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.76 52.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.513 1.149 . . . . 13.82 108.97 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 35.5 mt -160.36 -67.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 112.979 -1.919 . . . . 12.130000000000001 107.706 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 22' ' ' LYS . 40.8 ttmt 59.24 35.29 23.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.259 1.028 . . . . 14.1 110.156 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -155.13 107.67 2.73 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.95 -1.023 . . . . 11.050000000000001 110.808 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -100.7 164.74 18.79 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.375 -0.83 . . . . 10.050000000000001 111.241 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.0 OUTLIER 70.78 59.47 0.2 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.924 -1.139 . . . . 10.380000000000001 107.924 -178.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.405 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 18.2 mmm180 -126.14 137.07 53.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.762 -1.563 . . . . 8.3699999999999992 110.564 -174.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.6 mm -46.36 131.91 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.343 -1.299 . . . . 5.7599999999999998 113.66 -168.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -120.29 -29.9 4.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.843 -1.526 . . . . 8.2200000000000006 108.227 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.743 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 16.4 p90 -175.24 -176.63 0.95 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.315 -0.857 . . . . 7.9900000000000002 111.602 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.662 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.99 153.67 45.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.119 -0.946 . . . . 5.6100000000000003 110.593 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -157.36 152.22 25.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 9.0600000000000005 110.4 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.73 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.7 t70 -86.85 137.39 33.55 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.278 -0.638 . . . . 8.3100000000000005 109.278 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HG3' HG13 ' A' ' 54' ' ' ILE . 16.5 Cg_exo -63.4 -14.93 45.25 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.495 2.13 . . . . 10.41 112.358 177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.32 0.57 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.718 0.294 . . . . 10.85 111.147 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -126.84 40.08 0.54 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.276 0.473 . . . . 9.3200000000000003 112.276 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 13.8 Cg_endo -52.06 126.16 19.39 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.66 2.24 . . . . 11.1 112.812 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.36 -20.31 28.1 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 10.31 111.491 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.555 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 20.2 tp60 -81.42 102.92 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.239 0.542 . . . . 9.2100000000000009 110.339 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.536 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 21.1 ttp180 -89.95 111.85 23.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.571 -0.74 . . . . 11.51 110.515 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.743 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 91.8 m-85 -92.67 127.72 38.27 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 108.036 -1.098 . . . . 7.5 108.036 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.79 -18.12 64.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.332 -0.547 . . . . 10.609999999999999 112.173 -171.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.3 mttt -141.4 170.09 10.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.738 -0.385 . . . . 10.91 111.01 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -52.82 170.43 0.29 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.522 2.815 . . . . 7.5099999999999998 113.586 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.9 -167.15 29.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.39 -0.91 . . . . 7.5899999999999999 113.421 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 9.4 ttmt -97.03 148.06 23.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.203 -0.666 . . . . 11.68 109.203 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.477 ' HA ' HD21 ' A' ' 53' ' ' LEU . 75.6 p -62.9 136.51 96.56 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 115.457 -0.792 . . . . 9.1999999999999993 110.57 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.25 -25.4 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.894 1.729 . . . . 10.25 111.59 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.55 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 88.0 m-85 -81.82 -31.19 31.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.625 -0.716 . . . . 10.49 110.631 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.12 -159.74 0.88 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.501 -0.925 . . . . 10.380000000000001 108.501 173.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -130.67 54.92 1.86 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.687 0.756 . . . . 12.539999999999999 109.751 172.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 ptm -127.71 145.04 53.39 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 114.526 -1.216 . . . . 9.8699999999999992 109.394 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.57 133.28 47.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.679 1.586 . . . . 9.5099999999999998 109.971 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 46' ' ' SER . 24.2 mt -62.67 165.05 6.86 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.408 0.442 . . . . 6.71 110.735 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' A' ' 33' ' ' PRO . 32.8 mm -99.7 129.21 29.29 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.497 -0.557 . . . . 7.8899999999999997 109.497 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 56.0 Cg_endo -83.28 138.2 8.65 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.851 1.701 . . . . 5.7699999999999996 113.274 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.46 159.51 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.725 -1.58 . . . . 5.96 113.431 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.98 -86.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.966 2.106 . . . . 7.8399999999999999 115.512 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.695 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -49.65 -38.76 33.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.977 0.418 . . . . 6.6200000000000001 110.26 -177.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 63.69 84.85 0.14 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.885 -1.052 . . . . 8.5800000000000001 111.263 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 55' ' ' PRO . 30.4 tt0 62.27 60.05 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.102 0.953 . . . . 7.6399999999999997 110.684 168.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.59 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 1.9 t-20 -138.39 -5.45 1.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.67 -1.605 . . . . 7.0199999999999996 110.154 173.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.31 -35.08 62.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.828 0.823 . . . . 5.4100000000000001 110.416 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 8.0 p-10 -76.02 -4.2 39.98 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.16 -1.382 . . . . 7.0099999999999998 112.558 -167.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 52.6 36.34 47.79 Favored Glycine 0 C--N 1.313 -0.696 0 O-C-N 124.168 0.917 . . . . 7.2000000000000002 113.144 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 64' ' ' GLY . . . 75.03 56.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.294 0.644 . . . . 7.8200000000000003 111.442 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 79.78 12.78 1.08 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.536 -0.756 . . . . 8.6500000000000004 112.201 165.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' ' 164' ' ' THR . 11.9 t -58.89 -54.0 39.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.639 -1.245 . . . . 7.3099999999999996 107.639 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 10.5 ptp180 -105.94 -168.4 1.44 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.053 -1.885 . . . . 10.210000000000001 109.709 172.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.5 mp -57.73 144.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 115.44 -0.8 . . . . 8.8599999999999994 111.203 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.492 ' HB3' ' NE ' ' A' ' 72' ' ' ARG . 37.5 t70 -86.72 51.9 2.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 13.02 110.168 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.11 29.7 15.53 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.746 -0.661 . . . . 12.130000000000001 113.659 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 69' ' ' ILE . 15.3 ptp180 -106.05 -155.92 0.56 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 122.607 0.363 . . . . 12.380000000000001 110.324 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.4 m -32.24 -33.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.586 1.554 . . . . 11.609999999999999 114.679 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.415 ' HA ' HG21 ' A' ' 69' ' ' ILE . 10.2 t 42.49 85.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.743 1.217 . . . . 10.710000000000001 113.84 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.04 76.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.534 -0.757 . . . . 14.09 110.02 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -151.06 133.74 15.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.022 -0.733 . . . . 11.220000000000001 109.022 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.8 -20.1 63.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.199 0.524 . . . . 13.710000000000001 111.077 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.92 -44.67 1.2 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.266 -0.734 . . . . 11.44 111.266 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.447 HG11 ' CZ ' ' A' ' 120' ' ' PHE . 64.2 t 67.06 95.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.586 0.708 . . . . 9.9900000000000002 110.756 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 158' ' ' GLU . 61.2 ttm-85 -81.48 127.86 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.501 -0.772 . . . . 11.640000000000001 110.242 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.4 p -131.37 146.78 52.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.13 -0.941 . . . . 8.0 109.792 -176.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.0 128.08 56.07 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.867 -0.79 . . . . 6.6500000000000004 108.867 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.76 131.71 35.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.07 -0.345 . . . . 12.15 110.07 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' GLN . 73.4 t -56.7 127.2 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-O 122.293 1.044 . . . . 9.7100000000000009 112.066 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.83 136.27 8.99 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.888 -1.96 . . . . 11.029999999999999 109.035 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.603 ' H ' ' CD1' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.61 168.83 19.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.894 -1.048 . . . . 12.76 112.44 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.45 52.86 0.01 OUTLIER Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.635 -1.166 . . . . 13.25 111.135 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.66 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -74.55 -177.36 3.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.404 -0.898 . . . . 16.350000000000001 113.001 -170.212 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.56 111.86 13.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.071 -0.968 . . . . 18.219999999999999 108.62 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.21 -157.7 17.74 Favored Glycine 0 C--N 1.317 -0.474 0 CA-C-N 115.331 -0.849 . . . . 17.91 111.417 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.3 m -91.67 77.21 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.713 -0.847 . . . . 17.109999999999999 108.713 174.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.66 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 1.5 m -154.4 169.29 24.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 14.73 109.777 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -138.07 113.9 9.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.994 -0.743 . . . . 14.94 108.994 157.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 1.9 ttp180 -132.44 149.2 52.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.71 . . . . 10.57 111.062 -172.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.7 mm? -77.51 120.83 23.03 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.391 0.432 . . . . 8.8800000000000008 110.458 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.06 131.87 43.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.311 -0.404 . . . . 9.7799999999999994 111.318 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.7 156.12 59.66 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 6.4000000000000004 109.467 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.46 134.06 61.0 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.117 1.878 . . . . 6.5499999999999998 110.663 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 21.7 t -61.56 -26.05 67.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.958 0.355 . . . . 9.2899999999999991 111.958 -173.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.0 4.8 49.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.941 -0.474 . . . . 10.859999999999999 111.568 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -75.73 -32.88 60.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.413 0.625 . . . . 5.3399999999999999 110.54 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 2.9 pp -101.99 168.21 9.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.278 -0.874 . . . . 6.9699999999999998 111.918 -172.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' THR . 27.6 mm -121.26 101.84 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.062 -0.517 . . . . 10.199999999999999 110.129 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 104' ' ' ARG . 2.7 ppt_? -109.35 108.04 18.45 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.195 -1.402 . . . . 12.119999999999999 111.131 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -123.73 136.11 54.25 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.76 -1.564 . . . . 14.609999999999999 109.143 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.64 -102.99 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.401 -0.904 . . . . 15.52 112.333 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.22 4.53 10.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.914 0.709 . . . . 14.99 112.914 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 176.14 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.773 0.657 . . . . 15.199999999999999 112.773 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.5 m -123.99 156.74 35.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.015 -0.993 . . . . 9.2599999999999998 111.712 -169.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 26.4 mm -128.46 149.82 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.081 -0.711 . . . . 10.550000000000001 109.081 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -132.61 140.37 48.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.603 0.24 . . . . 7.3899999999999997 110.924 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 67.9 mtp -92.52 100.75 13.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.434 -0.58 . . . . 8.8499999999999996 109.434 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.7 p -88.86 132.95 32.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 9.6899999999999995 111.789 -174.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -79.19 83.85 5.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.376 -0.829 . . . . 10.699999999999999 109.774 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 46.5 mttm -75.18 146.93 40.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.771 -0.65 . . . . 14.880000000000001 110.972 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 172' ' ' THR . . . -76.0 5.2 42.28 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 16.920000000000002 111.138 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -85.61 9.77 15.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.626 0.727 . . . . 18.559999999999999 110.679 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.48 19.02 50.83 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.149 -0.932 . . . . 15.619999999999999 113.816 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.31 173.12 36.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.348 -0.93 . . . . 14.19 112.581 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 71.2 m-85 -109.84 109.24 19.83 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.194 -0.669 . . . . 12.029999999999999 109.194 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.596 ' O ' HG12 ' A' ' 113' ' ' VAL . 7.0 t70 -101.57 145.72 30.95 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 13.91 110.502 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 20.1 Cg_endo -89.32 132.82 2.24 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.151 1.9 . . . . 12.35 112.406 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.647 HG12 ' HB3' ' A' ' 111' ' ' ALA . 2.8 p -118.84 137.05 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.625 -0.716 . . . . 9.4299999999999997 109.542 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 111.85 13.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 12.93 110.101 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -119.1 160.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.929 -1.032 . . . . 8.0299999999999994 110.826 -175.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 23.5 ttmm -104.46 125.86 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.846 -0.615 . . . . 10.390000000000001 109.555 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.65 109.67 5.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.678 -0.237 . . . . 8.3000000000000007 111.61 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.579 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.63 70.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.166 -1.968 . . . . 10.1 113.905 169.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.34 162.24 40.47 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.831 -0.803 . . . . 10.609999999999999 108.831 155.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 23.6 m -138.89 129.4 25.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.11 0.481 . . . . 13.17 109.871 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.73 102.31 5.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.645 -0.707 . . . . 12.98 110.675 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.63 24.39 76.25 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.041 -0.527 . . . . 14.34 112.492 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 97.51 -10.72 64.99 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.766 -0.73 . . . . 13.119999999999999 112.195 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 130' ' ' THR . 2.4 mp0 -97.49 162.98 13.05 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.84 -0.8 . . . . 10.619999999999999 108.84 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.4 p -114.63 155.36 26.69 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.431 -0.507 . . . . 7.8200000000000003 111.172 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.905 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 25.7 mt-10 -100.02 128.5 46.09 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.5 0.667 . . . . 10.789999999999999 110.967 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 125' ' ' VAL . 24.3 mm -92.02 101.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.133 -0.94 . . . . 6.7300000000000004 109.772 175.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.579 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.6 mp -67.18 -45.63 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.836 -1.075 . . . . 8.7899999999999991 109.845 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.0 mt-10 -146.34 163.29 36.04 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.356 -0.609 . . . . 10.44 109.356 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.83 -46.95 1.05 Allowed Glycine 0 C--N 1.316 -0.572 0 C-N-CA 119.497 -1.335 . . . . 8.8699999999999992 114.242 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.7 mt -123.22 -178.49 4.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.416 0.895 . . . . 8.5 113.416 -170.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.9 ttpt -142.39 155.23 45.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.569 -1.196 . . . . 14.15 108.846 -176.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.61 129.6 40.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.985 -0.552 . . . . 12.119999999999999 110.063 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.17 48.46 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.251 -0.74 . . . . 11.539999999999999 111.251 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.8 mm100 -97.89 100.8 12.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.446 0.641 . . . . 11.24 109.334 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.1 mt-30 -74.11 127.4 32.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.356 -0.838 . . . . 10.49 110.307 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 149' ' ' VAL . 19.5 m -117.69 135.83 56.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.601 0.238 . . . . 5.4500000000000002 110.67 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.593 ' HA ' HG22 ' A' ' 81' ' ' THR . 42.6 t -66.43 115.05 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.864 -0.607 . . . . 6.5599999999999996 110.473 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 4.1 m -105.07 -17.75 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 6.9900000000000002 110.759 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.6 m 57.92 22.68 8.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.356 -0.838 . . . . 9.0600000000000005 112.038 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' H ' HG23 ' A' ' 149' ' ' VAL . . . -66.82 146.45 48.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.119 -0.562 . . . . 8.5 112.713 -175.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.4 -88.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.391 . . . . 11.84 110.966 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.26 82.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 12.24 110.818 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 -168.72 2.15 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.514 -0.55 . . . . 13.16 109.514 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 157' ' ' SER . 28.8 pt -59.57 163.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 11.949999999999999 111.91 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.9 24.54 0.62 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.008 0.908 . . . . 11.220000000000001 111.206 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 155' ' ' ILE . 6.4 p -56.92 -27.11 60.48 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 114.456 -1.247 . . . . 11.9 111.218 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 1.5 mm-40 -57.9 -35.79 71.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 112.922 -1.945 . . . . 11.17 111.057 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.53 64.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.595 -0.73 . . . . 7.8200000000000003 110.895 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.2 m -76.23 -25.64 55.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.507 0.67 . . . . 9.6400000000000006 109.571 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.76 -16.53 44.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.111 -0.949 . . . . 10.57 110.756 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.7 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 13.4 mmm180 -89.45 131.21 35.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.316 0.579 . . . . 8.9000000000000004 111.469 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -148.06 62.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.292 -1.523 . . . . 7.1500000000000004 109.292 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.571 ' O ' HG11 ' A' ' 67' ' ' VAL . 17.8 p 50.0 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.592 -0.521 . . . . 7.0899999999999999 109.592 -161.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 166' ' ' ALA . 2.7 p -100.18 -65.89 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 9.1999999999999993 109.997 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.651 ' H ' HG13 ' A' ' 165' ' ' VAL . . . 156.13 -178.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.993 1.317 . . . . 9.1099999999999994 108.547 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.25 58.82 0.65 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.157 0.979 . . . . 14.58 111.935 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.417 ' O ' ' HB3' ' A' ' 169' ' ' GLN . 28.9 mtm -111.15 77.4 1.04 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.578 -1.192 . . . . 11.94 109.522 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 168' ' ' MET . 35.6 tt0 68.1 83.17 0.16 Allowed 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.607 -0.516 . . . . 14.99 109.607 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.59 -84.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.265 -0.88 . . . . 15.01 110.45 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.8 p 37.14 59.51 1.11 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.677 0.61 . . . . 14.25 112.346 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.559 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 8.8 t -102.76 161.58 13.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.894 0.378 . . . . 14.890000000000001 110.148 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.9 p -131.8 -2.88 3.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.543 -0.753 . . . . 15.85 111.08 -176.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.18 41.72 3.02 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.86 -0.686 . . . . 17.539999999999999 113.457 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp 71.52 -63.55 0.42 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.756 0.788 . . . . 17.850000000000001 111.805 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.01 -163.54 1.56 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.471 -1.24 . . . . 19.670000000000002 109.848 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.1 m -58.69 142.3 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.907 0.384 . . . . 19.52 110.417 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.06 120.55 30.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.979 0.418 . . . . 21.149999999999999 110.369 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -72.51 -57.15 4.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 23.25 110.546 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.942 -0.572 . . . . 23.52 110.703 -178.877 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.719 0.295 . . . . 34.32 110.849 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.67 -139.22 24.23 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.828 -0.701 . . . . 33.090000000000003 112.096 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t 57.16 47.96 16.19 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.381 0.61 . . . . 34.119999999999997 110.141 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.62 158.78 18.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 32.32 111.056 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -132.18 100.4 5.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.638 0.732 . . . . 32.740000000000002 110.659 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.19 -35.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.624 -0.716 . . . . 31.289999999999999 112.086 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -127.7 155.09 44.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.916 0.389 . . . . 29.460000000000001 111.029 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.18 148.71 7.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 28.280000000000001 112.046 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.33 111.6 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.759 2.306 . . . . 27.510000000000002 111.772 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -69.4 -78.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.771 0.32 . . . . 26.48 111.014 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 168.01 147.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.116 -1.068 . . . . 24.899999999999999 108.116 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.42 -160.15 33.64 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.117 -1.04 . . . . 23.190000000000001 112.266 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.6 m80 51.48 53.72 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.747 0.419 . . . . 21.309999999999999 111.015 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p-10 -115.62 118.67 38.86 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.064 -0.516 . . . . 19.890000000000001 110.142 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 14' ' ' ASP . 30.3 Cg_exo -63.81 -170.38 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.229 2.619 . . . . 18.120000000000001 113.026 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 58.26 51.53 8.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.371 0.605 . . . . 16.579999999999998 110.341 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.23 82.38 3.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.438 -0.801 . . . . 14.800000000000001 110.437 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.34 78.87 0.24 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.778 -0.725 . . . . 13.17 112.095 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.38 -2.26 27.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.393 0.616 . . . . 12.17 110.842 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 59.33 61.16 2.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.681 -1.145 . . . . 13.82 110.732 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.9 mt 51.56 26.45 3.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 113.068 -1.878 . . . . 12.130000000000001 113.414 170.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -80.62 -1.51 42.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.339 0.59 . . . . 14.1 109.99 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.426 HG21 HD21 ' A' ' 28' ' ' LEU . 5.4 p -121.4 63.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.496 -0.774 . . . . 11.050000000000001 109.762 172.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -72.15 74.25 0.84 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.129 -0.941 . . . . 10.050000000000001 112.506 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.8 mptm? 71.02 64.23 0.17 Allowed 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.23 -1.026 . . . . 10.380000000000001 108.23 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.3 mtm180 -136.73 138.61 41.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.168 -1.378 . . . . 8.3699999999999992 109.484 -173.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' CH2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -49.59 124.13 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.962 0.887 . . . . 5.7599999999999998 112.21 -173.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 23' ' ' THR . 20.9 mt -112.16 -37.6 4.99 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.648 -1.614 . . . . 8.2200000000000006 110.942 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 4.0 p90 -176.29 -178.64 0.99 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 7.9900000000000002 109.464 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.683 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.0 156.61 30.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.867 -0.606 . . . . 5.6100000000000003 111.009 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 30.3 ptt180 -160.03 149.7 18.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.853 -1.067 . . . . 9.0600000000000005 110.311 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HB3' HG22 ' A' ' 35' ' ' VAL . 1.8 t0 -88.19 138.69 30.53 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.046 -0.724 . . . . 8.3100000000000005 109.046 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HG3' HG13 ' A' ' 54' ' ' ILE . 32.8 Cg_exo -57.55 -20.61 42.28 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 123.498 2.799 . . . . 10.41 113.088 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -89.44 -24.4 21.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.354 0.597 . . . . 10.85 109.993 -177.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.3 m -117.95 37.16 0.24 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.107 -0.951 . . . . 9.3200000000000003 113.526 -161.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 57.7 Cg_endo -60.78 108.29 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.881 2.387 . . . . 11.1 112.166 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.31 -18.29 0.91 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.496 -0.859 . . . . 10.31 112.474 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -77.26 -177.74 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.215 0.531 . . . . 9.2100000000000009 111.646 174.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.644 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 5.2 tpp180 -148.26 91.73 1.95 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 11.51 109.729 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 77.5 m-85 -75.63 137.02 40.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.851 -0.74 . . . . 7.5 110.442 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.84 -29.94 71.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.745 -1.116 . . . . 10.609999999999999 110.032 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -165.04 164.28 13.03 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.338 -0.846 . . . . 10.91 110.608 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.3 Cg_endo -48.63 169.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.872 3.048 . . . . 7.5099999999999998 114.351 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.14 -174.44 26.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.679 -0.772 . . . . 7.5899999999999999 112.606 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.9 ttpm? -86.19 146.0 26.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.186 0.517 . . . . 11.68 110.986 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 49' ' ' MET . 32.9 t -58.43 136.33 85.53 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.764 -1.107 . . . . 9.1999999999999993 110.924 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.55 -20.43 15.81 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 122.192 1.928 . . . . 10.25 110.912 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -86.15 -42.63 13.7 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.672 -1.603 . . . . 10.49 109.597 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.514 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.5 mtm -129.5 152.65 48.81 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 115.779 -0.646 . . . . 10.380000000000001 111.339 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.74 60.7 5.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.747 1.261 . . . . 12.539999999999999 111.294 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -139.51 145.55 44.28 Favored Pre-proline 0 C--N 1.304 -1.371 0 CA-C-N 113.891 -1.504 . . . . 9.8699999999999992 109.208 177.116 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 39.8 Cg_endo -67.57 133.86 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.934 1.756 . . . . 9.5099999999999998 111.936 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.4 163.23 11.1 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.576 -0.528 . . . . 6.71 109.576 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' A' ' 33' ' ' PRO . 24.1 mm -98.02 132.81 23.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 120.989 0.423 . . . . 7.8899999999999997 110.565 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.87 147.51 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.91 1.74 . . . . 5.7699999999999996 112.208 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 35.2 m -73.02 158.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 114.657 -1.156 . . . . 5.96 112.679 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.496 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.89 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.235 2.214 . . . . 7.8399999999999999 115.865 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.654 ' CD ' ' HB3' ' A' ' 61' ' ' ASN . 2.6 pt-20 -48.47 -44.16 35.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.477 0.711 . . . . 6.6200000000000001 111.231 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' N ' ' HG2' ' A' ' 58' ' ' GLU . 33.5 tt0 58.25 95.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.759 -1.109 . . . . 8.5800000000000001 111.414 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 31.2 tt0 75.84 63.46 0.05 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.033 -1.439 . . . . 7.6399999999999997 112.801 167.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.654 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 7.5 t30 -146.07 -50.2 0.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.995 -1.002 . . . . 7.0199999999999996 110.406 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -72.51 -53.2 12.71 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.124 -0.489 . . . . 5.4100000000000001 109.968 172.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.653 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 34.6 t70 -171.9 60.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 7.0099999999999998 110.59 174.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 60' ' ' GLU . . . -73.01 -38.5 55.63 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 119.497 -1.335 . . . . 7.2000000000000002 111.389 171.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.06 50.33 1.82 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.709 -0.746 . . . . 7.8200000000000003 110.388 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.601 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . . . 62.04 33.52 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.554 -0.748 . . . . 8.6500000000000004 111.504 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -10.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.081 -0.711 . . . . 7.3099999999999996 109.081 172.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.653 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 4.1 tmm_? -35.54 141.12 0.09 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.293 -1.321 . . . . 10.210000000000001 112.989 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.514 HG21 ' HG2' ' A' ' 72' ' ' ARG . 22.7 mt -67.12 144.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.514 -0.766 . . . . 8.8599999999999994 110.126 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -86.95 46.39 1.37 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.872 0.844 . . . . 13.02 110.524 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 73' ' ' VAL . . . 52.38 35.22 43.23 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.466 -1.243 . . . . 12.130000000000001 112.947 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.514 ' HG2' HG21 ' A' ' 69' ' ' ILE . 26.2 ptt180 -58.52 122.79 14.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.518 0.675 . . . . 12.380000000000001 110.534 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 71' ' ' GLY . 73.9 t -131.21 137.45 55.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.57 -0.741 . . . . 11.609999999999999 110.015 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 152' ' ' GLN . 9.2 t -141.89 102.38 4.14 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.895 0.855 . . . . 10.710000000000001 110.165 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -124.43 64.63 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 14.09 109.023 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.28 113.32 26.84 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.023 -0.989 . . . . 11.220000000000001 110.312 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.58 -44.83 70.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.297 -0.411 . . . . 13.710000000000001 110.657 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -79.28 -40.49 15.92 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.51 -0.636 . . . . 11.44 111.51 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 47.6 t 72.72 113.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.416 0.627 . . . . 9.9900000000000002 111.206 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 23.6 ttm180 -82.15 131.53 35.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.891 -0.781 . . . . 11.640000000000001 108.891 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 148' ' ' VAL . 68.0 p -131.12 159.19 38.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 8.0 110.097 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -121.59 128.64 52.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.668 -0.864 . . . . 6.6500000000000004 108.668 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 33.9 tt0 -84.56 130.46 34.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.465 -0.569 . . . . 12.15 109.465 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 143' ' ' ALA . 20.5 m -64.35 141.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 122.888 1.328 . . . . 9.7100000000000009 111.401 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -164.13 174.28 11.46 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.335 -2.212 . . . . 11.029999999999999 109.514 173.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 10.0 mp -70.48 167.91 17.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.572 0.701 . . . . 12.76 112.125 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 157.3 46.08 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.33 -0.85 . . . . 13.25 112.604 176.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.809 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -89.54 -178.22 5.51 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.688 -0.405 . . . . 16.350000000000001 111.933 -176.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.32 106.98 8.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.878 -0.601 . . . . 18.219999999999999 109.471 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.21 -162.72 23.13 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.899 -0.591 . . . . 17.91 111.784 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.1 m -91.34 75.37 6.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.282 1.039 . . . . 17.109999999999999 109.76 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.809 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 2.0 m -154.94 168.74 25.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.589 -1.634 . . . . 14.73 106.589 176.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 7.8 mt-10 -143.3 109.8 5.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.859 0.754 . . . . 14.94 110.575 165.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.633 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 1.5 mmp_? -121.11 168.13 11.89 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.87 -0.605 . . . . 10.57 111.248 -171.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.6 mm? -97.85 114.21 26.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.464 -0.789 . . . . 8.8800000000000008 109.294 176.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.2 mm? -91.39 130.91 37.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.349 -0.841 . . . . 9.7799999999999994 111.258 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.604 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 3.3 p -139.32 146.81 50.31 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.525 -1.216 . . . . 6.4000000000000004 108.927 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.7 Cg_exo -56.51 132.01 49.18 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.145 1.897 . . . . 6.5499999999999998 109.595 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t -57.74 -25.55 60.57 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 9.2899999999999991 112.312 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.38 4.48 52.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.945 0.35 . . . . 10.859999999999999 111.945 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.604 ' HB3' ' CG2' ' A' ' 97' ' ' VAL . . . -79.84 -33.6 40.07 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.225 -0.59 . . . . 5.3399999999999999 110.51 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -91.91 155.1 18.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.584 0.707 . . . . 6.9699999999999998 111.967 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -99.18 125.43 52.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.08 -0.964 . . . . 10.199999999999999 109.029 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 20.8 mmm180 -98.1 125.69 43.21 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.677 -0.809 . . . . 12.119999999999999 110.911 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.9 t -149.15 127.26 12.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.722 -0.672 . . . . 14.609999999999999 110.818 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.41 -121.91 16.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.03 -0.532 . . . . 15.52 112.794 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.09 36.79 2.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 14.99 111.418 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -156.98 177.43 11.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.002 -0.544 . . . . 15.199999999999999 111.526 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 25.8 m -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.644 -0.707 . . . . 9.2599999999999998 109.26 174.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.5 mm -126.92 150.7 33.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 10.550000000000001 109.125 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.602 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.35 130.02 32.22 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.242 -0.286 . . . . 7.3899999999999997 110.839 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.454 ' HE3' HG11 ' A' ' 148' ' ' VAL . 38.7 mtm -84.71 100.25 11.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.846 -0.798 . . . . 8.8499999999999996 108.846 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 11.3 p -81.95 134.46 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.825 -1.079 . . . . 9.6899999999999995 111.208 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.59 91.56 7.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.539 -0.755 . . . . 10.699999999999999 110.235 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.48 147.94 35.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 14.880000000000001 111.035 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.16 -2.35 47.16 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.658 -0.701 . . . . 16.920000000000002 112.021 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.17 6.84 12.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.456 0.646 . . . . 18.559999999999999 111.058 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.67 67.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.243 -0.889 . . . . 15.619999999999999 113.197 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.6 -174.74 13.51 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.336 -0.935 . . . . 14.19 112.981 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.08 128.26 37.83 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.068 0.547 . . . . 12.029999999999999 109.783 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 113' ' ' VAL . 8.2 m-20 -125.37 147.72 58.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.594 -0.275 . . . . 13.91 111.024 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -85.37 124.87 2.86 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.391 2.061 . . . . 12.35 112.484 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.623 HG11 HD13 ' A' ' 141' ' ' LEU . 4.4 p -106.19 135.73 43.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.87 -1.059 . . . . 9.4299999999999997 109.078 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.1 tt0 -82.23 122.75 28.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.057 -0.72 . . . . 12.93 109.057 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -137.02 157.16 35.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.402 0.62 . . . . 8.0299999999999994 112.215 -173.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 76.1 tttt -93.73 128.68 40.06 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.092 -0.958 . . . . 10.390000000000001 110.208 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.404 ' HB3' ' OG1' ' A' ' 109' ' ' THR . . . -142.19 104.39 4.44 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.782 -0.644 . . . . 8.3000000000000007 111.075 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.32 71.28 0.28 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 117.924 -2.084 . . . . 10.1 113.882 169.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.83 164.14 36.14 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.892 -0.781 . . . . 10.609999999999999 108.892 157.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -133.48 128.32 35.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.709 -0.478 . . . . 13.17 109.709 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.87 122.49 7.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.514 -0.312 . . . . 12.98 111.58 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.31 92.31 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.933 -0.576 . . . . 14.34 113.101 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.99 78.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 13.119999999999999 111.687 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -130.6 171.67 12.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.936 -0.765 . . . . 10.619999999999999 108.936 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -115.21 156.58 25.08 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.649 -0.501 . . . . 7.8200000000000003 109.649 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.7 mt-10 -102.36 124.07 47.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.562 0.696 . . . . 10.789999999999999 111.375 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 125' ' ' VAL . 26.0 mm -86.04 111.83 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.963 -1.017 . . . . 6.7300000000000004 109.16 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 3.8 mp -81.15 -45.69 16.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.974 -1.012 . . . . 8.7899999999999991 111.006 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 125' ' ' VAL . 42.6 mt-10 -146.59 173.02 12.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.139 -0.689 . . . . 10.44 109.139 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 93.2 -63.01 2.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.144 -1.027 . . . . 8.8699999999999992 113.715 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD13 HG11 ' A' ' 123' ' ' VAL . 35.9 tp -105.41 145.09 31.28 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.234 -1.024 . . . . 8.5 108.234 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 85.8 tttt -136.34 143.8 44.29 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 112.734 0.642 . . . . 14.15 112.734 -161.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 1.037 ' HA ' HG23 ' A' ' 84' ' ' VAL . . . -49.62 123.91 8.62 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.845 -1.525 . . . . 12.119999999999999 111.375 -173.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.1 1.12 38.72 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 114.853 -1.067 . . . . 11.539999999999999 111.286 -171.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 74.6 mm-40 -103.7 125.52 50.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.766 -0.773 . . . . 11.24 110.097 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 mp0 -85.39 142.83 29.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.728 -0.669 . . . . 10.49 110.577 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 16.1 m -135.27 147.27 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.472 0.177 . . . . 5.4500000000000002 110.597 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 81' ' ' THR . 22.6 m -57.84 133.72 22.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 O-C-N 123.855 0.722 . . . . 6.5599999999999996 111.878 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 82' ' ' ALA . 45.9 t -131.41 -35.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.2 -0.909 . . . . 6.9900000000000002 110.546 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 17.2 t -147.12 71.54 1.22 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.654 -0.869 . . . . 9.0600000000000005 108.654 173.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 79' ' ' VAL . . . -142.09 175.76 22.51 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.68 -0.691 . . . . 8.5 111.993 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 74' ' ' THR . 75.3 mt-30 -75.27 142.15 43.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.83 0.348 . . . . 11.84 111.02 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.91 -166.72 1.37 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 12.24 110.001 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.2 171.35 20.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.287 0.565 . . . . 13.16 110.23 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 158' ' ' GLU . 26.9 mt 63.84 61.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 114.393 -1.276 . . . . 11.949999999999999 111.183 176.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.26 -9.37 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 11.220000000000001 111.279 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.8 p -61.52 -41.13 96.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.308 0.575 . . . . 11.9 110.593 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' A' ' 155' ' ' ILE . 51.5 mm-40 -73.51 -30.8 63.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 11.17 109.799 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.65 -17.9 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.98 -1.009 . . . . 7.8200000000000003 110.482 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.3 m -81.44 -31.66 32.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.511 -0.768 . . . . 9.6400000000000006 110.465 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.3 -31.03 48.7 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.297 -0.865 . . . . 10.57 110.833 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -81.47 166.97 19.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.725 -0.671 . . . . 8.9000000000000004 109.546 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.95 71.95 2.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.089 -0.576 . . . . 7.1500000000000004 111.84 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.9 p 53.4 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.273 1.029 . . . . 7.0899999999999999 112.022 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.43 -45.92 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 110.209 -0.293 . . . . 9.1999999999999993 110.209 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 51.53 90.43 0.02 OUTLIER 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.589 0.556 . . . . 9.1099999999999994 111.601 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -84.63 168.74 15.04 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 122.271 1.034 . . . . 14.58 109.794 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 11.8 mmt -107.45 -35.1 6.86 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.257 -1.792 . . . . 11.94 110.111 -169.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 63.72 -80.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.348 1.03 . . . . 14.99 111.974 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -144.35 -75.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.47 0.652 . . . . 15.01 109.878 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 23.8 p -87.22 113.26 22.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.081 -0.963 . . . . 14.25 111.329 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.1 m -63.57 -55.62 22.37 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.719 -0.673 . . . . 14.890000000000001 110.157 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.5 m 58.74 -166.5 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.524 -0.762 . . . . 15.85 111.845 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 83.18 5.57 88.9 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.216 -0.754 . . . . 17.539999999999999 111.216 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.5 mt -122.77 18.34 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.433 -0.383 . . . . 17.850000000000001 110.948 -170.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 71.55 -44.07 0.58 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.972 0.795 . . . . 19.670000000000002 111.86 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.37 148.62 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.373 0.606 . . . . 19.52 111.336 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.64 -92.88 0.31 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.677 -0.692 . . . . 21.149999999999999 109.297 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -142.54 79.04 1.64 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.494 -0.928 . . . . 23.25 108.494 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 115.279 -0.873 . . . . 23.52 110.863 -171.561 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.876 0.369 . . . . 34.32 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.59 -143.33 36.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.813 -0.708 . . . . 33.090000000000003 111.501 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.2 p -167.74 175.32 7.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.62 0.248 . . . . 34.119999999999997 110.552 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.55 105.89 14.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.489 -0.323 . . . . 32.32 110.223 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 m -75.19 84.03 2.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.187 0.518 . . . . 32.740000000000002 110.184 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.99 119.08 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.561 0.696 . . . . 31.289999999999999 111.218 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.38 -30.8 20.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.551 -0.749 . . . . 29.460000000000001 109.556 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.29 -172.75 45.73 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.605 -0.998 . . . . 28.280000000000001 110.605 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.66 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.398 2.066 . . . . 27.510000000000002 111.16 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -174.27 143.42 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.496 -0.557 . . . . 26.48 109.496 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -72.0 150.99 43.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.323 -0.399 . . . . 24.899999999999999 110.319 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.05 -134.74 4.69 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.691 -0.766 . . . . 23.190000000000001 112.121 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -117.9 128.99 55.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.147 0.498 . . . . 21.309999999999999 110.197 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.542 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.6 m-20 -70.13 -47.17 21.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.379 -0.828 . . . . 19.890000000000001 111.581 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 20.8 Cg_endo -62.04 133.71 45.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.608 1.538 . . . . 18.120000000000001 111.73 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.53 -43.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 16.579999999999998 110.515 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.69 72.53 1.49 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.067 -0.515 . . . . 14.800000000000001 110.809 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.33 94.87 0.15 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.933 -0.651 . . . . 13.17 111.802 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.55 -72.11 0.67 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.802 -0.234 . . . . 12.17 111.528 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.06 118.0 0.02 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.753 0.787 . . . . 13.82 111.514 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 21' ' ' LEU . 2.8 tm? 73.81 -31.09 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.276 -1.329 . . . . 12.130000000000001 111.891 172.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -78.09 65.83 3.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.579 0.704 . . . . 14.1 111.263 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 m 46.47 48.16 13.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.654 -1.157 . . . . 11.050000000000001 111.821 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.17 -78.38 1.41 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.222 -0.99 . . . . 10.050000000000001 111.643 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -130.5 59.55 1.65 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.942 -1.132 . . . . 10.380000000000001 107.942 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.525 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 3.1 mtp180 -134.8 140.81 46.16 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.161 -1.381 . . . . 8.3699999999999992 109.239 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' A' ' 58' ' ' GLU . 46.2 mm -51.96 118.24 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.068 -0.969 . . . . 5.7599999999999998 113.286 -169.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.19 -32.97 7.0 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.8 -1.546 . . . . 8.2200000000000006 110.009 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 37.6 p90 -179.51 -176.09 0.37 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.734 -0.667 . . . . 7.9900000000000002 109.625 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -118.77 154.98 31.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.714 . . . . 5.6100000000000003 110.908 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 39.2 ptt180 -164.06 148.01 9.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.834 0.708 . . . . 9.0600000000000005 109.721 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 1.027 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 9.4 m-20 -70.73 142.05 88.04 Favored Pre-proline 0 CA--C 1.51 -0.585 0 N-CA-C 108.986 -0.746 . . . . 8.3100000000000005 108.986 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' CG1' ' A' ' 54' ' ' ILE . 74.6 Cg_endo -68.87 -11.82 32.86 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 123.142 2.562 . . . . 10.41 112.353 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . 1.027 ' SD ' ' HB3' ' A' ' 32' ' ' ASP . 1.2 pmm? -102.75 1.34 34.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.289 . . . . 10.85 111.265 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 3.8 m -124.63 39.41 0.45 Allowed Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 112.627 0.603 . . . . 9.3200000000000003 112.627 177.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.2 Cg_endo -54.41 126.37 22.02 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.305 2.003 . . . . 11.1 112.334 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.86 -12.51 17.65 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.174 -0.771 . . . . 10.31 111.174 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 6.4 tp-100 -90.61 108.22 19.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.323 0.583 . . . . 9.2100000000000009 110.394 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.589 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.7 tmm_? -91.48 97.35 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 11.51 109.414 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 78.5 m-85 -77.25 146.59 36.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 7.5 110.715 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.1 -26.68 68.94 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.255 -1.339 . . . . 10.609999999999999 111.264 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 12.7 ptmm? -173.12 168.37 2.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.005 -0.543 . . . . 10.91 110.156 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.2 Cg_endo -52.35 169.29 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.502 2.134 . . . . 7.5099999999999998 112.52 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.72 -160.01 27.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 7.5899999999999999 111.644 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 7.1 ttpm? -99.98 151.23 21.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.444 0.64 . . . . 11.68 110.627 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 49' ' ' MET . 36.3 t -67.89 145.32 97.84 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.718 -1.128 . . . . 9.1999999999999993 111.86 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.08 -19.9 4.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.783 2.322 . . . . 10.25 111.504 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CD2' HG11 ' A' ' 35' ' ' VAL . 59.3 m-85 -81.45 -38.01 27.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.79 -1.096 . . . . 10.49 109.321 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.7 pmm? -153.46 171.41 18.72 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.395 -0.82 . . . . 10.380000000000001 110.338 172.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.16 76.65 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.512 0.93 . . . . 12.539999999999999 113.512 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.414 ' C ' ' HG3' ' A' ' 45' ' ' LYS . 9.6 ptm -143.9 147.12 37.08 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.857 -1.164 . . . . 9.8699999999999992 107.857 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 36.6 Cg_endo -67.23 135.99 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.336 1.357 . . . . 9.5099999999999998 110.12 171.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.89 166.98 6.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.265 0.555 . . . . 6.71 112.096 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.546 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 39.1 mm -101.95 130.51 24.25 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.696 -0.684 . . . . 7.8899999999999997 109.65 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 17.6 Cg_endo -83.02 134.13 6.91 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.359 1.373 . . . . 5.7699999999999996 112.21 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 35.3 m -56.03 157.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.254 -1.339 . . . . 5.96 113.099 -176.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.48 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.935 2.094 . . . . 7.8399999999999999 115.122 -177.409 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE1' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -45.68 -41.94 11.03 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.022 0.529 . . . . 6.6200000000000001 110.747 -178.067 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 32.7 tt0 69.6 86.05 0.13 Allowed 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.669 0.606 . . . . 8.5800000000000001 111.8 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' H ' HD11 ' A' ' 27' ' ' ILE . 30.1 tt0 63.99 69.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 7.6399999999999997 111.751 164.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.667 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 13.3 t-20 -158.83 -28.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.417 -0.81 . . . . 7.0199999999999996 112.393 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.518 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . . . -39.45 -51.09 2.14 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.683 0.793 . . . . 5.4100000000000001 110.918 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.58 -11.0 0.4 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.504 -1.226 . . . . 7.0099999999999998 110.304 173.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.5 -55.79 0.67 Allowed Glycine 0 C--N 1.3 -1.462 0 N-CA-C 109.136 -1.586 . . . . 7.2000000000000002 109.136 -157.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.49 -65.97 0.24 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.143 -1.028 . . . . 7.8200000000000003 109.646 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 176.69 29.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.62 -1.173 . . . . 8.6500000000000004 109.248 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 9.7 t -67.53 -74.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.327 -0.852 . . . . 7.3099999999999996 109.088 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.634 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 20.2 ptt180 162.66 148.83 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.058 1.343 . . . . 10.210000000000001 108.334 170.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 71' ' ' GLY . 41.6 mm -67.81 -55.45 16.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 118.586 -1.246 . . . . 8.8599999999999994 110.448 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 15.9 t70 75.33 -45.62 0.56 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 125.583 1.802 . . . . 13.02 110.082 -170.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 69' ' ' ILE . . . -43.54 -40.18 4.84 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.157 -1.838 . . . . 12.130000000000001 114.059 174.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 74' ' ' THR . 2.0 ptm180 -139.26 -166.28 2.01 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.924 -0.398 . . . . 12.380000000000001 109.924 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.565 HG22 ' H ' ' A' ' 76' ' ' ASN . 7.7 p -34.77 -33.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.087 1.355 . . . . 11.609999999999999 113.87 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.535 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 9.8 t 42.62 54.22 4.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.938 0.895 . . . . 10.710000000000001 112.475 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 53.25 64.58 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.929 -1.032 . . . . 14.09 111.712 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.565 ' H ' HG22 ' A' ' 73' ' ' VAL . 5.9 m-20 -125.25 95.41 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.947 -1.024 . . . . 11.220000000000001 109.511 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 77' ' ' LEU . 4.3 mm? -68.05 -17.09 64.29 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.474 -1.239 . . . . 13.710000000000001 111.658 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -37.27 1.14 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.218 -0.753 . . . . 11.44 111.218 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.0 t 65.85 94.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.735 0.779 . . . . 9.9900000000000002 111.065 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HB3' ' OG ' ' A' ' 150' ' ' SER . 36.5 ttt180 -93.7 139.28 31.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.12 -0.946 . . . . 11.640000000000001 110.344 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 148' ' ' VAL . 25.9 p -125.37 137.5 54.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.552 -0.749 . . . . 8.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -110.47 128.0 55.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.247 -0.649 . . . . 6.6500000000000004 109.247 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 34.3 tt0 -74.27 132.78 42.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.072 -0.714 . . . . 12.15 109.072 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.614 HG13 ' HB3' ' A' ' 95' ' ' LEU . 49.6 t -55.04 132.63 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.013 -0.539 . . . . 9.7100000000000009 112.301 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 25.3 mmtp -138.37 148.35 44.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.966 -1.016 . . . . 11.029999999999999 109.284 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.83 149.98 36.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.854 -0.795 . . . . 12.76 108.854 167.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.427 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -167.33 41.42 0.24 Allowed Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 120.166 -1.016 . . . . 13.25 112.527 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -77.85 145.84 36.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 16.350000000000001 111.387 -175.637 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.2 tp -155.96 87.41 1.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.833 -0.621 . . . . 18.219999999999999 109.426 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.66 -10.13 75.37 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.672 -1.371 . . . . 17.91 109.672 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 41.0 p -110.99 156.85 20.65 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.793 -1.188 . . . . 17.109999999999999 107.793 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.451 ' HB ' ' NH1' ' A' ' 94' ' ' ARG . 13.3 m -71.82 158.2 36.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.487 -0.56 . . . . 14.73 109.487 175.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 12.3 mt-10 -55.09 113.0 1.19 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.775 0.798 . . . . 14.94 111.635 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' HG2' HD12 ' A' ' 138' ' ' LEU . 2.1 mpp_? -132.29 169.61 16.23 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.316 -1.311 . . . . 10.57 109.5 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -94.19 112.69 24.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.555 -0.906 . . . . 8.8800000000000008 108.555 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -88.44 131.78 34.73 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.532 -0.758 . . . . 9.7799999999999994 110.667 -175.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 98' ' ' PRO . 5.6 p -147.84 147.0 25.66 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.059 -0.973 . . . . 6.4000000000000004 109.089 -176.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 97' ' ' VAL . 74.9 Cg_exo -54.05 130.01 37.27 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.407 2.071 . . . . 6.5499999999999998 110.742 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 40.3 t -56.28 -28.07 57.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.017 0.747 . . . . 9.2899999999999991 113.017 -170.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.4 9.22 13.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.544 -0.462 . . . . 10.859999999999999 111.504 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -82.81 -33.7 27.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.156 0.503 . . . . 5.3399999999999999 111.469 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.532 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.6 pp -100.63 165.08 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.324 0.583 . . . . 6.9699999999999998 112.334 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 25.3 mm -104.29 118.62 51.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.45 -0.796 . . . . 10.199999999999999 110.294 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 11.0 mmm180 -103.91 94.83 5.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.811 0.339 . . . . 12.119999999999999 110.392 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.5 t -145.59 131.16 18.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.5 0.666 . . . . 14.609999999999999 111.602 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.88 -123.38 6.16 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.106 -0.952 . . . . 15.52 111.999 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.92 28.18 8.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.102 0.477 . . . . 14.99 111.16 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.42 178.36 9.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 15.199999999999999 111.165 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.1 m -128.58 149.99 50.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.937 -0.574 . . . . 9.2599999999999998 110.35 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.7 mp -126.23 153.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 110.214 -0.291 . . . . 10.550000000000001 110.214 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -130.78 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.459 -0.2 . . . . 7.3899999999999997 110.459 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.441 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 64.1 mtm -99.4 102.88 14.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.539 -0.541 . . . . 8.8499999999999996 109.539 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 8.3 p -85.77 137.24 21.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.111 0.482 . . . . 9.6899999999999995 111.451 -172.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 91.98 3.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.651 -0.704 . . . . 10.699999999999999 111.513 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -80.06 162.92 24.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.975 -0.557 . . . . 14.880000000000001 110.376 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.24 17.87 26.12 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.848 -0.614 . . . . 16.920000000000002 112.083 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.52 11.41 39.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 18.559999999999999 110.805 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.28 -6.59 67.34 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.56 -0.746 . . . . 15.619999999999999 112.467 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.3 167.25 12.92 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.851 -0.499 . . . . 14.19 111.851 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 56.5 m-85 -117.54 111.27 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.467 0.651 . . . . 12.029999999999999 109.976 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 30.4 t70 -91.49 134.11 30.04 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.093 -0.958 . . . . 13.91 111.328 -171.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 61.2 Cg_endo -80.58 137.1 11.32 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.201 1.934 . . . . 12.35 113.268 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.643 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.2 p -123.64 127.13 73.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.987 -1.006 . . . . 9.4299999999999997 109.821 177.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -82.62 114.63 21.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.652 -0.499 . . . . 12.93 109.652 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.455 HG12 ' HA3' ' A' ' 140' ' ' GLY . 35.6 m -130.06 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.671 -0.695 . . . . 8.0299999999999994 111.208 -173.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 3.5 ttmp? -109.52 127.33 54.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.146 -0.479 . . . . 10.390000000000001 110.471 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -143.18 112.4 6.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 8.3000000000000007 111.457 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.5 72.12 0.27 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 118.178 -1.963 . . . . 10.1 113.659 166.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.03 158.43 44.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.806 -0.812 . . . . 10.609999999999999 108.806 156.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 22.6 m -147.13 122.22 10.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.344 0.592 . . . . 13.17 109.891 169.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.02 107.45 8.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.14 -0.937 . . . . 12.98 110.7 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.97 38.16 92.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.188 -0.53 . . . . 14.34 112.4 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.01 87.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 13.119999999999999 112.584 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 130' ' ' THR . 30.2 mm-40 -106.04 154.53 20.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.286 -0.635 . . . . 10.619999999999999 109.286 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -115.25 165.97 12.36 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.455 -0.498 . . . . 7.8200000000000003 111.229 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 49.0 mt-10 -114.35 121.11 42.63 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.442 0.639 . . . . 10.789999999999999 111.521 175.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.4 mm -85.69 102.72 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.267 -0.879 . . . . 6.7300000000000004 108.663 169.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.519 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.35 -51.95 60.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.835 -1.075 . . . . 8.7899999999999991 109.766 -176.234 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -141.36 160.99 38.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.377 -0.829 . . . . 10.44 110.567 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.455 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 122.26 -64.01 0.52 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.539 -0.839 . . . . 8.8699999999999992 112.975 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 125' ' ' VAL . 30.6 mt -102.83 -177.31 3.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.931 0.715 . . . . 8.5 112.931 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -143.98 159.65 42.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.865 -1.061 . . . . 14.15 110.102 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.09 129.22 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.245 -0.889 . . . . 12.119999999999999 110.463 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.46 -7.0 26.46 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.729 -0.948 . . . . 11.539999999999999 110.729 -171.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.529 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.4 mm100 -97.83 117.41 32.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.514 . . . . 11.24 110.303 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -86.96 127.18 35.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.551 -0.749 . . . . 10.49 111.406 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.62 140.98 46.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.898 -0.592 . . . . 5.4500000000000002 110.179 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.561 ' HA ' HG22 ' A' ' 81' ' ' THR . 60.9 t -66.26 125.19 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 6.5599999999999996 110.548 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 82' ' ' ALA . 3.9 m -116.1 -19.3 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.221 0.452 . . . . 6.9900000000000002 112.221 -174.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 80' ' ' ARG . 11.6 p -162.26 100.61 1.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.511 0.672 . . . . 9.0600000000000005 111.584 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.14 -12.88 47.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.797 -0.921 . . . . 8.5 110.797 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 59.74 52.54 5.44 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.577 0.704 . . . . 11.84 111.088 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.1 18.39 5.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.722 -0.672 . . . . 12.24 110.833 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.92 -67.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.732 0.813 . . . . 13.16 109.936 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.7 mt -98.08 75.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.229 -0.656 . . . . 11.949999999999999 109.229 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -72.87 -17.12 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.972 -0.558 . . . . 11.220000000000001 111.134 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 m -66.67 -48.57 68.92 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.945 -0.702 . . . . 11.9 109.972 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.21 -22.03 59.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.653 -0.419 . . . . 11.17 110.589 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 162' ' ' ARG . . . -54.73 -42.18 71.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 7.8200000000000003 110.067 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.5 ' OG ' HD12 ' A' ' 103' ' ' ILE . 29.4 t -64.16 -30.01 71.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.238 -0.892 . . . . 9.6400000000000006 111.506 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.3 mt -85.45 -33.46 21.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 10.57 111.345 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 5.8 ptm180 -77.5 161.96 27.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.907 -0.588 . . . . 8.9000000000000004 110.696 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.53 57.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.344 -0.702 . . . . 7.1500000000000004 111.344 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.6 p 48.33 57.15 6.5 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.082 0.553 . . . . 7.0899999999999999 111.677 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t 64.62 94.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.743 -0.662 . . . . 9.1999999999999993 109.837 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.85 -173.94 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.637 . . . . 9.1099999999999994 111.816 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.728 ' HD3' ' C ' ' A' ' 167' ' ' ARG . 0.4 OUTLIER 63.68 107.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.495 -0.775 . . . . 14.58 109.603 -169.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 8.2 mtm -149.58 -123.02 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.381 -0.372 . . . . 11.94 111.055 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLN . . . . . 0.553 ' OE1' ' HB3' ' A' ' 168' ' ' MET . 0.8 OUTLIER -71.64 -61.6 1.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.566 -0.288 . . . . 14.99 110.233 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 56.28 47.05 19.99 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.602 -0.726 . . . . 15.01 110.278 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.4 p -96.37 125.22 40.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.642 -0.708 . . . . 14.25 111.023 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.8 t -153.06 151.7 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.072 -0.513 . . . . 14.890000000000001 110.349 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.8 m -134.8 28.51 3.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.893 -0.594 . . . . 15.85 110.353 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.78 -53.26 30.4 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.103 -0.57 . . . . 17.539999999999999 112.637 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.1 tt 67.13 100.74 0.05 OUTLIER 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.103 0.531 . . . . 17.850000000000001 109.959 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.07 -165.21 0.22 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.297 -0.865 . . . . 19.670000000000002 110.278 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.82 78.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.722 0.773 . . . . 19.52 109.538 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.69 145.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.78 -1.1 . . . . 21.149999999999999 110.605 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -74.55 118.14 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.993 -0.442 . . . . 23.25 109.873 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.522 -0.752 . . . . 23.52 110.67 -178.072 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 2' ' ' GLY . 13.9 tpt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 119.092 -0.48 . . . . 34.32 109.81 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -52.56 146.38 16.63 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.607 -0.806 . . . . 33.090000000000003 112.855 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t 61.99 15.71 7.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.844 0.458 . . . . 34.119999999999997 111.859 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.38 21.26 2.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.753 0.311 . . . . 32.32 111.51 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.4 m -72.32 119.89 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 32.740000000000002 110.261 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.49 141.91 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.919 -0.582 . . . . 31.289999999999999 110.965 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -96.07 -48.33 5.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 29.460000000000001 110.264 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -136.76 156.79 23.37 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.886 -0.673 . . . . 28.280000000000001 111.58 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.53 -56.39 1.54 Allowed 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.066 2.511 . . . . 27.510000000000002 113.163 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.3 m80 67.1 137.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.218 0.532 . . . . 26.48 110.881 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.57 -23.41 60.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.323 -0.399 . . . . 24.899999999999999 111.103 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.25 130.87 1.7 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.733 -0.746 . . . . 23.190000000000001 112.34 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -141.95 73.91 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.468 -0.567 . . . . 21.309999999999999 109.468 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -137.52 98.79 9.8 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.858 -0.61 . . . . 19.890000000000001 110.269 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.41 72.49 4.88 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.44 2.093 . . . . 18.120000000000001 111.866 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.4 -42.11 17.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.121 0.486 . . . . 16.579999999999998 110.305 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.7 -173.82 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 14.800000000000001 111.556 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' THR . . . -154.68 120.9 1.06 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.864 -0.894 . . . . 13.17 110.864 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 23' ' ' THR . . . -71.62 78.19 0.82 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.296 1.046 . . . . 12.17 111.563 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 34.3 tt0 -161.66 71.69 0.38 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.161 -1.836 . . . . 13.82 109.704 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 4.2 mm? 76.46 -43.17 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.472 -0.785 . . . . 12.130000000000001 110.984 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.71 -24.58 67.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.974 -1.012 . . . . 14.1 109.145 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 19' ' ' ALA . 76.8 m -165.17 150.72 9.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.081 -0.963 . . . . 11.050000000000001 108.737 -176.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.25 -104.08 0.6 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.333 -0.937 . . . . 10.050000000000001 112.077 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -114.78 61.3 0.68 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.352 1.073 . . . . 10.380000000000001 108.201 176.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.629 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 5.7 ppt_? -129.71 141.19 50.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.564 -1.653 . . . . 8.3699999999999992 109.085 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.4 mm -68.02 128.55 31.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 113.566 0.951 . . . . 5.7599999999999998 113.566 -169.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 26' ' ' ARG . 4.4 mp -117.94 -47.64 2.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.991 -1.459 . . . . 8.2200000000000006 110.39 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.4 p90 -155.65 -179.59 8.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 7.9900000000000002 111.023 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.721 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.23 149.62 41.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.172 -0.922 . . . . 5.6100000000000003 110.499 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HB2' HE22 ' A' ' 38' ' ' GLN . 38.9 ptt180 -148.27 146.3 28.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 9.0600000000000005 110.08 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.3 t0 -78.57 131.45 68.08 Favored Pre-proline 0 C--N 1.314 -0.944 0 N-CA-C 109.798 -0.445 . . . . 8.3100000000000005 109.798 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HG3' HG13 ' A' ' 54' ' ' ILE . 63.5 Cg_exo -45.11 -48.86 10.65 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.79 2.327 . . . . 10.41 111.944 -176.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.643 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.3 pmm? -91.57 9.99 29.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.212 -1.358 . . . . 10.85 112.985 -167.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 32' ' ' ASP . 6.6 m -126.32 44.92 1.32 Allowed Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 121.429 0.633 . . . . 9.3200000000000003 111.562 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.643 ' HD3' ' C ' ' A' ' 34' ' ' MET . 26.0 Cg_exo -61.66 119.9 7.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.194 2.596 . . . . 11.1 113.177 -169.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.5 4.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.467 -0.653 . . . . 10.31 111.467 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.09 142.56 30.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 9.2100000000000009 109.925 176.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -129.38 93.97 3.68 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.935 0.398 . . . . 11.51 110.606 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 23.8 m-85 -73.01 143.38 47.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.507 -0.769 . . . . 7.5 110.974 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.14 -27.82 68.99 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.348 -1.297 . . . . 10.609999999999999 110.455 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.0 ptpt -166.23 162.84 12.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.931 -0.577 . . . . 10.91 111.218 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.3 Cg_endo -51.3 169.56 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.64 2.893 . . . . 7.5099999999999998 113.78 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -171.1 30.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.503 -0.856 . . . . 7.5899999999999999 113.028 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 6.1 ttmm -88.63 143.26 27.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.447 -0.575 . . . . 11.68 109.447 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' MET . 37.8 t -62.28 136.2 95.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 9.1999999999999993 110.425 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 -21.06 19.51 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 122.186 1.924 . . . . 10.25 110.904 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -84.94 -41.23 16.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.878 -1.51 . . . . 10.49 109.485 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 3.1 mtm -133.72 153.51 51.64 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.36 -0.836 . . . . 10.380000000000001 111.27 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.7 p-10 -80.63 59.28 3.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.084 0.945 . . . . 12.539999999999999 111.168 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -136.33 143.25 42.76 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.899 -1.046 . . . . 9.8699999999999992 109.356 176.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 24.9 Cg_endo -63.93 133.41 38.6 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.0 1.8 . . . . 9.5099999999999998 111.158 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.8 mt -61.97 163.76 7.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 6.71 110.62 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' HG3' ' A' ' 33' ' ' PRO . 44.2 mm -105.27 129.39 24.84 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 7.8899999999999997 109.956 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.721 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 60.3 Cg_endo -73.83 140.14 28.56 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.818 1.678 . . . . 5.7699999999999996 112.189 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.43 156.51 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.395 -1.275 . . . . 5.96 112.791 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.629 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.73 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.945 2.098 . . . . 7.8399999999999999 115.553 -176.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.578 ' HG2' HG12 ' A' ' 27' ' ' ILE . 3.2 pt-20 -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.378 1.561 . . . . 6.6200000000000001 110.54 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 68.26 63.71 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 111.022 -2.808 . . . . 8.5800000000000001 111.705 168.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' H ' HD11 ' A' ' 27' ' ' ILE . 36.8 tt0 54.78 79.04 0.15 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.932 -1.486 . . . . 7.6399999999999997 110.354 -171.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -117.27 -43.52 2.83 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.36 -0.607 . . . . 7.0199999999999996 109.36 174.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . 63.36 -62.24 0.14 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.51 -1.677 . . . . 5.4100000000000001 110.801 -171.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 5.6 t70 179.79 115.9 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 124.087 0.867 . . . . 7.0099999999999998 109.632 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.68 7.12 79.38 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-N 115.429 -0.805 . . . . 7.2000000000000002 112.702 163.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 67.49 9.78 7.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 124.653 0.854 . . . . 7.8200000000000003 112.212 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.8 -35.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.31 0.576 . . . . 8.6500000000000004 109.956 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 164' ' ' THR . 40.5 t -54.75 -50.3 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.683 -1.144 . . . . 7.3099999999999996 110.961 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 12.1 ptm180 59.01 177.56 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.182 1.793 . . . . 10.210000000000001 112.309 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 71' ' ' GLY . 10.7 mt -40.27 146.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.301 -1.318 . . . . 8.8599999999999994 112.984 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.76 -39.85 42.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.521 -1.218 . . . . 13.02 109.098 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.566 ' H ' HG22 ' A' ' 69' ' ' ILE . . . -50.96 -40.07 42.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.698 -2.046 . . . . 12.130000000000001 112.637 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 ptp180 -142.07 107.01 4.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.999 0.905 . . . . 12.380000000000001 110.358 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 74' ' ' THR . 19.1 t -108.35 157.5 8.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.772 -1.104 . . . . 11.609999999999999 111.7 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.452 ' N ' HG12 ' A' ' 73' ' ' VAL . 7.8 t 37.38 74.23 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.576 1.151 . . . . 10.710000000000001 113.103 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -93.16 39.25 1.04 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.88 1.324 . . . . 14.09 108.052 173.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 78' ' ' GLY . 19.4 t-20 -156.89 107.04 2.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.976 -1.92 . . . . 11.220000000000001 109.02 -174.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.56 18.25 0.17 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.288 -1.324 . . . . 13.710000000000001 110.962 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 76' ' ' ASN . . . 90.29 -51.27 3.38 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.973 -1.251 . . . . 11.44 109.973 -173.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.57 HG11 ' CE1' ' A' ' 120' ' ' PHE . 49.1 t 53.16 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.418 0.628 . . . . 9.9900000000000002 112.268 167.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 150' ' ' SER . 6.4 mpt_? -84.59 121.4 27.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.82 -0.627 . . . . 11.640000000000001 109.746 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 148' ' ' VAL . 40.6 p -132.39 154.15 50.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 8.0 111.046 -172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 127.28 49.51 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.468 -0.938 . . . . 6.6500000000000004 108.468 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 42.1 tt0 -76.59 133.26 39.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.624 -0.51 . . . . 12.15 109.624 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 145' ' ' GLN . 48.0 t -53.32 130.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 9.7100000000000009 112.755 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 50.0 mmtt -134.89 142.8 46.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.856 -1.065 . . . . 11.029999999999999 109.925 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -75.53 158.32 32.7 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.504 -0.554 . . . . 12.76 109.504 171.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.71 41.38 0.05 OUTLIER Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.426 -0.893 . . . . 13.25 112.653 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -77.42 -178.03 4.99 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.329 0.492 . . . . 16.350000000000001 112.329 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 89' ' ' LEU . 1.7 pt? -133.84 109.06 8.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 18.219999999999999 109.803 171.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.94 -169.52 20.34 Favored Glycine 0 C--N 1.321 -0.297 0 CA-C-N 115.33 -0.85 . . . . 17.91 111.013 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.8 p -90.16 74.24 7.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.365 1.079 . . . . 17.109999999999999 109.358 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m -156.5 169.11 25.39 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.07 -1.826 . . . . 14.73 106.07 177.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -138.65 119.04 13.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 119.035 0.834 . . . . 14.94 111.494 170.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' CD ' ' HA ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -123.01 158.57 30.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.775 -1.102 . . . . 10.57 109.959 -176.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -98.37 122.08 41.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.152 0.501 . . . . 8.8800000000000008 109.894 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.25 134.33 38.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.073 -0.512 . . . . 9.7799999999999994 110.606 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 98' ' ' PRO . 3.8 p -150.07 147.99 23.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 6.4000000000000004 109.052 -175.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.4 Cg_exo -56.22 130.65 41.29 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.271 1.98 . . . . 6.5499999999999998 110.212 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.494 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 19.0 t -57.41 -27.08 62.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.465 0.543 . . . . 9.2899999999999991 112.465 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.36 3.97 33.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 10.859999999999999 111.547 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.61 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -77.93 -41.24 36.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.196 0.522 . . . . 5.3399999999999999 110.91 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -86.17 158.88 19.66 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.728 -0.669 . . . . 6.9699999999999998 111.898 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -101.61 126.35 55.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.327 -0.851 . . . . 10.199999999999999 108.826 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 11.6 mmm180 -101.13 128.41 47.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.519 -0.872 . . . . 12.119999999999999 111.027 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -149.32 129.17 13.35 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.285 -0.87 . . . . 14.609999999999999 110.516 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.76 -109.3 1.05 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 116.008 -0.542 . . . . 15.52 112.957 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.62 17.24 13.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 14.99 111.35 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.14 177.34 7.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.181 0.515 . . . . 15.199999999999999 111.745 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.7 m -129.2 144.71 51.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 9.2599999999999998 109.377 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.8 mm -126.56 153.04 34.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 10.550000000000001 109.375 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -134.68 132.47 38.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.394 -0.191 . . . . 7.3899999999999997 111.088 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 49.7 ttp -94.55 105.57 17.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.176 -0.675 . . . . 8.8499999999999996 109.176 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 121' ' ' ASP . 7.1 p -88.26 134.01 29.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.89 -1.05 . . . . 9.6899999999999995 112.423 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -83.3 92.47 7.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.187 -0.915 . . . . 10.699999999999999 110.108 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -86.5 149.96 24.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.057 -0.52 . . . . 14.880000000000001 111.332 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.05 0.15 74.12 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.156 -0.778 . . . . 16.920000000000002 111.156 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.27 -1.57 30.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.344 0.593 . . . . 18.559999999999999 110.887 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.89 -8.55 63.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.153 -0.93 . . . . 15.619999999999999 113.021 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.03 159.4 22.26 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.289 -0.958 . . . . 14.19 112.303 -174.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CE1' HG11 ' A' ' 79' ' ' VAL . 88.8 m-85 -109.53 121.23 44.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.377 -0.601 . . . . 12.029999999999999 109.377 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.6 m-20 -122.29 151.58 59.36 Favored Pre-proline 0 CA--C 1.514 -0.421 0 C-N-CA 120.555 -0.458 . . . . 13.91 111.471 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 84.1 Cg_endo -88.77 136.27 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.417 2.078 . . . . 12.35 112.433 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.63 138.31 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.331 -0.85 . . . . 9.4299999999999997 109.179 176.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.6 130.9 36.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.854 -0.424 . . . . 12.93 109.854 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -140.98 158.36 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.818 -0.628 . . . . 8.0299999999999994 111.157 -175.232 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.5 ttmm -100.2 128.61 46.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.632 -0.713 . . . . 10.390000000000001 109.89 174.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.438 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -140.84 105.62 4.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.478 -0.328 . . . . 8.3000000000000007 111.638 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.0 72.38 0.27 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 118.441 -1.838 . . . . 10.1 113.938 169.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.92 162.69 39.35 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.402 -0.962 . . . . 10.609999999999999 108.402 154.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.4 m -139.72 132.59 29.24 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.672 -0.411 . . . . 13.17 110.001 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.22 99.89 3.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.066 -0.516 . . . . 12.98 111.443 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.8 40.03 89.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.09 -0.576 . . . . 14.34 112.43 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.22 1.83 90.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.031 -0.604 . . . . 13.119999999999999 112.195 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.13 164.0 12.67 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.037 -1.097 . . . . 10.619999999999999 108.037 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 21.0 p -117.05 162.1 18.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.152 -0.619 . . . . 7.8200000000000003 111.108 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 36.6 mt-10 -112.99 123.94 51.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.616 0.722 . . . . 10.789999999999999 111.277 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 125' ' ' VAL . 24.4 mm -88.11 107.43 17.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.878 -1.056 . . . . 6.7300000000000004 109.323 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.9 mp -72.68 -49.9 28.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 8.7899999999999991 109.85 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 125' ' ' VAL . 46.6 mt-10 -142.11 166.76 23.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.008 -0.738 . . . . 10.44 109.008 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.538 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 114.29 -51.97 0.68 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.395 -1.383 . . . . 8.8699999999999992 113.885 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.64 -174.92 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 8.5 112.744 -172.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.7 ttmt -151.25 157.09 42.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 14.15 109.523 -175.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.64 126.71 30.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 12.119999999999999 109.95 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.85 -7.09 29.48 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.996 -0.842 . . . . 11.539999999999999 110.996 -170.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.0 mm-40 -95.5 112.92 24.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.209 -0.664 . . . . 11.24 109.209 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 71.5 mt-30 -85.95 123.65 31.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.028 -0.533 . . . . 10.49 110.502 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.55 139.8 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.864 -0.607 . . . . 5.4500000000000002 110.323 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 18.6 m -66.24 120.61 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.805 -0.634 . . . . 6.5599999999999996 111.478 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.8 m -108.5 -1.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 6.9900000000000002 109.889 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 36.2 t -174.13 115.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.547 -1.206 . . . . 9.0600000000000005 108.833 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.51 66.12 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.665 -0.779 . . . . 8.5 111.405 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -161.44 137.7 8.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.487 0.315 . . . . 11.84 110.19 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -88.24 -31.36 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.967 -0.753 . . . . 12.24 108.967 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 154' ' ' LEU . 1.1 mm? -97.42 -161.29 0.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.858 -1.064 . . . . 13.16 108.768 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 10.4 mm -95.86 -128.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.701 -0.851 . . . . 11.949999999999999 108.701 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.99 30.01 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.289 0.566 . . . . 11.220000000000001 110.005 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -72.5 -18.97 61.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.676 -0.693 . . . . 11.9 111.813 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -44.1 77.79 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.397 -0.921 . . . . 11.17 109.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.47 66.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.307 -0.86 . . . . 7.8200000000000003 110.832 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.3 m -70.01 -61.98 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.829 0.823 . . . . 9.6400000000000006 109.65 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.2 -31.66 70.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 113.74 -1.573 . . . . 10.57 112.256 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -82.52 -39.23 22.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 124.753 1.283 . . . . 8.9000000000000004 110.032 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 52.26 60.35 7.82 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.105 -0.952 . . . . 7.1500000000000004 113.015 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 67' ' ' VAL . 32.8 p 50.63 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.986 0.914 . . . . 7.0899999999999999 112.435 -172.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.1 p -72.41 95.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.831 . . . . 9.1999999999999993 112.08 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -153.16 102.46 2.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 9.1099999999999994 110.269 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.751 ' O ' ' HG3' ' A' ' 168' ' ' MET . 4.0 tmt_? -94.61 93.72 7.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.879 -0.415 . . . . 14.58 109.879 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.751 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 9.8 mtm -169.78 142.51 2.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.212 -0.904 . . . . 11.94 109.874 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -93.46 -160.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.283 0.563 . . . . 14.99 109.865 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 61.18 31.4 19.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.6 -1.182 . . . . 15.01 112.491 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 23.3 p -76.38 63.37 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.327 0.584 . . . . 14.25 110.882 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.8 m -74.35 -60.57 2.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.786 -0.643 . . . . 14.890000000000001 110.878 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t 53.29 53.22 12.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 15.85 110.336 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -103.46 21.55 38.83 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.833 -0.698 . . . . 17.539999999999999 112.046 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 175' ' ' LEU . 2.7 pt? -68.43 152.05 45.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.61 0.243 . . . . 17.850000000000001 110.626 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -168.94 98.31 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.996 -0.547 . . . . 19.670000000000002 109.892 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -105.18 -11.52 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 19.52 110.4 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 91.3 mt 71.39 -168.31 0.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.476 -0.784 . . . . 21.149999999999999 110.887 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -78.33 -37.18 45.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.764 0.283 . . . . 23.25 111.764 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.346 -0.835 . . . . 23.52 110.657 -177.188 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 122.45 1.119 . . . . 10.38 109.755 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.555 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -128.85 139.46 52.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.347 -1.297 . . . . 8.37 108.217 178.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 58' ' ' GLU . 23.5 mm -49.52 117.96 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.944 0.878 . . . . 5.76 112.636 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.13 -33.97 9.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.297 -1.774 . . . . 8.22 109.923 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 1.6 p90 -179.67 -177.49 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.607 -0.724 . . . . 7.99 109.884 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.727 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -116.83 147.38 42.17 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.388 -0.824 . . . . 5.61 110.281 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HB2' HE22 ' A' ' 38' ' ' GLN . 28.3 ptt180 -142.55 149.87 39.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.185 -0.916 . . . . 9.06 110.353 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.79 ' HB3' HG22 ' A' ' 35' ' ' VAL . 10.0 t70 -92.08 136.25 26.19 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.138 -1.06 . . . . 8.31 108.138 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' A' ' 54' ' ' ILE . 16.8 Cg_exo -62.33 -13.22 31.29 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.116 1.877 . . . . 10.41 112.201 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.55 0.36 42.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.782 -0.19 . . . . 10.85 111.504 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -128.28 38.42 0.43 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 112.802 0.668 . . . . 9.32 112.802 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 27.4 Cg_endo -57.92 131.81 45.94 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.576 2.184 . . . . 11.1 112.508 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.84 -7.45 31.45 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.651 -0.785 . . . . 10.31 111.204 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.577 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -82.68 -179.78 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.534 . . . . 9.21 109.731 176.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 7.0 tpt180 -151.29 94.26 2.01 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.098 -0.334 . . . . 11.51 110.098 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 90.7 m-85 -76.49 139.68 40.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.262 -0.575 . . . . 7.5 110.708 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.71 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.799 -1.091 . . . . 10.61 111.084 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.5 pttm -168.79 164.22 7.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 10.91 111.006 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.727 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.1 Cg_endo -48.19 169.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.992 3.128 . . . . 7.51 114.403 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.64 -162.57 27.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.918 -0.658 . . . . 7.59 112.392 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 4.0 ttmm -92.92 141.74 28.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.669 -0.493 . . . . 11.68 109.669 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.5 p -58.4 136.13 85.41 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 115.218 -0.901 . . . . 9.2 110.962 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.85 -27.16 7.37 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.136 1.891 . . . . 10.25 112.028 171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.624 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 91.4 m-85 -81.91 -31.05 31.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.153 0.502 . . . . 10.49 110.851 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.624 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.67 -161.06 0.98 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.481 -0.781 . . . . 10.38 108.911 174.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 6.5 p-10 -128.17 59.05 1.51 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.019 0.914 . . . . 12.54 109.623 170.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 ptm -132.82 145.1 55.69 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.484 -1.235 . . . . 9.87 109.766 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.62 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.669 1.58 . . . . 9.51 110.414 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.33 161.27 14.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.173 0.511 . . . . 6.71 111.415 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 ' HD3' ' A' ' 33' ' ' PRO . 1.7 mp -98.74 133.85 22.11 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.132 -0.692 . . . . 7.89 109.132 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 83.5 Cg_endo -85.28 150.18 10.52 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 121.265 1.31 . . . . 5.77 113.126 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 m -74.3 158.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.564 -1.198 . . . . 5.96 112.397 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 11.97 -76.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.358 2.263 . . . . 7.84 115.353 -178.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -57.84 -47.04 83.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.287 0.635 . . . . 6.62 109.596 -175.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 43.6 mt-10 . . . . . 0 C--N 1.318 -0.79 0 CA-C-O 121.629 0.728 . . . . 8.58 112.646 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.436 ' HD2' ' N ' ' A' ' 80' ' ' ARG . 8.0 mpt_? . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.686 -0.487 . . . . 11.64 109.686 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 114' ' ' ALA . 42.8 p -135.19 177.82 7.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.165 0.507 . . . . 8.0 111.484 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -142.71 131.63 22.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.366 -0.834 . . . . 6.65 109.044 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 35.3 tt0 -79.47 141.24 36.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.952 0.406 . . . . 12.15 110.515 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 95' ' ' LEU . 70.6 t -69.16 127.31 30.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 9.71 110.548 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -162.92 146.68 11.14 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.07 -0.968 . . . . 11.03 111.642 174.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 93' ' ' GLU . 7.5 mp -70.1 132.45 45.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.11 -1.405 . . . . 12.76 110.37 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.494 ' H ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.506 -0.471 0 C-N-CA 120.186 -1.007 . . . . 13.25 113.628 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.474 ' HB3' HD23 ' A' ' 86' ' ' LEU . 18.0 mt-10 . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 122.23 1.014 . . . . 14.94 112.539 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 23.1 mmt85 -135.09 164.49 27.54 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.454 -1.703 . . . . 10.57 107.026 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -88.83 113.21 24.13 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.919 -0.771 . . . . 8.88 108.919 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.5 mm? -87.47 129.89 34.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.082 -0.508 . . . . 9.78 111.369 -172.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.18 155.85 58.09 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.444 -0.798 . . . . 6.4 109.424 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.35 139.11 81.33 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.289 1.992 . . . . 6.55 111.559 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.3 m -57.71 -28.44 63.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.64 0.608 . . . . 9.29 112.64 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.85 -2.39 58.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 10.86 111.059 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -71.68 -41.09 69.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.48 0.657 . . . . 5.34 111.015 -175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -92.51 160.26 15.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.47 -0.786 . . . . 6.97 111.614 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.67 113.27 37.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.708 -0.678 . . . . 10.2 109.192 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 7.7 mmm180 -89.53 126.14 35.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.735 -0.786 . . . . 12.12 110.446 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -149.18 132.71 16.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.862 -0.608 . . . . 14.61 110.551 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.69 -115.57 5.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.26 -0.495 . . . . 15.52 112.568 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.92 36.21 4.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.803 0.335 . . . . 14.99 111.671 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.79 -178.96 6.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.313 -0.403 . . . . 15.2 110.502 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 27.3 m -132.11 150.95 52.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.725 0.298 . . . . 9.26 111.269 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.7 mm -123.33 149.11 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.099 -0.704 . . . . 10.55 109.099 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -129.49 125.85 37.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.282 -0.266 . . . . 7.39 110.282 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.521 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 48.6 ttp -85.95 99.56 11.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.687 -1.227 . . . . 8.85 107.687 171.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 121' ' ' ASP . 12.7 p -81.78 136.82 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.254 -0.884 . . . . 9.69 111.195 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.65 97.42 7.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.194 -0.669 . . . . 10.7 109.194 173.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.74 139.77 40.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.662 -0.699 . . . . 14.88 109.221 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -58.43 -16.81 30.02 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.005 -0.543 . . . . 16.92 113.027 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -79.17 4.72 13.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.164 0.507 . . . . 18.56 111.811 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.63 9.98 58.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.708 -0.678 . . . . 15.62 112.969 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.99 175.22 16.54 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.76 -0.733 . . . . 14.19 112.241 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.2 m-85 -126.03 136.76 53.33 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.059 -0.349 . . . . 12.03 110.059 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 113' ' ' VAL . 23.0 t70 -138.03 141.53 32.69 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 13.91 111.375 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -82.51 138.5 9.7 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.718 1.612 . . . . 12.35 112.482 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.8 p -135.39 136.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.622 -0.717 . . . . 9.43 109.82 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.8 tt0 -81.48 125.02 29.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.629 -0.508 . . . . 12.93 109.629 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -133.5 157.78 42.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.455 -0.793 . . . . 8.03 110.76 -172.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 4.3 ttmp? -95.19 120.3 35.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.73 -0.668 . . . . 10.39 109.388 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.46 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -143.9 104.48 4.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.969 -0.56 . . . . 8.3 111.469 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.46 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.744 -2.17 . . . . 10.1 114.265 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.17 163.12 39.55 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.689 -0.486 . . . . 10.61 109.689 157.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.0 m -133.59 134.24 43.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.381 -0.6 . . . . 13.17 109.381 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.35 107.18 3.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.105 0.409 . . . . 12.98 112.105 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.29 44.51 59.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.199 -0.524 . . . . 14.34 113.105 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.0 17.35 80.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.67 -0.776 . . . . 13.12 112.236 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -137.55 166.0 24.95 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.422 -0.584 . . . . 10.62 109.422 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -115.71 162.84 16.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.963 0.411 . . . . 7.82 110.246 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 66.7 mt-10 -106.27 121.16 43.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.659 . . . . 10.79 111.433 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 125' ' ' VAL . 21.1 mm -88.25 101.52 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.014 -0.994 . . . . 6.73 108.565 168.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.9 mp -68.84 -45.0 72.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.553 -1.203 . . . . 8.79 109.738 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 125' ' ' VAL . 40.9 mt-10 -150.45 165.52 32.92 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.776 -0.647 . . . . 10.44 109.353 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.555 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 128.63 -61.49 0.65 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.981 -1.104 . . . . 8.87 113.299 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 123' ' ' VAL . 36.7 mt -116.0 179.62 3.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.305 0.574 . . . . 8.5 112.347 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -129.64 152.44 49.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.875 -1.057 . . . . 14.15 110.481 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 132.35 45.98 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.058 -0.973 . . . . 12.12 110.168 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.51 -11.25 30.6 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.092 -0.803 . . . . 11.54 111.092 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.5 HE21 HG21 ' A' ' 113' ' ' VAL . 9.5 mt-30 -104.27 163.76 12.2 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 107.75 -1.204 . . . . 11.24 107.75 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 14.2 mt-30 -120.93 167.84 12.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 119.04 0.836 . . . . 10.49 111.561 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.14 156.68 41.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.217 -0.901 . . . . 5.45 108.853 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 7.6 p -76.62 128.52 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.63 0.252 . . . . 6.56 110.587 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.4 m . . . . . 0 C--N 1.326 -0.425 0 C-N-CA 120.975 -0.29 . . . . 6.99 111.602 -178.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.322 0 CA-C-O 120.895 0.379 . . . . 11.84 111.652 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -103.88 166.57 10.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.543 -0.54 . . . . 12.24 109.543 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -60.82 2.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.824 -0.35 . . . . 13.16 111.138 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.2 tt -125.08 113.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.549 0.69 . . . . 11.95 110.301 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.68 -0.15 49.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 11.22 112.017 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.667 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 13.2 m -58.54 -43.22 89.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.88 -0.6 . . . . 11.9 111.023 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -52.03 -54.99 23.42 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.76 -0.459 . . . . 11.17 109.76 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.3 92.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.845 -1.07 . . . . 7.82 111.395 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.1 m -58.94 -35.54 73.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.865 -0.607 . . . . 9.64 111.868 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 157' ' ' SER . 80.4 mt -61.99 -22.13 65.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.242 -0.89 . . . . 10.57 111.516 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -83.43 117.79 23.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.637 -0.505 . . . . 8.9 109.637 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 105.58 -18.28 41.38 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 119.927 -1.13 . . . . 7.15 112.734 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.7 p -102.17 -76.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 7.09 110.646 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.46 -24.16 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.29 0.567 . . . . 9.2 110.211 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.899 -0.591 . . . . 9.11 110.598 178.106 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 3.1 mppt? . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 108.3 -1.0 . . . . 10.38 108.3 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.584 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.29 130.67 35.47 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.133 -0.94 . . . . 8.37 111.042 -174.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.717 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.2 mm -55.2 133.29 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 122.268 1.032 . . . . 5.76 113.107 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.74 -25.97 6.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.37 -1.741 . . . . 8.22 109.712 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.558 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 14.1 p90 179.99 179.03 0.56 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.897 -0.592 . . . . 7.99 111.098 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -118.38 154.88 31.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.919 -1.037 . . . . 5.61 109.965 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.4 ptp180 -156.4 145.36 20.32 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.153 0.502 . . . . 9.06 110.29 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.0 t0 -67.85 133.13 92.23 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.48 -0.933 . . . . 8.31 108.48 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.556 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 84.4 Cg_endo -67.66 -12.6 36.08 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.293 1.995 . . . . 10.41 112.363 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.473 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 1.1 ptp -103.65 0.99 31.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.41 -0.359 . . . . 10.85 111.546 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.6 m -120.43 45.01 0.74 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 121.258 0.552 . . . . 9.32 112.003 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.85 124.5 16.04 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.134 2.556 . . . . 11.1 112.711 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.82 8.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.807 -0.711 . . . . 10.31 111.656 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.588 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 20.8 tp60 -78.95 105.55 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.15 0.5 . . . . 9.21 109.968 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.558 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 41.7 ttp180 -90.93 106.95 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 11.51 110.161 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 66.7 m-85 -84.58 142.46 29.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 7.5 109.466 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.28 -26.55 68.83 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.42 -0.809 . . . . 10.61 111.005 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 16.7 ptpt -169.8 165.11 6.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.869 -0.605 . . . . 10.91 110.264 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -49.37 169.15 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.37 2.713 . . . . 7.51 113.458 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.25 -166.98 29.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.65 -0.786 . . . . 7.59 112.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 46' ' ' SER . 12.9 ttmm -95.34 153.23 17.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.192 0.52 . . . . 11.68 110.604 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.494 ' HA ' HD21 ' A' ' 53' ' ' LEU . 95.5 p -64.59 105.91 0.84 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.467 -1.242 . . . . 9.2 110.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' SER . 41.6 Cg_endo -67.59 -10.12 27.67 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.3 2.666 . . . . 10.25 111.869 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -92.0 -31.4 15.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.564 -1.198 . . . . 10.49 110.789 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.616 ' HG2' ' H ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -134.64 -107.77 0.22 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.097 1.147 . . . . 10.38 114.097 172.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 49' ' ' MET . 12.6 p-10 -165.19 65.95 0.13 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.117 0.871 . . . . 12.54 113.275 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.02 148.82 56.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.784 -0.821 . . . . 9.87 108.784 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.44 132.28 30.73 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.198 1.265 . . . . 9.51 110.339 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 46' ' ' SER . 43.5 mt -61.25 163.49 6.34 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.338 0.399 . . . . 6.71 111.305 -175.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.543 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 43.0 mm -101.29 131.82 22.65 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 7.89 110.003 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.724 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 55.9 Cg_endo -86.51 139.38 5.81 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.93 1.753 . . . . 5.77 112.921 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.77 157.96 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.291 -1.322 . . . . 5.96 112.904 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.584 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.77 -89.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.753 2.021 . . . . 7.84 115.212 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.717 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -47.87 -40.98 23.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.73 0.412 . . . . 6.62 110.184 -177.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.484 ' CG ' ' HG2' ' A' ' 55' ' ' PRO . 26.8 tt0 . . . . . 0 C--N 1.315 -0.901 0 O-C-N 123.954 0.784 . . . . 8.58 111.677 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 109.045 -0.724 . . . . 11.64 109.045 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 148' ' ' VAL . 34.4 p -131.74 147.1 52.47 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.834 -0.621 . . . . 8.0 110.274 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.08 126.58 55.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.81 -0.811 . . . . 6.65 108.81 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 30.0 tt0 -83.92 133.87 34.69 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.459 -0.571 . . . . 12.15 109.459 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.613 HG11 HD23 ' A' ' 95' ' ' LEU . 42.4 t -55.49 127.92 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.769 0.655 . . . . 9.71 112.769 -176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 39.1 mmtt -140.88 142.5 34.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.828 -1.078 . . . . 11.03 108.777 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 9.3 mp -77.8 150.78 34.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.013 -0.675 . . . . 12.76 109.484 171.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.413 -0.898 . . . . 13.25 112.99 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 CA-C-O 121.475 0.655 . . . . 14.94 111.248 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -121.64 167.26 13.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.695 -1.139 . . . . 10.57 109.019 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 84' ' ' VAL . 5.3 mp -90.68 111.96 23.52 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.172 -1.048 . . . . 8.88 108.172 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.69 129.87 35.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.16 0.505 . . . . 9.78 110.634 -174.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.58 156.8 52.72 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.634 -1.167 . . . . 6.4 108.804 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.28 141.25 95.41 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 C-N-CA 122.153 1.902 . . . . 6.55 110.59 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -19.24 38.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.636 0.255 . . . . 9.29 111.367 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -88.76 9.64 23.78 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 116.514 -0.312 . . . . 10.86 111.017 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -86.63 -39.89 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.174 0.511 . . . . 5.34 111.17 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -99.92 158.47 15.79 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.758 0.651 . . . . 6.97 112.758 -170.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.91 121.56 53.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.239 -0.891 . . . . 10.2 108.86 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -94.25 122.54 36.89 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.312 -0.555 . . . . 12.12 110.895 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -149.57 131.26 14.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.105 -0.498 . . . . 14.61 111.406 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.3 5.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.161 -0.472 . . . . 15.52 113.017 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.1 25.03 10.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 14.99 111.235 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.76 -176.99 5.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 15.2 111.053 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.586 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 47.0 m -136.92 150.13 48.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.291 -0.413 . . . . 9.26 110.296 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -125.43 152.07 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.748 -0.464 . . . . 10.55 109.748 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -133.3 138.31 46.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.205 -0.295 . . . . 7.39 110.205 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 58.9 mtm -97.45 100.71 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.145 -0.687 . . . . 8.85 109.145 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 7.2 p -84.52 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.354 -0.839 . . . . 9.69 111.312 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -67.12 88.52 0.17 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.48 -0.782 . . . . 10.7 109.698 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -67.97 140.43 56.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.46 -0.791 . . . . 14.88 109.782 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.56 -12.0 38.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.061 -0.59 . . . . 16.92 112.808 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.18 10.47 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.493 . . . . 18.56 111.689 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.76 17.11 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.399 -0.818 . . . . 15.62 113.782 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.74 -161.25 9.38 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.505 -0.855 . . . . 14.19 112.305 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 52.8 m-85 -130.92 112.51 13.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.677 0.275 . . . . 12.03 110.325 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -100.44 139.05 20.34 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.426 -0.352 . . . . 13.91 110.737 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 55.7 Cg_endo -82.7 138.88 9.68 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.956 1.77 . . . . 12.35 111.989 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.654 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 13.9 p -129.5 126.69 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 9.43 110.139 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 110' ' ' ILE . 32.0 tt0 -79.18 112.84 16.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.487 -0.561 . . . . 12.93 109.487 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 123' ' ' VAL . 27.5 m -120.64 173.5 6.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 8.03 111.375 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -104.49 126.1 51.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.161 -0.681 . . . . 10.39 109.161 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -141.95 105.64 4.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.309 -0.405 . . . . 8.3 111.244 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.04 70.78 0.3 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 117.431 -2.319 . . . . 10.1 114.329 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.88 162.55 40.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.156 -0.683 . . . . 10.61 109.156 155.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.4 m -147.04 127.87 14.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.837 -0.431 . . . . 13.17 109.837 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.99 112.25 5.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.079 -0.51 . . . . 12.98 111.753 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.62 43.82 91.18 Favored Glycine 0 C--O 1.235 0.214 0 CA-C-N 116.107 -0.497 . . . . 14.34 112.992 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.69 13.43 82.13 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.852 -0.689 . . . . 13.12 112.553 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -126.47 157.84 37.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.264 -0.643 . . . . 10.62 109.264 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.5 p -111.92 166.66 11.02 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.882 -0.327 . . . . 7.82 110.328 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.921 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.4 mt-10 -116.73 113.32 22.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.486 0.66 . . . . 10.79 111.11 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.0 mm -83.1 111.84 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.121 -0.945 . . . . 6.73 108.87 171.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -77.12 -49.08 16.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.974 -1.012 . . . . 8.79 109.718 -175.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 140' ' ' GLY . 31.4 tt0 -148.68 166.42 28.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.961 -0.563 . . . . 10.44 110.284 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 139' ' ' GLU . . . 113.84 -23.58 12.97 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.047 -0.597 . . . . 8.87 112.085 172.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 123' ' ' VAL . 38.6 mt -127.49 -170.36 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.862 0.363 . . . . 8.5 111.76 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -154.56 156.16 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 14.15 109.663 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.08 128.01 34.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.713 -0.676 . . . . 12.12 110.196 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.68 -9.53 37.81 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.287 -0.725 . . . . 11.54 111.287 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.4 mm-40 -91.33 111.18 22.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.199 -0.667 . . . . 11.24 109.199 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 57.6 mt-30 -85.0 128.59 34.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.416 -0.811 . . . . 10.49 110.97 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -119.19 135.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.709 -0.478 . . . . 5.45 109.709 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 81' ' ' THR . 2.4 p -68.09 121.11 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.253 0.549 . . . . 6.56 110.581 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 101' ' ' ALA . 5.1 m . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.211 -0.904 . . . . 6.99 110.398 -175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.238 0.542 . . . . 11.84 110.441 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.438 ' O ' HD13 ' A' ' 155' ' ' ILE . 47.3 m-85 -72.67 165.42 24.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.823 -0.626 . . . . 12.24 110.611 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 tp -87.8 50.87 2.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.4 0.619 . . . . 13.16 110.058 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 155' ' ' ILE . 0.2 OUTLIER -83.11 39.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.461 0.648 . . . . 11.95 111.072 -177.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.0 -99.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.37 -0.832 . . . . 11.22 111.327 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.4 m -79.22 -41.48 28.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.732 0.777 . . . . 11.9 110.174 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 50.0 mm-40 -54.0 -30.17 46.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.084 -1.417 . . . . 11.17 110.701 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.461 ' HB2' ' CA ' ' A' ' 155' ' ' ILE . . . -68.02 -31.74 71.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.492 -1.231 . . . . 7.82 112.233 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.5 t -81.5 -19.46 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.457 0.646 . . . . 9.64 109.808 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.0 mt -87.79 -30.4 20.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.802 -1.09 . . . . 10.57 111.898 -173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 21.7 mmm180 -70.6 140.94 51.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.196 0.522 . . . . 8.9 110.565 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.38 30.59 13.44 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.978 -1.01 . . . . 7.15 111.291 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.7 p 49.99 54.87 10.32 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.347 0.659 . . . . 7.09 110.882 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 67.7 t 72.87 -56.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.171 -0.922 . . . . 9.2 111.415 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.698 0.761 . . . . 9.11 110.743 -178.06 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.438 -1.067 0 CA-C-O 122.556 1.17 . . . . 10.38 109.432 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.483 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 91.1 mtt180 -119.09 148.7 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.605 -1.634 . . . . 8.37 108.883 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 ' OE2' ' A' ' 58' ' ' GLU . 42.9 mm -52.0 124.4 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 113.923 -1.49 . . . . 5.76 114.251 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.71 -32.89 6.5 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.322 -1.763 . . . . 8.22 109.792 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.722 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 26.3 p90 -177.64 -175.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.919 -0.582 . . . . 7.99 110.839 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.749 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.21 145.81 46.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.65 -0.705 . . . . 5.61 111.243 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -150.99 145.8 25.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.03 -0.729 . . . . 9.06 109.03 179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.753 ' HB3' ' CE ' ' A' ' 34' ' ' MET . 1.2 m-20 -78.27 147.24 72.26 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 112.307 0.484 . . . . 8.31 112.307 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HG3' HG13 ' A' ' 54' ' ' ILE . 51.9 Cg_exo -53.68 -56.78 2.35 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.593 2.195 . . . . 10.41 112.797 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.753 ' CE ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -86.87 2.64 48.45 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.398 0.888 . . . . 10.85 113.398 -170.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 32' ' ' ASP . 21.6 m -120.46 51.83 2.31 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 121.657 0.741 . . . . 9.32 111.325 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.25 121.73 9.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.146 2.564 . . . . 11.1 112.622 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.62 -27.29 4.43 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.052 -0.819 . . . . 10.31 111.052 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.451 ' OE1' ' HE1' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -75.86 138.93 41.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.4 -0.4 . . . . 9.21 109.943 175.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.615 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 34.0 ttp180 -133.54 112.29 11.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.543 -0.299 . . . . 11.51 111.413 -174.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 73.6 m-85 -97.39 149.3 22.28 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.828 -0.804 . . . . 7.5 108.828 174.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.08 8.11 16.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.044 -0.662 . . . . 10.61 111.806 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.8 pttp -164.2 167.8 10.14 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 116.332 -0.395 . . . . 10.91 111.881 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.619 ' HD3' ' CZ3' ' A' ' 30' ' ' TRP . 18.6 Cg_endo -56.0 171.04 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.807 3.004 . . . . 7.51 112.984 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.37 -166.35 28.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.539 -0.839 . . . . 7.59 112.975 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 14.1 ttmm -96.96 148.44 22.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.058 0.456 . . . . 11.68 109.869 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -66.13 141.14 97.27 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.344 -0.844 . . . . 9.2 111.576 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.12 -20.29 10.09 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.844 2.362 . . . . 10.25 111.033 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.509 -1.223 . . . . 10.49 109.863 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.5 ptp -168.97 168.9 9.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.236 -0.893 . . . . 10.38 109.182 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 p-10 -81.22 72.74 8.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.734 0.778 . . . . 12.54 112.418 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 ptm -139.43 139.48 22.75 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.196 -0.911 . . . . 9.87 108.871 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.1 135.94 45.87 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.554 2.17 . . . . 9.51 111.604 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.591 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 18.1 mt -63.17 162.15 12.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.812 -0.631 . . . . 6.71 111.04 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.522 HG13 ' HG3' ' A' ' 33' ' ' PRO . 23.8 mm -102.92 134.41 19.83 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 121.322 0.582 . . . . 7.89 109.984 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.749 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 74.1 Cg_endo -81.98 139.1 10.65 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.308 1.339 . . . . 5.77 112.544 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -55.49 157.88 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 113.872 -1.513 . . . . 5.96 113.045 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.31 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.716 2.006 . . . . 7.84 115.037 -175.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.735 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -46.94 -42.6 18.05 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.167 0.587 . . . . 6.62 111.401 -176.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.585 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 13.9 tt0 . . . . . 0 C--O 1.241 0.639 0 CA-C-O 122.453 1.121 . . . . 8.58 111.011 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 152' ' ' GLN . 90.7 mtt180 . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.82 -0.807 . . . . 11.64 108.82 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 148' ' ' VAL . 11.5 p -114.38 170.49 8.26 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.279 0.562 . . . . 8.0 111.61 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -142.89 127.0 17.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.125 -0.943 . . . . 6.65 108.561 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 41.8 tt0 -79.38 138.46 37.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 12.15 109.965 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 95' ' ' LEU . 39.2 t -57.21 132.9 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.274 -0.876 . . . . 9.71 112.654 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -137.06 143.87 42.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.772 -1.104 . . . . 11.03 109.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.07 151.27 35.55 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.114 -0.634 . . . . 12.76 109.633 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 120.446 -0.883 . . . . 13.25 112.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 CA--C 1.513 -0.449 0 CA-C-O 121.284 0.564 . . . . 14.94 111.767 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.63 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 29.6 mmt180 -124.48 162.6 23.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.89 -1.05 . . . . 10.57 109.081 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 84' ' ' VAL . 1.8 mm? -87.31 113.33 22.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.588 -0.523 . . . . 8.88 109.588 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -89.98 129.94 36.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.117 -0.492 . . . . 9.78 110.656 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.23 159.81 57.11 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.136 -0.938 . . . . 6.4 108.955 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HG2' HG11 ' A' ' 149' ' ' VAL . 72.8 Cg_exo -54.46 130.79 41.86 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.86 1.707 . . . . 6.55 111.233 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 t -56.75 -26.02 56.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.254 0.465 . . . . 9.29 112.254 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.26 4.56 50.29 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.07 -0.394 . . . . 10.86 111.659 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.31 -39.16 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 5.34 110.721 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -80.28 158.9 26.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 6.97 112.276 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -106.03 127.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.073 -0.967 . . . . 10.2 109.183 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -99.78 123.6 44.2 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.876 -0.73 . . . . 12.12 110.943 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -148.91 144.67 27.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.558 -0.746 . . . . 14.61 109.573 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.61 -121.63 15.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.204 -0.522 . . . . 15.52 112.322 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.39 37.25 4.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.15 0.5 . . . . 14.99 110.729 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -149.45 177.78 9.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.655 -0.702 . . . . 15.2 111.203 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 12.0 m -123.65 145.87 48.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.31 -0.405 . . . . 9.26 109.986 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.7 mm -123.31 152.18 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.041 -0.725 . . . . 10.55 109.041 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -127.65 131.34 49.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.678 0.275 . . . . 7.39 110.495 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 76.9 mtp -88.03 100.36 12.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.433 -0.58 . . . . 8.85 109.433 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -85.69 136.82 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.868 -0.605 . . . . 9.69 110.993 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 146' ' ' GLN . . . -89.97 94.19 9.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.618 -0.719 . . . . 10.7 110.158 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.0 141.99 56.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.795 -0.639 . . . . 14.88 110.714 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.29 -6.59 48.34 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.149 -0.78 . . . . 16.92 111.149 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.83 -3.05 46.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.394 0.616 . . . . 18.56 110.4 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 166' ' ' ALA . . . 104.37 -21.1 38.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.244 -0.889 . . . . 15.62 113.128 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.13 177.8 26.52 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.818 -0.706 . . . . 14.19 112.598 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.22 122.44 28.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.553 -0.536 . . . . 12.03 109.553 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.2 m-20 -124.76 147.93 57.76 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.535 -0.466 . . . . 13.91 111.571 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.53 135.18 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.746 2.297 . . . . 12.35 112.55 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.675 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.8 p -121.4 129.97 75.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.541 -0.754 . . . . 9.43 109.916 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 110' ' ' ILE . 38.5 tt0 -74.58 116.86 15.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.988 0.423 . . . . 12.93 110.028 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 123' ' ' VAL . 28.4 m -128.55 167.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.868 -0.605 . . . . 8.03 110.884 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 138' ' ' LEU . 37.6 ttmt -106.2 129.72 54.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.464 -0.569 . . . . 10.39 109.464 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.84 104.09 4.29 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.621 0.601 . . . . 8.3 112.621 -173.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.59 70.9 0.29 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 117.752 -2.166 . . . . 10.1 114.498 167.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 162.69 39.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.876 -0.787 . . . . 10.61 108.876 154.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -138.02 124.34 20.55 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.606 -0.438 . . . . 13.17 109.844 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.05 111.21 6.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.063 -0.517 . . . . 12.98 111.575 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.93 44.17 94.94 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.932 -0.576 . . . . 14.34 112.818 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.15 8.55 85.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 13.12 112.378 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -120.71 166.73 13.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.662 -0.496 . . . . 10.62 109.662 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -120.62 155.51 33.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.749 0.309 . . . . 7.82 110.774 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 48.1 mt-10 -97.09 110.98 23.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.495 0.664 . . . . 10.79 111.014 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.5 mm -79.71 101.15 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.167 -1.049 . . . . 6.73 108.167 169.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.63 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -65.56 -49.35 69.19 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.049 -0.978 . . . . 8.79 110.183 -174.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.95 162.49 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.358 -0.837 . . . . 10.44 110.908 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.33 -59.78 0.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.605 -0.807 . . . . 8.87 113.304 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 123' ' ' VAL . 25.0 mt -103.35 -174.58 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.588 0.588 . . . . 8.5 112.588 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -149.37 157.56 43.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.451 -0.795 . . . . 14.15 109.605 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 126.01 28.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.626 -0.715 . . . . 12.12 110.075 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.03 -10.46 20.64 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.493 -1.043 . . . . 11.54 110.493 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.6 mm100 -100.74 120.02 39.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.444 -0.947 . . . . 11.24 108.444 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 11.1 pt20 -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.825 0.821 . . . . 10.49 110.364 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.58 145.96 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.336 -1.302 . . . . 5.45 109.603 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.8 p -69.5 124.57 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.329 0.585 . . . . 6.56 110.234 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.8 m . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.619 -0.719 . . . . 6.99 110.398 -174.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . 28.0 tt0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-O 121.277 0.561 . . . . 11.84 111.208 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -89.31 156.14 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.122 -0.695 . . . . 12.24 109.122 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.62 HD13 ' H ' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.12 84.85 1.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.512 0.672 . . . . 13.16 111.403 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 155' ' ' ILE . 9.4 tp -169.55 48.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.089 0.947 . . . . 11.95 110.15 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -66.24 -28.04 68.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.712 0.768 . . . . 11.22 111.249 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.0 m -56.2 -34.46 66.29 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 11.9 113.039 -171.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -70.64 -25.73 63.15 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.837 -0.619 . . . . 11.17 110.673 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -82.38 -19.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.376 -0.829 . . . . 7.82 110.031 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 m -81.73 -45.01 16.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.485 -0.78 . . . . 9.64 110.022 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.33 -33.78 75.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.543 -0.753 . . . . 10.57 111.055 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 13.7 ptt180 -88.48 165.91 14.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.964 -0.754 . . . . 8.9 108.964 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.12 61.82 3.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 7.15 112.449 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 44.35 -93.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.926 0.89 . . . . 7.09 112.469 -178.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.404 ' H ' ' HB ' ' A' ' 164' ' ' THR . 46.9 t -132.33 82.56 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.131 -1.063 . . . . 9.2 108.131 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' GLY . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 115.539 -0.755 . . . . 9.11 111.561 -173.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.6 mptt . . . . . 0 N--CA 1.441 -0.923 0 N-CA-C 107.726 -1.213 . . . . 10.38 107.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HA ' ' CB ' ' A' ' 58' ' ' GLU . 6.3 mtt-85 -144.09 141.46 30.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.706 -1.134 . . . . 8.37 109.659 -172.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -53.73 133.7 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 122.568 1.175 . . . . 5.76 113.242 -163.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.9 -35.33 6.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.743 -2.026 . . . . 8.22 109.642 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 3.7 p90 -179.54 -174.71 0.31 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.299 -0.864 . . . . 7.99 108.992 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.782 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m-90 -122.14 147.85 45.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 5.61 111.071 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 4.0 ptm180 -152.86 156.4 38.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.238 -0.892 . . . . 9.06 110.194 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.714 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.8 t70 -94.1 140.49 22.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.316 -0.624 . . . . 8.31 109.316 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.79 -15.58 38.76 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.889 2.393 . . . . 10.41 112.561 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.44 -3.46 43.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 111.592 0.219 . . . . 10.85 111.592 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.2 m -127.79 37.22 0.37 Allowed Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.031 0.752 . . . . 9.32 113.031 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -61.24 91.79 0.1 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.738 2.292 . . . . 11.1 112.745 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.86 -31.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.113 -0.565 . . . . 10.31 111.838 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -68.19 -178.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.057 0.762 . . . . 9.21 113.057 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.626 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 11.3 tpp180 -147.34 91.77 2.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.238 -0.892 . . . . 11.51 108.797 172.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 49.9 m-85 -73.97 141.3 45.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.57 -0.852 . . . . 7.5 111.065 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.66 -25.57 68.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 10.61 110.841 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 20.8 pttp -171.79 164.78 4.36 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.808 -0.633 . . . . 10.91 111.008 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -49.79 169.79 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.756 2.971 . . . . 7.51 113.62 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.93 -156.45 26.68 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.414 -0.898 . . . . 7.59 112.814 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 8.4 ttmt -98.75 148.27 24.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.729 -0.471 . . . . 11.68 109.729 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' MET . 8.7 t -77.29 139.16 64.15 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-O 121.168 0.508 . . . . 9.2 111.318 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.73 -22.27 20.69 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.971 2.448 . . . . 10.25 112.871 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.9 m-85 -85.51 -24.32 27.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.162 0.982 . . . . 10.49 109.496 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 46' ' ' SER . 2.2 ptp -157.9 134.08 9.44 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.868 -1.515 . . . . 10.38 111.081 -165.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -77.85 63.52 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.751 0.786 . . . . 12.54 111.565 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.6 ptm -139.05 143.96 39.04 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.74 -1.118 . . . . 9.87 108.215 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.59 133.93 39.0 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.043 1.829 . . . . 9.51 110.743 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.3 154.41 20.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 6.71 110.82 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -93.83 133.52 27.67 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 7.89 109.872 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 27' ' ' ILE . 81.6 Cg_endo -85.23 147.87 10.24 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 121.928 1.752 . . . . 5.77 113.425 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG13 ' A' ' 27' ' ' ILE . 32.2 m -75.69 157.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.639 -1.164 . . . . 5.96 111.994 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.64 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.19 2.196 . . . . 7.84 115.507 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.737 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -40.25 -48.46 2.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.94 0.896 . . . . 6.62 110.42 174.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.737 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 32.4 mt-10 . . . . . 0 C--N 1.317 -0.809 0 C-N-CA 124.203 1.001 . . . . 8.58 113.054 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.658 0.742 . . . . 11.64 111.612 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 148' ' ' VAL . 32.8 p -133.54 173.37 11.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.442 -1.254 . . . . 8.0 110.715 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.59 128.05 22.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.356 -0.838 . . . . 6.65 109.179 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 29.9 tt0 -84.24 135.68 34.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.109 -0.496 . . . . 12.15 110.063 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 95' ' ' LEU . 55.9 t -60.73 131.69 25.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.704 -0.68 . . . . 9.71 112.474 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 54.2 mmtt -138.53 146.16 41.58 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.714 -1.13 . . . . 11.03 109.519 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.729 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 6.6 mp -78.29 163.38 25.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.552 -0.459 . . . . 12.76 110.189 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.251 0 C-N-CA 119.774 -1.203 . . . . 13.25 113.744 -176.441 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.729 ' OE2' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.432 -1.334 0 CA-C-O 122.045 0.926 . . . . 14.94 112.835 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.62 ' CG ' ' HA ' ' A' ' 138' ' ' LEU . 1.1 mpp_? -147.45 175.4 10.84 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.873 -1.512 . . . . 10.57 111.135 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 84' ' ' VAL . 2.3 mm? -100.74 112.97 25.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.166 -0.925 . . . . 8.88 109.101 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.67 130.46 34.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 9.78 110.704 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -143.0 157.88 60.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.01 -0.996 . . . . 6.4 108.694 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 101' ' ' ALA . 15.1 Cg_endo -61.84 132.81 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.252 1.301 . . . . 6.55 109.95 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.467 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 29.1 t -56.07 -21.93 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.489 0.551 . . . . 9.29 112.489 -174.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.93 4.78 48.99 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.938 -0.477 . . . . 10.86 111.504 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . . . -80.51 -41.06 24.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.134 0.492 . . . . 5.34 110.576 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -84.3 158.45 21.19 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.538 -0.756 . . . . 6.97 111.573 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 20.2 mm -107.3 128.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.405 -0.816 . . . . 10.2 110.083 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 19.5 mmm180 -95.79 123.72 39.49 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.899 -0.72 . . . . 12.12 110.422 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -149.25 142.84 25.44 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.804 -0.635 . . . . 14.61 110.445 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.8 -116.53 4.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.194 -0.527 . . . . 15.52 112.302 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 36.84 4.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 14.99 110.877 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -151.63 -179.17 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.064 -0.516 . . . . 15.2 111.804 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.6 m -130.9 147.71 52.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.651 -0.704 . . . . 9.26 109.508 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.5 mm -122.36 145.92 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.782 0.325 . . . . 10.55 110.204 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 141' ' ' LEU . . . -119.48 130.68 55.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.969 -0.56 . . . . 7.39 110.118 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 49.2 mmm -90.88 98.35 11.72 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.819 -0.437 . . . . 8.85 109.819 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 121' ' ' ASP . 11.2 p -83.92 139.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.173 0.511 . . . . 9.69 111.967 -170.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.24 100.06 12.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.561 -0.745 . . . . 10.7 109.822 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.93 149.45 24.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.197 -0.456 . . . . 14.88 111.278 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.45 10.39 17.12 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.217 -0.753 . . . . 16.92 111.217 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.77 15.96 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 18.56 110.55 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.97 19.02 73.66 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.118 -0.947 . . . . 15.62 113.416 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.9 171.66 30.62 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.966 -1.111 . . . . 14.19 112.915 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 96.0 m-85 -120.27 112.67 19.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.612 -0.514 . . . . 12.03 109.612 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.6 m-20 -103.55 147.08 33.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.363 -0.38 . . . . 13.91 110.463 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.75 122.82 2.36 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.984 1.789 . . . . 12.35 112.384 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.34 122.88 59.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.816 -1.083 . . . . 9.43 109.564 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -70.56 111.46 6.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.31 -0.626 . . . . 12.93 109.31 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.483 HG12 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.68 160.46 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.446 0.641 . . . . 8.03 111.867 -173.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -91.83 130.36 37.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.76 -1.2 . . . . 10.39 107.76 172.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.8 102.42 4.28 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.221 -0.592 . . . . 8.3 112.022 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -156.19 71.43 0.26 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 118.595 -1.764 . . . . 10.1 114.028 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.11 163.79 38.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 10.61 109.24 156.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.2 m -139.08 133.11 31.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.179 0.445 . . . . 13.17 110.496 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.85 103.22 4.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 12.98 111.41 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 42.39 69.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.198 -0.525 . . . . 14.34 112.946 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.41 88.94 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.019 -0.61 . . . . 13.12 112.344 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.75 152.65 35.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.255 -0.646 . . . . 10.62 109.255 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.8 p -99.77 161.62 13.5 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.011 -0.276 . . . . 7.82 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 45.3 mt-10 -111.94 117.64 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.641 0.734 . . . . 10.79 111.122 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 35.4 mm -82.94 100.97 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.923 -1.035 . . . . 6.73 108.735 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . 8.7 mt -63.34 -41.67 98.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.138 -0.937 . . . . 8.79 110.319 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 37.0 mt-10 -148.47 155.89 41.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 10.44 110.642 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 125.0 -54.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.236 -0.983 . . . . 8.87 113.742 172.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 111' ' ' ALA . 24.7 mt -98.37 -174.82 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 8.5 112.049 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.76 152.12 36.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.561 -0.745 . . . . 14.15 109.966 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.84 137.4 51.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.104 . . . . 12.12 111.084 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.18 -6.9 59.95 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.629 -0.796 . . . . 11.54 111.518 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -103.44 155.9 18.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.503 -0.925 . . . . 11.24 108.503 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.2 mt-30 -111.38 166.38 11.16 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.734 -0.786 . . . . 10.49 111.874 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.7 OUTLIER -135.91 141.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.923 -1.035 . . . . 5.45 108.617 168.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 p -73.58 121.29 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 6.56 109.679 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 112.941 0.719 . . . . 6.99 112.941 -168.843 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 109.586 -0.524 . . . . 11.84 109.586 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.0 t80 73.86 170.08 0.3 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.473 -1.24 . . . . 12.24 110.419 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.47 -71.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.493 -0.483 . . . . 13.16 111.422 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.2 pp -116.76 149.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 11.95 111.086 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.464 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 2.9 p-10 -72.33 -17.74 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 11.22 111.938 -172.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -62.59 -52.52 63.08 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.02 -0.272 . . . . 11.9 111.213 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.54 -32.88 54.24 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.536 -0.466 . . . . 11.17 109.822 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -50.38 -52.44 37.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.606 0.241 . . . . 7.82 111.547 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.0 p -62.18 -29.87 70.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 9.64 112.035 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.8 -38.6 16.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.109 -0.496 . . . . 10.57 112.203 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 3.1 mpt_? -89.5 -27.1 20.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.929 0.395 . . . . 8.9 111.257 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.98 -8.72 66.68 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.843 -0.694 . . . . 7.15 111.546 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p 55.58 -78.83 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.434 1.094 . . . . 7.09 112.907 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.64 72.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 9.2 110.345 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.016 -0.538 . . . . 9.11 110.272 176.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.113 0 CA-C-O 121.4 0.619 . . . . 10.38 110.58 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.613 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 39.9 mtt180 -126.45 141.32 51.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.547 -0.751 . . . . 8.37 110.367 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' OE2' ' A' ' 58' ' ' GLU . 44.5 mm -55.66 120.08 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 5.76 112.687 -170.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.56 -38.02 5.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.287 -1.324 . . . . 8.22 110.182 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.76 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 21.4 p90 -168.82 -174.66 2.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 7.99 111.303 -175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 1.6 m-90 -124.89 155.02 40.18 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.102 -0.954 . . . . 5.61 111.078 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -160.44 153.58 21.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 9.06 110.133 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 19.1 m-20 -79.17 137.07 56.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.637 -0.875 . . . . 8.31 108.637 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.8 -11.8 19.26 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.65 2.233 . . . . 10.41 111.43 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.596 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.1 null -101.78 0.97 36.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.112 -0.494 . . . . 10.85 111.321 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' ASP . 6.9 m -127.81 43.65 1.11 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.244 0.545 . . . . 9.32 111.476 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 35' ' ' VAL . 16.6 Cg_exo -61.74 111.49 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.81 2.34 . . . . 11.1 112.009 -170.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.38 -26.18 4.17 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.793 -0.923 . . . . 10.31 110.793 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.461 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 38.1 tp60 -76.52 115.58 16.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 9.21 110.531 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 36.3 ttp180 -98.47 99.44 10.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.664 -0.698 . . . . 11.51 110.944 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.76 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 82.9 m-85 -79.77 133.02 36.3 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.343 -0.614 . . . . 7.5 109.343 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.88 -26.86 68.8 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.638 0.587 . . . . 10.61 110.766 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -160.06 147.66 12.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.437 0.636 . . . . 10.91 111.977 -172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 19.6 Cg_endo -56.33 135.68 71.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.947 3.765 . . . . 7.51 113.573 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.71 -145.93 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.076 -0.583 . . . . 7.59 111.919 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 2.0 ttmm -105.83 141.93 36.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.669 -0.863 . . . . 11.68 108.669 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB3' ' O ' ' A' ' 49' ' ' MET . 47.0 t -64.05 141.6 98.09 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.855 -0.612 . . . . 9.2 111.411 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.93 -21.49 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.664 2.243 . . . . 10.25 111.012 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.571 ' CD2' HG11 ' A' ' 35' ' ' VAL . 35.0 m-85 -84.64 -41.99 15.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.187 -1.37 . . . . 10.49 109.245 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -137.04 157.41 46.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.369 -0.832 . . . . 10.38 110.873 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.0 p-10 -84.11 53.38 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.07 0.938 . . . . 12.54 111.135 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.47 32.85 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 114.967 -1.015 . . . . 9.87 109.345 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.43 133.14 23.67 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 N-CA-C 108.86 -1.246 . . . . 9.51 108.86 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.498 HD23 ' OD1' ' A' ' 32' ' ' ASP . 31.6 mt -61.59 157.17 17.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.076 0.465 . . . . 6.71 111.331 -172.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.16 133.26 22.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 116.065 -0.516 . . . . 7.89 109.702 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.564 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 92.8 Cg_endo -78.65 138.18 14.99 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.912 1.741 . . . . 5.77 112.613 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HB ' ' CE1' ' A' ' 57' ' ' TYR . 34.5 m -61.07 159.64 2.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.301 -1.318 . . . . 5.96 112.869 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 15.47 -87.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.564 1.946 . . . . 7.84 115.11 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 26' ' ' ARG . 2.5 pt-20 -53.49 -34.49 58.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.244 -1.344 . . . . 6.62 111.675 -170.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 31.6 tt0 . . . . . 0 C--N 1.319 -0.718 0 O-C-N 124.44 1.088 . . . . 8.58 110.047 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 . . . . . 0 CA--C 1.51 -0.584 0 CA-C-O 121.484 0.659 . . . . 11.64 110.247 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.51 HG22 ' HA ' ' A' ' 148' ' ' VAL . 36.2 p -131.48 147.24 52.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.447 -1.251 . . . . 8.0 110.592 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.44 54.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.819 -0.808 . . . . 6.65 108.819 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 29.9 tt0 -73.02 138.08 45.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.083 -0.508 . . . . 12.15 109.724 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' LEU . 54.4 t -58.96 135.21 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.522 -0.763 . . . . 9.71 111.739 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 66.5 mmtt -126.89 154.36 44.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.327 -0.851 . . . . 11.03 111.56 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.8 mp -89.2 125.7 35.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.42 -0.956 . . . . 12.76 108.42 162.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.066 0 C-N-CA 118.979 -1.581 . . . . 13.25 113.371 -173.22 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HG3' ' CD2' ' A' ' 86' ' ' LEU . 1.6 tt0 . . . . . 0 N--CA 1.445 -0.69 0 CA-C-O 121.817 0.817 . . . . 14.94 111.949 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -132.17 163.8 27.73 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.892 -1.503 . . . . 10.57 107.567 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.609 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -91.6 114.53 27.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.719 -0.474 . . . . 8.88 109.719 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.14 130.61 37.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.951 -0.568 . . . . 9.78 110.974 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.54 158.24 50.72 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.405 -0.816 . . . . 6.4 109.628 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.572 ' HG2' HG11 ' A' ' 149' ' ' VAL . 34.5 Cg_exo -57.72 134.38 62.53 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.204 1.936 . . . . 6.55 111.049 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 t -58.05 -28.23 64.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.916 0.339 . . . . 9.29 111.916 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.05 1.24 51.1 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.234 -0.291 . . . . 10.86 111.552 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -76.75 -41.08 46.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.097 0.475 . . . . 5.34 111.378 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.92 163.43 14.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.847 -0.615 . . . . 6.97 112.073 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.4 mm -113.27 103.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.809 -0.632 . . . . 10.2 109.508 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.2 ptt180 -102.41 132.2 48.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 117.949 -1.501 . . . . 12.12 111.113 173.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -150.31 132.58 15.47 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.736 -1.575 . . . . 14.61 109.454 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.65 -108.79 2.14 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.519 -0.848 . . . . 15.52 112.317 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.5 29.09 7.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.381 0.511 . . . . 14.99 112.381 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -164.76 178.86 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.119 0.415 . . . . 15.2 112.119 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 7.2 m -133.15 152.29 51.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.668 -0.696 . . . . 9.26 110.137 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 124' ' ' GLU . 34.4 mm -128.95 151.76 36.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.777 -0.453 . . . . 10.55 109.777 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.84 130.12 31.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.649 -0.13 . . . . 7.39 110.649 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.4 mtm -89.31 101.47 14.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 8.85 109.388 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 10.0 p -87.19 139.17 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.601 -0.727 . . . . 9.69 111.364 -174.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.61 85.89 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 10.7 109.642 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -71.32 145.82 49.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 14.88 110.129 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.19 -7.78 33.36 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.031 -0.531 . . . . 16.92 113.168 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.33 10.98 17.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 18.56 110.966 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 14.4 69.3 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.487 -0.779 . . . . 15.62 113.282 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.0 167.47 21.09 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.683 -0.77 . . . . 14.19 111.501 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.7 m-85 -113.0 108.24 17.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.905 0.383 . . . . 12.03 110.047 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 16.8 t70 -101.54 141.11 21.93 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.054 -0.521 . . . . 13.91 110.637 -173.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 9.4 Cg_endo -86.19 124.7 2.5 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.485 2.123 . . . . 12.35 111.943 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 111' ' ' ALA . 8.7 p -107.47 131.8 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.397 -0.82 . . . . 9.43 109.304 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 110' ' ' ILE . 31.2 tt0 -78.0 109.86 12.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.969 -0.752 . . . . 12.93 108.969 171.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.832 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -116.62 155.78 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.193 -0.912 . . . . 8.03 111.465 -171.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -93.54 120.05 33.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.092 -0.958 . . . . 10.39 108.87 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.56 106.89 4.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.093 -0.503 . . . . 8.3 111.004 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.52 70.53 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.893 -2.099 . . . . 10.1 114.215 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.43 162.85 39.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.16 -0.681 . . . . 10.61 109.16 155.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -141.64 123.61 15.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.178 0.513 . . . . 13.17 109.759 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.92 126.45 11.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.673 -0.694 . . . . 12.98 111.156 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.78 32.08 83.03 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 116.09 -0.505 . . . . 14.34 112.528 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.41 15.62 80.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.933 -0.651 . . . . 13.12 111.878 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -123.37 174.98 7.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.036 -0.727 . . . . 10.62 109.036 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.7 m -126.58 157.53 38.6 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.001 0.429 . . . . 7.82 110.646 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 75.4 mt-10 -101.8 118.14 36.31 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.489 0.661 . . . . 10.79 110.888 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 125' ' ' VAL . 17.6 mm -86.09 101.23 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.097 -0.956 . . . . 6.73 108.927 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 2.6 mp -71.09 -36.77 72.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.573 -1.194 . . . . 8.79 110.264 -176.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 125' ' ' VAL . 12.5 tt0 -158.2 158.38 34.44 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.056 -0.72 . . . . 10.44 109.056 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 126.15 -33.69 3.43 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.903 -1.142 . . . . 8.87 111.772 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.34 -176.9 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.859 0.689 . . . . 8.5 112.859 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -148.38 155.97 41.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.731 -1.122 . . . . 14.15 108.944 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.46 133.44 47.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.293 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.54 -5.41 44.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.817 -0.913 . . . . 11.54 110.817 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 84' ' ' VAL . 38.5 mt-30 -101.06 122.03 42.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.364 0.602 . . . . 11.24 109.391 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 6.4 mt-30 -91.27 124.97 35.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.955 . . . . 10.49 110.718 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.39 139.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.792 -0.448 . . . . 5.45 109.792 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 81' ' ' THR . 35.3 m -65.36 132.25 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 6.56 110.764 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.572 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.2 m . . . . . 0 C--N 1.319 -0.76 0 CA-C-O 121.891 0.853 . . . . 6.99 109.247 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 112.398 0.518 . . . . 11.84 112.398 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -106.15 -161.38 0.79 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 12.24 109.761 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 61.7 tp 71.67 -71.25 0.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.202 0.601 . . . . 13.16 110.631 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.66 3.36 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.539 -0.755 . . . . 11.95 110.597 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.68 -21.67 65.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.841 -0.618 . . . . 11.22 110.056 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 p -59.1 -52.99 63.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.182 0.515 . . . . 11.9 110.17 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.94 -36.6 79.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.38 -0.827 . . . . 11.17 110.391 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.14 67.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.051 -0.977 . . . . 7.82 111.3 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -76.38 -19.33 58.26 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.966 -0.383 . . . . 9.64 109.966 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.01 -50.13 71.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.23 -0.655 . . . . 10.57 109.23 173.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -64.63 -34.97 79.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.257 -0.883 . . . . 8.9 110.248 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.437 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 106.82 43.65 1.4 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.439 -0.801 . . . . 7.15 111.666 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 49.2 p 54.95 -92.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.902 0.881 . . . . 7.09 112.156 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.56 74.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.501 0.667 . . . . 9.2 110.87 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 9.11 111.277 -177.739 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? . . . . . 0 CA--C 1.505 -0.785 0 N-CA-C 107.614 -1.254 . . . . 10.38 107.614 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.574 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 22.7 ptt85 -128.13 145.44 51.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.649 -1.614 . . . . 8.37 109.093 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.658 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.5 mm -54.05 125.28 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 114.227 1.195 . . . . 5.76 114.227 -166.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.5 mt -110.26 -37.24 5.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.205 -1.816 . . . . 8.22 110.507 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 20.5 p90 -170.0 -176.03 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.397 . . . . 7.99 111.369 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -123.86 148.82 46.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.533 -0.758 . . . . 5.61 111.09 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -153.61 151.16 29.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.337 -0.392 . . . . 9.06 110.631 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.746 ' HB3' HG22 ' A' ' 35' ' ' VAL . 6.1 t0 -75.82 129.16 81.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.011 -1.107 . . . . 8.31 108.011 172.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 54' ' ' ILE . 18.7 Cg_exo -60.46 -16.99 45.38 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.098 1.865 . . . . 10.41 113.77 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -104.51 4.84 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.243 -0.583 . . . . 10.85 111.921 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.4 m -119.42 41.88 0.44 Allowed Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 112.387 0.514 . . . . 9.32 112.387 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.09 134.63 65.62 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 11.1 112.465 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.08 43.38 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.976 -0.849 . . . . 10.31 110.976 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.578 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -92.86 116.42 29.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.217 0.532 . . . . 9.21 110.371 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 49.4 ttp180 -104.34 116.57 32.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.667 -0.697 . . . . 11.51 111.334 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 97.5 m-85 -101.84 114.23 28.13 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.862 -1.162 . . . . 7.5 107.862 171.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -64.35 -21.58 66.67 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.522 -0.871 . . . . 10.61 111.703 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 52.9 mttp -126.18 166.68 20.16 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.339 -0.544 . . . . 10.91 111.234 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 14.1 Cg_endo -56.4 171.58 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.399 2.733 . . . . 7.51 112.857 170.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.6 -170.8 29.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.651 -0.785 . . . . 7.59 112.424 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 31.2 ttmt -95.58 146.78 24.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.465 -0.568 . . . . 11.68 109.465 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.4 t -64.51 129.69 94.33 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.684 -0.689 . . . . 9.2 110.411 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.7 -26.35 33.09 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.44 2.093 . . . . 10.25 111.027 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 52.3 m-85 -73.98 -40.67 62.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.969 -1.468 . . . . 10.49 110.404 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.8 OUTLIER -154.52 160.96 41.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 10.38 110.788 174.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.2 p-10 -78.6 72.35 5.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.888 0.851 . . . . 12.54 112.804 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.2 ptm -140.41 144.74 38.12 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.531 -0.915 . . . . 9.87 108.531 168.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.4 133.3 29.84 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.095 1.863 . . . . 9.51 110.041 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.34 159.53 12.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.894 0.378 . . . . 6.71 110.382 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 33' ' ' PRO . 42.0 mm -103.24 130.84 22.83 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-O 121.25 0.548 . . . . 7.89 109.752 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.636 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 80.6 Cg_endo -75.48 144.14 28.39 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.707 1.605 . . . . 5.77 112.416 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.35 160.46 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.407 -1.27 . . . . 5.96 112.62 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.574 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.59 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.843 2.457 . . . . 7.84 116.389 -175.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -61.06 -45.21 95.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.766 0.793 . . . . 6.62 109.936 -173.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 47.5 mt-10 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 113.514 -1.675 . . . . 8.58 114.695 167.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 109.155 -0.683 . . . . 11.64 109.155 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.9 p -140.4 144.11 36.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.082 0.468 . . . . 8.0 110.78 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.479 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -114.94 140.64 48.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.872 -0.788 . . . . 6.65 108.872 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 34.4 tt0 -87.48 130.54 34.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.593 -0.521 . . . . 12.15 109.593 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 145' ' ' GLN . 61.2 t -54.69 128.96 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.432 0.635 . . . . 9.71 111.554 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -163.02 140.3 7.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.486 -1.233 . . . . 11.03 109.981 171.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.88 ' H ' HD23 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -77.58 158.01 30.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.148 -0.933 . . . . 12.76 110.484 -177.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.549 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.682 0 C-N-CA 120.883 -0.675 . . . . 13.25 112.427 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.511 -0.548 0 CA-C-O 121.493 0.663 . . . . 14.94 111.415 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 33.6 mmt180 -133.92 164.28 27.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.382 -1.281 . . . . 10.57 108.332 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.6 mp -85.16 112.21 20.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.101 -0.703 . . . . 8.88 109.101 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.0 mm? -87.81 130.23 34.94 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.84 0.352 . . . . 9.78 110.95 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.78 155.58 56.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 6.4 109.045 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.93 136.92 67.96 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.121 1.881 . . . . 6.55 111.117 170.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 15.9 t -56.46 -24.12 43.49 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.472 0.545 . . . . 9.29 112.472 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.89 9.47 27.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.217 -0.302 . . . . 10.86 111.138 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -80.44 -41.11 25.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.244 0.545 . . . . 5.34 111.339 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.8 155.61 19.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.646 0.736 . . . . 6.97 112.546 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.37 131.43 46.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.731 -1.122 . . . . 10.2 109.1 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -102.28 126.55 49.31 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.534 -0.466 . . . . 12.12 110.823 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 t -149.67 132.93 16.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.275 -0.421 . . . . 14.61 110.466 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.33 -114.22 3.61 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.262 -0.494 . . . . 15.52 113.111 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.57 36.65 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.195 0.521 . . . . 14.99 111.243 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -153.3 167.53 29.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 15.2 111.758 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.2 m -117.44 145.15 44.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.066 -0.515 . . . . 9.26 109.831 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.8 mm -125.49 153.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.306 -0.627 . . . . 10.55 109.306 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -129.42 129.88 45.24 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.353 -0.217 . . . . 7.39 110.467 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 41.2 ttp -90.61 100.86 13.63 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 8.85 108.668 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.3 p -84.49 133.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.49 -0.777 . . . . 9.69 111.894 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.86 84.06 7.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 10.7 110.188 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.19 149.03 46.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 14.88 110.665 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.79 5.39 39.44 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.118 -0.793 . . . . 16.92 111.118 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -87.23 6.39 33.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.471 0.653 . . . . 18.56 110.528 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 1.27 77.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.231 -0.895 . . . . 15.62 113.469 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.78 159.17 22.87 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.735 -0.745 . . . . 14.19 112.426 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.486 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.5 m-85 -109.87 116.82 32.34 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.572 -0.529 . . . . 12.03 109.572 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.8 t70 -113.46 144.2 30.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.002 -0.279 . . . . 13.91 111.267 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -84.44 131.21 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.512 2.141 . . . . 12.35 112.505 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.619 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 10.6 p -122.97 136.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.595 . . . . 9.43 110.27 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 110' ' ' ILE . 35.0 tt0 -83.11 120.23 25.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.97 0.414 . . . . 12.93 109.996 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 123' ' ' VAL . 22.8 m -129.11 165.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.031 -0.531 . . . . 8.03 111.567 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.73 127.17 44.57 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.873 -0.603 . . . . 10.39 109.397 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.14 106.19 4.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.198 -0.455 . . . . 8.3 111.393 -175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.75 71.05 0.28 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 117.655 -2.212 . . . . 10.1 114.094 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.51 162.16 40.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 10.61 108.817 155.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -146.96 129.76 16.17 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.645 -0.502 . . . . 13.17 109.645 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.96 110.72 4.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.034 -0.53 . . . . 12.98 111.364 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.61 40.28 90.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.056 -0.592 . . . . 14.34 112.9 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.79 0.73 90.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.72 -0.753 . . . . 13.12 112.543 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -114.49 155.69 25.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.507 -0.553 . . . . 10.62 109.507 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 57.7 m -113.4 164.85 13.07 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 110.072 -0.344 . . . . 7.82 110.072 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.9 mt-10 -112.53 113.57 25.79 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.57 0.7 . . . . 10.79 111.283 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 34.9 mm -83.24 104.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.946 -1.024 . . . . 6.73 108.401 170.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -70.34 -49.14 52.39 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.125 -0.943 . . . . 8.79 109.922 -174.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -144.38 162.04 37.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 10.44 111.311 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 119.31 -52.99 0.69 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.871 -0.68 . . . . 8.87 113.395 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 123' ' ' VAL . 16.0 mt -105.36 -171.63 1.95 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 8.5 111.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -144.26 155.37 43.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 14.15 110.066 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 129.51 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.15 -0.932 . . . . 12.12 110.348 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.28 -11.06 28.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.978 -0.849 . . . . 11.54 110.978 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 84' ' ' VAL . 88.5 mm-40 -94.19 118.22 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 11.24 109.465 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 26.1 mt-30 -85.38 132.38 34.24 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 10.49 110.797 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.4 m -122.8 142.34 39.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.184 -0.462 . . . . 5.45 110.133 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 8.9 p -65.29 124.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.231 0.539 . . . . 6.56 111.375 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 101' ' ' ALA . 10.9 m . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.273 0.558 . . . . 6.99 111.083 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 153' ' ' PHE . 15.8 mm-40 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 111.323 0.12 . . . . 11.84 111.323 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 152' ' ' GLN . 79.0 t80 72.01 -71.25 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.65 0.594 . . . . 12.24 111.062 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 155' ' ' ILE . 11.3 tp -118.02 -154.95 0.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.669 -0.863 . . . . 13.16 108.669 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.54 ' H ' ' HG ' ' A' ' 154' ' ' LEU . 61.0 mt -57.85 100.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.495 0.664 . . . . 11.95 110.191 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 5.6 p-10 -82.67 -6.44 59.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.472 -0.786 . . . . 11.22 111.09 -172.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.7 m -60.41 -42.89 96.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 11.9 110.807 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.41 -28.35 52.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.509 0.671 . . . . 11.17 109.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -74.6 -27.36 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 7.82 111.987 -174.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 p -81.48 -38.6 26.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.947 0.403 . . . . 9.64 110.804 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.52 -26.57 61.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.791 -0.64 . . . . 10.57 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 162' ' ' ARG . 1.8 ptm180 -94.63 161.68 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.667 0.746 . . . . 8.9 110.084 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.86 -70.19 0.52 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.628 -1.389 . . . . 7.15 109.628 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.7 p -144.98 -56.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.303 0.573 . . . . 7.09 109.767 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.54 -70.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.604 -0.725 . . . . 9.2 110.053 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.366 0 O-C-N 123.883 0.74 . . . . 9.11 111.856 178.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.44 -0.945 0 CA-C-O 122.757 1.265 . . . . 10.38 108.015 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.579 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 2.1 mmp_? -141.15 127.66 20.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.692 -1.594 . . . . 8.37 109.203 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -55.04 140.47 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 122.361 1.077 . . . . 5.76 112.7 -172.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -118.53 -39.2 3.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.35 -1.75 . . . . 8.22 109.18 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 13.7 p90 -170.15 -178.21 2.75 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.85 . . . . 7.99 110.011 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.76 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-90 -120.83 146.97 45.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.726 . . . . 5.61 109.665 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 149.97 37.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.784 0.326 . . . . 9.06 110.18 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.798 ' HB3' HG22 ' A' ' 35' ' ' VAL . 29.3 t0 -83.75 132.12 49.91 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 108.783 -0.821 . . . . 8.31 108.783 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.432 ' CD ' HD13 ' A' ' 54' ' ' ILE . 39.3 Cg_exo -56.05 -18.77 24.03 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.674 2.249 . . . . 10.41 112.461 172.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.507 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -90.14 -1.94 58.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.754 0.279 . . . . 10.85 111.754 175.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -131.91 39.65 0.52 Allowed Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.911 0.708 . . . . 9.32 112.911 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 19.1 Cg_endo -51.21 110.85 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.976 2.451 . . . . 11.1 112.799 -171.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.2 -31.81 3.38 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.766 -0.652 . . . . 10.31 111.503 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.494 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 20.6 tp60 -70.52 107.38 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 9.21 111.04 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.604 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 23.5 mtm180 -86.88 97.69 10.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.259 -0.882 . . . . 11.51 110.68 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.4 m-85 -75.11 143.55 43.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.75 -0.659 . . . . 7.5 109.232 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.54 -29.14 70.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.551 -1.204 . . . . 10.61 111.072 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 21.1 pttm -164.17 164.03 14.69 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.476 -0.329 . . . . 10.91 111.737 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.5 Cg_endo -50.75 170.85 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.006 3.137 . . . . 7.51 113.712 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.55 -162.99 26.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.739 -0.744 . . . . 7.59 112.115 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 37.6 ttpt -94.28 149.23 21.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.126 0.489 . . . . 11.68 110.687 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 49' ' ' MET . 34.2 t -65.64 132.47 94.96 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 115.122 -0.945 . . . . 9.2 110.986 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.54 -24.72 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.204 1.936 . . . . 10.25 111.706 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' A' ' 35' ' ' VAL . 78.1 m-85 -76.5 -37.13 57.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.99 -1.005 . . . . 10.49 110.098 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.3 pmm? -156.92 163.6 38.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.865 -0.607 . . . . 10.38 110.224 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.0 75.68 10.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 12.54 114.471 -167.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -142.59 145.38 34.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.057 -0.72 . . . . 9.87 109.057 168.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.9 Cg_exo -66.6 133.91 33.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.947 1.764 . . . . 9.51 111.219 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 32' ' ' ASP . 31.6 mt -62.67 159.03 16.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.004 0.431 . . . . 6.71 111.181 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 ' CD ' ' A' ' 33' ' ' PRO . 1.7 mp -95.69 135.4 23.03 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.952 -0.567 . . . . 7.89 109.691 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.577 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . 64.5 Cg_endo -87.52 162.1 8.06 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.585 1.524 . . . . 5.77 113.286 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG22 HG13 ' A' ' 27' ' ' ILE . 32.6 m -89.26 156.49 3.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.647 -1.16 . . . . 5.96 111.709 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.579 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.73 -80.88 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 126.971 2.108 . . . . 7.84 115.685 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.1 pt-20 -53.04 -39.98 63.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.942 -0.392 . . . . 6.62 109.942 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 57' ' ' TYR . 52.3 mt-10 . . . . . 0 C--N 1.314 -0.949 0 CA-C-N 115.192 -0.913 . . . . 8.58 110.976 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.202 -0.666 . . . . 11.64 109.202 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 148' ' ' VAL . 60.2 p -130.0 154.82 47.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.269 -0.423 . . . . 8.0 109.879 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.409 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 134.33 54.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 6.65 109.231 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 32.8 tt0 -83.65 136.97 34.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.314 -0.624 . . . . 12.15 109.314 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 95' ' ' LEU . 71.8 t -60.51 129.01 22.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 9.71 111.881 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 26.5 mmtp -129.51 151.0 50.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.64 -1.164 . . . . 11.03 109.622 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -84.98 162.37 19.41 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.728 -0.389 . . . . 12.76 109.967 169.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.273 0 C-N-CA 120.705 -0.76 . . . . 13.25 112.837 179.793 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HG2' HD23 ' A' ' 86' ' ' LEU . 3.8 mt-10 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-O 120.921 0.391 . . . . 14.94 109.981 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.506 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 3.1 tpp180 -122.64 159.94 26.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 10.57 110.358 -175.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -100.72 124.12 45.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.485 -0.561 . . . . 8.88 109.485 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.65 130.36 45.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.22 -0.445 . . . . 9.78 110.405 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.31 155.19 57.84 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.352 -0.84 . . . . 6.4 109.734 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.05 127.45 25.03 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.053 1.836 . . . . 6.55 111.124 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.489 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.5 p -54.26 -31.86 54.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.074 0.464 . . . . 9.29 112.227 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.88 -17.38 64.61 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.742 -0.663 . . . . 10.86 112.405 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -83.8 -7.29 59.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 5.34 111.31 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.539 HD21 HD11 ' A' ' 137' ' ' ILE . 26.5 mt -86.18 118.27 25.53 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.773 0.797 . . . . 6.97 112.093 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -89.54 111.32 22.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.409 -1.269 . . . . 10.2 108.817 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.59 125.42 34.34 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.345 -0.542 . . . . 12.12 110.45 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -148.81 141.47 24.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.966 -0.561 . . . . 14.61 109.875 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.64 -117.74 6.21 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 121.266 -0.492 . . . . 15.52 112.313 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.0 37.1 4.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.166 0.508 . . . . 14.99 111.342 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -148.28 174.65 11.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.986 -0.552 . . . . 15.2 111.081 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 m -121.36 149.84 42.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.267 -0.642 . . . . 9.26 109.267 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.8 mm -128.4 148.27 32.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.645 -0.502 . . . . 10.55 109.645 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.625 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -121.41 126.42 49.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.496 -0.32 . . . . 7.39 110.205 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.442 ' HB2' HG22 ' A' ' 148' ' ' VAL . 59.4 mtp -82.27 99.68 9.46 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.416 -0.587 . . . . 8.85 109.416 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.4 p -83.04 130.66 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.291 -0.868 . . . . 9.69 111.288 -174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.83 89.27 7.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.546 -0.752 . . . . 10.7 109.454 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.22 157.76 35.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.73 -0.668 . . . . 14.88 111.647 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.86 17.49 21.29 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.418 -0.81 . . . . 16.92 111.501 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -103.6 8.73 37.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.354 0.597 . . . . 18.56 110.337 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.36 9.09 70.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.184 -0.917 . . . . 15.62 113.481 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.81 170.51 23.97 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.2 -1.0 . . . . 14.19 113.038 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.4 m-85 -121.46 123.7 42.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.869 -0.419 . . . . 12.03 109.869 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.544 ' O ' HG12 ' A' ' 113' ' ' VAL . 26.1 m-20 -123.51 151.05 62.66 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.791 -0.364 . . . . 13.91 111.404 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.15 122.69 2.2 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.048 1.832 . . . . 12.35 112.31 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 8.1 p -108.28 132.76 55.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.32 -0.855 . . . . 9.43 109.784 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.6 tt0 -72.96 119.91 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.818 -0.438 . . . . 12.93 109.818 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.533 HG13 HG13 ' A' ' 123' ' ' VAL . 31.3 m -127.91 159.28 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 8.03 111.584 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' HD22 ' A' ' 138' ' ' LEU . 39.8 ttmt -104.46 128.88 52.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.319 -0.855 . . . . 10.39 109.32 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.96 106.73 5.12 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 111.82 0.304 . . . . 8.3 111.82 -174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.18 70.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 117.983 -2.056 . . . . 10.1 114.82 165.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.15 163.44 38.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.446 -1.316 . . . . 10.61 107.446 150.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -140.65 128.83 22.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.7 0.682 . . . . 13.17 110.375 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.86 117.3 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.136 0.421 . . . . 12.98 112.136 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 39.76 98.35 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 115.948 -0.569 . . . . 14.34 113.344 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.84 82.29 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.724 -0.75 . . . . 13.12 112.471 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -122.26 163.02 20.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.56 -0.904 . . . . 10.62 108.56 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.0 p -114.46 149.74 35.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.307 -0.557 . . . . 7.82 112.035 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.2 mp0 -93.43 119.17 32.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.46 -0.791 . . . . 10.79 111.513 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.539 HD11 HD21 ' A' ' 102' ' ' LEU . 16.2 mm -91.5 111.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.295 -0.866 . . . . 6.73 109.333 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -75.02 -51.59 13.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.63 -1.168 . . . . 8.79 109.487 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -143.05 169.03 18.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.067 -0.97 . . . . 10.44 110.893 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 117.38 -71.73 0.29 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.528 -0.844 . . . . 8.87 113.374 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 42.8 tp -108.56 172.41 6.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.778 0.289 . . . . 8.5 110.666 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.482 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 88.0 tttt -122.56 154.62 37.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.812 0.815 . . . . 14.15 111.656 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -66.25 135.13 54.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 113.979 -1.464 . . . . 12.12 109.834 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.48 -2.8 56.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.354 -0.927 . . . . 11.54 111.439 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.51 152.65 21.44 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.849 -0.797 . . . . 11.24 108.849 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 22.6 mt-30 -104.04 149.88 24.78 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.078 0.466 . . . . 10.49 111.203 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.9 m -135.73 146.66 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.644 -0.707 . . . . 5.45 109.286 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 112' ' ' MET . 27.7 m -72.88 128.13 35.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.352 0.596 . . . . 6.56 110.824 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.7 m . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.697 -0.683 . . . . 6.99 110.702 -174.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 . . . . . 0 N--CA 1.474 0.741 0 CA-C-O 121.186 0.517 . . . . 11.84 112.217 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.495 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 32.8 p90 -117.64 134.63 54.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.199 0.523 . . . . 12.24 111.115 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 158' ' ' GLU . 94.5 mt -87.22 -165.3 1.26 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.558 -0.746 . . . . 13.16 110.773 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 157' ' ' SER . 36.2 pt -78.46 -161.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 11.95 111.436 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -55.63 -23.79 29.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.307 0.484 . . . . 11.22 112.307 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.44 ' H ' HG13 ' A' ' 155' ' ' ILE . 15.8 m -54.71 -48.49 72.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.024 0.44 . . . . 11.9 110.669 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 153' ' ' PHE . 20.1 tt0 -61.17 -29.8 70.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.369 -0.832 . . . . 11.17 110.296 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.06 -25.73 31.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.954 -0.566 . . . . 7.82 112.028 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.0 t -75.91 -30.18 58.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.196 -0.668 . . . . 9.64 109.196 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 162' ' ' ARG . 3.5 pp -88.3 -30.19 19.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.719 -0.673 . . . . 10.57 112.407 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 161' ' ' LEU . 25.3 ptt180 -80.73 132.78 35.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 8.9 110.637 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.86 74.02 0.21 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.729 -0.748 . . . . 7.15 111.815 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.7 p 47.15 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.556 0.742 . . . . 7.09 111.787 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.4 t 64.48 82.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.419 -0.585 . . . . 9.2 109.419 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.329 -0.851 . . . . 9.11 110.994 -177.716 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 5.0 ptmm? . . . . . 0 N--CA 1.439 -0.996 0 CA-C-O 122.152 0.977 . . . . 10.38 109.958 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.522 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 45.1 mtm180 -134.65 140.34 45.95 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.927 -1.488 . . . . 8.37 109.217 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.767 HG21 ' CZ3' ' A' ' 30' ' ' TRP . 22.7 mm -54.85 129.73 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 122.455 1.121 . . . . 5.76 113.701 -167.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.86 HD13 ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -89.87 -29.49 18.54 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 112.355 -2.202 . . . . 8.22 111.376 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CD1' HD13 ' A' ' 28' ' ' LEU . 46.3 p90 158.0 -172.9 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.055 1.342 . . . . 7.99 107.597 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.767 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.3 m-90 -116.95 142.69 46.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.744 0.307 . . . . 5.61 110.835 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -148.28 154.62 40.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 9.06 110.476 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.667 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -92.41 137.11 24.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.556 -0.905 . . . . 8.31 108.556 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.65 -13.63 35.04 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.313 2.008 . . . . 10.41 112.191 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -99.72 2.31 44.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.59 -0.277 . . . . 10.85 111.206 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.8 m -128.86 40.89 0.65 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.396 0.517 . . . . 9.32 112.396 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 14.5 Cg_endo -52.3 113.38 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.916 2.411 . . . . 11.1 112.809 -172.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.3 -35.87 2.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.46 -0.656 . . . . 10.31 111.46 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -64.2 103.09 0.58 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.641 0.734 . . . . 9.21 110.856 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.784 ' NH1' ' HA ' ' A' ' 41' ' ' ASP . 2.1 tmm_? -81.96 103.49 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.015 -0.993 . . . . 11.51 109.702 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -87.91 133.59 33.89 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.297 -1.001 . . . . 7.5 108.297 173.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 17.8 t70 -63.89 -35.05 79.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.924 -1.035 . . . . 10.61 110.518 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.2 mttp -148.37 162.33 30.73 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.955 -0.566 . . . . 10.91 110.721 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.5 Cg_endo -50.21 171.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.01 3.14 . . . . 7.51 113.857 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.54 -165.91 27.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 7.59 112.491 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 7.7 ttmt -91.33 144.24 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.237 -0.653 . . . . 11.68 109.237 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 49' ' ' MET . 10.6 t -70.76 145.78 92.57 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.43 . . . . 9.2 110.863 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.52 -20.85 7.83 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.765 2.31 . . . . 10.25 111.547 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.774 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 96.4 m-85 -84.6 -39.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.426 -1.261 . . . . 10.49 109.842 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.774 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -136.66 151.92 49.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.663 -0.698 . . . . 10.38 110.522 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.5 p-10 -79.23 53.14 1.43 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.864 0.84 . . . . 12.54 111.418 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG2' ' HB2' ' A' ' 49' ' ' MET . 16.4 ptm -127.02 146.59 58.27 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.418 -0.81 . . . . 9.87 109.682 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' MET . 8.2 Cg_exo -69.58 133.5 26.04 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.143 1.896 . . . . 9.51 110.286 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.69 156.68 13.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.397 0.436 . . . . 6.71 110.592 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.65 131.16 27.51 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 121.205 0.526 . . . . 7.89 110.311 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 59' ' ' GLU . 96.7 Cg_endo -85.09 156.5 11.27 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.117 1.878 . . . . 5.77 113.158 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 28' ' ' LEU . 27.2 m -86.73 160.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.555 -1.202 . . . . 5.96 111.136 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.522 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 5.84 -71.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.392 2.277 . . . . 7.84 116.478 -176.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.682 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.8 pt-20 -65.47 -39.22 91.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.125 0.964 . . . . 6.62 110.726 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.592 ' HA ' HD11 ' A' ' 27' ' ' ILE . 9.9 pt-20 . . . . . 0 CA--C 1.509 -0.601 0 CA-C-N 112.473 -2.148 . . . . 8.58 114.02 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 149' ' ' VAL . 18.1 tpt180 . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 121.802 0.811 . . . . 11.64 112.762 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 148' ' ' VAL . 19.8 p -106.8 139.3 41.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.772 -1.104 . . . . 8.0 108.052 170.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 147' ' ' VAL . . . -107.69 127.85 54.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.607 -0.516 . . . . 6.65 109.607 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 43.5 tt0 -82.25 140.48 33.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.069 0.461 . . . . 12.15 110.696 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.715 HG11 HD23 ' A' ' 95' ' ' LEU . 79.7 t -62.92 130.67 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.325 -0.852 . . . . 9.71 112.026 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 27.5 mmtp -137.23 153.45 50.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.465 -1.243 . . . . 11.03 109.266 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 93' ' ' GLU . 9.7 mp -83.73 152.02 24.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.758 -0.46 . . . . 12.76 109.758 168.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.477 0 N-CA-C 111.47 -0.652 . . . . 13.25 111.47 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HG2' HD23 ' A' ' 86' ' ' LEU . 1.9 mp0 . . . . . 0 CA--C 1.506 -0.715 0 CA-C-O 121.414 0.626 . . . . 14.94 110.98 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 41.1 mmt180 -131.11 156.09 45.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.972 -1.013 . . . . 10.57 110.778 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.715 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -87.32 114.88 24.33 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.987 -1.006 . . . . 8.88 110.465 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.65 130.69 35.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.693 0.282 . . . . 9.78 110.826 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.96 152.94 56.44 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.431 -0.804 . . . . 6.4 109.856 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 149' ' ' VAL . 41.8 Cg_exo -56.3 122.64 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.094 1.863 . . . . 6.55 110.35 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.4 p -62.7 -22.81 66.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 9.29 112.845 -164.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.19 -4.88 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 119.754 -0.165 . . . . 10.86 111.177 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -40.93 68.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 5.34 110.452 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 104' ' ' ARG . 3.2 pp -78.73 160.3 27.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.229 -0.896 . . . . 6.97 111.424 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 mm -117.11 103.72 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.282 -0.417 . . . . 10.2 110.595 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -113.76 95.18 5.2 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.543 -1.263 . . . . 12.12 111.888 174.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 t -103.79 136.62 43.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.843 -1.526 . . . . 14.61 109.212 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.14 -113.13 4.18 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.343 -0.932 . . . . 15.52 112.018 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.8 28.16 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.268 0.84 . . . . 14.99 113.268 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -170.08 171.0 7.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.374 0.509 . . . . 15.2 112.374 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 1.8 m -121.89 155.3 35.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 9.26 111.767 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 36.5 mm -129.29 150.18 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.362 -0.836 . . . . 10.55 109.467 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -134.19 127.14 31.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.297 -0.26 . . . . 7.39 110.297 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 148' ' ' VAL . 4.1 mpp? -93.55 99.82 12.2 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.197 -0.668 . . . . 8.85 109.197 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.7 p -77.33 139.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.06 -0.973 . . . . 9.69 110.403 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -78.58 92.58 4.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.076 -0.511 . . . . 10.7 111.525 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 50.5 mttm -76.25 178.69 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 14.88 110.896 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.93 25.78 7.79 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.765 -0.934 . . . . 16.92 110.765 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.16 12.9 33.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.968 0.358 . . . . 18.56 111.968 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.16 16.76 36.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 15.62 113.159 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 115' ' ' LYS . . . 179.47 173.69 44.85 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.881 -0.888 . . . . 14.19 110.881 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 148' ' ' VAL . 54.3 m-85 -87.54 -176.54 5.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.991 0.424 . . . . 12.03 110.626 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 11.5 t70 -140.89 120.04 8.36 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.742 -0.663 . . . . 13.91 109.368 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.0 110.55 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.166 2.578 . . . . 12.35 112.537 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 125' ' ' VAL . 13.9 p -104.91 140.45 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.121 -0.945 . . . . 9.43 109.915 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.87 112.03 18.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 12.93 109.726 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 123' ' ' VAL . 23.2 m -117.03 163.31 14.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.662 -0.699 . . . . 8.03 111.23 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -100.68 133.85 44.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.582 -0.735 . . . . 10.39 109.219 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.56 103.14 4.48 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.964 -0.295 . . . . 8.3 111.43 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -152.88 69.89 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.142 -1.98 . . . . 10.1 113.633 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.37 163.85 37.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.49 -1.3 . . . . 10.61 107.49 154.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -143.61 130.41 20.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.787 0.722 . . . . 13.17 111.036 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.12 120.87 9.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 12.98 110.616 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.23 36.11 92.98 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.316 -0.469 . . . . 14.34 112.91 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 12.45 83.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.858 -0.687 . . . . 13.12 112.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -120.87 158.97 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.006 -0.368 . . . . 10.62 110.006 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 157.91 16.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.867 0.365 . . . . 7.82 110.045 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.992 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 32.0 mt-10 -106.78 115.33 30.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.474 0.654 . . . . 10.79 109.821 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.7 mm -81.67 104.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.974 -1.012 . . . . 6.73 109.154 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 3.0 mp -69.57 -44.97 69.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.607 -1.179 . . . . 8.79 110.562 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.59 158.13 44.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.779 -0.646 . . . . 10.44 111.327 -175.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.85 -53.31 0.64 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.287 -0.959 . . . . 8.87 114.529 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.436 HD21 HG11 ' A' ' 123' ' ' VAL . 18.0 mt -107.51 -170.9 1.77 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.434 0.531 . . . . 8.5 112.434 -174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.96 150.94 37.83 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.683 -0.689 . . . . 14.15 111.001 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.57 133.54 49.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.718 -1.128 . . . . 12.12 109.9 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.46 -2.3 53.65 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.244 -0.979 . . . . 11.54 111.575 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -104.05 143.57 32.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.254 -0.647 . . . . 11.24 109.254 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 22.9 mt-30 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.022 0.439 . . . . 10.49 111.593 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' ALA . 30.0 m -132.18 142.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 5.45 108.704 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.9 p -76.7 104.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.755 0.788 . . . . 6.56 110.956 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 N-CA-C 108.148 -1.056 . . . . 6.99 108.148 177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.467 0.397 0 CA-C-O 120.908 0.385 . . . . 11.84 110.582 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -152.18 91.18 1.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.533 0.568 . . . . 12.24 112.533 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.9 tp -115.78 -62.12 1.64 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.017 -1.105 . . . . 13.16 108.017 164.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.93 6.0 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.399 -1.334 . . . . 11.95 107.399 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.5 m-20 -83.44 35.65 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.71 -2.041 . . . . 11.22 111.537 -171.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -49.01 -49.08 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.364 0.875 . . . . 11.9 113.364 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -73.72 -26.4 60.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 11.17 110.002 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 156' ' ' ASP . . . -75.95 -20.96 57.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.173 -0.921 . . . . 7.82 111.432 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.2 m -69.22 -29.94 67.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.0 0.905 . . . . 9.64 109.244 172.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.23 -43.09 12.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.153 -1.385 . . . . 10.57 109.374 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 23.5 ttt180 -51.85 128.35 23.67 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.006 1.323 . . . . 8.9 112.891 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -117.85 31.16 5.81 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.43 -1.068 . . . . 7.15 110.43 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.6 p -70.71 126.27 29.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 123.924 0.426 . . . . 7.09 111.54 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 26' ' ' ARG . 48.2 t 54.21 82.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 9.2 111.332 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.64 0 CA-C-N 115.81 -0.632 . . . . 9.11 110.456 179.0 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 pttp . . . . . 0 N--CA 1.439 -1.014 0 CA-C-O 122.159 0.981 . . . . 10.38 109.725 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.564 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 29.7 mtm180 -132.47 135.35 45.98 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.276 -1.329 . . . . 8.37 109.045 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG12 ' OE1' ' A' ' 58' ' ' GLU . 34.7 mm -48.22 126.44 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 113.426 0.899 . . . . 5.76 113.426 -171.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.63 -34.73 5.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.824 -1.534 . . . . 8.22 109.821 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.691 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.5 p90 -168.92 -175.17 2.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.253 -0.43 . . . . 7.99 111.007 -174.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.43 153.68 43.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.707 -0.679 . . . . 5.61 111.666 -172.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB2' HE22 ' A' ' 38' ' ' GLN . 39.0 ptt180 -157.48 146.06 19.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.851 -0.613 . . . . 9.06 110.435 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.903 ' HB3' HG22 ' A' ' 35' ' ' VAL . 7.6 t0 -83.03 134.5 46.28 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 8.31 108.777 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.84 -22.53 62.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.233 2.622 . . . . 10.41 111.824 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.561 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -75.81 -22.22 56.56 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.895 -1.048 . . . . 10.85 110.647 178.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.3 m -128.3 50.33 5.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 121.529 0.681 . . . . 9.32 111.813 -166.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.78 119.59 6.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.187 2.591 . . . . 11.1 112.057 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.17 -30.53 4.08 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.414 -0.674 . . . . 10.31 111.414 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.642 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -70.55 136.43 49.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 9.21 109.797 174.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.86 98.97 5.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.122 -0.49 . . . . 11.51 110.749 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.691 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 m-85 -80.07 135.65 36.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.589 . . . . 7.5 111.017 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.98 -25.39 67.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.347 -0.842 . . . . 10.61 110.379 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -165.23 147.5 6.64 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-O 121.321 0.582 . . . . 10.91 110.531 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -51.61 128.92 27.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 125.139 3.893 . . . . 7.51 113.962 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.53 -161.71 11.49 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.232 -0.747 . . . . 7.59 111.232 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 25.8 ttpp -90.46 150.53 21.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.167 0.508 . . . . 11.68 109.979 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.8 t -65.82 135.13 95.34 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.211 -0.904 . . . . 9.2 110.138 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.83 -25.71 11.96 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.192 1.928 . . . . 10.25 111.626 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CD2' HG11 ' A' ' 35' ' ' VAL . 98.1 m-85 -77.53 -38.08 49.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.872 -1.058 . . . . 10.49 109.995 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -153.09 164.8 37.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.089 -0.505 . . . . 10.38 110.736 172.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 5.4 p-10 -82.69 76.69 9.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.748 1.018 . . . . 12.54 113.748 -170.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.1 ptm -143.14 141.02 18.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.757 -1.11 . . . . 9.87 108.036 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 17.8 Cg_endo -62.11 133.58 44.76 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.24 1.293 . . . . 9.51 109.512 172.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.0 mt -59.49 160.11 7.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.204 -0.453 . . . . 6.71 111.419 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.6 mm -95.67 132.58 27.1 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 7.89 109.657 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 90.6 Cg_endo -79.22 141.82 16.51 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 121.468 1.445 . . . . 5.77 112.797 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.04 158.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.585 -1.189 . . . . 5.96 113.326 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 21.85 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.948 2.099 . . . . 7.84 115.475 -177.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.592 ' OE1' HG12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -51.14 -37.75 48.0 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.776 1.274 . . . . 6.62 110.16 -176.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 CA--C 1.503 -0.852 0 CA-C-N 111.835 -2.438 . . . . 8.58 110.589 171.716 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.316 0.579 . . . . 11.64 109.72 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 148' ' ' VAL . 67.2 p -133.09 144.96 50.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.292 -0.867 . . . . 8.0 109.777 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.27 127.26 55.79 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.837 -0.801 . . . . 6.65 108.837 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.89 135.47 37.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.947 -0.39 . . . . 12.15 109.947 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 95' ' ' LEU . 75.8 t -59.89 128.84 21.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.713 -0.676 . . . . 9.71 112.416 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -135.24 148.41 49.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.501 -1.227 . . . . 11.03 109.005 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -78.9 147.73 32.97 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.965 -0.694 . . . . 12.76 109.453 169.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.361 -0.923 . . . . 13.25 112.811 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HG2' HD23 ' A' ' 86' ' ' LEU . 3.3 tt0 . . . . . 0 CA--C 1.513 -0.463 0 CA-C-O 121.071 0.463 . . . . 14.94 111.422 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -115.34 173.88 6.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 10.57 110.139 -175.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 84' ' ' VAL . 1.3 pt? -109.14 114.34 27.97 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.588 -0.893 . . . . 8.88 108.588 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -94.74 131.05 40.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.665 -1.152 . . . . 9.78 111.718 -166.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 137' ' ' ILE . 32.7 m -136.85 157.07 75.53 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.845 -1.07 . . . . 6.4 108.638 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.446 ' HG2' HG11 ' A' ' 149' ' ' VAL . 76.0 Cg_exo -52.49 129.31 31.38 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.738 1.626 . . . . 6.55 111.398 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 p -63.62 -22.91 67.15 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.451 0.643 . . . . 9.29 111.16 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -78.14 0.44 24.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.204 -0.907 . . . . 10.86 110.811 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -102.76 -1.37 30.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.775 -0.648 . . . . 5.34 112.598 -174.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -115.76 156.47 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 6.97 112.247 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.7 mm -101.46 124.36 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 10.2 109.982 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 18.8 mmm180 -96.18 125.48 40.73 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.868 -0.733 . . . . 12.12 110.452 173.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -149.13 137.16 20.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 14.61 110.556 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.4 -114.61 2.69 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 116.114 -0.494 . . . . 15.52 112.797 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.76 33.39 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.993 0.425 . . . . 14.99 111.394 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -179.21 7.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.163 -0.471 . . . . 15.2 111.381 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 10.7 m -131.43 152.51 50.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.922 -0.581 . . . . 9.26 110.392 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 25.3 mm -126.47 146.13 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.295 -0.261 . . . . 10.55 110.295 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -122.65 137.41 54.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.454 . . . . 7.39 109.989 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 45.2 mtm -92.85 99.93 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.722 -0.844 . . . . 8.85 108.722 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 121' ' ' ASP . 8.4 p -81.47 131.85 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.242 0.544 . . . . 9.69 110.696 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -86.87 91.31 8.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.59 -0.732 . . . . 10.7 110.417 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HD2' ' OD2' ' A' ' 121' ' ' ASP . 55.5 mttp -70.83 151.17 45.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 14.88 109.984 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.05 7.93 19.23 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 16.92 111.486 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -95.05 10.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.504 0.669 . . . . 18.56 110.973 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.64 75.16 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.163 -0.926 . . . . 15.62 113.613 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.24 25.84 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.482 -0.865 . . . . 14.19 112.441 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 40.5 m-85 -114.34 116.88 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.026 0.441 . . . . 12.03 109.933 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 113' ' ' VAL . 25.9 m-20 -106.17 141.89 23.71 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.882 -0.599 . . . . 13.91 110.323 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 60.2 Cg_endo -83.67 127.18 4.23 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.874 1.716 . . . . 12.35 112.742 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.74 124.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 9.43 109.321 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -72.57 127.09 31.49 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.149 -0.686 . . . . 12.93 109.149 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -135.68 151.69 30.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.794 0.807 . . . . 8.03 111.569 -173.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 25.3 ttmm -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.231 -1.349 . . . . 10.39 109.518 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.58 110.3 17.19 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 123.108 1.433 . . . . 8.3 112.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 138' ' ' LEU . . . -89.74 174.94 41.61 Favored Glycine 0 N--CA 1.411 -2.984 0 CA-C-N 111.25 -2.704 . . . . 10.1 110.718 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.17 161.32 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 126.07 1.748 . . . . 10.61 114.6 -167.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -100.88 139.24 36.86 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.312 -0.858 . . . . 13.17 108.721 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.84 111.99 4.64 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.851 0.358 . . . . 12.98 111.477 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.11 34.17 75.42 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.806 -0.712 . . . . 14.34 112.792 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.19 2.83 89.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.825 -0.703 . . . . 13.12 112.236 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -115.87 156.39 26.22 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.62 -0.511 . . . . 10.62 109.62 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 p -105.42 150.67 25.07 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.975 0.417 . . . . 7.82 111.326 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.79 100.51 11.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.925 -0.579 . . . . 10.79 109.619 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.74 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 20.3 mm -83.81 112.9 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 O-C-N 121.569 -0.707 . . . . 6.73 109.502 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -83.04 -47.45 11.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.177 -0.919 . . . . 8.79 110.288 -173.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -147.82 159.82 43.42 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.148 -0.686 . . . . 10.44 109.148 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 130.74 -61.28 0.67 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.046 -1.073 . . . . 8.87 112.318 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' A' ' 111' ' ' ALA . 26.5 mt -109.64 -170.83 1.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.262 0.553 . . . . 8.5 112.162 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -145.53 154.35 42.1 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.261 -0.882 . . . . 14.15 109.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.8 130.7 43.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.018 -0.992 . . . . 12.12 109.658 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.81 -1.51 38.86 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.721 -0.752 . . . . 11.54 111.232 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -103.57 139.21 39.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.55 -0.537 . . . . 11.24 109.55 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 48.2 mt-30 -91.03 138.72 31.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.891 0.377 . . . . 10.49 110.771 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.82 137.01 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.236 -0.438 . . . . 5.45 109.823 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 81' ' ' THR . 57.5 t -68.07 112.77 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.973 -0.558 . . . . 6.56 111.003 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' A' ' 98' ' ' PRO . 2.7 m . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.476 0.655 . . . . 6.99 109.995 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 121.405 0.622 . . . . 11.84 109.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -110.54 104.39 13.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.715 . . . . 12.24 109.506 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.84 63.5 4.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.521 0.677 . . . . 13.16 110.301 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 pt -131.47 40.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.216 -0.902 . . . . 11.95 109.732 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.45 -34.66 69.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.906 -0.588 . . . . 11.22 111.081 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.616 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 15.8 m -59.03 -58.36 9.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.657 -0.497 . . . . 11.9 109.657 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -56.61 -41.95 77.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.895 -1.048 . . . . 11.17 110.456 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -63.64 -33.88 76.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.151 -0.932 . . . . 7.82 111.733 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.3 t -72.94 -37.44 67.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.633 0.73 . . . . 9.64 109.818 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 157' ' ' SER . 79.2 mt -71.29 -38.89 71.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.739 -1.119 . . . . 10.57 111.151 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 31.7 ptt180 -80.0 -39.13 30.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.929 -0.578 . . . . 8.9 110.598 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.9 -57.17 5.02 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.196 -1.002 . . . . 7.15 111.943 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 1.3 p 45.16 67.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.173 0.589 . . . . 7.09 111.605 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 m 47.99 30.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.68 1.192 . . . . 9.2 112.946 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.25 0 CA-C-N 115.782 -0.644 . . . . 9.11 111.659 175.278 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.508 -0.667 0 N-CA-C 108.019 -1.104 . . . . 10.38 108.019 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HD3' ' OE1' ' A' ' 58' ' ' GLU . 13.1 mmt180 -133.57 140.52 47.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.922 -1.49 . . . . 8.37 109.74 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.873 HG12 ' OE2' ' A' ' 58' ' ' GLU . 23.6 mm -55.98 129.93 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 113.016 0.747 . . . . 5.76 113.016 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -113.23 -16.0 12.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.769 -1.105 . . . . 8.22 109.795 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 10.9 p90 167.44 179.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 7.99 110.359 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.765 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.7 m-90 -113.24 143.23 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.072 -0.967 . . . . 5.61 111.328 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.649 ' HB2' HE22 ' A' ' 38' ' ' GLN . 5.6 ptp180 -151.15 151.32 31.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 9.06 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.934 ' HB3' HG22 ' A' ' 35' ' ' VAL . 8.4 t70 -79.72 132.72 60.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.697 -0.853 . . . . 8.31 108.697 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -63.28 -13.71 37.53 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.095 1.863 . . . . 10.41 112.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.416 ' HE3' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -98.08 0.84 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.762 -0.199 . . . . 10.85 111.466 178.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 32' ' ' ASP . 10.9 m -129.62 48.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 121.351 0.596 . . . . 9.32 112.085 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.64 103.41 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.837 2.358 . . . . 11.1 113.245 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.5 -37.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 10.31 111.95 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.48 151.73 45.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.363 . . . . 9.21 110.198 177.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.658 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 2.6 tmm_? -136.35 98.83 3.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.6 -0.519 . . . . 11.51 109.6 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 42.1 m-85 -76.96 141.48 40.42 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.377 0.608 . . . . 7.5 110.972 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.7 -30.51 71.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.069 -1.423 . . . . 10.61 109.932 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 15.8 pttm -165.01 165.94 11.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.182 -0.917 . . . . 10.91 110.341 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.692 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -47.84 167.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.565 2.843 . . . . 7.51 113.654 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.08 -162.0 29.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.508 -0.853 . . . . 7.59 112.645 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.534 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.6 ttmt -103.48 140.63 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.05 -0.352 . . . . 11.68 110.05 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 49' ' ' MET . 22.6 t -65.38 142.37 98.4 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 9.2 110.649 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' CD ' ' HZ ' ' A' ' 40' ' ' PHE . 56.8 Cg_endo -79.16 -20.9 9.63 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.549 2.166 . . . . 10.25 111.33 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.473 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 53.0 m-85 -84.5 -39.64 18.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.218 -1.355 . . . . 10.49 109.726 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.552 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER -132.83 147.31 52.3 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.802 -0.635 . . . . 10.38 109.82 174.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.9 p-10 -77.82 58.23 1.84 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.084 0.945 . . . . 12.54 110.772 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 49' ' ' MET . 15.6 ptm -132.7 139.98 36.34 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.831 -1.077 . . . . 9.87 109.649 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 18.1 Cg_endo -60.58 134.17 52.95 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.522 2.148 . . . . 9.51 110.249 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 32' ' ' ASP . 1.4 mm? -56.65 157.3 5.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.803 -0.359 . . . . 6.71 110.367 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.97 129.76 28.97 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-O 121.272 0.558 . . . . 7.89 109.872 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 95.4 Cg_endo -82.12 138.66 10.25 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 121.842 1.695 . . . . 5.77 112.797 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 32.0 m -56.19 157.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.198 -1.365 . . . . 5.96 112.454 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.14 -72.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.453 2.301 . . . . 7.84 116.434 -177.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.873 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.6 pt-20 -59.47 -32.71 70.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.458 0.647 . . . . 6.62 110.065 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 13.8 pt-20 . . . . . 0 C--N 1.316 -0.872 0 CA-C-N 113.445 -1.707 . . . . 8.58 112.458 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.661 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 89.2 mtm180 . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 111.397 0.147 . . . . 11.64 111.397 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 80.7 p -156.39 170.63 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.957 0.786 . . . . 8.0 111.18 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.49 141.41 18.19 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.401 -1.333 . . . . 6.65 107.401 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 44.2 tt0 -97.21 136.46 37.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.616 -0.434 . . . . 12.15 110.744 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 145' ' ' GLN . 75.6 t -62.38 134.23 27.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.612 -0.722 . . . . 9.71 111.3 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -163.47 140.01 7.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.594 -1.185 . . . . 11.03 109.818 174.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.72 163.19 28.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.048 -0.978 . . . . 12.76 111.146 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 13.25 112.448 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 110.287 -0.264 . . . . 14.94 110.287 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG3' ' OE1' ' A' ' 136' ' ' GLU . 22.9 mmt85 -129.77 155.26 46.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.084 -0.339 . . . . 10.57 110.084 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.6 mm? -91.44 113.76 26.11 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.73 -0.841 . . . . 8.88 108.73 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.86 130.58 34.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.809 -0.356 . . . . 9.78 111.045 -175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.78 155.03 63.21 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.56 -0.904 . . . . 6.4 108.56 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.89 137.19 78.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.922 1.748 . . . . 6.55 111.046 174.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 23.6 t -62.43 -25.21 67.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.988 0.366 . . . . 9.29 111.988 -173.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.07 11.76 22.03 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.588 -0.445 . . . . 10.86 111.335 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.8 -33.14 35.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.06 0.457 . . . . 5.34 111.29 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -101.51 165.63 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 6.97 112.194 -170.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 28.7 mm -109.29 117.49 54.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.601 -0.727 . . . . 10.2 109.829 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -91.07 125.32 35.82 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.834 -0.747 . . . . 12.12 110.554 173.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -145.79 122.7 11.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.871 -0.604 . . . . 14.61 110.689 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.64 -108.01 1.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.745 -0.661 . . . . 15.52 112.848 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.77 24.62 10.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 14.99 111.732 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.62 179.69 8.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 15.2 111.692 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.563 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 58.1 m -134.68 150.96 50.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.862 -0.608 . . . . 9.26 110.831 -173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -119.63 146.23 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.871 -0.418 . . . . 10.55 109.871 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.577 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.237 -0.282 . . . . 7.39 110.237 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 81.7 mmm -106.56 98.1 7.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.208 -0.451 . . . . 8.85 109.999 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -88.1 142.07 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.005 0.431 . . . . 9.69 111.419 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 86.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 10.7 110.479 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.433 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 33.6 tttp -72.44 153.62 41.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.245 -0.888 . . . . 14.88 110.422 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.05 -2.04 51.1 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.945 -0.571 . . . . 16.92 112.998 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.18 17.47 10.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 18.56 111.077 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.12 11.34 85.21 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.618 -0.719 . . . . 15.62 112.785 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.9 -158.09 8.7 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.836 -0.697 . . . . 14.19 111.84 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 64.5 m-85 -128.11 124.34 36.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.376 0.608 . . . . 12.03 110.154 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 113' ' ' VAL . 10.2 t70 -101.13 117.4 62.37 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.041 -0.982 . . . . 13.91 110.314 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 72.7 Cg_endo -83.1 112.09 1.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.83 3.02 . . . . 12.35 113.458 -172.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 125' ' ' VAL . 9.5 p -105.21 142.83 17.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.423 -0.808 . . . . 9.43 110.404 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -82.23 123.41 29.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.156 0.503 . . . . 12.93 109.699 171.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -135.76 163.08 35.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.707 -0.679 . . . . 8.03 110.974 -172.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.424 ' N ' HG23 ' A' ' 125' ' ' VAL . 77.9 tttt -98.82 126.21 44.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.936 -0.575 . . . . 10.39 110.243 172.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.92 108.08 4.98 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.663 -0.699 . . . . 8.3 111.444 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.17 70.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.759 -2.162 . . . . 10.1 114.674 168.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.67 161.92 41.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.957 -0.757 . . . . 10.61 108.957 153.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.17 127.62 26.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.928 -0.397 . . . . 13.17 109.928 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.32 125.21 11.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.339 -0.391 . . . . 12.98 111.595 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.79 35.99 88.39 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.934 -0.576 . . . . 14.34 113.288 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.51 7.9 87.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.941 -0.647 . . . . 13.12 112.163 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.66 170.51 10.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.555 . . . . 10.62 109.503 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 13.3 p -122.36 156.51 33.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.741 0.305 . . . . 7.82 110.53 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 52.8 mt-10 -99.16 118.48 35.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.369 0.604 . . . . 10.79 110.853 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 125' ' ' VAL . 22.9 mm -85.37 103.79 12.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.096 -0.956 . . . . 6.73 108.615 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.4 mp -70.73 -46.63 62.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.926 -1.034 . . . . 8.79 109.805 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 125' ' ' VAL . 97.9 mt-10 -143.1 161.12 39.04 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.949 -0.569 . . . . 10.44 109.63 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.31 -60.36 0.59 Allowed Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.02 -1.086 . . . . 8.87 113.585 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.546 HD21 HG11 ' A' ' 123' ' ' VAL . 47.6 mt -110.44 -176.61 3.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.899 0.703 . . . . 8.5 112.899 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -143.78 157.32 44.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.792 -1.095 . . . . 14.15 109.201 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.32 129.83 41.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.296 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.21 -8.69 35.81 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.179 -0.768 . . . . 11.54 111.179 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.6 mm-40 -91.12 100.32 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.507 0.67 . . . . 11.24 109.64 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.4 mt-30 -74.72 135.32 41.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.14 -0.936 . . . . 10.49 110.58 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.5 m -129.75 136.62 58.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.717 -0.475 . . . . 5.45 109.717 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 2.8 p -61.25 119.09 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.872 0.693 . . . . 6.56 112.872 -171.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 147' ' ' VAL . 2.7 m . . . . . 0 CA--C 1.543 0.683 0 N-CA-C 112.233 0.457 . . . . 6.99 112.233 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 108.468 -0.938 . . . . 11.84 108.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.4 171.38 10.13 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.727 -0.389 . . . . 12.24 110.171 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.64 175.27 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.597 0.713 . . . . 13.16 112.747 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.549 ' C ' ' HB2' ' A' ' 159' ' ' ALA . 6.2 pt -114.57 77.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.607 0.718 . . . . 11.95 110.281 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -84.46 -100.44 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.359 -0.837 . . . . 11.22 111.459 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.0 p -83.36 -36.43 24.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 11.9 110.082 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 18.3 tt0 -66.07 -18.95 65.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.056 -0.975 . . . . 11.17 109.904 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 155' ' ' ILE . . . -45.16 -58.33 3.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.008 -0.996 . . . . 7.82 112.156 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -66.06 -29.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.678 0.752 . . . . 9.64 110.963 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 158' ' ' GLU . 46.8 mt -72.59 -28.04 62.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.684 -1.144 . . . . 10.57 110.94 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 71.9 mtt180 -92.73 -54.15 3.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.063 -0.971 . . . . 8.9 111.024 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 56.21 56.33 24.8 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.385 -0.686 . . . . 7.15 111.385 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 41.7 p -62.19 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.261 0.467 . . . . 7.09 112.261 -171.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.44 47.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.623 0.725 . . . . 9.2 109.344 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.752 -0.658 . . . . 9.11 111.421 -176.401 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.507 ' HA ' ' CD2' ' A' ' 57' ' ' TYR . 17.3 pttt . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 122.472 1.13 . . . . 10.38 112.101 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.598 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 19.8 mtm180 -141.31 142.17 33.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.309 -1.769 . . . . 8.37 108.281 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.703 HG12 ' CD ' ' A' ' 58' ' ' GLU . 25.5 mm -51.95 112.8 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 113.213 0.82 . . . . 5.76 113.213 -169.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -100.9 -31.9 10.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.007 -1.452 . . . . 8.22 109.734 172.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.0 p90 -175.02 -174.58 0.78 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.24 0.543 . . . . 7.99 112.089 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 m-90 -123.23 148.62 45.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 114.966 -1.015 . . . . 5.61 110.701 -174.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.602 ' HB2' HE22 ' A' ' 38' ' ' GLN . 29.5 ptt180 -148.22 152.53 37.36 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.472 0.482 . . . . 9.06 111.112 -176.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.804 ' HB2' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -76.66 139.37 66.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.791 -1.188 . . . . 8.31 107.791 163.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.584 ' CG ' HD12 ' A' ' 54' ' ' ILE . 44.7 Cg_exo -57.87 -15.49 22.02 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.865 2.377 . . . . 10.41 110.647 164.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -28.85 39.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 113.772 -1.558 . . . . 10.85 111.476 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 18.2 m -123.57 51.42 4.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.77 0.656 . . . . 9.32 112.77 -164.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.0 114.3 2.93 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.212 2.608 . . . . 11.1 112.317 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.09 -25.52 3.5 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.26 -0.736 . . . . 10.31 111.26 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.644 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -70.94 171.59 10.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.118 -0.541 . . . . 9.21 109.926 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -150.12 91.27 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.2 -0.667 . . . . 11.51 109.2 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 70.8 m-85 -71.07 141.86 50.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.298 0.571 . . . . 7.5 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.18 -30.43 71.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.821 -1.081 . . . . 10.61 111.668 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 13.2 ptmm? -167.33 163.29 10.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 119.29 -0.386 . . . . 10.91 111.279 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -49.72 170.89 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.781 2.988 . . . . 7.51 113.859 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.69 -163.34 26.91 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.302 -0.719 . . . . 7.59 111.302 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 51' ' ' MET . 38.9 ttpt -94.33 147.74 22.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.203 0.501 . . . . 11.68 110.242 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.2 t -66.1 139.07 96.4 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.413 -0.812 . . . . 9.2 111.226 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 -21.95 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.791 2.328 . . . . 10.25 111.957 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' A' ' 35' ' ' VAL . 33.2 m-85 -78.66 -39.02 38.08 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.865 -1.061 . . . . 10.49 109.769 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -156.94 166.55 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.454 -0.794 . . . . 10.38 109.105 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 8.3 p-10 -78.33 80.96 4.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 12.54 112.27 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 4.4 ptm -134.99 146.04 56.96 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.737 -1.579 . . . . 9.87 106.737 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.43 132.74 18.06 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 N-CA-C 108.234 -1.487 . . . . 9.51 108.234 165.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.28 161.73 18.86 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.165 -0.614 . . . . 6.71 110.964 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 33' ' ' PRO . 22.0 mt -110.08 132.35 21.49 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 109.571 -0.529 . . . . 7.89 109.571 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.667 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 39.9 Cg_endo -76.85 133.4 13.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 120.983 1.122 . . . . 5.77 112.749 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.28 157.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.07 -1.423 . . . . 5.96 113.245 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 21.58 -89.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.285 1.834 . . . . 7.84 114.893 -177.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.703 ' CD ' HG12 ' A' ' 27' ' ' ILE . 1.2 pt-20 -45.63 -40.69 9.32 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.091 0.556 . . . . 6.62 110.13 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 41.8 tt0 . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 114.904 -1.044 . . . . 8.58 110.541 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.565 ' NH1' ' HB3' ' A' ' 156' ' ' ASP . 53.7 ttt180 . . . . . 0 CA--C 1.515 -0.368 0 CA-C-O 121.67 0.748 . . . . 11.64 110.419 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 148' ' ' VAL . 75.9 p -128.47 159.16 36.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.529 -1.214 . . . . 8.0 109.212 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.434 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -119.49 126.5 51.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.693 -0.854 . . . . 6.65 108.693 171.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 28.0 tt0 -75.92 131.44 39.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.146 -0.687 . . . . 12.15 109.146 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 95' ' ' LEU . 41.3 t -55.64 132.02 19.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.94 0.718 . . . . 9.71 112.94 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 49.0 mmtt -136.41 140.46 43.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.607 -1.179 . . . . 11.03 109.429 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.2 157.9 36.88 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.954 -0.698 . . . . 12.76 109.496 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.704 0 C-N-CA 119.74 -1.219 . . . . 13.25 113.862 -178.303 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.148 0.499 . . . . 14.94 110.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 35.8 mmt180 -118.72 163.83 16.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.675 -0.693 . . . . 10.57 110.339 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.2 mm? -97.9 114.17 26.18 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.066 -0.716 . . . . 8.88 109.066 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.49 129.79 36.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.189 0.519 . . . . 9.78 110.99 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.82 157.22 68.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.895 -1.048 . . . . 6.4 109.17 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.97 131.25 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.817 1.678 . . . . 6.55 110.356 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -30.12 53.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.312 -0.404 . . . . 9.29 111.32 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.9 -8.34 57.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.624 0.231 . . . . 10.86 111.624 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -72.02 -41.32 67.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.433 0.635 . . . . 5.34 110.942 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -93.96 163.78 13.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.141 -0.936 . . . . 6.97 112.613 -169.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' THR . 22.7 mm -111.68 103.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 10.2 109.229 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 13.3 ptt180 -103.01 132.54 49.2 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 117.969 -1.493 . . . . 12.12 110.985 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -151.36 133.92 15.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.709 -1.587 . . . . 14.61 109.133 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.18 -113.63 6.06 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.352 -0.928 . . . . 15.52 111.952 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 34.99 5.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.85 0.315 . . . . 14.99 111.85 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.408 HH11 HD11 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -164.41 178.63 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.901 0.382 . . . . 15.2 111.801 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.3 m -136.68 158.55 44.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.749 -0.66 . . . . 9.26 110.431 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.408 HD11 HH11 ' A' ' 108' ' ' ARG . 25.1 mm -131.22 147.75 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 10.55 109.899 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.574 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.34 127.31 27.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.517 -0.31 . . . . 7.39 110.296 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.411 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 33.2 ttp -87.59 103.19 15.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.27 -0.641 . . . . 8.85 109.27 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 12.6 p -89.64 135.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 9.69 112.575 -170.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -76.01 90.28 3.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.359 -0.837 . . . . 10.7 109.672 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -85.38 152.84 22.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.425 . . . . 14.88 110.499 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.05 1.76 10.24 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.106 -0.497 . . . . 16.92 113.328 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -90.93 8.64 34.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.33 0.586 . . . . 18.56 111.062 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.19 6.45 86.34 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.29 -0.868 . . . . 15.62 112.512 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.78 156.18 19.99 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.985 -0.626 . . . . 14.19 111.567 -174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 82.5 m-85 -107.3 109.46 21.23 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.766 -0.457 . . . . 12.03 109.766 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -106.74 142.96 26.08 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 120.405 -0.518 . . . . 13.91 111.231 -172.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.66 121.28 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.281 1.987 . . . . 12.35 111.93 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 111' ' ' ALA . 5.7 p -105.43 137.29 35.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.667 -0.697 . . . . 9.43 109.663 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.93 119.95 19.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.1 -0.704 . . . . 12.93 109.1 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.06 155.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.695 -0.684 . . . . 8.03 110.918 -176.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 139' ' ' GLU . 38.5 ttmt -101.78 128.47 48.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.904 -0.776 . . . . 10.39 108.904 171.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.92 104.55 4.7 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.452 -0.34 . . . . 8.3 110.74 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.77 70.34 0.31 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.867 -2.111 . . . . 10.1 113.866 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 161.32 42.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.305 -1.368 . . . . 10.61 107.305 151.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.0 m -141.5 128.88 21.19 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 118.38 0.537 . . . . 13.17 110.081 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.61 8.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.592 -0.731 . . . . 12.98 110.847 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.43 38.22 96.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.362 -0.447 . . . . 14.34 112.704 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.58 9.76 84.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.649 . . . . 13.12 112.434 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -120.32 164.24 16.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.165 -0.309 . . . . 10.62 110.165 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -117.31 158.34 24.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.935 0.398 . . . . 7.82 110.883 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 57.7 mt-10 -101.7 124.82 47.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.454 0.645 . . . . 10.79 110.828 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 125' ' ' VAL . 23.9 mm -89.76 114.63 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 114.934 -1.03 . . . . 6.73 109.55 175.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.2 mp -87.73 -45.5 10.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.648 -1.16 . . . . 8.79 109.677 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -134.67 164.71 26.9 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.974 -1.121 . . . . 10.44 107.974 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.533 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 111.99 -62.49 0.3 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.275 -1.44 . . . . 8.87 113.722 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.64 -173.26 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.236 0.541 . . . . 8.5 112.455 -174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.9 ttmt -157.58 158.36 35.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 14.15 108.528 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 128.84 37.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.888 -0.596 . . . . 12.12 110.31 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.08 -10.3 40.08 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.444 -0.662 . . . . 11.54 111.444 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.9 mm100 -93.69 121.17 34.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.119 -0.697 . . . . 11.24 109.119 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.695 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 28.5 mt-30 -97.49 125.06 41.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.941 -0.572 . . . . 10.49 111.114 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.75 138.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.852 -0.613 . . . . 5.45 109.673 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 m -62.94 120.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.36 0.6 . . . . 6.56 111.136 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 101' ' ' ALA . 3.4 m . . . . . 0 C--N 1.318 -0.78 0 CA-C-N 115.476 -0.784 . . . . 6.99 110.484 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.457 -0.088 0 N-CA-C 112.319 0.489 . . . . 11.84 112.319 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -100.26 -27.74 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.478 -0.934 . . . . 12.24 108.478 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.17 137.47 36.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.833 -1.076 . . . . 13.16 108.839 177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 157' ' ' SER . 47.0 mt -54.07 108.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.001 0.429 . . . . 11.95 111.228 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.565 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 4.0 p30 -84.17 17.44 2.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.255 -0.43 . . . . 11.22 111.84 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 155' ' ' ILE . 70.7 m -64.52 -17.35 63.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.72 -0.218 . . . . 11.9 111.519 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 41.4 mt-10 -58.45 -46.87 85.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.252 -0.647 . . . . 11.17 109.252 171.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.73 -27.89 68.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 7.82 110.794 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 16.0 m -62.57 -39.0 92.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.581 0.705 . . . . 9.64 110.017 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -47.77 14.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.883 -1.053 . . . . 10.57 111.638 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 53.3 mtt180 -71.49 -36.24 71.07 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.592 0.711 . . . . 8.9 110.948 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.75 105.74 3.03 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.606 -1.179 . . . . 7.15 110.782 -171.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.9 p -49.71 -54.03 21.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 7.09 111.061 175.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.86 -48.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.818 -0.628 . . . . 9.2 109.491 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.163 0 CA-C-N 115.62 -0.718 . . . . 9.11 111.658 178.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.054 0 CA-C-O 122.507 1.146 . . . . 10.38 108.244 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 82.3 mtt180 -124.25 138.75 54.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.484 -1.235 . . . . 8.37 109.946 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.691 HG12 ' OE2' ' A' ' 58' ' ' GLU . 33.5 mm -48.72 127.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 114.369 -1.287 . . . . 5.76 114.18 -167.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.86 -38.77 3.84 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.504 -1.68 . . . . 8.22 110.029 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.759 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.0 p90 -176.51 -172.81 0.48 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.929 -0.578 . . . . 7.99 110.402 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.738 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m-90 -124.01 150.36 44.96 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.462 -0.79 . . . . 5.61 110.751 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.436 ' HB2' HE22 ' A' ' 38' ' ' GLN . 24.7 ptt180 -153.5 145.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.297 -0.41 . . . . 9.06 111.596 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.6 t0 -79.34 130.6 68.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.909 -1.145 . . . . 8.31 107.909 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.514 ' HG3' HD12 ' A' ' 54' ' ' ILE . 21.6 Cg_exo -61.17 -14.43 33.75 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 122.023 1.815 . . . . 10.41 112.293 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.11 2.06 52.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.473 -0.331 . . . . 10.85 111.193 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.9 m -129.1 39.35 0.5 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.624 0.601 . . . . 9.32 112.624 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -60.42 128.71 26.96 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.519 2.146 . . . . 11.1 112.579 -174.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.01 -6.45 19.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 10.31 111.618 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -89.95 -179.54 5.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.456 -0.372 . . . . 9.21 110.082 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.501 ' HD2' ' CE2' ' A' ' 29' ' ' TYR . 8.1 tpt180 -142.03 108.63 5.34 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.192 -0.203 . . . . 11.51 110.455 171.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.759 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -96.84 121.02 38.24 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.631 -0.828 . . . . 7.5 109.098 170.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.47 -35.3 78.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.958 -0.565 . . . . 10.61 110.125 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -147.86 149.39 33.06 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 121.78 0.8 . . . . 10.91 111.071 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.738 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 14.5 Cg_endo -52.77 142.38 51.49 Favored 'Trans proline' 0 C--N 1.348 0.515 1 C-N-CA 125.398 4.065 . . . . 7.51 114.027 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.8 -156.0 17.71 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.828 -0.624 . . . . 7.59 111.594 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 23.1 ttmt -98.1 143.56 28.51 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.093 -0.706 . . . . 11.68 109.093 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.7 t -66.83 132.66 93.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.309 -0.405 . . . . 9.2 110.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.71 -29.4 24.15 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 10.25 111.491 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.556 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.8 m-85 -70.38 -37.75 74.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.561 -1.2 . . . . 10.49 110.581 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.546 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.4 OUTLIER -156.99 153.62 28.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.678 -0.49 . . . . 10.38 109.678 169.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 3.7 m-20 -74.42 76.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 12.54 112.447 -173.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -140.28 145.15 40.17 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.491 -0.929 . . . . 9.87 108.491 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.4 Cg_exo -65.97 132.32 29.83 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.748 1.632 . . . . 9.51 110.208 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -61.37 160.09 11.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.342 -0.39 . . . . 6.71 110.303 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 33' ' ' PRO . 6.0 mt -104.6 133.59 20.1 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.947 0.403 . . . . 7.89 110.006 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.617 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 86.9 Cg_endo -77.71 152.07 28.87 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.766 1.644 . . . . 5.77 112.447 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 m -74.44 157.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.513 -1.221 . . . . 5.96 112.051 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.37 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.056 2.143 . . . . 7.84 115.701 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.691 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -52.81 -42.01 64.7 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.605 0.362 . . . . 6.62 110.386 -176.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 85.5 mt-10 . . . . . 0 C--N 1.316 -0.875 0 CA-C-O 121.846 0.831 . . . . 8.58 112.507 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 108.937 -0.764 . . . . 11.64 108.937 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 148' ' ' VAL . 33.1 p -130.13 148.19 51.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.575 -0.284 . . . . 8.0 110.661 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.435 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.91 136.08 54.73 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 6.65 109.433 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.428 ' OE1' ' HE2' ' A' ' 85' ' ' LYS . 41.2 tt0 -76.57 141.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.226 -0.443 . . . . 12.15 110.161 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 143' ' ' ALA . 97.1 t -67.89 131.34 33.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.776 0.798 . . . . 9.71 111.936 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' OE1' ' A' ' 83' ' ' GLU . 27.8 mmtp -127.3 155.4 43.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.237 -1.347 . . . . 11.03 109.114 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -90.38 165.58 13.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.395 -0.595 . . . . 12.76 109.395 165.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.5 0 C-N-CA 119.819 -1.181 . . . . 13.25 113.688 179.467 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.453 ' HG2' HD23 ' A' ' 86' ' ' LEU . 2.6 mt-10 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.644 0.259 . . . . 14.94 110.4 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.638 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 36.5 mmt180 -125.8 157.57 37.17 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.924 -0.31 . . . . 10.57 110.739 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.0 mm? -94.12 126.8 39.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.904 -0.776 . . . . 8.88 108.904 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.21 129.02 50.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.221 -0.445 . . . . 9.78 109.882 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.69 157.13 65.68 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.912 -1.04 . . . . 6.4 108.842 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.79 128.33 29.16 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.523 1.482 . . . . 6.55 110.631 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.506 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 50.8 p -54.43 -25.76 26.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.645 0.609 . . . . 9.29 112.645 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.45 12.12 21.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.825 -0.35 . . . . 10.86 111.526 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -85.43 -28.78 24.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.364 0.602 . . . . 5.34 110.338 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -99.68 158.73 15.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.799 -0.637 . . . . 6.97 111.572 -174.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 40.8 mm -104.02 123.67 57.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.203 -0.908 . . . . 10.2 110.356 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 20.4 mmm180 -95.26 121.81 37.3 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.592 -0.843 . . . . 12.12 110.629 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 t -149.5 143.49 25.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.713 -0.676 . . . . 14.61 110.605 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.67 -115.71 4.13 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 116.225 -0.443 . . . . 15.52 112.666 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.42 36.94 4.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 14.99 110.94 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -155.48 -177.98 6.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.107 0.48 . . . . 15.2 111.933 -175.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 19.1 m -131.74 147.19 52.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.529 -0.76 . . . . 9.26 109.399 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 22.6 mm -126.64 149.82 31.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 10.55 109.968 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.59 123.54 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.205 -0.294 . . . . 7.39 110.205 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 43.6 mtm -86.7 100.38 12.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.179 -0.674 . . . . 8.85 109.179 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 14.9 p -82.72 136.47 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.497 -0.774 . . . . 9.69 110.98 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.89 83.23 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.464 -0.939 . . . . 10.7 108.464 173.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -77.99 150.93 33.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.018 -0.992 . . . . 14.88 111.083 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.37 -5.88 18.56 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.566 -0.743 . . . . 16.92 113.15 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -73.32 -10.44 59.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 18.56 110.19 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.21 31.15 26.23 Favored Glycine 0 C--N 1.31 -0.866 0 C-N-CA 119.947 -1.121 . . . . 15.62 111.374 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.97 163.76 31.51 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 111.242 -0.743 . . . . 14.19 111.242 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.2 m-85 -97.27 112.44 24.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.806 0.336 . . . . 12.03 110.204 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.0 t70 -101.51 139.62 20.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.893 -0.594 . . . . 13.91 109.538 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -86.16 122.24 2.13 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.045 1.83 . . . . 12.35 112.971 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.53 121.52 59.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.177 -0.92 . . . . 9.43 110.167 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.24 121.1 20.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.849 -0.797 . . . . 12.93 108.849 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.17 153.26 38.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.742 0.782 . . . . 8.03 112.059 -173.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.2 ttmm -93.83 129.75 40.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.232 -1.349 . . . . 10.39 109.475 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.77 112.97 20.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.116 1.436 . . . . 8.3 112.261 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 136' ' ' GLU . . . -89.44 174.36 41.52 Favored Glycine 0 N--CA 1.41 -3.062 0 CA-C-N 111.364 -2.653 . . . . 10.1 111.177 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.38 162.35 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 112.367 -1.917 . . . . 10.61 114.683 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -106.7 133.17 51.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.219 -0.9 . . . . 13.17 109.248 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.24 119.82 9.13 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.055 -0.52 . . . . 12.98 111.261 -174.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.17 29.58 75.19 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.183 -0.532 . . . . 14.34 112.544 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.46 89.7 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.633 -0.794 . . . . 13.12 112.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -116.53 153.8 31.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.077 -0.342 . . . . 10.62 110.077 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 70.5 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.091 0.472 . . . . 7.82 111.387 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB2' ' C ' ' A' ' 128' ' ' GLY . 24.7 mt-10 -85.51 107.85 17.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.586 -0.733 . . . . 10.79 109.65 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 125' ' ' VAL . 23.2 mm -92.41 114.1 28.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 O-C-N 121.245 -0.909 . . . . 6.73 110.31 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.638 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.4 mp -86.6 -47.8 8.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.293 -1.321 . . . . 8.79 110.795 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mt-10 -144.29 167.25 22.9 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.052 -0.722 . . . . 10.44 109.052 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 114.51 -74.11 0.24 Allowed Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.631 -1.271 . . . . 8.87 113.413 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 61.5 tp -97.66 178.09 5.28 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.694 -0.253 . . . . 8.5 110.998 -168.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.486 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 26.3 tptp -137.62 148.84 46.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.4 0.619 . . . . 14.15 112.124 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.496 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . . . -68.15 143.45 55.39 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 114.439 -1.255 . . . . 12.12 110.802 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 1.34 85.95 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.524 -0.846 . . . . 11.54 112.124 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -103.8 152.69 21.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.552 -0.536 . . . . 11.24 109.552 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 69.4 mt-30 -97.46 140.07 32.44 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 120.929 0.395 . . . . 10.49 111.295 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -134.71 143.99 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.152 -0.477 . . . . 5.45 109.961 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.1 m -67.75 129.58 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.436 0.636 . . . . 6.56 111.365 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.6 m . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 122.346 1.069 . . . . 6.99 108.978 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.51 -0.552 . . . . 11.84 109.51 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.445 ' CD1' HG22 ' A' ' 155' ' ' ILE . 2.7 p90 -159.34 173.38 16.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.548 -0.296 . . . . 12.24 110.805 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.23 61.91 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 13.16 111.494 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 153' ' ' PHE . 12.8 tt -149.31 2.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.777 0.798 . . . . 11.95 109.416 171.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 10.3 p-10 -72.76 -16.41 61.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 11.22 110.651 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p -57.42 -43.14 83.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 11.9 109.556 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 38.8 tt0 -76.11 -36.52 58.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.251 -0.886 . . . . 11.17 108.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -59.97 -27.77 67.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.27 -1.332 . . . . 7.82 111.519 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 164' ' ' THR . 32.5 t -79.0 -37.92 38.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 9.64 110.496 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.96 -26.9 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.747 0.277 . . . . 10.57 111.747 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 11.2 ptp180 -74.62 2.46 9.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.136 0.421 . . . . 8.9 112.136 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.47 13.18 8.3 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.462 -0.875 . . . . 7.15 112.342 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 26.1 p 52.75 -97.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.672 0.789 . . . . 7.09 112.153 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' VAL . 5.7 p -74.67 84.85 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.855 0.836 . . . . 9.2 109.65 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.251 -0.886 . . . . 9.11 111.534 -176.381 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.88 0 CA-C-O 122.56 1.171 . . . . 10.38 109.809 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.487 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 77.6 mtm180 -119.54 143.32 47.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.127 -1.397 . . . . 8.37 109.87 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.571 HG12 ' OE2' ' A' ' 58' ' ' GLU . 31.1 mm -49.23 120.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 114.286 -1.324 . . . . 5.76 112.824 -169.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.5 -35.06 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.963 -1.471 . . . . 8.22 110.298 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.429 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 44.0 p90 -176.15 -173.54 0.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.858 -0.61 . . . . 7.99 109.387 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.731 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.15 154.11 41.99 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.105 -0.498 . . . . 5.61 111.599 -175.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -156.51 150.64 25.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.389 -0.823 . . . . 9.06 110.415 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.3 t0 -82.72 134.69 46.89 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.705 -1.221 . . . . 8.31 107.705 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -62.67 -13.27 32.88 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.113 1.875 . . . . 10.41 111.967 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.68 1.75 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 10.85 111.108 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -129.22 36.3 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 112.965 0.728 . . . . 9.32 112.965 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.8 Cg_endo -54.81 119.14 5.98 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.343 2.028 . . . . 11.1 112.517 -172.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.23 -21.0 6.97 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.889 -0.884 . . . . 10.31 110.889 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.511 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -85.0 115.42 22.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.25 -0.475 . . . . 9.21 110.635 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 47.9 ttt180 -99.73 102.8 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.343 0.592 . . . . 11.51 110.197 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 82.9 m-85 -76.74 146.84 37.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 7.5 109.801 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.65 -27.7 69.4 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.128 -1.397 . . . . 10.61 110.323 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.9 pttm -169.79 165.94 5.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.386 -0.825 . . . . 10.91 110.355 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.731 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.6 Cg_endo -51.25 168.63 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.113 2.542 . . . . 7.51 113.104 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.66 -159.94 28.21 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.67 -0.776 . . . . 7.59 112.036 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.1 ttmt -98.44 147.47 24.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.24 -0.281 . . . . 11.68 110.24 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 p -70.68 128.77 90.64 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.558 -0.292 . . . . 9.2 111.462 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.65 -22.94 17.45 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.827 1.684 . . . . 10.25 110.507 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.558 ' CD2' HG11 ' A' ' 35' ' ' VAL . 97.8 m-85 -72.57 -24.98 61.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.759 -1.109 . . . . 10.49 110.949 -175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.24 -104.38 0.13 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.737 -0.785 . . . . 10.38 112.616 167.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -166.55 58.17 0.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.313 0.578 . . . . 12.54 111.596 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.3 ptm -133.36 149.9 73.7 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.626 -0.509 . . . . 9.87 109.626 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -66.41 131.8 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.545 1.496 . . . . 9.51 109.772 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 mt -60.59 160.04 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.699 0.625 . . . . 6.71 110.756 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.1 mm -99.4 130.73 26.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.212 -0.662 . . . . 7.89 109.212 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 58.2 Cg_endo -73.46 146.07 38.95 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 121.389 1.393 . . . . 5.77 112.145 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 31.3 m -68.81 159.69 5.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.269 -1.332 . . . . 5.96 112.251 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.487 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.87 -74.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.526 2.33 . . . . 7.84 116.216 -178.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -61.63 -38.86 89.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.669 1.223 . . . . 6.62 111.93 -168.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 50.2 mt-10 . . . . . 0 CA--C 1.501 -0.908 0 CA-C-N 111.865 -2.425 . . . . 8.58 112.291 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 . . . . . 0 CA--C 1.513 -0.453 0 N-CA-C 109.737 -0.468 . . . . 11.64 109.737 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 148' ' ' VAL . 76.6 p -139.05 143.11 38.24 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.739 -0.664 . . . . 8.0 109.484 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -108.43 127.75 54.18 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.435 -0.58 . . . . 6.65 109.435 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 34.4 tt0 -73.1 139.24 46.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.888 -0.596 . . . . 12.15 109.932 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -61.74 135.32 26.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.278 -0.874 . . . . 9.71 111.727 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 28.2 mmtp -131.11 156.51 45.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.602 -1.181 . . . . 11.03 109.693 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.43 143.79 27.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.497 -0.557 . . . . 12.76 109.497 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.604 0 C-N-CA 119.702 -1.237 . . . . 13.25 112.678 178.523 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 121.198 0.523 . . . . 14.94 111.762 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 138' ' ' LEU . 1.5 mpp_? -119.61 156.74 29.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.829 -1.078 . . . . 10.57 109.118 170.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -90.68 113.58 25.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.629 -0.878 . . . . 8.88 108.629 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.68 129.95 34.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.646 . . . . 9.78 110.99 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.8 m -144.67 159.03 52.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.828 -1.078 . . . . 6.4 109.103 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.42 136.28 70.67 Favored 'Trans proline' 0 C--N 1.333 -0.277 0 C-N-CA 122.192 1.928 . . . . 6.55 110.589 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 m -57.92 -24.85 59.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 9.29 111.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.6 6.61 43.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.183 -0.207 . . . . 10.86 111.554 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -40.71 20.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.058 0.456 . . . . 5.34 110.707 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -90.87 161.85 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.732 -0.667 . . . . 6.97 111.98 -173.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 mm -113.15 103.79 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.892 -0.594 . . . . 10.2 109.442 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 7.2 ptt180 -101.53 134.27 44.91 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.33 -1.348 . . . . 12.12 110.997 173.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 t -150.47 128.88 12.12 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.06 -1.427 . . . . 14.61 109.589 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.76 -109.74 3.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.589 -0.815 . . . . 15.52 112.117 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.16 30.31 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.077 0.399 . . . . 14.99 112.077 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.547 HH11 HD11 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -163.75 176.91 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 15.2 112.004 -177.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.4 m -132.55 156.66 46.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 9.26 110.602 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.547 HD11 HH11 ' A' ' 108' ' ' ARG . 41.4 mm -129.26 149.48 33.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.277 -0.638 . . . . 10.55 109.277 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.592 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -128.94 141.82 51.14 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.658 0.265 . . . . 7.39 110.497 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 122' ' ' PRO . 62.0 mmm -103.37 99.84 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.648 -0.501 . . . . 8.85 109.648 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.0 p -82.05 135.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.979 0.418 . . . . 9.69 111.003 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.06 93.54 5.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 10.7 110.922 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -89.06 160.5 17.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.626 -0.716 . . . . 14.88 111.343 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.43 23.94 31.42 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.737 -0.945 . . . . 16.92 110.737 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -97.54 19.41 13.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.989 0.423 . . . . 18.56 111.102 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.5 68.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.951 -0.642 . . . . 15.62 112.702 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 -175.76 47.55 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.16 -0.776 . . . . 14.19 111.16 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 81.8 m-85 -100.36 178.7 4.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.868 0.366 . . . . 12.03 110.881 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.525 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 13.4 t70 -140.52 122.85 9.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.467 0.651 . . . . 13.91 109.721 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HB3' ' SD ' ' A' ' 112' ' ' MET . 71.1 Cg_endo -86.96 113.78 1.04 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.324 2.683 . . . . 12.35 112.422 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.3 p -103.91 140.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.183 -0.917 . . . . 9.43 109.647 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 110' ' ' ILE . 44.9 tt0 -76.24 120.97 22.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.108 -0.701 . . . . 12.93 109.108 171.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -131.65 159.35 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 8.03 111.566 -173.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.4 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 39.9 ttmt -103.11 128.04 50.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.186 -0.916 . . . . 10.39 109.415 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.66 108.25 5.34 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.589 0.218 . . . . 8.3 111.589 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.52 71.04 0.28 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 118.021 -2.038 . . . . 10.1 114.006 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.011 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.71 163.03 39.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.554 -0.906 . . . . 10.61 108.554 157.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.7 m -131.5 137.03 48.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.139 -0.689 . . . . 13.17 109.139 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -142.73 90.63 2.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 120.888 0.375 . . . . 12.98 111.954 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.2 60.19 8.74 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.733 -0.667 . . . . 14.34 113.411 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.84 82.26 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 13.12 112.41 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.64 165.54 24.99 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.9 -0.778 . . . . 10.62 108.9 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.0 m -117.81 163.46 16.48 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.633 -0.427 . . . . 7.82 110.714 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 1.011 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 23.9 mt-10 -110.44 120.11 41.37 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.734 0.778 . . . . 10.79 111.258 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.796 HD12 HG21 ' A' ' 125' ' ' VAL . 22.3 mm -85.23 107.95 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.777 -1.101 . . . . 6.73 109.644 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.0 mp -68.67 -46.54 68.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.298 -0.865 . . . . 8.79 109.984 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.9 mt-10 -144.45 155.79 43.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.122 -0.49 . . . . 10.44 110.101 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 129.28 -66.85 0.57 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.862 -1.161 . . . . 8.87 113.064 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 111' ' ' ALA . 3.1 mm? -97.71 -176.29 3.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.37 0.878 . . . . 8.5 113.37 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 23.0 tptm -144.34 151.91 39.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.019 -0.991 . . . . 14.15 109.89 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.17 132.41 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.345 -0.843 . . . . 12.12 110.21 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.0 47.32 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.485 -0.864 . . . . 11.54 111.315 -174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -104.17 141.15 36.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.64 -0.504 . . . . 11.24 109.64 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 22.5 mt-30 -97.21 147.1 24.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.695 0.283 . . . . 10.49 111.008 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.0 m -136.51 152.55 29.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.38 -0.6 . . . . 5.45 109.38 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 81' ' ' THR . 32.9 m -56.53 138.86 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.72 0.637 . . . . 6.56 111.881 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 82' ' ' ALA . 43.1 t . . . . . 0 C--N 1.317 -0.845 0 CA-C-N 115.235 -0.893 . . . . 6.99 110.043 -175.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.622 -0.14 . . . . 11.84 110.622 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.89 63.2 0.46 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.062 0.545 . . . . 12.24 111.139 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.95 94.84 5.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 13.16 110.707 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.28 -9.14 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 11.95 109.709 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -82.72 1.25 39.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.619 -0.719 . . . . 11.22 110.232 176.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -66.54 -40.41 89.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.809 -0.441 . . . . 11.9 109.809 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.11 -51.79 55.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.236 0.471 . . . . 11.17 110.038 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.06 66.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.834 . . . . 7.82 111.422 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 164' ' ' THR . 35.6 t -70.77 -38.39 73.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.181 0.515 . . . . 9.64 110.609 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.96 -32.44 65.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.83 0.824 . . . . 10.57 110.907 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -89.93 -67.02 0.87 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 114.327 -1.306 . . . . 8.9 111.019 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.71 77.88 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.563 -0.744 . . . . 7.15 112.658 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' SER . 56.1 p 47.26 -100.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.191 0.996 . . . . 7.09 113.267 174.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.33 -30.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.03 0.443 . . . . 9.2 111.235 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 121.16 0.505 . . . . 9.11 111.096 -177.704 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 pttp . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 122.385 1.088 . . . . 10.38 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.521 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 32.0 mtt180 -135.49 138.75 43.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.971 -1.468 . . . . 8.37 109.362 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.616 HG12 ' CG ' ' A' ' 58' ' ' GLU . 31.3 mm -52.92 120.64 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 121.982 0.896 . . . . 5.76 113.236 -170.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.34 -37.32 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.665 -1.607 . . . . 8.22 110.291 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.708 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.1 p90 -169.77 -173.47 1.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.165 0.507 . . . . 7.99 111.611 -174.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.58 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.57 145.71 50.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.252 -0.886 . . . . 5.61 110.908 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -149.26 157.52 43.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.585 . . . . 9.06 110.207 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -91.32 136.08 27.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.673 -0.862 . . . . 8.31 108.673 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.45 -12.48 27.94 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.247 1.965 . . . . 10.41 112.395 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.608 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -100.47 2.57 42.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.605 0.24 . . . . 10.85 111.622 176.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.0 m -126.1 45.39 1.46 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.276 0.56 . . . . 9.32 111.451 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HD3' ' C ' ' A' ' 34' ' ' MET . 22.7 Cg_exo -59.56 112.19 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.585 2.19 . . . . 11.1 112.252 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -32.7 3.35 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.309 -0.716 . . . . 10.31 111.309 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.45 ' CG ' ' CE2' ' A' ' 40' ' ' PHE . 3.3 tp-100 -68.1 125.67 27.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.276 0.56 . . . . 9.21 110.856 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.602 ' HG2' ' CE2' ' A' ' 29' ' ' TYR . 5.1 tmm_? -114.55 101.56 9.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.448 -0.797 . . . . 11.51 110.086 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 56.4 m-85 -85.79 141.23 29.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.498 0.666 . . . . 7.5 109.782 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.93 -36.59 84.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.313 -1.312 . . . . 10.61 111.067 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.5 mttp -146.32 163.31 30.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 123.406 0.441 . . . . 10.91 110.998 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -51.49 171.61 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.958 3.105 . . . . 7.51 114.175 175.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.71 -171.47 25.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 7.59 112.69 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 20.9 ttmt -83.86 144.8 29.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.604 -0.517 . . . . 11.68 109.604 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -64.76 136.65 96.86 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.922 -0.581 . . . . 9.2 109.623 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.98 -24.76 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.411 2.074 . . . . 10.25 112.099 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 64.3 m-85 -82.45 -34.47 28.12 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.671 -0.695 . . . . 10.49 110.839 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.6 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -117.75 -165.02 1.05 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.872 -1.058 . . . . 10.38 110.308 171.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.53 60.88 1.24 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.189 0.995 . . . . 12.54 109.066 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.8 ptm -138.32 146.15 50.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 113.86 -1.518 . . . . 9.87 109.325 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 19.4 Cg_exo -66.1 132.85 31.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.107 1.871 . . . . 9.51 110.177 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -61.63 161.8 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.309 0.38 . . . . 6.71 110.43 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.61 126.77 33.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.371 -0.603 . . . . 7.89 109.371 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 53.8 Cg_endo -73.37 131.75 16.79 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 121.309 1.339 . . . . 5.77 112.351 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.27 159.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.381 -1.282 . . . . 5.96 113.315 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 10.3 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.109 2.564 . . . . 7.84 116.304 -177.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -64.58 -38.22 90.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.56 1.172 . . . . 6.62 109.737 -171.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 10.9 tt0 . . . . . 0 CA--C 1.508 -0.652 0 CA-C-N 111.863 -2.426 . . . . 8.58 111.15 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 148' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.323 0 N-CA-C 109.78 -0.452 . . . . 11.64 109.78 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 114' ' ' ALA . 74.6 p -142.98 156.56 44.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.961 -0.563 . . . . 8.0 110.182 -175.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -120.01 129.3 54.2 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.567 -0.901 . . . . 6.65 108.567 171.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 43.3 tt0 -80.11 131.88 35.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.855 -0.611 . . . . 12.15 110.054 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 95' ' ' LEU . 77.2 t -55.6 131.36 18.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 9.71 110.955 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.36 145.06 9.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.462 -1.245 . . . . 11.03 109.455 172.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.476 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.3 mp -74.48 152.29 39.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.205 -0.907 . . . . 12.76 110.838 -176.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.501 -0.813 0 C-N-CA 120.011 -1.09 . . . . 13.25 112.94 -176.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HG2' HD23 ' A' ' 86' ' ' LEU . 5.1 tt0 . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 109.835 -0.431 . . . . 14.94 109.835 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -134.79 160.54 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.549 0.214 . . . . 10.57 111.36 -172.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.619 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -91.69 116.69 29.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.137 -0.69 . . . . 8.88 109.137 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -96.41 131.86 42.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.806 0.336 . . . . 9.78 111.388 -173.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.02 150.78 54.05 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.842 -0.799 . . . . 6.4 108.842 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HG2' HG11 ' A' ' 149' ' ' VAL . 50.8 Cg_exo -59.19 133.1 50.71 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 121.839 1.693 . . . . 6.55 110.704 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 22.9 t -61.45 -31.21 71.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 9.29 110.997 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -74.67 -5.25 42.09 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.372 -0.131 . . . . 10.86 111.043 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -73.57 -39.76 64.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.274 0.559 . . . . 5.34 109.984 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 109' ' ' THR . 74.5 mt -65.13 148.1 52.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.67 -1.15 . . . . 6.97 113.034 -170.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.54 127.49 52.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.755 -1.111 . . . . 10.2 108.433 170.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 16.3 mmt180 -104.72 123.46 47.67 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.909 -0.717 . . . . 12.12 110.811 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -146.58 138.99 25.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.432 -0.804 . . . . 14.61 109.691 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.98 -118.33 6.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.292 -0.48 . . . . 15.52 112.776 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.7 36.89 4.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.19 0.519 . . . . 14.99 110.949 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -148.22 173.93 12.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 15.2 111.581 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.506 HG21 HD13 ' A' ' 102' ' ' LEU . 5.8 m -121.77 146.45 47.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 9.26 109.87 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 26.3 mm -131.13 148.41 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.891 0.377 . . . . 10.55 110.047 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -116.55 159.64 21.82 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.474 -0.565 . . . . 7.39 109.474 173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.449 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 58.8 ttp -125.75 100.78 6.56 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.545 -0.909 . . . . 8.85 108.545 174.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 14.4 p -80.89 129.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.363 0.601 . . . . 9.69 111.715 -168.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 81' ' ' THR . . . -79.13 84.53 5.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.878 -1.056 . . . . 10.7 109.991 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -67.5 141.2 56.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.84 -0.618 . . . . 14.88 110.989 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.37 -2.21 40.43 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.627 -0.989 . . . . 16.92 110.627 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -83.57 6.54 20.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.932 -0.634 . . . . 18.56 111.123 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 6.01 70.39 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.41 -0.814 . . . . 15.62 113.241 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.9 175.41 20.85 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 14.19 112.486 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 85.5 m-85 -127.05 122.28 33.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.658 -0.497 . . . . 12.03 109.658 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 113' ' ' VAL . 20.4 t70 -116.29 134.43 22.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.145 -0.479 . . . . 13.91 111.968 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 3.1 Cg_endo -77.56 136.33 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.987 1.791 . . . . 12.35 112.505 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.94 123.76 64.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 9.43 109.8 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.0 tt0 -75.56 121.19 22.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 12.93 109.294 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 141' ' ' LEU . 27.3 m -128.45 163.7 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.199 0.523 . . . . 8.03 111.608 -173.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 138' ' ' LEU . 40.3 ttmt -102.88 126.18 49.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.008 -0.738 . . . . 10.39 109.008 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.453 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.57 104.03 4.66 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.1 -0.5 . . . . 8.3 110.998 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.496 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.2 71.19 0.28 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 117.922 -2.085 . . . . 10.1 114.968 169.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -147.68 162.52 38.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.054 -1.461 . . . . 10.61 107.054 150.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -134.15 129.52 35.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.694 0.679 . . . . 13.17 110.449 175.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.16 126.01 11.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.306 -0.407 . . . . 12.98 111.378 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.11 33.96 88.65 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.113 -0.494 . . . . 14.34 112.885 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.04 11.23 81.51 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.832 -0.699 . . . . 13.12 112.05 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.35 170.99 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.317 -0.623 . . . . 10.62 109.317 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 p -119.28 143.66 47.21 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.04 0.447 . . . . 7.82 110.907 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.3 mp0 -85.87 122.0 29.32 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.822 -0.626 . . . . 10.79 111.584 175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.492 HD11 HD21 ' A' ' 102' ' ' LEU . 19.5 mm -88.03 109.33 19.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.52 -0.764 . . . . 6.73 109.112 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 128' ' ' GLY . 1.3 mp -76.03 -52.17 10.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.379 -1.282 . . . . 8.79 109.264 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -144.74 170.83 15.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.688 -0.687 . . . . 10.44 110.322 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 109.85 -59.54 0.35 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.37 -0.919 . . . . 8.87 113.394 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 125' ' ' VAL . 17.9 mt -96.83 -172.66 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.14 0.495 . . . . 8.5 111.828 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 63.7 tttm -149.77 154.89 39.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 14.15 109.212 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . . . -67.8 127.16 31.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.641 -0.708 . . . . 12.12 110.274 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.6 -8.35 28.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.033 -0.827 . . . . 11.54 111.033 -171.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mm-40 -97.27 116.63 29.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 11.24 109.343 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.1 mt-30 -91.29 135.67 33.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.754 -0.657 . . . . 10.49 111.549 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 149' ' ' VAL . 2.5 p -127.97 138.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.756 -0.461 . . . . 5.45 109.756 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.5 m -62.71 134.55 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 O-C-N 123.442 0.464 . . . . 6.56 110.531 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 101' ' ' ALA . 13.2 m . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 113.332 0.864 . . . . 6.99 113.332 -170.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.493 -0.558 . . . . 11.84 109.493 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -109.41 -13.56 14.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.334 -0.394 . . . . 12.24 110.724 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.5 mt 67.25 -177.58 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 13.16 110.923 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.2 mt 62.72 52.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.997 0.904 . . . . 11.95 109.002 -175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.6 -28.18 31.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.038 -0.983 . . . . 11.22 111.441 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -59.24 -31.49 69.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.424 -1.262 . . . . 11.9 111.539 -169.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.66 -30.67 71.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.188 -1.369 . . . . 11.17 111.003 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.88 -25.68 40.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.656 -0.702 . . . . 7.82 110.525 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.5 m -80.79 -17.2 51.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 9.64 110.076 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' HH11 ' A' ' 162' ' ' ARG . 90.8 mt -65.53 -48.82 71.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.206 -0.664 . . . . 10.57 109.206 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.431 HH11 ' HB2' ' A' ' 161' ' ' LEU . 9.6 mpt_? -76.02 -173.33 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.444 -0.798 . . . . 8.9 109.968 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.44 -50.39 4.4 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.779 -0.724 . . . . 7.15 112.649 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.4 p -80.98 -86.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.309 . . . . 7.09 110.993 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.7 91.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.541 -0.54 . . . . 9.2 109.541 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 9.11 110.572 -176.796 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.442 -0.844 0 CA-C-O 122.561 1.172 . . . . 10.38 109.76 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.607 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.1 mtp180 -135.71 135.19 39.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.196 -1.366 . . . . 8.37 108.986 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.602 HG12 ' CG ' ' A' ' 58' ' ' GLU . 23.3 mm -57.43 115.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 122.433 1.111 . . . . 5.76 112.173 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 mt -118.97 -35.42 3.65 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.773 -2.012 . . . . 8.22 110.679 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.692 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 19.8 p90 -168.82 179.07 4.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 7.99 109.704 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.669 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -117.29 164.3 15.02 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.185 -0.461 . . . . 5.61 111.523 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -145.31 177.22 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 9.06 110.204 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.0 t70 -124.13 138.43 30.74 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 107.845 -1.168 . . . . 8.31 107.845 170.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -60.3 -14.2 28.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.451 2.101 . . . . 10.41 112.738 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -101.43 -2.09 31.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.123 0.416 . . . . 10.85 112.123 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.806 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.0 m -125.45 38.28 0.4 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 113.58 0.956 . . . . 9.32 113.58 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 29.6 Cg_endo -58.49 133.3 53.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.305 2.003 . . . . 11.1 112.518 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.78 -6.3 29.46 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.272 -0.731 . . . . 10.31 111.272 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.703 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -87.54 179.38 6.56 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 9.21 109.194 177.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.505 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 4.5 tmm_? -157.0 93.29 1.33 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.785 -0.82 . . . . 11.51 108.785 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.703 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 91.3 m-85 -73.71 142.24 46.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.071 0.462 . . . . 7.5 109.99 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.27 -30.58 71.63 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.886 -1.052 . . . . 10.61 110.273 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -165.15 164.39 12.77 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.699 -0.682 . . . . 10.91 111.586 -177.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.669 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.1 Cg_endo -50.73 170.21 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.689 2.926 . . . . 7.51 113.313 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.01 -159.34 27.63 Favored Glycine 0 CA--C 1.508 -0.383 0 C-N-CA 120.24 -0.981 . . . . 7.59 112.735 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 3.0 ttmm -95.3 144.33 25.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.335 -0.617 . . . . 11.68 109.335 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.548 ' OG ' ' HG3' ' A' ' 49' ' ' MET . 25.0 p -64.56 145.02 98.71 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 9.2 111.873 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.24 -22.2 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.258 1.972 . . . . 10.25 112.904 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.31 -15.83 39.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.41 1.1 . . . . 10.49 110.068 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.548 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.16 -164.06 1.85 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.506 -1.679 . . . . 10.38 109.012 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 5.7 p-10 -133.21 57.15 1.82 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.614 0.721 . . . . 12.54 110.781 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -133.35 142.93 46.03 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.134 -0.939 . . . . 9.87 108.954 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.09 132.13 37.8 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.617 1.545 . . . . 9.51 110.658 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.26 164.2 5.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.341 0.591 . . . . 6.71 111.854 -174.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.72 130.8 22.36 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.726 -0.842 . . . . 7.89 108.726 -177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.24 136.83 35.41 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.855 1.703 . . . . 5.77 112.405 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 27.1 m -63.18 160.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.64 -1.164 . . . . 5.96 112.419 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.692 ' CD1' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER 7.13 -66.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.476 2.31 . . . . 7.84 116.054 177.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.602 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -62.57 -48.32 79.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.236 1.017 . . . . 6.62 110.352 -171.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' HD11 ' A' ' 27' ' ' ILE . 12.2 pt-20 . . . . . 0 CA--C 1.512 -0.507 0 CA-C-N 112.532 -2.122 . . . . 8.58 113.37 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 . . . . . 0 N--CA 1.449 -0.518 0 N-CA-C 109.039 -0.726 . . . . 11.64 109.039 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 148' ' ' VAL . 82.5 p -127.92 177.86 6.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.367 0.603 . . . . 8.0 110.253 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.414 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -140.88 126.36 18.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.102 -1.073 . . . . 6.65 108.102 171.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 34.4 tt0 -79.02 139.39 38.18 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.639 -0.504 . . . . 12.15 109.639 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 95' ' ' LEU . 53.3 t -62.03 133.3 27.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.33 0.585 . . . . 9.71 112.395 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -137.47 150.57 47.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.452 -1.249 . . . . 11.03 108.393 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 8.1 mp -77.53 147.99 35.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.148 -0.686 . . . . 12.76 109.148 169.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.316 -0.945 . . . . 13.25 112.938 -178.858 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 . . . . . 0 CA--C 1.507 -0.709 0 CA-C-O 121.685 0.755 . . . . 14.94 110.668 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -112.62 170.21 8.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.435 -1.257 . . . . 10.57 110.384 -173.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -100.75 113.38 26.22 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.953 -0.758 . . . . 8.88 108.953 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.74 129.5 36.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 9.78 110.868 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 34.1 m -142.41 161.65 48.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.858 -1.064 . . . . 6.4 108.409 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.88 134.79 55.52 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.707 1.605 . . . . 6.55 110.5 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 p -67.28 -24.63 65.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.103 -0.373 . . . . 9.29 110.984 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -90.96 7.26 41.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.512 -0.313 . . . . 10.86 111.153 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 149' ' ' VAL . . . -84.9 -40.68 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.084 0.468 . . . . 5.34 110.615 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -83.18 162.36 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.608 -0.723 . . . . 6.97 111.572 -173.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 18.7 mm -104.63 119.81 54.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.524 -0.762 . . . . 10.2 109.997 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -96.13 120.75 36.98 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.629 -0.828 . . . . 12.12 109.97 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -147.3 140.59 25.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.955 -0.566 . . . . 14.61 110.36 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 56.88 -112.63 3.64 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.131 -0.557 . . . . 15.52 112.556 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.96 29.38 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.823 0.305 . . . . 14.99 111.823 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.416 ' NH1' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -162.41 -176.82 5.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 15.2 111.464 -174.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 46.7 m -125.43 147.94 49.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.725 -0.671 . . . . 9.26 110.572 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.9 mm -124.82 151.79 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.351 -0.611 . . . . 10.55 109.351 176.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -136.43 134.17 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.49 -0.131 . . . . 7.39 110.667 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.437 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 38.5 mtm -93.98 101.46 13.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 8.85 109.432 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 9.5 p -85.32 138.45 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 9.69 111.329 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.06 95.3 3.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.07 -0.513 . . . . 10.7 110.937 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -80.02 163.3 24.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.245 0.545 . . . . 14.88 110.454 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.52 15.15 47.81 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.417 -0.811 . . . . 16.92 111.406 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.26 11.6 39.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.449 0.642 . . . . 18.56 110.619 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.28 11.9 74.52 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.158 -0.928 . . . . 15.62 113.516 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.88 168.04 25.76 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.578 -0.82 . . . . 14.19 112.203 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 80.7 m-85 -110.18 109.86 20.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.533 -0.543 . . . . 12.03 109.533 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 9.3 t70 -92.6 140.58 23.96 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.781 -0.645 . . . . 13.91 110.772 -170.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 121' ' ' ASP . 19.4 Cg_endo -84.2 127.88 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.196 1.93 . . . . 12.35 112.71 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.8 t -115.48 129.05 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.119 -0.946 . . . . 9.43 109.351 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 110' ' ' ILE . 43.0 tt0 -73.03 120.86 19.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.37 -0.604 . . . . 12.93 109.37 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.753 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -132.48 159.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.411 0.624 . . . . 8.03 111.212 -174.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.0 ttmm -103.94 129.32 51.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.225 -0.898 . . . . 10.39 109.647 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.55 114.83 8.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.712 -0.222 . . . . 8.3 111.303 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.428 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.21 70.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 117.818 -2.134 . . . . 10.1 114.251 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.862 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.24 164.62 35.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.268 -1.012 . . . . 10.61 108.268 154.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -143.61 126.75 16.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.308 0.504 . . . . 13.17 110.086 170.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.21 118.95 6.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 12.98 111.336 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.27 36.24 92.54 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.231 -0.509 . . . . 14.34 112.697 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.32 20.96 80.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.559 -0.829 . . . . 13.12 111.618 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' VAL . 38.3 mt-30 -128.49 170.49 13.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.365 -0.606 . . . . 10.62 109.365 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.5 t -125.12 156.82 37.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.604 -0.517 . . . . 7.82 109.604 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 46.6 mt-10 -101.06 112.97 25.57 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.664 0.745 . . . . 10.79 110.577 175.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 125' ' ' VAL . 24.5 mm -79.87 106.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.741 -1.118 . . . . 6.73 109.641 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.49 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.4 mp -70.48 -49.67 46.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.885 -1.052 . . . . 8.79 109.878 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 125' ' ' VAL . 41.0 mt-10 -141.75 165.6 27.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.44 109.528 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 116.95 -67.42 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.683 -1.246 . . . . 8.87 113.593 175.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.32 -174.97 2.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 8.5 112.16 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 38.4 ttpt -149.32 154.97 39.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.558 -0.746 . . . . 14.15 109.748 -176.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.33 131.49 45.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.487 -0.779 . . . . 12.12 110.1 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.35 -7.72 47.48 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.948 -0.861 . . . . 11.54 110.948 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.584 ' HA ' HE21 ' A' ' 145' ' ' GLN . 0.0 OUTLIER -100.8 119.07 38.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.812 -0.81 . . . . 11.24 108.812 177.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.7 pt20 -104.88 132.27 51.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.686 0.755 . . . . 10.49 109.676 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 149' ' ' VAL . 17.1 m -116.38 153.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.439 -1.255 . . . . 5.45 110.025 -172.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.3 m -57.62 134.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.44 0.638 . . . . 6.56 111.413 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 147' ' ' VAL . 43.1 t . . . . . 0 C--N 1.319 -0.735 0 CA-C-N 115.092 -0.958 . . . . 6.99 111.029 -173.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.811 0.338 . . . . 11.84 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -94.55 -10.27 32.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 12.24 110.334 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 28.8 tp -70.92 -57.07 4.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.124 0.488 . . . . 13.16 109.755 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.6 tt -118.19 112.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.567 -0.742 . . . . 11.95 110.449 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -76.26 -23.33 54.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 11.22 110.718 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 9.3 m -56.14 -54.87 39.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.203 0.525 . . . . 11.9 110.92 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 34.9 mm-40 -59.4 -40.0 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.274 -0.876 . . . . 11.17 110.895 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 7.82 111.657 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.8 m -79.55 -28.95 41.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 9.64 110.431 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 157' ' ' SER . 71.8 mt -83.16 -28.29 29.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.517 -0.765 . . . . 10.57 110.561 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 20.1 mtp180 -70.53 146.13 50.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.331 -0.85 . . . . 8.9 112.404 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.08 23.98 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.783 -1.098 . . . . 7.15 111.888 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.8 p 46.99 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.751 0.821 . . . . 7.09 112.964 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.6 t 59.84 66.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.558 0.694 . . . . 9.2 109.587 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 115.621 -0.718 . . . . 9.11 110.875 -178.016 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.555 0 CA-C-O 122.963 1.363 . . . . 10.38 108.555 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 9.3 mmm180 -113.41 140.06 48.38 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.752 -1.567 . . . . 8.37 109.476 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.637 HG21 ' CZ3' ' A' ' 30' ' ' TRP . 11.9 mm -52.49 121.4 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 123.937 0.773 . . . . 5.76 112.661 -170.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.16 -37.43 10.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.177 -1.374 . . . . 8.22 110.284 172.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 29.8 p90 -172.24 -175.63 1.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.162 0.506 . . . . 7.99 111.125 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.689 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.29 154.25 35.24 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.14 -0.936 . . . . 5.61 110.627 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -162.91 148.98 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.567 0.542 . . . . 9.06 110.447 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -69.77 137.61 87.89 Favored Pre-proline 0 CA--C 1.514 -0.413 0 N-CA-C 108.386 -0.968 . . . . 8.31 108.386 169.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -62.01 -11.84 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.393 2.062 . . . . 10.41 110.77 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -98.76 1.33 45.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.613 -0.721 . . . . 10.85 111.215 177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.607 HG22 ' HB2' ' A' ' 32' ' ' ASP . 10.3 m -130.98 49.86 5.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 121.238 0.542 . . . . 9.32 112.03 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.05 121.13 7.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.781 2.321 . . . . 11.1 112.584 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.34 -25.86 11.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.82 -0.705 . . . . 10.31 112.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' A' ' 35' ' ' VAL . 21.0 tp60 -69.43 105.98 2.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.415 0.626 . . . . 9.21 111.004 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.734 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 45.2 ttp180 -89.61 101.28 13.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.343 -0.844 . . . . 11.51 110.521 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 72.0 m-85 -82.94 147.24 28.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 7.5 110.252 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.83 -25.63 68.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.396 -1.275 . . . . 10.61 111.406 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 53.8 pttt -172.46 164.62 3.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 10.91 111.3 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.0 Cg_endo -50.7 170.06 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.729 2.952 . . . . 7.51 113.626 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.16 -166.03 26.83 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.692 -0.766 . . . . 7.59 112.421 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 5.3 ttmm -93.21 141.56 28.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.059 -0.719 . . . . 11.68 109.059 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 49' ' ' MET . 41.2 t -61.07 139.87 94.21 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.535 -0.757 . . . . 9.2 111.64 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.19 -20.8 18.52 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.74 2.294 . . . . 10.25 111.468 171.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CD2' HG11 ' A' ' 35' ' ' VAL . 27.1 m-85 -87.67 -42.83 12.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.512 -1.222 . . . . 10.49 109.666 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -133.92 155.28 50.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.34 -0.846 . . . . 10.38 111.965 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.1 p-10 -82.35 61.42 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.282 1.039 . . . . 12.54 110.834 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -131.96 143.39 48.84 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.732 -1.122 . . . . 9.87 109.392 173.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.75 132.9 32.06 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.178 1.252 . . . . 9.51 109.218 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.44 158.69 14.21 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.029 -0.268 . . . . 6.71 110.681 -175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.95 130.51 24.96 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-O 121.217 0.532 . . . . 7.89 110.118 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 88.2 Cg_endo -79.09 139.74 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.135 1.89 . . . . 5.77 113.14 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 34.1 m -61.43 161.81 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.743 -1.571 . . . . 5.96 112.97 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.79 -84.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.049 2.14 . . . . 7.84 115.706 -178.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -48.6 -43.57 36.26 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.92 0.762 . . . . 6.62 111.421 -173.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 35.7 tt0 . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 122.271 1.034 . . . . 8.58 109.655 -171.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 108.429 -0.952 . . . . 11.64 108.429 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 146' ' ' GLN . 77.0 p -108.74 139.17 43.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.447 -0.342 . . . . 8.0 110.526 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -107.33 129.77 54.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.906 -0.776 . . . . 6.65 108.906 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 39.9 tt0 -76.04 134.79 40.0 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.237 -0.438 . . . . 12.15 110.065 -176.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 95' ' ' LEU . 73.6 t -63.13 130.05 27.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.686 0.755 . . . . 9.71 110.958 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.04 146.56 10.87 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.33 -1.305 . . . . 11.03 109.683 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.13 161.33 31.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 12.76 111.091 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.47 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.786 0 C-N-CA 120.432 -0.889 . . . . 13.25 112.82 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 CA--C 1.518 -0.263 0 N-CA-C 110.212 -0.292 . . . . 14.94 110.212 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -126.43 160.0 31.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.446 -0.343 . . . . 10.57 110.1 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -89.3 114.54 25.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.844 -0.799 . . . . 8.88 108.844 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -87.71 133.19 33.89 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.054 0.454 . . . . 9.78 111.365 -173.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 6.4 p -145.85 146.7 29.79 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.333 -0.849 . . . . 6.4 109.419 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 97' ' ' VAL . 50.8 Cg_exo -56.6 130.77 41.76 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.338 2.025 . . . . 6.55 110.518 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.9 p -55.22 -24.35 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.134 0.79 . . . . 9.29 113.134 -172.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -90.4 6.84 41.54 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.854 -0.529 . . . . 10.86 111.929 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -82.16 -39.14 23.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.257 0.551 . . . . 5.34 110.629 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -91.93 156.04 17.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.6 -0.727 . . . . 6.97 111.767 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.1 mm -120.07 103.51 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 115.409 -0.814 . . . . 10.2 110.376 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER -109.3 98.23 7.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.581 -1.248 . . . . 12.12 112.166 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -107.44 142.98 36.43 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.896 -1.502 . . . . 14.61 109.386 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.36 -107.07 1.93 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.59 -0.814 . . . . 15.52 112.23 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.66 17.48 11.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.028 0.751 . . . . 14.99 113.028 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 17.5 ptt180 -160.0 166.61 29.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.129 0.788 . . . . 15.2 113.129 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.1 m -113.79 154.42 27.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.229 -0.896 . . . . 9.26 110.729 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 124' ' ' GLU . 32.8 mm -133.97 149.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.981 -0.554 . . . . 10.55 109.834 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -135.19 130.17 34.91 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.476 0.31 . . . . 7.39 110.289 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 37.6 ttp -84.24 100.2 11.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.737 -0.838 . . . . 8.85 108.737 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 121' ' ' ASP . 13.6 p -87.77 134.48 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.602 -0.726 . . . . 9.69 111.736 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.98 94.45 8.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.668 -0.696 . . . . 10.7 109.638 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -75.41 148.82 38.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 14.88 110.748 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.18 -0.71 30.27 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.592 -0.731 . . . . 16.92 111.991 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.35 9.47 20.41 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.466 0.65 . . . . 18.56 110.59 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.77 10.69 78.63 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.282 -0.872 . . . . 15.62 113.295 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.65 160.77 23.89 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.436 -0.888 . . . . 14.19 112.475 -174.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 91.9 m-85 -112.3 126.57 55.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 12.03 109.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -129.24 150.69 76.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.968 -0.293 . . . . 13.91 111.495 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 123.65 2.01 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.47 2.113 . . . . 12.35 112.147 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.614 HG12 ' HB3' ' A' ' 111' ' ' ALA . 6.1 p -108.98 134.67 50.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.349 -0.841 . . . . 9.43 110.015 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.519 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.1 tt0 -74.26 120.47 19.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.514 . . . . 12.93 109.611 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.792 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -128.62 156.45 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.721 -0.672 . . . . 8.03 111.657 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.8 ttmm -101.61 126.67 48.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.918 -1.037 . . . . 10.39 109.459 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -142.46 107.79 5.01 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.379 -0.373 . . . . 8.3 111.625 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.01 0.29 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 117.684 -2.198 . . . . 10.1 114.539 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.57 163.04 38.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.494 -0.928 . . . . 10.61 108.494 154.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.93 128.28 26.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 118.12 0.418 . . . . 13.17 110.163 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.66 126.76 9.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.327 -0.397 . . . . 12.98 111.48 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.85 24.59 74.29 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.194 -0.457 . . . . 14.34 112.498 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 14.45 81.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.61 -0.805 . . . . 13.12 111.388 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -119.21 171.09 8.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.528 -0.545 . . . . 10.62 109.528 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 6.2 p -119.13 154.17 33.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 116.405 -0.361 . . . . 7.82 110.222 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 51.8 mt-10 -100.83 124.53 46.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.438 0.637 . . . . 10.79 111.4 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 125' ' ' VAL . 20.2 mm -88.86 112.16 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.183 -0.917 . . . . 6.73 109.908 174.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.8 mp -79.18 -44.99 20.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.603 -1.181 . . . . 8.79 109.649 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' VAL . 39.6 mt-10 -146.04 166.71 25.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.824 -0.626 . . . . 10.44 109.318 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 120.42 -70.47 0.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.798 -1.191 . . . . 8.87 113.528 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 mt -97.52 -179.19 4.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.382 0.611 . . . . 8.5 112.306 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -137.55 151.79 48.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.954 -1.021 . . . . 14.15 109.732 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.11 135.79 51.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.842 -1.072 . . . . 12.12 110.632 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.94 50.02 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.328 -0.709 . . . . 11.54 111.328 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -103.68 156.97 17.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.568 -0.53 . . . . 11.24 109.568 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.79 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.2 mt-30 -111.03 146.32 36.92 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.11 0.481 . . . . 10.49 110.703 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 101' ' ' ALA . 1.7 p -132.84 137.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.448 -0.796 . . . . 5.45 109.011 172.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.61 124.13 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.35 0.595 . . . . 6.56 110.69 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 101' ' ' ALA . 1.9 m . . . . . 0 C--N 1.32 -0.676 0 CA-C-N 115.676 -0.693 . . . . 6.99 109.71 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.468 -0.567 . . . . 11.84 109.468 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.4 85.44 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.62 0.248 . . . . 12.24 110.381 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.686 ' H ' HD12 ' A' ' 154' ' ' LEU . 6.3 mp -40.3 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.796 1.31 . . . . 13.16 112.43 -171.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.0 mt -149.35 114.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.936 -0.764 . . . . 11.95 108.936 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.93 -77.39 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.708 0.766 . . . . 11.22 112.454 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.3 p -64.48 -42.31 95.96 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.826 -1.079 . . . . 11.9 112.633 -162.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -68.63 -28.32 66.8 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.837 -0.62 . . . . 11.17 109.979 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.26 -18.86 54.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.435 -0.802 . . . . 7.82 110.562 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.3 t -81.29 -41.65 21.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.857 -0.61 . . . . 9.64 109.572 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.45 -35.67 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.706 -0.679 . . . . 10.57 110.937 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 162' ' ' ARG . 34.9 mtt180 -98.44 -161.47 0.88 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.363 -0.606 . . . . 8.9 109.363 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 177.89 -56.55 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.912 -0.661 . . . . 7.15 111.889 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.6 p -102.48 -26.38 13.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.672 . . . . 7.09 110.042 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.6 t -87.75 76.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.561 -0.745 . . . . 9.2 110.14 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 116.097 -0.501 . . . . 9.11 110.911 -179.5 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.507 -0.709 0 N-CA-C 107.924 -1.139 . . . . 10.38 107.924 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.405 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 18.2 mmm180 -126.14 137.07 53.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.762 -1.563 . . . . 8.37 110.564 -174.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.6 mm -46.36 131.91 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.343 -1.299 . . . . 5.76 113.66 -168.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -120.29 -29.9 4.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.843 -1.526 . . . . 8.22 108.227 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.743 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 16.4 p90 -175.24 -176.63 0.95 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.315 -0.857 . . . . 7.99 111.602 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.662 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.99 153.67 45.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.119 -0.946 . . . . 5.61 110.593 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -157.36 152.22 25.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 9.06 110.4 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.73 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.7 t70 -86.85 137.39 33.55 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.278 -0.638 . . . . 8.31 109.278 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HG3' HG13 ' A' ' 54' ' ' ILE . 16.5 Cg_exo -63.4 -14.93 45.25 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.495 2.13 . . . . 10.41 112.358 177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.32 0.57 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.718 0.294 . . . . 10.85 111.147 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -126.84 40.08 0.54 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.276 0.473 . . . . 9.32 112.276 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 13.8 Cg_endo -52.06 126.16 19.39 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.66 2.24 . . . . 11.1 112.812 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.36 -20.31 28.1 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 10.31 111.491 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.555 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 20.2 tp60 -81.42 102.92 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.239 0.542 . . . . 9.21 110.339 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.536 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 21.1 ttp180 -89.95 111.85 23.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.571 -0.74 . . . . 11.51 110.515 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.743 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 91.8 m-85 -92.67 127.72 38.27 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 108.036 -1.098 . . . . 7.5 108.036 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.79 -18.12 64.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.332 -0.547 . . . . 10.61 112.173 -171.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.3 mttt -141.4 170.09 10.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.738 -0.385 . . . . 10.91 111.01 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -52.82 170.43 0.29 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.522 2.815 . . . . 7.51 113.586 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.9 -167.15 29.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.39 -0.91 . . . . 7.59 113.421 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 9.4 ttmt -97.03 148.06 23.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.203 -0.666 . . . . 11.68 109.203 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.477 ' HA ' HD21 ' A' ' 53' ' ' LEU . 75.6 p -62.9 136.51 96.56 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 115.457 -0.792 . . . . 9.2 110.57 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.25 -25.4 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.894 1.729 . . . . 10.25 111.59 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.55 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 88.0 m-85 -81.82 -31.19 31.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.625 -0.716 . . . . 10.49 110.631 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.12 -159.74 0.88 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.501 -0.925 . . . . 10.38 108.501 173.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -130.67 54.92 1.86 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.687 0.756 . . . . 12.54 109.751 172.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 ptm -127.71 145.04 53.39 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 114.526 -1.216 . . . . 9.87 109.394 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.57 133.28 47.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.679 1.586 . . . . 9.51 109.971 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 46' ' ' SER . 24.2 mt -62.67 165.05 6.86 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.408 0.442 . . . . 6.71 110.735 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' A' ' 33' ' ' PRO . 32.8 mm -99.7 129.21 29.29 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.497 -0.557 . . . . 7.89 109.497 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 56.0 Cg_endo -83.28 138.2 8.65 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.851 1.701 . . . . 5.77 113.274 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.46 159.51 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.725 -1.58 . . . . 5.96 113.431 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.98 -86.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.966 2.106 . . . . 7.84 115.512 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.695 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -49.65 -38.76 33.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.977 0.418 . . . . 6.62 110.26 -177.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 C--N 1.315 -0.896 0 CA-C-N 114.885 -1.052 . . . . 8.58 111.263 173.298 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 158' ' ' GLU . 61.2 ttm-85 . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.192 0.52 . . . . 11.64 110.242 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.4 p -131.37 146.78 52.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.13 -0.941 . . . . 8.0 109.792 -176.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.0 128.08 56.07 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.867 -0.79 . . . . 6.65 108.867 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.76 131.71 35.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.07 -0.345 . . . . 12.15 110.07 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' GLN . 73.4 t -56.7 127.2 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-O 122.293 1.044 . . . . 9.71 112.066 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.83 136.27 8.99 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.888 -1.96 . . . . 11.03 109.035 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.603 ' CD1' ' H ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.61 168.83 19.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.894 -1.048 . . . . 12.76 112.44 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.586 0 CA-C-N 114.635 -1.166 . . . . 13.25 111.135 -169.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 . . . . . 0 CA--C 1.51 -0.56 0 N-CA-C 108.994 -0.743 . . . . 14.94 108.994 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 1.9 ttp180 -132.44 149.2 52.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.71 . . . . 10.57 111.062 -172.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.7 mm? -77.51 120.83 23.03 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.391 0.432 . . . . 8.88 110.458 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.06 131.87 43.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.311 -0.404 . . . . 9.78 111.318 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.7 156.12 59.66 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 6.4 109.467 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.46 134.06 61.0 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.117 1.878 . . . . 6.55 110.663 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 21.7 t -61.56 -26.05 67.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.958 0.355 . . . . 9.29 111.958 -173.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.0 4.8 49.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.941 -0.474 . . . . 10.86 111.568 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -75.73 -32.88 60.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.413 0.625 . . . . 5.34 110.54 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.494 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 2.9 pp -101.99 168.21 9.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.278 -0.874 . . . . 6.97 111.918 -172.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' THR . 27.6 mm -121.26 101.84 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.062 -0.517 . . . . 10.2 110.129 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.624 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 2.7 ppt_? -109.35 108.04 18.45 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.195 -1.402 . . . . 12.12 111.131 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -123.73 136.11 54.25 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.76 -1.564 . . . . 14.61 109.143 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.64 -102.99 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.401 -0.904 . . . . 15.52 112.333 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.22 4.53 10.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.914 0.709 . . . . 14.99 112.914 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 176.14 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.773 0.657 . . . . 15.2 112.773 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.5 m -123.99 156.74 35.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.015 -0.993 . . . . 9.26 111.712 -169.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 26.4 mm -128.46 149.82 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.081 -0.711 . . . . 10.55 109.081 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -132.61 140.37 48.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.603 0.24 . . . . 7.39 110.924 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 67.9 mtp -92.52 100.75 13.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.434 -0.58 . . . . 8.85 109.434 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.7 p -88.86 132.95 32.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 9.69 111.789 -174.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -79.19 83.85 5.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.376 -0.829 . . . . 10.7 109.774 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 46.5 mttm -75.18 146.93 40.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.771 -0.65 . . . . 14.88 110.972 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.0 5.2 42.28 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 16.92 111.138 172.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -85.61 9.77 15.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.626 0.727 . . . . 18.56 110.679 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.48 19.02 50.83 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.149 -0.932 . . . . 15.62 113.816 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.31 173.12 36.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.348 -0.93 . . . . 14.19 112.581 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 71.2 m-85 -109.84 109.24 19.83 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.194 -0.669 . . . . 12.03 109.194 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.596 ' O ' HG12 ' A' ' 113' ' ' VAL . 7.0 t70 -101.57 145.72 30.95 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 13.91 110.502 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 20.1 Cg_endo -89.32 132.82 2.24 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.151 1.9 . . . . 12.35 112.406 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.647 HG12 ' HB3' ' A' ' 111' ' ' ALA . 2.8 p -118.84 137.05 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.625 -0.716 . . . . 9.43 109.542 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 111.85 13.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 12.93 110.101 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -119.1 160.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.929 -1.032 . . . . 8.03 110.826 -175.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 23.5 ttmm -104.46 125.86 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.846 -0.615 . . . . 10.39 109.555 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.65 109.67 5.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.678 -0.237 . . . . 8.3 111.61 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.579 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.63 70.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.166 -1.968 . . . . 10.1 113.905 169.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.34 162.24 40.47 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.831 -0.803 . . . . 10.61 108.831 155.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 23.6 m -138.89 129.4 25.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.11 0.481 . . . . 13.17 109.871 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.73 102.31 5.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.645 -0.707 . . . . 12.98 110.675 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.63 24.39 76.25 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.041 -0.527 . . . . 14.34 112.492 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 97.51 -10.72 64.99 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.766 -0.73 . . . . 13.12 112.195 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 130' ' ' THR . 2.4 mp0 -97.49 162.98 13.05 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.84 -0.8 . . . . 10.62 108.84 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.4 p -114.63 155.36 26.69 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.431 -0.507 . . . . 7.82 111.172 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.905 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 25.7 mt-10 -100.02 128.5 46.09 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.5 0.667 . . . . 10.79 110.967 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 125' ' ' VAL . 24.3 mm -92.02 101.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.133 -0.94 . . . . 6.73 109.772 175.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.579 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.6 mp -67.18 -45.63 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.836 -1.075 . . . . 8.79 109.845 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.0 mt-10 -146.34 163.29 36.04 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.356 -0.609 . . . . 10.44 109.356 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.83 -46.95 1.05 Allowed Glycine 0 C--N 1.316 -0.572 0 C-N-CA 119.497 -1.335 . . . . 8.87 114.242 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.7 mt -123.22 -178.49 4.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.416 0.895 . . . . 8.5 113.416 -170.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.9 ttpt -142.39 155.23 45.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.569 -1.196 . . . . 14.15 108.846 -176.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.61 129.6 40.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.985 -0.552 . . . . 12.12 110.063 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.17 48.46 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.251 -0.74 . . . . 11.54 111.251 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.8 mm100 -97.89 100.8 12.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.446 0.641 . . . . 11.24 109.334 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.1 mt-30 -74.11 127.4 32.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.356 -0.838 . . . . 10.49 110.307 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 149' ' ' VAL . 19.5 m -117.69 135.83 56.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.601 0.238 . . . . 5.45 110.67 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.593 ' HA ' HG22 ' A' ' 81' ' ' THR . 42.6 t -66.43 115.05 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.864 -0.607 . . . . 6.56 110.473 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 4.1 m . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 6.99 110.759 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.922 0.391 . . . . 11.84 110.966 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.26 82.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 12.24 110.818 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 -168.72 2.15 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.514 -0.55 . . . . 13.16 109.514 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 157' ' ' SER . 28.8 pt -59.57 163.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 11.95 111.91 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.9 24.54 0.62 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.008 0.908 . . . . 11.22 111.206 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 155' ' ' ILE . 6.4 p -56.92 -27.11 60.48 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 114.456 -1.247 . . . . 11.9 111.218 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 1.5 mm-40 -57.9 -35.79 71.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 112.922 -1.945 . . . . 11.17 111.057 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.53 64.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.595 -0.73 . . . . 7.82 110.895 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.2 m -76.23 -25.64 55.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.507 0.67 . . . . 9.64 109.571 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.76 -16.53 44.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.111 -0.949 . . . . 10.57 110.756 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.7 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 13.4 mmm180 -89.45 131.21 35.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.316 0.579 . . . . 8.9 111.469 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -148.06 62.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.292 -1.523 . . . . 7.15 109.292 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.8 p 50.0 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.592 -0.521 . . . . 7.09 109.592 -161.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 166' ' ' ALA . 2.7 p -100.18 -65.89 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 9.2 109.997 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.651 ' H ' HG13 ' A' ' 165' ' ' VAL . . . . . . . . 0 N--CA 1.467 0.385 0 C-N-CA 124.993 1.317 . . . . 9.11 108.547 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.8 mptm? . . . . . 0 CA--C 1.507 -0.688 0 N-CA-C 108.23 -1.026 . . . . 10.38 108.23 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.3 mtm180 -136.73 138.61 41.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.168 -1.378 . . . . 8.37 109.484 -173.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' CH2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -49.59 124.13 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.962 0.887 . . . . 5.76 112.21 -173.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 28' ' ' LEU . 20.9 mt -112.16 -37.6 4.99 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.648 -1.614 . . . . 8.22 110.942 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 4.0 p90 -176.29 -178.64 0.99 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 7.99 109.464 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.683 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.0 156.61 30.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.867 -0.606 . . . . 5.61 111.009 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 30.3 ptt180 -160.03 149.7 18.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.853 -1.067 . . . . 9.06 110.311 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HB3' HG22 ' A' ' 35' ' ' VAL . 1.8 t0 -88.19 138.69 30.53 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.046 -0.724 . . . . 8.31 109.046 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HG3' HG13 ' A' ' 54' ' ' ILE . 32.8 Cg_exo -57.55 -20.61 42.28 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 123.498 2.799 . . . . 10.41 113.088 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -89.44 -24.4 21.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.354 0.597 . . . . 10.85 109.993 -177.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.3 m -117.95 37.16 0.24 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.107 -0.951 . . . . 9.32 113.526 -161.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 57.7 Cg_endo -60.78 108.29 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.881 2.387 . . . . 11.1 112.166 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.31 -18.29 0.91 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.496 -0.859 . . . . 10.31 112.474 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -77.26 -177.74 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.215 0.531 . . . . 9.21 111.646 174.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.644 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 5.2 tpp180 -148.26 91.73 1.95 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 11.51 109.729 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 77.5 m-85 -75.63 137.02 40.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.851 -0.74 . . . . 7.5 110.442 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.84 -29.94 71.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.745 -1.116 . . . . 10.61 110.032 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -165.04 164.28 13.03 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.338 -0.846 . . . . 10.91 110.608 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.3 Cg_endo -48.63 169.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.872 3.048 . . . . 7.51 114.351 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.14 -174.44 26.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.679 -0.772 . . . . 7.59 112.606 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.9 ttpm? -86.19 146.0 26.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.186 0.517 . . . . 11.68 110.986 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 49' ' ' MET . 32.9 t -58.43 136.33 85.53 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.764 -1.107 . . . . 9.2 110.924 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.55 -20.43 15.81 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 122.192 1.928 . . . . 10.25 110.912 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -86.15 -42.63 13.7 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.672 -1.603 . . . . 10.49 109.597 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.514 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.5 mtm -129.5 152.65 48.81 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 115.779 -0.646 . . . . 10.38 111.339 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.74 60.7 5.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.747 1.261 . . . . 12.54 111.294 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -139.51 145.55 44.28 Favored Pre-proline 0 C--N 1.304 -1.371 0 CA-C-N 113.891 -1.504 . . . . 9.87 109.208 177.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 39.8 Cg_endo -67.57 133.86 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.934 1.756 . . . . 9.51 111.936 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.4 163.23 11.1 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.576 -0.528 . . . . 6.71 109.576 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' A' ' 33' ' ' PRO . 24.1 mm -98.02 132.81 23.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 120.989 0.423 . . . . 7.89 110.565 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.87 147.51 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.91 1.74 . . . . 5.77 112.208 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 35.2 m -73.02 158.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 114.657 -1.156 . . . . 5.96 112.679 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.496 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.89 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.235 2.214 . . . . 7.84 115.865 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.6 pt-20 -48.47 -44.16 35.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.477 0.711 . . . . 6.62 111.231 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.452 ' N ' ' HG2' ' A' ' 58' ' ' GLU . 33.5 tt0 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.759 -1.109 . . . . 8.58 111.414 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 108.891 -0.781 . . . . 11.64 108.891 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 148' ' ' VAL . 68.0 p -131.12 159.19 38.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 8.0 110.097 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -121.59 128.64 52.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.668 -0.864 . . . . 6.65 108.668 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 33.9 tt0 -84.56 130.46 34.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.465 -0.569 . . . . 12.15 109.465 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 143' ' ' ALA . 20.5 m -64.35 141.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 122.888 1.328 . . . . 9.71 111.401 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.477 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -164.13 174.28 11.46 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.335 -2.212 . . . . 11.03 109.514 173.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 10.0 mp -70.48 167.91 17.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.572 0.701 . . . . 12.76 112.125 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.426 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 N--CA 1.448 -0.54 0 CA-C-N 115.33 -0.85 . . . . 13.25 112.604 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG2' HD23 ' A' ' 86' ' ' LEU . 7.8 mt-10 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.065 0.46 . . . . 14.94 110.575 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.633 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 1.5 mmp_? -121.11 168.13 11.89 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.87 -0.605 . . . . 10.57 111.248 -171.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.6 mm? -97.85 114.21 26.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.464 -0.789 . . . . 8.88 109.294 176.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.2 mm? -91.39 130.91 37.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.349 -0.841 . . . . 9.78 111.258 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.604 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 3.3 p -139.32 146.81 50.31 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.525 -1.216 . . . . 6.4 108.927 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.7 Cg_exo -56.51 132.01 49.18 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.145 1.897 . . . . 6.55 109.595 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t -57.74 -25.55 60.57 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 9.29 112.312 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.38 4.48 52.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.945 0.35 . . . . 10.86 111.945 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.604 ' HB3' ' CG2' ' A' ' 97' ' ' VAL . . . -79.84 -33.6 40.07 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.225 -0.59 . . . . 5.34 110.51 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -91.91 155.1 18.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.584 0.707 . . . . 6.97 111.967 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -99.18 125.43 52.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.08 -0.964 . . . . 10.2 109.029 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 20.8 mmm180 -98.1 125.69 43.21 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.677 -0.809 . . . . 12.12 110.911 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.9 t -149.15 127.26 12.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.722 -0.672 . . . . 14.61 110.818 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.41 -121.91 16.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.03 -0.532 . . . . 15.52 112.794 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.09 36.79 2.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 14.99 111.418 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -156.98 177.43 11.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.002 -0.544 . . . . 15.2 111.526 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 25.8 m -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.644 -0.707 . . . . 9.26 109.26 174.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.5 mm -126.92 150.7 33.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 10.55 109.125 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.602 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.35 130.02 32.22 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.242 -0.286 . . . . 7.39 110.839 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.454 ' HE3' HG11 ' A' ' 148' ' ' VAL . 38.7 mtm -84.71 100.25 11.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.846 -0.798 . . . . 8.85 108.846 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 11.3 p -81.95 134.46 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.825 -1.079 . . . . 9.69 111.208 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.59 91.56 7.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.539 -0.755 . . . . 10.7 110.235 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.48 147.94 35.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 14.88 111.035 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.16 -2.35 47.16 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.658 -0.701 . . . . 16.92 112.021 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.17 6.84 12.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.456 0.646 . . . . 18.56 111.058 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.67 67.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.243 -0.889 . . . . 15.62 113.197 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.6 -174.74 13.51 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.336 -0.935 . . . . 14.19 112.981 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.08 128.26 37.83 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.068 0.547 . . . . 12.03 109.783 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 113' ' ' VAL . 8.2 m-20 -125.37 147.72 58.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.594 -0.275 . . . . 13.91 111.024 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -85.37 124.87 2.86 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.391 2.061 . . . . 12.35 112.484 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.623 HG11 HD13 ' A' ' 141' ' ' LEU . 4.4 p -106.19 135.73 43.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.87 -1.059 . . . . 9.43 109.078 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.1 tt0 -82.23 122.75 28.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.057 -0.72 . . . . 12.93 109.057 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -137.02 157.16 35.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.402 0.62 . . . . 8.03 112.215 -173.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 76.1 tttt -93.73 128.68 40.06 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.092 -0.958 . . . . 10.39 110.208 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.404 ' HB3' ' OG1' ' A' ' 109' ' ' THR . . . -142.19 104.39 4.44 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.782 -0.644 . . . . 8.3 111.075 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.32 71.28 0.28 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 117.924 -2.084 . . . . 10.1 113.882 169.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.83 164.14 36.14 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.892 -0.781 . . . . 10.61 108.892 157.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -133.48 128.32 35.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.709 -0.478 . . . . 13.17 109.709 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.87 122.49 7.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.514 -0.312 . . . . 12.98 111.58 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.31 92.31 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.933 -0.576 . . . . 14.34 113.101 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.99 78.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 13.12 111.687 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -130.6 171.67 12.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.936 -0.765 . . . . 10.62 108.936 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -115.21 156.58 25.08 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.649 -0.501 . . . . 7.82 109.649 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.7 mt-10 -102.36 124.07 47.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.562 0.696 . . . . 10.79 111.375 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 125' ' ' VAL . 26.0 mm -86.04 111.83 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.963 -1.017 . . . . 6.73 109.16 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 3.8 mp -81.15 -45.69 16.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.974 -1.012 . . . . 8.79 111.006 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 125' ' ' VAL . 42.6 mt-10 -146.59 173.02 12.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.139 -0.689 . . . . 10.44 109.139 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 93.2 -63.01 2.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.144 -1.027 . . . . 8.87 113.715 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.623 HD13 HG11 ' A' ' 123' ' ' VAL . 35.9 tp -105.41 145.09 31.28 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.234 -1.024 . . . . 8.5 108.234 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 85.8 tttt -136.34 143.8 44.29 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 112.734 0.642 . . . . 14.15 112.734 -161.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 1.037 ' HA ' HG23 ' A' ' 84' ' ' VAL . . . -49.62 123.91 8.62 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.845 -1.525 . . . . 12.12 111.375 -173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.1 1.12 38.72 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 114.853 -1.067 . . . . 11.54 111.286 -171.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 14.8 mm100 -103.7 125.52 50.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.766 -0.773 . . . . 11.24 110.097 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 mp0 -85.39 142.83 29.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.728 -0.669 . . . . 10.49 110.577 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 16.1 m -135.27 147.27 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.472 0.177 . . . . 5.45 110.597 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 81' ' ' THR . 22.6 m -57.84 133.72 22.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 O-C-N 123.855 0.722 . . . . 6.56 111.878 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 82' ' ' ALA . 45.9 t . . . . . 0 C--N 1.318 -0.761 0 CA-C-N 115.2 -0.909 . . . . 6.99 110.546 -173.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.83 0.348 . . . . 11.84 111.02 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.91 -166.72 1.37 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 12.24 110.001 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.2 171.35 20.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.287 0.565 . . . . 13.16 110.23 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 158' ' ' GLU . 26.9 mt 63.84 61.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 114.393 -1.276 . . . . 11.95 111.183 176.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.26 -9.37 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 11.22 111.279 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.8 p -61.52 -41.13 96.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.308 0.575 . . . . 11.9 110.593 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' A' ' 155' ' ' ILE . 51.5 mm-40 -73.51 -30.8 63.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 11.17 109.799 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.65 -17.9 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.98 -1.009 . . . . 7.82 110.482 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.3 m -81.44 -31.66 32.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.511 -0.768 . . . . 9.64 110.465 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.3 -31.03 48.7 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.297 -0.865 . . . . 10.57 110.833 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -81.47 166.97 19.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.725 -0.671 . . . . 8.9 109.546 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.95 71.95 2.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.089 -0.576 . . . . 7.15 111.84 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.9 p 53.4 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.273 1.029 . . . . 7.09 112.022 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.43 -45.92 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 110.209 -0.293 . . . . 9.2 110.209 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.35 0 O-C-N 123.589 0.556 . . . . 9.11 111.601 -177.892 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt . . . . . 0 N--CA 1.443 -0.814 0 N-CA-C 107.942 -1.132 . . . . 10.38 107.942 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.525 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 3.1 mtp180 -134.8 140.81 46.16 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.161 -1.381 . . . . 8.37 109.239 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' A' ' 58' ' ' GLU . 46.2 mm -51.96 118.24 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.068 -0.969 . . . . 5.76 113.286 -169.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.19 -32.97 7.0 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.8 -1.546 . . . . 8.22 110.009 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 37.6 p90 -179.51 -176.09 0.37 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.734 -0.667 . . . . 7.99 109.625 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -118.77 154.98 31.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.714 . . . . 5.61 110.908 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 39.2 ptt180 -164.06 148.01 9.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.834 0.708 . . . . 9.06 109.721 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 1.027 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 9.4 m-20 -70.73 142.05 88.04 Favored Pre-proline 0 CA--C 1.51 -0.585 0 N-CA-C 108.986 -0.746 . . . . 8.31 108.986 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' CG1' ' A' ' 54' ' ' ILE . 74.6 Cg_endo -68.87 -11.82 32.86 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 123.142 2.562 . . . . 10.41 112.353 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 1.027 ' SD ' ' HB3' ' A' ' 32' ' ' ASP . 1.2 pmm? -102.75 1.34 34.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.289 . . . . 10.85 111.265 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 3.8 m -124.63 39.41 0.45 Allowed Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 112.627 0.603 . . . . 9.32 112.627 177.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.2 Cg_endo -54.41 126.37 22.02 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.305 2.003 . . . . 11.1 112.334 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.86 -12.51 17.65 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.174 -0.771 . . . . 10.31 111.174 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 15.7 tp60 -90.61 108.22 19.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.323 0.583 . . . . 9.21 110.394 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.589 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.7 tmm_? -91.48 97.35 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 11.51 109.414 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 78.5 m-85 -77.25 146.59 36.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 7.5 110.715 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.1 -26.68 68.94 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.255 -1.339 . . . . 10.61 111.264 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 12.7 ptmm? -173.12 168.37 2.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.005 -0.543 . . . . 10.91 110.156 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.2 Cg_endo -52.35 169.29 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.502 2.134 . . . . 7.51 112.52 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.72 -160.01 27.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 7.59 111.644 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 7.1 ttpm? -99.98 151.23 21.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.444 0.64 . . . . 11.68 110.627 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 49' ' ' MET . 36.3 t -67.89 145.32 97.84 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.718 -1.128 . . . . 9.2 111.86 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.08 -19.9 4.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.783 2.322 . . . . 10.25 111.504 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CD2' HG11 ' A' ' 35' ' ' VAL . 59.3 m-85 -81.45 -38.01 27.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.79 -1.096 . . . . 10.49 109.321 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.7 pmm? -153.46 171.41 18.72 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.395 -0.82 . . . . 10.38 110.338 172.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.16 76.65 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.512 0.93 . . . . 12.54 113.512 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.414 ' C ' ' HG3' ' A' ' 45' ' ' LYS . 9.6 ptm -143.9 147.12 37.08 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.857 -1.164 . . . . 9.87 107.857 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 36.6 Cg_endo -67.23 135.99 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.336 1.357 . . . . 9.51 110.12 171.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.89 166.98 6.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.265 0.555 . . . . 6.71 112.096 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.546 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 39.1 mm -101.95 130.51 24.25 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.696 -0.684 . . . . 7.89 109.65 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 17.6 Cg_endo -83.02 134.13 6.91 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.359 1.373 . . . . 5.77 112.21 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 35.3 m -56.03 157.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.254 -1.339 . . . . 5.96 113.099 -176.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.525 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.48 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.935 2.094 . . . . 7.84 115.122 -177.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.545 ' HG2' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -45.68 -41.94 11.03 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.022 0.529 . . . . 6.62 110.747 -178.067 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 32.7 tt0 . . . . . 0 C--N 1.317 -0.828 0 O-C-N 123.669 0.606 . . . . 8.58 111.8 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.969 0.414 . . . . 11.64 110.344 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 148' ' ' VAL . 25.9 p -125.37 137.5 54.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.552 -0.749 . . . . 8.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.497 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -110.47 128.0 55.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.247 -0.649 . . . . 6.65 109.247 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 34.3 tt0 -74.27 132.78 42.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.072 -0.714 . . . . 12.15 109.072 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.614 HG13 ' HB3' ' A' ' 95' ' ' LEU . 49.6 t -55.04 132.63 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.013 -0.539 . . . . 9.71 112.301 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 25.3 mmtp -138.37 148.35 44.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.966 -1.016 . . . . 11.03 109.284 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.83 149.98 36.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.854 -0.795 . . . . 12.76 108.854 167.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.427 ' N ' HD23 ' A' ' 96' ' ' LEU . . . . . . . . 0 CA--C 1.507 -0.407 0 C-N-CA 120.166 -1.016 . . . . 13.25 112.527 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 . . . . . 0 CA--C 1.51 -0.566 0 CA-C-O 121.775 0.798 . . . . 14.94 111.635 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.519 ' HG2' HD12 ' A' ' 138' ' ' LEU . 2.1 mpp_? -132.29 169.61 16.23 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.316 -1.311 . . . . 10.57 109.5 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -94.19 112.69 24.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.555 -0.906 . . . . 8.88 108.555 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -88.44 131.78 34.73 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.532 -0.758 . . . . 9.78 110.667 -175.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 98' ' ' PRO . 5.6 p -147.84 147.0 25.66 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.059 -0.973 . . . . 6.4 109.089 -176.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 97' ' ' VAL . 74.9 Cg_exo -54.05 130.01 37.27 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.407 2.071 . . . . 6.55 110.742 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 40.3 t -56.28 -28.07 57.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.017 0.747 . . . . 9.29 113.017 -170.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.4 9.22 13.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.544 -0.462 . . . . 10.86 111.504 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -82.81 -33.7 27.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.156 0.503 . . . . 5.34 111.469 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.532 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.6 pp -100.63 165.08 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.324 0.583 . . . . 6.97 112.334 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 25.3 mm -104.29 118.62 51.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.45 -0.796 . . . . 10.2 110.294 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 11.0 mmm180 -103.91 94.83 5.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.811 0.339 . . . . 12.12 110.392 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.5 t -145.59 131.16 18.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.5 0.666 . . . . 14.61 111.602 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.88 -123.38 6.16 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.106 -0.952 . . . . 15.52 111.999 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.92 28.18 8.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.102 0.477 . . . . 14.99 111.16 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.42 178.36 9.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 15.2 111.165 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.1 m -128.58 149.99 50.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.937 -0.574 . . . . 9.26 110.35 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.7 mp -126.23 153.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 110.214 -0.291 . . . . 10.55 110.214 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -130.78 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.459 -0.2 . . . . 7.39 110.459 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.441 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 64.1 mtm -99.4 102.88 14.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.539 -0.541 . . . . 8.85 109.539 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 8.3 p -85.77 137.24 21.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.111 0.482 . . . . 9.69 111.451 -172.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 91.98 3.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.651 -0.704 . . . . 10.7 111.513 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -80.06 162.92 24.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.975 -0.557 . . . . 14.88 110.376 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.24 17.87 26.12 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.848 -0.614 . . . . 16.92 112.083 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.52 11.41 39.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 18.56 110.805 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.28 -6.59 67.34 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.56 -0.746 . . . . 15.62 112.467 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.3 167.25 12.92 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.851 -0.499 . . . . 14.19 111.851 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 56.5 m-85 -117.54 111.27 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.467 0.651 . . . . 12.03 109.976 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 30.4 t70 -91.49 134.11 30.04 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.093 -0.958 . . . . 13.91 111.328 -171.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 61.2 Cg_endo -80.58 137.1 11.32 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.201 1.934 . . . . 12.35 113.268 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.643 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.2 p -123.64 127.13 73.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.987 -1.006 . . . . 9.43 109.821 177.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -82.62 114.63 21.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.652 -0.499 . . . . 12.93 109.652 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.455 HG12 ' HA3' ' A' ' 140' ' ' GLY . 35.6 m -130.06 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.671 -0.695 . . . . 8.03 111.208 -173.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 3.5 ttmp? -109.52 127.33 54.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.146 -0.479 . . . . 10.39 110.471 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -143.18 112.4 6.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 8.3 111.457 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.5 72.12 0.27 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 118.178 -1.963 . . . . 10.1 113.659 166.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.03 158.43 44.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.806 -0.812 . . . . 10.61 108.806 156.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 22.6 m -147.13 122.22 10.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.344 0.592 . . . . 13.17 109.891 169.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.02 107.45 8.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.14 -0.937 . . . . 12.98 110.7 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.97 38.16 92.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.188 -0.53 . . . . 14.34 112.4 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.01 87.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 13.12 112.584 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 130' ' ' THR . 30.2 mm-40 -106.04 154.53 20.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.286 -0.635 . . . . 10.62 109.286 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -115.25 165.97 12.36 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.455 -0.498 . . . . 7.82 111.229 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 49.0 mt-10 -114.35 121.11 42.63 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.442 0.639 . . . . 10.79 111.521 175.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.4 mm -85.69 102.72 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.267 -0.879 . . . . 6.73 108.663 169.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.519 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.35 -51.95 60.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.835 -1.075 . . . . 8.79 109.766 -176.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -141.36 160.99 38.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.377 -0.829 . . . . 10.44 110.567 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.455 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 122.26 -64.01 0.52 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.539 -0.839 . . . . 8.87 112.975 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 125' ' ' VAL . 30.6 mt -102.83 -177.31 3.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.931 0.715 . . . . 8.5 112.931 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -143.98 159.65 42.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.865 -1.061 . . . . 14.15 110.102 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.09 129.22 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.245 -0.889 . . . . 12.12 110.463 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.46 -7.0 26.46 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.729 -0.948 . . . . 11.54 110.729 -171.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.529 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.4 mm100 -97.83 117.41 32.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.514 . . . . 11.24 110.303 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -86.96 127.18 35.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.551 -0.749 . . . . 10.49 111.406 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.62 140.98 46.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.898 -0.592 . . . . 5.45 110.179 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.561 ' HA ' HG22 ' A' ' 81' ' ' THR . 60.9 t -66.26 125.19 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 6.56 110.548 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 82' ' ' ALA . 3.9 m . . . . . 0 C--N 1.325 -0.458 0 N-CA-C 112.221 0.452 . . . . 6.99 112.221 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 . . . . . 0 CA--C 1.53 0.181 0 CA-C-O 121.577 0.704 . . . . 11.84 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.1 18.39 5.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.722 -0.672 . . . . 12.24 110.833 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.92 -67.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.732 0.813 . . . . 13.16 109.936 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.7 mt -98.08 75.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.229 -0.656 . . . . 11.95 109.229 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -72.87 -17.12 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.972 -0.558 . . . . 11.22 111.134 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 m -66.67 -48.57 68.92 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.945 -0.702 . . . . 11.9 109.972 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.21 -22.03 59.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.653 -0.419 . . . . 11.17 110.589 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 162' ' ' ARG . . . -54.73 -42.18 71.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 7.82 110.067 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . 0.5 ' OG ' HD12 ' A' ' 103' ' ' ILE . 29.4 t -64.16 -30.01 71.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.238 -0.892 . . . . 9.64 111.506 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.3 mt -85.45 -33.46 21.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 10.57 111.345 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 5.8 ptm180 -77.5 161.96 27.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.907 -0.588 . . . . 8.9 110.696 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.53 57.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.344 -0.702 . . . . 7.15 111.344 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.6 p 48.33 57.15 6.5 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.082 0.553 . . . . 7.09 111.677 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t 64.62 94.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.743 -0.662 . . . . 9.2 109.837 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.637 . . . . 9.11 111.816 -174.64 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.922 0 CA-C-O 122.352 1.073 . . . . 10.38 108.201 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.629 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 5.7 ppt_? -129.71 141.19 50.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.564 -1.653 . . . . 8.37 109.085 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.4 mm -68.02 128.55 31.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 113.566 0.951 . . . . 5.76 113.566 -169.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 26' ' ' ARG . 4.4 mp -117.94 -47.64 2.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.991 -1.459 . . . . 8.22 110.39 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.4 p90 -155.65 -179.59 8.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 7.99 111.023 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.721 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.23 149.62 41.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.172 -0.922 . . . . 5.61 110.499 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HB2' HE22 ' A' ' 38' ' ' GLN . 38.9 ptt180 -148.27 146.3 28.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 9.06 110.08 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.3 t0 -78.57 131.45 68.08 Favored Pre-proline 0 C--N 1.314 -0.944 0 N-CA-C 109.798 -0.445 . . . . 8.31 109.798 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HG3' HG13 ' A' ' 54' ' ' ILE . 63.5 Cg_exo -45.11 -48.86 10.65 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.79 2.327 . . . . 10.41 111.944 -176.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.643 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.3 pmm? -91.57 9.99 29.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.212 -1.358 . . . . 10.85 112.985 -167.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 32' ' ' ASP . 6.6 m -126.32 44.92 1.32 Allowed Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 121.429 0.633 . . . . 9.32 111.562 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.643 ' HD3' ' C ' ' A' ' 34' ' ' MET . 26.0 Cg_exo -61.66 119.9 7.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.194 2.596 . . . . 11.1 113.177 -169.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.5 4.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.467 -0.653 . . . . 10.31 111.467 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.09 142.56 30.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 9.21 109.925 176.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -129.38 93.97 3.68 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.935 0.398 . . . . 11.51 110.606 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 23.8 m-85 -73.01 143.38 47.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.507 -0.769 . . . . 7.5 110.974 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.14 -27.82 68.99 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.348 -1.297 . . . . 10.61 110.455 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.0 ptpt -166.23 162.84 12.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.931 -0.577 . . . . 10.91 111.218 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.3 Cg_endo -51.3 169.56 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.64 2.893 . . . . 7.51 113.78 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -171.1 30.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.503 -0.856 . . . . 7.59 113.028 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 6.1 ttmm -88.63 143.26 27.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.447 -0.575 . . . . 11.68 109.447 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' MET . 37.8 t -62.28 136.2 95.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 9.2 110.425 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 -21.06 19.51 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 122.186 1.924 . . . . 10.25 110.904 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -84.94 -41.23 16.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.878 -1.51 . . . . 10.49 109.485 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 3.1 mtm -133.72 153.51 51.64 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.36 -0.836 . . . . 10.38 111.27 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.7 p-10 -80.63 59.28 3.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.084 0.945 . . . . 12.54 111.168 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -136.33 143.25 42.76 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.899 -1.046 . . . . 9.87 109.356 176.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 24.9 Cg_endo -63.93 133.41 38.6 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.0 1.8 . . . . 9.51 111.158 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.8 mt -61.97 163.76 7.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 6.71 110.62 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' HG3' ' A' ' 33' ' ' PRO . 44.2 mm -105.27 129.39 24.84 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 7.89 109.956 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.721 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 60.3 Cg_endo -73.83 140.14 28.56 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.818 1.678 . . . . 5.77 112.189 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.43 156.51 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.395 -1.275 . . . . 5.96 112.791 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.629 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.73 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.945 2.098 . . . . 7.84 115.553 -176.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.578 ' HG2' HG12 ' A' ' 27' ' ' ILE . 3.2 pt-20 -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.378 1.561 . . . . 6.62 110.54 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 111.022 -2.808 . . . . 8.58 111.705 168.772 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 80' ' ' ARG . 6.4 mpt_? . . . . . 0 CA--C 1.513 -0.447 0 CA-C-O 121.227 0.537 . . . . 11.64 109.746 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 148' ' ' VAL . 40.6 p -132.39 154.15 50.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 8.0 111.046 -172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 127.28 49.51 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.468 -0.938 . . . . 6.65 108.468 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 42.1 tt0 -76.59 133.26 39.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.624 -0.51 . . . . 12.15 109.624 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 145' ' ' GLN . 48.0 t -53.32 130.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 9.71 112.755 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 50.0 mmtt -134.89 142.8 46.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.856 -1.065 . . . . 11.03 109.925 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -75.53 158.32 32.7 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.504 -0.554 . . . . 12.76 109.504 171.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.571 0 C-N-CA 120.426 -0.893 . . . . 13.25 112.653 179.726 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.512 -0.499 0 CA-C-O 121.575 0.702 . . . . 14.94 111.494 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.514 ' CD ' ' HA ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -123.01 158.57 30.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.775 -1.102 . . . . 10.57 109.959 -176.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -98.37 122.08 41.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.152 0.501 . . . . 8.88 109.894 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.25 134.33 38.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.073 -0.512 . . . . 9.78 110.606 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 98' ' ' PRO . 3.8 p -150.07 147.99 23.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 6.4 109.052 -175.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.4 Cg_exo -56.22 130.65 41.29 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.271 1.98 . . . . 6.55 110.212 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.494 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 19.0 t -57.41 -27.08 62.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.465 0.543 . . . . 9.29 112.465 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.36 3.97 33.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 10.86 111.547 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.61 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -77.93 -41.24 36.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.196 0.522 . . . . 5.34 110.91 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -86.17 158.88 19.66 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.728 -0.669 . . . . 6.97 111.898 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -101.61 126.35 55.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.327 -0.851 . . . . 10.2 108.826 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 11.6 mmm180 -101.13 128.41 47.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.519 -0.872 . . . . 12.12 111.027 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -149.32 129.17 13.35 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.285 -0.87 . . . . 14.61 110.516 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.76 -109.3 1.05 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 116.008 -0.542 . . . . 15.52 112.957 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.62 17.24 13.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 14.99 111.35 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.14 177.34 7.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.181 0.515 . . . . 15.2 111.745 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.7 m -129.2 144.71 51.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 9.26 109.377 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.8 mm -126.56 153.04 34.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 10.55 109.375 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -134.68 132.47 38.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.394 -0.191 . . . . 7.39 111.088 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 49.7 ttp -94.55 105.57 17.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.176 -0.675 . . . . 8.85 109.176 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 121' ' ' ASP . 7.1 p -88.26 134.01 29.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.89 -1.05 . . . . 9.69 112.423 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -83.3 92.47 7.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.187 -0.915 . . . . 10.7 110.108 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -86.5 149.96 24.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.057 -0.52 . . . . 14.88 111.332 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.05 0.15 74.12 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.156 -0.778 . . . . 16.92 111.156 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.27 -1.57 30.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.344 0.593 . . . . 18.56 110.887 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.89 -8.55 63.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.153 -0.93 . . . . 15.62 113.021 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.03 159.4 22.26 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.289 -0.958 . . . . 14.19 112.303 -174.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 88.8 m-85 -109.53 121.23 44.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.377 -0.601 . . . . 12.03 109.377 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.6 m-20 -122.29 151.58 59.36 Favored Pre-proline 0 CA--C 1.514 -0.421 0 C-N-CA 120.555 -0.458 . . . . 13.91 111.471 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 84.1 Cg_endo -88.77 136.27 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.417 2.078 . . . . 12.35 112.433 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.63 138.31 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.331 -0.85 . . . . 9.43 109.179 176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.6 130.9 36.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.854 -0.424 . . . . 12.93 109.854 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -140.98 158.36 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.818 -0.628 . . . . 8.03 111.157 -175.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.5 ttmm -100.2 128.61 46.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.632 -0.713 . . . . 10.39 109.89 174.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.438 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -140.84 105.62 4.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.478 -0.328 . . . . 8.3 111.638 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.0 72.38 0.27 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 118.441 -1.838 . . . . 10.1 113.938 169.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.92 162.69 39.35 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.402 -0.962 . . . . 10.61 108.402 154.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.4 m -139.72 132.59 29.24 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.672 -0.411 . . . . 13.17 110.001 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.22 99.89 3.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.066 -0.516 . . . . 12.98 111.443 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.8 40.03 89.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.09 -0.576 . . . . 14.34 112.43 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.22 1.83 90.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.031 -0.604 . . . . 13.12 112.195 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.13 164.0 12.67 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.037 -1.097 . . . . 10.62 108.037 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 21.0 p -117.05 162.1 18.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.152 -0.619 . . . . 7.82 111.108 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 36.6 mt-10 -112.99 123.94 51.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.616 0.722 . . . . 10.79 111.277 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 125' ' ' VAL . 24.4 mm -88.11 107.43 17.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.878 -1.056 . . . . 6.73 109.323 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.9 mp -72.68 -49.9 28.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 8.79 109.85 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 125' ' ' VAL . 46.6 mt-10 -142.11 166.76 23.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.008 -0.738 . . . . 10.44 109.008 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.538 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 114.29 -51.97 0.68 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.395 -1.383 . . . . 8.87 113.885 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.64 -174.92 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 8.5 112.744 -172.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.7 ttmt -151.25 157.09 42.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 14.15 109.523 -175.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.64 126.71 30.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 12.12 109.95 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.85 -7.09 29.48 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.996 -0.842 . . . . 11.54 110.996 -170.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.0 mm-40 -95.5 112.92 24.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.209 -0.664 . . . . 11.24 109.209 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 28.5 mt-30 -85.95 123.65 31.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.028 -0.533 . . . . 10.49 110.502 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.55 139.8 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.864 -0.607 . . . . 5.45 110.323 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 18.6 m -66.24 120.61 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.805 -0.634 . . . . 6.56 111.478 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.8 m . . . . . 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 6.99 109.889 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.19 -0.3 . . . . 11.84 110.19 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -88.24 -31.36 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.967 -0.753 . . . . 12.24 108.967 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 154' ' ' LEU . 1.1 mm? -97.42 -161.29 0.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.858 -1.064 . . . . 13.16 108.768 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 10.4 mm -95.86 -128.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.701 -0.851 . . . . 11.95 108.701 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.99 30.01 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.289 0.566 . . . . 11.22 110.005 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -72.5 -18.97 61.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.676 -0.693 . . . . 11.9 111.813 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -44.1 77.79 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.397 -0.921 . . . . 11.17 109.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.47 66.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.307 -0.86 . . . . 7.82 110.832 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.3 m -70.01 -61.98 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.829 0.823 . . . . 9.64 109.65 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.2 -31.66 70.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 113.74 -1.573 . . . . 10.57 112.256 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -82.52 -39.23 22.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 124.753 1.283 . . . . 8.9 110.032 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 52.26 60.35 7.82 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.105 -0.952 . . . . 7.15 113.015 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 32.8 p 50.63 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.986 0.914 . . . . 7.09 112.435 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.1 p -72.41 95.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.831 . . . . 9.2 112.08 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 9.11 110.269 177.416 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.998 0.428 . . . . 34.32 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 118.29 168.82 14.44 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.942 -0.647 . . . . 33.09 111.83 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 p -105.57 111.44 24.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.928 0.394 . . . . 34.12 110.156 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.66 42.59 0.78 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.346 -0.388 . . . . 32.32 111.708 -174.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.2 t -131.53 38.85 3.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.47 0.652 . . . . 32.74 109.939 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -69.91 -31.06 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.586 -0.734 . . . . 31.29 111.441 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -84.74 156.31 21.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.064 -0.347 . . . . 29.46 110.064 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.76 -147.67 7.84 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 28.28 111.672 177.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.51 157.14 56.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.824 2.349 . . . . 27.51 111.868 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -100.54 -167.64 1.47 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.066 -0.346 . . . . 26.48 110.066 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.27 159.91 14.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.968 0.413 . . . . 24.9 110.66 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.85 42.22 21.18 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.361 -0.696 . . . . 23.19 111.361 -176.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.49 ' HA ' ' H ' ' A' ' 152' ' ' GLN . 7.3 p-80 -103.29 87.76 2.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.337 0.589 . . . . 21.31 111.92 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -72.83 120.18 79.45 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 108.949 -0.76 . . . . 19.89 108.949 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.32 52.93 3.32 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 123.73 2.953 . . . . 18.12 114.434 -165.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 82' ' ' ALA . . . -112.35 -28.92 7.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.11 0.411 . . . . 16.58 112.11 -178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.725 ' O ' ' HA ' ' A' ' 152' ' ' GLN . . . -148.63 115.87 6.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.872 0.367 . . . . 14.8 111.476 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.418 ' HA2' ' H ' ' A' ' 153' ' ' PHE . . . -96.97 -3.07 59.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 13.17 111.459 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 50.23 86.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.948 0.899 . . . . 12.17 113.042 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -93.51 96.09 9.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.783 -1.099 . . . . 13.82 108.83 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 66.53 36.17 5.12 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 113.805 -1.543 . . . . 12.13 110.564 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -109.65 -1.0 18.37 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 122.413 1.102 . . . . 14.1 108.452 167.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.3 t -153.86 -174.93 5.14 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 113.608 -1.633 . . . . 11.05 109.015 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.58 -96.9 1.43 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.572 -0.823 . . . . 10.05 112.528 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -137.5 66.21 1.46 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.45 1.119 . . . . 10.38 109.755 -174.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.555 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 0.2 OUTLIER -128.85 139.46 52.15 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.347 -1.297 . . . . 8.37 108.217 178.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 58' ' ' GLU . 23.5 mm -49.52 117.96 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.772 0 CA-C-O 121.944 0.878 . . . . 5.76 112.636 -172.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 15.3 tp -102.13 -33.97 9.46 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.297 -1.774 . . . . 8.22 109.923 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 1.6 p90 -179.67 -177.49 0.41 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.607 -0.724 . . . . 7.99 109.884 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.727 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -116.83 147.38 42.17 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 115.388 -0.824 . . . . 5.61 110.281 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.437 ' HB2' HE22 ' A' ' 38' ' ' GLN . 28.3 ptt180 -142.55 149.87 39.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.185 -0.916 . . . . 9.06 110.353 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.79 ' HB3' HG22 ' A' ' 35' ' ' VAL . 10.0 t70 -92.08 136.25 26.19 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.138 -1.06 . . . . 8.31 108.138 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' A' ' 54' ' ' ILE . 16.8 Cg_exo -62.33 -13.22 31.29 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.116 1.877 . . . . 10.41 112.201 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.55 0.36 42.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.782 -0.19 . . . . 10.85 111.504 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -128.28 38.42 0.43 Allowed Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 112.802 0.668 . . . . 9.32 112.802 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.455 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 27.4 Cg_endo -57.92 131.81 45.94 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.576 2.184 . . . . 11.1 112.508 -175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.84 -7.45 31.45 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.651 -0.785 . . . . 10.31 111.204 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.577 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -82.68 -179.78 7.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.534 . . . . 9.21 109.731 176.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 7.0 tpt180 -151.29 94.26 2.01 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.098 -0.334 . . . . 11.51 110.098 174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.577 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 90.7 m-85 -76.49 139.68 40.9 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.262 -0.575 . . . . 7.5 110.708 178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -64.71 -29.94 70.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.799 -1.091 . . . . 10.61 111.084 -175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.526 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.5 pttm -168.79 164.22 7.61 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.111 -0.495 . . . . 10.91 111.006 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.727 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.1 Cg_endo -48.19 169.69 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.992 3.128 . . . . 7.51 114.403 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 142.64 -162.57 27.35 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.918 -0.658 . . . . 7.59 112.392 178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 4.0 ttmm -92.92 141.74 28.08 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.669 -0.493 . . . . 11.68 109.669 177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.5 p -58.4 136.13 85.41 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 115.218 -0.901 . . . . 9.2 110.962 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -76.85 -27.16 7.37 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.136 1.891 . . . . 10.25 112.028 171.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.624 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 91.4 m-85 -81.91 -31.05 31.57 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.153 0.502 . . . . 10.49 110.851 -175.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.624 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.67 -161.06 0.98 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.481 -0.781 . . . . 10.38 108.911 174.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 6.5 p-10 -128.17 59.05 1.51 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 122.019 0.914 . . . . 12.54 109.623 170.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 15.1 ptm -132.82 145.1 55.69 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 114.484 -1.235 . . . . 9.87 109.766 177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.62 37.59 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.669 1.58 . . . . 9.51 110.414 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.1 mt -63.33 161.27 14.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.173 0.511 . . . . 6.71 111.415 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 ' HD3' ' A' ' 33' ' ' PRO . 1.7 mp -98.74 133.85 22.11 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 109.132 -0.692 . . . . 7.89 109.132 -178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 59' ' ' GLU . 83.5 Cg_endo -85.28 150.18 10.52 Favored 'Trans proline' 0 N--CA 1.438 -1.784 0 C-N-CA 121.265 1.31 . . . . 5.77 113.126 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.2 m -74.3 158.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 114.564 -1.198 . . . . 5.96 112.397 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.555 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 11.97 -76.92 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.358 2.263 . . . . 7.84 115.353 -178.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -57.84 -47.04 83.84 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.287 0.635 . . . . 6.62 109.596 -175.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 43.6 mt-10 68.99 79.3 0.21 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.629 0.728 . . . . 8.58 112.646 178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 81.26 68.26 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.795 -1.548 . . . . 7.64 113.099 157.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.635 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 62.5 t30 -164.11 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.645 -1.161 . . . . 7.02 108.493 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.548 ' HB2' ' H ' ' A' ' 27' ' ' ILE . . . 42.58 -86.1 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.247 1.019 . . . . 5.41 113.364 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.595 ' OD2' ' HA2' ' A' ' 71' ' ' GLY . 16.8 m-20 -84.69 21.24 1.57 Allowed 'General case' 0 N--CA 1.433 -1.3 0 CA-C-O 121.748 0.785 . . . . 7.01 111.685 -174.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 60.57 22.74 59.67 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 114.314 -1.312 . . . . 7.2 113.076 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 64' ' ' GLY . . . 70.59 57.96 0.24 Allowed 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 124.14 0.553 . . . . 7.82 110.418 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 78.88 1.41 2.47 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.191 -0.913 . . . . 8.65 112.99 173.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 64' ' ' GLY . 57.6 t -67.36 -51.19 55.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 122.038 0.923 . . . . 7.31 109.148 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HB2' ' CA ' ' A' ' 63' ' ' ASP . 23.1 mmt180 -70.78 -155.49 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 113.755 -1.566 . . . . 10.21 110.923 171.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.497 HG22 ' N ' ' A' ' 70' ' ' ASP . 9.9 mt -50.35 162.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 112.318 -2.219 . . . . 8.86 110.988 173.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' N ' HG22 ' A' ' 69' ' ' ILE . 36.4 t70 -70.41 32.52 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.57 -0.741 . . . . 13.02 112.179 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.595 ' HA2' ' OD2' ' A' ' 63' ' ' ASP . . . 73.83 14.74 79.83 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 121.361 -0.447 . . . . 12.13 112.33 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 116' ' ' GLY . 0.8 OUTLIER -112.24 141.04 46.43 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 107.58 -1.267 . . . . 12.38 107.58 175.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.7 t -114.68 92.15 2.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-O 121.64 0.734 . . . . 11.61 109.644 -170.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.0 t -76.86 40.13 0.24 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.946 -1.479 . . . . 10.71 110.691 -176.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.507 ' C ' ' H ' ' A' ' 77' ' ' LEU . 10.1 tp60 -123.03 99.22 6.27 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.268 -0.878 . . . . 14.09 108.729 -172.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 62.7 t30 -71.41 22.37 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.236 -0.893 . . . . 11.22 112.246 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 75' ' ' GLN . 23.3 tp 65.95 -70.69 0.1 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 124.087 0.955 . . . . 13.71 111.569 178.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.0 24.11 7.18 Favored Glycine 0 CA--C 1.503 -0.691 0 CA-C-N 116.185 -0.461 . . . . 11.44 112.791 -175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.497 ' HB ' ' HB3' ' A' ' 76' ' ' ASN . 4.0 t -148.18 113.06 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 109.766 -0.457 . . . . 9.99 109.766 -174.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.526 ' H ' ' HA ' ' A' ' 150' ' ' SER . 8.0 mpt_? -105.33 167.3 9.83 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.686 -0.487 . . . . 11.64 109.686 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.433 HG21 ' HB2' ' A' ' 114' ' ' ALA . 42.8 p -135.19 177.82 7.51 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.165 0.507 . . . . 8.0 111.484 -174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.415 ' HB2' ' HB1' ' A' ' 16' ' ' ALA . . . -142.71 131.63 22.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.366 -0.834 . . . . 6.65 109.044 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 35.3 tt0 -79.47 141.24 36.93 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.952 0.406 . . . . 12.15 110.515 -176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 95' ' ' LEU . 70.6 t -69.16 127.31 30.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 9.71 110.548 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -162.92 146.68 11.14 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.07 -0.968 . . . . 11.03 111.642 174.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD23 ' HB3' ' A' ' 93' ' ' GLU . 7.5 mp -70.1 132.45 45.86 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.11 -1.405 . . . . 12.76 110.37 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.494 ' H ' HD23 ' A' ' 96' ' ' LEU . . . -126.52 22.86 5.79 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 120.186 -1.007 . . . . 13.25 113.628 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.698 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 6.5 ptp180 -141.63 156.41 45.66 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 120.936 0.398 . . . . 16.35 111.183 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 77.0 mt -152.35 113.58 4.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.978 -1.01 . . . . 18.22 108.372 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.27 -47.97 1.04 Allowed Glycine 0 CA--C 1.502 -0.76 0 N-CA-C 108.56 -1.816 . . . . 17.91 108.56 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 15.1 m -69.87 177.94 2.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.028 -1.086 . . . . 17.11 108.766 166.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.479 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 2.9 m -86.27 108.76 18.54 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 115.903 -0.59 . . . . 14.73 110.38 -170.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.698 ' HA ' ' HG3' ' A' ' 88' ' ' ARG . 18.0 mt-10 -58.47 119.54 7.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 124.461 1.1 . . . . 14.94 112.539 -172.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.511 ' H ' ' HD2' ' A' ' 88' ' ' ARG . 23.1 mmt85 -135.09 164.49 27.54 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 113.454 -1.703 . . . . 10.57 107.026 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -88.83 113.21 24.13 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.919 -0.771 . . . . 8.88 108.919 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.5 mm? -87.47 129.89 34.9 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 116.082 -0.508 . . . . 9.78 111.369 -172.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.18 155.85 58.09 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 115.444 -0.798 . . . . 6.4 109.424 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.35 139.11 81.33 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.289 1.992 . . . . 6.55 111.559 171.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.3 m -57.71 -28.44 63.85 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.64 0.608 . . . . 9.29 112.64 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.85 -2.39 58.54 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.828 -0.349 . . . . 10.86 111.059 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -71.68 -41.09 69.11 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.48 0.657 . . . . 5.34 111.015 -175.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -92.51 160.26 15.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.47 -0.786 . . . . 6.97 111.614 -173.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.67 113.27 37.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.708 -0.678 . . . . 10.2 109.192 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 7.7 mmm180 -89.53 126.14 35.48 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.735 -0.786 . . . . 12.12 110.446 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -149.18 132.71 16.72 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.862 -0.608 . . . . 14.61 110.551 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 54.69 -115.57 5.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.26 -0.495 . . . . 15.52 112.568 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.92 36.21 4.66 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.803 0.335 . . . . 14.99 111.671 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.79 -178.96 6.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.313 -0.403 . . . . 15.2 110.502 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 27.3 m -132.11 150.95 52.03 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.725 0.298 . . . . 9.26 111.269 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.48 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.7 mm -123.33 149.11 27.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.099 -0.704 . . . . 10.55 109.099 175.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -129.49 125.85 37.34 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.282 -0.266 . . . . 7.39 110.282 177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.521 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 48.6 ttp -85.95 99.56 11.51 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.687 -1.227 . . . . 8.85 107.687 171.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 121' ' ' ASP . 12.7 p -81.78 136.82 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.254 -0.884 . . . . 9.69 111.195 -169.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.65 97.42 7.23 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.194 -0.669 . . . . 10.7 109.194 173.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -76.74 139.77 40.56 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.662 -0.699 . . . . 14.88 109.221 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.561 ' O ' ' HD2' ' A' ' 72' ' ' ARG . . . -58.43 -16.81 30.02 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 116.005 -0.543 . . . . 16.92 113.027 -175.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -79.17 4.72 13.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.164 0.507 . . . . 18.56 111.811 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 94.63 9.98 58.31 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.708 -0.678 . . . . 15.62 112.969 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -122.99 175.22 16.54 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.76 -0.733 . . . . 14.19 112.241 -174.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.2 m-85 -126.03 136.76 53.33 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.059 -0.349 . . . . 12.03 110.059 -177.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.54 ' O ' HG12 ' A' ' 113' ' ' VAL . 23.0 t70 -138.03 141.53 32.69 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 116.331 -0.395 . . . . 13.91 111.375 -175.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -82.51 138.5 9.7 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.718 1.612 . . . . 12.35 112.482 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.8 p -135.39 136.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.622 -0.717 . . . . 9.43 109.82 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.44 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.8 tt0 -81.48 125.02 29.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.629 -0.508 . . . . 12.93 109.629 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -133.5 157.78 42.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.455 -0.793 . . . . 8.03 110.76 -172.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 4.3 ttmp? -95.19 120.3 35.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.73 -0.668 . . . . 10.39 109.388 174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.46 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -143.9 104.48 4.16 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.969 -0.56 . . . . 8.3 111.469 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.21 70.46 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.744 -2.17 . . . . 10.1 114.265 169.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.661 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.17 163.12 39.55 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.689 -0.486 . . . . 10.61 109.689 157.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 22.0 m -133.59 134.24 43.03 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.381 -0.6 . . . . 13.17 109.381 169.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.35 107.18 3.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.105 0.409 . . . . 12.98 112.105 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.29 44.51 59.25 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.199 -0.524 . . . . 14.34 113.105 172.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.0 17.35 80.27 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.67 -0.776 . . . . 13.12 112.236 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -137.55 166.0 24.95 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.422 -0.584 . . . . 10.62 109.422 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.5 m -115.71 162.84 16.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 120.963 0.411 . . . . 7.82 110.246 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.661 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 66.7 mt-10 -106.27 121.16 43.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.483 0.659 . . . . 10.79 111.433 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 125' ' ' VAL . 21.1 mm -88.25 101.52 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.014 -0.994 . . . . 6.73 108.565 168.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.9 mp -68.84 -45.0 72.25 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.553 -1.203 . . . . 8.79 109.738 -176.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 125' ' ' VAL . 40.9 mt-10 -150.45 165.52 32.92 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-N 115.776 -0.647 . . . . 10.44 109.353 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.555 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 128.63 -61.49 0.65 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 119.981 -1.104 . . . . 8.87 113.299 176.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 123' ' ' VAL . 36.7 mt -116.0 179.62 3.93 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.305 0.574 . . . . 8.5 112.347 -173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -129.64 152.44 49.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.875 -1.057 . . . . 14.15 110.481 -173.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.72 132.35 45.98 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.058 -0.973 . . . . 12.12 110.168 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.51 -11.25 30.6 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.092 -0.803 . . . . 11.54 111.092 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.5 HE21 HG21 ' A' ' 113' ' ' VAL . 9.5 mt-30 -104.27 163.76 12.2 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 107.75 -1.204 . . . . 11.24 107.75 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 14.2 mt-30 -120.93 167.84 12.13 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 119.04 0.836 . . . . 10.49 111.561 177.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.14 156.68 41.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.217 -0.901 . . . . 5.45 108.853 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 7.6 p -76.62 128.52 37.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.63 0.252 . . . . 6.56 110.587 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.4 m -130.13 -19.79 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.975 -0.29 . . . . 6.99 111.602 -178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.526 ' HA ' ' H ' ' A' ' 80' ' ' ARG . 37.6 m 43.94 60.21 2.82 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.378 0.609 . . . . 9.06 112.478 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -146.8 163.26 28.58 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 110.284 -1.126 . . . . 8.5 110.284 174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.725 ' HA ' ' O ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -121.23 149.04 43.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.703 0.752 . . . . 11.84 111.652 -178.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.418 ' H ' ' HA2' ' A' ' 18' ' ' GLY . 17.7 t80 -103.88 166.57 10.33 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.543 -0.54 . . . . 12.24 109.543 176.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.6 mp -69.74 -60.82 2.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.824 -0.35 . . . . 13.16 111.138 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.2 tt -125.08 113.02 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.549 0.69 . . . . 11.95 110.301 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -83.68 -0.15 49.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.825 -0.625 . . . . 11.22 112.017 -172.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.667 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 13.2 m -58.54 -43.22 89.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 115.88 -0.6 . . . . 11.9 111.023 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -52.03 -54.99 23.42 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.76 -0.459 . . . . 11.17 109.76 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -59.74 -45.3 92.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 114.845 -1.07 . . . . 7.82 111.395 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.1 m -58.94 -35.54 73.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.865 -0.607 . . . . 9.64 111.868 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 157' ' ' SER . 80.4 mt -61.99 -22.13 65.43 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.242 -0.89 . . . . 10.57 111.516 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -83.43 117.79 23.29 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 109.637 -0.505 . . . . 8.9 109.637 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 105.58 -18.28 41.38 Favored Glycine 0 N--CA 1.435 -1.425 0 C-N-CA 119.927 -1.13 . . . . 7.15 112.734 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 16.7 p -102.17 -76.64 0.57 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.787 0.327 . . . . 7.09 110.646 177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 14.4 p -86.46 -24.16 6.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.29 0.567 . . . . 9.2 110.211 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -107.11 141.66 38.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.899 -0.591 . . . . 9.11 110.598 178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.745 ' HD2' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -131.26 -121.3 0.21 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.877 -0.786 . . . . 14.58 108.877 175.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 22.9 mtm 66.99 153.14 0.08 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.763 0.792 . . . . 11.94 112.044 175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.411 ' C ' ' H ' ' A' ' 171' ' ' THR . 0.3 OUTLIER -80.35 139.0 36.78 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.742 -0.663 . . . . 14.99 110.851 -177.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 74.55 -26.12 0.19 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.846 0.858 . . . . 15.01 112.301 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 167' ' ' ARG . 80.2 p 52.85 28.26 6.28 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.031 0.932 . . . . 14.25 113.203 176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.9 t -90.1 -179.61 5.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.779 0.323 . . . . 14.89 110.723 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 20.2 m -152.57 155.89 38.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 118.777 -0.63 . . . . 15.85 109.897 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 53.68 49.69 56.83 Favored Glycine 0 C--O 1.242 0.653 0 C-N-CA 119.778 -1.201 . . . . 17.54 110.732 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 33.6 tp -160.02 70.14 0.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.672 -0.764 . . . . 17.85 109.612 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.07 -52.8 6.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.896 -0.593 . . . . 19.67 110.286 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.0 m -126.86 139.28 52.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.892 -0.595 . . . . 19.52 110.188 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 39.9 tp -134.91 92.48 2.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.07 0.462 . . . . 21.15 110.517 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -118.23 -51.09 2.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.827 -0.624 . . . . 23.25 110.038 177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.198 -0.906 . . . . 23.52 110.493 -178.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.297 -0.26 . . . . 34.32 110.297 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.96 79.02 1.33 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 121.11 -0.567 . . . . 33.09 112.351 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.4 m -72.34 -33.19 67.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.951 0.405 . . . . 34.12 110.61 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -64.22 127.98 33.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.738 -0.665 . . . . 32.32 110.516 179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -79.74 63.39 4.29 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.441 0.639 . . . . 32.74 110.749 -176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.4 171.42 15.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.577 -0.738 . . . . 31.29 109.459 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -146.5 168.39 21.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.014 0.435 . . . . 29.46 111.447 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 121.47 -152.77 16.77 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.457 -0.792 . . . . 28.28 111.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -101.32 23.91 0.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 123.701 2.934 . . . . 27.51 111.754 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.8 m80 59.46 73.55 0.48 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.714 -0.847 . . . . 26.48 108.714 -170.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 13' ' ' HIS . 18.4 t70 -53.4 128.07 27.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.531 -1.213 . . . . 24.9 112.447 -172.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -120.42 45.02 1.28 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.458 -0.792 . . . . 23.19 111.649 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.402 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -62.27 139.72 58.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.359 0.599 . . . . 21.31 111.418 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.62 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 16.6 t70 -64.55 -36.53 18.43 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 114.721 -1.127 . . . . 19.89 113.085 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 21.1 Cg_endo -63.2 57.37 0.17 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.408 2.072 . . . . 18.12 112.739 170.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 166' ' ' ALA . . . -103.98 -11.31 17.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 16.58 111.298 -176.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.73 68.82 1.34 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.435 0.636 . . . . 14.8 110.148 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.21 60.33 3.92 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.543 -0.753 . . . . 13.17 112.674 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.01 -75.7 0.41 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.789 0.328 . . . . 12.17 110.655 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -91.66 77.06 5.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.727 -0.472 . . . . 13.82 109.727 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.5 tp 70.81 -10.32 0.74 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.474 -0.784 . . . . 12.13 110.822 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.438 ' HD2' ' O ' ' A' ' 15' ' ' PRO . 32.5 ttpt 65.95 18.14 10.99 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 122.17 0.986 . . . . 14.1 109.666 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 77.6 m -164.86 118.11 1.27 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.872 -1.513 . . . . 11.05 108.728 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.48 -114.29 0.6 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 119.512 -1.328 . . . . 10.05 113.833 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 3.1 mppt? -121.2 71.9 0.97 Allowed 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.3 -1.0 . . . . 10.38 108.3 -172.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.584 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -135.29 130.67 35.47 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.133 -0.94 . . . . 8.37 111.042 -174.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.763 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 41.2 mm -55.2 133.29 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-O 122.268 1.032 . . . . 5.76 113.107 -171.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 mt -118.74 -25.97 6.22 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 113.37 -1.741 . . . . 8.22 109.712 174.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.558 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 14.1 p90 179.99 179.03 0.56 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.897 -0.592 . . . . 7.99 111.098 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.724 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -118.38 154.88 31.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.919 -1.037 . . . . 5.61 109.965 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 40' ' ' PHE . 7.4 ptp180 -156.4 145.36 20.32 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.153 0.502 . . . . 9.06 110.29 175.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.717 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.0 t0 -67.85 133.13 92.23 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 108.48 -0.933 . . . . 8.31 108.48 173.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.556 ' HD2' ' OD1' ' A' ' 32' ' ' ASP . 84.4 Cg_endo -67.66 -12.6 36.08 Favored 'Trans proline' 0 C--N 1.325 -0.698 0 C-N-CA 122.293 1.995 . . . . 10.41 112.363 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.473 ' HE3' ' HG2' ' A' ' 33' ' ' PRO . 1.1 ptp -103.65 0.99 31.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.41 -0.359 . . . . 10.85 111.546 177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.717 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.6 m -120.43 45.01 0.74 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 121.258 0.552 . . . . 9.32 112.003 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -53.85 124.5 16.04 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.134 2.556 . . . . 11.1 112.711 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.26 -26.82 8.91 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.807 -0.711 . . . . 10.31 111.656 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.588 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 20.8 tp60 -78.95 105.55 10.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.15 0.5 . . . . 9.21 109.968 177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.558 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 41.7 ttp180 -90.93 106.95 18.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.662 -0.699 . . . . 11.51 110.161 178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 66.7 m-85 -84.58 142.46 29.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.805 -0.634 . . . . 7.5 109.466 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -63.28 -26.55 68.83 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.42 -0.809 . . . . 10.61 111.005 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 16.7 ptpt -169.8 165.11 6.16 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.869 -0.605 . . . . 10.91 110.264 -176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.704 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -49.37 169.15 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.37 2.713 . . . . 7.51 113.458 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.25 -166.98 29.56 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.65 -0.786 . . . . 7.59 112.142 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' HG2' ' N ' ' A' ' 46' ' ' SER . 12.9 ttmm -95.34 153.23 17.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.192 0.52 . . . . 11.68 110.604 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.494 ' HA ' HD21 ' A' ' 53' ' ' LEU . 95.5 p -64.59 105.91 0.84 Allowed Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-N 114.467 -1.242 . . . . 9.2 110.841 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' SER . 41.6 Cg_endo -67.59 -10.12 27.67 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.3 2.666 . . . . 10.25 111.869 -174.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -92.0 -31.4 15.61 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.564 -1.198 . . . . 10.49 110.789 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.616 ' HG2' ' H ' ' A' ' 50' ' ' ASP . 0.8 OUTLIER -134.64 -107.77 0.22 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.097 1.147 . . . . 10.38 114.097 172.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.616 ' H ' ' HG2' ' A' ' 49' ' ' MET . 12.6 p-10 -165.19 65.95 0.13 Allowed 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 119.117 0.871 . . . . 12.54 113.275 173.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -140.02 148.82 56.39 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 108.784 -0.821 . . . . 9.87 108.784 172.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.44 132.28 30.73 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.198 1.265 . . . . 9.51 110.339 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 46' ' ' SER . 43.5 mt -61.25 163.49 6.34 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.338 0.399 . . . . 6.71 111.305 -175.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.543 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 43.0 mm -101.29 131.82 22.65 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.208 -0.451 . . . . 7.89 110.003 -176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.724 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 55.9 Cg_endo -86.51 139.38 5.81 Favored 'Trans proline' 0 N--CA 1.439 -1.687 0 C-N-CA 121.93 1.753 . . . . 5.77 112.921 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.2 m -59.77 157.96 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 114.291 -1.322 . . . . 5.96 112.904 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.584 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.77 -89.79 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.753 2.021 . . . . 7.84 115.212 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.717 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.5 OUTLIER -47.87 -40.98 23.07 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.73 0.412 . . . . 6.62 110.184 -177.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.484 ' CG ' ' HG2' ' A' ' 55' ' ' PRO . 26.8 tt0 68.48 85.54 0.14 Allowed 'General case' 0 C--N 1.315 -0.901 0 O-C-N 123.954 0.784 . . . . 8.58 111.677 173.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' H ' HD11 ' A' ' 27' ' ' ILE . 28.8 tt0 74.36 60.32 0.08 Allowed 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 113.591 -1.64 . . . . 7.64 112.699 162.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.569 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 60.8 t30 -135.45 -52.16 0.76 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.716 -1.129 . . . . 7.02 110.67 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.763 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -48.45 -74.83 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.071 0 CA-C-O 121.652 0.739 . . . . 5.41 109.56 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 10.0 p-10 -111.19 31.47 6.05 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-O 122.646 1.212 . . . . 7.01 109.042 171.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.95 -11.83 56.07 Favored Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 113.675 -1.602 . . . . 7.2 110.286 170.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -162.84 -37.01 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.124 -0.538 . . . . 7.82 111.556 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' O ' HD13 ' A' ' 161' ' ' LEU . . . -90.1 -80.5 0.32 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.859 0.689 . . . . 8.65 112.859 -172.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 62' ' ' ALA . 3.3 t -65.63 -28.44 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.322 0.582 . . . . 7.31 111.122 -171.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 21.9 ptt180 -56.83 166.01 1.08 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.624 -1.171 . . . . 10.21 111.579 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.6 mt -91.22 152.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 113.963 -1.471 . . . . 8.86 109.096 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.23 40.36 0.21 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.212 0.529 . . . . 13.02 111.181 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 63.25 20.47 63.05 Favored Glycine 0 CA--C 1.502 -0.73 0 N-CA-C 111.508 -0.637 . . . . 12.13 111.508 -175.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.97 129.74 37.87 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 108.352 -0.981 . . . . 12.38 108.352 175.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.01 127.48 75.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.482 -1.303 . . . . 11.61 107.482 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 t -71.12 57.81 0.23 Allowed 'General case' 0 C--N 1.314 -0.972 0 O-C-N 124.502 1.126 . . . . 10.71 112.918 -168.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -107.65 81.18 1.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.184 -1.043 . . . . 14.09 108.184 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -71.26 112.34 7.33 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.655 0.741 . . . . 11.22 110.279 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 77' ' ' LEU . 2.6 tm? -69.63 -64.86 0.8 Allowed 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.56 -1.2 . . . . 13.71 108.419 173.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.85 74.32 1.71 Allowed Glycine 0 CA--C 1.495 -1.178 0 N-CA-C 110.699 -0.96 . . . . 11.44 110.699 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 120' ' ' PHE . 9.7 p -88.05 151.27 3.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 113.957 -1.122 . . . . 9.99 111.731 -173.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -111.09 125.14 53.45 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.045 -0.724 . . . . 11.64 109.045 173.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 148' ' ' VAL . 34.4 p -131.74 147.1 52.47 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.834 -0.621 . . . . 8.0 110.274 -174.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.08 126.58 55.25 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.81 -0.811 . . . . 6.65 108.81 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 30.0 tt0 -83.92 133.87 34.69 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.459 -0.571 . . . . 12.15 109.459 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.613 HG11 HD23 ' A' ' 95' ' ' LEU . 42.4 t -55.49 127.92 15.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 112.769 0.655 . . . . 9.71 112.769 -176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 39.1 mmtt -140.88 142.5 34.48 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 114.828 -1.078 . . . . 11.03 108.777 177.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 9.3 mp -77.8 150.78 34.23 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.013 -0.675 . . . . 12.76 109.484 171.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -168.74 47.79 0.22 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.413 -0.898 . . . . 13.25 112.99 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.5 ptt180 -69.01 132.19 46.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.034 0.445 . . . . 16.35 111.219 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.6 84.79 2.15 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.441 -0.948 . . . . 18.22 108.441 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.74 -3.68 74.7 Favored Glycine 0 CA--C 1.508 -0.39 0 N-CA-C 109.625 -1.39 . . . . 17.91 109.625 -176.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.7 t -110.82 178.56 4.32 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.936 -1.132 . . . . 17.11 108.506 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.574 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 14.2 m -84.44 161.17 20.4 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.636 -0.876 . . . . 14.73 108.636 174.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -60.98 103.33 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.475 0.655 . . . . 14.94 111.248 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 92' ' ' THR . 34.9 mmt180 -121.64 167.26 13.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.695 -1.139 . . . . 10.57 109.019 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.613 HD23 HG11 ' A' ' 84' ' ' VAL . 5.3 mp -90.68 111.96 23.52 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.172 -1.048 . . . . 8.88 108.172 177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.69 129.87 35.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.16 0.505 . . . . 9.78 110.634 -174.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.58 156.8 52.72 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.634 -1.167 . . . . 6.4 108.804 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -60.28 141.25 95.41 Favored 'Trans proline' 0 C--N 1.332 -0.331 0 C-N-CA 122.153 1.902 . . . . 6.55 110.59 173.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -19.24 38.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.636 0.255 . . . . 9.29 111.367 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -88.76 9.64 23.78 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-N 116.514 -0.312 . . . . 10.86 111.017 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -86.63 -39.89 15.66 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.174 0.511 . . . . 5.34 111.17 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.586 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -99.92 158.47 15.79 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.758 0.651 . . . . 6.97 112.758 -170.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -101.91 121.56 53.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.239 -0.891 . . . . 10.2 108.86 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -94.25 122.54 36.89 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.312 -0.555 . . . . 12.12 110.895 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.6 t -149.57 131.26 14.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.105 -0.498 . . . . 14.61 111.406 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.05 -114.3 5.97 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 116.161 -0.472 . . . . 15.52 113.017 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.1 25.03 10.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.029 0.443 . . . . 14.99 111.235 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.76 -176.99 5.73 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.896 -0.593 . . . . 15.2 111.053 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.586 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 47.0 m -136.92 150.13 48.03 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.291 -0.413 . . . . 9.26 110.296 -177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -125.43 152.07 31.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.748 -0.464 . . . . 10.55 109.748 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.654 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -133.3 138.31 46.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.205 -0.295 . . . . 7.39 110.205 175.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 58.9 mtm -97.45 100.71 12.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.145 -0.687 . . . . 8.85 109.145 174.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 7.2 p -84.52 137.82 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.354 -0.839 . . . . 9.69 111.312 -172.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.458 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -67.12 88.52 0.17 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.48 -0.782 . . . . 10.7 109.698 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 tttp -67.97 140.43 56.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.46 -0.791 . . . . 14.88 109.782 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.56 -12.0 38.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.061 -0.59 . . . . 16.92 112.808 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.18 10.47 19.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.134 0.493 . . . . 18.56 111.689 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 91.28 27.76 17.11 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.399 -0.818 . . . . 15.62 113.782 170.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -147.74 -161.25 9.38 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.505 -0.855 . . . . 14.19 112.305 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 52.8 m-85 -130.92 112.51 13.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.677 0.275 . . . . 12.03 110.325 -177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.403 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -100.44 139.05 20.34 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.426 -0.352 . . . . 13.91 110.737 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 55.7 Cg_endo -82.7 138.88 9.68 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.956 1.77 . . . . 12.35 111.989 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.654 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 13.9 p -129.5 126.69 63.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.577 -0.738 . . . . 9.43 110.139 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HA ' HD13 ' A' ' 110' ' ' ILE . 32.0 tt0 -79.18 112.84 16.79 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.487 -0.561 . . . . 12.93 109.487 173.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.568 HG13 HG13 ' A' ' 123' ' ' VAL . 27.5 m -120.64 173.5 6.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.455 -0.793 . . . . 8.03 111.375 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -104.49 126.1 51.27 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.161 -0.681 . . . . 10.39 109.161 170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.595 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -141.95 105.64 4.7 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.309 -0.405 . . . . 8.3 111.244 -177.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.04 70.78 0.3 Allowed Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 117.431 -2.319 . . . . 10.1 114.329 169.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.921 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.88 162.55 40.56 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.156 -0.683 . . . . 10.61 109.156 155.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 13.4 m -147.04 127.87 14.4 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.837 -0.431 . . . . 13.17 109.837 171.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.99 112.25 5.51 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.079 -0.51 . . . . 12.98 111.753 -175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.62 43.82 91.18 Favored Glycine 0 C--O 1.235 0.214 0 CA-C-N 116.107 -0.497 . . . . 14.34 112.992 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.69 13.43 82.13 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.852 -0.689 . . . . 13.12 112.553 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -126.47 157.84 37.62 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.264 -0.643 . . . . 10.62 109.264 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 10.5 p -111.92 166.66 11.02 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 120.882 -0.327 . . . . 7.82 110.328 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.921 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.4 mt-10 -116.73 113.32 22.42 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.486 0.66 . . . . 10.79 111.11 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 23.0 mm -83.1 111.84 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.121 -0.945 . . . . 6.73 108.87 171.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -77.12 -49.08 16.05 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.974 -1.012 . . . . 8.79 109.718 -175.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.577 ' HG2' ' N ' ' A' ' 140' ' ' GLY . 31.4 tt0 -148.68 166.42 28.43 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.961 -0.563 . . . . 10.44 110.284 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.577 ' N ' ' HG2' ' A' ' 139' ' ' GLU . . . 113.84 -23.58 12.97 Favored Glycine 0 N--CA 1.441 -0.993 0 C-N-CA 121.047 -0.597 . . . . 8.87 112.085 172.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.621 HD21 HG11 ' A' ' 123' ' ' VAL . 38.6 mt -127.49 -170.36 2.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.862 0.363 . . . . 8.5 111.76 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -154.56 156.16 36.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 14.15 109.663 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.401 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.08 128.01 34.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.713 -0.676 . . . . 12.12 110.196 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.68 -9.53 37.81 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.287 -0.725 . . . . 11.54 111.287 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.563 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.4 mm-40 -91.33 111.18 22.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.199 -0.667 . . . . 11.24 109.199 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 57.6 mt-30 -85.0 128.59 34.69 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.416 -0.811 . . . . 10.49 110.97 -176.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.9 m -119.19 135.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.709 -0.478 . . . . 5.45 109.709 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.521 ' HA ' HG22 ' A' ' 81' ' ' THR . 2.4 p -68.09 121.11 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.253 0.549 . . . . 6.56 110.581 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 101' ' ' ALA . 5.1 m -106.31 -21.03 5.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.211 -0.904 . . . . 6.99 110.398 -175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t 65.07 -72.57 0.07 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.253 -0.885 . . . . 9.06 112.208 174.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.23 104.34 1.2 Allowed Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.069 -0.812 . . . . 8.5 111.069 -173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 68.17 79.94 0.21 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.238 0.542 . . . . 11.84 110.441 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.438 ' O ' HD13 ' A' ' 155' ' ' ILE . 47.3 m-85 -72.67 165.42 24.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.823 -0.626 . . . . 12.24 110.611 177.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 tp -87.8 50.87 2.07 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.4 0.619 . . . . 13.16 110.058 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.644 HD13 ' H ' ' A' ' 155' ' ' ILE . 0.2 OUTLIER -83.11 39.85 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 121.461 0.648 . . . . 11.95 111.072 -177.205 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -86.0 -99.67 0.07 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.37 -0.832 . . . . 11.22 111.327 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.4 m -79.22 -41.48 28.18 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.732 0.777 . . . . 11.9 110.174 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 50.0 mm-40 -54.0 -30.17 46.28 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.084 -1.417 . . . . 11.17 110.701 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.461 ' HB2' ' CA ' ' A' ' 155' ' ' ILE . . . -68.02 -31.74 71.63 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.492 -1.231 . . . . 7.82 112.233 -173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.5 t -81.5 -19.46 42.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.457 0.646 . . . . 9.64 109.808 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 66' ' ' ALA . 94.0 mt -87.79 -30.4 20.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.802 -1.09 . . . . 10.57 111.898 -173.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 21.7 mmm180 -70.6 140.94 51.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.196 0.522 . . . . 8.9 110.565 -176.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 89.38 30.59 13.44 Favored Glycine 0 N--CA 1.442 -0.945 0 CA-C-N 114.978 -1.01 . . . . 7.15 111.291 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.7 p 49.99 54.87 10.32 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.347 0.659 . . . . 7.09 110.882 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 67.7 t 72.87 -56.26 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.171 -0.922 . . . . 9.2 111.415 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . . . 55.2 54.04 9.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.698 0.761 . . . . 9.11 110.743 -178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.727 ' O ' ' HG3' ' A' ' 168' ' ' MET . 1.6 tmt_? -77.28 88.64 3.71 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.887 -1.051 . . . . 14.58 109.217 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.727 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 23.3 mtm -158.65 39.17 0.23 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.969 -0.56 . . . . 11.94 111.167 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -74.02 -74.92 0.17 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 119.935 -0.706 . . . . 14.99 110.324 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.16 -55.8 28.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.002 0.43 . . . . 15.01 110.399 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 17.7 p -118.96 129.33 55.11 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.951 -0.568 . . . . 14.25 110.532 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 168' ' ' MET . 15.1 t -88.42 175.85 7.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.409 -0.589 . . . . 14.89 109.409 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 45.3 m -80.02 63.55 4.57 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.336 0.589 . . . . 15.85 110.66 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -126.67 21.18 5.99 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.266 -0.879 . . . . 17.54 111.559 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.446 ' HB3' ' H ' ' A' ' 176' ' ' GLU . 6.7 mp -93.39 -148.37 0.25 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.334 -0.617 . . . . 17.85 109.334 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.446 ' H ' ' HB3' ' A' ' 175' ' ' LEU . 39.4 mt-10 59.06 -141.0 0.69 Allowed 'General case' 0 C--O 1.231 0.111 0 N-CA-C 110.006 -0.368 . . . . 19.67 110.006 176.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 22.1 t 41.3 84.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 O-C-N 124.365 1.041 . . . . 19.52 112.814 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 10.2 mp -61.12 -82.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.503 -0.771 . . . . 21.15 110.571 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.8 -54.19 2.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.623 -0.717 . . . . 23.25 110.56 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.627 ' HA ' HE21 ' A' ' 180' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.262 -0.875 . . . . 23.52 110.197 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.166 -0.309 . . . . 34.32 110.166 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.14 59.87 7.44 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.45 -0.881 . . . . 33.09 112.855 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t 57.93 63.75 1.71 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.503 0.668 . . . . 34.12 111.684 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.53 98.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.641 -1.163 . . . . 32.32 111.843 177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 m -61.98 -42.35 99.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 32.74 110.739 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -145.15 120.38 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.058 -0.519 . . . . 31.29 110.57 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -146.57 -57.21 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.049 -0.523 . . . . 29.46 110.197 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -156.75 -136.72 2.18 Favored Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 111.173 -0.771 . . . . 28.28 111.173 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.08 149.09 86.05 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.386 2.057 . . . . 27.51 111.879 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -154.56 121.76 5.65 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.633 -0.506 . . . . 26.48 109.633 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.81 168.79 18.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.688 0.28 . . . . 24.9 110.326 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.47 -14.6 5.04 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.649 -0.786 . . . . 23.19 112.387 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 73.1 -39.04 0.43 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.244 0.618 . . . . 21.31 111.566 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -67.06 135.84 94.02 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 110.286 -0.265 . . . . 19.89 110.286 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.49 178.53 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.437 2.091 . . . . 18.12 112.414 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.25 89.8 3.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.145 -0.687 . . . . 16.58 109.145 175.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.75 82.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.2 -0.909 . . . . 14.8 110.595 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.59 78.96 1.81 Allowed Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.549 -0.75 . . . . 13.17 112.237 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.31 -39.63 94.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.844 -0.178 . . . . 12.17 110.604 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 44.63 79.18 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.206 0.941 . . . . 13.82 112.324 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 45.5 tp 65.58 16.69 10.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.846 -1.07 . . . . 12.13 111.268 174.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 0.5 OUTLIER 72.79 -4.92 2.0 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.242 -0.89 . . . . 14.1 110.744 -178.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 p -117.54 38.8 3.49 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.402 0.62 . . . . 11.05 110.669 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.56 4.01 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 115.22 -0.9 . . . . 10.05 113.023 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.6 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.3 OUTLIER -165.72 54.8 0.11 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 122.556 1.17 . . . . 10.38 109.432 -177.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.706 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . 91.1 mtt180 -119.09 148.7 42.76 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 113.605 -1.634 . . . . 8.37 108.883 175.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.735 HG12 ' OE2' ' A' ' 58' ' ' GLU . 42.9 mm -52.0 124.4 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 113.923 -1.49 . . . . 5.76 114.251 -166.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -111.71 -32.89 6.5 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.322 -1.763 . . . . 8.22 109.792 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.722 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 26.3 p90 -177.64 -175.41 0.52 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.919 -0.582 . . . . 7.99 110.839 -177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.749 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.21 145.81 46.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.65 -0.705 . . . . 5.61 111.243 -176.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.45 ' HB2' ' NE2' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -150.99 145.8 25.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.03 -0.729 . . . . 9.06 109.03 179.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.753 ' HB3' ' CE ' ' A' ' 34' ' ' MET . 1.2 m-20 -78.27 147.24 72.26 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 112.307 0.484 . . . . 8.31 112.307 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' HG3' HG13 ' A' ' 54' ' ' ILE . 51.9 Cg_exo -53.68 -56.78 2.35 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.593 2.195 . . . . 10.41 112.797 -178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.753 ' CE ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -86.87 2.64 48.45 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 113.398 0.888 . . . . 10.85 113.398 -170.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' CB ' ' A' ' 32' ' ' ASP . 21.6 m -120.46 51.83 2.31 Favored Pre-proline 0 CA--C 1.55 0.976 0 CA-C-O 121.657 0.741 . . . . 9.32 111.325 175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.25 121.73 9.26 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.146 2.564 . . . . 11.1 112.622 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.62 -27.29 4.43 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.052 -0.819 . . . . 10.31 111.052 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.451 ' OE1' ' HE1' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -75.86 138.93 41.42 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.4 -0.4 . . . . 9.21 109.943 175.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.615 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 34.0 ttp180 -133.54 112.29 11.38 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 116.543 -0.299 . . . . 11.51 111.413 -174.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.722 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 73.6 m-85 -97.39 149.3 22.28 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.828 -0.804 . . . . 7.5 108.828 174.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -84.08 8.11 16.52 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.044 -0.662 . . . . 10.61 111.806 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 19.8 pttp -164.2 167.8 10.14 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 116.332 -0.395 . . . . 10.91 111.881 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.619 ' HD3' ' CZ3' ' A' ' 30' ' ' TRP . 18.6 Cg_endo -56.0 171.04 0.87 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.807 3.004 . . . . 7.51 112.984 170.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 147.37 -166.35 28.61 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.539 -0.839 . . . . 7.59 112.975 175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 14.1 ttmm -96.96 148.44 22.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.058 0.456 . . . . 11.68 109.869 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.8 t -66.13 141.14 97.27 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.344 -0.844 . . . . 9.2 111.576 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.12 -20.29 10.09 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.844 2.362 . . . . 10.25 111.033 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -78.19 -33.4 50.1 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.509 -1.223 . . . . 10.49 109.863 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.5 ptp -168.97 168.9 9.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.236 -0.893 . . . . 10.38 109.182 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.5 p-10 -81.22 72.74 8.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.734 0.778 . . . . 12.54 112.418 -171.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 ptm -139.43 139.48 22.75 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.196 -0.911 . . . . 9.87 108.871 169.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.1 135.94 45.87 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.554 2.17 . . . . 9.51 111.604 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.591 ' HA ' ' OD1' ' A' ' 32' ' ' ASP . 18.1 mt -63.17 162.15 12.35 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.812 -0.631 . . . . 6.71 111.04 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.522 HG13 ' HG3' ' A' ' 33' ' ' PRO . 23.8 mm -102.92 134.41 19.83 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 121.322 0.582 . . . . 7.89 109.984 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.749 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 74.1 Cg_endo -81.98 139.1 10.65 Favored 'Trans proline' 0 N--CA 1.436 -1.865 0 C-N-CA 121.308 1.339 . . . . 5.77 112.544 177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -55.49 157.88 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 113.872 -1.513 . . . . 5.96 113.045 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.483 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.31 -89.63 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.716 2.006 . . . . 7.84 115.037 -175.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.735 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.9 OUTLIER -46.94 -42.6 18.05 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.167 0.587 . . . . 6.62 111.401 -176.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.585 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 13.9 tt0 66.92 88.22 0.11 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 122.453 1.121 . . . . 8.58 111.011 178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.442 ' H ' HD11 ' A' ' 27' ' ' ILE . 15.5 tt0 63.92 65.12 0.72 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 112.564 -2.107 . . . . 7.64 112.245 165.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 12.8 t-20 -148.13 -29.18 0.31 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.624 -0.716 . . . . 7.02 112.512 -173.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 66' ' ' ALA . . . -33.4 -56.72 0.42 Allowed 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 124.862 1.265 . . . . 5.41 111.831 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.587 ' HB3' ' H ' ' A' ' 68' ' ' ARG . 31.5 t70 -125.79 64.77 1.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 115.563 -0.744 . . . . 7.01 110.4 171.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.88 -55.28 5.02 Favored Glycine 0 CA--C 1.497 -1.06 0 CA-C-N 114.826 -1.079 . . . . 7.2 110.82 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -134.82 19.08 3.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.604 -1.298 . . . . 7.82 108.966 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.447 ' HA ' ' H ' ' A' ' 63' ' ' ASP . . . 61.4 33.21 18.85 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 114.679 -1.146 . . . . 8.65 110.881 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.09 -30.28 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.015 -0.993 . . . . 7.31 109.479 176.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.587 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 70.4 mtm180 -125.8 -169.64 2.04 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.616 -1.175 . . . . 10.21 111.749 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.575 ' C ' ' H ' ' A' ' 71' ' ' GLY . 6.2 mt -55.75 167.83 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.3 -2.227 . . . . 8.86 113.616 -170.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.706 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 9.5 t70 -57.97 22.05 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 126.602 1.961 . . . . 13.02 112.811 173.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 82.88 11.21 81.88 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.546 -0.621 . . . . 12.13 111.546 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -87.91 117.7 26.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-O 121.263 0.554 . . . . 12.38 109.778 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 39.0 t -121.64 140.91 44.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.143 -0.935 . . . . 11.61 111.079 -174.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -128.72 59.21 1.55 Allowed 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.617 0.723 . . . . 10.71 109.156 176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 64.99 71.16 0.46 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 114.821 -1.081 . . . . 14.09 110.099 -175.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -129.1 87.63 2.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.601 -0.727 . . . . 11.22 110.522 -179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' HB3' ' O ' ' A' ' 150' ' ' SER . 39.5 tp -57.68 -55.82 29.96 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.554 -0.459 . . . . 13.71 110.25 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.48 5.87 1.2 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.764 -0.732 . . . . 11.44 111.887 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 79' ' ' VAL . 24.4 t 58.25 45.58 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 122.139 0.971 . . . . 9.99 110.654 -178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 152' ' ' GLN . 90.7 mtt180 -87.47 150.85 23.49 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.395 -0.922 . . . . 11.64 108.82 172.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 148' ' ' VAL . 11.5 p -114.38 170.49 8.26 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.279 0.562 . . . . 8.0 111.61 -170.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -142.89 127.0 17.43 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.125 -0.943 . . . . 6.65 108.561 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 41.8 tt0 -79.38 138.46 37.67 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.95 0.405 . . . . 12.15 109.965 -177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.619 HG13 ' HB3' ' A' ' 95' ' ' LEU . 39.2 t -57.21 132.9 21.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.274 -0.876 . . . . 9.71 112.654 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -137.06 143.87 42.87 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.772 -1.104 . . . . 11.03 109.14 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.07 151.27 35.55 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 120.114 -0.634 . . . . 12.76 109.633 171.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -174.83 48.92 0.13 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.446 -0.883 . . . . 13.25 112.758 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 91' ' ' SER . 17.9 ptt180 -64.01 147.31 52.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 16.35 111.478 -177.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.6 tp -147.32 85.9 1.6 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.663 -0.495 . . . . 18.22 109.663 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.73 -4.76 85.68 Favored Glycine 0 CA--C 1.503 -0.662 0 N-CA-C 108.963 -1.655 . . . . 17.91 108.963 -174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.533 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 12.5 p -111.42 170.56 8.04 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.006 -1.597 . . . . 17.11 109.013 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.731 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 28.4 m -82.03 164.11 21.64 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.733 -1.121 . . . . 14.73 108.851 173.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.425 ' N ' HG22 ' A' ' 92' ' ' THR . 11.0 mt-10 -56.46 106.96 0.33 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.284 0.564 . . . . 14.94 111.767 -176.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.731 ' HG2' ' O ' ' A' ' 92' ' ' THR . 29.6 mmt180 -124.48 162.6 23.6 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.89 -1.05 . . . . 10.57 109.081 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB3' HG13 ' A' ' 84' ' ' VAL . 1.8 mm? -87.31 113.33 22.93 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.588 -0.523 . . . . 8.88 109.588 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -89.98 129.94 36.25 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.117 -0.492 . . . . 9.78 110.656 -177.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.23 159.81 57.11 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.136 -0.938 . . . . 6.4 108.955 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HG2' HG11 ' A' ' 149' ' ' VAL . 72.8 Cg_exo -54.46 130.79 41.86 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 121.86 1.707 . . . . 6.55 111.233 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.5 t -56.75 -26.02 56.34 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.254 0.465 . . . . 9.29 112.254 -176.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.26 4.56 50.29 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 122.07 -0.394 . . . . 10.86 111.659 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.31 -39.16 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.112 0.482 . . . . 5.34 110.721 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -80.28 158.9 26.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 6.97 112.276 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -106.03 127.56 61.05 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.073 -0.967 . . . . 10.2 109.183 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -99.78 123.6 44.2 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 119.876 -0.73 . . . . 12.12 110.943 172.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -148.91 144.67 27.01 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.558 -0.746 . . . . 14.61 109.573 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.61 -121.63 15.81 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.204 -0.522 . . . . 15.52 112.322 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.39 37.25 4.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.15 0.5 . . . . 14.99 110.729 177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -149.45 177.78 9.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.655 -0.702 . . . . 15.2 111.203 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.486 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 12.0 m -123.65 145.87 48.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.31 -0.405 . . . . 9.26 109.986 174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.522 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 38.7 mm -123.31 152.18 28.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.041 -0.725 . . . . 10.55 109.041 178.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.675 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -127.65 131.34 49.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.678 0.275 . . . . 7.39 110.495 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 76.9 mtp -88.03 100.36 12.86 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.433 -0.58 . . . . 8.85 109.433 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -85.69 136.82 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.868 -0.605 . . . . 9.69 110.993 -174.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB3' ' HG3' ' A' ' 146' ' ' GLN . . . -89.97 94.19 9.7 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.618 -0.719 . . . . 10.7 110.158 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -68.0 141.99 56.07 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.795 -0.639 . . . . 14.88 110.714 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.29 -6.59 48.34 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.149 -0.78 . . . . 16.92 111.149 174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -79.83 -3.05 46.16 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.394 0.616 . . . . 18.56 110.4 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 166' ' ' ALA . . . 104.37 -21.1 38.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.244 -0.889 . . . . 15.62 113.128 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -102.13 177.8 26.52 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.818 -0.706 . . . . 14.19 112.598 -173.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -130.22 122.44 28.1 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.553 -0.536 . . . . 12.03 109.553 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.514 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.2 m-20 -124.76 147.93 57.76 Favored Pre-proline 0 C--N 1.323 -0.572 0 C-N-CA 120.535 -0.466 . . . . 13.91 111.571 -176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.53 135.18 5.01 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.746 2.297 . . . . 12.35 112.55 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.675 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.8 p -121.4 129.97 75.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.541 -0.754 . . . . 9.43 109.916 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.419 ' HA ' HD13 ' A' ' 110' ' ' ILE . 38.5 tt0 -74.58 116.86 15.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.988 0.423 . . . . 12.93 110.028 176.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.511 HG13 HG13 ' A' ' 123' ' ' VAL . 28.4 m -128.55 167.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.868 -0.605 . . . . 8.03 110.884 -176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 138' ' ' LEU . 37.6 ttmt -106.2 129.72 54.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.464 -0.569 . . . . 10.39 109.464 174.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.494 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.84 104.09 4.29 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 112.621 0.601 . . . . 8.3 112.621 -173.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.59 70.9 0.29 Allowed Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 117.752 -2.166 . . . . 10.1 114.498 167.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 162.69 39.39 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.876 -0.787 . . . . 10.61 108.876 154.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.4 m -138.02 124.34 20.55 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.606 -0.438 . . . . 13.17 109.844 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.05 111.21 6.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.063 -0.517 . . . . 12.98 111.575 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.93 44.17 94.94 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.932 -0.576 . . . . 14.34 112.818 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.15 8.55 85.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.804 -0.712 . . . . 13.12 112.378 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -120.71 166.73 13.3 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.662 -0.496 . . . . 10.62 109.662 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.3 m -120.62 155.51 33.63 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 120.749 0.309 . . . . 7.82 110.774 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.763 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 48.1 mt-10 -97.09 110.98 23.41 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.495 0.664 . . . . 10.79 111.014 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.5 mm -79.71 101.15 4.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.167 -1.049 . . . . 6.73 108.167 169.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.63 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.1 OUTLIER -65.56 -49.35 69.19 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.049 -0.978 . . . . 8.79 110.183 -174.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.95 162.49 35.05 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.358 -0.837 . . . . 10.44 110.908 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.467 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.33 -59.78 0.44 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.605 -0.807 . . . . 8.87 113.304 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.6 HD21 HG11 ' A' ' 123' ' ' VAL . 25.0 mt -103.35 -174.58 2.58 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.588 0.588 . . . . 8.5 112.588 -173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -149.37 157.56 43.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.451 -0.795 . . . . 14.15 109.605 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.6 126.01 28.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.626 -0.715 . . . . 12.12 110.075 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.03 -10.46 20.64 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.493 -1.043 . . . . 11.54 110.493 -170.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' VAL . 13.6 mm100 -100.74 120.02 39.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.444 -0.947 . . . . 11.24 108.444 176.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 11.1 pt20 -106.35 135.09 48.45 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.825 0.821 . . . . 10.49 110.364 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.7 m -117.58 145.96 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.336 -1.302 . . . . 5.45 109.603 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.8 p -69.5 124.57 25.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.329 0.585 . . . . 6.56 110.234 -179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.8 m -105.58 0.05 10.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.619 -0.719 . . . . 6.99 110.398 -174.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.554 ' O ' ' HB3' ' A' ' 77' ' ' LEU . 8.5 t 71.91 -57.14 0.63 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.385 -1.279 . . . . 9.06 111.706 175.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.92 167.45 11.09 Favored Glycine 0 C--N 1.332 0.344 0 O-C-N 123.592 0.558 . . . . 8.5 113.398 -175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 80' ' ' ARG . 28.0 tt0 -91.32 90.4 7.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.277 0.561 . . . . 11.84 111.208 -176.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -89.31 156.14 18.92 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.122 -0.695 . . . . 12.24 109.122 170.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.62 HD13 ' H ' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -74.12 84.85 1.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.512 0.672 . . . . 13.16 111.403 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 155' ' ' ILE . 9.4 tp -169.55 48.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 122.089 0.947 . . . . 11.95 110.15 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -66.24 -28.04 68.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.712 0.768 . . . . 11.22 111.249 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.0 m -56.2 -34.46 66.29 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 114.328 -1.305 . . . . 11.9 113.039 -171.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -70.64 -25.73 63.15 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.837 -0.619 . . . . 11.17 110.673 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.418 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -82.38 -19.16 39.71 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.376 -0.829 . . . . 7.82 110.031 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.1 m -81.73 -45.01 16.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.485 -0.78 . . . . 9.64 110.022 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.33 -33.78 75.98 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.543 -0.753 . . . . 10.57 111.055 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 13.7 ptt180 -88.48 165.91 14.56 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.964 -0.754 . . . . 8.9 108.964 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.12 61.82 3.75 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.712 -0.756 . . . . 7.15 112.449 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 44.35 -93.67 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.926 0.89 . . . . 7.09 112.469 -178.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.404 ' H ' ' HB ' ' A' ' 164' ' ' THR . 46.9 t -132.33 82.56 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.131 -1.063 . . . . 9.2 108.131 175.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 118' ' ' GLY . . . -67.24 104.19 1.41 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.539 -0.755 . . . . 9.11 111.561 -173.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.815 ' O ' ' HG3' ' A' ' 168' ' ' MET . 0.5 OUTLIER -71.09 88.08 0.78 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.193 -0.912 . . . . 14.58 109.402 173.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.815 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 10.6 mtm -173.37 168.27 4.62 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 114.846 -1.07 . . . . 11.94 110.31 177.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -124.55 -169.2 1.93 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.215 -1.031 . . . . 14.99 108.215 169.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -86.89 -148.27 0.14 Allowed 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.215 0.531 . . . . 15.01 109.791 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 68.8 p 51.64 30.43 6.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.69 -1.141 . . . . 14.25 112.986 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.1 m -79.69 -70.98 0.47 Allowed 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.471 -0.332 . . . . 14.89 111.204 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.7 t 62.47 179.98 0.14 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.231 0.539 . . . . 15.85 111.178 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 103.38 -27.32 20.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.051 -0.595 . . . . 17.54 111.985 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.13 -171.63 1.87 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.493 -0.558 . . . . 17.85 109.493 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -83.68 -85.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 19.67 109.947 175.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 p -158.01 51.24 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 122.315 1.055 . . . . 19.52 110.178 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.94 76.11 8.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.437 -0.802 . . . . 21.15 110.452 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -128.97 59.01 1.58 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.024 -0.534 . . . . 23.25 110.334 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 C--O 1.251 1.152 0 CA-C-O 118.359 -0.829 . . . . 23.52 111.356 -179.396 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.3 mtp . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.903 -0.406 . . . . 34.32 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -160.14 88.07 0.11 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.426 -0.892 . . . . 33.09 112.666 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.9 t -137.12 -147.29 0.24 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.744 -0.465 . . . . 34.12 109.744 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -73.25 78.58 1.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.268 0.556 . . . . 32.32 110.74 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.7 m -73.78 -52.38 13.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.886 -0.597 . . . . 32.74 110.416 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 p -109.26 -39.22 3.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.05 -0.523 . . . . 31.29 110.49 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 7.7 t30 68.91 -67.36 0.21 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.254 0.622 . . . . 29.46 111.283 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.26 159.74 9.28 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.528 -1.029 . . . . 28.28 110.528 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -73.34 -164.38 0.2 Allowed 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 122.61 2.207 . . . . 27.51 112.63 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -58.39 155.11 12.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.894 0.378 . . . . 26.48 111.338 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 83.23 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 24.9 110.583 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -111.84 -88.66 1.81 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.837 -0.696 . . . . 23.19 111.544 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -106.48 122.16 45.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.863 0.363 . . . . 21.31 110.393 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -124.34 144.53 46.04 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.651 -0.704 . . . . 19.89 109.311 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.54 109.97 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.403 2.069 . . . . 18.12 111.556 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' HB1' ' H ' ' A' ' 21' ' ' LEU . . . -81.32 39.26 0.51 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 16.58 111.773 -176.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.37 116.26 10.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.104 -0.498 . . . . 14.8 110.28 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.16 -62.73 0.28 Allowed Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 111.183 -0.767 . . . . 13.17 111.183 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.57 -71.07 0.22 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 12.17 109.878 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -169.44 77.47 0.1 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.727 -0.842 . . . . 13.82 108.727 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.567 ' H ' ' HB1' ' A' ' 16' ' ' ALA . 3.7 tt 79.02 -58.57 0.41 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.42 -0.956 . . . . 12.13 108.42 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -158.23 -79.66 0.07 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.202 -0.908 . . . . 14.1 109.551 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.436 ' HA ' ' HG3' ' A' ' 26' ' ' ARG . 14.5 t -109.73 -175.86 2.86 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.809 -0.441 . . . . 11.05 109.809 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' C ' ' HD2' ' A' ' 25' ' ' LYS . . . 120.15 -56.5 0.6 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.977 -0.849 . . . . 10.05 110.977 -173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.454 ' HD2' ' C ' ' A' ' 24' ' ' GLY . 13.6 mptt -121.88 67.34 0.91 Allowed 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 107.726 -1.213 . . . . 10.38 107.726 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.616 ' CD ' ' HA ' ' A' ' 63' ' ' ASP . 6.3 mtt-85 -144.09 141.46 30.06 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.706 -1.134 . . . . 8.37 109.659 -172.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.545 HD11 ' HB2' ' A' ' 55' ' ' PRO . 0.9 OUTLIER -53.73 133.7 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 122.568 1.175 . . . . 5.76 113.242 -163.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -109.9 -35.33 6.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.743 -2.026 . . . . 8.22 109.642 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.626 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 3.7 p90 -179.54 -174.71 0.31 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.299 -0.864 . . . . 7.99 108.992 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.782 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 2.5 m-90 -122.14 147.85 45.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.843 -0.617 . . . . 5.61 111.071 -176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.486 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 4.0 ptm180 -152.86 156.4 38.92 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.238 -0.892 . . . . 9.06 110.194 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.714 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.8 t70 -94.1 140.49 22.89 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 109.316 -0.624 . . . . 8.31 109.316 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -60.79 -15.58 38.76 Favored 'Trans proline' 0 CA--C 1.529 0.27 0 C-N-CA 122.889 2.393 . . . . 10.41 112.561 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.44 -3.46 43.44 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 111.592 0.219 . . . . 10.85 111.592 175.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.714 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.2 m -127.79 37.22 0.37 Allowed Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 113.031 0.752 . . . . 9.32 113.031 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.8 Cg_endo -61.24 91.79 0.1 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.738 2.292 . . . . 11.1 112.745 -174.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.86 -31.68 0.14 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.113 -0.565 . . . . 10.31 111.838 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.486 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -68.19 -178.08 0.99 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.057 0.762 . . . . 9.21 113.057 178.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.626 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 11.3 tpp180 -147.34 91.77 2.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.238 -0.892 . . . . 11.51 108.797 172.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 49.9 m-85 -73.97 141.3 45.91 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 119.57 -0.852 . . . . 7.5 111.065 -177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.66 -25.57 68.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.687 -1.142 . . . . 10.61 110.841 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.511 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 20.8 pttp -171.79 164.78 4.36 Favored Pre-proline 0 N--CA 1.449 -0.523 0 CA-C-N 115.808 -0.633 . . . . 10.91 111.008 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.8 Cg_endo -49.79 169.79 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.756 2.971 . . . . 7.51 113.62 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.93 -156.45 26.68 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.414 -0.898 . . . . 7.59 112.814 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.485 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 8.4 ttmt -98.75 148.27 24.05 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.729 -0.471 . . . . 11.68 109.729 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' MET . 8.7 t -77.29 139.16 64.15 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-O 121.168 0.508 . . . . 9.2 111.318 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.73 -22.27 20.69 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.971 2.448 . . . . 10.25 112.871 175.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.9 m-85 -85.51 -24.32 27.37 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.162 0.982 . . . . 10.49 109.496 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 46' ' ' SER . 2.2 ptp -157.9 134.08 9.44 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 113.868 -1.515 . . . . 10.38 111.081 -165.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.485 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -77.85 63.52 2.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.751 0.786 . . . . 12.54 111.565 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 16.6 ptm -139.05 143.96 39.04 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 114.74 -1.118 . . . . 9.87 108.215 173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.59 133.93 39.0 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.043 1.829 . . . . 9.51 110.743 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.4 mt -60.3 154.41 20.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.097 0.475 . . . . 6.71 110.82 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.3 mm -93.83 133.52 27.67 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.85 -0.614 . . . . 7.89 109.872 -175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.545 ' HB2' HD11 ' A' ' 27' ' ' ILE . 81.6 Cg_endo -85.23 147.87 10.24 Favored 'Trans proline' 0 N--CA 1.439 -1.728 0 C-N-CA 121.928 1.752 . . . . 5.77 113.425 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 HG13 ' A' ' 27' ' ' ILE . 32.2 m -75.69 157.77 5.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.639 -1.164 . . . . 5.96 111.994 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 13.64 -80.9 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.19 2.196 . . . . 7.84 115.507 -179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.737 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -40.25 -48.46 2.61 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.94 0.896 . . . . 6.62 110.42 174.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.737 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 32.4 mt-10 69.71 83.04 0.16 Allowed 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 124.203 1.001 . . . . 8.58 113.054 176.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 87.68 64.35 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 113.836 -1.529 . . . . 7.64 111.592 160.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.639 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 16.6 t-20 -165.71 -110.04 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 113.547 -1.661 . . . . 7.02 107.472 171.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.435 ' CB ' ' HA ' ' A' ' 70' ' ' ASP . . . -175.7 -105.04 0.0 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 120.649 0.262 . . . . 5.41 110.657 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.616 ' HA ' ' CD ' ' A' ' 26' ' ' ARG . 7.2 t70 -163.79 67.1 0.17 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.877 0.846 . . . . 7.01 111.042 -174.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.24 -14.03 52.01 Favored Glycine 0 CA--C 1.503 -0.676 0 CA-C-N 114.772 -1.104 . . . . 7.2 111.942 172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 64.9 20.53 12.14 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 124.043 0.496 . . . . 7.82 111.56 174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.36 -69.18 0.38 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.704 0.261 . . . . 8.65 111.704 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.58 HG13 ' H ' ' A' ' 68' ' ' ARG . 7.1 p -71.22 -59.37 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.178 0.513 . . . . 7.31 111.049 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.619 ' HG2' ' OG1' ' A' ' 164' ' ' THR . 12.8 mtp180 -85.56 -177.74 6.5 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 122.582 1.182 . . . . 10.21 111.334 174.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.473 HG21 ' HG2' ' A' ' 72' ' ' ARG . 8.1 mt -99.27 150.83 4.95 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 112.702 -2.044 . . . . 8.86 112.014 -165.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 62' ' ' ALA . 33.1 t70 -75.54 47.7 0.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.778 -1.101 . . . . 13.02 111.087 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.65 30.91 66.29 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.564 -0.744 . . . . 12.13 112.833 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.473 ' HG2' HG21 ' A' ' 69' ' ' ILE . 2.1 ptt180 -100.91 126.28 47.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.529 -1.286 . . . . 12.38 107.529 170.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.29 100.24 10.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.287 -0.869 . . . . 11.61 110.005 -171.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -78.91 51.46 1.13 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.96 -1.473 . . . . 10.71 110.552 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 58.15 77.37 0.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.105 -0.952 . . . . 14.09 111.17 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -154.67 129.39 9.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 11.22 109.584 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.7 mm? -65.22 -32.26 73.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.78 -0.646 . . . . 13.71 110.126 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 91.06 16.62 53.72 Favored Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 110.371 -1.092 . . . . 11.44 110.371 -177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.572 HG13 ' HA ' ' A' ' 152' ' ' GLN . 44.8 t 72.14 129.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 121.387 0.613 . . . . 9.99 110.436 -177.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -88.28 114.21 24.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.658 0.742 . . . . 11.64 111.612 -173.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.493 HG22 ' HA ' ' A' ' 148' ' ' VAL . 32.8 p -133.54 173.37 11.57 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.442 -1.254 . . . . 8.0 110.715 -171.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.59 128.05 22.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.356 -0.838 . . . . 6.65 109.179 171.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 29.9 tt0 -84.24 135.68 34.25 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.109 -0.496 . . . . 12.15 110.063 -177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 95' ' ' LEU . 55.9 t -60.73 131.69 25.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.704 -0.68 . . . . 9.71 112.474 -176.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 54.2 mmtt -138.53 146.16 41.58 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.714 -1.13 . . . . 11.03 109.519 -178.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.729 ' HB3' ' OE2' ' A' ' 93' ' ' GLU . 6.6 mp -78.29 163.38 25.78 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.552 -0.459 . . . . 12.76 110.189 171.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -144.25 -45.55 0.04 OUTLIER Glycine 0 C--O 1.236 0.251 0 C-N-CA 119.774 -1.203 . . . . 13.25 113.744 -176.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 92' ' ' THR . 15.4 ttm-85 -62.46 162.13 10.71 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 124.459 1.104 . . . . 16.35 112.245 -174.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -158.73 109.9 2.12 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.74 -0.466 . . . . 18.22 109.74 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.39 -50.17 0.8 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 109.491 -1.444 . . . . 17.91 109.491 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 41.0 t -84.78 178.08 7.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.06 -1.07 . . . . 17.11 108.684 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.687 ' O ' ' HD2' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -76.72 117.44 18.35 Favored 'General case' 0 CA--C 1.486 -1.482 0 CA-C-N 115.086 -0.961 . . . . 14.73 110.949 -170.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.729 ' OE2' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -70.65 160.35 32.74 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 113.981 -1.463 . . . . 14.94 112.835 -165.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.62 ' CG ' ' HA ' ' A' ' 138' ' ' LEU . 1.1 mpp_? -147.45 175.4 10.84 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.873 -1.512 . . . . 10.57 111.135 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.537 ' HB3' HG13 ' A' ' 84' ' ' VAL . 2.3 mm? -100.74 112.97 25.48 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.166 -0.925 . . . . 8.88 109.101 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.67 130.46 34.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 9.78 110.704 -176.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -143.0 157.88 60.04 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.01 -0.996 . . . . 6.4 108.694 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 101' ' ' ALA . 15.1 Cg_endo -61.84 132.81 41.54 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.252 1.301 . . . . 6.55 109.95 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.467 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 29.1 t -56.07 -21.93 24.74 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.489 0.551 . . . . 9.29 112.489 -174.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -89.93 4.78 48.99 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.938 -0.477 . . . . 10.86 111.504 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . . . -80.51 -41.06 24.92 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.134 0.492 . . . . 5.34 110.576 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.476 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -84.3 158.45 21.19 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.538 -0.756 . . . . 6.97 111.573 -173.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 20.2 mm -107.3 128.6 62.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 115.405 -0.816 . . . . 10.2 110.083 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 19.5 mmm180 -95.79 123.72 39.49 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.899 -0.72 . . . . 12.12 110.422 171.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -149.25 142.84 25.44 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.804 -0.635 . . . . 14.61 110.445 178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.8 -116.53 4.98 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.194 -0.527 . . . . 15.52 112.302 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 36.84 4.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.164 0.507 . . . . 14.99 110.877 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.1 ptt180 -151.63 -179.17 7.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.064 -0.516 . . . . 15.2 111.804 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.6 m -130.9 147.71 52.58 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.651 -0.704 . . . . 9.26 109.508 176.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.555 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.5 mm -122.36 145.92 28.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.782 0.325 . . . . 10.55 110.204 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.477 ' HB1' HD11 ' A' ' 141' ' ' LEU . . . -119.48 130.68 55.35 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.969 -0.56 . . . . 7.39 110.118 176.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.619 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 49.2 mmm -90.88 98.35 11.72 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.819 -0.437 . . . . 8.85 109.819 178.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG12 ' O ' ' A' ' 121' ' ' ASP . 11.2 p -83.92 139.02 18.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.173 0.511 . . . . 9.69 111.967 -170.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.24 100.06 12.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.561 -0.745 . . . . 10.7 109.822 173.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -86.93 149.45 24.78 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.197 -0.456 . . . . 14.88 111.278 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.45 10.39 17.12 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.217 -0.753 . . . . 16.92 111.217 172.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -97.77 15.96 22.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.436 0.636 . . . . 18.56 110.55 178.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.97 19.02 73.66 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.118 -0.947 . . . . 15.62 113.416 173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.9 171.66 30.62 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 119.966 -1.111 . . . . 14.19 112.915 -176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 96.0 m-85 -120.27 112.67 19.34 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.612 -0.514 . . . . 12.03 109.612 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.554 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.6 m-20 -103.55 147.08 33.66 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 116.363 -0.38 . . . . 13.91 110.463 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -85.75 122.82 2.36 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 121.984 1.789 . . . . 12.35 112.384 177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 t -105.34 122.88 59.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.816 -1.083 . . . . 9.43 109.564 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -70.56 111.46 6.09 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.31 -0.626 . . . . 12.93 109.31 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.483 HG12 ' HA3' ' A' ' 140' ' ' GLY . 27.5 m -120.68 160.46 21.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.446 0.641 . . . . 8.03 111.867 -173.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.548 ' HD2' HD12 ' A' ' 138' ' ' LEU . 0.5 OUTLIER -91.83 130.36 37.62 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 107.76 -1.2 . . . . 10.39 107.76 172.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.8 102.42 4.28 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.221 -0.592 . . . . 8.3 112.022 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -156.19 71.43 0.26 Allowed Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 118.595 -1.764 . . . . 10.1 114.028 165.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.002 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -151.11 163.79 38.0 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.24 -0.652 . . . . 10.61 109.24 156.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 33.2 m -139.08 133.11 31.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.179 0.445 . . . . 13.17 110.496 171.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -143.85 103.22 4.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 12.98 111.41 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.93 42.39 69.27 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 121.198 -0.525 . . . . 14.34 112.946 175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.38 6.41 88.94 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.019 -0.61 . . . . 13.12 112.344 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -118.75 152.65 35.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.255 -0.646 . . . . 10.62 109.255 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.8 p -99.77 161.62 13.5 Favored 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 121.011 -0.276 . . . . 7.82 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 1.002 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 45.3 mt-10 -111.94 117.64 33.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.641 0.734 . . . . 10.79 111.122 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 35.4 mm -82.94 100.97 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 CA-C-N 114.923 -1.035 . . . . 6.73 108.735 171.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.62 ' HA ' ' CG ' ' A' ' 94' ' ' ARG . 8.7 mt -63.34 -41.67 98.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.138 -0.937 . . . . 8.79 110.319 -173.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' H ' ' HB3' ' A' ' 126' ' ' LYS . 37.0 mt-10 -148.47 155.89 41.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 10.44 110.642 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 125.0 -54.43 0.74 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.236 -0.983 . . . . 8.87 113.742 172.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 111' ' ' ALA . 24.7 mt -98.37 -174.82 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.158 0.504 . . . . 8.5 112.049 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -148.76 152.12 36.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.561 -0.745 . . . . 14.15 109.966 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.84 137.4 51.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.104 . . . . 12.12 111.084 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 99.18 -6.9 59.95 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.629 -0.796 . . . . 11.54 111.518 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -103.44 155.9 18.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.503 -0.925 . . . . 11.24 108.503 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.708 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.2 mt-30 -111.38 166.38 11.16 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.734 -0.786 . . . . 10.49 111.874 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 112' ' ' MET . 0.7 OUTLIER -135.91 141.14 42.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.923 -1.035 . . . . 5.45 108.617 168.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 p -73.58 121.29 24.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.679 -0.489 . . . . 6.56 109.679 177.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.5 -29.51 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.941 0.719 . . . . 6.99 112.941 -168.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.4 m -120.46 -26.01 5.47 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.767 -0.773 . . . . 9.06 112.382 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.405 ' HA2' ' HB2' ' A' ' 173' ' ' SER . . . 174.16 143.21 4.27 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.704 -1.236 . . . . 8.5 113.228 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.572 ' HA ' HG13 ' A' ' 79' ' ' VAL . 16.9 pt20 -106.29 41.56 1.4 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.586 -0.524 . . . . 11.84 109.586 176.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 21.0 t80 73.86 170.08 0.3 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 114.473 -1.24 . . . . 12.24 110.419 -177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.47 -71.52 0.47 Allowed 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.493 -0.483 . . . . 13.16 111.422 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 155' ' ' ILE . 2.2 pp -116.76 149.74 18.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.31 0.576 . . . . 11.95 111.086 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.464 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 2.9 p-10 -72.33 -17.74 61.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.69 -0.686 . . . . 11.22 111.938 -172.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 m -62.59 -52.52 63.08 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.02 -0.272 . . . . 11.9 111.213 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -77.54 -32.88 54.24 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.536 -0.466 . . . . 11.17 109.822 176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -50.38 -52.44 37.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.606 0.241 . . . . 7.82 111.547 -178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.0 p -62.18 -29.87 70.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.08 -0.509 . . . . 9.64 112.035 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.8 -38.6 16.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.109 -0.496 . . . . 10.57 112.203 -174.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.408 ' HD2' ' N ' ' A' ' 162' ' ' ARG . 3.1 mpt_? -89.5 -27.1 20.54 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.929 0.395 . . . . 8.9 111.257 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -89.98 -8.72 66.68 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.843 -0.694 . . . . 7.15 111.546 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.619 ' OG1' ' HG2' ' A' ' 68' ' ' ARG . 11.6 p 55.58 -78.83 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.434 1.094 . . . . 7.09 112.907 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.64 72.79 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.2 0.524 . . . . 9.2 110.345 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -135.06 115.14 13.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.016 -0.538 . . . . 9.11 110.272 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.537 ' CD ' ' H ' ' A' ' 168' ' ' MET . 0.0 OUTLIER -89.8 -134.39 0.11 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.554 -0.748 . . . . 14.58 109.712 -178.277 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.537 ' H ' ' CD ' ' A' ' 167' ' ' ARG . 20.4 mtm 63.93 178.95 0.17 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.534 0.734 . . . . 11.94 112.546 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -129.9 -33.04 1.82 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.771 -0.65 . . . . 14.99 111.899 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -141.18 98.9 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.252 0.549 . . . . 15.01 111.541 -178.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.4 p -81.25 106.45 13.24 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.608 -0.723 . . . . 14.25 110.013 176.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.5 m -87.58 -102.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.443 -0.344 . . . . 14.89 111.491 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.405 ' HB2' ' HA2' ' A' ' 151' ' ' GLY . 80.4 p 43.67 -145.38 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.189 0.596 . . . . 15.85 111.176 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.55 25.9 71.25 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.64 -0.79 . . . . 17.54 112.462 175.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 87.2 mt -90.22 22.55 3.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.252 0.549 . . . . 17.85 110.432 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -152.2 118.46 5.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.372 -0.831 . . . . 19.67 109.341 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.3 t -112.49 108.29 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.963 0.411 . . . . 19.52 110.544 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 56.2 mt -109.51 178.35 4.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.355 -0.384 . . . . 21.15 110.367 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -128.05 129.31 46.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.891 0.377 . . . . 23.25 110.766 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.4 -0.809 . . . . 23.52 110.204 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.16 -0.311 . . . . 34.32 110.16 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.05 63.76 3.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.147 -0.549 . . . . 33.09 112.109 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -159.15 9.81 0.13 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.971 0.415 . . . . 34.12 110.156 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -121.17 98.85 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.285 -0.416 . . . . 32.32 110.748 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.7 m -70.0 116.94 10.96 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.163 -0.471 . . . . 32.74 111.198 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.2 t -98.6 120.27 47.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 109.415 -0.587 . . . . 31.29 109.415 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -96.95 147.11 24.32 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.868 0.366 . . . . 29.46 110.938 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.34 131.83 2.47 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.844 -0.616 . . . . 28.28 111.906 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -86.72 177.36 4.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.357 2.704 . . . . 27.51 111.936 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -87.89 79.82 7.98 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.147 0.499 . . . . 26.48 109.692 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.19 145.62 49.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.574 -0.739 . . . . 24.9 111.615 -174.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.26 34.52 1.4 Allowed Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.654 -0.703 . . . . 23.19 112.111 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -140.59 121.28 14.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.093 0.473 . . . . 21.31 109.878 176.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -122.1 136.71 26.57 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.222 -0.444 . . . . 19.89 110.913 -176.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -69.7 147.36 63.06 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.255 1.97 . . . . 18.12 111.586 174.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.98 -45.73 7.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.045 0.45 . . . . 16.58 111.199 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.23 76.09 9.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.03 -0.532 . . . . 14.8 111.23 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -102.17 -88.79 2.06 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.282 -0.727 . . . . 13.17 111.282 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.457 ' HB3' ' HA2' ' A' ' 24' ' ' GLY . . . -139.22 -75.19 0.37 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.746 -0.464 . . . . 12.17 109.746 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -163.93 68.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.476 0.655 . . . . 13.82 110.628 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.9 tt 67.23 -75.54 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.209 -1.36 . . . . 12.13 110.905 172.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -62.63 -43.51 98.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 112.895 -1.957 . . . . 14.1 110.703 -164.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -128.96 40.27 3.66 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.622 -1.172 . . . . 11.05 109.865 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 19' ' ' ALA . . . -87.94 -35.66 8.92 Favored Glycine 0 CA--C 1.49 -1.476 0 CA-C-N 114.618 -1.173 . . . . 10.05 111.224 174.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.558 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -171.53 53.33 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.653 -0.773 . . . . 10.38 110.58 -175.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.613 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 39.9 mtt180 -126.45 141.32 51.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.547 -0.751 . . . . 8.37 110.367 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' OE2' ' A' ' 58' ' ' GLU . 44.5 mm -55.66 120.08 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 5.76 112.687 -170.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.56 -38.02 5.78 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.287 -1.324 . . . . 8.22 110.182 173.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.76 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 21.4 p90 -168.82 -174.66 2.16 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.104 0.478 . . . . 7.99 111.303 -175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CE2' ' HB3' ' A' ' 43' ' ' PRO . 1.6 m-90 -124.89 155.02 40.18 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 115.102 -0.954 . . . . 5.61 111.078 -173.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -160.44 153.58 21.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 9.06 110.133 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.653 ' HB2' HG22 ' A' ' 35' ' ' VAL . 19.1 m-20 -79.17 137.07 56.72 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 108.637 -0.875 . . . . 8.31 108.637 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -60.8 -11.8 19.26 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.65 2.233 . . . . 10.41 111.43 173.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.596 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.1 null -101.78 0.97 36.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.112 -0.494 . . . . 10.85 111.321 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.653 HG22 ' HB2' ' A' ' 32' ' ' ASP . 6.9 m -127.81 43.65 1.11 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 121.244 0.545 . . . . 9.32 111.476 176.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' HD3' ' N ' ' A' ' 35' ' ' VAL . 16.6 Cg_exo -61.74 111.49 1.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.81 2.34 . . . . 11.1 112.009 -170.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 130.38 -26.18 4.17 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 110.793 -0.923 . . . . 10.31 110.793 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.461 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 38.1 tp60 -76.52 115.58 16.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.263 0.554 . . . . 9.21 110.531 176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 36.3 ttp180 -98.47 99.44 10.61 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.664 -0.698 . . . . 11.51 110.944 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.76 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 82.9 m-85 -79.77 133.02 36.3 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 109.343 -0.614 . . . . 7.5 109.343 177.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -63.88 -26.86 68.8 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.638 0.587 . . . . 10.61 110.766 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -160.06 147.66 12.84 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.437 0.636 . . . . 10.91 111.977 -172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 19.6 Cg_endo -56.33 135.68 71.44 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 124.947 3.765 . . . . 7.51 113.573 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.71 -145.93 5.68 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.076 -0.583 . . . . 7.59 111.919 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 2.0 ttmm -105.83 141.93 36.42 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.669 -0.863 . . . . 11.68 108.669 175.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.58 ' HB3' ' O ' ' A' ' 49' ' ' MET . 47.0 t -64.05 141.6 98.09 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.855 -0.612 . . . . 9.2 111.411 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.93 -21.49 10.89 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.664 2.243 . . . . 10.25 111.012 171.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.571 ' CD2' HG11 ' A' ' 35' ' ' VAL . 35.0 m-85 -84.64 -41.99 15.8 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.187 -1.37 . . . . 10.49 109.245 -175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.58 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -137.04 157.41 46.78 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.369 -0.832 . . . . 10.38 110.873 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.0 p-10 -84.11 53.38 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.07 0.938 . . . . 12.54 111.135 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.47 32.85 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 114.967 -1.015 . . . . 9.87 109.345 174.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.43 133.14 23.67 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 N-CA-C 108.86 -1.246 . . . . 9.51 108.86 167.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.498 HD23 ' OD1' ' A' ' 32' ' ' ASP . 31.6 mt -61.59 157.17 17.99 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.076 0.465 . . . . 6.71 111.331 -172.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 mm -99.16 133.26 22.24 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 116.065 -0.516 . . . . 7.89 109.702 -176.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.564 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 92.8 Cg_endo -78.65 138.18 14.99 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 121.912 1.741 . . . . 5.77 112.613 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HB ' ' CE1' ' A' ' 57' ' ' TYR . 34.5 m -61.07 159.64 2.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 114.301 -1.318 . . . . 5.96 112.869 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.59 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 15.47 -87.45 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.564 1.946 . . . . 7.84 115.11 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.613 ' OE1' ' HA ' ' A' ' 26' ' ' ARG . 2.5 pt-20 -53.49 -34.49 58.24 Favored 'General case' 0 CA--C 1.51 -0.563 0 CA-C-N 114.244 -1.344 . . . . 6.62 111.675 -170.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.564 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 31.6 tt0 55.06 74.39 0.36 Allowed 'General case' 0 C--N 1.319 -0.718 0 O-C-N 124.44 1.088 . . . . 8.58 110.047 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 54.23 86.0 0.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.327 -1.306 . . . . 7.64 112.742 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.429 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 28.8 t30 -121.14 -44.09 2.41 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 107.82 -1.178 . . . . 7.02 107.82 169.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 67.69 -63.2 0.31 Allowed 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 113.741 -1.572 . . . . 5.41 112.411 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.552 ' CG ' ' HB3' ' A' ' 68' ' ' ARG . 3.1 p-10 -166.43 9.93 0.03 OUTLIER 'General case' 0 N--CA 1.426 -1.637 0 C-N-CA 119.047 -1.061 . . . . 7.01 113.082 -171.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.39 -0.6 74.55 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 114.314 -1.312 . . . . 7.2 112.074 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 67.66 49.73 0.95 Allowed 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.351 0.677 . . . . 7.82 110.269 -176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.36 -48.07 0.02 OUTLIER 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.0 -0.545 . . . . 8.65 111.796 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.417 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 15.9 t -81.82 -85.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.477 -0.329 . . . . 7.31 111.027 -173.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' HB3' ' CG ' ' A' ' 63' ' ' ASP . 16.1 ptp180 48.51 176.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.703 1.601 . . . . 10.21 115.254 174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.47 HG22 ' HG2' ' A' ' 72' ' ' ARG . 8.2 mt -112.55 154.98 13.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 112.345 -2.207 . . . . 8.86 109.071 172.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.405 ' N ' HG22 ' A' ' 69' ' ' ILE . 22.8 t70 -79.35 49.2 0.96 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.246 0.546 . . . . 13.02 111.148 -179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.4 33.55 76.67 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.564 -0.744 . . . . 12.13 112.148 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.47 ' HG2' HG22 ' A' ' 69' ' ' ILE . 12.3 ptm180 -135.16 -175.42 3.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 107.986 -1.116 . . . . 12.38 107.986 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.77 120.69 61.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.669 0.747 . . . . 11.61 110.389 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.7 t -104.29 101.62 11.33 Favored 'General case' 0 N--CA 1.425 -1.69 0 CA-C-N 114.51 -1.223 . . . . 10.71 108.254 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -71.21 73.72 0.67 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.919 -1.037 . . . . 14.09 111.257 -172.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -136.61 138.71 41.47 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.481 -0.933 . . . . 11.22 108.481 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.42 -20.63 66.46 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.341 -0.845 . . . . 13.71 111.228 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.97 -49.21 0.79 Allowed Glycine 0 CA--C 1.496 -1.129 0 N-CA-C 109.586 -1.406 . . . . 11.44 109.586 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 79' ' ' VAL . 9.0 p 38.37 73.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 122.9 1.333 . . . . 9.99 113.063 165.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 150' ' ' SER . 14.2 mtp180 -80.48 133.35 35.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.73 -1.123 . . . . 11.64 110.247 -174.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.51 HG22 ' HA ' ' A' ' 148' ' ' VAL . 36.2 p -131.48 147.24 52.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.447 -1.251 . . . . 8.0 110.592 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.49 127.44 54.0 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 108.819 -0.808 . . . . 6.65 108.819 173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 29.9 tt0 -73.02 138.08 45.77 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.083 -0.508 . . . . 12.15 109.724 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' LEU . 54.4 t -58.96 135.21 23.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.522 -0.763 . . . . 9.71 111.739 176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 83' ' ' GLU . 66.5 mmtt -126.89 154.36 44.53 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.327 -0.851 . . . . 11.03 111.56 -176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' CD2' ' HG3' ' A' ' 93' ' ' GLU . 8.8 mp -89.2 125.7 35.18 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.42 -0.956 . . . . 12.76 108.42 162.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -119.8 8.57 11.72 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 118.979 -1.581 . . . . 13.25 113.371 -173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.762 ' HG3' ' HA ' ' A' ' 93' ' ' GLU . 7.3 ptp180 -141.27 158.17 44.25 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.07 0.462 . . . . 16.35 110.548 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 50.3 tp -158.47 113.67 2.61 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.955 -1.02 . . . . 18.22 108.41 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.86 -50.46 0.84 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 108.59 -1.804 . . . . 17.91 108.59 -169.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.465 ' HB2' ' HB2' ' A' ' 88' ' ' ARG . 15.2 m -73.38 165.87 24.25 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.174 -1.047 . . . . 17.11 108.174 165.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.1 m -72.15 106.48 4.39 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 115.728 -0.669 . . . . 14.73 111.085 -171.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.762 ' HA ' ' HG3' ' A' ' 88' ' ' ARG . 1.6 tt0 -53.31 124.09 13.71 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 124.585 1.178 . . . . 14.94 111.949 -174.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.581 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -132.17 163.8 27.73 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 113.892 -1.503 . . . . 10.57 107.567 178.486 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.609 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -91.6 114.53 27.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.719 -0.474 . . . . 8.88 109.719 -179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -91.14 130.61 37.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.951 -0.568 . . . . 9.78 110.974 -176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.54 158.24 50.72 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.405 -0.816 . . . . 6.4 109.628 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.572 ' HG2' HG11 ' A' ' 149' ' ' VAL . 34.5 Cg_exo -57.72 134.38 62.53 Favored 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.204 1.936 . . . . 6.55 111.049 171.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.0 t -58.05 -28.23 64.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.916 0.339 . . . . 9.29 111.916 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -86.05 1.24 51.1 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 122.234 -0.291 . . . . 10.86 111.552 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.528 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -76.75 -41.08 46.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.097 0.475 . . . . 5.34 111.378 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.92 163.43 14.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.847 -0.615 . . . . 6.97 112.073 -172.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.4 mm -113.27 103.57 15.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.809 -0.632 . . . . 10.2 109.508 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 14.2 ptt180 -102.41 132.2 48.56 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 117.949 -1.501 . . . . 12.12 111.113 173.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -150.31 132.58 15.47 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 113.736 -1.575 . . . . 14.61 109.454 -170.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.65 -108.79 2.14 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.519 -0.848 . . . . 15.52 112.317 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.5 29.09 7.63 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.381 0.511 . . . . 14.99 112.381 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.45 HH11 HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -164.76 178.86 6.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.119 0.415 . . . . 15.2 112.119 -177.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 7.2 m -133.15 152.29 51.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.668 -0.696 . . . . 9.26 110.137 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 124' ' ' GLU . 34.4 mm -128.95 151.76 36.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.777 -0.453 . . . . 10.55 109.777 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.84 130.12 31.33 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.649 -0.13 . . . . 7.39 110.649 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.4 mtm -89.31 101.47 14.14 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.388 -0.597 . . . . 8.85 109.388 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 10.0 p -87.19 139.17 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 115.601 -0.727 . . . . 9.69 111.364 -174.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.588 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.61 85.89 2.1 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.77 -0.65 . . . . 10.7 109.642 174.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -71.32 145.82 49.24 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.231 -0.44 . . . . 14.88 110.129 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.19 -7.78 33.36 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 116.031 -0.531 . . . . 16.92 113.168 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -88.33 10.98 17.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.249 0.547 . . . . 18.56 110.966 178.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.12 14.4 69.3 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.487 -0.779 . . . . 15.62 113.282 173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.0 167.47 21.09 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.683 -0.77 . . . . 14.19 111.501 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 98.7 m-85 -113.0 108.24 17.07 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 120.905 0.383 . . . . 12.03 110.047 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 16.8 t70 -101.54 141.11 21.93 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.054 -0.521 . . . . 13.91 110.637 -173.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 9.4 Cg_endo -86.19 124.7 2.5 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.485 2.123 . . . . 12.35 111.943 178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.586 HG12 ' HB3' ' A' ' 111' ' ' ALA . 8.7 p -107.47 131.8 56.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.397 -0.82 . . . . 9.43 109.304 176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.5 ' HA ' HD13 ' A' ' 110' ' ' ILE . 31.2 tt0 -78.0 109.86 12.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.969 -0.752 . . . . 12.93 108.969 171.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.832 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -116.62 155.78 18.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.193 -0.912 . . . . 8.03 111.465 -171.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -93.54 120.05 33.33 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.092 -0.958 . . . . 10.39 108.87 172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.56 106.89 4.77 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.093 -0.503 . . . . 8.3 111.004 -175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.52 70.53 0.29 Allowed Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 117.893 -2.099 . . . . 10.1 114.215 169.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.729 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.43 162.85 39.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.16 -0.681 . . . . 10.61 109.16 155.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -141.64 123.61 15.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.178 0.513 . . . . 13.17 109.759 170.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.92 126.45 11.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.673 -0.694 . . . . 12.98 111.156 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.78 32.08 83.03 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 116.09 -0.505 . . . . 14.34 112.528 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.41 15.62 80.25 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.933 -0.651 . . . . 13.12 111.878 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -123.37 174.98 7.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.036 -0.727 . . . . 10.62 109.036 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.7 m -126.58 157.53 38.6 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.001 0.429 . . . . 7.82 110.646 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.729 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 75.4 mt-10 -101.8 118.14 36.31 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.489 0.661 . . . . 10.79 110.888 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.832 HD12 HG21 ' A' ' 125' ' ' VAL . 17.6 mm -86.09 101.23 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 115.097 -0.956 . . . . 6.73 108.927 171.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 2.6 mp -71.09 -36.77 72.34 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.573 -1.194 . . . . 8.79 110.264 -176.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 125' ' ' VAL . 12.5 tt0 -158.2 158.38 34.44 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 109.056 -0.72 . . . . 10.44 109.056 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.419 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 126.15 -33.69 3.43 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 119.903 -1.142 . . . . 8.87 111.772 174.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 77.0 mt -132.34 -176.9 4.24 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 112.859 0.689 . . . . 8.5 112.859 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -148.38 155.97 41.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.731 -1.122 . . . . 14.15 108.944 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.46 133.44 47.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.293 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.54 -5.41 44.14 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 110.817 -0.913 . . . . 11.54 110.817 -172.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.442 ' O ' HG23 ' A' ' 84' ' ' VAL . 38.5 mt-30 -101.06 122.03 42.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.364 0.602 . . . . 11.24 109.391 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 6.4 mt-30 -91.27 124.97 35.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.1 -0.955 . . . . 10.49 110.718 -174.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.39 139.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.792 -0.448 . . . . 5.45 109.792 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.51 ' HA ' HG22 ' A' ' 81' ' ' THR . 35.3 m -65.36 132.25 31.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 6.56 110.764 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.572 HG11 ' HG2' ' A' ' 98' ' ' PRO . 3.2 m -119.29 19.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.891 0.853 . . . . 6.99 109.247 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 27.5 m 73.79 154.54 0.15 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 113.713 -1.585 . . . . 9.06 112.038 177.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.25 71.51 2.24 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.671 -0.972 . . . . 8.5 110.671 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -60.34 140.98 56.86 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.398 0.518 . . . . 11.84 112.398 -172.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -106.15 -161.38 0.79 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.691 -0.686 . . . . 12.24 109.761 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 61.7 tp 71.67 -71.25 0.14 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.202 0.601 . . . . 13.16 110.631 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 15.9 tt -86.66 3.36 4.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.539 -0.755 . . . . 11.95 110.597 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.68 -21.67 65.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.841 -0.618 . . . . 11.22 110.056 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.4 p -59.1 -52.99 63.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.182 0.515 . . . . 11.9 110.17 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -60.94 -36.6 79.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.38 -0.827 . . . . 11.17 110.391 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -68.63 -29.14 67.57 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.051 -0.977 . . . . 7.82 111.3 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.8 t -76.38 -19.33 58.26 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.966 -0.383 . . . . 9.64 109.966 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 94.8 mt -63.01 -50.13 71.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.23 -0.655 . . . . 10.57 109.23 173.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -64.63 -34.97 79.52 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.257 -0.883 . . . . 8.9 110.248 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.437 ' C ' ' HG1' ' A' ' 164' ' ' THR . . . 106.82 43.65 1.4 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.439 -0.801 . . . . 7.15 111.666 -178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.437 ' HG1' ' C ' ' A' ' 163' ' ' GLY . 49.2 p 54.95 -92.57 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.902 0.881 . . . . 7.09 112.156 -178.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.4 m -91.56 74.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.501 0.667 . . . . 9.2 110.87 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.33 146.94 53.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.686 -0.688 . . . . 9.11 111.277 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.728 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 0.2 OUTLIER -109.24 111.12 22.53 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 116.296 -0.411 . . . . 14.58 110.386 -178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -149.9 -69.27 0.2 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.354 -0.839 . . . . 11.94 110.168 173.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -138.34 -68.21 0.46 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.193 -0.912 . . . . 14.99 110.156 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.424 ' HG2' ' N ' ' A' ' 171' ' ' THR . 0.0 OUTLIER -134.03 -54.24 0.86 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.677 -0.692 . . . . 15.01 110.067 -177.527 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.424 ' N ' ' HG2' ' A' ' 170' ' ' GLU . 11.1 p -153.46 -46.52 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.111 0.564 . . . . 14.25 110.295 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.2 t 175.79 161.51 0.3 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.318 -0.855 . . . . 14.89 110.38 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.2 m -98.6 -2.66 38.03 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 15.85 109.714 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -112.66 46.66 1.14 Allowed Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 110.557 -1.017 . . . . 17.54 110.557 172.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.613 HD13 ' N ' ' A' ' 176' ' ' GLU . 2.2 tm? -56.98 150.91 15.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.258 -0.471 . . . . 17.85 110.111 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.613 ' N ' HD13 ' A' ' 175' ' ' LEU . 33.6 mt-10 -68.52 77.0 0.28 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.342 0.592 . . . . 19.67 110.942 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.6 p -146.95 132.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.412 -0.813 . . . . 19.52 109.198 178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.447 ' N ' HD23 ' A' ' 178' ' ' LEU . 1.4 pt? -136.95 145.44 44.21 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.098 0.475 . . . . 21.15 111.036 -174.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -74.08 146.72 43.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.532 -0.758 . . . . 23.25 110.39 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.318 -0.849 . . . . 23.52 109.772 177.4 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.892 0.377 . . . . 34.32 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.83 108.49 0.21 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.247 -0.741 . . . . 33.09 111.247 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m 63.78 -161.1 0.29 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.972 0.415 . . . . 34.12 110.918 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 67.54 12.48 8.9 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.778 0.831 . . . . 32.32 111.825 176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.4 p -110.04 -5.92 15.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.036 -0.529 . . . . 32.74 111.001 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.03 -28.64 44.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.924 -0.58 . . . . 31.29 111.022 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -142.73 141.61 31.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.327 -0.397 . . . . 29.46 110.384 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.95 -172.96 36.01 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.638 -0.791 . . . . 28.28 111.872 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.84 27.36 0.61 Allowed 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 123.016 2.477 . . . . 27.51 112.421 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -137.92 46.09 2.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.505 -0.316 . . . . 26.48 110.98 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.06 44.58 1.14 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.631 0.729 . . . . 24.9 110.507 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.85 23.01 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.103 -0.953 . . . . 23.19 110.811 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -150.74 152.63 34.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.205 0.503 . . . . 21.31 110.463 177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -96.53 160.82 28.66 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.283 -0.636 . . . . 19.89 109.283 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -56.81 -50.9 10.25 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.129 1.886 . . . . 18.12 111.952 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . . . 68.22 115.57 0.04 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.086 -0.961 . . . . 16.58 111.82 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.37 108.28 17.11 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.685 -0.689 . . . . 14.8 110.209 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.75 -96.89 0.31 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.982 -0.628 . . . . 13.17 111.665 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.66 -87.28 0.05 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.904 -0.174 . . . . 12.17 110.604 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 68.63 122.28 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.557 0.694 . . . . 13.82 110.926 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.3 tm? 78.07 -45.87 0.43 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.517 -1.219 . . . . 12.13 110.349 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.6 -18.55 61.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.389 0.614 . . . . 14.1 109.511 176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.5 p -105.15 145.85 30.01 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.428 -0.805 . . . . 11.05 110.508 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -101.1 43.89 1.65 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.758 -0.735 . . . . 10.05 111.738 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.1 mptm? 72.68 62.62 0.11 Allowed 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 107.614 -1.254 . . . . 10.38 107.614 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.574 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 22.7 ptt85 -128.13 145.44 51.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 113.649 -1.614 . . . . 8.37 109.093 -176.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.667 HG13 ' H ' ' A' ' 61' ' ' ASN . 22.5 mm -54.05 125.28 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 114.227 1.195 . . . . 5.76 114.227 -166.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.5 mt -110.26 -37.24 5.59 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 113.205 -1.816 . . . . 8.22 110.507 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.697 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 20.5 p90 -170.0 -176.03 2.19 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 120.935 0.397 . . . . 7.99 111.369 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -123.86 148.82 46.46 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.533 -0.758 . . . . 5.61 111.09 -174.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -153.61 151.16 29.42 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.337 -0.392 . . . . 9.06 110.631 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.746 ' HB3' HG22 ' A' ' 35' ' ' VAL . 6.1 t0 -75.82 129.16 81.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.011 -1.107 . . . . 8.31 108.011 172.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HG3' HG13 ' A' ' 54' ' ' ILE . 18.7 Cg_exo -60.46 -16.99 45.38 Favored 'Trans proline' 0 C--N 1.333 -0.26 0 C-N-CA 122.098 1.865 . . . . 10.41 113.77 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -104.51 4.84 33.49 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.243 -0.583 . . . . 10.85 111.921 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.4 m -119.42 41.88 0.44 Allowed Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 112.387 0.514 . . . . 9.32 112.387 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -57.09 134.63 65.62 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 11.1 112.465 -172.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.08 43.38 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.976 -0.849 . . . . 10.31 110.976 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.578 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -92.86 116.42 29.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.217 0.532 . . . . 9.21 110.371 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 49.4 ttp180 -104.34 116.57 32.38 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.667 -0.697 . . . . 11.51 111.334 -177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.697 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 97.5 m-85 -101.84 114.23 28.13 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 107.862 -1.162 . . . . 7.5 107.862 171.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -64.35 -21.58 66.67 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.522 -0.871 . . . . 10.61 111.703 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.532 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 52.9 mttp -126.18 166.68 20.16 Favored Pre-proline 0 C--N 1.323 -0.548 0 C-N-CA 120.339 -0.544 . . . . 10.91 111.234 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 14.1 Cg_endo -56.4 171.58 0.88 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.399 2.733 . . . . 7.51 112.857 170.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 149.6 -170.8 29.76 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.651 -0.785 . . . . 7.59 112.424 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 31.2 ttmt -95.58 146.78 24.2 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 109.465 -0.568 . . . . 11.68 109.465 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.4 t -64.51 129.69 94.33 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.684 -0.689 . . . . 9.2 110.411 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.7 -26.35 33.09 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 122.44 2.093 . . . . 10.25 111.027 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HB2' ' CE ' ' A' ' 49' ' ' MET . 52.3 m-85 -73.98 -40.67 62.82 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.969 -1.468 . . . . 10.49 110.404 -175.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.505 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.8 OUTLIER -154.52 160.96 41.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 10.38 110.788 174.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.2 p-10 -78.6 72.35 5.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.888 0.851 . . . . 12.54 112.804 -173.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.2 ptm -140.41 144.74 38.12 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.531 -0.915 . . . . 9.87 108.531 168.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.4 133.3 29.84 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.095 1.863 . . . . 9.51 110.041 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 mt -61.34 159.53 12.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.894 0.378 . . . . 6.71 110.382 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.456 HG13 ' HG3' ' A' ' 33' ' ' PRO . 42.0 mm -103.24 130.84 22.83 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-O 121.25 0.548 . . . . 7.89 109.752 -175.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.636 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 80.6 Cg_endo -75.48 144.14 28.39 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 121.707 1.605 . . . . 5.77 112.416 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.1 m -64.35 160.46 3.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 114.407 -1.27 . . . . 5.96 112.62 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.574 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.59 -71.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.843 2.457 . . . . 7.84 116.389 -175.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' HG12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -61.06 -45.21 95.67 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.766 0.793 . . . . 6.62 109.936 -173.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 47.5 mt-10 71.72 43.31 0.58 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.514 -1.675 . . . . 8.58 114.695 167.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 173.73 56.38 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.161 0 O-C-N 124.316 1.01 . . . . 7.64 111.966 172.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.667 ' H ' HG13 ' A' ' 27' ' ' ILE . 10.4 t30 62.71 -52.13 0.17 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 112.624 -2.08 . . . . 7.02 114.647 170.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' H ' ' H ' ' A' ' 63' ' ' ASP . . . -170.51 -18.14 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.873 -0.603 . . . . 5.41 112.38 -176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.646 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 56.9 m-20 55.83 37.0 28.34 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.797 0.808 . . . . 7.01 109.632 -164.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 53.34 31.14 42.09 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 114.73 -1.123 . . . . 7.2 112.577 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 64' ' ' GLY . . . 88.94 48.66 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.809 1.244 . . . . 7.82 111.466 -175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 72.45 -26.84 0.18 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.264 1.209 . . . . 8.65 114.264 170.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 p -63.97 -20.56 26.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 122.587 1.184 . . . . 7.31 109.92 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.683 ' HB3' ' OG1' ' A' ' 164' ' ' THR . 5.9 ttt180 66.86 113.95 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 111.988 -2.369 . . . . 10.21 112.836 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.491 HG21 ' O ' ' A' ' 72' ' ' ARG . 2.6 mt -126.16 156.2 36.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 113.608 -1.633 . . . . 8.86 110.465 177.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -90.28 54.32 2.73 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 122.1 0.952 . . . . 13.02 110.236 175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.48 -20.16 9.52 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 114.441 -1.254 . . . . 12.13 114.687 169.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' O ' HG21 ' A' ' 69' ' ' ILE . 17.0 ptm180 -72.65 127.01 31.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.803 -0.814 . . . . 12.38 108.803 176.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 67.6 t -123.23 135.52 62.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 121.275 0.559 . . . . 11.61 111.828 -172.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 76' ' ' ASN . 8.0 t -147.82 117.44 7.06 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 114.904 -1.044 . . . . 10.71 109.457 171.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -80.81 35.93 0.38 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 122.578 1.18 . . . . 14.09 109.598 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 74' ' ' THR . 38.6 m-80 -156.57 98.55 1.82 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 113.384 -1.735 . . . . 11.22 107.922 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.0 mt -83.2 -3.92 57.88 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.494 0.664 . . . . 13.71 110.746 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.31 -1.28 26.47 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.202 -0.908 . . . . 11.44 112.184 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.3 t -148.1 124.96 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.851 0.358 . . . . 9.99 110.349 -174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -113.53 138.65 49.84 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.155 -0.683 . . . . 11.64 109.155 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.9 p -140.4 144.11 36.03 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.082 0.468 . . . . 8.0 110.78 -178.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.479 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -114.94 140.64 48.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.872 -0.788 . . . . 6.65 108.872 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 34.4 tt0 -87.48 130.54 34.66 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.593 -0.521 . . . . 12.15 109.593 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 145' ' ' GLN . 61.2 t -54.69 128.96 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.432 0.635 . . . . 9.71 111.554 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -163.02 140.3 7.7 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.486 -1.233 . . . . 11.03 109.981 171.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.88 ' H ' HD23 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -77.58 158.01 30.02 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.148 -0.933 . . . . 12.76 110.484 -177.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.549 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -169.53 47.89 0.21 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.883 -0.675 . . . . 13.25 112.427 -171.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -68.58 134.47 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.821 0.343 . . . . 16.35 110.924 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 78.9 mt -135.68 85.52 2.17 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.709 -0.848 . . . . 18.22 108.709 173.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.88 2.09 75.68 Favored Glycine 0 CA--C 1.504 -0.641 0 N-CA-C 108.418 -1.873 . . . . 17.91 108.418 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -110.44 178.3 4.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 112.829 -1.686 . . . . 17.11 108.572 -178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.4 m -94.44 156.37 16.51 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.552 -0.907 . . . . 14.73 108.552 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -65.88 105.76 1.38 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.493 0.663 . . . . 14.94 111.415 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 33.6 mmt180 -133.92 164.28 27.64 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.382 -1.281 . . . . 10.57 108.332 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 5.6 mp -85.16 112.21 20.5 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.101 -0.703 . . . . 8.88 109.101 -177.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.0 mm? -87.81 130.23 34.94 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 120.84 0.352 . . . . 9.78 110.95 -175.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.1 m -144.78 155.58 56.08 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.293 -0.867 . . . . 6.4 109.045 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -53.93 136.92 67.96 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.121 1.881 . . . . 6.55 111.117 170.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 15.9 t -56.46 -24.12 43.49 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.472 0.545 . . . . 9.29 112.472 -178.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.89 9.47 27.5 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 122.217 -0.302 . . . . 10.86 111.138 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.687 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -80.44 -41.11 25.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.244 0.545 . . . . 5.34 111.339 -178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.538 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -89.8 155.61 19.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.646 0.736 . . . . 6.97 112.546 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.37 131.43 46.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-N 114.731 -1.122 . . . . 10.2 109.1 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -102.28 126.55 49.31 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.534 -0.466 . . . . 12.12 110.823 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 t -149.67 132.93 16.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.275 -0.421 . . . . 14.61 110.466 175.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.33 -114.22 3.61 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.262 -0.494 . . . . 15.52 113.111 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.57 36.65 4.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.195 0.521 . . . . 14.99 111.243 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -153.3 167.53 29.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.061 -0.518 . . . . 15.2 111.758 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 7.2 m -117.44 145.15 44.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.066 -0.515 . . . . 9.26 109.831 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.558 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.8 mm -125.49 153.5 33.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.306 -0.627 . . . . 10.55 109.306 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.619 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -129.42 129.88 45.24 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 122.353 -0.217 . . . . 7.39 110.467 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.486 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 41.2 ttp -90.61 100.86 13.63 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 8.85 108.668 175.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.3 p -84.49 133.16 29.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.49 -0.777 . . . . 9.69 111.894 -171.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.86 84.06 7.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.081 -0.963 . . . . 10.7 110.188 177.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -71.19 149.03 46.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 14.88 110.665 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.79 5.39 39.44 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.118 -0.793 . . . . 16.92 111.118 174.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -87.23 6.39 33.42 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.471 0.653 . . . . 18.56 110.528 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 1.27 77.05 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.231 -0.895 . . . . 15.62 113.469 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -130.78 159.17 22.87 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.735 -0.745 . . . . 14.19 112.426 -175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.486 ' HB3' ' HG2' ' A' ' 112' ' ' MET . 97.5 m-85 -109.87 116.82 32.34 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.572 -0.529 . . . . 12.03 109.572 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.8 t70 -113.46 144.2 30.84 Favored Pre-proline 0 C--N 1.328 -0.351 0 C-N-CA 121.002 -0.279 . . . . 13.91 111.267 -173.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -84.44 131.21 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.512 2.141 . . . . 12.35 112.505 176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.619 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 10.6 p -122.97 136.02 61.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.595 . . . . 9.43 110.27 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 110' ' ' ILE . 35.0 tt0 -83.11 120.23 25.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.97 0.414 . . . . 12.93 109.996 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.469 HG13 HG13 ' A' ' 123' ' ' VAL . 22.8 m -129.11 165.8 28.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.031 -0.531 . . . . 8.03 111.567 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.73 127.17 44.57 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.873 -0.603 . . . . 10.39 109.397 173.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.449 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -142.14 106.19 4.75 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.198 -0.455 . . . . 8.3 111.393 -175.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.75 71.05 0.28 Allowed Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 117.655 -2.212 . . . . 10.1 114.094 167.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.892 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.51 162.16 40.7 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.817 -0.809 . . . . 10.61 108.817 155.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.9 m -146.96 129.76 16.17 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.645 -0.502 . . . . 13.17 109.645 169.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.96 110.72 4.97 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.034 -0.53 . . . . 12.98 111.364 -178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.61 40.28 90.55 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 121.056 -0.592 . . . . 14.34 112.9 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.79 0.73 90.36 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.72 -0.753 . . . . 13.12 112.543 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -114.49 155.69 25.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.507 -0.553 . . . . 10.62 109.507 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 57.7 m -113.4 164.85 13.07 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 110.072 -0.344 . . . . 7.82 110.072 178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.892 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.9 mt-10 -112.53 113.57 25.79 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.57 0.7 . . . . 10.79 111.283 177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 34.9 mm -83.24 104.31 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.946 -1.024 . . . . 6.73 108.401 170.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.465 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -70.34 -49.14 52.39 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.125 -0.943 . . . . 8.79 109.922 -174.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -144.38 162.04 37.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 10.44 111.311 -175.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 119.31 -52.99 0.69 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.871 -0.68 . . . . 8.87 113.395 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 123' ' ' VAL . 16.0 mt -105.36 -171.63 1.95 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 8.5 111.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -144.26 155.37 43.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.629 -0.714 . . . . 14.15 110.066 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.08 129.51 40.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.15 -0.932 . . . . 12.12 110.348 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.28 -11.06 28.78 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.978 -0.849 . . . . 11.54 110.978 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 84' ' ' VAL . 88.5 mm-40 -94.19 118.22 31.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.465 -0.569 . . . . 11.24 109.465 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 26.1 mt-30 -85.38 132.38 34.24 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.955 -0.566 . . . . 10.49 110.797 -177.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.4 m -122.8 142.34 39.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.184 -0.462 . . . . 5.45 110.133 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 8.9 p -65.29 124.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.231 0.539 . . . . 6.56 111.375 -176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.687 HG12 ' HB2' ' A' ' 101' ' ' ALA . 10.9 m -129.34 29.6 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.273 0.558 . . . . 6.99 111.083 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.2 m -53.01 112.7 0.9 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.105 -0.952 . . . . 9.06 110.999 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 157.93 127.12 0.93 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.935 -0.866 . . . . 8.5 110.935 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 153' ' ' PHE . 15.8 mm-40 -150.79 76.61 1.25 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.708 0.254 . . . . 11.84 111.323 -175.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.402 ' HB3' ' O ' ' A' ' 152' ' ' GLN . 79.0 t80 72.01 -71.25 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.65 0.594 . . . . 12.24 111.062 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 155' ' ' ILE . 11.3 tp -118.02 -154.95 0.58 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.669 -0.863 . . . . 13.16 108.669 -176.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.54 ' H ' ' HG ' ' A' ' 154' ' ' LEU . 61.0 mt -57.85 100.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.495 0.664 . . . . 11.95 110.191 177.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.435 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 5.6 p-10 -82.67 -6.44 59.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.472 -0.786 . . . . 11.22 111.09 -172.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.7 m -60.41 -42.89 96.92 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.048 0.451 . . . . 11.9 110.807 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -77.41 -28.35 52.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.509 0.671 . . . . 11.17 109.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -74.6 -27.36 60.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.013 -0.994 . . . . 7.82 111.987 -174.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.3 p -81.48 -38.6 26.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.947 0.403 . . . . 9.64 110.804 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.52 -26.57 61.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.791 -0.64 . . . . 10.57 111.155 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 162' ' ' ARG . 1.8 ptm180 -94.63 161.68 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.667 0.746 . . . . 8.9 110.084 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -113.86 -70.19 0.52 Allowed Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 109.628 -1.389 . . . . 7.15 109.628 170.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.683 ' OG1' ' HB3' ' A' ' 68' ' ' ARG . 21.7 p -144.98 -56.23 0.33 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.303 0.573 . . . . 7.09 109.767 170.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.54 -70.37 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.604 -0.725 . . . . 9.2 110.053 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 70.69 132.58 0.03 OUTLIER 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.883 0.74 . . . . 9.11 111.856 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -88.62 110.38 20.88 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.176 -1.046 . . . . 14.58 108.176 175.128 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 13.1 ptp -103.59 123.92 47.85 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 113.985 -1.461 . . . . 11.94 112.224 -170.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -152.07 -44.93 0.11 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.427 -1.26 . . . . 14.99 108.045 173.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.33 -58.94 2.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.842 -1.072 . . . . 15.01 109.11 173.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 32.2 p -108.92 117.78 35.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.662 -0.699 . . . . 14.25 110.725 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.5 m -91.45 151.21 20.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 14.89 109.934 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 44.2 m -94.47 76.09 3.84 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.506 0.669 . . . . 15.85 110.203 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -68.3 -38.02 86.97 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.011 -0.995 . . . . 17.54 111.137 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.404 ' CD1' ' HB ' ' A' ' 155' ' ' ILE . 80.6 mt -98.87 73.64 1.99 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.049 -0.352 . . . . 17.85 110.049 170.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -90.79 -26.69 19.32 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.238 -0.585 . . . . 19.67 110.211 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.9 t -74.88 89.28 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.169 0.509 . . . . 19.52 110.687 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 57.4 tp -141.65 93.86 2.61 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.909 -0.587 . . . . 21.15 109.696 175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.39 -79.48 0.59 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.212 -0.449 . . . . 23.25 110.446 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.79 -0.624 . . . . 23.52 109.639 179.796 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpt . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 120.575 0.226 . . . . 34.32 110.841 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 172.46 -47.89 0.17 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.595 -0.812 . . . . 33.09 111.978 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.493 ' O ' HG22 ' A' ' 6' ' ' VAL . 18.7 t -81.6 102.64 10.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.347 0.594 . . . . 34.12 109.546 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.06 4.77 2.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.677 -0.692 . . . . 32.32 111.985 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -77.39 -30.44 53.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.062 0.458 . . . . 32.74 110.19 177.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 3' ' ' SER . 35.8 m -93.88 38.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.383 0.611 . . . . 31.29 110.875 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -73.66 -21.15 60.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.61 . . . . 29.46 111.409 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.62 139.18 3.73 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.753 -0.737 . . . . 28.28 112.124 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.77 -30.91 69.03 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.845 2.364 . . . . 27.51 112.561 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -153.34 136.21 15.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.471 -0.332 . . . . 26.48 110.426 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.7 175.5 7.86 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.852 -0.613 . . . . 24.9 110.67 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.53 -99.21 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.085 -0.507 . . . . 23.19 112.056 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -154.33 -59.92 0.12 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.589 0.709 . . . . 21.31 110.304 175.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 52.65 65.31 6.19 Favored Pre-proline 0 N--CA 1.467 0.41 0 CA-C-N 113.991 -1.459 . . . . 19.89 112.285 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -35.66 98.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.268 2.645 . . . . 18.12 112.721 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 52.39 46.81 25.99 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.144 0.497 . . . . 16.58 111.606 175.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.08 162.82 36.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.714 -0.675 . . . . 14.8 109.776 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.37 37.0 63.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.546 -0.835 . . . . 13.17 112.023 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.52 10.9 15.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 12.17 111.088 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.442 ' HG3' ' HE2' ' A' ' 25' ' ' LYS . 29.2 tt0 52.28 66.19 1.28 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.341 -1.3 . . . . 13.82 111.779 -179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.5 tp 175.85 -81.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.608 -1.178 . . . . 12.13 108.931 172.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -82.72 97.2 8.44 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.418 1.104 . . . . 14.1 108.969 172.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.6 p 55.91 52.12 11.14 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 112.446 -2.161 . . . . 11.05 112.288 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.3 -62.69 2.53 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.471 -0.786 . . . . 10.05 111.374 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -148.48 67.96 1.08 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.757 1.265 . . . . 10.38 108.015 176.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.579 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 2.1 mmp_? -141.15 127.66 20.04 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.692 -1.594 . . . . 8.37 109.203 -174.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 58' ' ' GLU . 1.0 OUTLIER -55.04 140.47 12.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 122.361 1.077 . . . . 5.76 112.7 -172.873 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.6 mt -118.53 -39.2 3.03 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.35 -1.75 . . . . 8.22 109.18 174.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 13.7 p90 -170.15 -178.21 2.75 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.331 -0.85 . . . . 7.99 110.011 179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.76 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 3.3 m-90 -120.83 146.97 45.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.604 -0.726 . . . . 5.61 109.665 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.87 149.97 37.74 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.784 0.326 . . . . 9.06 110.18 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.798 ' HB3' HG22 ' A' ' 35' ' ' VAL . 29.3 t0 -83.75 132.12 49.91 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 108.783 -0.821 . . . . 8.31 108.783 175.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.432 ' CD ' HD13 ' A' ' 54' ' ' ILE . 39.3 Cg_exo -56.05 -18.77 24.03 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.674 2.249 . . . . 10.41 112.461 172.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.493 ' HE3' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -90.14 -1.94 58.01 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 111.754 0.279 . . . . 10.85 111.754 175.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -131.91 39.65 0.52 Allowed Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 112.911 0.708 . . . . 9.32 112.911 -177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 19.1 Cg_endo -51.21 110.85 0.45 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.976 2.451 . . . . 11.1 112.799 -171.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 129.2 -31.81 3.38 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.766 -0.652 . . . . 10.31 111.503 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.494 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 20.6 tp60 -70.52 107.38 3.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.405 0.621 . . . . 9.21 111.04 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.604 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 23.5 mtm180 -86.88 97.69 10.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.259 -0.882 . . . . 11.51 110.68 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.4 m-85 -75.11 143.55 43.29 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.75 -0.659 . . . . 7.5 109.232 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.54 -29.14 70.45 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.551 -1.204 . . . . 10.61 111.072 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.503 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 21.1 pttm -164.17 164.03 14.69 Favored Pre-proline 0 N--CA 1.449 -0.481 0 CA-C-N 116.476 -0.329 . . . . 10.91 111.737 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.5 Cg_endo -50.75 170.85 0.12 Allowed 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.006 3.137 . . . . 7.51 113.712 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.55 -162.99 26.55 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.739 -0.744 . . . . 7.59 112.115 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.624 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 37.6 ttpt -94.28 149.23 21.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 121.126 0.489 . . . . 11.68 110.687 177.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 49' ' ' MET . 34.2 t -65.64 132.47 94.96 Favored Pre-proline 0 N--CA 1.446 -0.628 0 CA-C-N 115.122 -0.945 . . . . 9.2 110.986 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -72.54 -24.72 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.204 1.936 . . . . 10.25 111.706 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' A' ' 35' ' ' VAL . 78.1 m-85 -76.5 -37.13 57.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.99 -1.005 . . . . 10.49 110.098 -173.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.3 pmm? -156.92 163.6 38.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.865 -0.607 . . . . 10.38 110.224 169.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.0 75.68 10.12 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.471 1.285 . . . . 12.54 114.471 -167.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -142.59 145.38 34.12 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.057 -0.72 . . . . 9.87 109.057 168.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.9 Cg_exo -66.6 133.91 33.63 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.947 1.764 . . . . 9.51 111.219 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.428 ' CD2' ' HB2' ' A' ' 32' ' ' ASP . 31.6 mt -62.67 159.03 16.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.004 0.431 . . . . 6.71 111.181 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.432 HD13 ' CD ' ' A' ' 33' ' ' PRO . 1.7 mp -95.69 135.4 23.03 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 115.952 -0.567 . . . . 7.89 109.691 -175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.577 ' HB3' ' NE1' ' A' ' 30' ' ' TRP . 64.5 Cg_endo -87.52 162.1 8.06 Favored 'Trans proline' 0 N--CA 1.436 -1.891 0 C-N-CA 121.585 1.524 . . . . 5.77 113.286 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG22 HG13 ' A' ' 27' ' ' ILE . 32.6 m -89.26 156.49 3.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.647 -1.16 . . . . 5.96 111.709 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.579 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.73 -80.88 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 126.971 2.108 . . . . 7.84 115.685 -178.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.599 ' HG2' ' CD1' ' A' ' 27' ' ' ILE . 2.1 pt-20 -53.04 -39.98 63.6 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 109.942 -0.392 . . . . 6.62 109.942 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 57' ' ' TYR . 52.3 mt-10 62.73 95.25 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.192 -0.913 . . . . 8.58 110.976 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.478 ' HG2' ' HA3' ' A' ' 64' ' ' GLY . 26.6 tt0 63.33 52.74 2.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 113.554 -1.657 . . . . 7.64 111.986 159.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.556 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 10.4 t30 -122.6 -35.37 3.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 113.664 -1.607 . . . . 7.02 110.006 -177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.62 -30.79 33.24 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 113.792 -1.549 . . . . 5.41 111.368 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 8.6 p-10 -162.03 22.18 0.11 Allowed 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 115.312 -0.858 . . . . 7.01 110.757 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.478 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -89.72 -31.03 11.77 Favored Glycine 0 CA--C 1.496 -1.139 0 CA-C-N 115.083 -0.962 . . . . 7.2 111.375 176.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.19 -41.48 6.37 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.592 -0.804 . . . . 7.82 110.37 -172.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.26 -24.21 22.14 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.703 -0.68 . . . . 8.65 110.047 177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 63' ' ' ASP . 3.7 t 65.78 -39.2 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 114.149 -1.387 . . . . 7.31 111.908 -169.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -57.74 136.36 56.89 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 109.735 -0.469 . . . . 10.21 109.735 165.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG22 ' N ' ' A' ' 70' ' ' ASP . 15.4 mt -67.49 159.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.1 0.476 . . . . 8.86 110.349 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' N ' HG22 ' A' ' 69' ' ' ILE . 33.8 t70 -74.07 35.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.457 -0.792 . . . . 13.02 111.017 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 69.31 11.05 63.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 121.344 -0.455 . . . . 12.13 112.945 -178.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HG3' HG12 ' A' ' 73' ' ' VAL . 13.9 ptm180 -100.43 177.88 4.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 119.218 -0.42 . . . . 12.38 110.3 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 72' ' ' ARG . 5.0 p 33.31 115.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 N-CA-C 115.432 1.642 . . . . 11.61 115.432 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.6 t -71.34 59.89 0.29 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.265 -1.334 . . . . 10.71 111.792 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -91.24 67.74 5.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.807 0.813 . . . . 14.09 109.161 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -112.14 119.65 39.13 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 114.88 -1.054 . . . . 11.22 109.23 -176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.625 ' H ' HD22 ' A' ' 77' ' ' LEU . 2.9 mm? -47.0 -37.6 9.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.595 -1.184 . . . . 13.71 111.85 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . 126.26 42.01 0.31 Allowed Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 109.111 -1.596 . . . . 11.44 109.111 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 92.7 t 78.19 121.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 113.964 -1.118 . . . . 9.99 110.659 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.38 124.2 29.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.202 -0.666 . . . . 11.64 109.202 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.419 HG22 ' HA ' ' A' ' 148' ' ' VAL . 60.2 p -130.0 154.82 47.01 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 116.269 -0.423 . . . . 8.0 109.879 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.409 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 134.33 54.61 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.731 -0.668 . . . . 6.65 109.231 174.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.414 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 32.8 tt0 -83.65 136.97 34.01 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 109.314 -0.624 . . . . 12.15 109.314 178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 95' ' ' LEU . 71.8 t -60.51 129.01 22.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.47 0.652 . . . . 9.71 111.881 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 26.5 mmtp -129.51 151.0 50.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.64 -1.164 . . . . 11.03 109.622 -178.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.426 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -84.98 162.37 19.41 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.728 -0.389 . . . . 12.76 109.967 169.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.05 46.86 0.02 OUTLIER Glycine 0 CA--C 1.51 -0.273 0 C-N-CA 120.705 -0.76 . . . . 13.25 112.837 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.599 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -84.23 -178.62 6.99 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.872 0.368 . . . . 16.35 111.696 -177.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.26 124.08 28.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.731 -0.668 . . . . 18.22 109.419 176.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 107.5 -159.47 14.5 Favored Glycine 0 C--N 1.31 -0.889 0 CA-C-N 115.222 -0.899 . . . . 17.91 111.59 176.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.7 p -86.31 76.71 9.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.949 0.881 . . . . 17.11 109.087 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.599 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 2.5 m -153.87 168.28 26.88 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.559 -1.201 . . . . 14.73 108.841 -176.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HG2' HD23 ' A' ' 86' ' ' LEU . 3.8 mt-10 -142.05 113.71 7.87 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.921 0.391 . . . . 14.94 109.981 163.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.506 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 3.1 tpp180 -122.64 159.94 26.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 10.57 110.358 -175.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.5 mm? -100.72 124.12 45.89 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.485 -0.561 . . . . 8.88 109.485 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -99.65 130.36 45.87 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.22 -0.445 . . . . 9.78 110.405 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.31 155.19 57.84 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.352 -0.84 . . . . 6.4 109.734 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -58.05 127.45 25.03 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.053 1.836 . . . . 6.55 111.124 172.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.489 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.5 p -54.26 -31.86 54.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.074 0.464 . . . . 9.29 112.227 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.88 -17.38 64.61 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.742 -0.663 . . . . 10.86 112.405 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -83.8 -7.29 59.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.486 . . . . 5.34 111.31 -175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.539 HD21 HD11 ' A' ' 137' ' ' ILE . 26.5 mt -86.18 118.27 25.53 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.773 0.797 . . . . 6.97 112.093 178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -89.54 111.32 22.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 114.409 -1.269 . . . . 10.2 108.817 173.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -87.59 125.42 34.34 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.345 -0.542 . . . . 12.12 110.45 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -148.81 141.47 24.47 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.966 -0.561 . . . . 14.61 109.875 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.64 -117.74 6.21 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 121.266 -0.492 . . . . 15.52 112.313 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.0 37.1 4.41 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.166 0.508 . . . . 14.99 111.342 176.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -148.28 174.65 11.79 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.986 -0.552 . . . . 15.2 111.081 -177.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.7 m -121.36 149.84 42.36 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.267 -0.642 . . . . 9.26 109.267 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.541 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 37.8 mm -128.4 148.27 32.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.645 -0.502 . . . . 10.55 109.645 -177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.625 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -121.41 126.42 49.3 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.496 -0.32 . . . . 7.39 110.205 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.442 ' HB2' HG22 ' A' ' 148' ' ' VAL . 59.4 mtp -82.27 99.68 9.46 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.416 -0.587 . . . . 8.85 109.416 174.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.4 p -83.04 130.66 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.291 -0.868 . . . . 9.69 111.288 -174.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -87.83 89.27 7.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.546 -0.752 . . . . 10.7 109.454 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -74.22 157.76 35.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.73 -0.668 . . . . 14.88 111.647 -174.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.86 17.49 21.29 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.418 -0.81 . . . . 16.92 111.501 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -103.6 8.73 37.6 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.354 0.597 . . . . 18.56 110.337 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 88.36 9.09 70.22 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.184 -0.917 . . . . 15.62 113.481 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.81 170.51 23.97 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.2 -1.0 . . . . 14.19 113.038 -175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 87.4 m-85 -121.46 123.7 42.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.869 -0.419 . . . . 12.03 109.869 -176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.544 ' O ' HG12 ' A' ' 113' ' ' VAL . 26.1 m-20 -123.51 151.05 62.66 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.791 -0.364 . . . . 13.91 111.404 -176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -86.15 122.69 2.2 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.048 1.832 . . . . 12.35 112.31 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.625 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 8.1 p -108.28 132.76 55.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.32 -0.855 . . . . 9.43 109.784 178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.454 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.6 tt0 -72.96 119.91 17.85 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.818 -0.438 . . . . 12.93 109.818 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.533 HG13 HG13 ' A' ' 123' ' ' VAL . 31.3 m -127.91 159.28 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.521 0.677 . . . . 8.03 111.584 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.451 ' HG2' HD22 ' A' ' 138' ' ' LEU . 39.8 ttmt -104.46 128.88 52.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.319 -0.855 . . . . 10.39 109.32 174.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.96 106.73 5.12 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 111.82 0.304 . . . . 8.3 111.82 -174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.18 70.03 0.29 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 117.983 -2.056 . . . . 10.1 114.82 165.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.626 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.15 163.44 38.2 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 107.446 -1.316 . . . . 10.61 107.446 150.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.7 m -140.65 128.83 22.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 118.7 0.682 . . . . 13.17 110.375 175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.86 117.3 12.03 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.136 0.421 . . . . 12.98 112.136 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 62.74 39.76 98.35 Favored Glycine 0 C--N 1.329 0.16 0 CA-C-N 115.948 -0.569 . . . . 14.34 113.344 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.99 13.84 82.29 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.724 -0.75 . . . . 13.12 112.471 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -122.26 163.02 20.38 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.56 -0.904 . . . . 10.62 108.56 176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.0 p -114.46 149.74 35.83 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.307 -0.557 . . . . 7.82 112.035 -177.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.2 mp0 -93.43 119.17 32.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.46 -0.791 . . . . 10.79 111.513 176.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.539 HD11 HD21 ' A' ' 102' ' ' LEU . 16.2 mm -91.5 111.96 24.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.295 -0.866 . . . . 6.73 109.333 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 0.4 OUTLIER -75.02 -51.59 13.2 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.63 -1.168 . . . . 8.79 109.487 -178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -143.05 169.03 18.34 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.067 -0.97 . . . . 10.44 110.893 -176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 117.38 -71.73 0.29 Allowed Glycine 0 N--CA 1.441 -1.029 0 C-N-CA 120.528 -0.844 . . . . 8.87 113.374 173.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.482 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 42.8 tp -108.56 172.41 6.86 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 116.778 0.289 . . . . 8.5 110.666 -172.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.482 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 88.0 tttt -122.56 154.62 37.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.812 0.815 . . . . 14.15 111.656 -172.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -66.25 135.13 54.01 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 113.979 -1.464 . . . . 12.12 109.834 176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.48 -2.8 56.2 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.354 -0.927 . . . . 11.54 111.439 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -103.51 152.65 21.44 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 108.849 -0.797 . . . . 11.24 108.849 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 22.6 mt-30 -104.04 149.88 24.78 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.078 0.466 . . . . 10.49 111.203 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 149' ' ' VAL . 18.9 m -135.73 146.66 29.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.644 -0.707 . . . . 5.45 109.286 173.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.442 HG22 ' HB2' ' A' ' 112' ' ' MET . 27.7 m -72.88 128.13 35.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.352 0.596 . . . . 6.56 110.824 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.7 m -132.5 13.22 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.697 -0.683 . . . . 6.99 110.702 -174.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.4 m -36.12 106.73 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.267 0.979 . . . . 9.06 112.593 -174.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.08 -73.94 0.32 Allowed Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.321 -0.854 . . . . 8.5 111.291 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 38.57 56.75 1.83 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.179 0.992 . . . . 11.84 112.217 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.495 ' HA ' ' OE1' ' A' ' 158' ' ' GLU . 32.8 p90 -117.64 134.63 54.68 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.199 0.523 . . . . 12.24 111.115 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 158' ' ' GLU . 94.5 mt -87.22 -165.3 1.26 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.558 -0.746 . . . . 13.16 110.773 -177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.44 HG13 ' H ' ' A' ' 157' ' ' SER . 36.2 pt -78.46 -161.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.279 -0.419 . . . . 11.95 111.436 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -55.63 -23.79 29.74 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.307 0.484 . . . . 11.22 112.307 -176.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.44 ' H ' HG13 ' A' ' 155' ' ' ILE . 15.8 m -54.71 -48.49 72.41 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.024 0.44 . . . . 11.9 110.669 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 153' ' ' PHE . 20.1 tt0 -61.17 -29.8 70.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.369 -0.832 . . . . 11.17 110.296 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.06 -25.73 31.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.954 -0.566 . . . . 7.82 112.028 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 34.0 t -75.91 -30.18 58.67 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.196 -0.668 . . . . 9.64 109.196 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 162' ' ' ARG . 3.5 pp -88.3 -30.19 19.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.719 -0.673 . . . . 10.57 112.407 -175.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.555 ' N ' HD12 ' A' ' 161' ' ' LEU . 25.3 ptt180 -80.73 132.78 35.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 8.9 110.637 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.86 74.02 0.21 Allowed Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.729 -0.748 . . . . 7.15 111.815 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.7 p 47.15 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.556 0.742 . . . . 7.09 111.787 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 43.4 t 64.48 82.79 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 109.419 -0.585 . . . . 9.2 109.419 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.76 135.66 57.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.329 -0.851 . . . . 9.11 110.994 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.597 ' HD2' ' O ' ' A' ' 167' ' ' ARG . 3.2 ppt_? -71.26 -8.99 57.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.808 -0.633 . . . . 14.58 110.887 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 5.0 mtm -99.09 132.05 44.69 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.576 -0.738 . . . . 11.94 109.518 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -86.4 -136.98 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.072 -0.513 . . . . 14.99 110.346 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -80.93 47.94 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.248 0.547 . . . . 15.01 111.47 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.5 p -91.43 40.9 1.05 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.429 0.633 . . . . 14.25 110.078 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.8 t -114.49 -179.38 3.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.236 -0.893 . . . . 14.89 109.939 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.4 t 68.41 80.95 0.19 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.736 0.648 . . . . 15.85 111.099 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.12 -15.26 65.13 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.44 -0.886 . . . . 17.54 111.066 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 44.5 tp 68.03 79.85 0.21 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.373 0.669 . . . . 17.85 110.615 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -95.51 -162.14 0.92 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.75 -0.659 . . . . 19.67 110.062 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.78 -24.46 10.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.207 0.527 . . . . 19.52 109.966 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 72.2 mt 66.37 -84.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.01 -0.995 . . . . 21.15 111.26 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -171.75 75.54 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.061 0.457 . . . . 23.25 110.225 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 116.197 -0.456 . . . . 23.52 110.115 176.849 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.729 0.299 . . . . 34.32 110.781 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.27 -91.33 0.46 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.702 -0.761 . . . . 33.09 111.531 -177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 p 47.32 -95.42 0.03 OUTLIER 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.996 0.918 . . . . 34.12 112.01 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 7' ' ' ASN . . . -165.51 150.2 8.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.357 -0.383 . . . . 32.32 110.109 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.6 p -108.29 -34.29 6.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.965 -0.561 . . . . 32.74 110.696 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 28.71 0.87 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.116 -0.493 . . . . 31.29 111.61 -178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.443 ' HB2' ' HB1' ' A' ' 4' ' ' ALA . 3.3 m-20 -124.56 -70.17 0.77 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.12 0.486 . . . . 29.46 110.983 178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 141.24 -175.77 22.1 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.292 -0.723 . . . . 28.28 111.292 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.52 -72.97 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.885 2.39 . . . . 27.51 111.635 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -171.25 137.93 1.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.102 -0.703 . . . . 26.48 109.102 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -92.23 -164.85 1.24 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.88 0.371 . . . . 24.9 110.692 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.71 174.31 42.73 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 111.372 -0.691 . . . . 23.19 111.372 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -125.07 10.67 8.18 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.459 0.647 . . . . 21.31 109.854 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -130.2 78.63 74.23 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.681 -0.69 . . . . 19.89 110.711 178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -177.62 3.86 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.446 2.097 . . . . 18.12 111.92 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -110.85 48.17 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.328 0.585 . . . . 16.58 110.148 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.24 123.36 35.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.846 -0.615 . . . . 14.8 110.716 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.72 32.1 4.07 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.765 -0.731 . . . . 13.17 112.918 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.438 ' O ' ' HA3' ' A' ' 24' ' ' GLY . . . -128.14 1.4 5.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.585 0.707 . . . . 12.17 110.131 177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 26.5 tt0 -77.24 73.07 3.82 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.911 -1.04 . . . . 13.82 108.956 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 19.6 mt 77.89 -22.47 0.28 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 114.568 -1.197 . . . . 12.13 111.391 -177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -78.81 60.64 2.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.185 0.517 . . . . 14.1 110.355 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.5 m 67.94 82.96 0.17 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.991 -1.004 . . . . 11.05 109.848 -174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 19' ' ' ALA . . . -170.76 -50.72 0.04 OUTLIER Glycine 0 CA--C 1.497 -1.072 0 CA-C-N 115.572 -0.74 . . . . 10.05 111.71 -177.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 5.0 ptmm? -138.33 68.51 1.39 Allowed 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 122.152 0.977 . . . . 10.38 109.958 -172.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.522 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 45.1 mtm180 -134.65 140.34 45.95 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 113.927 -1.488 . . . . 8.37 109.217 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.767 HG21 ' CZ3' ' A' ' 30' ' ' TRP . 22.7 mm -54.85 129.73 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.176 0 CA-C-O 122.455 1.121 . . . . 5.76 113.701 -167.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.86 HD13 ' CD1' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -89.87 -29.49 18.54 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 112.355 -2.202 . . . . 8.22 111.376 177.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.86 ' CD1' HD13 ' A' ' 28' ' ' LEU . 46.3 p90 158.0 -172.9 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 125.055 1.342 . . . . 7.99 107.597 -177.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.767 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.3 m-90 -116.95 142.69 46.62 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.744 0.307 . . . . 5.61 110.835 -176.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.0 ptt180 -148.28 154.62 40.28 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 9.06 110.476 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.667 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -92.41 137.11 24.77 Favored Pre-proline 0 C--N 1.317 -0.821 0 N-CA-C 108.556 -0.905 . . . . 8.31 108.556 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -62.65 -13.63 35.04 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.313 2.008 . . . . 10.41 112.191 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -99.72 2.31 44.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.59 -0.277 . . . . 10.85 111.206 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.667 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.8 m -128.86 40.89 0.65 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.396 0.517 . . . . 9.32 112.396 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 14.5 Cg_endo -52.3 113.38 1.18 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.916 2.411 . . . . 11.1 112.809 -172.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 125.3 -35.87 2.96 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.46 -0.656 . . . . 10.31 111.46 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 21.0 tp60 -64.2 103.09 0.58 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.641 0.734 . . . . 9.21 110.856 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.784 ' NH1' ' HA ' ' A' ' 41' ' ' ASP . 2.1 tmm_? -81.96 103.49 11.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.015 -0.993 . . . . 11.51 109.702 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -87.91 133.59 33.89 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 108.297 -1.001 . . . . 7.5 108.297 173.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.784 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . 17.8 t70 -63.89 -35.05 79.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.924 -1.035 . . . . 10.61 110.518 -172.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.2 mttp -148.37 162.33 30.73 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.955 -0.566 . . . . 10.91 110.721 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.741 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.5 Cg_endo -50.21 171.29 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.01 3.14 . . . . 7.51 113.857 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.54 -165.91 27.02 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.74 -0.743 . . . . 7.59 112.491 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.518 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 7.7 ttmt -91.33 144.24 25.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.237 -0.653 . . . . 11.68 109.237 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 49' ' ' MET . 10.6 t -70.76 145.78 92.57 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.43 . . . . 9.2 110.863 -178.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.52 -20.85 7.83 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.765 2.31 . . . . 10.25 111.547 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.774 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 96.4 m-85 -84.6 -39.24 18.93 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.426 -1.261 . . . . 10.49 109.842 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.774 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -136.66 151.92 49.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.663 -0.698 . . . . 10.38 110.522 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.5 p-10 -79.23 53.14 1.43 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.864 0.84 . . . . 12.54 111.418 176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.44 ' HG2' ' HB2' ' A' ' 49' ' ' MET . 16.4 ptm -127.02 146.59 58.27 Favored Pre-proline 0 C--N 1.313 -1.021 0 CA-C-N 115.418 -0.81 . . . . 9.87 109.682 174.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 51' ' ' MET . 8.2 Cg_exo -69.58 133.5 26.04 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.143 1.896 . . . . 9.51 110.286 177.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.3 mt -59.69 156.68 13.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 123.397 0.436 . . . . 6.71 110.592 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.65 131.16 27.51 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-O 121.205 0.526 . . . . 7.89 110.311 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 59' ' ' GLU . 96.7 Cg_endo -85.09 156.5 11.27 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.117 1.878 . . . . 5.77 113.158 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.672 HG11 HD11 ' A' ' 28' ' ' LEU . 27.2 m -86.73 160.08 3.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.555 -1.202 . . . . 5.96 111.136 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.522 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.2 OUTLIER 5.84 -71.15 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 127.392 2.277 . . . . 7.84 116.478 -176.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.682 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.8 pt-20 -65.47 -39.22 91.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.125 0.964 . . . . 6.62 110.726 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.592 ' HA ' HD11 ' A' ' 27' ' ' ILE . 9.9 pt-20 39.25 42.96 0.84 Allowed 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 112.473 -2.148 . . . . 8.58 114.02 178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 59' ' ' GLU . 5.0 mt-10 177.8 59.5 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.427 -1.261 . . . . 7.64 112.251 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.468 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 36.0 t-20 -170.91 -86.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.591 -0.732 . . . . 7.02 111.826 167.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.646 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . . . 47.48 83.19 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.459 0 CA-C-O 122.152 0.977 . . . . 5.41 112.268 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.591 ' HA ' ' HB ' ' A' ' 67' ' ' VAL . 1.1 m-20 49.64 44.19 24.43 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 112.588 -2.096 . . . . 7.01 111.393 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -54.93 -56.15 24.36 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.399 -0.819 . . . . 7.2 113.056 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 66' ' ' ALA . . . -171.55 -0.62 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.027 0.441 . . . . 7.82 110.904 -176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' H ' ' H ' ' A' ' 65' ' ' ALA . . . -128.73 -49.37 1.25 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.32 -0.622 . . . . 8.65 109.32 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 63' ' ' ASP . 1.8 t -65.43 -27.16 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-N 115.362 -0.835 . . . . 7.31 108.766 173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.566 ' HA ' ' OD2' ' A' ' 63' ' ' ASP . 24.9 ttt180 -46.4 112.22 0.47 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.291 -1.322 . . . . 10.21 112.502 -178.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.426 HG21 ' HG2' ' A' ' 72' ' ' ARG . 10.1 mt -98.63 148.71 5.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 114.235 -1.348 . . . . 8.86 110.18 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.05 57.34 4.45 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.976 0.893 . . . . 13.02 110.492 -176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 73' ' ' VAL . . . 49.11 46.7 33.65 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 113.668 -1.606 . . . . 12.13 113.038 178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' HG2' HG21 ' A' ' 69' ' ' ILE . 26.7 ptt180 -59.35 123.7 17.6 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.665 -0.494 . . . . 12.38 109.665 174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 161' ' ' LEU . 51.6 t -117.92 130.19 73.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.904 -0.589 . . . . 11.61 110.464 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.6 t -95.38 48.5 1.16 Allowed 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.201 -0.908 . . . . 10.71 110.679 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 53.5 79.87 0.12 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 114.694 -1.139 . . . . 14.09 112.153 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -140.95 122.77 15.35 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.546 -0.297 . . . . 11.22 110.951 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.42 -47.32 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.762 -0.829 . . . . 13.71 108.762 172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 150' ' ' SER . . . 179.66 -43.13 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 109.313 -1.515 . . . . 11.44 109.313 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 150' ' ' SER . 39.9 t 66.47 163.6 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 114.644 -0.778 . . . . 9.99 111.337 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.646 ' O ' HG22 ' A' ' 149' ' ' VAL . 18.1 tpt180 -102.72 172.04 7.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.802 0.811 . . . . 11.64 112.762 -171.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 148' ' ' VAL . 19.8 p -106.8 139.3 41.45 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.772 -1.104 . . . . 8.0 108.052 170.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.427 ' O ' HG22 ' A' ' 147' ' ' VAL . . . -107.69 127.85 54.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.607 -0.516 . . . . 6.65 109.607 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 43.5 tt0 -82.25 140.48 33.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.069 0.461 . . . . 12.15 110.696 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.715 HG11 HD23 ' A' ' 95' ' ' LEU . 79.7 t -62.92 130.67 27.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.325 -0.852 . . . . 9.71 112.026 -178.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 27.5 mmtp -137.23 153.45 50.38 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.465 -1.243 . . . . 11.03 109.266 -178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 93' ' ' GLU . 9.7 mp -83.73 152.02 24.92 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.758 -0.46 . . . . 12.76 109.758 168.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.69 42.79 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 111.47 -0.652 . . . . 13.25 111.47 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.831 ' HG3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -64.04 -178.09 0.31 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 113.201 0.815 . . . . 16.35 113.201 -174.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.9 tp -139.58 112.45 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.929 -1.032 . . . . 18.22 109.549 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.88 -148.4 18.91 Favored Glycine 0 C--N 1.322 -0.222 0 N-CA-C 111.286 -0.726 . . . . 17.91 111.286 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 p -101.14 75.68 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.92 0.867 . . . . 17.11 109.322 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.831 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 1.7 m -155.42 168.31 27.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.457 -1.247 . . . . 14.73 107.865 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HG2' HD23 ' A' ' 86' ' ' LEU . 1.9 mp0 -139.24 121.86 16.31 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.414 0.626 . . . . 14.94 110.98 166.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 41.1 mmt180 -131.11 156.09 45.85 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.972 -1.013 . . . . 10.57 110.778 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.715 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -87.32 114.88 24.33 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.987 -1.006 . . . . 8.88 110.465 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -88.65 130.69 35.24 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.693 0.282 . . . . 9.78 110.826 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.96 152.94 56.44 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.431 -0.804 . . . . 6.4 109.856 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 149' ' ' VAL . 41.8 Cg_exo -56.3 122.64 12.13 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.094 1.863 . . . . 6.55 110.35 171.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 57.4 p -62.7 -22.81 66.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.546 -0.752 . . . . 9.29 112.845 -164.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.19 -4.88 55.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 119.754 -0.165 . . . . 10.86 111.177 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.04 -40.93 68.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 5.34 110.452 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.484 HD13 ' HG3' ' A' ' 104' ' ' ARG . 3.2 pp -78.73 160.3 27.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.229 -0.896 . . . . 6.97 111.424 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 26.7 mm -117.11 103.72 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 116.282 -0.417 . . . . 10.2 110.595 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -113.76 95.18 5.2 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.543 -1.263 . . . . 12.12 111.888 174.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.4 t -103.79 136.62 43.14 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.843 -1.526 . . . . 14.61 109.212 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.14 -113.13 4.18 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.343 -0.932 . . . . 15.52 112.018 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.8 28.16 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.268 0.84 . . . . 14.99 113.268 -175.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -170.08 171.0 7.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 112.374 0.509 . . . . 15.2 112.374 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 1.8 m -121.89 155.3 35.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.451 -0.795 . . . . 9.26 111.767 -169.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 36.5 mm -129.29 150.18 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.362 -0.836 . . . . 10.55 109.467 178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.63 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -134.19 127.14 31.37 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.297 -0.26 . . . . 7.39 110.297 176.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.475 ' HB2' HG12 ' A' ' 148' ' ' VAL . 4.1 mpp? -93.55 99.82 12.2 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.197 -0.668 . . . . 8.85 109.197 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.7 p -77.33 139.8 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 115.06 -0.973 . . . . 9.69 110.403 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -78.58 92.58 4.72 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.076 -0.511 . . . . 10.7 111.525 -176.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 50.5 mttm -76.25 178.69 6.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.411 -0.813 . . . . 14.88 110.896 173.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.93 25.78 7.79 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.765 -0.934 . . . . 16.92 110.765 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.16 12.9 33.32 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.968 0.358 . . . . 18.56 111.968 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 96.16 16.76 36.87 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.859 -0.686 . . . . 15.62 113.159 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 115' ' ' LYS . . . 179.47 173.69 44.85 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.881 -0.888 . . . . 14.19 110.881 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.473 ' CE1' ' HB ' ' A' ' 148' ' ' VAL . 54.3 m-85 -87.54 -176.54 5.62 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.991 0.424 . . . . 12.03 110.626 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.461 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 11.5 t70 -140.89 120.04 8.36 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.742 -0.663 . . . . 13.91 109.368 173.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -83.0 110.55 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.204 0 C-N-CA 123.166 2.578 . . . . 12.35 112.537 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 125' ' ' VAL . 13.9 p -104.91 140.45 22.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.121 -0.945 . . . . 9.43 109.915 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -81.87 112.03 18.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.161 0.505 . . . . 12.93 109.726 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.717 HG13 HG13 ' A' ' 123' ' ' VAL . 23.2 m -117.03 163.31 14.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.662 -0.699 . . . . 8.03 111.23 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 50.8 tttp -100.68 133.85 44.52 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 115.582 -0.735 . . . . 10.39 109.219 174.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.56 103.14 4.48 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 120.964 -0.295 . . . . 8.3 111.43 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.419 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -152.88 69.89 0.3 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 118.142 -1.98 . . . . 10.1 113.633 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.992 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.37 163.85 37.3 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.49 -1.3 . . . . 10.61 107.49 154.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 27.8 m -143.61 130.41 20.37 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 118.787 0.722 . . . . 13.17 111.036 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.12 120.87 9.23 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 12.98 110.616 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.23 36.11 92.98 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 121.316 -0.469 . . . . 14.34 112.91 177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.86 12.45 83.91 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.858 -0.687 . . . . 13.12 112.521 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -120.87 158.97 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.006 -0.368 . . . . 10.62 110.006 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.7 t -103.81 157.91 16.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 120.867 0.365 . . . . 7.82 110.045 -178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.992 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 32.0 mt-10 -106.78 115.33 30.0 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.474 0.654 . . . . 10.79 109.821 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.649 ' HB ' ' HB2' ' A' ' 95' ' ' LEU . 39.7 mm -81.67 104.76 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 114.974 -1.012 . . . . 6.73 109.154 175.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 3.0 mp -69.57 -44.97 69.75 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.607 -1.179 . . . . 8.79 110.562 -177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -139.59 158.13 44.64 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.779 -0.646 . . . . 10.44 111.327 -175.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 116.85 -53.31 0.64 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.287 -0.959 . . . . 8.87 114.529 168.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.436 HD21 HG11 ' A' ' 123' ' ' VAL . 18.0 mt -107.51 -170.9 1.77 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.434 0.531 . . . . 8.5 112.434 -174.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -144.96 150.94 37.83 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.683 -0.689 . . . . 14.15 111.001 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -67.57 133.54 49.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.718 -1.128 . . . . 12.12 109.9 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 101.46 -2.3 53.65 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.244 -0.979 . . . . 11.54 111.575 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -104.05 143.57 32.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.254 -0.647 . . . . 11.24 109.254 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 22.9 mt-30 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.022 0.439 . . . . 10.49 111.593 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' ALA . 30.0 m -132.18 142.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.704 -0.85 . . . . 5.45 108.704 173.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 81' ' ' THR . 6.9 p -76.7 104.42 4.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.755 0.788 . . . . 6.56 110.956 -178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -92.92 -15.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.148 -1.056 . . . . 6.99 108.148 177.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.491 ' HA ' ' CG1' ' A' ' 79' ' ' VAL . 1.2 m -57.46 163.26 2.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.333 -1.303 . . . . 9.06 111.427 162.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 160' ' ' SER . . . -81.51 63.64 4.32 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.938 -0.865 . . . . 8.5 110.938 170.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 66.83 89.02 0.1 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.043 0.537 . . . . 11.84 110.582 -178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -152.18 91.18 1.58 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.533 0.568 . . . . 12.24 112.533 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 42.9 tp -115.78 -62.12 1.64 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.017 -1.105 . . . . 13.16 108.017 164.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 42.7 pt -122.93 6.0 5.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.399 -1.334 . . . . 11.95 107.399 168.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 2.5 m-20 -83.44 35.65 0.51 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 112.71 -2.041 . . . . 11.22 111.537 -171.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -49.01 -49.08 42.76 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.364 0.875 . . . . 11.9 113.364 -172.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -73.72 -26.4 60.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.173 0.511 . . . . 11.17 110.002 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 156' ' ' ASP . . . -75.95 -20.96 57.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.173 -0.921 . . . . 7.82 111.432 -175.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 151' ' ' GLY . 9.2 m -69.22 -29.94 67.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.0 0.905 . . . . 9.64 109.244 172.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.534 ' HA ' HG13 ' A' ' 73' ' ' VAL . 11.4 mt -87.23 -43.09 12.46 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.153 -1.385 . . . . 10.57 109.374 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 159' ' ' ALA . 23.5 ttt180 -51.85 128.35 23.67 Favored 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.006 1.323 . . . . 8.9 112.891 176.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -117.85 31.16 5.81 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.43 -1.068 . . . . 7.15 110.43 172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.6 p -70.71 126.27 29.14 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 123.924 0.426 . . . . 7.09 111.54 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 26' ' ' ARG . 48.2 t 54.21 82.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 124.05 0.844 . . . . 9.2 111.332 177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -75.96 123.62 26.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.81 -0.632 . . . . 9.11 110.456 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.439 ' O ' ' HD3' ' A' ' 167' ' ' ARG . 3.2 tmt_? -62.82 -40.04 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.22 -0.9 . . . . 14.58 108.893 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -138.63 159.84 41.09 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 114.173 -1.376 . . . . 11.94 110.726 -176.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -81.22 83.21 6.89 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.878 -0.416 . . . . 14.99 109.878 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 45.84 85.85 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 O-C-N 123.922 0.764 . . . . 15.01 112.259 170.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.5 p -79.42 -10.35 59.79 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.329 0.492 . . . . 14.25 112.329 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.6 t -89.07 147.16 24.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.423 0.63 . . . . 14.89 111.189 -178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 11.7 p -167.19 13.29 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.811 -1.086 . . . . 15.85 111.721 -176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.77 -36.18 53.53 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.794 -0.717 . . . . 17.54 111.885 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 26.2 tp -100.53 129.92 46.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.413 -0.588 . . . . 17.85 109.413 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -155.81 -174.74 5.09 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 121.161 -0.215 . . . . 19.67 111.0 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.2 t -83.79 -57.8 4.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.489 -0.559 . . . . 19.52 109.489 175.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 41.6 tp 63.21 83.4 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.436 -0.802 . . . . 21.15 110.433 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -74.98 151.54 38.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.426 -0.806 . . . . 23.25 110.563 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.547 -0.739 . . . . 23.52 109.642 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.879 0.371 . . . . 34.32 110.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.65 49.12 3.82 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.205 -0.521 . . . . 33.09 113.031 -173.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.2 t -151.11 21.86 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.07 -0.715 . . . . 34.12 109.07 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.94 89.43 2.57 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.745 -0.662 . . . . 32.32 111.517 -173.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.7 p 51.02 35.28 12.4 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.234 0.827 . . . . 32.74 113.234 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 49.5 t 61.99 92.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 121.13 0.491 . . . . 31.29 110.998 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -88.28 -9.94 51.21 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.075 0.464 . . . . 29.46 110.241 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.95 -164.46 26.44 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.125 -0.79 . . . . 28.28 111.125 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.15 2.27 5.74 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.892 2.395 . . . . 27.51 112.892 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 74.72 130.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.293 -0.867 . . . . 26.48 111.512 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -153.72 173.52 15.73 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.123 -0.944 . . . . 24.9 108.605 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 169.43 59.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 119.808 -1.187 . . . . 23.19 113.301 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -103.84 57.07 0.73 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.082 -0.71 . . . . 21.31 109.082 175.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.503 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 26.5 t70 -73.01 -48.49 7.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 119.077 -0.487 . . . . 19.89 112.185 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 17.8 Cg_endo -60.23 101.55 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 121.316 1.344 . . . . 18.12 111.897 176.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -169.48 91.54 0.23 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.932 -0.577 . . . . 16.58 110.899 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' H ' ' HB2' ' A' ' 21' ' ' LEU . . . -82.91 56.93 3.63 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.312 0.577 . . . . 14.8 109.836 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.96 -86.9 0.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.756 -0.937 . . . . 13.17 110.756 -174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.28 -18.15 4.12 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.11 -0.545 . . . . 12.17 110.464 177.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -84.78 61.0 6.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.984 0.897 . . . . 13.82 110.196 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.522 ' HB2' ' H ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -158.33 -66.91 0.09 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.457 -1.247 . . . . 12.13 108.51 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -83.18 56.3 3.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.904 0.859 . . . . 14.1 109.712 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.3 t 40.53 51.65 2.95 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.143 -1.844 . . . . 11.05 113.018 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.93 -37.91 42.66 Favored Glycine 0 CA--C 1.498 -1.001 0 N-CA-C 110.618 -0.993 . . . . 10.05 110.618 173.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -166.0 57.75 0.1 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 122.159 0.981 . . . . 10.38 109.725 -176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.564 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 29.7 mtm180 -132.47 135.35 45.98 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.276 -1.329 . . . . 8.37 109.045 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG12 ' OE1' ' A' ' 58' ' ' GLU . 34.7 mm -48.22 126.44 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 N-CA-C 113.426 0.899 . . . . 5.76 113.426 -171.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.1 mt -114.63 -34.73 5.1 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.824 -1.534 . . . . 8.22 109.821 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.691 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.5 p90 -168.92 -175.17 2.27 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.253 -0.43 . . . . 7.99 111.007 -174.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.502 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.43 153.68 43.11 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.707 -0.679 . . . . 5.61 111.666 -172.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.642 ' HB2' HE22 ' A' ' 38' ' ' GLN . 39.0 ptt180 -157.48 146.06 19.45 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.851 -0.613 . . . . 9.06 110.435 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.903 ' HB3' HG22 ' A' ' 35' ' ' VAL . 7.6 t0 -83.03 134.5 46.28 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 108.777 -0.823 . . . . 8.31 108.777 172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.84 -22.53 62.74 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.233 2.622 . . . . 10.41 111.824 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.561 ' HB2' ' OD1' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -75.81 -22.22 56.56 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 114.895 -1.048 . . . . 10.85 110.647 178.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.903 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.3 m -128.3 50.33 5.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-O 121.529 0.681 . . . . 9.32 111.813 -166.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -61.78 119.59 6.79 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.187 2.591 . . . . 11.1 112.057 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 127.17 -30.53 4.08 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.414 -0.674 . . . . 10.31 111.414 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.642 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -70.55 136.43 49.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.136 0.493 . . . . 9.21 109.797 174.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.86 98.97 5.75 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 116.122 -0.49 . . . . 11.51 110.749 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.691 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 16.5 m-85 -80.07 135.65 36.39 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.903 -0.589 . . . . 7.5 111.017 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.98 -25.39 67.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.347 -0.842 . . . . 10.61 110.379 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -165.23 147.5 6.64 Favored Pre-proline 0 N--CA 1.451 -0.406 0 CA-C-O 121.321 0.582 . . . . 10.91 110.531 -174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -51.61 128.92 27.73 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 125.139 3.893 . . . . 7.51 113.962 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.53 -161.71 11.49 Favored Glycine 0 N--CA 1.452 -0.248 0 N-CA-C 111.232 -0.747 . . . . 7.59 111.232 176.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 25.8 ttpp -90.46 150.53 21.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.167 0.508 . . . . 11.68 109.979 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 49' ' ' MET . 24.8 t -65.82 135.13 95.34 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 115.211 -0.904 . . . . 9.2 110.138 176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.83 -25.71 11.96 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.192 1.928 . . . . 10.25 111.626 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.736 ' CD2' HG11 ' A' ' 35' ' ' VAL . 98.1 m-85 -77.53 -38.08 49.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.872 -1.058 . . . . 10.49 109.995 -173.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.464 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -153.09 164.8 37.35 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.089 -0.505 . . . . 10.38 110.736 172.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 5.4 p-10 -82.69 76.69 9.53 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.748 1.018 . . . . 12.54 113.748 -170.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 10.1 ptm -143.14 141.02 18.53 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 114.757 -1.11 . . . . 9.87 108.036 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 17.8 Cg_endo -62.11 133.58 44.76 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.24 1.293 . . . . 9.51 109.512 172.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.0 mt -59.49 160.11 7.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.204 -0.453 . . . . 6.71 111.419 -174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.6 mm -95.67 132.58 27.1 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 116.034 -0.53 . . . . 7.89 109.657 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.496 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 90.6 Cg_endo -79.22 141.82 16.51 Favored 'Trans proline' 0 N--CA 1.441 -1.588 0 C-N-CA 121.468 1.445 . . . . 5.77 112.797 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.9 m -67.04 158.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 114.585 -1.189 . . . . 5.96 113.326 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.564 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 21.85 -85.34 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.948 2.099 . . . . 7.84 115.475 -177.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.592 ' OE1' HG12 ' A' ' 27' ' ' ILE . 0.4 OUTLIER -51.14 -37.75 48.0 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 122.776 1.274 . . . . 6.62 110.16 -176.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 59.35 40.29 21.27 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 111.835 -2.438 . . . . 8.58 110.589 171.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.468 ' OE2' ' HA2' ' A' ' 64' ' ' GLY . 13.5 tt0 -161.85 49.41 0.2 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.175 -1.375 . . . . 7.64 112.091 -172.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 71.12 -53.29 0.68 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 112.104 -2.316 . . . . 7.02 114.575 162.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . -166.11 -41.79 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.075 -0.512 . . . . 5.41 111.902 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.619 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 4.9 t70 173.45 74.1 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 123.986 0.804 . . . . 7.01 109.611 -169.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.468 ' HA2' ' OE2' ' A' ' 60' ' ' GLU . . . 90.46 -17.73 52.85 Favored Glycine 0 C--N 1.315 -0.601 0 CA-C-N 115.438 -0.801 . . . . 7.2 112.132 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 72.66 -6.87 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.985 0.735 . . . . 7.82 112.985 172.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 164' ' ' THR . . . -112.62 -39.41 4.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.744 -0.382 . . . . 8.65 111.539 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG13 ' N ' ' A' ' 68' ' ' ARG . 15.0 p -102.66 -47.84 10.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.218 0.532 . . . . 7.31 110.4 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 3.7 ptp180 49.04 -177.01 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 113.839 -1.528 . . . . 10.21 113.644 -174.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' ' 71' ' ' GLY . 5.4 mt -73.16 155.61 6.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.624 -0.716 . . . . 8.86 110.728 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -74.72 -43.87 52.84 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.047 -0.979 . . . . 13.02 109.065 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.616 ' H ' HG22 ' A' ' 69' ' ' ILE . . . -59.53 -38.51 93.71 Favored Glycine 0 N--CA 1.442 -0.964 0 CA-C-N 113.96 -1.473 . . . . 12.13 113.231 176.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -84.57 109.59 18.07 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.593 0.711 . . . . 12.38 109.827 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.411 HG12 ' H ' ' A' ' 75' ' ' GLN . 67.3 t -103.09 140.03 22.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.842 -1.072 . . . . 11.61 111.019 -172.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -143.64 30.9 1.33 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 122.17 0.986 . . . . 10.71 109.68 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.411 ' H ' HG12 ' A' ' 73' ' ' VAL . 3.5 tp-100 -112.69 86.91 2.46 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.328 -1.306 . . . . 14.09 109.168 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 151' ' ' GLY . 1.6 p-10 -70.99 95.35 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.2 1.0 . . . . 11.22 111.551 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 42.7 mt -97.8 -12.24 22.43 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.632 -1.167 . . . . 13.71 109.436 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 164.64 40.16 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.311 -1.116 . . . . 11.44 110.311 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.492 HG11 ' CZ ' ' A' ' 120' ' ' PHE . 93.7 t 63.79 108.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.63 -0.785 . . . . 9.99 111.221 -173.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 29.6 tpt180 -84.33 130.64 34.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.801 -0.636 . . . . 11.64 109.72 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 148' ' ' VAL . 67.2 p -133.09 144.96 50.32 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.292 -0.867 . . . . 8.0 109.777 -176.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.27 127.26 55.79 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.837 -0.801 . . . . 6.65 108.837 175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -77.89 135.47 37.89 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.947 -0.39 . . . . 12.15 109.947 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.835 HG11 HD12 ' A' ' 95' ' ' LEU . 75.8 t -59.89 128.84 21.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.713 -0.676 . . . . 9.71 112.416 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -135.24 148.41 49.58 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 114.501 -1.227 . . . . 11.03 109.005 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.494 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -78.9 147.73 32.97 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.965 -0.694 . . . . 12.76 109.453 169.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.445 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -170.27 51.54 0.2 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.361 -0.923 . . . . 13.25 112.811 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.505 ' HB3' ' HA ' ' A' ' 93' ' ' GLU . 23.0 ptt180 -67.24 144.11 56.12 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 122.698 -0.295 . . . . 16.35 110.611 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 86.92 1.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.041 -0.726 . . . . 18.22 109.041 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.37 -5.71 84.61 Favored Glycine 0 CA--C 1.507 -0.438 0 N-CA-C 108.728 -1.749 . . . . 17.91 108.728 -173.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 16.3 m -111.62 156.79 21.25 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.001 -1.6 . . . . 17.11 107.835 176.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.8 m -71.84 157.95 36.96 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.105 -0.702 . . . . 14.73 109.105 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 88' ' ' ARG . 3.3 tt0 -58.96 97.45 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.463 0 O-C-N 124.163 0.914 . . . . 14.94 111.422 -167.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.74 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -115.34 173.88 6.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.541 -0.754 . . . . 10.57 110.139 -175.88 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.835 HD12 HG11 ' A' ' 84' ' ' VAL . 1.3 pt? -109.14 114.34 27.97 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.588 -0.893 . . . . 8.88 108.588 174.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -94.74 131.05 40.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.665 -1.152 . . . . 9.78 111.718 -166.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG22 HG12 ' A' ' 137' ' ' ILE . 32.7 m -136.85 157.07 75.53 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 114.845 -1.07 . . . . 6.4 108.638 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.446 ' HG2' HG11 ' A' ' 149' ' ' VAL . 76.0 Cg_exo -52.49 129.31 31.38 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 121.738 1.626 . . . . 6.55 111.398 171.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 p -63.62 -22.91 67.15 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.451 0.643 . . . . 9.29 111.16 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -78.14 0.44 24.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.204 -0.907 . . . . 10.86 110.811 -177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.412 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -102.76 -1.37 30.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.775 -0.648 . . . . 5.34 112.598 -174.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.465 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -115.76 156.47 25.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.498 0.666 . . . . 6.97 112.247 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 33.7 mm -101.46 124.36 55.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 10.2 109.982 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 18.8 mmm180 -96.18 125.48 40.73 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.868 -0.733 . . . . 12.12 110.452 173.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -149.13 137.16 20.67 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.923 -0.58 . . . . 14.61 110.556 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.4 -114.61 2.69 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 116.114 -0.494 . . . . 15.52 112.797 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.76 33.39 5.64 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.993 0.425 . . . . 14.99 111.394 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.01 -179.21 7.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.163 -0.471 . . . . 15.2 111.381 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.465 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 10.7 m -131.43 152.51 50.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.922 -0.581 . . . . 9.26 110.392 -174.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.532 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 25.3 mm -126.47 146.13 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.295 -0.261 . . . . 10.55 110.295 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -122.65 137.41 54.91 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.2 -0.454 . . . . 7.39 109.989 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 45.2 mtm -92.85 99.93 12.5 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.722 -0.844 . . . . 8.85 108.722 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 121' ' ' ASP . 8.4 p -81.47 131.85 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.242 0.544 . . . . 9.69 110.696 -175.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -86.87 91.31 8.62 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.59 -0.732 . . . . 10.7 110.417 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HD2' ' OD2' ' A' ' 121' ' ' ASP . 55.5 mttp -70.83 151.17 45.07 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.792 -0.64 . . . . 14.88 109.984 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.05 7.93 19.23 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 16.92 111.486 176.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -95.05 10.81 34.31 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.504 0.669 . . . . 18.56 110.973 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.65 13.64 75.16 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.163 -0.926 . . . . 15.62 113.613 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -138.82 161.24 25.84 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.482 -0.865 . . . . 14.19 112.441 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.492 ' CZ ' HG11 ' A' ' 79' ' ' VAL . 40.5 m-85 -114.34 116.88 29.67 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.026 0.441 . . . . 12.03 109.933 -178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.548 ' O ' HG12 ' A' ' 113' ' ' VAL . 25.9 m-20 -106.17 141.89 23.71 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.882 -0.599 . . . . 13.91 110.323 -178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 60.2 Cg_endo -83.67 127.18 4.23 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.874 1.716 . . . . 12.35 112.742 -179.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.74 124.27 70.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 9.43 109.321 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -72.57 127.09 31.49 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.149 -0.686 . . . . 12.93 109.149 174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -135.68 151.69 30.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.794 0.807 . . . . 8.03 111.569 -173.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.448 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 25.3 ttmm -90.94 130.19 36.89 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.231 -1.349 . . . . 10.39 109.518 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.58 110.3 17.19 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-O 123.108 1.433 . . . . 8.3 112.1 -170.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 138' ' ' LEU . . . -89.74 174.94 41.61 Favored Glycine 0 N--CA 1.411 -2.984 0 CA-C-N 111.25 -2.704 . . . . 10.1 110.718 171.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.17 161.32 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 126.07 1.748 . . . . 10.61 114.6 -167.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.1 m -100.88 139.24 36.86 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.312 -0.858 . . . . 13.17 108.721 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.84 111.99 4.64 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-O 120.851 0.358 . . . . 12.98 111.477 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.11 34.17 75.42 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.806 -0.712 . . . . 14.34 112.792 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 80.19 2.83 89.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.825 -0.703 . . . . 13.12 112.236 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -115.87 156.39 26.22 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.62 -0.511 . . . . 10.62 109.62 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 p -105.42 150.67 25.07 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.975 0.417 . . . . 7.82 111.326 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -84.79 100.51 11.58 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.925 -0.579 . . . . 10.79 109.619 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.74 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 20.3 mm -83.81 112.9 21.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 O-C-N 121.569 -0.707 . . . . 6.73 109.502 176.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.479 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.8 OUTLIER -83.04 -47.45 11.68 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.177 -0.919 . . . . 8.79 110.288 -173.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.568 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -147.82 159.82 43.42 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 109.148 -0.686 . . . . 10.44 109.148 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 130.74 -61.28 0.67 Allowed Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.046 -1.073 . . . . 8.87 112.318 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.427 HD11 ' CB ' ' A' ' 111' ' ' ALA . 26.5 mt -109.64 -170.83 1.72 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.262 0.553 . . . . 8.5 112.162 -174.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -145.53 154.35 42.1 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.261 -0.882 . . . . 14.15 109.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.8 130.7 43.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.018 -0.992 . . . . 12.12 109.658 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 105.81 -1.51 38.86 Favored Glycine 0 N--CA 1.438 -1.172 0 C-N-CA 120.721 -0.752 . . . . 11.54 111.232 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -103.57 139.21 39.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.55 -0.537 . . . . 11.24 109.55 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 48.2 mt-30 -91.03 138.72 31.39 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.891 0.377 . . . . 10.49 110.771 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.82 137.01 59.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.236 -0.438 . . . . 5.45 109.823 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 81' ' ' THR . 57.5 t -68.07 112.77 3.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.973 -0.558 . . . . 6.56 111.003 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' A' ' 98' ' ' PRO . 2.7 m -103.75 -2.99 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.476 0.655 . . . . 6.99 109.995 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 45.0 t -161.66 111.93 1.63 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.117 -0.947 . . . . 9.06 109.391 171.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' ASN . . . -79.45 -136.63 1.37 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.406 -0.902 . . . . 8.5 112.057 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -107.6 120.72 42.99 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.405 0.622 . . . . 11.84 109.965 175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -110.54 104.39 13.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.628 -0.715 . . . . 12.24 109.506 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.84 63.5 4.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.521 0.677 . . . . 13.16 110.301 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 16.4 pt -131.47 40.96 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.216 -0.902 . . . . 11.95 109.732 177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.45 -34.66 69.21 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.906 -0.588 . . . . 11.22 111.081 -175.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.616 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 15.8 m -59.03 -58.36 9.0 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.657 -0.497 . . . . 11.9 109.657 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -56.61 -41.95 77.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.895 -1.048 . . . . 11.17 110.456 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.451 ' HA ' ' HG2' ' A' ' 162' ' ' ARG . . . -63.64 -33.88 76.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.151 -0.932 . . . . 7.82 111.733 -178.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.3 t -72.94 -37.44 67.16 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.633 0.73 . . . . 9.64 109.818 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 157' ' ' SER . 79.2 mt -71.29 -38.89 71.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 114.739 -1.119 . . . . 10.57 111.151 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG2' ' HA ' ' A' ' 159' ' ' ALA . 31.7 ptt180 -80.0 -39.13 30.65 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.929 -0.578 . . . . 8.9 110.598 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.9 -57.17 5.02 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.196 -1.002 . . . . 7.15 111.943 -175.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 68' ' ' ARG . 1.3 p 45.16 67.21 0.75 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.173 0.589 . . . . 7.09 111.605 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.0 m 47.99 30.88 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.68 1.192 . . . . 9.2 112.946 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 58.15 -151.85 0.41 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.782 -0.644 . . . . 9.11 111.659 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 167' ' ' ARG . 3.5 tmm_? -67.4 -35.38 79.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.464 0.65 . . . . 14.58 109.418 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.32 165.88 28.4 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.955 -1.02 . . . . 11.94 110.74 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.403 HE21 ' HG ' ' A' ' 173' ' ' SER . 61.6 tp60 -118.78 -18.49 8.92 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.741 0.782 . . . . 14.99 110.696 -179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.44 ' CD ' ' H ' ' A' ' 170' ' ' GLU . 1.4 mp0 -43.08 -63.39 0.81 Allowed 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 113.837 -1.529 . . . . 15.01 111.58 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 44.3 p -87.79 4.66 43.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.736 -0.665 . . . . 14.25 111.552 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.7 m -91.24 -35.31 14.56 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.18 -0.674 . . . . 14.89 109.18 174.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.403 ' HG ' HE21 ' A' ' 169' ' ' GLN . 39.0 m -82.81 -95.46 0.05 Allowed 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.115 -0.948 . . . . 15.85 109.261 172.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.53 -69.99 1.13 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.779 -0.724 . . . . 17.54 112.666 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 60.2 25.13 14.5 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.12 0.486 . . . . 17.85 111.139 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -153.39 55.36 0.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.487 0.66 . . . . 19.67 110.044 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -130.45 -3.66 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 19.52 110.09 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.63 -159.54 0.86 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.487 -0.779 . . . . 21.15 109.762 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -86.23 -35.83 19.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.169 0.509 . . . . 23.25 109.757 174.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.437 -0.792 . . . . 23.52 110.137 -179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 tpp . . . . . 0 N--CA 1.481 1.101 0 CA-C-O 120.75 0.309 . . . . 34.32 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.13 78.55 0.86 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.763 -0.732 . . . . 33.09 112.556 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.7 m -149.16 30.72 0.77 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.137 0.494 . . . . 34.12 110.442 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -163.08 112.69 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.612 -0.722 . . . . 32.32 110.064 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m 65.96 97.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 123.47 0.481 . . . . 32.74 111.076 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 7' ' ' ASN . 16.7 m -60.14 164.22 0.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 116.297 -0.41 . . . . 31.29 111.408 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.57 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 5.5 t30 78.06 142.96 0.08 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.061 0.851 . . . . 29.46 109.782 -170.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 155' ' ' ILE . . . -68.47 120.77 11.89 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.507 -0.854 . . . . 28.28 112.767 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -86.0 28.02 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.48 2.787 . . . . 27.51 112.558 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.531 ' HB3' ' O ' ' A' ' 156' ' ' ASP . 9.1 t60 -142.83 83.54 1.81 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.629 -0.878 . . . . 26.48 108.629 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 10' ' ' HIS . 10.1 m-20 67.92 -86.0 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.804 -0.634 . . . . 24.9 109.916 -172.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 62.1 -112.59 4.98 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.647 -0.787 . . . . 23.19 112.484 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 64.35 78.98 0.27 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.317 0.579 . . . . 21.31 110.286 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -73.98 147.28 85.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.665 -0.698 . . . . 19.89 110.427 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.31 132.1 13.42 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.014 1.809 . . . . 18.12 112.339 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.17 -61.44 1.72 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.71 -0.478 . . . . 16.58 109.71 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.46 79.58 1.67 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.419 -0.81 . . . . 14.8 110.009 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -78.89 66.73 3.33 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.93 -0.652 . . . . 13.17 112.356 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.66 27.11 10.09 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.35 0.595 . . . . 12.17 111.555 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 57.67 69.22 0.76 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.522 -1.217 . . . . 13.82 109.902 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 18.8 tp 59.5 12.8 2.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 113.408 -1.724 . . . . 12.13 111.979 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 21' ' ' LEU . 6.7 ttpm? 71.06 -35.42 0.33 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.756 0.822 . . . . 14.1 111.14 -173.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.472 ' H ' ' C ' ' A' ' 21' ' ' LEU . 73.4 m 48.18 73.4 0.21 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 122.036 0.922 . . . . 11.05 110.441 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.69 122.41 0.77 Allowed Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 114.707 -1.133 . . . . 10.05 110.606 -175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 70.99 59.61 0.19 Allowed 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.019 -1.104 . . . . 10.38 108.019 -178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.572 ' HD3' ' OE1' ' A' ' 58' ' ' GLU . 13.1 mmt180 -133.57 140.52 47.2 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 113.922 -1.49 . . . . 8.37 109.74 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.873 HG12 ' OE2' ' A' ' 58' ' ' GLU . 23.6 mm -55.98 129.93 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 113.016 0.747 . . . . 5.76 113.016 -169.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -113.23 -16.0 12.62 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.769 -1.105 . . . . 8.22 109.795 177.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.658 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 10.9 p90 167.44 179.46 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 7.99 110.359 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.765 ' CZ3' HG21 ' A' ' 27' ' ' ILE . 1.7 m-90 -113.24 143.23 44.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.072 -0.967 . . . . 5.61 111.328 -176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.649 ' HB2' HE22 ' A' ' 38' ' ' GLN . 5.6 ptp180 -151.15 151.32 31.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 9.06 110.861 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.934 ' HB3' HG22 ' A' ' 35' ' ' VAL . 8.4 t70 -79.72 132.72 60.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.697 -0.853 . . . . 8.31 108.697 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -63.28 -13.71 37.53 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 122.095 1.863 . . . . 10.41 112.361 178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.416 ' HE3' ' N ' ' A' ' 34' ' ' MET . 0.2 OUTLIER -98.08 0.84 46.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.762 -0.199 . . . . 10.85 111.466 178.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 32' ' ' ASP . 10.9 m -129.62 48.11 3.42 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-O 121.351 0.596 . . . . 9.32 112.085 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -57.64 103.41 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.837 2.358 . . . . 11.1 113.245 -173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.5 -37.83 0.96 Allowed Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 121.081 -0.58 . . . . 10.31 111.95 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.649 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -65.48 151.73 45.68 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.861 0.363 . . . . 9.21 110.198 177.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.658 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 2.6 tmm_? -136.35 98.83 3.93 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.6 -0.519 . . . . 11.51 109.6 -176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 30' ' ' TRP . 42.1 m-85 -76.96 141.48 40.42 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.377 0.608 . . . . 7.5 110.972 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.7 -30.51 71.6 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.069 -1.423 . . . . 10.61 109.932 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.468 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 15.8 pttm -165.01 165.94 11.43 Favored Pre-proline 0 N--CA 1.449 -0.492 0 CA-C-N 115.182 -0.917 . . . . 10.91 110.341 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.692 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.3 Cg_endo -47.84 167.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.565 2.843 . . . . 7.51 113.654 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 150.08 -162.0 29.07 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.508 -0.853 . . . . 7.59 112.645 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.6 ttmt -103.48 140.63 37.23 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.05 -0.352 . . . . 11.68 110.05 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.552 ' HB3' ' O ' ' A' ' 49' ' ' MET . 22.6 t -65.38 142.37 98.4 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.811 -0.631 . . . . 9.2 110.649 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' CD ' ' HZ ' ' A' ' 40' ' ' PHE . 56.8 Cg_endo -79.16 -20.9 9.63 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.549 2.166 . . . . 10.25 111.33 172.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.473 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 53.0 m-85 -84.5 -39.64 18.61 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.218 -1.355 . . . . 10.49 109.726 -176.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.552 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.3 OUTLIER -132.83 147.31 52.3 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.802 -0.635 . . . . 10.38 109.82 174.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.9 p-10 -77.82 58.23 1.84 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 122.084 0.945 . . . . 12.54 110.772 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.422 ' HG2' ' CB ' ' A' ' 49' ' ' MET . 15.6 ptm -132.7 139.98 36.34 Favored Pre-proline 0 C--N 1.315 -0.917 0 CA-C-N 114.831 -1.077 . . . . 9.87 109.649 175.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 18.1 Cg_endo -60.58 134.17 52.95 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.522 2.148 . . . . 9.51 110.249 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 32' ' ' ASP . 1.4 mm? -56.65 157.3 5.44 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.803 -0.359 . . . . 6.71 110.367 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 39.3 mm -98.97 129.76 28.97 Favored Pre-proline 0 C--N 1.31 -1.12 0 CA-C-O 121.272 0.558 . . . . 7.89 109.872 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 95.4 Cg_endo -82.12 138.66 10.25 Favored 'Trans proline' 0 N--CA 1.44 -1.675 0 C-N-CA 121.842 1.695 . . . . 5.77 112.797 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 32.0 m -56.19 157.41 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 114.198 -1.365 . . . . 5.96 112.454 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 9.14 -72.72 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 127.453 2.301 . . . . 7.84 116.434 -177.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.873 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.6 pt-20 -59.47 -32.71 70.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.458 0.647 . . . . 6.62 110.065 -174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 13.8 pt-20 51.3 89.72 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.445 -1.707 . . . . 8.58 112.458 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 78.33 67.15 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 113.2 -1.818 . . . . 7.64 111.121 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.707 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 20.2 t-20 -152.27 -34.44 0.13 Allowed 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 115.527 -0.76 . . . . 7.02 111.067 -173.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' ARG . . . -55.25 -75.52 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.075 0.941 . . . . 5.41 108.91 173.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -129.76 53.8 1.89 Allowed 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 113.739 -1.573 . . . . 7.01 108.452 170.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.79 41.44 1.03 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 112.731 -2.031 . . . . 7.2 113.742 -173.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 56.11 28.12 12.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.359 0.6 . . . . 7.82 110.648 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.68 -53.64 0.12 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.237 -0.892 . . . . 8.65 109.759 -178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' HA ' HG22 ' A' ' 164' ' ' THR . 10.7 t -76.45 -84.98 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.107 -0.497 . . . . 7.31 109.883 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 62' ' ' ALA . 14.0 mtm105 -91.99 149.22 21.65 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 109.224 -0.658 . . . . 10.21 109.224 167.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.499 HD12 ' NE ' ' A' ' 72' ' ' ARG . 1.7 mt -148.52 140.67 18.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 116.142 -0.481 . . . . 8.86 109.859 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -117.48 -20.99 8.83 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 122.046 0.927 . . . . 13.02 109.436 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -68.27 -6.26 46.43 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 114.263 -1.335 . . . . 12.13 112.09 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.499 ' NE ' HD12 ' A' ' 69' ' ' ILE . 31.0 ptt180 -138.41 162.18 35.1 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.35 -1.352 . . . . 12.38 107.35 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.2 t -105.85 126.39 61.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.978 -0.689 . . . . 11.61 110.506 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 p -83.89 84.19 7.66 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.235 -0.893 . . . . 10.71 110.597 -176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -79.37 67.65 5.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.357 -0.838 . . . . 14.09 111.078 -175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.75 120.35 27.74 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.49 -0.93 . . . . 11.22 108.49 175.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.4 mp -97.46 13.68 29.02 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.172 -1.376 . . . . 13.71 110.573 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -89.13 -66.47 1.26 Allowed Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.223 -0.898 . . . . 11.44 111.466 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.79 103.98 12.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.156 -0.522 . . . . 9.99 110.189 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.672 ' HB3' ' N ' ' A' ' 150' ' ' SER . 89.2 mtm180 -116.15 132.03 56.77 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 116.201 -0.454 . . . . 11.64 111.397 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 148' ' ' VAL . 80.7 p -156.39 170.63 21.86 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.957 0.786 . . . . 8.0 111.18 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -155.49 141.41 18.19 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 107.401 -1.333 . . . . 6.65 107.401 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 44.2 tt0 -97.21 136.46 37.68 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 120.616 -0.434 . . . . 12.15 110.744 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 145' ' ' GLN . 75.6 t -62.38 134.23 27.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.612 -0.722 . . . . 9.71 111.3 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -163.47 140.01 7.03 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.594 -1.185 . . . . 11.03 109.818 174.247 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.72 163.19 28.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.048 -0.978 . . . . 12.76 111.146 -173.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.451 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 170.89 45.74 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 13.25 112.448 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.61 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -83.89 175.37 9.65 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.918 0.39 . . . . 16.35 111.5 -176.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.31 115.41 21.62 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.477 0.656 . . . . 18.22 110.075 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 111.31 -147.18 17.85 Favored Glycine 0 C--N 1.313 -0.727 0 CA-C-N 115.184 -0.917 . . . . 17.91 111.814 174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.3 p -95.4 77.47 3.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.95 0.881 . . . . 17.11 109.119 174.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.61 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -152.47 167.61 28.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.673 -1.149 . . . . 14.73 108.268 -179.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -142.83 118.95 10.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 118.06 0.391 . . . . 14.94 110.287 162.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG3' ' OE1' ' A' ' 136' ' ' GLU . 22.9 mmt85 -129.77 155.26 46.23 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 110.084 -0.339 . . . . 10.57 110.084 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.587 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.6 mm? -91.44 113.76 26.11 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.73 -0.841 . . . . 8.88 108.73 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.4 mm? -87.86 130.58 34.85 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.809 -0.356 . . . . 9.78 111.045 -175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.9 m -142.78 155.03 63.21 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.56 -0.904 . . . . 6.4 108.56 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.89 137.19 78.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 121.922 1.748 . . . . 6.55 111.046 174.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 23.6 t -62.43 -25.21 67.84 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.988 0.366 . . . . 9.29 111.988 -173.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.07 11.76 22.03 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.588 -0.445 . . . . 10.86 111.335 178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.8 -33.14 35.0 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.06 0.457 . . . . 5.34 111.29 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -101.51 165.63 11.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 6.97 112.194 -170.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 28.7 mm -109.29 117.49 54.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.601 -0.727 . . . . 10.2 109.829 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 104' ' ' ARG . 0.9 OUTLIER -91.07 125.32 35.82 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 119.834 -0.747 . . . . 12.12 110.554 173.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.1 t -145.79 122.7 11.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.871 -0.604 . . . . 14.61 110.689 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 57.64 -108.01 1.22 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.745 -0.661 . . . . 15.52 112.848 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.77 24.62 10.47 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.673 0.273 . . . . 14.99 111.732 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.62 179.69 8.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.964 0.411 . . . . 15.2 111.692 -179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.563 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 58.1 m -134.68 150.96 50.69 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.862 -0.608 . . . . 9.26 110.831 -173.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.6 mm -119.63 146.23 24.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.871 -0.418 . . . . 10.55 109.871 174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.577 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -122.54 143.03 49.98 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.237 -0.282 . . . . 7.39 110.237 177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.595 ' O ' ' HA ' ' A' ' 147' ' ' VAL . 81.7 mmm -106.56 98.1 7.81 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.208 -0.451 . . . . 8.85 109.999 -177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 121' ' ' ASP . 9.2 p -88.1 142.07 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.005 0.431 . . . . 9.69 111.419 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.5 86.54 0.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 10.7 110.479 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.433 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 33.6 tttp -72.44 153.62 41.3 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.245 -0.888 . . . . 14.88 110.422 -175.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.05 -2.04 51.1 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.945 -0.571 . . . . 16.92 112.998 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -93.18 17.47 10.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.198 0.523 . . . . 18.56 111.077 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 79.12 11.34 85.21 Favored Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.618 -0.719 . . . . 15.62 112.785 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.9 -158.09 8.7 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.836 -0.697 . . . . 14.19 111.84 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.524 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 64.5 m-85 -128.11 124.34 36.73 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.376 0.608 . . . . 12.03 110.154 -176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 113' ' ' VAL . 10.2 t70 -101.13 117.4 62.37 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.041 -0.982 . . . . 13.91 110.314 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 72.7 Cg_endo -83.1 112.09 1.97 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.83 3.02 . . . . 12.35 113.458 -172.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.597 HG13 HG12 ' A' ' 125' ' ' VAL . 9.5 p -105.21 142.83 17.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.423 -0.808 . . . . 9.43 110.404 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -82.23 123.41 29.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.156 0.503 . . . . 12.93 109.699 171.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.729 HG21 HD12 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -135.76 163.08 35.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.707 -0.679 . . . . 8.03 110.974 -172.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.424 ' N ' HG23 ' A' ' 125' ' ' VAL . 77.9 tttt -98.82 126.21 44.41 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.936 -0.575 . . . . 10.39 110.243 172.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -142.92 108.08 4.98 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.663 -0.699 . . . . 8.3 111.444 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.45 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.17 70.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 117.759 -2.162 . . . . 10.1 114.674 168.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.75 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.67 161.92 41.69 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.957 -0.757 . . . . 10.61 108.957 153.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.17 127.62 26.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.928 -0.397 . . . . 13.17 109.928 171.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -147.32 125.21 11.96 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.339 -0.391 . . . . 12.98 111.595 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 59.79 35.99 88.39 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.934 -0.576 . . . . 14.34 113.288 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.51 7.9 87.67 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.941 -0.647 . . . . 13.12 112.163 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -124.66 170.51 10.89 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 109.503 -0.555 . . . . 10.62 109.503 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 13.3 p -122.36 156.51 33.78 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.741 0.305 . . . . 7.82 110.53 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 52.8 mt-10 -99.16 118.48 35.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.369 0.604 . . . . 10.79 110.853 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.729 HD12 HG21 ' A' ' 125' ' ' VAL . 22.9 mm -85.37 103.79 12.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.096 -0.956 . . . . 6.73 108.615 170.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.4 mp -70.73 -46.63 62.69 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.926 -1.034 . . . . 8.79 109.805 -176.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' O ' HG23 ' A' ' 125' ' ' VAL . 97.9 mt-10 -143.1 161.12 39.04 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.949 -0.569 . . . . 10.44 109.63 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.52 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.31 -60.36 0.59 Allowed Glycine 0 C--N 1.314 -0.687 0 C-N-CA 120.02 -1.086 . . . . 8.87 113.585 175.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.546 HD21 HG11 ' A' ' 123' ' ' VAL . 47.6 mt -110.44 -176.61 3.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.899 0.703 . . . . 8.5 112.899 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -143.78 157.32 44.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.792 -1.095 . . . . 14.15 109.201 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.32 129.83 41.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.735 -0.666 . . . . 12.12 110.296 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 108.21 -8.69 35.81 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.179 -0.768 . . . . 11.54 111.179 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.602 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.6 mm-40 -91.12 100.32 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.507 0.67 . . . . 11.24 109.64 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 32.4 mt-30 -74.72 135.32 41.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.14 -0.936 . . . . 10.49 110.58 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.5 m -129.75 136.62 58.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.717 -0.475 . . . . 5.45 109.717 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 2.8 p -61.25 119.09 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 112.872 0.693 . . . . 6.56 112.872 -171.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.561 HG23 ' N ' ' A' ' 150' ' ' SER . 2.7 m -137.25 -55.66 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 112.233 0.457 . . . . 6.99 112.233 179.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.672 ' N ' ' HB3' ' A' ' 80' ' ' ARG . 51.1 m -165.12 -35.16 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 109.018 -0.734 . . . . 9.06 109.018 -174.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.489 ' CA ' ' H ' ' A' ' 81' ' ' THR . . . 65.29 -121.06 19.9 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 114.947 -1.024 . . . . 8.5 113.583 170.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.98 135.31 10.23 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.468 -0.938 . . . . 11.84 108.468 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -70.4 171.38 10.13 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.727 -0.389 . . . . 12.24 110.171 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 88.1 mt -59.64 175.27 0.37 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.597 0.713 . . . . 13.16 112.747 -169.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.549 ' C ' ' HB2' ' A' ' 159' ' ' ALA . 6.2 pt -114.57 77.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.607 0.718 . . . . 11.95 110.281 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.531 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 26.3 m-20 -84.46 -100.44 0.05 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.359 -0.837 . . . . 11.22 111.459 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.0 p -83.36 -36.43 24.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 11.9 110.082 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 18.3 tt0 -66.07 -18.95 65.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.056 -0.975 . . . . 11.17 109.904 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.549 ' HB2' ' C ' ' A' ' 155' ' ' ILE . . . -45.16 -58.33 3.31 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.008 -0.996 . . . . 7.82 112.156 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.7 m -66.06 -29.26 69.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.678 0.752 . . . . 9.64 110.963 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 158' ' ' GLU . 46.8 mt -72.59 -28.04 62.55 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.684 -1.144 . . . . 10.57 110.94 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 71.9 mtt180 -92.73 -54.15 3.88 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.063 -0.971 . . . . 8.9 111.024 -178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 56.21 56.33 24.8 Favored Glycine 0 C--N 1.334 0.417 0 N-CA-C 111.385 -0.686 . . . . 7.15 111.385 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.5 HG22 ' HA ' ' A' ' 67' ' ' VAL . 41.7 p -62.19 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.261 0.467 . . . . 7.09 112.261 -171.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.8 t -100.44 47.68 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.623 0.725 . . . . 9.2 109.344 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -106.29 25.04 11.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.752 -0.658 . . . . 9.11 111.421 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -74.13 102.72 4.33 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.949 0.88 . . . . 14.58 110.005 177.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.1 76.08 9.35 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.088 -1.414 . . . . 11.94 110.548 -177.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -148.62 96.14 2.54 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.523 -0.762 . . . . 14.99 109.579 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 59.98 40.25 19.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 114.126 -1.397 . . . . 15.01 111.717 175.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 20.0 p -54.42 -45.86 73.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.159 0.505 . . . . 14.25 111.752 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.7 t -174.79 -162.5 0.12 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.56 -0.745 . . . . 14.89 109.597 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.6 m -52.35 114.32 1.32 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.965 0.412 . . . . 15.85 110.881 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.87 53.45 4.26 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.873 -0.603 . . . . 17.54 112.425 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.422 ' H ' ' CD1' ' A' ' 175' ' ' LEU . 0.0 OUTLIER -62.54 156.5 22.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.768 0.318 . . . . 17.85 110.807 178.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -59.45 -79.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.746 -0.661 . . . . 19.67 110.685 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 9.4 p -169.45 23.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.767 0.794 . . . . 19.52 110.537 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.81 166.79 14.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 21.15 109.856 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -124.44 178.76 5.23 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.393 -0.595 . . . . 23.25 109.393 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.446 -0.788 . . . . 23.52 110.663 -176.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptm . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 120.639 0.257 . . . . 34.32 111.119 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.39 -91.52 1.67 Allowed Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.78 -0.724 . . . . 33.09 112.03 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.5 t -168.55 -168.7 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.651 -0.5 . . . . 34.12 109.651 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 63.02 11.02 4.82 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.044 0.938 . . . . 32.32 112.818 171.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.9 p 48.16 40.09 13.12 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.666 0.786 . . . . 32.74 112.027 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.0 p -129.46 135.37 61.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.437 . . . . 31.29 110.85 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -92.97 -28.03 16.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.502 0.668 . . . . 29.46 109.906 176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 87.93 -174.27 44.03 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.362 -0.835 . . . . 28.28 111.895 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -91.42 37.98 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.223 2.615 . . . . 27.51 111.925 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -90.37 -33.6 16.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.848 -0.615 . . . . 26.48 110.371 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -159.45 146.37 16.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.902 -0.59 . . . . 24.9 109.889 -176.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.25 -164.46 31.88 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.906 -0.664 . . . . 23.19 111.699 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -78.69 -88.58 0.05 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.768 0.284 . . . . 21.31 110.623 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 52.17 83.69 0.22 Allowed Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 123.679 0.612 . . . . 19.89 111.799 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -88.4 -168.82 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.628 2.218 . . . . 18.12 112.266 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -121.65 45.37 2.33 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.266 0.555 . . . . 16.58 110.024 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 130.08 42.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.558 -0.746 . . . . 14.8 111.102 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -97.86 -127.75 5.83 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.409 -0.814 . . . . 13.17 111.926 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.02 -50.68 0.09 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.915 -0.168 . . . . 12.17 111.396 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' O ' ' HE2' ' A' ' 25' ' ' LYS . 32.8 tt0 62.59 58.32 1.66 Allowed 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.722 1.249 . . . . 13.82 108.541 -172.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.443 HD13 ' C ' ' A' ' 21' ' ' LEU . 3.4 tm? -163.17 -61.06 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 112.901 -1.954 . . . . 12.13 106.736 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.509 ' HA ' ' NH2' ' A' ' 26' ' ' ARG . 33.5 ttmt -51.32 -48.25 62.42 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 114.729 -1.123 . . . . 14.1 108.864 169.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 20' ' ' GLU . 2.9 p -140.78 166.99 23.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 113.882 -1.508 . . . . 11.05 108.381 176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.09 -57.03 0.47 Allowed Glycine 0 CA--C 1.493 -1.307 0 C-N-CA 120.074 -1.06 . . . . 10.05 111.33 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' HE2' ' O ' ' A' ' 20' ' ' GLU . 17.3 pttt -146.91 61.58 1.19 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.472 1.13 . . . . 10.38 112.101 -175.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.598 ' HA ' ' OE1' ' A' ' 58' ' ' GLU . 19.8 mtm180 -141.31 142.17 33.86 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.309 -1.769 . . . . 8.37 108.281 170.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.703 HG12 ' CD ' ' A' ' 58' ' ' GLU . 25.5 mm -51.95 112.8 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 113.213 0.82 . . . . 5.76 113.213 -169.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -100.9 -31.9 10.92 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.007 -1.452 . . . . 8.22 109.734 172.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.0 p90 -175.02 -174.58 0.78 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.24 0.543 . . . . 7.99 112.089 -174.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.755 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.7 m-90 -123.23 148.62 45.67 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 114.966 -1.015 . . . . 5.61 110.701 -174.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.602 ' HB2' HE22 ' A' ' 38' ' ' GLN . 29.5 ptt180 -148.22 152.53 37.36 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.472 0.482 . . . . 9.06 111.112 -176.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.804 ' HB2' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -76.66 139.37 66.84 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 107.791 -1.188 . . . . 8.31 107.791 163.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.584 ' CG ' HD12 ' A' ' 54' ' ' ILE . 44.7 Cg_exo -57.87 -15.49 22.02 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 122.865 2.377 . . . . 10.41 110.647 164.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.05 -28.85 39.17 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 113.772 -1.558 . . . . 10.85 111.476 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 18.2 m -123.57 51.42 4.02 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.77 0.656 . . . . 9.32 112.77 -164.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -66.0 114.3 2.93 Favored 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.212 2.608 . . . . 11.1 112.317 -174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.09 -25.52 3.5 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.26 -0.736 . . . . 10.31 111.26 -176.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.644 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -70.94 171.59 10.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.118 -0.541 . . . . 9.21 109.926 176.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -150.12 91.27 1.75 Allowed 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 109.2 -0.667 . . . . 11.51 109.2 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 70.8 m-85 -71.07 141.86 50.86 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.298 0.571 . . . . 7.5 110.292 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.18 -30.43 71.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.821 -1.081 . . . . 10.61 111.668 -174.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.479 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 13.2 ptmm? -167.33 163.29 10.07 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 119.29 -0.386 . . . . 10.91 111.279 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 10.7 Cg_endo -49.72 170.89 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.781 2.988 . . . . 7.51 113.859 178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.69 -163.34 26.91 Favored Glycine 0 N--CA 1.451 -0.3 0 N-CA-C 111.302 -0.719 . . . . 7.59 111.302 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 51' ' ' MET . 38.9 ttpt -94.33 147.74 22.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.203 0.501 . . . . 11.68 110.242 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.2 t -66.1 139.07 96.4 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.413 -0.812 . . . . 9.2 111.226 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.94 -21.95 11.94 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.791 2.328 . . . . 10.25 111.957 174.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' A' ' 35' ' ' VAL . 33.2 m-85 -78.66 -39.02 38.08 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.865 -1.061 . . . . 10.49 109.769 -173.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.49 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.6 pmm? -156.94 166.55 33.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.454 -0.794 . . . . 10.38 109.105 171.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 8.3 p-10 -78.33 80.96 4.71 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.531 0.681 . . . . 12.54 112.27 -172.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.418 ' O ' ' HG3' ' A' ' 45' ' ' LYS . 4.4 ptm -134.99 146.04 56.96 Favored Pre-proline 0 CA--C 1.501 -0.92 0 N-CA-C 106.737 -1.579 . . . . 9.87 106.737 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.43 132.74 18.06 Favored 'Trans proline' 0 N--CA 1.437 -1.815 0 N-CA-C 108.234 -1.487 . . . . 9.51 108.234 165.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.28 161.73 18.86 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.165 -0.614 . . . . 6.71 110.964 -174.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.584 HD12 ' CG ' ' A' ' 33' ' ' PRO . 22.0 mt -110.08 132.35 21.49 Favored Pre-proline 0 C--N 1.312 -1.053 0 N-CA-C 109.571 -0.529 . . . . 7.89 109.571 -177.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.667 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 39.9 Cg_endo -76.85 133.4 13.84 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 C-N-CA 120.983 1.122 . . . . 5.77 112.749 -177.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -56.28 157.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.07 -1.423 . . . . 5.96 113.245 -176.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.507 ' CD2' ' HA ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER 21.58 -89.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.285 1.834 . . . . 7.84 114.893 -177.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.703 ' CD ' HG12 ' A' ' 27' ' ' ILE . 1.2 pt-20 -45.63 -40.69 9.32 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.091 0.556 . . . . 6.62 110.13 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 41.8 tt0 59.85 81.03 0.18 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.904 -1.044 . . . . 8.58 110.541 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 47.23 77.1 0.09 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 114.505 -1.225 . . . . 7.64 111.359 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.455 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 27.6 t-20 -110.54 -39.84 4.79 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.171 -1.048 . . . . 7.02 108.171 172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 51.04 56.76 7.51 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.709 -1.132 . . . . 5.41 111.935 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 66' ' ' ALA . 11.8 m-20 61.73 40.8 12.68 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.407 -1.724 . . . . 7.01 111.55 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -96.01 -15.12 43.26 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.249 -1.14 . . . . 7.2 110.249 172.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -127.01 46.77 2.44 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.228 -1.027 . . . . 7.82 108.228 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 63' ' ' ASP . . . -173.94 -33.57 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.734 -1.575 . . . . 8.65 107.67 -171.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 164' ' ' THR . 4.0 t 74.55 -38.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 CA-C-N 112.707 -2.042 . . . . 7.31 113.647 173.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.4 ptt180 -147.02 140.15 25.31 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.571 0.701 . . . . 10.21 111.117 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.532 HG21 ' HG2' ' A' ' 72' ' ' ARG . 3.8 mt -67.66 156.65 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 114.643 -1.162 . . . . 8.86 111.855 -177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.415 ' HB2' HH22 ' A' ' 26' ' ' ARG . 23.3 t70 -90.48 57.27 3.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 122.175 0.988 . . . . 13.02 109.964 174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.86 -8.11 38.49 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.422 -1.263 . . . . 12.13 114.89 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HG2' HG21 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -81.3 132.96 35.36 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.901 -1.148 . . . . 12.38 107.901 176.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.0 t -114.77 93.75 2.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.651 0.739 . . . . 11.61 109.531 -176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.2 t -75.16 59.73 1.0 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 113.844 -1.525 . . . . 10.71 110.491 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 43.26 70.3 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.167 -0.924 . . . . 14.09 111.344 -172.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -153.53 130.96 11.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.924 -1.035 . . . . 11.22 108.908 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -74.11 -22.52 59.44 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.692 0.758 . . . . 13.71 109.764 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 136.02 -22.93 3.39 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.098 -0.956 . . . . 11.44 112.167 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.8 t 59.27 46.44 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 122.316 1.055 . . . . 9.99 108.579 -177.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.565 ' NH1' ' HB3' ' A' ' 156' ' ' ASP . 53.7 ttt180 -81.62 119.0 23.25 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.592 -1.185 . . . . 11.64 110.419 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.485 HG22 ' HA ' ' A' ' 148' ' ' VAL . 75.9 p -128.47 159.16 36.29 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.529 -1.214 . . . . 8.0 109.212 -176.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.434 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -119.49 126.5 51.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.693 -0.854 . . . . 6.65 108.693 171.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 28.0 tt0 -75.92 131.44 39.64 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 109.146 -0.687 . . . . 12.15 109.146 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.632 HG13 ' HB3' ' A' ' 95' ' ' LEU . 41.3 t -55.64 132.02 19.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 112.94 0.718 . . . . 9.71 112.94 -176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 49.0 mmtt -136.41 140.46 43.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 114.607 -1.179 . . . . 11.03 109.429 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 mp -72.2 157.9 36.88 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.954 -0.698 . . . . 12.76 109.496 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.09 49.25 0.05 OUTLIER Glycine 0 CA--C 1.503 -0.704 0 C-N-CA 119.74 -1.219 . . . . 13.25 113.862 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.647 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -89.29 -177.56 5.41 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.799 0.666 . . . . 16.35 112.799 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 tt -139.94 112.89 8.13 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.944 -1.026 . . . . 18.22 108.275 172.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 124.16 -167.58 16.44 Favored Glycine 0 C--N 1.318 -0.434 0 N-CA-C 111.121 -0.792 . . . . 17.91 111.121 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 p -89.92 75.78 7.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 122.242 1.02 . . . . 17.11 109.967 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.647 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 1.6 m -154.8 167.67 29.46 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 106.862 -1.533 . . . . 14.73 106.862 175.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.615 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 3.8 mt-10 -141.68 109.49 5.74 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.657 0.662 . . . . 14.94 110.518 165.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.549 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 35.8 mmt180 -118.72 163.83 16.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.675 -0.693 . . . . 10.57 110.339 -175.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.2 mm? -97.9 114.17 26.18 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.066 -0.716 . . . . 8.88 109.066 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.49 129.79 36.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.189 0.519 . . . . 9.78 110.99 -174.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.82 157.22 68.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 114.895 -1.048 . . . . 6.4 109.17 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.97 131.25 40.63 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 121.817 1.678 . . . . 6.55 110.356 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.9 t -54.57 -30.12 53.36 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.312 -0.404 . . . . 9.29 111.32 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -77.9 -8.34 57.96 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.624 0.231 . . . . 10.86 111.624 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.658 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -72.02 -41.32 67.67 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.433 0.635 . . . . 5.34 110.942 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.516 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.5 pp -93.96 163.78 13.36 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.141 -0.936 . . . . 6.97 112.613 -169.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' THR . 22.7 mm -111.68 103.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 10.2 109.229 171.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 13.3 ptt180 -103.01 132.54 49.2 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 117.969 -1.493 . . . . 12.12 110.985 173.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -151.36 133.92 15.52 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 113.709 -1.587 . . . . 14.61 109.133 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.18 -113.63 6.06 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.352 -0.928 . . . . 15.52 111.952 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.24 34.99 5.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 111.85 0.315 . . . . 14.99 111.85 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.408 HH11 HD11 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -164.41 178.63 7.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.901 0.382 . . . . 15.2 111.801 -178.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.3 m -136.68 158.55 44.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.749 -0.66 . . . . 9.26 110.431 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.408 HD11 HH11 ' A' ' 108' ' ' ARG . 25.1 mm -131.22 147.75 32.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.272 -0.422 . . . . 10.55 109.899 177.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.574 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.34 127.31 27.69 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.517 -0.31 . . . . 7.39 110.296 177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.411 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 33.2 ttp -87.59 103.19 15.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.27 -0.641 . . . . 8.85 109.27 176.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 12.6 p -89.64 135.05 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.623 -0.717 . . . . 9.69 112.575 -170.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.695 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -76.01 90.28 3.02 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.359 -0.837 . . . . 10.7 109.672 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -85.38 152.84 22.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.264 -0.425 . . . . 14.88 110.499 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.05 1.76 10.24 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 116.106 -0.497 . . . . 16.92 113.328 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -90.93 8.64 34.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.33 0.586 . . . . 18.56 111.062 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.19 6.45 86.34 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.29 -0.868 . . . . 15.62 112.512 175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -126.78 156.18 19.99 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.985 -0.626 . . . . 14.19 111.567 -174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.573 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 82.5 m-85 -107.3 109.46 21.23 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.766 -0.457 . . . . 12.03 109.766 -178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' HG12 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -106.74 142.96 26.08 Favored Pre-proline 0 C--N 1.326 -0.445 0 C-N-CA 120.405 -0.518 . . . . 13.91 111.231 -172.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -80.66 121.28 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.281 1.987 . . . . 12.35 111.93 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 111' ' ' ALA . 5.7 p -105.43 137.29 35.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.667 -0.697 . . . . 9.43 109.663 178.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.93 119.95 19.8 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.1 -0.704 . . . . 12.93 109.1 170.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.777 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.06 155.98 41.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.695 -0.684 . . . . 8.03 110.918 -176.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 139' ' ' GLU . 38.5 ttmt -101.78 128.47 48.11 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.904 -0.776 . . . . 10.39 108.904 171.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -140.92 104.55 4.7 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.452 -0.34 . . . . 8.3 110.74 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -150.77 70.34 0.31 Allowed Glycine 0 N--CA 1.438 -1.173 0 C-N-CA 117.867 -2.111 . . . . 10.1 113.866 171.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.99 161.32 42.15 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.305 -1.368 . . . . 10.61 107.305 151.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 20.0 m -141.5 128.88 21.19 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 118.38 0.537 . . . . 13.17 110.081 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.87 121.61 8.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.592 -0.731 . . . . 12.98 110.847 -176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.43 38.22 96.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.362 -0.447 . . . . 14.34 112.704 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.58 9.76 84.71 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.938 -0.649 . . . . 13.12 112.434 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -120.32 164.24 16.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.165 -0.309 . . . . 10.62 110.165 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.4 m -117.31 158.34 24.55 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.935 0.398 . . . . 7.82 110.883 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.769 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 57.7 mt-10 -101.7 124.82 47.98 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.454 0.645 . . . . 10.79 110.828 177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 125' ' ' VAL . 23.9 mm -89.76 114.63 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-N 114.934 -1.03 . . . . 6.73 109.55 175.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 2.2 mp -87.73 -45.5 10.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.648 -1.16 . . . . 8.79 109.677 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 125' ' ' VAL . 9.2 tp10 -134.67 164.71 26.9 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.974 -1.121 . . . . 10.44 107.974 179.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.533 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 111.99 -62.49 0.3 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 119.275 -1.44 . . . . 8.87 113.722 169.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.64 -173.26 2.27 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.236 0.541 . . . . 8.5 112.455 -174.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.416 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.9 ttmt -157.58 158.36 35.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.042 -0.981 . . . . 14.15 108.528 -177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 128.84 37.61 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.888 -0.596 . . . . 12.12 110.31 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 107.08 -10.3 40.08 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.444 -0.662 . . . . 11.54 111.444 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.523 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.9 mm100 -93.69 121.17 34.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.119 -0.697 . . . . 11.24 109.119 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.695 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 28.5 mt-30 -97.49 125.06 41.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.941 -0.572 . . . . 10.49 111.114 -176.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.75 138.21 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 115.852 -0.613 . . . . 5.45 109.673 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.485 ' HA ' HG22 ' A' ' 81' ' ' THR . 5.8 m -62.94 120.72 10.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.36 0.6 . . . . 6.56 111.136 -178.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.658 HG12 ' HB2' ' A' ' 101' ' ' ALA . 3.4 m -110.17 -20.16 6.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.476 -0.784 . . . . 6.99 110.484 -176.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m 38.1 45.88 0.79 Allowed 'General case' 0 C--O 1.235 0.313 0 O-C-N 124.305 1.003 . . . . 9.06 112.861 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -91.16 46.99 2.87 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.277 -1.129 . . . . 8.5 110.277 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.427 ' HG2' ' H ' ' A' ' 152' ' ' GLN . 13.9 pt20 -75.78 23.01 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.319 0.489 . . . . 11.84 112.319 -171.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -100.26 -27.74 13.34 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.478 -0.934 . . . . 12.24 108.478 169.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.17 137.47 36.7 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.833 -1.076 . . . . 13.16 108.839 177.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 157' ' ' SER . 47.0 mt -54.07 108.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.001 0.429 . . . . 11.95 111.228 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.565 ' HB3' ' NH1' ' A' ' 80' ' ' ARG . 4.0 p30 -84.17 17.44 2.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.255 -0.43 . . . . 11.22 111.84 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 155' ' ' ILE . 70.7 m -64.52 -17.35 63.82 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.72 -0.218 . . . . 11.9 111.519 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.595 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 41.4 mt-10 -58.45 -46.87 85.71 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.252 -0.647 . . . . 11.17 109.252 171.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -65.73 -27.89 68.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.74 -0.664 . . . . 7.82 110.794 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 16.0 m -62.57 -39.0 92.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.581 0.705 . . . . 9.64 110.017 175.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.15 -47.77 14.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.883 -1.053 . . . . 10.57 111.638 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.595 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 53.3 mtt180 -71.49 -36.24 71.07 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.592 0.711 . . . . 8.9 110.948 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 107.75 105.74 3.03 Favored Glycine 0 N--CA 1.439 -1.154 0 CA-C-N 114.606 -1.179 . . . . 7.15 110.782 -171.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.406 ' H ' HG13 ' A' ' 67' ' ' VAL . 13.9 p -49.71 -54.03 21.24 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.104 0.478 . . . . 7.09 111.061 175.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.4 t -86.86 -48.05 15.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.818 -0.628 . . . . 9.2 109.491 173.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 53.32 67.8 0.94 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.62 -0.718 . . . . 9.11 111.658 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.603 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -70.42 -19.48 62.98 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.28 -0.873 . . . . 14.58 109.831 179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.83 -10.06 59.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.972 -1.013 . . . . 11.94 110.763 -176.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -111.17 142.98 42.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.755 -0.657 . . . . 14.99 109.776 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -150.01 114.96 5.35 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.809 -0.441 . . . . 15.01 109.809 176.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.6 p -98.89 40.01 1.23 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.032 -0.531 . . . . 14.25 112.092 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 17.8 m -67.04 -46.62 73.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.172 0.511 . . . . 14.89 110.055 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.2 p -89.64 59.44 4.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.811 -0.632 . . . . 15.85 110.72 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.19 66.8 0.23 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.817 -0.706 . . . . 17.54 111.687 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.02 121.6 26.74 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.032 -0.358 . . . . 17.85 110.032 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -81.03 -41.81 22.08 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.542 -0.463 . . . . 19.67 110.594 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.4 t 71.42 -72.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.545 -0.752 . . . . 19.52 110.665 -176.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 82.7 mt -146.79 37.14 0.97 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.648 0.261 . . . . 21.15 111.55 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -85.64 104.64 15.56 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.685 -0.406 . . . . 23.25 110.489 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.475 -0.774 . . . . 23.52 109.755 177.587 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.1 mtp . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 121.206 0.527 . . . . 34.32 110.239 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.27 51.84 1.4 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.973 -0.632 . . . . 33.09 112.262 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.3 p -121.07 118.98 31.14 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.043 0.449 . . . . 34.12 110.5 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.09 -54.97 16.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.806 -0.633 . . . . 32.32 110.34 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 30.2 m -99.9 135.52 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.421 -0.585 . . . . 32.74 109.421 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.4 t -49.94 -64.03 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 123.247 0.342 . . . . 31.29 111.538 -174.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 55.07 75.14 0.32 Allowed 'General case' 0 C--N 1.331 -0.232 0 O-C-N 123.813 0.695 . . . . 29.46 111.364 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.68 149.34 49.45 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.497 -0.859 . . . . 28.28 111.883 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.41 111.82 1.75 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.359 2.039 . . . . 27.51 111.699 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 66.91 177.72 0.23 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.551 -0.749 . . . . 26.48 111.793 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -159.7 -55.37 0.06 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.353 -0.839 . . . . 24.9 109.157 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.81 -118.8 0.56 Allowed Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.822 -1.081 . . . . 23.19 110.877 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.41 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 39.6 m80 52.17 56.0 8.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.991 0.424 . . . . 21.31 110.661 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -108.58 98.91 30.79 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.836 -0.62 . . . . 19.89 110.185 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 13' ' ' HIS . 3.6 Cg_exo -74.51 107.43 2.45 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.418 2.078 . . . . 18.12 112.513 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.76 0.32 10.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.048 0.451 . . . . 16.58 110.161 173.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.59 50.57 3.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 114.976 -1.011 . . . . 14.8 110.188 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.02 38.68 3.08 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.645 -0.707 . . . . 13.17 112.484 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.409 ' HB3' ' HA2' ' A' ' 24' ' ' GLY . . . -103.72 -23.95 13.39 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.727 0.299 . . . . 12.17 110.859 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 71.04 113.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.015 -0.993 . . . . 13.82 110.242 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.6 tt -26.45 -49.27 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.872 1.669 . . . . 12.13 114.018 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -41.67 -39.58 1.71 Allowed 'General case' 0 C--N 1.345 0.409 0 CA-C-N 114.067 -1.424 . . . . 14.1 111.721 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.1 p -140.47 47.21 1.78 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.368 -0.975 . . . . 11.05 108.368 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 19' ' ' ALA . . . -56.01 -36.44 67.34 Favored Glycine 0 CA--C 1.5 -0.864 0 CA-C-N 114.616 -1.174 . . . . 10.05 112.285 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.652 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.1 OUTLIER -170.23 61.36 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 122.507 1.146 . . . . 10.38 108.244 178.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.458 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 82.3 mtt180 -124.25 138.75 54.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.484 -1.235 . . . . 8.37 109.946 -176.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.691 HG12 ' OE2' ' A' ' 58' ' ' GLU . 33.5 mm -48.72 127.13 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.573 0 CA-C-N 114.369 -1.287 . . . . 5.76 114.18 -167.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp -114.86 -38.77 3.84 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.504 -1.68 . . . . 8.22 110.029 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.759 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 2.0 p90 -176.51 -172.81 0.48 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.929 -0.578 . . . . 7.99 110.402 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.738 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.8 m-90 -124.01 150.36 44.96 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.462 -0.79 . . . . 5.61 110.751 -174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' HB2' HE22 ' A' ' 38' ' ' GLN . 24.7 ptt180 -153.5 145.63 23.77 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.297 -0.41 . . . . 9.06 111.596 -178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.828 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.6 t0 -79.34 130.6 68.22 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.909 -1.145 . . . . 8.31 107.909 170.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.514 ' HG3' HD12 ' A' ' 54' ' ' ILE . 21.6 Cg_exo -61.17 -14.43 33.75 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 122.023 1.815 . . . . 10.41 112.293 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.11 2.06 52.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.473 -0.331 . . . . 10.85 111.193 176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.9 m -129.1 39.35 0.5 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 112.624 0.601 . . . . 9.32 112.624 177.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 36.3 Cg_endo -60.42 128.71 26.96 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.519 2.146 . . . . 11.1 112.579 -174.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.01 -6.45 19.68 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.845 -0.693 . . . . 10.31 111.618 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.563 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -89.95 -179.54 5.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.456 -0.372 . . . . 9.21 110.082 178.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.501 ' HD2' ' CE2' ' A' ' 29' ' ' TYR . 8.1 tpt180 -142.03 108.63 5.34 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.192 -0.203 . . . . 11.51 110.455 171.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.759 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 89.2 m-85 -96.84 121.02 38.24 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.631 -0.828 . . . . 7.5 109.098 170.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -62.47 -35.3 78.88 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.958 -0.565 . . . . 10.61 110.125 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -147.86 149.39 33.06 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 121.78 0.8 . . . . 10.91 111.071 -174.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.738 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 14.5 Cg_endo -52.77 142.38 51.49 Favored 'Trans proline' 0 C--N 1.348 0.515 1 C-N-CA 125.398 4.065 . . . . 7.51 114.027 -177.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 178.8 -156.0 17.71 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.828 -0.624 . . . . 7.59 111.594 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 23.1 ttmt -98.1 143.56 28.51 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.093 -0.706 . . . . 11.68 109.093 176.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.546 ' HB3' ' O ' ' A' ' 49' ' ' MET . 33.7 t -66.83 132.66 93.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.309 -0.405 . . . . 9.2 110.624 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.71 -29.4 24.15 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.684 2.256 . . . . 10.25 111.491 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.556 ' CD2' HG11 ' A' ' 35' ' ' VAL . 96.8 m-85 -70.38 -37.75 74.6 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.561 -1.2 . . . . 10.49 110.581 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.546 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.4 OUTLIER -156.99 153.62 28.32 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.678 -0.49 . . . . 10.38 109.678 169.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.484 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 3.7 m-20 -74.42 76.19 1.91 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.447 0.536 . . . . 12.54 112.447 -173.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -140.28 145.15 40.17 Favored Pre-proline 0 C--N 1.315 -0.913 0 N-CA-C 108.491 -0.929 . . . . 9.87 108.491 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 16.4 Cg_exo -65.97 132.32 29.83 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.748 1.632 . . . . 9.51 110.208 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 mt -61.37 160.09 11.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.342 -0.39 . . . . 6.71 110.303 -177.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.514 HD12 ' HG3' ' A' ' 33' ' ' PRO . 6.0 mt -104.6 133.59 20.1 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.947 0.403 . . . . 7.89 110.006 -176.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.617 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 86.9 Cg_endo -77.71 152.07 28.87 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.766 1.644 . . . . 5.77 112.447 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.8 m -74.44 157.65 6.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.513 -1.221 . . . . 5.96 112.051 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.458 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.37 -86.13 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.056 2.143 . . . . 7.84 115.701 -177.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.691 ' OE2' HG12 ' A' ' 27' ' ' ILE . 1.0 OUTLIER -52.81 -42.01 64.7 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 122.605 0.362 . . . . 6.62 110.386 -176.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 55' ' ' PRO . 85.5 mt-10 67.88 86.34 0.13 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.846 0.831 . . . . 8.58 112.507 177.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.422 ' H ' HD11 ' A' ' 27' ' ' ILE . 16.4 tt0 72.31 60.64 0.13 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 113.645 -1.616 . . . . 7.64 112.242 162.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.569 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 46.1 t30 -141.04 -51.21 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.693 -1.14 . . . . 7.02 110.855 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.733 ' O ' ' HA ' ' A' ' 68' ' ' ARG . . . -38.78 -59.56 0.94 Allowed 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.579 0.549 . . . . 5.41 110.351 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' HA ' ' H ' ' A' ' 68' ' ' ARG . 28.8 t70 -175.7 32.64 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.251 -1.34 . . . . 7.01 107.737 170.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.9 -20.41 57.41 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 114.006 -1.452 . . . . 7.2 113.333 -174.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.63 36.34 1.64 Allowed 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 108.931 -0.766 . . . . 7.82 108.931 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.96 31.05 20.98 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 114.653 -1.158 . . . . 8.65 110.439 -171.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 61' ' ' ASN . 21.0 t -66.9 -68.22 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.543 -0.753 . . . . 7.31 109.771 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 62' ' ' ALA . 2.4 ttp180 65.32 136.43 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.286 -1.324 . . . . 10.21 112.54 -177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 72' ' ' ARG . 20.5 mt -74.5 153.2 6.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.356 -0.838 . . . . 8.86 110.003 177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -87.79 25.94 1.42 Allowed 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.482 -0.781 . . . . 13.02 111.091 -177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.07 13.41 83.69 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.21 -0.904 . . . . 12.13 110.899 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 69' ' ' ILE . 40.2 mtm180 49.77 98.57 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.295 1.038 . . . . 12.38 112.543 -170.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.4 t -129.52 -59.83 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.603 -1.181 . . . . 11.61 110.349 177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 74' ' ' THR . 1.3 t -50.53 113.31 0.86 Allowed 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 113.676 -1.602 . . . . 10.71 111.14 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -80.71 54.75 2.19 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.529 -1.214 . . . . 14.09 110.805 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 68.19 146.81 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.144 -1.389 . . . . 11.22 111.366 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -88.19 -15.72 35.24 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.632 -0.713 . . . . 13.71 111.496 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.04 -33.43 1.14 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.72 -0.752 . . . . 11.44 112.424 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG11 ' CZ ' ' A' ' 120' ' ' PHE . 63.8 t 64.85 88.67 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 122.097 0.951 . . . . 9.99 111.346 178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -90.82 132.01 36.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 114.528 -1.215 . . . . 11.64 108.937 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 148' ' ' VAL . 33.1 p -130.13 148.19 51.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.575 -0.284 . . . . 8.0 110.661 -174.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.435 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.91 136.08 54.73 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.433 -0.58 . . . . 6.65 109.433 175.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.428 ' OE1' ' HE2' ' A' ' 85' ' ' LYS . 41.2 tt0 -76.57 141.0 41.29 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.226 -0.443 . . . . 12.15 110.161 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.496 ' CG1' ' HA ' ' A' ' 143' ' ' ALA . 97.1 t -67.89 131.34 33.28 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.776 0.798 . . . . 9.71 111.936 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.428 ' HE2' ' OE1' ' A' ' 83' ' ' GLU . 27.8 mmtp -127.3 155.4 43.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.237 -1.347 . . . . 11.03 109.114 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.453 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.5 mp -90.38 165.58 13.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.395 -0.595 . . . . 12.76 109.395 165.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.03 53.65 0.03 OUTLIER Glycine 0 CA--C 1.506 -0.5 0 C-N-CA 119.819 -1.181 . . . . 13.25 113.688 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.736 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -92.23 -177.29 4.61 Favored 'General case' 0 C--N 1.314 -0.972 0 C-N-CA 120.852 -0.339 . . . . 16.35 111.66 176.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 57.9 tp -140.19 110.88 6.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.28 0.562 . . . . 18.22 110.189 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 122.82 -162.3 16.68 Favored Glycine 0 C--N 1.319 -0.383 0 CA-C-N 115.689 -0.687 . . . . 17.91 111.484 178.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 17.2 p -81.9 76.45 8.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.954 0.883 . . . . 17.11 109.525 175.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.736 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -154.01 166.52 32.74 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.557 -1.202 . . . . 14.73 107.832 178.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.571 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 2.6 mt-10 -144.37 111.78 6.02 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 118.368 0.531 . . . . 14.94 110.4 162.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.638 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 36.5 mmt180 -125.8 157.57 37.17 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.924 -0.31 . . . . 10.57 110.739 -175.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.0 mm? -94.12 126.8 39.57 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.904 -0.776 . . . . 8.88 108.904 175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.21 129.02 50.03 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.221 -0.445 . . . . 9.78 109.882 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.4 m -141.69 157.13 65.68 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.912 -1.04 . . . . 6.4 108.842 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.79 128.33 29.16 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 121.523 1.482 . . . . 6.55 110.631 170.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.506 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 50.8 p -54.43 -25.76 26.83 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.645 0.609 . . . . 9.29 112.645 -179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -91.45 12.12 21.71 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.825 -0.35 . . . . 10.86 111.526 177.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -85.43 -28.78 24.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.364 0.602 . . . . 5.34 110.338 175.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -99.68 158.73 15.56 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.799 -0.637 . . . . 6.97 111.572 -174.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 40.8 mm -104.02 123.67 57.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.203 -0.908 . . . . 10.2 110.356 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.44 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 20.4 mmm180 -95.26 121.81 37.3 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.592 -0.843 . . . . 12.12 110.629 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 t -149.5 143.49 25.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.713 -0.676 . . . . 14.61 110.605 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 51.67 -115.71 4.13 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 116.225 -0.443 . . . . 15.52 112.666 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.42 36.94 4.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.939 0.4 . . . . 14.99 110.94 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -155.48 -177.98 6.94 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.107 0.48 . . . . 15.2 111.933 -175.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 19.1 m -131.74 147.19 52.48 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.529 -0.76 . . . . 9.26 109.399 176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.497 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 22.6 mm -126.64 149.82 31.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.968 -0.382 . . . . 10.55 109.968 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.59 123.54 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.205 -0.294 . . . . 7.39 110.205 175.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 43.6 mtm -86.7 100.38 12.44 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.179 -0.674 . . . . 8.85 109.179 176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 14.9 p -82.72 136.47 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.497 -0.774 . . . . 9.69 110.98 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.55 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -74.89 83.23 2.19 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.464 -0.939 . . . . 10.7 108.464 173.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -77.99 150.93 33.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.018 -0.992 . . . . 14.88 111.083 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.37 -5.88 18.56 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 115.566 -0.743 . . . . 16.92 113.15 -178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -73.32 -10.44 59.75 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.19 -0.3 . . . . 18.56 110.19 175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.21 31.15 26.23 Favored Glycine 0 C--N 1.31 -0.866 0 C-N-CA 119.947 -1.121 . . . . 15.62 111.374 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -154.97 163.76 31.51 Favored Glycine 0 N--CA 1.439 -1.112 0 N-CA-C 111.242 -0.743 . . . . 14.19 111.242 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 94.2 m-85 -97.27 112.44 24.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.806 0.336 . . . . 12.03 110.204 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.489 ' O ' HG12 ' A' ' 113' ' ' VAL . 4.0 t70 -101.51 139.62 20.56 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.893 -0.594 . . . . 13.91 109.538 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -86.16 122.24 2.13 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.045 1.83 . . . . 12.35 112.971 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.53 121.52 59.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.177 -0.92 . . . . 9.43 110.167 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -74.24 121.1 20.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.849 -0.797 . . . . 12.93 108.849 171.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.731 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -129.17 153.26 38.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.742 0.782 . . . . 8.03 112.059 -173.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 24.2 ttmm -93.83 129.75 40.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.232 -1.349 . . . . 10.39 109.475 177.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.77 112.97 20.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 123.116 1.436 . . . . 8.3 112.261 -169.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 136' ' ' GLU . . . -89.44 174.36 41.52 Favored Glycine 0 N--CA 1.41 -3.062 0 CA-C-N 111.364 -2.653 . . . . 10.1 111.177 170.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.38 162.35 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 112.367 -1.917 . . . . 10.61 114.683 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.7 m -106.7 133.17 51.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.219 -0.9 . . . . 13.17 109.248 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.24 119.82 9.13 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.055 -0.52 . . . . 12.98 111.261 -174.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.17 29.58 75.19 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.183 -0.532 . . . . 14.34 112.544 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.03 5.46 89.7 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.633 -0.794 . . . . 13.12 112.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -116.53 153.8 31.54 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.077 -0.342 . . . . 10.62 110.077 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 70.5 m -102.33 149.17 24.61 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.091 0.472 . . . . 7.82 111.387 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB2' ' C ' ' A' ' 128' ' ' GLY . 24.7 mt-10 -85.51 107.85 17.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.586 -0.733 . . . . 10.79 109.65 173.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.731 HD12 HG21 ' A' ' 125' ' ' VAL . 23.2 mm -92.41 114.1 28.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 O-C-N 121.245 -0.909 . . . . 6.73 110.31 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.638 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.4 mp -86.6 -47.8 8.88 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.293 -1.321 . . . . 8.79 110.795 -173.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 125' ' ' VAL . 37.3 mt-10 -144.29 167.25 22.9 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.052 -0.722 . . . . 10.44 109.052 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 114.51 -74.11 0.24 Allowed Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 119.631 -1.271 . . . . 8.87 113.413 175.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.486 ' HG ' ' H ' ' A' ' 142' ' ' LYS . 61.5 tp -97.66 178.09 5.28 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.694 -0.253 . . . . 8.5 110.998 -168.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.486 ' H ' ' HG ' ' A' ' 141' ' ' LEU . 26.3 tptp -137.62 148.84 46.15 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.4 0.619 . . . . 14.15 112.124 -173.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.496 ' HA ' ' CG1' ' A' ' 84' ' ' VAL . . . -68.15 143.45 55.39 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 114.439 -1.255 . . . . 12.12 110.802 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 1.34 85.95 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.524 -0.846 . . . . 11.54 112.124 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 69.6 mm-40 -103.8 152.69 21.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 109.552 -0.536 . . . . 11.24 109.552 175.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 69.4 mt-30 -97.46 140.07 32.44 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 120.929 0.395 . . . . 10.49 111.295 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.3 m -134.71 143.99 36.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 116.152 -0.477 . . . . 5.45 109.961 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.456 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.1 m -67.75 129.58 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.436 0.636 . . . . 6.56 111.365 -175.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.6 m -121.89 26.37 3.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 122.346 1.069 . . . . 6.99 108.978 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -71.34 16.61 0.1 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 113.848 -1.524 . . . . 9.06 112.861 -172.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -77.13 -28.32 58.55 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.128 -0.789 . . . . 8.5 111.128 174.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -156.32 139.66 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.51 -0.552 . . . . 11.84 109.51 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.445 ' CD1' HG22 ' A' ' 155' ' ' ILE . 2.7 p90 -159.34 173.38 16.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.548 -0.296 . . . . 12.24 110.805 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 97.3 mt -106.23 61.91 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.231 0.539 . . . . 13.16 111.494 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.445 HG22 ' CD1' ' A' ' 153' ' ' PHE . 12.8 tt -149.31 2.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.777 0.798 . . . . 11.95 109.416 171.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 10.3 p-10 -72.76 -16.41 61.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.645 -0.707 . . . . 11.22 110.651 -176.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 6.4 p -57.42 -43.14 83.56 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.393 0.616 . . . . 11.9 109.556 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 38.8 tt0 -76.11 -36.52 58.83 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 115.251 -0.886 . . . . 11.17 108.892 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 156' ' ' ASP . . . -59.97 -27.77 67.11 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 114.27 -1.332 . . . . 7.82 111.519 -178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.421 ' HA ' HG22 ' A' ' 164' ' ' THR . 32.5 t -79.0 -37.92 38.0 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.359 -0.382 . . . . 9.64 110.496 177.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 77.5 mt -79.96 -26.9 39.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.747 0.277 . . . . 10.57 111.747 -175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 11.2 ptp180 -74.62 2.46 9.76 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.136 0.421 . . . . 8.9 112.136 -178.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 116.47 13.18 8.3 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.462 -0.875 . . . . 7.15 112.342 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 159' ' ' ALA . 26.1 p 52.75 -97.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.672 0.789 . . . . 7.09 112.153 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 165' ' ' VAL . 5.7 p -74.67 84.85 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.855 0.836 . . . . 9.2 109.65 175.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.39 124.6 22.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.251 -0.886 . . . . 9.11 111.534 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.662 ' O ' ' HG3' ' A' ' 168' ' ' MET . 5.9 tmm_? -75.09 90.35 2.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.715 -0.675 . . . . 14.58 110.433 -178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.662 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 14.5 mtm -161.87 26.31 0.12 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.973 -1.012 . . . . 11.94 109.953 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -138.65 47.17 1.96 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.422 -0.808 . . . . 14.99 110.217 -175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -90.89 1.48 56.95 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.116 -0.947 . . . . 15.01 110.207 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.7 p -131.34 151.08 51.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.407 -0.815 . . . . 14.25 110.469 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 13.6 t -169.88 171.65 7.08 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.504 -0.554 . . . . 14.89 109.504 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.3 t -151.61 166.49 31.05 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.665 -0.495 . . . . 15.85 109.665 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.28 49.02 7.72 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.718 -0.753 . . . . 17.54 111.379 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.9 mp -79.87 44.06 0.63 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.982 0.42 . . . . 17.85 111.588 -176.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.31 113.62 25.55 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.111 -0.7 . . . . 19.67 109.111 173.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.478 HG23 HD23 ' A' ' 178' ' ' LEU . 18.6 m 45.68 -163.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 124.132 0.895 . . . . 19.52 111.674 -175.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.478 HD23 HG23 ' A' ' 177' ' ' VAL . 2.9 mm? 57.63 50.27 11.2 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.083 0.401 . . . . 21.15 112.083 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 56.04 100.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.763 1.023 . . . . 23.25 113.763 168.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 . . . . . 0 C--O 1.245 0.834 0 CA-C-O 118.935 -0.555 . . . . 23.52 109.697 176.149 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 120.689 0.281 . . . . 34.32 110.522 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.16 17.86 79.73 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.98 -0.628 . . . . 33.09 112.222 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -84.11 -46.99 11.36 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.059 -0.071 . . . . 34.12 110.91 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 55.05 58.31 4.85 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.327 0.584 . . . . 32.32 110.572 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 m -56.19 -40.88 74.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.326 -0.852 . . . . 32.74 111.311 -177.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.3 m -98.74 12.58 5.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.91 -0.586 . . . . 31.29 110.776 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 72.49 -53.67 0.69 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.567 0.747 . . . . 29.46 111.278 -176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.54 -146.53 7.86 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.952 -0.642 . . . . 28.28 111.932 177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -74.13 132.0 16.1 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.563 2.175 . . . . 27.51 112.488 -178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -116.64 44.78 1.95 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.369 -0.604 . . . . 26.48 109.369 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 61.3 -165.97 0.22 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.051 -0.977 . . . . 24.9 111.55 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.3 -149.37 22.8 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 111.4 -0.68 . . . . 23.19 111.4 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -111.55 121.57 45.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.94 -0.393 . . . . 21.31 109.94 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -116.59 88.45 24.53 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-O 120.711 0.291 . . . . 19.89 110.572 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.57 171.83 2.84 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.605 2.203 . . . . 18.12 112.276 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.72 -60.5 3.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.095 0.474 . . . . 16.58 110.467 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -118.86 -177.8 3.41 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 14.8 109.873 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -86.75 -120.66 1.29 Allowed Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.218 -0.991 . . . . 13.17 111.729 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -108.94 5.03 23.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.067 0.461 . . . . 12.17 110.334 177.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 64.53 74.32 0.4 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.665 -1.152 . . . . 13.82 109.74 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 96.8 mt 63.37 86.13 0.12 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.622 0.725 . . . . 12.13 110.31 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -49.62 -32.61 13.27 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.165 -1.38 . . . . 14.1 112.313 -173.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 t -163.99 54.52 0.15 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.043 0.925 . . . . 11.05 110.101 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -56.73 14.56 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 110.559 -1.016 . . . . 10.05 110.559 174.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -160.79 53.48 0.3 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.56 1.171 . . . . 10.38 109.809 173.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.487 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 77.6 mtm180 -119.54 143.32 47.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.127 -1.397 . . . . 8.37 109.87 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.571 HG12 ' OE2' ' A' ' 58' ' ' GLU . 31.1 mm -49.23 120.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 114.286 -1.324 . . . . 5.76 112.824 -169.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.2 tp -109.5 -35.06 6.34 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.963 -1.471 . . . . 8.22 110.298 -177.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.429 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 44.0 p90 -176.15 -173.54 0.57 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.858 -0.61 . . . . 7.99 109.387 -178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.731 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -125.15 154.11 41.99 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.105 -0.498 . . . . 5.61 111.599 -175.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -156.51 150.64 25.2 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.389 -0.823 . . . . 9.06 110.415 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.608 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.3 t0 -82.72 134.69 46.89 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.705 -1.221 . . . . 8.31 107.705 170.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -62.67 -13.27 32.88 Favored 'Trans proline' 0 N--CA 1.464 -0.224 0 C-N-CA 122.113 1.875 . . . . 10.41 111.967 177.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -95.68 1.75 53.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 10.85 111.108 175.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.9 m -129.22 36.3 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 112.965 0.728 . . . . 9.32 112.965 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.8 Cg_endo -54.81 119.14 5.98 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.343 2.028 . . . . 11.1 112.517 -172.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.23 -21.0 6.97 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.889 -0.884 . . . . 10.31 110.889 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' HG3' ' CE1' ' A' ' 40' ' ' PHE . 40.5 tp60 -85.0 115.42 22.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.25 -0.475 . . . . 9.21 110.635 177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.429 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 47.9 ttt180 -99.73 102.8 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.343 0.592 . . . . 11.51 110.197 176.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 38' ' ' GLN . 82.9 m-85 -76.74 146.84 37.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.16 -0.927 . . . . 7.5 109.801 177.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -63.65 -27.7 69.4 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 114.128 -1.397 . . . . 10.61 110.323 -175.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.528 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.9 pttm -169.79 165.94 5.8 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.386 -0.825 . . . . 10.91 110.355 -176.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.731 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.6 Cg_endo -51.25 168.63 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.113 2.542 . . . . 7.51 113.104 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.66 -159.94 28.21 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.67 -0.776 . . . . 7.59 112.036 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 10.1 ttmt -98.44 147.47 24.7 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.24 -0.281 . . . . 11.68 110.24 178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 p -70.68 128.77 90.64 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.558 -0.292 . . . . 9.2 111.462 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.65 -22.94 17.45 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.827 1.684 . . . . 10.25 110.507 174.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.558 ' CD2' HG11 ' A' ' 35' ' ' VAL . 97.8 m-85 -72.57 -24.98 61.18 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.759 -1.109 . . . . 10.49 110.949 -175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.24 -104.38 0.13 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.737 -0.785 . . . . 10.38 112.616 167.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 2.0 p-10 -166.55 58.17 0.09 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.313 0.578 . . . . 12.54 111.596 171.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.3 ptm -133.36 149.9 73.7 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.626 -0.509 . . . . 9.87 109.626 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -66.41 131.8 27.48 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 121.545 1.496 . . . . 9.51 109.772 177.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.0 mt -60.59 160.04 9.69 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 123.699 0.625 . . . . 6.71 110.756 -174.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 45.1 mm -99.4 130.73 26.34 Favored Pre-proline 0 C--N 1.312 -1.032 0 N-CA-C 109.212 -0.662 . . . . 7.89 109.212 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 58.2 Cg_endo -73.46 146.07 38.95 Favored 'Trans proline' 0 N--CA 1.438 -1.774 0 C-N-CA 121.389 1.393 . . . . 5.77 112.145 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.498 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 31.3 m -68.81 159.69 5.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.269 -1.332 . . . . 5.96 112.251 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.487 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.87 -74.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 127.526 2.33 . . . . 7.84 116.216 -178.007 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -61.63 -38.86 89.21 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 122.669 1.223 . . . . 6.62 111.93 -168.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 55' ' ' PRO . 50.2 mt-10 49.96 36.42 11.66 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 111.865 -2.425 . . . . 8.58 112.291 177.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 49.0 mt-10 -163.22 54.63 0.18 Allowed 'General case' 0 C--N 1.312 -1.059 0 O-C-N 124.803 1.314 . . . . 7.64 111.834 -171.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 58' ' ' GLU . 64.8 t30 -148.68 -34.93 0.2 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.568 -1.196 . . . . 7.02 110.309 173.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' HB2' ' CZ2' ' A' ' 30' ' ' TRP . . . -29.77 -59.22 0.17 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 125.413 1.485 . . . . 5.41 111.969 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' HB3' ' H ' ' A' ' 68' ' ' ARG . 37.8 t70 -130.14 65.36 1.51 Allowed 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 114.596 -1.184 . . . . 7.01 108.953 173.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.99 -54.16 4.94 Favored Glycine 0 CA--C 1.503 -0.677 0 CA-C-N 114.23 -1.35 . . . . 7.2 111.498 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -151.45 28.05 0.65 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.076 -1.062 . . . . 7.82 109.005 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.88 24.76 11.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.311 -1.313 . . . . 8.65 110.815 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.439 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 47.5 t -53.43 -53.32 25.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.746 -0.835 . . . . 7.31 108.746 174.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.553 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 54.9 mtm180 73.16 141.29 0.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.713 1.375 . . . . 10.21 114.713 165.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.547 ' CG2' ' HG2' ' A' ' 72' ' ' ARG . 17.2 mt -75.74 155.09 6.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 113.338 -1.755 . . . . 8.86 110.226 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 69' ' ' ILE . 24.4 t70 -85.53 64.12 8.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.597 1.189 . . . . 13.02 109.324 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.04 25.31 59.5 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 112.925 -1.943 . . . . 12.13 114.554 170.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HG2' ' CG2' ' A' ' 69' ' ' ILE . 7.7 ptm180 -121.66 179.33 4.5 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 107.546 -1.279 . . . . 12.38 107.546 175.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 t -124.32 123.43 66.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 109.337 -0.616 . . . . 11.61 109.337 175.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.4 t -110.54 30.69 6.57 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.188 0.995 . . . . 10.71 109.897 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 60.04 107.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.649 -1.614 . . . . 14.09 111.45 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 7.1 p-10 -88.24 91.72 8.89 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.825 0.822 . . . . 11.22 111.189 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.79 -17.38 53.51 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.58 -1.191 . . . . 13.71 110.562 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.78 -60.2 4.74 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.123 -1.037 . . . . 11.44 111.107 -176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 49.7 t -133.1 98.83 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 113.969 -1.115 . . . . 9.99 109.481 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 76' ' ' ASN . 65.6 ttt180 -126.22 132.37 51.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.797 -0.638 . . . . 11.64 109.737 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 148' ' ' VAL . 76.6 p -139.05 143.11 38.24 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.739 -0.664 . . . . 8.0 109.484 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -108.43 127.75 54.18 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.435 -0.58 . . . . 6.65 109.435 -178.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 34.4 tt0 -73.1 139.24 46.32 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.888 -0.596 . . . . 12.15 109.932 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG13 ' HB3' ' A' ' 95' ' ' LEU . 79.7 t -61.74 135.32 26.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 115.278 -0.874 . . . . 9.71 111.727 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 83' ' ' GLU . 28.2 mmtp -131.11 156.51 45.13 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.602 -1.181 . . . . 11.03 109.693 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.1 mp -86.43 143.79 27.62 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.497 -0.557 . . . . 12.76 109.497 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -112.39 -33.12 2.18 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 119.702 -1.237 . . . . 13.25 112.678 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.524 ' HG2' ' HA ' ' A' ' 93' ' ' GLU . 9.3 ptt180 -47.37 143.52 3.42 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 114.258 1.207 . . . . 16.35 114.258 -169.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 tt -155.57 86.17 1.06 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.286 -1.376 . . . . 18.22 107.286 173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 -6.38 82.2 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 109.07 -1.612 . . . . 17.91 109.07 -172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 5.5 p -111.26 173.93 6.1 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.4 -1.4 . . . . 17.11 108.504 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.7 m -86.66 148.01 25.65 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.746 0.784 . . . . 14.73 110.645 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.524 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 10.9 tt0 -67.39 114.79 6.36 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 113.14 -1.845 . . . . 14.94 111.762 -170.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.521 ' CG ' HD12 ' A' ' 138' ' ' LEU . 1.5 mpp_? -119.61 156.74 29.81 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 114.829 -1.078 . . . . 10.57 109.118 170.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -90.68 113.58 25.68 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.629 -0.878 . . . . 8.88 108.629 176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.68 129.95 34.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.78 -0.646 . . . . 9.78 110.99 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 30.8 m -144.67 159.03 52.32 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.828 -1.078 . . . . 6.4 109.103 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.42 136.28 70.67 Favored 'Trans proline' 0 C--N 1.333 -0.277 0 C-N-CA 122.192 1.928 . . . . 6.55 110.589 170.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.1 m -57.92 -24.85 59.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.886 0.328 . . . . 9.29 111.886 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -90.6 6.61 43.07 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 121.183 -0.207 . . . . 10.86 111.554 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -82.42 -40.71 20.85 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.058 0.456 . . . . 5.34 110.707 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.479 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -90.87 161.85 15.05 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.732 -0.667 . . . . 6.97 111.98 -173.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 mm -113.15 103.79 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.892 -0.594 . . . . 10.2 109.442 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.559 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 7.2 ptt180 -101.53 134.27 44.91 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.33 -1.348 . . . . 12.12 110.997 173.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.8 t -150.47 128.88 12.12 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.06 -1.427 . . . . 14.61 109.589 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.76 -109.74 3.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.589 -0.815 . . . . 15.52 112.117 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.16 30.31 6.89 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.077 0.399 . . . . 14.99 112.077 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.547 HH11 HD11 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -163.75 176.91 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.942 0.401 . . . . 15.2 112.004 -177.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 5.4 m -132.55 156.66 46.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.693 -0.685 . . . . 9.26 110.602 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.547 HD11 HH11 ' A' ' 108' ' ' ARG . 41.4 mm -129.26 149.48 33.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.277 -0.638 . . . . 10.55 109.277 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.592 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -128.94 141.82 51.14 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.658 0.265 . . . . 7.39 110.497 177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 122' ' ' PRO . 62.0 mmm -103.37 99.84 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.648 -0.501 . . . . 8.85 109.648 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 121' ' ' ASP . 14.0 p -82.05 135.78 24.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.979 0.418 . . . . 9.69 111.003 -175.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -80.06 93.54 5.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.658 -0.701 . . . . 10.7 110.922 -178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -89.06 160.5 17.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.626 -0.716 . . . . 14.88 111.343 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.43 23.94 31.42 Favored Glycine 0 N--CA 1.451 -0.358 0 N-CA-C 110.737 -0.945 . . . . 16.92 110.737 172.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -97.54 19.41 13.48 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.989 0.423 . . . . 18.56 111.102 -176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 86.31 13.5 68.19 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.951 -0.642 . . . . 15.62 112.702 176.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.85 -175.76 47.55 Favored Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 111.16 -0.776 . . . . 14.19 111.16 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.416 ' CD1' ' HA ' ' A' ' 114' ' ' ALA . 81.8 m-85 -100.36 178.7 4.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.868 0.366 . . . . 12.03 110.881 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.525 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 13.4 t70 -140.52 122.85 9.73 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.467 0.651 . . . . 13.91 109.721 177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.544 ' HB3' ' SD ' ' A' ' 112' ' ' MET . 71.1 Cg_endo -86.96 113.78 1.04 Allowed 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.324 2.683 . . . . 12.35 112.422 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 111' ' ' ALA . 9.3 p -103.91 140.26 22.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.183 -0.917 . . . . 9.43 109.647 -177.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HA ' HD13 ' A' ' 110' ' ' ILE . 44.9 tt0 -76.24 120.97 22.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.108 -0.701 . . . . 12.93 109.108 171.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.796 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -131.65 159.35 43.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.363 0.602 . . . . 8.03 111.566 -173.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.4 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 39.9 ttmt -103.11 128.04 50.17 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.186 -0.916 . . . . 10.39 109.415 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.66 108.25 5.34 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 111.589 0.218 . . . . 8.3 111.589 -176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.583 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.52 71.04 0.28 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 118.021 -2.038 . . . . 10.1 114.006 168.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.011 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.71 163.03 39.54 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.554 -0.906 . . . . 10.61 108.554 157.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 15.7 m -131.5 137.03 48.36 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.139 -0.689 . . . . 13.17 109.139 173.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -142.73 90.63 2.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-O 120.888 0.375 . . . . 12.98 111.954 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 61.2 60.19 8.74 Favored Glycine 0 N--CA 1.453 -0.19 0 CA-C-N 115.733 -0.667 . . . . 14.34 113.411 173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.54 12.84 82.26 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.676 -0.773 . . . . 13.12 112.41 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -134.64 165.54 24.99 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.9 -0.778 . . . . 10.62 108.9 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 58.0 m -117.81 163.46 16.48 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.633 -0.427 . . . . 7.82 110.714 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 1.011 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 23.9 mt-10 -110.44 120.11 41.37 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.734 0.778 . . . . 10.79 111.258 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.796 HD12 HG21 ' A' ' 125' ' ' VAL . 22.3 mm -85.23 107.95 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.777 -1.101 . . . . 6.73 109.644 174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.0 mp -68.67 -46.54 68.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.298 -0.865 . . . . 8.79 109.984 -178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.533 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.9 mt-10 -144.45 155.79 43.89 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.122 -0.49 . . . . 10.44 110.101 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 129.28 -66.85 0.57 Allowed Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 119.862 -1.161 . . . . 8.87 113.064 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.461 HD21 ' CB ' ' A' ' 111' ' ' ALA . 3.1 mm? -97.71 -176.29 3.43 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.37 0.878 . . . . 8.5 113.37 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 23.0 tptm -144.34 151.91 39.99 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.019 -0.991 . . . . 14.15 109.89 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.17 132.41 47.14 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.345 -0.843 . . . . 12.12 110.21 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 103.16 -2.0 47.32 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.485 -0.864 . . . . 11.54 111.315 -174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -104.17 141.15 36.75 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.64 -0.504 . . . . 11.24 109.64 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 22.5 mt-30 -97.21 147.1 24.44 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.695 0.283 . . . . 10.49 111.008 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 112' ' ' MET . 27.0 m -136.51 152.55 29.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.38 -0.6 . . . . 5.45 109.38 174.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.554 ' HA ' HG22 ' A' ' 81' ' ' THR . 32.9 m -56.53 138.86 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 123.72 0.637 . . . . 6.56 111.881 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 82' ' ' ALA . 43.1 t -136.28 -39.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 115.235 -0.893 . . . . 6.99 110.043 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 12.0 t -137.45 96.83 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.081 -0.711 . . . . 9.06 109.081 170.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -171.57 61.9 0.16 Allowed Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 110.71 -0.956 . . . . 8.5 110.71 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -123.66 -136.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.629 -0.286 . . . . 11.84 110.622 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -71.89 63.2 0.46 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.062 0.545 . . . . 12.24 111.139 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.9 tp -103.95 94.84 5.62 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.83 -0.623 . . . . 13.16 110.707 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 44.0 mm -75.28 -9.14 12.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.337 -0.847 . . . . 11.95 109.709 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 169' ' ' GLN . 1.4 t70 -82.72 1.25 39.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.619 -0.719 . . . . 11.22 110.232 176.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.0 t -66.54 -40.41 89.07 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.809 -0.441 . . . . 11.9 109.809 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -52.11 -51.79 55.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.236 0.471 . . . . 11.17 110.038 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.06 66.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.834 . . . . 7.82 111.422 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 164' ' ' THR . 35.6 t -70.77 -38.39 73.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.181 0.515 . . . . 9.64 110.609 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.96 -32.44 65.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.83 0.824 . . . . 10.57 110.907 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -89.93 -67.02 0.87 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 114.327 -1.306 . . . . 8.9 111.019 -175.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -88.44 -3.71 77.88 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.563 -0.744 . . . . 7.15 112.658 -173.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 160' ' ' SER . 56.1 p 47.26 -100.09 0.05 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.191 0.996 . . . . 7.09 113.267 174.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.4 m -65.33 -30.97 51.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.03 0.443 . . . . 9.2 111.235 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -113.56 58.62 0.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.16 0.505 . . . . 9.11 111.096 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 164' ' ' THR . 0.0 OUTLIER -71.98 -106.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.745 -0.661 . . . . 14.58 110.931 173.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 25.3 mtm 62.98 103.44 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.925 0.49 . . . . 11.94 112.271 176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.405 ' HB2' ' OD1' ' A' ' 156' ' ' ASP . 24.6 tm0? -47.25 -51.68 18.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.512 -0.767 . . . . 14.99 110.539 175.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -108.65 27.75 9.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.812 0.815 . . . . 15.01 110.254 -174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 75.4 p 51.08 33.3 8.94 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 114.38 -1.282 . . . . 14.25 113.593 173.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.4 t -153.25 170.29 20.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.251 0.548 . . . . 14.89 111.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 65.3 p -134.78 32.72 3.24 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.257 -0.883 . . . . 15.85 108.785 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -85.29 8.94 68.78 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.447 -0.797 . . . . 17.54 111.894 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 5.7 tt -69.1 97.96 0.94 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 17.85 108.965 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -120.89 -60.89 1.62 Allowed 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.669 -0.696 . . . . 19.67 110.319 -174.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 178' ' ' LEU . 3.0 m 36.17 -108.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 112.984 0.735 . . . . 19.52 112.984 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.448 ' H ' HG23 ' A' ' 177' ' ' VAL . 80.3 mt -116.29 29.1 8.17 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.709 -0.619 . . . . 21.15 111.256 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -93.61 158.84 15.49 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.523 -0.547 . . . . 23.25 109.523 176.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.409 ' OXT' ' HG3' ' A' ' 180' ' ' GLN . 3.5 pt20 . . . . . 0 C--O 1.247 0.948 0 CA-C-O 118.268 -0.872 . . . . 23.52 110.548 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.394 0.14 . . . . 34.32 110.821 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.63 -127.13 33.65 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.918 -0.658 . . . . 33.09 111.842 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.5 t -89.88 120.58 31.23 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.742 -0.466 . . . . 34.12 109.742 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -104.68 44.41 1.03 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.026 0.441 . . . . 32.32 110.392 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.7 m -84.43 -19.4 33.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.917 -0.583 . . . . 32.74 110.274 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.3 m -86.22 -20.02 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.874 -0.603 . . . . 31.29 110.771 176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -103.44 83.88 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.325 -0.62 . . . . 29.46 109.325 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.57 -151.98 33.22 Favored Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 111.066 -0.814 . . . . 28.28 111.066 -175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.06 153.54 5.75 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.412 2.075 . . . . 27.51 111.982 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -55.27 -64.3 0.88 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.506 -0.553 . . . . 26.48 109.506 -178.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -98.46 120.89 39.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.556 -0.747 . . . . 24.9 109.049 177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.3 -73.55 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.523 -0.846 . . . . 23.19 111.533 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -83.98 54.77 3.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.535 . . . . 21.31 109.554 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -118.21 146.87 40.35 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.7 -0.682 . . . . 19.89 110.804 -174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.7 114.37 2.72 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 123.061 2.508 . . . . 18.12 111.67 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.43 4.83 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.965 -0.561 . . . . 16.58 111.911 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.2 72.08 0.35 Allowed 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.974 0.796 . . . . 14.8 111.953 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.56 70.6 2.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.78 -0.724 . . . . 13.17 111.43 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.82 1.77 54.71 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.457 0.54 . . . . 12.17 112.457 -173.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' LYS . 32.6 tt0 62.77 75.09 0.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.792 -0.64 . . . . 13.82 111.074 177.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.7 tp 70.61 -17.51 0.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.451 0.7 . . . . 12.13 112.482 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 20' ' ' GLU . 35.1 ttmt -80.47 61.1 4.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.451 0.643 . . . . 14.1 110.441 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.0 t 42.12 49.96 4.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 113.905 -1.498 . . . . 11.05 112.764 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.27 -55.84 1.89 Allowed Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.514 -0.85 . . . . 10.05 111.01 173.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -153.72 66.8 0.74 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 122.385 1.088 . . . . 10.38 110.043 -175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.521 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 32.0 mtt180 -135.49 138.75 43.44 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.971 -1.468 . . . . 8.37 109.362 174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.616 HG12 ' CG ' ' A' ' 58' ' ' GLU . 31.3 mm -52.92 120.64 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 CA-C-O 121.982 0.896 . . . . 5.76 113.236 -170.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.34 -37.32 7.69 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 113.665 -1.607 . . . . 8.22 110.291 172.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.708 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 13.1 p90 -169.77 -173.47 1.62 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.165 0.507 . . . . 7.99 111.611 -174.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.58 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.57 145.71 50.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.252 -0.886 . . . . 5.61 110.908 -176.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -149.26 157.52 43.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.912 -0.585 . . . . 9.06 110.207 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.646 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.1 t70 -91.32 136.08 27.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 108.673 -0.862 . . . . 8.31 108.673 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -62.45 -12.48 27.94 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.247 1.965 . . . . 10.41 112.395 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.608 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -100.47 2.57 42.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.605 0.24 . . . . 10.85 111.622 176.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' ASP . 5.0 m -126.1 45.39 1.46 Allowed Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.276 0.56 . . . . 9.32 111.451 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.608 ' HD3' ' C ' ' A' ' 34' ' ' MET . 22.7 Cg_exo -59.56 112.19 1.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.585 2.19 . . . . 11.1 112.252 -169.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.17 -32.7 3.35 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.309 -0.716 . . . . 10.31 111.309 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.45 ' CG ' ' CE2' ' A' ' 40' ' ' PHE . 3.3 tp-100 -68.1 125.67 27.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.276 0.56 . . . . 9.21 110.856 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.602 ' HG2' ' CE2' ' A' ' 29' ' ' TYR . 5.1 tmm_? -114.55 101.56 9.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.448 -0.797 . . . . 11.51 110.086 -177.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.708 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 56.4 m-85 -85.79 141.23 29.81 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.498 0.666 . . . . 7.5 109.782 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -63.93 -36.59 84.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.313 -1.312 . . . . 10.61 111.067 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 53.5 mttp -146.32 163.31 30.67 Favored Pre-proline 0 C--N 1.328 -0.343 0 O-C-N 123.406 0.441 . . . . 10.91 110.998 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -51.49 171.61 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.958 3.105 . . . . 7.51 114.175 175.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.71 -171.47 25.34 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 7.59 112.69 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 20.9 ttmt -83.86 144.8 29.0 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.604 -0.517 . . . . 11.68 109.604 175.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.3 t -64.76 136.65 96.86 Favored Pre-proline 0 N--CA 1.445 -0.709 0 CA-C-N 115.922 -0.581 . . . . 9.2 109.623 177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.98 -24.76 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.411 2.074 . . . . 10.25 112.099 173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 64.3 m-85 -82.45 -34.47 28.12 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.671 -0.695 . . . . 10.49 110.839 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.6 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -117.75 -165.02 1.05 Allowed 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.872 -1.058 . . . . 10.38 110.308 171.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -125.53 60.88 1.24 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.189 0.995 . . . . 12.54 109.066 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 13.8 ptm -138.32 146.15 50.15 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 113.86 -1.518 . . . . 9.87 109.325 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 19.4 Cg_exo -66.1 132.85 31.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.107 1.871 . . . . 9.51 110.177 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 45.5 mt -61.63 161.8 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 123.309 0.38 . . . . 6.71 110.43 -177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 mm -101.61 126.77 33.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.371 -0.603 . . . . 7.89 109.371 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 53.8 Cg_endo -73.37 131.75 16.79 Favored 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 121.309 1.339 . . . . 5.77 112.351 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.27 159.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 114.381 -1.282 . . . . 5.96 113.315 -175.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.4 OUTLIER 10.3 -69.04 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 128.109 2.564 . . . . 7.84 116.304 -177.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.64 ' HG3' ' N ' ' A' ' 59' ' ' GLU . 0.3 OUTLIER -64.58 -38.22 90.27 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 122.56 1.172 . . . . 6.62 109.737 -171.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 10.9 tt0 54.63 40.55 31.94 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-N 111.863 -2.426 . . . . 8.58 111.15 170.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -165.54 45.96 0.08 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 113.909 -1.496 . . . . 7.64 109.644 -172.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' A' ' 27' ' ' ILE . 18.4 t-20 44.12 126.11 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.818 1.784 . . . . 7.02 115.818 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.605 ' H ' ' HB ' ' A' ' 27' ' ' ILE . . . -26.78 -63.16 0.08 Allowed 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 109.518 -3.492 . . . . 5.41 112.306 176.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 68' ' ' ARG . 15.0 t70 -169.24 90.43 0.22 Allowed 'General case' 0 N--CA 1.428 -1.525 0 C-N-CA 118.257 -1.377 . . . . 7.01 113.229 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.19 26.14 69.2 Favored Glycine 0 CA--C 1.5 -0.866 0 CA-C-N 115.431 -0.804 . . . . 7.2 111.97 169.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 72.69 -32.61 0.25 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.545 0.738 . . . . 7.82 112.908 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.19 -4.02 0.09 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.197 0.443 . . . . 8.65 112.197 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 164' ' ' THR . 21.5 t -74.67 -74.85 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 111.675 0.25 . . . . 7.31 111.675 -174.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 33.8 mtm180 65.57 142.4 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.009 0.909 . . . . 10.21 113.172 -173.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 70' ' ' ASP . 17.6 mt -87.18 161.28 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.809 -1.087 . . . . 8.86 110.218 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' N ' HG22 ' A' ' 69' ' ' ILE . 37.6 t70 -79.34 47.67 0.83 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.913 -0.585 . . . . 13.02 110.736 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 58.2 30.73 64.57 Favored Glycine 0 N--CA 1.452 -0.263 0 CA-C-N 115.568 -0.742 . . . . 12.13 112.517 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -131.61 172.83 11.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 108.547 -0.908 . . . . 12.38 108.547 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 38.4 t -116.1 136.05 54.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.873 -0.417 . . . . 11.61 109.873 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.9 44.69 0.76 Allowed 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.576 0.703 . . . . 10.71 111.432 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -90.12 70.04 7.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.249 -0.887 . . . . 14.09 109.205 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -133.6 119.01 18.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.806 -1.088 . . . . 11.22 108.27 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.554 ' H ' HD22 ' A' ' 77' ' ' LEU . 1.7 mm? -70.88 -2.68 15.83 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.579 -1.191 . . . . 13.71 112.822 -165.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 140.6 24.51 0.25 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.864 -0.684 . . . . 11.44 112.505 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 91.0 t 63.71 94.74 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 121.707 0.765 . . . . 9.99 111.22 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.611 ' HD3' ' H ' ' A' ' 80' ' ' ARG . 0.0 OUTLIER -96.28 131.52 42.71 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.053 -0.976 . . . . 11.64 109.78 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.491 HG21 ' HB2' ' A' ' 114' ' ' ALA . 74.6 p -142.98 156.56 44.89 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.961 -0.563 . . . . 8.0 110.182 -175.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -120.01 129.3 54.2 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 108.567 -0.901 . . . . 6.65 108.567 171.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 43.3 tt0 -80.11 131.88 35.83 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.855 -0.611 . . . . 12.15 110.054 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.619 HG11 HD23 ' A' ' 95' ' ' LEU . 77.2 t -55.6 131.36 18.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.39 0.614 . . . . 9.71 110.955 176.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.36 145.06 9.64 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.462 -1.245 . . . . 11.03 109.455 172.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.476 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.3 mp -74.48 152.29 39.43 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.205 -0.907 . . . . 12.76 110.838 -176.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 178.4 45.63 0.07 OUTLIER Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.011 -1.09 . . . . 13.25 112.94 -176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.717 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -75.7 -177.95 3.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.21 0.528 . . . . 16.35 112.029 -178.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.2 tp -136.17 112.34 9.75 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.533 -0.758 . . . . 18.22 109.147 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.1 -169.37 19.76 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 115.406 -0.816 . . . . 17.91 111.234 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.2 m -84.89 75.09 10.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 122.491 1.138 . . . . 17.11 109.47 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.717 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 2.1 m -155.36 168.75 26.05 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.641 -1.618 . . . . 14.73 106.758 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 5.1 tt0 -143.43 116.59 8.94 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 118.803 0.729 . . . . 14.94 109.835 163.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -134.79 160.54 37.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.549 0.214 . . . . 10.57 111.36 -172.015 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.619 HD23 HG11 ' A' ' 84' ' ' VAL . 5.0 mp -91.69 116.69 29.09 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.137 -0.69 . . . . 8.88 109.137 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.5 mm? -96.41 131.86 42.54 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.806 0.336 . . . . 9.78 111.388 -173.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.02 150.78 54.05 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 108.842 -0.799 . . . . 6.4 108.842 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HG2' HG11 ' A' ' 149' ' ' VAL . 50.8 Cg_exo -59.19 133.1 50.71 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 121.839 1.693 . . . . 6.55 110.704 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.463 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 22.9 t -61.45 -31.21 71.16 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.501 -0.318 . . . . 9.29 110.997 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -74.67 -5.25 42.09 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 121.372 -0.131 . . . . 10.86 111.043 179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -73.57 -39.76 64.44 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.274 0.559 . . . . 5.34 109.984 176.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 109' ' ' THR . 74.5 mt -65.13 148.1 52.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.67 -1.15 . . . . 6.97 113.034 -170.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.8 mp -99.54 127.49 52.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.755 -1.111 . . . . 10.2 108.433 170.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 104' ' ' ARG . 16.3 mmt180 -104.72 123.46 47.67 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 119.909 -0.717 . . . . 12.12 110.811 175.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -146.58 138.99 25.03 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.432 -0.804 . . . . 14.61 109.691 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 50.98 -118.33 6.38 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.292 -0.48 . . . . 15.52 112.776 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.7 36.89 4.44 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.19 0.519 . . . . 14.99 110.949 178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -148.22 173.93 12.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.964 -0.562 . . . . 15.2 111.581 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.506 HG21 HD13 ' A' ' 102' ' ' LEU . 5.8 m -121.77 146.45 47.04 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.039 -0.528 . . . . 9.26 109.87 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.565 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 26.3 mm -131.13 148.41 32.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.891 0.377 . . . . 10.55 110.047 -177.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.623 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -116.55 159.64 21.82 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.474 -0.565 . . . . 7.39 109.474 173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.449 ' HG2' ' HB3' ' A' ' 120' ' ' PHE . 58.8 ttp -125.75 100.78 6.56 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.545 -0.909 . . . . 8.85 108.545 174.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 14.4 p -80.89 129.03 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.363 0.601 . . . . 9.69 111.715 -168.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.491 ' HB2' HG21 ' A' ' 81' ' ' THR . . . -79.13 84.53 5.1 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.878 -1.056 . . . . 10.7 109.991 176.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -67.5 141.2 56.99 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.84 -0.618 . . . . 14.88 110.989 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.37 -2.21 40.43 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.627 -0.989 . . . . 16.92 110.627 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -83.57 6.54 20.23 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 114.932 -0.634 . . . . 18.56 111.123 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.84 6.01 70.39 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.41 -0.814 . . . . 15.62 113.241 173.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.9 175.41 20.85 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 14.19 112.486 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 85.5 m-85 -127.05 122.28 33.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.658 -0.497 . . . . 12.03 109.658 -178.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 113' ' ' VAL . 20.4 t70 -116.29 134.43 22.82 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 116.145 -0.479 . . . . 13.91 111.968 -174.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 3.1 Cg_endo -77.56 136.33 15.43 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.987 1.791 . . . . 12.35 112.505 177.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.94 123.76 64.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.806 -0.634 . . . . 9.43 109.8 -179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.0 tt0 -75.56 121.19 22.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.294 -0.632 . . . . 12.93 109.294 176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.54 HG11 ' HG ' ' A' ' 141' ' ' LEU . 27.3 m -128.45 163.7 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.199 0.523 . . . . 8.03 111.608 -173.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HG2' HD22 ' A' ' 138' ' ' LEU . 40.3 ttmt -102.88 126.18 49.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.008 -0.738 . . . . 10.39 109.008 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.453 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -140.57 104.03 4.66 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 116.1 -0.5 . . . . 8.3 110.998 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.496 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -154.2 71.19 0.28 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 117.922 -2.085 . . . . 10.1 114.968 169.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.696 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -147.68 162.52 38.99 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 107.054 -1.461 . . . . 10.61 107.054 150.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.3 m -134.15 129.52 35.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 118.694 0.679 . . . . 13.17 110.449 175.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.16 126.01 11.94 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.306 -0.407 . . . . 12.98 111.378 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.11 33.96 88.65 Favored Glycine 0 N--CA 1.453 -0.186 0 CA-C-N 116.113 -0.494 . . . . 14.34 112.885 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.04 11.23 81.51 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.832 -0.699 . . . . 13.12 112.05 -178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.35 170.99 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.317 -0.623 . . . . 10.62 109.317 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.463 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.3 p -119.28 143.66 47.21 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.04 0.447 . . . . 7.82 110.907 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 1.3 mp0 -85.87 122.0 29.32 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.822 -0.626 . . . . 10.79 111.584 175.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.492 HD11 HD21 ' A' ' 102' ' ' LEU . 19.5 mm -88.03 109.33 19.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.52 -0.764 . . . . 6.73 109.112 169.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.496 HD13 ' H ' ' A' ' 128' ' ' GLY . 1.3 mp -76.03 -52.17 10.77 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.379 -1.282 . . . . 8.79 109.264 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -144.74 170.83 15.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.688 -0.687 . . . . 10.44 110.322 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 109.85 -59.54 0.35 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.37 -0.919 . . . . 8.87 113.394 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.54 ' HG ' HG11 ' A' ' 125' ' ' VAL . 17.9 mt -96.83 -172.66 2.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.14 0.495 . . . . 8.5 111.828 -176.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.43 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 63.7 tttm -149.77 154.89 39.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.398 -0.819 . . . . 14.15 109.212 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 84' ' ' VAL . . . -67.8 127.16 31.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.641 -0.708 . . . . 12.12 110.274 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.6 -8.35 28.14 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.033 -0.827 . . . . 11.54 111.033 -171.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.535 ' O ' HG23 ' A' ' 84' ' ' VAL . 32.5 mm-40 -97.27 116.63 29.83 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.343 -0.614 . . . . 11.24 109.343 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.559 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 22.1 mt-30 -91.29 135.67 33.64 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.754 -0.657 . . . . 10.49 111.549 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 149' ' ' VAL . 2.5 p -127.97 138.12 55.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.756 -0.461 . . . . 5.45 109.756 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 80' ' ' ARG . 33.5 m -62.71 134.55 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 O-C-N 123.442 0.464 . . . . 6.56 110.531 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.554 HG12 ' HB2' ' A' ' 101' ' ' ALA . 13.2 m -119.94 -58.09 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 113.332 0.864 . . . . 6.99 113.332 -170.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.609 ' O ' ' HG3' ' A' ' 80' ' ' ARG . 22.9 t 158.21 170.72 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 108.357 -0.979 . . . . 9.06 108.357 -178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 151.86 134.49 2.13 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.505 -0.855 . . . . 8.5 112.552 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -109.49 102.8 11.63 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.493 -0.558 . . . . 11.84 109.493 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.453 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 70.5 m-85 -109.41 -13.56 14.57 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.334 -0.394 . . . . 12.24 110.724 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.5 mt 67.25 -177.58 0.2 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.707 -0.679 . . . . 13.16 110.923 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 21.2 mt 62.72 52.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-O 121.997 0.904 . . . . 11.95 109.002 -175.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -82.6 -28.18 31.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.038 -0.983 . . . . 11.22 111.441 -176.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.6 m -59.24 -31.49 69.11 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.424 -1.262 . . . . 11.9 111.539 -169.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -62.66 -30.67 71.55 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 114.188 -1.369 . . . . 11.17 111.003 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.88 -25.68 40.57 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.656 -0.702 . . . . 7.82 110.525 -178.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.5 m -80.79 -17.2 51.63 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.236 -0.438 . . . . 9.64 110.076 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.431 ' HB2' HH11 ' A' ' 162' ' ' ARG . 90.8 mt -65.53 -48.82 71.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.206 -0.664 . . . . 10.57 109.206 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.431 HH11 ' HB2' ' A' ' 161' ' ' LEU . 9.6 mpt_? -76.02 -173.33 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.444 -0.798 . . . . 8.9 109.968 175.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.44 -50.39 4.4 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.779 -0.724 . . . . 7.15 112.649 174.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.467 ' HA ' HG11 ' A' ' 67' ' ' VAL . 20.4 p -80.98 -86.17 0.09 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.309 . . . . 7.09 110.993 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 60.0 t -116.7 91.08 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.541 -0.54 . . . . 9.2 109.541 177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.95 155.77 3.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.886 -0.597 . . . . 9.11 110.572 -176.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.448 ' NE ' ' H ' ' A' ' 168' ' ' MET . 0.0 OUTLIER -120.35 -109.14 0.35 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.486 -0.486 . . . . 14.58 111.674 170.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.448 ' H ' ' NE ' ' A' ' 167' ' ' ARG . 26.0 mtm 58.2 16.62 4.05 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.508 0.723 . . . . 11.94 112.441 173.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 62.12 81.44 0.2 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.833 0.825 . . . . 14.99 109.38 -172.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -62.29 -39.99 94.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.952 -1.476 . . . . 15.01 111.935 -172.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.3 p -131.4 93.11 3.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.819 0.342 . . . . 14.25 111.019 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 13.5 t -150.57 170.7 18.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.144 0.497 . . . . 14.89 110.849 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 34.7 t -149.48 -8.31 0.33 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.398 -0.819 . . . . 15.85 110.248 175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -91.23 32.77 5.03 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.85 -0.691 . . . . 17.54 112.139 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 175' ' ' LEU . 2.6 pt? -86.15 148.59 25.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 121.405 0.621 . . . . 17.85 110.275 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 50.99 43.83 28.75 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 113.829 -1.532 . . . . 19.67 112.837 171.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.19 103.79 15.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.486 -0.324 . . . . 19.52 110.494 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 53.8 tp -153.44 -41.97 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.437 -0.347 . . . . 21.15 110.8 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -163.29 144.61 9.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.665 -0.494 . . . . 23.25 109.665 175.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.51 -0.757 . . . . 23.52 110.349 178.065 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 120.698 0.285 . . . . 34.32 110.706 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.68 48.81 0.73 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.934 -0.867 . . . . 33.09 110.934 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -62.85 -20.65 65.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.663 0.268 . . . . 34.12 111.658 -174.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.82 -6.95 41.68 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.727 0.299 . . . . 32.32 111.393 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 p -117.24 21.49 13.11 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.906 0.384 . . . . 32.74 111.924 -177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.3 m -114.86 124.68 71.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.351 0.596 . . . . 31.29 110.815 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -74.72 -24.77 58.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.451 -0.795 . . . . 29.46 110.443 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.04 -172.29 44.67 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.197 -0.761 . . . . 28.28 111.197 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.34 157.05 52.35 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.397 2.065 . . . . 27.51 112.64 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -76.2 92.9 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.011 0.434 . . . . 26.48 110.308 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -116.35 -56.44 2.3 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.018 -0.537 . . . . 24.9 109.845 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.93 -70.21 2.32 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.896 -0.668 . . . . 23.19 113.943 170.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -102.05 -179.5 4.02 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.999 0.428 . . . . 21.31 112.069 -170.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.76 156.73 72.75 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.867 -0.606 . . . . 19.89 110.14 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.36 -79.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.307 2.005 . . . . 18.12 113.027 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 61.89 27.53 16.76 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.307 0.643 . . . . 16.58 112.094 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.21 63.26 0.66 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.965 0.412 . . . . 14.8 111.237 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.15 -130.27 6.72 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.724 -0.75 . . . . 13.17 112.198 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 61.86 17.61 9.02 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 123.5 0.72 . . . . 12.17 112.226 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 28.7 tt0 60.4 69.04 0.72 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.737 -1.12 . . . . 13.82 110.348 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 34.8 mt 73.77 -42.24 0.51 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.932 -1.031 . . . . 12.13 111.758 -178.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 60.0 tttp 70.43 -63.67 0.39 Allowed 'General case' 0 N--CA 1.463 0.219 0 O-C-N 123.72 0.638 . . . . 14.1 111.485 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 15.0 t -130.47 -179.27 5.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.493 -0.321 . . . . 11.05 110.385 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 -56.91 0.5 Allowed Glycine 0 CA--C 1.498 -1.029 0 N-CA-C 110.972 -0.851 . . . . 10.05 110.972 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.692 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -167.22 63.3 0.08 Allowed 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 122.561 1.172 . . . . 10.38 109.76 178.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.607 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.1 mtp180 -135.71 135.19 39.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.196 -1.366 . . . . 8.37 108.986 177.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.602 HG12 ' CG ' ' A' ' 58' ' ' GLU . 23.3 mm -57.43 115.22 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 122.433 1.111 . . . . 5.76 112.173 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.9 mt -118.97 -35.42 3.65 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 112.773 -2.012 . . . . 8.22 110.679 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.692 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 19.8 p90 -168.82 179.07 4.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.059 -0.519 . . . . 7.99 109.704 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.669 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.5 m-90 -117.29 164.3 15.02 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.185 -0.461 . . . . 5.61 111.523 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -145.31 177.22 8.97 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.36 -0.836 . . . . 9.06 110.204 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.806 ' HB3' HG22 ' A' ' 35' ' ' VAL . 12.0 t70 -124.13 138.43 30.74 Favored Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 107.845 -1.168 . . . . 8.31 107.845 170.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -60.3 -14.2 28.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.451 2.101 . . . . 10.41 112.738 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -101.43 -2.09 31.66 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.123 0.416 . . . . 10.85 112.123 175.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.806 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.0 m -125.45 38.28 0.4 Allowed Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 113.58 0.956 . . . . 9.32 113.58 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 29.6 Cg_endo -58.49 133.3 53.72 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.305 2.003 . . . . 11.1 112.518 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.78 -6.3 29.46 Favored Glycine 0 N--CA 1.452 -0.251 0 N-CA-C 111.272 -0.731 . . . . 10.31 111.272 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.703 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -87.54 179.38 6.56 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.194 -0.669 . . . . 9.21 109.194 177.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.505 ' N ' ' HG2' ' A' ' 38' ' ' GLN . 4.5 tmm_? -157.0 93.29 1.33 Allowed 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.785 -0.82 . . . . 11.51 108.785 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.703 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 91.3 m-85 -73.71 142.24 46.36 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.071 0.462 . . . . 7.5 109.99 -178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -64.27 -30.58 71.63 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.886 -1.052 . . . . 10.61 110.273 -175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -165.15 164.39 12.77 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.699 -0.682 . . . . 10.91 111.586 -177.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.669 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 12.1 Cg_endo -50.73 170.21 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.689 2.926 . . . . 7.51 113.313 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 144.01 -159.34 27.63 Favored Glycine 0 CA--C 1.508 -0.383 0 C-N-CA 120.24 -0.981 . . . . 7.59 112.735 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 3.0 ttmm -95.3 144.33 25.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.335 -0.617 . . . . 11.68 109.335 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.548 ' OG ' ' HG3' ' A' ' 49' ' ' MET . 25.0 p -64.56 145.02 98.71 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 114.883 -1.053 . . . . 9.2 111.873 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.24 -22.2 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.258 1.972 . . . . 10.25 112.904 175.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -86.31 -15.83 39.37 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-O 122.41 1.1 . . . . 10.49 110.068 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.548 ' HG3' ' OG ' ' A' ' 46' ' ' SER . 0.2 OUTLIER -145.16 -164.06 1.85 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 113.506 -1.679 . . . . 10.38 109.012 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 5.7 p-10 -133.21 57.15 1.82 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.614 0.721 . . . . 12.54 110.781 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 8.9 ptm -133.35 142.93 46.03 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 115.134 -0.939 . . . . 9.87 108.954 178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.09 132.13 37.8 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.617 1.545 . . . . 9.51 110.658 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.26 164.2 5.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.341 0.591 . . . . 6.71 111.854 -174.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 42.4 mm -106.72 130.8 22.36 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.726 -0.842 . . . . 7.89 108.726 -177.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.24 136.83 35.41 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.855 1.703 . . . . 5.77 112.405 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 27.1 m -63.18 160.39 2.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.64 -1.164 . . . . 5.96 112.419 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.692 ' CD1' ' HA ' ' A' ' 25' ' ' LYS . 0.5 OUTLIER 7.13 -66.04 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 127.476 2.31 . . . . 7.84 116.054 177.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.602 ' CG ' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -62.57 -48.32 79.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.236 1.017 . . . . 6.62 110.352 -171.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.401 ' H ' HD11 ' A' ' 27' ' ' ILE . 12.2 pt-20 38.99 43.47 0.78 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 112.532 -2.122 . . . . 8.58 113.37 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' H ' ' HG3' ' A' ' 58' ' ' GLU . 40.0 tt0 -178.23 59.54 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.235 -1.348 . . . . 7.64 110.586 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -147.57 -39.0 0.19 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.51 -1.223 . . . . 7.02 109.7 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.54 -14.51 62.41 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.08 -0.964 . . . . 5.41 110.126 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.612 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.0 t70 -84.83 9.89 13.0 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.309 -0.859 . . . . 7.01 109.681 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.88 -51.16 4.53 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.009 -0.996 . . . . 7.2 111.105 -178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.76 30.57 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.881 -0.659 . . . . 7.82 110.101 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.28 32.02 20.63 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.756 0.789 . . . . 8.65 109.726 -172.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 63' ' ' ASP . 8.4 p -72.78 -51.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.718 -1.128 . . . . 7.31 110.766 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' N ' HG13 ' A' ' 67' ' ' VAL . 29.0 mtm180 -66.62 -70.82 0.22 Allowed 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 114.52 -1.218 . . . . 10.21 110.242 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.429 ' C ' ' H ' ' A' ' 71' ' ' GLY . 12.0 mt -102.15 157.55 4.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 113.545 -1.661 . . . . 8.86 110.966 -175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' N ' HG22 ' A' ' 69' ' ' ILE . 38.3 t70 -76.49 36.68 0.16 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.436 -0.802 . . . . 13.02 111.469 -178.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 69' ' ' ILE . . . 55.33 21.03 24.97 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.155 -0.929 . . . . 12.13 112.596 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' O ' HG22 ' A' ' 74' ' ' THR . 13.1 ptm180 -93.13 174.0 7.44 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 120.872 0.368 . . . . 12.38 110.457 -173.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 74' ' ' THR . 2.6 p -17.73 -57.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 125.794 1.934 . . . . 11.61 115.384 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.57 ' H ' HG13 ' A' ' 73' ' ' VAL . 10.1 t 34.26 62.89 0.45 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.332 1.053 . . . . 10.71 112.885 -173.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -81.19 67.07 6.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.407 -0.815 . . . . 14.09 109.392 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.516 ' OD1' ' HG3' ' A' ' 152' ' ' GLN . 13.0 m120 -136.4 165.43 25.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.17 -0.923 . . . . 11.22 109.104 -177.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.59 10.07 33.14 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 13.71 110.153 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 113.67 14.47 9.49 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 114.843 -1.071 . . . . 11.44 110.445 -173.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.9 t 60.39 74.08 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 CA-C-O 121.881 0.848 . . . . 9.99 110.083 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -81.78 151.83 27.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.977 -1.011 . . . . 11.64 109.039 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 148' ' ' VAL . 82.5 p -127.92 177.86 6.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.367 0.603 . . . . 8.0 110.253 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.414 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -140.88 126.36 18.83 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.102 -1.073 . . . . 6.65 108.102 171.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 34.4 tt0 -79.02 139.39 38.18 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.639 -0.504 . . . . 12.15 109.639 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' A' ' 95' ' ' LEU . 53.3 t -62.03 133.3 27.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.33 0.585 . . . . 9.71 112.395 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -137.47 150.57 47.69 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.452 -1.249 . . . . 11.03 108.393 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 8.1 mp -77.53 147.99 35.49 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.148 -0.686 . . . . 12.76 109.148 169.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.73 40.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.316 -0.945 . . . . 13.25 112.938 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 92' ' ' THR . 2.4 ptt180 -63.44 126.3 27.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.161 0.505 . . . . 16.35 111.423 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -120.36 84.06 2.16 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.267 -0.642 . . . . 18.22 109.267 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 88.33 -1.62 84.47 Favored Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 109.68 -1.368 . . . . 17.91 109.68 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 8.4 p -110.69 -178.65 3.54 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 114.138 -1.031 . . . . 17.11 110.397 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 88' ' ' ARG . 5.6 m -76.61 159.95 29.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.508 -0.553 . . . . 14.73 109.508 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 11.1 mt-10 -59.16 97.79 0.04 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 121.685 0.755 . . . . 14.94 110.668 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 137' ' ' ILE . 0.0 OUTLIER -112.62 170.21 8.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.435 -1.257 . . . . 10.57 110.384 -173.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -100.75 113.38 26.22 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.953 -0.758 . . . . 8.88 108.953 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -89.74 129.5 36.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.296 0.57 . . . . 9.78 110.868 -175.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 134' ' ' GLN . 34.1 m -142.41 161.65 48.96 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 114.858 -1.064 . . . . 6.4 108.409 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.88 134.79 55.52 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.707 1.605 . . . . 6.55 110.5 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.5 p -67.28 -24.63 65.8 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.103 -0.373 . . . . 9.29 110.984 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -90.96 7.26 41.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.512 -0.313 . . . . 10.86 111.153 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.438 ' HB2' HG22 ' A' ' 149' ' ' VAL . . . -84.9 -40.68 16.76 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.084 0.468 . . . . 5.34 110.615 176.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 4.0 pp -83.18 162.36 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.608 -0.723 . . . . 6.97 111.572 -173.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 18.7 mm -104.63 119.81 54.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.524 -0.762 . . . . 10.2 109.997 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -96.13 120.75 36.98 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.629 -0.828 . . . . 12.12 109.97 172.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 t -147.3 140.59 25.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.955 -0.566 . . . . 14.61 110.36 -178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 56.88 -112.63 3.64 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.131 -0.557 . . . . 15.52 112.556 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.96 29.38 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.823 0.305 . . . . 14.99 111.823 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.416 ' NH1' HD11 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -162.41 -176.82 5.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.116 0.484 . . . . 15.2 111.464 -174.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.555 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 46.7 m -125.43 147.94 49.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.725 -0.671 . . . . 9.26 110.572 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.47 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 30.9 mm -124.82 151.79 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.351 -0.611 . . . . 10.55 109.351 176.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -136.43 134.17 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 122.49 -0.131 . . . . 7.39 110.667 177.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.437 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 38.5 mtm -93.98 101.46 13.52 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 8.85 109.432 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 9.5 p -85.32 138.45 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 9.69 111.329 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -75.06 95.3 3.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.07 -0.513 . . . . 10.7 110.937 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -80.02 163.3 24.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.245 0.545 . . . . 14.88 110.454 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.52 15.15 47.81 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.417 -0.811 . . . . 16.92 111.406 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.26 11.6 39.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.449 0.642 . . . . 18.56 110.619 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 85.28 11.9 74.52 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.158 -0.928 . . . . 15.62 113.516 174.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -141.88 168.04 25.76 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 120.578 -0.82 . . . . 14.19 112.203 -177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 80.7 m-85 -110.18 109.86 20.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.533 -0.543 . . . . 12.03 109.533 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 9.3 t70 -92.6 140.58 23.96 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.781 -0.645 . . . . 13.91 110.772 -170.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 121' ' ' ASP . 19.4 Cg_endo -84.2 127.88 4.1 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.196 1.93 . . . . 12.35 112.71 -177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 125' ' ' VAL . 1.8 t -115.48 129.05 72.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.119 -0.946 . . . . 9.43 109.351 177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 110' ' ' ILE . 43.0 tt0 -73.03 120.86 19.25 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.37 -0.604 . . . . 12.93 109.37 171.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.753 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -132.48 159.26 43.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.411 0.624 . . . . 8.03 111.212 -174.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.0 ttmm -103.94 129.32 51.49 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.225 -0.898 . . . . 10.39 109.647 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.55 114.83 8.79 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.712 -0.222 . . . . 8.3 111.303 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.428 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.21 70.72 0.29 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 117.818 -2.134 . . . . 10.1 114.251 168.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.862 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -150.24 164.62 35.26 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.268 -1.012 . . . . 10.61 108.268 154.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 17.0 m -143.61 126.75 16.51 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 118.308 0.504 . . . . 13.17 110.086 170.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.21 118.95 6.13 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.975 -0.557 . . . . 12.98 111.336 -174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.27 36.24 92.54 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 121.231 -0.509 . . . . 14.34 112.697 175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.32 20.96 80.02 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.559 -0.829 . . . . 13.12 111.618 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 97' ' ' VAL . 38.3 mt-30 -128.49 170.49 13.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.365 -0.606 . . . . 10.62 109.365 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 35.5 t -125.12 156.82 37.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.604 -0.517 . . . . 7.82 109.604 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.862 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 46.6 mt-10 -101.06 112.97 25.57 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.664 0.745 . . . . 10.79 110.577 175.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.753 HD12 HG21 ' A' ' 125' ' ' VAL . 24.5 mm -79.87 106.53 11.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.741 -1.118 . . . . 6.73 109.641 176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.49 ' HA ' ' CD ' ' A' ' 94' ' ' ARG . 2.4 mp -70.48 -49.67 46.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.885 -1.052 . . . . 8.79 109.878 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 125' ' ' VAL . 41.0 mt-10 -141.75 165.6 27.04 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-N 115.814 -0.63 . . . . 10.44 109.528 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.578 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 116.95 -67.42 0.31 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.683 -1.246 . . . . 8.87 113.593 175.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -98.32 -174.97 2.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.078 0.466 . . . . 8.5 112.16 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.434 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 38.4 ttpt -149.32 154.97 39.79 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.558 -0.746 . . . . 14.15 109.748 -176.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.33 131.49 45.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.487 -0.779 . . . . 12.12 110.1 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 104.35 -7.72 47.48 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.948 -0.861 . . . . 11.54 110.948 -172.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.584 ' HA ' HE21 ' A' ' 145' ' ' GLN . 0.0 OUTLIER -100.8 119.07 38.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.812 -0.81 . . . . 11.24 108.812 177.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 3.7 pt20 -104.88 132.27 51.34 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.686 0.755 . . . . 10.49 109.676 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 149' ' ' VAL . 17.1 m -116.38 153.01 18.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.439 -1.255 . . . . 5.45 110.025 -172.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 81' ' ' THR . 27.3 m -57.62 134.66 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.44 0.638 . . . . 6.56 111.413 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 147' ' ' VAL . 43.1 t -129.7 -37.45 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.092 -0.958 . . . . 6.99 111.029 -173.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -135.9 53.27 1.95 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.043 -0.526 . . . . 9.06 109.891 175.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -133.48 -169.15 12.05 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.633 -0.712 . . . . 8.5 112.043 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.516 ' HG3' ' OD1' ' A' ' 76' ' ' ASN . 95.4 mt-30 -78.9 95.5 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.811 0.338 . . . . 11.84 110.63 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -94.55 -10.27 32.64 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.273 -0.421 . . . . 12.24 110.334 176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 28.8 tp -70.92 -57.07 4.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.124 0.488 . . . . 13.16 109.755 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 7.6 tt -118.19 112.97 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.567 -0.742 . . . . 11.95 110.449 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -76.26 -23.33 54.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.073 -0.512 . . . . 11.22 110.718 -176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.481 ' O ' ' HG ' ' A' ' 161' ' ' LEU . 9.3 m -56.14 -54.87 39.96 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.203 0.525 . . . . 11.9 110.92 -178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 162' ' ' ARG . 34.9 mm-40 -59.4 -40.0 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.274 -0.876 . . . . 11.17 110.895 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.212 -0.904 . . . . 7.82 111.657 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.8 m -79.55 -28.95 41.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.401 0.619 . . . . 9.64 110.431 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 157' ' ' SER . 71.8 mt -83.16 -28.29 29.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.517 -0.765 . . . . 10.57 110.561 -176.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 158' ' ' GLU . 20.1 mtp180 -70.53 146.13 50.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.331 -0.85 . . . . 8.9 112.404 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -176.08 23.98 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.783 -1.098 . . . . 7.15 111.888 169.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.8 p 46.99 88.44 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.751 0.821 . . . . 7.09 112.964 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 18.6 t 59.84 66.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-O 121.558 0.694 . . . . 9.2 109.587 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -112.6 92.33 3.98 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.621 -0.718 . . . . 9.11 110.875 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.673 ' O ' ' HD3' ' A' ' 167' ' ' ARG . 0.1 OUTLIER -84.7 8.59 16.5 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.868 0.842 . . . . 14.58 109.916 177.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.518 ' SD ' HG23 ' A' ' 171' ' ' THR . 0.0 OUTLIER -156.62 -178.37 7.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.695 -1.138 . . . . 11.94 108.955 177.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 7.25 6.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.318 0.58 . . . . 14.99 109.977 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 168' ' ' MET . 10.0 pt-20 -95.53 36.15 1.29 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.618 -0.719 . . . . 15.01 112.506 -166.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.518 HG23 ' SD ' ' A' ' 168' ' ' MET . 16.4 p -103.95 -22.53 13.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.86 0.362 . . . . 14.25 111.894 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 t -88.3 -50.3 6.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.38 -0.373 . . . . 14.89 111.517 -176.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 92.1 p -120.62 -5.09 9.75 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.693 -0.231 . . . . 15.85 111.139 176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -57.28 -35.76 72.52 Favored Glycine 0 C--N 1.329 0.159 0 C-N-CA 120.952 -0.642 . . . . 17.54 112.417 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.511 ' H ' HD23 ' A' ' 175' ' ' LEU . 2.1 pt? -130.41 41.69 3.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.425 0.631 . . . . 17.85 109.541 176.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' A' ' 177' ' ' VAL . 9.4 tt0 65.27 177.0 0.2 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.697 -1.138 . . . . 19.67 109.901 -175.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.516 ' H ' ' HG2' ' A' ' 176' ' ' GLU . 9.9 p -124.9 -7.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.363 0.602 . . . . 19.52 111.172 -177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 55.7 tp -115.05 -44.67 3.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.084 -0.507 . . . . 21.15 110.674 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -57.87 134.69 56.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.469 . . . . 23.25 110.905 177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--O 1.247 0.923 0 CA-C-O 118.747 -0.644 . . . . 23.52 109.799 179.089 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 109.953 -0.388 . . . . 34.32 109.953 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 3' ' ' SER . . . -105.48 -153.26 21.31 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.835 -0.698 . . . . 33.09 112.121 -179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 2' ' ' GLY . 38.4 t 74.46 -53.93 0.67 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.3 0.64 . . . . 34.12 111.015 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.51 141.42 51.39 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.814 -0.439 . . . . 32.32 109.814 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -77.63 66.76 3.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.265 0.555 . . . . 32.74 110.795 -178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 m -104.91 151.12 7.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.739 -0.664 . . . . 31.29 110.453 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -98.34 144.86 27.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.955 -0.566 . . . . 29.46 110.502 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.34 -155.19 25.59 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.593 -0.813 . . . . 28.28 112.15 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.03 -74.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.987 2.458 . . . . 27.51 111.517 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -153.71 53.41 0.72 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.608 0.718 . . . . 26.48 109.865 -176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -98.7 88.63 4.11 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.988 -1.005 . . . . 24.9 109.963 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.41 143.15 27.95 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.8 -0.714 . . . . 23.19 112.203 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.466 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 30.2 m80 -119.83 48.98 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.144 0.497 . . . . 21.31 110.03 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -100.79 101.4 15.52 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.605 -0.725 . . . . 19.89 109.712 176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 13' ' ' HIS . 4.8 Cg_exo -76.81 86.0 1.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.97 2.447 . . . . 18.12 112.02 -179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.61 -28.61 58.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.908 -0.587 . . . . 16.58 110.64 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.27 96.39 1.11 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.077 -0.511 . . . . 14.8 110.348 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 25' ' ' LYS . . . 129.35 -99.07 0.46 Allowed Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 111.055 -0.818 . . . . 13.17 111.055 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.436 ' HB3' ' HA3' ' A' ' 24' ' ' GLY . . . 63.67 -63.32 0.14 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.042 0.937 . . . . 12.17 112.692 178.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 63.02 63.84 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 122.076 0.941 . . . . 13.82 111.489 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.24 -100.19 0.12 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.25 -1.341 . . . . 12.13 109.968 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -92.36 -40.7 10.75 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.389 0.614 . . . . 14.1 109.705 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.9 m -149.9 149.88 31.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.539 -0.755 . . . . 11.05 109.475 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 19' ' ' ALA . . . 161.63 -44.26 0.38 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.923 -0.656 . . . . 10.05 111.777 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.624 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.0 OUTLIER -150.14 52.61 0.91 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 122.963 1.363 . . . . 10.38 108.555 177.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 9.3 mmm180 -113.41 140.06 48.38 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 113.752 -1.567 . . . . 8.37 109.476 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.975 ' HB ' ' HB2' ' A' ' 62' ' ' ALA . 11.9 mm -52.49 121.4 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 O-C-N 123.937 0.773 . . . . 5.76 112.661 -170.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 75' ' ' GLN . 2.8 mm? -96.16 -37.43 10.58 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.177 -1.374 . . . . 8.22 110.284 172.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 29.8 p90 -172.24 -175.63 1.46 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.162 0.506 . . . . 7.99 111.125 -176.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.689 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.29 154.25 35.24 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.14 -0.936 . . . . 5.61 110.627 -177.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -162.91 148.98 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.567 0.542 . . . . 9.06 110.447 -176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.607 ' HB2' HG22 ' A' ' 35' ' ' VAL . 0.6 OUTLIER -69.77 137.61 87.89 Favored Pre-proline 0 CA--C 1.514 -0.413 0 N-CA-C 108.386 -0.968 . . . . 8.31 108.386 169.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -62.01 -11.84 23.41 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.393 2.062 . . . . 10.41 110.77 168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -98.76 1.33 45.91 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.613 -0.721 . . . . 10.85 111.215 177.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.607 HG22 ' HB2' ' A' ' 32' ' ' ASP . 10.3 m -130.98 49.86 5.32 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 121.238 0.542 . . . . 9.32 112.03 176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -50.05 121.13 7.02 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.781 2.321 . . . . 11.1 112.584 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.34 -25.86 11.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.82 -0.705 . . . . 10.31 112.421 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.604 ' HB3' HG23 ' A' ' 35' ' ' VAL . 21.0 tp60 -69.43 105.98 2.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.415 0.626 . . . . 9.21 111.004 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.734 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 45.2 ttp180 -89.61 101.28 13.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.343 -0.844 . . . . 11.51 110.521 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 72.0 m-85 -82.94 147.24 28.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.614 -0.721 . . . . 7.5 110.252 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.83 -25.63 68.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.396 -1.275 . . . . 10.61 111.406 -175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.485 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 53.8 pttt -172.46 164.62 3.84 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.335 -0.393 . . . . 10.91 111.3 -179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.689 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.0 Cg_endo -50.7 170.06 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.729 2.952 . . . . 7.51 113.626 176.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.16 -166.03 26.83 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.692 -0.766 . . . . 7.59 112.421 178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 5.3 ttmm -93.21 141.56 28.29 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.059 -0.719 . . . . 11.68 109.059 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 49' ' ' MET . 41.2 t -61.07 139.87 94.21 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.535 -0.757 . . . . 9.2 111.64 -178.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.19 -20.8 18.52 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.74 2.294 . . . . 10.25 111.468 171.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CD2' HG11 ' A' ' 35' ' ' VAL . 27.1 m-85 -87.67 -42.83 12.38 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.512 -1.222 . . . . 10.49 109.666 -176.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.579 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.3 mtm -133.92 155.28 50.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.34 -0.846 . . . . 10.38 111.965 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 10.1 p-10 -82.35 61.42 5.54 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.282 1.039 . . . . 12.54 110.834 176.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.408 ' HE2' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -131.96 143.39 48.84 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 114.732 -1.122 . . . . 9.87 109.392 173.362 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.75 132.9 32.06 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.178 1.252 . . . . 9.51 109.218 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.0 mt -61.44 158.69 14.21 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.029 -0.268 . . . . 6.71 110.681 -175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.95 130.51 24.96 Favored Pre-proline 0 C--N 1.314 -0.961 0 CA-C-O 121.217 0.532 . . . . 7.89 110.118 -175.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.484 ' HG2' ' HG3' ' A' ' 59' ' ' GLU . 88.2 Cg_endo -79.09 139.74 15.3 Favored 'Trans proline' 0 N--CA 1.443 -1.499 0 C-N-CA 122.135 1.89 . . . . 5.77 113.14 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.482 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 34.1 m -61.43 161.81 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 113.743 -1.571 . . . . 5.96 112.97 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.79 -84.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.049 2.14 . . . . 7.84 115.706 -178.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.624 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -48.6 -43.57 36.26 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.92 0.762 . . . . 6.62 111.421 -173.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 35.7 tt0 47.39 64.06 1.74 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 122.271 1.034 . . . . 8.58 109.655 -171.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' N ' ' HG3' ' A' ' 58' ' ' GLU . 45.4 mt-10 -142.79 35.07 1.41 Allowed 'General case' 0 CA--C 1.504 -0.805 0 CA-C-N 114.173 -1.376 . . . . 7.64 109.526 173.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' ASP . 66.4 t30 60.74 13.14 4.14 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 111.83 -2.441 . . . . 7.02 113.694 162.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.975 ' HB2' ' HB ' ' A' ' 27' ' ' ILE . . . 69.96 -7.14 0.97 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.061 -1.881 . . . . 5.41 112.017 176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 68' ' ' ARG . 11.1 t70 -162.7 -162.46 0.79 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.799 -1.091 . . . . 7.01 109.598 -174.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.468 ' H ' ' CG ' ' A' ' 63' ' ' ASP . . . -133.8 21.39 3.98 Favored Glycine 0 N--CA 1.44 -1.041 0 N-CA-C 111.012 -0.835 . . . . 7.2 111.012 -174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 62.97 39.4 10.31 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 124.159 0.564 . . . . 7.82 111.318 174.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.11 -45.34 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.6 -0.727 . . . . 8.65 110.33 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.55 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 4.5 t -72.52 -65.28 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 108.972 -0.751 . . . . 7.31 108.972 176.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.558 ' H ' ' CG ' ' A' ' 63' ' ' ASP . 7.7 mtt180 64.07 131.99 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.017 -1.447 . . . . 10.21 113.812 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.556 HG21 ' HG2' ' A' ' 72' ' ' ARG . 10.1 mt -67.8 153.32 8.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.425 -1.262 . . . . 8.86 111.005 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.76 48.22 1.3 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 13.02 110.855 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.44 32.33 80.69 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 115.63 -0.713 . . . . 12.13 112.252 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.556 ' HG2' HG21 ' A' ' 69' ' ' ILE . 1.4 ptt180 -104.44 129.11 52.43 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.042 -0.725 . . . . 12.38 109.042 176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 5.6 t -108.36 34.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 123.248 1.499 . . . . 11.61 108.318 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.53 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 2.9 t -133.59 76.88 1.69 Allowed 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 112.26 -2.246 . . . . 10.71 109.764 178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.417 ' H ' HD13 ' A' ' 28' ' ' LEU . 5.4 tp-100 -79.77 73.75 6.5 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.139 -0.937 . . . . 14.09 110.644 -177.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -137.43 107.14 6.21 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.038 -0.983 . . . . 11.22 109.48 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -74.5 -6.49 48.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.034 -1.439 . . . . 13.71 110.974 -174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -108.31 -12.79 20.88 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.087 -0.96 . . . . 11.44 112.063 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.5 t -138.49 91.56 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.923 0.868 . . . . 9.99 110.651 -172.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -101.93 118.06 36.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.947 -1.024 . . . . 11.64 108.429 175.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' A' ' 146' ' ' GLN . 77.0 p -108.74 139.17 43.92 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.447 -0.342 . . . . 8.0 110.526 -174.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -107.33 129.77 54.86 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.906 -0.776 . . . . 6.65 108.906 176.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 39.9 tt0 -76.04 134.79 40.0 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 116.237 -0.438 . . . . 12.15 110.065 -176.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 HG13 ' HB3' ' A' ' 95' ' ' LEU . 73.6 t -63.13 130.05 27.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.686 0.755 . . . . 9.71 110.958 178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -163.04 146.56 10.87 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.33 -1.305 . . . . 11.03 109.683 176.15 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.2 mp -72.13 161.33 31.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.572 -1.195 . . . . 12.76 111.091 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.47 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 171.06 55.09 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.432 -0.889 . . . . 13.25 112.82 -177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.576 ' HG2' ' HA ' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -90.62 -178.81 5.39 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 111.837 0.31 . . . . 16.35 111.837 -179.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.4 mt -135.25 108.21 7.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.595 -0.73 . . . . 18.22 109.365 170.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 129.56 -164.22 22.47 Favored Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.7 -0.682 . . . . 17.91 111.397 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.6 p -90.33 75.36 6.89 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 122.017 0.913 . . . . 17.11 110.047 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.473 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 1.6 m -155.58 167.34 30.7 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.247 -1.39 . . . . 14.73 107.247 173.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 4.6 mt-10 -141.44 114.44 8.58 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 118.228 0.467 . . . . 14.94 110.212 167.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 34.9 mmt180 -126.43 160.0 31.73 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.446 -0.343 . . . . 10.57 110.1 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.635 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.7 mm? -89.3 114.54 25.94 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.844 -0.799 . . . . 8.88 108.844 175.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -87.71 133.19 33.89 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.054 0.454 . . . . 9.78 111.365 -173.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 6.4 p -145.85 146.7 29.79 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.333 -0.849 . . . . 6.4 109.419 -177.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 97' ' ' VAL . 50.8 Cg_exo -56.6 130.77 41.76 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.338 2.025 . . . . 6.55 110.518 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 8.9 p -55.22 -24.35 26.93 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.134 0.79 . . . . 9.29 113.134 -172.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -90.4 6.84 41.54 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.854 -0.529 . . . . 10.86 111.929 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.542 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -82.16 -39.14 23.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.257 0.551 . . . . 5.34 110.629 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.505 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.7 pp -91.93 156.04 17.74 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.6 -0.727 . . . . 6.97 111.767 -173.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.449 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 27.1 mm -120.07 103.51 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 115.409 -0.814 . . . . 10.2 110.376 178.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 109' ' ' THR . 0.2 OUTLIER -109.3 98.23 7.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 118.581 -1.248 . . . . 12.12 112.166 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -107.44 142.98 36.43 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.896 -1.502 . . . . 14.61 109.386 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.36 -107.07 1.93 Allowed Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.59 -0.814 . . . . 15.52 112.23 179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -121.66 17.48 11.17 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.028 0.751 . . . . 14.99 113.028 -175.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.525 ' O ' ' HA ' ' A' ' 104' ' ' ARG . 17.5 ptt180 -160.0 166.61 29.66 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.129 0.788 . . . . 15.2 113.129 -174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.1 m -113.79 154.42 27.43 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.229 -0.896 . . . . 9.26 110.729 -177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 124' ' ' GLU . 32.8 mm -133.97 149.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.981 -0.554 . . . . 10.55 109.834 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -135.19 130.17 34.91 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.476 0.31 . . . . 7.39 110.289 177.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 37.6 ttp -84.24 100.2 11.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.737 -0.838 . . . . 8.85 108.737 174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 121' ' ' ASP . 13.6 p -87.77 134.48 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 115.602 -0.726 . . . . 9.69 111.736 -172.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.98 94.45 8.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.668 -0.696 . . . . 10.7 109.638 172.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -75.41 148.82 38.85 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.208 -0.451 . . . . 14.88 110.748 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.18 -0.71 30.27 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.592 -0.731 . . . . 16.92 111.991 177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -87.35 9.47 20.41 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.466 0.65 . . . . 18.56 110.59 176.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 84.77 10.69 78.63 Favored Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.282 -0.872 . . . . 15.62 113.295 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.65 160.77 23.89 Favored Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.436 -0.888 . . . . 14.19 112.475 -174.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 91.9 m-85 -112.3 126.57 55.4 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.814 -0.439 . . . . 12.03 109.814 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.468 ' O ' HG12 ' A' ' 113' ' ' VAL . 5.9 m-20 -129.24 150.69 76.16 Favored Pre-proline 0 C--N 1.325 -0.466 0 C-N-CA 120.968 -0.293 . . . . 13.91 111.495 -176.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -87.04 123.65 2.01 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.47 2.113 . . . . 12.35 112.147 175.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.614 HG12 ' HB3' ' A' ' 111' ' ' ALA . 6.1 p -108.98 134.67 50.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.349 -0.841 . . . . 9.43 110.015 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.519 ' HA ' HD13 ' A' ' 110' ' ' ILE . 34.1 tt0 -74.26 120.47 19.87 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.611 -0.514 . . . . 12.93 109.611 171.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.792 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -128.62 156.45 41.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.721 -0.672 . . . . 8.03 111.657 -175.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.8 ttmm -101.61 126.67 48.47 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.918 -1.037 . . . . 10.39 109.459 172.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.414 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -142.46 107.79 5.01 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.379 -0.373 . . . . 8.3 111.625 -176.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -152.48 71.01 0.29 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 117.684 -2.198 . . . . 10.1 114.539 169.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.861 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.57 163.04 38.94 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.494 -0.928 . . . . 10.61 108.494 154.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 m -137.93 128.28 26.24 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 118.12 0.418 . . . . 13.17 110.163 173.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.66 126.76 9.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.327 -0.397 . . . . 12.98 111.48 -177.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.85 24.59 74.29 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.194 -0.457 . . . . 14.34 112.498 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.47 14.45 81.37 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.61 -0.805 . . . . 13.12 111.388 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -119.21 171.09 8.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 109.528 -0.545 . . . . 10.62 109.528 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.513 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 6.2 p -119.13 154.17 33.68 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 116.405 -0.361 . . . . 7.82 110.222 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.861 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 51.8 mt-10 -100.83 124.53 46.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.438 0.637 . . . . 10.79 111.4 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.792 HD12 HG21 ' A' ' 125' ' ' VAL . 20.2 mm -88.86 112.16 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.183 -0.917 . . . . 6.73 109.908 174.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.572 ' HA ' ' HD2' ' A' ' 94' ' ' ARG . 1.8 mp -79.18 -44.99 20.79 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.603 -1.181 . . . . 8.79 109.649 -178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' VAL . 39.6 mt-10 -146.04 166.71 25.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.824 -0.626 . . . . 10.44 109.318 177.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.55 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 120.42 -70.47 0.37 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.798 -1.191 . . . . 8.87 113.528 176.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.6 mt -97.52 -179.19 4.39 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.382 0.611 . . . . 8.5 112.306 -174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -137.55 151.79 48.75 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.954 -1.021 . . . . 14.15 109.732 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.475 ' HA ' HG12 ' A' ' 84' ' ' VAL . . . -69.11 135.79 51.27 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.842 -1.072 . . . . 12.12 110.632 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.88 -4.94 50.02 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 111.328 -0.709 . . . . 11.54 111.328 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -103.68 156.97 17.39 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 109.568 -0.53 . . . . 11.24 109.568 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.79 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.2 mt-30 -111.03 146.32 36.92 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.11 0.481 . . . . 10.49 110.703 -177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.46 HG22 ' HB1' ' A' ' 101' ' ' ALA . 1.7 p -132.84 137.73 53.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.448 -0.796 . . . . 5.45 109.011 172.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -66.61 124.13 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.35 0.595 . . . . 6.56 110.69 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 101' ' ' ALA . 1.9 m -112.29 5.41 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.676 -0.693 . . . . 6.99 109.71 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.3 t 71.91 -53.54 0.69 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 114.465 -1.243 . . . . 9.06 110.849 -176.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 106.04 -152.32 17.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 121.071 -0.585 . . . . 8.5 111.654 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -130.26 166.14 20.97 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.468 -0.567 . . . . 11.84 109.468 178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -84.4 85.44 7.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.62 0.248 . . . . 12.24 110.381 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.686 ' H ' HD12 ' A' ' 154' ' ' LEU . 6.3 mp -40.3 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 O-C-N 124.796 1.31 . . . . 13.16 112.43 -171.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 77.0 mt -149.35 114.06 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.936 -0.764 . . . . 11.95 108.936 -174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -86.93 -77.39 0.33 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.708 0.766 . . . . 11.22 112.454 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.3 p -64.48 -42.31 95.96 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 114.826 -1.079 . . . . 11.9 112.633 -162.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -68.63 -28.32 66.8 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.837 -0.62 . . . . 11.17 109.979 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.26 -18.86 54.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.435 -0.802 . . . . 7.82 110.562 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.3 t -81.29 -41.65 21.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.857 -0.61 . . . . 9.64 109.572 176.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.45 -35.67 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.706 -0.679 . . . . 10.57 110.937 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 162' ' ' ARG . 34.9 mtt180 -98.44 -161.47 0.88 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.363 -0.606 . . . . 8.9 109.363 178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 177.89 -56.55 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.912 -0.661 . . . . 7.15 111.889 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.6 p -102.48 -26.38 13.27 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.512 0.672 . . . . 7.09 110.042 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 45.6 t -87.75 76.44 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.561 -0.745 . . . . 9.2 110.14 -178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.513 ' O ' ' HA ' ' A' ' 67' ' ' VAL . . . -151.16 97.95 2.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.097 -0.501 . . . . 9.11 110.911 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.696 ' HD3' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -127.85 -80.7 0.59 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.21 -1.033 . . . . 14.58 108.21 178.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.441 ' H ' ' HB2' ' A' ' 167' ' ' ARG . 15.5 mtm 49.47 80.88 0.06 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 113.555 -1.657 . . . . 11.94 112.232 173.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -69.04 117.18 10.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.43 0.634 . . . . 14.99 110.142 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -104.58 94.81 5.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.127 0.489 . . . . 15.01 109.87 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 41.2 p -74.05 84.26 1.79 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.45 -0.796 . . . . 14.25 111.093 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 17.3 m -95.35 -73.99 0.57 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.918 -0.583 . . . . 14.89 110.243 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 49.8 m -157.77 133.88 9.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.181 0.515 . . . . 15.85 109.946 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.65 79.14 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.196 -0.911 . . . . 17.54 113.321 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 176' ' ' GLU . 10.2 mp 62.81 -158.84 0.32 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 122.827 0.451 . . . . 17.85 110.299 -174.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.419 ' H ' ' HB3' ' A' ' 175' ' ' LEU . 1.8 mp0 -65.23 119.49 11.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.465 -0.569 . . . . 19.67 109.465 175.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 14.6 p -136.33 144.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.296 0.57 . . . . 19.52 111.036 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 70.8 mt -88.66 -76.34 0.4 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.458 -0.941 . . . . 21.15 108.458 171.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 4.1 t80 179.61 133.31 0.1 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.05 -1.093 . . . . 23.25 108.05 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 120.763 -0.375 . . . . 23.52 111.11 -175.893 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.477 0.902 0 CA-C-O 120.932 0.396 . . . . 34.32 110.305 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.02 42.39 4.69 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.686 -0.688 . . . . 33.09 112.029 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.6 m 71.29 168.93 0.32 Allowed 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.003 0.521 . . . . 34.12 111.49 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . . . 66.66 174.96 0.24 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.544 -0.753 . . . . 32.32 111.524 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.9 p -78.77 -81.87 0.1 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.188 0.44 . . . . 32.74 112.188 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.78 105.37 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.085 0.469 . . . . 31.29 111.181 -175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' A' ' 4' ' ' ALA . 19.2 m120 -129.32 -54.78 1.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.781 -0.645 . . . . 29.46 109.655 177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 120.98 -158.11 15.83 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.595 -0.73 . . . . 28.28 111.439 -178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.09 165.04 21.91 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.415 2.077 . . . . 27.51 112.18 178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -78.39 98.22 5.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.366 -0.379 . . . . 26.48 110.219 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.99 97.06 3.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.189 0.518 . . . . 24.9 110.285 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 151.58 -25.23 0.95 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.055 -0.818 . . . . 23.19 111.055 -176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -175.55 125.31 0.23 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.625 -0.509 . . . . 21.31 109.625 174.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -157.79 157.93 29.99 Favored Pre-proline 0 C--N 1.318 -0.763 0 N-CA-C 108.838 -0.801 . . . . 19.89 108.838 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -74.12 65.84 5.2 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.051 1.834 . . . . 18.12 112.149 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.85 -83.69 0.22 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.626 0.25 . . . . 16.58 110.893 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -156.93 92.99 1.31 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.862 -0.608 . . . . 14.8 110.019 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 21' ' ' LEU . . . 76.15 48.34 9.81 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.577 -0.821 . . . . 13.17 111.923 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.43 -32.18 73.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.801 0.334 . . . . 12.17 111.046 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -87.76 52.32 2.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.513 1.149 . . . . 13.82 108.97 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 35.5 mt -160.36 -67.68 0.07 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 112.979 -1.919 . . . . 12.13 107.706 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 22' ' ' LYS . 40.8 ttmt 59.24 35.29 23.4 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.259 1.028 . . . . 14.1 110.156 175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 t -155.13 107.67 2.73 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.95 -1.023 . . . . 11.05 110.808 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -100.7 164.74 18.79 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.375 -0.83 . . . . 10.05 111.241 177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.0 OUTLIER 70.78 59.47 0.2 Allowed 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.924 -1.139 . . . . 10.38 107.924 -178.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.405 ' O ' ' HE2' ' A' ' 57' ' ' TYR . 18.2 mmm180 -126.14 137.07 53.56 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 113.762 -1.563 . . . . 8.37 110.564 -174.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.695 HG12 ' OE2' ' A' ' 58' ' ' GLU . 41.6 mm -46.36 131.91 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 CA-C-N 114.343 -1.299 . . . . 5.76 113.66 -168.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 46.3 tp -120.29 -29.9 4.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.843 -1.526 . . . . 8.22 108.227 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.743 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 16.4 p90 -175.24 -176.63 0.95 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.315 -0.857 . . . . 7.99 111.602 -175.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.662 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.4 m-90 -126.99 153.67 45.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.119 -0.946 . . . . 5.61 110.593 -174.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -157.36 152.22 25.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 9.06 110.4 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.73 ' HB3' HG22 ' A' ' 35' ' ' VAL . 9.7 t70 -86.85 137.39 33.55 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.278 -0.638 . . . . 8.31 109.278 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HG3' HG13 ' A' ' 54' ' ' ILE . 16.5 Cg_exo -63.4 -14.93 45.25 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.495 2.13 . . . . 10.41 112.358 177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.32 0.57 48.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.718 0.294 . . . . 10.85 111.147 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.73 HG22 ' HB3' ' A' ' 32' ' ' ASP . 4.8 m -126.84 40.08 0.54 Allowed Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.276 0.473 . . . . 9.32 112.276 178.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 13.8 Cg_endo -52.06 126.16 19.39 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.66 2.24 . . . . 11.1 112.812 -172.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.36 -20.31 28.1 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.798 -0.715 . . . . 10.31 111.491 -177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.555 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 20.2 tp60 -81.42 102.92 10.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.239 0.542 . . . . 9.21 110.339 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.536 ' HG3' ' CD2' ' A' ' 29' ' ' TYR . 21.1 ttp180 -89.95 111.85 23.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.571 -0.74 . . . . 11.51 110.515 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.743 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 91.8 m-85 -92.67 127.72 38.27 Favored 'General case' 0 CA--C 1.511 -0.558 0 N-CA-C 108.036 -1.098 . . . . 7.5 108.036 173.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -64.79 -18.12 64.81 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.332 -0.547 . . . . 10.61 112.173 -171.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 85.3 mttt -141.4 170.09 10.0 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.738 -0.385 . . . . 10.91 111.01 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 42' ' ' LYS . 9.8 Cg_endo -52.82 170.43 0.29 Allowed 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.522 2.815 . . . . 7.51 113.586 169.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 148.9 -167.15 29.37 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.39 -0.91 . . . . 7.59 113.421 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.49 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 9.4 ttmt -97.03 148.06 23.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.203 -0.666 . . . . 11.68 109.203 177.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.477 ' HA ' HD21 ' A' ' 53' ' ' LEU . 75.6 p -62.9 136.51 96.56 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 115.457 -0.792 . . . . 9.2 110.57 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.25 -25.4 3.95 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.894 1.729 . . . . 10.25 111.59 173.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.55 ' HB2' ' HE2' ' A' ' 49' ' ' MET . 88.0 m-85 -81.82 -31.19 31.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.625 -0.716 . . . . 10.49 110.631 -176.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.55 ' HE2' ' HB2' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -124.12 -159.74 0.88 Allowed 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.501 -0.925 . . . . 10.38 108.501 173.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 0.7 OUTLIER -130.67 54.92 1.86 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.687 0.756 . . . . 12.54 109.751 172.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 14.1 ptm -127.71 145.04 53.39 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 114.526 -1.216 . . . . 9.87 109.394 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.57 133.28 47.7 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.679 1.586 . . . . 9.51 109.971 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 46' ' ' SER . 24.2 mt -62.67 165.05 6.86 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.408 0.442 . . . . 6.71 110.735 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.448 HG13 ' HG3' ' A' ' 33' ' ' PRO . 32.8 mm -99.7 129.21 29.29 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.497 -0.557 . . . . 7.89 109.497 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.662 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 56.0 Cg_endo -83.28 138.2 8.65 Favored 'Trans proline' 0 N--CA 1.438 -1.762 0 C-N-CA 121.851 1.701 . . . . 5.77 113.274 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.3 m -56.46 159.51 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.725 -1.58 . . . . 5.96 113.431 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.405 ' HE2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.98 -86.69 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.966 2.106 . . . . 7.84 115.512 -175.392 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.695 ' OE2' HG12 ' A' ' 27' ' ' ILE . 0.3 OUTLIER -49.65 -38.76 33.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.977 0.418 . . . . 6.62 110.26 -177.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 63.69 84.85 0.14 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.885 -1.052 . . . . 8.58 111.263 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 55' ' ' PRO . 30.4 tt0 62.27 60.05 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 122.102 0.953 . . . . 7.64 110.684 168.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.59 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 1.9 t-20 -138.39 -5.45 1.6 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.67 -1.605 . . . . 7.02 110.154 173.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.31 -35.08 62.27 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.828 0.823 . . . . 5.41 110.416 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.676 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 8.0 p-10 -76.02 -4.2 39.98 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.16 -1.382 . . . . 7.01 112.558 -167.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 65' ' ' ALA . . . 52.6 36.34 47.79 Favored Glycine 0 C--N 1.313 -0.696 0 O-C-N 124.168 0.917 . . . . 7.2 113.144 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 64' ' ' GLY . . . 75.03 56.56 0.07 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.294 0.644 . . . . 7.82 111.442 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 79.78 12.78 1.08 Allowed 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 115.536 -0.756 . . . . 8.65 112.201 165.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.571 HG11 ' O ' ' A' ' 164' ' ' THR . 11.9 t -58.89 -54.0 39.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 107.639 -1.245 . . . . 7.31 107.639 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.676 ' HG2' ' HA ' ' A' ' 63' ' ' ASP . 10.5 ptp180 -105.94 -168.4 1.44 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.053 -1.885 . . . . 10.21 109.709 172.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.689 ' H ' HD12 ' A' ' 69' ' ' ILE . 2.5 mp -57.73 144.74 9.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 115.44 -0.8 . . . . 8.86 111.203 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.492 ' HB3' ' NE ' ' A' ' 72' ' ' ARG . 37.5 t70 -86.72 51.9 2.36 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.467 -0.788 . . . . 13.02 110.168 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.11 29.7 15.53 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.746 -0.661 . . . . 12.13 113.659 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.519 ' HG2' HG22 ' A' ' 69' ' ' ILE . 15.3 ptp180 -106.05 -155.92 0.56 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 122.607 0.363 . . . . 12.38 110.324 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 24.4 m -32.24 -33.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 125.586 1.554 . . . . 11.61 114.679 176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.415 ' HA ' HG21 ' A' ' 69' ' ' ILE . 10.2 t 42.49 85.59 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.743 1.217 . . . . 10.71 113.84 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -118.04 76.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.534 -0.757 . . . . 14.09 110.02 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -151.06 133.74 15.66 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.022 -0.733 . . . . 11.22 109.022 177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 87.0 mt -69.8 -20.1 63.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.199 0.524 . . . . 13.71 111.077 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 129.92 -44.67 1.2 Allowed Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.266 -0.734 . . . . 11.44 111.266 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.447 HG11 ' CZ ' ' A' ' 120' ' ' PHE . 64.2 t 67.06 95.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.586 0.708 . . . . 9.99 110.756 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.403 ' NH1' ' HG3' ' A' ' 158' ' ' GLU . 61.2 ttm-85 -81.48 127.86 33.27 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.501 -0.772 . . . . 11.64 110.242 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 148' ' ' VAL . 45.4 p -131.37 146.78 52.43 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.13 -0.941 . . . . 8.0 109.792 -176.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.0 128.08 56.07 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.867 -0.79 . . . . 6.65 108.867 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.76 131.71 35.27 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.07 -0.345 . . . . 12.15 110.07 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 145' ' ' GLN . 73.4 t -56.7 127.2 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 CA-C-O 122.293 1.044 . . . . 9.71 112.066 177.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.83 136.27 8.99 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.888 -1.96 . . . . 11.03 109.035 171.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.603 ' CD1' ' H ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -75.61 168.83 19.27 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.894 -1.048 . . . . 12.76 112.44 -177.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.45 52.86 0.01 OUTLIER Glycine 0 C--N 1.315 -0.586 0 CA-C-N 114.635 -1.166 . . . . 13.25 111.135 -169.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.66 ' HG3' ' C ' ' A' ' 92' ' ' THR . 0.1 OUTLIER -74.55 -177.36 3.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.404 -0.898 . . . . 16.35 113.001 -170.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 tt -129.56 111.86 13.15 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.071 -0.968 . . . . 18.22 108.62 173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 123.21 -157.7 17.74 Favored Glycine 0 C--N 1.317 -0.474 0 CA-C-N 115.331 -0.849 . . . . 17.91 111.417 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 14.3 m -91.67 77.21 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.713 -0.847 . . . . 17.11 108.713 174.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.66 ' C ' ' HG3' ' A' ' 88' ' ' ARG . 1.5 m -154.4 169.29 24.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.188 -0.914 . . . . 14.73 109.777 -173.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -138.07 113.9 9.84 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.994 -0.743 . . . . 14.94 108.994 157.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' A' ' 138' ' ' LEU . 1.9 ttp180 -132.44 149.2 52.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.637 -0.71 . . . . 10.57 111.062 -172.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.654 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.7 mm? -77.51 120.83 23.03 Favored 'General case' 0 C--N 1.318 -0.803 0 O-C-N 123.391 0.432 . . . . 8.88 110.458 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -97.06 131.87 43.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 116.311 -0.404 . . . . 9.78 111.318 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.7 156.12 59.66 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.642 -0.708 . . . . 6.4 109.467 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.46 134.06 61.0 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.117 1.878 . . . . 6.55 110.663 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.536 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 21.7 t -61.56 -26.05 67.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.958 0.355 . . . . 9.29 111.958 -173.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -90.0 4.8 49.06 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.941 -0.474 . . . . 10.86 111.568 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.523 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -75.73 -32.88 60.21 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.413 0.625 . . . . 5.34 110.54 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.494 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 2.9 pp -101.99 168.21 9.55 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.278 -0.874 . . . . 6.97 111.918 -172.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 109' ' ' THR . 27.6 mm -121.26 101.84 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 CA-C-N 116.062 -0.517 . . . . 10.2 110.129 174.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.624 ' O ' ' HD2' ' A' ' 104' ' ' ARG . 2.7 ppt_? -109.35 108.04 18.45 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 118.195 -1.402 . . . . 12.12 111.131 175.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.7 t -123.73 136.11 54.25 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 113.76 -1.564 . . . . 14.61 109.143 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 71.64 -102.99 1.19 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.401 -0.904 . . . . 15.52 112.333 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.22 4.53 10.81 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.914 0.709 . . . . 14.99 112.914 -174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.94 176.14 12.22 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.773 0.657 . . . . 15.2 112.773 -174.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 104' ' ' ARG . 2.5 m -123.99 156.74 35.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.015 -0.993 . . . . 9.26 111.712 -169.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 26.4 mm -128.46 149.82 33.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.081 -0.711 . . . . 10.55 109.081 177.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.647 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -132.61 140.37 48.19 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.603 0.24 . . . . 7.39 110.924 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 67.9 mtp -92.52 100.75 13.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.434 -0.58 . . . . 8.85 109.434 176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.596 HG12 ' O ' ' A' ' 121' ' ' ASP . 14.7 p -88.86 132.95 32.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.354 0.597 . . . . 9.69 111.789 -174.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.471 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -79.19 83.85 5.21 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.376 -0.829 . . . . 10.7 109.774 175.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HD2' ' HB2' ' A' ' 121' ' ' ASP . 46.5 mttm -75.18 146.93 40.85 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.771 -0.65 . . . . 14.88 110.972 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 172' ' ' THR . . . -76.0 5.2 42.28 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.564 -0.827 . . . . 16.92 111.138 172.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -85.61 9.77 15.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.626 0.727 . . . . 18.56 110.679 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.48 19.02 50.83 Favored Glycine 0 N--CA 1.453 -0.224 0 CA-C-N 115.149 -0.932 . . . . 15.62 113.816 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -160.31 173.12 36.87 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.348 -0.93 . . . . 14.19 112.581 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 71.2 m-85 -109.84 109.24 19.83 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.194 -0.669 . . . . 12.03 109.194 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.596 ' O ' HG12 ' A' ' 113' ' ' VAL . 7.0 t70 -101.57 145.72 30.95 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.368 -0.378 . . . . 13.91 110.502 -171.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 20.1 Cg_endo -89.32 132.82 2.24 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.151 1.9 . . . . 12.35 112.406 177.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.647 HG12 ' HB3' ' A' ' 111' ' ' ALA . 2.8 p -118.84 137.05 54.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.625 -0.716 . . . . 9.43 109.542 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -77.61 111.85 13.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.446 0.641 . . . . 12.93 110.101 173.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -119.1 160.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.929 -1.032 . . . . 8.03 110.826 -175.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 23.5 ttmm -104.46 125.86 51.04 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 115.846 -0.615 . . . . 10.39 109.555 172.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -141.65 109.67 5.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.678 -0.237 . . . . 8.3 111.61 -176.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.579 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.63 70.9 0.28 Allowed Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 118.166 -1.968 . . . . 10.1 113.905 169.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.905 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.34 162.24 40.47 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.831 -0.803 . . . . 10.61 108.831 155.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 23.6 m -138.89 129.4 25.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.11 0.481 . . . . 13.17 109.871 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -135.73 102.31 5.04 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.645 -0.707 . . . . 12.98 110.675 -177.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 72.63 24.39 76.25 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 116.041 -0.527 . . . . 14.34 112.492 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 97.51 -10.72 64.99 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.766 -0.73 . . . . 13.12 112.195 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 130' ' ' THR . 2.4 mp0 -97.49 162.98 13.05 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.84 -0.8 . . . . 10.62 108.84 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.536 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 11.4 p -114.63 155.36 26.69 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 120.431 -0.507 . . . . 7.82 111.172 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.905 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 25.7 mt-10 -100.02 128.5 46.09 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.5 0.667 . . . . 10.79 110.967 176.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.768 HD12 HG21 ' A' ' 125' ' ' VAL . 24.3 mm -92.02 101.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.133 -0.94 . . . . 6.73 109.772 175.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.579 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.6 mp -67.18 -45.63 76.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.836 -1.075 . . . . 8.79 109.845 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' O ' HG23 ' A' ' 125' ' ' VAL . 38.0 mt-10 -146.34 163.29 36.04 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.356 -0.609 . . . . 10.44 109.356 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 123.83 -46.95 1.05 Allowed Glycine 0 C--N 1.316 -0.572 0 C-N-CA 119.497 -1.335 . . . . 8.87 114.242 173.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 79.7 mt -123.22 -178.49 4.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.416 0.895 . . . . 8.5 113.416 -170.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 37.9 ttpt -142.39 155.23 45.12 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.569 -1.196 . . . . 14.15 108.846 -176.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.61 129.6 40.41 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.985 -0.552 . . . . 12.12 110.063 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 102.89 -0.17 48.46 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.251 -0.74 . . . . 11.54 111.251 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.66 ' O ' HG23 ' A' ' 84' ' ' VAL . 15.8 mm100 -97.89 100.8 12.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.446 0.641 . . . . 11.24 109.334 177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.471 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.1 mt-30 -74.11 127.4 32.84 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.356 -0.838 . . . . 10.49 110.307 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 149' ' ' VAL . 19.5 m -117.69 135.83 56.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 120.601 0.238 . . . . 5.45 110.67 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.593 ' HA ' HG22 ' A' ' 81' ' ' THR . 42.6 t -66.43 115.05 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.864 -0.607 . . . . 6.56 110.473 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 101' ' ' ALA . 4.1 m -105.07 -17.75 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.911 -0.586 . . . . 6.99 110.759 -175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.6 m 57.92 22.68 8.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.356 -0.838 . . . . 9.06 112.038 173.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.512 ' H ' HG23 ' A' ' 149' ' ' VAL . . . -66.82 146.45 48.3 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.119 -0.562 . . . . 8.5 112.713 -175.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -62.4 -88.48 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.922 0.391 . . . . 11.84 110.966 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.26 82.52 1.79 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.39 -0.368 . . . . 12.24 110.818 -176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.3 pp -90.98 -168.72 2.15 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.514 -0.55 . . . . 13.16 109.514 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 157' ' ' SER . 28.8 pt -59.57 163.32 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.139 0.495 . . . . 11.95 111.91 -176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -81.9 24.54 0.62 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.008 0.908 . . . . 11.22 111.206 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 155' ' ' ILE . 6.4 p -56.92 -27.11 60.48 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 114.456 -1.247 . . . . 11.9 111.218 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.7 ' O ' ' HG2' ' A' ' 162' ' ' ARG . 1.5 mm-40 -57.9 -35.79 71.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 112.922 -1.945 . . . . 11.17 111.057 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.86 -27.53 64.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.595 -0.73 . . . . 7.82 110.895 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 17.2 m -76.23 -25.64 55.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.507 0.67 . . . . 9.64 109.571 174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 97.9 mt -83.76 -16.53 44.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.111 -0.949 . . . . 10.57 110.756 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.7 ' HG2' ' O ' ' A' ' 158' ' ' GLU . 13.4 mmm180 -89.45 131.21 35.61 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.316 0.579 . . . . 8.9 111.469 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -148.06 62.95 0.43 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 109.292 -1.523 . . . . 7.15 109.292 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.571 ' O ' HG11 ' A' ' 67' ' ' VAL . 17.8 p 50.0 -94.38 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 109.592 -0.521 . . . . 7.09 109.592 -161.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.651 HG13 ' H ' ' A' ' 166' ' ' ALA . 2.7 p -100.18 -65.89 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 120.344 -0.542 . . . . 9.2 109.997 171.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.651 ' H ' HG13 ' A' ' 165' ' ' VAL . . . 156.13 -178.19 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.993 1.317 . . . . 9.11 108.547 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.25 58.82 0.65 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 122.157 0.979 . . . . 14.58 111.935 175.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.417 ' O ' ' HB3' ' A' ' 169' ' ' GLN . 28.9 mtm -111.15 77.4 1.04 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.578 -1.192 . . . . 11.94 109.522 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 168' ' ' MET . 35.6 tt0 68.1 83.17 0.16 Allowed 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.607 -0.516 . . . . 14.99 109.607 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 70.59 -84.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.265 -0.88 . . . . 15.01 110.45 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 27.8 p 37.14 59.51 1.11 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.677 0.61 . . . . 14.25 112.346 -176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.559 ' O ' ' HA3' ' A' ' 116' ' ' GLY . 8.8 t -102.76 161.58 13.62 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.894 0.378 . . . . 14.89 110.148 178.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 26.9 p -131.8 -2.88 3.68 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.543 -0.753 . . . . 15.85 111.08 -176.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.18 41.72 3.02 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.86 -0.686 . . . . 17.54 113.457 -170.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp 71.52 -63.55 0.42 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.756 0.788 . . . . 17.85 111.805 177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -141.01 -163.54 1.56 Allowed 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.471 -1.24 . . . . 19.67 109.848 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 16.1 m -58.69 142.3 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.907 0.384 . . . . 19.52 110.417 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.06 120.55 30.56 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.979 0.418 . . . . 21.15 110.369 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -72.51 -57.15 4.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 23.25 110.546 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.942 -0.572 . . . . 23.52 110.703 -178.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.719 0.295 . . . . 34.32 110.849 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.67 -139.22 24.23 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.828 -0.701 . . . . 33.09 112.096 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 t 57.16 47.96 16.19 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.381 0.61 . . . . 34.12 110.141 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.62 158.78 18.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.624 -0.716 . . . . 32.32 111.056 -176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 t -132.18 100.4 5.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.638 0.732 . . . . 32.74 110.659 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG23 HD22 ' A' ' 7' ' ' ASN . 3.8 m -135.19 -35.66 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.624 -0.716 . . . . 31.29 112.086 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.415 HD22 HG23 ' A' ' 6' ' ' VAL . 10.1 p30 -127.7 155.09 44.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.916 0.389 . . . . 29.46 111.029 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.18 148.71 7.36 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.79 -0.719 . . . . 28.28 112.046 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.33 111.6 3.06 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.759 2.306 . . . . 27.51 111.772 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -69.4 -78.23 0.07 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.771 0.32 . . . . 26.48 111.014 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.0 t70 168.01 147.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.116 -1.068 . . . . 24.9 108.116 -174.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.42 -160.15 33.64 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.117 -1.04 . . . . 23.19 112.266 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.6 m80 51.48 53.72 12.31 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 122.747 0.419 . . . . 21.31 111.015 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 5.2 p-10 -115.62 118.67 38.86 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.064 -0.516 . . . . 19.89 110.142 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 14' ' ' ASP . 30.3 Cg_exo -63.81 -170.38 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.229 2.619 . . . . 18.12 113.026 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . 58.26 51.53 8.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.371 0.605 . . . . 16.58 110.341 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.23 82.38 3.74 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.438 -0.801 . . . . 14.8 110.437 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.34 78.87 0.24 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.778 -0.725 . . . . 13.17 112.095 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.38 -2.26 27.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.393 0.616 . . . . 12.17 110.842 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 59.33 61.16 2.11 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.681 -1.145 . . . . 13.82 110.732 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.9 mt 51.56 26.45 3.3 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 113.068 -1.878 . . . . 12.13 113.414 170.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -80.62 -1.51 42.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.339 0.59 . . . . 14.1 109.99 174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.426 HG21 HD21 ' A' ' 28' ' ' LEU . 5.4 p -121.4 63.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.496 -0.774 . . . . 11.05 109.762 172.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' LYS . . . -72.15 74.25 0.84 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.129 -0.941 . . . . 10.05 112.506 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 1.8 mptm? 71.02 64.23 0.17 Allowed 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.23 -1.026 . . . . 10.38 108.23 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 13.3 mtm180 -136.73 138.61 41.17 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.168 -1.378 . . . . 8.37 109.484 -173.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG12 ' CH2' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -49.59 124.13 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-O 121.962 0.887 . . . . 5.76 112.21 -173.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.426 HD21 HG21 ' A' ' 23' ' ' THR . 20.9 mt -112.16 -37.6 4.99 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.648 -1.614 . . . . 8.22 110.942 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.644 ' CE2' ' HD3' ' A' ' 39' ' ' ARG . 4.0 p90 -176.29 -178.64 0.99 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 7.99 109.464 -179.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.683 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.9 m-90 -120.0 156.61 30.54 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.867 -0.606 . . . . 5.61 111.009 -176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.53 ' HB2' ' OE1' ' A' ' 38' ' ' GLN . 30.3 ptt180 -160.03 149.7 18.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.853 -1.067 . . . . 9.06 110.311 -173.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.586 ' HB3' HG22 ' A' ' 35' ' ' VAL . 1.8 t0 -88.19 138.69 30.53 Favored Pre-proline 0 C--N 1.321 -0.674 0 N-CA-C 109.046 -0.724 . . . . 8.31 109.046 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HG3' HG13 ' A' ' 54' ' ' ILE . 32.8 Cg_exo -57.55 -20.61 42.28 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 123.498 2.799 . . . . 10.41 113.088 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.519 ' N ' ' SD ' ' A' ' 34' ' ' MET . 0.0 OUTLIER -89.44 -24.4 21.88 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 121.354 0.597 . . . . 10.85 109.993 -177.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 32' ' ' ASP . 3.3 m -117.95 37.16 0.24 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.107 -0.951 . . . . 9.32 113.526 -161.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 57.7 Cg_endo -60.78 108.29 0.53 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.881 2.387 . . . . 11.1 112.166 -171.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 151.31 -18.29 0.91 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.496 -0.859 . . . . 10.31 112.474 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -77.26 -177.74 4.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.215 0.531 . . . . 9.21 111.646 174.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.644 ' HD3' ' CE2' ' A' ' 29' ' ' TYR . 5.2 tpp180 -148.26 91.73 1.95 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.636 -0.711 . . . . 11.51 109.729 175.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 77.5 m-85 -75.63 137.02 40.45 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 119.851 -0.74 . . . . 7.5 110.442 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -63.84 -29.94 71.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.745 -1.116 . . . . 10.61 110.032 -175.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.483 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -165.04 164.28 13.03 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 115.338 -0.846 . . . . 10.91 110.608 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.683 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 9.3 Cg_endo -48.63 169.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.872 3.048 . . . . 7.51 114.351 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 146.14 -174.44 26.06 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.679 -0.772 . . . . 7.59 112.606 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.645 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 6.9 ttpm? -86.19 146.0 26.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.186 0.517 . . . . 11.68 110.986 177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 49' ' ' MET . 32.9 t -58.43 136.33 85.53 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 114.764 -1.107 . . . . 9.2 110.924 -177.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.55 -20.43 15.81 Favored 'Trans proline' 0 CA--C 1.517 -0.327 0 C-N-CA 122.192 1.928 . . . . 10.25 110.912 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -86.15 -42.63 13.7 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.672 -1.603 . . . . 10.49 109.597 -176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.514 ' O ' ' HB3' ' A' ' 46' ' ' SER . 3.5 mtm -129.5 152.65 48.81 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 115.779 -0.646 . . . . 10.38 111.339 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.74 60.7 5.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 122.747 1.261 . . . . 12.54 111.294 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.506 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -139.51 145.55 44.28 Favored Pre-proline 0 C--N 1.304 -1.371 0 CA-C-N 113.891 -1.504 . . . . 9.87 109.208 177.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 39.8 Cg_endo -67.57 133.86 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.934 1.756 . . . . 9.51 111.936 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 mt -63.4 163.23 11.1 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.576 -0.528 . . . . 6.71 109.576 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.534 HG13 ' HG3' ' A' ' 33' ' ' PRO . 24.1 mm -98.02 132.81 23.99 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-O 120.989 0.423 . . . . 7.89 110.565 -174.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.87 147.51 19.22 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 121.91 1.74 . . . . 5.77 112.208 178.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.513 ' CG2' ' HA ' ' A' ' 27' ' ' ILE . 35.2 m -73.02 158.68 6.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 114.657 -1.156 . . . . 5.96 112.679 -176.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.496 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 7.89 -86.26 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 127.235 2.214 . . . . 7.84 115.865 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.654 ' CD ' ' HB3' ' A' ' 61' ' ' ASN . 2.6 pt-20 -48.47 -44.16 35.43 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.477 0.711 . . . . 6.62 111.231 -174.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.452 ' N ' ' HG2' ' A' ' 58' ' ' GLU . 33.5 tt0 58.25 95.41 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.759 -1.109 . . . . 8.58 111.414 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.577 ' HA ' ' HA3' ' A' ' 64' ' ' GLY . 31.2 tt0 75.84 63.46 0.05 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 114.033 -1.439 . . . . 7.64 112.801 167.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.654 ' HB3' ' CD ' ' A' ' 58' ' ' GLU . 7.5 t30 -146.07 -50.2 0.22 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.995 -1.002 . . . . 7.02 110.406 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . . . -72.51 -53.2 12.71 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 116.124 -0.489 . . . . 5.41 109.968 172.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.653 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 34.6 t70 -171.9 60.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.724 -0.671 . . . . 7.01 110.59 174.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 60' ' ' GLU . . . -73.01 -38.5 55.63 Favored Glycine 0 C--N 1.314 -0.68 0 C-N-CA 119.497 -1.335 . . . . 7.2 111.389 171.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.06 50.33 1.82 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.709 -0.746 . . . . 7.82 110.388 -173.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.601 ' HA ' ' OD1' ' A' ' 63' ' ' ASP . . . 62.04 33.52 17.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.554 -0.748 . . . . 8.65 111.504 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -76.04 -10.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.081 -0.711 . . . . 7.31 109.081 172.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.653 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 4.1 tmm_? -35.54 141.12 0.09 Allowed 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 114.293 -1.321 . . . . 10.21 112.989 178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.514 HG21 ' HG2' ' A' ' 72' ' ' ARG . 22.7 mt -67.12 144.04 14.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.514 -0.766 . . . . 8.86 110.126 -178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -86.95 46.39 1.37 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.872 0.844 . . . . 13.02 110.524 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 73' ' ' VAL . . . 52.38 35.22 43.23 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 114.466 -1.243 . . . . 12.13 112.947 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.514 ' HG2' HG21 ' A' ' 69' ' ' ILE . 26.2 ptt180 -58.52 122.79 14.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.518 0.675 . . . . 12.38 110.534 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 71' ' ' GLY . 73.9 t -131.21 137.45 55.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.57 -0.741 . . . . 11.61 110.015 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.612 ' O ' ' HG2' ' A' ' 152' ' ' GLN . 9.2 t -141.89 102.38 4.14 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.895 0.855 . . . . 10.71 110.165 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -124.43 64.63 1.09 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.059 -0.973 . . . . 14.09 109.023 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -105.28 113.32 26.84 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.023 -0.989 . . . . 11.22 110.312 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 tp -69.58 -44.83 70.02 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.297 -0.411 . . . . 13.71 110.657 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -79.28 -40.49 15.92 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.51 -0.636 . . . . 11.44 111.51 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 47.6 t 72.72 113.95 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.416 0.627 . . . . 9.99 111.206 176.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 150' ' ' SER . 23.6 ttm180 -82.15 131.53 35.24 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.891 -0.781 . . . . 11.64 108.891 177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.54 HG22 ' HA ' ' A' ' 148' ' ' VAL . 68.0 p -131.12 159.19 38.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.847 0.356 . . . . 8.0 110.097 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 149' ' ' VAL . . . -121.59 128.64 52.17 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 108.668 -0.864 . . . . 6.65 108.668 176.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 146' ' ' GLN . 33.9 tt0 -84.56 130.46 34.73 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.465 -0.569 . . . . 12.15 109.465 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.037 HG23 ' HA ' ' A' ' 143' ' ' ALA . 20.5 m -64.35 141.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 CA-C-O 122.888 1.328 . . . . 9.71 111.401 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.477 ' H ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -164.13 174.28 11.46 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.335 -2.212 . . . . 11.03 109.514 173.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.6 ' HA ' ' O ' ' A' ' 94' ' ' ARG . 10.0 mp -70.48 167.91 17.34 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.572 0.701 . . . . 12.76 112.125 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' N ' HD23 ' A' ' 96' ' ' LEU . . . 157.3 46.08 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.33 -0.85 . . . . 13.25 112.604 176.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.809 ' HD3' ' O ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -89.54 -178.22 5.51 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.688 -0.405 . . . . 16.35 111.933 -176.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.6 mt -131.32 106.98 8.63 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.878 -0.601 . . . . 18.22 109.471 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 130.21 -162.72 23.13 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.899 -0.591 . . . . 17.91 111.784 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 30.1 m -91.34 75.37 6.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.282 1.039 . . . . 17.11 109.76 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.809 ' O ' ' HD3' ' A' ' 88' ' ' ARG . 2.0 m -154.94 168.74 25.93 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.589 -1.634 . . . . 14.73 106.589 176.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.539 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 7.8 mt-10 -143.3 109.8 5.44 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 118.859 0.754 . . . . 14.94 110.575 165.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.633 ' HD3' ' HA ' ' A' ' 138' ' ' LEU . 1.5 mmp_? -121.11 168.13 11.89 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.87 -0.605 . . . . 10.57 111.248 -171.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 1.6 mm? -97.85 114.21 26.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.464 -0.789 . . . . 8.88 109.294 176.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.2 mm? -91.39 130.91 37.17 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-N 115.349 -0.841 . . . . 9.78 111.258 -172.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.604 ' CG2' ' HB3' ' A' ' 101' ' ' ALA . 3.3 p -139.32 146.81 50.31 Favored Pre-proline 0 C--N 1.317 -0.842 0 CA-C-N 114.525 -1.216 . . . . 6.4 108.927 -176.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.7 Cg_exo -56.51 132.01 49.18 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.145 1.897 . . . . 6.55 109.595 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.6 t -57.74 -25.55 60.57 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 9.29 112.312 -168.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.38 4.48 52.32 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 111.945 0.35 . . . . 10.86 111.945 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.604 ' HB3' ' CG2' ' A' ' 97' ' ' VAL . . . -79.84 -33.6 40.07 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.225 -0.59 . . . . 5.34 110.51 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.504 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.9 pp -91.91 155.1 18.41 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.584 0.707 . . . . 6.97 111.967 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.6 mp -99.18 125.43 52.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.08 -0.964 . . . . 10.2 109.029 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 20.8 mmm180 -98.1 125.69 43.21 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.677 -0.809 . . . . 12.12 110.911 175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.9 t -149.15 127.26 12.01 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.722 -0.672 . . . . 14.61 110.818 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 52.41 -121.91 16.44 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.03 -0.532 . . . . 15.52 112.794 177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -109.09 36.79 2.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.026 0.441 . . . . 14.99 111.418 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -156.98 177.43 11.52 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.002 -0.544 . . . . 15.2 111.526 -178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 25.8 m -129.19 150.14 50.7 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.644 -0.707 . . . . 9.26 109.26 174.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.5 mm -126.92 150.7 33.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.125 -0.695 . . . . 10.55 109.125 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.602 ' HB3' HG12 ' A' ' 123' ' ' VAL . . . -136.35 130.02 32.22 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 122.242 -0.286 . . . . 7.39 110.839 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.454 ' HE3' HG11 ' A' ' 148' ' ' VAL . 38.7 mtm -84.71 100.25 11.37 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.846 -0.798 . . . . 8.85 108.846 174.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 146' ' ' GLN . 11.3 p -81.95 134.46 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 114.825 -1.079 . . . . 9.69 111.208 -172.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -83.59 91.56 7.46 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.539 -0.755 . . . . 10.7 110.235 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -77.48 147.94 35.62 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.938 -0.574 . . . . 14.88 111.035 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.16 -2.35 47.16 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.658 -0.701 . . . . 16.92 112.021 177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -81.17 6.84 12.67 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.456 0.646 . . . . 18.56 111.058 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 89.05 9.67 67.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.243 -0.889 . . . . 15.62 113.197 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -135.6 -174.74 13.51 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.336 -0.935 . . . . 14.19 112.981 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.08 128.26 37.83 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 123.068 0.547 . . . . 12.03 109.783 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.498 ' O ' HG12 ' A' ' 113' ' ' VAL . 8.2 m-20 -125.37 147.72 58.67 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.594 -0.275 . . . . 13.91 111.024 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -85.37 124.87 2.86 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.391 2.061 . . . . 12.35 112.484 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.623 HG11 HD13 ' A' ' 141' ' ' LEU . 4.4 p -106.19 135.73 43.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.87 -1.059 . . . . 9.43 109.078 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.426 ' HA ' HD13 ' A' ' 110' ' ' ILE . 36.1 tt0 -82.23 122.75 28.32 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.057 -0.72 . . . . 12.93 109.057 172.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 139' ' ' GLU . 0.1 OUTLIER -137.02 157.16 35.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.402 0.62 . . . . 8.03 112.215 -173.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 76.1 tttt -93.73 128.68 40.06 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.092 -0.958 . . . . 10.39 110.208 173.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.404 ' HB3' ' OG1' ' A' ' 109' ' ' THR . . . -142.19 104.39 4.44 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.782 -0.644 . . . . 8.3 111.075 -177.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.32 71.28 0.28 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 117.924 -2.084 . . . . 10.1 113.882 169.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -149.83 164.14 36.14 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.892 -0.781 . . . . 10.61 108.892 157.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 m -133.48 128.32 35.14 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.709 -0.478 . . . . 13.17 109.709 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.87 122.49 7.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.514 -0.312 . . . . 12.98 111.58 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 65.56 36.31 92.31 Favored Glycine 0 N--CA 1.453 -0.211 0 CA-C-N 115.933 -0.576 . . . . 14.34 113.101 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 72.02 19.99 78.69 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.68 -0.772 . . . . 13.12 111.687 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -130.6 171.67 12.79 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.936 -0.765 . . . . 10.62 108.936 -178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.1 t -115.21 156.58 25.08 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.649 -0.501 . . . . 7.82 109.649 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 50.7 mt-10 -102.36 124.07 47.29 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.562 0.696 . . . . 10.79 111.375 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.687 HD12 HG21 ' A' ' 125' ' ' VAL . 26.0 mm -86.04 111.83 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.963 -1.017 . . . . 6.73 109.16 172.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.633 ' HA ' ' HD3' ' A' ' 94' ' ' ARG . 3.8 mp -81.15 -45.69 16.02 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.974 -1.012 . . . . 8.79 111.006 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 125' ' ' VAL . 42.6 mt-10 -146.59 173.02 12.7 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.139 -0.689 . . . . 10.44 109.139 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' ' 125' ' ' VAL . . . 93.2 -63.01 2.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.144 -1.027 . . . . 8.87 113.715 172.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.623 HD13 HG11 ' A' ' 123' ' ' VAL . 35.9 tp -105.41 145.09 31.28 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.234 -1.024 . . . . 8.5 108.234 -177.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 145' ' ' GLN . 85.8 tttt -136.34 143.8 44.29 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 112.734 0.642 . . . . 14.15 112.734 -161.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 1.037 ' HA ' HG23 ' A' ' 84' ' ' VAL . . . -49.62 123.91 8.62 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 113.845 -1.525 . . . . 12.12 111.375 -173.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 106.1 1.12 38.72 Favored Glycine 0 N--CA 1.435 -1.405 0 CA-C-N 114.853 -1.067 . . . . 11.54 111.286 -171.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 142' ' ' LYS . 14.8 mm100 -103.7 125.52 50.23 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.766 -0.773 . . . . 11.24 110.097 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 83' ' ' GLU . 20.4 mp0 -85.39 142.83 29.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.728 -0.669 . . . . 10.49 110.577 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.48 ' O ' HG23 ' A' ' 149' ' ' VAL . 16.1 m -135.27 147.27 29.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.472 0.177 . . . . 5.45 110.597 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.54 ' HA ' HG22 ' A' ' 81' ' ' THR . 22.6 m -57.84 133.72 22.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 O-C-N 123.855 0.722 . . . . 6.56 111.878 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 82' ' ' ALA . 45.9 t -131.41 -35.12 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.2 -0.909 . . . . 6.99 110.546 -173.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 80' ' ' ARG . 17.2 t -147.12 71.54 1.22 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.654 -0.869 . . . . 9.06 108.654 173.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 79' ' ' VAL . . . -142.09 175.76 22.51 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.68 -0.691 . . . . 8.5 111.993 -177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 74' ' ' THR . 22.6 mt-30 -75.27 142.15 43.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.83 0.348 . . . . 11.84 111.02 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -99.91 -166.72 1.37 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.085 -0.507 . . . . 12.24 110.001 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -157.2 171.35 20.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.287 0.565 . . . . 13.16 110.23 177.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.435 HG22 ' HG2' ' A' ' 158' ' ' GLU . 26.9 mt 63.84 61.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 114.393 -1.276 . . . . 11.95 111.183 176.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.26 -9.37 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.133 -0.485 . . . . 11.22 111.279 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 4.8 p -61.52 -41.13 96.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.308 0.575 . . . . 11.9 110.593 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' HG2' HG22 ' A' ' 155' ' ' ILE . 51.5 mm-40 -73.51 -30.8 63.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.466 -0.788 . . . . 11.17 109.799 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.65 -17.9 62.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.98 -1.009 . . . . 7.82 110.482 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 50.3 m -81.44 -31.66 32.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.511 -0.768 . . . . 9.64 110.465 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.3 -31.03 48.7 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 115.297 -0.865 . . . . 10.57 110.833 -176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -81.47 166.97 19.87 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.725 -0.671 . . . . 8.9 109.546 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -78.95 71.95 2.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 121.089 -0.576 . . . . 7.15 111.84 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 55.9 p 53.4 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.273 1.029 . . . . 7.09 112.022 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.43 -45.92 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 110.209 -0.293 . . . . 9.2 110.209 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . 51.53 90.43 0.02 OUTLIER 'General case' 0 C--O 1.236 0.35 0 O-C-N 123.589 0.556 . . . . 9.11 111.601 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -84.63 168.74 15.04 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 122.271 1.034 . . . . 14.58 109.794 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 11.8 mmt -107.45 -35.1 6.86 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 113.257 -1.792 . . . . 11.94 110.111 -169.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 63.72 -80.16 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.348 1.03 . . . . 14.99 111.974 176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -144.35 -75.64 0.24 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.47 0.652 . . . . 15.01 109.878 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 23.8 p -87.22 113.26 22.8 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.081 -0.963 . . . . 14.25 111.329 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 45.1 m -63.57 -55.62 22.37 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.719 -0.673 . . . . 14.89 110.157 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.5 m 58.74 -166.5 0.16 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.524 -0.762 . . . . 15.85 111.845 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 83.18 5.57 88.9 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.216 -0.754 . . . . 17.54 111.216 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 36.5 mt -122.77 18.34 10.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.433 -0.383 . . . . 17.85 110.948 -170.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 71.55 -44.07 0.58 Allowed 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.972 0.795 . . . . 19.67 111.86 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.37 148.62 8.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.373 0.606 . . . . 19.52 111.336 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -101.64 -92.88 0.31 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.677 -0.692 . . . . 21.15 109.297 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -142.54 79.04 1.64 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.494 -0.928 . . . . 23.25 108.494 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 115.279 -0.873 . . . . 23.52 110.863 -171.561 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.2 mtt . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 120.876 0.369 . . . . 34.32 110.266 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.59 -143.33 36.76 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.813 -0.708 . . . . 33.09 111.501 -177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.2 p -167.74 175.32 7.01 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.62 0.248 . . . . 34.12 110.552 177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.55 105.89 14.98 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.489 -0.323 . . . . 32.32 110.223 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.2 m -75.19 84.03 2.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.187 0.518 . . . . 32.74 110.184 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.99 119.08 19.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.561 0.696 . . . . 31.29 111.218 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.38 -30.8 20.49 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.551 -0.749 . . . . 29.46 109.556 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.29 -172.75 45.73 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.605 -0.998 . . . . 28.28 110.605 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.66 -75.38 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.398 2.066 . . . . 27.51 111.16 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -174.27 143.42 0.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.496 -0.557 . . . . 26.48 109.496 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -72.0 150.99 43.53 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.323 -0.399 . . . . 24.9 110.319 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.05 -134.74 4.69 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.691 -0.766 . . . . 23.19 112.121 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -117.9 128.99 55.36 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.147 0.498 . . . . 21.31 110.197 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.542 ' N ' ' HD2' ' A' ' 15' ' ' PRO . 5.6 m-20 -70.13 -47.17 21.61 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.379 -0.828 . . . . 19.89 111.581 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 14' ' ' ASP . 20.8 Cg_endo -62.04 133.71 45.62 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.608 1.538 . . . . 18.12 111.73 174.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -163.53 -43.91 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.988 -0.551 . . . . 16.58 110.515 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.69 72.53 1.49 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.067 -0.515 . . . . 14.8 110.809 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.33 94.87 0.15 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.933 -0.651 . . . . 13.17 111.802 177.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -125.55 -72.11 0.67 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.802 -0.234 . . . . 12.17 111.528 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 63.06 118.0 0.02 OUTLIER 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.753 0.787 . . . . 13.82 111.514 -174.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 21' ' ' LEU . 2.8 tm? 73.81 -31.09 0.21 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.276 -1.329 . . . . 12.13 111.891 172.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -78.09 65.83 3.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.579 0.704 . . . . 14.1 111.263 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.7 m 46.47 48.16 13.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.654 -1.157 . . . . 11.05 111.821 179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -94.17 -78.38 1.41 Allowed Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.222 -0.99 . . . . 10.05 111.643 178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -130.5 59.55 1.65 Allowed 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.942 -1.132 . . . . 10.38 107.942 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.525 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 3.1 mtp180 -134.8 140.81 46.16 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 114.161 -1.381 . . . . 8.37 109.239 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' A' ' 58' ' ' GLU . 46.2 mm -51.96 118.24 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.068 -0.969 . . . . 5.76 113.286 -169.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.6 tp -109.19 -32.97 7.0 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.8 -1.546 . . . . 8.22 110.009 -178.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 39' ' ' ARG . 37.6 p90 -179.51 -176.09 0.37 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.734 -0.667 . . . . 7.99 109.625 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.583 ' CE3' ' HD3' ' A' ' 43' ' ' PRO . 1.4 m-90 -118.77 154.98 31.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.63 -0.714 . . . . 5.61 110.908 -176.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HA ' ' CD2' ' A' ' 40' ' ' PHE . 39.2 ptt180 -164.06 148.01 9.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.834 0.708 . . . . 9.06 109.721 -178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 1.027 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 9.4 m-20 -70.73 142.05 88.04 Favored Pre-proline 0 CA--C 1.51 -0.585 0 N-CA-C 108.986 -0.746 . . . . 8.31 108.986 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.546 ' HD3' ' CG1' ' A' ' 54' ' ' ILE . 74.6 Cg_endo -68.87 -11.82 32.86 Favored 'Trans proline' 0 C--N 1.323 -0.783 0 C-N-CA 123.142 2.562 . . . . 10.41 112.353 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 1.027 ' SD ' ' HB3' ' A' ' 32' ' ' ASP . 1.2 pmm? -102.75 1.34 34.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.708 0.289 . . . . 10.85 111.265 175.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.804 HG22 ' HB2' ' A' ' 32' ' ' ASP . 3.8 m -124.63 39.41 0.45 Allowed Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 112.627 0.603 . . . . 9.32 112.627 177.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 35' ' ' VAL . 17.2 Cg_endo -54.41 126.37 22.02 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.305 2.003 . . . . 11.1 112.334 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 115.86 -12.51 17.65 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.174 -0.771 . . . . 10.31 111.174 -175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.54 ' HG3' ' CE2' ' A' ' 40' ' ' PHE . 15.7 tp60 -90.61 108.22 19.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.323 0.583 . . . . 9.21 110.394 178.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.589 ' HA ' ' CE2' ' A' ' 29' ' ' TYR . 1.7 tmm_? -91.48 97.35 11.01 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.658 -0.701 . . . . 11.51 109.414 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 38' ' ' GLN . 78.5 m-85 -77.25 146.59 36.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 7.5 110.715 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.1 -26.68 68.94 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.255 -1.339 . . . . 10.61 111.264 -175.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 12.7 ptmm? -173.12 168.37 2.55 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.005 -0.543 . . . . 10.91 110.156 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.2 Cg_endo -52.35 169.29 0.32 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.502 2.134 . . . . 7.51 112.52 174.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 143.72 -160.01 27.65 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.855 -0.688 . . . . 7.59 111.644 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 52' ' ' PRO . 7.1 ttpm? -99.98 151.23 21.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.444 0.64 . . . . 11.68 110.627 177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.54 ' HB3' ' O ' ' A' ' 49' ' ' MET . 36.3 t -67.89 145.32 97.84 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 114.718 -1.128 . . . . 9.2 111.86 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -84.08 -19.9 4.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.783 2.322 . . . . 10.25 111.504 173.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.505 ' CD2' HG11 ' A' ' 35' ' ' VAL . 59.3 m-85 -81.45 -38.01 27.1 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.79 -1.096 . . . . 10.49 109.321 -174.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.54 ' O ' ' HB3' ' A' ' 46' ' ' SER . 1.7 pmm? -153.46 171.41 18.72 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.395 -0.82 . . . . 10.38 110.338 172.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.16 76.65 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.512 0.93 . . . . 12.54 113.512 -170.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.414 ' C ' ' HG3' ' A' ' 45' ' ' LYS . 9.6 ptm -143.9 147.12 37.08 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 107.857 -1.164 . . . . 9.87 107.857 173.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 36.6 Cg_endo -67.23 135.99 38.89 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.336 1.357 . . . . 9.51 110.12 171.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.0 mt -63.89 166.98 6.62 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.265 0.555 . . . . 6.71 112.096 -172.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.546 ' CG1' ' HD3' ' A' ' 33' ' ' PRO . 39.1 mm -101.95 130.51 24.25 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.696 -0.684 . . . . 7.89 109.65 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' HB3' ' CZ2' ' A' ' 30' ' ' TRP . 17.6 Cg_endo -83.02 134.13 6.91 Favored 'Trans proline' 0 N--CA 1.435 -1.915 0 C-N-CA 121.359 1.373 . . . . 5.77 112.21 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 57' ' ' TYR . 35.3 m -56.03 157.27 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 114.254 -1.339 . . . . 5.96 113.099 -176.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.525 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 14.48 -90.7 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.935 2.094 . . . . 7.84 115.122 -177.409 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.667 ' OE1' ' HB3' ' A' ' 61' ' ' ASN . 0.0 OUTLIER -45.68 -41.94 11.03 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 123.022 0.529 . . . . 6.62 110.747 -178.067 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.48 ' HG3' ' HG2' ' A' ' 55' ' ' PRO . 32.7 tt0 69.6 86.05 0.13 Allowed 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.669 0.606 . . . . 8.58 111.8 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.461 ' H ' HD11 ' A' ' 27' ' ' ILE . 30.1 tt0 63.99 69.72 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.827 -1.079 . . . . 7.64 111.751 164.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.667 ' HB3' ' OE1' ' A' ' 58' ' ' GLU . 13.3 t-20 -158.83 -28.07 0.07 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.417 -0.81 . . . . 7.02 112.393 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.518 ' HB2' ' OE2' ' A' ' 58' ' ' GLU . . . -39.45 -51.09 2.14 Favored 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 123.683 0.793 . . . . 5.41 110.918 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.58 -11.0 0.4 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 114.504 -1.226 . . . . 7.01 110.304 173.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 122.5 -55.79 0.67 Allowed Glycine 0 C--N 1.3 -1.462 0 N-CA-C 109.136 -1.586 . . . . 7.2 109.136 -157.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.49 -65.97 0.24 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 114.143 -1.028 . . . . 7.82 109.646 178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 176.69 29.09 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.62 -1.173 . . . . 8.65 109.248 179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 9.7 t -67.53 -74.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.327 -0.852 . . . . 7.31 109.088 -178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.634 ' HB3' ' O ' ' A' ' 67' ' ' VAL . 20.2 ptt180 162.66 148.83 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 125.058 1.343 . . . . 10.21 108.334 170.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.565 HG22 ' N ' ' A' ' 71' ' ' GLY . 41.6 mm -67.81 -55.45 16.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 C-N-CA 118.586 -1.246 . . . . 8.86 110.448 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 69' ' ' ILE . 15.9 t70 75.33 -45.62 0.56 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 125.583 1.802 . . . . 13.02 110.082 -170.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.565 ' N ' HG22 ' A' ' 69' ' ' ILE . . . -43.54 -40.18 4.84 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 113.157 -1.838 . . . . 12.13 114.059 174.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 74' ' ' THR . 2.0 ptm180 -139.26 -166.28 2.01 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.924 -0.398 . . . . 12.38 109.924 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.565 HG22 ' H ' ' A' ' 76' ' ' ASN . 7.7 p -34.77 -33.96 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 125.087 1.355 . . . . 11.61 113.87 174.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.535 ' H ' ' HG3' ' A' ' 72' ' ' ARG . 9.8 t 42.62 54.22 4.57 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.938 0.895 . . . . 10.71 112.475 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 53.25 64.58 1.8 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.929 -1.032 . . . . 14.09 111.712 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.565 ' H ' HG22 ' A' ' 73' ' ' VAL . 5.9 m-20 -125.25 95.41 4.47 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.947 -1.024 . . . . 11.22 109.511 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 77' ' ' LEU . 4.3 mm? -68.05 -17.09 64.29 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.474 -1.239 . . . . 13.71 111.658 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.44 -37.27 1.14 Allowed Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.218 -0.753 . . . . 11.44 111.218 -177.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 80.0 t 65.85 94.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.735 0.779 . . . . 9.99 111.065 176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.501 ' HB3' ' OG ' ' A' ' 150' ' ' SER . 36.5 ttt180 -93.7 139.28 31.0 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.12 -0.946 . . . . 11.64 110.344 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.561 HG22 ' HA ' ' A' ' 148' ' ' VAL . 25.9 p -125.37 137.5 54.03 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.552 -0.749 . . . . 8.0 109.949 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -110.47 128.0 55.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.247 -0.649 . . . . 6.65 109.247 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 34.3 tt0 -74.27 132.78 42.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.072 -0.714 . . . . 12.15 109.072 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.614 HG13 ' HB3' ' A' ' 95' ' ' LEU . 49.6 t -55.04 132.63 18.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.013 -0.539 . . . . 9.71 112.301 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 25.3 mmtp -138.37 148.35 44.43 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.966 -1.016 . . . . 11.03 109.284 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.1 mp -76.83 149.98 36.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.854 -0.795 . . . . 12.76 108.854 167.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.427 ' N ' HD23 ' A' ' 96' ' ' LEU . . . -167.33 41.42 0.24 Allowed Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 120.166 -1.016 . . . . 13.25 112.527 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -77.85 145.84 36.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.003 0.43 . . . . 16.35 111.387 -175.637 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 51.2 tp -155.96 87.41 1.07 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.833 -0.621 . . . . 18.22 109.426 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.66 -10.13 75.37 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 109.672 -1.371 . . . . 17.91 109.672 -172.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.561 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 41.0 p -110.99 156.85 20.65 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 107.793 -1.188 . . . . 17.11 107.793 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.451 ' HB ' ' NH1' ' A' ' 94' ' ' ARG . 13.3 m -71.82 158.2 36.5 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.487 -0.56 . . . . 14.73 109.487 175.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 88' ' ' ARG . 12.3 mt-10 -55.09 113.0 1.19 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.775 0.798 . . . . 14.94 111.635 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' HG2' HD12 ' A' ' 138' ' ' LEU . 2.1 mpp_? -132.29 169.61 16.23 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.316 -1.311 . . . . 10.57 109.5 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.619 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.4 mm? -94.19 112.69 24.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.555 -0.906 . . . . 8.88 108.555 175.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 87' ' ' GLY . 4.6 mm? -88.44 131.78 34.73 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.532 -0.758 . . . . 9.78 110.667 -175.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.462 HG23 ' HD2' ' A' ' 98' ' ' PRO . 5.6 p -147.84 147.0 25.66 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.059 -0.973 . . . . 6.4 109.089 -176.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' HG23 ' A' ' 97' ' ' VAL . 74.9 Cg_exo -54.05 130.01 37.27 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 122.407 2.071 . . . . 6.55 110.742 173.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 40.3 t -56.28 -28.07 57.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.017 0.747 . . . . 9.29 113.017 -170.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.4 9.22 13.82 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.544 -0.462 . . . . 10.86 111.504 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 148' ' ' VAL . . . -82.81 -33.7 27.15 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.156 0.503 . . . . 5.34 111.469 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.532 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.6 pp -100.63 165.08 11.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.324 0.583 . . . . 6.97 112.334 -170.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 25.3 mm -104.29 118.62 51.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.45 -0.796 . . . . 10.2 110.294 178.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 11.0 mmm180 -103.91 94.83 5.62 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.811 0.339 . . . . 12.12 110.392 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.5 t -145.59 131.16 18.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.5 0.666 . . . . 14.61 111.602 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.88 -123.38 6.16 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.106 -0.952 . . . . 15.52 111.999 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -119.92 28.18 8.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.102 0.477 . . . . 14.99 111.16 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.42 178.36 9.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.083 -0.508 . . . . 15.2 111.165 -175.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.1 m -128.58 149.99 50.39 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.937 -0.574 . . . . 9.26 110.35 -177.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 3.7 mp -126.23 153.45 34.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 110.214 -0.291 . . . . 10.55 110.214 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HB3' ' CG1' ' A' ' 123' ' ' VAL . . . -130.78 143.82 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.459 -0.2 . . . . 7.39 110.459 176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.441 ' HB3' ' HB3' ' A' ' 120' ' ' PHE . 64.1 mtm -99.4 102.88 14.6 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.539 -0.541 . . . . 8.85 109.539 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' PHE . 8.3 p -85.77 137.24 21.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 121.111 0.482 . . . . 9.69 111.451 -172.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 91.98 3.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.651 -0.704 . . . . 10.7 111.513 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -80.06 162.92 24.56 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.975 -0.557 . . . . 14.88 110.376 174.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.24 17.87 26.12 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.848 -0.614 . . . . 16.92 112.083 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -101.52 11.41 39.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.251 0.548 . . . . 18.56 110.805 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 82.28 -6.59 67.34 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.56 -0.746 . . . . 15.62 112.467 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -118.3 167.25 12.92 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.851 -0.499 . . . . 14.19 111.851 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 113' ' ' VAL . 56.5 m-85 -117.54 111.27 19.01 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.467 0.651 . . . . 12.03 109.976 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.466 ' O ' HG12 ' A' ' 113' ' ' VAL . 30.4 t70 -91.49 134.11 30.04 Favored Pre-proline 0 C--N 1.32 -0.703 0 CA-C-N 115.093 -0.958 . . . . 13.91 111.328 -171.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 61.2 Cg_endo -80.58 137.1 11.32 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.201 1.934 . . . . 12.35 113.268 -174.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.643 ' CG1' ' HB3' ' A' ' 111' ' ' ALA . 12.2 p -123.64 127.13 73.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.987 -1.006 . . . . 9.43 109.821 177.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -82.62 114.63 21.13 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.652 -0.499 . . . . 12.93 109.652 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.455 HG12 ' HA3' ' A' ' 140' ' ' GLY . 35.6 m -130.06 -179.93 3.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.671 -0.695 . . . . 8.03 111.208 -173.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.426 ' HG2' ' HB2' ' A' ' 138' ' ' LEU . 3.5 ttmp? -109.52 127.33 54.38 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 116.146 -0.479 . . . . 10.39 110.471 174.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 137' ' ' ILE . . . -143.18 112.4 6.7 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 8.3 111.457 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -153.5 72.12 0.27 Allowed Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 118.178 -1.963 . . . . 10.1 113.659 166.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.828 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.03 158.43 44.05 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.806 -0.812 . . . . 10.61 108.806 156.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 134' ' ' GLN . 22.6 m -147.13 122.22 10.12 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.344 0.592 . . . . 13.17 109.891 169.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.02 107.45 8.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.14 -0.937 . . . . 12.98 110.7 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 66.97 38.16 92.62 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.188 -0.53 . . . . 14.34 112.4 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.01 87.31 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.738 . . . . 13.12 112.584 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 130' ' ' THR . 30.2 mm-40 -106.04 154.53 20.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.286 -0.635 . . . . 10.62 109.286 178.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.468 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 10.2 p -115.25 165.97 12.36 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 120.455 -0.498 . . . . 7.82 111.229 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.828 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 49.0 mt-10 -114.35 121.11 42.63 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.442 0.639 . . . . 10.79 111.521 175.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 127' ' ' ALA . 39.4 mm -85.69 102.72 11.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.267 -0.879 . . . . 6.73 108.663 169.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.519 HD12 ' HG2' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -64.35 -51.95 60.82 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.835 -1.075 . . . . 8.79 109.766 -176.234 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -141.36 160.99 38.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.377 -0.829 . . . . 10.44 110.567 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.455 ' HA3' HG12 ' A' ' 125' ' ' VAL . . . 122.26 -64.01 0.52 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.539 -0.839 . . . . 8.87 112.975 173.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' HG ' HG11 ' A' ' 125' ' ' VAL . 30.6 mt -102.83 -177.31 3.34 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.931 0.715 . . . . 8.5 112.931 -173.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -143.98 159.65 42.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 114.865 -1.061 . . . . 14.15 110.102 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.09 129.22 39.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.245 -0.889 . . . . 12.12 110.463 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.46 -7.0 26.46 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.729 -0.948 . . . . 11.54 110.729 -171.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.529 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.4 mm100 -97.83 117.41 32.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.178 0.514 . . . . 11.24 110.303 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -86.96 127.18 35.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.551 -0.749 . . . . 10.49 111.406 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 m -125.62 140.98 46.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.898 -0.592 . . . . 5.45 110.179 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.561 ' HA ' HG22 ' A' ' 81' ' ' THR . 60.9 t -66.26 125.19 22.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 6.56 110.548 -179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.497 HG11 ' CB ' ' A' ' 82' ' ' ALA . 3.9 m -116.1 -19.3 6.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.221 0.452 . . . . 6.99 112.221 -174.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 80' ' ' ARG . 11.6 p -162.26 100.61 1.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.511 0.672 . . . . 9.06 111.584 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -97.14 -12.88 47.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.797 -0.921 . . . . 8.5 110.797 172.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 59.74 52.54 5.44 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.577 0.704 . . . . 11.84 111.088 174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -90.1 18.39 5.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.722 -0.672 . . . . 12.24 110.833 -175.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.4 tm? 68.92 -67.93 0.2 Allowed 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.732 0.813 . . . . 13.16 109.936 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 33.7 mt -98.08 75.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.229 -0.656 . . . . 11.95 109.229 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -72.87 -17.12 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.972 -0.558 . . . . 11.22 111.134 -174.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 m -66.67 -48.57 68.92 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.945 -0.702 . . . . 11.9 109.972 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -74.21 -22.03 59.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.653 -0.419 . . . . 11.17 110.589 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 162' ' ' ARG . . . -54.73 -42.18 71.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.3 0.572 . . . . 7.82 110.067 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.5 ' OG ' HD12 ' A' ' 103' ' ' ILE . 29.4 t -64.16 -30.01 71.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.238 -0.892 . . . . 9.64 111.506 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 71.3 mt -85.45 -33.46 21.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.911 -0.586 . . . . 10.57 111.345 -174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 5.8 ptm180 -77.5 161.96 27.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.907 -0.588 . . . . 8.9 110.696 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -178.53 57.15 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.344 -0.702 . . . . 7.15 111.344 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.6 p 48.33 57.15 6.5 Favored 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.082 0.553 . . . . 7.09 111.677 -176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 54.7 t 64.62 94.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 115.743 -0.662 . . . . 9.2 109.837 -175.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -71.85 -173.94 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.637 . . . . 9.11 111.816 -174.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.728 ' C ' ' HD3' ' A' ' 167' ' ' ARG . 0.4 OUTLIER 63.68 107.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.495 -0.775 . . . . 14.58 109.603 -169.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.615 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 8.2 mtm -149.58 -123.02 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.381 -0.372 . . . . 11.94 111.055 -176.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . 0.553 ' OE1' ' HB3' ' A' ' 168' ' ' MET . 0.8 OUTLIER -71.64 -61.6 1.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.566 -0.288 . . . . 14.99 110.233 -179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 56.28 47.05 19.99 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.602 -0.726 . . . . 15.01 110.278 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 21.4 p -96.37 125.22 40.72 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.642 -0.708 . . . . 14.25 111.023 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.8 t -153.06 151.7 30.52 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.072 -0.513 . . . . 14.89 110.349 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 17.8 m -134.8 28.51 3.55 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.893 -0.594 . . . . 15.85 110.353 -177.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -51.78 -53.26 30.4 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.103 -0.57 . . . . 17.54 112.637 -177.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.1 tt 67.13 100.74 0.05 OUTLIER 'General case' 0 C--O 1.236 0.359 0 O-C-N 124.103 0.531 . . . . 17.85 109.959 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 61.07 -165.21 0.22 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.297 -0.865 . . . . 19.67 110.278 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.82 78.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.722 0.773 . . . . 19.52 109.538 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 67.69 145.54 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.78 -1.1 . . . . 21.15 110.605 -174.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -74.55 118.14 17.17 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.993 -0.442 . . . . 23.25 109.873 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.522 -0.752 . . . . 23.52 110.67 -178.072 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' N ' ' A' ' 2' ' ' GLY . 13.9 tpt . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 119.092 -0.48 . . . . 34.32 109.81 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 1' ' ' MET . . . -52.56 146.38 16.63 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.607 -0.806 . . . . 33.09 112.855 177.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t 61.99 15.71 7.5 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.844 0.458 . . . . 34.12 111.859 175.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.38 21.26 2.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.753 0.311 . . . . 32.32 111.51 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.4 m -72.32 119.89 17.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.009 0.433 . . . . 32.74 110.261 179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.49 141.91 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.919 -0.582 . . . . 31.29 110.965 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -96.07 -48.33 5.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.874 -0.603 . . . . 29.46 110.264 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.454 ' O ' ' HD2' ' A' ' 10' ' ' HIS . . . -136.76 156.79 23.37 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.886 -0.673 . . . . 28.28 111.58 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.53 -56.39 1.54 Allowed 'Trans proline' 0 CA--C 1.528 0.197 0 C-N-CA 123.066 2.511 . . . . 27.51 113.163 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HD2' ' O ' ' A' ' 8' ' ' GLY . 60.3 m-70 67.1 137.58 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.218 0.532 . . . . 26.48 110.881 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.57 -23.41 60.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.323 -0.399 . . . . 24.9 111.103 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.25 130.87 1.7 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.733 -0.746 . . . . 23.19 112.34 178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -141.95 73.91 1.43 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.468 -0.567 . . . . 21.31 109.468 176.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -137.52 98.79 9.8 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.858 -0.61 . . . . 19.89 110.269 -178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.41 72.49 4.88 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.44 2.093 . . . . 18.12 111.866 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -83.4 -42.11 17.38 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.121 0.486 . . . . 16.58 110.305 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.7 -173.82 1.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.424 -0.807 . . . . 14.8 111.556 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' O ' ' HB ' ' A' ' 23' ' ' THR . . . -154.68 120.9 1.06 Allowed Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 110.864 -0.894 . . . . 13.17 110.864 -176.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 23' ' ' THR . . . -71.62 78.19 0.82 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.296 1.046 . . . . 12.17 111.563 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 34.3 tt0 -161.66 71.69 0.38 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.161 -1.836 . . . . 13.82 109.704 178.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 4.2 mm? 76.46 -43.17 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.472 -0.785 . . . . 12.13 110.984 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -64.71 -24.58 67.61 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.974 -1.012 . . . . 14.1 109.145 171.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 19' ' ' ALA . 76.8 m -165.17 150.72 9.55 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.081 -0.963 . . . . 11.05 108.737 -176.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 130.25 -104.08 0.6 Allowed Glycine 0 CA--C 1.502 -0.78 0 C-N-CA 120.333 -0.937 . . . . 10.05 112.077 173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 57' ' ' TYR . 0.0 OUTLIER -114.78 61.3 0.68 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.352 1.073 . . . . 10.38 108.201 176.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.629 ' O ' ' HE1' ' A' ' 57' ' ' TYR . 5.7 ppt_? -129.71 141.19 50.94 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-N 113.564 -1.653 . . . . 8.37 109.085 -177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 58' ' ' GLU . 22.4 mm -68.02 128.55 31.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 113.566 0.951 . . . . 5.76 113.566 -169.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 26' ' ' ARG . 4.4 mp -117.94 -47.64 2.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.991 -1.459 . . . . 8.22 110.39 174.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 14.4 p90 -155.65 -179.59 8.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.803 -0.635 . . . . 7.99 111.023 -173.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.721 ' CE2' ' HB3' ' A' ' 55' ' ' PRO . 1.6 m-90 -120.23 149.62 41.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.172 -0.922 . . . . 5.61 110.499 -175.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.63 ' HB2' HE22 ' A' ' 38' ' ' GLN . 38.9 ptt180 -148.27 146.3 28.55 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.858 -0.61 . . . . 9.06 110.08 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.738 ' HB3' HG22 ' A' ' 35' ' ' VAL . 2.3 t0 -78.57 131.45 68.08 Favored Pre-proline 0 C--N 1.314 -0.944 0 N-CA-C 109.798 -0.445 . . . . 8.31 109.798 176.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HG3' HG13 ' A' ' 54' ' ' ILE . 63.5 Cg_exo -45.11 -48.86 10.65 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.79 2.327 . . . . 10.41 111.944 -176.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.643 ' C ' ' HD3' ' A' ' 36' ' ' PRO . 1.3 pmm? -91.57 9.99 29.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.212 -1.358 . . . . 10.85 112.985 -167.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.738 HG22 ' HB3' ' A' ' 32' ' ' ASP . 6.6 m -126.32 44.92 1.32 Allowed Pre-proline 0 CA--C 1.55 0.947 0 CA-C-O 121.429 0.633 . . . . 9.32 111.562 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.643 ' HD3' ' C ' ' A' ' 34' ' ' MET . 26.0 Cg_exo -61.66 119.9 7.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.194 2.596 . . . . 11.1 113.177 -169.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 132.21 -20.5 4.46 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.467 -0.653 . . . . 10.31 111.467 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -84.09 142.56 30.31 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.049 0.452 . . . . 9.21 109.925 176.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -129.38 93.97 3.68 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 120.935 0.398 . . . . 11.51 110.606 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 23.8 m-85 -73.01 143.38 47.58 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.507 -0.769 . . . . 7.5 110.974 -176.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.14 -27.82 68.99 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.348 -1.297 . . . . 10.61 110.455 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 17.0 ptpt -166.23 162.84 12.07 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.931 -0.577 . . . . 10.91 111.218 -176.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD3' ' CE3' ' A' ' 30' ' ' TRP . 11.3 Cg_endo -51.3 169.56 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.64 2.893 . . . . 7.51 113.78 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 151.16 -171.1 30.84 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.503 -0.856 . . . . 7.59 113.028 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 50' ' ' ASP . 6.1 ttmm -88.63 143.26 27.05 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.447 -0.575 . . . . 11.68 109.447 177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' MET . 37.8 t -62.28 136.2 95.49 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.04 -0.527 . . . . 9.2 110.425 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.68 -21.06 19.51 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 C-N-CA 122.186 1.924 . . . . 10.25 110.904 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -84.94 -41.23 16.1 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.878 -1.51 . . . . 10.49 109.485 -175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.497 ' HB3' ' HG3' ' A' ' 51' ' ' MET . 3.1 mtm -133.72 153.51 51.64 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 115.36 -0.836 . . . . 10.38 111.27 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 4.7 p-10 -80.63 59.28 3.53 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 122.084 0.945 . . . . 12.54 111.168 176.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.497 ' HG3' ' HB3' ' A' ' 49' ' ' MET . 0.2 OUTLIER -136.33 143.25 42.76 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 114.899 -1.046 . . . . 9.87 109.356 176.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 24.9 Cg_endo -63.93 133.41 38.6 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.0 1.8 . . . . 9.51 111.158 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 23.8 mt -61.97 163.76 7.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.134 -0.485 . . . . 6.71 110.62 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' HG3' ' A' ' 33' ' ' PRO . 44.2 mm -105.27 129.39 24.84 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-O 121.375 0.607 . . . . 7.89 109.956 -177.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.721 ' HB3' ' CE2' ' A' ' 30' ' ' TRP . 60.3 Cg_endo -73.83 140.14 28.56 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 121.818 1.678 . . . . 5.77 112.189 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.43 156.51 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.395 -1.275 . . . . 5.96 112.791 -175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.629 ' HE1' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 16.73 -78.21 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.945 2.098 . . . . 7.84 115.553 -176.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.578 ' HG2' HG12 ' A' ' 27' ' ' ILE . 3.2 pt-20 -58.83 -34.0 71.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.378 1.561 . . . . 6.62 110.54 -173.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 68.26 63.71 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 111.022 -2.808 . . . . 8.58 111.705 168.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.411 ' H ' HD11 ' A' ' 27' ' ' ILE . 36.8 tt0 54.78 79.04 0.15 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.932 -1.486 . . . . 7.64 110.354 -171.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -117.27 -43.52 2.83 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 109.36 -0.607 . . . . 7.02 109.36 174.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' ASP . . . 63.36 -62.24 0.14 Allowed 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 113.51 -1.677 . . . . 5.41 110.801 -171.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.461 ' O ' ' HB ' ' A' ' 67' ' ' VAL . 5.6 t70 179.79 115.9 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 124.087 0.867 . . . . 7.01 109.632 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.68 7.12 79.38 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-N 115.429 -0.805 . . . . 7.2 112.702 163.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 67.49 9.78 7.28 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 124.653 0.854 . . . . 7.82 112.212 177.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.8 -35.13 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.31 0.576 . . . . 8.65 109.956 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 164' ' ' THR . 40.5 t -54.75 -50.3 61.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 114.683 -1.144 . . . . 7.31 110.961 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 67' ' ' VAL . 12.1 ptm180 59.01 177.56 0.07 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 126.182 1.793 . . . . 10.21 112.309 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.566 HG22 ' H ' ' A' ' 71' ' ' GLY . 10.7 mt -40.27 146.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 114.301 -1.318 . . . . 8.86 112.984 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -77.76 -39.85 42.85 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 114.521 -1.218 . . . . 13.02 109.098 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.566 ' H ' HG22 ' A' ' 69' ' ' ILE . . . -50.96 -40.07 42.01 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 112.698 -2.046 . . . . 12.13 112.637 172.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 72' ' ' ARG . 19.0 ptp180 -142.07 107.01 4.91 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.999 0.905 . . . . 12.38 110.358 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 74' ' ' THR . 19.1 t -108.35 157.5 8.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.772 -1.104 . . . . 11.61 111.7 -168.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.452 ' N ' HG12 ' A' ' 73' ' ' VAL . 7.8 t 37.38 74.23 0.08 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.576 1.151 . . . . 10.71 113.103 172.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -93.16 39.25 1.04 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 122.88 1.324 . . . . 14.09 108.052 173.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 78' ' ' GLY . 19.4 t-20 -156.89 107.04 2.29 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.976 -1.92 . . . . 11.22 109.02 -174.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mp -74.56 18.25 0.17 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.288 -1.324 . . . . 13.71 110.962 -175.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 76' ' ' ASN . . . 90.29 -51.27 3.38 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.973 -1.251 . . . . 11.44 109.973 -173.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.57 HG11 ' CE1' ' A' ' 120' ' ' PHE . 49.1 t 53.16 89.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.418 0.628 . . . . 9.99 112.268 167.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 150' ' ' SER . 6.4 mpt_? -84.59 121.4 27.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.82 -0.627 . . . . 11.64 109.746 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 148' ' ' VAL . 40.6 p -132.39 154.15 50.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.471 -0.786 . . . . 8.0 111.046 -172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' CB ' HG11 ' A' ' 149' ' ' VAL . . . -122.4 127.28 49.51 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.468 -0.938 . . . . 6.65 108.468 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 42.1 tt0 -76.59 133.26 39.71 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.624 -0.51 . . . . 12.15 109.624 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 145' ' ' GLN . 48.0 t -53.32 130.62 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.524 -0.762 . . . . 9.71 112.755 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 50.0 mmtt -134.89 142.8 46.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-N 114.856 -1.065 . . . . 11.03 109.925 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.47 HD23 ' HG2' ' A' ' 93' ' ' GLU . 6.8 mp -75.53 158.32 32.7 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.504 -0.554 . . . . 12.76 109.504 171.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.71 41.38 0.05 OUTLIER Glycine 0 CA--C 1.505 -0.571 0 C-N-CA 120.426 -0.893 . . . . 13.25 112.653 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 92' ' ' THR . 0.2 OUTLIER -77.42 -178.03 4.99 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 112.329 0.492 . . . . 16.35 112.329 -176.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 1.7 pt? -133.84 109.06 8.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.54 0.686 . . . . 18.22 109.803 171.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.94 -169.52 20.34 Favored Glycine 0 C--N 1.321 -0.297 0 CA-C-N 115.33 -0.85 . . . . 17.91 111.013 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.8 p -90.16 74.24 7.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 122.365 1.079 . . . . 17.11 109.358 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.658 ' O ' ' HG3' ' A' ' 88' ' ' ARG . 3.9 m -156.5 169.11 25.39 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.07 -1.826 . . . . 14.73 106.07 177.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HG2' HD23 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -138.65 119.04 13.73 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 119.035 0.834 . . . . 14.94 111.494 170.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' CD ' ' HA ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -123.01 158.57 30.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.775 -1.102 . . . . 10.57 109.959 -176.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.626 ' HB2' ' HB ' ' A' ' 137' ' ' ILE . 2.3 mm? -98.37 122.08 41.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.152 0.501 . . . . 8.88 109.894 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -95.25 134.33 38.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.073 -0.512 . . . . 9.78 110.606 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 98' ' ' PRO . 3.8 p -150.07 147.99 23.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 6.4 109.052 -175.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 97' ' ' VAL . 51.4 Cg_exo -56.22 130.65 41.29 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.271 1.98 . . . . 6.55 110.212 173.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.494 ' HA ' ' OG ' ' A' ' 135' ' ' SER . 19.0 t -57.41 -27.08 62.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.465 0.543 . . . . 9.29 112.465 -170.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.36 3.97 33.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.046 -0.409 . . . . 10.86 111.547 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.61 ' HB2' HG12 ' A' ' 149' ' ' VAL . . . -77.93 -41.24 36.98 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.196 0.522 . . . . 5.34 110.91 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 109' ' ' THR . 3.8 pp -86.17 158.88 19.66 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.728 -0.669 . . . . 6.97 111.898 -174.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 110' ' ' ILE . 1.7 mp -101.61 126.35 55.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.327 -0.851 . . . . 10.2 108.826 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 11.6 mmm180 -101.13 128.41 47.22 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 119.519 -0.872 . . . . 12.12 111.027 173.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -149.32 129.17 13.35 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.285 -0.87 . . . . 14.61 110.516 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 53.76 -109.3 1.05 Allowed Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 116.008 -0.542 . . . . 15.52 112.957 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -118.62 17.24 13.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.619 0.247 . . . . 14.99 111.35 -177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -135.14 177.34 7.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.181 0.515 . . . . 15.2 111.745 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 102' ' ' LEU . 24.7 m -129.2 144.71 51.31 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.851 -0.613 . . . . 9.26 109.377 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 103' ' ' ILE . 28.8 mm -126.56 153.04 34.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.375 -0.602 . . . . 10.55 109.375 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 122' ' ' PRO . . . -134.68 132.47 38.94 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.394 -0.191 . . . . 7.39 111.088 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 49.7 ttp -94.55 105.57 17.53 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.176 -0.675 . . . . 8.85 109.176 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 121' ' ' ASP . 7.1 p -88.26 134.01 29.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.89 -1.05 . . . . 9.69 112.423 -169.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HA ' ' CD1' ' A' ' 120' ' ' PHE . . . -83.3 92.47 7.51 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.187 -0.915 . . . . 10.7 110.108 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -86.5 149.96 24.6 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.057 -0.52 . . . . 14.88 111.332 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.05 0.15 74.12 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.156 -0.778 . . . . 16.92 111.156 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -77.27 -1.57 30.36 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.344 0.593 . . . . 18.56 110.887 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 97.89 -8.55 63.46 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.153 -0.93 . . . . 15.62 113.021 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -129.03 159.4 22.26 Favored Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 120.289 -0.958 . . . . 14.19 112.303 -174.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CE1' HG11 ' A' ' 79' ' ' VAL . 88.8 m-85 -109.53 121.23 44.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.377 -0.601 . . . . 12.03 109.377 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 113' ' ' VAL . 3.6 m-20 -122.29 151.58 59.36 Favored Pre-proline 0 CA--C 1.514 -0.421 0 C-N-CA 120.555 -0.458 . . . . 13.91 111.471 -174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' ALA . 84.1 Cg_endo -88.77 136.27 3.09 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.417 2.078 . . . . 12.35 112.433 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -123.63 138.31 53.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.331 -0.85 . . . . 9.43 109.179 176.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -78.6 130.9 36.44 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.854 -0.424 . . . . 12.93 109.854 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.748 HG21 HD12 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -140.98 158.36 23.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.818 -0.628 . . . . 8.03 111.157 -175.232 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 139' ' ' GLU . 24.5 ttmm -100.2 128.61 46.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.632 -0.713 . . . . 10.39 109.89 174.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.438 ' CB ' HD22 ' A' ' 102' ' ' LEU . . . -140.84 105.62 4.93 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.478 -0.328 . . . . 8.3 111.638 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 138' ' ' LEU . . . -153.0 72.38 0.27 Allowed Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 118.441 -1.838 . . . . 10.1 113.938 169.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 136' ' ' GLU . . . -148.92 162.69 39.35 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.402 -0.962 . . . . 10.61 108.402 154.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 19.4 m -139.72 132.59 29.24 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.672 -0.411 . . . . 13.17 110.001 174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -140.22 99.89 3.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.066 -0.516 . . . . 12.98 111.443 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 67.8 40.03 89.74 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.09 -0.576 . . . . 14.34 112.43 176.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 81.22 1.83 90.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.031 -0.604 . . . . 13.12 112.195 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -108.13 164.0 12.67 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.037 -1.097 . . . . 10.62 108.037 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.494 ' OG ' ' HA ' ' A' ' 99' ' ' SER . 21.0 p -117.05 162.1 18.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.152 -0.619 . . . . 7.82 111.108 -176.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 1.019 ' HB2' ' HB3' ' A' ' 129' ' ' ALA . 36.6 mt-10 -112.99 123.94 51.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.616 0.722 . . . . 10.79 111.277 176.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.748 HD12 HG21 ' A' ' 125' ' ' VAL . 24.4 mm -88.11 107.43 17.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.878 -1.056 . . . . 6.73 109.323 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 128' ' ' GLY . 2.9 mp -72.68 -49.9 28.46 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.011 -0.995 . . . . 8.79 109.85 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.498 ' O ' HG23 ' A' ' 125' ' ' VAL . 46.6 mt-10 -142.11 166.76 23.83 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 109.008 -0.738 . . . . 10.44 109.008 -179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.538 ' HA3' ' HB ' ' A' ' 125' ' ' VAL . . . 114.29 -51.97 0.68 Allowed Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 119.395 -1.383 . . . . 8.87 113.885 174.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -114.64 -174.92 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 8.5 112.744 -172.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.404 ' O ' ' HB ' ' A' ' 84' ' ' VAL . 40.7 ttmt -151.25 157.09 42.13 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.374 -0.83 . . . . 14.15 109.523 -175.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.64 126.71 30.54 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 12.12 109.95 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.85 -7.09 29.48 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.996 -0.842 . . . . 11.54 110.996 -170.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 84' ' ' VAL . 29.0 mm-40 -95.5 112.92 24.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.209 -0.664 . . . . 11.24 109.209 178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.448 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 28.5 mt-30 -85.95 123.65 31.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.028 -0.533 . . . . 10.49 110.502 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.55 139.8 44.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.864 -0.607 . . . . 5.45 110.323 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 101' ' ' ALA . 18.6 m -66.24 120.61 13.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.805 -0.634 . . . . 6.56 111.478 -177.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.61 HG12 ' HB2' ' A' ' 101' ' ' ALA . 2.8 m -108.5 -1.28 9.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.478 0.656 . . . . 6.99 109.889 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 80' ' ' ARG . 36.2 t -174.13 115.15 0.2 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.547 -1.206 . . . . 9.06 108.833 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -61.34 -50.51 66.12 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.665 -0.779 . . . . 8.5 111.405 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -161.44 137.7 8.19 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 122.487 0.315 . . . . 11.84 110.19 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -88.24 -31.36 19.08 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.967 -0.753 . . . . 12.24 108.967 173.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.435 HD22 ' N ' ' A' ' 154' ' ' LEU . 1.1 mm? -97.42 -161.29 0.86 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.858 -1.064 . . . . 13.16 108.768 177.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . . . . . . . . . 10.4 mm -95.86 -128.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.701 -0.851 . . . . 11.95 108.701 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.99 30.01 0.46 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.289 0.566 . . . . 11.22 110.005 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 5.2 m -72.5 -18.97 61.62 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.676 -0.693 . . . . 11.9 111.813 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -44.1 77.79 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.397 -0.921 . . . . 11.17 109.358 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.37 -28.47 66.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.307 -0.86 . . . . 7.82 110.832 177.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.3 m -70.01 -61.98 1.57 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.829 0.823 . . . . 9.64 109.65 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 57.4 mt -60.2 -31.66 70.36 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 113.74 -1.573 . . . . 10.57 112.256 -166.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -82.52 -39.23 22.67 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 124.753 1.283 . . . . 8.9 110.032 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 52.26 60.35 7.82 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.105 -0.952 . . . . 7.15 113.015 178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 67' ' ' VAL . 32.8 p 50.63 -91.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.986 0.914 . . . . 7.09 112.435 -172.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.1 p -72.41 95.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.831 . . . . 9.2 112.08 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -153.16 102.46 2.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 9.11 110.269 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.751 ' O ' ' HG3' ' A' ' 168' ' ' MET . 4.0 tmt_? -94.61 93.72 7.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.879 -0.415 . . . . 14.58 109.879 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.751 ' HG3' ' O ' ' A' ' 167' ' ' ARG . 9.8 mtm -169.78 142.51 2.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.212 -0.904 . . . . 11.94 109.874 -179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -93.46 -160.75 0.78 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.283 0.563 . . . . 14.99 109.865 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 61.18 31.4 19.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 114.6 -1.182 . . . . 15.01 112.491 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 23.3 p -76.38 63.37 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.327 0.584 . . . . 14.25 110.882 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.8 m -74.35 -60.57 2.21 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.786 -0.643 . . . . 14.89 110.878 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.3 t 53.29 53.22 12.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.424 0.631 . . . . 15.85 110.336 -177.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -103.46 21.55 38.83 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.833 -0.698 . . . . 17.54 112.046 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 175' ' ' LEU . 2.7 pt? -68.43 152.05 45.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.61 0.243 . . . . 17.85 110.626 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -168.94 98.31 0.37 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.996 -0.547 . . . . 19.67 109.892 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 12.5 p -105.18 -11.52 9.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.182 0.515 . . . . 19.52 110.4 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 91.3 mt 71.39 -168.31 0.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.476 -0.784 . . . . 21.15 110.887 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -78.33 -37.18 45.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.764 0.283 . . . . 23.25 111.764 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.346 -0.835 . . . . 23.52 110.657 -177.188 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ' AG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_